HP_MULTICYSTIC_KIDNEY_DYSPLASIA 6.35 6.32 6.87 6.56 6.46 6.7 6.51 6.39 6.57 6.73 6.56 6.65 6.54 6.58 6.43 6.79 6.47 6.61 6.54 6.63 6.65 6.5 6.63 6.59 6.48 6.65
HP_RECURRENT_URINARY_TRACT_INFECTIONS 5.99 5.95 6 6.31 5.91 5.99 6.11 6.12 6.08 6.05 5.94 5.94 5.94 5.98 6 6.12 5.91 6.04 5.9 6.11 5.92 5.96 6.14 6.08 5.96 5.87
HP_NEUROGENIC_BLADDER 7.69 7.97 8.31 8.17 8.31 8.41 8.15 8.1 8.18 8.26 8.05 7.97 7.95 8.16 7.77 7.46 7.36 7.54 8.31 8.35 7.56 7.77 8.19 8.16 7.94 8.04
HP_URINARY_URGENCY 7.48 7.49 7.14 7.61 7.79 7.82 7.57 7.58 7.53 7.57 7.41 7.61 7.63 7.69 7.52 7.46 7.48 7.38 7.65 7.87 7.4 7.74 7.51 7.69 7.52 7.39
HP_HYPOPLASIA_OF_THE_UTERUS 5.54 5.31 5.79 5.87 5.47 4.94 5.21 5.6 5.35 5.49 5.59 5.34 5.26 5.1 5.81 5.33 5.66 5.42 5.6 5.44 5.7 5.38 5.08 4.86 5.05 5.36
HP_ABNORMALITY_OF_THE_BLADDER 7.03 6.93 7.11 7.01 7.14 7.17 7.31 7.2 7.25 7.31 7.02 7.19 7.26 7.27 7.26 7.23 7.06 6.88 7.18 7.26 7.16 7.21 7.39 7.38 7.26 7.26
HP_BLADDER_DIVERTICULUM 6.2 5.95 5.71 6.38 5.94 5.89 5.92 5.98 5.82 5.76 6.22 5.88 5.85 6.2 5.97 5.97 5.87 6.13 5.89 6.12 6.49 6.01 6.11 5.85 5.98 6.22
HP_URINARY_RETENTION 5.9 5.8 5.89 6.08 5.77 5.97 5.75 5.69 6.19 5.78 5.82 5.62 5.86 5.71 5.2 5.7 5.94 5.8 5.96 5.64 6.13 5.99 6.26 5.51 5.79 5.96
HP_URINARY_INCONTINENCE 7.3 7.49 7.53 7.46 7.83 7.79 7.77 7.62 7.84 7.88 7.49 7.79 7.88 7.93 7.69 7.74 7.58 7.46 7.6 7.98 7.5 7.78 7.92 8.23 7.87 7.57
HP_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA 5.66 5.94 5.96 6.11 5.6 5.79 5.93 6.01 6.07 5.93 5.81 5.87 5.88 5.59 5.91 5.84 5.74 5.44 5.76 5.82 6.05 5.94 6.2 6.03 5.59 5.89
HP_INGUINAL_HERNIA 6.63 6.71 6.8 6.7 6.89 6.9 6.93 6.95 6.79 6.87 6.64 6.85 6.82 6.84 6.9 6.81 6.83 6.69 6.74 6.83 7 7.05 7 6.98 6.92 7.01
HP_FUNCTIONAL_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA 5.52 5.41 5.33 5.48 5.19 5.14 5.38 5.34 5.29 5.56 5.41 5.36 5.42 5.23 5.5 5.4 5.49 5.62 5.48 5.29 5.5 5.38 5.28 5.11 5.14 5.35
HP_MALE_HYPOGONADISM 5.6 5.41 5.81 5.99 5.67 5.45 5.85 5.7 5.97 5.75 5.95 5.77 5.66 5.47 5.79 5.49 5.83 5.63 5.54 5.71 5.92 5.68 5.48 5.38 5.7 6.04
HP_CRYPTORCHIDISM 6.64 6.72 6.83 6.8 6.87 7 6.78 6.91 6.91 6.89 6.85 6.9 7.03 6.95 6.89 6.86 6.71 6.72 6.81 6.92 6.77 6.87 7.02 7.01 6.87 6.89
HP_TESTICULAR_ATROPHY 5.04 4.86 5.09 4.87 4.84 5.11 5.44 5.36 5.38 4.88 4.91 4.96 5.21 5.17 5.03 4.81 5.07 5.15 4.91 5.14 5.2 4.69 4.99 5.04 5.04 4.82
HP_AMBIGUOUS_GENITALIA_MALE 5.29 5.42 5.66 5.69 5.37 5.17 5.64 5.75 5.54 5.41 5.46 5.45 5.45 5.45 5.42 5.56 5.56 5.67 5.27 5.4 5.73 5.76 5.25 5.18 5.55 5.69
HP_HYDROCELE_TESTIS 6.98 6.84 6.6 6.55 6.96 6.88 6.97 6.77 7.04 7.1 6.73 7.04 7.14 6.89 6.99 7.05 7.14 6.67 7.12 6.87 6.6 6.73 6.8 7.21 7 6.7
HP_ABNORMAL_TESTIS_MORPHOLOGY 6.45 6.5 6.6 6.57 6.59 6.66 6.52 6.59 6.64 6.69 6.56 6.61 6.7 6.66 6.62 6.59 6.5 6.47 6.59 6.57 6.58 6.62 6.79 6.77 6.63 6.62
HP_ABNORMAL_PENIS_MORPHOLOGY 6.44 6.5 6.66 6.68 6.65 6.66 6.6 6.61 6.66 6.72 6.61 6.65 6.72 6.67 6.64 6.66 6.55 6.55 6.57 6.7 6.54 6.58 6.75 6.81 6.63 6.61
HP_MALE_PSEUDOHERMAPHRODITISM 5.4 5.53 5.55 5.63 5.43 5.12 5.46 5.41 5.39 5.26 5.34 5.2 5.17 5.21 5.26 5.42 5.41 5.44 5 5.29 5.24 5.35 5.13 5.11 5.18 5.42
HP_EPISPADIAS 5.81 6.2 6.45 6.07 5.73 5.43 6.29 5.56 6.13 5.39 6.06 5.39 5.68 6.13 5.72 5.43 6.01 6.02 5.84 5.9 6.03 5.86 5.58 5.78 6.22 5.73
HP_LONG_PENIS 6.56 6.62 7.54 7.59 6.63 6.79 7.18 7.43 6.99 7.11 7.36 6.94 6.88 6.66 7.61 7.52 6.78 6.6 6.76 7.17 7.32 7.35 7.64 7.71 7.12 7.46
HP_CHORDEE 8.47 8.5 8.64 8.79 8.59 8.54 8.82 8.62 8.93 8.63 8.86 8.37 8.69 8.82 8.87 9 8.5 8.42 9.06 8.69 8.49 8.51 8.64 8.95 8.78 8.67
HP_HYPOGONADOTROPIC_HYPOGONADISM 6.09 5.95 6.34 6.19 6.12 6.08 6.28 6.19 6.33 6.3 6.26 6.24 6.29 6.35 6.36 6.3 6.16 6.26 6.02 6.36 6.16 6.31 6.23 6.23 6.15 6.32
HP_ABNORMALITY_OF_THE_SCROTUM 6.51 6.57 6.91 6.68 6.88 6.76 6.83 7 6.91 6.98 6.71 6.85 6.88 6.86 6.88 6.93 6.67 6.66 6.66 6.99 6.9 6.86 6.82 6.88 6.92 7.08
HP_SCROTAL_HYPOPLASIA 6.51 6.59 7.03 6.74 6.88 6.76 6.83 6.92 6.89 6.98 6.85 6.9 6.93 7.03 6.88 7.05 6.66 6.74 6.82 6.99 6.9 7.09 6.82 6.88 6.79 7.08
HP_BIFID_SCROTUM 5.8 6.04 5.78 5.83 5.81 5.22 5.46 5.76 6.04 5.77 5.88 5.41 5.83 5.73 5.72 5.46 5.61 5.55 5.74 5.68 5.36 5.63 5.73 5.78 5.47 5.4
HP_SHAWL_SCROTUM 6.27 6.57 7.15 6.87 6.34 6.59 6.36 7.28 7.17 6.72 6.46 6.59 6.88 6.82 7.18 7 6.81 6.93 6.43 6.8 6.84 6.98 6.82 7.09 6.92 6.81
HP_MACROORCHIDISM 7.83 7.62 7.45 7.3 8.48 8.23 8.36 8.27 8.54 8.38 7.81 8.38 8.18 8.29 8.5 8.26 7.93 7.48 7.85 8.14 7.95 8.24 8.73 8.72 8.42 8.35
HP_MICROPENIS 6.59 6.64 6.75 6.87 6.91 7.01 6.83 6.91 6.9 6.95 6.7 6.91 7.09 7.02 6.91 6.67 6.83 6.76 6.94 6.96 6.75 6.76 6.97 7.13 6.8 6.73
HP_ABNORMALITY_OF_FEMALE_EXTERNAL_GENITALIA 6.52 6.55 6.65 6.78 6.74 6.79 6.65 6.64 6.47 6.95 6.5 6.65 6.84 6.81 6.7 6.48 6.5 6.48 6.72 6.74 6.52 6.5 6.72 6.81 6.48 6.55
HP_ABNORMALITY_OF_THE_CLITORIS 6.54 6.56 6.95 6.87 6.81 6.97 6.81 6.46 6.68 7.01 6.78 6.86 6.87 6.88 6.42 6.49 6.38 6.66 6.9 6.93 6.67 6.56 6.82 6.81 6.76 6.65
HP_ABNORMAL_LABIA_MORPHOLOGY 6.1 6.29 6.21 6.3 6.13 6.19 6.24 6.1 6.14 6.44 6.17 6.35 6.25 6.27 6.16 6.14 6.32 6.21 6.34 6.05 6.2 6.06 6.05 6.26 6.17 6.28
HP_HYPOPLASTIC_LABIA_MAJORA 6.19 6.35 6.62 6.69 6.62 6.65 6.68 6.74 6.59 7.22 6.61 6.69 6.85 6.76 6.91 6.42 6.54 6.64 6.68 6.39 6.63 6.6 6.75 7.02 6.63 6.95
HP_CLITORAL_HYPOPLASIA 5.57 5.75 6.1 5.87 5.42 5.31 5.74 5.53 5.42 5.16 5.86 5.33 5.24 5.19 5.62 5.35 5.52 5.23 5.22 5.35 5.59 5.47 5.47 5.41 5.43 5.11
HP_AMBIGUOUS_GENITALIA 5.7 5.77 5.85 6.13 5.67 5.75 5.85 5.79 5.78 5.87 5.97 5.77 5.71 5.93 5.91 5.98 5.8 5.88 5.82 5.81 6.11 6.05 5.85 5.83 5.84 5.87
HP_HYPOPLASTIC_LABIA_MINORA 5.98 6.2 6.28 6.06 5.84 5.67 6.34 5.98 6.14 5.96 6 5.9 6.07 6.28 6.03 5.97 6.02 6.43 6.34 6.01 6.21 6.16 5.83 6.16 6.41 6.21
HP_URETHRAL_ATRESIA 5.65 5.77 5.81 5.94 5.55 5.95 5.7 5.83 5.44 5.91 5.89 5.79 5.79 5.62 6.19 5.72 5.67 5.81 5.77 5.76 5.93 6.05 5.77 5.97 5.95 5.89
HP_ABNORMALITY_OF_THE_URETER 6.51 6.55 6.56 6.57 6.66 6.7 6.62 6.7 6.67 6.66 6.49 6.75 6.65 6.59 6.62 6.6 6.55 6.51 6.52 6.66 6.62 6.67 6.83 6.82 6.62 6.66
HP_URETEROCELE 6.61 6.9 7.1 6.75 6.71 7.12 7.07 6.63 6.73 7.14 6.55 7.14 7.01 7.05 6.94 6.9 7.13 6.9 6.52 7 7.55 7.21 7.05 7.18 7.11 6.94
HP_URETERAL_STENOSIS 6.72 6.72 6.41 6.4 6.68 6.85 6.65 7.08 6.58 6.76 6.05 6.59 6.82 6.71 7.08 6.6 6.19 6.47 6.74 6.64 6.59 6.61 6.42 6.85 6.61 6.89
HP_HYDROURETER 5.95 5.76 5.71 5.77 5.9 6.06 6.01 5.88 6.14 6.09 5.48 5.92 6.02 6.06 5.97 5.69 5.82 6.03 5.9 6.14 5.85 5.8 6.43 6.11 6.01 5.8
HP_URETERAL_DUPLICATION 6.47 6.36 6.6 6.56 6.55 6.59 6.4 6.39 6.32 6.76 6.55 6.67 6.36 6.49 6.48 6.54 6.47 6.66 6.38 6.18 6.6 6.42 6.46 6.55 6.74 6.51
HP_URETEROPELVIC_JUNCTION_OBSTRUCTION 6.65 6.63 6.13 6.35 6.62 6.81 6.5 6.84 6.45 6.72 5.97 6.43 6.52 6.54 6.56 6.34 6.17 6.36 6.74 6.47 6.42 6.27 6.31 6.63 6.44 6.6
HP_RENAL_DUPLICATION 6.22 6.5 6.99 6.7 6.08 6.07 6.26 6.42 6.32 6.39 6.66 6.13 6.2 6.4 6.36 6.43 6.1 6.48 6.52 6.4 6.94 6.11 6.31 6.06 6.19 6.59
HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY 6.06 6 6.17 6.2 6 6.07 6.08 6.13 6.02 6.13 6.16 6.03 6.05 6.09 6.08 6.22 5.99 6.06 6.02 6.14 6.11 6.09 6.04 6.08 6.08 6.23
HP_DUPLICATED_COLLECTING_SYSTEM 5.89 5.5 5.19 5.84 5.79 5.39 5.37 5.18 5.5 5.66 5.64 5.29 5.44 5.47 5.37 5.13 5.63 5.37 5.62 5.44 5.42 5.48 5.15 5.32 5.49 5.77
HP_RENAL_INSUFFICIENCY 6.16 6.24 6.01 6.21 5.95 5.97 6.15 6.14 5.94 6.15 6.08 6.08 5.94 5.96 6.02 5.97 6.13 6.11 6.04 6.13 6.11 6.07 5.94 5.98 5.99 6.14
HP_HORSESHOE_KIDNEY 6.29 6.11 6.11 6.45 6.4 6.03 6.06 6.24 6.23 6.19 6.37 6.24 6.41 6.22 6.22 6.39 6.11 6.3 6.12 5.96 6.06 6.23 6.43 6.35 6.07 6.28
HP_ECTOPIC_KIDNEY 6.91 6.9 7.1 7.06 7.17 7 7.08 7.23 6.7 6.71 6.95 7.25 6.82 7.03 6.86 7 6.83 6.75 7.31 7.32 7.08 7.12 7.03 7.26 6.85 6.97
HP_RENAL_HYPOPLASIA 6.51 6.68 6.39 6.43 6.76 6.58 6.55 6.63 6.66 6.6 6.5 6.74 6.51 6.53 6.39 6.63 6.53 6.56 6.58 6.53 6.69 6.47 6.61 6.62 6.61 6.66
HP_NEPHRONOPHTHISIS 6.63 6.56 6.34 6.61 6.61 6.54 6.13 6.31 6.03 6.47 6.35 6.57 6.2 6.16 6.24 6.53 6.25 6.69 6.72 6.34 6.19 6.32 6.3 6.36 6.2 6.52
HP_ABNORMAL_RENAL_TUBULE_MORPHOLOGY 6.25 6.44 6.32 6.33 6.12 6.04 6.14 6.28 5.98 6.27 6.21 6.32 6.02 5.97 5.98 6.15 6.13 6.22 6.29 6.15 6.22 6.06 6.13 6.08 6.11 6.28
HP_RENAL_TUBULAR_ATROPHY 6.21 6.29 6.24 6.26 5.75 5.64 5.89 6.19 5.75 6.07 6.16 6.34 5.85 5.91 5.97 6.22 6.15 6.22 5.92 5.97 6.17 6.14 5.71 5.82 6.15 6.37
HP_ABNORMAL_RENAL_GLOMERULUS_MORPHOLOGY 6.48 6.35 6.41 6.2 6.37 6.48 6.29 6.2 6.22 6.33 6.12 6.28 6.38 6.27 6.25 6.29 6.28 6.27 6.39 6.38 6.21 6.11 6.35 6.36 6.42 6.46
HP_GLOMERULAR_SCLEROSIS 6.62 6.73 6.63 6.5 6.71 6.6 6.8 6.86 6.73 7 6.5 6.81 6.73 6.61 6.67 6.85 6.75 6.81 6.55 6.86 6.65 6.7 7.04 6.74 6.82 6.66
HP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS 6.14 6.09 6.05 5.95 6.22 5.96 6.22 6.14 6.14 6.33 5.86 6.28 6.15 5.95 6.13 6.2 6.06 5.74 5.94 6.28 5.97 5.88 6.28 6.33 6.15 6.3
HP_TALL_STATURE 6.6 6.58 6.66 6.61 6.84 6.78 6.74 6.83 6.91 6.76 6.65 6.9 6.82 6.74 6.77 6.69 6.8 6.65 6.74 6.83 6.9 6.92 7 6.98 6.85 7
HP_GLOMERULONEPHRITIS 5.93 5.9 6.17 6.5 5.89 5.85 5.92 5.67 5.87 5.73 5.86 5.78 6.03 5.93 5.62 5.76 5.67 5.71 5.82 5.44 5.9 5.99 5.84 5.82 5.8 6.3
HP_NEPHROTIC_SYNDROME 6.11 6.1 6.05 6.06 6.02 6.02 6.21 6.12 5.95 6.16 6 6.27 6.12 5.93 6.12 6.22 5.9 6.12 6.17 6.04 6.12 6.14 6.05 6.14 6.08 6.15
HP_POLYURIA 5.47 5.33 5.18 5.55 4.89 4.87 5.16 5.03 5.35 4.89 5.21 5 4.95 5.01 5.08 5.06 5.41 5.26 5.02 5.07 5.39 4.99 4.99 4.72 5.04 4.92
HP_RENAL_AGENESIS 6.27 6.15 6.17 6.27 6.32 6.33 6.17 6.4 6.27 6.3 6.32 6.15 6.42 6.29 6.28 6.19 6.24 6.29 6.19 6.22 6.44 6.32 6.29 6.37 6.2 6.23
HP_ENLARGED_KIDNEY 5.82 5.82 5.73 6.02 5.83 5.83 5.9 6.14 5.76 5.8 5.77 5.76 5.86 5.74 5.83 5.73 5.94 5.76 5.64 6.1 5.75 5.91 5.8 5.91 5.78 5.86
HP_RENAL_CYST 6.51 6.57 6.78 6.68 6.71 6.87 6.65 6.71 6.68 6.83 6.54 6.72 6.77 6.71 6.77 6.81 6.62 6.66 6.72 6.86 6.76 6.84 6.7 6.8 6.69 6.75
HP_RENAL_DYSPLASIA 6.97 6.92 7.16 6.89 7.03 7.05 7.18 7 7.08 7.3 6.84 7.1 7.13 6.98 6.97 7.21 7.14 6.88 6.88 7.09 7.47 7.26 7.1 7.13 6.92 7.21
HP_NEPHROPATHY 5.87 5.81 5.95 6.03 5.67 5.53 5.81 5.65 5.65 5.87 5.79 5.74 5.74 5.5 5.82 5.71 5.65 5.74 5.76 5.64 5.91 6.07 5.64 5.64 5.69 5.89
HP_POLYCYSTIC_KIDNEY_DYSPLASIA 6.44 6.55 6.55 6.53 6.57 6.61 6.44 6.52 6.53 6.43 6.45 6.58 6.51 6.56 6.5 6.68 6.51 6.71 6.48 6.56 6.71 6.6 6.32 6.43 6.7 6.68
HP_PROXIMAL_TUBULOPATHY 7.27 7.03 8.14 7.57 7.36 7.47 7.51 7.57 7.77 7.61 7.57 7.45 7.46 7.39 7.26 7.61 7.08 7.26 7.52 7.61 7.77 7.8 7.75 7.75 7.74 7.57
HP_RENAL_PHOSPHATE_WASTING 5.6 5.46 4.89 5.64 5.06 4.89 5.02 4.84 5.13 5.3 5.06 4.9 4.78 5.11 4.99 5.04 5.34 5.19 5.04 4.89 5.27 5.21 5.23 4.66 5.02 4.8
HP_NEPHROCALCINOSIS 6.16 6.01 5.81 6.08 5.77 5.67 6.03 6.07 5.76 5.79 6.23 5.67 5.74 5.72 5.93 5.65 5.87 6.09 5.87 5.79 5.95 5.88 5.77 5.34 5.81 5.89
HP_UNILATERAL_RENAL_AGENESIS 6.54 6.7 6.63 6.77 7.03 6.92 6.95 6.86 6.79 6.78 6.84 6.71 6.84 7.03 6.81 6.63 6.73 6.51 6.58 6.83 6.6 6.62 7 6.71 6.81 6.67
HP_NEPHRITIS 6.01 6.22 5.85 6.18 5.84 5.74 6.06 5.82 6.05 5.78 5.87 5.78 5.46 5.7 5.77 5.74 5.67 5.89 6.05 5.57 5.92 5.99 5.83 5.48 5.8 6.02
HP_RENAL_TUBULAR_DYSFUNCTION 6.52 6.59 6.72 6.46 6.59 6.75 6.55 6.77 6.6 6.61 6.37 6.61 6.64 6.66 6.42 6.69 6.43 6.53 6.5 6.72 6.67 6.85 6.6 6.5 6.57 6.6
HP_PELVIC_KIDNEY 7.24 6.9 7.11 7.13 7.41 7.16 6.98 7.28 6.7 6.71 6.99 7.37 7.09 7.29 7.34 7 6.83 6.99 7.61 7.37 7.15 7.12 7.07 7.26 7.08 6.86
HP_RENAL_SALT_WASTING 4.75 4.76 4.65 5.06 4.41 4.31 4.57 4.64 4.55 4.35 4.67 4.5 4.36 4.31 4.56 4.3 4.64 4.93 4.51 4.41 4.79 4.56 4.42 4.2 4.33 4.36
HP_ABNORMALITY_OF_THE_UTERUS 6.32 6.24 6.39 6.35 6.21 6.31 6.35 6.58 6.49 6.27 6.26 6.41 6.41 6.48 6.31 6.38 6.14 6.21 6.25 6.25 6.25 6.35 6.38 6.55 6.22 6.34
HP_MENORRHAGIA 5.73 5.52 5.69 5.48 5.27 5.12 5.42 5.11 5.33 5.28 5.65 4.94 5.33 5.28 5.23 5.21 5.38 5.37 5.22 4.98 5.73 5.59 5.38 5.34 5.83 5.59
HP_GONADAL_DYSGENESIS 5.74 5.8 5.92 6.15 5.51 5.54 5.73 5.79 5.69 5.75 5.67 5.63 5.81 5.58 5.73 5.72 5.84 5.84 5.44 5.75 5.81 5.91 5.75 5.76 5.94 5.97
HP_FEMALE_HYPOGONADISM 5.76 5.39 5.95 5.72 5.41 5.12 5.81 5.69 5.83 5.61 5.85 5.59 5.6 5.44 5.99 5.45 5.73 5.94 5.62 5.63 5.91 5.63 5.45 5.06 5.65 5.85
HP_HYPOGONADISM 6.22 6.29 6.47 6.42 6.34 6.45 6.35 6.41 6.43 6.42 6.39 6.41 6.43 6.39 6.37 6.46 6.29 6.28 6.34 6.36 6.25 6.34 6.54 6.49 6.25 6.41
HP_ABNORMALITY_OF_THE_OVARY 6.34 6.41 6.47 6.49 6.43 6.5 6.33 6.42 6.33 6.53 6.44 6.39 6.4 6.44 6.33 6.44 6.22 6.4 6.4 6.4 6.24 6.42 6.38 6.51 6.23 6.44
HP_OVARIAN_CYST 6.3 6.54 6.6 6.63 6.13 6.33 6.59 6.45 6.55 6.62 6.39 6.23 6.44 6.42 6.43 6.44 6.16 6.43 6.4 6.39 6.43 6.44 6.43 6.66 6.33 6.64
HP_ABNORMALITY_OF_THE_MENSTRUAL_CYCLE 5.94 5.9 6.27 6.15 5.87 5.88 5.95 6.07 5.85 5.93 6.03 5.89 5.89 5.95 6.02 5.95 5.98 5.9 5.92 6.02 6.05 6.05 5.79 5.79 6.1 6.14
HP_AMENORRHEA 5.93 5.7 6.29 6.16 5.8 5.75 5.95 6.02 5.85 5.96 6.03 5.89 5.89 5.94 6.02 5.96 5.92 5.92 5.97 6.02 6 5.98 5.7 5.75 5.99 5.98
HP_ABNORMAL_VAGINA_MORPHOLOGY 5.79 5.75 5.94 6.13 5.82 5.66 6 5.95 5.84 5.88 5.98 6.02 5.88 5.59 6.02 5.88 5.78 5.92 5.88 5.71 6.08 5.97 5.97 5.73 5.86 5.96
HP_DECREASED_FERTILITY 5.5 5.44 5.34 5.54 5.13 5.18 5.3 5.33 5.26 5.35 5.34 5.28 5.32 5.16 5.35 5.39 5.39 5.52 5.29 5.19 5.53 5.35 5.13 5.1 5.12 5.31
HP_VAGINAL_ATRESIA 5.74 5.65 6.09 5.86 5.16 5.61 5.65 5.62 5.56 5.98 5.76 5.62 5.99 5.36 6.29 5.95 5.27 5.56 5.7 5.46 5.66 5.74 6.13 6.1 6.24 6.08
HP_OVARIAN_GONADOBLASTOMA 5.3 5.15 5.48 5.85 4.93 4.63 5.26 5.25 5.28 5.12 5.16 5.08 5.33 4.99 5.21 4.9 5.17 5.66 4.77 4.98 5.25 5.07 4.79 4.99 4.97 5.3
HP_GONADOBLASTOMA 5.55 5.55 5.48 5.71 4.95 5.09 5.74 5.59 5.3 5.12 5.45 5.14 5.33 5.03 5.36 5.27 5.33 5.56 4.96 4.98 5.29 5.1 5.01 5.09 5.06 5.39
HP_APLASIA_OF_THE_UTERUS 7 6.72 6.55 6.51 6.48 6.7 6.83 6.91 6.57 6.85 6.96 6.6 6.79 6.57 6.43 6.86 6.53 6.66 7 7.08 6.56 6.4 6.6 6.42 6.87 6.69
HP_WIDE_MOUTH 7.52 7.75 7.54 7.48 8.09 7.97 8.05 8.06 7.98 8.07 7.68 8 7.99 8.08 7.78 7.83 7.8 7.79 7.61 8.01 7.81 7.82 7.95 8.21 7.91 7.91
HP_ORAL_ULCER 5.59 5.36 5.86 5.88 5.42 5.26 5.54 5.47 5.36 5.51 5.83 5.2 5.56 5.68 5.47 5.48 5.7 5.44 5.18 5.5 5.71 5.9 5.47 5.32 5.63 5.56
HP_ABNORMALITY_OF_THE_TONGUE 6.48 6.58 6.69 6.7 6.73 6.8 6.73 6.63 6.69 6.82 6.62 6.81 6.76 6.7 6.69 6.7 6.73 6.57 6.79 6.68 6.69 6.67 6.82 6.81 6.72 6.69
HP_MACROGLOSSIA 6.31 6.62 6.88 6.78 6.75 6.7 6.82 6.77 6.7 6.86 6.55 6.77 6.79 6.75 6.83 6.74 6.76 6.45 6.67 6.74 6.91 6.8 6.84 6.81 6.82 6.77
HP_ABNORMAL_LIP_MORPHOLOGY 6.89 6.91 7.04 6.97 7.08 7.19 7.16 7.16 7.17 7.15 6.99 7.15 7.27 7.19 7.18 7.07 6.99 6.97 7.1 7.23 7.1 7.18 7.17 7.35 7.2 7.22
HP_NARROW_MOUTH 6.82 6.92 6.99 6.87 6.91 6.93 6.77 6.93 6.95 7.06 6.62 7.07 6.97 6.95 6.88 6.77 6.89 6.76 6.95 7.09 6.76 6.83 7.12 7.18 7.08 7.04
HP_MEDIAN_CLEFT_LIP 5.72 5.65 5.94 6.22 5.6 5.34 5.73 5.56 5.62 5.72 5.92 5.49 5.72 5.86 5.57 5.8 5.86 5.95 5.92 5.71 5.98 5.66 5.67 5.66 5.73 5.59
HP_GLOSSOPTOSIS 6.39 6.42 6.48 6.57 6.59 6.52 6.14 6.16 6.54 6.67 6.51 6.81 6.42 6.71 6.08 6.41 6.6 6.31 6.65 6.33 6.59 6.28 6.69 6.38 6.25 6.3
HP_ABNORMALITY_OF_THE_DENTITION 6.62 6.65 6.75 6.65 6.79 6.91 6.75 6.86 6.79 6.85 6.69 6.81 6.86 6.82 6.83 6.74 6.7 6.68 6.71 6.85 6.69 6.84 6.83 6.98 6.83 6.81
HP_ABNORMALITY_OF_THE_GINGIVA 6.47 6.65 6.63 6.55 6.75 6.67 6.51 6.77 6.66 6.66 6.44 6.6 6.74 6.66 6.56 6.64 6.6 6.47 6.56 6.53 6.85 6.76 6.77 6.69 6.78 6.88
HP_GINGIVAL_FIBROMATOSIS 7.23 7.33 7.1 7.22 7.49 7.78 7.67 7.6 7.44 7.31 7.38 8.07 7.82 8.06 7.47 7.37 7.8 7.83 7.54 7.84 7.88 7.81 7.88 7.71 7.55 7.48
HP_MICROGLOSSIA 6.51 6.22 6.55 6.89 6.57 6.42 6.13 6.24 6.26 6.44 6.72 6.46 6.27 6.56 6.08 6.59 6.75 6.4 6.82 6.4 6.56 6.75 6.89 6.5 6.46 6.6
HP_ABNORMALITY_OF_THE_UVULA 6.2 6.36 6.44 6.56 6.52 6.43 6.34 6.41 6.43 6.55 6.53 6.4 6.56 6.42 6.39 6.56 6.45 6.29 6.31 6.44 6.49 6.39 6.51 6.63 6.43 6.4
HP_ABNORMAL_PALATE_MORPHOLOGY 6.61 6.66 6.83 6.78 6.86 6.93 6.79 6.88 6.83 6.9 6.73 6.83 6.88 6.86 6.85 6.76 6.8 6.77 6.79 6.87 6.79 6.85 6.92 6.91 6.87 6.84
HP_ABNORMALITY_OF_UPPER_LIP 6.98 7.09 7.13 7.01 7.14 7.28 7.28 7.27 7.36 7.31 7.08 7.37 7.41 7.37 7.31 7.23 7.17 7.07 7.23 7.33 7.15 7.32 7.31 7.46 7.34 7.29
HP_ABNORMALITY_OF_LOWER_LIP 7.09 7.14 7.26 7.13 7.32 7.49 7.2 7.31 7.3 7.36 7.18 7.34 7.45 7.44 7.37 7.36 7.14 7.05 7.42 7.4 7.16 7.33 7.42 7.6 7.3 7.24
HP_THICK_LOWER_LIP_VERMILION 7.31 7.53 7.74 7.22 7.51 7.8 7.73 7.78 7.9 7.88 7.54 7.82 7.93 8.03 7.82 7.78 7.46 7.33 7.61 7.93 7.39 7.57 8.21 8.2 7.89 7.5
HP_LOBULATED_TONGUE 5.82 6.4 6.27 6.38 6.17 6.31 6.37 6.43 6.04 6.27 6.52 6.04 6.15 6.45 6.22 6.69 6.29 6.75 6.06 6.03 6.55 6.41 6.2 6.13 6.62 6.08
HP_CLEFT_SOFT_PALATE 6.68 6.59 6.84 6.79 6.85 6.87 6.63 6.72 6.7 6.78 6.75 6.72 6.73 6.6 6.63 6.67 6.71 6.76 6.66 6.63 6.93 6.8 6.73 6.73 6.86 6.73
HP_BROAD_ALVEOLAR_RIDGES 6.66 6.83 6.82 6.83 6.45 6.98 7.2 7.25 6.87 6.89 6.59 6.68 7.34 7 7.09 6.81 6.55 6.67 7.02 7.41 6.66 7.12 6.79 6.98 7.09 7.03
HP_NARROW_PALATE 7.08 7.14 7.12 6.94 7.31 7.37 7.25 7.27 7.29 7.34 7.1 7.34 7.39 7.39 7.27 7.25 7.19 7.09 7.38 7.38 7.14 7.42 7.52 7.49 7.23 7.29
HP_ABNORMAL_ORAL_FRENULUM_MORPHOLOGY 5.82 6.29 6.18 6.53 5.92 5.8 6.29 6.32 6.09 6.17 6.32 6.07 6.27 6.06 6.04 6.08 6.04 5.97 6.19 6.05 6.21 6.11 6.05 6.13 6.24 6.21
HP_ACCESSORY_ORAL_FRENULUM 6.32 6.62 6.76 6.6 6.65 6.55 6.52 6.89 6.57 6.49 6.94 6.73 6.71 6.68 6.97 7.03 6.68 6.72 6.73 6.84 6.42 7.18 6.92 6.78 6.79 7.1
HP_BIFID_UVULA 6.68 6.68 6.84 6.89 6.88 6.92 6.64 6.74 6.73 6.85 6.75 6.78 6.73 6.67 6.63 6.67 6.74 6.77 6.59 6.66 6.93 6.89 6.89 6.77 7.04 6.93
HP_OPEN_MOUTH 7.83 7.83 7.88 7.77 8.1 8.16 8.11 8.14 8.13 7.97 7.73 8.07 8.19 8.18 8.13 8.09 7.79 7.88 8.05 8.13 7.74 8.05 7.98 8.41 8.3 8.09
HP_ABNORMAL_PAROTID_GLAND_MORPHOLOGY 6.1 5.99 5.52 5.78 5.72 5.31 6.03 6.88 6.11 5.95 5.6 5.03 6.12 6.34 5.74 5.7 6.24 6.21 6.39 6.26 6.16 5.5 5.63 5.25 4.69 5.43
HP_TONGUE_NODULES 6.3 6.48 6.25 6.22 6.6 6.47 6.23 6.05 6.04 6.28 6.5 6.57 6.34 6.54 6.06 6.22 6.43 6.65 6.57 6.14 6.55 6.53 6.17 6.2 6.34 6.36
HP_PIERRE_ROBIN_SEQUENCE 6.99 7.1 7.41 6.98 7.5 7.65 7.57 7.51 7.87 7.95 7.33 7.61 7.95 7.83 7.86 7.75 7.25 7.45 7.63 7.83 7.43 7.34 8.12 7.95 7.72 7.86
HP_ORAL_CLEFT 6.35 6.37 6.44 6.5 6.46 6.5 6.46 6.4 6.42 6.53 6.42 6.47 6.5 6.52 6.43 6.52 6.49 6.41 6.4 6.43 6.4 6.39 6.45 6.46 6.46 6.51
HP_CLEFT_UPPER_LIP 6.02 6.15 6.09 6.19 5.95 6.02 6.06 6.21 6.06 6.09 6.1 6.11 6.15 6.08 6.14 6.19 6.15 6.06 6.08 6.14 6.29 6.19 6.14 6.06 6.13 6.23
HP_TRIANGULAR_MOUTH 5.92 5.82 5.82 6.23 6.12 6 6.17 6.28 6 5.91 5.92 5.95 6.25 6.07 5.73 5.97 6.25 5.75 5.74 5.84 5.91 6.09 5.96 6.15 6.33 6.46
HP_TRISMUS 8.18 8.04 8.26 7.47 7.89 7.98 7.95 7.76 7.51 7.42 7.52 7.91 7.87 8.11 7.94 8.09 7.43 7.86 8.51 8.41 8.5 8.5 7.59 7.33 7.92 7.58
HP_GINGIVAL_OVERGROWTH 6.95 6.88 7.1 7.12 7.13 7.05 6.97 7.25 6.91 7.05 7.12 7.08 7.24 7.1 7.11 7.04 7.08 6.95 7.27 7.03 7.08 6.92 7.15 7.34 7.09 7.25
HP_THICK_UPPER_LIP_VERMILION 6.81 6.89 6.55 6.88 7 6.7 6.62 6.91 6.75 6.88 6.59 6.71 6.98 7.12 6.55 6.59 6.84 6.93 6.79 6.83 6.86 6.42 7.14 7.08 6.87 6.69
HP_XEROSTOMIA 7.17 7.37 7.59 7.76 7.8 7.57 7.92 7.49 7.58 7.63 7.38 7.86 7.62 7.23 7.41 7.82 7.66 7.22 7.6 7.87 7.5 7.96 7.62 8.02 7.35 7.28
HP_HIGH_PALATE 6.86 6.92 7.15 7.04 7.1 7.32 7.15 7.14 7.19 7.24 7.11 7.23 7.24 7.26 7.17 7.17 7.13 7.03 7.1 7.22 7.1 7.13 7.26 7.29 7.2 7.16
HP_THIN_UPPER_LIP_VERMILION 7.54 7.76 7.74 7.52 7.91 7.88 8.09 8 7.97 8.03 7.62 8.01 8 8.09 7.9 7.89 7.7 7.64 7.76 7.99 7.67 7.79 8.04 8.23 7.94 7.82
HP_VELOPHARYNGEAL_INSUFFICIENCY 6.03 6.14 5.81 6.49 6.2 6.32 6.35 6.39 6.03 6.28 5.91 6.48 6.15 6.27 5.86 6.03 6.19 6.15 6.44 5.95 6.08 5.94 6.26 6.25 6.37 6.58
HP_FURROWED_TONGUE 6.3 6.59 7.02 7.19 6.65 6.81 6.58 6.46 6.69 7.12 6.86 6.81 6.74 7 6.8 7.21 6.69 6.99 6.69 6.7 6.81 6.71 6.98 7.16 6.86 6.56
HP_GINGIVAL_BLEEDING 5.9 5.83 6.18 5.83 5.87 5.65 5.68 5.6 5.78 5.54 6 5.64 5.64 5.65 5.68 5.58 6.08 5.89 5.47 5.57 6.11 6.05 5.77 5.52 6.12 6.19
HP_GINGIVITIS 6.09 5.86 6.5 6.44 5.98 6.08 6.1 6.19 6.27 6.13 5.91 5.94 6.06 5.84 6.12 6.03 6.1 6.02 6.01 6.29 6.39 6.23 6.39 6.3 6.64 6.98
HP_THIN_VERMILION_BORDER 7.32 7.56 7.67 7.43 7.67 7.67 7.8 7.75 7.84 7.85 7.41 7.82 7.9 7.92 7.79 7.77 7.54 7.48 7.64 7.92 7.56 7.71 7.86 7.98 7.87 7.73
HP_ABNORMALITY_OF_THE_FONTANELLES_OR_CRANIAL_SUTURES 6.53 6.55 6.63 6.64 6.79 6.83 6.66 6.78 6.66 6.69 6.55 6.66 6.78 6.67 6.68 6.68 6.59 6.55 6.63 6.73 6.55 6.72 6.73 6.83 6.7 6.75
HP_ABNORMALITY_OF_THE_ANTERIOR_FONTANELLE 6.54 6.56 6.98 6.74 7.13 7.16 6.79 6.87 6.87 6.89 6.82 6.88 6.82 7.03 6.88 6.95 6.63 6.69 6.82 6.99 6.81 6.93 6.89 6.92 6.75 6.72
HP_HYDROCEPHALUS 6.51 6.48 6.68 6.57 6.69 6.74 6.62 6.58 6.6 6.74 6.61 6.62 6.65 6.66 6.63 6.75 6.49 6.57 6.5 6.56 6.61 6.62 6.6 6.73 6.7 6.66
HP_TRIGONOCEPHALY 7.93 8.2 7.7 7.64 8.04 8.21 8.08 8.19 7.87 8.41 7.35 7.9 7.93 8.02 8.03 7.84 7.89 7.76 8.02 8.18 7.92 7.96 7.71 8.03 8.14 8.2
HP_ABNORMAL_PARANASAL_SINUS_MORPHOLOGY 5.9 5.69 5.89 5.83 5.79 5.62 5.79 5.67 5.79 5.9 5.73 5.68 5.64 5.66 5.67 5.96 5.94 5.98 5.72 5.69 5.85 5.77 5.7 5.47 5.74 5.87
HP_BRACHYCEPHALY 7.1 7.31 7.4 7.1 7.28 7.44 7.61 7.46 7.48 7.36 7.15 7.53 7.39 7.37 7.38 7.24 7.27 7.13 7.35 7.51 7.27 7.39 7.45 7.63 7.33 7.4
HP_PROGRESSIVE_MICROCEPHALY 7.61 7.78 8.01 7.6 7.76 8.05 7.83 7.87 8.03 7.77 7.86 7.81 7.99 7.9 7.92 7.6 7.71 7.39 7.71 7.83 7.45 7.91 7.94 8.24 7.9 7.99
HP_WIDE_ANTERIOR_FONTANEL 6.56 6.58 7.1 6.74 7.17 7.17 6.94 6.87 6.89 6.98 6.82 6.91 7.16 7.12 6.89 7.1 6.55 6.8 6.82 7.03 6.84 7 7.14 7.08 6.81 7.16
HP_TURRICEPHALY 6.56 6.73 7.08 6.59 6.81 6.96 6.96 6.86 6.95 6.81 6.73 6.79 6.97 6.99 6.84 6.89 6.93 6.97 6.77 6.81 6.86 6.88 7.23 7.13 7.08 6.94
HP_CRANIAL_ASYMMETRY 7.35 7.24 7.86 8.02 7.62 7.64 7.54 7.36 7.96 7.85 7.38 7.88 7.76 7.53 8.01 8.01 8.03 7.42 7.4 7.67 7.07 7.11 8.37 8.06 7.81 7.88
HP_DOLICHOCEPHALY 6.59 6.72 6.79 6.59 6.77 6.92 6.74 6.78 6.79 6.91 6.85 6.85 6.82 6.76 6.82 6.77 6.69 6.68 6.76 6.92 6.81 6.91 6.82 6.92 6.92 6.87
HP_PROMINENT_OCCIPUT 6.52 6.45 6.38 6.49 6.56 6.74 6.63 6.53 6.54 6.35 6.54 6.6 6.38 6.57 6.68 6.65 6.53 6.5 6.52 6.7 6.51 6.67 6.59 6.57 6.64 6.56
HP_DELAYED_CRANIAL_SUTURE_CLOSURE 7.2 7.16 7.3 7.43 7.5 7.77 7.69 7.93 7.46 7.82 7.28 7.68 7.77 7.79 7.62 7.57 7.65 7.44 7.31 7.68 7.56 7.65 7.66 7.85 7.52 7.43
HP_SMALL_FACE 6.53 6.54 6.65 6.74 6.84 6.85 6.64 6.76 6.63 6.85 6.66 6.59 6.81 6.68 6.86 6.66 6.63 6.48 6.67 6.68 6.74 6.63 6.81 6.98 6.83 6.85
HP_RETROGNATHIA 6.61 6.7 6.87 6.89 6.86 6.96 6.95 6.92 6.86 6.92 6.82 7.01 6.84 6.84 6.85 6.69 6.88 6.73 6.92 6.94 6.75 6.81 7 6.99 6.91 6.87
HP_COARSE_FACIAL_FEATURES 7.12 6.96 7.05 7.01 6.98 7.24 7.17 7.1 7.13 7.21 6.89 7 7.22 7.04 7.2 7 6.95 6.94 6.95 7.37 6.94 7.01 7.15 7.31 7.12 7.09
HP_FACIAL_EDEMA 6.58 6.73 6.89 6.68 6.37 6.5 6.63 6.9 6.59 6.7 6.9 6.65 6.67 6.84 6.56 6.75 6.79 6.6 6.78 6.63 6.96 6.84 6.63 6.98 6.84 6.73
HP_BROAD_FACE 7.17 7.09 6.99 6.67 7.12 7.26 6.78 7.12 7.05 7.06 7.86 7.98 7.42 7.42 7.15 6.97 7.67 6.92 7.39 6.88 7.15 7.38 7.51 7.09 7.35 7.74
HP_EPICANTHUS 6.92 6.91 7.15 7.03 7.04 7.19 7.04 7.15 7.14 7.14 7 7.12 7.22 7.22 7.19 7.13 7.08 6.98 7.11 7.16 7.13 7.15 7.12 7.28 7.19 7.22
HP_ABNORMALITY_OF_THE_PHILTRUM 7.25 7.38 7.43 7.3 7.46 7.64 7.64 7.54 7.61 7.59 7.29 7.66 7.72 7.72 7.66 7.67 7.46 7.34 7.48 7.61 7.38 7.58 7.65 7.81 7.66 7.48
HP_BROAD_PHILTRUM 7.13 7.09 7.15 7.11 6.88 7.18 7.11 7.39 7.15 6.82 6.53 6.81 6.88 6.82 7.22 6.94 6.81 7.33 6.73 7.25 6.93 7.07 6.81 7.19 7.28 7.09
HP_ABNORMALITY_OF_THE_FOREHEAD 7 7.04 7.16 7.04 7.23 7.32 7.2 7.2 7.19 7.29 7.1 7.23 7.34 7.34 7.22 7.2 7.03 7.05 7.23 7.32 7.15 7.19 7.24 7.37 7.21 7.24
HP_FULL_CHEEKS 6.96 7.14 7.23 7.27 7.11 7.27 7.2 7.06 7.19 7.31 7.19 7.19 7.21 7.13 7.4 7.35 6.92 7.04 7.27 7.22 7.19 7.36 7.29 7.32 7.29 7.29
HP_LOW_ANTERIOR_HAIRLINE 7.43 7.62 7.61 7.22 7.82 7.93 7.71 7.56 7.68 7.85 7.47 7.68 7.67 7.69 7.63 7.63 7.71 7.35 7.57 7.82 7.43 7.58 7.89 7.86 7.7 7.58
HP_FACIAL_HYPOTONIA 7.43 7.62 7.13 7.44 7.46 7.67 7.84 7.68 7.63 7.96 7.52 7.86 7.72 7.79 7.46 7.63 7.44 7.43 7.6 7.74 7.75 7.65 7.82 7.85 7.94 7.74
HP_MASK_LIKE_FACIES 7.32 7.15 7.21 7.45 7.65 7.84 7.55 7.46 7.51 7.3 7.18 7.46 7.66 7.67 7.32 7.16 7.41 7.33 7.59 7.55 7.23 7.32 7.67 7.67 7.5 7.36
HP_OVAL_FACE 7.55 7.59 7.99 8.1 7.64 7.56 8.29 8.37 7.97 7.79 7.66 7.75 7.78 7.89 8.01 7.98 7.73 7.68 7.89 8.25 7.89 8.26 8.06 8.12 7.56 7.54
HP_ABNORMALITY_OF_FACIAL_MUSCULATURE 6.91 6.92 6.99 6.86 7.07 7.2 7.07 7.02 7.05 7.12 6.85 7.13 7.11 7.05 7.17 7.03 7.14 6.96 7.17 7.23 7.05 7.07 7.16 7.12 7.21 7.13
HP_MANDIBULAR_PROGNATHIA 6.72 6.87 6.83 6.79 6.96 6.97 6.94 7.19 6.99 6.91 6.61 6.92 7.01 6.86 6.99 6.93 6.79 6.78 6.79 7.02 7.02 7.11 6.96 7.09 7.18 7.27
HP_ABNORMALITY_OF_THE_CHIN 7.15 7.15 7.16 7.01 7.34 7.42 7.38 7.44 7.26 7.43 7.13 7.44 7.48 7.43 7.42 7.37 7.19 7.23 7.33 7.51 7.33 7.51 7.31 7.38 7.49 7.44
HP_POINTED_CHIN 7.48 7.58 7.53 7.65 8.01 7.82 7.86 8.04 8.13 8.12 7.62 8.07 8.13 8.09 8.08 7.86 7.83 7.83 7.83 8.1 7.86 7.86 8.2 8.18 8.09 7.85
HP_MICRORETROGNATHIA 6.45 6.42 6.61 6.73 6.4 6.76 6.55 6.54 6.54 6.72 6.39 6.37 6.65 6.54 6.54 6.29 6.5 6.44 6.77 6.49 6.14 6.38 6.6 6.64 6.84 6.52
HP_ABNORMALITY_OF_THE_MIDFACE 6.74 6.75 6.98 6.84 7.02 7.09 6.97 7.03 7.01 7.14 6.9 7.01 7.1 7.05 6.98 7.05 6.9 6.85 6.98 7.05 7.01 7.08 7.18 7.18 7.07 7.08
HP_ROUND_FACE 7.08 7.03 6.82 6.87 7.07 7.19 7.06 7.11 7.06 7.24 6.84 7.16 7.13 7.03 7.05 7.07 7.12 7 7.09 7.15 6.97 7.08 7.09 7.22 7.19 7.27
HP_HYPERTELORISM 6.79 6.84 7.03 6.88 7.02 7.06 6.9 7 6.96 7.08 6.93 6.99 7.05 7.02 6.98 7.01 6.91 6.93 7.02 6.99 6.97 6.99 7.11 7.13 7.05 7.06
HP_SMOOTH_PHILTRUM 7.55 7.63 7.72 7.7 8 8.05 8.11 7.96 8.08 8.1 7.57 8.08 8.07 8.06 7.93 7.86 7.93 7.73 7.77 8.05 7.74 8.02 8.14 8.26 8.15 7.86
HP_BIRD_LIKE_FACIES 6.68 6.79 6.53 6.67 6.72 6.67 6.55 6.73 6.59 6.82 6.56 6.7 6.68 6.69 6.6 6.5 6.59 6.72 6.51 6.79 6.41 6.24 6.66 7.18 6.56 6.73
HP_SHORT_PHILTRUM 7.14 7.09 7.1 7.06 7.39 7.43 7.26 7.39 7.33 7.38 6.96 7.35 7.44 7.41 7.42 7.48 7.27 7.13 7.27 7.36 7.25 7.43 7.31 7.42 7.46 7.48
HP_FACIAL_ASYMMETRY 6.56 6.52 6.72 6.7 7.03 7.02 6.58 6.71 7.12 6.99 6.77 6.82 7.04 6.93 6.68 6.74 6.68 6.46 6.77 6.72 6.63 6.68 6.97 6.95 6.86 6.73
HP_TRIANGULAR_FACE 6.86 6.89 7.38 7.03 7.21 7.16 7.35 7.28 7.32 7.33 7.23 7.33 7.23 7.33 7.44 7.27 7.1 7.12 7.08 7.23 7.3 7.35 7.35 7.42 7.17 7.35
HP_ABNORMALITY_OF_THE_MAXILLA 6.54 6.53 6.68 6.45 6.85 6.91 6.59 6.55 6.85 6.66 6.67 6.77 6.74 6.69 6.39 6.66 6.7 6.87 6.44 6.59 6.72 6.48 6.8 6.81 6.84 6.8
HP_FACIAL_HEMANGIOMA 6.1 6.05 5.89 5.97 5.56 5.68 5.94 6.28 5.73 5.66 5.59 5.99 5.95 5.98 5.93 5.75 5.98 5.99 5.81 6.09 6.16 6.43 5.9 6.07 6.11 6.09
HP_SHORT_CHIN 7.48 7.48 7.53 7.45 7.93 8.02 7.77 7.89 7.78 7.95 7.58 7.77 7.95 7.94 7.82 7.68 7.64 7.6 7.47 7.91 7.61 7.8 7.89 8.05 7.89 7.8
HP_PROMINENT_SUPRAORBITAL_RIDGES 7.11 6.69 7.61 7.12 7.1 7.13 7.47 7.05 7.28 7.49 7.12 7.08 7.29 7.47 7.06 6.98 7.5 6.89 7.04 7.23 7.23 7.09 8 7.57 7.22 7.04
HP_BROAD_FOREHEAD 6.81 6.88 6.8 7 6.96 6.95 6.87 7.12 7 7.17 6.92 7 6.97 6.94 7.27 7.08 6.84 6.88 7.02 7.18 7.09 7.07 7.1 7.23 7.02 7.12
HP_HYPOMIMIC_FACE 7.52 7.83 7.33 7.31 7.99 8.19 7.86 7.67 7.81 8.08 7.35 8 7.97 7.99 7.95 7.91 7.51 7.62 8.07 8.21 7.62 7.89 7.88 8.01 7.9 7.66
HP_SLOPING_FOREHEAD 6.39 6.37 6.33 6.42 6.46 6.61 6.46 6.48 6.33 6.48 6.27 6.46 6.54 6.49 6.48 6.32 6.31 6.31 6.35 6.44 6.46 6.4 6.42 6.55 6.36 6.33
HP_NARROW_FOREHEAD 7.39 7.54 7.66 7.68 7.6 7.66 7.61 7.69 7.71 7.58 7.4 7.6 7.73 7.71 7.62 7.76 7.45 7.45 7.39 7.61 7.4 7.75 7.74 7.81 7.75 7.61
HP_LONG_PHILTRUM 7.23 7.37 7.48 7.31 7.49 7.62 7.64 7.57 7.68 7.69 7.3 7.63 7.78 7.73 7.67 7.74 7.45 7.33 7.46 7.61 7.37 7.56 7.75 7.88 7.53 7.45
HP_HIGH_FOREHEAD 7.64 7.68 7.99 7.86 8.05 8.06 8.04 7.95 8.01 8.06 7.77 8.05 8.16 8.23 8.02 8.04 7.84 7.77 7.91 8 7.79 7.83 8.16 8.25 8.01 7.85
HP_WIDOW_S_PEAK 6.63 6.76 6.8 6.71 7.15 7.25 6.57 6.97 7.02 7.06 6.07 7.08 6.64 6.57 7.09 6.87 6.65 6.71 6.49 6.86 6.51 6.61 6.72 6.81 6.79 6.67
HP_ABNORMALITY_OF_THE_OUTER_EAR 6.78 6.83 7.05 6.93 7.02 7.12 7 7.02 7.04 7.07 6.94 7.01 7.13 7.06 7.07 7.02 6.87 6.87 7.01 7.08 6.93 7.07 7.06 7.2 7.06 7.09
HP_ABNORMAL_LOCATION_OF_EARS 6.87 6.9 7.16 7.04 7.12 7.25 7.15 7.19 7.14 7.24 7.06 7.19 7.22 7.24 7.26 7.19 6.99 7.01 7.18 7.21 7.08 7.24 7.19 7.33 7.23 7.22
HP_POSTERIORLY_ROTATED_EARS 6.99 6.95 7.16 7.1 7.15 7.32 7.16 7.18 7.18 7.24 7.1 7.27 7.27 7.27 7.3 7.32 7.01 7.04 7.25 7.22 7.08 7.23 7.23 7.37 7.18 7.21
HP_ABNORMALITY_OF_THE_INNER_EAR 6.4 6.44 6.67 6.6 6.59 6.66 6.52 6.59 6.66 6.69 6.55 6.6 6.65 6.67 6.55 6.61 6.53 6.52 6.48 6.59 6.53 6.66 6.73 6.74 6.68 6.63
HP_TINNITUS 7.12 7.19 6.81 6.79 7.32 7.44 7.09 7.25 7.09 7.32 7.33 7.27 7.16 7.27 7.31 7.27 7.14 7.27 7.2 7.36 7 7.21 7.29 7.34 7.38 7.31
HP_ABNORMALITY_OF_EARLOBE 6.86 7.07 7.15 7.02 7.02 7.44 7.26 7.2 7.63 7.46 7.21 7.46 7.74 7.49 7.58 7.32 7.21 7.34 7.09 7.42 7.18 7.33 7.86 7.85 7.4 7.28
HP_LOW_SET_POSTERIORLY_ROTATED_EARS 6.95 6.95 7.23 7.17 7.15 7.33 7.15 7.14 7.21 7.24 6.99 7.23 7.21 7.26 7.34 7.32 6.94 6.99 7.27 7.22 7.06 7.16 7.23 7.45 7.18 7.2
HP_ABNORMALITY_OF_THE_MIDDLE_EAR 6.21 6.2 6.09 6.21 6.21 6.23 6.23 6.24 6.15 6.31 6.25 6.16 6.37 6.37 6.18 6.27 6.19 6.2 6.23 6.2 6.21 6.21 6.24 6.19 6.26 6.37
HP_ABNORMALITY_OF_THE_AUDITORY_CANAL 6.72 6.72 6.27 6.49 7 6.96 6.62 6.88 6.66 6.85 6.55 6.91 7.1 6.98 6.77 6.67 6.69 6.68 6.87 6.91 6.73 6.75 6.8 6.68 6.86 6.97
HP_ABNORMAL_COCHLEA_MORPHOLOGY 5.47 5.43 5.35 5.68 5.26 5.1 5.49 5.23 5.59 5.26 5.56 5.44 5.3 5.29 5.49 5.27 5.25 5.53 5.19 5.37 5.64 5.35 5.04 5.12 5.31 5.22
HP_ABNORMALITY_OF_THE_PINNA 6.94 6.97 7.15 7 7.11 7.27 7.2 7.19 7.28 7.24 7 7.21 7.27 7.18 7.22 7.18 7.03 6.99 7.09 7.26 7.13 7.13 7.23 7.37 7.25 7.24
HP_CUPPED_EAR 7.19 7.43 7.29 7.01 7.37 7.64 7.64 7.39 7.68 7.47 6.98 7.79 7.63 7.48 7.22 7.17 7.42 7.23 7.4 7.37 7.15 7.26 7.7 7.62 7.48 7.34
HP_ABNORMALITY_OF_PERIAURICULAR_REGION 6.53 6.59 6.81 6.66 6.84 7.09 6.75 7.05 7.06 7.2 6.61 7.04 7.03 7.05 6.5 6.92 6.81 6.54 6.77 6.71 6.93 6.94 7.15 7.13 7.05 6.89
HP_PREAURICULAR_SKIN_TAG 6.8 6.81 6.89 6.69 7.06 7.14 7.02 7.16 7.34 7.31 6.78 7.4 7.21 7.26 7.08 7.14 6.96 6.88 6.98 7.19 7.06 7.04 7.27 7.39 7.17 6.98
HP_SMALL_EARLOBE 6.82 6.96 6.73 6.7 6.87 7.26 7.16 7.03 7.09 7.17 6.84 7.31 7.18 7.09 7.34 7.12 6.72 7.09 7.01 7.24 7.38 6.85 7.28 7.33 7.11 7
HP_ABSENT_EARLOBE 5.82 5.96 5.83 6.21 5.71 5.97 5.83 6.13 5.94 6.65 5.99 6.4 5.99 6.42 6.02 6.3 5.96 5.62 5.9 6.21 5.95 6.23 6.36 6.23 6.07 6.24
HP_OTITIS_MEDIA 6.06 5.94 5.9 6.06 5.84 5.92 6.02 5.93 5.87 6 5.92 5.9 5.86 5.95 5.95 6.02 5.99 6.05 5.77 5.91 5.98 5.98 5.85 5.72 6.01 6.03
HP_CHRONIC_OTITIS_MEDIA 5.89 5.86 5.82 5.78 5.61 5.51 5.68 5.61 5.71 5.9 5.72 5.71 5.58 5.54 5.7 5.85 5.84 5.93 5.52 5.62 5.89 5.73 5.5 5.35 5.81 5.88
HP_THICKENED_HELICES 8.11 8.15 8.28 7.99 8.52 8.29 8.55 7.84 8.68 8.1 8.4 8.24 8.58 8.65 8.17 7.91 7.96 7.69 7.93 8.63 8.25 8.03 8.57 8.6 8.65 7.98
HP_MACROTIA 7.48 7.51 7.79 7.62 7.89 7.85 7.68 7.75 7.86 7.85 7.72 7.73 7.97 7.88 7.79 7.8 7.55 7.41 7.64 7.75 7.62 7.68 7.98 8.04 7.76 7.79
HP_STENOSIS_OF_THE_EXTERNAL_AUDITORY_CANAL 6.73 6.63 6.63 6.61 7.07 7.02 6.3 6.58 7.12 7.03 6.71 7.23 7.02 7.05 6.59 6.86 6.68 6.72 6.92 6.76 6.84 6.84 6.94 6.87 7.03 7.04
HP_RECURRENT_OTITIS_MEDIA 5.87 5.67 5.82 5.8 5.68 5.56 5.68 5.79 5.77 6 5.71 5.68 5.66 5.62 5.69 5.87 5.78 5.98 5.43 5.49 5.63 5.73 5.64 5.44 5.88 5.96
HP_PROGRESSIVE_SENSORINEURAL_HEARING_IMPAIRMENT 6.27 6.41 6.5 6.24 6.23 6.58 6.61 6.67 6.32 6.43 6.42 6.3 6.29 6.29 6.37 6.53 6.63 6.7 6.4 6.62 6.4 6.75 6.19 6.09 6.95 6.44
HP_MIXED_HEARING_IMPAIRMENT 6.61 6.21 5.98 6.32 6.65 6.18 6.32 6.37 6.38 6.1 5.89 6.27 6.42 6.53 6.37 6.41 6.49 5.83 5.93 6.25 6.06 6.26 6.14 6.49 6.34 6.4
HP_PROTRUDING_EAR 6.76 6.74 7.01 6.89 7.08 7.07 6.85 7.13 6.92 6.93 6.9 7.08 7.03 6.97 7.14 6.88 6.92 6.84 6.92 7.04 7.08 7.12 7.08 7.05 6.99 6.93
HP_ATRESIA_OF_THE_EXTERNAL_AUDITORY_CANAL 6.51 6.62 6.23 6.18 6.47 6.8 6.63 6.78 6.63 6.71 6.49 6.58 6.9 6.69 6.75 6.52 6.61 6.59 6.84 6.81 6.49 6.66 6.66 6.63 6.68 6.91
HP_BULBOUS_NOSE 7.31 7.43 7.65 7.2 7.48 7.84 7.86 7.68 7.77 7.77 7.48 7.68 7.93 7.99 7.57 7.59 7.61 7.39 7.66 7.85 7.32 7.58 7.95 7.83 7.73 7.74
HP_ABNORMALITY_OF_THE_CHOANAE 6.17 6.18 6.13 6.45 6.27 6.43 6.28 6.39 6.3 6.23 6.24 6.21 6.41 6.36 6.26 6.22 6.2 6.14 6.08 6.22 6.26 6.16 6.32 6.37 6.28 6.24
HP_NARROW_NASAL_RIDGE 6.53 6.38 6.18 6.45 6.68 6.5 6.34 6.64 6.62 6.71 5.99 6.6 6.5 6.45 6.28 6.4 6.13 6.12 6.33 6.38 6.2 6.31 6.73 6.82 6.6 6.48
HP_ABNORMALITY_OF_THE_NASAL_SEPTUM 7.4 7.15 6.96 7.25 8.32 8.13 7.52 7.76 7.52 7.9 7.89 8.08 7.87 7.7 7.15 7.85 8 7.87 7.75 7.73 7.92 8.03 7.68 7.5 8.02 7.42
HP_EPISTAXIS 6.01 5.93 5.93 5.83 5.75 5.51 5.6 5.78 5.78 5.54 5.81 5.64 5.73 5.65 5.68 5.59 5.87 5.68 5.47 5.64 6 6.05 5.74 5.61 6.12 5.98
HP_ABNORMAL_NASAL_BRIDGE_MORPHOLOGY 6.82 6.86 7.13 6.97 7.05 7.19 7.03 7.13 7.05 7.14 6.95 7.12 7.17 7.12 7.15 7.12 6.95 6.92 7.04 7.11 7.02 7.12 7.14 7.26 7.1 7.13
HP_PROMINENT_NASAL_BRIDGE 7.16 7.15 7.35 7.21 7.33 7.6 7.29 7.29 7.28 7.34 7.23 7.39 7.47 7.35 7.39 7.48 7.13 7.06 7.35 7.43 7.14 7.33 7.42 7.48 7.42 7.25
HP_ABNORMALITY_OF_THE_NASAL_ALAE 6.88 6.98 7.11 6.99 7.09 7.23 7.16 7.15 7.11 7.24 6.95 7.2 7.25 7.27 7.22 7.18 7 7.02 7.14 7.21 7.09 7.2 7.14 7.32 7.21 7.21
HP_UNDERDEVELOPED_NASAL_ALAE 7.16 7.26 7.07 6.97 7.23 7.47 7.64 7.45 7.49 7.78 7.12 7.42 7.55 7.41 7.41 7.39 7.46 7.21 7.29 7.41 7.39 7.47 7.5 7.54 7.48 7.29
HP_WIDE_NASAL_BRIDGE 6.79 6.84 7.08 6.9 7.03 7.16 6.99 7.13 7 7.07 6.95 7.13 7.16 7.08 7.1 6.96 6.91 6.88 7.02 7.1 6.99 7.05 7.06 7.21 7.08 7.09
HP_ABNORMAL_NASAL_MUCOSA_MORPHOLOGY 5.62 5.46 5.44 5.46 5.12 5.25 5.59 5.48 5.52 5.75 5.65 5.63 5.42 5.23 5.48 5.77 5.56 5.84 5.45 5.37 5.54 5.43 5.2 5.11 5.29 5.56
HP_ABNORMALITY_OF_THE_NASAL_TIP 7.31 7.43 7.54 7.26 7.55 7.75 7.81 7.61 7.79 7.81 7.44 7.68 7.84 7.85 7.67 7.58 7.53 7.34 7.62 7.87 7.44 7.69 7.95 7.87 7.76 7.54
HP_DEPRESSED_NASAL_TIP 6.72 6.79 7.22 6.95 7.48 7.23 7.13 7.35 7.5 7.46 7.6 7.34 7.23 7.13 7 6.87 7.15 6.76 7.29 7.15 7.46 7.42 7.48 7.64 7.02 7.3
HP_CONVEX_NASAL_RIDGE 6.54 6.59 6.67 6.97 6.77 6.69 6.56 6.73 6.54 6.75 6.71 6.79 6.62 6.55 6.69 6.51 6.68 6.55 6.66 6.75 6.48 6.61 6.76 6.87 6.68 6.7
HP_WIDE_NOSE 7.11 7.08 7.18 7.22 7.02 7.35 7.37 7.23 7.3 7.4 7.08 7.27 7.39 7.21 7.49 7.39 6.9 6.93 7.4 7.42 7.15 7.38 7.3 7.53 7.27 7.36
HP_NARROW_NASAL_BRIDGE 6.41 6.15 6.42 6.54 6.13 6.17 6.65 6.34 6.33 6.55 6.22 6.41 6.6 6.43 6.17 6.29 6.4 6.28 6.25 6.44 6.52 6.39 6.41 6.56 6.38 6.28
HP_PROMINENT_NOSE 7.64 7.77 8.04 7.57 7.86 8.04 8.01 7.73 8.11 8.09 7.69 7.98 8.21 8.25 7.92 8.03 7.77 7.67 7.9 8.01 7.66 7.8 8.04 8.2 7.97 7.85
HP_CHOANAL_STENOSIS 6.14 6.14 5.84 6.24 6.56 6.62 6.17 6.34 6.11 6.45 6.39 6.21 6.53 6.44 6.15 6.21 6.07 6.21 6.25 6.13 6.31 6.28 6.09 6.21 6.16 6.16
HP_BROAD_NASAL_TIP 7.4 7.62 7.66 7.25 7.71 7.98 7.9 7.71 7.9 7.88 7.55 7.74 7.87 7.98 7.67 7.7 7.67 7.36 7.75 7.95 7.47 7.74 8.04 8.17 7.81 7.47
HP_DEPRESSED_NASAL_RIDGE 6.14 6.09 6.04 6.34 6.09 6.06 6 5.92 6.04 6.11 6.07 5.9 6.08 6.2 6.07 6.2 5.98 6.04 6.08 6.01 6.24 6.14 6.14 6 6.23 6.26
HP_ANOSMIA 5.77 5.47 6.07 6.34 5.71 5.61 5.81 5.76 5.97 5.93 6 5.77 5.67 6.1 6.16 5.9 5.82 5.92 5.96 5.85 6.01 5.85 5.54 5.71 5.65 5.96
HP_NARROW_NOSE 6.93 6.77 6.31 6.48 7.04 6.98 6.91 7.1 6.95 7.11 6.73 7.47 7.09 7.05 6.72 6.84 7.4 6.98 7.12 6.97 7.21 7.03 7.11 7.41 7.22 7.13
HP_ABNORMALITY_OF_THE_NECK 6.88 6.89 7.19 7.04 7.09 7.18 7.14 7.15 7.15 7.24 6.97 7.15 7.23 7.23 7.17 7.25 6.99 6.99 7.09 7.17 7.04 7.18 7.2 7.31 7.23 7.16
HP_WEBBED_NECK 7.13 6.95 7.15 6.99 7.1 7.08 6.99 7.12 7.2 7.27 7.25 7.27 7.21 7.32 7.3 7.31 7.43 7.27 7 7.05 7.08 7.17 7.26 7.31 7.35 7.06
HP_LIMITED_NECK_RANGE_OF_MOTION 7.78 8.09 7.47 7.8 8.55 8.27 7.97 8.14 8.11 7.8 8.22 7.71 7.67 7.88 7.96 8.1 7.71 7.84 8.23 8.35 7.55 8.17 8 8.19 7.84 7.99
HP_NECK_MUSCLE_WEAKNESS 6.37 6.37 6.29 6.34 6.43 6.59 6.32 6.28 6.55 6.54 6.33 6.37 6.4 6.46 6.33 6.25 6.38 6.47 6.39 6.37 6.08 6.08 6.47 6.49 6.75 6.41
HP_THICKENED_NUCHAL_SKIN_FOLD 7.22 7.23 7.88 7.72 7.54 7.5 7.18 7.12 7.32 7.51 7.38 7.43 7.41 7.53 7.51 7.33 7.16 6.99 7.55 7.5 7.18 7.25 7.63 7.75 7.4 7.22
HP_BROAD_NECK 7.62 7.8 7.24 6.94 7.96 8.03 7.89 7.95 8 7.96 7.12 7.99 7.74 7.8 7.62 7.54 7.42 7.1 7.54 7.79 7.49 7.7 7.89 8.15 8.02 7.52
HP_CYSTIC_HYGROMA 6.49 6.58 6.91 6.79 6.89 6.74 6.32 6.48 6.69 6.67 6.61 6.4 6.62 6.56 6.57 6.49 6.65 6.37 6.44 6.57 6.54 6.86 6.72 6.6 6.62 6.83
HP_ABNORMAL_RETINAL_MORPHOLOGY 6.54 6.6 6.85 6.77 6.7 6.73 6.74 6.76 6.67 6.83 6.64 6.77 6.72 6.78 6.65 6.84 6.67 6.62 6.72 6.81 6.67 6.81 6.84 6.84 6.79 6.75
HP_RETINAL_COLOBOMA 6.89 6.85 6.73 6.83 6.89 7.08 7.14 6.96 6.73 6.87 6.7 6.8 7.03 6.94 6.73 6.9 6.8 6.7 6.74 7.19 6.72 6.74 6.66 6.63 6.92 6.92
HP_ABNORMAL_CORNEA_MORPHOLOGY 6.3 6.3 6.39 6.45 6.44 6.48 6.44 6.44 6.41 6.53 6.35 6.53 6.47 6.41 6.41 6.39 6.31 6.26 6.28 6.44 6.28 6.39 6.45 6.5 6.42 6.49
HP_MICROCORNEA 6.11 6.14 6.25 6.42 6.25 6.19 6.24 6.38 6.27 6.15 6.31 6.32 6.25 6.27 6.35 6.3 6.17 6.21 6 6.22 6.23 6.41 6.4 6.19 6.38 6.37
HP_ASTIGMATISM 6.88 7.14 7.13 7.23 7.32 7.29 7.2 7.14 7.26 7.32 7.16 7.02 7.3 7.04 7.23 7.33 7.2 6.96 7.15 7.22 6.87 7.08 7.31 7.42 7.08 7.25
HP_MEGALOCORNEA 7.01 6.89 7.15 6.89 7.04 7.05 7.06 7.25 7.16 6.98 6.92 7.03 6.96 6.98 7.3 7.08 6.81 7.22 7.24 7.25 7.13 7.07 7.07 7.09 7.18 7.35
HP_RETINOPATHY 6.23 6.56 6.56 6.62 6.32 6.37 6.52 6.39 6.52 6.57 6.43 6.52 6.55 6.52 6.41 6.31 6.23 6.38 6.24 6.44 6.3 6.57 6.4 6.46 6.6 6.38
HP_DEEPLY_SET_EYE 7.32 7.61 7.79 7.7 7.66 7.7 8.01 7.92 8.02 7.82 7.56 7.77 7.96 7.95 7.89 7.94 7.67 7.58 7.69 7.98 7.75 7.85 8.04 8.15 8.01 7.81
HP_KERATITIS 6.05 6.19 6.12 6.05 5.82 6.01 6.14 6.04 6.34 6.03 6.16 5.92 6.09 6.09 5.84 5.93 5.99 6.1 6.01 5.94 6.05 5.9 6.02 5.74 6.09 6.13
HP_ABNORMAL_EYELID_MORPHOLOGY 6.84 6.88 7.1 6.99 7.07 7.18 7.05 7.1 7.12 7.08 6.97 7.09 7.2 7.15 7.14 7.08 6.94 6.92 7.05 7.13 7.03 7.07 7.08 7.25 7.1 7.16
HP_ABNORMAL_FOVEAL_MORPHOLOGY 5.19 5.17 5.81 5.3 5.41 5.4 5.29 5.44 5.38 5.23 5.58 5.3 5.17 5.21 5.2 5.51 5.26 5.57 5.11 5.36 5.29 5.28 5.47 5.61 5.16 5.16
HP_DOWNSLANTED_PALPEBRAL_FISSURES 7.45 7.44 7.72 7.55 7.7 7.86 7.85 7.74 7.87 7.84 7.64 7.85 7.83 8.01 7.81 7.78 7.53 7.57 7.7 7.82 7.48 7.75 7.9 8.05 7.86 7.58
HP_RECURRENT_CORNEAL_EROSIONS 6.01 6.04 5.83 5.85 5.9 6.22 6.07 6.07 5.98 6.3 5.93 6.08 5.92 5.98 6.08 5.91 6.07 5.87 5.89 5.81 5.94 5.9 6.66 6.05 6.01 6.15
HP_BLEPHARITIS 6.98 6.88 6.97 7.06 7.04 7.19 6.98 6.9 7.11 6.81 6.82 7.01 7.1 7.01 6.81 6.5 7.04 6.69 7.03 7.12 6.99 6.89 6.83 7.02 6.96 7.05
HP_ABNORMAL_EYELASH_MORPHOLOGY 6.53 6.5 6.74 6.85 6.72 6.68 6.59 6.85 6.73 6.82 6.64 6.71 6.78 6.77 6.91 6.66 6.56 6.47 6.64 6.71 6.61 6.65 6.8 6.86 6.7 6.69
HP_GLAUCOMA 6.34 6.3 6.38 6.49 6.38 6.41 6.33 6.34 6.49 6.38 6.42 6.32 6.49 6.46 6.38 6.44 6.31 6.3 6.32 6.35 6.43 6.38 6.45 6.46 6.42 6.39
HP_ABNORMAL_CONJUNCTIVA_MORPHOLOGY 6.12 6.23 6.2 6.34 6.09 6.07 6.21 6.22 6.24 6.03 6.22 6.07 6.3 6.14 6.01 6.09 6.17 6.1 6.02 6.2 6.06 6.08 6.18 6.16 6.16 6.24
HP_ABNORMALITY_OF_VISION 6.72 6.82 7.05 6.99 6.96 7.11 7.03 7 6.95 7.04 6.85 7.05 7.09 7.04 6.92 7.02 6.84 6.85 7 7.08 6.85 6.92 7.01 7.08 7.05 7.03
HP_VISUAL_IMPAIRMENT 6.69 6.78 7.05 6.96 6.95 7.08 7 6.97 6.94 7.04 6.84 7.04 7.08 7.04 6.93 7.04 6.84 6.85 7 7.07 6.83 6.93 7.01 7.07 7.05 7.04
HP_TELECANTHUS 7.16 6.97 7.44 7.1 7.21 7.26 7.52 7.37 7.45 7.34 7.15 7.31 7.47 7.42 7.4 7.35 7.24 7.01 7.04 7.29 7.28 7.54 7.35 7.54 7.35 7.37
HP_PTOSIS 7.06 7.06 7.33 7.22 7.22 7.33 7.26 7.31 7.27 7.34 7.3 7.26 7.32 7.37 7.32 7.36 7.13 7.07 7.31 7.33 7.17 7.32 7.37 7.5 7.36 7.29
HP_ROD_CONE_DYSTROPHY 6.14 6.12 6.24 6.39 6.09 6.17 6.22 6.19 6.1 6.3 6.31 6.34 6.2 6.25 6.16 6.57 6.09 6.18 6.2 6.16 6.2 6.29 6.18 6.17 6.12 6.26
HP_VERTICAL_SUPRANUCLEAR_GAZE_PALSY 7.93 8.59 8.83 8.5 8.5 8.33 8.02 8.65 7.74 8.3 8.07 8.42 8.48 8.61 8.4 8.35 8.23 8.04 8.3 8.68 8.49 8.54 8.06 8.21 8.42 8.5
HP_ABNORMAL_ELECTRORETINOGRAM 5.98 5.97 6.1 6.23 5.95 6.18 5.82 6.17 6 6.13 6.17 6.34 6.05 6.01 6.06 6.27 6.03 6.1 6.12 6.14 6.12 6.21 5.92 6.04 5.94 6.26
HP_SLOW_SACCADIC_EYE_MOVEMENTS 8.48 8.53 9.03 8.53 8.34 8.79 9.36 9.21 8.83 8.98 8.56 8.8 8.93 9.04 9.09 9.24 8.47 8.33 8.54 9.38 8.9 9.25 8.65 9.08 9.35 9.03
HP_ABNORMALITY_OF_THE_LENS 6.45 6.46 6.51 6.59 6.47 6.52 6.49 6.49 6.56 6.53 6.49 6.57 6.49 6.48 6.44 6.53 6.41 6.4 6.56 6.5 6.46 6.49 6.55 6.58 6.45 6.58
HP_DEVELOPMENTAL_CATARACT 6.61 6.56 6.88 6.73 6.86 6.67 6.79 6.76 6.9 6.79 6.66 6.83 6.9 6.74 6.73 6.71 6.75 6.79 6.77 6.74 6.77 6.85 6.82 6.74 6.84 6.74
HP_PROPTOSIS 6.53 6.49 6.72 6.63 6.8 6.85 6.62 6.78 6.66 6.8 6.58 6.69 6.74 6.68 6.55 6.57 6.61 6.44 6.51 6.65 6.63 6.68 6.94 6.91 6.78 6.81
HP_ALACRIMA 6.95 7.33 6.6 6.71 7.43 7.41 7.09 7.31 6.86 6.87 6.43 6.96 7.11 7.03 7.12 6.53 6.81 7.1 6.72 7.6 6.69 6.85 6.54 6.83 7.04 7.33
HP_SUBCAPSULAR_CATARACT 5.99 6 5.76 6.14 6.15 5.77 6.22 6.15 6.08 6.15 6.09 6.31 6.35 6.24 6.01 6.07 6.31 5.98 5.77 6.06 6.23 6.32 6.03 5.98 5.85 6.25
HP_ABNORMALITY_IRIS_MORPHOLOGY 6.23 6.27 6.59 6.51 6.37 6.48 6.41 6.38 6.34 6.45 6.39 6.52 6.42 6.39 6.36 6.42 6.37 6.34 6.32 6.4 6.39 6.44 6.54 6.58 6.45 6.5
HP_ANIRIDIA 7.22 7.26 7.62 7.35 7.44 7.6 7.29 7.6 7.3 7.38 7.62 7.52 7.58 7.61 7.7 7.49 7.24 7.43 7.32 7.78 7.03 7.72 7.39 7.37 7.59 7.34
HP_LONG_EYELASHES 7.33 7.58 7.45 7.25 7.72 7.84 7.68 7.56 7.6 7.63 7.3 7.81 7.75 7.84 7.62 7.71 7.52 7.27 7.72 7.67 7.6 7.73 7.83 7.82 7.65 7.36
HP_ANOPHTHALMIA 6.04 6.09 6.19 6.47 6.12 6.22 6.09 6.24 6.04 6.35 6.26 6.35 6.2 6.17 6.33 6.24 5.95 6.07 5.91 6.09 6.26 6.29 6.31 6.27 6.22 6.02
HP_PROGRESSIVE_VISUAL_LOSS 6.6 6.59 7.14 6.68 6.95 7 6.73 6.64 6.88 6.93 6.54 7.06 6.71 6.58 6.57 6.93 6.76 6.63 6.88 6.9 6.69 6.59 6.94 7.01 7.17 6.79
HP_ABNORMAL_CHORIORETINAL_MORPHOLOGY 6.39 6.5 6.72 6.53 6.5 6.67 6.7 6.55 6.55 6.55 6.52 6.75 6.52 6.63 6.51 6.61 6.51 6.48 6.61 6.67 6.53 6.64 6.62 6.79 6.67 6.63
HP_CHORIORETINAL_ATROPHY 5.37 5.34 6.07 5.59 5.28 5.24 5.63 5.5 5.46 5.67 5.41 5.02 5.44 5.25 5.39 5.81 5.37 5.55 5.68 5.08 5.41 5.42 5.71 5.36 5.24 5.25
HP_ABNORMAL_EYEBROW_MORPHOLOGY 6.85 6.89 7.1 7.02 7.05 7.18 7.06 7.18 7.15 7.19 6.96 7.15 7.2 7.15 7.26 7.16 6.97 6.94 7.01 7.16 7 7.16 7.14 7.36 7.17 7.23
HP_ABNORMALITY_OF_REFRACTION 6.77 6.87 6.96 6.87 6.97 7.03 6.94 6.99 6.94 7 6.82 6.97 7.09 6.98 7.03 6.93 6.82 6.75 6.95 7.03 6.86 7 6.95 7.08 6.95 6.98
HP_HYPERMETROPIA 6.92 7.09 6.98 6.85 7.02 7.13 6.99 7 6.91 6.92 6.92 7.14 7.15 7 7.16 6.94 6.92 6.87 7.09 6.99 7.07 7.1 6.85 7.09 7.1 7.13
HP_RETINAL_DETACHMENT 6.03 5.92 5.84 5.83 6.01 6.05 5.98 5.95 6.04 6.02 5.97 6.11 6.05 5.97 5.86 5.83 6.05 5.94 6.03 6.07 6.09 5.98 6.02 5.98 6.02 6.08
HP_OPTIC_DISC_PALLOR 6.7 6.74 7.32 7.18 6.81 6.91 6.99 7.1 6.93 7.07 6.99 7.07 7.08 7.05 6.98 7.07 6.85 6.85 6.99 6.98 6.73 7.04 7.03 7.3 7.06 6.86
HP_EXTERNAL_OPHTHALMOPLEGIA 6.98 6.87 6.81 7.08 7.02 7.35 6.98 6.85 7.17 7 6.92 7.26 7.3 7.34 6.93 6.78 7.07 6.54 7 6.97 6.53 6.59 7.38 7.51 7.3 6.68
HP_MYOPIA 6.82 6.83 6.94 6.87 6.95 6.97 6.99 7.07 6.96 7.03 6.79 6.89 7.13 7.04 7.15 7 6.83 6.78 6.94 7.06 6.94 7.01 7.07 7.1 6.95 7
HP_RETINAL_DEGENERATION 7.04 7.22 7.32 7.01 7.15 7.38 7.29 7.25 7.27 7.28 7.17 7.16 7.39 7.27 7.31 7.25 7 7.04 7.34 7.3 7.09 7.29 7.23 7.42 7.31 7.28
HP_CONE_CONE_ROD_DYSTROPHY 6.04 5.89 6.29 6.27 6.42 6.58 6.13 5.77 6.37 6.83 6.33 5.99 6.12 6.29 6.17 6.22 6.1 6.07 6.35 6.27 5.72 6.14 6.63 6.58 5.92 5.76
HP_ABNORMAL_CONJUGATE_EYE_MOVEMENT 7.04 7.12 7.31 7.22 7.24 7.36 7.25 7.34 7.28 7.32 7.18 7.26 7.39 7.39 7.34 7.33 7.18 7.08 7.27 7.34 7.15 7.41 7.31 7.48 7.33 7.29
HP_UNDETECTABLE_ELECTRORETINOGRAM 5.69 5.46 6.07 5.75 5.76 5.55 5.55 5.32 5.6 5.65 5.89 5.76 5.78 5.55 5.49 6 5.65 5.85 5.63 5.48 6.19 5.91 5.66 5.45 5.84 5.73
HP_COLOR_VISION_DEFECT 5.82 5.87 6.1 5.93 5.77 6.07 6.01 5.8 5.96 6.14 6.11 5.97 5.8 5.91 6.16 5.92 5.97 6.06 6.02 6.19 5.96 5.95 5.9 6.12 5.84 5.91
HP_ABNORMAL_UVEA_MORPHOLOGY 6.18 6.24 6.39 6.38 6.26 6.3 6.26 6.29 6.19 6.27 6.29 6.32 6.28 6.29 6.23 6.23 6.24 6.22 6.14 6.25 6.27 6.34 6.33 6.33 6.3 6.31
HP_UVEITIS 5.46 5.44 5.22 5.49 5.05 5.13 5.26 5.27 5.17 5.25 5.37 5.17 5.2 5.18 5.18 5.23 5.17 5.32 5.49 5.24 5.48 5.05 5.11 4.91 5.12 5.29
HP_RETINAL_DYSTROPHY 6.23 6.32 6.34 6.52 6.38 6.44 6.34 6.25 6.21 6.54 6.45 6.52 6.37 6.34 6.32 6.59 6.25 6.39 6.43 6.33 6.26 6.5 6.4 6.36 6.27 6.46
HP_BUPHTHALMOS 6.65 7.01 6.76 6.67 7.22 7.18 7.07 7.06 7.1 6.76 6.55 7.21 7.34 7.04 7.35 7.22 7.28 7.11 6.9 6.98 7.39 7.36 7.36 6.94 7.35 7.32
HP_RIEGER_ANOMALY 7.5 7.66 7.11 6.97 8.13 8.14 8.06 7.54 7.89 8.03 7.37 8.45 8.08 8.21 7.76 8.07 8.16 8.21 7.91 7.93 7.53 7.52 7.97 8.15 8.08 7.77
HP_CORNEAL_SCARRING 5.9 5.79 5.85 6.15 5.65 5.46 5.59 5.77 5.71 5.63 5.92 5.84 5.65 5.7 5.52 5.84 5.87 5.64 5.63 5.56 5.78 5.62 6.06 5.54 5.32 5.51
HP_CHORIORETINAL_COLOBOMA 6.48 6.61 6.48 6.47 6.5 6.46 6.6 6.51 6.59 6.66 6.46 6.75 6.84 6.8 6.69 6.99 6.47 6.6 6.5 6.3 6.71 6.81 6.72 6.79 6.91 6.71
HP_ABNORMAL_SACCADIC_EYE_MOVEMENTS 7.99 7.87 8.17 8.09 8 8.39 8.16 8.35 8.08 8.19 8 8.41 8.26 8.17 8.35 8.36 8.2 8.15 8.12 8.26 8.19 8.24 8.17 8.34 8.34 8.31
HP_HYPOMETRIC_SACCADES 7.48 7.44 7.85 7.32 7.72 7.59 7.79 8.18 7.58 8.11 7.5 8 7.82 7.59 7.98 7.94 7.58 7.81 7.37 7.64 7.88 7.99 7.77 8.32 7.96 7.98
HP_VISUAL_LOSS 6.54 6.53 6.74 6.65 6.76 6.8 6.62 6.6 6.7 6.87 6.5 6.83 6.7 6.58 6.6 6.58 6.59 6.55 6.69 6.77 6.48 6.58 6.84 6.99 6.85 6.72
HP_RETINAL_HEMORRHAGE 5.86 5.7 5.64 5.57 5.33 5.51 5.56 5.27 6.01 5.94 5.97 5.89 5.61 5.73 5.47 5.35 5.47 5.62 5.61 5.77 5.54 5.34 5.73 5.74 5.31 5.43
HP_THICK_EYEBROW 7.42 7.47 7.43 7.3 7.7 7.73 7.64 7.76 7.63 7.77 7.52 7.85 7.81 7.73 7.8 7.84 7.55 7.43 7.75 7.74 7.56 7.76 7.9 7.89 7.88 7.68
HP_SCOTOMA 5.47 5.42 5.74 5.69 5.53 5.36 5.5 5.5 5.55 5.23 5.7 5.48 5.37 5.42 5.44 5.42 5.74 5.64 5.46 5.4 5.72 5.59 5.36 5.41 5.58 5.5
HP_NASOLACRIMAL_DUCT_OBSTRUCTION 6.5 6.57 6.41 6.33 6.54 6.51 6.36 6.53 6.57 6.51 6.46 6.41 6.48 6.37 6.29 6.2 6.35 6.72 6.63 6.42 6.44 6.64 6.57 6.53 6.42 6.61
HP_PIGMENTARY_RETINOPATHY 6.79 6.7 7.24 6.98 6.92 7.01 6.94 6.85 6.91 7.04 6.88 7.01 6.88 7.08 6.8 7.12 6.78 6.8 7.01 7.09 6.74 6.93 6.99 7.18 6.92 6.9
HP_BLEPHAROPHIMOSIS 6.83 6.86 7.2 7.08 7.05 7.19 6.9 7.13 7.03 7.24 6.91 7.28 7.43 7.32 7.3 7.23 7.31 6.98 7.11 7.2 7.15 7.06 7.33 7.57 7.19 7.33
HP_UPSLANTED_PALPEBRAL_FISSURE 6.83 6.93 7.17 6.95 7.15 7.18 7.16 7.14 7.18 7.26 7.03 7.24 7.21 7.32 7.2 7.15 6.97 6.96 7.1 7.09 7.09 7.24 7.16 7.32 7.13 7.21
HP_SHALLOW_ORBITS 6.56 6.59 6.89 6.93 7.22 7.36 7.03 7.24 7.01 7.32 6.82 7.2 6.97 6.81 6.86 6.92 6.91 6.58 6.79 6.82 6.92 6.88 7.13 7.07 6.96 6.92
HP_ABNORMALITY_OF_THE_OPTIC_NERVE 6.91 6.93 7.31 7.18 7.06 7.19 7.16 7.25 7.15 7.2 7.01 7.09 7.16 7.25 7.16 7.22 6.96 6.96 7.09 7.23 7 7.12 7.1 7.34 7.23 7.16
HP_OPTIC_NERVE_COLOBOMA 6.75 6.9 6.86 7.19 6.62 6.76 6.92 7.32 7.06 7.05 6.71 6.76 6.84 6.82 6.96 7.45 6.75 6.98 6.64 7.01 6.79 6.77 7.04 7.35 7.08 7.07
HP_COLOBOMA 6.69 6.65 6.83 6.85 6.73 6.89 6.88 7 6.87 6.95 6.7 6.99 6.86 6.85 6.96 7 6.68 6.81 6.72 7.01 6.81 6.93 6.92 6.92 7.02 6.92
HP_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA 6.91 6.72 6.72 6.98 7.02 6.97 6.97 6.54 6.94 7.02 6.76 6.83 6.79 7.17 6.64 6.76 6.37 6.6 6.75 6.7 6.26 6.35 6.78 7.21 6.92 6.46
HP_ABNORMAL_SCLERA_MORPHOLOGY 6.27 6.3 6.67 6.43 6.44 6.33 6.4 6.51 6.5 6.56 6.29 6.47 6.56 6.43 6.44 6.32 6.46 6.26 6.21 6.3 6.63 6.5 6.51 6.65 6.64 6.58
HP_BLUE_SCLERAE 6.26 6.23 6.32 6.37 6.44 6.25 6.32 6.4 6.33 6.53 6.19 6.31 6.27 6.35 6.33 6.27 6.39 6.13 6.17 6.19 6.51 6.29 6.46 6.5 6.62 6.54
HP_ABNORMAL_ANTERIOR_CHAMBER_MORPHOLOGY 6.07 5.96 5.87 6.05 6.22 6.01 6.21 6 5.92 5.98 5.9 6.16 6.12 5.86 5.88 5.87 6.26 5.94 5.8 6.04 6.15 5.94 6.07 5.69 5.93 6.1
HP_SHALLOW_ANTERIOR_CHAMBER 6.68 6.53 6.11 6.32 6.65 6.87 6.27 6.09 6.32 6.38 6.14 6.51 6.53 6.49 6.03 6.16 6.31 6.17 6.41 6.6 6.29 5.93 6.13 6.31 6.59 6.4
HP_OPHTHALMOPARESIS 6.53 6.51 6.65 6.63 6.65 6.6 6.69 6.68 6.74 6.79 6.61 6.68 6.71 6.8 6.65 6.76 6.61 6.61 6.7 6.77 6.64 6.78 6.8 6.8 6.94 6.74
HP_ABNORMALITY_OF_THE_FRONTAL_HAIRLINE 7.43 7.59 7.65 7.28 7.91 7.89 7.84 7.6 7.75 7.85 7.48 7.7 7.83 7.73 7.65 7.64 7.53 7.39 7.67 7.87 7.43 7.59 7.9 7.89 7.7 7.58
HP_ABNORMALITY_OF_THE_PHARYNX 5.95 5.9 5.94 6.04 5.95 5.94 6.06 5.96 6.02 6.1 6.03 5.88 6.07 6.13 5.97 6.14 6.09 6.15 5.91 6.03 6.22 6.19 6.09 5.92 6.13 6.14
HP_HYPOTELORISM 6.85 6.71 6.64 6.85 7.07 7.14 6.71 7 6.7 6.79 6.86 6.84 7.01 6.86 6.82 6.86 6.83 6.84 6.93 6.83 6.79 7 6.79 7.01 6.87 6.79
HP_CENTRAL_SCOTOMA 5.21 5.31 5.36 5.45 5.32 5.27 5.29 5.36 5.28 5.06 5.47 4.92 5.13 5.26 5.12 5.3 5.42 5.44 5.25 5.19 5.45 5.06 5.31 5.14 5.35 5.06
HP_SUPRANUCLEAR_GAZE_PALSY 7.84 8.04 8.88 8.33 8.37 8.47 8.26 8.2 8.38 8.38 8.11 8.42 8.39 8.35 8.48 8.28 8.2 8.02 8.25 8.56 8.4 8.54 8.25 8.74 8.41 8.43
HP_ABNORMALITY_OF_THE_PERIORBITAL_REGION 6.89 6.75 7.16 7.03 6.98 7.24 7.14 7.11 7.2 7.31 7.14 7.11 7.25 7.34 7.16 7.27 6.91 6.92 7 7.29 7.08 7.12 7.47 7.47 7.17 7.12
HP_MACULAR_DEGENERATION 6 5.98 6.19 6.19 6.3 6.22 6.22 6.12 6.04 6.15 6.2 6.05 5.96 6.04 6.02 6.17 6.1 6.07 6.04 6.24 6.24 6.22 6.23 6.22 6.09 6.21
HP_OPTIC_NERVE_HYPOPLASIA 6.34 6.55 6.53 6.79 6.63 6.71 6.65 6.34 6.66 6.62 6.64 6.66 6.47 6.18 6.66 6.53 6.66 6.44 6.34 6.47 6.58 6.75 6.95 6.57 6.49 6.49
HP_ABNORMAL_CHOROID_MORPHOLOGY 6.31 6.28 6.46 6.43 6.37 6.42 6.55 6.36 6.23 6.32 6.45 6.37 6.36 6.38 6.37 6.47 6.24 6.34 6.4 6.47 6.34 6.43 6.4 6.38 6.31 6.29
HP_IRIS_COLOBOMA 6.52 6.5 6.75 6.68 6.58 6.71 6.7 6.67 6.76 6.85 6.55 6.88 6.76 6.73 6.74 6.96 6.49 6.7 6.52 6.77 6.73 6.85 6.79 6.79 6.81 6.72
HP_PHOTOPHOBIA 5.85 5.89 6.03 6.02 5.77 5.86 5.81 5.77 5.93 5.89 5.94 5.87 5.69 5.75 5.73 5.85 5.89 5.96 5.83 5.91 5.82 5.89 5.91 5.77 5.76 5.77
HP_ABNORMAL_NASOLACRIMAL_SYSTEM_MORPHOLOGY 6.41 6.56 6.65 6.41 6.36 6.35 6.41 6.68 6.7 6.35 6.33 6.6 6.19 6.52 6.44 6.25 6.3 6.43 6.32 6.44 6.11 6.44 6.31 6.28 6.22 6.38
HP_ABNORMAL_PUPIL_MORPHOLOGY 6.43 6.16 6.81 6.44 6.27 6.46 6.41 6.35 6.18 6.27 6.3 6.43 6.21 6.26 6.13 6.25 6.37 6.22 6.17 6.18 6.25 6.69 6.17 5.87 6.44 6.54
HP_MIOSIS 5.77 5.53 6.22 6.41 5.56 5.48 5.79 5.91 5.58 5.66 5.94 5.65 5.48 5.67 5.56 5.86 5.5 5.97 5.64 5.66 6.46 6.69 5.76 5.69 5.55 5.66
HP_ABNORMALITY_OF_OCULAR_SMOOTH_PURSUIT 7.89 7.83 7.98 7.75 8.03 8.23 8.2 8.25 7.94 8.3 7.96 8.42 8.21 8.29 8.29 8.36 7.94 7.62 8.11 8.16 7.6 8.16 8.22 8.3 8.29 8.05
HP_BLINDNESS 6.26 6.37 6.5 6.47 6.38 6.48 6.44 6.46 6.58 6.58 6.47 6.57 6.56 6.43 6.49 6.58 6.36 6.46 6.39 6.49 6.39 6.44 6.59 6.66 6.57 6.47
HP_ENTROPION 6.56 6.48 6.53 6.98 6.93 6.71 6.7 6.81 6.81 6.81 6.36 6.99 7 6.73 6.63 6.5 6.61 6.4 7.13 6.96 6.36 6.47 6.77 7.02 6.83 6.84
HP_BLURRED_VISION 5.77 5.54 5.35 5.63 5.12 5.15 5.67 5.7 5.34 4.96 5.26 5.23 5.01 5.12 5.33 5.45 5.45 5.54 5.6 5.25 5.38 5.34 5.45 4.82 5.14 5.16
HP_POSTERIOR_EMBRYOTOXON 6.88 6.89 7.17 7.04 7.2 7.16 7.04 6.96 6.97 7.21 7.01 7.21 7.21 7.47 6.91 7.25 6.85 6.95 7.33 7.36 7.18 7.12 7.32 7.54 7.18 7.21
HP_PERIORBITAL_FULLNESS 7.45 7.55 7.76 7.38 7.63 7.89 8.08 7.93 7.96 7.86 7.57 7.68 7.95 8.05 7.83 7.8 7.48 7.5 7.65 7.98 7.52 7.75 8.24 8.33 7.93 7.52
HP_ABNORMAL_RETINAL_ARTERY_MORPHOLOGY 6.82 6.74 7.1 7.12 6.87 7 6.95 7.14 6.78 6.62 6.92 6.99 6.97 6.96 6.8 6.91 6.76 6.63 7.09 7.04 7.13 6.97 7.07 7.12 7.05 6.76
HP_LACRIMATION_ABNORMALITY 6.59 6.74 6.61 6.7 6.92 6.84 6.87 7.03 6.85 6.67 6.64 6.56 6.76 6.7 6.75 6.62 6.76 6.96 6.81 7.03 7 6.84 6.54 7 6.69 6.79
HP_DECREASED_LACRIMATION 6.59 6.91 6.54 6.68 6.97 6.88 6.79 6.74 7.01 6.76 6.43 6.9 6.95 6.7 6.93 6.53 6.53 6.94 6.72 7.03 6.46 6.84 6.67 7.06 6.95 6.82
HP_BLUE_IRIDES 6.64 6.74 6.64 6.62 6.63 6.33 6.47 6.78 6.64 6.59 6.65 6.48 6.61 6.64 6.44 6.69 6.58 6.55 6.84 6.62 6.81 6.42 6.49 6.72 6.64 6.77
HP_LONG_PALPEBRAL_FISSURE 7.62 7.59 7.89 7.28 7.97 8.11 8.21 8.08 7.99 7.96 7.59 8.08 7.95 8.05 8.18 7.84 7.59 7.63 7.86 8.11 7.8 7.81 8.24 8.33 7.93 7.64
HP_GAZE_EVOKED_NYSTAGMUS 7.59 7.67 7.98 7.57 8.24 8.29 8.15 8.04 8.06 8.26 8.12 8.37 8.39 8.29 7.91 7.89 7.84 7.65 8.16 8.07 7.51 8.05 8.22 8.36 8.06 8.14
HP_DYSMETRIC_SACCADES 8.91 8.88 8.63 8.97 9.17 9.11 9.23 8.91 9.18 9.18 8.83 9.23 8.88 8.96 9.11 9.3 8.84 9.25 9.02 9.08 9.18 8.83 9.15 9.47 9.19 8.98
HP_AMBLYOPIA 6.69 6.55 6.81 6.68 6.75 6.54 6.67 6.56 6.32 6.53 6.49 6.54 6.6 6.41 6.44 6.24 6.54 6.49 6.58 6.69 6.51 6.43 6.41 6.68 6.45 6.44
HP_SCLEROCORNEA 6.04 6.09 6.83 6.51 6.17 6.11 6.37 6.24 6.03 5.97 6.39 6.35 6.2 6.01 6.33 6.24 6.01 6.07 6.03 6.18 6.26 6.37 6.09 6.17 6.23 6.02
HP_OPTIC_ATROPHY 7.05 7.13 7.48 7.4 7.21 7.32 7.33 7.41 7.32 7.41 7.23 7.23 7.37 7.37 7.36 7.37 7.12 7.07 7.31 7.46 7.16 7.33 7.27 7.54 7.39 7.35
HP_ABNORMALITY_OF_VISUAL_EVOKED_POTENTIALS 6.9 7.14 7.46 7.35 7.48 7.54 7.73 7.75 7.48 7.7 7.37 7.62 7.65 7.62 7.52 7.39 7.57 7.29 7.49 7.83 7.32 7.51 7.61 7.81 7.45 7.52
HP_DIPLOPIA 7.47 7.5 7.28 7.22 7.87 8.08 7.79 7.8 7.62 8.04 7.69 8.01 8.03 7.82 7.78 7.89 7.48 7.56 7.74 8.01 7.41 7.77 7.88 8.08 7.74 7.76
HP_SPARSE_EYELASHES 6.17 6.23 6 6.03 6.03 6.02 6.06 6.32 6.06 6.3 5.99 6.22 6.15 6.05 6.01 6.14 6.13 6.17 6.05 6.24 6.15 6.22 6.24 6.18 6.07 6.48
HP_DECREASED_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM_AMPLITUDE 7.22 7.03 8.12 7.56 7.03 7.75 7.91 7.92 7.41 7.24 7.02 7.37 7.36 7.42 7.37 6.91 7.12 7.27 7.51 7.82 7.56 7.53 7.02 7.45 7.73 7.65
HP_ECTROPION 6.32 6.27 6.31 6.26 6.34 6.31 6.38 6.56 6.35 6.35 6.16 6.32 6.42 6.22 6.28 6.27 6.16 6.03 6.27 6.47 6.29 6.28 6.34 6.29 6.57 6.52
HP_OCULOMOTOR_APRAXIA 7.09 7.16 7.41 7.29 6.99 7.2 7.22 7.17 7.05 7.26 7 7.21 7.24 7.08 7.22 7.41 6.67 6.96 6.99 7.31 6.81 7.25 6.99 7.21 7.32 7.37
HP_PETERS_ANOMALY 6.15 6.29 6.4 6.59 6.54 6.74 6.69 6.32 6.59 6.49 6.46 6.75 6.66 6.28 6.64 6.33 6.84 6.26 6.25 6.42 6.61 6.45 6.8 6.62 6.48 6.45
HP_NYCTALOPIA 6.14 6.02 6.33 6.4 6.11 6.27 6.2 6.17 6.14 6.28 6.3 6.29 6.25 6.36 6.2 6.3 6.15 6.1 6.11 6.25 6.27 6.21 6.3 6.33 6.09 6.28
HP_HORIZONTAL_NYSTAGMUS 6.91 6.86 7.15 7.23 7.39 7.18 7.33 7.29 7.36 7.2 7.35 7.29 7.58 7.34 7.31 7.18 7.15 7.11 6.96 7.46 7.05 7.3 7.47 7.67 7.33 7.22
HP_PHTHISIS_BULBI 7.11 7.4 7.22 7.18 8.14 7.97 7.43 7.2 7.68 7.97 6.98 7.87 7.9 7.87 7.39 7.21 7.46 6.97 7.59 7.38 7.13 7.22 7.91 7.92 7.17 7.31
HP_HYPODONTIA 7.16 7.11 7.23 7.09 7.23 7.28 7.3 7.4 7.29 7.41 7.18 7.29 7.49 7.42 7.25 7.29 7.19 7.26 7.4 7.27 7.19 7.25 7.43 7.5 7.3 7.32
HP_CARIOUS_TEETH 6.53 6.45 6.42 6.38 6.34 6.38 6.41 6.54 6.34 6.43 6.52 6.5 6.44 6.42 6.31 6.45 6.41 6.51 6.58 6.56 6.4 6.49 6.36 6.54 6.34 6.59
HP_ANODONTIA 6.03 6.37 6.24 6.52 6.4 6.52 6.57 6.49 6.72 6.76 6.38 6.86 6.74 6.42 6.17 6.47 6.6 6.74 6.74 6.21 6.42 6.24 6.84 7.19 6.56 5.96
HP_ABNORMALITY_OF_THE_INCISOR 6.64 6.71 6.54 6.93 6.77 6.74 6.8 6.84 6.64 6.83 6.66 6.81 6.76 6.64 6.82 6.7 6.52 6.48 6.82 6.76 6.59 6.92 6.81 6.96 6.93 6.96
HP_OLIGODONTIA 6.84 6.73 6.83 6.45 6.93 7.02 6.91 7.07 6.9 7.29 6.9 7.05 7.11 7.06 7.21 6.81 7 7.04 7.02 6.81 6.99 7.03 7.34 7.49 6.93 6.84
HP_DENTAL_CROWDING 6.84 6.91 6.89 7.01 7.32 7.35 7.66 7.67 7.58 7.57 6.92 7.3 7.28 7.36 7.44 7.37 7.2 6.99 7.11 7.52 7.31 7.53 7.59 7.53 7.32 7.36
HP_DELAYED_ERUPTION_OF_PRIMARY_TEETH 6.24 6.37 6.09 6.38 6.92 6.74 6.62 6.58 7 6.66 6.16 7 6.83 6.68 6.62 6.7 6.6 6.43 6.59 6.52 6.6 6.62 6.8 7.09 6.6 6.31
HP_DELAYED_ERUPTION_OF_TEETH 6.83 6.72 6.84 6.64 7.07 7.18 6.99 7.08 7 7.04 6.65 7.08 7.16 7.13 7.19 6.93 6.64 6.81 6.97 6.95 6.87 6.93 7.18 7.35 7.06 6.88
HP_HYPOPLASIA_OF_TEETH 6.62 6.89 6.65 6.66 6.78 6.68 6.62 6.58 6.91 6.86 6.72 7.01 6.86 6.67 6.67 6.7 6.71 6.88 6.87 6.85 6.6 6.85 6.81 7.01 6.79 6.77
HP_WIDELY_SPACED_TEETH 7.39 7.43 7.71 7.43 7.79 7.88 7.66 7.65 7.61 7.77 7.51 7.78 7.83 7.85 7.63 7.65 7.38 7.43 7.7 7.65 7.39 7.57 7.94 7.91 7.58 7.73
HP_DENTAL_MALOCCLUSION 6.53 6.65 6.65 6.79 7.03 7 6.64 6.76 6.78 6.86 6.71 6.71 6.9 6.71 6.57 6.62 6.75 6.76 6.84 6.56 6.68 6.47 6.8 6.98 6.81 6.62
HP_MICRODONTIA 6.57 6.58 6.47 6.37 6.56 6.37 6.37 6.5 6.35 6.52 6.63 6.38 6.4 6.51 6.46 6.66 6.5 6.48 6.59 6.59 6.79 6.56 6.5 6.54 6.64 6.8
HP_MISALIGNMENT_OF_TEETH 6.88 6.94 7.05 6.94 7.13 7.25 7.19 7.25 7.08 7.32 6.94 7.04 7.24 7.36 7.2 7.14 7.12 7.02 7.18 7.3 7.16 7.35 7.24 7.33 7.19 7.2
HP_NATAL_TOOTH 6.91 6.88 6.83 6.9 7.06 7.1 7.37 7.02 7.53 7.35 6.92 7.07 7.18 7.11 6.89 6.91 7 6.8 7.09 7.36 6.81 7.11 6.89 7.15 7.25 7.2
HP_DELAYED_ERUPTION_OF_PERMANENT_TEETH 6.63 6.54 5.93 6.32 6.02 6.18 6.24 6.4 6.18 6.37 6.12 6.1 6.54 6.25 6.41 6.35 6.58 6.49 6.26 6.14 6.18 6.25 6.15 6.2 6.5 6.46
HP_CONICAL_TOOTH 5.44 5.97 5.82 6.16 6.17 5.88 5.91 5.77 6.07 5.94 5.66 5.89 5.68 5.74 5.56 5.87 5.38 5.66 5.55 5.93 5.48 5.68 5.94 5.74 5.58 5.33
HP_DIASTEMA 7.05 7.16 7.43 6.91 7.46 7.36 7.34 7.76 7.51 7.67 7.33 7.9 7.66 7.46 7.65 7.84 7.54 7.3 7.57 7.56 7.73 7.65 7.63 7.74 7.65 7.72
HP_PERIODONTITIS 6.07 5.86 6.31 6.05 5.98 5.97 6.1 6.24 6.09 6.13 6 5.94 6 5.8 6.12 6.14 6.25 5.98 5.84 6.29 6.54 6.79 6.24 6.03 6.66 6.68
HP_AMELOGENESIS_IMPERFECTA 5.44 5.34 5.7 5.59 5.36 5.23 5.42 5.39 5.42 5.21 5.47 5.33 5.39 5.19 5.54 5.12 5.07 5.58 5.25 5.32 5.43 5.32 5.05 5.18 5.59 5.43
HP_UNERUPTED_TOOTH 7.62 7.69 7.06 7.36 8.15 7.95 7.56 7.65 7.61 8.05 7.8 8.19 7.92 7.87 7.65 7.78 7.82 7.89 7.97 7.81 7.61 7.9 7.79 7.88 8 7.97
HP_PSYCHOSIS 6.78 6.94 7.09 6.85 7.16 7.37 7.05 7.29 7.01 7.21 6.78 7.07 7.24 6.98 6.86 7.17 6.98 6.83 6.82 7.18 7.2 7.33 7.04 7.32 7.1 7.14
HP_HYPERORALITY 8.81 8.71 9.43 9 8.97 9.28 9.58 8.98 9.34 9.2 9.06 8.86 8.99 8.93 8.72 8.73 8.75 8.41 8.95 9.33 8.98 8.91 9.46 9.03 9.22 8.78
HP_RESTLESSNESS 7.87 7.95 8.12 7.84 8.52 8.55 8.43 8.21 8.35 8.52 8.26 8.52 8.35 8.46 8.27 8.39 8.16 7.9 8.31 8.41 8.21 8.34 8.38 8.7 8.36 8.25
HP_EMOTIONAL_LABILITY 7.2 7.27 7.63 7.71 7.55 7.48 7.45 7.47 7.34 7.64 7.17 7.34 7.46 7.2 7.49 7.35 7.58 7.25 7.48 7.69 7.23 7.72 7.46 7.87 7.36 7.34
HP_DEPRESSIVITY 6.98 6.97 7.14 7.28 7.11 7.2 7.2 7.23 7.08 7.31 6.97 7.15 7.33 7.34 7.32 7.2 7.08 6.95 7.25 7.18 7.12 7.07 7.25 7.4 7.23 7.15
HP_AUTISM 7.67 7.77 7.95 7.8 8.18 8.15 8.16 8.13 8 8.3 7.88 8.2 8.21 8.23 8.23 8.05 7.82 7.89 8.14 8.16 7.84 7.88 8.32 8.28 8.17 8.05
HP_AGGRESSIVE_BEHAVIOR 7.79 7.95 8.11 7.94 8.28 8.19 8.19 8.22 8.24 8.26 8.17 8.2 8.31 8.4 8.25 8.26 7.98 8 8.13 8.19 8.03 8.32 8.29 8.44 8.42 8.22
HP_INAPPROPRIATE_BEHAVIOR 8.12 8.48 8.84 8.51 8.73 8.88 8.75 8.75 9.09 8.58 8.4 8.63 8.76 8.59 8.45 8.38 8.23 8.22 8.49 8.64 8.62 8.47 8.79 8.83 8.61 8.26
HP_OBSESSIVE_COMPULSIVE_BEHAVIOR 7.74 7.88 7.9 7.85 8.38 8.14 8.32 8.15 8.33 8.24 7.89 8.17 8.19 8.2 8.21 8.2 8.01 8.01 8.03 8.23 7.92 8.14 8.3 8.41 8.28 7.99
HP_RESTRICTIVE_BEHAVIOR 9.09 9.03 9.32 8.93 9.04 9.6 9.59 9.48 9.41 9.4 8.93 9.07 9.2 9.24 9.49 9.29 8.92 8.58 9.21 9.42 9.27 9.07 9.51 9.64 9.5 9.08
HP_DEMENTIA 7.8 8.05 7.79 8.07 8.18 8.19 8.06 8.04 8.18 8.11 7.74 8.04 8.09 8.07 8.22 8.1 7.75 7.8 8.03 8.12 7.9 8.2 8.17 8.14 8.11 7.94
HP_FRONTAL_LOBE_DEMENTIA 9.21 9.16 9.2 8.65 9.29 9.12 9.31 9.33 8.75 8.79 8.95 9.02 9.2 9.44 8.89 9.03 8.68 8.73 9.01 8.74 9.3 9.29 9.07 9.17 9.42 8.83
HP_AUTISTIC_BEHAVIOR 7.79 7.85 8.04 7.89 8.22 8.16 8.22 8.15 8.14 8.24 7.9 8.14 8.19 8.21 8.24 8.12 7.92 7.89 8.04 8.17 7.95 8.13 8.25 8.35 8.23 8.05
HP_STEREOTYPY 7.86 8.11 8.09 8.05 8.4 8.39 8.39 8.33 8.17 8.33 8.04 8.26 8.31 8.47 8.46 8.34 8.2 8.13 8.3 8.35 8.15 8.34 8.24 8.44 8.42 8.18
HP_DISINHIBITION 8.06 8.16 8.07 8.05 8.46 8.52 8.34 8.15 8.41 8.46 8.05 8.36 8.42 8.5 8.26 8.28 8.1 8.05 8.39 8.38 8.04 8.37 8.44 8.49 8.28 8.21
HP_IMPAIRED_SOCIAL_INTERACTIONS 7.92 8.04 8.34 8.05 8.26 8.14 8.37 8.24 8.21 8.52 8.12 8.34 8.31 8.45 8.44 8.37 8.16 7.95 8.22 8.32 8.27 8.35 8.34 8.64 8.49 8.27
HP_SHORT_ATTENTION_SPAN 7.54 7.64 7.74 7.63 8 8.02 7.85 7.67 7.92 7.91 7.6 7.87 7.97 8.06 7.79 7.77 7.56 7.58 7.78 7.93 7.47 7.66 7.98 8.13 7.87 7.73
HP_IRRITABILITY 6.66 6.94 7.14 7.51 7.32 7.2 7.13 7.08 7.2 7.22 6.95 7.09 7.33 7.21 7.03 7.27 7.02 6.86 6.98 7.11 7.12 7.12 7.22 7.4 7.08 7.07
HP_HALLUCINATIONS 7.35 7.37 7.7 7.71 7.69 7.9 7.83 7.57 7.61 7.84 7.21 7.77 7.72 7.87 7.52 7.52 7.61 7.36 7.57 7.79 7.42 7.69 7.74 8 7.62 7.64
HP_SELF_MUTILATION 7.28 7.28 7.43 7.19 7.66 7.6 7.13 7.51 7.25 7.3 7.36 7.52 7.4 7.48 7.77 7.43 7.23 7.45 7.26 7.18 7.22 7.38 7.57 7.69 7.7 7.71
HP_LOW_FRUSTRATION_TOLERANCE 8.1 8.11 7.97 7.48 8.89 8.79 8.47 8.16 8.32 8.23 8.05 8.13 8.32 8.35 8.02 8.14 8.16 7.96 8.25 8.39 8.19 8.24 7.89 8.21 8.47 8.59
HP_DIMINISHED_MOTIVATION 7.78 7.94 8.03 8.24 8.41 8.24 8.26 8.16 8.33 8.3 8.12 8.29 8.35 8.42 8.22 8.2 7.95 7.8 8.04 8.2 7.95 8.37 8.29 8.64 8.28 8.29
HP_DELUSIONS 6.72 7.07 7.38 7.21 7.06 7.19 6.88 7.12 6.88 7.05 6.75 6.85 6.99 6.97 7.18 6.97 6.92 6.92 7.08 7.07 6.55 6.91 7.04 7.34 7.04 7.02
HP_INAPPROPRIATE_LAUGHTER 7.97 8.28 7.9 8.21 8.75 8.88 8.68 8.75 8.51 8.45 8.24 8.36 8.48 8.56 9.06 8.35 8.23 8.21 8.66 8.46 8.28 8.43 8.42 8.66 8.61 8.26
HP_DELAYED_SPEECH_AND_LANGUAGE_DEVELOPMENT 7.46 7.54 7.77 7.62 7.73 7.85 7.83 7.73 7.82 7.81 7.55 7.73 7.86 7.88 7.78 7.76 7.51 7.46 7.76 7.82 7.55 7.74 7.9 7.99 7.75 7.65
HP_PERSONALITY_CHANGES 7.15 7.23 7.69 7.99 7.45 7.65 7.46 7.45 7.26 7.34 7.21 7.41 7.46 7.67 7.67 7.39 7.23 7.33 7.33 7.67 7.49 7.76 7.46 7.71 7.3 7.27
HP_HYPERACTIVITY 7.53 7.61 7.75 7.69 7.99 7.97 7.89 7.77 7.91 7.91 7.61 7.88 7.97 8.07 7.81 7.82 7.6 7.64 7.77 7.95 7.54 7.7 7.98 8.11 7.89 7.74
HP_LACK_OF_INSIGHT 8.93 8.74 9.23 8.7 8.9 8.96 9.57 8.91 9.33 9 8.79 8.8 8.92 8.94 8.22 8.64 8.66 8.38 8.76 9.25 9.06 8.42 9.26 8.99 8.94 8.68
HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_MORPHOLOGY 6.93 7.03 7.23 7.1 7.2 7.29 7.24 7.24 7.27 7.29 7.1 7.25 7.27 7.31 7.25 7.23 7.12 6.95 7.16 7.32 7.09 7.2 7.35 7.37 7.32 7.28
HP_SENSORY_NEUROPATHY 6.73 6.97 7.11 6.94 7.18 7.29 7.29 7.27 7.28 7.2 7.17 7.19 7.16 7.3 7.17 7.23 6.95 6.98 7.17 7.33 7.06 7.07 7.36 7.55 7.28 7.24
HP_PERIPHERAL_AXONAL_DEGENERATION 7.16 7.39 7.34 7.36 7.37 7.38 7.39 7.33 7.5 7.54 7.23 7.42 7.46 7.56 7.39 7.33 7.14 7.26 7.2 7.41 7.29 7.42 7.57 7.65 7.5 7.42
HP_ABNORMAL_THORAX_MORPHOLOGY 6.63 6.66 6.7 6.71 6.88 6.91 6.79 6.86 6.77 6.85 6.72 6.83 6.82 6.76 6.78 6.75 6.78 6.68 6.75 6.85 6.69 6.8 6.9 6.92 6.86 6.87
HP_ABNORMAL_STERNUM_MORPHOLOGY 6.85 6.85 6.99 6.92 7.02 7.13 7.1 7.07 7.02 7.08 6.92 7.03 7.2 7.14 7.11 7.03 7.06 6.9 7 7.06 7.03 7.03 7.2 7.29 7.13 7.1
HP_PECTUS_EXCAVATUM 7.14 7.14 7.14 6.99 7.16 7.33 7.31 7.29 7.27 7.31 7.14 7.3 7.39 7.34 7.31 7.27 7.19 7.07 7.09 7.25 7.14 7.26 7.38 7.46 7.29 7.27
HP_PECTUS_CARINATUM 6.57 6.59 7.06 7 6.95 6.92 6.79 6.95 6.94 7.05 6.91 7.01 7.06 7.07 6.96 6.81 6.79 6.7 6.61 6.82 7.01 6.88 7.1 7.22 6.86 6.93
HP_ABNORMALITY_OF_THE_BREAST 6.52 6.58 6.67 6.63 6.7 6.9 6.67 6.69 6.71 6.75 6.6 6.69 6.8 6.74 6.63 6.55 6.53 6.56 6.68 6.67 6.48 6.59 6.79 6.91 6.72 6.76
HP_GYNECOMASTIA 6.04 5.95 6.2 6.13 6.07 5.91 6.13 6.13 6.16 6.21 6.04 6.44 6.25 6.15 6.24 6 6.1 5.95 6.02 6.12 6.08 6.13 6.18 6.22 6.14 6.32
HP_ABNORMALITY_OF_THE_RIBS 6.24 6.26 6.17 6.26 6.31 6.37 6.28 6.33 6.12 6.46 6.28 6.33 6.34 6.39 6.3 6.3 6.35 6.27 6.29 6.24 6.33 6.42 6.25 6.37 6.31 6.41
HP_SHORT_RIBS 6.37 6.29 6.34 6.34 6.21 6.42 6.17 6.31 6.03 6.53 6.44 6.56 6.37 6.56 6.14 6.55 6.38 6.4 6.43 6.41 6.26 6.44 6.09 6.35 6.27 6.6
HP_ABNORMALITY_OF_THE_DIAPHRAGM 6.94 6.87 6.9 6.58 7.06 7.1 7.01 7.07 7.23 7.11 6.88 7.16 7 7.04 7.03 6.98 6.94 6.72 7 7.13 6.9 6.83 7.09 7.22 6.93 6.99
HP_CONGENITAL_DIAPHRAGMATIC_HERNIA 7.08 7.07 7.07 6.64 7.36 7.66 7.31 7.21 7.37 7.45 7.07 7.58 7.45 7.36 7.12 7.27 7.34 7.14 7.34 7.37 7.25 7.26 7.16 7.73 7.2 7.26
HP_ABNORMALITY_OF_THE_THYMUS 6.38 6.36 6.18 6.33 6.45 6.11 6.21 6.45 6.19 6.3 6.26 6.46 6.16 6.39 6.37 6.29 6.23 6.43 6.37 6.24 6.11 6.09 6.29 6.27 6.3 6.61
HP_ABNORMAL_SCAPULA_MORPHOLOGY 6.36 6.18 6.17 5.98 6.22 6.32 6.15 6.28 6.17 6.27 6.16 6.4 6.34 6.22 6.17 6.29 6.34 6.31 6.25 6.17 6.27 6.36 6.29 6.42 6.25 6.47
HP_PRIMARY_AMENORRHEA 5.71 5.54 6.01 5.99 5.56 5.4 5.57 5.72 5.56 5.67 5.84 5.53 5.51 5.55 5.93 5.69 5.68 5.68 5.83 5.73 5.6 5.61 5.52 5.58 5.61 5.67
HP_NEPHROLITHIASIS 6.12 6.02 5.69 5.99 5.65 5.46 5.85 5.87 5.85 5.68 5.99 5.69 5.81 5.73 5.59 5.43 5.93 5.97 5.66 5.82 6.04 5.78 5.7 5.4 5.78 5.89
HP_INFERTILITY 5.35 5.28 5.15 5.21 4.99 5.01 5.19 5.13 5.07 5.13 5.15 5.05 5.1 5.02 5.21 5.22 5.1 5.35 5.05 5 5.26 5.18 4.91 4.88 4.95 4.99
HP_ABNORMALITY_OF_THE_URETHRA 6.51 6.54 6.71 6.59 6.68 6.66 6.58 6.61 6.64 6.69 6.6 6.69 6.7 6.58 6.67 6.59 6.51 6.53 6.54 6.7 6.59 6.53 6.78 6.86 6.57 6.61
HP_URETHRAL_OBSTRUCTION 6.51 6.71 6.56 6.35 6.71 6.32 6.42 6.7 6.67 6.58 6.54 6.3 6.28 6.4 6.36 6.63 6.47 6.54 6.49 6.61 6.94 6.71 6.46 6.83 6.21 6.75
HP_OLIGOSPERMIA 5.28 5.35 4.98 4.99 4.75 4.68 4.61 4.73 4.92 4.56 4.69 4.6 4.76 4.78 4.87 4.69 4.93 5.08 4.83 4.76 4.74 4.63 4.81 4.67 4.5 4.59
HP_RENAL_STEATOSIS 5.35 5.39 5.45 5.98 4.67 4.79 4.99 4.92 5 5.01 5.33 5.13 5.07 5.04 5.11 5.18 5.75 5.31 5.14 4.83 5.77 5.31 4.85 4.66 4.73 4.71
HP_IMPOTENCE 6.28 5.7 6.34 6.42 5.74 5.51 5.95 6.13 6.08 6.16 6.04 6.04 6.02 6.25 6.22 6.32 6.23 6.06 6 6.18 6.16 6.35 5.74 5.7 5.99 6.48
HP_RENAL_CORTICAL_CYSTS 6.29 6.34 6.45 6.28 6.98 7.07 6.39 6.28 6.17 6.25 6.27 6.42 6.5 6.43 6.41 6.65 6.48 6.26 6.5 6.61 6.11 6.63 6.34 6.28 6.3 6.64
HP_ENURESIS 6.32 6.04 5.82 5.8 6.48 5.92 6.07 5.93 5.74 6.39 6.19 6.12 5.67 5.95 5.88 5.98 6.62 6.05 6.12 6.41 6.27 6.13 6.08 5.49 5.96 5.98
HP_ABNORMAL_EXTERNAL_GENITALIA 6.49 6.51 6.64 6.62 6.58 6.66 6.56 6.61 6.6 6.71 6.59 6.61 6.72 6.66 6.63 6.61 6.54 6.48 6.57 6.61 6.6 6.68 6.79 6.77 6.64 6.64
HP_ABNORMAL_INTERNAL_GENITALIA 6.26 6.37 6.41 6.43 6.36 6.42 6.33 6.43 6.35 6.36 6.4 6.39 6.39 6.39 6.31 6.35 6.16 6.3 6.35 6.37 6.29 6.36 6.39 6.48 6.24 6.4
HP_BICORNUATE_UTERUS 5.74 5.46 5.38 5.74 5.74 5.4 5.35 5.77 5.82 5.8 5.28 5.54 5.83 5.59 5.69 5.53 5.49 5.3 5.79 5.68 5.43 5.61 5.73 5.62 5.24 5.53
HP_HYPERGONADOTROPIC_HYPOGONADISM 5.85 5.98 6.23 6.2 5.89 6.07 6.08 6.12 5.92 6.12 6.29 6.16 6.14 6.07 6.14 6.12 6.06 5.94 5.92 6.02 5.99 6.07 6.31 6.22 6.15 6.14
HP_POOR_EYE_CONTACT 7.55 7.63 8.29 8.01 7.89 8.05 8.2 8.13 8 8.03 7.96 8.04 8.03 8.1 8.27 8.19 7.93 7.84 7.94 8.15 8.11 8.12 8.12 8.3 8.21 8.04
HP_ABNORMALITY_OF_THE_THYROID_GLAND 6.3 6.41 6.36 6.35 6.39 6.5 6.46 6.4 6.47 6.56 6.35 6.46 6.47 6.45 6.43 6.45 6.24 6.35 6.41 6.45 6.4 6.41 6.45 6.53 6.45 6.46
HP_DELAYED_PUBERTY 6.32 6.41 6.51 6.41 6.5 6.66 6.48 6.65 6.63 6.69 6.37 6.59 6.78 6.66 6.5 6.44 6.4 6.43 6.42 6.78 6.48 6.49 6.73 6.82 6.61 6.54
HP_HYPERINSULINEMIC_HYPOGLYCEMIA 5.95 5.81 6.03 6.3 5.9 6.06 6.25 6 6.21 5.95 6.01 5.75 6.44 6.39 6.2 5.89 5.93 5.97 5.71 6.12 6.4 6.28 5.69 6.21 6.14 6.09
HP_ABNORMALITY_OF_THE_PARATHYROID_GLAND 6.4 6.61 6.43 6.46 6.02 6.3 6.4 6.54 6.34 6.51 6.4 6.62 6.11 6.2 6.49 6.35 6.21 6.49 6.56 6.53 6.31 6.17 6.79 6.26 6.39 6.43
HP_HYPOPARATHYROIDISM 5.99 6.27 5.89 5.93 5.77 5.85 6.24 5.84 5.95 5.8 6.19 6.26 5.66 5.7 5.89 5.54 6.07 6.27 5.98 5.75 6.04 5.78 5.72 5.57 5.98 5.94
HP_INSULIN_RESISTANT_DIABETES_MELLITUS 5.91 5.8 5.99 6.16 5.6 5.3 5.85 5.66 5.77 5.46 6 5.89 5.74 5.78 5.54 5.56 5.88 5.76 5.74 5.66 5.69 5.82 5.71 5.5 5.72 5.69
HP_ABNORMALITY_OF_THE_ADRENAL_GLANDS 6.31 6.38 6.35 6.37 6.39 6.54 6.57 6.46 6.31 6.36 6.34 6.48 6.46 6.43 6.32 6.44 6.38 6.29 6.36 6.67 6.38 6.43 6.43 6.66 6.4 6.51
HP_ADRENAL_HYPOPLASIA 6.18 6.09 5.84 6.02 5.81 5.87 6.05 6.28 6 5.93 5.82 5.94 5.78 5.81 6 5.98 5.98 6.02 5.81 5.84 6.14 5.94 6.08 5.66 5.97 5.92
HP_HYPERTHYROIDISM 6.12 6.57 6.02 6.29 5.86 6.07 6.55 6.71 6.62 6.12 6.22 6.6 6.09 6.51 6 6.12 6.13 6.05 6.71 6.78 6.2 6.23 5.66 6.22 6.07 6.34
HP_INCREASED_CIRCULATING_GONADOTROPIN_LEVEL 5.25 5.17 5.05 5.28 4.85 4.7 4.93 4.86 5.04 4.8 5.13 5 4.86 4.88 4.87 4.91 5 5.05 4.99 4.81 5.02 4.95 4.77 4.85 4.82 4.92
HP_PITUITARY_DWARFISM 4.76 4.41 4.61 4.82 4.27 4.23 4.5 4.39 4.38 4.62 4.85 4.37 4.45 4.37 4.38 4.49 4.49 4.5 4.79 4.15 4.81 4.46 4.45 4.05 4.38 4.37
HP_HYPERPARATHYROIDISM 5.69 5.89 5.84 5.95 5.53 5.27 5.29 5.06 5.67 5.07 5.86 5.19 5.42 5.29 5.27 5.28 5.87 5.59 5.37 5.24 5.71 5.66 5.47 5.13 6.01 6.11
HP_GROWTH_HORMONE_EXCESS 5.69 6.12 6.34 6.34 5.8 5.64 5.62 5.42 5.97 6 6.25 7.03 5.81 5.77 5.59 5.39 5.98 5.76 5.53 5.59 6.91 6.52 5.47 5.37 6.51 6.96
HP_ADRENAL_INSUFFICIENCY 6.42 6.52 6.65 6.4 6.69 6.64 6.69 6.63 6.54 6.64 6.48 6.67 6.84 6.71 6.49 6.62 6.44 6.43 6.44 6.87 6.49 6.53 6.62 6.79 6.59 6.69
HP_ABNORMALITY_OF_RENIN_ANGIOTENSIN_SYSTEM 5.05 4.91 5 5.07 4.59 4.57 4.62 4.69 4.78 4.4 4.75 4.51 4.56 4.56 4.59 4.59 4.84 4.91 4.7 4.62 4.95 4.68 4.57 4.67 4.78 4.75
HP_INCREASED_CIRCULATING_RENIN_LEVEL 5.05 4.75 4.79 5.21 4.45 4.4 4.58 4.6 4.6 4.4 4.88 4.54 4.39 4.48 4.51 4.55 4.86 5.06 4.58 4.55 4.95 4.64 4.45 4.55 4.32 4.59
HP_ADRENOCORTICAL_ABNORMALITY 6.44 6.52 7.16 6.63 6.71 6.97 6.85 6.31 6.88 6.94 6.61 6.25 6.95 7 6.97 6.69 6.95 6.44 6.52 7.09 6.99 7.4 7.21 7.25 7.68 7.16
HP_CONGENITAL_HYPOTHYROIDISM 5.84 5.62 5.51 5.89 5.4 5.06 5.86 5.37 5.56 5.25 5.77 5.34 5.18 4.99 5.51 5.26 5.4 5.71 5.32 5 5.69 5.37 5.51 5.27 5.3 5.16
HP_GOITER 5.99 6.1 6.25 6.18 6.01 6.31 6.36 6.06 6 6.45 6.28 6.81 6.13 6.06 6.16 6.33 5.98 5.76 6.22 5.96 6.18 6.48 5.76 6.13 6.38 6.62
HP_THYROID_ADENOMA 8.41 8.19 9.43 9.17 8.97 8.98 8.82 8.57 9.06 9.13 9.16 9.01 8.95 9.02 9 9.07 8.62 8.59 8.49 8.81 8.56 9.04 9.22 9.16 8.88 8.7
HP_INSULIN_RESISTANCE 5.89 5.87 5.95 5.97 5.53 5.31 5.76 5.67 5.74 5.52 5.81 5.56 5.66 5.53 5.55 5.57 5.73 5.78 5.89 5.59 5.61 5.66 5.66 5.32 5.69 5.6
HP_NEONATAL_INSULIN_DEPENDENT_DIABETES_MELLITUS 5.84 5.55 5.3 5.58 5.4 5.02 5.46 5.17 5.56 5.18 5.42 5.1 5.24 5.23 5.35 5.37 5.37 5.37 5 5.01 5.34 5.12 5.17 4.97 5.08 5.14
HP_IRREGULAR_MENSTRUATION 6.57 6.69 6.61 6.85 6.92 7.2 6.9 6.95 7 7.09 6.66 7.01 6.84 6.71 6.83 6.94 6.77 6.7 6.81 6.95 6.77 6.98 7.2 6.99 6.88 6.91
HP_HYPERALDOSTERONISM 4.81 4.73 4.59 4.96 4.41 4.37 4.59 4.54 4.58 4.29 4.68 4.39 4.36 4.46 4.62 4.22 4.64 4.93 4.44 4.5 4.85 4.56 4.42 4.2 4.52 4.36
HP_CENTRAL_DIABETES_INSIPIDUS 5.53 5.48 5.49 5.98 5.46 5.41 5.76 5.25 5.7 5.87 5.69 5.37 5.87 5.81 5.69 5.83 5.76 5.48 5.68 5.57 6.03 5.34 5.95 5.72 5.75 5.7
HP_ABNORMALITY_OF_THE_HYPOTHALAMUS_PITUITARY_AXIS 6.07 6.15 6.23 6.29 6.13 6.19 6.24 6.19 6.21 6.21 6.26 6.3 6.28 6.29 6.16 6.24 6.14 6.1 6.02 6.19 6.19 6.22 6.26 6.27 6.17 6.29
HP_DECREASED_FERTILITY_IN_FEMALES 5.35 5.35 5.29 5.47 5.05 5.13 5.36 5.24 5.19 5.66 5.3 5.51 5.32 5.11 5.33 5.47 5.4 5.71 5.08 5 5.45 5.35 5.03 5.07 5.07 5.29
HP_SECONDARY_AMENORRHEA 6.09 5.7 6.33 6.27 5.87 5.91 6.08 6.13 6.08 6.12 6.25 5.94 5.97 5.92 6.15 5.96 6.22 6.26 6.1 6.18 5.99 5.94 5.64 5.77 6.04 6.3
HP_INCREASED_CIRCULATING_PROLACTIN_CONCENTRATION 6.71 6.57 6.81 6.62 6.68 7.08 7.2 6.83 7.28 7.14 6.8 7.04 6.86 6.58 7.09 7.18 6.53 6.46 7.09 7.36 6.91 6.66 7.24 7.62 7.17 7
HP_PANHYPOPITUITARISM 5.9 5.96 6.1 6.17 6.1 6.03 6.19 5.91 6.3 6.2 6.26 5.96 6.44 6.36 6.07 6.13 6.09 6.03 6.1 6.23 6.33 6.41 6.3 6.04 6.2 6.14
HP_HASHIMOTO_THYROIDITIS 5.83 5.8 5.62 5.71 5.78 5.65 5.68 5.6 5.37 5.46 5.6 5.38 5.29 5.47 5.45 5.39 5.62 5.64 5.67 5.44 5.84 5.65 5.43 5.19 5.92 6.09
HP_DIABETES_INSIPIDUS 6.12 6.15 6.17 6.5 6.06 5.9 6.17 6.13 6.13 6.12 6.22 5.77 6.09 6.23 5.97 5.87 6.24 5.98 6.08 6.2 6.38 6.02 6.14 5.9 5.83 6.03
HP_OLIGOMENORRHEA 6.64 6.57 7.04 6.43 6.72 6.73 6.92 6.8 6.9 6.99 6.43 6.8 6.82 6.61 6.61 6.66 6.54 6.71 6.94 6.89 6.5 6.69 6.58 6.73 6.71 6.57
HP_11_PAIRS_OF_RIBS 6.95 6.98 6.92 6.86 7.11 7.22 7.17 7.45 6.88 7.07 7.05 7.44 7.25 7.19 7.16 7.17 6.88 6.82 7 7.46 6.97 7.17 7.19 7.33 7.21 7.16
HP_THIN_RIBS 6.14 5.96 6.01 6.09 6.29 5.77 6.14 6.22 6.06 6.02 6.06 5.86 6.02 5.92 6.23 6.23 6.06 6.05 6.23 6.04 6.08 6.02 6.09 5.69 6.09 6.09
HP_PROMINENT_STERNUM 6.16 6.05 6.25 6.08 6.51 6.66 6.59 6.72 6.35 6.4 6.13 6.36 6.46 6.43 6.45 6.59 6.03 6.17 6.22 6.31 6.09 6.38 6.49 6.68 6.04 6.14
HP_BROAD_RIBS 5.92 6.03 5.61 5.63 6.01 6.31 6.17 5.84 5.75 6.21 5.51 5.6 6.14 6.36 5.86 6.02 5.82 6.09 6.17 6.1 5.64 5.73 6.13 6.11 5.71 5.88
HP_CUPPED_RIBS 6.15 6.14 6.09 5.82 6.5 6.42 6.36 6.54 6.16 6.37 6.26 6.36 6.45 6.48 6.28 6.64 6.23 5.95 6.29 6.19 5.94 6.36 6.48 6.52 6.07 6.39
HP_HORIZONTAL_RIBS 6.46 6.34 6.58 6.5 6.38 6.36 6.02 6.19 6.06 6.28 6.61 6.59 6.31 6.44 6.13 6.56 6.22 6.37 6.62 6.11 6.31 6.7 6.29 6.33 6.2 6.49
HP_ABNORMAL_CLAVICLE_MORPHOLOGY 6.51 6.4 6.27 6.44 6.67 6.65 6.29 6.4 6.39 6.63 6.54 6.64 6.53 6.58 6.41 6.6 6.46 6.43 6.47 6.39 6.3 6.39 6.49 6.51 6.51 6.65
HP_LONG_CLAVICLES 6.33 6.22 5.75 6.1 6.31 6.69 6.13 6.04 6.03 6.58 6.21 6.56 6.51 6.58 6.18 6.29 6.39 6.23 6.41 6.15 6.1 6.2 6.22 6.35 6.1 6.16
HP_SHORT_CLAVICLES 6.62 6.87 6.97 6.9 6.94 6.76 6.64 6.76 6.72 7.16 6.93 7 6.92 6.71 6.91 6.74 7 6.76 6.79 6.83 7.02 7.18 6.85 6.93 7.04 7.19
HP_LATERAL_CLAVICLE_HOOK 6.56 6.36 6.1 5.96 6.57 6.42 5.54 5.87 5.61 6.17 6.42 6.56 6.27 6.56 6.08 6.59 5.87 6.4 6.54 6.05 6.21 6.36 5.89 6.32 5.58 6.38
HP_RIB_FUSION 6.98 6.92 6.81 6.63 6.98 7 7.16 7.1 6.98 7.07 7.04 7.35 7.29 7.19 7.19 7.56 7.13 7.28 7.25 7.27 7.21 7.36 6.98 7.05 7.18 7.42
HP_ANTERIOR_RIB_CUPPING 6.14 6.12 6.19 5.78 6.41 6.65 6.4 6.71 5.87 6.63 6.25 6.46 6.64 6.44 6.09 6.58 5.97 6 6.54 6.13 5.94 6.45 6.65 6.54 5.8 6.41
HP_SPRENGEL_ANOMALY 6.78 6.38 6.49 6.67 6.47 6.5 6.61 6.4 6.57 6.37 6.64 6.57 6.57 6.26 6.59 6.55 6.8 6.57 6.72 6.56 7.15 6.51 6.45 6.51 6.56 6.61
HP_SHIELD_CHEST 6.04 6.08 6.69 6.55 6.35 6.17 6.39 6.61 6.13 6.62 6.19 6.74 6.13 6.06 6.38 5.84 6.16 6.05 6.02 6.48 6.14 6.71 6.17 6.67 6.42 6.13
HP_BROAD_CLAVICLES 5.49 5.51 5.6 6.22 5.65 5.56 5.45 5.63 5.59 5.84 5.7 5.58 5.57 5.64 5.58 5.1 5.87 5.98 5.5 5.48 5.57 5.48 5.85 5.74 5.41 5.72
HP_ABNORMALITY_OF_THE_COSTOCHONDRAL_JUNCTION 6.16 5.81 6.34 6.04 5.92 6.37 6.3 6.34 5.95 5.74 6.37 6.03 6.98 6.76 6.05 6.59 5.81 5.69 6.45 5.88 5.94 5.93 5.9 6.48 6.02 6.24
HP_MISSING_RIBS 6.53 6.38 6.1 6.21 6.7 6.75 6.16 6.56 6.21 6.68 6.36 6.54 6.29 6.41 6.38 6.29 6.4 6.36 6.31 6.33 6.45 6.54 6.33 6.38 6.44 6.43
HP_PLATYSPONDYLY 6.14 6.12 6.34 6.34 6.46 6.31 6.23 6.32 6.25 6.31 6.22 6.38 6.26 6.32 6.29 6.26 6.18 6.12 6.23 6.31 6.15 6.28 6.26 6.43 6.35 6.36
HP_ABNORMALITY_OF_SKELETAL_MATURATION 6.42 6.58 6.67 6.67 6.75 6.69 6.64 6.75 6.61 6.75 6.61 6.67 6.77 6.71 6.81 6.65 6.57 6.47 6.59 6.69 6.66 6.72 6.85 6.95 6.65 6.76
HP_CHONDROCALCINOSIS 6.35 6.38 6.18 6.04 6.27 6.38 6.21 6.02 6.25 6.6 6.37 6.2 6.4 5.81 6.02 6.44 6.32 6.26 6.33 6.24 6.14 5.92 6.28 6.51 6.6 6.53
HP_THICKENED_CORTEX_OF_LONG_BONES 5.89 6.06 5.99 6.18 5.94 6.52 6.28 6.61 6.08 6.53 6.08 6.33 6.42 6.39 6.34 6.32 6.31 6.21 6.29 6.13 6.28 6.47 6.14 6.55 6.09 6.05
HP_OSTEOPENIA 6.33 6.24 6.49 6.44 6.45 6.51 6.42 6.42 6.56 6.39 6.39 6.45 6.53 6.51 6.36 6.44 6.26 6.35 6.33 6.44 6.24 6.31 6.49 6.54 6.46 6.5
HP_OSTEOPOROSIS 5.95 5.9 5.98 6 5.87 5.77 5.92 5.87 5.91 5.96 5.96 5.94 5.95 5.94 5.99 5.97 5.92 5.93 5.89 5.88 5.97 5.94 5.88 5.88 5.96 6.05
HP_ABNORMAL_DIAPHYSIS_MORPHOLOGY 6.37 6.31 6.41 6.44 6.5 6.47 6.42 6.54 6.4 6.53 6.42 6.54 6.49 6.51 6.45 6.53 6.39 6.44 6.35 6.44 6.4 6.49 6.55 6.58 6.63 6.64
HP_DYSOSTOSIS_MULTIPLEX 6.59 6.65 6.99 7.04 6.92 6.93 6.97 7.13 7.2 7.18 6.86 6.79 6.81 6.92 7.34 6.98 6.77 6.72 6.65 7.04 6.6 6.89 7.21 7.08 6.81 6.87
HP_ABNORMALITY_OF_THE_METAPHYSIS 6.49 6.38 6.55 6.43 6.69 6.7 6.47 6.58 6.46 6.6 6.42 6.64 6.64 6.62 6.46 6.6 6.51 6.45 6.57 6.67 6.4 6.54 6.63 6.66 6.52 6.65
HP_HYPOPLASTIC_ILIA 6.1 6.17 5.99 6.17 6.67 6.47 6.42 6.47 6.23 6.46 6.08 6.3 6.22 6.35 6.38 6.35 6.5 6.11 6.26 6.36 6.34 6.34 6.17 6.52 6.43 6.34
HP_JAUNDICE 6.07 6.02 5.96 6.12 6.14 6.09 5.96 6 6 5.82 6.1 6 5.93 6.12 5.79 5.95 5.97 6.03 5.84 5.97 5.92 6.07 6.03 5.9 5.96 6.04
HP_HYPERPIGMENTATION_OF_THE_SKIN 6.3 6.3 6.4 6.43 6.37 6.49 6.41 6.42 6.34 6.48 6.31 6.3 6.44 6.35 6.24 6.24 6.25 6.28 6.1 6.42 6.35 6.36 6.49 6.56 6.47 6.48
HP_SINGLE_TRANSVERSE_PALMAR_CREASE 7.14 7.28 7.16 7.19 7.39 7.52 7.33 7.38 7.45 7.46 7.07 7.48 7.45 7.53 7.51 7.39 7.34 7.32 7.48 7.5 7.2 7.42 7.63 7.75 7.48 7.33
HP_ACANTHOSIS_NIGRICANS 6.48 6.56 6.9 6.91 6.63 6.62 6.66 6.65 6.67 7.1 6.41 6.72 6.74 6.73 6.69 6.51 6.71 6.25 6.41 6.86 6.24 6.37 6.78 6.88 6.78 6.88
HP_CAFE_AU_LAIT_SPOT 6.97 7.06 7.16 7.46 7.33 7.46 7.18 7.41 7.31 7.33 7.27 7.31 7.31 7.19 7.34 7.37 7.01 7.03 7.12 7.34 7.06 7.28 7.33 7.64 7.27 7.29
HP_DRY_SKIN 6.15 6.23 6.38 6.39 6.19 6.05 6.29 6.27 6.14 6.38 6.32 6.15 6.26 6.18 6.22 6.16 6.33 6.32 5.9 6.2 6.27 6.29 6.29 6.2 6.22 6.37
HP_CYANOSIS 6.14 6.11 6.53 6.53 6.26 6.1 6.29 6.34 6.28 6.16 6.33 6.12 5.98 6.17 5.93 6.23 6.46 6.24 6.03 6.24 6.34 6.17 6.44 6.3 6.45 6.26
HP_HYPERKERATOSIS 6.05 6.02 5.99 6.12 5.85 5.8 5.91 5.87 5.95 5.91 5.94 5.96 5.87 5.81 5.84 5.86 5.95 5.96 5.79 5.76 6.05 5.97 6.06 5.74 5.99 6.04
HP_THIN_SKIN 6.71 6.67 6.97 6.82 6.94 6.78 6.83 6.92 7.08 7.02 6.93 6.99 6.98 6.79 6.91 6.74 7 6.98 7.09 7.14 7.02 7.07 7.27 7.42 7.17 7.22
HP_ECZEMA 6.02 5.96 5.86 5.96 6.32 6.16 6.04 6.25 6.33 5.92 6.04 5.9 6.1 6.26 5.95 5.94 6.18 6.02 6.01 6.25 6.05 6.18 5.86 6.14 6.29 6.38
HP_CUTIS_MARMORATA 7.35 7.28 7.45 7.44 7.46 7.72 7.43 7.39 7.53 7.72 7.5 7.78 7.63 7.8 7.5 7.56 7.52 7.13 7.51 7.46 7.39 7.64 8.1 7.92 7.58 7.75
HP_HYPOHIDROSIS 5.96 5.73 5.94 6.11 5.87 5.68 5.78 5.79 5.89 5.83 5.88 5.64 5.61 5.68 5.62 5.62 5.79 5.8 5.76 5.78 5.91 5.64 5.55 5.45 5.74 5.79
HP_PETECHIAE 6.23 6.51 6.27 5.63 6.38 6.28 5.83 6.21 6.29 6.03 6.34 6.22 6.05 5.98 5.98 6.15 6.21 5.99 5.97 6.19 6.15 6.09 6.39 6.33 6.43 6.23
HP_ECTODERMAL_DYSPLASIA 5.31 5.12 5.07 5.1 5 5.1 5.31 5.22 5.19 5.11 5.68 5.09 5.06 5.18 5.19 4.89 5.06 5.38 5.1 5.08 5.34 5.28 4.82 4.95 5.1 5.09
HP_ANHIDROSIS 6.12 6.23 5.79 5.98 5.88 6.01 5.73 5.89 5.93 6.41 6.32 6.18 5.65 6.09 5.91 5.93 6.27 6.14 6.01 5.49 6.03 5.77 6.03 5.51 5.79 6.04
HP_CUTIS_LAXA 6.96 6.9 7.16 7.04 7.02 7.01 7.05 7.05 7.06 7.23 7.13 7.05 7.18 7.36 7.19 7.29 6.82 7.05 7.16 7.1 7.07 7.2 7.21 7.14 7.15 7.33
HP_HYPEREXTENSIBLE_SKIN 6.3 6.23 6.36 6.43 6.55 6.25 6.33 6.45 6.37 6.62 6.41 6.4 6.61 6.6 6.52 6.49 6.54 6.28 6.23 6.47 6.61 6.37 6.5 6.5 6.7 6.63
HP_HYPERHIDROSIS 6.13 6 5.99 6.1 6.12 6.01 6.03 6.12 6.2 6.29 6.33 6.22 6.19 6.12 6.04 6.12 6.23 6.06 5.95 6.12 6.22 6.22 6.24 6.07 6.17 6.46
HP_SOFT_SKIN 6.33 6.08 5.98 6.43 6.19 5.97 6.18 6.13 5.95 6.1 6.15 6.1 5.98 6.29 6.02 6.15 6.32 6.15 6.02 6.13 6.37 6.26 6.14 5.83 6.03 6.34
HP_BRUISING_SUSCEPTIBILITY 6.17 6.11 6.08 6.07 6.19 6.02 5.95 5.93 5.97 6.1 6.31 6.24 6.19 6.13 5.92 6.02 6.26 6.15 5.9 6.07 6.3 6.23 6.2 5.96 6.3 6.28
HP_PURPURA 5.9 5.77 5.79 5.79 5.56 5.38 5.6 5.57 5.66 5.4 5.85 5.53 5.59 5.56 5.68 5.44 5.88 5.64 5.45 5.51 5.77 5.79 5.52 5.33 5.71 5.74
HP_PALLOR 6.7 6.75 7.07 6.97 6.97 7.01 6.95 7.05 6.81 6.99 7.02 7.06 6.97 6.9 6.98 6.95 6.62 6.67 6.81 6.92 6.91 7.09 7.09 7.09 7.08 6.88
HP_PALMOPLANTAR_KERATODERMA 5.72 5.81 5.69 5.84 5.49 5.55 5.76 5.61 5.73 5.73 5.83 5.69 5.63 5.74 5.67 5.71 5.74 5.81 5.62 5.55 5.85 5.69 5.79 5.41 5.83 5.95
HP_SKIN_RASH 5.81 5.63 5.77 5.89 5.6 5.53 5.91 5.71 5.81 5.53 5.69 5.33 5.59 5.61 5.52 5.48 5.78 5.73 5.6 5.73 5.75 5.86 5.43 5.35 5.67 5.61
HP_PRURITUS 5.35 5.22 5.22 5.38 5.11 4.93 5.25 5 5.01 5.08 5.24 4.84 5.03 5.07 5.08 5.01 5.2 5.39 4.93 4.8 5.22 5.14 5.04 4.77 5.09 4.95
HP_XANTHOMATOSIS 5.9 5.67 6.19 6.15 5.36 5.29 5.82 5.68 5.56 5.54 5.97 5.57 5.77 5.7 5.6 5.54 6.11 5.53 5.74 5.77 5.89 5.79 5.51 5.53 5.65 5.61
HP_CUTANEOUS_PHOTOSENSITIVITY 6.17 6.19 6.48 6.15 6.02 6.21 6.44 6.35 6.35 6.36 6.19 6.07 6.39 6.17 6.22 6.44 6.4 6.31 6.25 6.42 6.26 6.28 6.34 6.24 6.38 6.34
HP_MELANOCYTIC_NEVUS 6.8 6.9 7.13 7.2 7.11 7.22 7.12 6.95 7.13 7.05 7.07 6.92 7.1 7.15 7.54 7.22 6.92 7.01 7.13 7.17 6.95 7.13 7.33 7.33 6.99 7.02
HP_HYPERTRICHOSIS 7.29 7.45 7.57 7.41 7.44 7.66 7.57 7.48 7.55 7.7 7.43 7.7 7.62 7.51 7.6 7.64 7.58 7.23 7.53 7.65 7.33 7.59 7.72 7.8 7.56 7.54
HP_ABNORMALITY_OF_SKIN_PIGMENTATION 6.34 6.36 6.48 6.41 6.38 6.43 6.4 6.48 6.34 6.48 6.34 6.36 6.44 6.35 6.28 6.32 6.3 6.32 6.27 6.44 6.4 6.51 6.49 6.45 6.51 6.61
HP_ABNORMALITY_OF_SUBCUTANEOUS_FAT_TISSUE 6.59 6.59 6.5 6.9 6.9 6.91 6.78 6.69 6.72 7.05 6.44 6.84 6.79 6.61 6.63 6.53 6.5 6.47 6.79 6.78 6.6 6.75 7.14 6.93 6.83 6.86
HP_MULTIPLE_LENTIGINES 7.78 8.34 8.65 8.2 8.92 8.51 8.6 8.49 8.81 8.7 8.4 8.47 8.59 8.86 8.59 8.48 8.77 7.69 8.47 8.55 8.53 8.55 8.66 8.6 8.65 8.48
HP_LYMPHEDEMA 6.65 6.6 6.8 6.59 6.91 6.74 6.7 6.85 6.82 6.76 6.49 6.59 6.97 7.09 6.62 6.61 6.88 6.93 6.8 6.79 6.8 6.71 7.02 6.89 6.64 6.64
HP_DERMATOLOGICAL_MANIFESTATIONS_OF_SYSTEMIC_DISORDERS 6.07 6.05 6.19 6.2 6.2 6.08 6.12 6.02 6.05 5.95 6.24 6.02 5.92 6.1 5.85 6 6.02 6.04 5.95 6 5.99 6.05 6.14 6.04 6.04 6.07
HP_HIRSUTISM 7.08 7.35 7.59 7.26 7.41 7.59 7.53 7.38 7.55 7.55 7.33 7.46 7.44 7.41 7.59 7.57 7.2 7.13 7.44 7.57 7.17 7.42 7.77 7.87 7.37 7.36
HP_TELANGIECTASIA 6.47 6.38 6.65 6.73 6.82 6.71 6.5 6.57 6.49 6.66 6.48 6.52 6.52 6.42 6.21 6.44 6.57 6.37 6.43 6.53 6.35 6.26 6.43 6.69 6.38 6.42
HP_HYPOPIGMENTATION_OF_THE_SKIN 6.3 6.24 6.4 6.34 6.21 6.24 6.35 6.39 6.3 6.26 6.19 6.24 6.28 6.27 6.12 6.15 6.22 6.11 6.03 6.3 6.15 6.19 6.28 6.42 6.3 6.37
HP_MULTIPLE_LIPOMAS 6.71 7.02 7.23 7.87 7.03 7.11 7.12 6.95 7.6 7.19 6.79 6.94 7.05 7.18 7.5 7.22 6.82 7.03 6.78 7.35 7.08 7.06 7.54 7.67 7.22 7.07
HP_ABNORMAL_PALMAR_DERMATOGLYPHICS 7.17 7.27 7.31 7.22 7.39 7.57 7.47 7.44 7.53 7.58 7.23 7.52 7.46 7.54 7.6 7.41 7.3 7.32 7.44 7.53 7.27 7.46 7.64 7.81 7.5 7.32
HP_ERYTHRODERMA 5.19 5.21 5.02 5.2 4.98 4.83 5.31 4.97 4.9 4.96 5.24 4.87 5 5.08 5.05 4.83 4.74 5.36 4.73 4.88 5.05 5.14 4.82 4.74 4.97 4.77
HP_ALBINISM 6.41 6.55 6.42 6.21 6.24 6.12 6.34 6.33 5.97 6.32 6.08 6.45 6.27 6.24 6.01 5.88 6.25 6.29 6.55 6.21 6.14 6.47 6.35 6.34 6.43 6.55
HP_URTICARIA 6.21 5.86 5.94 5.65 5.78 5.56 6.22 6.35 6.29 6.05 6.05 5.74 5.71 5.81 5.68 5.84 5.85 5.99 6.07 5.95 5.6 5.97 6.12 6.16 6.1 5.61
HP_SOFT_DOUGHY_SKIN 6.14 5.63 5.79 5.59 5.88 5.49 5.88 5.73 5.8 5.77 6.26 5.82 5.77 5.97 5.45 5.82 6.01 5.93 5.76 5.51 5.97 5.72 5.81 5.26 5.69 5.77
HP_POIKILODERMA 6.05 6.07 6 5.99 5.89 5.98 6.11 6.34 6.29 5.81 6.13 6.07 6.06 5.83 5.73 5.86 6.03 5.81 6.08 6.01 6.24 5.97 5.67 6.03 6.32 6.31
HP_FRAGILE_SKIN 5.78 5.69 5.48 5.64 5.58 5.63 5.84 5.49 5.57 5.55 5.82 5.84 5.49 5.56 5.45 5.73 6.01 5.77 5.56 5.44 5.78 5.72 5.86 5.41 5.69 5.45
HP_HYPERMELANOTIC_MACULE 6.38 6.54 6.87 6.9 6.68 6.68 6.7 6.79 6.91 6.86 6.56 6.76 6.86 6.79 6.8 6.61 6.61 6.62 6.35 6.69 6.84 6.97 6.91 7.02 6.83 6.96
HP_PARAKERATOSIS 5.59 5.44 5.34 5.23 5.14 5.04 5.35 5.19 5.45 5.23 5.45 4.96 5.39 5.37 5.27 5.11 5.55 5.47 5.04 5 5.33 5.33 5.24 5.07 5.24 5.33
HP_VITILIGO 5.81 5.82 5.68 5.9 5.85 5.49 5.89 5.88 6.04 5.79 5.59 5.27 5.88 5.84 5.79 5.46 6.15 6 5.65 5.77 5.67 5.73 5.73 5.39 5.55 5.41
HP_ATOPIC_DERMATITIS 5.97 5.48 5.58 5.7 5.64 5.22 5.3 5.62 5.5 5.43 5.68 5.66 5.62 5.53 5.47 5.31 5.52 5.53 5.4 5.27 5.67 5.39 5.21 5.22 5.37 5.64
HP_CAVERNOUS_HEMANGIOMA 7.37 7.65 8.39 8.11 8.09 7.75 8.47 8.12 8.1 7.65 8.09 7.77 8.22 8.1 8.17 7.91 7.96 7.46 7.59 8.18 8.19 8.25 8.38 8.08 8.29 8.09
HP_SEBORRHEIC_DERMATITIS 5.9 5.7 5.79 5.96 6.53 6.13 5.77 6.22 6 6.16 6.04 5.79 5.95 5.7 5.83 5.71 6.29 5.62 5.71 6.06 5.98 6.07 5.96 6.27 6.02 6.03
HP_HYPOPIGMENTED_SKIN_PATCHES 6.05 6.07 6.18 6.32 5.98 6.06 6.24 6.24 6.17 6.16 6.04 6.05 6.05 5.92 5.99 6.03 6.12 6.02 5.91 6.18 5.98 6.07 6.05 6.27 6.15 6.31
HP_ERYSIPELAS 5.27 5.44 5.1 5.35 5.12 5 4.92 5.42 5.24 5.01 5.61 4.85 5.09 5.16 5.04 5.03 5.24 5 5.25 4.91 5.04 5.06 5.02 4.73 5.2 5.43
HP_MILIA 5.67 5.66 5.59 5.88 5.41 5.5 5.5 5.31 5.53 5.51 5.75 5.34 5.35 5.4 5.24 5.45 5.55 5.89 5.67 5.66 5.67 5.19 5.35 5.06 5.16 5.44
HP_APLASIA_CUTIS_CONGENITA 6.53 6.53 6.5 6.25 6.44 6.82 6.46 6.37 6.71 6.79 6.36 6.92 6.84 6.76 6.7 6.53 6.43 6.85 6.5 6.53 6.19 6.69 6.75 7.07 6.64 6.38
HP_POOR_WOUND_HEALING 5.91 5.76 6.01 6.1 5.86 5.55 5.79 5.55 5.61 5.44 6 5.84 5.68 5.67 5.45 5.61 6.05 6.01 5.41 5.5 6.22 5.73 5.83 5.6 6.06 6.24
HP_PTERYGIUM 6.17 5.91 5.81 6.31 5.52 5.83 5.93 6.05 5.91 5.94 5.87 5.85 5.59 5.8 5.84 5.8 5.85 5.74 5.96 5.77 5.85 5.95 5.97 5.88 5.92 6.34
HP_ACNE 5.97 6.26 6.45 6.37 6.35 6.39 6.44 6.05 6.82 6.3 6.33 6.61 6.67 6.38 6.48 6.2 6.11 5.88 6.2 6.43 6.01 6.09 7.06 6.76 6.7 6.47
HP_ACROCYANOSIS 6.21 6.12 6.4 6.71 5.89 5.73 6.27 6.1 6.28 5.71 6.2 5.81 5.55 5.52 5.98 6 5.88 6.12 5.9 5.81 6.29 6.15 6.15 6.07 6.23 5.85
HP_STRIAE_DISTENSAE 6.7 6.67 7.86 7.16 7.3 7.07 7.62 7.76 7.32 7.05 7.25 6.98 7.3 7.3 7.34 7.99 7.01 6.89 6.86 7.66 7.68 7.93 8.05 8 7.65 7.93
HP_NEUROFIBROMAS 7.52 7.76 8.04 8.64 8.22 8.16 8.63 8.15 8.03 8.01 7.89 8.02 7.84 8.15 8.08 8.01 7.92 7.72 8.06 8.18 7.2 7.61 8.19 8.18 8.08 7.36
HP_EPISODIC_HYPERHIDROSIS 8.98 9.27 9.27 8.65 9.16 8.9 9.42 8.73 8.87 8.67 8.54 8.88 9.22 9.08 8.66 8.43 8.97 8.49 8.91 9.4 8.75 8.57 9.17 8.96 8.7 8.23
HP_THICKENED_SKIN 6.13 6.07 6.12 6.16 6.03 5.96 6.07 6.09 6.07 6.06 6.06 6.03 6.01 6.07 6 6.02 6.03 6.01 5.89 6.01 6.12 6.02 6.23 6.03 6.06 6.14
HP_ATROPHIC_SCARS 5.95 5.65 5.49 5.85 5.87 5.6 5.78 5.29 5.62 5.52 5.92 5.73 5.64 5.47 5.3 5.74 5.71 5.83 5.4 5.53 5.92 5.72 5.93 5.72 6 5.59
HP_BILIARY_TRACT_ABNORMALITY 5.89 5.84 6.13 6.23 5.98 6.02 6.09 5.96 5.91 6.15 5.95 6.16 6.04 6.01 5.89 6.18 6.19 5.86 5.97 6 6.03 5.98 6.08 6.14 6.02 5.98
HP_CHOLELITHIASIS 6.18 6.52 6.6 6.69 6.08 6.09 6.4 6.42 6.32 5.91 6.37 6.28 6.1 6.29 6.32 6.43 6.4 6.48 6.15 6.4 6.61 6.25 6.31 6.12 6.33 6.59
HP_CHOLECYSTITIS 6.27 6.41 6.17 6.39 6.37 6.39 6.3 6.82 6.19 6.32 6.08 6.51 6.09 6.07 6.47 6.39 6.34 6.17 6.27 6.37 6.47 6.5 6.14 6.49 6.72 6.82
HP_ECTOPIA_LENTIS 6.43 6.18 6.16 6.34 6.44 6.29 6.36 6.3 6.49 5.98 6.4 6.41 6.3 6.29 6.05 6.1 6.41 6.2 6.22 6.29 6.28 6.29 6.35 5.92 6.29 6.44
HP_PAPILLEDEMA 7.67 8.03 8.14 8.09 8.27 8.16 8.31 8.53 8.26 8.27 7.83 8.27 8.1 8.41 8.54 8.28 7.78 7.72 7.82 8.18 8.19 8.52 8.19 8.42 8.75 8.16
HP_DEVELOPMENTAL_GLAUCOMA 6.58 6.4 6.82 6.67 6.99 6.9 6.69 6.81 6.79 6.52 6.55 6.57 6.81 6.66 6.73 6.71 7.15 6.78 6.52 6.52 7.07 6.69 6.81 6.68 7.06 6.61
HP_BRUSHFIELD_SPOTS 6.89 6.91 7.31 7.03 7.43 7.42 7.1 6.9 7.07 7.29 7.32 7.32 7.28 7.51 6.88 7.29 7 6.97 7.51 7.43 7.01 7.13 7.24 7.62 7.24 7.21
HP_ABNORMALLY_LARGE_GLOBE 6.68 6.7 6.9 6.89 7.07 7.11 6.65 6.87 6.91 6.73 6.8 6.99 7.13 6.98 7.21 7.07 7.22 6.94 6.68 6.55 7.38 7.29 7.09 6.87 7.31 7.3
HP_IRIDOCYCLITIS 5.41 5.18 5.21 5.17 4.64 4.69 5.13 4.99 4.83 4.7 5.12 4.65 4.78 4.72 4.81 5.02 5.16 5.33 5.37 5.17 5.48 4.79 4.55 4.53 4.94 4.75
HP_KERATOCONJUNCTIVITIS 6.04 6.13 5.95 6.17 5.97 6.14 6.13 6.03 6.63 5.97 6.3 5.91 6.27 6.01 5.71 5.97 6.07 6.17 6.02 6.36 5.8 5.9 5.93 5.8 5.94 5.93
HP_HETEROCHROMIA_IRIDIS 6.71 7.08 7.09 7.48 6.93 7.05 7.49 7.44 7.21 7.17 6.77 7.03 6.94 7.26 7.46 7.27 7 6.99 6.95 7.41 7.03 7.21 7.03 7.51 7.16 7.2
HP_ANGIOID_STREAKS_OF_THE_FUNDUS 6.17 5.86 6.52 6.5 6.43 6.18 6.09 6.06 6.06 6.23 6.2 6.33 6.28 6.2 6.32 6.2 6.01 5.84 5.84 6.46 6.25 6.26 6.02 6.25 6.15 6.05
HP_ABNORMAL_MACULAR_MORPHOLOGY 6.3 6.11 6.36 6.34 6.38 6.35 6.43 6.29 6.44 6.3 6.42 6.34 6.43 6.35 6.31 6.56 6.36 6.26 6.24 6.44 6.45 6.58 6.38 6.37 6.39 6.68
HP_RETINAL_ATROPHY 6.37 6.53 6.47 6.5 6.46 6.56 6.46 6.49 6.71 6.81 6.55 6.62 6.7 6.74 6.49 6.74 6.44 6.49 6.73 6.47 6.57 6.71 6.8 6.71 6.84 6.65
HP_OCULAR_ALBINISM 6.74 6.83 6.87 7.06 6.67 6.66 6.95 6.98 6.93 7.17 6.83 7.03 7.02 7.02 7.15 6.85 6.71 6.77 6.81 7.05 6.89 7.06 6.93 7.03 7.13 7.15
HP_XANTHELASMA 5.87 5.4 6.12 6.21 5.26 5.29 5.73 5.54 5.5 5.44 5.84 5.6 5.64 5.64 5.32 5.54 6.26 5.41 5.81 5.72 6.01 5.38 5.5 5.53 5.68 5.53
HP_ABNORMALITY_OF_CORNEAL_SIZE 6.23 6.34 6.41 6.53 6.38 6.32 6.43 6.42 6.41 6.53 6.51 6.5 6.39 6.44 6.41 6.48 6.36 6.42 6.15 6.42 6.49 6.5 6.5 6.39 6.55 6.56
HP_VISUAL_FIELD_DEFECT 6.35 6.37 6.59 6.55 6.5 6.59 6.44 6.48 6.61 6.67 6.49 6.63 6.68 6.51 6.38 6.57 6.43 6.46 6.53 6.57 6.34 6.57 6.63 6.79 6.5 6.5
HP_CORNEAL_DYSTROPHY 6.07 5.95 6.09 6.14 5.52 5.5 6.08 6.06 6.1 5.83 5.8 5.67 5.73 5.75 6.15 5.97 6.34 6.09 5.76 6.21 5.92 6.25 6.4 6.04 6.63 6.39
HP_LENS_SUBLUXATION 7.91 7.89 7.91 8.18 8.11 8.2 8.35 8.72 8.08 7.59 7.41 7.83 8.25 8.27 8.41 8.32 8.31 8.35 8.15 8.35 8.46 8.9 8.12 8.58 8.53 8.24
HP_CONSTRICTION_OF_PERIPHERAL_VISUAL_FIELD 6.18 6.27 6.48 6.51 6.33 6.35 6.22 6.21 6.12 6.28 6.48 6.25 6.64 6.38 6.05 6.44 6.36 6.79 6.5 6.25 6.17 6.25 6.41 6.38 6.01 6.27
HP_RETINAL_ARTERIOLAR_TORTUOSITY 6.35 6.04 6.18 6.7 6.08 6.02 6.28 6.42 6.32 6.15 6.52 6.29 6.22 6.4 6.36 6.43 6.31 6.28 6.32 6.4 6.68 6.3 6.31 5.98 6.08 6.62
HP_OPTIC_NEUROPATHY 6.96 6.71 7.54 7.38 6.89 7.15 7.13 7.2 7 7.28 6.99 7.16 7.34 7.19 7.06 7.36 7.11 7.04 7.28 7.11 6.82 7.26 6.99 7.26 7.07 7.3
HP_SEVERELY_REDUCED_VISUAL_ACUITY 5.72 5.69 5.53 5.75 5.75 5.56 5.65 5.51 5.52 5.93 5.92 5.89 5.82 5.77 5.67 5.87 5.67 5.85 5.78 5.82 5.88 5.87 5.65 5.72 5.62 5.74
HP_SACCADIC_SMOOTH_PURSUIT 7.56 7.56 7.97 7.96 8.04 8.17 8.36 8.63 8.14 8.54 7.75 8.49 8.39 8.35 8.47 8.41 7.97 7.68 7.96 8.19 8.09 8.33 8.23 8.47 8.31 8.24
HP_SEPTATE_VAGINA 6.37 6.55 7.36 6.41 6.98 6.85 6.53 7.1 7.09 7.05 6.62 7.17 6.8 6.99 6.65 6.92 6.13 6.54 6.15 6.88 6.54 6.51 7.2 7.42 7.03 6.81
HP_BRACHYDACTYLY 6.77 6.87 6.96 6.93 7.1 7.19 6.97 7.11 6.93 7.14 6.96 7.14 7.17 7.15 7.14 7.13 7.01 6.92 7.11 7.05 7.11 7.18 7.38 7.15 7.07 7.12
HP_SYNDACTYLY 6.67 6.7 6.96 6.74 6.94 7.04 6.91 7.01 6.93 7.02 6.83 7 7.1 7.04 7.15 7.01 6.88 6.84 6.95 6.97 6.88 7.04 7.01 7.09 6.95 7.04
HP_HAND_POLYDACTYLY 6.51 6.59 6.87 6.68 6.75 6.91 6.72 6.72 6.75 6.88 6.81 6.78 6.82 6.84 6.88 6.99 6.54 6.75 6.69 6.85 6.7 6.87 6.87 6.89 6.75 6.92
HP_POSTAXIAL_HAND_POLYDACTYLY 6.56 6.6 7.16 6.99 6.85 6.92 6.57 6.61 6.79 6.95 6.95 6.73 6.71 6.81 6.71 7.22 6.53 6.74 6.82 6.83 6.62 6.87 6.89 6.82 6.66 6.93
HP_ABNORMALITY_OF_THE_METACARPAL_BONES 6.6 6.63 6.55 6.56 6.82 6.84 6.76 6.87 6.77 6.8 6.69 6.91 6.88 6.79 6.77 6.86 6.71 6.79 6.85 6.86 6.81 6.84 6.97 6.96 6.78 6.84
HP_ABNORMALITY_OF_FINGER 6.61 6.65 6.81 6.71 6.79 6.87 6.71 6.84 6.78 6.87 6.7 6.81 6.86 6.8 6.85 6.78 6.71 6.68 6.71 6.81 6.76 6.87 6.93 6.95 6.86 6.84
HP_BROAD_PALM 6.23 6.3 6.44 6.55 6.56 6.54 6.64 6.71 6.51 6.69 6.29 6.67 6.78 6.52 6.68 6.62 6.31 6.25 6.26 6.44 6.48 6.45 6.81 6.91 6.92 6.64
HP_ABNORMAL_THUMB_MORPHOLOGY 6.62 6.65 6.8 6.7 6.77 6.76 6.66 6.85 6.72 6.82 6.73 6.67 6.79 6.71 6.76 6.85 6.65 6.67 6.71 6.67 6.75 6.76 6.85 6.87 6.76 6.74
HP_LARGE_HANDS 7.48 7.18 7.86 7.37 7.46 7.67 7.38 7.27 7.57 7.81 7.69 7.52 7.34 7.44 7.79 7.87 7.53 7.26 7.7 7.5 7.33 7.13 8.04 7.75 7.47 7.4
HP_PREAXIAL_HAND_POLYDACTYLY 6.23 6.24 6.22 6.41 6.38 6.22 6.11 6.36 6 6.19 6.29 6.42 6.27 6.43 6.33 6.55 6.15 6.11 6.16 6.18 6.59 6.39 6.33 6.17 6.39 6.6
HP_ADDUCTED_THUMB 6.6 6.63 6.65 6.62 6.7 6.48 6.57 6.7 6.47 6.62 6.55 6.53 6.47 6.56 6.47 6.49 6.57 6.51 6.64 6.54 6.71 6.36 6.57 6.58 6.56 6.6
HP_TAPERED_FINGER 7.21 7.46 7.56 7.43 7.4 7.67 7.68 7.73 7.66 7.71 7.53 7.72 7.73 7.8 7.84 7.93 7.48 7.4 7.57 7.83 7.55 7.73 7.92 7.98 7.82 7.54
HP_HYPEREXTENSIBILITY_OF_THE_FINGER_JOINTS 7.24 7.38 7.55 7.62 7.62 7.57 7.7 7.72 8.09 7.74 7.53 7.75 8.04 7.87 7.85 7.55 7.61 7.65 7.55 7.64 7.69 7.58 8.24 8.24 7.81 7.38
HP_HAND_CLENCHING 6.92 7.48 6.92 7.11 7.26 7.06 6.88 7.23 7.04 7.31 7.15 7.32 7.52 7.36 7.59 7.21 7.44 7.43 7.23 7.12 6.74 7.16 7.43 7.23 7.52 7.76
HP_ABNORMALITY_OF_THE_CARPAL_BONES 5.98 5.99 6.06 6.05 5.95 6.17 6.3 6.35 6.22 6.17 6.01 6.07 6.27 6.38 6.26 6.41 6.1 5.96 5.91 6.21 6.28 6.23 6.25 6.45 6.32 6.17
HP_ULNAR_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND 5.76 5.91 5.85 6.23 5.74 6.09 5.92 5.76 6.02 6.04 6.19 6.18 5.72 5.98 5.72 5.93 5.88 5.96 5.88 5.83 5.75 5.63 5.78 5.82 5.71 5.84
HP_ABNORMALITIES_OF_PLACENTA_OR_UMBILICAL_CORD 6.25 6.22 6.17 6.26 6.2 6.27 6.07 6.24 6.15 6.05 6.09 5.94 6.16 6.02 6.07 5.9 6.17 6.1 6.07 6.23 6.22 6.1 6.14 6.19 6.24 6.24
HP_ABNORMALITY_OF_PRENATAL_DEVELOPMENT_OR_BIRTH 6.48 6.44 6.63 6.54 6.5 6.58 6.51 6.48 6.53 6.53 6.53 6.51 6.53 6.5 6.48 6.57 6.49 6.47 6.43 6.46 6.51 6.57 6.55 6.59 6.62 6.6
HP_TRIPHALANGEAL_THUMB 5.8 5.77 5.93 6.03 5.76 5.77 5.75 5.79 6.14 5.8 5.81 5.63 6.01 5.92 5.79 5.73 5.62 5.92 5.8 5.82 5.74 5.56 5.76 5.85 5.76 5.75
HP_ABNORMAL_FINGERTIP_MORPHOLOGY 7.77 7.76 8 7.72 7.9 8.14 8.18 7.95 8.36 8.26 7.46 8.06 7.97 7.94 7.98 7.95 7.85 7.8 7.83 7.98 7.7 7.98 8.07 8.19 7.96 7.85
HP_DELAYED_OSSIFICATION_OF_CARPAL_BONES 5.75 5.59 6.05 5.92 5.43 5.54 5.71 5.83 5.94 5.58 6.25 5.88 5.69 5.89 5.83 5.9 5.9 6.12 5.52 5.85 6.11 5.99 5.81 5.83 6.2 6.19
HP_CLUBBING 5.77 5.73 5.78 5.94 5.61 5.49 5.65 5.55 5.71 5.83 5.68 5.65 5.48 5.56 5.5 5.73 5.65 5.86 5.54 5.72 5.66 5.59 5.41 5.34 5.61 5.73
HP_AUTOAMPUTATION 7.82 8.33 8.02 7.23 8.24 8.3 8.42 7.93 9.05 8.53 8.06 8.22 8.38 8.29 7.9 7.97 8.08 7.75 8.1 8.35 7.69 7.43 8.66 8.86 8.5 7.61
HP_ABNORMALITY_OF_THE_THENAR_EMINENCE 6.81 5.49 7.15 5.58 5.76 5.51 5.72 5.06 6.57 4.57 7.17 5.63 6.01 5.95 6.14 6.76 6.67 6.55 5.47 5.44 7.15 5.22 6.25 6.17 5.81 5.86
HP_BROAD_METACARPALS 6.54 6.71 6.14 6.36 6.51 6.71 6.62 6.37 6.31 6.61 6.54 6.62 6.72 6.56 6.37 6.46 6.67 6.96 6.69 6.61 6.77 6.67 6.56 6.53 6.87 6.82
HP_ABNORMAL_FINGERNAIL_MORPHOLOGY 6.55 6.59 6.71 6.68 6.54 6.56 6.59 6.53 6.62 6.66 6.57 6.56 6.46 6.52 6.46 6.58 6.62 6.54 6.53 6.61 6.6 6.82 6.52 6.53 6.64 6.76
HP_SLENDER_FINGER 6.78 6.88 6.98 6.75 6.88 6.84 6.84 6.92 6.97 6.87 6.88 6.97 6.87 6.8 6.92 6.76 7.1 6.87 6.86 6.91 7.08 7.04 7.18 7.06 7.09 7.09
HP_WRIST_FLEXION_CONTRACTURE 6.35 6.15 5.92 5.88 6.3 6.2 6.3 6.12 6.29 6.12 6.04 5.93 6.03 5.78 5.83 6.11 6.03 6.07 6.26 5.94 5.88 5.66 6.16 6.09 6.18 6.42
HP_LETHARGY 6.38 6.36 6.81 6.76 6.54 6.54 6.67 6.65 6.57 6.56 6.61 6.32 6.68 6.6 6.5 6.66 6.48 6.53 6.39 6.72 6.73 6.8 6.46 6.56 6.66 6.66
HP_INTELLECTUAL_DISABILITY_MILD 7.33 7.42 7.72 7.43 7.69 7.8 7.76 7.57 7.72 7.85 7.38 7.66 7.71 7.83 7.67 7.6 7.52 7.32 7.7 7.73 7.4 7.51 7.81 7.83 7.65 7.54
HP_SPASTICITY 7.54 7.59 7.95 7.76 7.88 7.98 7.9 7.83 7.93 7.94 7.74 7.86 7.94 7.91 7.92 7.85 7.64 7.58 7.76 7.95 7.67 7.85 7.9 8.07 7.88 7.78
HP_SPASTIC_PARAPLEGIA 7.53 7.66 8.22 7.92 7.95 8.21 8.15 8 8.06 8.21 7.78 8.25 8.05 7.94 8.04 8.14 7.93 7.7 7.82 8.27 7.89 8.07 8.07 8.33 8.19 7.95
HP_COMA 6.25 6.31 6.56 6.34 6.55 6.51 6.46 6.21 6.53 6.38 6.36 6.18 6.62 6.54 6.35 6.33 6.37 6.2 6.28 6.63 6.48 6.52 6.49 6.49 6.59 6.66
HP_DYSARTHRIA 7.32 7.37 7.7 7.5 7.62 7.75 7.62 7.57 7.65 7.71 7.42 7.65 7.66 7.67 7.61 7.61 7.5 7.33 7.59 7.72 7.4 7.63 7.7 7.81 7.61 7.61
HP_EXCESSIVE_DAYTIME_SOMNOLENCE 6.21 6.12 6.61 6.57 6.21 6.45 6.61 6.43 6.41 6.4 6.4 6.16 6.2 6.3 6.54 6.42 6.53 6.3 6.39 6.65 6.39 6.54 6.46 6.41 6.35 6.39
HP_SPASTIC_DIPLEGIA 7.74 7.55 7.98 7.78 7.97 7.99 7.71 7.56 7.86 8 7.77 7.7 7.6 7.71 7.78 7.71 7.62 7.67 7.68 7.69 7.55 7.89 7.92 7.84 8 7.83
HP_HYPOREFLEXIA 7.37 7.51 7.79 7.49 7.8 7.97 7.76 7.62 7.69 7.9 7.52 7.67 7.83 7.87 7.71 7.61 7.5 7.4 7.8 7.79 7.48 7.59 7.92 8.01 7.71 7.62
HP_CHOREOATHETOSIS 7.56 7.51 7.81 7.68 7.83 8.05 7.66 7.68 7.59 7.83 7.58 7.7 7.75 7.62 7.93 7.75 7.59 7.54 7.73 7.56 7.65 7.9 7.93 7.9 7.73 7.67
HP_MENTAL_DETERIORATION 7.88 8 7.99 8 8.25 8.28 8.11 8.05 8.06 8.17 7.89 8.07 8.16 8.09 8.05 8.1 7.74 7.83 8.12 8.17 7.9 8.12 8.24 8.26 8.11 7.96
HP_HEMIPARESIS 6.95 6.98 6.94 6.7 7.15 6.99 7.18 6.95 7 7.14 6.61 6.74 7.23 7.08 7.25 7.14 6.83 6.83 6.96 7.2 7.18 7 7.28 7.04 7.33 7.12
HP_MOTOR_DELAY 7.22 7.24 7.49 7.34 7.45 7.52 7.58 7.56 7.55 7.65 7.41 7.59 7.65 7.63 7.6 7.55 7.4 7.32 7.51 7.63 7.39 7.6 7.62 7.74 7.55 7.49
HP_POLYNEUROPATHY 7.1 7.15 7.13 7.23 7.12 7.47 7.43 7.48 7.31 7.22 6.91 7.23 7.28 7.05 7.21 7.23 7.45 6.92 7.18 7.43 6.64 6.93 7.11 7.32 7.44 7.18
HP_CEREBELLAR_ATROPHY 7.61 7.66 7.98 7.82 7.89 8.11 8.09 8.03 7.9 7.94 7.79 7.93 7.92 7.91 7.94 7.85 7.67 7.62 7.81 8.09 7.62 7.82 7.92 8.06 7.91 7.82
HP_ABNORMAL_CORPUS_CALLOSUM_MORPHOLOGY 7.42 7.52 7.75 7.58 7.73 7.84 7.78 7.76 7.8 7.77 7.49 7.7 7.83 7.84 7.78 7.72 7.52 7.49 7.65 7.83 7.54 7.76 7.77 7.94 7.77 7.65
HP_AGENESIS_OF_CORPUS_CALLOSUM 6.85 6.84 6.89 6.85 7.17 7.2 6.98 7.06 7.04 6.95 6.85 7.01 7.1 7.03 7.12 7.01 6.83 6.8 7.09 7.1 6.77 6.95 7.02 7.09 6.87 7.1
HP_HYPERTONIA 7.47 7.53 7.83 7.74 7.77 7.89 7.81 7.76 7.83 7.86 7.67 7.79 7.83 7.84 7.79 7.74 7.58 7.5 7.71 7.88 7.59 7.77 7.84 8 7.78 7.74
HP_ORTHOSTATIC_HYPOTENSION 6.26 6.31 6.01 6.28 5.83 5.61 6.05 5.84 6.03 6.19 5.97 6.08 5.81 5.6 5.89 5.86 6.1 6.11 5.6 5.5 6.34 6.24 5.8 5.7 5.75 5.93
HP_SYNCOPE 5.96 6.04 6.19 6.2 5.84 5.78 6.31 6.31 5.99 6.16 6.21 6.11 6.02 5.81 5.99 6.28 6.33 6.11 6 6.18 5.99 5.9 6.09 5.84 5.92 6.09
HP_TETANY 5.43 5.45 5.35 5.58 5.27 5.15 5.41 5.36 5.34 5.17 5.23 5.09 5.46 5.32 5.45 5.42 5.51 5.52 5.29 5.3 5.64 5.34 5.1 4.94 5.39 5.17
HP_BULBAR_PALSY 6.97 7.22 7.23 7 7 6.99 7.11 6.9 6.92 7.41 7.24 7.11 7.23 6.96 7.15 6.9 7.27 6.9 7.27 7.12 6.85 6.91 7.34 6.95 7.32 7.09
HP_AREFLEXIA 7.13 7.32 7.39 7.08 7.26 7.44 7.4 7.29 7.5 7.48 7.14 7.41 7.43 7.46 7.38 7.31 7.33 7.07 7.33 7.45 7.17 7.3 7.63 7.66 7.45 7.35
HP_SPASTIC_TETRAPARESIS 6.61 6.83 7.54 7.32 7.11 7.26 7.12 7.2 7.29 7.05 7.1 7.11 7.25 7.2 7.14 7.1 6.86 6.85 7.2 7.31 7.05 6.99 7.26 7.44 7.53 7.35
HP_MENINGITIS 5.27 5.27 5.13 5.36 4.99 4.95 5.38 5.26 5.34 4.97 5.18 4.91 5.13 5.08 5.28 5.06 5.42 5.13 4.93 5.13 5.31 5.31 4.93 4.87 5.12 5.07
HP_GAIT_DISTURBANCE 7.28 7.32 7.69 7.48 7.53 7.67 7.57 7.56 7.57 7.66 7.45 7.59 7.63 7.68 7.65 7.61 7.41 7.3 7.53 7.67 7.43 7.6 7.66 7.78 7.63 7.51
HP_CONFUSION 6.5 6.59 6.55 6.43 6.64 6.66 6.67 6.72 6.81 6.6 6.38 6.57 6.82 6.61 6.51 6.43 6.59 6.3 6.56 6.76 6.33 6.51 6.56 6.77 6.57 6.63
HP_GENERALIZED_HYPOTONIA 7.28 7.38 7.61 7.54 7.5 7.63 7.61 7.57 7.55 7.64 7.48 7.59 7.61 7.64 7.67 7.6 7.42 7.31 7.51 7.64 7.43 7.66 7.65 7.78 7.66 7.54
HP_ABNORMAL_CRANIAL_NERVE_MORPHOLOGY 6.79 6.89 6.9 6.69 7.01 7.17 7.04 6.96 6.97 7.06 6.81 7.12 7.1 7.01 7.1 7 7.01 6.92 7.02 7.23 6.94 7 7.06 7.01 7.17 7.1
HP_CRANIAL_NERVE_COMPRESSION 7.48 7.35 7.9 7.65 8.13 7.83 7.95 8.14 7.56 7.77 7.94 7.7 7.71 7.81 7.97 7.73 7.61 7.65 7.98 8.19 7.44 7.85 7.76 8.01 7.88 7.72
HP_STROKE 6.45 6.37 6.39 6.45 6.55 6.5 6.35 6.45 6.58 6.39 6.4 6.4 6.56 6.51 6.2 6.43 6.5 6.45 6.33 6.46 6.6 6.41 6.51 6.55 6.57 6.59
HP_ENCEPHALOPATHY 7.7 7.76 8.08 7.8 7.99 8.11 8.04 8.04 7.98 8.09 7.89 8.06 8.06 8.09 8.02 8.05 7.75 7.84 7.97 8.09 7.82 7.99 7.9 8.15 8.05 7.93
HP_PARKINSONISM 7.75 7.95 7.97 8.03 8.26 8.25 8.06 8.03 8.18 8.14 8.01 8.07 8.16 8.14 8.13 8.12 7.74 7.8 7.96 8.16 7.88 8.23 8.1 8.14 8.23 7.96
HP_TONGUE_FASCICULATIONS 8.67 8.41 8.58 8.72 8.75 8.86 9.19 8.4 8.74 9.05 8.57 9.08 8.86 8.98 8.71 8.61 8.41 8.45 8.5 8.8 8.82 8.74 8.71 9.02 8.91 8.7
HP_DYSMETRIA 7.39 7.24 7.74 7.57 7.63 7.73 7.66 7.82 7.74 7.71 7.47 7.96 7.82 7.74 7.68 7.79 7.56 7.31 7.66 7.82 7.71 7.7 7.72 7.83 7.83 7.74
HP_ABNORMAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY 7.52 7.59 7.84 7.74 7.87 8.01 7.92 7.92 7.84 7.91 7.69 7.88 7.92 7.87 7.9 7.85 7.63 7.6 7.83 7.98 7.68 7.83 7.94 8.05 7.84 7.83
HP_REDUCED_TENDON_REFLEXES 7.22 7.32 7.43 7.22 7.39 7.52 7.41 7.34 7.5 7.48 7.32 7.43 7.52 7.5 7.41 7.32 7.32 7.09 7.35 7.5 7.2 7.32 7.56 7.65 7.45 7.42
HP_NEONATAL_HYPOTONIA 7.13 7.19 7.54 7.4 7.53 7.5 7.55 7.54 7.59 7.58 7.3 7.61 7.72 7.64 7.54 7.46 7.35 7.26 7.41 7.5 7.17 7.43 7.77 7.76 7.56 7.49
HP_CEREBELLAR_HYPOPLASIA 6.89 6.95 7.21 7.27 7.17 7.15 7.11 7.23 7.25 7.14 7.18 7.11 7.19 7.22 7.27 7.2 6.94 6.94 7.08 7.31 6.98 7.11 7.17 7.36 7.24 7.18
HP_MUSCLE_WEAKNESS 7 6.98 7.31 7.16 7.14 7.3 7.21 7.2 7.25 7.24 7.09 7.17 7.21 7.27 7.2 7.18 7.06 6.93 7.18 7.28 7.09 7.13 7.25 7.35 7.3 7.24
HP_HYPOGLYCEMIC_COMA 6.17 6.6 6.49 6.76 6.34 6.86 6.62 6.25 6.45 6.27 6.32 6.36 6.73 6.94 6.42 6.26 6.43 6.31 6.45 6.91 6.31 6.54 5.93 6.35 6.41 6.57
HP_SPECIFIC_LEARNING_DISABILITY 6.82 7.02 7.11 7.06 7.12 7.17 7.22 7.23 7.14 7.29 6.93 7.12 7.13 7.12 7.22 7.08 7.13 6.86 7.09 7.06 7.15 7.12 7.36 7.38 7.08 7.27
HP_ABSENT_SEPTUM_PELLUCIDUM 7.04 7.26 7.39 7.51 7.07 7.25 7.38 7.23 7.28 7.37 7.06 7.28 7.42 7.37 7.44 7.56 7.23 7.09 7.24 7.22 7.34 7.26 7.44 7.49 7.4 7.35
HP_DYSTONIA 7.54 7.63 7.81 7.77 7.79 7.97 7.92 7.82 7.9 7.98 7.76 7.92 7.89 7.87 7.93 7.84 7.69 7.61 7.77 8.01 7.69 7.95 7.88 8.04 7.88 7.79
HP_COMMUNICATING_HYDROCEPHALUS 6.05 6.18 6.8 6.45 6.79 6.7 6.38 6.2 6.41 6.64 6.07 6.39 6.46 6.41 6.43 6.39 6.07 6.06 6.4 6.47 6.37 6.35 6.26 6.53 6.57 6.73
HP_BIMANUAL_SYNKINESIA 6.1 5.88 6.22 5.84 5.84 5.76 6.4 6.16 6.47 6.26 6.25 6.04 6.58 6.45 6.3 6.1 6.11 6.29 6.06 6.33 6.12 6.18 5.94 6.13 6.01 6.24
HP_MYOCLONUS 8.15 8.14 8.29 8.08 8.44 8.49 8.38 8.3 8.32 8.3 8.04 8.41 8.33 8.4 8.43 8.31 8.08 8.19 8.39 8.43 8.12 8.28 8.34 8.41 8.37 8.22
HP_TREMOR 7.35 7.32 7.6 7.49 7.53 7.72 7.62 7.57 7.53 7.69 7.46 7.64 7.7 7.67 7.63 7.62 7.47 7.43 7.61 7.78 7.42 7.68 7.64 7.78 7.67 7.58
HP_PARTIAL_AGENESIS_OF_THE_CORPUS_CALLOSUM 7.51 7.53 7.12 7.17 8.03 7.93 7.78 8.05 7.82 7.88 7.2 7.91 7.91 7.9 7.96 7.53 7.45 7.6 7.71 7.8 7.5 7.82 7.83 7.83 7.94 7.85
HP_LISSENCEPHALY 6.98 7.2 7.39 7.04 7.31 7.48 7.38 7.38 7.47 7.49 7.33 7.5 7.55 7.55 7.57 7.34 7.11 7.07 7.22 7.37 7.37 7.61 7.35 7.57 7.38 7.43
HP_CEREBRAL_HEMORRHAGE 6.88 6.9 6.9 6.68 7.28 7.35 6.87 6.89 6.92 7.23 7.3 7.56 7.16 7.13 7.25 7.16 6.95 7.14 7.04 7.27 7.02 6.94 7.28 7.31 7.14 7.3
HP_ABSENT_SPEECH 7.73 7.77 8.06 7.95 8 8.13 8.16 8.11 8.12 8.19 7.92 8.07 8.19 8.18 8.2 8.24 7.72 7.78 8 8.18 7.88 8.08 8.21 8.36 8.15 7.92
HP_HYPERREFLEXIA 7.07 7.13 7.5 7.34 7.31 7.39 7.34 7.39 7.42 7.48 7.29 7.41 7.51 7.47 7.4 7.4 7.18 7.11 7.34 7.41 7.2 7.39 7.44 7.63 7.4 7.33
HP_BRISK_REFLEXES 7.62 7.5 7.95 8.11 7.58 7.87 7.52 7.76 7.78 7.88 7.35 7.59 7.75 7.7 7.65 7.66 7.51 7.48 7.66 7.87 7.67 7.75 7.72 7.75 7.48 7.31
HP_FACIAL_DIPLEGIA 6.4 6.47 6.43 6.47 6.48 6.84 6.63 6.57 6.56 6.53 6.43 6.61 6.45 6.57 6.63 6.57 6.71 6.69 6.51 6.51 6.66 6.71 6.65 6.38 6.7 6.69
HP_SLURRED_SPEECH 7.26 7.19 7.9 7.76 7.24 7.69 7.86 7.37 7.34 7.56 7.69 7.34 7.52 7.61 7.32 7.38 7.45 7.39 7.63 7.77 7.39 7.4 7.71 7.67 7.57 7.11
HP_MEGALENCEPHALY 6.74 6.83 7.14 7.7 7.06 6.95 7.16 6.95 7.91 7.32 6.86 6.85 7.61 7.32 7.58 7.27 6.95 6.99 6.57 7.2 6.93 6.89 8.15 7.5 7.27 7.13
HP_PLAGIOCEPHALY 7.45 7.51 7.67 7.64 7.63 7.78 8.13 8 8.03 7.91 7.32 8.03 8.07 8.03 8.01 7.85 7.7 7.67 7.55 8.13 7.73 7.93 8.22 8.22 8.03 8.01
HP_HOLOPROSENCEPHALY 6.16 6.19 6.24 6.51 6.34 6.2 6.18 6.32 6.2 6.2 6.27 6.1 6.24 6.31 6.29 6.42 6.07 6.31 6.13 6.18 6.38 6.38 6.35 6.2 6.46 6.24
HP_CALVARIAL_SKULL_DEFECT 6.5 6.34 6.15 6.19 6.61 6.58 6.39 6.39 6.84 6.58 6.41 6.76 6.55 6.65 6.55 6.56 6.28 6.74 6.38 6.31 6.21 6.22 6.46 6.54 6.25 6.34
HP_CRANIOSYNOSTOSIS 6.53 6.58 6.6 6.67 6.75 6.76 6.65 6.85 6.64 6.69 6.61 6.62 6.81 6.71 6.82 6.68 6.6 6.6 6.67 6.68 6.58 6.73 6.63 6.82 6.7 6.86
HP_ABNORMAL_JOINT_MORPHOLOGY 6.47 6.45 6.62 6.58 6.65 6.66 6.58 6.67 6.62 6.63 6.54 6.56 6.63 6.58 6.54 6.57 6.53 6.47 6.48 6.6 6.51 6.64 6.62 6.71 6.65 6.68
HP_ARTHRITIS 5.81 5.64 5.72 5.89 5.46 5.38 5.71 5.53 5.73 5.43 5.69 5.47 5.51 5.44 5.57 5.48 5.69 5.68 5.75 5.44 5.75 5.65 5.54 5.4 5.74 5.64
HP_RHEUMATOID_ARTHRITIS 5.15 5.18 4.64 4.86 4.64 4.35 4.5 4.7 4.61 4.45 4.78 4.55 4.21 4.7 4.21 4.56 4.82 5.28 4.76 4.59 4.87 4.41 4.49 4.25 4.47 4.56
HP_JOINT_DISLOCATION 6.45 6.43 6.57 6.62 6.58 6.66 6.54 6.62 6.59 6.67 6.59 6.51 6.63 6.59 6.51 6.56 6.51 6.46 6.44 6.52 6.51 6.52 6.61 6.68 6.65 6.77
HP_CONGENITAL_HIP_DISLOCATION 6.28 6.2 6.56 6.46 6.35 6.48 6.61 6.65 6.71 6.68 6.54 6.59 6.64 6.68 6.44 6.54 6.49 6.47 6.29 6.52 6.59 6.57 6.58 6.69 6.82 6.64
HP_LIMITATION_OF_JOINT_MOBILITY 6.48 6.41 6.43 6.64 6.65 6.62 6.63 6.63 6.56 6.66 6.44 6.57 6.61 6.57 6.48 6.45 6.62 6.51 6.52 6.49 6.48 6.6 6.79 6.65 6.64 6.69
HP_LIMITED_ELBOW_EXTENSION 6.49 6.98 6.44 6.67 6.09 6.11 6.61 6.48 6.25 6.37 6.45 6.67 6.6 6.45 6.74 6.25 6.76 6.81 6.77 6.36 6.48 6.6 6.28 6.63 6.63 6.69
HP_JOINT_HYPERMOBILITY 7.02 7.05 7.1 6.98 7.2 7.34 7.2 7.14 7.26 7.31 7.17 7.38 7.47 7.35 7.27 7.16 7.18 7.14 7.24 7.15 7.13 7.25 7.38 7.46 7.29 7.33
HP_HIP_DYSPLASIA 6.69 6.68 6.61 6.73 6.96 7.07 6.74 6.87 6.72 6.84 6.78 6.99 6.82 6.83 6.81 6.72 6.68 6.61 6.88 6.79 6.66 6.77 6.89 6.96 6.91 6.93
HP_JOINT_SWELLING 5.22 4.97 4.88 5.06 4.76 4.61 5.02 4.91 4.87 4.72 5.05 4.66 4.79 4.73 4.87 4.77 5.08 5.06 4.92 4.76 5.21 4.87 4.68 4.5 4.87 4.76
HP_JOINT_STIFFNESS 6.53 6.45 6.41 6.81 6.87 6.88 6.78 6.82 6.7 6.66 6.61 6.68 6.82 6.68 6.62 6.59 6.81 6.55 6.55 6.7 6.68 6.68 6.88 6.85 6.79 6.9
HP_JOINT_LAXITY 6.73 6.73 6.73 6.72 6.83 6.78 6.66 6.86 6.7 6.66 6.65 6.7 6.79 6.74 6.78 6.67 6.76 6.57 6.68 6.66 6.91 6.71 6.82 6.9 6.97 6.88
HP_ABNORMALITY_OF_THE_LIVER 6.4 6.42 6.61 6.61 6.55 6.55 6.52 6.52 6.48 6.57 6.43 6.52 6.51 6.51 6.43 6.49 6.41 6.4 6.46 6.52 6.45 6.48 6.51 6.53 6.54 6.64
HP_CIRRHOSIS 6.57 6.55 6.52 6.46 6.49 6.53 6.4 6.45 6.38 6.57 6.32 6.33 6.32 6.34 6.33 6.29 6.46 6.41 6.59 6.57 6.42 6.3 6.48 6.44 6.54 6.68
HP_HEPATIC_FIBROSIS 6.54 6.55 6.57 6.76 6.55 6.59 6.49 6.52 6.41 6.72 6.53 6.61 6.41 6.56 6.5 6.81 6.49 6.66 6.56 6.61 6.55 6.58 6.4 6.44 6.62 6.7
HP_CHOLESTASIS 6.23 6.3 6.36 6.3 6.41 6.38 6.23 6.15 6.31 6.17 6.29 6.19 6.16 6.28 6.02 6.24 6.25 6.25 6.26 6.27 6.06 6.21 6.28 6.14 6.19 6.2
HP_HEPATIC_FAILURE 6.34 6.33 6.57 6.46 6.37 6.56 6.38 6.48 6.37 6.36 6.37 6.3 6.28 6.38 6.43 6.46 6.26 6.37 6.47 6.57 6.36 6.46 6.53 6.39 6.36 6.36
HP_HEPATOCELLULAR_CARCINOMA 5.95 6.18 6.36 6.15 6.37 6.01 6.02 6.29 6.39 6.32 6.36 6.14 6.21 6.1 5.92 6.28 5.96 6.19 6.04 6.38 6.11 6.17 6.49 6.28 6.29 6.24
HP_MACROVESICULAR_HEPATIC_STEATOSIS 6.18 5.83 6.17 5.88 6.16 6.07 6.22 5.86 5.79 6.14 6.13 5.94 5.97 5.7 6.01 6.23 5.68 5.94 5.92 5.9 5.99 6.23 6.1 6.1 6.07 6.14
HP_HEPATIC_CYSTS 7.29 7.36 7.1 7.19 7.59 7.75 7.31 7.47 7.01 7.55 7.26 7.5 7.39 7.33 7.26 7.85 7.42 7.51 7.83 7.14 7.57 7.8 7.49 7.52 7.2 7.3
HP_BILE_DUCT_PROLIFERATION 5.85 6.09 6.16 6.02 6.38 6.22 6.08 6.15 5.79 6.12 6.19 6.35 5.92 5.95 6 6.14 5.85 5.84 6.16 5.94 6.2 6.23 5.82 6.14 6.12 6.14
HP_MICRONODULAR_CIRRHOSIS 6.82 6.69 6.77 6.59 7.09 7.37 6.89 6.48 6.75 6.95 6.77 7.33 7.24 7.22 6.84 6.87 6.83 6.72 7.22 6.81 6.66 6.39 6.83 7.16 6.93 6.77
HP_MICROVESICULAR_HEPATIC_STEATOSIS 6.4 6.87 7.54 7.52 6.85 6.73 6.45 6.88 6.64 6.96 6.95 6.77 7.12 7.05 7.39 7.46 6.88 6.74 6.6 6.72 6.8 6.85 7.03 6.99 6.67 6.87
HP_X_LINKED_RECESSIVE_INHERITANCE 6.5 6.74 6.91 6.74 6.81 7.16 6.94 6.96 7.16 7 6.77 6.98 7 6.9 6.87 6.84 6.86 6.65 6.81 7.06 6.76 7 7.24 7.34 6.98 6.83
HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_HAND 6.5 6.56 6.51 6.65 6.81 6.68 6.42 6.63 6.77 6.71 6.41 6.59 6.61 6.68 6.65 6.7 6.65 6.58 6.75 6.46 6.63 6.64 6.46 6.56 6.52 6.63
HP_X_LINKED_DOMINANT_INHERITANCE 7.09 7.14 7.91 7.4 7.32 7.75 8.06 7.6 7.76 7.92 7.64 7.64 7.64 7.64 7.87 7.42 7.15 7.06 7.31 7.73 7.4 7.68 7.84 7.94 7.74 7.47
HP_HETEROGENEOUS 5.93 6 6 6.03 5.92 5.93 6.11 6.13 5.98 6.06 6.02 5.97 5.92 5.85 5.95 5.96 5.99 5.96 5.76 5.89 6.05 5.9 5.94 5.94 6.07 6
HP_MULTIFACTORIAL_INHERITANCE 5.4 5.5 5.39 5.54 5.14 4.89 5.2 5.05 5.14 5.02 5.42 4.83 5.01 5.16 5.15 5.04 5.5 5.31 5.17 5.19 5.19 5.13 5.03 4.7 5.07 4.92
HP_SOMATIC_MUTATION 6.65 6.59 6.65 6.64 6.71 7.03 6.73 6.95 6.7 6.89 6.62 6.73 6.89 6.72 6.85 6.91 6.84 6.61 6.67 6.88 6.83 6.94 7.06 7.01 6.95 7.08
HP_ABNORMALITY_OF_THE_CALF_MUSCULATURE 6.54 6.71 6.35 6.51 6.83 6.58 6.42 6.42 6.57 6.59 6.53 6.71 6.5 6.47 6.39 6.47 6.6 6.47 6.41 6.51 6.37 6.4 6.73 6.52 6.7 6.67
HP_HEPATOSPLENOMEGALY 6.58 6.58 6.85 6.89 6.91 7.06 6.67 6.89 6.8 6.85 6.63 6.68 6.81 6.75 6.51 6.5 6.61 6.63 6.67 6.83 6.53 6.39 7.06 6.89 6.54 6.71
HP_ABNORMALITY_OF_THE_SHOULDER_GIRDLE_MUSCULATURE 6.39 6.27 6.35 6.17 6.38 6.52 6.35 6.4 6.33 6.43 6.35 6.55 6.36 6.44 6.39 6.44 6.49 6.47 6.53 6.38 6.48 6.43 6.46 6.44 6.4 6.67
HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LOWER_LIMBS 6.97 7.12 6.71 6.69 7.07 6.98 6.94 6.96 7.02 7.06 6.78 7.09 6.78 6.87 7.04 6.78 7 6.86 7.11 6.93 6.73 6.83 7 6.87 7.03 7.02
HP_ABNORMAL_ABDOMEN_MORPHOLOGY 6.4 6.38 6.55 6.55 6.54 6.53 6.41 6.44 6.52 6.53 6.4 6.41 6.55 6.52 6.45 6.41 6.36 6.38 6.43 6.48 6.37 6.46 6.5 6.54 6.51 6.52
HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_THIGH 6.78 7.02 6.76 7.31 7.25 7.47 7.24 7.21 7.13 7.46 6.88 7.12 7.1 6.97 7.27 7.09 7.21 7.16 7.04 7.3 6.77 6.89 7.28 7.54 7.52 7.19
HP_SOMATIC_MOSAICISM 7.33 7.48 7.97 8.3 7.8 7.71 7.84 7.59 8.16 8.05 8.22 8 8.29 8.27 8.08 8.07 7.55 7.19 7.52 7.85 7.18 7.14 8.46 8.5 7.83 7.73
HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_LIMBS 6.63 6.69 6.51 6.66 7.01 6.93 6.86 6.68 6.97 6.97 6.54 6.95 6.78 6.74 6.78 6.7 6.9 6.73 6.75 6.85 6.63 6.68 6.81 6.78 6.74 6.85
HP_ABNORMALITY_OF_THE_UPPER_ARM 6.02 6.06 6.05 6.36 6.28 6.43 6.35 6.42 6.7 6.6 6.37 6.6 6.5 6.51 6.48 6.44 6.22 6.45 6.25 6.44 6.14 6.49 6.79 6.74 6.6 6.65
HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_ARM 6.27 6.17 5.97 6.42 6.79 6.92 6.65 6.84 6.74 7.06 6.33 7.05 6.64 6.52 6.55 6.57 6.47 6.52 6.39 6.53 6.12 6.4 6.89 7.16 6.8 7.08
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETAL_MUSCULATURE 6.44 6.71 6.4 6.37 6.49 6.65 6.54 6.52 6.51 6.53 6.55 6.06 6.56 6.32 6.51 6.58 6.58 6.44 6.51 6.11 6.27 6.57 6.65 6.64 6.62 6.55
HP_DELAYED_CLOSURE_OF_THE_ANTERIOR_FONTANELLE 6.81 6.7 7.09 6.7 7.61 7.55 7.57 7.37 6.94 7.48 6.88 7.06 6.94 7.18 7.14 7.3 7.12 6.93 7.16 7.64 7.23 7.32 7.19 6.87 7.2 7.24
HP_FRECKLING 6.44 6.57 6.67 6.71 6.44 6.57 6.66 6.54 6.64 6.71 6.48 6.66 6.75 6.71 6.24 6.5 6.39 6.49 6.42 6.49 6.43 6.6 6.51 7.02 6.53 6.58
HP_SUBCUTANEOUS_NODULE 6.58 6.65 6.82 6.74 6.73 6.96 6.98 6.77 7 7.03 6.73 6.73 6.76 7.33 6.79 6.98 6.75 6.99 7.03 7.2 6.5 6.74 7.13 7.22 6.74 6.62
HP_BILATERAL_PTOSIS 7.13 7.14 6.94 7.08 7.12 7.2 7.51 7.45 7.17 7.31 7.02 7.45 7.31 7.39 7.26 7.31 7.13 7.26 7.31 7.38 7.38 7.47 7.45 7.51 7.34 7.05
HP_CARPAL_BONE_HYPOPLASIA 6.29 6.29 6.02 6.03 5.94 6.37 6.34 6.64 6.46 6.31 6 6.1 6.5 6.45 6.44 6.42 5.97 6.12 6.25 6.27 6.33 6.24 6.42 6.53 6.35 6.24
HP_BROAD_FINGER 7.27 7.22 7.35 7.11 7.33 7.62 7.51 7.57 7.51 7.54 7.33 7.43 7.76 7.68 7.47 7.6 7.53 7.26 7.51 7.44 7.43 7.71 7.58 7.64 7.57 7.55
HP_FAILURE_TO_THRIVE 6.69 6.68 6.99 7 6.89 7.03 6.89 6.94 6.89 6.9 6.82 6.88 6.97 6.96 6.86 6.9 6.79 6.75 6.8 6.95 6.79 6.95 6.95 7 6.91 6.9
HP_INTRAUTERINE_GROWTH_RETARDATION 6.54 6.62 6.65 6.7 6.72 6.86 6.67 6.79 6.6 6.75 6.61 6.7 6.73 6.66 6.65 6.73 6.62 6.55 6.65 6.8 6.6 6.69 6.79 6.87 6.66 6.69
HP_SMALL_FOR_GESTATIONAL_AGE 6.42 6.46 6.91 6.73 6.65 6.7 6.68 6.81 6.78 6.81 6.69 6.84 6.64 6.59 6.86 6.78 6.6 6.46 6.47 6.82 6.85 6.75 6.83 6.85 6.81 6.67
HP_DISPROPORTIONATE_TALL_STATURE 7.8 7.78 7.52 7.51 8 8.03 7.86 7.88 7.44 7.29 7.38 7.4 7.63 8 7.37 7.73 7.66 7.23 7.55 7.93 7.56 7.82 7.89 8 7.87 7.74
HP_LARGE_FOR_GESTATIONAL_AGE 6.51 6.34 5.95 6.26 6.53 6.73 6.56 6.57 6.59 6.68 6.24 6.66 6.82 6.76 6.44 6.32 6.61 6.4 6.58 6.78 6.53 6.42 6.42 6.65 6.6 6.6
HP_DEATH_IN_INFANCY 6.53 6.64 6.7 6.65 6.83 6.96 6.72 6.7 6.68 6.9 6.62 6.85 6.93 6.88 6.71 6.72 6.75 6.8 6.71 6.86 6.61 6.81 6.87 6.89 6.78 6.79
HP_SEVERE_FAILURE_TO_THRIVE 7.04 7.19 7.32 7.26 7.33 7.51 7.48 7.54 7.3 7.37 7 7.49 7.67 7.56 7.38 7.35 7.19 7.18 7.47 7.76 7.27 7.62 7.39 7.66 7.46 7.19
HP_HEMIHYPERTROPHY 7.19 7.19 7.76 8.24 8.06 7.75 7.72 7.53 7.91 7.76 7.75 7.77 8.03 7.91 8 7.65 7.14 7.07 7.49 7.83 7.21 7.17 8.15 8.19 7.37 7.43
HP_FAILURE_TO_THRIVE_IN_INFANCY 6.39 6.49 6.77 6.56 6.5 6.43 6.64 6.65 6.69 6.61 6.39 6.43 6.8 6.6 6.53 6.49 6.52 6.45 6.32 6.5 6.64 6.38 6.59 6.8 6.58 6.63
HP_SLENDER_BUILD 6.64 6.58 6.31 6.33 6.77 6.57 6.38 6.31 6.61 6.54 6.54 6.55 6.65 6.49 6.49 6.46 6.4 6.46 6.72 6.57 6.47 6.56 6.82 6.58 6.66 6.83
HP_PROTUBERANT_ABDOMEN 5.97 5.64 5.61 5.98 5.77 5.68 5.57 5.51 5.5 5.39 5.94 5.49 5.72 5.84 5.43 5.51 5.63 5.68 6.05 5.84 5.64 5.51 5.54 5.55 5.84 6.16
HP_OMPHALOCELE 6.03 5.91 5.97 6.02 5.91 5.9 6.09 6.04 6.17 5.87 6.26 6.24 6.05 6.06 5.86 5.93 6.31 6.1 6.05 5.99 6.47 6.3 6.31 6.23 6.02 6.04
HP_DIASTASIS_RECTI 6.22 6.18 6.3 6.15 5.95 5.97 6.32 6.52 6.07 6.06 6.14 6.2 6.17 6.24 6.25 5.96 6.57 6.14 6.08 6.11 6.51 6.53 5.93 6.39 6.25 6.33
HP_ASCITES 6.13 6.14 6.05 6.05 6.32 6.16 6.08 6.11 6.2 6.16 6.29 6 6.23 6.26 5.98 5.93 5.99 5.91 6.16 6.18 5.93 6.08 6.01 5.7 6.27 6.19
HP_ANTERIORLY_PLACED_ANUS 7.13 7.08 7.02 7.11 7.04 7.18 7.11 6.94 7.09 7.14 6.8 7 6.88 6.93 6.93 6.94 6.67 6.68 6.97 7.05 6.8 6.91 6.95 7.29 7.06 7.09
HP_ABNORMAL_RIB_CAGE_MORPHOLOGY 6.29 6.32 6.3 6.36 6.54 6.52 6.33 6.48 6.33 6.59 6.36 6.5 6.49 6.52 6.42 6.47 6.45 6.33 6.39 6.39 6.39 6.47 6.4 6.54 6.43 6.48
HP_OVERGROWTH 7.21 6.92 7.23 7.25 7.52 7.77 7.54 7.41 7.64 7.58 7.25 7.88 7.77 7.98 7.79 7.65 7.09 7.19 7.51 7.73 7.38 7.25 8.07 8.01 7.36 7.32
HP_ABNORMAL_ILEUM_MORPHOLOGY 6.34 6.24 6.56 6.45 6.45 6.66 6.52 6.43 6.78 6.64 6.37 6.52 6.61 6.38 6.55 6.38 6.22 6.24 6.18 6.44 6.24 6.1 6.62 6.85 6.36 6.26
HP_ABNORMAL_UMBILICUS_MORPHOLOGY 6.17 6.2 6.21 6.32 6.24 6.3 6.3 6.41 6.34 6.26 6.25 6.29 6.41 6.32 6.31 6.26 6.27 6.17 6.27 6.39 6.29 6.15 6.44 6.51 6.31 6.51
HP_BARREL_SHAPED_CHEST 5.75 5.93 5.98 6.03 5.92 5.71 6.08 5.82 6.08 6.5 5.63 6.06 5.98 5.95 5.86 5.64 6.13 5.55 5.81 6.02 5.57 5.77 6.26 6.28 5.71 5.99
HP_PRENATAL_MOVEMENT_ABNORMALITY 7.22 7.32 7.42 7.38 7.66 7.72 7.55 7.34 7.54 7.83 7.49 7.77 7.65 7.69 7.63 7.42 7.43 7.25 7.51 7.74 7.17 7.32 7.76 7.83 7.6 7.54
HP_ABNORMALITY_OF_THE_AMNIOTIC_FLUID 6.39 6.24 6.24 6.32 6.33 6.3 6.24 6.37 6.22 6.27 6.33 6.13 6.35 6.29 6.26 6.2 6.33 6.14 6.19 6.27 6.24 6.28 6.36 6.42 6.39 6.43
HP_POLYHYDRAMNIOS 6.49 6.46 6.37 6.49 6.38 6.43 6.31 6.48 6.49 6.48 6.52 6.5 6.53 6.47 6.37 6.37 6.5 6.47 6.44 6.51 6.47 6.52 6.59 6.54 6.66 6.62
HP_OLIGOHYDRAMNIOS 6.05 6.15 5.93 6.19 6.22 6.19 5.91 6.03 6 6.06 6.13 5.89 6 5.96 6.05 5.89 5.85 5.92 6 6.1 5.83 5.9 5.88 6.14 6.07 6.02
HP_FETAL_POLYURIA 4.75 4.74 4.41 5.08 4.37 4.29 4.49 4.55 4.56 4.51 4.7 4.6 4.36 4.4 4.55 4.28 4.75 4.96 4.6 4.37 4.76 4.47 4.65 4.18 4.34 4.46
HP_MACRODONTIA 6.95 7.55 7.85 7.41 8.09 8.06 7.99 7.62 7.97 7.96 7.48 7.95 8.12 8.24 7.91 7.84 7.74 7.43 7.89 7.95 7.59 7.74 7.95 8.23 8.12 8.14
HP_MOOD_CHANGES 7.3 7.27 7.98 7.92 7.66 7.65 7.71 7.6 7.66 7.4 7.77 8.03 7.57 7.75 7.77 7.37 7.49 7.34 7.53 7.84 7.82 7.81 7.98 8.11 7.67 7.48
HP_RECURRENT_SKIN_INFECTIONS 5.81 5.59 5.63 5.84 5.55 5.25 5.63 5.56 5.63 5.51 5.8 5.73 5.73 5.61 5.53 5.42 5.66 5.66 5.43 5.44 5.84 5.64 5.39 5.36 5.67 5.63
HP_REDUNDANT_SKIN 7.15 7.01 7.32 7.13 7.16 7.16 7.2 7.27 7.12 7.35 7.16 7.21 7.23 7.47 7.28 7.6 6.96 7.26 7.3 7.47 7.23 7.26 7.45 7.46 7.18 7.38
HP_ROTARY_NYSTAGMUS 7.77 7.94 7.44 7.26 7.7 8.16 7.55 6.99 7.54 7.92 7.3 7.68 7.98 8.19 7.3 7.39 7.11 7.62 7.8 7.77 7.16 7.3 7.82 7.83 7.32 7.33
HP_BELL_SHAPED_THORAX 6.72 6.83 6.74 6.87 6.87 6.93 6.62 6.85 6.66 6.92 6.44 6.72 6.77 6.77 6.65 6.9 6.84 6.89 6.99 7.03 6.64 6.86 6.94 6.54 7.11 7.04
HP_SELECTIVE_TOOTH_AGENESIS 5.57 5.83 5.81 5.66 5.89 5.59 5.43 6 5.66 5.61 5.63 5.52 5.57 5.79 5.51 5.87 5.35 5.54 5.52 5.2 5.34 5.81 5.86 5.95 5.5 5.4
HP_ABNORMAL_HAIR_MORPHOLOGY 6.69 6.68 6.86 6.87 6.9 6.94 6.81 6.92 6.87 6.91 6.81 6.85 6.88 6.93 6.91 6.93 6.75 6.76 6.84 6.96 6.81 6.93 6.9 7.04 6.86 6.9
HP_ALOPECIA 6.04 6.07 6 5.99 5.73 5.54 6.11 6.14 6.09 5.77 6.08 5.85 5.9 5.98 5.81 5.86 6.03 6 5.78 5.9 6.03 5.98 5.78 5.7 6.05 5.98
HP_ABNORMALITY_OF_THE_NAIL 6.49 6.53 6.51 6.56 6.49 6.62 6.56 6.56 6.49 6.57 6.53 6.56 6.58 6.51 6.55 6.44 6.55 6.41 6.5 6.55 6.54 6.55 6.51 6.54 6.61 6.62
HP_CONCAVE_NAIL 6.17 6.07 6.23 6.44 6.22 6.66 5.83 6.54 6.37 5.92 6.56 5.9 6.43 6.19 6.31 6.44 6.18 6.93 6.35 6.62 6.19 6.47 6.48 6.22 6.09 6.68
HP_ABNORMALITY_OF_THE_LARYNX 6.79 6.76 6.92 6.94 6.98 6.97 7.05 7.08 6.95 7.13 6.71 7 7.01 7 7.04 7.09 6.85 6.82 7.06 7.07 7.09 7.06 7.03 7.27 7.07 7.21
HP_LARYNGOMALACIA 6.77 6.62 6.6 6.64 6.89 6.92 6.81 6.93 6.72 6.87 6.62 6.91 6.85 6.82 6.92 6.92 6.62 6.68 6.99 6.91 6.95 6.93 6.81 7 6.92 7.08
HP_LARYNGEAL_STENOSIS 5.74 6.04 5.6 5.55 5.55 5.94 5.84 5.51 5.63 5.81 5.48 6.07 6.03 6.06 5.66 5.72 5.54 5.64 5.96 6.27 5.94 5.73 5.67 6.03 6.11 6.18
HP_VOCAL_CORD_PARALYSIS 7.84 7.71 8.21 7.81 8 8.05 8.23 8.14 7.74 7.98 7.98 7.67 8.01 7.69 8.18 7.77 7.68 7.87 8.03 8.21 7.45 7.98 8.16 8.11 8.11 7.84
HP_ABNORMALITY_OF_THE_VOICE 6.85 6.97 7.03 7.05 7.08 7.25 7.16 7.2 7.14 7.31 7 7.25 7.18 7.16 7.27 7.12 7.08 6.89 7.13 7.24 7.08 7.17 7.2 7.32 7.25 7.27
HP_HOARSE_VOICE 6.59 6.74 6.99 7.11 6.8 6.76 6.84 7.12 7 7.16 6.87 6.95 6.83 6.68 7.27 6.82 6.81 6.62 6.75 7.02 6.94 7.13 7.05 7.23 7.09 7.12
HP_NASAL_SPEECH 6.77 7.19 6.89 6.74 6.97 7.31 7.34 7.13 7.4 7.27 7.02 7.28 7.16 7.03 7.31 7.03 7.01 6.85 7.15 7.08 7.13 7.04 7.35 7.34 7.29 7.28
HP_WEAK_CRY 6.36 6.48 6.39 6.2 6.39 6.75 6.35 6.28 6.52 6.48 6.44 6.66 6.57 6.37 6.38 6.19 6.48 6.4 6.29 6.39 6.21 6.4 6.57 6.8 6.97 6.52
HP_HOARSE_CRY 5.8 5.46 5.31 5.55 5.46 4.9 5.17 5.26 4.96 5.13 5.56 5.05 5.06 4.91 5.07 5.05 5.35 5.42 5.04 4.91 5.04 4.99 5.19 4.94 5.08 4.96
HP_DYSPHONIA 7.13 7.24 7.25 7.45 7.66 7.58 7.34 7.47 7.29 7.71 7.48 7.63 7.52 7.48 7.5 7.49 7.37 7.27 7.59 7.47 7.32 7.68 7.41 7.6 7.48 7.48
HP_HIGH_PITCHED_VOICE 6.67 6.68 7 6.72 6.86 6.97 6.9 7.14 6.94 7.06 6.78 7.31 6.96 6.91 6.97 6.91 6.95 6.83 6.76 6.85 7.09 7.19 6.95 7.27 7.07 7.17
HP_WEAK_VOICE 8.79 8.76 9 8.64 8.92 8.79 9.1 9.08 8.43 8.56 8.27 8.41 8.69 8.67 8.89 9.02 8.18 8.31 8.76 8.74 8.7 9.07 8.22 8.77 9.12 8.83
HP_PREMATURE_BIRTH 6.25 6.1 6.24 6.44 6.26 5.96 6.22 6.09 6.2 6.27 6.3 6.16 6.22 6.27 6.08 6.2 6.21 6.27 6.06 6.21 6.23 6.24 6.26 6.05 6.19 6.23
HP_BREECH_PRESENTATION 5.95 6.04 6.2 6.16 6.38 5.9 6.09 5.93 6.04 5.85 6.08 5.94 5.75 6.06 5.85 6.16 6 6.12 5.72 5.99 6.17 6.35 6.06 5.55 7.07 7.02
HP_ABNORMAL_MITRAL_VALVE_MORPHOLOGY 6.56 6.58 6.65 6.57 6.65 6.63 6.64 6.76 6.67 6.63 6.53 6.63 6.71 6.62 6.47 6.57 6.49 6.48 6.39 6.58 6.64 6.61 6.96 6.96 6.74 6.89
HP_MITRAL_VALVE_PROLAPSE 6.58 6.65 6.96 6.68 6.75 6.71 6.66 6.89 6.75 6.85 6.64 6.71 6.84 6.68 6.56 6.61 6.85 6.55 6.43 6.69 6.71 6.66 7.01 6.99 6.95 6.91
HP_CONGESTIVE_HEART_FAILURE 6.69 6.88 7.06 7 6.87 6.89 6.86 6.88 6.73 6.91 6.66 6.81 6.63 6.58 6.7 6.74 6.95 6.74 6.82 6.91 6.68 7.06 7 6.93 6.95 6.9
HP_TETRALOGY_OF_FALLOT 6.41 6.24 6.18 6.28 6.28 6.3 6.24 6.42 6.27 6.32 6.29 6.3 6.39 6.39 6.31 6.32 6.25 6.14 6.24 6.25 6.51 6.3 6.31 6.41 6.25 6.25
HP_ABNORMAL_MYOCARDIUM_MORPHOLOGY 6.55 6.58 6.9 6.87 6.72 6.76 6.79 6.6 6.74 6.83 6.66 6.68 6.74 6.73 6.66 6.63 6.65 6.64 6.66 6.71 6.66 6.71 6.87 6.89 6.74 6.71
HP_HYPERTROPHIC_CARDIOMYOPATHY 6.61 6.68 7.24 7.12 6.79 6.89 6.86 6.75 6.86 6.91 6.91 6.72 6.89 6.94 6.81 6.89 6.74 6.72 6.78 6.89 6.81 6.82 7.05 7.06 6.79 6.79
HP_CARDIOMEGALY 6.55 6.64 6.95 6.94 6.86 6.77 6.84 6.94 6.9 6.68 6.71 7.02 6.78 6.59 6.75 6.68 6.89 6.67 6.68 6.74 7.1 6.99 7.11 7.02 6.95 6.94
HP_ABNORMAL_PULMONARY_VALVE_MORPHOLOGY 6.71 6.68 6.92 6.8 6.95 6.98 6.7 6.91 6.76 6.86 6.54 6.78 6.91 6.9 6.87 6.61 6.61 6.65 7.02 6.97 6.99 7.05 7.2 7.01 6.88 6.89
HP_PULMONIC_STENOSIS 6.91 6.71 7.16 7.01 7.18 7.11 7.19 7.45 7.32 7.33 7.07 7.17 7.57 7.48 7.1 7.53 7.09 6.91 7.14 7.13 7.15 7.18 7.33 7.52 7.13 7.2
HP_PATENT_DUCTUS_ARTERIOSUS 6.78 6.74 6.98 6.96 6.94 7.11 6.97 7.08 7.09 7.08 6.92 7.01 7.11 7.03 6.92 7.06 6.92 6.83 7.05 7.06 6.9 6.93 7.27 7.25 7.06 7.1
HP_DILATED_CARDIOMYOPATHY 6.31 6.36 6.5 6.56 6.56 6.52 6.41 6.26 6.53 6.47 6.45 6.62 6.38 6.41 6.41 6.43 6.62 6.49 6.52 6.51 6.6 6.38 6.83 6.44 6.56 6.45
HP_ABNORMAL_AORTIC_VALVE_MORPHOLOGY 6.47 6.36 6.5 6.47 6.51 6.42 6.41 6.45 6.64 6.5 6.36 6.53 6.49 6.44 6.37 6.41 6.47 6.3 6.2 6.46 6.48 6.37 6.57 6.59 6.49 6.57
HP_TACHYCARDIA 6.15 6.05 6.18 6.26 5.93 6.17 6.31 6.12 6.11 6.27 6.25 6.02 6.18 6.1 5.96 6.02 6.31 6.11 6.27 6.38 6.14 5.82 6.49 6.36 6.01 6.14
HP_AORTIC_VALVE_STENOSIS 6.47 6.44 6.51 6.48 6.56 6.35 6.31 6.6 6.33 6.53 6.38 6.54 6.4 6.43 6.16 6.37 6.49 6.35 6.24 6.44 6.41 6.64 6.5 6.42 6.64 6.6
HP_ABNORMAL_HEART_VALVE_MORPHOLOGY 6.57 6.53 6.65 6.51 6.74 6.63 6.64 6.71 6.69 6.66 6.47 6.64 6.69 6.61 6.59 6.57 6.6 6.52 6.44 6.66 6.62 6.64 6.85 6.82 6.65 6.86
HP_PATENT_FORAMEN_OVALE 7.71 7.83 8.04 7.74 7.98 7.95 8.2 7.96 8 8.26 7.94 8.16 8.15 7.88 8.21 8.25 7.69 7.86 7.95 8.11 7.75 8 7.95 8.28 8.02 8.01
HP_MYOCARDIAL_INFARCTION 6.41 6.41 6.44 6.41 6.6 6.5 6.26 6.32 6.59 6.5 6.42 6.29 6.48 6.4 6.27 6.15 6.3 6.33 6.57 6.38 6.42 6.07 6.51 6.45 6.44 6.44
HP_AORTIC_REGURGITATION 6.63 6.74 6.67 6.71 6.89 6.74 6.71 6.56 6.7 6.87 6.63 6.85 6.75 6.57 6.76 6.81 6.91 6.7 6.7 6.77 6.94 6.98 6.84 6.84 6.93 6.98
HP_TRUNCUS_ARTERIOSUS 5.89 5.62 5.73 6.33 5.4 5.09 5.79 5.46 5.87 5.25 6.04 5.4 5.61 5.45 5.85 5.44 5.68 5.61 5.31 5.37 5.78 5.83 5.52 5.18 5.7 5.83
HP_BRADYCARDIA 6.36 6.18 6.93 6.63 6.34 6.48 6.32 6.48 6.25 6.55 7.03 6.51 6.29 6.43 6.68 6.71 6.69 6.49 6.32 6.52 6.33 6.39 6.59 6.42 6.64 6.33
HP_VENTRICULAR_FIBRILLATION 6.76 6.6 7.07 6.48 6.58 6.99 7.16 7.24 7.13 7.31 7.07 6.91 7.34 7.57 7.3 7.18 7.1 7 7.18 7.18 6.94 6.81 7.48 7.63 7.54 7.25
HP_TORSADE_DE_POINTES 6.83 6.84 6.84 6.61 6.88 7.33 7.53 7.41 7.51 7.7 7.28 7.67 7.23 7.74 7.65 7.57 7.34 7.51 6.79 7.65 7.28 7.58 7.3 7.7 7.66 7.31
HP_RIGHT_VENTRICULAR_HYPERTROPHY 6.39 6.56 6.04 6.12 6.26 6.17 6.07 6.15 5.74 6.12 6.19 6.26 5.92 5.8 5.91 5.91 6.37 5.84 5.96 5.96 5.84 5.78 6.08 6.14 6.15 6.34
HP_TRANSPOSITION_OF_THE_GREAT_ARTERIES 5.57 5.46 5.41 5.47 5.13 5.18 5.48 5.43 5.29 5.69 5.42 5.63 5.42 5.18 5.49 5.66 5.55 5.84 5.25 5.24 5.54 5.41 5.22 5.11 5.43 5.53
HP_ASYMMETRIC_SEPTAL_HYPERTROPHY 4.95 4.84 4.84 5.38 4.38 4.25 5.54 5.02 4.71 5.58 5.28 5.01 5.32 4.68 4.83 5.11 5.72 5.68 5.07 4.9 4.99 4.78 4.36 4.71 4.61 5.1
HP_ABNORMAL_CARDIAC_SEPTUM_MORPHOLOGY 6.92 6.88 7.07 7.03 7.04 7.17 7.12 7.2 7.14 7.2 6.97 7.13 7.21 7.15 7.13 7.17 6.99 6.93 7.05 7.21 7.11 7.13 7.22 7.35 7.1 7.2
HP_COMPLETE_ATRIOVENTRICULAR_CANAL_DEFECT 6.04 6.06 6.05 6.28 6.01 5.56 6.01 6.01 6.07 5.69 6.29 5.89 5.68 5.74 6.05 6.18 6.18 6.12 5.75 5.7 6.7 6.69 5.86 5.76 5.97 5.88
HP_CORONARY_ARTERY_ATHEROSCLEROSIS 6.03 5.77 6.07 6.21 6.3 6.19 6.11 5.93 6.14 6.24 6.27 6.37 6.27 5.92 5.99 6 6.3 6.1 5.97 6.1 6.14 6.16 6.11 6.1 6.14 5.84
HP_ABNORMAL_AORTIC_MORPHOLOGY 6.61 6.59 6.6 6.67 6.82 6.74 6.68 6.72 6.77 6.82 6.61 6.78 6.79 6.62 6.65 6.7 6.71 6.61 6.59 6.68 6.87 6.8 6.87 6.92 6.84 6.89
HP_COARCTATION_OF_AORTA 6.69 6.59 6.67 6.71 6.74 6.67 6.71 6.95 6.7 6.82 6.66 6.79 6.73 6.6 6.83 6.76 6.79 6.76 6.43 6.79 7.13 7.08 6.89 6.78 6.84 6.86
HP_ANGINA_PECTORIS 6.23 6.07 6.18 6.25 6.44 6.03 5.86 6.32 6.02 6.27 5.96 5.84 6.27 5.81 5.61 5.97 6.11 5.93 5.71 5.72 5.88 5.94 5.75 6.1 5.84 6.03
HP_SUBVALVULAR_AORTIC_STENOSIS 4.98 4.95 4.84 5.08 4.99 4.92 5.09 5.02 4.71 5.25 5.36 5.01 4.85 4.68 4.82 5.08 5.4 5.13 5.13 4.96 4.99 4.95 4.59 4.4 4.72 5.1
HP_SECUNDUM_ATRIAL_SEPTAL_DEFECT 6.09 6.35 6.31 6.37 6.26 6.33 6.1 6.29 6.39 6.23 6.36 6.38 6.49 6.28 6.42 6.38 6.54 6.11 6.05 6.08 6.42 6.63 6.29 6.26 6.33 6.3
HP_MYOCARDIAL_FIBROSIS 6.3 6.38 6.26 6.19 6.34 6.14 6.41 6.14 6.25 6.35 6.39 6.57 6.31 6.14 6.06 6.43 6.7 6.33 5.94 6.35 6.05 6.08 6.26 6.02 6.22 6.4
HP_SINUS_BRADYCARDIA 6.57 6.44 6.85 6.63 6.41 6.55 6.93 6.9 6.75 7.09 6.94 6.78 6.71 6.75 7.37 7.13 6.95 7.13 6.89 6.81 6.63 6.25 6.63 6.82 6.93 6.51
HP_ATRIAL_ARRHYTHMIA 5.96 5.85 6.08 6.13 5.4 5.69 6.02 5.82 5.87 5.64 6.07 5.77 5.97 5.7 5.87 5.64 5.95 6.05 5.92 5.69 5.69 5.66 6.39 5.55 5.82 6.02
HP_CARDIAC_SHUNT 5.57 5.41 5.79 6.24 5.1 4.97 5.55 5.37 5.51 5.26 5.72 5.28 5.26 5.03 5.47 5.1 5.67 5.83 5.23 4.98 5.47 5.3 5.53 5.06 5.06 5.22
HP_CARDIAC_ARREST 6.52 6.67 6.86 6.8 6.61 6.55 6.53 6.81 6.66 6.92 6.56 6.8 6.84 6.61 6.84 6.61 6.9 6.62 6.6 6.67 6.83 6.55 7.05 6.92 6.92 6.89
HP_ABNORMAL_PERICARDIUM_MORPHOLOGY 5.91 6.13 5.85 5.85 5.77 5.77 6.11 5.93 6.19 6.02 6.03 5.8 6 5.86 5.95 5.76 5.9 5.81 5.92 5.95 6 5.9 6.21 5.75 6.05 5.97
HP_PERICARDIAL_EFFUSION 6.07 6.33 6.17 5.85 6.32 6.38 6.21 6.14 6.7 6.16 6.32 6.33 6.42 6.44 5.99 6.26 6.48 6.13 6.37 6.28 6.14 6.07 6.44 6.31 6.43 6.22
HP_SUDDEN_DEATH 6.61 6.64 6.66 6.6 6.58 6.49 6.55 6.6 6.62 6.94 6.56 6.82 6.72 6.45 6.69 6.56 6.9 6.55 6.55 6.48 6.81 6.41 6.83 6.91 6.75 6.88
HP_ABNORMAL_TRICUSPID_VALVE_MORPHOLOGY 6.54 6.53 6.6 6.45 6.56 6.58 6.67 6.71 6.7 6.53 6.54 6.72 6.79 6.45 6.72 6.45 6.46 6.55 6.25 6.89 6.41 6.64 6.85 6.51 6.59 6.44
HP_TRICUSPID_VALVE_PROLAPSE 6.64 6.59 7.08 7 6.65 6.86 6.84 7.09 7.41 7.05 6.83 6.93 6.98 7.05 7.37 7.19 6.61 6.78 6.58 7.31 6.26 6.87 7.57 7.53 6.61 6.65
HP_ABNORMAL_RIGHT_VENTRICLE_MORPHOLOGY 5.99 5.83 5.97 6.16 5.83 5.62 5.81 5.84 5.57 5.45 5.83 5.41 5.61 5.51 5.66 5.64 5.67 5.78 5.53 5.35 5.66 5.54 5.71 5.1 5.71 5.78
HP_RIGHT_VENTRICULAR_FAILURE 5.31 4.96 5.35 5.4 4.92 4.82 5.09 5.06 4.99 5.23 5.29 5.28 4.9 4.88 5.13 4.89 4.79 4.75 4.72 4.85 5.04 5.09 5.43 4.93 4.88 4.97
HP_ABNORMAL_LEFT_VENTRICLE_MORPHOLOGY 6.1 6.06 6.24 6.13 6.31 6.23 6.09 6.06 6.04 6.21 6.25 6.09 6.15 6.21 5.99 6.27 6.2 6.17 6.13 6.19 6.42 6.18 6.31 6.25 6.37 6.42
HP_LEFT_VENTRICULAR_HYPERTROPHY 6.18 6.2 6.45 6.34 6.46 6.37 6.35 6.18 6.18 6.5 6.33 6.34 6.48 6.37 6.11 6.35 6.46 6.26 6.57 6.36 6.44 6.42 6.68 6.52 6.47 6.63
HP_ABNORMAL_CARDIAC_VENTRICLE_MORPHOLOGY 6.81 6.73 6.94 6.84 6.96 7.06 6.97 7 6.93 6.93 6.85 7.01 6.96 7 6.95 6.93 6.89 6.87 6.94 7.05 7 6.97 7.06 7.15 7.03 7.03
HP_VENTRICULAR_HYPERTROPHY 6.37 6.35 6.52 6.35 6.5 6.5 6.29 6.26 6.17 6.5 6.38 6.34 6.34 6.36 6.01 6.4 6.5 6.31 6.45 6.39 6.42 6.24 6.59 6.51 6.56 6.6
HP_MITRAL_STENOSIS 6.82 6.72 6.69 6.44 6.95 7.11 7.02 7.47 6.82 7.29 6.66 7.28 7.03 6.99 7.23 6.92 7.01 6.68 6.84 6.86 7.11 6.77 7.19 7.32 6.79 7.22
HP_RESTRICTIVE_CARDIOMYOPATHY 5.29 5.2 5.09 6.35 5.09 4.84 5.14 5.16 5.22 5.25 5.33 5.08 4.83 4.82 5.12 4.96 5.32 5.49 4.85 5.07 5.03 5.01 5.51 4.72 5.36 5.03
HP_PROGRESSIVE_HEARING_IMPAIRMENT 6.42 6.51 6.73 6.38 6.37 6.73 6.89 6.84 6.59 6.66 6.68 6.64 6.64 6.48 6.65 6.8 6.67 6.89 6.65 6.86 6.51 6.82 6.54 6.77 7.02 6.75
HP_ABNORMALITY_OF_THE_PANCREAS 6.21 6.34 6.37 6.41 6.34 6.27 6.28 6.33 6.14 6.3 6.24 6.28 6.27 6.34 6.25 6.31 6.25 6.35 6.14 6.31 6.31 6.46 6.33 6.33 6.29 6.42
HP_PANCREATITIS 6.23 6.25 6.5 6.41 6.32 6.16 6.13 6.02 5.8 6.24 6.28 5.92 5.8 5.9 5.96 5.94 5.96 5.95 6.01 6.38 6.12 5.94 6.36 6.35 6.13 6.22
HP_ANNULAR_PANCREAS 6.38 6.4 6.26 6.37 6.38 6.05 6.44 6.81 6.23 6.4 6.31 6.37 6.04 6.36 6.64 6.26 6.6 6.53 6.4 6.19 6.83 6.97 6.17 5.92 6.51 6.95
HP_PANCREATIC_CYSTS 6.29 6.39 6.12 6.33 6.44 6.61 6.29 6.37 6.02 6.44 6.3 6.35 6.08 6.47 6.37 6.64 6.51 6.72 6.29 6.18 6.61 6.69 6.21 6.22 6.62 6.69
HP_NASAL_OBSTRUCTION 5.54 5.43 5.51 5.46 5.12 5.36 5.53 5.37 5.26 6 5.45 5.65 5.42 5.31 5.49 5.82 5.52 5.84 5.37 5.14 5.54 5.53 5.25 5.15 5.36 5.47
HP_ABNORMALITY_OF_THE_SPLEEN 6.16 6.17 6.1 6.22 6.06 6.21 6.13 6.1 6.12 6.17 6.23 6.16 6.21 6.15 6.12 6.16 6.09 6.18 6.08 6.14 6.2 6.18 6.14 6.09 6.21 6.27
HP_SPLENOMEGALY 6.21 6.21 6.21 6.25 6.32 6.29 6.17 6.18 6.27 6.22 6.28 6.22 6.3 6.23 6.12 6.14 6.15 6.2 6.15 6.24 6.21 6.21 6.26 6.33 6.27 6.33
HP_ACCESSORY_SPLEEN 6.23 6.24 6.8 6.51 6.38 6.11 6.24 6.38 6 6.15 6.61 6.35 5.84 6.15 6.41 6.82 6.06 6.66 6.14 6.18 6.67 6.44 6.4 6 6.62 6.26
HP_POLYSPLENIA 5.57 5.47 5.28 5.45 5.13 5.22 5.48 5.34 5.37 5.93 5.42 5.63 5.42 5.33 5.49 5.81 5.55 5.84 5.35 5.3 5.55 5.41 5.27 5.19 5.43 5.58
HP_VESTIBULAR_DYSFUNCTION 6.58 6.72 6.64 6.53 6.61 6.94 6.61 6.8 6.86 6.8 6.57 6.76 6.88 6.75 6.53 6.62 6.55 6.38 6.72 6.66 6.76 6.81 7.09 6.88 7.08 6.94
HP_PES_CAVUS 7.31 7.37 7.66 7.33 7.71 7.72 7.57 7.53 7.66 7.78 7.36 7.53 7.6 7.71 7.52 7.37 7.46 7.28 7.48 7.68 7.36 7.45 7.72 7.73 7.67 7.54
HP_TALIPES_EQUINOVARUS 6.56 6.62 6.66 6.64 6.85 6.89 6.75 6.84 6.74 6.75 6.57 6.79 6.82 6.78 6.8 6.62 6.7 6.66 6.64 6.78 6.69 6.78 6.89 6.82 6.92 6.91
HP_PES_PLANUS 6.9 6.89 6.96 6.87 7.02 7.17 7.07 7.11 7.1 7.1 6.91 7.04 7.11 7.28 7.19 7 7.02 6.84 6.93 7.11 6.98 7.01 7.28 7.25 7.16 7.01
HP_HAMMERTOE 7.79 7.67 7.74 7.46 8.18 7.8 7.48 7.38 7.96 7.99 7.34 7.68 8.17 8.18 7.73 7.96 7.66 7.61 7.89 8.37 7.89 8.1 8.29 8.19 7.6 7.48
HP_BROAD_FOOT 6.34 6.76 6.99 6.94 6.7 7.19 7.16 7.33 7.22 7.04 7.03 6.97 7.18 7.04 7.45 7.2 6.85 6.96 7.21 7.19 7.11 7.13 7.41 7.27 7.12 7.17
HP_TOE_SYNDACTYLY 6.69 6.72 7 6.87 6.94 7.19 6.96 7.03 7.01 7.08 6.87 7.01 7.13 7.04 7.17 6.98 6.95 6.85 6.95 6.93 6.91 7.05 7.02 7.15 7.06 7.13
HP_ACHILLES_TENDON_CONTRACTURE 6.48 6.57 6.2 6.66 6.64 6.8 6.36 6.32 6.72 6.71 6.37 6.59 6.64 6.7 6.45 6.44 6.69 6.35 6.43 6.5 6.21 6.59 6.92 6.61 6.86 6.63
HP_SHORT_FOOT 7.08 7.15 7.2 7.12 7.32 7.38 7.24 7.19 7.4 7.53 7.07 7.39 7.39 7.34 7.43 7.14 7.13 6.93 7.34 7.25 7.12 7.18 7.54 7.84 7.24 7.27
HP_BILATERAL_TALIPES_EQUINOVARUS 7.62 7.28 9.4 7.92 8.28 8.17 8.85 8.7 9.04 9.06 9.41 9.09 8.99 8.71 9.38 8.44 9.15 8.47 8.32 8.56 8.7 8.79 9.4 9.43 8.22 7.84
HP_ABNORMALITY_OF_TOE 6.8 6.88 7.05 7 7.02 7.14 7.01 7.07 7.03 7.11 6.93 7.08 7.23 7.15 7.17 7.09 6.94 6.91 7.09 7.06 7.03 7.13 7.14 7.23 7.1 7.12
HP_BROAD_METATARSAL 6.41 6.37 6.55 6.87 6.57 6.42 6.47 5.93 6.55 6.53 6.07 6.69 6.66 6.56 6.08 6.26 6.15 6.4 6.57 6.44 6.21 6.42 6.94 6.92 6.63 6.5
HP_ABNORMAL_DELIVERY 5.76 5.64 5.37 5.48 5.63 5.38 5.46 5.43 5.53 5.3 5.48 5.46 5.38 5.51 5.08 5.5 5.52 5.55 5.39 5.25 5.71 5.33 5.6 5.33 5.55 5.34
HP_HYDROPS_FETALIS 6.4 6.12 6.57 6.38 6.53 6.42 6.13 6.38 6.57 6.27 6.38 6.17 6.44 6.38 6.17 6.59 6.28 6.14 6.26 6.05 6.3 6.31 6.43 6.34 6.16 6.52
HP_NONIMMUNE_HYDROPS_FETALIS 6.49 6.08 6.71 6.34 6.32 6.37 6.13 6.04 6.61 6.27 6.89 6.15 6.49 6.26 6.14 6.57 6.31 6.12 6.12 6.19 6.03 6.08 6.45 6.48 5.92 6.15
HP_SMALL_NAIL 6.6 6.7 6.72 6.53 6.65 6.73 6.7 6.78 6.65 6.68 6.54 6.61 6.62 6.56 6.58 6.58 6.63 6.56 6.65 6.65 6.61 6.69 6.51 6.76 6.67 6.76
HP_HYPERCONVEX_NAIL 7.31 7.02 7.18 7.36 7.6 7.41 7.62 7.55 7.71 7.55 7.11 7.61 7.68 7.6 7.81 7.65 7.71 7.55 7.25 7.43 7.56 7.7 7.87 7.94 7.6 7.48
HP_ANONYCHIA 6.61 6.76 6.72 6.7 6.59 6.79 6.89 6.63 6.72 6.76 6.52 6.68 6.92 6.68 6.78 6.71 6.59 6.62 6.47 6.96 6.58 6.88 6.77 6.85 6.79 6.64
HP_HYPOPLASTIC_TOENAILS 7.14 6.88 7.05 7.12 6.93 7.01 7.04 7.25 6.84 6.9 7.02 6.97 7.22 6.84 7.31 7.04 7.18 6.93 7.44 7.2 7.16 7.16 7.11 7.06 7.26 7.29
HP_ABSENT_TOENAIL 8.4 8.77 8.16 7.32 8.08 8.74 8.67 8.08 8.49 8.36 7.71 8.17 8.37 8.69 8.1 8.47 8.4 8.26 8.02 8.74 8.23 8.5 8.22 8.6 8.19 8.11
HP_HYPOPLASTIC_FINGERNAIL 6.63 6.68 6.55 6.5 7.07 7 7.18 7.04 6.91 7.31 6.54 6.95 7.16 6.62 7.17 6.93 7.03 6.59 6.85 7.1 6.78 6.92 7.1 7.04 6.91 7.05
HP_ONYCHOGRYPOSIS 5.78 5.57 5.71 5.74 5.39 5.23 5.58 5.2 5.85 5.33 5.71 5.36 5.43 5.26 5.42 5.23 5.69 5.55 5.42 5.79 5.59 5.26 5.56 5.66 5.37 5.32
HP_ONYCHOLYSIS 6.02 5.29 5.45 5.76 5.36 5.24 5.24 5.3 5.58 5.41 5.67 5.75 5.19 5.29 4.69 5.4 5.71 5.31 5.26 4.97 5.66 5 5.55 5 5.52 5.41
HP_RIDGED_NAIL 5.91 5.74 5.81 5.89 5.47 5.67 5.79 5.49 5.86 5.87 5.65 5.9 5.81 5.69 5.7 5.82 5.93 5.74 5.57 5.77 5.88 5.76 5.76 5.62 5.84 5.75
HP_FRAGILE_NAILS 6.17 6.07 6.18 6.27 6.22 6.32 5.83 6.32 6.37 5.92 6.03 5.9 5.94 5.81 6.02 6.44 6.3 6.47 6.33 6.38 6.14 5.94 6.49 6.12 6.34 6.68
HP_DYSTROPHIC_TOENAIL 6.58 6.53 6.29 6.11 6.44 6.17 6.25 6.05 6.51 6.58 6.45 6.65 6.21 6.12 6.2 6.18 6.81 6.49 6.17 6.16 6.37 5.98 6.38 6.34 6.35 6.62
HP_THIN_NAIL 7.08 7.01 6.61 6.87 7 6.95 6.95 6.93 6.85 6.97 6.95 7.07 7.03 6.91 6.87 7.2 6.97 6.62 7.31 6.92 7.02 7.06 7.15 7.22 6.96 7.26
HP_ABSENT_FINGERNAIL 8.11 8.36 8.23 7.82 8.22 8.49 8.34 8.33 8.46 8.19 7.88 8.35 8.28 8.38 8.22 8.39 8.26 8.2 7.99 8.71 8.24 8.45 8.17 8.53 8.24 8.31
HP_PARONYCHIA 5.31 5.36 5.24 5.37 4.99 5.04 5.16 5 4.92 5.13 5.19 4.81 5.33 5.24 5.25 4.83 4.99 5.08 5.12 5.23 5.52 5.25 5.01 5.38 4.97 5.05
HP_LEUKONYCHIA 6.38 6.11 6.76 6.39 6.36 6.23 6.26 6.49 6.06 6.05 6.1 6.25 6.09 6.37 5.9 6.74 6.56 6.37 6.32 6.27 6.64 6.31 6.42 5.88 6.07 6.08
HP_HALLUX_VALGUS 7.57 7.4 7.83 7.24 7.39 7.61 7.48 7.79 7.68 7.58 7.53 7.52 7.74 7.9 7.68 8 7.61 7.62 7.55 7.66 7.88 7.61 7.64 7.67 7.78 7.66
HP_WEIGHT_LOSS 6.3 6.37 6.34 6.36 6.43 6.34 6.31 6.35 6.45 6.58 6.28 6.48 6.54 6.44 6.33 6.24 6.14 6.3 6.25 6.38 6.21 6.23 6.61 6.66 6.31 6.36
HP_POSTAXIAL_FOOT_POLYDACTYLY 6.57 6.58 6.75 6.96 6.82 6.83 6.37 6.39 6.17 6.73 6.91 6.73 6.45 6.72 6.53 6.85 6.48 6.75 6.89 6.5 6.42 6.72 6.45 6.41 6.6 6.71
HP_SHORT_TOE 6.93 6.95 7 6.93 7.24 7.36 7.1 7.32 7 7.09 7.16 7.22 7.42 7.38 7.27 7.18 7.26 7.05 7.2 7.16 7.21 7.24 7.34 7.44 7.33 7.45
HP_ABNORMAL_METATARSAL_MORPHOLOGY 6.55 6.59 6.67 6.57 6.87 6.92 6.66 6.84 6.75 6.75 6.69 6.84 7.08 6.98 6.62 6.86 6.69 6.8 6.89 6.77 6.73 6.8 7.07 7.01 6.94 6.86
HP_LONG_FOOT 7.4 7.15 7.63 7.06 7.31 7.6 7.38 7.27 7.43 7.62 7.72 7.87 7.58 7.59 7.54 7.52 7.21 7.29 7.63 7.57 7.65 7.45 8.02 7.81 7.48 7.44
HP_CAMPTODACTYLY_OF_TOE 6.66 6.79 6.71 6.58 7.19 7.18 7.42 7.28 7.42 7.28 7.37 6.96 7.32 7.26 7.36 7.52 7.45 6.95 6.92 7.36 7.28 7.54 7.52 7.7 7.62 7.65
HP_BROAD_TOE 7.13 7.08 7.12 6.98 7.12 7.26 7.33 7.21 7.15 7.31 6.95 7.4 7.4 7.44 7.43 7.31 7.17 7.15 7.15 7.08 7.23 7.26 7.37 7.46 7.24 7.35
HP_METATARSUS_ADDUCTUS 6.66 6.77 6.81 6.55 7.25 7.34 6.86 7.08 6.9 7.11 6.88 7.14 7.31 7.24 6.96 7.29 7 7.03 7.13 7.12 7.04 6.94 7.31 7.11 7.13 7.29
HP_PREAXIAL_FOOT_POLYDACTYLY 7.12 6.81 7.08 6.98 7.24 7.44 7.22 7.3 7.33 7.32 7.22 7.47 7.62 7.57 7.19 7.64 7.68 7.59 7.25 7.27 7.23 7.7 7.39 7.3 7.25 7.57
HP_ABNORMALITY_OF_THE_HALLUX 7.05 7.01 7.12 7.03 7.16 7.26 7.2 7.26 7.3 7.35 6.95 7.31 7.42 7.39 7.34 7.31 7.17 7.15 7.21 7.17 7.18 7.42 7.38 7.45 7.28 7.35
HP_OVERLAPPING_TOE 7.85 7.69 7.88 7.83 8.04 7.96 8.16 7.99 8.09 7.76 7.89 7.97 8 8.11 7.91 8.05 8.19 7.8 7.85 8.14 7.78 8.09 7.79 7.95 8.16 8.14
HP_LONG_HALLUX 7.74 7.9 7.64 7.1 7.88 8.02 7.81 7.79 8 8.19 7.81 7.86 7.93 8.01 7.69 7.77 7.71 7.86 8.05 8.06 7.73 7.77 8.21 8.08 7.78 7.87
HP_ABNORMALITY_OF_THE_TARSAL_BONES 6.48 6.41 6.35 6.5 6.69 6.65 6.58 6.74 6.56 6.68 6.42 6.56 6.63 6.67 6.55 6.53 6.5 6.55 6.37 6.48 6.46 6.6 6.65 6.51 6.74 6.53
HP_SANDAL_GAP 6.77 7 6.96 6.85 7.13 7.28 6.94 6.96 7 7.4 7.07 7.25 7.41 7.19 7.28 7.27 7.14 6.93 7.24 7.11 7.17 7.18 7.31 7.38 7.35 7.23
HP_TOE_CLINODACTYLY 7.43 7.46 7.63 7.15 7.98 7.91 7.99 8.02 7.96 7.77 7.5 7.54 7.89 7.99 7.8 7.74 7.59 7.41 7.7 7.97 7.58 7.79 8.24 8.27 7.93 7.7
HP_DEEP_PLANTAR_CREASES 7.58 8.14 8.23 7.89 7.31 8.04 8.53 8.43 7.97 8.54 7.89 8.41 8.51 8.67 8.35 8.52 8.16 7.99 7.79 8.14 8.29 8.59 8.53 8.59 8.24 8.34
HP_ABNORMALITY_OF_BLOOD_AND_BLOOD_FORMING_TISSUES 6.36 6.36 6.5 6.44 6.45 6.5 6.35 6.4 6.35 6.43 6.41 6.37 6.45 6.42 6.35 6.38 6.37 6.35 6.34 6.4 6.4 6.42 6.48 6.5 6.42 6.48
HP_ABNORMAL_THROMBOCYTE_MORPHOLOGY 6.45 6.41 6.56 6.37 6.44 6.54 6.41 6.49 6.56 6.49 6.51 6.41 6.56 6.52 6.31 6.38 6.4 6.37 6.33 6.41 6.34 6.4 6.49 6.64 6.42 6.54
HP_ABNORMALITY_OF_NEUTROPHILS 6.16 6.19 6.11 6.16 6.22 6.1 6.21 6.17 6.25 6.16 6.07 6.2 6.26 6.28 6.14 6.25 6.2 6.27 6.17 6.26 6.21 6.18 6.33 6.33 6.22 6.29
HP_PANCYTOPENIA 6.23 6.44 6.57 6.37 6.44 6.51 6.41 6.51 6.36 6.37 6.51 6.22 6.56 6.47 6.25 6.38 6.42 6.42 6.11 6.51 6.3 6.58 6.31 6.54 6.64 6.63
HP_ABNORMAL_ERYTHROCYTE_MORPHOLOGY 6.28 6.28 6.47 6.43 6.37 6.38 6.37 6.46 6.35 6.38 6.39 6.27 6.43 6.29 6.31 6.37 6.36 6.35 6.27 6.42 6.31 6.32 6.39 6.52 6.42 6.44
HP_HEMOLYTIC_ANEMIA 6.04 5.86 5.89 6.14 5.97 6.05 6.15 6.03 5.87 5.94 5.97 6.01 6.05 6.15 5.76 5.87 6.16 6.04 5.87 6.01 5.93 6.07 6.08 5.7 6.01 6.15
HP_ABNORMAL_EOSINOPHIL_MORPHOLOGY 5.97 6.11 5.84 5.75 5.56 5.43 5.98 6.1 6.14 5.83 6.05 6.06 6.12 6.01 5.61 5.73 6 6.02 5.71 5.86 5.82 5.7 5.73 5.67 5.66 5.78
HP_LEUKOPENIA 5.95 5.89 5.88 5.97 5.85 5.83 5.93 5.96 6.13 5.9 5.87 5.7 6.06 6.12 5.83 5.75 5.98 5.92 5.83 5.82 5.85 5.95 6.03 5.75 5.88 5.91
HP_LYMPHOPENIA 5.86 5.7 5.82 5.85 5.81 5.84 5.88 5.6 5.85 5.73 5.86 5.64 5.91 6.12 5.65 5.53 5.93 5.7 5.78 5.81 5.75 5.9 5.86 5.59 5.78 5.91
HP_MEGALOBLASTIC_ANEMIA 6.99 6.74 7.52 7.22 7.39 7.51 7.83 7.62 7.32 7.86 7.38 7.11 7.9 8.03 7.42 7.72 6.95 7.04 6.92 7.96 7.29 8.09 7.23 7.26 8.08 8.38
HP_AUTOIMMUNE_HEMOLYTIC_ANEMIA 5.59 5.5 5.12 5.42 5.48 5.44 5.69 5.31 5.4 5.41 5.72 5.06 5.28 5.36 5.43 5.18 5.44 5.63 5.16 5.01 5.47 5.32 4.93 5.02 5.38 5.28
HP_IRON_DEFICIENCY_ANEMIA 5.8 5.59 5.57 5.64 5.37 5.21 5.66 5.36 5.46 5.31 5.69 5.12 5.09 5.34 5.45 5.23 5.61 5.54 5.29 5.11 5.4 5.54 5.13 4.85 5.63 5.38
HP_ABNORMAL_BLEEDING 6.42 6.37 6.54 6.41 6.53 6.49 6.41 6.42 6.55 6.51 6.44 6.54 6.56 6.52 6.4 6.44 6.44 6.36 6.33 6.41 6.5 6.52 6.57 6.54 6.53 6.6
HP_THROMBOCYTOSIS 6.65 6.18 6.59 6.27 6.23 6.21 6.03 6.21 6.54 6.39 6.51 6.26 6.32 6.41 6.31 6.45 6.57 6.55 6.42 5.97 6.65 6.55 6.37 6.4 6.18 5.97
HP_NORMOCHROMIC_ANEMIA 6.9 6.08 7.1 7 7.05 6.56 6.58 6.4 6.57 6.69 7.17 6.24 6.32 6.26 6.49 6.76 6.67 6.6 7 5.82 7.08 6.8 6.45 6.33 5.92 5.91
HP_RETICULOCYTOPENIA 5.43 5.29 5.45 5.65 5.05 4.92 5.24 4.95 5.33 4.75 5.37 5.26 4.97 4.95 5.32 5.01 5.19 5.1 4.99 5.13 5.31 5.24 5.02 4.67 5.04 5.35
HP_NORMOCYTIC_ANEMIA 7.5 7.51 7.1 6.5 7.8 7.91 7.07 7 7.34 7.28 7.79 7.2 7.2 7 7.01 7.49 7.22 6.88 7.21 6.94 6.81 6.99 7.34 7.13 7.11 7.01
HP_POLYCYTHEMIA 6.67 6.38 6.78 6.6 7.06 7.17 6.84 6.89 6.73 7.06 6.64 7.16 7.16 7.08 7.1 6.89 6.75 6.94 6.83 6.85 6.86 7.09 6.94 6.96 6.9 7.31
HP_NEUTROPENIA_IN_PRESENCE_OF_ANTI_NEUTROPIL_ANTIBODIES 5.84 5.68 5.82 6.04 5.89 6.02 6.04 5.51 5.91 5.58 5.83 5.83 6.43 6.29 5.65 5.74 5.93 5.76 5.97 5.84 5.84 5.67 6.1 5.96 5.67 5.86
HP_THROMBOEMBOLISM 6.05 5.87 6.05 6.06 6.03 5.59 5.91 5.87 5.77 5.66 5.85 5.77 5.68 5.68 5.57 5.5 5.98 5.79 5.59 5.71 5.82 5.77 5.85 5.58 6.08 6.26
HP_LEUKEMIA 6.72 6.59 6.8 6.56 6.89 6.98 6.67 6.73 6.76 6.88 6.79 6.69 6.83 6.87 6.79 6.78 6.79 6.68 6.75 6.81 6.74 6.78 6.85 7.06 6.79 6.86
HP_APLASTIC_ANEMIA 6.08 6.14 5.9 6.16 6.03 6.11 6.09 6.42 5.92 5.88 6.01 5.93 6.11 5.91 5.84 5.85 5.82 5.92 5.77 5.93 6.04 6.13 5.94 5.88 6.05 6.4
HP_ACUTE_KIDNEY_INJURY 6.13 6.32 6.25 5.83 5.64 5.88 6.24 5.85 5.73 5.79 6.16 5.81 6.17 6.05 5.45 5.36 6.1 5.96 5.62 6.05 6.3 6.47 5.92 5.65 6.76 6.79
HP_RETICULOCYTOSIS 6.25 6.12 6.44 6.52 6.22 6.38 6.44 6.13 6.31 6.26 6.49 6.23 6.23 6.22 6.21 6.33 6.47 6.22 6.04 6.06 6.46 6.63 6.29 5.7 6.35 6.6
HP_SIDEROBLASTIC_ANEMIA 5.94 5.92 6.19 6.03 5.74 5.92 5.75 5.77 6.01 5.8 5.47 5.65 5.85 5.84 5.95 5.53 5.68 5.57 5.8 6.1 5.74 5.56 5.83 6.09 5.78 5.78
HP_ACANTHOCYTOSIS 5.97 5.78 5.57 6.19 5.42 5.88 5.94 5.87 5.63 5.81 5.62 5.75 5.8 5.79 5.96 5.56 5.41 5.69 5.96 5.8 5.86 5.76 5.85 6.03 5.72 5.94
HP_ABNORMALITY_OF_COAGULATION 6.39 6.38 6.76 6.69 6.53 6.52 6.38 6.41 6.37 6.41 6.53 6.35 6.4 6.52 6.41 6.38 6.3 6.37 6.32 6.41 6.37 6.3 6.52 6.37 6.53 6.63
HP_HYPOCHROMIC_ANEMIA 5.92 5.78 6.03 5.81 5.67 5.56 5.93 5.74 5.82 5.92 6.02 5.52 5.42 5.44 5.7 6.17 6.15 6.02 5.46 5.39 6.09 5.95 5.83 5.62 6.09 5.96
HP_SUBCUTANEOUS_HEMORRHAGE 6.16 6.13 6.17 6.14 6.06 5.95 5.94 5.88 5.96 6.01 6.27 6.02 6.02 6.02 5.93 5.88 6.19 6.03 5.77 6 6.22 6.09 6.13 5.93 6.18 6.14
HP_PERSISTENT_BLEEDING_AFTER_TRAUMA 5.33 5.49 5.52 5.3 4.95 4.86 5.22 4.6 5.34 5.01 5.14 4.88 4.71 4.52 5.03 4.6 4.93 5.3 4.93 4.53 5.36 5.19 5.23 4.85 5.1 5.23
HP_MICROCYTIC_ANEMIA 6 6.02 6.67 6.57 6.37 6.21 6.32 6.34 6.15 6.24 6.16 6.28 6.17 6.17 6.13 6.6 6.19 6.09 5.95 6.37 6.41 6.16 6.35 6.48 6.49 6.36
HP_MICROANGIOPATHIC_HEMOLYTIC_ANEMIA 6.01 6.26 5.89 6.25 6.32 6.41 6.19 6.04 6.32 6.03 6.35 6.11 5.74 5.92 5.89 5.77 5.99 6.03 5.78 6.05 5.92 6.07 6.22 5.64 6.26 6.22
HP_METABOLIC_ACIDOSIS 6.4 6.3 6.92 6.7 6.62 6.79 6.45 6.69 6.47 6.63 6.47 6.39 6.73 6.61 6.5 6.66 6.47 6.27 6.48 6.68 6.46 6.87 6.4 6.5 6.54 6.46
HP_DEHYDRATION 5.3 5.29 5.37 5.59 5.28 5.03 5.26 5.06 5.29 5.16 5.28 5.05 5.07 5.03 5.13 5.14 5.22 5.32 5.02 5.03 5.23 5.22 5.06 4.84 5.17 5.15
HP_FEVER 5.94 6 6.06 6.08 5.83 5.88 5.93 6.01 5.94 5.85 6.03 5.87 5.81 5.84 5.86 5.86 5.89 5.95 5.84 5.92 5.99 5.97 5.89 5.75 5.93 6.04
HP_KETOSIS 6.07 6.33 6.22 6.32 6.28 6.58 6.14 5.85 6.42 6.33 6.22 6.13 6.36 6.12 6.23 6.26 6.16 6.24 6.27 6.11 6.27 6.24 5.79 6.36 6.47 6.39
HP_RENAL_TUBULAR_ACIDOSIS 6.01 5.77 5.4 5.94 5.76 5.87 5.72 5.86 5.51 5.72 5.68 5.66 5.48 5.69 5.58 5.43 5.73 5.74 5.88 5.75 5.75 5.76 5.5 5.8 5.61 5.75
HP_ALKALOSIS 5.3 5.05 4.65 5.09 4.68 4.62 4.59 4.59 4.94 4.5 4.74 4.54 4.56 4.69 4.81 4.74 4.85 4.93 4.78 4.79 4.89 4.5 4.77 4.45 4.58 4.74
HP_HYPOKALEMIC_ALKALOSIS 5.13 4.72 4.55 4.96 4.58 4.44 4.54 4.45 4.83 4.36 4.67 4.35 4.45 4.65 4.65 4.47 4.68 4.68 4.7 4.57 4.78 4.43 4.58 4.3 4.36 4.41
HP_GLUCOSE_INTOLERANCE 6.22 6.28 6.36 6.37 6.15 6.29 6.31 6.23 6.33 6.36 6.27 6.22 6.28 6.37 6.21 6.29 6.18 6.26 6.19 6.31 6.29 6.22 6.31 6.32 6.25 6.34
HP_RECURRENT_FEVER 6.01 6.06 6.34 6.47 6.06 5.93 6.06 6.07 6.14 6.17 6.13 6.07 6.11 6.14 6.12 6.02 6.14 6.01 5.87 6.15 6.32 6.03 6.12 6.03 6.11 6.25
HP_UNEXPLAINED_FEVERS 6.43 6.29 6.33 6.6 5.91 5.47 6.19 5.87 5.96 5.98 6.32 6.03 5.58 5.67 5.83 6.03 6.11 6.36 5.86 5.58 6.34 6.03 5.97 5.7 5.92 5.83
HP_TRUNCAL_OBESITY 7.13 7.26 7.35 7.29 8.05 7.97 7.57 7.6 7.61 7.94 7.44 7.71 7.88 7.82 7.64 7.68 7.46 7.2 7.57 7.83 7.2 7.57 7.82 7.9 7.55 7.62
HP_NONKETOTIC_HYPOGLYCEMIA 5.94 5.98 6.16 6.4 6.33 6.08 5.57 5.87 5.63 6 6.24 5.73 5.67 5.69 5.89 6.06 5.59 5.92 5.71 5.57 5.67 5.91 5.76 5.75 5.97 6.13
HP_HYPOPLASTIC_HEART 6.17 6.11 6.21 6.19 5.73 5.88 6.06 6.1 5.95 5.67 5.99 5.41 5.73 6.04 5.65 5.82 5.98 6.07 5.84 5.97 6.05 6.27 5.64 5.61 5.84 6.06
HP_PALPITATIONS 6.63 6.44 6.41 6.34 6.7 6.61 6.64 6.66 6.58 6.69 6.38 6.81 6.86 6.58 6.6 6.53 6.46 6.61 6.59 6.4 6.22 6.68 6.84 6.74 6.53 6.8
HP_APLASIA_HYPOPLASIA_OF_METATARSAL_BONES 6.61 7.01 6.96 6.87 6.87 7.08 6.9 6.93 7.05 6.92 6.88 6.96 6.79 6.77 6.8 6.97 6.84 6.83 7.05 6.94 7.05 6.96 7.41 7.29 7.08 6.9
HP_ABNORMAL_SCALP_MORPHOLOGY 6.95 6.92 7.05 6.96 7.1 7.2 7.06 7.13 7.16 7.13 6.92 7.03 7.2 7.16 7.17 7.1 7.08 6.97 7 7.22 7.15 7.17 7.15 7.28 7.11 7.16
HP_ABNORMAL_GLOMERULAR_MESANGIUM_MORPHOLOGY 6.22 6.13 6.27 6.26 6.07 6.43 6.32 6.47 5.96 6.43 5.75 6.48 6.22 6.26 6.19 6.16 6.56 6.5 6.5 6.42 6.13 5.89 6.44 6.36 6.18 6.52
HP_DIFFUSE_MESANGIAL_SCLEROSIS 5.65 6.05 6.12 5.92 5.73 5.8 6.01 5.95 5.65 5.99 5.6 6.25 6.13 5.79 6.12 5.88 5.98 6.03 6.15 5.95 5.86 5.65 5.98 5.95 5.79 6.43
HP_ABNORMAL_TUBULOINTERSTITIAL_MORPHOLOGY 6.17 6.44 5.85 6.08 6.02 5.91 6.03 6.17 5.91 5.93 6.16 6.12 5.87 5.91 5.9 6.13 5.87 6.1 6.29 6 6.13 5.94 5.76 5.78 5.96 5.97
HP_TUBULOINTERSTITIAL_NEPHRITIS 6.23 6.49 5.74 6.02 6.2 5.93 6.14 6.27 5.98 5.92 6.01 6.24 6.03 6.04 5.8 5.92 6.06 5.92 6.31 5.93 6.12 5.94 5.92 5.71 5.96 5.97
HP_HYPERSPLENISM 7.28 7.35 7.72 7.45 8.08 7.89 8.32 8.25 8.14 7.43 7.36 7.94 8.08 8.07 8.15 7.7 7.03 7.74 7.45 8.15 7.9 8.29 7.88 7.91 7.74 8.09
HP_MACROCYTIC_ANEMIA 6.81 6.61 7.03 6.76 7.05 7.07 6.97 6.7 6.57 6.69 6.7 6.35 7.03 6.86 6.36 6.93 6.67 6.55 6.71 6.94 6.81 6.8 6.67 6.48 7.06 6.87
HP_AUTOIMMUNE_THROMBOCYTOPENIA 5.9 5.7 5.94 5.99 5.89 6.02 6.13 5.67 5.79 6 5.86 5.83 6.07 6.13 5.78 5.74 6.18 6.31 5.68 6.28 5.93 5.98 5.95 5.96 5.8 5.97
HP_LEUKOCYTOSIS 6.09 6.12 6.03 6.21 5.96 5.96 6.1 6.35 6.23 6.13 6.09 5.91 6.16 6.19 6.22 6.12 5.89 6.28 5.84 6.11 6.23 6.17 6.11 6.24 6.29 6.34
HP_REDUCED_ANTITHROMBIN_III_ACTIVITY 7.32 7.32 8.04 7.68 7.5 8.02 7.81 7.48 7.45 6.99 6.9 6.96 7.21 7.48 7.44 7.23 7.53 7.54 7.81 8 6.84 6.95 7.46 7.94 7.5 7.02
HP_ABNORMAL_THROMBOSIS 6.29 6.24 6.23 6.18 6.21 6.03 6.09 5.98 6.01 6.13 6.25 6.16 6.03 6.14 5.83 5.93 6.05 5.92 6.03 5.91 5.96 5.9 6.04 5.89 6.28 6.21
HP_EXTRAMEDULLARY_HEMATOPOIESIS 6.71 6.94 6.49 6.73 6.99 7.34 6.22 6.47 6.99 6.96 6.82 7.19 6.82 6.85 6.6 6.71 6.71 6.69 6.89 6.63 6.29 6.51 7.16 6.89 6.72 6.67
HP_HYPOKETOTIC_HYPOGLYCEMIA 5.93 5.76 6.63 6.26 6.16 6.81 6.65 6.74 6.6 6.38 6.43 6.32 6.84 6.67 6.44 6.49 6.37 6.2 6.19 6.76 6.87 7.17 6.5 6.59 6.6 6.66
HP_HYPERAMMONEMIA 6.92 7.13 7.45 7.49 7.35 7.34 7.22 7.29 7.22 7.3 7.25 7.42 7.48 7.37 7.16 7.38 7.24 7.06 7.3 7.39 7.42 7.48 7.11 7.32 7.23 7.37
HP_RECURRENT_HYPOGLYCEMIA 5.93 6.39 6.37 6.63 6.03 6.11 6.23 6.47 6.36 6.17 6.24 6.24 6.29 6.12 6.36 6.1 6.19 6.06 6.25 6.65 6.56 6.76 6.28 6.38 6.18 6.31
HP_FETAL_AKINESIA_SEQUENCE 6.31 5.78 6 6.12 5.74 5.91 6.05 5.99 5.97 6.1 6.08 5.91 5.95 6.01 6.11 5.84 6.2 6.22 6.07 6.05 6.01 6.05 5.96 5.76 6.01 6.4
HP_APLASIA_HYPOPLASIA_OF_TOE 6.84 6.89 7.02 6.91 7.24 7.34 7.24 7.41 6.95 7.29 7 7.24 7.42 7.39 7.27 7.29 7.31 7.06 7.15 7.22 7.39 7.42 7.3 7.45 7.37 7.48
HP_ORGANIC_ACIDURIA 6.69 6.64 7.38 7.08 6.83 6.98 6.94 6.88 6.89 6.92 6.93 6.88 6.97 7 6.53 6.97 6.77 6.64 6.78 7.01 6.65 6.98 6.85 6.98 7.04 7
HP_KETOACIDOSIS 5.95 6.24 5.51 5.74 5.9 6.01 5.6 5.76 5.71 5.57 5.81 5.93 6.11 6.07 5.75 5.61 5.88 5.88 5.73 5.66 5.73 5.81 5.26 5.66 5.86 6.07
HP_HYPERCHLOREMIC_ACIDOSIS 6.38 5.94 6.44 6.42 6.17 6.44 6.3 6.21 6.15 6.35 6.69 6.07 6 6.24 6.33 6.05 6.6 6.07 6.34 6.5 6.5 6.83 6.03 5.87 6.26 6.26
HP_GOUT 5.8 5.54 6.11 6.02 5.46 5.15 5.57 5.36 5.35 5.65 5.62 5.23 5.64 5.64 5.45 5.43 5.96 5.54 5.29 5.79 5.38 5.38 5.54 5.36 5.74 5.53
HP_NEONATAL_HYPOGLYCEMIA 5.96 5.81 6.03 6.09 5.81 6 6.3 6.27 6.26 5.96 6.01 5.82 6.39 6.23 6.14 5.83 6 5.65 5.71 5.89 5.96 6.12 5.72 6.06 6.05 6.01
HP_ABNORMAL_FACIAL_SHAPE 6.81 6.86 7.05 6.91 7.02 7.11 7.04 7.06 7.05 7.08 6.92 7.03 7.16 7.05 7.12 7.07 6.9 6.89 7.02 7.06 7 7.05 7.14 7.25 7.08 7.05
HP_SHORT_COLUMELLA 7.59 7.62 7.91 7.03 7.88 7.9 8.3 7.65 8.07 8.13 7.72 7.92 7.64 7.65 7.8 7.7 7.93 7.27 7.51 7.69 7.6 7.74 8.06 7.79 7.66 7.27
HP_DEEP_PHILTRUM 7.68 7.78 8.01 7.71 7.88 8.03 8.16 8 8.12 8.13 7.83 7.92 8.15 8.17 8.15 8.02 7.91 7.7 7.7 8.14 7.62 7.94 8.19 8.15 8.29 8.07
HP_LARGE_FOREHEAD 7.2 7.14 7.56 7.07 7.1 7.39 7.57 7.5 7.46 7.71 7.53 7.5 7.7 7.76 7.73 7.31 7.22 7.32 7.58 7.44 7.66 7.77 7.82 7.66 7.47 7.62
HP_FACIAL_CLEFT 6.04 5.98 5.8 5.61 6.17 6.04 6.14 6.22 6.12 6.2 6.41 6.08 6.16 6.08 6.08 6.51 6.08 6.14 6.4 6.22 5.96 5.97 6.22 6.1 6.14 6.11
HP_ABNORMALITY_OF_THE_ABDOMINAL_ORGANS 6.31 6.3 6.47 6.48 6.43 6.46 6.37 6.4 6.35 6.39 6.37 6.35 6.41 6.39 6.33 6.38 6.3 6.33 6.35 6.39 6.32 6.38 6.39 6.41 6.42 6.48
HP_VOMITING 6.42 6.48 6.7 6.58 6.57 6.51 6.57 6.46 6.66 6.54 6.6 6.42 6.73 6.66 6.5 6.6 6.57 6.48 6.41 6.67 6.58 6.81 6.49 6.73 6.6 6.7
HP_DIARRHEA 5.95 5.92 5.89 5.97 5.8 5.87 5.91 5.84 5.87 5.85 5.95 5.83 5.87 5.83 5.73 5.76 5.86 5.8 5.79 5.84 5.94 5.82 5.91 5.75 5.87 5.91
HP_DYSPHAGIA 7.2 7.28 7.49 7.48 7.57 7.52 7.62 7.52 7.57 7.6 7.3 7.51 7.62 7.55 7.55 7.45 7.41 7.34 7.59 7.78 7.41 7.61 7.63 7.71 7.62 7.4
HP_NAUSEA_AND_VOMITING 6.56 6.7 6.84 6.75 6.85 6.84 6.73 6.71 6.79 6.81 6.79 6.82 6.86 6.86 6.62 6.74 6.78 6.65 6.84 6.88 6.75 6.89 6.9 6.92 6.86 6.83
HP_NAUSEA 7.1 6.86 6.97 6.65 7.26 7.33 6.98 7 7.05 7.24 6.68 7.29 7.07 7.22 6.99 7.12 6.87 7.04 7.17 7.14 6.96 7.08 6.94 7.26 7.2 7.14
HP_CONSTIPATION 6.95 6.92 6.88 6.88 7.02 7.11 7 7.14 6.98 7.11 6.85 6.99 7.07 7.07 7.2 7.15 7.06 6.89 7.03 7.1 7.08 7.14 7.16 7.2 7.15 7.11
HP_GASTROESOPHAGEAL_REFLUX 7.36 7.47 7.56 7.49 7.73 7.83 7.74 7.7 7.69 7.83 7.38 7.78 7.92 7.94 7.72 7.71 7.61 7.47 7.7 7.89 7.45 7.64 7.79 8 7.82 7.61
HP_ANAL_ATRESIA 6.08 6.08 6.07 6.21 6 5.96 6.2 6.37 6.18 6.09 5.95 6.03 6.1 6.14 6.22 6.13 6.01 6.04 5.96 6.17 6.11 6.13 6.28 6.25 6.1 5.93
HP_MALABSORPTION 6.17 6.25 6.39 6.24 6.27 6.13 6.23 6.15 6.3 6.22 6.32 6.21 6.37 6.38 6.02 6.26 6.15 6.16 6.14 6.29 6.13 6.12 6.33 6.25 6.13 6.14
HP_ANAL_STENOSIS 6.07 6.14 5.98 5.83 6.98 6.76 6.22 6.31 6.47 6.44 6.22 6.42 6.53 6.44 6.37 6.52 6.23 6.06 6.07 6.18 6.11 6.19 6.31 6.21 6.38 6.34
HP_ABDOMINAL_PAIN 6.23 6.24 6.24 6.22 6.23 6.16 6.22 6.16 6.29 6.2 6.23 6.14 6.31 6.24 5.98 6.12 6.15 6.19 6.08 6.12 6.19 6.19 6.31 6.22 6.26 6.34
HP_CHRONIC_DIARRHEA 6.15 6.11 5.9 5.96 6.1 6.05 6.07 6.02 6.18 6.05 6.14 5.91 6.19 6.24 6.13 6.12 6.26 6.24 6 6.11 5.95 5.97 6.2 6.16 6.1 5.89
HP_ABNORMAL_ESOPHAGUS_MORPHOLOGY 6.15 6.18 6.32 6.43 6.21 6.09 6.24 6.3 6.22 6.2 6.31 6.13 6.23 6.08 6.25 6.14 6.15 6.15 6.08 6.22 6.24 6.19 6.28 6.35 6.15 6.14
HP_ESOPHAGEAL_ATRESIA 6.53 6.47 6.9 6.72 6.42 6.24 6.58 6.45 7.04 6.68 6.84 6.69 6.51 6.34 6.52 6.53 6.72 6.82 6.22 6.46 6.66 6.9 6.94 6.88 6.55 6.45
HP_POOR_SUCK 6.55 6.71 6.71 6.77 6.8 6.85 6.92 6.68 6.67 6.85 6.86 6.7 6.79 6.61 6.78 6.71 6.84 6.68 6.66 6.62 6.73 6.87 6.58 6.8 6.9 6.94
HP_ABNORMAL_RECTUM_MORPHOLOGY 6.51 6.65 7.1 7.11 6.81 6.95 6.79 6.98 6.91 6.94 6.62 6.82 6.9 6.84 6.83 6.94 6.45 6.56 6.61 6.92 6.83 6.83 7.14 7.25 6.83 6.75
HP_RECTAL_PROLAPSE 6.23 6.74 6.99 6.9 6.81 6.54 6.78 7.13 6.63 6.83 6.56 6.71 6.7 6.8 6.83 6.75 6.6 6.48 6.46 6.91 7.01 6.83 7.07 7.08 6.65 6.73
HP_HIATUS_HERNIA 5.87 5.77 6.05 6.32 5.87 5.77 5.88 5.84 5.84 6.06 5.89 5.97 5.96 5.86 5.99 6.02 5.95 6.07 5.92 5.64 6.29 5.93 6 5.86 5.84 6.11
HP_INFLAMMATION_OF_THE_LARGE_INTESTINE 5.69 5.68 5.64 5.78 5.65 5.38 5.62 5.55 5.73 5.43 5.62 5.42 5.46 5.5 5.51 5.49 5.88 5.72 5.43 5.58 5.84 5.73 5.66 5.22 5.67 5.56
HP_ANOREXIA 6.04 6.1 6.09 5.93 5.78 6.17 5.97 6.1 6.23 5.79 6.1 5.8 6.02 6.13 5.91 6.01 5.92 6.05 5.87 6.12 6.06 6.1 5.89 6.1 6.19 6.18
HP_ESOPHAGEAL_VARIX 6.63 6.68 6.5 6.55 6.86 7.18 6.67 6.82 6.8 6.9 6.53 7.35 6.82 6.85 6.62 6.63 6.93 6.94 7.04 6.77 6.86 6.87 6.88 6.96 6.85 6.88
HP_ESOPHAGEAL_STRICTURE 5.52 5.46 5.29 5.55 5.38 5.22 5.16 5.06 5.53 5.24 5.72 5.12 5.09 5.22 5.01 5.21 5.44 5.06 5.32 5.23 5.4 4.98 5.21 4.8 5.06 5.23
HP_HYPOTHERMIA 5.97 6.23 6.5 6.29 5.88 6.01 6.06 6.64 6.11 6.1 6.24 6.09 6.09 6.39 5.67 5.94 6.37 6.14 6.19 6.19 5.76 5.74 6.03 6.1 5.79 6
HP_HEAT_INTOLERANCE 6.56 5.94 6.38 5.98 5.98 5.74 6.42 6.47 6.36 6.09 6.37 5.98 6.33 6.39 6.43 6.36 6.7 6.96 5.16 6.54 6.7 6.41 6.36 6.04 6.45 6.39
HP_MALIGNANT_HYPERTHERMIA 5.61 5.31 5.19 5.38 5.29 5.05 5.28 5.29 5.36 5.08 5.59 5.12 5.27 5.14 5.11 5.1 5.32 5.46 5.38 5.16 5.48 5.23 5.07 4.84 5.07 4.97
HP_ABNORMALITY_OF_THE_GLABELLA 7.63 7.6 7.81 7.84 8.19 8.01 7.81 7.72 7.92 7.69 7.86 8.17 8.08 7.99 7.94 8.1 7.95 8.05 7.6 7.95 7.4 7.58 7.93 8.3 7.99 7.72
HP_MYOPATHIC_FACIES 6.33 6.86 6.2 6.17 6.65 6.74 6.23 6.3 6.6 6.31 6.16 6.37 6.36 6.47 6.43 6.16 6.2 6.55 6.57 6.51 6.17 6.35 6.48 6.28 6.74 6.83
HP_LOWER_LIMB_SPASTICITY 7.58 7.7 8.02 7.9 7.91 8.05 7.92 7.88 8 8.03 7.92 7.97 8.04 7.94 7.96 7.85 7.83 7.63 7.77 8.2 7.7 7.95 7.99 8.27 8.07 7.83
HP_MORPHOLOGICAL_ABNORMALITY_OF_THE_PYRAMIDAL_TRACT 7.02 7.29 7.77 7.71 7.69 7.56 7.44 7.54 7.73 7.88 7.53 7.53 7.62 7.76 7.47 7.64 7.34 7.31 7.48 7.57 7.4 7.57 7.67 7.69 7.46 7.36
HP_RIGIDITY 7.91 8.02 8.02 7.74 8.42 8.34 8.33 8.23 8.34 8.28 8.1 8.28 8.28 8.34 8.26 8.24 7.93 7.99 8.33 8.41 7.92 8.18 8.34 8.42 8.27 8.2
HP_SPASTIC_GAIT 7.86 8.08 8.13 7.93 8.28 8.4 8.32 8.22 8.45 8.45 8.33 8.38 8.33 8.5 8.4 8.2 8.23 7.95 8.12 8.34 8.05 8.38 8.57 8.61 8.46 8.07
HP_GAIT_ATAXIA 7.52 7.59 7.89 7.71 7.9 8.05 8.03 7.96 7.93 8.04 7.82 8.05 7.99 8.06 7.98 8.07 7.72 7.68 7.74 8.15 7.62 7.86 8.05 8.21 8.06 7.88
HP_BRADYKINESIA 7.74 7.9 7.7 7.64 8.19 8.17 8.06 8.06 8.14 8.07 7.85 8.08 8.12 8.05 8.08 8.13 7.73 7.8 7.98 8.16 7.72 8.14 8.07 8.11 8.08 7.91
HP_BILATERAL_TONIC_CLONIC_SEIZURE 7.82 8.06 8.21 7.85 8.37 8.46 8.38 8.25 8.29 8.35 7.97 8.32 8.25 8.39 8.42 8.27 7.93 8.06 8.27 8.43 8.09 8.21 8.33 8.52 8.28 8.22
HP_LIMB_ATAXIA 7.88 7.66 8.11 7.94 8.08 8.36 8.3 8.31 8.27 8.3 8.06 8.41 8.39 8.32 8.16 8.26 7.96 7.87 8.13 8.25 7.74 8.06 8.2 8.38 8.4 8.22
HP_ABNORMALITY_OF_EXTRAPYRAMIDAL_MOTOR_FUNCTION 7.58 7.51 7.7 7.63 7.92 8.03 7.86 7.8 7.83 7.97 7.55 7.89 7.84 7.86 7.9 7.78 7.6 7.53 7.73 8.01 7.57 7.76 7.88 7.95 7.7 7.7
HP_CHOREA 7.74 7.96 8 7.92 8.01 8.12 8.05 8.07 8.06 8.12 7.87 8.18 8.15 8.14 8.04 8.05 7.91 7.88 8.02 8.22 7.83 8.13 8.07 8.24 8.14 7.92
HP_PROGRESSIVE_CEREBELLAR_ATAXIA 8.01 8.06 8.22 7.98 8.06 8.35 8.26 8.39 8.23 8.42 8.16 8.48 8.33 8.22 8.57 8.43 7.99 8.06 8.21 8.28 8.03 8.24 8.4 8.67 8.35 8.36
HP_DYSDIADOCHOKINESIS 7.23 7.15 7.34 7.43 7.71 7.78 8.02 7.91 7.82 7.6 7.46 8.01 7.97 8.06 7.91 7.79 7.8 7.08 7.66 8.07 7.48 7.64 7.75 7.91 8.02 7.78
HP_MIGRAINE 7.04 6.94 6.93 6.71 7.23 7.35 7.16 7.3 7.24 7.2 7.11 7.18 7.24 7.13 6.93 7.23 6.86 6.85 7.3 7.29 7.12 7.06 7.27 7.36 7.21 7.08
HP_MIGRAINE_WITH_AURA 7.41 7.38 6.55 6.28 8.05 7.82 7.65 7.53 7.63 7.5 7.6 7.64 7.57 7.81 7.38 7.63 7.15 7.38 7.93 7.85 7.55 7.75 7.88 7.81 7.43 7.51
HP_TRUNCAL_ATAXIA 7.79 7.65 8.1 7.91 8.02 8.2 8.18 8.1 7.89 8.23 7.99 8.41 8.16 8.3 8.17 8.21 7.78 7.82 7.9 8.21 7.96 8.04 8.18 8.3 8.15 8.17
HP_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM 7.68 7.81 7.96 7.77 8.03 8.11 8.1 8.1 8.07 8.06 7.72 8.01 8.1 8.14 8.13 8.02 7.75 7.75 7.9 8.18 7.77 7.95 8 8.27 8.08 7.95
HP_ENCEPHALOCELE 5.89 6.11 6.04 6.34 5.95 6 5.96 6.06 5.94 6.13 6.25 6.17 6.16 6.18 5.99 6.31 6.05 6.07 6.12 6.18 6.28 6.14 6.14 5.95 5.97 6.23
HP_OCCIPITAL_ENCEPHALOCELE 6.23 6.24 6.21 6.45 6.3 6.11 6.18 6.29 6 6.44 6.53 6.42 6.22 6.38 6.33 6.55 6.26 6.1 6 6.18 6.34 6.39 6.37 6.17 6.48 6.6
HP_ABNORMALITY_OF_THE_UPPER_RESPIRATORY_TRACT 6.3 6.29 6.36 6.37 6.36 6.36 6.35 6.33 6.3 6.33 6.34 6.36 6.38 6.4 6.3 6.44 6.26 6.4 6.28 6.31 6.38 6.45 6.32 6.5 6.42 6.51
HP_ABNORMAL_LUNG_MORPHOLOGY 6.23 6.25 6.24 6.33 6.28 6.24 6.2 6.27 6.26 6.28 6.3 6.28 6.33 6.37 6.21 6.28 6.25 6.25 6.2 6.28 6.3 6.35 6.29 6.31 6.34 6.42
HP_PNEUMONIA 5.89 5.8 5.89 6.03 5.74 5.76 5.8 5.84 5.9 5.81 5.8 5.74 5.76 5.84 5.84 5.82 5.79 5.93 5.67 5.71 5.89 5.76 5.76 5.63 5.84 5.86
HP_RESTRICTIVE_VENTILATORY_DEFECT 6.2 5.82 5.96 5.92 5.67 5.77 6.01 5.97 5.94 5.77 5.88 5.77 6.03 5.82 5.92 5.58 5.94 5.84 5.79 5.98 6.07 5.89 5.58 5.63 5.9 5.92
HP_RESPIRATORY_INSUFFICIENCY 6.54 6.62 6.8 6.61 6.74 6.87 6.71 6.65 6.65 6.75 6.62 6.72 6.65 6.73 6.66 6.77 6.64 6.66 6.69 6.68 6.61 6.73 6.82 6.76 6.86 6.72
HP_DYSPNEA 6.51 6.46 6.5 6.6 6.63 6.58 6.41 6.53 6.57 6.63 6.45 6.61 6.56 6.57 6.46 6.46 6.57 6.54 6.48 6.39 6.51 6.52 6.75 6.51 6.53 6.58
HP_EMPHYSEMA 6.33 6.22 5.99 6.2 5.93 5.95 6.12 6.13 6 5.88 6.14 5.73 5.93 6.16 5.68 5.96 6.54 6.41 6.28 5.89 6.12 6 5.85 5.51 6.24 6.06
HP_RESPIRATORY_DISTRESS 6.58 6.58 6.62 6.63 6.74 6.73 6.83 6.63 6.59 6.73 6.58 6.67 6.77 6.71 6.82 6.74 6.69 6.73 6.88 6.87 6.67 6.8 6.67 6.69 6.85 6.85
HP_ASTHMA 6.04 6.11 6.16 6.28 6.16 6.16 6.07 5.97 6.25 6.17 6.2 6.18 6.38 6.35 6 6.14 6.17 6.2 6.1 6.15 6.29 6.29 6.22 6.19 6.03 6.13
HP_RECURRENT_ASPIRATION_PNEUMONIA 6.69 6.95 7.54 7.45 6.61 7 6.97 6.98 6.91 7.42 6.87 7.23 7.21 6.94 7.08 6.91 6.79 6.66 7.27 7.1 7 7.26 7.1 6.88 6.91 6.68
HP_ABNORMAL_LUNG_LOBATION 6.27 6.35 6.12 6.31 6.25 6.13 6.05 6.34 6.4 6.16 6.34 6.5 6.41 6.3 6.3 6.11 6.22 6.19 5.98 6.17 6.58 6.36 6.25 6.19 6.21 6.15
HP_PLEURITIS 5.77 4.98 5.47 5.79 5.37 5.22 4.98 5.29 5.36 5.37 5.43 5.05 5.03 5.3 5.34 5.45 5.61 5.2 5.32 5.17 5.48 5.88 5.4 4.91 5.49 5.46
HP_ABNORMAL_PLEURA_MORPHOLOGY 5.92 6.13 5.89 6.21 5.72 5.79 6.08 5.93 6.14 6.01 6.22 5.85 6.09 6.17 5.86 5.84 5.98 5.75 6.01 6 6.05 6.05 6.11 5.68 6.13 6.13
HP_APNEA 6.92 7.08 7.35 7.18 7.19 7.26 7.28 7.47 7.16 7.34 7.15 7.34 7.31 7.22 7.37 7.35 7.12 7.09 7.35 7.38 7.17 7.51 7.24 7.43 7.32 7.37
HP_HEMOPTYSIS 5.92 5.69 5.81 5.81 5.65 5.34 5.93 5.69 5.68 5.68 6.24 5.76 5.88 5.64 5.73 5.53 5.92 5.86 5.69 5.81 5.93 5.87 5.93 5.42 5.76 5.68
HP_PNEUMOTHORAX 6.3 6.33 6.07 6.37 6.53 6.43 6.29 6.29 6.66 6.42 6.44 6.53 6.45 6.49 6.13 6.44 7.08 6.62 6.24 6.46 6.57 6.37 6.64 6.5 6.38 6.3
HP_PULMONARY_INFILTRATES 6.23 6.61 6.61 6.29 6.32 6.7 6.58 6.08 6.59 6.36 6.47 6.28 6.42 6.58 6.13 6.15 6.42 6.36 6.96 6.48 6.3 6.07 6.95 6.35 6.31 6.31
HP_ABNORMALITY_OF_THE_CEREBRAL_VENTRICLES 6.86 6.9 7.16 7.04 7.09 7.2 7.08 7.15 7.08 7.22 6.97 7.14 7.21 7.28 7.2 7.2 6.98 6.97 7.07 7.18 7.03 7.17 7.2 7.33 7.18 7.21
HP_VENTRICULOMEGALY 6.95 7.06 7.15 7.07 7.16 7.28 7.18 7.2 7.18 7.3 7.07 7.28 7.32 7.33 7.27 7.23 7.09 7.06 7.17 7.25 7.07 7.22 7.22 7.42 7.28 7.27
HP_CEREBRAL_CORTICAL_ATROPHY 7.16 7.27 7.65 7.58 7.56 7.61 7.62 7.57 7.75 7.56 7.32 7.53 7.71 7.7 7.67 7.66 7.36 7.27 7.43 7.64 7.41 7.67 7.63 7.85 7.6 7.49
HP_POLYMICROGYRIA 7.53 7.51 7.78 7.77 7.78 7.95 7.92 7.83 7.83 7.82 7.68 7.78 7.92 7.9 7.84 7.71 7.53 7.62 7.77 7.88 7.62 7.85 7.89 7.94 7.88 7.64
HP_ABNORMAL_UPPER_MOTOR_NEURON_MORPHOLOGY 7.15 7.32 7.59 8.13 7.69 7.69 7.33 7.49 7.72 7.51 6.93 7.12 7.65 7.78 7.41 7.72 7.24 7.52 7.34 7.67 7.58 7.97 7.46 7.91 7.35 7.24
HP_EPISODIC_ATAXIA 8.92 9.03 8.55 8.7 9.26 9.53 9.49 9.47 9.4 9.37 8.83 9.49 9.4 9.47 9.52 9.29 9.15 9.27 9.48 9.54 9.18 9.21 9.42 9.5 9.14 8.94
HP_PORENCEPHALIC_CYST 6.58 6.75 8.03 7.74 7.36 7.26 7.42 7.53 7.79 7.32 6.96 7.42 7.61 7.32 7.73 7.62 7.19 6.99 7.13 7.37 7.43 7.35 7.9 8 8.13 8.07
HP_STATUS_EPILEPTICUS 8.22 8.33 8.38 8.07 8.57 8.81 8.79 8.64 8.66 8.63 8.3 8.59 8.67 8.69 8.66 8.59 8.12 8.33 8.5 8.88 8.25 8.53 8.71 8.78 8.59 8.32
HP_ABNORMALITY_OF_THE_BASAL_GANGLIA 7.28 7.49 7.76 7.66 7.59 7.68 7.6 7.54 7.83 7.71 7.63 7.56 7.64 7.72 7.72 7.6 7.57 7.46 7.65 7.68 7.45 7.68 7.69 7.75 7.67 7.52
HP_BASAL_GANGLIA_CALCIFICATION 7.15 6.7 7.42 7.03 7.39 7.53 7.36 7.28 7.11 7.28 6.95 7.2 7.61 7.72 6.82 7.09 7.23 7.36 7.18 7.37 7.43 7.35 7.41 7.37 7.36 7.22
HP_BROAD_BASED_GAIT 7.62 7.81 7.98 7.79 8.2 8.26 8.14 8.14 8.27 8.26 7.89 8.31 8.23 8.29 8.23 8.28 7.94 7.85 8.14 8.25 7.95 7.96 8.24 8.35 8.25 8.1
HP_SUBARACHNOID_HEMORRHAGE 6.03 6.17 6.01 5.78 6.29 6.31 6.09 6.01 6.46 6.17 6.32 6.43 6.15 5.92 5.95 6.03 6.48 6.21 6.01 6.16 6.48 6.14 6.24 6.06 6.05 5.84
HP_ARRHINENCEPHALY 6.58 6.61 6.77 6.9 6.81 6.92 7.04 6.91 6.75 6.81 6.63 6.67 6.83 6.75 6.82 6.61 6.56 6.69 6.62 6.97 6.68 6.6 6.95 7.08 6.89 6.93
HP_ISCHEMIC_STROKE 6.84 6.71 6.65 6.69 6.91 6.77 6.73 6.6 6.98 6.78 6.87 7.2 6.78 6.58 6.65 6.58 7.22 6.79 7.04 6.73 7 6.8 7.4 6.98 7.07 6.71
HP_GAIT_IMBALANCE 7.63 7.81 7.98 7.62 7.8 8.1 7.91 7.87 8.2 8.39 8.17 8.44 8.2 8.08 8.23 8.22 8 7.57 8.15 8.1 7.96 7.71 8.33 8.26 8.04 7.89
HP_ABNORMALITY_OF_THE_SPINAL_CORD 6.51 6.57 6.65 6.55 6.71 6.76 6.73 6.74 6.66 6.66 6.56 6.66 6.72 6.69 6.62 6.6 6.62 6.57 6.53 6.68 6.68 6.73 6.84 6.82 6.82 6.87
HP_FRONTOTEMPORAL_DEMENTIA 8.71 8.68 9.22 8.93 9.04 9.09 9.57 8.91 9.33 9 8.93 8.92 8.92 8.94 8.59 8.64 8.66 8.23 8.88 9.25 8.54 8.82 9.26 9.04 8.94 8.7
HP_HYPOPHOSPHATEMIA 5.6 5.7 5.28 5.68 5.53 5.33 5.35 5.05 5.5 5.69 5.66 5.64 5.02 5.57 5.27 5.17 5.76 5.69 5.55 5.8 5.68 5.74 5.42 5.37 5.52 6.04
HP_HYPERURICEMIA 5.68 5.59 6.11 6.02 5.43 5.22 5.5 5.51 5.6 5.69 5.65 5.15 5.24 5.19 5.43 5.79 6.02 5.76 5.3 5.64 5.77 5.67 5.53 5.38 5.62 5.88
HP_INCREASED_SERUM_LACTATE 7 7.05 7.94 7.68 7.18 7.33 7.32 7.47 7.2 7.45 7.33 7.18 7.33 7.41 7.41 7.53 7.16 7.1 7.32 7.45 7.27 7.51 7.35 7.53 7.34 7.31
HP_HYPERKALEMIA 5.73 5.75 5.51 5.83 5.07 5.19 5.91 5.42 5.52 5.56 5.76 5.73 5.4 5.15 5.72 5.34 5.33 5.67 5.59 5.46 5.75 5.6 5.51 5.4 5.51 5.5
HP_HYPERTRIGLYCERIDEMIA 6.51 6.57 6.52 6.41 6.68 6.72 6.58 6.78 6.6 6.82 6.37 6.59 6.75 6.66 6.49 6.44 6.79 6.43 6.37 6.68 6.69 6.58 6.58 6.64 6.74 6.87
HP_HOMOCYSTINURIA 7.39 7.38 7.52 7.95 8.04 8.02 7.84 7.62 8.15 8.44 8.2 7.62 8.3 8.51 8.25 8.74 7.51 7.27 7.45 8.02 7.25 8.51 7.78 8.16 8.38 8.46
HP_HYPERHOMOCYSTINEMIA 6.74 6.61 7.52 7.79 7.39 7.51 7.61 7.3 7.49 7.69 7.68 6.87 7.82 8.03 7.66 8.07 6.84 6.66 6.53 7.96 6.81 7.67 7.56 8.13 7.92 7.69
HP_LOW_POSTERIOR_HAIRLINE 7.46 7.45 7.73 7.23 7.96 7.83 8 7.58 7.78 7.86 7.42 8.02 7.74 7.62 7.85 7.82 7.8 7.6 7.64 7.9 7.82 7.61 8.07 7.92 7.69 7.51
HP_NAIL_DYSPLASIA 6.04 6.16 5.97 6.16 5.92 5.83 6.06 6.13 5.94 5.92 6 6.05 5.87 5.8 5.97 5.87 6.03 6.1 5.84 5.94 6.11 6.08 5.94 5.88 6.03 6.09
HP_IMPAIRED_VIBRATION_SENSATION_IN_THE_LOWER_LIMBS 7.53 7.51 8.24 7.92 7.98 8.33 8.21 8 8.35 8.39 7.83 8.4 8.11 8.07 8.06 8.14 8.12 7.65 7.8 8.32 7.9 7.84 8.07 8.3 8.11 7.83
HP_NEUROLOGICAL_SPEECH_IMPAIRMENT 7.43 7.51 7.82 7.68 7.71 7.89 7.82 7.72 7.77 7.84 7.53 7.79 7.79 7.85 7.78 7.73 7.52 7.46 7.72 7.85 7.52 7.75 7.86 7.96 7.8 7.68
HP_SCANNING_SPEECH 8.11 8.85 8.35 8.16 9.07 9.39 9.06 8.99 9.09 9 8.74 9.36 9.57 9.48 9.17 9.14 8.83 8.85 9.24 9.42 9.28 9.48 9.33 9.53 9.49 9.3
HP_CLONUS 7.64 7.56 8.01 7.8 8 8.11 8.2 8.03 7.96 8.02 7.84 8 8.18 8.14 8.04 8 7.9 7.7 7.78 8.23 7.9 7.89 8.04 8.3 8.12 7.92
HP_INTRACRANIAL_HEMORRHAGE 6.48 6.31 6.5 6.45 6.86 6.72 6.5 6.5 6.63 6.58 6.61 6.59 6.63 6.47 6.45 6.52 6.77 6.45 6.49 6.58 6.6 6.64 6.59 6.72 6.64 6.67
HP_GLIOSIS 7.63 7.85 7.77 7.99 7.94 8.11 8.06 7.72 8.21 7.98 7.74 8.08 8.09 8.1 7.86 7.96 7.73 7.8 7.9 8.01 7.66 8.15 8.18 8.21 8.16 7.67
HP_POSTURAL_INSTABILITY 7.43 7.62 7.4 7.23 7.49 7.85 7.59 7.41 7.7 7.57 7.52 7.76 7.82 7.85 7.67 7.4 7.47 7.41 7.59 7.63 7.32 7.49 7.67 7.82 7.62 7.5
HP_HYPOGLYCEMIC_SEIZURES 6.17 6.65 6.36 6.9 6.55 6.81 6.78 6.68 6.63 6.81 6.34 6.84 6.7 6.8 6.87 6.31 6.74 6.22 6.46 6.94 6.87 6.75 7.15 6.69 6.6 6.45
HP_POSTURAL_TREMOR 7.75 7.87 8.54 7.85 8.55 8.53 8.56 8.95 8.67 8.75 8.36 8.62 8.66 8.53 8.89 8.82 8.31 7.82 8.11 8.41 8.44 8.53 8.84 9 8.89 8.6
HP_SPINAL_CORD_COMPRESSION 7.1 7.14 6.87 6.7 7.36 7.6 7.42 7.53 7.09 7.52 7.71 7.4 7.29 7.35 7.01 7.27 7.67 7.45 7.44 7.51 7.6 7.97 7.17 7.04 7.59 7.65
HP_OPISTHOTONUS 7.18 7.46 7.67 7.48 7.58 7.8 7.67 7.54 7.7 7.45 7.37 7.49 7.69 7.71 7.52 7.54 7.4 7.39 7.57 7.61 7.55 7.52 7.69 7.65 7.65 7.3
HP_NEURODEGENERATION 7.63 7.86 7.97 7.82 7.99 8.18 8.08 7.7 7.88 8.01 7.81 7.82 7.94 7.88 7.9 7.71 7.67 7.62 8.01 7.94 7.66 7.96 8.12 8.3 7.99 7.79
HP_CEREBRAL_EDEMA 7.19 7.37 7.12 7.08 7.83 7.82 7.64 7.47 7.54 7.82 7.66 7.64 7.62 7.72 7.31 7.76 7.05 7.28 7.67 7.71 6.87 7.51 7.67 8.02 7.52 7.57
HP_PHONOPHOBIA 7.15 6.74 7.1 7.12 7.32 6.96 6.79 7.14 6.78 6.58 6.92 7.26 6.69 7.19 6.53 6.74 6.81 6.56 7.38 6.56 7.08 6.3 6.8 6.98 6.65 6.75
HP_NEUROFIBRILLARY_TANGLES 8.57 8.68 9.02 8.09 8.9 9.2 9.34 9.48 9.2 8.79 8.28 8.8 9.05 8.94 8.59 8.78 8.66 8.04 8.4 9.34 9.11 9.27 8.57 8.74 9.26 8.7
HP_APRAXIA 7.15 7.24 7.59 7.51 7.22 7.35 7.4 7.32 7.32 7.4 7.14 7.38 7.4 7.34 7.43 7.44 6.92 7.01 7.17 7.36 7.16 7.55 7.36 7.46 7.48 7.47
HP_INTELLECTUAL_DISABILITY_PROFOUND 7.66 7.81 8.14 7.9 8.12 8.23 8.36 8.21 8.13 8.17 7.8 8.19 8.14 8.21 8.45 8.11 7.79 7.84 8.14 8.29 7.91 8.04 8.24 8.43 8.21 8.07
HP_DELAYED_CNS_MYELINATION 7.44 7.55 7.65 7.44 7.64 7.81 8.31 8.23 7.95 7.84 7.33 7.68 7.95 8.16 8.08 7.79 7.61 7.46 7.57 8.25 7.67 7.73 7.94 8.08 7.91 7.79
HP_PROGRESSIVE_SPASTICITY 7.42 7.63 7.23 7.21 8.03 8.05 7.56 7.53 7.93 7.41 7 7.59 7.66 7.35 7.61 7.36 7.39 7.32 7.54 7.88 7.34 7.35 7.78 7.87 7.86 7.36
HP_DELAYED_GROSS_MOTOR_DEVELOPMENT 7.63 7.76 7.86 7.79 8.03 8.06 8.13 8.21 7.98 8.1 7.8 7.98 8.15 8.1 8.19 8.2 7.8 7.75 7.95 8.15 7.92 7.99 8.03 8.23 8.24 7.99
HP_MYELOPATHY 6.81 6.55 6.41 6.25 6.88 7.19 7.01 7.14 6.74 6.78 6.32 6.87 6.96 6.74 6.68 6.93 6.58 6.78 6.67 6.96 6.37 6.72 7.09 6.91 6.79 6.87
HP_GENERALIZED_ONSET_SEIZURE 7.79 8 8.04 7.82 8.36 8.29 8.31 8.18 8.21 8.27 7.89 8.16 8.23 8.26 8.33 8.17 7.87 7.88 8.18 8.27 7.89 8.16 8.24 8.41 8.14 8.03
HP_DILATED_FOURTH_VENTRICLE 6.45 6.54 6.76 6.63 6.5 6.68 6.63 6.54 6.53 6.7 6.59 6.63 6.62 6.57 6.76 6.63 6.52 6.56 6.55 6.59 6.62 6.6 6.59 6.77 6.76 6.62
HP_HYPOCALCEMIC_SEIZURES 5.51 5.46 4.74 5.13 4.98 5.19 5.47 4.98 5.19 4.93 5.28 5.22 4.82 4.85 5.14 4.82 5.34 5.53 4.86 5.21 5.22 4.88 5.01 4.72 4.76 4.99
HP_PSEUDOBULBAR_SIGNS 6.43 6.61 6.78 7.18 6.75 6.74 7.05 6.85 6.86 7.03 6.48 6.63 6.92 6.85 6.63 6.41 6.5 6.35 6.64 6.83 6.83 6.49 6.61 6.86 6.56 6.41
HP_PLEURAL_EFFUSION 5.88 5.97 5.7 5.86 5.7 5.41 6.08 5.91 6.31 6.07 6.25 5.92 6.21 6.28 5.65 5.53 5.9 5.57 6.03 5.93 5.94 5.96 6.23 5.64 5.93 5.93
HP_PULMONARY_EMBOLISM 6.4 6.35 6.39 6.27 6.32 6.13 6.23 6.08 6.38 6.3 6.32 6.22 6.35 6.37 6.02 6.08 6.17 5.95 6.31 5.92 6.05 6.07 6.31 6.18 6.33 6.22
HP_RECURRENT_RESPIRATORY_INFECTIONS 6.18 6.16 6.1 6.21 6.13 6.08 6.11 6.13 6.12 6.16 6.17 6.07 6.18 6.26 6.09 6.18 6.13 6.13 6.05 6.15 6.2 6.23 6.15 6.11 6.21 6.37
HP_PULMONARY_FIBROSIS 6.08 5.93 5.99 6.23 5.92 5.82 5.69 5.95 5.89 5.77 5.96 6.01 5.99 5.92 5.97 5.73 6.12 5.9 5.85 5.89 6.13 6.04 5.64 5.63 5.9 6.03
HP_COARSE_HAIR 6.95 6.82 7.24 7.09 7.35 7.34 7.08 7.09 7.36 7.22 7.31 7.3 7.39 7.24 7.51 7.32 6.93 6.84 7.02 7.12 6.86 7.05 7.39 7.49 6.82 6.96
HP_SPARSE_SCALP_HAIR 6.54 6.54 6.46 6.65 6.7 6.64 6.58 6.65 6.5 6.72 6.54 6.55 6.58 6.47 6.72 6.56 6.58 6.45 6.55 6.71 6.7 6.6 6.67 6.84 6.6 6.66
HP_WHITE_FORELOCK 6.43 6.4 6.44 6.9 6.93 6.72 6.29 6.77 6.58 6.65 6.51 6.51 6.47 6.61 6.27 6.6 6.57 6.51 6.54 6.33 6.13 6.26 6.8 6.72 6.69 6.71
HP_CURLY_HAIR 8.18 7.92 8.43 8.26 8.68 8.64 8.78 8.54 8.69 8.64 8.35 8.36 8.61 8.74 8.64 8.7 8.56 8.18 8.27 8.51 8.57 8.65 8.69 8.62 8.67 8.81
HP_FINE_HAIR 6.84 6.65 6.75 6.86 6.77 6.92 6.73 6.96 6.72 6.88 6.79 6.85 6.95 7.01 7.03 7.08 6.77 6.77 6.65 6.96 6.7 6.99 7.05 6.99 6.72 7.02
HP_PREMATURE_GRAYING_OF_HAIR 6.04 6.26 5.82 6.38 5.99 6.09 6.26 6.24 6.09 6.19 6 6.2 5.95 5.81 6.02 6.09 6.19 6.22 5.84 6.14 6.12 6.12 6.13 5.88 6.15 6.31
HP_FACIAL_HYPERTRICHOSIS 7.46 7.62 7.43 7.52 7.71 7.89 7.65 7.63 7.68 7.84 7.54 7.84 7.83 7.98 7.74 7.73 7.72 7.27 7.61 7.93 7.35 7.65 7.95 8.08 7.66 7.73
HP_ABSENT_EYEBROW 6.65 6.58 7.16 7.12 6.94 6.87 6.68 7.06 7.44 7.16 6.71 7 7.28 7.37 6.98 7.56 7 6.84 6.69 7.06 6.81 7.05 7.26 7.08 6.74 7.38
HP_WOOLLY_HAIR 5.42 5.42 5.6 5.24 4.92 5.01 5.15 5.14 5.53 5.08 5.16 5.1 5.04 4.99 5.28 5.04 5.1 5.35 5.42 4.82 5.39 5.32 5.21 5.46 5.2 5.24
HP_WHITE_EYEBROW 6.23 6.03 6.24 5.94 6.19 6.11 6.04 6.55 6.39 6.39 5.89 6.51 6.31 6.16 6.11 6.22 6.37 6.16 6.23 6.33 5.92 6.07 6.25 6.24 6.79 6.49
HP_GENERALIZED_HIRSUTISM 7.35 7.44 7.86 7.68 7.64 8.19 7.79 7.63 7.82 8.09 7.77 7.85 7.83 8.02 7.84 7.77 7.34 7.27 7.77 7.73 7.27 7.69 8.08 8.09 7.55 7.47
HP_SPARSE_BODY_HAIR 5.25 5.12 5.15 5.2 5.04 4.68 5.02 5.03 5.11 4.92 5.2 4.87 5.04 4.76 5.28 4.88 5.04 5.09 5.12 4.98 5.21 5.16 4.97 4.66 4.96 4.84
HP_PATCHY_ALOPECIA 5.67 5.31 5.48 5.82 4.84 4.95 5.44 5.24 5.48 5.09 5.11 5.24 4.96 4.82 5.2 4.62 5.4 5.5 5.09 5.2 5.27 5 5.04 4.74 5.29 4.83
HP_GASTROINTESTINAL_HEMORRHAGE 6.23 6.28 6.38 6.34 6.21 6.08 6.19 6.29 6.18 6.23 6.29 6.29 6.31 6.28 6.06 6.1 6.13 6.23 5.99 6.08 6.21 6.18 6.36 6.33 6.27 6.28
HP_HEPATOMEGALY 6.5 6.53 6.67 6.69 6.7 6.66 6.62 6.57 6.6 6.66 6.46 6.59 6.65 6.61 6.51 6.57 6.5 6.43 6.55 6.67 6.52 6.57 6.63 6.68 6.65 6.71
HP_ABNORMAL_INTESTINE_MORPHOLOGY 6.25 6.28 6.36 6.34 6.28 6.29 6.24 6.3 6.3 6.28 6.33 6.33 6.35 6.35 6.24 6.38 6.22 6.23 6.27 6.28 6.31 6.3 6.41 6.35 6.3 6.34
HP_PROTEIN_LOSING_ENTEROPATHY 6.62 6.61 6.48 6.09 6.49 6.44 6.39 6.32 6.21 6.24 6.38 6.07 6.55 6.44 6.57 6.45 6.33 6.06 6.49 6.13 6.38 6.41 6.51 6.59 6.42 6.22
HP_ABNORMALITY_OF_THE_SMALL_INTESTINE 6.28 6.19 6.13 6.17 6.28 6.3 6.2 6.13 6.32 6.26 6.19 6.2 6.36 6.29 6.31 6.26 6.12 6.13 6.16 6.28 6.25 6.13 6.34 6.39 6.25 6.22
HP_ABNORMAL_DUODENUM_MORPHOLOGY 5.75 5.67 5.78 5.97 5.74 5.54 5.75 5.45 5.93 5.8 5.57 5.43 5.8 5.84 5.86 5.54 5.79 5.43 5.82 5.77 5.74 5.7 5.63 5.63 5.73 5.74
HP_DUODENAL_ATRESIA 6.1 6.15 6.1 6.17 6.03 5.91 6.16 6.16 6.23 6.13 6.08 5.64 6.04 6.28 6.11 5.87 6.02 6.03 6.07 6.23 6.45 6.39 6.27 5.83 6.26 6.13
HP_HEMATEMESIS 5.95 6.08 6.34 5.73 5.73 5.49 5.66 5.76 5.87 5.75 6.12 5.58 5.34 5.56 5.68 5.84 6.1 5.56 5.47 5.32 6.19 6.09 5.67 5.33 6.1 6
HP_MELENA 6.09 6.13 5.86 5.65 5.71 5.78 5.74 5.98 5.87 5.63 5.79 5.62 5.58 5.64 5.76 5.92 6.09 5.61 5.59 5.61 5.91 6.01 5.91 5.71 6.01 6.07
HP_ABNORMAL_LARGE_INTESTINE_MORPHOLOGY 6.16 6.27 6.48 6.35 6.26 6.29 6.31 6.33 6.35 6.26 6.33 6.3 6.4 6.32 6.17 6.38 6.24 6.25 6.27 6.37 6.47 6.2 6.41 6.39 6.25 6.34
HP_AGANGLIONIC_MEGACOLON 6.23 6.3 6.32 6.48 6.5 6.53 6.33 6.44 6.42 6.54 6.35 6.4 6.43 6.44 6.41 6.52 6.38 6.24 6.16 6.22 6.24 6.38 6.54 6.63 6.43 6.35
HP_COLONIC_DIVERTICULA 7.19 6.91 7.14 7.13 7.41 7.16 7.2 7.34 6.94 7.35 7.17 7.43 7.55 7.73 7.34 7.27 7.25 7.07 7.47 7.47 7.18 7.38 7.07 7.6 7.18 7.13
HP_INTERMITTENT_DIARRHEA 5.72 5.83 5.6 5.75 5.58 5.41 5.85 5.77 5.79 5.75 5.87 5.65 5.53 5.51 5.61 6.11 5.63 5.64 5.14 5.69 5.92 5.82 5.67 5.42 5.87 5.92
HP_CHRONIC_RHINITIS 5.4 5.36 5.22 5.27 5.03 5.16 5.47 5.18 5.14 5.71 5.36 5.57 5.34 5.17 5.37 5.69 5.45 5.79 5.23 5.03 5.49 5.4 5.14 5.11 5.11 5.33
HP_EXAGGERATED_CUPID_S_BOW 8.22 8.62 8.06 7.44 8.36 8.14 8.48 8.53 8.43 8.38 7.54 8.26 8.91 8.55 8.67 8.37 8.73 8.54 8.48 8.88 8.05 8.14 8.34 8.47 8.54 8.23
HP_LARGE_FLESHY_EARS 8.47 8.54 8.31 8.5 8.82 8.88 8.67 8.37 8.83 8.76 8.6 8.48 8.71 8.92 8.44 8.67 8.46 8.57 9.13 8.84 8.23 8.22 8.96 9.03 8.37 8.18
HP_FOCAL_CLONIC_SEIZURE 8.34 8.88 8.45 8.45 8.88 9.23 9.34 9.23 9.17 9.1 8.79 8.62 9.02 9.13 9.37 8.95 8.21 8.44 9.12 9.22 8.92 8.96 8.8 9.36 8.59 8.51
HP_EXAGGERATED_STARTLE_RESPONSE 7.95 7.9 7.72 7.68 8.04 8.14 8.21 8.25 7.89 8.04 7.41 7.92 8.1 8.23 8.05 8.18 8 7.83 8.05 8.21 7.99 7.97 7.98 8.07 8.14 8.09
HP_PAROXYSMAL_DYSTONIA 7.13 7.35 8.04 7.77 7.89 8.22 7.51 7.76 7.51 7.98 7.88 7.91 8.05 8 7.94 8.21 7.12 7.7 8.3 8.17 6.97 7.91 7.59 7.96 7.47 7.58
HP_ABNORMALITY_OF_NEURONAL_MIGRATION 7.15 7.21 7.39 7.34 7.37 7.5 7.42 7.46 7.45 7.52 7.33 7.48 7.53 7.56 7.5 7.45 7.2 7.25 7.42 7.4 7.25 7.57 7.42 7.58 7.47 7.44
HP_TETRAPARESIS 7.68 7.37 7.95 7.96 7.8 7.89 7.85 7.61 8.18 7.9 7.65 8.12 8.04 7.94 7.84 7.75 7.65 7.56 7.79 7.85 7.51 7.92 8.34 8.4 8 7.47
HP_POOR_MOTOR_COORDINATION 7.08 7.18 7.24 6.84 7.39 7.54 7.37 7.36 7.32 7.33 7.22 7.43 7.61 7.71 7.58 7.65 7.36 7.27 7.45 7.62 7.34 7.69 7.54 7.81 7.39 7.5
HP_ENLARGED_CISTERNA_MAGNA 7.36 7.5 7.21 6.87 7.91 7.77 7.58 7.44 7.5 7.64 7.26 7.55 7.4 7.54 7.49 7.46 7.84 7.54 7.4 7.55 7.71 7.41 7.17 7.42 7.4 7.48
HP_GRAY_MATTER_HETEROTOPIA 7.29 7.25 7.15 6.91 7.38 7.55 7.33 7.31 7.4 7.72 7.2 7.59 7.78 7.54 7.49 7.41 7.23 7.16 7.33 7.48 7.33 7.6 7.22 7.64 7.32 7.43
HP_GLOBAL_BRAIN_ATROPHY 8.36 8.33 8.53 8.5 8.57 8.71 8.35 8.19 8.39 8.1 8.37 8.07 8.09 8.13 8.52 8.31 8.17 8.27 8.24 8.62 8.05 8.27 8.34 8.69 8.3 8.18
HP_FAIR_HAIR 7.38 7.33 7.99 7.96 7.47 7.57 7.45 6.94 7.67 7.76 8.23 7.46 7.51 7.69 7.48 7.34 7.28 7.12 7.43 7.29 6.79 7.24 7.98 7.71 7.34 7.05
HP_ALOPECIA_OF_SCALP 5.95 5.73 5.44 5.71 5.11 5.39 5.66 5.82 5.78 5.66 5.69 4.91 5.81 5.73 5.41 5.5 6.18 5.84 5.39 5.78 5.76 5.79 5.77 5.86 5.79 5.54
HP_ABSENT_HAIR 6.26 6.33 6.56 6.88 6.41 6.07 6.29 6.51 6.38 6.78 6.5 6.61 6.46 6.13 6.46 6.43 6.31 6.45 6.22 6.31 6.12 6.26 6.61 6.43 6.58 6.62
HP_BRITTLE_HAIR 6.17 6.21 6.65 6.44 6.22 6 6.03 5.99 6.22 5.92 6.47 5.9 6.03 6.19 6.31 6.33 5.88 5.95 5.75 6.43 6.03 6.05 6.29 6.37 6.09 6.03
HP_MUTISM 8.29 8.16 8.08 8.22 8.38 8.54 8.38 8.22 8.2 8.35 8.27 8.44 8.23 8.29 8.44 8.26 7.66 7.6 8.03 8.38 8.23 8.47 8.33 8.69 8.28 8.35
HP_HEMIPLEGIA 6.62 6.62 6.83 6.3 6.37 6.95 6.98 6.95 6.74 6.89 6.61 6.62 6.79 6.58 7.17 7 6.54 7.01 6.52 6.9 6.44 6.92 7.09 7.01 7.08 6.53
HP_AKINESIA 8.13 8.11 7.55 7.23 8.66 8.79 8.06 8.14 8.32 8.33 7.63 8.3 8.32 8.25 7.96 7.72 8.16 7.8 8.07 8.1 7.91 8.17 8.33 8.41 8.29 7.94
HP_ATHETOSIS 7.67 7.67 8.16 7.75 8.14 8.13 8.13 8.42 8.32 8.19 8.21 8.06 8.25 8.16 8.12 8.07 7.75 7.88 8.02 8.41 7.69 8.33 8.24 8.35 8.18 8.03
HP_ARNOLD_CHIARI_MALFORMATION 7.22 7.22 7.16 7.14 7.41 7.5 7.2 7.54 7.36 7.31 7.18 7.53 7.57 7.73 7.44 7.29 7.15 7.27 7.38 7.55 7.21 7.42 7.61 7.71 7.37 7.44
HP_OROFACIAL_DYSKINESIA 8.2 8.67 8.45 7.72 8.71 8.81 8.5 8.36 8.61 8.64 8.4 8.08 8.5 8.45 8.36 8.45 7.59 7.49 8.71 8.5 8.15 8.72 8.67 8.81 8.45 8.26
HP_INCOORDINATION 7.42 7.51 7.65 7.48 7.82 7.85 7.71 7.69 7.72 7.79 7.58 7.69 7.78 7.84 7.67 7.66 7.48 7.38 7.71 7.84 7.38 7.65 7.8 7.97 7.67 7.55
HP_CLUMSINESS 6.69 6.91 6.77 7.05 7.01 6.89 6.86 7.17 6.81 6.89 6.7 6.93 6.97 6.63 6.82 6.77 6.86 6.56 6.97 7.07 6.64 6.8 6.73 6.82 7.12 7.06
HP_SPASTIC_PARAPARESIS 7.4 7.71 7.69 7.55 7.76 7.84 7.68 7.66 7.8 7.67 7.5 7.65 7.67 7.49 7.63 7.45 7.7 7.11 7.46 7.88 7.43 7.33 7.67 7.85 7.64 7.38
HP_DEGENERATION_OF_THE_LATERAL_CORTICOSPINAL_TRACTS 7.84 7.85 8.93 8.49 8.79 8.7 8.27 8.09 8.75 8.85 8.79 8.81 8.66 8.5 8.59 8.27 8.38 7.77 7.96 8.17 8.28 8.4 9.11 8.88 8.39 8.16
HP_HEADACHE 6.62 6.65 6.69 6.63 6.7 6.93 6.87 6.85 6.87 6.97 6.73 6.83 6.71 6.73 6.75 6.89 6.66 6.53 6.87 6.88 6.8 6.9 7.04 7.01 6.87 6.96
HP_UNSTEADY_GAIT 8.1 8.16 8.23 8.03 8.39 8.41 8.58 8.45 8.36 8.45 7.93 8.41 8.42 8.54 8.41 8.39 8.16 8.33 8.36 8.58 8.12 8.28 8.43 8.65 8.42 8.27
HP_VERTIGO 6.63 6.81 6.8 6.62 6.9 7.17 6.87 7 7.07 7.15 6.8 7.07 7.15 7 6.94 7.16 6.75 6.53 6.96 6.88 6.91 7.06 7.19 7.27 7.37 7.31
HP_RESTING_TREMOR 8.1 8.11 7.7 7.74 8.52 8.65 8.06 8.14 8.26 8.2 7.68 8.1 8.23 8.29 8.36 8.14 7.99 7.8 8.4 8.2 7.91 8.42 7.94 8.21 8.23 7.94
HP_ANENCEPHALY 6.23 6.24 6.57 6.53 6.38 6.53 6.33 6.38 6 6.19 6.52 6.6 6.27 6.38 6.37 6.24 6.22 6.55 5.95 6.18 6.61 6.44 6.4 6.27 6.39 6.32
HP_TRANSIENT_ISCHEMIC_ATTACK 6.25 6.22 6.17 6.23 6.49 6.49 6.17 6.17 6.58 6.32 6.35 6.32 6.38 6.33 5.97 6.19 6.36 6.37 6.15 6.35 6.31 6.25 6.54 6.38 6.26 6.09
HP_DROWSINESS 5.9 5.76 6.37 6.22 6.09 6.18 6.17 6.09 6.2 6.18 6.32 6.08 6.08 6.42 6.34 6.29 5.99 6.18 5.99 6.35 6.32 6.41 6.19 6.03 6.36 6.36
HP_RECURRENT_PAROXYSMAL_HEADACHE 8.98 9.27 9.27 8.65 9.16 8.9 9.42 8.73 8.87 8.67 8.54 8.88 9.22 9.08 8.66 8.43 8.97 8.49 8.91 9.4 8.75 8.57 9.17 8.96 8.7 8.23
HP_MOTOR_DETERIORATION 7.79 8 7.77 7.81 7.78 8.03 8 8.12 7.79 7.9 7.77 8.03 8.03 7.87 8.01 7.58 7.51 7.34 7.68 8 7.58 7.73 7.88 8.11 7.8 7.56
HP_ABNORMALITY_OF_THE_CEREBELLAR_VERMIS 6.57 6.57 6.85 6.89 6.71 6.84 6.73 6.85 6.66 6.87 6.81 6.8 6.79 6.77 6.84 6.85 6.68 6.66 6.79 6.69 6.71 6.71 6.79 6.85 6.82 6.71
HP_AGENESIS_OF_CEREBELLAR_VERMIS 6 6.01 6.09 6.22 6.24 6.14 6.39 6.26 6.23 6.18 6.16 6.26 6.03 5.91 6.42 5.97 5.99 6.04 5.99 6 6.16 6.21 6.15 6.12 6.36 6.64
HP_ABNORMAL_CAUDATE_NUCLEUS_MORPHOLOGY 7.98 8.16 8.36 7.72 7.81 7.85 7.54 7.54 8.2 7.77 7.7 7.77 8.02 7.79 7.78 7.94 7.69 7.95 8.05 8.1 7.96 8.41 7.88 7.74 7.67 7.47
HP_CAUDATE_ATROPHY 7.3 8.15 7.69 7.47 7.81 7.77 7.46 7.45 7.02 7.28 6.95 7.52 7.46 7.75 7.77 7.94 7.39 7.8 7.53 7.96 7.96 8.41 7.41 7.71 7.67 7.47
HP_INTELLECTUAL_DISABILITY_MODERATE 7.41 7.56 7.8 7.75 7.91 8.05 8.1 7.97 8.02 7.91 7.69 7.84 8.01 8.06 7.91 7.85 7.67 7.63 7.8 7.99 7.6 7.79 8.04 8.26 7.94 7.76
HP_PROGRESSIVE_NEUROLOGIC_DETERIORATION 7.08 6.94 7.22 7.26 7.3 7.53 7.4 7.28 7.19 7.29 7.1 7.19 7.33 7.35 7.21 7.07 7.07 7.13 7.3 7.55 7.4 7.36 7.27 7.42 7.38 7.3
HP_ACTION_TREMOR 7.59 7.56 7.99 7.79 8.02 8.14 8.1 8.07 7.98 8.1 7.94 8.07 8.14 8.09 7.98 8.17 7.78 7.69 7.78 8.17 7.58 8.04 8.11 8.31 8.24 8.14
HP_HEAD_TREMOR 7.66 7.51 7.99 8.13 8.02 7.99 7.71 8.07 7.79 8.16 8.01 8.41 8.11 7.75 8.21 7.99 7.69 7.71 7.66 8.16 8.12 8.06 8.03 8.29 8.27 8.18
HP_FOCAL_AWARE_SEIZURE 7.74 7.85 7.18 8.22 8.3 8.25 7.92 7.69 8.39 7.91 7.96 8.03 7.77 8.04 8.34 7.96 7.41 7.6 7.96 7.87 7.23 7.97 8.12 8.46 8.15 7.67
HP_CEREBELLAR_CYST 6.45 6.54 6.65 6.69 6.5 6.68 6.63 6.48 6.52 6.71 6.61 6.66 6.6 6.57 6.77 6.66 6.52 6.56 6.5 6.59 6.62 6.6 6.66 6.78 6.7 6.63
HP_LEUKOENCEPHALOPATHY 7.24 7.42 7.85 7.59 7.69 7.72 7.67 7.76 7.84 7.64 7.38 7.67 7.72 7.71 7.67 7.61 7.45 7.47 7.57 7.92 7.52 7.73 7.75 7.87 7.73 7.57
HP_MEMORY_IMPAIRMENT 7 6.95 7.35 7.32 7.32 7.38 7.33 7.27 7.29 7.29 7.1 7.18 7.32 7.31 7.14 7.26 7.08 7 7.23 7.41 7.04 7.05 7.31 7.41 7.33 7.08
HP_DIFFICULTY_WALKING 7.54 7.61 7.94 7.62 7.9 8.03 7.87 7.77 7.9 8.01 7.71 7.93 7.97 7.92 7.84 7.86 7.68 7.55 7.75 8.01 7.66 7.78 8.05 8.23 8.03 7.76
HP_WRITER_S_CRAMP 8.71 8.62 8.25 8.01 8.75 8.52 8.39 8.83 8.07 8.3 8.1 8.56 8.22 8.24 8.63 8.42 8.19 8.55 8.7 8.77 8.68 8.86 8.35 8.13 8.42 8.28
HP_DYSPHASIA 6.69 6.98 7.86 7.74 7.15 7.17 7.69 7.32 7.76 7.7 7.02 7.45 7.36 7.32 7.65 7.55 7.16 6.99 7.11 7.42 7.39 7.47 7.84 7.93 7.38 7.53
HP_FREQUENT_FALLS 7.36 7.32 7.55 7.43 7.52 7.53 7.62 7.53 7.69 7.62 7.45 7.7 7.66 7.55 7.67 7.36 7.47 7.26 7.48 7.78 7.32 7.6 7.66 7.75 7.66 7.59
HP_SLEEP_DISTURBANCE 7.11 7.25 7.33 7.33 7.41 7.46 7.43 7.44 7.45 7.54 7.2 7.44 7.46 7.5 7.58 7.33 7.34 7.27 7.37 7.51 7.24 7.35 7.42 7.55 7.55 7.4
HP_PSYCHOMOTOR_DETERIORATION 7.8 7.39 7.61 7.49 7.45 7.61 8.19 7.53 7.51 7.61 7.4 7.85 7.28 7.55 7.54 7.36 7.54 7.26 7.57 7.73 7.45 7.35 7.53 7.82 8.09 7.35
HP_SHUFFLING_GAIT 7.74 7.85 7.7 7.48 7.75 8.13 8.06 8.14 7.89 8.13 7.63 8.08 7.91 7.9 8.02 8.14 7.5 7.89 7.9 7.92 7.73 8.14 7.88 7.78 8.29 8.05
HP_ABNORMALITY_OF_BRAINSTEM_MORPHOLOGY 7.07 7.19 7.39 7.38 7.32 7.37 7.2 7.28 7.36 7.36 7.48 7.43 7.32 7.34 7.31 7.45 7.16 7.07 7.33 7.37 7.2 7.35 7.28 7.34 7.37 7.36
HP_HYPOPLASIA_OF_THE_BRAINSTEM 6.76 6.89 7.11 6.88 7.07 7.05 7.08 7.2 6.73 7.08 6.94 7.1 7.15 7.04 7.17 7.21 6.91 6.8 6.98 7.08 6.97 7.26 6.99 6.97 7.01 7.23
HP_ABNORMAL_LOWER_MOTOR_NEURON_MORPHOLOGY 8.06 8.24 9.15 8.49 8.56 8.76 8.55 8.21 8.76 8.56 8.41 8.74 8.47 8.52 8.31 8.25 8.36 7.99 8.13 8.42 8.43 8.38 8.97 9.01 8.52 8.3
HP_VISUAL_HALLUCINATIONS 8.59 8.24 8.47 8.05 8.91 8.81 9.06 9.07 8.71 8.74 8.42 8.53 8.71 8.68 9.13 9.1 8.34 8.69 8.79 9.34 8.27 8.62 8.76 8.87 8.96 8.9
HP_POOR_COORDINATION 7.53 7.45 7.73 7.57 7.53 7.85 7.57 7.28 7.71 7.68 7.7 7.5 7.69 7.68 7.42 7.48 7.39 7.41 7.67 7.58 7.26 7.49 7.69 7.76 7.52 7.37
HP_LOSS_OF_SPEECH 7.82 8 8.36 8.13 8.38 8.5 8.63 8.52 8.7 8.47 8.15 8.34 8.23 8.58 8.43 8.12 8.2 8.04 8.3 8.63 7.6 8.24 8.47 8.6 8.45 8.15
HP_DIMINISHED_MOVEMENT 7.28 7.21 7.15 7.04 7.58 7.42 7.56 7.35 7.52 7.61 7.16 7.45 7.76 7.55 7.67 7.4 7.47 7.29 7.53 7.57 7.2 7.19 7.7 7.75 7.73 7.31
HP_HYPOKINESIA 6.98 6.85 6.81 6.79 7.14 7.03 7.07 6.85 7.17 6.98 6.98 7.1 7.21 7.27 7.04 6.91 7.1 6.9 7.24 6.97 7.06 6.86 7.23 7.2 7.31 7.09
HP_DEVELOPMENTAL_REGRESSION 7.48 7.42 7.98 7.72 7.77 7.81 7.73 7.77 7.84 7.83 7.66 7.77 7.73 7.84 7.73 7.63 7.51 7.49 7.77 7.87 7.58 7.62 7.77 8.02 7.69 7.58
HP_HAND_TREMOR 7.59 7.22 8.39 7.99 8.24 8.25 7.93 7.72 7.74 8.3 7.78 8.07 8.21 8.01 8.4 8.35 7.33 7.45 7.8 8.18 7.6 8.17 8.06 8.21 8.06 7.96
HP_FASCICULATIONS 7.95 7.91 8.4 8.37 8.49 8.46 8.16 8.17 8.02 8.32 8.18 8.43 8.43 8.42 8.29 8.32 8.05 7.72 8.37 8.17 8.01 8.18 8.31 8.55 8.34 8.4
HP_APHASIA 8 8.17 8.26 8.25 8.37 8.39 8.69 8.67 8.65 8.45 8.08 8.34 8.64 8.58 8.48 8.28 7.8 8.14 8.35 8.63 8.22 8.49 8.33 8.62 8.61 8.15
HP_ENCEPHALITIS 5.67 5.42 6.03 5.79 5.68 5.97 5.85 5.51 5.79 5.75 5.83 5.83 5.52 5.38 5.65 5.86 5.72 5.39 5.43 5.84 5.75 5.88 5.95 5.74 5.63 5.38
HP_FOCAL_IMPAIRED_AWARENESS_SEIZURE 8.08 8.36 8.39 8.21 8.62 8.68 8.56 8.53 8.71 8.7 8.34 8.43 8.73 8.74 8.68 8.71 8.25 8.11 8.6 8.73 8.27 8.59 8.73 8.74 8.65 8.31
HP_PARAPARESIS 7.42 7.66 7.91 7.81 7.76 7.72 7.82 7.82 8 7.85 7.52 7.7 7.7 7.78 7.63 7.59 7.72 7.32 7.61 7.98 7.45 7.51 7.79 8.03 7.66 7.58
HP_CAVUM_SEPTUM_PELLUCIDUM 7.41 7.34 6.99 7.33 8.06 7.87 7.38 7.93 7.62 7.56 7.56 7.77 8 7.88 7.58 7.41 7.69 7.76 7.7 7.55 7.21 7.65 7.31 7.46 7.47 7.53
HP_EEG_WITH_POLYSPIKE_WAVE_COMPLEXES 7.37 7.56 7.7 7.15 7.55 8.07 7.9 8.15 7.4 8.18 7.25 7.96 7.88 8.02 8.13 7.87 7.43 7.47 7.84 7.98 7.82 7.98 7.54 7.83 7.73 7.74
HP_LOWER_LIMB_HYPERREFLEXIA 7.43 7.29 8.04 7.52 7.64 7.56 7.61 8.14 7.91 8.07 7.83 7.97 7.7 7.71 8.21 8.01 8.02 7.7 7.5 8.05 8.07 8.31 7.91 8.06 7.93 7.87
HP_COGWHEEL_RIGIDITY 7.79 8.33 8.2 7.43 7.75 8.25 8.15 8.78 7.98 7.91 8.18 8.17 7.97 8.04 8.13 8.31 7.74 7.97 8.27 8.29 7.64 7.68 8.12 8.46 8.3 8.45
HP_POSITIVE_ROMBERG_SIGN 7.54 7.37 7.65 7.78 7.75 7.7 7.39 7.56 7.66 7.72 7.44 7.44 6.96 7.65 7.45 7.67 7.19 6.6 7.34 7.43 7.11 7.54 7.73 7.7 7.57 7.76
HP_LIMB_DYSMETRIA 7.23 6.65 6.81 7.43 7.02 7.4 7.36 6.85 7 7.3 6.92 7.45 7.27 7.55 6.82 6.84 7.07 7.26 7.3 7.6 7.07 6.83 7.53 7.58 7.3 6.83
HP_AQUEDUCTAL_STENOSIS 6.42 6.36 6.99 6.98 6.42 6.25 6.41 6.61 6.67 6.52 7.06 6.59 6.38 6.37 6.51 6.56 6.52 6.6 6.1 6.45 6.56 6.45 6.77 6.68 6.18 6.52
HP_MYOKYMIA 8.82 8.87 9.21 8.67 9 9.25 9.14 9.52 9.28 9.21 9.06 9.25 9.26 9.32 9.24 9.34 8.84 8.99 9.05 9.34 9.48 9.27 9.33 9.46 9.23 9.22
HP_LEUKODYSTROPHY 7.48 7.47 8.28 7.8 7.76 7.69 7.61 7.71 7.93 7.9 7.87 7.73 7.73 7.69 7.79 7.72 7.83 7.48 7.72 7.78 7.5 7.64 7.77 7.9 7.86 7.69
HP_ABNORMALITY_OF_MIDBRAIN_MORPHOLOGY 6.44 6.46 6.68 6.52 6.54 6.69 6.57 6.48 6.38 6.69 6.42 6.57 6.65 6.58 6.63 6.78 6.53 6.81 6.43 6.25 6.67 6.61 6.4 6.56 6.61 6.58
HP_MOLAR_TOOTH_SIGN_ON_MRI 6.36 6.45 6.76 6.48 6.62 6.69 6.67 6.47 6.48 6.79 6.71 6.76 6.68 6.65 6.74 7.23 6.58 6.88 6.5 6.22 6.76 6.77 6.47 6.79 6.69 6.67
HP_POOR_HEAD_CONTROL 7.82 7.55 8.11 7.84 8.01 8.13 8.08 8 7.93 7.98 7.87 7.93 8.01 8.04 8.07 7.88 7.72 7.79 7.9 8.1 7.7 7.86 8.15 8.22 7.93 7.79
HP_ANARTHRIA 8.31 8.82 8.29 8.65 8.52 8.72 8.38 8.02 8.33 8.26 7.77 8.25 8.02 7.94 8.38 7.97 8.05 8.13 8.34 8.56 8.65 8.64 8.1 8.39 8 7.65
HP_MOTOR_APHASIA 8.13 8.18 9.27 8.66 8.64 8.8 9.18 8.75 9.28 8.73 8.47 8.63 8.98 8.89 8.32 8.45 8.3 7.51 8.22 8.94 7.91 8.6 8.75 8.84 8.96 8.51
HP_MENINGOCELE 6.15 6.12 6 6.34 6.47 6.37 6.14 6.1 6.16 6.21 6.4 6.12 6.21 6.25 6.34 6.18 6.21 6.23 6.23 6.11 6.3 6.38 6.1 6.13 6.3 6.4
HP_CEREBELLAR_MALFORMATION 6.71 6.68 6.93 6.98 6.84 6.9 6.84 6.98 6.77 6.91 6.87 6.95 6.82 6.83 6.9 6.99 6.81 6.74 6.88 6.79 6.81 6.89 6.9 6.98 6.96 6.89
HP_DYSCALCULIA 8.56 8.46 9.15 8.71 8.97 8.95 8.8 8.44 8.92 8.88 8.7 8.86 8.92 8.87 8.59 8.51 8.49 8.2 8.56 8.94 8.36 8.82 8.94 9.01 8.73 8.74
HP_HYPOTHALAMIC_HAMARTOMA 6 6.05 6.05 6.19 6.11 6.13 6.27 6.27 5.91 6.29 6.56 6.28 6.22 6.47 6.01 6.2 6.62 6.48 6.1 6.2 6.67 6.51 6.05 5.89 6.14 6.35
HP_TETRAPLEGIA 6.37 6.61 7.73 7.62 6.57 6.93 6.83 7.09 6.6 7.17 6.45 6.78 6.78 6.61 7.33 6.9 6.73 6.8 7.09 7.1 6.5 6.93 7.07 7.28 7.14 6.76
HP_ASTROCYTOSIS 8.43 8.43 8.35 8.09 8.41 8.64 8.49 8.91 8.7 8.47 8.15 8.63 8.8 8.84 8.22 8.64 8.56 8.17 8.4 8.88 8.33 8.27 8.51 8.69 8.61 8.52
HP_LIMB_DYSTONIA 6.41 6.54 7.18 7.45 6.64 6.87 6.58 6.72 6.81 6.74 6.29 6.98 6.73 6.6 6.86 6.67 6.63 6.6 6.58 6.61 6.79 6.91 6.85 6.74 6.92 6.83
HP_ABNORMAL_GLOBUS_PALLIDUS_MORPHOLOGY 7.27 7.52 7.25 6.91 7.49 7.61 7.33 7.31 7.08 7.32 6.69 7.52 7.39 7.21 7.13 7.25 7.48 7.24 7.49 7.97 7.47 7.21 7.16 7.2 7.25 7.3
HP_ABNORMAL_HEAD_MOVEMENTS 7.87 7.83 8.95 8.68 8.49 8.33 8.57 8.48 8.64 8.41 8.31 8.54 8.45 8.56 8.57 8.57 8.44 8.12 8.13 8.68 8.33 8.66 8.45 9.1 8.67 8.35
HP_DISTAL_MUSCLE_WEAKNESS 7.28 7.32 7.32 7.21 7.53 7.56 7.55 7.45 7.43 7.55 7.25 7.47 7.58 7.55 7.52 7.35 7.43 7.26 7.51 7.63 7.27 7.51 7.58 7.66 7.52 7.58
HP_LANGUAGE_IMPAIRMENT 7.48 7.3 8.12 7.79 7.65 7.81 8.19 7.99 8.04 8.11 7.35 7.91 8 7.99 8.13 8.04 7.63 7.4 7.89 7.97 7.45 7.88 8.05 8.32 8.17 7.74
HP_SPASTIC_DYSARTHRIA 6.79 6.75 6.71 6.77 6.78 6.89 6.73 6.87 6.55 6.87 6.68 6.61 6.96 6.89 6.77 6.51 6.32 6.24 6.97 6.86 6.35 6.56 6.61 6.84 6.82 6.81
HP_POOR_SPEECH 7.57 7.66 7.94 7.82 8 8.12 8.08 8.05 8.01 7.94 7.81 7.89 8.1 8.15 8.01 7.95 7.67 7.71 7.86 8.12 7.72 7.83 8.04 8.23 7.96 7.78
HP_EXPRESSIVE_LANGUAGE_DELAY 7.18 7.05 6.84 7.48 7.09 7.44 7.14 7.27 7.46 7.31 6.91 6.98 7.24 7.55 7.28 6.94 6.88 7.12 7.06 7.38 6.94 7.18 7.41 7.49 7.41 7.38
HP_MYELOMENINGOCELE 6.15 5.89 5.64 5.95 5.88 6.35 5.55 5.66 5.73 5.53 5.88 5.56 6.07 6.2 5.71 5.81 5.95 5.95 5.84 5.53 6.23 6.05 5.71 5.36 5.78 6.18
HP_PRIMITIVE_REFLEX 8.05 8.31 9.01 8.6 8.41 8.31 8.28 8.59 8.58 8.24 8.04 8.16 7.91 7.93 8.34 8.51 8.23 8.55 8.24 8.43 8.72 8.53 8.25 8.43 8.44 8.07
HP_BULBAR_SIGNS 7.32 7.55 7.2 7.7 7.82 7.68 7.44 7.43 7.82 7.61 7.35 7.53 7.69 7.53 7.56 7.11 7.5 7.37 7.58 7.54 7.35 7.52 7.88 7.76 7.66 7.46
HP_MYOTONIA 7.81 7.85 7.86 7.77 7.71 8.1 8.23 8.16 7.86 8.12 7.83 8.08 8.22 8.24 8.18 7.9 7.91 7.87 7.86 8.23 7.85 7.89 8.07 8.27 8.34 7.79
HP_HYPERKINETIC_MOVEMENTS 7.33 7.51 8.13 7.71 7.77 8.06 8.03 7.95 7.62 7.96 7.83 8.06 7.99 8.01 7.93 8.02 7.41 7.59 8.01 8.11 7.75 8.32 7.74 8.04 7.68 7.63
HP_ACUTE_LEUKEMIA 6.64 6.59 6.61 6.32 6.79 6.74 6.32 6.51 6.58 6.7 6.56 6.53 6.59 6.62 6.66 6.71 6.55 6.55 6.66 6.65 6.55 6.61 6.57 6.65 6.65 6.81
HP_INCREASED_CSF_LACTATE 7.61 7.47 8.41 8.22 7.69 7.85 7.71 7.6 7.9 7.92 8.12 7.64 7.8 7.8 7.95 7.78 7.73 7.53 7.84 7.92 7.77 8.07 7.75 7.86 7.7 7.72
HP_MORPHOLOGICAL_ABNORMALITY_OF_THE_CORTICOSPINAL_TRACT 7.57 7.37 7.98 7.84 7.88 7.73 7.71 7.69 7.89 8.03 7.73 7.98 7.91 7.9 7.68 7.8 7.57 7.48 7.72 7.75 7.57 7.7 7.75 8.02 7.51 7.58
HP_UPPER_MOTOR_NEURON_DYSFUNCTION 7.32 7.44 7.7 7.6 7.6 7.74 7.66 7.6 7.68 7.7 7.48 7.63 7.71 7.72 7.67 7.62 7.45 7.35 7.58 7.75 7.46 7.68 7.71 7.83 7.67 7.56
HP_ABNORMAL_RAPID_EYE_MOVEMENT_SLEEP 5.34 5.63 5.38 5.44 5.76 5.45 6.08 6.19 5.47 5.22 5.41 5.41 5.39 5.03 5.47 5.4 5.79 5.62 5.78 6.3 5.42 5.58 5.45 5.63 5.39 5.49
HP_IMPAIRED_VIBRATORY_SENSATION 7.48 7.41 7.99 7.74 7.89 8.14 8.18 8 7.93 8.3 7.79 8.28 8.11 8 8.02 8.07 8 7.48 7.81 8.23 7.9 7.78 8.13 8.33 8.09 7.76
HP_SPASTIC_ATAXIA 6.44 6.61 6.81 6.86 7.32 7.33 7.3 7.1 7.05 7.41 7.06 6.99 7.08 7.04 7.01 6.83 6.61 6.96 6.63 7.22 6.28 6.76 6.79 7.46 7.29 7.03
HP_PROGRESSIVE_INABILITY_TO_WALK 7.36 7.45 7.77 7.78 7.75 7.85 8 7.79 7.93 7.71 7.71 7.7 7.87 7.84 7.77 7.66 7.5 7.26 7.63 7.97 7.54 7.47 7.94 7.96 7.8 7.47
HP_DIFFUSE_CEREBRAL_ATROPHY 7.81 7.6 7.97 7.79 8.31 8.14 8.32 8.42 8.32 8.03 7.97 8.34 7.77 7.72 8.04 8.31 7.73 7.36 7.87 8 7.56 8.12 8.22 8.46 8.23 8.07
HP_LIMB_HYPERTONIA 7.57 7.66 8.04 7.79 7.96 8.05 7.9 7.98 8.02 8.01 7.82 7.87 7.93 8 8 7.98 7.58 7.75 7.81 8.16 7.77 7.85 8.2 8.2 8.06 7.83
HP_SPASTIC_TETRAPLEGIA 7.58 7.64 7.83 7.87 7.7 7.88 7.91 7.72 7.9 7.91 7.68 7.68 7.68 7.91 7.93 7.68 7.55 7.57 7.7 7.91 7.67 7.7 7.65 7.93 7.73 7.8
HP_ALZHEIMER_DISEASE 5.69 5.82 5.85 6.03 5.41 5.31 5.5 5.58 5.49 5.48 5.87 5.48 5.4 5.71 5.79 5.84 5.81 5.71 5.55 5.57 5.82 5.69 5.23 5.18 5.7 5.62
HP_BRAIN_STEM_COMPRESSION 6.89 6.74 6.74 6.93 6.71 7.06 6.96 6.68 6.8 6.92 6.82 6.97 6.9 6.83 6.92 6.9 7.04 6.76 6.84 7.12 6.94 6.62 6.95 7.45 6.96 6.87
HP_CEREBRAL_CALCIFICATION 6.73 6.79 7.29 7.28 6.88 6.9 6.99 7.08 7.05 6.99 6.91 6.86 7.03 7.03 6.86 7.04 6.96 6.99 6.88 7.23 7.11 7.12 7.3 7.4 7.16 7.08
HP_WADDLING_GAIT 6.33 6.27 6.2 6.22 6.45 6.5 6.3 6.37 6.3 6.51 6.24 6.48 6.4 6.47 6.24 6.38 6.19 6.26 6.33 6.38 6.2 6.35 6.42 6.5 6.39 6.55
HP_INCREASED_INTRACRANIAL_PRESSURE 7.26 7.32 7.52 7.49 7.62 7.66 7.51 7.41 7.44 7.43 7.53 7.56 7.64 7.57 7.5 7.48 7.04 7.07 7.49 7.55 7.16 7.26 7.86 7.89 7.42 7.13
HP_ABNORMALITY_OF_THE_PERIVENTRICULAR_WHITE_MATTER 7.26 7.4 7.39 7.4 7.42 7.52 7.55 7.56 7.65 7.43 6.9 7.59 7.62 7.46 7.54 7.36 7.39 7.11 7.34 7.61 7.32 7.4 7.39 7.64 7.44 7.38
HP_HYPSARRHYTHMIA 7.94 7.96 8.07 7.88 8.02 8.29 8.33 8.14 8.03 8.15 7.92 7.98 8.1 8.32 8.18 8.09 7.73 7.94 7.97 8.2 7.78 7.91 8.16 8.23 8.03 7.97
HP_AREFLEXIA_OF_LOWER_LIMBS 7.02 7.13 7.65 7.15 7.11 7.35 7.12 7.2 7.48 7.43 7.33 7.38 7.29 7.51 7.4 6.89 7.36 7.16 6.96 7.3 7.12 7.44 7.88 7.73 7.41 7.55
HP_CATAPLEXY 5.71 6.01 6.78 6.86 6.46 6.74 7.05 6.85 6.86 6.15 6.13 5.64 6.36 5.94 6.63 6.41 6.68 6.34 6.64 7.01 6.36 6.49 6.09 6.55 6.56 6.41
HP_FALLS 6.83 7.27 6.63 7.43 7.66 7.44 6.95 7.29 7.02 7.22 7.41 7.25 7.46 7.34 7.31 7.05 7.16 6.86 7.02 7.18 7.11 6.68 7.38 7.22 7.03 7.36
HP_NEURONAL_LOSS_IN_CENTRAL_NERVOUS_SYSTEM 8.41 8.68 9.22 8.74 8.54 8.79 9.19 8.93 9.06 8.59 8.37 8.56 8.86 8.84 8.59 8.78 8.18 8.31 8.62 9.09 8.19 8.74 8.88 8.81 8.98 8.76
HP_AXIAL_DYSTONIA 7.99 8.47 8.53 8.2 8.52 8.4 8.57 8.21 7.83 8.41 7.93 8.87 8.38 8.17 8.21 7.72 8.52 8.85 7.76 8.69 8.9 8.38 8.45 8.7 8.39 7.95
HP_ABNORMALITY_OF_THE_CEREBRAL_CORTEX 7.28 7.39 7.59 7.58 7.6 7.66 7.62 7.66 7.64 7.65 7.58 7.61 7.72 7.8 7.73 7.63 7.41 7.45 7.57 7.66 7.47 7.75 7.63 7.82 7.66 7.54
HP_CORTICAL_DYSPLASIA 7.74 8.06 8.08 8.04 8.36 8.29 8.28 8.03 8.12 8.1 7.89 8.11 8.1 8.15 8.13 8.16 7.61 7.67 7.96 8.21 7.7 7.9 8.12 8.43 8.25 7.89
HP_INABILITY_TO_WALK 7.43 7.53 7.78 7.82 7.66 7.87 7.76 7.74 7.73 7.9 7.7 7.7 7.86 7.85 7.78 7.73 7.53 7.46 7.63 7.86 7.53 7.66 7.86 7.87 7.73 7.67
HP_PARKINSONISM_WITH_FAVORABLE_RESPONSE_TO_DOPAMINERGIC_MEDICATION 8.14 8.28 9.12 7.88 8.89 8.79 8.67 8.95 8.43 8.59 8.19 8.41 8.69 8.67 8.36 8.65 8.18 8.21 8.62 8.6 8.34 8.37 8.34 8.77 8.6 8.91
HP_ABSENT_FACIAL_HAIR 6.51 6.38 6.18 6.86 6.49 6.5 6.27 6.39 6.57 6.83 6.49 6.91 6.4 6.08 6.14 6.44 6.23 6.47 6.44 6.38 6.12 6.08 6.57 6.41 6.51 6.61
HP_HIGHLY_ARCHED_EYEBROW 7.39 7.55 7.61 7.46 7.71 7.88 7.95 7.71 7.55 7.67 7.44 7.75 7.83 7.72 7.66 7.72 7.64 7.44 7.66 7.91 7.63 7.8 7.77 7.89 7.87 7.59
HP_HYPOPLASTIC_NIPPLES 7.07 7.02 7.02 6.73 6.93 7.23 7.26 7.05 7.49 7.5 6.88 7.32 6.96 7.2 7.14 6.78 6.87 6.72 6.88 7.18 6.8 6.96 7.31 7.35 6.68 7.02
HP_SUPERNUMERARY_NIPPLE 6.79 6.82 7.26 7 6.91 7.09 6.96 6.95 7.02 7.22 6.62 7.05 7.11 6.95 7.13 7.05 6.88 6.96 6.86 7.16 6.81 7.25 6.95 7.2 7.13 7.09
HP_INTESTINAL_MALROTATION 6.21 6.24 6.11 6.18 5.92 6.28 6.06 6.06 6.05 6.23 6.21 6.48 6.19 6.3 6.04 6.48 6.13 6.21 6.15 6.22 6.26 6.38 6.16 6.11 6.17 6.29
HP_STEATORRHEA 6.39 5.79 5.65 6.07 5.54 5.2 5.38 5.49 5.68 5.61 5.73 5.47 5.57 5.93 5.35 5.92 5.47 5.77 5.78 5.65 5.85 5.65 5.65 5.75 5.37 5.39
HP_ACHALASIA 6.98 7.11 7.15 6.78 7.32 7.18 7.22 7.21 7.36 7.08 6.54 7.33 7.05 7.18 7.23 6.88 7.01 7.12 7.13 7.33 6.85 6.86 6.73 7.11 7.32 7.38
HP_EPISODIC_VOMITING 7.26 7.28 7.1 6.98 7.53 7.25 6.61 7.01 6.98 7.07 7.23 6.51 7.43 7.54 6.9 6.92 6.89 6.83 7.42 7.05 6.93 6.93 7.16 7.22 6.95 7.19
HP_HEMATOCHEZIA 7.45 7.65 7.02 6.8 8.09 8.11 8.58 8.48 8.1 7.22 7.07 7.72 8.16 8.1 7.1 6.89 6.21 6.23 7.53 8.52 8.52 9 7.28 7.18 8.51 8.37
HP_EPISODIC_ABDOMINAL_PAIN 7.36 7.22 7.98 7.65 7.63 7.6 7.31 7.79 7.37 7.59 7.9 7.64 7.61 7.52 7.72 7.65 7.53 7.32 7.73 7.7 7.02 7.85 7.55 7.38 7.82 7.64
HP_TRACHEOESOPHAGEAL_FISTULA 5.83 5.73 5.79 6.1 5.76 5.77 5.77 5.89 5.95 5.85 5.67 5.66 5.67 5.82 6 5.79 5.79 5.76 5.82 5.74 5.83 5.93 5.76 5.61 5.87 5.83
HP_ABNORMAL_STOMACH_MORPHOLOGY 6.91 6.84 7.12 6.86 7.13 7.15 7.16 7.01 7.16 7.09 6.86 7.09 7.1 7.34 7.04 7.14 6.85 6.88 6.98 7.11 7.03 7.05 7.16 7.27 7.18 7.21
HP_GASTROPARESIS 8.5 8.47 7.79 7.71 8.63 8.77 8.32 8.03 8.52 8.56 8.19 8.48 8.45 8.45 8.46 8.25 8.24 7.91 8.29 8.37 8.27 8.46 8.57 8.57 8.27 8.3
HP_GASTROINTESTINAL_DYSMOTILITY 6.43 6.69 6.66 6.44 6.59 6.74 6.68 6.63 6.98 6.72 6.44 6.95 6.89 6.66 6.42 6.63 6.88 6.87 6.67 6.92 6.65 6.94 6.85 6.99 6.64 6.83
HP_VOLVULUS 7.28 7.4 7.23 7.32 8.05 7.81 7.43 7.29 7.53 7.69 7.17 7.81 7.85 7.81 7.39 7.38 7.52 7.2 7.73 7.62 7.2 7.34 7.69 7.78 7.22 7.31
HP_COLITIS 5.65 5.63 5.6 5.74 5.6 5.38 5.62 5.51 5.63 5.43 5.49 5.42 5.46 5.5 5.44 5.49 5.81 5.66 5.35 5.58 5.84 5.67 5.34 5.05 5.53 5.47
HP_ABNORMALITY_OF_THE_PERITONEUM 5.64 5.49 5.89 5.76 5.29 5.13 5.85 6.12 5.78 5.73 5.91 5.34 5.59 5.59 5.51 5.53 5.78 5.84 5.75 5.95 5.93 5.98 5.44 5.86 6.04 5.94
HP_GASTROINTESTINAL_ATRESIA 6.53 6.29 6.7 6.7 6.4 6.3 6.52 6.48 6.66 6.66 6.29 6.57 6.55 6.39 6.55 6.24 6.44 6.28 6.18 6.45 6.52 6.58 6.62 6.85 6.53 6.29
HP_POLYPHAGIA 7.01 7.17 7.16 6.91 7.57 7.5 7.42 7.56 7.48 7.9 7.38 7.72 7.71 7.85 7.81 7.85 7.34 7.33 7.41 7.66 7.27 7.7 7.54 7.98 7.56 7.58
HP_PANCREATIC_HYPOPLASIA 5.43 5.26 5.32 5.58 5.03 5.02 5.52 5.17 5.68 5.18 5.42 5.1 5.24 5.23 5.35 5.37 5.37 5.37 4.95 5.01 5.34 5.26 5.2 4.97 5.08 5.14
HP_ILEUS 5.84 6 5.99 5.85 5.58 5.59 5.76 5.84 5.63 5.43 5.74 5.34 5.61 5.83 5.28 5.69 5.42 5.78 5.89 5.94 5.93 5.57 5.73 5.13 5.48 5.65
HP_HEAD_TITUBATION 7.54 7.51 7.72 8.09 8.07 7.83 7.62 7.97 7.77 8.08 7.86 8.26 7.62 7.73 7.85 7.79 7.67 7.59 7.57 7.62 7.97 8.04 7.86 8 7.77 7.93
HP_HYPOREFLEXIA_OF_LOWER_LIMBS 7.98 7.8 8.13 7.39 7.96 8.29 8.39 8.42 8.15 8.11 7.72 8.14 8.24 8.16 8.13 7.98 8.19 7.77 8.03 8.47 8.02 8 8.23 8.29 8.6 8.75
HP_HEPATIC_NECROSIS 7.37 8.25 8.57 8.33 8.13 7.46 7.53 8.04 7.99 7.62 8.44 7.7 8.22 7.56 8.47 7.66 7.54 7.49 8.04 8.18 7.78 8.47 8.15 8.35 7.8 7.65
HP_CELIAC_DISEASE 7.13 6.74 5.82 6.9 6.49 6.49 6.26 6.13 6.32 6.39 6.66 6.3 5.95 6.4 6.53 6.43 7.25 6.56 7.38 6.56 7.18 6.13 6.31 5.49 6.08 6.62
HP_CHOLESTATIC_LIVER_DISEASE 6.61 6.47 6.63 6.9 6.85 7.02 6.76 6.73 6.83 6.89 6.93 6.85 6.55 6.56 6.23 6.4 6.66 6.32 6.54 6.77 7 6.82 6.73 6.69 6.67 6.61
HP_CONGENITAL_HEPATIC_FIBROSIS 6.36 6.38 6.2 6.14 6.41 6.2 6.22 6.17 5.92 6.27 6.23 6.34 6.12 6.16 6.03 6.41 6.12 6.37 6.42 6.15 6.24 6.38 6.19 6.15 6.34 6.47
HP_BILIARY_CIRRHOSIS 5.44 5.28 5.18 5.4 5.08 4.93 5.25 5.15 5.37 5.02 5.35 5.14 5.13 5.07 5.08 5.4 5.01 5.39 4.81 5.1 5.21 5.12 5.21 4.67 4.93 4.95
HP_HYPOTENSION 5.56 5.54 5.57 5.83 5.4 5.38 5.66 5.48 5.73 5.64 5.81 5.62 5.35 5.38 5.52 5.64 5.51 5.63 5.42 5.34 5.73 5.66 5.55 5.4 5.51 5.5
HP_AORTIC_ROOT_ANEURYSM 6.59 6.68 6.2 6.44 6.87 6.74 6.44 6.43 6.82 6.63 6.61 7 6.77 6.61 6.53 6.57 7.14 6.68 6.53 6.56 6.64 6.64 7.04 6.8 7.03 6.9
HP_VASCULAR_DILATATION 6.91 6.93 6.99 6.8 7.12 7.1 6.97 7.04 6.97 7.17 6.92 7.3 7.15 7.02 6.92 6.96 7.14 6.86 7.15 7.03 7.05 7 7.2 7.22 7.23 7.26
HP_VARICOSE_VEINS 6.51 6.73 6.57 6.32 6.81 6.86 6.96 6.7 6.72 6.75 6.53 6.66 6.91 6.9 6.86 6.61 6.58 6.65 6.54 6.84 6.81 6.59 6.95 6.82 6.98 6.78
HP_OVERRIDING_AORTA 7.57 6.9 7.23 7.14 7.41 7.16 7.2 7.78 7.63 7.35 7.17 7.37 7.55 7.73 7.34 7.77 7.25 7.3 7.57 7.47 7.18 7.42 7.62 7.74 7.35 7.58
HP_ABNORMAL_VENOUS_MORPHOLOGY 6.26 6.37 6.28 6.28 6.06 6.32 6.44 6.24 6.22 6.42 6.42 6.47 6.38 6.35 6.36 6.6 6.17 6.41 6.33 6.35 6.4 6.32 6.23 6.11 6.34 6.43
HP_DEEP_VENOUS_THROMBOSIS 5.87 6.12 6.17 5.72 5.73 5.64 5.44 5.37 5.34 5.3 5.19 5.51 5.42 5.22 5.49 5.21 5.5 5.76 5.89 5.51 5.76 5.5 5.77 5.36 5.84 5.6
HP_FAT_MALABSORPTION 6.02 5.79 5.51 5.84 5.41 5.03 5.32 5.06 5.28 5.09 5.4 5.18 5.17 5.28 5.27 5.36 5.35 5.51 5.3 5.14 5.67 5.28 5.16 5.06 5.18 5.27
HP_VASCULITIS 5.21 5.28 5.13 5.03 5.09 5.03 5.1 5 5.1 5.04 5.19 4.9 5.02 4.99 5.16 5.04 5.3 5.19 4.99 5 5.35 5.12 4.87 4.98 5.03 4.95
HP_ARTERIOSCLEROSIS 6.32 6.15 6.4 6.48 6.75 6.56 6.26 6.32 6.56 6.53 6.37 6.52 6.54 6.34 6.2 6.44 6.5 6.34 6.21 6.38 6.47 6.32 6.51 6.5 6.35 6.44
HP_HYPERTENSION_ASSOCIATED_WITH_PHEOCHROMOCYTOMA 8.98 9.27 9.27 8.65 9.16 8.9 9.42 8.73 8.87 8.67 8.54 8.88 9.22 9.08 8.66 8.43 8.97 8.49 8.91 9.4 8.75 8.57 9.17 8.96 8.7 8.23
HP_NEONATAL_RESPIRATORY_DISTRESS 6.16 6.3 6 5.97 5.86 5.96 6.03 5.99 5.85 6.21 6.08 6.05 5.96 6.04 6.18 6.35 6.03 6.14 6.11 6.05 6.01 5.96 5.93 5.99 6.14 6.24
HP_ABNORMALITY_OF_PELVIC_GIRDLE_BONE_MORPHOLOGY 6.51 6.44 6.49 6.54 6.68 6.67 6.58 6.63 6.57 6.67 6.57 6.62 6.62 6.59 6.46 6.55 6.5 6.54 6.54 6.51 6.48 6.54 6.63 6.65 6.65 6.65
HP_WORMIAN_BONES 6.53 6.38 6.54 6.41 6.66 6.9 6.34 6.71 6.72 6.53 6.36 6.65 6.82 6.71 6.68 6.44 6.84 6.47 6.39 6.38 6.48 6.46 6.83 7.01 6.74 6.6
HP_AORTIC_DISSECTION 6.06 6.18 6.01 5.94 6.52 6.43 6.18 6.01 6.63 6.29 6.37 6.53 6.45 6.21 6.09 6.25 6.87 6.49 6.15 6.35 6.57 6.37 6.44 6.22 6.14 5.84
HP_SPONDYLOEPIMETAPHYSEAL_DYSPLASIA 6.2 6.16 6.32 5.95 6 6.28 6.36 6.52 6.45 6.21 6.14 6.19 6.14 6.34 6.43 6.5 6.16 5.81 5.93 6.19 6.02 6.25 6.26 6.51 6.53 6.39
HP_SKELETAL_DYSPLASIA 6.45 6.34 6.63 6.47 6.58 6.66 6.42 6.44 6.53 6.55 6.49 6.61 6.62 6.6 6.42 6.55 6.39 6.45 6.51 6.56 6.21 6.34 6.57 6.54 6.46 6.5
HP_BONE_PAIN 6.26 6.31 6.49 6.44 6.32 6.26 6.06 6.32 6.25 6.31 6.44 6.21 6.34 6.26 6.17 6.17 6.35 6.38 6.11 6.04 6.24 6.47 6.4 6.38 6.57 6.72
HP_SPONDYLOEPIPHYSEAL_DYSPLASIA 5.39 5.64 5.28 5.18 5.8 5.46 5.29 5.34 5.36 5.71 5.07 5.45 5.51 5.47 5.53 5.08 5.52 5.37 5.7 5.26 5.32 5.21 5.47 5.56 5.45 5.6
HP_EPIPHYSEAL_DYSPLASIA 6.06 6.13 5.92 6.22 6.47 6.14 6.17 5.87 5.99 6.07 6.11 6.18 5.89 6.09 5.95 5.93 5.95 5.94 6.04 6.07 5.88 5.61 5.91 6.2 5.9 6.25
HP_INCREASED_SUSCEPTIBILITY_TO_FRACTURES 6.4 6.37 6.54 6.43 6.54 6.54 6.35 6.37 6.52 6.52 6.42 6.45 6.62 6.56 6.43 6.38 6.39 6.4 6.42 6.41 6.32 6.31 6.49 6.54 6.41 6.52
HP_DELAYED_EPIPHYSEAL_OSSIFICATION 5.88 5.52 5.82 6.08 5.53 5.33 5.33 5.1 5.46 5.39 6.03 6.03 5.6 5.57 5.43 5.38 5.54 5.69 5.55 5.83 5.64 5.51 5.41 5.37 5.86 6.16
HP_NEOPLASM 6.14 6.18 6.2 6.22 6.17 6.13 6.18 6.25 6.2 6.18 6.24 6.19 6.23 6.2 6.11 6.17 6.19 6.2 6.07 6.13 6.25 6.26 6.29 6.21 6.24 6.26
HP_LYMPHOMA 5.79 6.05 5.79 5.85 5.65 5.51 5.77 5.67 5.82 5.76 5.8 5.68 5.81 5.8 5.68 5.76 5.93 5.88 5.83 5.73 5.85 5.88 5.81 5.59 5.9 5.89
HP_PHEOCHROMOCYTOMA 8.61 7.9 8.74 8.18 8.41 8.52 8.28 8.28 8.12 8.46 8.36 8.36 8.46 8.47 8.61 8.1 8.56 8.1 8.35 8.78 7.58 8.29 8.51 8.08 8.52 7.9
HP_PARAGANGLIOMA 8.18 7.64 9.07 8.51 8.31 8.33 8.63 8.22 8.22 8.14 8.42 8.03 8.48 8.07 8.43 7.94 8.31 7.98 8.22 8.48 7.54 8.27 8.5 8.06 8.22 7.84
HP_OSTEOSARCOMA 6.53 6.08 6.52 6.9 6.94 5.94 6.21 6.32 6.57 6.27 6.65 6.2 6.4 5.95 6.14 6.55 6.67 6.47 6.33 5.82 6.14 5.94 6.45 6.48 5.92 5.91
HP_BASAL_CELL_CARCINOMA 6.7 6.67 7.13 7.21 6.99 6.81 7.16 6.91 7.13 6.93 6.68 6.92 7.01 6.96 6.85 7.08 6.74 6.66 6.86 7.11 6.56 6.69 6.84 7.06 6.76 6.69
HP_GASTROINTESTINAL_CARCINOMA 6.81 6.53 7.14 6.9 7.05 6.49 6.94 7.27 6.94 6.66 7.07 6.82 6.59 6.51 6.76 6.97 6.38 6.55 6.74 6.38 7.06 6.72 6.91 6.88 6.6 6.77
HP_COXA_VALGA 6.43 6.41 6.34 6.44 6.82 6.58 6.5 6.58 6.55 6.64 6.57 6.68 6.62 6.58 6.46 6.6 6.6 6.47 6.57 6.51 6.23 6.55 6.82 6.8 6.64 6.68
HP_ABNORMALITY_OF_THE_SELLA_TURCICA 6.77 6.98 7 6.98 6.95 7.05 6.95 7.25 6.75 7.03 7.07 7.39 7.24 7.42 6.86 6.98 7.07 6.97 6.92 6.97 6.86 6.73 7.29 7.44 6.79 7.08
HP_DEFORMED_SELLA_TURCICA 7.16 7 7.79 7.27 7.71 7.77 7.6 7.56 7.79 7.6 7.86 7.67 7.74 7.47 7.67 7.56 7.5 7.38 7.42 7.62 7.17 7.13 7.5 7.54 7.41 7.08
HP_ABNORMALITY_OF_THE_CALVARIA 6.69 6.7 6.93 6.82 6.95 7.05 6.9 6.95 6.91 6.94 6.84 6.99 7.04 6.94 6.92 6.94 6.83 6.84 6.88 6.99 6.87 6.98 6.97 7.09 7.02 7.05
HP_THICKENED_CALVARIA 6.71 6.89 7.16 6.82 7.44 7.26 7.58 7.54 7.05 7.57 7.34 7.2 7.42 7.49 7.55 7.65 7.21 7.02 7.18 6.78 7.17 7.58 7.48 7.53 7.2 7.36
HP_PRENATAL_MATERNAL_ABNORMALITY 5.67 5.47 5.6 5.64 5.48 5.41 5.6 5.52 5.58 5.87 5.64 5.69 5.5 5.6 5.59 5.81 5.76 5.75 5.45 5.4 5.57 5.59 5.47 5.48 5.72 5.66
HP_ABNORMALITY_OF_FRONTAL_SINUS 6.17 5.98 5.97 5.91 6.07 5.5 5.74 5.74 5.78 5.89 5.71 5.74 5.73 5.69 5.77 5.99 6.19 5.99 5.88 5.61 5.9 5.72 6.26 5.45 5.77 5.7
HP_PLATYBASIA 6.42 6.62 6.18 6.33 6.88 6.92 6.93 6.71 6.72 6.62 6.52 6.7 6.97 6.86 6.8 6.63 6.62 6.67 6.71 6.89 6.84 6.52 7.06 7.12 6.92 6.66
HP_HYPOPLASTIC_FACIAL_BONES 7.15 6.82 7.2 7.22 6.91 7.17 7.5 7.42 7.58 7.36 7.19 7.42 7.45 7.51 7.38 7.74 7.22 7.36 7.23 7.4 7.16 7.44 7.46 7.67 7.35 7.39
HP_ABNORMALITY_OF_THE_SKULL_BASE 6.51 6.57 6.79 6.67 6.61 6.71 6.68 6.89 6.7 6.76 6.71 6.73 6.81 6.71 6.84 6.74 6.62 6.66 6.71 6.7 6.69 6.77 6.69 6.85 6.79 6.68
HP_SCLEROSIS_OF_SKULL_BASE 7.08 6.9 6.54 6.34 7.36 7.35 7.6 7.54 7.44 7.31 7.3 8.03 7.57 7.58 7.44 7.37 7.15 7.34 7.36 7.84 7.29 7.81 7.88 7.71 7.48 7.48
HP_ABNORMAL_PARIETAL_BONE_MORPHOLOGY 6.85 6.99 7.19 7.01 6.88 7.18 7.11 6.95 7.15 7.21 6.53 6.85 7.33 6.93 7.18 6.94 6.63 6.99 6.73 7.2 6.8 7.05 6.92 7.21 7.28 7.09
HP_ABNORMALITY_OF_SKULL_OSSIFICATION 6.54 6.65 6.96 6.86 7.22 7.13 6.99 6.94 6.97 7.1 7.06 6.99 6.85 6.98 6.54 6.85 6.89 6.81 7.08 7.4 6.61 6.98 6.8 6.9 7.03 7.1
HP_HIGH_NARROW_PALATE 6.96 6.84 7.11 6.94 7.24 7.33 7.22 7.25 6.99 7.24 7.1 7.31 7.23 7.26 7.16 7.2 7.18 7.04 7.36 7.32 7.05 7.1 7.38 7.46 7.18 7.26
HP_DOWNTURNED_CORNERS_OF_MOUTH 7.1 7.25 7.12 7.01 7.6 7.56 7.61 7.42 7.44 7.51 7.07 7.6 7.53 7.45 7.43 7.32 7.16 7.25 7.35 7.51 7.16 7.44 7.41 7.47 7.38 7.45
HP_ADRENAL_OVERACTIVITY 5.06 5.06 5.15 5.54 4.83 4.61 4.98 4.89 5.23 4.73 5.01 4.83 4.85 4.72 4.82 4.79 5.03 5.08 4.82 4.62 5.24 4.84 4.9 4.72 5.06 4.86
HP_RECURRENT_BACTERIAL_INFECTIONS 5.56 5.4 5.62 5.54 5.37 5.21 5.45 5.31 5.38 5.56 5.58 5.34 5.32 5.22 5.42 5.39 5.55 5.64 5.34 5.23 5.5 5.39 5.23 5.13 5.35 5.37
HP_DECREASED_CIRCULATING_IGA_LEVEL 4.94 5.03 4.98 5.08 4.68 4.69 4.98 4.99 4.84 4.54 4.84 4.72 4.59 4.45 4.78 4.75 4.88 5.03 4.73 4.74 4.89 4.75 4.54 4.46 4.7 4.69
HP_IMMUNODEFICIENCY 6.08 6.07 6.01 6.1 6.33 6.16 6.07 6.02 6.12 6.05 6.25 6.12 6.07 6.13 5.99 6.02 6.06 6.11 6.02 6.11 6.1 6.1 6.15 6.16 6.1 6.34
HP_RECURRENT_ABSCESS_FORMATION 5.7 5.55 5.36 5.27 5.51 5.38 5.21 5.05 5.57 5.25 5.73 5.4 5.4 5.44 4.97 5.28 5.59 5.58 5.51 5 5.55 4.91 5.14 4.83 5.36 5.36
HP_SYSTEMIC_LUPUS_ERYTHEMATOSUS 6.06 6.19 6.22 6.25 5.89 5.66 6.08 5.51 6.43 5.85 6.12 5.47 5.54 5.92 5.42 5.81 5.99 6.47 5.91 6.22 5.92 6.07 6.22 5.79 6.57 6.62
HP_RECURRENT_STAPHYLOCOCCUS_AUREUS_INFECTIONS 5.98 5.66 5.95 6.02 6.01 5.99 6.05 5.83 5.92 6.08 5.85 6.07 6.14 6.19 5.75 5.88 6.18 5.97 5.87 5.67 6.2 5.83 6.07 5.84 5.77 5.91
HP_CHRONIC_MUCOCUTANEOUS_CANDIDIASIS 5.7 5.58 5.63 5.61 5.54 5.43 5.61 5.42 5.65 5.33 5.75 5.37 5.55 5.45 5.5 5.31 5.59 5.7 5.44 5.4 5.67 5.43 5.44 5.21 5.44 5.46
HP_FOLLICULAR_HYPERPLASIA 4.87 4.79 4.86 4.72 4.53 4.62 4.54 4.49 4.79 4.34 5 4.84 4.56 4.35 4.49 4.56 5.28 4.87 4.5 4.28 4.96 4.77 4.43 4.52 4.67 4.51
HP_CHRONIC_NONINFECTIOUS_LYMPHADENOPATHY 5.66 5.35 5.78 5.36 5.6 5.81 5.75 5.98 5.81 5.63 5.58 5.62 5.28 5.44 5.72 6.02 5.93 5.46 5.34 5.66 5.73 5.92 6.13 5.83 5.78 5.73
HP_ABNORMALITY_OF_THE_LYMPH_NODES 5.84 5.81 5.75 5.76 5.67 5.66 5.81 5.85 5.81 5.74 5.96 5.63 5.81 5.82 5.72 5.79 5.78 5.83 5.77 5.81 5.93 5.91 5.63 5.56 5.78 5.93
HP_ORAL_LEUKOPLAKIA 5.57 5.51 5.61 5.8 5.1 5.24 5.3 5.21 5.59 5.28 5.59 5.4 5.46 5.35 5.44 5.19 5.52 5.51 5.21 5.42 5.53 5.32 5.21 4.84 5.29 5.42
HP_RICKETS 5.6 5.74 5.69 5.98 5.69 5.78 5.55 5.54 5.65 5.72 5.56 5.43 5.23 5.45 5.31 5.14 5.75 5.64 5.51 5.24 5.66 5.73 5.44 5.77 5.49 5.54
HP_OSTEOMALACIA 5.51 5.34 5.05 5.58 5.32 5.21 5.11 5.09 5.34 5.26 5.29 5.16 5.1 5.04 5.06 4.85 5.49 5.59 5.34 4.99 5.38 5.07 5.3 4.99 5.24 4.9
HP_KYPHOSCOLIOSIS 6.52 6.58 6.5 6.54 6.7 6.79 6.68 6.62 6.72 6.85 6.59 6.85 6.86 6.69 6.9 6.64 6.59 6.56 6.51 6.71 6.5 6.63 6.93 6.93 7.01 6.84
HP_THIN_BONY_CORTEX 5.44 5.6 5.08 5.31 5.39 5.3 5.49 5.25 5.31 5.66 5.45 5.78 5.21 5.32 5.53 5.5 5.65 5.67 5.44 5.54 5.62 5.46 5.31 5.19 5.71 5.83
HP_OSTEOMYELITIS 6.48 6.45 6.43 6.22 6.35 6.5 6.38 6.52 6.48 6.35 6.31 6.39 6.54 6.42 6.7 6.35 6.41 6.4 6.4 6.5 6.63 6.74 6.35 6.5 6.48 6.6
HP_PATHOLOGIC_FRACTURE 6.66 6.72 7.35 6.95 7.12 7.02 6.99 7.28 7.24 6.94 7.01 6.99 7.1 7.17 6.87 6.9 7.14 6.83 6.75 7.32 7.08 7.36 7.26 7.21 7.34 7.3
HP_RECURRENT_FRACTURES 6.4 6.27 6.53 6.3 6.42 6.34 6.38 6.36 6.42 6.39 6.43 6.3 6.53 6.55 6.34 6.38 6.35 6.36 6.33 6.33 6.31 6.29 6.5 6.53 6.34 6.41
HP_OSTEOARTHRITIS 5.82 5.6 5.79 5.87 5.6 5.71 5.85 5.53 5.63 6.04 5.83 6.02 5.82 5.81 5.58 5.73 5.69 5.71 5.92 5.85 5.82 5.71 6.06 5.82 6.03 5.99
HP_GENERALIZED_JOINT_LAXITY 5.58 5.35 5.72 5.53 5.56 5.28 5.43 5.64 5.53 5.38 5.85 5.47 5.44 5.3 5.77 5.54 5.73 5.89 5.6 5.44 5.85 5.63 5.45 5.2 5.59 5.34
HP_ABNORMAL_CARTILAGE_MORPHOLOGY 6.54 6.53 6.89 6.84 6.5 6.81 6.83 6.97 7.08 7.11 6.67 6.73 7.08 6.9 6.58 7.21 7.07 6.91 6.87 6.73 6.94 6.92 7.41 7.12 7.07 6.95
HP_TRACHEAL_STENOSIS 6.77 6.65 6.09 6.29 6.78 7.05 6.81 6.93 6.45 6.88 6.72 6.91 7.04 7.04 6.86 7.11 6.91 6.84 7.07 6.71 7.19 7.04 6.31 6.42 7.28 7.22
HP_ABNORMAL_TRACHEA_MORPHOLOGY 6.45 6.21 6.17 6.34 6.15 6.18 6.26 6.37 6.33 6.17 6.33 6.05 6.12 6.23 6.23 6.23 6.15 6.1 6.06 6.19 6.24 6.19 6.26 6.27 6.27 6.37
HP_TRACHEOMALACIA 6.79 6.63 6.88 6.53 6.71 6.73 6.61 7.03 6.64 6.82 6.62 6.71 6.74 6.84 6.83 6.92 6.84 6.79 6.92 6.91 7.01 7.05 6.83 6.68 6.95 7.22
HP_BRONCHOMALACIA 6.77 6.59 6.83 6.67 6.66 6.62 6.94 7.23 6.7 6.83 6.87 6.81 6.88 6.84 6.93 7 6.71 6.78 6.58 6.91 7.01 7.12 7.24 7.05 7.08 7.22
HP_UPPER_AIRWAY_OBSTRUCTION 6.63 6.61 6.97 6.69 6.91 6.62 6.94 6.92 6.94 7.16 6.85 6.95 6.78 6.82 6.93 6.71 7.11 7.04 6.97 7.38 6.63 6.25 7.24 7.23 6.74 6.9
HP_RECURRENT_LOWER_RESPIRATORY_TRACT_INFECTIONS 5.74 5.62 5.69 5.78 5.58 5.6 5.62 5.66 5.78 5.53 5.54 5.26 5.69 5.55 5.68 5.57 5.63 5.66 5.47 5.47 5.75 5.65 5.54 5.46 5.67 5.56
HP_RECURRENT_UPPER_RESPIRATORY_TRACT_INFECTIONS 5.9 5.7 5.93 5.93 5.84 5.88 5.93 5.67 5.78 6.03 5.79 5.74 5.85 5.95 5.78 6.02 6.07 5.99 5.67 5.84 6.02 5.99 5.77 5.72 6 5.94
HP_TACHYPNEA 6.56 6.51 7.21 7.13 6.73 6.87 6.77 6.62 6.65 7.08 6.96 7.1 7.01 6.88 7.11 7.33 6.72 6.93 6.95 6.71 6.89 7.16 6.92 6.84 6.79 6.71
HP_HYPOVENTILATION 6.21 5.86 6.13 5.98 6.16 5.8 5.95 6 6.05 5.98 6.06 6.13 5.89 5.93 5.77 5.93 6.02 5.74 5.79 5.69 5.9 5.94 6.26 5.92 5.89 5.97
HP_REDUCED_VITAL_CAPACITY 5.47 5.2 5.08 5.36 5.47 5.2 4.99 5.17 5.17 4.83 5.34 5.25 5.04 4.92 4.85 5.02 5.22 5.32 5.3 5 5.13 4.98 4.98 4.76 4.79 4.91
HP_ABNORMAL_PATTERN_OF_RESPIRATION 6.8 7.01 7.16 7.08 7.08 7.19 7.12 7.34 7.03 7.19 7.07 7.16 7.12 7.13 7.2 7.21 7.01 6.97 7.17 7.25 7.09 7.26 7.02 7.23 7.23 7.3
HP_ABNORMAL_RESPIRATORY_SYSTEM_PHYSIOLOGY 6.52 6.54 6.65 6.61 6.62 6.65 6.64 6.61 6.6 6.69 6.55 6.66 6.65 6.67 6.6 6.65 6.6 6.6 6.57 6.68 6.62 6.67 6.69 6.67 6.7 6.71
HP_OSTEOLYSIS 6.44 6.44 6.41 6.41 6.41 6.52 6.62 6.66 6.67 6.68 6.25 6.53 6.47 6.38 6.12 6.41 6.39 6.47 6.33 6.51 6.39 6.52 6.81 6.72 6.74 6.86
HP_CONGENITAL_CONTRACTURE 6.66 6.78 6.67 6.68 6.94 6.95 6.99 6.83 6.87 6.95 6.73 6.99 7.08 6.86 6.89 6.67 6.86 6.78 6.96 6.99 6.66 6.85 6.9 7.01 7 7.08
HP_ARTHROGRYPOSIS_MULTIPLEX_CONGENITA 6.62 6.78 6.67 6.67 6.89 6.87 6.89 6.75 6.87 6.91 6.73 6.98 7.08 6.82 6.84 6.6 6.81 6.72 6.96 6.95 6.62 6.77 6.85 7.01 7 6.96
HP_KYPHOSIS 6.88 7.05 7.15 7 7.16 7.23 7.25 7.25 7.28 7.29 7.17 7.27 7.46 7.33 7.29 7.29 7.14 7.06 7.24 7.4 7.08 7.23 7.29 7.46 7.38 7.31
HP_COXA_VARA 6.01 6.05 5.74 5.69 6.17 5.86 5.91 5.8 5.99 5.9 5.96 5.92 5.85 5.95 5.8 5.74 5.98 5.94 6.03 5.9 6.03 5.72 5.97 5.8 5.91 5.79
HP_ABNORMALITY_OF_THE_KNEE 6.58 6.58 6.65 6.67 6.81 6.73 6.65 6.84 6.67 6.67 6.61 6.69 6.82 6.71 6.68 6.69 6.63 6.66 6.69 6.77 6.69 6.8 6.92 6.78 6.8 6.85
HP_ABNORMALITY_OF_FEMUR_MORPHOLOGY 6.43 6.32 6.35 6.34 6.52 6.56 6.45 6.52 6.46 6.53 6.37 6.5 6.57 6.47 6.43 6.44 6.31 6.27 6.35 6.35 6.2 6.38 6.6 6.65 6.39 6.5
HP_MULTIPLE_JOINT_CONTRACTURES 6.58 6.57 6.63 6.71 6.76 6.94 6.42 6.45 6.59 6.68 6.56 6.74 6.67 6.7 6.56 6.5 6.68 6.77 6.54 6.63 6.41 6.62 6.86 6.63 6.55 6.68
HP_ARTHRALGIA 5.84 5.98 5.71 5.79 5.6 5.44 5.79 5.6 5.63 5.71 5.7 5.65 5.59 5.65 5.54 5.51 5.85 5.78 5.67 5.67 5.88 5.78 5.57 5.49 5.86 5.94
HP_ASPIRATION 7.99 8.3 7.99 7.8 8.18 8.57 8.22 8.29 8.28 7.96 7.86 8.21 8.03 8.14 8.39 8.18 8.1 7.85 8.27 8.19 8.2 8.22 8.5 8.57 8.21 8.28
HP_RECURRENT_BRONCHITIS 6.56 6.57 5.94 5.67 5.98 6.34 6.07 6.1 6.38 6 6.47 6.54 6.07 6.41 5.95 6.62 6.92 6.48 6.2 5.98 6.22 6.4 5.77 5.9 6.62 6.46
HP_URINARY_BLADDER_SPHINCTER_DYSFUNCTION 7.32 7.15 7.18 7.4 7.49 7.35 7.58 7.56 7.52 7.3 7.73 7.53 7.52 7.5 7.72 7.2 7.43 7.08 7.19 7.49 7.39 7.7 7.75 7.73 7.47 7.14
HP_LYMPHADENITIS 6.07 5.7 5.73 5.61 4.97 5.56 5.8 5.59 6.12 5.36 5.54 5.01 5.59 5.81 6.02 5.76 5.78 5.99 5.51 5.5 5.99 5.97 5.31 5.59 5.77 5.12
HP_ABNORMAL_T_CELL_MORPHOLOGY 5.51 5.42 5.31 5.35 5.34 5.07 5.31 5.3 5.46 5.18 5.36 4.97 5.21 5.19 5.13 5.22 5.27 5.35 5.22 5.4 5.35 5.23 5.13 5.02 5.19 5.42
HP_ABNORMAL_B_CELL_MORPHOLOGY 5.9 5.66 5.62 5.51 5.6 5.62 5.31 5.38 5.5 5.38 5.54 5.38 5.65 5.58 5.44 5.31 5.62 5.54 5.51 5.44 5.51 5.37 5.33 5.37 5.72 5.89
HP_DECREASED_CIRCULATING_TOTAL_IGM 4.97 5.08 5.31 5.31 4.87 5.09 5.2 5.38 5.02 4.95 5.07 4.91 4.96 4.86 5.13 5.01 5.25 5.19 4.92 4.94 5.17 5.24 4.86 4.84 5.15 5
HP_GENU_VALGUM 6.27 6.29 6.44 6.32 6.65 6.4 6.41 6.52 6.4 6.53 6.36 6.48 6.46 6.43 6.43 6.47 6.39 6.39 6.29 6.51 6.36 6.49 6.55 6.63 6.61 6.59
HP_MENINGIOMA 7.26 7.28 7.52 7.3 7.74 7.66 7.59 7.41 7.98 7.65 7.68 7.7 7.88 7.84 7.99 7.66 7.51 7.31 7.61 7.85 7.18 7.17 8.15 8.03 7.64 7.3
HP_RHABDOMYOSARCOMA 6.1 6.58 7.09 7.1 6.4 6.49 6.71 6.4 6.94 7.01 6.64 6.66 6.74 6.8 6.84 7.06 6.08 6.45 6.43 6.79 6.95 6.64 6.63 7.22 7.02 6.43
HP_SQUAMOUS_CELL_CARCINOMA 5.99 5.93 6.14 5.93 5.82 5.8 5.85 6.03 5.86 5.92 5.94 5.88 5.91 5.74 5.87 5.82 5.87 5.74 5.79 5.85 6.12 5.93 5.89 5.96 6.02 6.01
HP_MELANOMA 6.53 6.7 7.12 7.18 6.91 6.95 6.69 6.79 6.78 6.76 6.61 6.85 6.89 6.78 6.62 6.7 6.71 6.72 6.97 7.08 6.47 6.84 6.81 7.04 6.79 6.82
HP_MYELODYSPLASIA 6.08 6.06 5.97 5.96 5.99 6.03 5.91 6.07 6.3 6.12 6.11 6.01 6.15 6.03 6.01 6.11 6.11 6.07 5.81 6.05 5.87 6 6.28 6.41 6.06 5.9
HP_HYPOPLASTIC_ILIAC_WING 6.1 6.24 5.72 5.97 6.48 6.52 6.52 6.59 6.17 6.46 6.08 6.36 6.16 6.27 6.42 6.25 6.51 6.32 6.26 6.41 6.35 6.46 6.17 6.68 6.15 6.01
HP_ABNORMALITY_OF_THE_ILIUM 6.16 6.28 6.3 6.18 6.58 6.52 6.4 6.6 6.38 6.53 6.36 6.56 6.32 6.41 6.43 6.49 6.36 6.39 6.29 6.39 6.51 6.39 6.32 6.51 6.6 6.41
HP_FLARED_ILIAC_WINGS 6.61 6.55 7 6.67 6.77 6.9 6.95 7.03 6.66 7.03 7.37 6.66 6.98 6.78 6.68 6.95 7.08 7.03 6.89 6.87 6.87 6.8 7 7.04 6.77 7.04
HP_OBSTRUCTIVE_SLEEP_APNEA 7.54 7.88 7.79 7.95 7.94 8.19 8.51 8.62 8.06 8.51 7.88 8.27 8.57 8.5 8.48 8.46 8.22 8.18 8.15 8.34 8.5 8.47 8.2 8.15 8.26 8.17
HP_CENTRAL_APNEA 6.09 6.15 6.27 6.59 6.44 6.17 6.57 6.48 6.27 6.55 6.26 6.35 6.46 6.43 6.62 6.19 6.35 6.22 6.2 6.41 6.61 6.39 6.31 6.13 6.32 6.29
HP_APNEIC_EPISODES_PRECIPITATED_BY_ILLNESS_FATIGUE_STRESS 6.54 7.22 6.67 5.9 7.9 8.07 7.34 8 7.05 8.18 7.17 7.76 7.57 7.01 7.01 6.22 7.01 7.47 7.41 7.9 5.88 6.45 6.61 7.46 7.29 7.67
HP_EXERTIONAL_DYSPNEA 6.36 6.35 6.23 6.47 6.52 6.5 6.17 6.14 6.61 6.47 6.36 6.43 6.38 6.39 6.09 6.35 6.56 6.47 6.16 6.33 6.55 6.36 6.79 6.4 6.34 6.38
HP_EPISODIC_TACHYPNEA 6.63 6.82 7.46 7.45 6.76 7.16 6.91 7.05 6.88 7.13 7.16 7.23 7.15 6.99 7.35 7.51 6.7 6.97 7.24 7.13 7.03 7.21 6.97 7.31 7.04 7.12
HP_NOCTURNAL_HYPOVENTILATION 5.73 5.56 5.93 5.8 5.73 5.51 5.75 5.71 5.93 5.52 5.92 5.74 5.5 5.52 5.52 5.67 5.38 5.47 5.55 5.58 5.56 5.3 5.75 5.23 5.58 5.44
HP_RESPIRATORY_FAILURE 6.29 6.37 6.67 6.61 6.57 6.6 6.53 6.3 6.28 6.56 6.53 6.53 6.38 6.37 6.4 6.63 6.2 6.3 6.42 6.41 6.44 6.51 6.48 6.37 6.49 6.47
HP_SUDDEN_EPISODIC_APNEA 6.69 7.17 7.37 7.36 7.77 7.98 7.75 8.21 7.24 8.19 7.98 7.85 7.7 7.7 7.72 7.2 7.19 7.25 7.52 7.94 7.31 7.39 7.42 7.65 7.54 7.58
HP_HYPERVENTILATION 8.75 8.75 8.3 8.54 8.98 8.99 9.3 9.59 8.87 9.19 8.57 8.79 8.77 8.76 9.62 9.3 8.6 8.72 9.02 9.02 8.54 8.69 8.89 9.27 8.92 8.93
HP_HEPATOBLASTOMA 6.14 5.86 5.69 5.83 5.77 5.6 6.02 5.75 5.87 5.65 5.67 5.89 5.64 5.64 5.64 5.65 5.66 5.65 5.13 5.88 5.94 5.73 5.71 5.97 5.78 5.89
HP_MEDULLOBLASTOMA 6.65 6.58 7.09 6.72 7.05 6.65 6.73 6.58 6.94 7.09 6.5 6.76 6.94 6.8 6.59 7.06 6.15 6.57 6.72 6.86 6.52 6.51 6.87 7.09 6.56 6.61
HP_EPENDYMOMA 6.28 6.44 6.62 6.45 6.9 6.67 6.7 6.61 6.94 7.06 6.3 6.75 6.86 6.91 6.88 7.06 6.42 6.75 6.39 6.38 6.69 6.46 6.87 7.09 7.35 7
HP_THYROID_CARCINOMA 6.99 7.17 7.11 7.25 7.6 7.33 7.21 6.91 7.64 7.5 7.04 7.44 7.26 7.3 7.38 7.22 6.86 7.07 7.26 7.53 7.09 7.17 7.82 7.79 7.46 7.06
HP_PITUITARY_ADENOMA 7.47 7.52 7.82 7.63 7.96 7.81 7.49 7.54 7.55 7.72 7.66 7.71 7.72 7.74 7.54 7.73 7.46 7.14 7.56 7.56 7.22 7.48 7.92 8.03 7.48 7.54
HP_NEOPLASM_OF_THE_PANCREAS 6.49 6.58 6.79 6.47 6.72 6.77 6.65 6.78 6.62 6.67 6.48 6.67 6.75 6.58 6.47 6.52 6.41 6.56 6.37 6.54 6.59 6.75 6.81 6.81 6.64 6.83
HP_PAPILLARY_THYROID_CARCINOMA 7.47 7.78 7.09 6.73 7.54 7.75 8.28 7.53 8.24 7.64 7.72 7.53 7.91 8.05 7.66 8.07 7.61 7.31 7.56 7.98 7.32 7.84 8.08 8 7.75 7.77
HP_NEOPLASM_OF_THE_LIVER 5.88 6.09 5.95 6.06 5.89 5.9 5.97 6.19 6.03 6.01 5.91 5.98 5.87 5.87 5.93 5.95 5.8 6.02 5.86 5.96 5.97 6.14 5.9 5.95 6 5.98
HP_PARATHYROID_ADENOMA 7.78 8.45 7.69 7.52 8.09 8.17 8.2 8.39 7.94 8.46 7.4 8.34 7.79 7.88 8.21 8.27 8.56 8.73 8.21 8.12 8.63 8.64 8.14 8.29 8.65 8.49
HP_EMBRYONAL_NEOPLASM 6.14 6.19 5.96 6.03 6.08 6.16 6.07 6.35 6.14 6.03 6.15 6.16 6.34 5.94 6.16 6.05 5.96 5.97 6.17 6.02 6.19 6.18 6.09 6.23 6.11 6.09
HP_HYPOKALEMIA 5.56 5.44 5.24 5.77 5.19 5.08 5.56 5.34 5.45 5.31 5.54 5.08 5.12 5.06 5.23 5.12 5.55 5.54 5.02 5.08 5.67 5.17 5.24 4.85 5.29 5.1
HP_HYPOCALCEMIA 6.35 6.32 6.22 6.33 6.57 6.5 6.08 6.28 6.14 6.16 6.11 6.03 6.53 6.44 6.37 6.19 5.99 5.98 6.3 5.84 6.28 5.95 6.2 6.21 6.09 6.24
HP_HYPERPHOSPHATEMIA 6.13 6.31 5.93 6.02 5.66 6.14 6.15 6.2 5.95 6.6 6.17 6.3 5.86 5.92 6.44 6.36 5.77 6.32 6.41 6.26 6.07 5.93 6.19 6.11 6.09 6.09
HP_MICROSCOPIC_HEMATURIA 6.81 6.16 5.59 5.76 5.99 6.39 6.03 5.92 5.92 5.7 5.73 5.9 5.57 5.5 5.86 5.35 5.88 5.52 6.13 5.68 6.08 5.78 5.68 5.45 5.65 5.71
HP_CONJUGATED_HYPERBILIRUBINEMIA 5.08 4.71 5 4.83 4.32 4.23 4.53 4.71 4.43 4.43 4.54 4.37 4.5 4.58 4.56 4.41 4.84 4.86 4.61 4.28 4.86 4.37 4.46 4.18 4.39 4.57
HP_GENERALIZED_AMINOACIDURIA 6.29 6.29 5.83 6.61 5.92 6.37 5.85 6.32 6.3 5.74 6.33 5.89 6.12 6.34 6.01 6.22 6.06 6.18 6.45 6.27 5.68 6.29 5.96 6.13 6.02 6.3
HP_ELEVATED_HEPATIC_TRANSAMINASE 6.4 6.45 6.71 6.7 6.55 6.66 6.43 6.41 6.54 6.63 6.47 6.59 6.48 6.56 6.46 6.43 6.47 6.43 6.48 6.57 6.28 6.29 6.62 6.52 6.53 6.52
HP_METHYLMALONIC_ACIDEMIA 6.8 6.61 7.77 7.41 7.21 7.44 7.52 7.3 7.36 6.66 7.33 7.19 7.55 7.59 7.86 7.35 6.78 6.55 6.47 7.95 6.42 7.93 6.95 6.97 7.42 7.29
HP_MYOGLOBINURIA 7.1 7.55 7.89 8.38 7.47 7.75 7.72 7.79 7.53 7.5 7.86 7.8 8.06 8.01 7.76 7.76 7.93 7.67 7.73 7.75 7.73 7.81 7.96 7.99 7.57 7.55
HP_ABNORMALITY_OF_CHROMOSOME_SEGREGATION 6.24 6.19 6.12 6.34 6.06 6.48 6.09 6.04 6.27 6.63 6.29 6.47 6.49 6.56 6.17 6.26 6.31 6.25 6.26 6.41 6.53 6.39 6.34 6.43 6.27 6.22
HP_KETONURIA 6.14 6.28 6.63 6.58 6.12 6.51 6.36 6.51 6.55 6.1 6.24 6.18 6.51 6.42 6.02 6.37 6.15 6.01 6.46 6.6 6.37 6.07 5.91 6.1 6.57 6.69
HP_DECREASED_CIRCULATING_ACTH_LEVEL 5.56 5.42 6.42 6.34 5.6 5.75 5.91 5.82 5.97 6 6.25 6.1 5.67 5.95 6.12 6.06 5.81 5.63 5.53 5.7 6.08 6.35 5.6 5.7 5.96 6.09
HP_ABNORMALITY_OF_THE_CEREBROSPINAL_FLUID 6.64 6.64 7.06 6.89 6.84 6.93 6.85 6.92 6.85 6.9 6.81 6.88 6.88 6.93 6.95 7.04 6.73 6.8 6.71 6.93 6.89 6.94 6.89 7.02 6.85 6.91
HP_RHEUMATOID_FACTOR_POSITIVE 5.23 5.2 5.04 4.99 5.37 5.22 4.5 4.94 5.17 4.45 5.12 4.8 4.98 5.11 4.32 5.12 5.27 4.98 4.95 4.59 5.48 5.4 4.59 4.58 4.9 4.78
HP_ABNORMALITY_OF_THYROID_PHYSIOLOGY 6.36 6.45 6.31 6.35 6.39 6.56 6.57 6.6 6.46 6.55 6.34 6.46 6.57 6.52 6.56 6.49 6.42 6.39 6.43 6.63 6.51 6.51 6.42 6.55 6.39 6.56
HP_DECREASED_ACTIVITY_OF_THE_PYRUVATE_DEHYDROGENASE_COMPLEX 8.26 8.15 9.01 8.17 8.32 8.23 8.23 8.25 8.01 8.2 8.14 8.29 8.27 8.02 8.84 8.56 7.99 8.07 8.3 8.41 8.36 8.49 8.34 8.67 8.32 8.35
HP_DISTAL_SENSORY_IMPAIRMENT 7.43 7.6 7.78 7.39 7.95 7.86 7.71 7.84 7.81 7.95 7.41 7.87 7.9 7.87 7.76 7.91 7.85 7.45 7.76 7.96 7.66 7.68 7.98 8.33 7.96 7.82
HP_HEMIVERTEBRAE 6.23 6.32 6.43 6.21 6.11 6.38 6.61 6.45 6.29 6.57 6.43 6.44 6.33 6.26 6.4 6.3 6.47 6.44 6.29 6.46 6.48 6.6 6.48 6.65 6.39 6.58
HP_LUMBAR_HYPERLORDOSIS 6.49 6.37 6.46 6.66 6.75 6.76 6.53 6.76 6.82 6.54 6.56 6.79 6.89 6.74 6.65 6.62 6.49 6.54 6.53 6.7 6.48 6.42 6.92 6.82 7.04 6.99
HP_THORACIC_KYPHOSIS 6.65 6.98 6.73 6.81 6.82 6.88 6.85 6.97 7.02 6.75 6.68 6.82 6.83 6.69 6.75 6.76 6.79 6.97 6.88 6.91 6.63 6.79 6.67 7.07 6.91 7
HP_THORACIC_SCOLIOSIS 6.49 6.2 6.48 6.5 6.52 6.57 6.38 6.2 6.58 6.32 6.81 6.52 6.37 6.46 6.63 6.53 6.69 6.67 6.35 6.54 6.68 6.53 6.82 6.65 6.75 6.29
HP_THORACOLUMBAR_SCOLIOSIS 5.95 5.9 6 6.14 5.8 5.95 5.86 5.91 6.05 6.03 5.87 5.96 6.02 6.04 6 6.09 6.17 5.96 5.7 5.88 6.12 6.44 6.43 6.14 7 6.72
HP_VERTEBRAL_FUSION 5.82 5.76 5.95 5.9 5.53 5.33 5.71 5.91 5.57 5.44 5.8 5.44 5.81 5.69 5.72 5.82 5.72 5.76 5.49 5.72 5.87 5.74 5.7 5.45 5.75 5.91
HP_FUSED_CERVICAL_VERTEBRAE 5.24 5.3 5.68 5.39 5.07 4.95 5.45 5.45 5.05 5.21 5.09 4.95 5.13 5.19 5.38 5.16 4.89 5.33 5.04 5.19 5.56 5.27 5.29 5.08 5.08 5.19
HP_VERTEBRAL_COMPRESSION_FRACTURES 6.87 6.8 7.29 6.44 6.66 7.03 7.31 7.31 7.28 7.06 6.93 7.04 7.09 7.02 7.51 7.48 7.22 6.88 6.52 6.99 7.33 7.32 7.35 7.43 7.34 7.52
HP_AUTOIMMUNITY 5.84 5.72 5.72 5.8 5.62 5.62 5.76 5.6 5.61 5.43 5.7 5.39 5.51 5.41 5.55 5.48 5.63 5.68 5.56 5.44 5.75 5.67 5.43 5.35 5.67 5.56
HP_ABNORMAL_DELAYED_HYPERSENSITIVITY_SKIN_TEST 5.24 5.34 5.01 5.03 5.28 5.22 5.44 5.26 5.34 5.07 5.1 5 5.08 4.98 5.34 4.88 5.44 5.27 4.95 5 5.54 5.59 4.93 5.05 5.34 5.22
HP_CUBITUS_VALGUS 6.69 6.73 7.16 6.91 6.87 6.85 6.94 6.89 7.1 7.04 6.94 6.91 7.18 7.34 6.91 7.34 6.88 6.96 7.05 6.96 6.41 6.99 7.34 7.47 7.11 7.05
HP_GENU_VARUM 5.76 5.49 5.26 5.57 5.38 5.37 4.95 5.21 5.02 5.04 5.5 5.27 5.17 5.11 4.94 5.1 5.51 5.47 5.49 5.23 5.47 5.11 5.04 4.97 5.69 5.38
HP_ABNORMALITY_OF_THE_FOREARM 6.3 6.39 6.37 6.5 6.47 6.49 6.49 6.56 6.46 6.64 6.54 6.47 6.64 6.53 6.48 6.45 6.4 6.32 6.29 6.44 6.43 6.49 6.6 6.71 6.47 6.64
HP_RADIOULNAR_SYNOSTOSIS 7.05 6.77 7.07 7.06 7.1 7.12 6.81 7 7.09 7.22 6.92 7.27 7.16 7.15 7.12 7.07 6.83 6.81 7.2 7.11 7 7.05 7.16 7.38 7.04 7.03
HP_BOWING_OF_THE_LEGS 6.22 6.24 6.34 6.17 6.44 6.38 6.33 6.48 6.34 6.5 6.35 6.38 6.42 6.43 6.4 6.45 6.17 6.21 6.29 6.39 6.31 6.37 6.46 6.55 6.46 6.46
HP_FEMORAL_BOWING 5.88 5.65 5.91 5.77 5.91 5.49 5.72 5.5 5.5 5.34 5.78 5.68 5.55 5.44 5.46 5.69 5.61 5.85 5.68 5.57 5.67 5.8 5.5 5.3 5.6 5.6
HP_ABNORMALITY_OF_THE_CALF 6.47 6.37 6.55 6.39 6.65 6.5 6.44 6.67 6.46 6.55 6.54 6.56 6.6 6.53 6.46 6.59 6.46 6.44 6.42 6.52 6.43 6.72 6.65 6.65 6.66 6.73
HP_TIBIAL_BOWING 5.97 6.04 5.69 5.73 5.94 6.22 5.79 5.6 5.84 5.77 6.02 5.9 5.9 6 5.63 5.74 5.81 5.69 5.48 5.83 5.94 5.88 5.88 6.13 6.02 6.09
HP_MICROMELIA 6.72 6.5 6.55 6.59 6.74 6.68 6.58 6.52 6.45 6.63 6.72 6.69 6.6 6.7 6.47 6.74 6.83 6.74 6.98 6.68 6.53 6.58 6.63 6.6 6.77 6.79
HP_HYPOPLASIA_OF_THE_RADIUS 6.13 6.14 6.55 6.78 6.28 6.42 6.3 6.28 5.96 6.37 6.54 6.24 6.12 6.29 6.31 6.08 6.22 6.11 6 6.22 6.11 6.31 6.26 6.58 6.07 5.84
HP_RADIAL_BOWING 6.5 6.4 5.95 6.1 6.42 6.55 6.55 6.42 6.45 6.39 6.68 6.48 6.56 6.61 6.56 6.8 6.58 6.84 6.56 6.24 6.66 6.71 6.8 6.65 6.47 6.53
HP_ELBOW_FLEXION_CONTRACTURE 6.53 6.61 6.65 6.55 6.66 6.58 6.56 6.64 6.66 6.66 6.57 6.65 6.58 6.67 6.43 6.54 6.75 6.47 6.64 6.51 6.62 6.62 6.94 6.65 6.77 6.89
HP_ABNORMALITY_OF_FIBULA_MORPHOLOGY 6.65 6.73 6.73 6.69 6.88 6.92 6.86 6.98 6.75 6.84 6.93 6.62 6.9 6.86 6.75 6.95 7.17 7.02 6.63 7.07 7.11 6.83 6.97 6.81 6.98 7.06
HP_ABNORMALITY_OF_TIBIA_MORPHOLOGY 6.34 6.41 6.51 6.21 6.51 6.55 6.32 6.66 6.36 6.51 6.61 6.52 6.62 6.54 6.53 6.58 6.36 6.31 6.36 6.28 6.5 6.8 6.79 6.62 6.53 6.83
HP_LIMITED_ELBOW_MOVEMENT 6.35 6.2 6.34 6.5 6.38 6.42 6.5 6.44 6.29 6.5 6.45 6.53 6.4 6.45 6.13 6.39 6.53 6.4 6.3 6.36 6.48 6.42 6.54 6.54 6.55 6.64
HP_ABNORMALITY_OF_THE_ULNA 6.52 6.52 6.68 6.68 6.77 6.61 6.64 6.73 6.68 6.78 6.62 6.54 6.75 6.64 6.54 6.59 6.4 6.33 6.41 6.57 6.53 6.56 6.86 6.85 6.64 6.74
HP_PATELLAR_DISLOCATION 7.25 7.12 7.13 7.01 7.25 7.37 7.27 7.65 7.24 7.41 7.01 7.08 7.47 7.68 7.24 7.51 7.23 7.17 7.55 7.3 7.11 7.44 7.24 7.49 7.33 7.46
HP_BREAST_CARCINOMA 6.1 6.3 6.8 6.79 6.46 6.66 6.24 6.29 6.32 6.51 6.48 6.53 6.58 6.47 6.23 6.38 6.25 6.29 5.94 6.24 5.96 6.2 6.87 6.73 6.29 6.53
HP_COLON_CANCER 6.1 6.37 6.42 6.72 6.4 6.54 6.68 6.33 6.49 6.72 6.44 6.68 6.48 6.47 6.45 6.54 6.08 6.25 6.3 6.38 6.11 6.2 6.63 6.39 6.4 6.61
HP_PROLONGED_BLEEDING_TIME 6.13 6.08 5.83 5.91 5.78 5.87 5.85 5.71 5.86 5.82 6.18 5.89 6.11 6.05 5.7 5.83 6.1 6.01 5.64 5.82 6 6.09 5.85 5.92 5.96 5.89
HP_FLARED_METAPHYSIS 6.52 6.48 6.41 6.61 6.79 6.87 6.59 6.77 6.56 6.71 6.61 6.59 6.79 6.67 6.5 6.45 6.58 6.6 6.55 6.76 6.82 6.25 6.64 6.54 6.66 6.65
HP_METAPHYSEAL_WIDENING 6.29 6.29 6.3 6.34 6.65 6.66 6.4 6.54 6.45 6.51 6.29 6.4 6.64 6.59 6.43 6.42 6.45 6.26 6.39 6.56 6.23 6.26 6.5 6.54 6.52 6.46
HP_ABNORMALITY_OF_THE_WRIST 6.14 6.05 6.17 6.05 6.21 6.24 6.32 6.36 6.27 6.27 6.14 6.1 6.28 6.23 6.28 6.42 6.08 6.07 5.96 6.19 6.14 6.24 6.28 6.42 6.31 6.27
HP_METAPHYSEAL_CUPPING 5.95 5.96 6.06 5.91 5.98 6.12 6.16 5.97 5.93 6.27 6.27 6.59 6.22 6.09 5.96 6.23 6.25 6.25 6.27 6.27 6.02 6.16 5.89 6.21 6.2 6.21
HP_METAPHYSEAL_IRREGULARITY 6.1 6.14 6.53 6.44 6.36 6.42 6.16 6.04 5.94 6.07 6.2 6.16 6.28 6.09 6.24 5.95 5.81 5.74 6.38 6.1 6.01 5.9 6.19 6.4 6.02 6.17
HP_SHORT_LONG_BONE 6.42 6.31 6.49 6.46 6.51 6.46 6.35 6.44 6.53 6.49 6.36 6.55 6.49 6.5 6.38 6.3 6.33 6.33 6.29 6.29 6.2 6.38 6.57 6.62 6.4 6.49
HP_MESOMELIA 5.81 6.16 6.09 6.48 6.52 6.5 6.05 6.28 5.99 6.18 6.43 6.4 6.28 6.56 6.27 6.22 6.29 6.21 6.21 6.16 6.06 6.2 6.1 6.38 6.31 6.37
HP_ABNORMALITY_OF_THE_ANKLES 7.02 6.98 7.18 6.99 7.41 7.26 7.3 7.33 7.24 7.32 7.3 7.47 7.55 7.47 7.28 7.36 7.39 7.09 7.24 7.47 7.23 7.35 7.24 7.43 7.33 7.25
HP_ULNAR_BOWING 5.95 6.04 5.68 5.49 6.2 5.87 5.79 5.97 5.79 6.06 5.66 5.94 5.93 5.78 5.68 5.69 6.05 5.84 5.86 5.57 5.84 5.78 5.96 5.9 6.12 5.82
HP_FIBULAR_HYPOPLASIA 6.77 7.06 6.98 6.83 6.88 7.16 7.11 7.21 6.8 7.09 6.96 7.27 7.31 7.09 7.08 7.11 7.17 7.16 6.61 7.14 7.31 6.99 7.09 7.38 7.49 7.43
HP_ARTHROPATHY 5.27 5.26 4.99 4.98 4.79 4.7 4.88 4.89 4.74 4.77 4.96 4.71 4.7 4.78 4.87 4.76 4.88 5.07 4.93 4.74 5.15 4.96 4.57 4.57 4.84 4.78
HP_HUMERORADIAL_SYNOSTOSIS 5.98 6.3 6.69 6.93 6.38 6.39 6.58 6.49 6.23 6.51 6.7 6.08 6.47 6.53 6.52 6.73 6.3 6.37 6.12 6.33 6.5 6.72 6.47 6.62 6.32 6.36
HP_ABNORMAL_SHOULDER_MORPHOLOGY 6.39 6.38 6.18 6.2 6.46 6.49 6.3 6.4 6.33 6.58 6.35 6.55 6.4 6.4 6.37 6.43 6.44 6.4 6.35 6.46 6.52 6.29 6.42 6.33 6.56 6.62
HP_ABNORMAL_PATELLA_MORPHOLOGY 6.49 6.69 6.7 6.7 6.79 6.8 6.81 6.79 6.7 6.66 6.73 6.56 6.56 6.65 6.52 6.66 6.66 6.61 6.59 6.7 6.78 6.73 6.87 6.97 6.98 6.96
HP_ULNAR_DEVIATION_OF_THE_WRIST 5.7 5.72 6 5.73 5.74 5.6 5.92 5.93 5.87 6.27 5.61 6.22 6.13 5.97 6.1 5.96 5.97 6.02 5.6 6.03 6.04 6.49 5.61 5.8 6.3 6.22
HP_ABNORMALITY_OF_THE_HUMERUS 6.02 6.06 6.05 6.36 6.21 6.35 6.35 6.42 6.62 6.53 6.54 6.09 6.5 6.51 6.48 6.3 6.22 6.11 6.01 6.44 6.2 6.49 6.79 6.72 6.48 6.48
HP_LIMITED_KNEE_EXTENSION 7.78 8.09 8.16 8.79 8.37 8.27 7.99 8.34 8.11 7.8 7.85 7.83 7.74 7.95 8.37 8.1 7.59 7.84 8.23 8.35 7.66 8.17 8 8.22 7.84 7.68
HP_FLATTENED_EPIPHYSIS 6.13 6.12 6.02 6.08 6.69 6.37 6.2 6.21 6.51 6.55 6 6.45 6.62 6.23 6.42 5.93 5.97 5.89 6.35 6.15 5.97 5.71 6.72 6.53 6.38 6.34
HP_HYPERCALCEMIA 7.12 6.9 6.95 6.76 7.32 7.33 7.34 7.3 7.14 7.31 7.18 7.32 7.43 7.43 7.31 7.35 7.49 7.28 7.37 7.53 7.04 7.34 7.28 7.38 7.38 7.31
HP_HYPERGLYCEMIA 5.43 5.51 5.3 5.58 5.4 5.02 5.44 5.2 5.47 5.18 5.42 5.1 5.18 5.22 5.35 5.37 5.51 5.37 5 5.08 5.41 5.12 5.17 5.03 5.22 5.14
HP_HYPOPROTEINEMIA 7.27 6.9 6.86 6.65 7.08 7.16 6.72 6.65 6.97 6.87 6.73 7.44 7.04 7.2 6.5 7.24 6.95 6.71 7.31 6.8 6.48 6.26 7.07 6.78 6.57 7.07
HP_GLYCOSURIA 5.44 5.34 5.22 5.58 5.17 5.02 5.25 5.09 5.47 5.14 5.34 5.1 5.03 5.22 5.1 5.17 5.37 5.29 5.06 5.01 5.34 5.14 5.17 4.79 5.08 4.96
HP_HYPERLIPIDEMIA 6.24 6.26 6.38 6.21 6.5 6.5 6.51 6.32 6.32 6.63 6.16 6.39 6.37 6.29 6 6.28 6.52 6.21 6.18 6.36 6.41 6.31 6.39 6.49 6.53 6.65
HP_DEFECTIVE_DNA_REPAIR_AFTER_ULTRAVIOLET_RADIATION_DAMAGE 6.58 6.7 6.5 6.7 6.5 6.68 6.62 6.58 6.91 6.76 6.56 6.85 6.93 6.67 6.62 6.45 6.5 6.8 6.87 6.62 6.46 6.62 6.62 7.02 6.79 6.68
HP_SHORT_FEMUR 6.95 6.9 6.41 6.44 6.56 6.47 6.43 6.79 7.04 6.95 6.46 6.75 6.98 6.73 6.89 6.67 6.83 6.4 6.62 6.55 6.46 6.54 6.76 6.85 7.36 7.3
HP_SLENDER_LONG_BONE 6.5 6.34 6.47 6.44 6.62 6.54 6.54 6.73 6.42 6.63 6.47 6.43 6.43 6.53 6.48 6.67 6.39 6.29 6.36 6.28 6.28 6.63 6.43 6.57 6.5 6.63
HP_ABNORMAL_CORTICAL_BONE_MORPHOLOGY 6.3 6.37 5.99 6.18 6.63 6.57 6.17 6.5 6.23 6.52 6.16 6.33 6.36 6.39 6.18 6.26 6.21 6.21 6.35 6.18 6.28 6.47 6.2 6.4 6.15 6.24
HP_ABNORMAL_CIRCULATING_CHOLESTEROL_CONCENTRATION 6.62 6.6 6.5 6.9 6.89 6.79 6.72 6.77 6.8 6.91 6.44 6.88 6.75 6.68 6.49 6.42 6.86 6.54 6.53 6.72 6.73 6.82 6.64 6.58 6.6 6.74
HP_HYPERPHOSPHATURIA 5.43 5.45 5.11 5.54 5.17 5.27 5.03 4.9 5.46 5.02 5.41 5.23 4.99 5.2 5.07 5.01 5.69 5.49 5.11 5.07 5.62 5.14 5.05 4.85 5.18 4.91
HP_ABNORMALITY_OF_URINE_HOMEOSTASIS 6.25 6.27 6.39 6.35 6.25 6.29 6.3 6.34 6.25 6.27 6.28 6.25 6.19 6.17 6.12 6.23 6.21 6.21 6.24 6.27 6.21 6.2 6.19 6.22 6.25 6.37
HP_ABNORMAL_BLOOD_ION_CONCENTRATION 6.18 6.18 6.21 6.3 6.03 6.22 6.2 6.22 6.09 6.32 6.26 6.03 6.03 6.1 6.03 6.16 6.1 6.08 6.25 6.33 6.24 6.11 6 6.18 6.09 6.27
HP_ABNORMAL_CIRCULATING_AMINO_ACID_CONCENTRATION 6.68 6.61 6.96 7.08 6.94 7.03 6.97 6.81 6.81 6.9 6.7 6.84 7.03 6.91 6.84 6.93 6.78 6.77 6.79 6.81 6.66 6.83 6.75 7 6.73 6.89
HP_ABNORMAL_ECHOCARDIOGRAM 5.85 5.97 6.04 5.7 6.16 6.07 5.93 5.82 5.79 6.06 5.76 6.16 5.93 5.8 5.76 5.75 5.89 5.64 5.92 6.07 5.84 5.97 5.68 5.94 6.15 6.43
HP_ABNORMAL_CIRCULATING_HORMONE_LEVEL 5.95 5.92 6.11 6.17 5.8 5.87 5.94 6.05 5.97 6.02 6.09 5.9 5.93 5.94 5.97 5.95 5.92 5.96 5.96 6 5.97 5.98 5.87 5.92 5.91 6.14
HP_INCREASED_CIRCULATING_CORTISOL_LEVEL 6.43 6.48 6.24 6.17 5.64 5.31 5.84 5.7 6.09 5.24 6.07 5.29 5.76 5.62 5.42 5.34 6.07 5.81 5.37 5.53 6.57 5.96 5.55 5.15 6.1 6.16
HP_ABNORMAL_CIRCULATING_LIPID_CONCENTRATION 6.35 6.39 6.51 6.43 6.53 6.53 6.53 6.45 6.48 6.58 6.41 6.39 6.4 6.49 6.23 6.3 6.5 6.3 6.35 6.44 6.47 6.33 6.4 6.46 6.57 6.6
HP_LIMB_JOINT_CONTRACTURE 6.51 6.57 6.64 6.68 6.75 6.76 6.62 6.82 6.66 6.71 6.51 6.66 6.8 6.73 6.63 6.59 6.67 6.55 6.61 6.68 6.59 6.64 6.84 6.82 6.79 6.8
HP_HYPERCHOLESTEROLEMIA 6.53 6.53 6.44 6.41 6.55 6.5 6.59 6.63 6.49 6.66 6.1 6.41 6.4 6.47 6.1 6.28 6.45 6.43 6.39 6.38 6.6 6.26 6.4 6.37 6.48 6.66
HP_HYPOCALCIURIA 5.6 5.5 5.5 5.62 4.96 4.99 5.55 5.14 5.39 5.01 5.58 5.06 5.07 4.98 5.51 5.13 5.48 5.61 5.07 5.13 5.91 5.17 5.03 4.83 5.04 4.94
HP_LACTIC_ACIDOSIS 7 7.01 8.04 7.68 7.11 7.39 7.29 7.36 7.25 7.48 7.4 7.31 7.38 7.4 7.33 7.41 7.07 7.03 7.34 7.45 7.14 7.48 7.36 7.53 7.3 7.32
HP_ABNORMAL_PERIPHERAL_MYELINATION 7.17 7.25 7.57 7.14 7.76 7.71 7.54 7.73 7.78 7.67 7.29 7.54 7.75 7.77 7.61 7.63 7.54 7.27 7.48 7.64 7.43 7.45 7.8 7.83 7.67 7.65
HP_ABNORMALITY_OF_THE_SPINOCEREBELLAR_TRACTS 7.39 7.19 7.5 7.15 7.35 7.37 7.45 7.66 7.52 7.46 7.47 7.45 7.29 7.52 7.52 6.81 7.51 7.16 7.04 7.69 7.13 7.16 7.86 7.94 7.39 7.5
HP_INCREASED_BLOOD_UREA_NITROGEN 5.4 5.54 5.79 6.21 5.89 6.3 5.86 5.57 5.75 5.81 5.66 6.08 5.74 5.49 5.29 5.38 5.85 5.53 5.73 5.64 5.77 5.7 6.11 5.64 5.95 5.61
HP_PANHYPOGAMMAGLOBULINEMIA 5.72 5.64 5.63 5.68 5.96 5.99 5.73 5.42 5.85 5.52 5.85 5.87 5.93 5.86 5.6 5.33 6.13 5.76 5.64 5.64 5.95 5.54 5.72 5.54 5.72 5.74
HP_INCREASED_LDL_CHOLESTEROL_CONCENTRATION 6.35 6.22 6.32 6.57 6.86 6.53 6.44 6.49 6.2 6.97 6.15 6.51 6.35 6.15 6.05 6.17 6.66 6.25 6.18 6.48 6.47 6.16 6.34 6.1 6.37 6.5
HP_INCREASED_SERUM_SEROTONIN 6.99 7.09 7.19 7.05 7.51 7.33 7.34 7.49 7.65 7.34 7.18 7.36 7.54 7.3 7.82 7.42 7 7.1 7.32 7.84 7.3 7.59 8.06 7.66 7.68 7.19
HP_HYPOCHOLESTEROLEMIA 7.46 7.8 7.55 7.46 7.76 8.05 7.95 7.93 8 7.76 7.51 7.8 7.67 8 7.85 7.79 7.68 7.72 7.97 7.81 8.05 8.02 8.16 8.3 8.26 7.79
HP_INCREASED_CIRCULATING_ACTH_LEVEL 5.22 5.3 5.57 5.06 5.58 5.41 5.66 5.76 5.74 5.52 4.8 5.58 5.22 5.38 5.57 5.84 5.08 5.11 4.68 5.28 5.02 5.66 5.67 5.02 5.63 5.16
HP_FASTING_HYPOGLYCEMIA 5.91 5.72 5.8 5.5 6.29 6.13 5.68 6.24 6.11 6.22 6.19 6.32 6.27 6.13 5.67 6.22 6.15 6.13 6.19 6.19 6.37 6.15 6.39 6.36 6.59 6.18
HP_HYPOTHALAMIC_GONADOTROPIN_RELEASING_HORMONE_DEFICIENCY 6.23 5.66 6.09 5.62 5.74 5.45 5.94 6.13 6.56 5.75 6.25 6.03 6.79 6.52 6.22 5.88 5.99 6.26 6.02 6.22 6.11 6.02 5.64 5.74 5.69 6.05
HP_ELEVATED_CIRCULATING_PARATHYROID_HORMONE_LEVEL 6.6 6.85 6.52 6.53 5.81 6.38 6.66 6.34 7.05 6.92 6.37 6.69 5.9 6.1 6.8 6.86 5.81 6.66 7.04 6.77 5.89 5.93 7.24 7.05 6.9 6.29
HP_ABNORMALITY_OF_THE_ACETABULUM 6.45 6.24 6.44 6.49 6.65 6.6 6.24 6.37 6.21 6.33 6.42 6.27 6.5 6.45 6.39 6.53 6.18 6.12 6.33 6.36 6.03 6.26 6.28 6.54 6.67 6.68
HP_ABNORMALITY_OF_THE_PUBIC_BONE 6.15 6.2 5.69 5.68 6.19 6.42 6.59 6.61 6.68 6.53 6.07 6.33 6.35 6.53 5.99 6.32 6.53 6.66 6.39 6.22 6.11 6.42 6.28 6.44 6.11 6.09
HP_ABNORMALITY_OF_THE_ISCHIUM 5.87 6.17 5.37 5.42 6.01 5.86 6.47 5.89 6.33 5.9 6.07 6.33 6.26 5.87 5.96 6.2 6.84 6.55 6.28 6.7 6.04 6.3 5.83 6.08 6.12 6.14
HP_HYPOPLASTIC_ISCHIA 5.82 5.9 5.26 5.22 5.85 5.53 5.99 5.67 5.68 5.55 5.66 5.8 5.67 5.56 5.71 5.81 5.85 6.17 6.16 5.61 5.91 5.9 5.48 5.46 5.71 5.73
HP_PROTRUSIO_ACETABULI 6.42 6.19 5.48 5.57 6.56 6.25 5.82 5.74 5.76 6.15 6.03 6.17 5.85 5.92 5.82 5.77 6.06 6.1 6.1 6.03 5.93 5.73 6.34 5.67 6.32 6.45
HP_FLAT_ACETABULAR_ROOF 6.87 7.19 6.85 6.77 6.92 6.79 6.9 6.88 6.68 6.69 6.53 6.7 6.71 6.75 6.8 6.86 7.12 6.87 7.15 7.12 7.11 6.99 6.83 7.1 7.31 7.23
HP_INVERTED_NIPPLES 7.76 7.9 7.79 7.74 7.87 8.16 7.81 8.02 7.93 7.81 7.35 8.03 7.77 7.87 7.85 7.42 7.53 7.54 7.91 7.57 7.86 7.73 8.2 8.3 7.84 7.87
HP_BREAST_HYPOPLASIA 5.32 5.21 5.8 5.42 5.13 5.08 5.18 5.63 5.53 5.39 5.58 5.31 5.33 5.28 5.79 5.43 5.37 5.45 5.39 5.4 5.61 5.48 5.42 5.18 5.05 5.31
HP_LONG_NOSE 7.27 7.47 7.62 7.19 7.84 7.94 7.91 7.74 8.16 7.75 7.44 7.74 8.06 8.06 7.8 7.7 7.79 7.75 7.31 8.07 7.69 7.71 8.08 8.25 7.88 7.79
HP_SHORT_NOSE 7.08 7.07 7.16 7.12 7.27 7.23 7.25 7.35 7.43 7.4 6.99 7.37 7.44 7.47 7.35 7.12 7.24 7.19 7.25 7.26 7.15 7.26 7.33 7.48 7.3 7.29
HP_MYOPATHY 6.39 6.37 6.42 6.52 6.56 6.5 6.38 6.38 6.47 6.59 6.46 6.48 6.5 6.45 6.39 6.41 6.58 6.47 6.35 6.46 6.52 6.38 6.55 6.59 6.55 6.57
HP_DECREASED_MUSCLE_MASS 6.76 6.72 6.82 6.56 7.03 7 6.6 6.72 6.76 6.96 6.7 7.11 6.6 6.68 6.74 6.52 6.88 6.88 6.59 6.78 6.86 6.7 6.75 6.93 6.97 6.91
HP_RAGGED_RED_MUSCLE_FIBERS 6.58 6.87 6.71 7.08 6.85 6.9 6.56 6.84 6.72 6.87 6.6 6.66 6.78 6.69 6.89 6.74 6.75 6.59 6.87 6.84 6.63 6.71 6.72 6.86 6.82 6.77
HP_RHABDOMYOLYSIS 6.37 6.66 7.27 7.55 6.78 7.31 6.95 6.7 6.75 7.08 6.74 6.79 6.8 7.11 6.71 7.11 6.72 6.41 6.94 6.88 6.43 6.49 6.84 7.18 6.78 6.54
HP_SKELETAL_MUSCLE_ATROPHY 6.98 7.11 7.43 7.2 7.24 7.36 7.31 7.28 7.38 7.36 7.28 7.27 7.36 7.26 7.3 7.31 7.16 6.93 7.24 7.38 7.14 7.29 7.49 7.54 7.3 7.26
HP_DICARBOXYLIC_ACIDURIA 6.57 6.61 7.59 7.41 6.74 6.93 6.94 7.02 6.88 6.74 6.9 6.94 6.96 6.94 6.52 6.96 6.78 6.56 6.75 6.92 6.66 7.16 6.85 6.97 6.98 6.96
HP_ABNORMALITY_OF_CHROMOSOME_STABILITY 5.94 5.76 6.23 6.03 5.89 5.87 5.91 5.97 6.14 6.06 6 5.72 6.05 5.97 5.99 5.88 5.79 5.83 5.84 6.18 5.79 5.76 6.26 6.47 5.78 5.78
HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_CROSSLINKING_AGENTS 4.99 4.8 4.41 5.17 4.11 4.39 4.33 4.49 4.35 4.21 4.44 4.55 4.39 4.31 4.25 4.39 4.68 5.08 4.63 4.47 4.78 4.34 4.13 4.35 4.51 4.52
HP_DECREASED_HDL_CHOLESTEROL_CONCENTRATION 6.23 6.22 6.4 6.91 6.89 6.53 6.44 6.49 6.37 7.03 6.57 6.81 6.35 5.95 6.25 6.38 6.66 6.53 6.25 6.55 6.31 6.3 6.26 6.36 6.35 6.64
HP_DECREASED_PLASMA_CARNITINE 6.43 6.41 6.78 6.43 6.38 6.4 6.33 6.46 6.69 6.55 6.73 6.27 6.59 6.52 6.19 6.66 6.89 6.41 6.42 6.54 6.22 6.78 6.48 6.54 6.59 6.65
HP_INCREASED_CIRCULATING_IGG_LEVEL 5.31 5.44 5.04 5.04 5.08 5.22 5.13 5.11 5.17 4.99 5.04 4.91 4.98 5.34 5.19 5.23 5.17 5.13 4.73 4.81 5.28 5.65 4.78 4.6 5.49 5.46
HP_EXTERNAL_GENITAL_HYPOPLASIA 6.33 6.36 6.49 6.53 6.49 6.51 6.44 6.46 6.47 6.55 6.44 6.53 6.6 6.51 6.46 6.56 6.47 6.4 6.43 6.44 6.4 6.43 6.58 6.65 6.44 6.54
HP_MALE_INFERTILITY 5.4 5.41 5.13 5.29 4.99 5.07 5.28 5.06 5.14 5.26 5.2 5.17 5.18 5.09 5.25 5.4 5.3 5.61 5.01 5 5.26 5.23 5.01 4.97 4.98 5.21
HP_ABNORMALITY_OF_DNA_REPAIR 6.05 6.07 6.23 6.38 5.89 6.3 5.86 6.39 6.29 5.92 6.13 5.9 6.41 6.17 5.84 6.24 5.85 6.01 6.18 5.77 6.24 5.97 6.49 6.22 6.11 6.31
HP_ABNORMALITY_OF_THE_COAGULATION_CASCADE 6.23 6.21 6.39 6.32 6.39 6.28 6.1 6.09 6.06 6.25 6.43 6.13 6.06 6.23 6.06 6.02 6.1 5.94 6.11 6.08 6.15 6.09 6.1 6.04 6.26 6.25
HP_INCREASED_CIRCULATING_IGA_LEVEL 5.34 5.14 5.05 5.06 4.81 4.84 4.91 4.97 4.97 5.01 5.05 4.65 4.75 4.88 4.82 4.92 4.97 5.17 4.73 4.57 5.11 5.05 4.58 4.54 4.88 4.78
HP_NEONATAL_HYPERBILIRUBINEMIA 6.11 5.97 6.85 6.88 5.9 6.09 6.21 6.32 6.35 6.21 6.45 6.25 6.03 6.05 6.32 6.86 6.62 6.3 6.29 6.33 6.43 6.46 6.85 5.61 6.24 6.47
HP_ABDOMINAL_DISTENTION 5.54 5.35 5.32 5.63 5.07 4.93 5.2 5.15 5.24 5.23 5.43 5.04 5.17 5.18 5.12 5.36 5.36 5.44 5.13 5.05 5.29 5.14 5.24 4.93 5.17 5.16
HP_HIP_CONTRACTURE 6.17 6.05 6.2 6.16 6.22 6.1 6.21 6.4 6.13 6.27 6.27 6.5 6.3 6.34 6.22 6.08 6.24 6.54 6.27 6.46 6.25 6.6 6.48 6.28 6.8 6.67
HP_SPINA_BIFIDA_OCCULTA 6.95 6.9 7.1 7.04 7.15 7.16 7.08 7.18 6.7 6.89 6.92 6.62 7.23 7.16 7.15 6.93 6.81 6.88 6.85 6.96 6.94 7.08 7.07 7.14 7.07 7.38
HP_OVOID_VERTEBRAL_BODIES 6.52 6.32 6.05 6.25 6.46 6.73 6.54 6.25 6.2 6.32 6 6.61 6.58 6.5 6.29 6.25 6.29 6.23 6.37 6.63 6.19 6.15 6.24 6.54 6.53 6.45
HP_IRREGULAR_VERTEBRAL_ENDPLATES 5.69 5.8 6 5.83 5.58 5.71 5.97 6.05 6.02 6.04 5.75 5.9 5.81 5.92 5.63 5.64 6.02 5.83 5.9 5.98 5.83 5.88 5.95 5.96 6.13 5.99
HP_SPONDYLOLISTHESIS 6.56 6.37 6.33 6.35 6.95 6.45 6.34 6.53 6.47 6.67 6.06 6.55 6.49 6.2 6.51 6.5 6.71 6.28 6.3 6.51 6.44 6.66 6.16 6.51 6.78 7.07
HP_SPINAL_RIGIDITY 6.28 6.38 6.35 6.17 6.39 6.47 6.32 6.28 6.53 6.53 6.39 6.5 6.4 6.18 6.29 6.35 6.69 6.34 6.33 6.23 6.14 6.18 6.81 6.61 6.58 6.48
HP_HYPERLORDOSIS 6.47 6.37 6.39 6.43 6.59 6.58 6.45 6.46 6.47 6.54 6.37 6.54 6.5 6.52 6.45 6.46 6.49 6.38 6.47 6.49 6.27 6.38 6.53 6.6 6.59 6.62
HP_ABNORMALITY_OF_THE_ODONTOID_PROCESS 6.34 6.26 6.52 6.56 6.64 6.68 6.47 6.88 6.54 6.73 6.32 6.72 6.78 6.48 6.46 6.59 6.27 6.42 6.5 6.46 6.33 6.47 6.82 6.78 6.38 6.41
HP_HYPOPLASIA_OF_THE_ODONTOID_PROCESS 6.45 6.43 6.62 6.62 6.73 6.8 6.58 6.94 6.61 6.73 6.41 6.78 6.8 6.6 6.49 6.66 6.41 6.43 6.59 6.54 6.56 6.64 6.84 6.84 6.4 6.54
HP_ABNORMAL_FORM_OF_THE_VERTEBRAL_BODIES 6.46 6.44 6.64 6.58 6.58 6.66 6.6 6.69 6.54 6.63 6.44 6.62 6.64 6.56 6.54 6.54 6.53 6.47 6.52 6.56 6.6 6.66 6.7 6.72 6.69 6.71
HP_BUTTERFLY_VERTEBRAE 6.96 6.94 6.67 6.38 6.48 6.66 6.52 6.47 6.61 6.17 6.87 6.23 6.95 6.82 6.91 6.64 6.97 6.78 6.66 6.46 7.12 6.89 6.39 6.75 7.05 6.69
HP_ABNORMALITY_OF_THE_CERVICAL_SPINE 6.69 6.65 6.96 6.78 6.89 6.95 6.93 6.96 6.91 6.98 6.8 6.87 6.97 6.85 6.93 6.86 6.83 6.76 6.88 6.98 6.82 6.86 7.02 7.04 6.95 6.97
HP_PROGRESSIVE_MUSCLE_WEAKNESS 6.51 6.64 6.84 6.57 6.69 6.61 6.73 6.8 6.86 6.66 6.68 6.58 6.76 6.72 6.61 6.83 6.85 6.82 6.63 6.68 6.68 6.83 6.8 6.69 6.7 6.72
HP_GENERALIZED_MUSCLE_WEAKNESS 6.63 6.86 6.81 6.67 6.97 6.99 7 6.87 6.96 6.98 6.58 7.1 6.87 6.9 6.94 6.69 6.91 6.79 6.92 6.85 6.7 6.99 6.99 6.88 7.1 7.01
HP_LIMB_GIRDLE_MUSCLE_WEAKNESS 6.54 6.32 6.38 6.46 6.76 6.6 6.86 6.64 6.79 6.84 6.42 7.1 6.71 6.67 6.65 6.51 6.67 6.62 6.61 6.66 6.39 6.53 6.8 6.73 6.65 6.81
HP_MYALGIA 6.35 6.29 6.33 6.32 6.41 6.38 6.28 6.27 6.51 6.33 6.26 6.34 6.34 6.18 6.33 6.28 6.23 6.23 6.3 6.38 6.2 6.18 6.38 6.42 6.36 6.37
HP_AXIAL_MUSCLE_WEAKNESS 5.98 5.84 6.18 5.8 6.22 5.99 6 6.02 5.97 6.02 6.05 5.87 5.84 5.83 5.98 6.09 5.94 6.13 5.79 5.89 6.06 5.83 6.13 5.53 6.02 6.11
HP_ABNORMAL_HAIR_LABORATORY_EXAMINATION 6.09 6.05 6.23 6.11 6.22 5.88 5.72 6.02 5.59 5.81 6.1 5.9 6.03 5.81 5.9 6.41 6.18 5.84 6.27 6.24 6.03 5.94 6.26 5.94 5.76 5.98
HP_ABNORMAL_BONE_STRUCTURE 6.3 6.29 6.35 6.34 6.37 6.37 6.28 6.37 6.3 6.32 6.25 6.27 6.32 6.35 6.25 6.26 6.21 6.26 6.32 6.27 6.26 6.31 6.32 6.4 6.3 6.44
HP_ABNORMAL_ENCHONDRAL_OSSIFICATION 6.54 6.41 6.68 6.54 6.61 6.65 6.47 6.48 6.53 6.63 6.52 6.53 6.62 6.67 6.46 6.71 6.53 6.48 6.51 6.55 6.51 6.55 6.55 6.53 6.66 6.65
HP_AMINOACIDURIA 6.35 6.24 6.52 6.63 6.5 6.58 6.43 6.43 6.3 6.32 6.33 6.38 6.41 6.61 6.2 6.33 6.2 6.25 6.46 6.56 6.22 6.39 6.18 6.33 6.2 6.44
HP_ABNORMAL_FEMORAL_NECK_HEAD_MORPHOLOGY 6.46 6.41 6.46 6.43 6.68 6.64 6.51 6.56 6.52 6.66 6.55 6.65 6.61 6.57 6.46 6.58 6.57 6.46 6.55 6.42 6.26 6.52 6.79 6.75 6.61 6.7
HP_ABNORMAL_FEMORAL_HEAD_MORPHOLOGY 6.18 6.16 6.09 6.21 6.47 6.34 6.37 6.25 6.33 6.53 6.24 6.28 6.36 6.23 6.24 6.22 6.16 6.06 6.26 6.13 6.11 6.15 6.35 6.54 6.36 6.39
HP_FLAT_CAPITAL_FEMORAL_EPIPHYSIS 5.92 6.17 5.62 6.12 5.38 6.03 5.76 6.09 6.04 5.82 5.76 5.58 5.88 6.15 5.93 5.61 5.33 5.4 5.73 5.77 5.93 5.45 5.73 6.04 6.71 6.62
HP_STEPPAGE_GAIT 7.11 7.45 7.44 7.22 8.06 7.73 7.35 7.19 7.82 7.88 7.27 7.49 7.93 8.15 7.65 7.68 7.51 7.24 7.63 7.71 7.33 7.43 7.79 7.88 7.6 7.3
HP_DECREASED_NUMBER_OF_PERIPHERAL_MYELINATED_NERVE_FIBERS 7.43 7.45 7.95 7.31 8.03 7.97 7.71 7.84 7.95 7.99 7.7 7.87 8.03 7.87 7.76 7.71 7.96 7.45 7.6 7.78 7.66 7.76 8.07 8.33 8.03 7.86
HP_ONION_BULB_FORMATION 7.62 7.67 7.99 7.46 8.44 8.05 8.15 8.14 8.3 8.27 7.74 8.3 8.38 8.18 8.04 8.24 7.95 7.67 8.02 8.26 7.81 8 8.23 8.61 8.1 8.08
HP_DECREASED_NUMBER_OF_LARGE_PERIPHERAL_MYELINATED_NERVE_FIBERS 7.8 7.16 6.81 7.08 7.8 8.14 7.51 7.33 7.22 7.95 7.1 8.07 7.27 7.55 7.26 6.83 7.96 7.26 7.3 7.6 7.07 6.83 7.53 7.75 7.3 7.33
HP_EASY_FATIGABILITY 6.54 6.56 6.6 6.46 6.58 6.68 6.4 6.57 6.82 6.75 6.6 7.01 6.78 6.74 6.65 6.44 6.6 6.54 6.67 6.84 6.61 6.64 6.61 6.75 6.98 6.8
HP_SENSORY_AXONAL_NEUROPATHY 7.5 8.23 8.21 8.02 7.81 7.97 8.18 8.19 7.97 8.02 7.95 7.93 8.15 8.12 8.2 8.17 7.9 7.84 7.99 7.75 8.03 7.94 8.23 8.57 8.35 8.03
HP_GOWERS_SIGN 6.74 6.57 6.98 6.79 6.63 6.94 6.44 6.57 6.94 6.82 6.81 7.1 7.03 6.74 7.04 6.61 6.74 6.84 6.88 6.84 6.63 6.77 7 6.77 6.86 7.02
HP_MUSCLE_SPASM 7.34 7.44 7.65 7.7 7.58 7.71 7.54 7.34 7.58 7.56 7.72 7.55 7.53 7.67 7.67 7.64 7.33 7.17 7.66 7.66 7.3 7.56 7.62 7.9 7.58 7.51
HP_SYRINGOMYELIA 7.08 7.07 7.39 6.57 7.36 7.35 7.67 7.53 7.44 7.31 7.3 7.46 7.57 7.58 7.44 7.37 7.34 7.31 7.36 7.61 7.27 7.58 7.88 7.71 7.48 7.68
HP_ABNORMAL_SYNAPTIC_TRANSMISSION_AT_THE_NEUROMUSCULAR_JUNCTION 6.6 6.86 6.62 6.68 6.81 6.68 6.86 6.49 6.72 6.87 6.5 6.68 6.57 6.61 6.65 6.47 6.58 6.56 6.78 6.51 6.61 6.64 6.69 6.64 6.87 6.62
HP_PARESTHESIA 6.59 6.73 6.71 6.59 6.85 6.96 7.08 6.86 7.08 7.02 6.61 6.84 6.95 6.96 6.88 7.02 6.54 6.61 6.96 6.98 6.78 6.72 7.19 7.05 6.79 6.77
HP_DECREASED_MINIATURE_ENDPLATE_POTENTIALS 5.29 5 4.9 5.1 4.74 4.63 4.98 4.94 4.89 4.62 4.98 4.72 4.8 4.75 4.78 4.76 4.8 4.97 5.09 4.87 5.06 4.77 4.77 4.58 4.63 4.7
HP_EMG_DECREMENTAL_RESPONSE_OF_COMPOUND_MUSCLE_ACTION_POTENTIAL_TO_REPETITIVE_NERVE_STIMULATION 5.82 5.55 5.35 5.87 5.65 5.89 5.97 5.8 5.52 5.6 5.87 5.76 5.85 5.72 5.85 5.69 5.62 5.74 5.59 5.33 5.61 5.35 5.53 5.47 5.7 5.8
HP_DISTAL_SENSORY_IMPAIRMENT_OF_ALL_MODALITIES 7.82 8.33 8.29 8.37 8.27 8.45 8.76 8.31 9.05 8.63 8.2 8.52 8.59 8.66 8.5 8.29 8.11 7.84 8.36 8.68 7.86 7.84 8.89 9.01 8.61 7.96
HP_ATLANTOAXIAL_ABNORMALITY 6.61 6.3 5.98 6.32 6.41 6.18 6.32 6.37 6.45 6.1 6.02 6.27 6.53 6.53 6.09 6.3 6.13 6.05 6.16 6.25 6.2 6.26 6.32 6.49 6.55 6.36
HP_SPINAL_CANAL_STENOSIS 7.17 7.17 7.78 7.48 7.32 7.33 7.58 7.65 7.36 7.54 7.7 7.49 7.69 7.49 7.82 7.87 6.97 7.04 7.29 7.4 7.39 7.77 7.61 7.9 7.45 7.5
HP_CORONAL_CLEFT_VERTEBRAE 5.73 6.03 5.84 6 5.66 5.75 5.6 5.73 5.85 5.82 5.73 5.85 5.89 6.06 5.57 5.78 6.13 6.02 5.76 5.68 5.7 5.5 6.14 5.99 6.56 6.56
HP_BACK_PAIN 6.45 6.38 6.67 6.55 6.9 6.64 6.61 6.64 6.72 6.69 6.61 6.54 6.59 6.47 6.55 6.47 6.75 6.4 6.33 6.68 6.69 6.66 6.78 6.93 6.64 6.87
HP_VERTEBRAL_SEGMENTATION_DEFECT 6.18 6.3 6.27 6.18 6.11 6.28 6.47 6.42 6.32 6.34 6.36 6.29 6.38 6.39 6.48 6.26 6.46 6.45 6.36 6.46 6.52 6.44 6.37 6.53 6.5 6.43
HP_CNS_HYPOMYELINATION 7.49 7.53 8.1 7.89 7.6 7.68 7.68 7.64 7.74 7.64 7.62 7.55 7.66 7.58 7.53 7.52 7.66 7.33 7.46 7.67 7.51 7.57 7.67 7.9 7.7 7.57
HP_DECREASED_SIZE_OF_NERVE_TERMINALS 5.64 5.18 5.08 5.92 5.32 4.96 5.41 5.11 5.26 5.01 5.39 4.78 5.14 5.19 5.08 5.01 5.05 5.45 5.27 5 5.14 5 4.98 4.72 5 4.78
HP_EMG_CHRONIC_DENERVATION_SIGNS 8.77 8.78 8.44 8.21 9.04 9.11 9.05 8.53 9.2 9.28 8.93 8.92 9.14 9.22 8.76 8.56 8.73 8.54 9.21 9.08 8.05 8.14 9.15 9.47 8.54 8.23
HP_EMG_NEUROPATHIC_CHANGES 7.3 7.37 7.95 8.13 7.84 7.75 7.76 8.14 7.74 8.2 7.7 7.89 7.92 7.75 7.77 8.12 7.94 7.45 7.75 8.18 7.57 7.99 7.94 8.21 8.18 7.74
HP_AXONAL_LOSS 7.24 7.75 7.87 7.58 7.76 7.62 7.55 7.83 7.87 7.51 7.07 7.39 7.93 7.83 7.49 7.48 7.53 7.25 7.16 7.96 7.71 7.74 7.44 7.75 7.79 7.77
HP_ANTINEUTROPHIL_ANTIBODY_POSITIVITY 6.41 6.46 6.29 6.33 6.27 6.6 6.43 6.09 6.66 6.41 6.54 6.32 6.35 6.36 6.43 6.16 6.24 6.48 6.51 6.25 5.94 6.16 6.5 6.2 6.42 6.27
HP_EMG_ABNORMALITY 6.44 6.42 6.42 6.51 6.63 6.64 6.51 6.48 6.49 6.72 6.53 6.66 6.6 6.52 6.59 6.43 6.61 6.52 6.51 6.58 6.53 6.45 6.79 6.66 6.71 6.67
HP_EMG_MYOPATHIC_ABNORMALITIES 6.38 6.29 6.29 6.29 6.39 6.41 6.29 6.28 6.47 6.5 6.42 6.45 6.51 6.42 6.36 6.28 6.39 6.37 6.29 6.37 6.38 6.3 6.46 6.45 6.55 6.38
HP_ABNORMAL_VERTEBRAL_MORPHOLOGY 6.24 6.29 6.39 6.35 6.4 6.47 6.42 6.41 6.32 6.4 6.28 6.39 6.44 6.41 6.42 6.3 6.36 6.32 6.29 6.37 6.38 6.44 6.31 6.51 6.48 6.48
HP_PARALYSIS 7.33 7.27 7.49 7.64 7.51 7.51 7.42 7.48 7.47 7.57 7.36 7.27 7.59 7.53 7.47 7.43 7.38 7.13 7.36 7.75 7.33 7.68 7.51 7.73 7.47 7.51
HP_SENSORY_IMPAIRMENT 7.32 7.37 7.71 7.33 7.75 7.72 7.62 7.53 7.68 7.81 7.47 7.64 7.68 7.79 7.67 7.66 7.56 7.32 7.59 7.68 7.51 7.64 7.84 7.96 7.72 7.63
HP_PERIPHERAL_AXONAL_NEUROPATHY 7.15 7.23 7.3 7.2 7.37 7.34 7.29 7.22 7.34 7.43 7.18 7.37 7.41 7.45 7.35 7.22 7.08 7.25 7.14 7.33 7.16 7.2 7.54 7.53 7.4 7.3
HP_SEGMENTAL_PERIPHERAL_DEMYELINATION_REMYELINATION 7.9 8.42 8.21 8.28 8.89 9.1 8.6 8.52 8.71 8.75 8.13 8.65 8.88 8.72 8.55 8.31 8.71 8.38 8.46 8.67 8.64 8.64 8.79 8.83 8.57 8.59
HP_UPPER_LIMB_MUSCLE_WEAKNESS 6.37 6.36 6.49 6.38 6.68 6.6 6.61 6.52 6.72 6.75 6.41 6.63 6.59 6.58 6.53 6.49 6.53 6.46 6.45 6.69 6.28 6.46 6.49 6.86 6.55 6.6
HP_BABINSKI_SIGN 7.6 7.76 8.02 7.77 7.99 8.05 8.16 8.05 8.1 8.06 7.8 8.07 8.06 8.07 8.11 8.04 7.84 7.49 7.8 8.12 7.66 7.96 8.23 8.34 8.05 7.81
HP_ANTINUCLEAR_ANTIBODY_POSITIVITY 5.34 5.09 5.13 5.01 4.81 4.74 4.66 4.86 4.78 4.83 4.9 4.57 4.75 4.75 4.77 5.03 4.98 5.05 4.74 4.59 5.17 5.02 4.54 4.54 4.84 4.81
HP_INCREASED_CIRCULATING_IGM_LEVEL 5.37 5.02 5.19 5.26 4.81 4.76 5.05 4.97 4.91 5.01 5.21 4.83 4.96 4.92 4.82 5.02 4.97 5.32 4.77 4.59 5.11 5.05 4.69 4.54 4.88 4.83
HP_DISPROPORTIONATE_SHORT_STATURE 6.39 6.28 6.45 6.57 6.52 6.5 6.54 6.57 6.25 6.63 6.54 6.71 6.57 6.54 6.45 6.57 6.53 6.6 6.43 6.57 6.37 6.66 6.44 6.55 6.51 6.72
HP_MILD_SHORT_STATURE 6.5 6.43 6.36 6.57 6.97 6.83 6.31 6.46 6.6 6.68 6.26 6.59 6.56 6.66 6.39 6.4 6.16 6.17 6.49 6.59 6.16 6.15 6.61 6.74 6.4 6.57
HP_PROPORTIONATE_SHORT_STATURE 6.49 6.43 6.55 6.66 6.55 6.72 6.51 6.61 6.53 6.65 6.55 6.55 6.61 6.57 6.48 6.57 6.53 6.52 6.43 6.48 6.28 6.55 6.48 6.61 6.57 6.65
HP_SEVERE_SHORT_STATURE 6.38 6.37 6.54 6.47 6.52 6.56 6.51 6.64 6.55 6.63 6.54 6.54 6.51 6.48 6.47 6.6 6.5 6.32 6.3 6.44 6.29 6.55 6.49 6.63 6.61 6.67
HP_DISPROPORTIONATE_SHORT_TRUNK_SHORT_STATURE 6.03 5.89 5.96 5.86 6.41 6.23 6.16 6.03 6.1 6.27 5.62 6.34 6.27 6.06 5.92 5.92 5.87 5.65 6.17 6.34 5.78 5.66 6.12 6.52 6.04 6.12
HP_ELEVATED_CALCITONIN 8.77 7.9 9.1 8.65 8.5 8.76 9.09 8.28 8.43 8.66 8.47 8.36 8.73 8.47 8.61 8.1 8.8 8.1 8.35 8.78 7.58 8.29 8.62 8.08 8.52 7.9
HP_3_METHYLGLUTACONIC_ACIDURIA 6.32 6.43 7.4 6.95 6.74 6.52 6.36 6.6 6.54 6.91 6.76 6.65 6.56 6.44 6.89 6.85 6.42 6.71 6.58 6.84 6.63 6.97 6.97 6.97 6.56 6.84
HP_HYPOURICEMIA 6.1 5.91 5.48 5.94 5.53 5.47 5.63 5.48 5.81 5.63 5.78 5.28 5.74 5.58 5.35 5.3 5.85 5.83 5.62 5.64 5.54 5.56 5.42 5.48 5.51 5.65
HP_URINARY_GLYCOSAMINOGLYCAN_EXCRETION 6.49 6.29 6.4 6.81 6.77 6.88 6.96 6.86 6.56 6.73 6.38 6.68 6.51 6.41 6.59 6.6 6.3 6.44 6.46 6.7 6.27 6.28 6.79 6.82 6.74 6.49
HP_INCREASED_SERUM_PYRUVATE 7.27 7.39 8.49 8.02 7.6 7.51 7.54 7.6 7.93 7.9 8.04 8.22 8.05 7.73 7.95 7.79 8.06 7.92 7.84 7.92 7.9 8.16 7.88 7.88 7.91 7.96
HP_EXERCISE_INTOLERANCE 6.58 6.82 6.7 6.83 6.78 6.96 6.44 6.56 6.83 6.61 6.5 6.83 6.78 6.69 6.57 6.63 6.8 6.73 6.78 6.68 6.71 6.73 6.91 6.8 6.83 6.85
HP_SHOULDER_GIRDLE_MUSCLE_WEAKNESS 6.26 5.97 6.21 6.04 6.22 6.08 6.09 6.19 6.05 6.22 6.05 6.19 6.01 6 6.34 6.25 6.06 6.42 6.04 6.23 6.27 6.24 6.01 6.1 6.18 6.46
HP_DIFFICULTY_CLIMBING_STAIRS 6.69 6.43 6.48 6.35 6.91 6.8 6.43 6.44 6.88 6.93 6.55 6.98 6.67 6.74 6.68 6.59 6.83 6.47 6.65 6.6 6.43 6.36 7 6.73 6.63 6.73
HP_MUSCLE_STIFFNESS 7.07 7.28 7.74 7.64 7.59 7.86 7.64 7.65 7.81 7.6 7.34 7.78 7.65 7.78 7.53 7.5 7.57 7.08 7.62 7.65 7.41 7.27 8.08 8.09 7.87 7.67
HP_TYPE_2_MUSCLE_FIBER_ATROPHY 6.39 6.56 6.22 6.22 6.26 6.17 6.63 6.6 5.67 5.93 6.19 5.96 5.87 5.72 6.34 5.91 6.13 6.43 5.77 6.82 6.02 6.32 5.86 5.77 6.01 6.13
HP_MUSCLE_FIBER_SPLITTING 6.42 6.24 6.12 6 6.44 5.8 6.22 6.34 6.23 6.32 6.09 6.2 5.96 5.89 6.08 6.28 6.21 6.12 6.08 6.01 6.13 5.69 6.1 5.72 6.22 6.41
HP_MUSCULAR_DYSTROPHY 6.33 6.47 6.61 6.57 6.59 6.7 6.53 6.36 6.52 6.86 6.53 6.66 6.53 6.4 6.65 6.51 6.56 6.39 6.42 6.44 6.34 6.5 6.86 6.71 6.66 6.74
HP_BIRTH_LENGTH_LESS_THAN_3RD_PERCENTILE 6.44 6.64 6.34 6.22 7.32 7.08 6.33 7.06 6.38 7.04 6.75 6.85 6.65 6.68 6.49 6.83 6.66 6.96 6.88 7.02 6.28 6.4 6.51 6.3 6.09 6.05
HP_DECREASED_LDL_CHOLESTEROL_CONCENTRATION 5.8 5.44 5.65 6.23 5.9 5.49 5.34 5.51 5.95 5.89 5.67 6.07 5.52 5.63 5.68 5.65 6 5.87 5.75 5.59 5.69 5.87 5.78 5.63 5.46 5.66
HP_INCREASED_TOTAL_BILIRUBIN 5.75 5.88 5.81 6.2 6.04 5.72 5.96 5.68 5.71 5.72 5.93 6.04 5.9 5.97 5.92 5.77 5.97 6 5.62 5.88 6.11 6.18 5.77 5.79 5.74 6.01
HP_CONGENITAL_ONSET 6.62 6.73 6.84 6.88 6.82 6.93 6.9 6.74 6.84 6.86 6.81 6.84 6.9 6.89 6.64 6.94 6.74 6.72 6.89 6.86 6.61 6.93 6.85 7.01 6.8 6.76
HP_ADULT_ONSET 7.15 7.11 7.18 7.02 7.31 7.32 7.24 7.23 7.13 7.31 7.18 7.33 7.35 7.19 7.26 7.21 7.22 7.09 7.16 7.38 7.06 7.22 7.37 7.43 7.36 7.22
HP_LATE_ONSET 5.79 5.55 5.6 5.67 5.5 4.98 5.68 5.27 5.68 5.37 5.64 5.4 5.24 5.43 5.55 5.45 5.55 5.56 5.17 5.26 5.5 5.26 5.33 5.21 5.52 5.14
HP_INSIDIOUS_ONSET 8.23 8.15 8.93 8.33 8.9 8.72 8.43 8.78 8.66 8.76 8.49 8.56 8.82 8.57 8.74 8.53 8.31 8.03 8.37 8.61 8.09 8.42 8.67 8.79 8.85 8.47
HP_INFANTILE_ONSET 6.9 6.92 7.24 7.11 7.14 7.2 7.24 7.2 7.09 7.03 7.1 7 7.13 7.13 7.22 7.21 6.94 6.93 7.04 7.22 6.92 7.08 7.09 7.26 7.19 7.05
HP_ANTIPHOSPHOLIPID_ANTIBODY_POSITIVITY 5.89 5.65 5.68 6.02 5.66 5.56 5.59 5.68 6.04 5.75 5.71 5.26 5.29 5.65 5.68 5.74 5.8 5.89 5.85 5.56 5.7 5.99 5.82 5.22 5.87 5.76
HP_JUVENILE_ONSET 6.57 6.69 6.87 6.85 7.05 6.93 6.9 6.82 7.07 6.94 6.62 6.71 7.02 6.72 6.72 6.86 7 6.69 7.1 6.97 6.56 6.84 6.92 7.11 7 6.82
HP_NEONATAL_ONSET 5.96 5.96 6.34 6 5.65 5.9 5.96 5.74 6.01 6.16 5.9 6.02 6.12 6.11 6.16 6.01 5.87 5.96 6.19 6.11 5.95 5.89 6.37 6.09 5.91 6.1
HP_TYPE_I_TRANSFERRIN_ISOFORM_PROFILE 7.41 7.58 8.06 7.75 7.81 8 8 8.01 7.91 7.8 7.56 7.84 7.99 8 7.77 7.65 7.56 7.56 7.84 8.25 7.6 8.05 7.93 8.18 7.85 7.91
HP_PROLONGED_PARTIAL_THROMBOPLASTIN_TIME 5.84 5.54 5.9 5.33 5.56 5.38 5.51 5.33 5.4 5.25 5.68 5.45 5.67 5.45 5.42 5.21 5.5 5.75 5.6 5.34 5.79 5.63 5.61 5.23 5.68 5.79
HP_ONSET 6.75 6.74 6.99 6.92 7.03 7.04 6.98 6.96 6.98 6.98 6.91 6.96 6.97 6.94 6.87 6.96 6.87 6.81 6.96 6.99 6.73 6.97 6.93 7.08 6.95 6.87
HP_PROGRESSIVE 7.32 7.37 7.54 7.6 7.58 7.66 7.56 7.61 7.61 7.71 7.38 7.65 7.63 7.57 7.52 7.54 7.5 7.33 7.42 7.65 7.47 7.66 7.64 7.73 7.61 7.54
HP_SLOW_PROGRESSION 7.24 7.27 7.42 7.51 7.44 7.44 7.45 7.49 7.64 7.68 7.38 7.53 7.65 7.71 7.69 7.61 7.53 7.2 7.48 7.55 7.28 7.54 7.72 7.73 7.63 7.49
HP_RAPIDLY_PROGRESSIVE 6.84 7.12 7.39 7.22 6.96 7.2 7 6.92 7.18 7.41 6.82 7.4 7.29 7.39 7.06 7.2 6.97 6.78 6.85 7.16 7.02 7.01 7.36 7.28 7.28 7.22
HP_PACE_OF_PROGRESSION 7.28 7.32 7.56 7.51 7.5 7.58 7.54 7.53 7.59 7.67 7.38 7.58 7.62 7.57 7.52 7.53 7.43 7.29 7.42 7.63 7.39 7.58 7.64 7.69 7.59 7.49
HP_NONPROGRESSIVE 6.65 6.37 7.11 6.42 6.74 6.78 6.45 6.89 6.87 6.66 5.82 6.41 6 6.04 6.55 6.44 6.35 6.19 6.46 6.56 6.72 6.51 6.73 6.63 6.47 6.63
HP_LARGE_BEAKED_NOSE 6.58 6.59 7.12 7.41 7.03 7.02 7 7.06 6.96 6.89 6.61 6.73 7.06 7.09 7.04 6.66 6.74 6.82 6.82 7.13 6.63 6.79 7.1 7.63 6.7 6.63
HP_CENTRALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS 6.55 6.71 6.53 6.66 6.65 6.93 6.44 6.57 6.6 6.75 6.78 6.66 6.78 6.74 6.39 7.03 6.74 6.84 6.67 6.58 6.53 6.64 6.91 6.63 7.27 7.02
HP_CYTOCHROME_C_OXIDASE_NEGATIVE_MUSCLE_FIBERS 6.12 6.49 6.64 6.56 6.56 6.42 6.35 6.67 6.7 6.45 6.47 6.01 6.2 6.39 6.5 6.74 6.5 6.65 6.25 6.4 6.65 6.48 6.25 6.47 6.4 6.29
HP_LIMB_MUSCLE_WEAKNESS 6.96 7.15 7.23 7 7.19 7.31 7.27 7.27 7.28 7.34 7.02 7.37 7.16 7.15 7.26 7.12 7.14 6.88 7.17 7.38 7.07 7.01 7.38 7.38 7.33 7.28
HP_SCAPULAR_WINGING 6.39 6.37 6.42 6.33 6.39 6.52 6.38 6.43 6.41 6.54 6.35 6.56 6.4 6.45 6.39 6.44 6.74 6.39 6.53 6.46 6.48 6.43 6.48 6.63 6.55 6.71
HP_DISTAL_AMYOTROPHY 7.43 7.42 7.79 7.4 7.9 7.95 7.7 7.93 7.79 8 7.62 7.87 7.92 7.88 7.76 7.72 7.75 7.43 7.66 7.98 7.66 7.78 7.98 8.07 7.81 7.74
HP_DIFFICULTY_STANDING 6.35 6.32 6.52 7.26 6.14 6.22 6.27 6.34 6.24 6.35 6.37 6.59 6.6 6.4 6.17 6.11 6.37 6.39 6.46 5.96 5.99 6.4 5.8 6.28 6.32 6.35
HP_GENERALIZED_AMYOTROPHY 6.44 6.56 6.61 6.57 6.64 6.73 6.35 6.38 6.61 6.68 6.46 6.61 6.61 6.55 6.64 6.42 6.69 6.55 6.64 6.49 6.23 6.44 6.77 6.74 6.67 6.57
HP_PROXIMAL_MUSCLE_WEAKNESS 6.8 6.9 6.88 6.73 6.98 6.97 7.08 6.91 7 7.06 6.75 7.11 7.03 6.93 7.01 6.78 7.09 6.83 7.07 7.09 6.74 6.78 6.99 6.92 7 6.89
HP_CALF_MUSCLE_PSEUDOHYPERTROPHY 6.05 6.13 6.9 6.68 6.6 6.67 6.07 6.09 6.94 6.98 6.53 7.09 5.93 6.04 7.04 6.43 5.93 6.24 6.41 6.33 6.05 6 6.99 6.61 5.87 6.15
HP_EXERCISE_INDUCED_MUSCLE_CRAMPS 7.51 7.37 7.26 8.17 8.32 8.32 8.22 7.47 8.6 7.2 8.03 8.52 8.52 8.61 7.3 8.02 8.24 7.21 7.72 7.67 7.09 7.26 8.52 8.56 7.92 7.61
HP_SKELETAL_MUSCLE_HYPERTROPHY 6.38 6.56 6.62 6.61 6.71 6.67 6.66 6.61 6.63 6.8 6.47 6.7 6.68 6.54 6.66 6.48 6.65 6.37 6.57 6.62 6.66 6.59 6.75 6.74 6.73 6.71
HP_MYOFIBRILLAR_MYOPATHY 7.37 7.1 7.63 7.63 7.12 7.36 7.53 7.62 7.59 7.42 7.52 7.76 7.84 7.87 7.3 7.2 7.85 7.04 7.2 7.93 7.51 7.24 7.38 7.16 7.81 7.91
HP_NECK_FLEXOR_WEAKNESS 6.29 6.05 6.2 6.11 6.38 5.94 6.09 5.8 6.04 6.06 6.03 6.16 5.91 5.85 5.85 5.96 5.93 6.11 5.96 6.28 6.04 5.83 6.31 5.76 6.15 6.13
HP_SHOULDER_GIRDLE_MUSCLE_ATROPHY 7.12 7.12 6.97 6.6 6.65 6.98 6.32 6.43 6.82 6.43 6.97 6.5 6.78 6.74 6.86 6.71 6.2 6.84 6.75 6.68 6.29 6.25 7.47 6.28 6.75 6.71
HP_MITOCHONDRIAL_MYOPATHY 7.17 7.27 8.36 7.82 7.36 7.47 7.39 7.51 7.85 7.69 7.99 7.48 7.52 7.48 7.6 7.66 7.28 7.54 7.81 7.71 7.63 7.72 7.64 7.67 7.66 7.47
HP_EXERCISE_INDUCED_MYALGIA 6.57 6.7 6.72 7.08 7.02 6.91 6.81 6.71 7.03 7.11 6.69 6.95 7.12 7.24 6.65 6.68 6.97 6.65 6.92 7.25 6.61 6.71 7.34 7.28 6.84 6.86
HP_MYOCLONIC_SPASMS 7.35 7.75 6.97 7.94 7.8 7.74 7.86 7.29 7.71 7.83 7.66 7.57 7.84 7.88 7.54 7.26 7.6 7.45 7.38 7.65 7.41 7.45 8.16 8.24 7.63 7.66
HP_CONGENITAL_MUSCULAR_DYSTROPHY 6.26 6.05 5.98 5.95 5.72 5.81 5.87 6.07 5.95 5.82 6.07 6.17 5.86 5.77 5.89 5.68 5.73 5.47 6.24 6.06 6.14 5.97 6.54 5.94 5.95 6.37
HP_GENETIC_ANTICIPATION 8.55 8.72 8.04 8.42 8.97 9.07 8.99 9.38 8.82 9.03 8.64 9.05 9.2 9.17 9.15 8.91 9.3 9.35 9.29 9.45 8.97 9.12 8.83 9.03 9.1 9.07
HP_SPORADIC 7.4 7.29 7.38 7.52 7.92 7.91 7.52 7.47 7.58 7.86 7.52 7.76 7.87 7.7 7.67 7.73 7.86 7.33 7.7 7.73 7.17 7.55 7.88 7.71 7.83 7.53
HP_PELVIC_GIRDLE_MUSCLE_WEAKNESS 6.49 6.12 6.21 6.28 6.31 6.49 6.11 6.2 6.05 6.31 6.15 6.36 6.01 6.42 6.41 6.24 6.31 6.44 6.02 6.32 6.27 6.17 6.39 6.17 6.33 6.43
HP_INCREASED_MUSCLE_FATIGUABILITY 5.57 5.48 5.35 6.14 5.12 4.82 5.7 5.37 5.51 5.34 5.58 5.28 5.4 5.03 5.25 5.16 5.7 5.73 4.9 4.87 5.46 5.3 5.16 4.93 4.97 5.22
HP_REDUCED_SUBCUTANEOUS_ADIPOSE_TISSUE 6.04 6.37 6.1 6.68 6.68 6.66 6.18 6.04 6.18 6.53 5.99 6.54 6.4 5.83 5.91 6.22 5.92 6.22 6.32 6.07 6.2 6.08 6.12 6.21 6.42 6.39
HP_CALCINOSIS 6.04 6.05 5.75 6.34 5.38 5.43 5.94 6.04 5.73 5.62 5.96 5.99 5.87 5.5 5.73 5.75 6.03 5.67 5.68 5.59 6.09 5.94 5.63 5.52 5.79 5.51
HP_BRUXISM 8.57 8.99 8.08 8.27 9.02 8.89 9.27 9.3 8.97 9.22 8.64 8.93 8.84 8.89 9.51 9.48 8.45 8.58 9.1 8.86 9.27 8.72 8.89 9.28 9.34 9.08
HP_NEVUS 6.56 6.69 6.83 6.82 6.71 6.96 6.71 6.83 6.69 6.8 6.69 6.68 6.8 6.77 6.81 6.67 6.77 6.59 6.73 6.73 6.73 6.84 6.8 6.98 6.72 6.82
HP_PSORIASIFORM_DERMATITIS 5.36 5.19 5.21 5.35 5.17 5.02 5.6 5.38 5.37 5.2 5.63 4.97 5.12 5.34 5.41 5.23 5.36 5.41 5.11 5.22 5.38 5.24 5.15 4.99 5.15 5.29
HP_PERIODIC_PARALYSIS 5.47 5.65 5.8 6.16 5.59 5.44 5.82 5.82 5.87 6.16 6.35 5.93 5.86 5.83 5.92 5.99 5.66 5.99 5.73 5.77 6.16 6.28 5.67 5.85 6.04 6.32
HP_STAGE_5_CHRONIC_KIDNEY_DISEASE 6.48 6.45 5.95 6.07 6.23 6.27 6.09 6.14 5.92 6.2 6.13 6.34 5.91 5.93 6 6.1 6.12 6.41 6.35 5.97 6.13 6.04 6.06 6.09 5.96 6.06
HP_PILI_TORTI 6 6.22 6.31 6.62 6.6 6.19 5.95 6.02 5.9 6.11 6.24 6.11 6.06 6.04 5.96 6.43 6.34 5.94 6.33 6.25 6.05 5.93 6.3 6.01 5.93 5.83
HP_EXCESSIVE_SALIVATION 7.16 7.22 7.71 7.44 7.53 7.66 7.77 7.83 7.82 7.64 7.4 7.53 7.74 7.76 7.67 7.69 7.17 7.33 7.59 7.9 7.5 7.67 7.92 8.18 7.87 7.5
HP_EUNUCHOID_HABITUS 5.21 5.09 5.4 5.03 4.89 4.63 5.01 5.37 5.12 4.97 5.42 4.94 5.15 4.88 5.71 5.08 5.2 5.42 5.42 5.2 5.6 5.33 4.91 4.71 4.77 4.94
HP_LIMB_GIRDLE_MUSCLE_ATROPHY 7.03 7.3 6.94 6.68 7.01 7.01 6.97 6.78 6.97 6.99 6.91 7.05 6.95 6.9 7.17 6.87 6.75 6.81 6.99 7.01 6.5 6.52 7.1 7.08 6.92 6.99
HP_NEMALINE_BODIES 5.76 5.73 5.35 5.56 5.74 5.65 5.97 5.76 5.52 5.7 5.81 5.82 5.62 5.73 5.61 5.96 5.51 5.47 5.59 5.61 5.37 5.21 5.59 5.37 5.9 5.28
HP_MUSCLE_ABNORMALITY_RELATED_TO_MITOCHONDRIAL_DYSFUNCTION 6.81 7 8.14 7.63 7.01 7.4 7.13 7.36 7.17 7.59 7.57 7.19 7.32 7.4 7.11 7.41 7.07 7.07 7.3 7.34 7.27 7.55 7.24 7.39 7.3 7.32
HP_TYPE_1_MUSCLE_FIBER_PREDOMINANCE 6.21 5.8 6.2 6.1 6.23 6.02 6.06 5.99 5.96 6.04 6.05 5.91 5.94 5.93 6.02 6 5.85 6.02 5.77 6.03 6.23 6.16 6.13 5.8 6.01 6.13
HP_RIMMED_VACUOLES 7.94 7.78 7.63 7.68 7.56 7.6 7.63 8.09 7.68 7.74 7.71 8.02 7.87 7.9 7.7 7.74 7.75 7.72 7.76 8.04 7.86 7.81 7.71 7.73 8.12 8.1
HP_NEONATAL_DEATH 7.24 7.06 7.15 6.8 7.38 7.45 7.39 7.29 7.5 7.3 7.07 7.28 7.36 7.5 6.97 7.27 7.03 6.89 7.35 7.29 7.37 7.44 7.43 7.67 7.35 7.33
HP_PHENOTYPIC_VARIABILITY 6.79 6.83 7.01 7.01 7.06 7.05 7.18 7.04 6.94 7.14 6.92 7.15 7.1 7.03 7.12 7 7.06 6.85 6.96 7.1 6.91 6.99 6.99 7.13 7.21 7.09
HP_DEATH_IN_CHILDHOOD 7.12 7.36 8.03 7.69 7.55 7.75 7.96 7.41 8.01 7.76 7.72 7.49 7.56 7.78 7.41 7.46 7.49 7.43 7.44 7.55 7.24 7.25 7.79 8.01 7.35 7.3
HP_STILLBIRTH 5.88 5.81 5.97 6.29 6.01 5.77 5.84 5.74 5.63 5.93 6.29 6.15 5.72 5.95 5.55 5.8 6.18 6.1 6.05 5.95 5.92 5.94 5.69 5.55 6.27 6.22
HP_VARIABLE_EXPRESSIVITY 6.76 6.82 6.97 7.1 7.04 7.01 7.18 7.03 6.86 7.09 6.91 7.17 7.1 7.06 7.03 6.96 7.03 6.8 6.9 7.13 6.77 6.97 6.98 7.13 7.25 7.11
HP_INCOMPLETE_PENETRANCE 6.68 6.69 6.86 6.5 6.83 6.85 6.98 6.97 6.81 7.06 6.71 6.75 6.79 6.66 6.91 6.74 6.88 6.79 6.67 6.89 6.69 6.86 6.98 7.01 6.97 6.86
HP_SHOULDER_DISLOCATION 7.46 7.36 7.16 6.67 7.36 7.7 7.6 7.54 7.6 7.77 7.16 8.14 7.81 7.39 7.87 7.71 7.66 7.59 7.47 7.83 7.96 7.87 8 7.81 7.9 7.61
HP_ABNORMALITY_OF_UPPER_LIMB_EPIPHYSIS_MORPHOLOGY 6.53 6.55 6.65 6.51 6.78 7.05 6.61 6.58 6.45 6.73 6.63 6.84 6.62 6.67 6.46 6.75 6.58 6.54 6.95 6.67 6.6 6.93 6.73 6.72 6.38 6.62
HP_ABSENT_FOREARM_BONE 5.88 5.9 5.85 5.95 5.8 5.81 5.85 6.29 5.79 5.98 6.25 6.03 5.67 5.77 6.34 5.74 6.12 5.88 5.78 5.91 5.98 6.09 5.89 6.06 5.74 5.52
HP_ABNORMALITY_OF_THE_RADIAL_HEAD 6.3 6.39 6.55 6.62 6.65 6.37 6.42 6.37 6.27 6.5 6.57 6.27 6.58 6.59 6.48 6.6 6.6 6.29 6.44 6.27 6.37 6.26 6.32 6.53 6.46 6.48
HP_ABNORMALITY_OF_ULNAR_METAPHYSIS 4.9 4.75 4.82 5.24 4.52 4.58 4.94 4.7 4.87 4.89 4.93 4.75 4.76 4.8 5.18 4.69 4.79 5.08 4.87 4.76 4.86 4.88 4.65 4.84 4.73 4.5
HP_ABSENT_HAND 6.63 6.68 6.51 6.05 7.42 7.26 6.99 6.93 6.93 7.38 6.53 7.08 7.16 6.93 7.14 6.96 7.03 6.88 7.1 7.17 7.06 7.24 7.05 7.01 7.01 7.36
HP_ABNORMAL_2ND_FINGER_MORPHOLOGY 6.04 5.63 5.82 5.48 5.36 5.41 5.48 5.72 5.47 5.39 5.53 5.97 5.48 5.55 5.66 5.65 5.8 5.86 5.32 5.43 5.9 5.63 5.65 5.43 5.82 5.96
HP_MIDLINE_DEFECT_OF_THE_NOSE 5.62 5.22 5.8 5.26 4.98 4.98 5.3 5.26 5.53 4.76 5.66 5.1 4.96 5.36 5.52 5.3 5.28 5.26 5.2 4.95 5.63 5.61 4.95 5.09 5.46 5.39
HP_ABNORMAL_3RD_FINGER_MORPHOLOGY 6.17 6.06 5.61 5.61 5.92 5.95 6 5.8 6.04 5.64 5.83 5.96 5.74 5.88 5.88 5.78 6.08 6.07 5.63 5.93 5.88 5.93 5.71 5.76 5.75 5.91
HP_ABNORMAL_4TH_FINGER_MORPHOLOGY 5.5 5.1 5.51 5.31 5.42 5.02 5.31 5.27 5.37 5.35 5.29 5.48 5.57 5.52 5.69 5.31 5.61 5.32 5.14 5.08 5.24 5.56 5.24 5.45 5.46 5.52
HP_ABNORMAL_5TH_FINGER_MORPHOLOGY 6.64 6.74 6.93 6.93 6.92 6.97 6.79 6.91 6.89 6.91 6.83 6.8 6.91 6.86 6.87 6.92 6.65 6.66 6.89 6.96 6.76 6.93 7.01 7.04 6.91 6.95
HP_ABNORMAL_5TH_FINGER_PHALANX_MORPHOLOGY 6.34 6.44 6.44 6.43 6.92 6.61 7 7.26 6.82 6.85 7.27 6.96 6.81 6.69 7.1 7.1 6.84 6.56 6.79 6.83 7.22 6.99 7.04 7 6.73 7.37
HP_ABNORMALITY_OF_THE_MIDDLE_PHALANX_OF_THE_5TH_FINGER 5.61 5.96 5.8 5.56 5.55 5.6 6.35 6.16 5.79 5.97 5.74 5.58 5.99 6.15 6.55 6.59 6.02 5.6 5.77 5.88 5.9 5.64 5.9 5.43 6.02 6.03
HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER 7.87 8.19 7.78 7.4 8.41 8.22 8.66 8.83 8.23 8.31 7.69 8.34 7.92 8.41 8.59 8.4 7.71 7.81 7.93 8.38 8.32 8.11 8.23 8.37 8.71 8.36
HP_DUPLICATION_OF_HAND_BONES 6.48 6.5 6.87 6.69 6.75 6.89 6.69 6.72 6.69 6.84 6.81 6.72 6.76 6.77 6.82 6.88 6.54 6.72 6.61 6.8 6.69 6.83 6.82 6.83 6.75 6.81
HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_HAND 6.32 6.13 6.06 6.16 6.5 6.18 6.5 6.38 6.29 6.09 6.35 6.29 6.71 6.64 6.51 6.67 6.47 6.15 6.09 6.49 6.63 6.37 6.3 6.49 6.35 6.29
HP_SHORT_PALM 6.64 6.85 7.16 6.91 6.87 7.03 6.99 7.11 6.72 7.1 6.88 6.98 7.09 7 7.19 7 6.84 6.91 6.84 7.02 6.98 7 7.17 7.01 6.99 6.89
HP_ABNORMALITY_OF_THE_GASTRIC_MUCOSA 6.49 6.58 6.53 6.7 6.37 6.47 6.25 6.49 6.53 6.58 6.48 6.3 6.4 6.51 6.36 6.43 6.39 6.48 6.26 6.41 6.68 6.11 6.31 6.18 6.27 6.39
HP_ABNORMALITY_OF_THE_BILIARY_SYSTEM 6.23 6.3 6.41 6.39 6.38 6.36 6.31 6.29 6.32 6.29 6.29 6.26 6.3 6.29 6.12 6.32 6.36 6.3 6.26 6.35 6.21 6.29 6.31 6.22 6.27 6.4
HP_ABNORMALITY_OF_THE_ABDOMINAL_WALL 6.45 6.48 6.57 6.55 6.58 6.66 6.59 6.67 6.63 6.63 6.46 6.65 6.65 6.56 6.57 6.56 6.63 6.47 6.43 6.56 6.63 6.69 6.77 6.77 6.66 6.7
HP_FUNCTIONAL_MOTOR_DEFICIT 7.28 7.32 7.69 7.45 7.53 7.67 7.52 7.46 7.59 7.65 7.49 7.68 7.66 7.66 7.65 7.51 7.43 7.32 7.41 7.65 7.39 7.54 7.66 7.78 7.65 7.49
HP_ABNORMAL_MUSCLE_FIBER_MORPHOLOGY 6.52 6.6 6.61 6.7 6.81 6.85 6.63 6.7 6.79 6.79 6.72 6.68 6.78 6.7 6.73 6.63 6.74 6.63 6.79 6.78 6.62 6.66 6.76 6.74 6.76 6.8
HP_INVOLUNTARY_MOVEMENTS 7.49 7.52 7.81 7.65 7.75 7.86 7.86 7.78 7.77 7.86 7.6 7.79 7.84 7.86 7.82 7.79 7.61 7.54 7.74 7.89 7.57 7.78 7.84 8.01 7.84 7.74
HP_ABNORMAL_ENDOCARDIUM_MORPHOLOGY 6.57 6.6 6.37 6.51 6.38 6.35 6.21 6.13 6.31 6.27 6.4 6.18 6.21 6.37 6.2 6.15 6.15 6.37 6.4 6.39 6.19 6.16 6.33 6.22 6.22 6.27
HP_ABNORMAL_ANATOMIC_LOCATION_OF_THE_HEART 5.85 6.09 5.94 6.08 5.79 5.95 5.96 5.78 5.72 6.11 5.97 5.94 5.84 5.75 5.93 6.18 5.84 6.07 5.82 5.91 6.03 6.03 5.78 5.84 5.97 6.06
HP_VENTRICULAR_ARRHYTHMIA 6.61 6.37 6.92 6.76 6.79 6.81 6.98 6.94 6.81 7.06 6.6 7.04 7.05 7.09 7.11 6.76 7.05 6.84 6.69 6.96 6.85 6.63 7.33 7.16 7.04 6.92
HP_VENTRICULAR_PREEXCITATION 8.02 8.22 7.73 7.85 7.81 7.86 7.91 8.18 7.57 8.08 7.56 7.85 7.66 7.85 8.06 7.99 7.5 7.54 8.41 8.03 7.61 7.43 7.84 8.22 7.81 7.64
HP_ABNORMAL_MACROPHAGE_MORPHOLOGY 6.42 6.34 6.52 6.23 6.41 6.65 6.06 6.07 6.42 6.3 6 6.17 6.3 6.55 5.77 5.78 6.47 6.31 5.98 6.23 6.36 6.2 6.02 6.22 6.39 6.14
HP_ABNORMAL_RETICULOCYTE_MORPHOLOGY 5.85 5.84 5.95 6.21 5.74 5.87 5.84 5.66 5.78 5.54 6.37 5.78 5.74 5.73 5.74 5.38 6.12 5.94 5.47 5.81 6.31 6.09 6.11 5.61 5.81 5.87
HP_DECREASED_CIRCULATING_ANTIBODY_LEVEL 5.94 5.97 5.98 5.92 6.12 5.99 5.96 5.95 6.09 6.08 5.89 5.9 6.06 6.14 5.89 5.8 6.17 5.95 5.93 6.11 6.07 6.07 5.99 5.89 5.93 5.94
HP_DECREASED_CIRCULATING_IGG_LEVEL 5.51 5.37 5.32 5.33 5.33 5.15 5.24 5.37 5.1 5.09 5.45 4.95 5.24 5.21 5.13 5.2 5.53 5.35 5.02 5.15 5.17 5.27 5.14 4.95 5.24 5.44
HP_DECREASED_CIRCULATING_ALDOSTERONE_LEVEL 5.1 5.13 5.1 5.06 4.68 4.77 4.83 4.81 5.21 4.56 4.8 4.66 4.43 4.46 4.84 4.72 4.88 4.99 4.62 4.79 4.87 4.92 4.62 4.72 5.12 5.09
HP_VAGINAL_FISTULA 6.07 5.98 6.83 6.31 6.22 6.25 6.26 6.68 6.24 6.2 6.39 6.24 6.31 6.13 6.17 6.4 6.15 6.44 6.28 6.38 6.41 6.35 6.43 6.57 6.48 6.46
HP_INCREASED_BODY_WEIGHT 6.52 6.59 6.71 6.68 6.72 6.83 6.75 6.81 6.82 6.89 6.67 6.89 6.82 6.85 6.83 6.79 6.63 6.61 6.75 6.9 6.71 6.82 6.92 7.04 6.95 6.8
HP_DECREASED_BODY_WEIGHT 6.6 6.63 6.92 6.88 6.82 6.89 6.79 6.84 6.8 6.87 6.71 6.81 6.88 6.83 6.83 6.76 6.69 6.61 6.71 6.86 6.74 6.85 6.92 6.97 6.81 6.83
HP_CACHEXIA 6.74 6.79 6.66 7.08 6.94 7.17 6.78 6.85 6.94 6.88 6.72 7.09 7.04 6.79 6.86 6.59 7 6.47 7.07 6.85 6.83 6.94 6.93 7.02 7.04 6.89
HP_ABNORMAL_VITREOUS_HUMOR_MORPHOLOGY 6.42 6.35 6.27 6.46 6.21 6.42 6.64 6.24 6.3 6.31 6.25 6.48 6.22 6.31 6.4 6.29 6.17 6.1 6.11 6.15 6.32 6.3 6.37 6.01 5.94 6.47
HP_ABNORMAL_ANTERIOR_EYE_SEGMENT_MORPHOLOGY 6.47 6.51 6.63 6.64 6.61 6.63 6.59 6.63 6.6 6.66 6.5 6.64 6.62 6.58 6.5 6.58 6.5 6.47 6.59 6.61 6.5 6.61 6.62 6.68 6.61 6.66
HP_DECREASED_SKULL_OSSIFICATION 6.53 6.65 7.37 6.94 7.22 7.13 6.68 6.94 6.91 7.1 7.06 6.99 6.85 6.98 6.5 6.85 6.89 6.81 7.08 7.4 6.61 6.98 6.8 6.84 7 7.1
HP_ABNORMAL_LYMPHOCYTE_MORPHOLOGY 5.94 5.87 5.84 5.93 5.88 5.93 5.97 5.81 5.97 5.81 5.89 5.72 6 6.17 5.67 5.71 5.98 5.83 5.86 5.84 5.84 5.83 5.91 5.65 5.86 5.95
HP_DERMAL_ATROPHY 6.35 6.3 6.31 6.44 6.5 6.32 6.51 6.39 6.45 6.63 6.35 6.4 6.41 6.53 6.28 6.44 6.49 6.29 6.18 6.38 6.46 6.26 6.5 6.51 6.68 6.61
HP_ABNORMAL_CIRCULATING_AROMATIC_AMINO_ACID_CONCENTRATION 5.69 5.75 6.92 6.61 5.29 5.78 5.95 6.36 6.39 6.19 6.38 5.95 5.85 6.34 6.3 6.59 5.74 6 5.83 6.35 5.72 6.39 6.24 6.09 6.54 6.14
HP_ABNORMAL_CIRCULATING_SULFUR_AMINO_ACID_CONCENTRATION 6.74 6.61 6.98 7.33 7.39 7.51 7.25 7.21 7.21 7.64 7.29 6.87 7.52 7.62 6.89 7.41 6.84 6.71 6.53 7.34 6.62 7 7.27 7.72 7.11 7.02
HP_ABNORMALITY_OF_VITAMIN_B_METABOLISM 6.66 6.63 6.71 6.69 7.02 7.08 7.26 7.13 6.9 6.74 6.49 7.07 7.06 7.23 6.87 6.96 6.63 6.7 6.47 6.99 6.64 7.27 6.77 6.93 7.07 6.92
HP_ABNORMALITY_OF_VITAMIN_B12_METABOLISM 6.8 6.66 6.83 7.05 7.16 7.44 7.47 7.3 7.36 6.91 6.91 7.16 7.4 7.48 7.03 7.35 6.78 6.86 6.72 7.29 6.42 7.38 6.95 6.97 7.42 7.29
HP_WEAKNESS_OF_MUSCLES_OF_RESPIRATION 6.39 6.4 6.35 6.25 6.59 6.5 6.4 6.32 6.57 6.66 6.39 6.62 6.48 6.44 6.42 6.38 6.31 6.3 6.33 6.38 6.14 6.4 6.69 6.59 6.58 6.47
HP_ABNORMALITY_OF_BONE_MINERAL_DENSITY 6.16 6.15 6.2 6.24 6.15 6.18 6.18 6.17 6.2 6.26 6.1 6.18 6.23 6.22 6.15 6.13 6.11 6.12 6.11 6.19 6.12 6.18 6.17 6.28 6.23 6.32
HP_ABNORMAL_CIRCULATING_CARBOXYLIC_ACID_CONCENTRATION 6.4 6.38 6.81 6.71 6.61 6.55 6.53 6.51 6.5 6.51 6.51 6.52 6.47 6.6 6.43 6.66 6.44 6.44 6.58 6.72 6.4 6.54 6.62 6.66 6.55 6.52
HP_ABNORMAL_CIRCULATING_FATTY_ACID_CONCENTRATION 6.34 6.3 6.74 6.46 6.41 6.44 6.51 6.46 6.62 6.29 6.46 6.2 6.66 6.61 6.04 6.54 6.69 6.19 6.39 6.73 6.22 6.61 6.45 6.48 6.59 6.62
HP_ABNORMALITY_OF_ACID_BASE_HOMEOSTASIS 6.57 6.66 7.37 7.05 6.85 6.91 6.81 6.88 6.81 6.93 6.93 6.83 6.9 6.96 6.82 6.98 6.73 6.65 6.76 6.87 6.72 6.9 6.88 7.02 6.81 6.87
HP_ABNORMALITY_OF_CIRCULATING_LEPTIN_LEVEL 6.52 6.57 6.93 6.7 6.95 6.77 6.81 6.94 7.14 7.17 6.72 7.19 6.91 6.88 6.38 6.44 7.16 6.48 6.54 6.74 6.35 6.54 6.8 7.18 7.03 7.19
HP_ABNORMAL_CIRCULATING_NITROGEN_COMPOUND_CONCENTRATION 6.4 6.35 6.61 6.6 6.59 6.64 6.51 6.39 6.53 6.58 6.58 6.48 6.46 6.55 6.33 6.7 6.71 6.53 6.54 6.35 6.46 6.48 6.48 6.53 6.61 6.83
HP_ABNORMALITY_OF_TEMPERATURE_REGULATION 5.98 5.99 6.08 6.16 5.86 5.88 5.92 5.95 5.96 5.88 6.05 5.87 5.85 5.84 5.86 5.87 5.97 5.98 5.88 5.95 6.01 5.97 5.95 5.81 5.93 6.05
HP_REDUCED_CONSCIOUSNESS_CONFUSION 6.29 6.31 6.61 6.56 6.46 6.53 6.6 6.52 6.53 6.52 6.41 6.4 6.48 6.44 6.53 6.49 6.47 6.33 6.33 6.58 6.42 6.61 6.45 6.52 6.57 6.47
HP_FOCAL_DYSTONIA 6.85 7.01 7.23 7.34 7.07 7.17 7.18 7.25 7.02 7.34 7.15 7.52 7.23 7.12 7.5 7.26 7.29 7.33 7.06 7.44 7.41 7.72 6.99 7.49 7.37 7.33
HP_HEMIPLEGIA_HEMIPARESIS 6.4 6.41 6.65 6.52 6.44 6.45 6.58 6.45 6.52 6.36 6.53 6.57 6.5 6.43 6.5 6.53 6.48 6.46 6.44 6.48 6.51 6.59 6.55 6.55 6.38 6.53
HP_NEOPLASM_OF_THE_NERVOUS_SYSTEM 6.82 6.9 6.9 6.74 7.28 7.32 7.11 7.19 7 7.11 6.95 7.16 7.16 7.04 7.04 7.25 7.14 7.05 7.04 7.2 7.06 7.09 7.16 7.21 7.14 7.2
HP_HEMATOLOGICAL_NEOPLASM 6.11 6.18 6.06 6.2 6.14 6.15 6.16 6.23 6.25 6.2 6.25 6.16 6.3 6.22 5.98 6.13 6.16 6.21 6.01 6.12 6.11 6.19 6.31 6.35 6.26 6.31
HP_ABNORMALITY_OF_THE_ANUS 6.12 6.14 6.05 6.16 6.15 6.17 6.2 6.37 6.23 6.2 6.16 6.18 6.28 6.22 6.13 6.16 6.11 6.09 6.08 6.21 6.26 6.21 6.27 6.39 6.23 6.22
HP_ABNORMALITY_OF_ALKALINE_PHOSPHATASE_LEVEL 5.95 5.7 5.4 5.97 5.53 5.39 5.65 5.55 5.71 5.69 5.83 5.6 5.57 5.57 5.59 5.38 5.81 5.69 5.55 5.8 5.63 5.71 5.41 5.51 5.84 5.77
HP_SUPRAVALVULAR_AORTIC_STENOSIS 6.78 6.74 6.71 6.8 6.88 6.79 6.68 6.81 6.5 6.8 6.55 6.35 6.76 6.45 6.4 6.46 6.89 6.5 6.79 6.48 6.87 6.3 6.55 6.35 6.5 6.68
HP_PROTRACTED_DIARRHEA 5.46 5.36 5 4.9 5.58 5.41 5.62 5.3 5.51 5.38 5.17 4.93 5.18 5.11 5.55 5.04 4.51 5.33 4.73 4.85 4.98 5.4 4.88 5.02 4.9 4.78
HP_GASTROINTESTINAL_INFLAMMATION 5.72 5.61 5.67 5.76 5.71 5.42 5.68 5.54 5.76 5.48 5.66 5.49 5.56 5.53 5.48 5.5 5.88 5.73 5.46 5.52 5.84 5.66 5.67 5.26 5.64 5.59
HP_INTESTINAL_PSEUDO_OBSTRUCTION 6.07 6.24 6.16 6.43 6.37 6.66 6.24 6.58 6.32 6.39 6.13 6.25 6.41 6.47 6.23 6.38 6.39 6.96 5.92 6.47 6.03 6.23 7.05 6.36 6.24 6.38
HP_HAMARTOMATOUS_POLYPOSIS 8.3 7.9 9.43 8.98 9.12 9.02 9.4 8.45 8.61 8.93 8.77 8.4 9.23 9.19 8.81 8.77 8.14 8.06 8.61 8.96 8.35 8.78 9.36 9.07 8.86 8.44
HP_MALNUTRITION 5.24 5.3 5.22 5.43 5.09 4.76 4.95 4.8 5.1 5.02 5.2 4.81 4.85 5.01 4.98 4.92 5.01 5.11 5.06 4.87 5.05 4.88 5.11 4.81 5.02 4.72
HP_POOR_APPETITE 5.85 5.83 5.88 5.76 5.79 6.04 5.85 5.93 5.87 5.78 6.09 5.69 5.79 5.54 5.87 6.12 5.76 6.07 5.74 5.82 6.03 6.14 5.67 5.88 5.93 6.04
HP_ECTOPIC_ANUS 6.53 6.55 6.43 6.56 6.82 6.85 6.62 6.61 6.69 6.73 6.38 6.44 6.68 6.64 6.55 6.42 6.24 6.24 6.45 6.6 6.47 6.43 6.36 6.55 6.63 6.35
HP_PEPTIC_ULCER 7.16 6.88 7.2 7.12 7.12 7.17 7.42 7.77 7.05 7.34 7.07 7.2 7.47 7.41 7.19 7.35 7.19 7.18 7.47 7.6 7.13 7.44 7.16 7.45 7.42 7.34
HP_ABNORMALITY_OF_THE_PYLORUS 7.03 7.11 7.29 7.03 7.34 7.49 7.4 7.2 7.56 7.5 7.11 7.47 7.56 7.64 7.27 7.3 7.19 7.08 7.29 7.38 7.27 7.5 7.72 7.8 7.42 7.41
HP_ABNORMAL_NIPPLE_MORPHOLOGY 7.09 6.99 7.16 7.01 7.13 7.3 7.22 7.12 7.3 7.3 6.88 7.2 7.21 7.17 7.2 7.09 6.98 7.01 7.19 7.21 7.03 7.21 7.16 7.32 7.22 7.18
HP_SPONTANEOUS_RECURRENT_EPISTAXIS 6.23 6.18 6.55 6.25 5.89 6.06 6.24 6.52 5.96 5.82 6.29 6.28 5.88 6.05 5.85 6 5.87 6.04 5.71 5.89 6.6 6.1 6.02 6.05 6.32 5.77
HP_ABNORMALITY_OF_THE_SENSE_OF_SMELL 6.78 6.77 6.68 6.7 6.56 6.82 6.99 6.91 6.91 6.84 6.7 6.65 7.1 7.01 6.94 6.69 7.07 6.89 6.68 6.9 6.79 6.8 7.01 7.04 7.04 6.99
HP_HYPOSMIA 7.7 7.81 6.92 7.2 7.98 8.05 7.91 7.62 7.66 7.99 7.22 7.54 7.92 7.64 7.85 7.33 7.49 7.3 7.48 8.07 7.21 7.39 7.71 7.93 7.59 7.46
HP_ABNORMALITY_OF_THE_PULMONARY_ARTERY 6.81 6.75 7.16 7.14 7.07 7.1 6.98 7.21 6.93 7.14 6.92 7.1 7.21 7.04 7.03 7 6.97 6.86 6.98 7.05 7.08 7.12 7.25 7.37 7.06 6.94
HP_PULMONARY_ARTERY_STENOSIS 6.99 6.76 7.13 7.03 7.04 6.98 6.95 7.13 6.8 7.12 6.9 6.94 6.96 6.99 6.9 6.96 6.9 6.93 6.93 6.98 7.11 7.08 7.19 7.19 6.91 6.88
HP_ARTERIAL_THROMBOSIS 5.84 6.23 5.22 5.79 5.72 5.79 5.56 5.55 6.05 6.24 6.26 5.92 6.32 6.19 5.54 5.93 5.85 5.38 6.01 5.82 5.73 5.9 6.32 6.1 5.72 5.89
HP_ELEVATED_SYSTOLIC_BLOOD_PRESSURE 6.35 6.52 6.41 6.02 5.58 6.15 6.27 6.46 5.75 5.97 6.27 6.11 6.1 5.99 6.08 6.3 6.13 6.23 6.4 6.74 6.09 6.41 6.65 5.82 6.54 5.98
HP_BIPARIETAL_NARROWING 6.63 6.82 7.61 7.34 6.87 7.23 7.09 7.36 7.05 7.2 7.16 7.21 7.24 7.29 7.42 7.6 6.99 7.03 7.24 7.23 7.2 7.45 7.34 7.5 7.44 7.41
HP_FLAT_FOREHEAD 6.27 6.25 6.53 6.19 6.79 6.23 6.56 6.34 6.27 6.48 6.37 6.4 6.46 6.56 6.22 6.1 6.61 6.38 6.51 6.61 6.61 6.24 6.26 6.48 6.36 6.74
HP_ABNORMALITY_OF_THE_CHEEK 6.78 6.92 7.05 6.98 7.03 7.12 7.11 7.09 7.14 7.3 7.14 7.13 7.2 7.16 7.09 7.3 6.92 7.01 7.1 7.18 7.08 7.29 7.28 7.2 7.21 7.13
HP_ELFIN_FACIES 7.15 6.74 7.1 7.12 6.87 6.91 6.79 7.14 6.67 7.05 6.92 6.84 6.7 6.8 6.83 6.74 6.81 6.56 7.38 6.94 7.18 6.75 7.07 7.34 6.83 6.75
HP_RECURRENT_VIRAL_INFECTIONS 5.67 5.66 5.82 5.9 5.79 5.92 5.63 5.49 5.51 5.53 5.8 5.38 5.8 5.63 5.55 5.53 5.61 5.66 5.56 5.44 5.84 5.4 5.49 5.58 5.61 5.86
HP_SEVERE_COMBINED_IMMUNODEFICIENCY 5.9 6.12 5.82 5.63 5.89 6.16 6.04 5.6 5.68 5.58 5.89 5.56 6.5 6.31 5.42 5.57 5.64 5.76 6.18 5.81 5.35 5.65 6.11 6.11 5.61 5.84
HP_AGAMMAGLOBULINEMIA 5.85 5.62 5.71 5.88 5.69 5.81 5.76 5.83 5.8 5.74 5.85 5.83 5.8 5.52 5.62 5.56 6.08 6.02 5.66 5.84 5.91 5.53 5.68 5.59 5.62 5.29
HP_CRANIAL_HYPEROSTOSIS 6.91 6.84 6.92 7.17 7.34 7.27 7.09 7.23 7.28 7.31 7.08 7.26 7.42 7.43 7.4 7.23 7.19 7.04 7.25 7.29 7.21 7.12 7.55 7.63 7.32 7.27
HP_CORONAL_CRANIOSYNOSTOSIS 6.22 6.28 5.94 6.37 5.89 5.91 5.89 6.27 5.82 5.89 6.23 5.97 5.85 5.85 6.25 5.74 6.05 6.28 5.96 6.07 6.27 6.18 5.89 5.75 5.94 6.24
HP_SAGITTAL_CRANIOSYNOSTOSIS 7 7.14 7.57 7.24 7.19 7.38 7.18 7.56 7.16 7.32 7.12 7.08 7.47 7.32 7.39 7.55 7.3 7.26 6.89 7.41 7.38 7.55 7.38 7.14 7.33 7.56
HP_LAMBDOIDAL_CRANIOSYNOSTOSIS 6.46 6.28 6.17 5.78 5.93 6.23 6.24 6.34 5.73 6.48 5.96 6.22 6.01 5.88 6.28 6.18 6.03 6.02 5.85 6.03 6.28 6.24 5.7 5.8 6.3 6.37
HP_ELLIPTOCYTOSIS 6.44 6.3 7.19 6.81 6.45 6.36 6.16 5.9 6.4 6.34 6.7 6.31 6.14 6.72 6.36 6.91 6.52 6.18 6.31 6.2 6.66 6.47 7.08 5.9 6.38 6.85
HP_STOMATOCYTOSIS 6.07 5.88 6.17 5.7 5.74 6.09 5.84 5.66 5.77 5.84 5.84 5.92 5.14 5.75 5.74 6.18 5.85 5.84 5.42 5.85 6.17 5.54 5.88 5.35 6.11 6.36
HP_POIKILOCYTOSIS 6.14 5.88 5.71 6.21 5.86 6.08 5.84 5.79 5.77 5.81 5.8 5.78 5.74 5.75 5.84 5.6 5.64 5.78 5.85 5.85 5.99 5.88 6.05 5.64 5.72 5.89
HP_ABNORMALITY_OF_THE_MIDDLE_EAR_OSSICLES 5.75 5.63 5.61 5.6 5.77 5.55 6.01 5.84 5.69 5.63 5.68 5.68 6.17 6.17 6.05 6.03 5.19 5.79 5.33 5.93 5.86 5.68 5.89 5.89 5.86 5.66
HP_CHRONIC_BRONCHITIS 5.4 5.18 5.07 4.96 4.9 4.92 4.92 4.91 5.06 4.96 5.13 4.97 5.17 5 5.13 5.27 5.01 5.24 5.11 5 5.23 5.02 4.92 4.85 4.9 4.85
HP_RELATIVE_MACROCEPHALY 7.57 7.42 7.84 7.75 8.19 8.02 7.91 8.03 8.21 8.21 7.46 7.85 7.98 8.1 8.18 8.25 8.03 7.67 7.75 8 7.96 7.96 8.11 8.29 8.2 7.99
HP_CESSATION_OF_HEAD_GROWTH 6.65 6.46 7.4 7.53 7.2 7.35 7.04 6.99 6.9 6.93 6.99 6.65 6.92 6.7 6.98 6.76 6.71 6.68 7.22 7.05 6.86 6.86 7.07 7.29 6.57 6.51
HP_CALVARIAL_HYPEROSTOSIS 8.22 8.72 8.17 8.3 8.37 8.9 8.7 9.14 8.14 8.99 8.4 8.86 8.45 8.51 8.73 8.44 8.26 8.98 8.69 8.95 9.2 8.84 8.38 8.49 8.79 8.56
HP_WIDELY_PATENT_FONTANELLES_AND_SUTURES 6.25 6.26 6.1 6.33 6.11 6.44 6.23 6.36 6.14 6.56 6.23 6.49 6.59 6.16 6.03 6.31 5.97 6.13 6.42 6.25 6.25 6.12 6.02 6.65 6.35 6.36
HP_CRANIOFACIAL_HYPEROSTOSIS 6.73 6.68 7.14 7.28 7.18 7.09 7.09 7.24 7.37 7.11 6.8 7 7.4 7.38 7.44 7.19 7.37 7.18 7.08 7.29 7.33 7.21 7.98 7.64 7.28 7.25
HP_PANCREATIC_ISLET_CELL_HYPERPLASIA 5.92 5.98 6.12 6.3 5.98 6.26 6.05 6.36 6.5 6.35 6.26 5.98 6.35 6.45 6.13 6.24 5.93 6.21 6.11 6.49 6.59 6.38 6.13 6.38 6.41 6.26
HP_SCARRING_ALOPECIA_OF_SCALP 5.67 5.73 5.29 5.55 5.38 5.59 5.02 5.03 5.52 5.31 5.35 4.87 6.12 6.13 5.35 4.88 6.49 5.99 5.39 5.7 5.59 5.79 5.77 6.18 5.79 5.42
HP_BEAKING_OF_VERTEBRAL_BODIES 6.31 6.14 6.32 6.46 6.77 6.47 6.31 6.43 6.21 6.31 6.36 6.42 6.46 6.51 6.45 6.26 6.18 5.85 6.33 6.27 5.97 6.27 6.17 6.5 6.49 6.65
HP_BICONCAVE_VERTEBRAL_BODIES 6.29 6.29 6.71 6.7 6.58 6.51 7.1 7.37 6.56 6.67 6.79 6.65 6.97 6.37 7.44 7.37 6.89 6.44 6.42 7.06 7.33 7.43 6.88 7 7.17 7.48
HP_ABSENT_OR_MINIMALLY_OSSIFIED_VERTEBRAL_BODIES 6.26 5.96 5.73 6.07 5.85 6.27 5.69 5.8 5.94 6.1 6.04 6.13 6.44 6.31 5.83 6.07 5.76 6 6.22 6.12 5.56 5.68 5.89 6 6.76 6.72
HP_DECREASED_CERVICAL_SPINE_MOBILITY 4.96 4.7 5.11 5.35 4.51 4.39 4.93 4.65 5.16 4.89 5.36 4.95 4.7 4.57 4.99 4.62 4.56 4.79 4.9 4.28 4.82 4.62 4.71 4.43 4.57 4.57
HP_DECREASED_FACIAL_EXPRESSION 7.08 7.15 6.81 6.94 7.49 7.7 7.11 7.07 7.12 7.22 6.9 7.36 7.3 7.34 7.26 6.96 7.22 7.08 7.53 7.37 7.08 7.13 7.22 7.36 7.3 7.22
HP_TALIPES_VALGUS 7.86 8.42 8.53 9.11 8.67 8.69 8.41 8.53 8.9 8.69 8.55 8.41 8.69 8.85 8.61 8.45 7.96 8.27 8.75 8.83 8.28 8.68 8.87 8.78 8.3 8.11
HP_2_3_TOE_SYNDACTYLY 7.57 7.62 7.69 7.44 8.06 8.09 8.1 8.06 8.02 7.88 7.54 7.92 7.98 8.05 7.8 7.84 7.53 7.47 7.75 8.03 7.6 7.79 8.2 8.24 7.94 7.74
HP_ABNORMAL_RENAL_COLLECTING_SYSTEM_MORPHOLOGY 6.4 6.09 5.29 6.09 6.42 5.8 5.86 6.12 6.13 6.31 5.9 5.76 5.97 6.26 5.59 5.89 6.04 6.06 6.21 5.67 6.25 6.07 6.14 5.66 6.24 6.25
HP_ATRIAL_FLUTTER 5.89 5.62 6.18 6.28 5.4 5.05 5.38 5.29 5.22 5.26 6.25 5.34 5.19 5.08 5.18 5.21 5.68 5.89 5.33 5 5.54 5.39 5.61 5.14 5.08 5.29
HP_PAROXYSMAL_VENTRICULAR_TACHYCARDIA 6.96 7.53 7.31 6.99 7.48 7.82 7.37 7.41 7.65 7.84 7.28 7.68 7.65 7.71 7.55 7.4 7.17 7.44 7.71 7.6 7.27 7.31 7.96 7.7 7.73 7.34
HP_SUPRAVENTRICULAR_TACHYCARDIA 6.11 5.99 6.19 6.26 5.73 6.12 6.14 6.02 5.8 6.3 6.18 6.21 5.95 5.89 6 6.14 6.45 6.45 6.3 6.06 6.2 5.88 6.46 6.23 6.05 6.16
HP_VENTRICULAR_TACHYCARDIA 6.16 6.61 6.97 6.26 6.46 6.61 7.1 7.04 6.94 6.92 6.61 7.01 7.23 7.19 6.8 6.75 7.17 6.93 6.79 7.53 6.84 6.42 7.67 7.15 6.84 7.01
HP_PAROXYSMAL_ATRIAL_FIBRILLATION 5.62 5.61 5.29 5.13 5.12 5.15 5.34 5.29 5.39 5.59 5.63 5.2 5.49 5.4 5.27 5.47 5.5 5.97 5.32 5.77 5.72 5.81 5.51 5.53 5.78 6.01
HP_GASTROINTESTINAL_OBSTRUCTION 6.18 6.14 6.24 6.21 6.17 6.05 6.07 6.35 6.18 6.32 6.05 5.85 6.21 6.1 6.22 6.04 6.11 6.15 5.89 6 6.07 6.2 6.51 5.96 6.09 6.13
HP_RECURRENT_INFECTION_OF_THE_GASTROINTESTINAL_TRACT 5.89 5.68 5.94 6.04 5.79 6.05 6.11 5.96 6.31 6.27 5.88 5.98 6.02 6.29 5.78 6.26 6.15 5.83 5.84 6.28 6.06 5.86 6.02 5.96 5.88 5.97
HP_ACUTE_MYELOID_LEUKEMIA 6.21 6.27 5.98 5.87 6.55 6.42 6.07 6.32 6.58 6.5 6.56 6.26 6.46 6.42 6.21 6.31 6.64 6.49 6.12 5.97 6.24 6.43 6.38 6.51 6.65 6.5
HP_NEONATAL_ALLOIMMUNE_THROMBOCYTOPENIA 6.57 6.36 5.56 5.57 5.94 5.41 5.83 5.86 6 5.4 5.67 5.87 5.51 5.24 5.74 6.24 5.97 5.64 5.95 5.66 5.64 5.49 5.91 5.9 5.74 5.66
HP_HYPOCHROMIC_MICROCYTIC_ANEMIA 6.25 6.28 7.02 6.76 6.75 6.43 6.53 6.29 6.5 6.82 6.62 6.39 6.87 6.95 6.51 6.92 6.74 6.6 6.67 6.6 6.55 6.55 6.9 6.89 6.91 6.77
HP_PROLONGED_BLEEDING_AFTER_SURGERY 5.7 5.49 5.64 5.3 5.03 5.03 5.28 5.01 5.33 5.03 5.47 4.72 5.12 4.98 5.03 4.77 5.27 5.11 5.19 4.63 5.55 5.27 5.36 5.19 5.52 5.05
HP_RESPIRATORY_FAILURE_REQUIRING_ASSISTED_VENTILATION 6.25 6.31 6.71 6.56 6.59 6.6 6.4 6.55 6.61 6.72 6.44 6.62 6.4 6.5 6.61 6.48 6.52 6.36 6.28 6.41 6.61 6.83 6.25 6.36 6.58 6.51
HP_INTERMITTENT_EPISODES_OF_RESPIRATORY_INSUFFICIENCY_DUE_TO_MUSCLE_WEAKNESS 5.7 5.56 6.35 5.87 6.19 5.22 7.22 6.49 6.44 8.06 6.1 6.11 6.66 6.28 5.6 5.83 6.58 5.42 6.05 5.29 5.43 5.91 6.16 6.9 6.98 6.4
HP_MATURITY_ONSET_DIABETES_OF_THE_YOUNG 5.43 5.26 5.27 5.5 5.03 4.98 5.25 5.09 5.47 5.14 5.34 5.01 5.24 5.23 5.1 5.37 5.36 5.29 4.96 4.92 5.32 5.09 5.08 4.79 5.07 4.92
HP_HYPOPHOSPHATEMIC_RICKETS 5.6 5.7 5.12 5.67 5.47 5.27 5.16 5.05 5.56 5.69 5.46 5.23 4.99 5.34 5.16 5.12 5.74 5.31 5.07 5.07 5.4 5.74 5.42 4.74 5.38 4.89
HP_ABNORMAL_MAGNESIUM_CONCENTRATION 5.8 5.54 5.64 5.63 5.67 5.15 5.76 5.36 5.46 5.43 5.74 5.23 5.27 5.12 5.58 5.18 5.5 5.66 5.29 5.25 5.98 5.34 5.1 5.01 5.23 5.18
HP_ABNORMAL_ORAL_GLUCOSE_TOLERANCE 5.32 5.15 5.19 5.48 4.79 4.85 5.1 4.97 5.27 5.02 5.12 4.76 4.98 5.15 4.94 5.21 4.95 5.09 4.84 4.81 5.29 4.98 5.05 4.54 4.9 4.8
HP_ORTHOSTATIC_HYPOTENSION_DUE_TO_AUTONOMIC_DYSFUNCTION 8.12 8.15 7.23 7.34 8.41 8.46 8.37 7.82 8.05 8.38 7.52 8.09 8.24 8.3 8.19 8.4 7.81 7.85 8.11 8.21 8.13 8.29 7.75 7.99 7.95 7.91
HP_PULMONARY_ARTERY_DILATATION 7.84 7.95 8.12 8.21 8.36 8.19 8.13 8.49 8.43 8.38 8.17 8.26 8.41 8.55 8.4 8.21 8.22 8.24 8.48 8.49 8.54 8.67 8.34 8.47 8.82 8.6
HP_ABNORMALITY_OF_THE_PULMONARY_VASCULATURE 6.53 6.55 6.64 6.57 6.56 6.58 6.64 6.66 6.58 6.68 6.54 6.67 6.54 6.52 6.53 6.65 6.61 6.54 6.42 6.46 6.77 6.7 6.78 6.52 6.65 6.66
HP_ASCENDING_AORTIC_DISSECTION 6.07 6.21 5.88 6.05 6.75 6.49 6.18 6.08 6.66 6.44 6.39 6.54 6.55 6.4 6.17 6.43 7.03 6.56 6.16 6.37 6.64 6.42 6.97 6.5 6.19 5.95
HP_VASCULAR_CALCIFICATION 6.04 5.96 5.79 5.98 5.94 5.51 6.08 5.86 6 5.51 6.08 5.87 5.67 5.39 6.07 6.03 5.97 6.05 5.73 5.66 6.28 6.32 5.91 5.9 6.05 5.95
HP_PULMONARY_ARTERY_ATRESIA 5.82 5.47 5.36 6.03 5.45 5.77 5.79 6.11 5.6 5.41 5.67 5.62 6.18 5.87 5.85 5.65 5.5 5.42 5.4 5.37 5.57 5.79 5.61 5.84 5.84 6.03
HP_VENOUS_THROMBOSIS 6.08 6.21 6.2 6.15 5.79 5.76 5.79 5.67 5.97 5.97 6.05 6.1 5.59 5.92 5.64 5.69 5.92 5.85 5.8 5.79 5.92 5.84 5.85 5.68 5.91 6.13
HP_AORTIC_ANEURYSM 7.2 6.97 7.01 6.85 7.15 7.08 7.01 7.17 7.04 7.22 7.09 7.39 7.32 7.09 7.1 7.04 7.23 6.84 7.2 7.09 7.14 7.21 7.35 7.35 7.32 7.39
HP_DILATATION_OF_THE_CEREBRAL_ARTERY 6.51 6.68 6.74 6.63 6.85 6.76 6.74 6.53 6.66 6.63 6.61 7.03 6.77 6.57 6.53 6.57 7.22 6.71 6.6 6.63 7.02 6.91 6.97 6.8 6.95 6.91
HP_ARTERIOVENOUS_FISTULA 5.82 5.6 5.8 5.65 5.78 5.38 5.85 5.48 5.51 5.28 6.08 5.62 5.35 5.32 5.57 5.74 5.39 5.5 5.11 5.3 5.7 5.55 5.93 4.96 5.71 5.44
HP_VASCULAR_TORTUOSITY 7.7 7.73 7.42 7.24 7.7 8.23 7.98 7.92 7.36 7.23 7.42 7.69 7.67 8.02 7.54 7.99 7.5 7.75 8.12 7.94 7.79 8.2 8.11 7.98 8.02 8.17
HP_PERIPHERAL_ARTERIAL_STENOSIS 6.1 6.11 6.02 6.23 6.8 6.49 6.22 6.1 6.65 6.48 6.36 6.53 6.48 6.03 6.05 6.25 7.04 6.44 6.15 6.35 6.48 6.32 6.73 6.35 6.31 6.19
HP_DESCENDING_THORACIC_AORTA_ANEURYSM 6.37 6.52 6.54 6.69 6.86 6.75 6.49 6.17 6.93 6.58 6.63 7.03 6.67 6.49 6.46 6.51 7.32 6.7 6.52 6.6 7 6.8 7.39 6.74 6.77 6.68
HP_CALCIFICATION_OF_THE_AORTA 6.07 5.96 5.49 5.98 5.41 5.22 5.66 5.3 5.17 5.25 5.75 5.75 5.33 5.24 5.16 5.36 5.78 6.01 5.17 5.06 5.87 6.12 5.41 5.34 5.54 5.52
HP_PERIPHERAL_PULMONARY_ARTERY_STENOSIS 7.2 6.92 7.13 7.09 6.97 6.94 7.05 7.35 6.9 7.4 6.9 7.12 7.05 6.99 7.05 7.25 7.05 6.93 7.32 6.98 7.34 7.12 7.27 7.35 7.06 6.95
HP_ASCENDING_TUBULAR_AORTA_ANEURYSM 7.39 6.98 7.22 6.75 7.32 7.14 7.41 7.5 7.16 7.17 6.83 7.19 7.11 7.36 6.99 7.04 6.83 6.75 7.36 7.59 7.1 7.26 7.58 7.53 7.5 7.49
HP_APLASIA_HYPOPLASIA_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS 5.69 5.64 5.61 5.57 5.58 5.71 5.71 5.6 5.84 6.21 5.89 5.9 5.98 5.68 5.64 5.64 5.63 5.64 5.42 5.69 5.65 5.87 6.06 6.28 5.84 5.99
HP_DIAPHYSEAL_THICKENING 6.52 6.08 6.05 6.35 6.88 6.34 6.18 6.25 6.32 6.45 6.33 6.43 6.36 6.45 6.08 6.29 6.31 6.25 6.27 6.21 6.12 6.38 6.3 6.2 6.22 6.49
HP_SYNOSTOSIS_OF_CARPAL_BONES 5.33 5.39 6.05 5.27 5.55 5.5 6.29 6.16 5.03 5.25 5.28 5.26 6.28 6.06 5.35 6.03 5.41 5.46 5.34 5.88 5.5 5.64 5.9 6.35 6.02 5.87
HP_ABNORMAL_METAPHYSEAL_TRABECULATION 5.59 5.64 5.89 5.86 5.62 5.53 5.88 5.9 5.78 5.63 5.7 5.53 5.56 5.74 5.64 5.83 5.77 5.73 5.52 5.55 6.1 6.13 5.54 5.73 6.14 6.12
HP_ABNORMAL_NASAL_MORPHOLOGY 6.85 6.9 7.12 6.99 7.07 7.18 7.11 7.13 7.11 7.17 6.97 7.14 7.2 7.15 7.17 7.11 6.92 6.93 7.07 7.15 7.03 7.13 7.14 7.29 7.13 7.13
HP_ABNORMALITY_OF_THE_VERTEBRAL_ENDPLATES 5.76 5.65 5.96 5.76 5.58 5.48 5.78 5.82 5.84 5.71 5.72 5.53 5.69 5.82 5.61 5.48 5.8 5.74 5.68 5.47 5.73 5.78 5.63 5.84 5.98 5.92
HP_ABNORMAL_SACRUM_MORPHOLOGY 6.38 6.37 6.63 6.59 6.32 6.67 6.5 6.42 6.47 6.63 6.59 6.56 6.48 6.53 6.43 6.24 6.49 6.48 6.39 6.41 6.67 6.31 6.46 6.53 6.45 6.55
HP_ABNORMALITY_OF_THE_INTERVERTEBRAL_DISK 6.43 6.38 6.34 6.49 6.36 6.06 6.25 6.25 6.4 6.33 6.27 6.04 6.15 6.2 6.18 6.44 6.17 6.32 6.05 6.2 6.15 6.34 6.28 6.34 6.46 6.51
HP_ABNORMALITY_OF_THE_ACHILLES_TENDON 6.6 6.81 6.98 6.89 6.94 6.96 6.92 6.96 7.18 7.08 7.02 6.99 7.1 6.79 7.18 6.93 6.88 6.66 7.11 6.93 6.47 6.68 7.14 7.04 6.95 6.85
HP_ABDOMINAL_AORTIC_ANEURYSM 6.2 6.29 6.54 6.69 6.8 6.61 6.22 6.17 6.77 6.55 6.49 6.78 6.56 6.41 6.28 6.44 7.22 6.62 6.25 6.59 6.75 6.56 7.12 6.59 6.4 6.4
HP_AORTIC_ARCH_ANEURYSM 6.79 6.74 7.05 7.09 6.94 6.82 6.99 7.46 6.73 6.96 6.79 6.86 7.02 6.98 6.93 7.16 6.71 6.55 7.21 7.01 7.13 6.86 6.77 7.29 6.91 7.06
HP_SUPRAVENTRICULAR_ARRHYTHMIA 5.93 5.92 6.12 6.12 5.43 5.73 5.99 5.84 5.83 5.97 6.09 5.87 5.89 5.72 5.92 5.8 5.97 6.01 5.95 5.71 5.92 5.76 6.26 5.55 5.94 6.11
HP_ELEVATED_DIASTOLIC_BLOOD_PRESSURE 6.35 6.52 6.41 6.02 5.58 6.15 6.27 6.46 5.75 5.97 6.27 6.11 6.1 5.99 6.08 6.3 6.13 6.27 6.4 6.74 6.09 6.41 6.65 5.82 6.54 5.98
HP_ABNORMAL_CARDIAC_ATRIUM_MORPHOLOGY 6.71 6.65 6.82 6.77 6.81 6.83 6.78 6.86 6.79 6.89 6.72 6.84 6.82 6.71 6.86 6.83 6.79 6.68 6.69 6.85 6.9 6.82 6.99 7 6.91 6.89
HP_RIGHT_VENTRICULAR_DILATATION 4.81 4.58 5.02 5.64 4.68 4.55 4.89 4.77 4.75 5.17 5.29 4.97 4.68 4.58 4.7 4.69 4.79 4.6 4.72 4.69 5.04 4.78 4.94 4.64 4.71 4.85
HP_ABNORMAL_T_WAVE 6.57 6.36 6.41 6.57 6.49 6.52 6.65 7.21 6.58 6.84 6.51 6.59 6.28 6.48 7.1 6.62 6.46 6.39 6.43 6.31 6.59 6.61 6.19 6.85 6.61 7.23
HP_CARDIAC_VALVE_CALCIFICATION 6.56 6.38 5.83 5.6 6.84 6.63 6.01 5.97 6.1 6.84 6.06 6.77 6.16 5.82 5.89 6.12 6.5 6.26 6.33 6.23 6 6.03 6.47 6.44 6.58 6.67
HP_ABNORMAL_ATRIOVENTRICULAR_CONDUCTION 6.98 7.12 7 6.79 6.94 7.12 7.07 6.85 6.73 7.16 6.91 7 6.96 7.26 7.18 6.86 7.07 7.06 7.02 6.97 7.03 6.97 7.53 7.02 7.06 6.9
HP_PREMATURE_CORONARY_ARTERY_ATHEROSCLEROSIS 6.04 5.98 5.79 5.98 6.89 6.5 6.31 6.32 6.15 6.86 6.1 6.41 6.4 5.81 6.02 6.03 6.5 6.01 5.73 5.72 6.14 5.94 6.64 6.25 6.47 6.31
HP_PROLONGED_QTC_INTERVAL 6.23 6.1 6.57 6.5 5.83 5.71 6.17 6.11 5.91 6.37 6.45 5.83 5.9 5.87 6.79 6.44 6.36 6.81 6.19 6.07 6.05 6.11 6.17 6.32 6.16 6.08
HP_POLYARTICULAR_ARTHROPATHY 5.11 5.07 4.85 4.92 4.65 4.37 4.62 4.71 4.62 4.53 4.76 4.55 4.55 4.54 4.46 4.66 4.8 4.91 4.83 4.59 4.88 4.65 4.52 4.34 4.53 4.53
HP_IMPAIRED_MASTICATION 6.56 6.85 5.92 6.95 7.09 6.98 6.15 5.75 6.63 6.77 6.48 6.81 6.84 6.88 6.27 6.48 6.53 6.56 7.08 6.3 6.4 6.41 6.82 6.67 6.73 6.47
HP_BOWEL_DIVERTICULOSIS 7.19 6.91 7.14 7.12 7.4 7.16 7.2 7.34 6.94 7.35 7.17 7.43 7.55 7.73 7.34 7.27 7.14 7.07 7.47 7.47 7.18 7.38 7.07 7.6 7.18 7.13
HP_ADENOMATOUS_COLONIC_POLYPOSIS 7.44 7.65 7.61 7.44 8.09 8.17 7.62 7.69 7.65 7.58 7.08 7.73 8.14 8.04 7.3 7.14 6.73 6.78 7.87 7.98 7.45 8.23 7.57 7.6 8.26 8.19
HP_GASTROINTESTINAL_INFARCTIONS 5.52 5.56 5.35 5.67 5.42 5.13 5.43 5.32 5.4 5.1 5.5 5.05 5.47 5.28 4.98 5.08 5.46 5.16 5.44 5.38 5.9 5.35 5.97 5.09 5.17 5.05
HP_INTESTINAL_HYPOPLASIA 6.05 5.49 5.32 5.85 5.68 5.49 6.02 5.54 5.98 5.7 6.15 5.64 5.56 5.62 5.47 5.44 6.28 6.28 5.81 5.88 5.92 5.66 6.75 5.47 5.97 5.96
HP_THORACIC_HYPOPLASIA 6.57 6.53 6.59 6.6 6.75 6.69 6.45 6.54 6.6 6.69 6.6 6.73 6.62 6.72 6.53 6.64 6.56 6.66 6.75 6.7 6.52 6.61 6.73 6.57 6.83 6.78
HP_JOINT_HEMORRHAGE 5.33 5.4 5.38 5.17 5.01 4.96 5.22 4.98 5.27 5.01 5.15 4.6 4.7 4.58 4.79 4.6 4.8 5.11 5.1 4.53 5.32 5.19 4.97 4.85 5.24 5.03
HP_ABNORMALITY_OF_THE_SYNOVIA 6.47 6.38 6.46 6.49 6.61 6.6 6.47 6.64 6.57 6.64 6.57 6.53 6.61 6.59 6.43 6.53 6.49 6.45 6.35 6.48 6.37 6.43 6.61 6.63 6.59 6.65
HP_GASTRITIS 5.84 5.68 5.12 5.96 5.77 5.54 5.76 5.55 5.93 5.43 5.74 5.29 5.71 5.48 5.51 5.24 6.1 5.73 5.49 5.24 5.59 5.9 5.63 5.63 5.49 5.37
HP_ABNORMALITY_OF_THE_GALLBLADDER 6.44 6.61 6.65 6.66 6.37 6.4 6.6 6.73 6.35 6.45 6.46 6.43 6.26 6.4 6.54 6.56 6.58 6.5 6.66 6.51 6.65 6.55 6.51 6.5 6.46 6.69
HP_INTESTINAL_POLYP 6.82 7.03 7.15 7.2 7.19 6.96 7.16 7.11 7.27 7.16 6.86 7.13 7.16 6.99 6.96 7.18 6.32 6.57 6.88 6.98 6.88 6.92 7.33 7.2 7 6.78
HP_SPONTANEOUS_ABORTION 5.44 5.35 5.1 5.26 4.95 4.6 4.96 4.7 4.95 4.79 5.17 4.58 4.85 4.52 4.64 4.67 4.97 5.11 4.86 4.63 5.25 4.89 4.89 4.55 4.87 4.71
HP_PROMINENT_NASOLABIAL_FOLD 6.51 6.66 6.27 6.5 5.88 6.24 6.09 6.76 6.11 6.92 6.33 6 6.21 6.18 7.01 6.31 6.12 6.36 6.27 6.48 6.21 5.91 7.15 6.73 6.55 6.24
HP_PROMINENT_NASAL_TIP 8.22 7.88 7.61 7.59 8.09 8.17 8.2 8.36 7.94 8.35 7.67 8.03 7.73 7.88 8.21 8.35 8.48 8.28 8.28 8.12 7.98 8.64 8.14 8.27 8.65 8.49
HP_DEPRESSED_NASAL_BRIDGE 6.98 7 7.15 7 7.2 7.32 7.16 7.17 7.11 7.29 7 7.22 7.39 7.46 7.2 7.23 7.14 7.01 7.19 7.21 7.15 7.27 7.25 7.38 7.28 7.25
HP_ABNORMALITY_OF_THE_NASOLABIAL_REGION 6.51 6.66 7.13 7.74 7.02 6.48 6.66 6.76 6.8 7.14 6.88 7 6.58 6.39 7.17 6.75 6.37 6.36 6.27 6.98 6.61 6.6 7.15 7.03 6.95 6.84
HP_VENOUS_INSUFFICIENCY 6.66 6.59 6.64 6.51 6.81 6.96 6.98 6.8 6.85 6.75 6.83 6.78 7.27 6.96 6.93 6.96 6.82 6.7 6.43 6.94 7.01 6.68 7.07 7.15 7.11 7.07
HP_CEREBRAL_VENOUS_THROMBOSIS 6.48 6.38 6.3 6.25 6.08 5.76 6.05 6.1 6.19 6.17 6.41 6.23 5.6 6.14 5.84 6.11 6.32 6.17 6.18 5.71 6.35 5.93 6.03 5.78 6.57 6.38
HP_CAPILLARY_HEMANGIOMA 6.95 6.83 7.08 7.36 7.57 7.32 7.31 7.49 7.32 7.31 7.27 7.48 7.46 7.65 7.44 7.49 7.52 7.34 7.45 7.46 7.36 7.51 7.37 7.53 7.39 7.31
HP_INCREASED_PULMONARY_VASCULAR_RESISTANCE 5.48 5.22 5.51 6.14 5.05 4.99 5.55 5.37 5.38 5.26 5.73 5.34 5.26 5.03 5.47 5.1 5.33 5.66 5.23 4.98 5.21 5.3 5.72 5.06 5.06 5.22
HP_DISTURBANCE_OF_FACIAL_EXPRESSION 8.42 8.58 8.17 7.95 9 8.92 9.03 8.94 8.65 8.8 8.35 8.61 8.45 8.4 8.72 8.48 8.55 8.45 8.74 8.8 8.62 8.66 8.75 8.98 8.79 8.59
HP_PROGEROID_FACIAL_APPEARANCE 6.56 6.49 6.42 6.89 6.89 6.58 6.47 6.44 6.67 6.78 6.63 6.49 6.66 6.47 6.58 6.5 6.55 6.38 6.92 6.53 6.4 6.17 6.67 6.88 6.62 6.5
HP_SPARSE_LATERAL_EYEBROW 6.54 6.9 7.84 7.19 7.02 7.1 6.71 7.15 6.73 6.98 7.31 6.99 7.01 6.79 7.34 6.92 6.85 6.4 6.81 7.01 6.83 7.13 7.13 7.35 6.85 6.82
HP_ABNORMALITY_OF_COMPLEMENT_SYSTEM 5.54 5.69 5.89 5.85 5.57 5.54 5.17 5.19 5.05 5.69 5.66 5.72 5.31 5.25 5.04 5.38 5.61 5.62 5.66 5.07 5.35 5.69 5.31 5.42 6.1 6.2
HP_ABNORMAL_CAROTID_ARTERY_MORPHOLOGY 6.04 5.98 6.16 6.17 6.28 6.23 6.18 6.08 6.32 6.17 6.13 6.3 6.27 5.97 6.01 6.03 6.01 6.03 5.91 6.19 5.88 5.94 6.38 6.45 6.04 5.83
HP_ABNORMAL_VENA_CAVA_MORPHOLOGY 5.62 5.46 5.86 5.51 5.22 5.44 5.66 5.53 5.69 6 5.65 5.68 5.47 5.44 5.54 5.94 5.61 5.91 5.37 5.4 5.57 5.62 5.43 5.25 5.72 5.76
HP_ABNORMAL_FACIAL_EXPRESSION 7.32 7.39 7.21 7.23 7.75 7.88 7.55 7.46 7.51 7.56 7.32 7.46 7.64 7.67 7.58 7.36 7.47 7.41 7.76 7.63 7.32 7.4 7.59 7.75 7.6 7.47
HP_RECURRENT_HERPES 5.48 5.39 4.82 5.27 5.32 5.17 5.38 5.14 5.21 5.19 5.24 4.86 4.98 4.91 5.18 4.92 5.08 5.36 4.89 4.81 5.36 5.08 4.83 4.9 4.87 4.76
HP_ABNORMALITY_OF_HUMORAL_IMMUNITY 5.88 5.86 5.87 5.89 5.85 5.65 5.88 5.77 5.84 5.85 5.89 5.83 5.72 5.77 5.63 5.63 5.91 5.84 5.78 5.83 5.89 5.84 5.71 5.59 5.82 5.93
HP_CELLULAR_IMMUNODEFICIENCY 6.54 6.71 7.14 7.81 7.37 7.44 6.59 6.78 6.79 7.1 7.06 6.99 6.96 7.24 6.49 6.83 6.66 6.96 7.08 7.22 6.28 6.43 6.79 6.66 6.21 6.8
HP_COMBINED_IMMUNODEFICIENCY 5.51 5.48 5.61 5.36 5.33 5.12 5.41 5.45 5.36 5.25 5.72 5.1 5.52 5.21 5.23 5.26 5.4 5.6 5.57 5.42 5.25 5.27 5.63 5.31 5.24 5.56
HP_RECURRENT_OPPORTUNISTIC_INFECTIONS 5.04 4.98 5.08 5.06 4.92 4.76 4.49 4.99 4.98 4.9 4.96 4.49 4.57 4.8 4.69 4.83 4.89 4.95 4.83 4.9 4.94 4.81 4.86 4.55 4.96 4.84
HP_RECURRENT_CANDIDA_INFECTIONS 5.49 5.39 5.1 5.23 5.19 5.3 5.38 5.15 5.5 5.46 5.18 4.87 5.19 5.09 5.5 5.13 5.22 5.47 5.1 5 5.38 5.24 4.87 5.09 4.93 4.79
HP_T_LYMPHOCYTOPENIA 5.49 5.32 5.22 5.26 5.31 5.14 5.15 5.07 5.2 5.07 5.25 4.94 5.08 5.02 5.07 5.21 5.26 5.43 5.05 5 5.29 5.26 4.92 5.01 5.14 5.44
HP_RECURRENT_BACTERIAL_SKIN_INFECTIONS 5.93 5.52 5.31 5.61 5.38 5.2 5.8 5.56 5.5 5.73 5.61 5.05 6.02 5.84 5.47 5.38 5.71 5.9 5.36 5.47 6.07 5.92 5.05 5.16 5.77 5.02
HP_RECURRENT_GRAM_NEGATIVE_BACTERIAL_INFECTIONS 5.3 5.03 4.68 4.9 4.56 4.43 4.59 4.54 4.61 4.29 4.61 4.52 4.3 4.46 4.39 4.62 4.85 5.13 4.63 4.5 5.13 4.62 4.62 4.31 4.5 4.86
HP_DECREASED_SERUM_COMPLEMENT_C3 6.89 6.68 7 6.65 7.11 7.08 7.19 6.3 7.27 7.06 7.16 6.49 6.72 6.81 6.97 7.06 6.76 6.88 7.07 6.67 6.89 6.95 7.36 7.23 7.31 7.37
HP_RECURRENT_SINOPULMONARY_INFECTIONS 5.46 5.36 5.32 5.35 5.23 5.19 5.53 5.36 5.24 5.71 5.47 5.57 5.29 5.16 5.46 5.68 5.45 5.73 5.25 5.03 5.44 5.37 5.17 5.11 5.15 5.34
HP_IMPAIRED_T_CELL_FUNCTION 5.93 5.92 5.96 6.06 5.74 5.5 5.68 5.73 5.76 5.58 5.83 5.35 5.78 5.68 5.79 5.62 5.73 5.73 5.68 5.65 5.69 5.85 5.8 5.63 5.7 5.76
HP_ENLARGED_POSTERIOR_FOSSA 6.58 6.59 6.83 6.68 6.68 6.83 6.73 6.94 6.75 6.85 6.82 6.73 6.81 6.84 6.91 6.93 6.69 6.67 6.85 6.79 6.73 6.9 6.89 6.87 6.91 6.73
HP_CRANIOFACIAL_OSTEOSCLEROSIS 6.43 6.71 7.21 6.74 6.51 6.97 6.5 6.98 6.56 6.91 6.81 6.68 6.62 6.75 6.68 6.65 6.68 6.94 6.99 7.25 6.31 6.61 6.79 6.6 6.58 6.39
HP_FLAT_OCCIPUT 6.91 6.95 7.31 7.22 7.33 7.34 7.08 6.98 7 7.2 7.18 7.07 7.28 7.48 7.2 7.21 7 6.97 7.32 7.29 7.15 7.23 7.24 7.52 7.17 7.21
HP_DECREASED_CALVARIAL_OSSIFICATION 7.22 7.04 7.97 6.94 7.37 7.33 7.36 7.15 7.34 7.27 7.31 7.28 7.26 7.37 6.66 7.05 7.65 7.24 7.45 7.67 7.16 7.36 6.99 7.28 7.55 7.31
HP_ABNORMAL_EPIGLOTTIS_MORPHOLOGY 7.15 6.84 6.91 6.99 7.27 7.25 7.41 7.13 7.17 6.94 6.94 7.33 7.23 7.3 7.15 7.27 6.91 7.09 7.38 7.47 6.67 7.04 6.98 6.94 7.07 7.33
HP_POSTNATAL_MICROCEPHALY 7.83 7.78 8.13 7.81 8.01 8.13 8.05 8 8.05 8.03 7.89 7.93 8.09 8.09 8.07 7.88 7.75 7.59 7.89 8.16 7.67 7.94 8 8.21 8 7.93
HP_PROMINENT_METOPIC_RIDGE 7.26 7.48 7.34 7.21 7.46 7.73 7.44 7.58 7.37 7.35 7.18 7.49 7.29 7.43 7.38 7.3 7.1 7.36 7.44 7.6 7.64 7.55 7.3 7.53 7.34 7.41
HP_INCREASED_MEAN_CORPUSCULAR_VOLUME 6.81 6.44 7.11 6.34 7.05 7.29 6.94 6.4 7.15 6.87 7.47 7.19 6.69 7.47 6.76 6.76 7.22 6.61 6.47 6.15 6.69 6.8 6.45 6.59 6.65 6.38
HP_DISSEMINATED_INTRAVASCULAR_COAGULATION 6.83 6.89 7.05 6.73 6.98 6.5 6.57 6.77 7.22 7.02 6.87 7.35 7.04 6.83 7.29 7.34 7.46 7.54 6.34 6.53 7.14 6.81 7.21 7.62 7.88 7.99
HP_PYRIDOXINE_RESPONSIVE_SIDEROBLASTIC_ANEMIA 5.56 5.45 5.24 5.95 5.17 5.1 5.17 4.92 5.31 5.3 4.84 5.52 4.87 4.94 5.22 5.04 5.45 5.24 5.63 5.16 5.34 5.25 5.13 4.91 5.01 5.31
HP_LYMPHOPROLIFERATIVE_DISORDER 6.18 6.39 7.19 6.91 6.14 6.49 6.76 6.79 6.63 6.78 6.67 6.79 6.98 6.63 6.39 7.33 6.36 6.5 6.09 6.89 6.23 6.74 6.95 6.91 6.69 6.7
HP_BONE_MARROW_HYPOCELLULARITY 6.4 6.19 6.12 6.34 6.34 6.3 6.23 6.24 6.29 6.13 6.17 6.22 6.35 6.26 6.05 6.14 6.25 6.03 6.18 6.25 6.2 6.22 6.31 6.33 6.27 6.31
HP_MYELOPROLIFERATIVE_DISORDER 6.7 6.65 6.65 6.54 6.86 7.17 6.35 6.89 6.71 6.9 6.62 6.73 6.81 6.96 6.82 6.69 6.91 6.67 6.83 6.85 6.86 7.09 7.09 6.91 6.98 7.01
HP_ABNORMALITY_OF_THE_METOPIC_SUTURE 7.24 7.4 7.12 7.16 7.39 7.45 7.26 7.56 7.29 7.31 7.09 7.44 7.11 7.29 7.31 7.32 7.15 7.34 7.36 7.57 7.62 7.51 7.17 7.42 7.2 7.39
HP_CHRONIC_LEUKEMIA 6.59 6.81 6.7 7.22 7.43 7.72 6.72 6.94 7.09 7.23 7.26 7.52 7.16 7.13 7.34 7.16 7.11 7.01 6.96 6.85 6.83 7.09 7.98 7.49 7.47 7.4
HP_ABNORMALITY_OF_BONE_MARROW_CELL_MORPHOLOGY 6.21 6.24 6.23 6.18 6.34 6.16 6.24 6.39 6.29 6.22 6.34 6.22 6.36 6.29 6.08 6.24 6.22 6.15 6.1 6.21 6.22 6.25 6.28 6.33 6.32 6.32
HP_MULTIPLE_RENAL_CYSTS 6.67 6.74 6.96 6.7 6.89 7 7 7.14 6.73 6.87 6.56 6.91 6.97 6.96 6.92 6.81 6.75 6.56 7.04 7.03 7 6.94 7.06 7.27 6.95 6.89
HP_HEMOLYTIC_UREMIC_SYNDROME 6.41 6.28 6.9 6.38 7.18 7.02 6.99 6.67 6.43 6.13 6.21 6.1 6.94 6.99 5.96 6.36 6.72 5.95 6.33 7.22 6.5 6.46 6.18 5.93 7.59 7.54
HP_RENAL_CELL_CARCINOMA 7.19 7.19 7.61 7.48 7.38 7.44 7.28 7.47 7.34 7.43 7.4 7.64 7.47 7.56 7.5 7.49 7.51 7.14 7.3 7.46 7.06 7.38 7.62 7.47 7.42 7.61
HP_GENERALIZED_HYPERKERATOSIS 7.37 7.32 9.01 8.43 8.13 7.66 7.53 7.94 8 7.65 8.36 7.77 8.22 7.91 8.26 7.66 7.51 7.14 7.61 8.18 7.21 8.14 8.38 8.08 7.8 7.13
HP_ABNORMAL_TRACHEOBRONCHIAL_MORPHOLOGY 6.12 6.09 5.97 6.06 5.91 6.01 6.02 6.11 6.02 6.05 6.08 5.92 6 6.07 6.03 6.15 5.93 6.09 5.96 6 6.1 6.07 5.9 5.87 6.12 6.16
HP_APLASIA_HYPOPLASIA_OF_THE_FEMUR 6.57 6.45 6.73 6.43 6.46 6.54 6.48 6.72 6.53 6.72 6.37 6.63 6.45 6.52 6.49 6.55 6.47 6.13 6.49 6.24 6.17 6.31 6.76 6.82 6.64 6.49
HP_ACCELERATED_SKELETAL_MATURATION 6.32 6.58 6.55 6.67 6.79 6.65 6.78 6.68 6.75 6.76 6.54 6.69 6.82 6.77 6.8 6.78 6.6 6.6 6.74 6.77 6.95 6.75 7 6.99 6.86 6.89
HP_THORACOLUMBAR_KYPHOSIS 6.73 7.12 6.5 6.78 7.19 7.35 6.87 7.18 6.66 6.86 7.01 7.06 7.17 7.15 6.9 6.8 6.93 7.32 7.45 7.05 6.98 7.03 6.66 6.85 7.25 7.24
HP_BROAD_LONG_BONES 6.74 7.09 6.83 6.85 7.12 7.34 7.18 7.18 6.92 7.31 6.95 7.15 7.4 7.36 7.2 7.29 7.3 7.05 7.16 7.08 7.14 7.13 7.31 7.37 7.08 7.25
HP_OSTEOPOROSIS_OF_VERTEBRAE 4.96 4.89 4.64 4.99 4.42 4.34 4.51 4.62 4.82 4.72 4.83 4.49 4.51 4.55 4.53 4.53 4.56 4.81 4.76 4.28 4.81 4.62 4.58 4.43 4.57 4.41
HP_ABNORMAL_VERTEBRAL_SEGMENTATION_AND_FUSION 5.29 5.32 5.34 5.27 5.02 5.31 5.38 5.09 5.28 5.02 5.2 4.95 5.59 5.49 5.05 5.16 5.05 5.12 5.05 5.21 5.34 5.12 5.27 4.88 5.2 5.2
HP_POSITIONAL_FOOT_DEFORMITY 6.53 6.61 6.66 6.62 6.83 6.77 6.64 6.8 6.72 6.75 6.6 6.79 6.81 6.71 6.77 6.6 6.63 6.63 6.6 6.7 6.67 6.78 6.85 6.8 6.85 6.86
HP_THORACIC_KYPHOSCOLIOSIS 6.38 6.1 6.48 6.36 6.38 6.22 6.22 6.1 6.33 6.11 6.59 6.23 5.97 5.84 6.31 6.44 6.69 6.67 6.32 6.32 6.62 5.88 6.59 5.85 6.5 6.15
HP_JUVENILE_RHEUMATOID_ARTHRITIS 5.14 4.97 5.1 5.27 4.52 4.29 4.8 4.96 4.66 4.52 4.91 4.54 4.34 4.71 4.26 4.74 5.12 5.31 4.74 4.59 4.89 4.51 4.44 4.2 4.65 4.57
HP_DISTAL_ARTHROGRYPOSIS 6.1 6.17 5.95 5.86 6.29 6.6 6.66 6.71 6.34 6.11 6.61 6.62 6.56 6.6 6.49 6.49 7.29 6.87 6.55 6.89 7.04 7.05 6.37 6.48 6.7 7.11
HP_JOINT_HYPERFLEXIBILITY 6.56 6.68 6.89 6.82 6.89 6.96 6.68 6.78 6.71 6.86 6.76 6.88 6.86 6.82 6.86 6.76 6.8 6.56 6.98 6.92 6.97 6.95 6.99 7.04 6.92 6.93
HP_AVASCULAR_NECROSIS_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS 5.91 5.87 5.85 5.78 6.18 5.86 6.12 5.73 6.08 6.03 6.01 5.92 5.89 6.06 5.84 5.82 6.01 6.06 5.79 5.9 6.03 5.79 6.08 5.94 5.82 5.72
HP_CONTRACTURES_OF_THE_JOINTS_OF_THE_LOWER_LIMBS 6.71 6.76 6.65 6.81 6.93 6.93 6.76 6.95 6.94 6.79 6.8 7.06 7.05 6.85 6.85 6.68 7.14 6.8 7.04 6.93 6.71 6.79 6.99 7.05 6.94 6.96
HP_APLASIA_HYPOPLASIA_OF_THE_TIBIA 6.56 6.65 6.67 6.98 6.75 6.68 6.31 6.78 6.79 6.48 6.93 6.9 6.82 6.7 6.85 7.04 6.83 6.74 6.33 6.68 6.9 7.09 6.79 6.65 6.62 7.3
HP_SHORT_MIDDLE_PHALANX_OF_FINGER 5.8 6.22 5.91 6.09 6.12 5.95 6.27 6.23 6.36 6.41 6.3 6.57 6 6.29 6.63 6.67 6.1 5.83 6.07 6.2 6.24 6.38 6.76 6.03 6.8 6.82
HP_MULTIPLE_PRENATAL_FRACTURES 6.31 6.29 6.31 6.4 6.55 6.84 6.06 6.17 6.67 6.53 6.34 6.57 6.56 6.5 6.08 6.32 6.26 6.36 6.3 6.32 6.05 6.06 6.41 6.36 6.52 6.29
HP_METAPHYSEAL_CHONDRODYSPLASIA 7.01 6.94 6.8 6.52 7.51 7.44 7.11 6.9 6.99 7.41 7.19 7 7.18 6.87 7.06 6.97 7.01 6.84 7.05 6.74 6.82 6.79 7.37 7.28 6.85 6.94
HP_ABNORMALITY_OF_METACARPAL_EPIPHYSES 7.23 6.98 6.83 6.51 7.71 7.52 7.06 7.18 7.16 7.29 6.72 7.53 7.42 7.33 7.3 7.39 7.91 7.22 7.25 7.22 7.19 7.33 7.08 7.45 7.44 7.42
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_METACARPAL_BONES 6.61 6.65 6.55 6.67 6.78 6.81 6.81 6.85 6.79 6.69 6.72 6.73 6.82 6.77 6.73 6.86 6.8 6.77 6.82 6.88 6.69 6.8 7 6.92 6.73 6.86
HP_ABNORMAL_METACARPAL_MORPHOLOGY 6.57 6.59 6.49 6.56 6.76 6.75 6.73 6.81 6.67 6.64 6.64 6.72 6.8 6.71 6.62 6.73 6.7 6.67 6.62 6.71 6.68 6.75 6.84 6.73 6.63 6.79
HP_ABNORMAL_FINGER_PHALANX_MORPHOLOGY 6.51 6.51 6.65 6.57 6.69 6.7 6.62 6.65 6.64 6.69 6.54 6.69 6.66 6.62 6.66 6.7 6.54 6.55 6.58 6.63 6.6 6.7 6.81 6.8 6.67 6.67
HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY_OF_THE_PHALANGES_OF_THE_HAND 6.51 6.4 6.57 6.79 6.62 6.7 6.47 6.43 6.3 6.48 6.62 6.76 6.52 6.59 6.42 6.64 6.48 6.44 6.78 6.43 6.47 6.62 6.72 6.62 6.29 6.32
HP_ABNORMAL_HAND_MORPHOLOGY 6.76 6.78 6.86 6.78 6.84 6.96 6.96 6.87 6.8 6.92 6.8 6.89 6.89 6.8 6.91 6.88 6.77 6.67 6.91 6.95 6.81 6.96 7.02 7.05 6.95 6.89
HP_ABNORMALITY_OF_EPIPHYSIS_MORPHOLOGY 6.45 6.37 6.59 6.56 6.59 6.66 6.34 6.41 6.29 6.56 6.44 6.54 6.49 6.56 6.41 6.55 6.37 6.4 6.45 6.38 6.22 6.48 6.47 6.51 6.39 6.48
HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_MORPHOLOGY 5.46 5.28 5.3 5.18 5.03 5.14 5.27 5.14 5.24 5.35 5.08 5.33 5.25 5.1 5.21 5.35 5.37 5.73 5.08 4.96 5.35 5.42 5.2 5.06 5.07 5.3
HP_RESPIRATORY_ARREST 6.54 7.22 6.87 6.26 7.84 8.07 7.34 8 7.05 8.06 7.17 7.52 7.46 7.01 7.01 6.78 7.01 7.42 7.41 7.9 6.14 6.45 6.61 7.46 7.29 7.4
HP_DECREASED_PULMONARY_FUNCTION 6.13 5.7 6.42 6.42 6.05 6.03 5.91 6.4 5.95 6.29 6.26 6.17 6.23 6.17 6.12 6.32 6.45 6.06 6 6.18 6.21 6.35 6.42 5.87 6.16 6.6
HP_BREATHING_DYSREGULATION 5.15 5.16 5.38 5.92 4.92 4.99 5.01 4.95 5.04 5.17 5.33 5.11 5.1 5.03 5.04 5.08 5.53 5.34 4.96 4.98 5.21 5.28 5.47 5.01 5.05 5.22
HP_TEMPERATURE_INSTABILITY 5.9 5.96 6.22 6.45 6.04 5.96 6.02 6 6.31 6.37 6.25 6.28 6.37 6.42 6.07 6.29 6.27 6.03 6.1 6.3 6.38 6.48 6.3 6.16 6.49 6.26
HP_TYPE_II_DIABETES_MELLITUS 6.01 5.97 6.1 6.2 6.03 6.05 5.83 5.9 6 6.14 6.18 6.17 6.06 6.15 6.05 6.1 5.97 6.04 6.08 6.13 6.1 5.96 6.07 5.99 5.95 6.24
HP_LIMITATION_OF_NECK_MOTION 6.08 6.16 6.05 6.08 6.56 6.22 6.35 6.17 6.26 6.55 5.94 6.48 6.27 6.05 6.35 6.44 6.28 5.74 6.25 6.38 6.23 6.17 6.77 6.49 6.29 6.38
HP_REDUNDANT_NECK_SKIN 7.42 7.62 7.78 7.74 7.65 7.75 7.82 7.79 7.8 7.81 8.16 7.7 7.93 7.72 7.88 7.87 7.1 7.5 7.56 7.79 7.54 7.79 8.16 7.96 8.11 7.82
HP_NODULAR_GOITER 5.5 5.58 5.85 5.93 5.65 5.8 6.03 5.59 5.81 5.78 5.85 5.76 5.88 5.9 5.73 5.68 5.38 5.29 5.46 5.62 6.23 6.04 5.78 5.9 5.8 5.64
HP_URETERAL_OBSTRUCTION 6.57 6.54 6.38 6.3 6.56 6.77 6.35 6.61 6.33 6.68 5.9 6.38 6.61 6.59 6.88 6.32 6.16 6.25 6.73 6.31 6.31 6.46 6.28 6.55 6.27 6.31
HP_Y_SHAPED_METACARPALS 6.51 6.51 6.17 6.16 6.63 6.51 6.62 6.24 6.09 6.19 6.69 6.68 6.41 6.56 6.08 6.59 6.72 6.9 6.82 6.22 6.89 6.97 6.33 6.32 6.56 6.62
HP_PALMAR_HYPERHIDROSIS 5.34 5.24 5.24 5.16 4.77 4.77 5.07 4.91 4.9 5.03 5.09 4.96 4.93 4.84 5.1 4.74 4.87 5.01 4.9 5.09 5.16 5.25 4.99 4.91 5.1 4.86
HP_FINGER_SYNDACTYLY 6.27 6.37 6.34 6.36 6.46 6.5 6.49 6.49 6.33 6.38 6.29 6.61 6.41 6.48 6.32 6.6 6.46 6.47 6.3 6.43 6.3 6.43 6.54 6.68 6.45 6.52
HP_ABSENT_PHALANGEAL_CREASE 5.09 5.43 5.44 5.26 4.98 5.13 5.4 5.15 5.11 5.35 5.17 4.97 5.54 5.47 5.25 5.32 5.24 5.29 4.89 5.23 5.32 5.43 5.14 5.07 5.16 5.16
HP_SHORTENING_OF_ALL_DISTAL_PHALANGES_OF_THE_FINGERS 7.25 7.37 7.7 7.01 7.44 7.59 7.68 7.65 7.88 7.55 7.13 7.49 7.75 7.76 7.66 7.51 7.18 7.33 7.42 7.63 7.18 7.51 8.19 8.15 7.85 7.47
HP_ABNORMAL_FINGER_FLEXION_CREASES 5.12 5.47 5.48 5.26 5.2 5.17 5.57 5.24 5.14 5.48 5.31 4.97 5.75 5.88 5.32 5.63 5.35 5.46 4.92 5.32 5.5 5.62 5.17 5.29 5.25 5.27
HP_DEEP_PALMAR_CREASE 7.7 7.85 8.26 8.21 7.54 7.95 8.47 8.36 8.14 8.45 8.08 8.19 8.47 8.58 8.28 8.44 8.11 7.93 7.71 8.14 8.25 8.27 8.48 8.55 8.19 8.11
HP_LIMITED_WRIST_MOVEMENT 6.63 6.74 6.86 6.67 6.94 7.16 6.94 6.91 6.97 7.16 6.85 7 6.78 7.05 6.78 6.71 7 6.77 6.75 7.38 6.63 6.25 7.28 6.93 6.74 6.9
HP_ABNORMALITY_OF_HAND_JOINT_MOBILITY 7.07 7.03 6.91 6.74 6.94 6.93 6.93 6.99 7.05 6.69 6.73 6.98 6.82 6.8 7.36 6.74 7.22 7.24 6.79 6.87 7.21 7.05 6.96 6.87 7.07 6.93
HP_ABNORMALITY_OF_CARPAL_BONE_OSSIFICATION 6 6.13 5.96 6.3 6.06 6.25 5.98 6.38 6.31 6.27 6.24 6.13 6.08 6.18 6.16 5.94 6.16 5.92 5.86 6.22 6.1 5.86 6.24 6.46 6.4 6.27
HP_ABNORMAL_PHALANGEAL_JOINT_MORPHOLOGY_OF_THE_HAND 6.05 6.13 6.08 6.14 6.04 6.04 6.05 6.06 6.1 6.16 6.11 6.11 6.18 6.13 6.09 6.09 6.13 6.06 6.1 6.09 6.12 6.09 6.12 6.07 6.29 6.31
HP_APLASIA_HYPOPLASIA_OF_THE_5TH_FINGER 6.19 6.27 6.68 6.39 6.2 6.26 6.68 6.94 6.44 6.59 6.5 6.48 6.15 6.48 6.8 6.71 6.53 6.23 6.29 6.44 6.5 6.58 6.67 6.54 6.62 6.3
HP_APLASIA_HYPOPLASIA_OF_THE_2ND_FINGER 5.71 5.57 5.19 5.05 5.27 5.05 5.23 5.35 5.31 4.95 5.27 5.33 5.38 5.2 5.64 5.23 5.66 5.08 5.13 5.18 5.79 5.47 5.36 5.35 5.37 4.89
HP_APLASIA_HYPOPLASIA_OF_FINGERS 6.65 6.7 6.8 6.67 6.81 6.93 6.83 6.84 6.79 6.89 6.69 6.84 6.88 6.71 6.86 6.8 6.67 6.66 6.73 6.87 6.8 6.92 6.95 7.01 6.89 6.79
HP_ADVANCED_ERUPTION_OF_TEETH 7.15 7.12 6.96 6.98 7.74 7.6 7.38 7.34 7.56 7.56 7.1 7.57 7.47 7.65 7.14 7.31 7.17 7.26 7.57 7.48 7.39 7.37 7.31 7.48 7.56 7.37
HP_ABNORMALITY_OF_DENTAL_ERUPTION 6.73 6.69 6.82 6.7 7.03 7.05 6.98 7.01 6.99 6.98 6.65 7.01 7.09 7.06 7.11 6.88 6.78 6.8 6.9 6.92 6.81 6.96 7.15 7.16 7 6.87
HP_HYPOPLASIA_OF_DENTAL_ENAMEL 6.62 6.89 6.65 6.56 6.78 6.74 6.81 6.7 6.91 6.86 6.72 7.09 6.93 6.75 6.82 6.71 6.71 6.93 6.87 6.93 6.64 6.85 6.87 7.13 7.18 6.77
HP_PROLONGED_BLEEDING_AFTER_DENTAL_EXTRACTION 5.63 5.48 5.26 5.29 4.98 5 5.06 4.84 5.23 5.02 5.14 4.66 4.91 4.56 4.91 4.57 5.1 5.1 5.1 4.54 5.43 5.23 5.3 5.02 5.31 5.04
HP_SINGLE_MEDIAN_MAXILLARY_INCISOR 6.15 6.22 6.22 6.34 6.32 6.26 6.37 6.2 6.3 6.62 6.1 6.28 6.65 6.46 6.19 6.25 6.09 6.14 6.12 6.35 6.38 6.29 6.36 6.4 6.41 6.26
HP_PREMATURE_LOSS_OF_PRIMARY_TEETH 6.58 6.71 6.96 6.3 6.22 6.23 6.4 6.43 6.49 6.53 6.65 6.4 6.38 6.54 6.25 6.25 6.67 6.49 6.42 6.85 6.8 7.1 6.51 6.42 7.11 7.15
HP_PERSISTENCE_OF_PRIMARY_TEETH 6.46 6.34 6.22 6.69 6.74 6.52 6.44 6.46 6.58 6.84 6.37 6.79 6.65 6.46 6.21 6.58 6.45 6.44 6.22 6.54 6.22 6.26 6.83 6.99 6.79 6.65
HP_PEG_SHAPED_MAXILLARY_LATERAL_INCISORS 5.42 5.7 5.74 5.95 5.63 5.46 5.18 5.5 5.76 5.23 5.38 5.42 5.47 5.44 5.47 5.55 5.05 5.43 5.07 5.01 5.24 5.3 5.71 5.31 5.11 5.07
HP_AGENESIS_OF_PERMANENT_TEETH 6.47 6.89 6.71 6.44 7.19 7.36 7.18 7.43 6.85 7.35 6.89 7.08 7.6 7.89 6.39 7.39 7.3 7.03 6.44 6.73 6.87 7.47 7.48 7.14 7.09 7.57
HP_KNEE_FLEXION_CONTRACTURE 6.72 6.8 6.66 6.71 6.92 6.92 6.65 6.97 6.91 6.67 6.95 7.15 7.08 7.02 6.85 6.71 7.32 6.84 7.13 7.03 7.07 7.03 7 7.25 6.98 7.04
HP_INCREASED_DENSITY_OF_LONG_BONES 6.58 6.87 6.25 6.52 6.85 7.23 6.88 6.89 6.8 7.36 6.84 7.26 7.39 7.37 7.19 6.79 6.81 6.74 7.07 6.93 6.96 7.39 7.29 7.29 6.86 6.79
HP_PATELLAR_APLASIA 5.81 6.05 5.97 6.05 5.46 5.43 5.68 5.91 5.63 5.54 6.06 5.39 5.4 5.5 5.53 5.62 6.03 5.67 5.68 5.59 5.85 5.58 5.63 5.32 5.71 5.84
HP_ANKLE_FLEXION_CONTRACTURE 6.81 6.83 6.43 6.55 6.84 6.94 6.62 6.99 6.77 6.67 6.93 6.85 7.03 6.78 6.86 6.71 7.29 6.8 6.74 6.68 6.74 6.88 6.99 6.82 7 7.02
HP_ABNORMALITY_OF_THE_ALVEOLAR_RIDGES 6.48 6.7 6.37 6.48 6.41 6.69 6.68 6.95 6.57 6.7 6.37 6.49 6.82 6.66 6.99 6.46 6.66 6.67 6.54 6.3 6.77 6.85 6.51 6.69 6.95 7
HP_ABNORMALITY_OF_THE_DENTAL_PULP 5.86 5.86 6.09 5.87 6.05 5.88 5.85 6.02 5.91 5.94 6.03 6.02 6.09 6.02 5.99 6.29 6.15 6.04 6.16 6.05 6.06 6.29 6.19 5.88 6.12 6.31
HP_PREMATURE_LOSS_OF_TEETH 6.37 6.38 6.22 6.05 6.27 6.38 6.3 6.37 6.34 6.47 6.15 6.43 6.4 6.31 6.28 6.23 6.56 6.26 6.18 6.38 6.4 6.22 6.5 6.52 6.74 6.68
HP_ABNORMALITY_OF_PRIMARY_TEETH 6.46 6.46 6.48 6.68 6.86 6.64 6.59 6.59 6.83 6.84 6.58 6.87 6.91 6.71 6.51 6.61 6.67 6.49 6.54 6.71 6.8 7.05 6.82 7.03 7.06 7.12
HP_ABNORMALITY_OF_DENTAL_MORPHOLOGY 6.7 6.72 6.99 6.89 6.85 6.89 6.8 6.99 6.69 6.88 6.76 7.01 6.89 6.82 7 6.93 6.82 6.78 6.85 6.98 7.02 7.14 6.83 7.03 6.98 7.12
HP_ABNORMAL_NUMBER_OF_TEETH 6.77 6.82 6.84 6.84 6.94 7.04 6.98 6.99 6.92 6.96 6.86 7.02 7.1 7.12 6.96 6.93 6.85 6.8 6.97 6.94 6.96 6.97 7.04 7.15 7.05 6.93
HP_AGENESIS_OF_INCISOR 5.4 5.35 5.12 5.37 5.1 4.96 4.88 5.19 5.16 4.95 5.3 5.15 5.21 5.23 5.09 4.95 5.02 5.08 5.02 4.81 5.15 5.07 4.92 5.06 4.98 4.68
HP_ABNORMALITY_OF_THE_DENTAL_ROOT 6.23 6.37 6.38 6.39 6.36 6.42 6.35 6.56 6.09 6.22 6.1 6.47 6.28 6.48 6.31 6.62 6.25 6.25 6.32 6.35 6.35 6.61 6.33 6.59 6.21 6.73
HP_BOWING_OF_THE_ARM 6.49 6.21 5.93 5.87 6.38 6.42 6.49 6.38 6.45 6.41 6.64 6.27 6.47 6.59 6.47 6.74 6.49 6.66 6.29 6.22 6.56 6.49 6.79 6.65 6.46 6.36
HP_ABNORMALITY_OF_LOWER_LIMB_METAPHYSES 6.14 6.16 6.09 5.75 6.26 6.69 6.21 6.32 6.03 6.63 5.73 6.52 6.65 6.52 6.7 6.45 5.61 6.05 6.41 6.13 6.19 6.45 6.24 6.41 6.24 6.25
HP_APLASIA_HYPOPLASIA_OF_THE_FIBULA 6.97 7.18 7.06 6.74 6.91 7.28 7.38 7.5 7.2 7.28 7.09 7.27 7.46 7.35 7.21 7.2 7.32 7.31 6.85 7.49 7.31 7.24 7.16 7.38 7.58 7.55
HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS 6.8 6.89 6.96 6.93 7.07 7.24 7.01 7.04 6.93 7.05 6.93 7.03 7.2 7.09 7.03 7.05 7.01 6.86 7.07 7.11 6.88 7.11 7.09 7.11 7.17 7.22
HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_FEET 7.01 7.09 7.15 6.99 7.19 7.36 7.2 7.21 7.16 7.35 7.06 7.25 7.41 7.37 7.21 7.18 7.17 6.99 7.24 7.22 7.13 7.26 7.39 7.45 7.29 7.35
HP_APLASIA_HYPOPLASIA_OF_THE_ULNA 5.87 5.99 5.78 5.96 5.91 6.06 5.85 6.04 6.17 6.09 5.64 5.89 6.02 5.94 6.02 5.74 5.85 5.61 5.81 6 5.76 5.73 6.25 6.36 5.78 5.68
HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS 6.66 6.72 6.82 6.72 6.86 6.98 6.85 6.92 6.8 6.92 6.76 6.93 6.9 6.82 6.9 6.9 6.83 6.76 6.85 6.93 6.83 6.95 6.98 7.01 6.91 6.88
HP_APLASIA_HYPOPLASIA_OF_THE_PATELLA 6.43 6.65 6.45 6.5 6.36 6.42 6.3 6.54 6.42 6.48 6.54 6.09 6.19 6.53 6.43 6.59 6.53 6.32 6.44 6.29 6.56 6.76 6.34 6.6 6.62 7.03
HP_ABNORMALITY_OF_LOWER_LIMB_EPIPHYSIS_MORPHOLOGY 6.15 6.1 5.93 5.95 6.42 6.27 6.17 6.08 6.21 6.3 6.11 6.12 5.98 6.11 6.06 5.9 6.02 5.98 6.04 6.06 6.03 5.93 6.28 6.29 6.22 6.26
HP_APLASIA_HYPOPLASIA_OF_THE_RADIUS 5.81 5.94 5.99 6.07 5.89 5.92 5.94 5.97 5.96 6.12 6.13 5.99 6.05 5.97 6.02 5.93 5.95 5.98 5.88 6.18 5.95 6.12 6.02 6.23 5.78 5.78
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CARPAL_BONES 6.15 6.06 6.02 6.03 5.94 6.37 6.34 6.64 6.46 6.31 6 6.06 6.14 6.45 6.43 6.42 6.03 6.12 6.25 6.22 6.33 6.24 6.42 6.53 6.31 6.18
HP_APLASIA_HYPOPLASIA_INVOLVING_FOREARM_BONES 5.94 6.05 6.17 6.17 6.19 6.24 6.24 6.13 6.19 6.2 6.16 6.06 6.14 6.12 6.08 6.08 6.01 6.02 5.91 6.18 6.04 6.31 6.26 6.51 6.07 5.84
HP_ABNORMALITY_OF_LIMB_EPIPHYSIS_MORPHOLOGY 6.38 6.37 6.39 6.33 6.55 6.56 6.43 6.51 6.34 6.52 6.45 6.59 6.5 6.57 6.42 6.58 6.47 6.4 6.51 6.26 6.21 6.52 6.45 6.52 6.36 6.44
HP_APLASIA_HYPOPLASIA_OF_THE_HUMERUS 6.02 6.05 6.02 6.21 5.91 6.19 6.35 6.42 6.62 6.6 5.99 6.6 6.61 6.51 6.55 6.3 6.22 6.11 6.01 6.48 6.1 6.12 6.73 6.74 6.02 5.87
HP_CHRONIC_PULMONARY_OBSTRUCTION 5.92 5.69 5.76 5.96 5.23 5.15 5.74 5.57 5.77 5.34 5.58 5.02 5.47 5.38 5.64 5.44 5.71 5.58 5.39 5.42 5.82 5.9 5.24 5.25 5.73 5.76
HP_PROGRESSIVE_PULMONARY_FUNCTION_IMPAIRMENT 7.12 7.19 6.81 7.24 7.32 7.47 7.2 6.69 7.28 7.15 6.84 7.37 7.09 7.08 7.25 7.25 7.14 7.07 7.17 7.36 7.18 6.66 7.29 7.89 7.37 7.13
HP_CHRONIC_LUNG_DISEASE 5.8 5.81 6.06 6.44 5.95 5.9 6.02 5.89 6.04 6.2 6.16 5.72 6.26 6.31 5.86 6.19 6.1 5.93 6.12 6.1 6.38 6.39 6.14 5.83 6.21 6.03
HP_ABNORMAL_PULMONARY_INTERSTITIAL_MORPHOLOGY 5.94 5.86 5.93 5.88 5.63 5.53 5.7 5.79 5.71 6 5.8 5.75 5.52 5.74 5.77 5.82 5.83 5.9 5.69 5.7 5.8 5.76 5.64 5.43 5.88 5.96
HP_RECURRENT_PNEUMONIA 5.88 5.74 5.82 5.97 5.58 5.6 5.71 5.84 5.81 5.69 5.52 5.47 5.71 5.84 5.95 5.84 5.78 5.8 5.49 5.71 5.89 5.92 5.69 5.59 5.77 5.86
HP_AIRWAY_OBSTRUCTION 5.52 5.38 5.43 5.51 5.09 5.06 5.41 5.24 5.24 5.34 5.43 5.25 5.25 5.14 5.38 5.44 5.48 5.62 5.26 5.08 5.52 5.36 5.11 4.99 5.23 5.25
HP_ACUTE_HEPATIC_FAILURE 6.5 6.83 7.34 7.32 6.71 6.74 6.32 6.81 6.76 6.99 7.32 6.96 6.89 6.83 6.99 6.95 6.53 6.71 6.62 6.71 6.91 7.07 7.21 6.89 6.9 6.96
HP_LIPID_ACCUMULATION_IN_HEPATOCYTES 6.89 6.8 7.3 7.08 6.89 6.81 6.91 6.85 6.89 7.03 6.77 6.96 7.03 7.05 6.75 6.93 6.89 6.66 6.83 6.87 6.73 6.85 6.84 7.1 6.85 6.87
HP_VIRAL_HEPATITIS 5.8 5.66 5.99 6.04 5.96 5.98 5.78 5.85 5.9 5.78 5.71 5.82 5.81 5.77 5.71 6.08 6.06 5.78 5.85 5.86 6.09 5.91 5.92 5.73 5.82 5.76
HP_PROLONGED_NEONATAL_JAUNDICE 6.88 7.13 7.12 7.22 7.43 7.36 7.14 7.08 7.25 7.56 7.02 7.21 7.21 7.35 7.23 7.25 7 7.07 7.12 7.37 7.23 7.12 7.46 7.46 7.18 7.29
HP_WIDE_INTERMAMILLARY_DISTANCE 7.16 6.95 7.33 7.23 7.28 7.33 6.98 7.12 7.18 7.14 6.9 7.2 7.21 7.32 7.17 7.18 6.97 7.03 7.2 7.05 7.06 7.25 7.16 7.29 7.08 7.01
HP_APLASTIC_CLAVICLE 5.34 5.47 5.35 5.77 5.49 5.38 5.4 5.03 5.48 5.57 5.77 5.29 5.38 5.19 5.12 5.22 5.57 5.24 5.34 5.31 5.59 5.44 5.27 5.27 5.62 5.54
HP_REDUCED_SYSTOLIC_FUNCTION 5.71 5.59 5.38 5.2 6.06 5.88 5.86 5.73 6.22 5.98 5.85 6.06 5.77 6.05 5.6 5.88 6.08 6.26 5.78 5.67 6.3 5.67 6.6 5.46 6.04 6.03
HP_VENTRICULAR_EXTRASYSTOLES 5.91 5.8 6.86 6.26 5.93 5.89 5.6 6.12 5.52 6.22 6.3 5.9 5.85 5.73 5.67 6.02 6.37 6.11 5.88 5.74 6.14 6.09 5.59 5.55 6.09 6.14
HP_ATRIOVENTRICULAR_CANAL_DEFECT 6.52 6.46 6.58 6.37 6.36 6.24 6.11 6.47 6.2 6.18 6.64 6.67 6.42 6.42 6.42 6.57 6.43 6.43 6.04 6.28 6.62 7.03 6.41 6.33 6.15 6.43
HP_APLASIA_HYPOPLASIA_OF_THE_LUNGS 6.26 6.23 6.19 6.38 6.34 6.3 6.07 6.15 6.03 6.27 6.33 6.4 6.31 6.36 6.21 6.22 6.22 6.2 6.25 6.24 6.15 6.29 6.3 6.28 6.22 6.46
HP_ABNORMAL_CORONARY_ARTERY_MORPHOLOGY 6.1 5.99 6.17 6.35 6.64 6.43 6.18 6.12 6.24 6.33 6.27 6.4 6.38 6.05 6.05 6.08 6.61 6.31 6.12 6.24 6.38 6.28 6.27 6.44 6.26 6.32
HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_MORPHOLOGY 6.55 6.57 6.62 6.6 6.69 6.56 6.65 6.81 6.69 6.6 6.54 6.67 6.75 6.59 6.56 6.58 6.58 6.54 6.38 6.63 6.71 6.64 7.01 6.93 6.76 6.87
HP_CYSTIC_LIVER_DISEASE 6.99 6.91 6.91 6.95 7.03 7.11 6.49 6.46 6.53 7.04 7.17 6.79 6.41 6.81 6.59 7.15 6.62 7.02 7.19 6.35 6.76 6.99 6.63 6.82 6.84 6.79
HP_ABNORMALITY_OF_THE_HEPATIC_VASCULATURE 6.08 6.16 5.77 6.14 5.92 5.97 6.15 6.16 6.16 6.01 5.92 6.09 6.06 6.28 5.85 6.05 6.6 6.26 5.93 5.96 6.08 6.11 5.98 5.82 5.98 6.01
HP_APLASIA_HYPOPLASIA_OF_THE_NIPPLES 7.01 6.89 6.97 6.69 7.04 7.08 7.06 6.91 7.3 7.44 6.87 7.2 7.1 7.05 7.12 6.71 6.61 6.66 7 7.1 6.63 6.73 7.1 7.25 6.86 6.77
HP_APLASIA_HYPOPLASIA_OF_THE_CLAVICLES 6.23 6.37 6.27 6.58 6.74 6.42 6.29 6.32 6.27 6.53 6.37 6.21 6.44 6.44 6.15 6.44 6.5 6.29 6.29 6.38 6.34 6.19 6.5 6.35 6.45 6.73
HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_THORAX 6.51 6.38 6.27 6.34 6.57 6.54 6.3 6.48 6.27 6.68 6.54 6.56 6.49 6.58 6.41 6.59 6.49 6.52 6.43 6.48 6.43 6.44 6.36 6.44 6.49 6.62
HP_APLASIA_HYPOPLASIA_OF_THE_RIBS 6.53 6.37 6.27 6.33 6.4 6.58 6.23 6.37 6.08 6.61 6.47 6.55 6.36 6.57 6.34 6.51 6.47 6.46 6.47 6.44 6.41 6.49 6.3 6.37 6.4 6.61
HP_APLASIA_HYPOPLASIA_OF_THE_SCAPULAE 6.19 6.37 5.46 5.68 6.21 5.77 5.64 5.72 5.87 5.97 6.02 5.77 6.01 5.88 5.66 5.88 6.56 6 6.16 5.65 5.94 5.63 5.61 5.41 5.92 6.03
HP_APLASIA_HYPOPLASIA_OF_THE_STERNUM 6.78 6.65 6.86 6.5 6.92 7.22 6.88 7.18 6.89 7.1 6.82 7.01 7.28 7.23 7.27 7.17 6.56 7.04 6.94 7.32 7 7.01 6.72 7.12 7.11 7.11
HP_HEREDITARY_NONPOLYPOSIS_COLORECTAL_CARCINOMA 7.09 7 7.05 7.3 7.6 7.41 7.26 7.35 7.28 7 7.31 7.27 7.19 7.42 6.88 7.28 7.38 6.82 7.16 7.42 7.06 6.89 7.6 7.63 7.39 7.46
HP_ACUTE_LYMPHOBLASTIC_LEUKEMIA 5.94 6.59 6.41 6.35 6.4 6.67 6.14 6.4 6.17 6.68 6.25 6.04 6.44 6.32 5.97 6.19 5.82 6.06 6.43 6.64 6.25 5.76 5.51 5.66 6.27 6.25
HP_PANCREATIC_ADENOCARCINOMA 6.34 6.58 7.14 6.72 6.83 6.95 6.7 6.95 6.94 6.94 6.61 6.85 6.94 6.91 6.88 7.27 6.39 6.75 6.44 6.87 6.7 6.72 7.16 6.99 6.64 6.77
HP_FOLLICULAR_THYROID_CARCINOMA 7.82 7.85 9.05 8.43 9.03 8.3 8.47 8.12 8.34 8.45 8.36 8.24 8.56 8.63 8.26 8.1 7.96 7.62 8.17 8.18 7.32 8.25 8.59 8.36 8.29 7.77
HP_SQUAMOUS_CELL_CARCINOMA_OF_THE_SKIN 5.94 5.91 6.1 5.89 5.42 5.44 5.8 5.89 5.62 5.54 5.79 5.65 5.59 5.73 5.53 5.62 5.66 5.62 5.33 5.72 5.65 5.7 5.37 5.35 5.82 5.61
HP_ADRENOCORTICAL_CARCINOMA 6.22 6.25 6.07 6.08 5.81 5.68 6.17 6.06 6.09 5.53 6.07 5.63 5.84 5.75 5.73 5.53 6.23 5.52 5.24 5.91 6.29 6.12 5.63 5.74 6.14 6.43
HP_NEOPLASM_OF_THE_STOMACH 6.91 7.03 7.1 7.1 7.24 7.12 6.96 7.27 7.3 7.08 6.82 6.88 7.04 7.3 7.16 7.02 6.69 6.85 6.86 7.2 6.91 6.95 7.09 7.25 7.09 7.03
HP_MALIGNANT_GENITOURINARY_TRACT_TUMOR 6.45 6.07 7.12 6.43 6.42 5.95 6.21 5.97 6.76 6.25 6.82 6.19 6.42 6.14 6.03 6.85 6.41 6.65 5.89 5.86 6.63 5.95 6.35 6.35 5.91 6.03
HP_POSTERIOR_PHARYNGEAL_CLEFT 5.19 5.26 5.48 5.12 4.68 4.84 5.03 5.29 5.18 4.81 5.21 4.88 5.07 4.91 5.08 4.97 5.39 5.41 4.72 5.03 5.35 5.15 4.96 4.96 5 5.38
HP_LIMB_GIRDLE_MUSCULAR_DYSTROPHY 7.35 7.49 7.13 6.92 7.66 8.1 8.2 7.85 7.69 7.84 6.98 7.46 7.88 7.6 8.03 7.7 7.56 7.68 7.8 8.15 7.45 7.64 7.71 8.01 8.21 7.49
HP_HYPERACTIVE_DEEP_TENDON_REFLEXES 7.71 7.65 8.09 7.86 8.19 8.15 8.55 8.69 8.33 8.42 8.16 8.46 8.22 8.15 8.75 8.6 8.03 7.76 7.87 8.24 8.07 8.64 8.7 8.66 8.51 8.26
HP_ABNORMAL_ANTERIOR_HORN_CELL_MORPHOLOGY 7.78 7.74 8.27 7.92 8.05 8.21 8.05 7.48 8.28 8.27 7.99 8.16 7.92 8 8.09 7.78 7.88 7.25 7.8 7.9 7.53 8.01 8.67 8.6 8.15 7.72
HP_CEREBRAL_HYPOMYELINATION 7.47 7.57 7.95 7.73 7.38 7.68 7.65 7.71 7.54 7.47 7.09 7.39 7.68 7.36 7.31 7.17 7.23 7.13 7.1 7.72 7.28 7.47 7.58 7.88 7.56 7.47
HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLAR_VERMIS 6.48 6.49 6.67 6.7 6.61 6.7 6.63 6.51 6.56 6.75 6.61 6.72 6.69 6.6 6.74 6.69 6.53 6.59 6.68 6.57 6.63 6.61 6.63 6.73 6.68 6.66
HP_SEVERE_MUSCULAR_HYPOTONIA 7.04 7.21 7.41 7.43 7.6 7.53 7.42 7.58 7.35 7.58 7.38 7.48 7.43 7.58 7.52 7.42 7.43 7.46 7.51 7.5 7.51 7.59 7.32 7.69 7.48 7.47
HP_CEREBELLAR_VERMIS_ATROPHY 8.13 8.1 7.98 7.43 8.19 8.54 8.52 8.44 8.22 8.46 8.37 8.29 8.48 8.51 8.41 8.41 8.1 7.89 8.46 8.38 7.96 8.39 8.45 8.53 8.34 8.37
HP_LOBAR_HOLOPROSENCEPHALY 6.23 6.24 6.7 6.53 6.38 6.17 6.24 6.38 6 6.15 6.61 6.15 5.9 6.38 6.41 6.67 6.06 6.13 6.14 6.18 6.67 6.44 6.4 6.17 6.53 6.23
HP_CEREBRAL_HYPOPLASIA 6.5 6.41 6.71 6.78 7.1 6.88 6.44 6.66 6.65 6.76 6.86 6.63 6.68 6.61 6.64 6.69 6.5 6.4 6.43 6.64 6.47 6.74 6.48 6.66 6.57 6.85
HP_IMPAIRED_DISTAL_VIBRATION_SENSATION 7.28 7.37 7.97 7.44 7.88 8.22 8.29 7.64 8.15 8.4 7.82 8.42 8.11 8 7.98 8.12 8.02 7.6 8.05 8.19 7.63 7.62 8.06 8.34 8.09 7.62
HP_INTELLECTUAL_DISABILITY_PROGRESSIVE 6.74 6.77 7.73 7.49 7.32 7.2 6.94 6.81 7.11 6.9 7.13 7.01 6.93 6.95 6.85 6.73 6.83 6.6 7.01 7.3 6.48 6.84 7.09 7.42 6.79 6.85
HP_INTELLECTUAL_DISABILITY_BORDERLINE 7.13 7.44 7.29 7.13 7.8 7.77 7.91 7.62 7.67 7.42 6.91 7.31 7.7 7.62 7.52 7.1 7.64 7.54 7.84 7.75 7.32 7.24 7.63 7.99 7.39 7.12
HP_FRONTOTEMPORAL_CEREBRAL_ATROPHY 8.64 8.71 9.27 8.71 8.67 9.28 9.58 8.98 9.34 9.2 8.86 8.86 8.99 9.09 8.4 8.71 8.53 8.36 8.78 9.33 8.69 8.47 9.38 9.03 9.14 8.78
HP_LOWER_LIMB_HYPERTONIA 7.25 7.19 7.83 7.68 7.65 7.56 7.37 7.41 7.83 7.4 7.55 7.51 7.69 7.58 7.08 7.31 7.43 7.03 7.4 7.45 6.97 7.31 7.55 7.47 7.27 7.18
HP_FRONTAL_CORTICAL_ATROPHY 8.14 8.55 8.45 8.35 8.59 8.8 8.88 8.91 9.11 8.85 8.6 8.57 8.89 8.99 8.84 8.72 8.48 8.45 8.64 8.89 8.69 8.84 8.91 9.04 9.05 8.73
HP_ABNORMAL_AGGRESSIVE_IMPULSIVE_OR_VIOLENT_BEHAVIOR 7.74 7.85 8.08 7.9 8.32 8.19 8.28 8.26 8.24 8.23 8.08 8.2 8.23 8.29 8.32 8.26 7.87 7.98 8.03 8.2 8.03 8.29 8.24 8.43 8.3 8.15
HP_CONGENITAL_NYSTAGMUS 7.83 8.55 8.12 8.08 8.36 8.19 8.48 8.27 8.76 8.49 8.42 8.28 8.87 8.62 8.68 8.37 8.22 8.24 8.48 8.88 8.54 8.67 8.88 8.87 9.02 8.55
HP_OLIVOPONTOCEREBELLAR_HYPOPLASIA 7.04 7.4 7.05 6.85 7.07 7.05 6.98 7.25 6.66 6.98 6.96 7.43 7.09 6.98 6.81 6.68 6.62 6.75 7.34 7.37 6.67 6.88 6.99 6.61 6.87 6.69
HP_DILATION_OF_LATERAL_VENTRICLES 8.47 8.62 8.35 8.17 8.78 8.71 9.12 8.68 8.57 8.5 8.21 8.55 8.73 8.64 8.46 8.64 8.44 8.32 8.31 8.75 8.34 8.62 8.55 8.64 8.65 8.54
HP_LOSS_OF_ABILITY_TO_WALK 7.35 7.12 7.69 7.65 7.46 7.67 7.72 7.73 7.79 7.66 7.61 7.69 7.78 7.58 7.65 7.64 7.42 7.13 7.44 7.78 7.53 7.38 7.79 7.81 7.67 7.45
HP_ABNORMAL_AUDITORY_EVOKED_POTENTIALS 7.5 7.16 6.66 6.41 8.34 7.95 6.62 7.33 7.22 7.34 6.91 7.39 7.08 6.91 6.89 6.7 7.63 6.97 6.93 6.98 6.6 6.97 6.81 7.01 7.2 6.93
HP_JERKY_HEAD_MOVEMENTS 9.71 9.89 9.81 9.37 9.57 10.02 10.06 9.75 9.94 9.99 9.03 9.67 9.42 9.59 9.85 9.79 9.33 9.17 9.77 9.87 9.45 9.53 9.96 10.05 9.36 9.34
HP_PERIVENTRICULAR_LEUKOMALACIA 7.36 7.42 7.59 7.71 7.45 7.51 7.74 8.05 7.84 7.43 7.12 7.48 7.91 7.85 7.67 7.79 7.43 7.46 7.69 8.06 7.5 7.83 7.83 7.87 7.85 7.85
HP_GRAMMAR_SPECIFIC_SPEECH_DISORDER 8.13 8.18 9.27 8.66 8.64 8.8 9.18 8.64 9.28 8.73 8.47 8.63 8.98 8.89 8.32 8.45 8.13 7.51 8.22 8.94 7.91 8.6 8.75 8.84 8.96 8.51
HP_SLEEP_WAKE_CYCLE_DISTURBANCE 6.41 6.35 6.27 6.94 6.56 6.48 6.78 7.12 6.73 6.73 6.4 6.47 6.81 6.6 6.84 6.76 6.6 6.6 6.59 6.45 6.79 7.12 6.43 7.09 6.77 6.74
HP_UPPER_LIMB_SPASTICITY 7.53 7.51 7.24 7.95 7.91 7.99 7.71 7.56 7.79 8 7.38 7.64 7.6 7.71 7.38 7.2 7.57 7.43 7.61 7.65 7.41 7.78 7.75 7.69 7.43 7.33
HP_DYSPLASTIC_CORPUS_CALLOSUM 7.21 7.62 7.56 7.74 7.93 8.07 7.53 7.37 7.78 7.76 7.07 7.84 7.84 7.71 7.83 7.49 7.53 7.52 7.79 7.58 7.38 7.64 7.78 7.86 7.58 7.48
HP_MORNING_MYOCLONIC_JERKS 8.71 9.05 8.23 8.31 8.24 8.48 8.84 8.87 9.14 8.7 8.16 8.06 8.89 8.81 9.12 8.87 8.06 8.64 8.9 8.72 8.15 8.67 9.09 9.02 8.76 8.31
HP_MOTOR_AXONAL_NEUROPATHY 6.5 6.7 7.05 6.68 6.93 6.9 6.99 7.01 6.77 7.03 6.54 7.1 6.87 6.82 6.98 6.7 6.43 6.79 6.89 6.85 6.49 6.86 6.83 7.11 6.87 7.16
HP_POOR_FINE_MOTOR_COORDINATION 6.95 7.17 7.16 7.06 7.66 7.7 7.47 7.43 7.4 7.7 7.3 7.49 7.63 7.72 7.44 7.87 7.19 7.09 7.41 7.87 7.23 7.7 7.54 7.97 7.38 7.53
HP_POOR_GROSS_MOTOR_COORDINATION 6.77 7.15 6.9 6.17 7.07 7.05 7.24 7.08 7.28 6.93 6.45 6.61 7.13 6.98 7.69 7.21 7.19 7.09 7.34 7.28 6.71 7.29 6.99 6.71 6.77 6.49
HP_ATTENTION_DEFICIT_HYPERACTIVITY_DISORDER 7.47 7.54 7.69 7.57 7.98 7.9 7.73 7.75 7.88 7.9 7.53 7.85 7.97 8.05 7.77 7.7 7.53 7.57 7.75 7.93 7.45 7.63 8.04 8.11 7.87 7.7
HP_PROGRESSIVE_SPASTIC_PARAPLEGIA 7.83 7.79 8.53 8.48 8.06 8.15 8.22 8.16 8.24 8.39 8.14 8.29 8.27 8.02 8.52 8.45 7.99 8.03 8.17 8.41 8.31 8.32 8.07 8.52 8.4 8.26
HP_PAIN_INSENSITIVITY 6.34 6.41 6.05 6.01 6.37 6.3 6.01 6.33 6.28 6.53 6.21 6.17 6.23 6.39 6.11 6.07 6.27 6.4 6.18 6.2 6.32 6.03 6.14 6.21 5.94 6.39
HP_PSEUDOBULBAR_PARALYSIS 7.08 6.9 7.05 7.18 7.36 7.35 7.67 7.57 7.68 7.78 6.78 7.92 7.57 7.34 6.98 7.13 7.15 7.02 7.22 7.84 7.42 7.69 7.41 7.71 7.23 7.48
HP_CEREBELLAR_DYSPLASIA 7.04 7.25 6.9 6.78 7.1 7.05 6.85 7.25 7.28 7.55 7.29 7.5 7.41 7.43 7.44 7.21 7.33 7.29 7.26 7.18 7.22 7.29 7.22 7.01 7.31 7.35
HP_FOCAL_WHITE_MATTER_LESIONS 8.61 8.45 8.35 7.85 9.1 9.07 8.49 8.99 8.7 8.93 8.36 8.63 8.83 8.98 8.72 8.95 8.6 8.74 9.05 8.95 8.63 8.86 8.75 8.89 8.72 8.94
HP_LARGE_BASAL_GANGLIA 7.68 7.97 7.77 7.97 7.89 8.24 7.93 7.66 8.03 8.1 7.83 7.89 8.04 8.26 7.91 7.96 7.58 7.64 7.96 7.99 7.57 7.77 7.95 8.22 7.96 7.81
HP_MULTIFOCAL_CEREBRAL_WHITE_MATTER_ABNORMALITIES 6.83 6.75 6.93 6.9 6.97 6.97 7.19 6.9 7.03 6.77 6.9 7.2 7.02 6.98 6.88 6.81 6.86 6.98 6.73 6.86 6.94 6.84 7.03 7.11 7.21 6.98
HP_GENERALIZED_CEREBRAL_ATROPHY_HYPOPLASIA 8.24 8.56 8.18 8.66 8.57 8.54 8.4 8.68 8.36 8.35 8.08 8.4 8.5 8.42 8.59 8.34 8.26 8.46 8.63 8.78 8.23 8.55 8.17 8.36 8.7 8.57
HP_EXTRAPYRAMIDAL_MUSCULAR_RIGIDITY 7.63 7.92 8.7 8.08 8.05 8.23 8.59 8.25 8.46 8.47 8.58 8.33 8.05 8.2 8.73 7.62 8.56 8.24 8.3 8.5 8.41 8.24 8.47 8.6 8.46 8.2
HP_DECREASED_AMPLITUDE_OF_SENSORY_ACTION_POTENTIALS 7.5 7.36 7.7 7.39 7.27 7.27 7.48 7.41 7.3 7.1 7.11 7.6 7.17 7.55 7.81 7.07 7.25 7.13 7.24 7.23 7.75 7.49 7.46 7.55 7.44 7.44
HP_HYPERACTIVE_PATELLAR_REFLEX 8.63 8.97 9.34 8.9 8.66 8.77 9.11 9.16 9.13 9.27 9.08 9.09 9.36 9.41 9.24 9.11 8.77 8.33 8.99 9.33 9.06 9.22 9.17 9.17 9.52 9.28
HP_SOCIAL_AND_OCCUPATIONAL_DETERIORATION 6.86 7.1 7.99 7.34 6.54 8 7.43 7.23 6.99 6.95 6.58 6.52 7.67 8.01 7.47 7.5 6.48 7.58 7.98 8.02 6.56 7.15 7.58 7.95 7.37 6.58
HP_ARNOLD_CHIARI_TYPE_I_MALFORMATION 7.47 7.13 6.59 7.12 7.36 7.5 7.67 7.6 7.44 7.31 7.33 7.7 7.57 7.58 7.44 7.37 7.25 7.34 7.38 7.84 7.38 7.81 7.45 7.71 7.48 7.48
HP_HYPOINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI 6.7 6.88 7.96 7.6 7.43 7.72 7.13 7.41 7.6 7.28 7.36 7.47 7.3 7.84 7.54 7.36 6.88 7.11 6.96 7.3 7.43 7.29 6.85 7.36 7.15 6.83
HP_DEMYELINATING_PERIPHERAL_NEUROPATHY 6.83 6.74 7.22 7.23 7.01 7.27 7.41 7.01 7.31 7.14 6.81 7.34 7.19 7.2 7.26 6.72 7.03 7.01 7.07 7.34 6.94 7.02 7.44 7.4 7.55 7.24
HP_CENTRAL_HYPOVENTILATION 5.84 5.8 5.82 5.73 5.56 5.45 5.42 5.93 6.06 5.37 5.82 5.68 5.35 5.34 5.35 5.46 6.2 6 5.51 5.5 6.02 5.9 5.99 5.91 5.67 5.69
HP_TEMPORAL_CORTICAL_ATROPHY 7.98 8.15 8.61 8.39 8.38 8.64 8.78 8.22 8.96 8.47 8.15 8.34 8.82 8.67 8.13 8.12 8.4 7.95 8.09 8.63 7.73 8.37 8.67 8.69 8.42 8.15
HP_PROXIMAL_AMYOTROPHY 6.49 6.38 6.62 6.51 6.63 6.89 6.52 6.32 6.52 6.59 6.37 6.99 6.4 6.37 6.65 6.59 6.69 6.47 6.46 6.38 6.47 6.59 6.92 6.61 6.58 6.61
HP_SENSORIMOTOR_NEUROPATHY 7.28 7.46 7.82 7.18 7.39 7.27 7.39 7.53 7.68 7.66 7.36 7.45 7.52 7.64 7.54 7.58 7.37 7.26 7.3 7.6 7.45 7.35 7.54 7.9 7.55 7.42
HP_DISTAL_UPPER_LIMB_AMYOTROPHY 7.53 7.51 7.18 7.95 7.91 7.86 7.59 7.69 7.79 7.77 7.19 7.76 7.6 7.71 7.26 7.08 7.73 7.04 7.61 7.93 6.72 7.16 7.71 7.66 7.43 7.33
HP_PERIVENTRICULAR_HETEROTOPIA 7.41 7.41 7.35 7.3 8.03 8.06 7.78 7.83 7.83 8.2 7.35 8.13 7.98 8.02 8 7.66 7.33 7.22 8 7.87 7.5 7.73 7.85 8.14 7.88 7.83
HP_MOTOR_POLYNEUROPATHY 6.7 7.23 7.27 7.28 7.92 8.03 7.63 7.64 7.47 8.12 7.27 7.68 7.76 7.62 7.34 7.3 7.25 7.44 7.68 7.84 7.12 7.41 7.8 7.73 7.38 7.5
HP_FOCAL_T2_HYPERINTENSE_BASAL_GANGLIA_LESION 7.96 7.95 8.76 7.99 7.75 7.7 7.88 7.93 7.81 7.98 8.13 8.11 7.96 7.78 8.5 8.5 7.96 8.05 8.1 8.26 8.34 8.36 7.66 8.27 8.2 8.47
HP_LOSS_OF_CONSCIOUSNESS 5.95 6.19 6.52 6.46 6.18 6.65 6.36 6.51 6.47 6.63 6.4 6.27 6.3 6.42 6.61 6.37 6.18 6.1 6.28 6.53 6.51 6.91 6.39 6.49 6.65 6.51
HP_DIFFUSE_WHITE_MATTER_ABNORMALITIES 8.13 8.3 8.43 8.2 8.5 8.45 8.73 8.58 8.3 8.09 8.43 8.49 8.09 8.13 8.53 8.29 8.05 8.2 8.12 8.59 8.39 8.39 8.02 8.26 8.28 8.21
HP_HEMIMEGALENCEPHALY 8.23 7.85 8.19 8.18 8.41 8.52 8.47 8.93 8.34 8.46 8.34 8.63 8.56 8.63 8.66 8.74 8.56 8.73 8.62 8.82 8.35 8.75 8.59 8.63 8.61 8.52
HP_LOWER_LIMB_AMYOTROPHY 7.32 7.32 8.06 7.68 7.75 7.86 8.1 8.03 8.24 8.21 7.78 8.13 8.03 8.1 7.83 7.87 7.94 7.13 7.61 7.92 7.56 7.7 8.21 8.4 8.03 7.76
HP_MACROGYRIA 8.27 7.58 8.54 7.86 8.54 8.3 8.62 8.37 8.49 7.95 8.33 8.17 8.26 8.8 8.1 8.1 8.23 8.13 8.29 8.33 7.83 8.34 8.36 8.39 8.45 8.07
HP_PROGRESSIVE_GAIT_ATAXIA 7.92 8.16 8.38 8.9 8.61 8.57 8.52 8.82 8.74 8.65 8.55 8.54 8.55 8.51 8.61 8.42 8.41 8.27 8.5 8.65 8.63 8.66 8.79 8.96 8.53 8.44
HP_ABNORMAL_PYRAMIDAL_SIGN 7.41 7.53 7.86 7.67 7.85 7.85 7.71 7.81 7.92 7.87 7.59 7.72 7.78 7.79 7.74 7.73 7.58 7.4 7.71 7.88 7.49 7.76 7.98 8.08 7.86 7.68
HP_CEREBRAL_DYSMYELINATION 7.63 7.94 8.34 7.83 8.39 8.62 7.91 8.26 8.05 8.27 7.79 7.93 8.08 7.85 8.03 8.45 7.63 7.47 8.22 8.37 7.5 8.12 8.24 8.24 8.04 7.85
HP_SPINAL_MUSCULAR_ATROPHY 6.66 6.78 7.34 7.5 7.17 7.4 6.96 7.15 6.83 7 6.84 7.05 7 6.85 6.99 6.94 6.79 6.75 7.17 7.18 6.4 6.73 6.99 7.33 7.08 6.98
HP_ATYPICAL_ABSENCE_SEIZURE 8.41 8.8 9.45 9.35 8.89 9.3 9.04 8.88 9.07 9.16 9.08 8.66 9.03 8.97 9.26 9.01 8.59 8.58 9.11 9.06 8.84 8.87 9.56 9.33 8.6 8.42
HP_PROGRESSIVE_PSYCHOMOTOR_DETERIORATION 8.28 8.38 9.93 8.52 8.67 8.91 8.51 8.69 8.44 8.53 8.91 8.46 8.86 8.66 8.84 8.73 8.15 8.32 8.62 8.52 8.45 9.14 9.36 8.67 8.57 8.4
HP_DEVELOPMENTAL_STAGNATION 7.9 8.18 8.39 8.1 8.5 8.43 8.66 8.7 8.22 8.06 8.13 8.18 7.9 8.01 8.67 8.38 7.87 7.61 7.9 8.57 7.92 8.19 8.02 8.34 8.46 8.3
HP_POSTERIOR_FOSSA_CYST 6.25 6.4 7 6.78 6.55 6.84 6.64 6.67 6.28 6.72 6.73 7.02 6.71 6.39 6.99 6.8 6.61 6.69 6.45 6.37 6.63 6.92 6.54 6.44 6.62 6.64
HP_OROMOTOR_APRAXIA 6.07 6.15 6.17 6.59 6.54 6.25 6.49 6.1 6.38 6.56 6.29 6.24 6.6 6.4 6.57 6.25 6.24 6.13 6.19 6.25 6.39 6.39 6.31 6.23 6.27 6.23
HP_CNS_DEMYELINATION 6.71 6.92 7.93 7.72 7.21 7.36 7.47 7.3 7.39 7.57 7.39 7.07 7.55 7.43 7 7.36 7.21 7.07 7.23 7.72 7.09 7.51 7.2 7.4 7.08 6.93
HP_SHORT_STEPPED_SHUFFLING_GAIT 8.67 8.43 8.49 8.31 8.9 8.72 8.83 8.87 8.37 8.41 7.9 8.4 8.55 8.48 8.7 8.7 8.08 8.26 8.69 8.73 8.16 8.86 8.05 8.26 9 8.7
HP_GENERALIZED_DYSTONIA 6.88 6.65 6.41 6.19 6.58 7.39 6.58 6.67 6.74 6.73 6.26 6.87 6.63 6.25 6.71 6.62 6.87 6.97 6.52 6.81 6.42 6.59 6.1 6.67 6.92 6.68
HP_IMPAIRED_PAIN_SENSATION 6.75 7.13 7.62 6.82 7.31 7.43 7.71 7.84 7.61 7.73 7.05 7.45 7.53 7.43 7.68 7.64 7.13 7.06 7.2 7.7 7.64 7.52 7.68 7.9 7.67 7.69
HP_HYPOPLASIA_OF_THE_FRONTAL_LOBES 6.5 6.58 6.42 6.7 7.15 6.7 6.34 6.66 6.55 6.67 6.86 6.44 6.6 6.82 6.38 6.66 6.51 6.4 6.38 6.58 6.49 6.62 6.48 6.58 6.57 6.51
HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_FOCAL_ONSET 7.12 7.38 7.18 7.07 7.45 7.51 7.87 8.1 7.66 7.72 7.48 7.84 8.18 8.03 8.34 7.9 7.41 7.75 7.76 7.84 7.1 8 7.58 8.16 7.72 7.93
HP_LOWER_LIMB_MUSCLE_WEAKNESS 7.12 7.26 7.79 7.48 7.32 7.47 7.62 7.47 7.66 7.65 7.66 7.64 7.6 7.67 7.63 7.47 7.43 7.16 7.41 7.63 7.41 7.45 7.79 7.83 7.64 7.33
HP_ABNORMAL_MORPHOLOGY_OF_THE_LIMBIC_SYSTEM 7.81 8.33 8.38 8.22 8.75 8.29 8.41 8.27 8.39 8.49 8.55 8.44 8.31 8.51 8.61 8.31 8.26 8.15 8.5 8.5 8.43 8.53 8.46 8.48 8.42 8.35
HP_ATROPHY_DEGENERATION_INVOLVING_THE_SPINAL_CORD 6.21 6.38 6.52 6.38 6.45 6.76 6.8 6.83 6.66 6.54 6.29 6.57 6.97 6.82 6.77 6.47 6.39 6.09 6.46 6.77 6.38 6.68 6.79 7.02 6.77 6.82
HP_HYPERREFLEXIA_IN_UPPER_LIMBS 7.72 7.34 8.92 8.17 8.04 8.23 8.04 7.8 8.22 8.29 8.38 7.97 8.3 7.9 8.57 8.18 7.57 7.51 7.97 8.43 7.97 8.49 8.65 8.47 8.08 7.75
HP_AMYOTROPHIC_LATERAL_SCLEROSIS 7.99 7.96 8.48 8.26 8.68 8.58 8.52 8.21 8.6 8.41 8.29 8.68 8.4 8.51 8.22 8.38 8.24 7.83 8.32 8.22 8.23 8.38 8.85 8.99 8.42 8.36
HP_FOCAL_ONSET_SEIZURE 7.95 8.11 8.16 7.96 8.37 8.27 8.31 8.21 8.22 8.32 8.01 8.29 8.25 8.34 8.47 8.22 8.04 7.98 8.2 8.37 8.05 8.27 8.44 8.45 8.28 8.2
HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLUM 6.85 6.89 7.13 7.14 7.11 7.08 7.06 7.18 7.2 7.11 7.12 7.1 7.14 7.11 7.2 7.17 6.94 6.94 7.03 7.21 6.97 7.05 7.08 7.36 7.18 7.13
HP_ABNORMALITY_OF_THE_PONS 6.72 6.73 7.05 6.89 6.84 6.78 6.88 7.01 6.6 6.84 6.93 6.6 6.78 6.6 6.78 7.02 6.62 6.77 7 6.64 6.76 6.88 6.51 6.82 6.77 6.89
HP_ATROPHY_DEGENERATION_AFFECTING_THE_BRAINSTEM 7.61 7.66 7.97 8 8.31 8.38 8.19 8.26 8.18 8.49 7.93 8.27 8.42 8.29 8.21 8.5 7.99 8.23 8.58 8.37 7.82 8.4 8.22 8.36 8.46 8.52
HP_ATROPHY_DEGENERATION_AFFECTING_THE_CENTRAL_NERVOUS_SYSTEM 7.54 7.6 7.95 7.77 7.9 8.05 7.94 7.84 7.92 7.99 7.76 7.91 7.95 7.93 7.93 7.85 7.65 7.57 7.8 7.98 7.63 7.85 7.94 8.07 7.9 7.79
HP_CORPUS_CALLOSUM_ATROPHY 7.74 7.95 8.15 7.91 7.94 8.09 8.5 8.79 8.29 8.51 8.08 8.23 7.87 7.98 8.81 8.25 8 7.22 7.8 8.28 7.97 7.81 8.58 8.54 8.61 8.38
HP_ATROPHY_DEGENERATION_INVOLVING_THE_CORTICOSPINAL_TRACTS 7.66 7.37 8.22 8.08 8.24 7.86 7.72 7.79 8.11 8.2 7.81 8.01 8.12 8.09 7.73 7.93 7.76 7.58 7.76 7.8 7.86 7.88 8.04 8.14 7.78 7.63
HP_MOTOR_NEURON_ATROPHY 7.87 7.91 8.52 8.3 8.64 8.58 8.43 8.19 8.53 8.38 8.29 8.45 8.39 8.38 8.21 8.34 7.96 7.7 8.27 8.1 8.17 8.34 8.65 8.85 8.41 8.26
HP_ATROPHY_DEGENERATION_INVOLVING_THE_CAUDATE_NUCLEUS 7.3 8.15 7.69 7.47 7.81 7.77 7.46 7.45 7.02 7.28 6.95 7.52 7.46 7.75 7.77 7.94 7.39 7.8 7.53 7.96 7.96 8.41 7.41 7.71 7.67 7.47
HP_ABNORMALITY_OF_THE_SEPTUM_PELLUCIDUM 6.96 7.09 7.15 7.49 7.04 7.1 7.02 7.15 7.16 7.3 6.92 7.16 7.33 7.33 7.37 7.32 7.14 7.08 7.13 7.21 7.12 7.05 7.25 7.33 7.34 7.15
HP_ABNORMALITY_OF_THE_CHOROID_PLEXUS 6.63 6.57 7.21 7.15 7.03 7.11 6.51 6.65 6.73 6.88 6.27 6.57 7.04 6.71 6.88 6.93 6.02 6.35 6.96 6.59 6.39 6.79 6.57 6.66 6.7 6.98
HP_ABNORMALITY_OF_SOMATOSENSORY_EVOKED_POTENTIALS 7.05 7.13 7.32 7.04 7.38 7.49 7.56 7.57 7.3 7.57 6.9 7.42 7.67 7.31 7.3 7.16 7.34 7.09 7.49 7.79 7.18 7.36 7.43 7.72 7.34 7.46
HP_NEOPLASM_OF_THE_GASTROINTESTINAL_TRACT 6.13 6.2 6.23 6.19 6.16 6.01 6.17 6.29 6.14 6.21 6.11 6.2 6.18 6.08 6.12 6.19 5.98 6.19 6.04 6.04 6.14 6.17 6.2 6.18 6.14 6.15
HP_NEOPLASM_OF_THE_GENITOURINARY_TRACT 6.66 6.45 6.64 6.64 6.73 6.67 6.68 6.62 6.57 6.71 6.56 6.75 6.58 6.58 6.67 6.76 6.4 6.46 6.51 6.43 6.67 6.69 6.8 6.81 6.62 6.82
HP_FACIAL_TELANGIECTASIA 5.61 5.5 5.84 5.66 5.49 5.4 5.83 5.76 5.76 5.62 5.82 5.78 5.75 5.68 5.51 5.74 6.06 5.85 5.49 5.88 6.04 5.96 5.66 5.43 5.91 5.85
HP_APLASIA_CUTIS_CONGENITA_OF_SCALP 6.98 6.81 6.81 6.59 6.87 7.07 6.65 6.74 6.77 6.92 6.75 7.14 7.01 6.91 6.9 7.16 7.01 7.05 6.82 7.05 7.04 6.94 6.82 7.07 7.18 7.12
HP_EXCESSIVE_WRINKLED_SKIN 7.05 6.89 7.99 7.52 7.37 7.31 7.54 7.56 7.76 7.3 7.7 6.94 7.4 7.41 7.58 7.85 7.3 7.3 6.85 7.3 8 7.61 7.95 7.76 7.74 7.54
HP_PROMINENT_SUPERFICIAL_BLOOD_VESSELS 7.55 7.29 7.78 7.37 7.16 7.2 7.4 6.95 7.28 7.81 7.16 7.37 7.34 7.3 7.61 7.13 7.72 6.78 7.09 7.11 7.65 7.58 7.74 7.41 7.35 7
HP_IRREGULAR_HYPERPIGMENTATION 6.28 6.24 6.4 6.44 6.34 6.35 6.37 6.42 6.33 6.48 6.29 6.28 6.44 6.44 6.17 6.24 6.26 6.27 6.03 6.38 6.37 6.55 6.51 6.59 6.47 6.68
HP_MACULAR_ATROPHY 5.6 5.7 5.84 5.82 5.56 5.68 5.75 5.77 5.56 5.76 5.72 5.71 5.51 5.45 5.76 5.84 5.77 5.71 5.41 5.58 5.86 6.06 5.8 5.7 5.38 5.55
HP_PALMOPLANTAR_HYPERHIDROSIS 5.7 5.31 5.44 5.19 4.87 5.04 5.16 5.02 5.33 5.08 5.11 5.38 5.7 5.24 5.54 4.65 5.27 5.08 4.78 5.68 5.52 5.34 5.3 5.43 5.28 5.41
HP_ALOPECIA_TOTALIS 7.07 6.82 6.67 7.54 7.22 6.89 6.96 7.13 7.35 7.47 6.58 7.14 7.17 6.83 6.99 7 7.04 6.59 6.71 7.01 6.75 7.03 7.49 7.68 7.25 7.41
HP_SPONTANEOUS_HEMATOMAS 5.69 5.51 5.68 5.24 5.23 5.17 5.3 5.04 5.5 5.22 5.46 4.93 5.19 4.94 5.09 5.05 5.5 5.38 5.32 5.02 5.5 5.23 5.38 5.34 5.61 5.07
HP_GENERALIZED_EDEMA 6.19 5.83 7.12 6.5 5.99 6.18 6.13 5.88 6.02 6.16 6.91 6 6.18 6.41 5.89 6.02 6.6 5.9 6.3 6.28 6.56 6.67 6.35 5.86 6.18 6.44
HP_CONGENITAL_ICHTHYOSIFORM_ERYTHRODERMA 5.34 5.35 5.43 5.98 4.84 4.77 5.3 5.02 5.34 4.92 5.23 4.91 4.89 4.78 5.12 5.01 4.89 5.43 5.44 4.91 5.4 5.31 4.85 4.78 5.33 5.02
HP_GENERALIZED_HYPERPIGMENTATION 6.79 6.77 7.61 7.22 6.89 6.64 6.93 7 7.36 7.08 6.91 6.96 6.96 6.98 6.97 7.05 6.9 6.79 6.58 7.16 7.05 7.33 7.24 7.36 7.17 7.44
HP_AUTOAMPUTATION_OF_DIGITS 6.21 6.37 5.99 5.87 5.69 5.78 5.87 5.65 5.61 6.32 6.21 6.17 5.57 5.96 5.58 5.87 6.36 6.51 5.89 5.35 6.49 5.52 5.6 5.44 5.64 6.23
HP_HEMANGIOMATOSIS 6.9 6.87 7.08 7.61 7.82 7.49 7.26 7.39 7.77 7.38 7.18 7.4 7.74 7.52 7.5 7.35 7.41 7.19 7.51 7.48 7.29 7.61 7.66 7.53 7.55 7.35
HP_ABNORMAL_DERMATOGLYPHICS 7.18 7.25 7.31 7.22 7.38 7.52 7.43 7.44 7.51 7.58 7.27 7.51 7.47 7.55 7.6 7.39 7.25 7.28 7.42 7.5 7.22 7.42 7.63 7.75 7.44 7.31
HP_CONGENITAL_NONBULLOUS_ICHTHYOSIFORM_ERYTHRODERMA 5.76 5.71 6.28 6.3 5.61 5.72 6.25 5.97 6.12 5.84 5.95 5.88 5.91 5.86 5.96 5.79 5.86 6.23 5.9 6.11 5.78 6 5.67 6.1 5.92 5.84
HP_ABSENCE_OF_SUBCUTANEOUS_FAT 6.71 6.57 6.56 6.9 6.68 6.66 6.55 6.83 7.11 6.76 6.56 6.85 6.78 6.51 6.31 6.44 6.83 6.78 6.87 6.78 6.24 6.47 6.73 7.01 6.74 6.77
HP_PREMATURELY_AGED_APPEARANCE 6.27 6.47 6.38 6.7 6.43 6.49 6.38 6.54 6.33 6.66 6.52 6.33 6.49 6.48 6.35 6.44 6.29 6.36 6.34 6.49 6.48 6.41 6.51 6.68 6.54 6.51
HP_RECURRENT_STAPHYLOCOCCAL_INFECTIONS 6.02 5.78 6.08 6.06 6.14 6.02 6.06 5.89 5.93 6.13 5.91 6.04 6 6.09 5.78 5.94 6.1 6.02 5.77 5.84 6.4 5.92 6.1 5.96 5.78 5.97
HP_FOLLICULAR_HYPERKERATOSIS 5.39 5.52 5.44 5.5 5.02 4.88 5.31 5.12 5.3 5.03 5.01 5.19 5.3 5.22 5.46 4.71 5.22 5.37 4.99 4.95 5.52 5.24 5.25 5.11 5.53 5.39
HP_GENERALIZED_HYPOPIGMENTATION 6.57 6.57 6.58 6.26 6.32 6.32 6.42 6.51 6.43 6.57 6.21 6.66 6.45 6.49 6.25 6.63 6.51 6.59 6.57 6.75 6.51 6.64 6.53 6.49 6.62 6.83
HP_DESQUAMATION_OF_SKIN_SOON_AFTER_BIRTH 5.13 5.24 5.63 5.38 5.29 5.05 5.31 5.39 5.35 5.25 5.54 5 5.29 5.19 5.11 4.92 5.55 5.68 4.76 5.44 4.95 5.23 5.39 5.12 5.27 4.94
HP_PLANTAR_HYPERKERATOSIS 5.79 5.72 5.57 5.89 5.38 5.43 5.55 5.29 5.63 5.54 5.82 5.6 5.61 5.5 5.57 5.23 5.66 5.62 5.45 5.38 5.54 5.32 5.21 4.99 5.53 5.43
HP_MULTIPLE_CAFE_AU_LAIT_SPOTS 6.13 6.16 6.56 6.43 6.4 6.48 6.37 6.4 6.45 6.27 6.3 6.3 6.55 6.39 6.24 6.24 6.15 6.11 5.94 6.45 5.91 6.18 6.6 6.8 6.25 6.38
HP_BILATERAL_SINGLE_TRANSVERSE_PALMAR_CREASES 7 6.92 7.08 7.04 7.16 7.36 7.16 7.01 7.19 7.24 7 7.41 7.16 7.47 7.1 7.14 7.2 6.95 7.34 7.36 7 7.18 7.16 7.46 7.2 7.21
HP_BILATERAL_MICROPHTHALMOS 6.68 6.74 6.67 6.67 6.93 7.14 6.55 6.8 6.72 6.74 6.71 6.88 7.01 7.15 6.79 6.62 6.4 6.89 7.03 7 6.44 6.66 6.5 6.77 6.52 6.68
HP_DYSCHROMATOPSIA 5.27 5.47 5.53 5.59 5.67 5.81 5.76 5.37 5.63 5.62 5.52 5.32 5.31 5.56 5.54 5.86 5.33 5.5 5.73 5.31 5.31 5.05 5.94 5.73 5.29 4.89
HP_CONGENITAL_STATIONARY_NIGHT_BLINDNESS 5.39 5.17 5.22 5.26 4.71 4.79 5.13 5.2 5.29 4.9 5.23 4.85 4.85 4.91 5.11 4.95 5.23 5.31 4.92 4.88 5.29 4.87 4.88 4.76 5.08 4.88
HP_PUNCTATE_CATARACT 6.26 5.96 5.85 6.46 5.66 5.95 5.24 5.96 5.72 5.97 5.8 6.13 5.71 5.84 5.83 5.47 5.64 5.71 5.88 5.93 5.96 6.38 5.55 5.49 5.58 5.78
HP_REDUCED_VISUAL_ACUITY 6.37 6.41 6.58 6.52 6.47 6.5 6.57 6.55 6.49 6.6 6.44 6.57 6.59 6.52 6.5 6.54 6.44 6.52 6.46 6.58 6.44 6.46 6.57 6.66 6.59 6.6
HP_CURLY_EYELASHES 7.11 7.4 7.45 7.18 8.14 7.97 7.64 7.29 7.68 7.97 7.21 8.01 7.9 7.89 7.51 7.45 7.66 7.08 7.52 7.38 7.27 7.4 8.19 7.92 7.17 7.36
HP_PROGRESSIVE_NIGHT_BLINDNESS 5.84 5.89 6.1 6.14 5.88 6 5.71 5.77 5.98 6.11 5.99 6.07 5.99 6.06 6.02 6 5.97 6.04 5.81 6.01 6.01 6.03 5.86 5.96 5.74 6.24
HP_HYPOPLASIA_OF_THE_IRIS 6.78 6.65 6.66 6.41 6.92 7.1 6.62 7.18 6.87 6.85 6.7 7.2 7.04 6.78 6.62 6.86 6.61 6.77 6.75 6.67 6.99 6.93 6.96 6.78 7.08 6.92
HP_ABNORMAL_PUPILLARY_FUNCTION 6.4 6.75 6.32 6.53 6.48 6.4 6.3 6.66 6.76 6.35 6.75 6.8 6.23 6.26 6.27 6.7 6.75 6.44 6.38 6.32 6.37 6.37 6.28 6.57 6.95 6.69
HP_UNDETECTABLE_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM 4.64 4.94 5.02 5.48 4.24 4.17 4.68 4.6 4.9 4.71 4.74 4.49 4.02 4.49 4.41 4.97 4.45 4.63 4.6 4.46 4.99 4.34 4.27 4.17 4.18 4.72
HP_ABNORMAL_PUPILLARY_LIGHT_REFLEX 5.82 6.07 5.26 5.72 5.51 5.9 5.72 5.68 5.67 5.62 5.76 5.67 5.32 5.38 5.52 5.56 5.81 5.9 5.32 5.08 5.64 5.39 5.26 5.32 5.32 5.36
HP_OCULAR_ANTERIOR_SEGMENT_DYSGENESIS 6.41 6.37 6.68 6.54 6.55 6.59 6.52 6.58 6.6 6.58 6.53 6.56 6.57 6.51 6.43 6.56 6.44 6.45 6.33 6.48 6.49 6.55 6.62 6.63 6.64 6.65
HP_ABNORMALITY_OF_RETINAL_PIGMENTATION 6.54 6.58 6.92 6.77 6.73 6.71 6.72 6.76 6.72 6.86 6.63 6.85 6.72 6.81 6.65 6.8 6.65 6.63 6.79 6.81 6.57 6.83 6.83 6.94 6.76 6.81
HP_PAROXYSMAL_INVOLUNTARY_EYE_MOVEMENTS 7.07 7.39 8.8 8.22 7.76 7.67 7.53 7.6 7.93 7.92 8.33 7.99 7.65 7.38 7.95 7.86 7.96 7.83 7.72 7.87 7.89 7.93 7.78 7.88 7.86 8.02
HP_FLAT_CORNEA 7.15 6.74 7.16 7.12 6.87 6.49 6.79 7.14 6.67 6.58 6.92 6.3 6.48 6.51 6.53 6.74 6.81 6.56 7.38 6.56 7.08 6.3 6.46 6.98 6.65 6.75
HP_RETINAL_PIGMENT_EPITHELIAL_ATROPHY 5.82 5.91 6.03 5.71 6.1 6.38 6.3 5.74 6.5 6.52 6.3 6.35 6.49 6.44 6.26 6.4 5.91 5.86 6.19 6.12 6.28 5.93 6.74 6.4 6.37 6.29
HP_IRIS_HYPOPIGMENTATION 6.01 5.94 6.1 6.07 6.07 5.87 5.86 5.7 5.88 5.87 6.15 6.2 6.08 5.79 5.89 5.75 5.97 5.93 5.77 6.01 5.92 5.98 5.92 5.85 6.01 6.01
HP_CHORIORETINAL_DYSPLASIA 7.04 7.46 7.39 6.89 7.07 7.11 7.49 7.25 7.52 6.98 6.93 7.43 7.13 6.98 7.44 7.21 7.22 7.29 7.34 7.42 7.39 7.29 7.62 7.73 7.31 7.35
HP_BONE_SPICULE_PIGMENTATION_OF_THE_RETINA 5.33 5.46 5.84 5.88 5.47 5.17 5.26 5.63 5.47 5.49 5.78 5.6 5.2 5.29 5.54 5.54 5.69 5.65 4.96 5.41 5.68 5.57 5.48 5.16 5.27 5.33
HP_HYPOPLASIA_OF_THE_FOVEA 5.21 5.08 5.83 5.25 4.99 5.38 5.62 5.27 5.15 5.13 5.09 5.41 5.16 4.9 4.99 4.85 4.76 5.22 5.12 5.37 5.16 5 5.45 5.63 4.96 4.73
HP_MACULAR_DYSTROPHY 6.02 5.86 5.58 5.71 7.25 7.44 6.94 6.76 6.65 7.14 5.83 6.05 7.1 5.96 6.5 6.35 6.7 6.13 6.06 7.24 5.57 6.93 7.16 7.12 7.18 7.33
HP_OPTIC_DISC_HYPOPLASIA 7.46 7.53 7.73 7.54 7.95 7.85 8.22 7.74 8.12 7.71 7.71 7.9 7.83 8.19 7.79 7.37 7.58 7.58 7.77 8.13 7.47 7.9 7.77 8.25 7.78 7.54
HP_IMPAIRED_SMOOTH_PURSUIT 8.1 8.08 8.2 7.68 8.52 8.65 8.23 8.04 7.94 8.44 8.16 8.44 8.39 8.49 8.29 8.35 7.84 7.65 8.57 8.19 7.6 8.17 8.36 8.39 8.29 8.14
HP_VITREORETINOPATHY 6 5.9 5.85 5.52 5.92 5.65 5.63 5.53 6.01 5.95 6.09 5.76 5.74 5.64 5.58 5.74 6.02 5.96 5.77 5.9 6.19 5.91 5.8 5.7 5.69 5.66
HP_POSTERIOR_SUBCAPSULAR_CATARACT 5.68 5.86 5.34 6.28 5.66 5.95 5.34 5.64 5.27 5.99 5.67 5.98 5.71 5.61 5.68 5.84 5.64 5.98 5.93 5.57 5.41 5.81 5.25 5.55 5.27 5.82
HP_MONOCHROMACY 4.7 4.83 4.81 4.89 4.19 4.14 4.94 4.84 4.85 4.41 4.73 4.42 4.33 4.35 4.31 4.58 4.63 4.94 4.28 4.16 5.13 4.42 4.21 4.03 4.54 4.18
HP_RETINAL_PIGMENT_EPITHELIAL_MOTTLING 5.17 5.2 5.22 5.3 5.28 5.33 5.26 5.16 5.34 4.92 5.41 4.71 4.99 5.18 5.15 5.2 5.15 5.31 4.9 5.03 5.36 4.99 5.11 4.82 5.07 4.81
HP_ANTERIOR_CHAMBER_SYNECHIAE 5.54 5.38 5.73 5.83 6.03 5.62 5.91 5.7 5.51 5.74 5.83 5.71 5.9 5.62 5.33 5.45 6.25 5.51 5.64 5.73 5.75 5.9 5.99 5.31 5.85 5.63
HP_ATTENUATION_OF_RETINAL_BLOOD_VESSELS 5.55 5.71 5.69 5.77 5.37 5.33 5.29 5.44 5.41 5.22 5.76 5.02 5.44 5.25 5.38 5.21 5.78 5.54 4.94 5.34 5.68 5.6 5.26 5.25 5.28 5.48
HP_HYPOPIGMENTATION_OF_THE_FUNDUS 5.37 5.22 5.9 5.36 5.2 5.13 5.6 5.29 5.43 5.13 5.38 5.27 5.12 5.08 5.32 5.41 4.94 5.42 5.03 5.19 5.32 5.21 5.68 5.44 5 4.75
HP_VITREOUS_HEMORRHAGE 6.78 6.39 8.47 7.56 6.17 7.51 6.95 7.6 7.59 6.31 7.13 7.09 7.72 6.96 6.62 6.91 7.02 6.95 6.32 7.34 7.84 7.33 7.09 7.54 7.71 7.27
HP_SLOW_DECREASE_IN_VISUAL_ACUITY 7.16 7.4 6.97 6.66 7.36 7.32 7.4 7.05 7.63 7.04 6.54 7.48 7.36 7.21 7.09 6.9 7.26 6.76 7.09 7.46 6.94 6.63 7.34 7.62 7.49 7.22
HP_CORNEAL_OPACITY 6.22 6.13 6.4 6.41 6.39 6.37 6.34 6.36 6.27 6.42 6.34 6.32 6.38 6.37 6.34 6.31 6.26 6.16 6.2 6.39 6.26 6.36 6.39 6.39 6.29 6.27
HP_RETINAL_DYSPLASIA 6.78 6.57 6.96 6.89 6.49 7.11 6.95 7.25 7.52 6.98 6.93 7.09 7.13 6.96 7.15 7.21 7.19 6.55 7.01 7.41 7.51 7.29 7.22 7.54 7.31 7.27
HP_GAZE_EVOKED_HORIZONTAL_NYSTAGMUS 7.49 7.73 7.36 7.49 8.11 8.31 7.89 7.38 7.88 8.07 7.72 7.84 7.99 8.27 7.43 7.56 7.42 7.53 8.38 7.9 7.04 7.48 8.06 8.15 7.72 7.35
HP_PERIPHERAL_VISUAL_FIELD_LOSS 5.35 5.26 5.36 5.21 5.46 5.36 5.29 5.3 5.38 4.96 5.58 4.77 5.13 5.3 5.12 5.3 5.41 5.47 5 5.19 5.72 5.31 5.28 5.03 5.15 4.97
HP_ABNORMALITY_OF_MACULAR_PIGMENTATION 5.79 5.58 6.13 5.92 6.02 5.66 5.97 5.68 5.98 5.5 5.54 5.7 5.76 5.65 5.95 5.74 5.67 5.63 5.78 5.63 5.64 5.68 5.83 5.47 5.79 5.37
HP_PERIPHERAL_OPACIFICATION_OF_THE_CORNEA 5.68 5.28 6.1 6.08 5.1 5.09 5.46 5.49 5.34 5.33 5.72 5.22 5.57 5.4 5.24 5.37 5.87 5.36 5.62 5.3 5.82 5.38 5.34 5.08 5.55 5.59
HP_ABNORMAL_IRIS_PIGMENTATION 6.34 6.53 6.71 6.69 6.24 6.2 6.69 6.25 6.34 6.42 6.44 6.54 6.35 6.42 6.25 6.34 6.52 6.5 6.66 6.56 6.58 6.41 6.53 6.47 6.43 6.4
HP_ABNORMAL_RETINAL_VASCULAR_MORPHOLOGY 6.23 6.23 6.22 6.51 6.2 6.34 6.31 6.33 6.19 6.26 6.39 6.32 6.42 6.38 6.36 6.44 6.24 6.25 6.11 6.22 6.35 6.32 6.33 6.34 6.35 6.45
HP_ABNORMALITY_OF_THE_VASCULATURE_OF_THE_EYE 6.15 6.19 6.16 6.36 6.12 6.18 6.22 6.21 6.13 6.15 6.27 6.13 6.27 6.24 6.18 6.18 6.15 6.14 6.02 6.14 6.24 6.18 6.2 6.18 6.13 6.31
HP_ABNORMALITY_OF_THE_PALPEBRAL_FISSURES 7.09 7.13 7.28 7.12 7.3 7.43 7.32 7.28 7.42 7.44 7.27 7.42 7.51 7.47 7.44 7.37 7.18 7.16 7.31 7.36 7.16 7.32 7.5 7.54 7.35 7.36
HP_ABNORMAL_MORPHOLOGY_OF_THE_CONJUNCTIVAL_VASCULATURE 6.47 6.22 6.76 7.16 6.48 6.3 6.78 6.79 6.5 6.66 6.71 6.52 6.56 6.4 6.5 6.56 6.83 6.31 6.32 6.68 6.48 6.84 6.62 7.01 6.79 6.73
HP_APLASIA_HYPOPLASIA_AFFECTING_THE_EYE 6.41 6.52 6.59 6.64 6.5 6.65 6.55 6.54 6.54 6.61 6.54 6.65 6.48 6.43 6.59 6.55 6.44 6.45 6.43 6.56 6.46 6.55 6.59 6.65 6.53 6.61
HP_APLASIA_HYPOPLASIA_AFFECTING_THE_FUNDUS 6.13 6.28 6.19 6.68 6.43 6.35 6.51 6.26 6.52 6.53 6.47 6.56 6.35 6.08 6.25 6.18 6.25 6.19 6.11 6.44 6.22 6.43 6.55 6.53 6.39 6.37
HP_APLASIA_HYPOPLASIA_OF_THE_OPTIC_NERVE 6.58 6.58 6.73 6.86 6.85 7 6.8 7.23 6.68 6.76 6.75 6.89 6.86 6.73 6.88 6.64 6.95 6.66 6.91 6.85 6.7 6.85 7 6.85 6.97 6.77
HP_APLASIA_HYPOPLASIA_OF_THE_RETINA 5.67 5.89 6.03 6.01 5.79 5.87 5.91 5.63 6.05 5.85 5.83 5.89 5.9 5.64 5.91 5.74 5.67 5.58 5.64 5.94 5.8 5.85 6.03 5.72 5.93 5.63
HP_APLASIA_HYPOPLASIA_AFFECTING_THE_ANTERIOR_SEGMENT_OF_THE_EYE 6.14 6.24 6.37 6.41 6.42 6.3 6.28 6.38 6.32 6.17 6.22 6.35 6.35 6.17 6.33 6.18 6.14 6.15 6.14 6.25 6.2 6.24 6.38 6.46 6.25 6.25
HP_APLASIA_HYPOPLASIA_OF_THE_LENS 5.79 5.83 5.42 5.83 5.41 5.78 5.81 5.59 5.72 5.82 5.62 6.05 5.93 5.74 5.84 5.89 5.59 5.59 5.3 5.9 5.7 5.98 5.97 5.46 5.92 5.56
HP_ICHTHYOSIS 6.4 6.38 6.79 6.47 6.37 6.35 6.46 6.49 6.63 6.36 6.52 6.47 6.6 6.52 6.35 6.44 6.49 6.47 6.32 6.62 6.41 6.46 6.49 6.45 6.41 6.6
HP_APLASIA_HYPOPLASIA_OF_THE_SKIN 6.48 6.41 6.56 6.49 6.5 6.51 6.44 6.49 6.56 6.66 6.48 6.52 6.55 6.53 6.47 6.45 6.49 6.35 6.35 6.38 6.47 6.57 6.5 6.54 6.64 6.6
HP_ABNORMAL_BLISTERING_OF_THE_SKIN 5.84 5.7 5.68 5.79 5.37 5.45 5.84 5.67 5.73 5.58 5.81 5.42 5.52 5.54 5.47 5.66 5.66 5.66 5.68 5.61 5.71 5.73 5.63 5.51 5.79 5.54
HP_ABNORMALLY_LAX_OR_HYPEREXTENSIBLE_SKIN 6.86 6.8 7.14 7 6.95 6.93 6.94 6.96 6.96 7.07 6.96 6.88 7.01 7.2 6.94 7.08 6.81 7.01 6.8 7.02 7.07 7.1 7.13 7.07 7.1 7.1
HP_NEOPLASM_OF_THE_SKIN 6.42 6.39 6.55 6.44 6.4 6.46 6.56 6.51 6.53 6.53 6.46 6.62 6.42 6.44 6.33 6.52 6.38 6.45 6.34 6.5 6.46 6.49 6.5 6.46 6.58 6.61
HP_SPARSE_HAIR 6.17 6.23 6.2 6.18 6.2 6.09 6.3 6.25 6.21 6.3 6.32 6.17 6.29 6.28 6.31 6.14 6.18 6.15 6.05 6.24 6.19 6.26 6.32 6.3 6.24 6.35
HP_PES_VALGUS 7.12 7.32 6.68 6.87 7.11 7.38 7.6 7.33 7.81 7.31 7.38 7.25 7.58 7.68 7.31 7.71 7.43 7.26 7.24 7.68 7.23 7.45 7.72 7.87 7.48 7.53
HP_DEFORMED_TARSAL_BONES 5.7 5.65 5.48 5.61 5.74 5.6 5.79 5.52 5.66 5.76 5.67 5.74 5.75 6 5.33 5.63 6 6.1 5.31 5.67 6.03 5.72 5.81 5.3 5.39 5.36
HP_DECREASED_CIRCULATING_CORTISOL_LEVEL 6.07 5.83 5.93 5.97 6.05 6.32 6.21 6.31 6.18 6.16 6 6.1 6.19 6.43 6.45 6.32 5.86 6.06 6 6.24 5.79 6.34 6.08 6.47 5.73 6.09
HP_VERY_LONG_CHAIN_FATTY_ACID_ACCUMULATION 7.05 7.04 7.31 7.22 7.43 7.42 7.29 6.98 7.1 7.29 7.32 7.45 7.28 7.51 7.07 7.31 7.18 7.2 7.51 7.47 7.19 7.33 7.24 7.62 7.35 7.28
HP_MILDLY_ELEVATED_CREATINE_KINASE 6.27 6.28 6.2 6.32 6.37 6.42 6.18 6.28 6.51 6.48 6.38 6.57 6.38 6.37 6.26 6.42 6.37 6.33 6.28 6.28 6.23 6.29 6.5 6.25 6.41 6.58
HP_ABSENCE_OF_SECONDARY_SEX_CHARACTERISTICS 5.22 5.03 5.38 5.26 4.85 4.59 5.01 5.15 5.15 4.93 5.29 4.95 5.14 4.83 5.03 4.88 5.03 5.42 4.93 4.97 5.25 5.15 4.79 4.73 4.77 4.94
HP_PRIMARY_GONADAL_INSUFFICIENCY 5.84 5.83 6.36 6.15 6.16 5.89 6.1 6.35 5.8 6.21 6.44 6.11 5.95 5.92 6.04 6.19 6.06 5.87 6.2 6.37 5.8 6.14 6.18 6.04 5.97 6.27
HP_ABSENCE_OF_PUBERTAL_DEVELOPMENT 5.54 5.27 5.46 5.28 5.13 5.04 5.18 5.66 5.23 5.19 5.51 5.31 5.33 5.28 5.79 5.39 5.61 5.45 5.49 5.49 5.61 5.41 4.99 4.83 4.97 5.33
HP_PRIMARY_HYPERPARATHYROIDISM 6.44 6.61 6.48 6.39 6.35 6.36 6.27 5.97 6.58 6.13 6.07 6.2 6.34 6.4 6.19 6.23 6.23 6.27 6.15 6.25 6.96 6.71 6.36 6.27 7.03 6.98
HP_REDUCED_CIRCULATING_PROLACTIN_CONCENTRATION 6.89 7 6.74 6.93 6.95 7.29 6.96 6.68 6.8 6.92 6.82 6.97 6.9 6.83 6.92 6.9 7.04 6.76 6.84 7.12 6.94 6.62 6.95 7.45 6.96 6.87
HP_PRIMARY_ADRENAL_INSUFFICIENCY 6.57 6.58 6.76 6.62 6.91 6.87 6.78 6.67 6.79 6.63 6.52 6.65 6.88 6.82 6.67 6.74 6.68 6.68 6.82 6.99 6.59 6.57 6.73 6.92 6.56 6.6
HP_PREMATURE_OVARIAN_INSUFFICIENCY 6.36 6.38 6.34 6.17 6.43 6.18 6.2 6.18 5.94 6.3 6.37 6.35 6.02 5.95 6 6.16 6.15 6.35 6.39 6.18 6.12 6.21 6.08 6.14 6.07 6.32
HP_ADRENAL_HYPERPLASIA 6.57 6.54 6.13 6.01 5.48 5.13 6.25 5.7 6.16 6 6.48 6.62 5.71 5.41 5.59 5.41 6.07 6.22 5.49 5.4 5.92 5.78 5.63 5.4 5.96 6.34
HP_FEMALE_INFERTILITY 5.34 5.27 5.13 5.2 4.98 5.1 5.27 5.13 4.9 5.65 5.13 5.37 5.17 5.03 5.25 5.56 5.27 5.62 5.08 4.96 5.4 5.29 5 5.02 4.94 5.04
HP_ELEVATED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL 5.25 5.19 5.12 5.36 4.85 4.68 5.34 5.05 5.23 4.95 5.09 5.07 4.85 4.9 4.97 4.93 5.01 5.29 5 4.86 5.16 4.9 4.78 4.92 4.97 5.16
HP_HYPOTHALAMIC_HYPOTHYROIDISM 6.89 6.74 6.74 6.93 6.71 7.06 6.96 6.68 6.8 6.92 6.82 6.97 6.9 6.83 6.92 6.9 7.04 6.76 6.84 7.12 6.94 6.62 6.95 7.45 6.96 6.87
HP_SECONDARY_GROWTH_HORMONE_DEFICIENCY 6.55 6.44 6.63 6.52 6.74 6.86 7.18 6.8 7 6.75 6.61 7.03 6.85 6.85 6.86 6.86 6.66 6.76 6.48 7.13 7.05 6.92 6.98 7.03 6.88 6.85
HP_PITUITARY_HYPOTHYROIDISM 6.22 6.16 6.57 6.36 6.34 6.61 6.39 6.34 6.37 6.31 6.45 6.5 6.46 6.39 6.51 6.52 6.15 6.25 6.34 6.41 6.34 6.54 6.51 6.67 6.18 6.49
HP_TRANSIENT_NEONATAL_DIABETES_MELLITUS 5.43 5.26 5.27 5.5 5.03 4.98 5.25 5.09 5.47 5.14 5.34 5.01 5.24 5.23 5.1 5.37 5.36 5.29 5 5.01 5.32 5.09 5.08 4.79 5.07 5.14
HP_ABNORMAL_MITOCHONDRIA_IN_MUSCLE_TISSUE 8 7.39 8.8 8.34 7.76 7.86 7.54 7.6 7.93 7.92 8.33 8.22 8.13 7.73 8.1 7.86 8.06 7.92 7.9 7.92 7.9 8.35 7.88 7.88 7.91 8.02
HP_ABNORMAL_MITOCHONDRIAL_MORPHOLOGY 7.28 7.32 7.67 8.35 7.69 7.61 7.89 7.59 7.71 7.59 7.61 7.66 7.8 7.78 7.41 7.89 7.66 7.52 7.74 7.67 7.75 7.97 7.52 8.02 7.62 7.68
HP_ABNORMAL_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM 5.77 5.71 5.79 6.03 5.57 5.74 5.55 5.78 5.53 5.67 5.89 5.79 5.74 5.55 5.72 5.83 5.9 5.81 5.54 5.47 5.74 5.89 5.65 5.45 5.57 6.02
HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_IV 6.5 6.51 7.97 7.35 6.98 6.99 7.24 6.96 6.86 7.03 7.15 6.76 7.08 7.26 6.82 6.96 6.86 6.65 6.97 6.92 6.72 6.91 6.99 7.31 6.66 6.98
HP_APLASIA_HYPOPLASIA_OF_THE_HALLUX 7.23 7.24 7.51 7.34 7.27 7.53 7.33 7.47 7.44 7.31 7.38 7.48 7.42 7.6 7.46 7.51 7.83 7.3 7.25 7.32 7.54 7.65 7.64 7.76 7.72 7.48
HP_ABNORMALITY_OF_THE_CALCANEUS 7.18 7.05 6.8 6.57 7.16 7.1 7.14 6.93 7.12 7.28 7.16 7.1 7.6 7.55 7.15 7.71 7.43 6.95 7.05 6.84 6.99 7.13 7.41 7.36 7.46 7
HP_ABNORMALITY_OF_THE_TALUS 6.52 6.65 6.46 6.62 6.72 6.71 6.67 6.77 6.66 6.81 6.52 6.85 6.76 6.62 6.71 6.49 6.53 6.56 6.81 6.51 6.47 6.68 6.75 6.78 6.93 6.7
HP_CONTRACTURES_INVOLVING_THE_JOINTS_OF_THE_FEET 6.39 6.51 6.19 6.49 6.49 6.54 6.52 6.39 6.72 6.66 6.16 6.59 6.5 6.48 6.29 6.38 6.47 6.27 6.43 6.38 6.24 6.23 6.63 6.61 6.59 6.52
HP_PUBERTY_AND_GONADAL_DISORDERS 6.38 6.45 6.59 6.61 6.5 6.62 6.51 6.58 6.56 6.66 6.47 6.56 6.67 6.5 6.55 6.58 6.47 6.42 6.44 6.6 6.48 6.57 6.7 6.71 6.58 6.59
HP_APLASIA_HYPOPLASIA_OF_THE_NAILS 6.62 6.74 6.8 6.7 6.71 6.77 6.79 6.74 6.68 6.71 6.55 6.73 6.66 6.62 6.65 6.7 6.67 6.66 6.63 6.83 6.68 6.84 6.65 6.83 6.74 6.76
HP_ABNORMAL_TOENAIL_MORPHOLOGY 6.53 6.59 6.51 6.74 6.42 6.42 6.52 6.49 6.67 6.58 6.57 6.62 6.49 6.53 6.46 6.74 6.53 6.52 6.54 6.44 6.59 6.53 6.55 6.56 6.63 6.76
HP_DYSTROPHIC_FINGERNAILS 6.82 6.89 7.16 7.12 6.71 6.66 6.82 6.92 7.29 7.03 6.72 6.85 6.93 7.02 6.82 7 7 6.99 6.35 7.2 6.59 7.05 7.04 7.13 6.79 6.9
HP_NAIL_DYSTROPHY 6.19 6.31 6.18 6.15 5.98 6 6.22 6.24 6.08 5.97 6.32 5.91 5.99 5.83 6.02 5.93 6.06 6.1 5.84 5.94 6.3 6.12 5.94 5.74 6.09 6.35
HP_VERTEBRAL_HYPOPLASIA 6.58 6.57 6.61 6.34 6.87 6.71 6.55 6.28 6.68 6.71 6.42 6.56 6.53 6.6 6.54 6.3 6.53 6.88 6.52 6.49 6.46 6.55 6.65 6.54 6.6 6.76
HP_VERTEBRAL_CLEFTING 6.45 6.32 6.45 6.25 6.16 6.3 6.2 6.14 6.12 6.17 6.49 5.95 6.24 6.44 6.08 6.39 6.55 6.46 6.45 6.19 6.54 6.56 6.14 6.46 6.77 6.57
HP_VERTEBRAL_ARCH_ANOMALY 7.46 7.43 7.15 6.98 7.48 7.75 7.97 7.9 7.51 8.16 7.24 8.27 7.94 7.96 8.22 7.55 7.8 8.19 7.99 8.11 7.92 7.58 7.94 8.09 8.12 7.97
HP_SPINAL_DEFORMITIES 6.75 7.23 6.94 6.68 7.49 7.67 7.41 7.63 7.34 7.98 7.01 7.55 7.35 7.03 7.48 6.96 7.17 7.38 7.38 7.66 7.07 6.87 7.23 7.35 7.34 7.55
HP_HYPOPLASTIC_VERTEBRAL_BODIES 6.58 6.57 6.61 6.59 6.87 6.71 6.55 6.28 6.68 6.71 6.42 6.56 6.53 6.6 6.54 6.3 6.53 6.88 6.52 6.49 6.41 6.48 6.65 6.54 6.5 6.68
HP_HIGH_HYPERMETROPIA 6.23 6.34 6.15 6.61 6.06 6.16 6.29 6.2 6.22 6.23 6.37 6.51 6.22 6.4 6.32 6.29 6.52 6.48 6.6 6.37 6.61 6.3 6.25 6.2 6.19 6.5
HP_MEDIAN_CLEFT_LIP_AND_PALATE 5.18 5.01 5.27 5.49 4.65 4.68 5.13 5.07 5.02 4.89 5.58 5.05 4.95 5.05 5.03 4.75 4.83 5.09 4.99 4.66 5.42 4.89 4.82 4.43 4.61 4.72
HP_MODERATE_SENSORINEURAL_HEARING_IMPAIRMENT 7.33 7.62 7.75 7.28 8.06 8.14 8.21 8.11 8.04 7.95 7.59 7.94 7.95 8.05 8.19 7.8 7.48 7.56 7.79 8.07 7.52 7.79 8.42 8.47 7.93 7.52
HP_APLASIA_HYPOPLASIA_OF_THE_SACRUM 5.34 5.35 5.82 6.46 5.53 5.31 5.38 5.43 5.36 5.41 5.44 5.44 5.6 5.59 5.3 5.71 5.79 5.12 5.55 5.45 5.36 5.51 5.41 4.95 5.6 5.75
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_VERTEBRAL_COLUMN 6.16 6.12 6.5 6.53 6.44 6.65 6.24 6.28 6.51 6.6 6.29 6.5 6.5 6.51 6.31 6.3 6.18 6.39 6.29 6.35 6.26 6.31 6.4 6.54 6.36 6.4
HP_CONGENITAL_SENSORINEURAL_HEARING_IMPAIRMENT 5.36 5.32 5.6 5.26 5.42 5.17 5.39 5.61 5.35 5.2 5.7 5.36 5.37 5.41 5.57 5.41 5.71 5.64 5.42 5.35 5.63 5.38 5.3 5.05 5.46 5.48
HP_ABNORMALLY_FOLDED_HELIX 6.69 6.84 6.6 6.64 6.72 6.92 6.67 6.63 6.91 6.87 6.61 6.86 6.85 6.71 6.77 6.62 6.62 6.55 6.71 6.66 6.58 6.67 7.09 7.12 7.01 6.68
HP_EXTERNAL_EAR_MALFORMATION 6.26 6.21 6.09 6.23 6.28 6.19 6.13 6.14 6.19 6.07 6.1 6.07 6.12 6.18 6.05 6.11 6.01 6.05 6.07 6.18 6.06 6.07 6.32 6.27 6.07 5.94
HP_MORPHOLOGICAL_ABNORMALITY_OF_THE_MIDDLE_EAR 6.44 6.45 6.11 5.91 6.36 6.67 6.61 6.67 6.26 6.59 6.46 6.43 6.95 6.78 6.66 6.82 6.19 6.7 6.56 6.63 6.29 6.59 6.34 6.54 6.64 6.53
HP_BILATERAL_SENSORINEURAL_HEARING_IMPAIRMENT 6.6 6.7 6.9 6.81 6.73 6.77 6.68 6.9 6.69 6.88 6.66 6.71 6.91 6.87 6.82 6.82 6.62 6.78 6.8 6.89 6.46 6.82 6.83 7.03 6.85 6.73
HP_ABNORMALITY_OF_THE_STAPES 5.95 5.65 5.69 5.5 5.94 5.6 6.17 6.16 5.66 5.76 5.67 5.74 6.59 6.34 6.53 6.32 5.25 6.12 5.34 5.99 6.03 5.72 5.9 6.48 6.02 5.87
HP_URETHRAL_STENOSIS 6.1 5.98 5.9 6.31 5.85 5.83 6 6.13 5.91 5.86 6 6.05 5.76 5.75 5.98 6.14 5.88 6.06 5.96 6.25 6.35 6.13 6.09 5.88 6.11 6.59
HP_ABNORMAL_SPERMATOGENESIS 5.3 5.23 5.17 5.31 5 4.88 5.03 4.87 5.12 4.93 5.02 5.02 5 4.97 5.26 5.02 5.08 5.29 5.05 5.01 5.17 5.13 4.94 4.87 4.96 4.92
HP_RENAL_HYPOPLASIA_APLASIA 6.38 6.31 6.34 6.39 6.48 6.38 6.35 6.47 6.37 6.36 6.36 6.33 6.45 6.43 6.31 6.39 6.28 6.34 6.2 6.27 6.47 6.35 6.38 6.48 6.31 6.45
HP_APLASIA_HYPOPLASIA_OF_THE_UTERUS 5.6 5.44 5.93 6.11 5.61 5.15 5.69 5.69 5.7 5.57 5.94 5.45 5.54 5.47 5.97 5.5 5.83 5.9 5.76 5.77 5.91 5.64 5.48 5.32 5.61 5.84
HP_BILATERAL_CRYPTORCHIDISM 6.03 6.45 6.17 6.16 6.49 6.21 6.45 6.24 6.09 6.38 6.32 6.14 6.41 6.52 6.04 5.85 6.72 6.81 6.19 6.22 6.43 6.08 6.02 6.09 6.56 6.43
HP_TESTICULAR_DYSGENESIS 5.25 4.96 5.41 5.36 4.85 4.63 5.19 4.95 5.23 4.83 5.22 4.83 4.92 4.92 4.99 4.8 5.01 4.86 4.71 4.96 5.24 4.99 4.7 4.84 4.78 4.93
HP_HYPOPLASIA_OF_THE_VAGINA 5.25 5.35 5.41 6.1 4.85 4.74 5.19 5.05 5.23 4.98 5.19 4.95 5.16 4.9 4.99 4.89 5.07 5.56 4.73 4.96 5.24 4.9 4.78 4.92 4.98 5.29
HP_FEMALE_EXTERNAL_GENITALIA_IN_INDIVIDUAL_WITH_46_XY_KARYOTYPE 5.3 5.17 5.27 5.47 4.93 4.9 5.26 5.22 5.19 5.12 4.97 4.89 5 4.88 5.12 4.9 5.04 5.42 4.77 4.98 5.2 5.02 4.79 4.99 4.97 5.27
HP_DECREASED_TESTICULAR_SIZE 5.93 5.94 6.1 5.71 5.67 5.7 5.8 5.82 5.85 5.76 5.8 5.85 5.8 5.8 5.97 5.8 5.87 5.8 5.88 5.82 5.88 5.7 5.79 5.86 5.84 5.89
HP_HYPOPLASIA_OF_PENIS 6.38 6.44 6.54 6.58 6.51 6.54 6.51 6.57 6.58 6.68 6.55 6.56 6.69 6.57 6.57 6.59 6.53 6.52 6.5 6.51 6.51 6.53 6.71 6.69 6.59 6.6
HP_OBSESSIVE_COMPULSIVE_TRAIT 7.74 7.85 7.97 8.1 8.39 8.25 8.32 8.48 8.39 7.91 7.89 8.17 7.77 8.04 8.61 8.31 7.96 7.41 7.96 8.16 7.88 8.57 8.12 8.46 8.3 7.83
HP_APLASIA_HYPOPLASIA_OF_THE_EAR 6.84 6.89 6.98 6.66 7.04 7.05 6.94 6.92 7.22 7.12 6.91 7.02 7.16 7.03 6.91 6.93 6.91 6.81 7.05 6.93 7.08 6.8 7.1 7.12 7.17 7.09
HP_ABNORMAL_PROSTATE_MORPHOLOGY 5.85 6.13 6.19 6.55 6.26 5.88 6.08 6.23 6.12 6.17 6.01 6.07 6.03 5.84 5.95 5.98 5.9 5.64 5.91 5.83 6.3 6.06 6.29 6.18 6.04 6.06
HP_ABNORMAL_RENAL_ARTERY_MORPHOLOGY 6.79 6.78 6.52 6.9 6.89 7.09 6.91 6.85 6.73 7.14 6.59 7.01 7.03 6.66 6.53 6.49 6.79 6.56 7.04 6.82 7 6.82 6.84 7.04 6.92 6.66
HP_LIMITED_HIP_MOVEMENT 6.23 6.2 6.18 6.16 6.23 6.29 6.21 6.32 6.13 6.38 6.27 6.5 6.32 6.2 6.13 6.08 6.37 6.47 6.27 6.38 6.22 6.53 6.48 6.28 6.74 6.67
HP_ACETABULAR_DYSPLASIA 6.61 6.21 6.84 6.68 6.72 6.18 6.25 6.4 6.45 6.27 6.82 6.27 6.25 6.62 6.25 6.74 6.3 6.07 6.27 6.25 6.22 6.28 6.25 6.49 6.34 6.48
HP_HYPOPLASTIC_PELVIS 5.85 5.86 5.94 6.09 5.72 6.02 6.18 6.09 5.96 6.25 5.97 5.84 6.07 5.84 6.24 6.24 5.84 5.95 6.01 5.82 5.91 6.03 6.19 6.27 5.98 5.96
HP_HIP_OSTEOARTHRITIS 5.2 5.48 5.98 5.96 5.1 5.18 5.74 5.8 5.56 5.83 5.58 5.92 5.34 5.26 5.92 5.08 5.33 4.83 5.43 5.6 5.51 6.08 5.43 5.85 5.59 5.25
HP_SEVERE_POSTNATAL_GROWTH_RETARDATION 7.11 6.88 6.81 6.96 7.42 7.58 7.26 7.2 7.4 7.47 6.87 7.38 7.36 7.22 7.14 7.25 7.12 6.97 7.23 7.27 7.04 6.94 7.15 7.46 7.09 7.21
HP_FEEDING_DIFFICULTIES_IN_INFANCY 7.04 7.14 7.33 7.31 7.32 7.44 7.36 7.38 7.35 7.39 7.2 7.41 7.44 7.48 7.42 7.38 7.19 7.13 7.37 7.41 7.18 7.37 7.31 7.51 7.42 7.36
HP_DISPROPORTIONATE_SHORT_LIMB_SHORT_STATURE 6.41 6.37 6.7 6.62 6.61 6.65 6.54 6.58 6.52 6.69 6.63 6.73 6.6 6.67 6.5 6.69 6.79 6.67 6.65 6.66 6.48 6.98 6.63 6.54 6.75 6.79
HP_ADIPOSE_TISSUE_LOSS 6.34 6.46 6.3 6.6 6.36 6.58 6.53 6.44 6.63 6.73 6.25 6.49 6.57 6.35 6.16 6.37 6.16 6.32 6.35 6.45 6.22 6.37 6.56 6.88 6.46 6.46
HP_POSTNATAL_GROWTH_RETARDATION 6.53 6.55 6.61 6.7 6.78 6.76 6.62 6.67 6.54 6.86 6.61 6.69 6.76 6.71 6.57 6.74 6.56 6.47 6.67 6.63 6.53 6.64 6.81 6.99 6.73 6.77
HP_RHIZOMELIA 6.58 6.66 6.96 6.94 7.12 7.16 6.98 6.91 6.7 7.06 6.85 7.1 6.81 6.96 7.03 7 6.91 6.8 7.09 6.87 6.72 7.11 6.95 6.88 6.98 7.22
HP_NEONATAL_SHORT_LIMB_SHORT_STATURE 5.55 5.65 5.49 6.1 5.6 5.6 5.79 5.51 5.63 5.76 6.08 5.74 5.72 6 5.43 5.63 6 6.12 5.5 5.95 5.92 5.55 5.53 5.37 5.86 6.16
HP_GENERALIZED_NEONATAL_HYPOTONIA 7.24 7.12 7.42 7.37 7.66 7.58 7.74 7.68 7.56 7.78 7.13 7.84 7.56 7.74 7.51 7.37 7.33 7.31 7.51 7.54 7.55 7.55 7.81 7.89 7.66 7.49
HP_MUSCULAR_HYPOTONIA_OF_THE_TRUNK 7.28 7.47 7.8 7.69 7.55 7.86 7.71 7.76 7.87 7.77 7.49 7.69 7.92 7.87 7.67 7.63 7.51 7.31 7.62 7.74 7.49 7.7 7.72 7.91 7.75 7.75
HP_DISTAL_LOWER_LIMB_AMYOTROPHY 7.82 7.81 8.06 7.67 8.22 7.97 8.22 8.07 8.31 8.21 7.96 8.43 8.23 8.27 8.06 8.17 8.09 7.45 7.82 8.26 8.06 8.24 8.37 8.53 8.47 8.2
HP_INFANTILE_MUSCULAR_HYPOTONIA 6.7 6.86 7.06 7.03 7.09 7.23 7.14 7.26 6.92 7.21 6.85 7.17 7.17 7.11 7.2 7.09 6.85 6.92 6.98 7.2 6.95 7.11 7.05 7.24 7.08 7.08
HP_INTRINSIC_HAND_MUSCLE_ATROPHY 7.37 7.1 6.24 6.63 7.91 7.69 7.71 8.13 7.38 7.42 6.41 7.76 7.49 7.02 7.26 7.08 8.09 7.04 7.51 7.93 6.67 7.16 7.38 7.16 7.81 8.63
HP_DISTAL_UPPER_LIMB_MUSCLE_WEAKNESS 7.71 7.54 7.22 6.41 7.34 7.59 7.66 7.42 7.7 7.56 7.21 7.47 7.23 7.69 7.57 7.35 7.13 7.11 7.58 7.57 7.44 7.49 7.55 7.65 7.3 7.47
HP_MUSCLE_HYPERTROPHY_OF_THE_LOWER_EXTREMITIES 6.34 6.24 6.19 6.06 6.62 6.54 6.23 6.27 6.38 6.45 6.44 6.6 6.26 6.11 6.22 6.34 6.45 6.15 6.35 6.36 6.21 6.15 6.44 6.38 6.29 6.53
HP_LEG_MUSCLE_STIFFNESS 8.28 8.23 8.94 8.78 8.63 8.68 8.88 9.05 8.82 8.74 8.84 8.86 9.06 8.94 8.74 8.86 8.56 8.22 8.52 8.6 8.36 8.92 9.1 9.06 8.77 8.81
HP_PROXIMAL_MUSCLE_WEAKNESS_IN_LOWER_LIMBS 6.6 6.71 6.93 6.9 7.01 6.72 6.99 6.85 7.17 7.16 6.6 7.12 6.98 6.94 6.77 6.7 6.95 6.58 6.67 7.1 6.29 6.46 6.97 7.25 6.91 6.88
HP_PROXIMAL_MUSCLE_WEAKNESS_IN_UPPER_LIMBS 6.34 6.07 5.99 5.95 6.31 6.4 6.11 6.09 6.05 6.22 6.2 6.14 5.95 5.82 5.93 5.89 6.15 6.06 6.18 6.32 6.06 5.96 6.28 5.85 6.18 6.38
HP_HYPOPLASIA_OF_THE_MUSCULATURE 6.61 6.86 5.97 5.96 6.58 6.74 6.96 6.88 6.76 6.52 6.16 6.07 6.63 6.57 6.77 6.28 6.2 6.55 6.57 6.18 6.51 7.07 6.69 6.64 6.95 6.47
HP_WEAKNESS_OF_THE_INTRINSIC_HAND_MUSCLES 5.89 5.49 5.12 5.87 6.16 5.37 5.93 5.21 5.78 5.46 5.77 5.66 5.32 5.34 5.29 5.16 5.72 5.74 5.7 5.24 5.14 5.24 5.06 4.79 5.21 5.28
HP_EXERCISE_INDUCED_MUSCLE_FATIGUE 5.89 5.62 5.41 6.2 5.4 5.05 5.86 5.45 5.87 5.26 5.95 5.34 5.49 5.08 5.43 5.21 5.68 5.78 4.92 5 5.67 5.37 5.61 4.97 5.08 5.29
HP_ABDOMINAL_WALL_MUSCLE_WEAKNESS 6.38 6.28 6.39 6.62 6.82 6.71 6.74 6.65 6.11 6.47 6.06 6.5 6.32 6.35 6.76 6.32 6.68 6.49 6.21 6.58 6.34 6.64 6.2 6.5 6.45 6.55
HP_INCREASED_CONNECTIVE_TISSUE 6.49 6.2 6.18 6.21 6.68 6.57 6.31 6.32 6.62 6.71 6.25 6.6 6.47 6.44 6.39 6.44 6.13 6.05 6.35 6.38 6.2 6.31 6.73 6.69 6.55 6.48
HP_FOOT_DORSIFLEXOR_WEAKNESS 6.86 6.87 6.81 6.69 7.21 7.33 6.99 7.12 7.17 7.16 6.66 7.32 7.1 7.05 7.25 6.85 7.39 6.84 7.02 7.38 6.74 6.86 7.38 7.23 7.3 7.27
HP_DIFFICULTY_RUNNING 6.34 6.24 6.42 5.96 6.43 6.55 6.39 6.5 6.79 6.62 6.27 6.83 6.69 6.7 6.34 6.5 6.47 6.47 6.5 6.68 6.37 6.62 6.67 6.73 6.63 6.73
HP_DISTAL_LOWER_LIMB_MUSCLE_WEAKNESS 6.92 7.22 7.27 6.79 6.99 7.29 7.28 7.38 7.15 7.52 7.09 7.43 7.15 7.25 7.39 7.08 7.18 7.11 7.11 7.42 7.15 7.45 7.42 7.42 7.29 7.27
HP_GENERALIZED_LIMB_MUSCLE_ATROPHY 6.04 5.8 6.2 6.02 6.38 6.1 6.01 5.77 6.01 5.83 6.07 5.78 5.69 5.88 6.02 5.96 5.68 5.96 5.8 6.15 5.74 5.91 6.06 5.87 5.9 5.92
HP_INCREASED_MUSCLE_LIPID_CONTENT 5.93 5.77 6.2 5.95 6.27 5.95 6.12 5.84 6.32 5.98 6.23 5.95 5.99 6.1 5.78 6.06 5.86 6.16 5.79 5.92 5.77 5.78 6.08 5.62 6.24 6.27
HP_INFANTILE_AXIAL_HYPOTONIA 6.14 6.28 6.38 6.72 6.55 6.44 6.39 6.6 6.39 6.62 6.39 6.37 6.65 6.51 6.36 6.3 6.49 6.25 6.28 6.45 6.6 6.47 6.3 6.4 6.39 6.39
HP_PROGRESSIVE_DISTAL_MUSCLE_WEAKNESS 6.92 6.86 6.16 6.18 6.93 6.97 7.15 7.32 6.97 6.84 6.61 7.07 6.98 6.74 6.99 6.85 7.17 6.74 6.81 7.04 6.68 6.95 6.51 6.94 7.27 7.15
HP_PROGRESSIVE_PROXIMAL_MUSCLE_WEAKNESS 6.82 6.75 6.45 6.36 6.95 6.89 7.16 7 6.97 6.74 6.61 7.3 6.96 6.9 7.18 6.88 7.35 6.84 6.91 6.78 6.87 7.1 6.87 6.88 6.96 7.05
HP_WEAKNESS_OF_LONG_FINGER_EXTENSOR_MUSCLES 5.83 5.42 5.08 5.92 5.78 5.2 5.49 5.17 5.49 5.01 5.61 5.25 5.14 5.19 5.08 5.11 5.22 5.6 5.55 5.14 5.14 5.18 4.98 4.76 5 5.05
HP_SPEECH_ARTICULATION_DIFFICULTIES 6.58 6.44 6.29 6.99 6.65 6.65 6.38 6.33 6.4 6.83 6.4 6.73 6.58 6.72 6.21 6.22 6.44 6.41 6.73 6.75 6.43 6.5 6.69 6.53 6.72 6.48
HP_CHRONIC_ORAL_CANDIDIASIS 5.35 5.24 5.31 5.35 5.04 5.03 5.31 5.21 5.13 5.01 5.54 4.93 5.2 4.95 5.13 5.14 5.21 5.33 4.9 5.16 5.18 5.13 5.15 4.8 5.15 4.94
HP_MEDIAN_CLEFT_PALATE 5.41 5.36 5.5 5.58 5.33 5.01 5.55 5.25 5.34 4.9 5.8 5.26 5.61 5.53 5.29 5.26 5.73 5.51 5.11 5.36 5.63 5.18 4.95 4.89 5.38 5.15
HP_ANTERIOR_OPEN_BITE_MALOCCLUSION 5.2 5.34 5.34 5.34 4.58 4.4 4.9 4.78 5.08 4.55 5.21 4.96 4.72 4.2 4.94 4.34 4.85 4.94 4.72 4.42 4.87 4.96 4.56 4.34 4.83 4.72
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_PELVIS 6.19 6.31 6.49 6.32 6.46 6.65 6.49 6.58 6.51 6.63 6.35 6.56 6.64 6.62 6.47 6.53 6.49 6.33 6.54 6.22 6.22 6.43 6.65 6.65 6.69 6.36
HP_APLASIA_HYPOPLASIA_OF_THE_PUBIC_BONE 6.14 6.18 5.99 5.71 6.2 6.47 6.58 6.58 6.5 6.53 6.21 6.36 6.56 6.62 6.3 6.43 6.41 6.5 6.34 6.19 6.44 6.43 6.45 6.55 6.19 6.11
HP_ABNORMAL_OSSIFICATION_INVOLVING_THE_FEMORAL_HEAD_AND_NECK 6.55 6.23 6.54 6.5 6.89 6.73 6.28 6.2 6.67 6.86 6.73 6.92 6.51 6.61 6.59 7.03 6.51 6.64 6.35 6.33 6.09 6.76 6.37 6.46 6.36 6.52
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_FEMORAL_HEAD_AND_NECK 6.37 6.26 6.61 6.25 6.43 6.5 6.43 6.45 6.43 6.65 6.2 6.46 6.14 6.34 6.45 6.48 6.19 5.99 6.49 6.15 6.12 6.25 6.35 6.66 6.57 6.45
HP_DIAPHRAGMATIC_EVENTRATION 6.4 6.59 6.2 6.47 6.48 6.57 5.91 6.16 6.43 6.62 6.26 6.56 6.37 6.17 6.03 5.9 6.43 6.22 6.39 6.19 5.96 5.74 6.25 5.99 6.64 6.51
HP_DIAPHRAGMATIC_WEAKNESS 6.09 5.64 5.72 6.01 5.97 6.08 6.36 6.14 6.22 6.32 6.1 6.4 6.37 6.19 6.22 5.88 6.06 5.64 5.75 6.17 6.11 6.12 6.48 6.11 6.45 6.35
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETON 6.56 6.6 6.71 6.67 6.75 6.82 6.66 6.76 6.66 6.77 6.62 6.72 6.75 6.68 6.71 6.69 6.62 6.59 6.71 6.68 6.62 6.76 6.81 6.82 6.78 6.76
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SINUSES 6.15 5.95 5.99 6.23 6.12 5.6 5.73 5.76 5.79 5.97 5.74 5.91 5.8 5.88 5.87 6.04 6.24 5.98 5.9 5.65 5.91 5.79 6.33 5.54 5.82 5.89
HP_APLASIA_HYPOPLASIA_AFFECTING_BONES_OF_THE_AXIAL_SKELETON 6.53 6.56 6.66 6.59 6.69 6.7 6.58 6.61 6.59 6.71 6.57 6.63 6.64 6.59 6.55 6.57 6.56 6.54 6.62 6.56 6.58 6.62 6.69 6.71 6.65 6.67
HP_ABNORMAL_ADIPOSE_TISSUE_MORPHOLOGY 6.33 6.37 6.55 6.59 6.58 6.66 6.39 6.25 6.48 6.66 6.38 6.54 6.44 6.49 6.43 6.3 6.41 6.4 6.41 6.36 6.42 6.44 6.81 6.66 6.53 6.45
HP_LIPODYSTROPHY 6.27 6.37 6.52 6.41 6.49 6.5 6.33 6.09 6.27 6.53 6.37 6.43 6.24 6.22 6.02 6.28 6.34 6.4 6.33 6.25 6.29 6.23 6.59 6.51 6.5 6.39
HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LIMBS 7.12 7.19 7.3 7.08 7.32 7.38 7.29 7.33 7.38 7.43 7.19 7.43 7.41 7.35 7.28 7.23 7.29 7.1 7.28 7.45 7.15 7.19 7.38 7.41 7.34 7.31
HP_UPPER_LIMB_AMYOTROPHY 7.34 7.58 7.44 7.85 7.8 7.92 7.65 7.88 7.79 7.81 7.24 7.87 7.67 7.8 7.32 7.11 7.84 7.24 7.68 7.98 7.28 7.3 7.73 7.8 7.47 7.41
HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_FEET 6.18 5.97 5.7 6.06 6.13 6.25 5.99 5.66 5.9 6.61 5.85 6.29 5.95 5.82 5.64 6.18 6.16 6.3 6.17 5.7 5.91 5.71 6.37 6.16 6.22 6.05
HP_DUPLICATION_INVOLVING_BONES_OF_THE_FEET 6.54 6.58 6.85 6.96 6.8 7.01 6.7 6.63 6.63 6.88 6.94 6.93 6.8 6.86 6.86 6.97 6.62 6.88 6.89 6.7 6.73 6.93 6.87 6.79 6.8 6.81
HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_LOWER_LIMBS 6.46 6.56 6.51 6.08 6.69 6.49 6.89 7.01 6.74 6.48 6.65 6.82 6.85 6.92 6.89 7.02 6.66 6.61 6.26 6.86 6.89 6.97 7.27 6.87 7.03 6.96
HP_SUPERNUMERARY_BONES_OF_THE_AXIAL_SKELETON 6.19 6.29 6.03 6.23 6.12 6.28 5.91 6.37 6.08 6.27 5.98 6.24 6.25 6.22 6.14 6.32 6.15 5.86 6.15 6.05 6.5 6.51 5.76 5.97 6.23 6.6
HP_ABNORMAL_CEREBRAL_ARTERY_MORPHOLOGY 6.54 6.61 6.63 6.6 6.92 7 6.78 6.7 6.77 6.91 6.6 7.03 6.78 6.59 6.51 6.53 7.13 6.65 6.66 6.73 6.85 6.69 6.84 6.74 6.82 6.88
HP_JOINT_CONTRACTURE_OF_THE_5TH_FINGER 7.6 7.75 7.18 7.08 8.19 7.96 8.2 8.1 8.13 7.97 7.26 7.99 8.34 8.3 8.18 8.32 8.38 7.89 7.93 8.42 8.07 8.43 8.2 8.25 8.16 7.9
HP_APLASIA_OF_THE_FINGERS 6.53 6.22 6.8 6.9 6.43 6.3 6.41 6.4 6.78 6.53 6.69 6.64 6.28 6.29 6.37 6.51 6.53 6.55 6.15 6.33 6.39 6.31 6.62 6.7 6.12 6.03
HP_ULNAR_DEVIATION_OF_FINGER 5.63 5.76 5.77 6.2 5.09 5.13 5.48 5.51 5.65 5.36 5.53 5.31 5.37 5.31 5.61 5.43 5.25 5.72 5.41 5.22 5.58 5.31 5.34 5.34 5.26 5.36
HP_DEVIATION_OF_THE_2ND_FINGER 6.13 6.31 5.83 5.83 5.36 5.76 6.36 6.21 6.2 5.89 5.52 6.15 6.21 6.4 6.32 6.05 5.91 6.09 6.15 6.36 5.97 5.71 5.81 6.12 6.31 6.4
HP_JOINT_CONTRACTURE_OF_THE_HAND 6.25 6.38 6.29 6.39 6.41 6.47 6.35 6.43 6.41 6.36 6.29 6.48 6.36 6.4 6.32 6.44 6.35 6.34 6.33 6.31 6.37 6.29 6.54 6.42 6.57 6.48
HP_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND 6.51 6.56 6.64 6.69 6.65 6.78 6.66 6.78 6.67 6.73 6.57 6.65 6.66 6.67 6.65 6.61 6.63 6.55 6.6 6.72 6.67 6.8 6.8 6.84 6.71 6.78
HP_RADIAL_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND 6.49 6.57 6.8 6.45 6.81 6.94 7.12 6.99 6.72 6.74 6.34 6.73 6.94 6.9 6.7 6.81 6.49 6.72 6.8 7.14 6.61 6.47 6.91 6.99 6.92 6.77
HP_RADIAL_DEVIATION_OF_THE_HAND 6.24 6.17 5.89 5.4 6.4 6.3 6.03 6.08 6.16 6.12 6.02 6.32 5.77 6.03 5.9 5.82 5.95 5.94 6.06 6.07 5.73 5.7 6.1 6 5.82 6.13
HP_ULNAR_DEVIATION_OF_THE_HAND 6.38 6.37 5.92 5.9 6.7 6.62 6.11 6.04 6.24 6.53 6.23 6.45 6.17 6.04 5.89 6.08 5.95 6.1 6.13 6.07 5.79 5.92 6.07 6.19 5.95 6.31
HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_2ND_FINGER 5.26 5.37 5.09 5.07 5.35 5 5.04 4.71 5.19 5.32 5.56 5.37 4.86 4.96 5.43 5.04 5.18 5.19 4.93 5.17 4.85 5.12 4.98 4.84 4.92 5
HP_ABNORMALITY_OF_THE_HAIRLINE 7.45 7.57 7.69 7.26 7.91 7.88 7.93 7.61 7.75 7.81 7.5 7.75 7.74 7.71 7.76 7.72 7.64 7.44 7.67 7.89 7.57 7.63 7.9 7.88 7.75 7.63
HP_ASTROCYTOMA 7.11 6.93 7.1 6.89 7.67 7.58 7.19 7.17 7.24 7.35 7.18 7.11 7.44 7.22 7.26 7.29 7.47 7.07 7.44 7.37 6.88 6.89 7.3 7.43 7.51 7.35
HP_RETINAL_HAMARTOMA 8.87 8.54 9.07 8.54 8.55 8.83 8.79 8.83 8.57 8.66 8.42 8.75 8.77 8.74 8.66 8.58 8.82 8.61 8.98 9.09 8.69 8.71 8.75 8.77 8.67 8.38
HP_APLASIA_HYPOPLASIA_OF_THE_THUMB 6.64 6.55 6.6 6.55 6.8 6.72 6.64 6.77 6.74 6.72 6.7 6.56 6.89 6.79 6.76 6.79 6.59 6.58 6.69 6.71 6.54 6.61 6.83 6.95 6.5 6.65
HP_DEVIATION_OF_THE_THUMB 7.08 7.16 7.15 6.96 7.16 7.33 7.31 7.27 7.51 7.53 7.12 7.68 7.65 7.37 7.21 7.14 7.13 7.03 7.34 7.32 7 7.18 7.63 7.67 7.24 7.27
HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_THUMB 6.65 6.48 6.85 6.67 6.79 6.85 6.7 6.74 6.44 6.71 6.72 6.62 6.67 6.67 6.72 6.54 6.6 6.48 6.64 7 6.51 6.56 6.91 6.86 7.09 6.93
HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_THUMB 6.85 6.98 6.74 6.67 7.14 7.2 7.01 6.88 6.95 6.95 6.85 7.31 7.1 7.34 6.88 7.09 6.91 6.81 7.07 7 6.98 7.18 7.12 7.38 7.11 6.81
HP_SHORT_PHALANX_OF_THE_THUMB 6.77 6.84 6.27 6.19 6.78 6.93 6.73 6.84 6.45 6.75 6.5 6.38 6.98 6.8 6.59 6.55 6.7 6.6 6.72 6.91 6.52 6.51 6.81 7.01 6.5 6.61
HP_CARPAL_SYNOSTOSIS 6 5.95 6.02 5.9 6.06 5.99 6.34 6.35 6.12 5.92 6.05 6.17 6.44 6.64 6.15 6.58 6.26 5.83 5.79 6.13 6.26 6.19 6.25 6.42 6.18 6.11
HP_ABNORMALITY_OF_THE_EPIDIDYMIS 5.53 5.6 6.02 5.95 5.71 5.55 5.42 5.6 6.02 5.65 5.88 5.71 5.55 5.53 5.5 5.47 5.37 6.02 5.83 5.76 5.91 5.59 5.77 5.94 5.84 5.45
HP_ADENOMA_SEBACEUM 7.47 7.78 8.03 8.18 8.06 7.75 7.56 7.53 8 7.87 8.34 8 8.22 8.11 8.17 8.1 7.51 7.31 7.61 8.14 7.21 7.38 8.51 8.36 8.1 7.38
HP_ABNORMALITY_OF_THE_SUBUNGUAL_REGION 5.72 5.45 5.24 5.48 5.31 5.06 5.27 5.06 5.31 5.2 5.61 5.13 5.1 5.24 5.11 5.17 5.44 5.45 5.25 5.01 5.38 5.22 5.19 4.85 5.16 5.17
HP_BLADDER_NEOPLASM 6.69 6.58 6.96 6.64 6.48 6.95 6.69 6.95 7.64 7.06 6.61 6.85 7.15 7.27 6.87 6.97 6.39 6.57 6.44 7.2 6.98 6.66 7.35 7.27 6.9 7.13
HP_NEOPLASM_OF_STRIATED_MUSCLE 6.65 6.86 7.09 6.72 6.4 6.64 6.71 6.48 6.94 6.91 6.6 6.64 6.74 6.8 6.82 6.8 6.15 6.57 6.72 6.79 6.85 6.64 6.63 7.09 7.02 6.61
HP_CEREBRAL_HAMARTOMA 6.01 6.37 6.25 6.23 6.54 6.71 6.49 6.41 6.37 6.41 6.56 6.42 6.46 6.47 6.28 6.46 6.62 6.59 6.33 6.22 6.67 6.8 6.23 6.37 6.57 6.63
HP_GLIOMA 7.12 7.14 7.13 7.3 7.41 7.66 7.2 7.26 7.36 7.32 7.24 7.37 7.61 7.32 7.25 7.33 7.37 6.99 7.3 7.37 7.06 6.94 7.29 7.46 7.41 7.2
HP_ABNORMALITY_OF_THE_ANTIHELIX 7.68 7.54 7.54 7.26 7.75 7.78 7.49 7.74 7.69 7.92 7.47 7.75 7.97 7.97 7.87 7.71 7.54 7.44 7.77 8.01 7.64 7.74 7.72 8.04 7.9 7.99
HP_LARGE_EARLOBE 7.57 7.85 7.79 7.86 7.98 7.98 7.98 8.22 8.34 7.83 8.17 7.81 8.42 8.5 8.1 8.4 8.32 8.06 7.77 8.14 7.93 7.94 8.3 8.63 8.29 8.41
HP_ANKYLOBLEPHARON 6.11 6.04 6.33 6.27 5.69 5.87 6.19 6.27 5.85 6.21 5.65 6.18 6 5.98 5.61 5.94 5.82 5.82 5.99 5.76 6.25 5.96 5.94 6.18 6.22 6.39
HP_LIMB_PAIN 5.88 5.67 5.86 5.72 5.94 6.09 5.92 5.55 6.02 5.78 6.08 5.43 5.7 5.83 5.57 5.76 5.86 5.78 5.84 5.81 5.71 5.57 5.66 5.63 5.71 5.74
HP_LOW_HANGING_COLUMELLA 8.29 8.58 8.04 8.09 8.64 8.77 8.77 8.93 8.73 8.66 7.81 8.68 9.01 8.88 8.7 8.6 8.82 8.71 8.88 9.02 8.6 8.63 8.63 8.77 9.02 8.68
HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HAND 6.74 6.73 6.84 6.67 6.94 7.17 6.99 6.95 6.9 6.97 6.8 7 7.07 6.97 6.87 6.92 6.84 6.78 6.95 6.95 6.95 7.11 7.11 7.09 6.99 7.03
HP_SYMPHALANGISM_AFFECTING_THE_PHALANGES_OF_THE_HAND 5.05 5.39 5.41 6.16 4.98 5.21 5.1 5.51 5.26 5.33 5.48 5.14 5.4 5.53 4.83 5.49 5.05 5.16 5.34 5.27 5.49 5.02 5.27 5.32 5.36 5.87
HP_TRIANGULAR_SHAPED_PHALANGES_OF_THE_HAND 6.64 6.64 6.84 6.79 6.82 6.92 6.85 6.95 6.85 6.86 6.86 6.67 6.89 6.75 6.86 6.86 6.85 6.84 6.75 6.89 6.96 6.89 6.99 6.99 6.84 6.95
HP_ABSENT_THUMB 6.08 5.99 6.15 6.07 5.83 5.85 5.85 6.15 6.38 6.09 6.04 5.81 6.03 5.96 6.03 5.8 6.09 5.84 5.81 5.8 5.79 5.63 6.25 6.32 5.8 5.68
HP_SHORT_THUMB 6.61 6.3 6.27 6.19 6.71 6.65 6.57 6.53 6.5 6.28 6.29 6.25 6.67 6.64 6.52 6.57 6.44 6.44 6.54 6.5 6.4 6.45 6.44 6.51 6.33 6.55
HP_BRANCHIAL_ANOMALY 6.5 6.37 7.57 7.82 6.59 6.62 7.14 6.77 7.06 6.8 7.04 6.83 6.76 6.8 6.53 7.18 6.81 7.2 6.76 6.84 6.84 7.06 7.2 7.11 6.68 6.67
HP_SUPERNUMERARY_SPLEENS 5.67 5.62 5.53 5.72 5.54 5.41 5.68 5.53 5.49 6 5.69 5.7 5.47 5.55 5.63 5.83 5.62 5.84 5.63 5.46 5.74 5.6 5.68 5.41 5.77 5.73
HP_MATERNAL_DIABETES 5.56 5.51 5.5 5.8 5.48 5.31 5.55 5.36 5.53 5.52 5.64 5.43 5.67 5.95 5.63 5.72 5.79 5.53 5.45 5.41 5.62 5.34 5.52 5.63 5.73 5.74
HP_APLASIA_OF_THE_PHALANGES_OF_THE_HAND 7.57 7.63 7.54 7.82 7.38 7.66 7.82 7.87 7.69 7.66 7.71 7.74 7.96 8.23 8.03 8.2 7.53 7.84 7.71 7.97 8.13 7.97 7.9 7.96 8.07 7.87
HP_ABNORMALITY_OF_UPPER_LIMB_METAPHYSIS 5 4.96 4.92 5.52 4.61 4.58 4.94 4.71 4.87 4.89 4.99 4.91 4.77 4.8 5.18 4.73 4.79 5.23 4.98 4.76 5.01 4.88 4.65 4.84 4.73 4.64
HP_ABNORMALITY_OF_UPPER_LIMB_JOINT 6.43 6.5 6.5 6.54 6.65 6.61 6.52 6.67 6.52 6.59 6.54 6.53 6.62 6.57 6.55 6.57 6.5 6.44 6.45 6.48 6.48 6.59 6.69 6.63 6.62 6.64
HP_ABNORMALITY_OF_THE_ELBOW 6.43 6.5 6.45 6.55 6.58 6.5 6.58 6.63 6.45 6.61 6.57 6.54 6.6 6.58 6.5 6.56 6.52 6.44 6.33 6.46 6.43 6.55 6.69 6.63 6.63 6.73
HP_APLASIA_HYPOPLASIA_OF_THE_EXTREMITIES 6.66 6.71 6.87 6.76 6.88 7.01 6.87 6.92 6.8 6.98 6.82 6.93 6.92 6.91 6.91 6.91 6.84 6.75 6.89 6.94 6.81 6.98 6.95 7.01 6.95 7.01
HP_UPPER_LIMB_UNDERGROWTH 6.04 6.06 6.23 6.33 6.19 6.24 6.08 6.13 6.14 6.26 6.14 6.06 6.05 6.06 6.05 5.93 6.01 6.03 5.91 6.17 5.95 6.12 6.24 6.44 6.07 5.84
HP_APLASIA_INVOLVING_BONES_OF_THE_EXTREMITIES 7.32 7.37 7.43 7.22 7.28 7.63 7.57 7.79 7.68 7.58 7.25 7.7 7.81 7.81 7.65 7.88 7.53 7.69 7.49 7.91 7.92 7.78 7.71 7.92 7.88 7.81
HP_LIMB_UNDERGROWTH 6.43 6.35 6.55 6.52 6.47 6.46 6.38 6.5 6.34 6.58 6.58 6.6 6.41 6.56 6.45 6.51 6.5 6.39 6.29 6.39 6.39 6.56 6.39 6.54 6.48 6.65
HP_PERIPHERAL_NEUROPATHY 6.99 7.15 7.34 7.2 7.33 7.36 7.32 7.33 7.35 7.37 7.23 7.37 7.43 7.35 7.29 7.28 7.14 7.02 7.23 7.39 7.16 7.27 7.46 7.59 7.37 7.34
HP_ABNORMAL_DISTAL_PHALANX_MORPHOLOGY_OF_FINGER 6.77 6.82 7 6.67 6.85 7.02 7.14 6.95 6.79 6.98 6.66 7 6.98 6.8 6.88 6.85 6.81 6.63 6.9 7.06 6.89 7.15 7.05 7.15 7.06 7.03
HP_ABNORMAL_MIDDLE_PHALANX_MORPHOLOGY_OF_THE_HAND 6.19 6.38 6.45 6.35 6.69 6.4 6.66 6.32 6.63 6.65 6.72 6.73 6.62 6.51 6.8 6.82 6.56 6.39 6.44 6.44 6.53 6.72 6.81 6.92 6.87 6.99
HP_ABNORMAL_PROXIMAL_PHALANX_MORPHOLOGY_OF_THE_HAND 7.31 7.26 7.47 7.44 7.29 7.52 7.42 7.66 7.6 7.56 7.67 7.81 7.92 7.9 7.34 7.7 7.46 7.49 7.35 7.65 7.83 7.84 7.78 7.81 7.8 7.71
HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_HAND 6.82 6.83 7 6.66 6.91 7.19 7.17 7.09 6.87 7.18 6.76 7.12 7.2 6.97 7.07 7.03 6.95 6.72 6.95 7.11 7.06 7.29 7.2 7.2 7.07 7.15
HP_BROAD_DISTAL_PHALANX_OF_FINGER 7.39 7.43 7.16 6.94 7.36 7.7 7.6 7.59 7.52 7.71 7.89 8.14 7.81 7.47 7.6 7.85 7.66 7.59 7.81 7.73 7.92 8.03 7.65 7.71 8.12 8.22
HP_APLASIA_HYPOPLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND 6.85 6.84 7.43 7.34 6.83 7.37 7.33 7.56 7.68 7.45 6.88 7.31 7.72 7.6 7.46 7.18 6.56 7.04 7.18 7.58 7.54 7.72 7.64 7.92 7.72 7.48
HP_SIMPLIFIED_GYRAL_PATTERN 6.77 7.01 6.97 6.89 7.31 7.29 7.02 7.08 6.52 7.17 6.95 7.41 7.2 7.22 7.09 6.91 6.81 6.73 6.98 7.01 6.64 6.88 6.94 7.21 6.81 7.12
HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_HAND 5.75 5.7 6.74 6.79 6.09 6.08 6.47 6.63 6.17 6.73 5.56 6.15 6.51 6.18 6.5 6.15 5.8 6.09 6.1 6.23 5.97 5.71 6.94 6.71 6.81 6.5
HP_ABNORMALITY_OF_HAIR_PIGMENTATION 6.17 6.38 6.18 6.38 6.23 6.24 6.26 6.24 6.17 6.22 6.19 6.24 6.32 6.13 6.13 6.14 6.25 6.22 6.27 6.28 6.21 6.19 6.29 6.35 6.3 6.34
HP_ABNORMALITY_OF_SECONDARY_SEXUAL_HAIR 5.21 5.06 5.42 5.35 4.93 4.7 5.18 5.23 5.18 5.05 5.16 5.05 5.14 4.95 5.1 4.85 5.14 5.22 4.98 4.96 5.36 5.26 4.91 4.92 4.94 5.05
HP_HIGH_ANTERIOR_HAIRLINE 7.66 7.62 7.74 7.79 8 7.95 8.09 8.06 8.14 8.01 7.83 7.84 8.1 8.08 8.1 7.95 7.53 7.44 7.71 8.23 7.62 7.95 7.95 8.36 8.19 7.74
HP_UNDERDEVELOPED_SUPRAORBITAL_RIDGES 6.55 6.65 7.1 6.86 6.93 7.12 6.94 6.95 6.94 7.21 6.88 6.99 7.2 7.32 6.91 7.25 6.79 6.9 6.69 7.06 6.84 7.05 7.23 7.14 6.98 7.01
HP_ANOTIA 5.11 5.21 6.1 6.05 5.17 4.5 4.8 4.82 5.22 5.18 5.79 5.18 5.15 5.07 4.73 5.22 5.41 5.12 5.17 5.28 5.47 5.36 4.76 4.95 5.38 5.06
HP_APLASIA_HYPOPLASIA_OF_THE_EARLOBES 6.35 6.39 6.44 6.55 6.72 6.66 6.55 6.71 6.34 6.71 6.54 6.6 6.78 6.58 6.8 6.59 6.13 6.29 6.68 6.73 6.83 6.63 6.73 6.82 6.66 6.66
HP_UPLIFTED_EARLOBE 8.04 7.99 7.29 7.13 8.04 8.12 8.1 8.19 7.86 7.83 7.62 8.12 8.16 8.16 8.06 7.61 7.42 7.6 7.96 8.17 7.59 7.6 8.14 8.12 7.89 7.99
HP_CYCLOPIA 5.73 5.77 6.04 6.5 5.95 5.9 5.94 5.89 6.13 6.2 5.98 5.77 6.28 6.31 5.86 5.87 5.95 5.93 6.08 6.2 6.38 6.02 6.29 5.85 5.79 6.03
HP_ECTOPIA_PUPILLAE 6.04 5.89 5.69 5.92 5.88 5.84 5.81 5.85 5.63 5.74 5.78 6.31 5.93 5.65 5.82 5.87 5.81 5.54 5.66 5.73 5.75 5.96 5.93 5.65 6.01 6.18
HP_APLASIA_HYPOPLASIA_INVOLVING_THE_NOSE 6.95 6.99 6.92 6.86 7.02 7.32 6.97 7.17 6.97 7.23 6.97 7.23 7.26 7.35 7.16 7.21 7.4 7.11 7.09 7.04 7.14 7.23 7.12 7.06 7.25 7.26
HP_EPIPHORA 6.18 6.44 5.79 5.87 5.97 5.83 6.25 6.24 6.06 5.94 5.83 6.05 5.58 5.8 5.68 6.11 5.9 6.62 6.03 6.61 5.85 6.22 6 6.02 6.05 6.49
HP_THICK_NASAL_ALAE 8.79 8.97 8.86 8.54 9.12 8.99 9.26 8.67 9.17 8.83 8.58 9.03 9.23 8.94 8.88 9.03 8.95 8.8 9.04 9.25 9.23 8.88 9.19 9.15 8.9 8.19
HP_ABNORMALITY_OF_THE_COLUMELLA 8.11 8.36 7.95 7.82 8.31 8.37 8.44 8.58 8.31 8.38 7.72 8.26 8.31 8.43 8.53 8.37 8.23 8.11 8.47 8.48 7.95 8.2 8.07 8.26 8.62 8.05
HP_SINGLE_NARIS 5.73 5.77 6.04 6.47 5.95 5.9 5.79 5.89 5.87 6.2 6.06 5.77 6.08 6.31 5.97 5.95 5.95 5.53 5.91 6.09 6.28 6.02 6.29 6.1 6.2 6.03
HP_MANDIBULAR_APLASIA 5.33 5.91 6.45 6.43 5.46 5.43 5.68 5.56 5.51 5.39 6.06 5.39 5.33 5.31 5.53 5.43 5.63 5.13 5.27 5.33 5.7 5.58 5.5 5.18 6.22 5.73
HP_DUPLICATION_OF_THUMB_PHALANX 6.18 6.19 6.79 6.89 6.63 6.31 6.65 6.7 6.58 6.36 6.68 6.32 6.6 6.49 6.44 6.59 6.6 6.15 6.24 6.47 6.39 6.47 6.53 6.56 6.54 6.55
HP_COMPLETE_DUPLICATION_OF_PHALANX_OF_HAND 6.23 6.51 6.84 6.91 6.81 6.94 6.99 7.33 7.01 6.85 6.53 6.78 6.9 6.71 6.4 6.62 6.88 7.03 6.36 6.73 6.87 7.18 7.23 7.14 7.04 6.73
HP_PARTIAL_DUPLICATION_OF_THE_PHALANX_OF_HAND 5.75 5.7 6.74 6.35 5.76 5.51 5.72 5.76 6.17 5.57 5.56 5.63 6.01 5.95 6.14 6.15 5.8 6.09 5.47 5.48 5.97 5.64 6.25 6.17 5.81 5.91
HP_ABNORMALITY_OF_THE_1ST_METACARPAL 6.81 6.91 6.8 6.86 7.05 7.13 7.1 6.91 7.2 6.91 6.87 7.23 7.07 7.17 7 7.01 6.91 6.84 7.04 7.06 6.99 7.22 7.03 7.42 7.11 7.04
HP_ABNORMALITY_OF_THE_4TH_METACARPAL 6.58 6.44 6.09 6.1 6.92 6.75 6.41 6.42 6.72 6.45 6.39 6.63 6.62 6.57 6.37 6.43 6.38 6.48 6.42 6.72 6.53 6.47 6.6 6.54 6.51 6.61
HP_ABNORMALITY_OF_THE_5TH_METACARPAL 6.36 6.3 6.08 5.91 6.68 6.73 6.16 6.04 5.92 6.58 6.02 6.64 6.51 6.58 6.21 6.43 6.42 6.05 6.29 6.29 5.92 5.87 6.23 6.35 6.33 6.33
HP_SHORT_1ST_METACARPAL 6.16 6.31 6.05 5.87 6.78 6.93 6.5 6.84 6.45 6.75 6.02 6.27 6.98 6.8 6.55 6.53 6.7 6.6 6.57 6.91 6.31 6.46 6.81 7 6.46 6.5
HP_APLASIA_HYPOPLASIA_OF_THE_4TH_METACARPAL 6.58 6.44 6.09 6.1 7.03 6.75 6.41 6.42 6.72 6.45 6.39 6.63 6.62 6.57 6.37 6.43 6.38 6.48 6.61 6.72 6.53 6.47 6.6 6.54 6.51 6.61
HP_DEVIATION_OF_THE_HALLUX 7.73 7.73 8.08 7.79 8.01 7.8 7.88 8.05 8.04 7.99 7.6 8.06 8.05 8.17 7.76 8.07 7.69 7.68 7.86 8.06 8.05 7.93 7.91 7.86 8.17 7.8
HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_HALLUX 6.07 6.31 6.25 6.23 6.46 6.31 6.47 6.84 6.33 6.17 6.19 6.15 6.28 6.52 6.09 6.26 6.15 6.24 6.25 6.25 6.62 6.42 6.33 6.51 6.5 6.5
HP_BROAD_HALLUX_PHALANX 5.75 5.57 5.8 5.6 5.61 5.25 5.25 5.76 5.83 5.39 5.4 5.3 5.64 5.55 5.57 5.65 5.69 5.82 5.18 5.43 6.54 5.84 5.71 5.7 5.82 5.96
HP_DUPLICATION_OF_PHALANX_OF_HALLUX 6.56 6.55 6.83 7.17 7.19 7.36 7.18 7.34 7.5 7.35 6.92 7.08 7.92 8 6.5 7.31 6.86 7.03 6.95 7.11 6.62 6.97 7.7 7.38 7.11 7.2
HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_TOES 6.46 6.46 6.46 6.77 6.51 6.58 6.56 6.65 6.55 6.52 6.27 6.54 6.62 6.53 6.46 6.59 6.54 6.43 6.43 6.47 6.48 6.4 6.62 6.83 6.54 6.62
HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES 6.85 6.83 6.85 6.9 6.83 6.89 7.01 6.84 6.93 6.95 6.88 6.62 7.17 6.8 6.43 6.93 6.56 6.66 6.73 6.73 6.56 6.92 6.81 7.04 6.74 6.9
HP_BROAD_PHALANX_OF_THE_TOES 6.51 6.59 6.43 6.76 6.56 6.92 6.96 6.85 6.49 6.51 6.19 6.72 6.79 6.81 6.85 6.77 6.83 6.92 6.52 6.7 7.14 6.95 6.89 6.65 6.79 6.79
HP_ABNORMALITY_OF_THE_DISTAL_PHALANGES_OF_THE_TOES 6.69 6.68 6.54 6.89 7.26 7.3 7.05 7.52 7.01 7.37 6.71 7.35 7.22 7.17 7.8 6.89 6.78 6.76 6.94 7.35 7.04 7.05 7.05 7.56 7.42 7.19
HP_ABNORMALITY_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES 6.44 6.57 7.08 7.81 6.87 6.85 7.08 7.33 7.1 7.02 6.88 6.9 7.35 7.2 6.99 7.09 6.7 7.01 6.35 6.58 7.01 7.42 7.47 7.03 7.08 7.17
HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES 7.31 7.52 7.54 7.22 7.39 7.73 7.82 8.17 7.68 7.67 7.2 7.85 7.66 7.6 7.96 7.53 7.34 7.14 7.75 7.97 7.95 7.82 7.64 7.96 7.94 8
HP_CONE_SHAPED_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND 6.54 6.4 6.66 6.94 6.62 6.87 6.27 6.35 6.1 6.48 6.64 6.76 6.52 6.57 6.46 6.45 6.31 6.41 6.82 6.51 6.27 6.56 6.54 6.51 6.29 6.36
HP_STOMATITIS 5.42 5.71 6.03 5.81 5.62 5.46 5.78 5.89 5.8 5.42 5.69 5.72 5.63 5.51 5.73 5.65 5.71 5.66 5.43 5.62 5.77 5.9 5.57 5.37 5.93 6.09
HP_ABNORMAL_SALIVARY_GLAND_MORPHOLOGY 5.95 6.05 5.5 6.13 5.95 5.86 5.97 6.17 6.05 5.97 5.84 5.23 6.15 6.05 5.58 5.73 5.88 6.03 6 6.07 5.8 5.47 5.88 5.75 5.36 5.56
HP_APLASIA_HYPOPLASIA_OF_THE_UVULA 5.33 5.28 5.12 5.74 5.17 5.1 5.17 4.92 5.31 5.25 4.84 5.52 4.87 4.94 5.22 5.04 5.21 5.24 5.53 5.16 5.34 5.25 5.13 4.91 5.01 5.17
HP_APLASIA_HYPOPLASIA_OF_THE_TONGUE 6.29 6.23 6.46 6.86 6.44 6.32 6.19 6.33 6.12 6.43 6.66 6.44 6.15 6.49 6.29 6.63 6.51 6.53 6.42 6.18 6.6 6.74 6.45 6.34 6.53 6.56
HP_ANKYLOGLOSSIA 5.62 5.47 5.71 5.99 5.46 5.26 5.78 5.06 5.63 5.24 5.95 5.61 5.36 5.31 5.35 5.21 5.58 5.75 5.07 5.37 5.4 5.1 5.31 5.1 5.06 5.23
HP_BIFID_TONGUE 5.85 5.95 6.27 5.96 5.7 5.45 6.06 6.05 6.05 5.72 6.18 5.99 6.02 6.1 5.63 6.28 6.34 6.19 6.23 5.96 6.11 6.18 5.81 6.02 5.85 5.84
HP_ABNORMALITY_OF_DENTIN 5.87 5.67 5.73 5.69 6.07 5.58 6.01 5.95 5.82 5.65 6.06 5.68 6.03 6.18 6.37 6.11 6.15 5.95 5.64 6.04 5.88 5.99 6 5.69 5.82 5.85
HP_ABNORMALLY_LOW_PITCHED_VOICE 7.14 7.18 7.07 7.29 8.06 7.87 7.55 7.27 7.66 7.77 7.1 7.73 7.98 7.88 7.55 7.27 7.53 7.12 7.57 7.45 7.27 7.18 7.76 7.98 7.24 7.35
HP_SPINAL_DYSRAPHISM 6.29 6.29 6.28 6.45 6.31 6.37 6.35 6.42 6.33 6.31 6.35 6.24 6.26 6.39 6.31 6.32 6.22 6.33 6.43 6.22 6.34 6.32 6.33 6.53 6.3 6.51
HP_ABNORMAL_SPINAL_MENINGEAL_MORPHOLOGY 6.84 6.71 6.87 6.69 6.91 6.77 6.73 6.37 6.98 6.78 6.98 7.2 6.78 6.58 6.65 6.58 7.32 6.79 7.04 6.73 7.15 6.98 7.7 6.98 7.13 7.1
HP_SHORT_THORAX 6.14 6.17 6.06 6.57 5.58 6.16 6.02 6.21 6.11 6.33 6.14 6.33 6.29 6.16 6.18 6.08 6.18 6.39 6.22 6.2 6.12 6.22 5.9 6.35 6.31 6.34
HP_STRIDOR 6.12 5.97 6.51 5.89 6.23 5.66 6.38 6.44 6.19 6.69 6.45 5.9 6.42 6.06 5.91 6.02 6.43 5.82 6.28 5.87 5.66 5.92 6.17 6.48 6.58 6.36
HP_CHYLOTHORAX 6.64 6.63 5.79 5.87 6.87 6.63 6.73 6.88 6.8 6.14 6.27 6.03 6.61 6.79 6.03 6.27 6.64 6.67 7.18 6.76 6.4 6.09 6.6 6.6 6.08 6.13
HP_APLASIA_HYPOPLASIA_OF_THE_BREASTS 5.33 5.13 5.71 5.42 5.13 4.96 5.02 5.35 5.34 5.18 5.46 5.18 5.18 5.08 5.52 5.26 5.21 5.21 5.27 5.28 5.6 5.38 4.93 4.95 4.97 5.28
HP_APLASIA_HYPOPLASIA_OF_THE_ABDOMINAL_WALL_MUSCULATURE 6.82 6.86 6.95 6.94 7.06 7.15 6.7 6.95 6.87 7.12 6.9 7.06 7.12 7.15 6.99 6.91 6.63 6.68 7.02 7.08 6.73 7.05 7.38 7.25 6.95 6.86
HP_ABNORMALITY_OF_THE_2ND_TOE 7.13 7.16 7.51 6.97 7.13 7.54 7.39 7.56 7.81 7.53 7.13 7.49 7.75 7.76 7.46 7.51 7.18 7.3 7.42 7.56 7.42 7.65 8.19 8.15 7.85 7.42
HP_ABNORMALITY_OF_THE_5TH_TOE 7 6.89 6.91 6.99 7.11 7.16 6.85 7.02 6.88 7.08 6.99 7.1 6.82 7.11 6.85 7.22 6.83 6.92 7.19 7.11 6.76 7.11 7.02 7.2 7.03 7.14
HP_DEVIATION_OF_THE_5TH_TOE 7.27 7.03 7.02 6.91 7.13 7.12 7.38 7.44 7.36 7.14 7.03 7.37 7.41 7.37 7.04 7.29 7.43 7.07 7.21 7.47 7.56 7.63 7.3 7.45 7.48 7.42
HP_ABNORMAL_VENTRICULAR_SEPTUM_MORPHOLOGY 6.99 6.9 7.15 7.04 7.14 7.2 7.18 7.27 7.15 7.25 7.07 7.2 7.21 7.26 7.22 7.25 7.14 6.98 7.09 7.3 7.17 7.24 7.26 7.39 7.21 7.24
HP_POLYDACTYLY 6.5 6.58 6.83 6.65 6.72 6.86 6.7 6.65 6.65 6.84 6.73 6.78 6.7 6.75 6.84 6.88 6.57 6.66 6.65 6.8 6.7 6.85 6.82 6.83 6.75 6.81
HP_PULMONARY_INSUFFICIENCY 6.1 6.22 6.14 6.38 6.56 6.48 6.11 6.09 5.86 6.44 6.21 6.34 6.17 6.39 6.14 6.29 6.56 6.39 6.23 6.25 6.36 6.65 6.2 6.33 6.06 6.39
HP_ESOPHAGEAL_STENOSIS 5.57 5.59 5.64 5.74 5.55 5.51 5.59 5.49 5.63 5.53 5.72 5.42 5.31 5.4 5.47 5.35 5.52 5.5 5.45 5.4 5.67 5.38 5.22 4.87 5.51 5.43
HP_APLASIA_HYPOPLASIA_OF_THE_SPLEEN 5.54 5.47 5.59 5.63 5.28 5.41 5.59 5.53 5.42 5.77 5.65 5.63 5.42 5.34 5.54 5.72 5.56 5.81 5.38 5.29 5.54 5.53 5.3 5.19 5.57 5.51
HP_ABNORMAL_GREATER_SCIATIC_NOTCH_MORPHOLOGY 7.42 7.43 7.46 7.06 7.85 7.88 7.82 7.37 7.91 7.69 7.42 7.47 7.55 7.81 7.27 7.52 7.77 7.48 7.51 7.18 7.3 7.07 7.59 7.58 7.8 7.48
HP_TRUE_HERMAPHRODITISM 5.51 5.93 5.66 5.87 5.55 5.95 5.79 5.81 5.28 5.82 5.89 5.79 5.64 5.62 5.97 5.67 5.67 5.81 5.77 5.76 6.11 6.07 5.69 5.69 5.94 5.89
HP_ABNORMALITY_OF_THE_FEMALE_GENITALIA 6.35 6.44 6.55 6.47 6.43 6.5 6.42 6.45 6.41 6.51 6.45 6.47 6.41 6.45 6.32 6.44 6.24 6.37 6.39 6.44 6.34 6.43 6.42 6.52 6.3 6.44
HP_APLASIA_HYPOPLASIA_OF_THE_OVARY 6.14 5.97 6.03 6.15 5.9 6.05 5.99 6.12 6.02 6.11 6.21 6.29 6.14 6.35 6.16 6.23 5.96 6.21 6.22 6.07 6.12 6.16 5.88 6.09 6.01 6.14
HP_STREAK_OVARY 5.6 5.45 5.69 6.1 5.42 5.38 5.34 5.58 5.53 5.57 5.22 5.36 5.49 5.08 5.52 5.39 5.27 5.75 5.74 5.48 5.52 5.64 5.49 5.54 5.79 5.96
HP_ABSENT_TESTIS 5.56 5.45 5.24 5.95 5.17 5.1 5.17 4.92 5.31 5.3 4.84 5.52 4.87 4.94 5.22 5.04 5.45 5.24 5.63 5.16 5.34 5.25 5.13 4.91 5.01 5.31
HP_APLASIA_HYPOPLASIA_OF_THE_BLADDER 5.64 5.72 5.78 6.09 5.63 5.37 5.55 5.68 5.75 5.71 6.03 5.45 5.35 5.56 5.84 5.72 5.77 5.47 5.46 5.54 5.93 5.99 5.45 5.21 5.55 5.73
HP_URETHRAL_VALVE 7.35 7.05 6.84 6.32 7.93 7.63 7.44 7.84 7.26 7.59 6.82 7.35 7.48 7.36 7.43 7.31 7.67 6.97 7.28 7.65 7.74 7.46 7.45 7.32 7.18 7.44
HP_APLASIA_HYPOPLASIA_OF_THE_PALMAR_CREASES 6.43 5.55 5.12 5.97 5.88 5.36 5.93 5.31 6.09 5.91 6.02 5.73 6.04 6.18 5.29 5.84 6.12 6.05 6.16 5.22 6.21 5.82 6.02 5.96 5.92 6.24
HP_HYPEREXTENSIBILITY_OF_THE_KNEE 6.27 6.58 6.97 7.01 6.82 6.95 6.47 6.87 6.91 6.75 6.61 6.64 7.03 6.96 6.95 6.66 6.39 6.88 6.57 7.13 6.25 7.05 6.94 7.09 6.92 6.81
HP_LIMITATION_OF_KNEE_MOBILITY 7.3 7.43 6.56 6.5 7.02 7.22 7.6 7.47 7.4 7.54 7.3 7.25 7.58 7.72 7.31 7.71 7.16 7.16 7.29 7.66 7.29 6.86 7.54 7.92 7.33 7.47
HP_METATARSUS_VALGUS 6.5 6.85 6.76 6.6 6.54 6.92 6.98 7.01 6.9 6.8 6.83 7.12 6.96 6.72 7.35 7.18 7.2 6.73 6.89 6.92 7.09 6.94 7.1 6.8 7.08 7.12
HP_LONG_TOE 6.54 6.47 6.41 6.28 6.73 6.71 6.44 6.5 6.48 6.54 6.4 6.55 6.75 6.55 6.64 6.3 6.33 6.2 6.6 6.58 6.75 6.32 6.62 6.71 6.61 6.65
HP_HYPERPITUITARISM 5.56 5.42 5.71 5.94 5.56 5.11 5.42 5.33 5.55 5.4 5.56 5.48 5.51 5.32 5.45 5.32 5.43 5.55 5.47 5.3 5.55 5.45 5.3 5.29 5.43 5.58
HP_APLASIA_HYPOPLASIA_OF_THE_THYMUS 6.35 6.17 6.11 6.33 6.45 6.07 6.06 6.39 6.07 6.3 6.28 6.17 6.16 6.35 6.37 6.29 6.23 6.31 6.37 6.24 5.94 5.99 6.29 6.41 6.07 6.26
HP_DYSLEXIA 8.57 8.74 9.22 8.5 8.95 8.97 9.57 8.9 9.33 9.18 8.86 8.8 9.05 9.24 8.59 8.78 8.43 8.55 8.98 9.25 8.33 8.66 9.44 9.08 8.94 8.68
HP_AGNOSIA 7.42 7.62 8.01 8.09 8.02 7.83 7.53 7.54 7.75 7.68 7.45 7.71 7.72 7.85 7.56 7.73 7.44 7.03 7.59 7.58 7.19 7.29 7.86 8.03 7.51 7.5
HP_DYSGRAPHIA 7.57 7.56 7.98 7.9 8.04 7.9 7.56 7.6 7.84 7.72 7.53 7.77 7.81 7.98 7.58 7.8 7.6 7.3 7.69 7.6 7.21 7.42 7.86 8.01 7.51 7.58
HP_ECHOLALIA 7.28 7.63 8.26 8.14 8.09 7.86 8.19 8.05 7.91 7.9 7.4 7.72 7.61 7.69 8 7.91 7.6 7.09 7.57 7.42 7.49 7.7 7.84 7.97 7.85 7.74
HP_TRANSIENT_GLOBAL_AMNESIA 6.07 6.05 6.62 6.42 6.1 6.64 6.73 6.67 6.33 6.44 6.25 6.42 6.36 6.43 6.59 6.55 6.53 6.46 6.51 7.01 6.69 6.57 6.42 6.55 6.56 6.6
HP_SLEEP_APNEA 7.36 7.26 7.64 7.51 7.63 7.71 7.75 8.09 7.66 8.1 7.42 7.84 7.61 7.71 7.8 7.92 7.44 7.57 7.73 8 7.78 7.92 7.8 7.96 7.82 7.89
HP_CENTRAL_SLEEP_APNEA 6.4 6.54 6.51 6.62 6.89 6.92 6.87 6.92 6.71 7.75 6.68 6.52 7.05 6.84 6.73 6.22 6.73 6.51 6.88 6.64 5.8 6.37 6.48 7.06 6.96 6.85
HP_WIDE_CRANIAL_SUTURES 6.25 6.17 6.1 6.33 6.11 6.44 6.23 6.36 6.27 6.34 6.04 6.29 6.51 6.45 6.1 6.31 5.94 6.09 6.36 5.98 6.33 6.29 6.25 6.59 6.38 6.36
HP_VERTICAL_NYSTAGMUS 7.64 7.66 7.54 7.73 7.69 8.06 7.87 8.26 7.83 7.76 7.79 7.72 7.77 7.98 7.87 8.15 7.78 7.63 7.91 7.98 7.81 7.95 7.87 8 7.65 7.73
HP_MUSCLE_FIBRILLATION 7.88 7.92 8.11 8.07 8.5 8.31 8.21 8.14 7.94 8.3 7.99 8.25 8.25 8.14 8.28 8.36 8.18 8.01 8.21 8.38 8.09 8.07 8.38 8.23 8.2 8.29
HP_MUSCLE_FLACCIDITY 6.23 6.21 6.76 6.39 6.5 6.56 6.45 6.77 6.51 6.61 6.74 6.02 6.78 6.47 6.15 7.16 6.7 6.32 6.32 6.27 6.06 6.55 6.61 6.63 6.34 6.9
HP_WEAKNESS_DUE_TO_UPPER_MOTOR_NEURON_DYSFUNCTION 6.89 6.98 7.22 7.06 7.17 7.22 7.23 7.23 7.01 7.24 7.09 7.16 7.13 7.16 7.11 7.06 6.98 6.94 7.13 7.22 7.05 7.1 7.18 7.38 7.28 7.15
HP_PARAPLEGIA 7.3 7.3 7.84 7.43 7.56 7.72 7.66 7.59 7.67 7.92 7.28 7.64 7.64 7.65 7.72 7.45 7.43 7.34 7.48 7.81 7.42 7.65 7.72 7.84 7.58 7.58
HP_PARAPLEGIA_PARAPARESIS 7.32 7.36 7.9 7.69 7.69 7.71 7.67 7.6 7.69 7.87 7.38 7.65 7.66 7.68 7.67 7.51 7.56 7.32 7.53 7.79 7.43 7.61 7.72 7.97 7.61 7.54
HP_OCULOGYRIC_CRISIS 8.41 8.8 8.7 8.42 8.66 8.79 9.2 9.33 8.92 9.26 8.98 8.94 8.67 9.15 8.96 8.87 8.79 9.1 8.99 9.18 9 9.22 8.81 9.32 9.32 9.11
HP_CUTANEOUS_FINGER_SYNDACTYLY 6.29 5.92 5.95 5.48 6.33 6.25 6.21 6.24 6.05 6.18 6.13 6.31 6.45 6.62 6.23 6.57 6.07 6.05 6.03 6.03 6.09 6.31 6.19 6.24 6.24 6.54
HP_OVERLAPPING_FINGERS 6.48 6.31 6.52 6.43 6.22 6.49 6.5 6.26 6.29 6.5 6.38 6.55 6.42 6.52 6.61 6.35 6.57 6.44 6.46 6.59 6.36 6.7 6.4 6.51 6.34 6.48
HP_HAMARTOMA 7.35 7.32 7.19 7.42 7.46 7.66 7.31 7.53 7.45 7.36 7.28 7.56 7.7 7.56 7.5 7.49 7.51 7.31 7.57 7.55 7.25 7.51 7.58 7.43 7.8 7.39
HP_HAMARTOMA_OF_THE_EYE 8.61 7.9 8.74 8.43 8.41 8.52 8.28 8.28 8.12 8.46 8.36 8.36 8.46 8.47 8.61 8.1 8.56 8.1 8.35 8.78 7.58 8.29 8.51 8.36 8.52 7.9
HP_ABSENT_EPIPHYSES 5.66 5.7 5.66 5.63 5.58 6.01 5.87 5.86 6.03 6.26 5.91 6 5.98 5.87 5.7 5.69 5.64 5.67 5.69 5.98 5.78 5.88 6.13 6.4 5.93 6.07
HP_CONE_SHAPED_EPIPHYSIS 6.53 6.39 6.49 6.58 6.58 6.71 6.29 6.24 6.04 6.53 6.44 6.66 6.38 6.53 6.38 6.58 6.17 6.39 6.6 6.33 6.18 6.45 6.39 6.48 6.38 6.41
HP_ENLARGED_EPIPHYSES 5.02 4.79 4.7 4.96 4.6 4.57 4.77 4.75 4.74 4.79 4.78 4.66 4.52 4.55 4.65 4.59 4.81 4.85 4.87 4.65 4.78 4.9 4.48 4.52 4.72 4.52
HP_IRREGULAR_EPIPHYSES 5.55 5.8 5.71 5.57 5.58 5.68 5.64 5.53 5.84 5.7 5.75 5.36 5.64 5.68 5.58 5.49 5.43 5.64 5.5 5.39 5.57 5.4 5.8 5.82 5.94 5.86
HP_PSEUDOEPIPHYSES 7.31 7.07 7.18 7.36 7.45 7.45 7.25 7.5 7.63 7.4 7.41 7.46 8.02 8.04 7.38 7.64 7.57 7.46 7.28 7.4 7.24 7.82 7.8 7.68 7.73 7.57
HP_SMALL_EPIPHYSES 5.94 5.72 5.78 5.63 5.89 5.85 5.78 5.56 5.86 5.87 5.82 5.63 5.54 5.7 5.61 5.69 5.58 5.71 5.65 5.47 5.85 5.5 5.87 5.82 5.84 5.8
HP_SKIN_TAGS 7.01 6.99 7.02 6.87 7.11 7.24 7.2 7.18 7.52 7.34 6.85 7.53 7.24 7.53 7.15 7.29 7.14 7.07 7.24 7.33 7.08 7.12 7.52 7.45 7.32 7.08
HP_ANGIOFIBROMAS 7.37 7.32 7.98 7.81 7.99 7.66 7.53 7.53 7.98 7.65 8.09 7.77 8.03 7.91 8 7.91 7.5 7.14 7.56 7.56 7.16 7.17 8.38 8.08 8 7.33
HP_FIBROADENOMA_OF_THE_BREAST 8.6 8.32 8.21 8 8.86 8.83 9.02 8.57 8.93 8.54 8.62 8.77 8.84 9.02 9.05 8.8 8.12 8.63 8.94 8.73 8.56 8.94 8.91 8.85 8.45 8.43
HP_CUTANEOUS_SYNDACTYLY_OF_TOES 6.4 6.35 6.79 7.07 7.23 6.51 6.77 6.85 7.03 6.7 7.37 6.9 7.09 7.17 6.48 6.61 6.9 6.22 6.68 6.81 6.46 6.81 7.08 7.35 6.79 7.01
HP_NEOPLASM_OF_THE_SKELETAL_SYSTEM 6.81 6.59 7.18 7.3 7.18 7.07 7.05 7.09 7.38 7.24 7.26 6.93 7.22 7.19 6.97 7.35 7.38 7.03 7.01 7.26 7.16 7.05 7.34 7.25 7.07 7.08
HP_APLASTIC_HYPOPLASTIC_TOENAIL 6.63 6.74 6.94 7.04 6.87 6.74 6.83 7.14 6.78 6.69 6.96 6.73 6.9 6.7 7.16 6.93 6.83 6.76 6.85 6.87 7.12 7.12 6.79 6.98 6.86 7.05
HP_ANTERIOR_PITUITARY_DYSGENESIS 5.63 5.19 5.66 5.7 5.36 5.27 5.79 5.85 5.64 5.29 5.77 5.34 5.2 5.43 5.69 5.55 5.38 5.45 5.1 5.15 5.72 5.38 5.57 5.18 5.23 5.11
HP_ABNORMALITY_OF_THE_NASAL_CAVITY 5.7 5.69 5.77 6.17 5.78 5.74 5.86 5.6 6 6.07 5.89 5.6 6.18 6.16 5.83 5.87 5.87 5.73 6 5.99 6.24 5.69 6.22 5.83 5.78 5.89
HP_ABNORMAL_ELASTICITY_OF_SKIN 6.81 6.74 7.1 6.94 6.95 6.94 6.96 7.11 6.93 7.06 6.93 6.9 6.97 7.04 6.92 7.08 6.81 6.95 6.79 7.06 7.06 7.07 7.15 7.05 7.11 7.13
HP_DERMAL_TRANSLUCENCY 6.53 6.38 6.02 6.32 6.73 6.5 6.31 6.37 6.62 6.63 6.34 6.34 6.4 6.51 6.38 6.44 6.32 6.12 6.33 6.25 6.14 6.26 6.73 6.8 6.6 6.5
HP_ABNORMAL_MENINGEAL_MORPHOLOGY 6.31 6.43 6.31 6.53 6.55 6.58 6.54 6.32 6.54 6.56 6.53 6.59 6.51 6.54 6.53 6.58 6.53 6.56 6.38 6.44 6.62 6.55 6.48 6.55 6.46 6.61
HP_ABNORMAL_DURA_MATER_MORPHOLOGY 5.8 5.71 5.77 6.09 6.06 6.03 5.91 5.77 5.92 6.23 5.89 5.96 6.26 6.13 5.83 5.87 6.05 5.97 6.06 6.23 6.33 5.72 6.22 5.83 5.78 6.13
HP_EPIPHYSEAL_STIPPLING 6.89 6.9 7.31 7.03 7.13 7.31 7.14 6.98 7.12 7.24 7.24 7.18 7.27 7.41 6.91 7.33 7.18 6.97 7.43 7.38 7.16 7.09 7.41 7.59 7.14 7.17
HP_ABNORMAL_EPIPHYSEAL_OSSIFICATION 6.61 6.57 6.97 6.82 6.86 6.92 6.8 6.72 6.87 6.92 6.85 6.73 7.02 7.05 6.69 7.01 6.62 6.83 6.85 6.9 6.68 6.96 6.81 6.73 6.76 6.77
HP_ABNORMAL_HAND_BONE_OSSIFICATION 6.29 6.29 6.06 6.27 6.17 6.37 6.31 6.4 6.33 6.31 6.44 6.21 6.25 6.23 6.24 6.32 6.18 6.09 5.96 6.27 6.37 6.26 6.28 6.49 6.46 6.5
HP_ABNORMALITY_OF_THE_DIENCEPHALON 6.41 6.43 6.67 6.61 6.6 6.76 6.73 6.68 6.66 6.57 6.64 6.52 6.76 6.63 6.51 6.53 6.77 6.56 6.51 6.59 6.84 6.61 6.61 6.63 6.56 6.6
HP_ABNORMALITY_OF_THALAMUS_MORPHOLOGY 7.35 7.53 7.49 7.51 7.88 7.62 7.46 7.33 7.4 7.71 7.05 7.55 7.36 7.28 7.39 7.6 7.6 7.52 7.5 7.71 7.53 7.4 7.25 7.66 7.49 7.33
HP_BILATERAL_COXA_VALGA 6.24 6.3 6.51 6.25 6.89 6.44 6.36 6.25 6.34 6.59 6.34 6.43 6.24 6.07 6.43 6.17 6.39 6.06 6.06 6.33 6.37 6.42 6.5 6.4 6.47 6.71
HP_ABNORMALITY_OF_THE_ZYGOMATIC_BONE 6.55 6.55 6.63 6.68 6.8 6.7 6.68 6.8 6.67 6.71 6.59 6.71 6.78 6.72 6.64 6.75 6.62 6.56 6.58 6.75 6.68 6.73 6.81 6.87 6.76 6.79
HP_HYPOPLASIA_OF_THE_ZYGOMATIC_BONE 7.38 6.82 7.49 7.2 7.17 7.17 7.64 7.62 7.76 7.36 7.25 7.47 7.58 7.63 7.47 7.78 7.32 7.5 7.5 7.45 7.37 7.51 7.44 7.67 7.35 7.39
HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_VERTEBRAL_COLUMN 6.8 6.88 7.1 6.92 7.04 7.15 7.08 7.13 7.07 7.08 6.96 7.09 7.16 7.12 7.17 7.11 7 6.92 7.02 7.12 7.03 7.13 7.15 7.26 7.18 7.13
HP_ABNORMAL_FOOT_BONE_OSSIFICATION 6 6.03 5.92 5.85 5.87 5.71 5.5 5.57 5.81 6.24 5.94 5.96 5.86 6.04 5.65 5.77 5.99 6.04 5.75 6.07 5.74 5.61 5.71 5.9 6.07 6.19
HP_ELEVATED_TISSUE_NON_SPECIFIC_ALKALINE_PHOSPHATASE 5.39 5.45 5.05 5.59 5.09 4.98 5.07 4.93 5.23 4.97 5.19 4.98 4.79 4.95 5 5.06 5.34 5.19 5.04 4.94 5.14 5.31 5.23 4.64 5 4.78
HP_POLAR_CATARACT 7.89 8.23 8.04 7.58 8.62 8.7 8.57 8.4 8.9 8.37 8.09 8.58 8.73 8.98 8.42 8.63 8.39 8.78 8.77 8.48 8.69 8.71 8.76 8.92 8.23 8.02
HP_INCREASED_CIRCULATING_ANTIBODY_LEVEL 5.57 5.52 5.68 5.62 5.36 5.21 5.43 5.31 5.46 5.27 5.65 5.23 5.26 5.33 5.37 5.28 5.46 5.46 5.22 5.24 5.56 5.35 5.23 5.01 5.37 5.37
HP_ABNORMALITY_OF_HAIR_TEXTURE 6.79 6.7 6.96 6.91 6.95 6.96 6.81 7.04 6.89 6.94 6.97 6.85 6.92 6.9 6.97 6.95 6.85 6.79 6.74 6.92 6.86 6.99 7.09 7.08 6.79 6.97
HP_ABNORMAL_HAIR_PATTERN 7.41 7.5 7.57 7.14 7.71 7.7 7.67 7.43 7.59 7.76 7.34 7.68 7.62 7.62 7.6 7.48 7.53 7.39 7.47 7.61 7.44 7.59 7.76 7.83 7.7 7.51
HP_ABNORMAL_HAIR_WHORL 8.18 8.55 8.15 8.34 8.83 8.77 8.51 8.86 8.88 8.49 8.42 8.68 8.87 8.62 8.68 8.37 8.43 8.55 8.48 8.88 8.6 8.59 8.93 8.87 9.02 8.55
HP_CHERRY_RED_SPOT_OF_THE_MACULA 7.82 8 8.4 8.76 8.46 8.35 8.56 8.83 8.88 8.22 8.32 8.34 8.27 8.26 8.15 7.9 8.13 7.94 7.99 8.62 7.94 8.33 8.69 8.56 8.94 8.99
HP_PEDAL_EDEMA 6.54 6.45 6.1 6.2 6.13 6.7 5.86 6.07 6.29 6.55 6.25 6.22 6.32 6.43 5.89 6.15 6.4 6.36 6.42 5.77 6.11 5.65 6.58 6.33 5.72 5.89
HP_MEDIAL_FLARING_OF_THE_EYEBROW 7.04 6.73 7.94 7.68 7.21 7.38 6.78 6.78 7.39 7.19 6.98 6.96 7.2 7.19 7.38 7.41 6.79 6.75 7.34 7.09 6.8 6.87 7.76 7.53 6.84 6.95
HP_DIMPLE_CHIN 5.07 4.94 5.09 5.5 4.96 4.58 5.17 5.37 5.79 5.77 4.96 5.06 4.71 4.55 5.66 5.32 5.04 5.06 5.23 5.19 5.04 4.68 5.05 5.35 5.07 5.29
HP_ABNORMALITY_OF_THE_TEMPOROMANDIBULAR_JOINT 6.33 6.19 6.03 6.65 6.94 6.5 6.12 5.64 6.2 7.12 6.37 6.37 5.86 5.76 5.77 5.77 6.75 6.2 6.4 6.28 6.19 5.97 6.5 6.36 6.04 6.43
HP_ABSENT_TOE 7.27 7.32 7.32 7.02 7.39 7.57 7.49 7.68 7.56 7.44 7.19 7.51 7.63 7.66 7.61 7.52 7.67 7.32 7.28 7.59 7.67 7.76 7.63 7.74 7.91 7.64
HP_BROAD_COLUMELLA 8.33 8.36 7.16 7.79 8.28 8.43 8.44 8.81 8.12 8.43 7.84 8.38 8.31 8.19 8.52 8.27 7.72 8 8.43 8.7 7.95 7.62 7.98 8.26 8.62 8.49
HP_PALMAR_HYPERKERATOSIS 5.79 5.72 5.57 5.89 5.45 5.51 5.55 5.29 5.63 5.54 5.82 5.6 5.7 5.65 5.57 5.23 5.66 5.62 5.45 5.68 5.54 5.34 5.22 5.58 5.53 5.43
HP_ECTOPIC_CALCIFICATION 6.58 6.64 6.85 6.86 6.89 6.86 6.73 6.79 6.89 6.9 6.65 6.82 6.96 6.8 6.59 6.74 6.76 6.66 6.78 6.9 6.6 6.9 6.84 7.01 6.77 6.81
HP_HYPERACUSIS 6.68 6.74 7.1 7.12 7.06 6.97 6.79 7.15 6.78 7.17 6.92 7 6.92 6.83 7.28 6.94 7.14 6.72 7.38 7.02 7.15 7.38 6.97 7.32 7.18 7.38
HP_SKIN_DIMPLE 6.8 6.74 7.19 6.94 7.15 7.14 7.13 7.18 6.87 7.21 6.88 7.28 7.3 7.28 7.27 7.26 7.28 7.04 7.04 7.19 7.13 7.39 7.15 7.44 7.13 7.33
HP_ERYTHEMA 6.04 5.98 6.02 6.05 5.69 5.9 5.93 5.9 6.13 5.96 6.07 5.9 5.93 5.83 5.73 5.87 5.85 5.96 5.86 5.95 6.17 5.91 5.81 5.7 6.04 5.99
HP_GONADAL_NEOPLASM 6.45 6.44 6.52 6.48 6.84 6.77 6.68 6.63 6.64 6.76 6.5 6.82 6.71 6.58 6.75 6.63 6.45 6.47 6.51 6.56 6.52 6.55 6.84 6.93 6.64 6.77
HP_URINARY_TRACT_NEOPLASM 6.66 6.58 6.9 6.73 7.01 6.95 6.84 7.02 6.73 6.98 6.73 6.91 6.94 6.72 6.87 7.05 6.51 6.54 6.74 6.87 6.83 6.9 6.91 6.93 6.74 7.02
HP_GENITAL_NEOPLASM 6.53 6.45 6.55 6.63 6.75 6.67 6.68 6.66 6.53 6.72 6.54 6.76 6.59 6.58 6.75 6.64 6.35 6.44 6.46 6.47 6.55 6.64 6.84 6.88 6.56 6.8
HP_ABNORMALITY_OF_THE_LEYDIG_CELLS 5.42 5.44 5.65 5.21 4.74 4.78 5.4 5.14 5.39 5.4 5.36 4.96 4.88 4.73 5.15 4.78 5.21 5.39 5.15 5.23 5.27 5.24 5.32 5.1 5.24 4.96
HP_IMPAIRED_VISUOSPATIAL_CONSTRUCTIVE_COGNITION 7.57 7.56 7.61 7.12 8.08 7.67 7.67 8.27 7.59 7.88 7.54 8.17 7.96 8.28 8.07 8.09 7.66 7.34 7.89 8.01 7.88 8.13 7.88 8.4 7.71 8.14
HP_HEMANGIOBLASTOMA 8.87 8.59 9.43 8.85 9.16 9.07 9.55 8.68 8.94 8.93 8.87 8.66 9.23 9.19 8.84 8.57 8.88 8.37 8.68 9.09 8.79 8.78 9.22 9.26 8.95 8.3
HP_EVERTED_UPPER_LIP_VERMILION 6.09 6.16 6.25 6.31 5.94 6.11 6.21 6.47 5.88 6.27 6.19 6.2 6.36 6.4 6.13 6.32 6.04 6.39 6.41 6.44 6.09 6.63 6.05 6.22 6.26 6.1
HP_TENTED_UPPER_LIP_VERMILION 6.65 6.64 6.42 6.52 6.88 6.97 6.73 6.61 6.66 6.69 6.47 6.72 6.71 6.61 6.75 6.63 6.66 6.66 6.59 6.69 6.74 6.72 6.77 6.8 6.91 6.85
HP_OPEN_BITE 6.39 6.49 6.79 6.76 6.59 6.48 6.65 6.41 6.5 6.61 6.69 6.38 6.7 6.67 6.44 6.8 6.67 6.7 6.73 6.48 7.01 6.42 6.52 7.01 6.73 6.67
HP_PROTRUDING_TONGUE 6.38 6.15 6.12 6.28 6.47 6.63 6.5 6.27 6.36 6.41 6.06 6.36 6.34 6.43 6.58 6.19 6.33 6.3 6.41 6.28 6.03 6.43 6.59 6.61 6.5 6.41
HP_ATONIC_SEIZURE 8.55 9 8.61 8.61 8.99 9.2 9.39 9.07 9.06 9.53 8.82 8.92 9.34 9.36 9.22 8.95 8.54 8.99 9.11 9.29 9 9.34 9.31 9.6 8.99 8.9
HP_HEMIFACIAL_SPASM 6.89 6.74 6.74 6.93 6.71 7.06 6.96 6.68 6.8 6.92 6.82 6.97 6.9 6.83 6.93 6.9 7.04 6.76 6.84 7.12 6.94 6.62 6.95 7.45 6.96 6.92
HP_IMPAIRED_TEMPERATURE_SENSATION 6.21 6.34 6.09 5.87 5.69 5.48 5.93 5.89 5.61 5.84 6.15 6.17 5.37 5.55 5.9 5.72 6.33 6.37 5.64 5.43 6.49 5.51 5.74 5.57 5.78 6.18
HP_IMPAIRED_TACTILE_SENSATION 7.82 7.81 7.98 7.49 8.46 8.53 8.52 8.37 8.94 8.59 8.2 8.68 8.49 8.51 8.41 8.34 8.02 7.81 8.23 8.22 8.01 7.45 8.99 8.87 8.54 8
HP_IMPAIRED_PROPRIOCEPTION 7.46 7.37 7.96 7.79 7.92 8.16 7.96 7.96 8.07 8.02 7.74 8.26 8.22 8.12 7.81 7.87 7.71 7.36 7.7 8.15 7.43 7.8 8.12 7.98 8.1 7.83
HP_ABNORMALITY_OF_PAIN_SENSATION 6.77 7.13 7.49 6.63 7.42 7.5 7.7 7.75 7.65 7.7 7.07 7.45 7.58 7.52 7.59 7.65 7.14 7.09 7.41 7.78 7.6 7.53 7.77 7.92 7.59 7.68
HP_MULTIFOCAL_EPILEPTIFORM_DISCHARGES 7.99 8.13 8.14 8.02 8.41 8.38 8.33 7.96 8.25 8.32 8.18 8.19 8.21 8.34 8.36 8.17 8.07 8.02 8.31 8.3 7.8 7.94 8.28 8.44 8.17 8.03
HP_EEG_WITH_MULTIFOCAL_SLOW_ACTIVITY 8.85 8.99 9.14 9.35 9.05 9.45 9.67 9.39 9.17 9.47 9.05 9.29 9.43 9.42 9.46 9.34 8.52 9.13 9.43 9.66 8.84 8.89 9.41 9.48 9.36 8.94
HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY 8.94 8.68 9.32 8.88 9.04 9.6 9.57 8.91 9.36 9.4 8.93 8.92 9.05 9.24 8.59 8.78 8.85 8.17 8.83 9.27 8.69 8.9 9.51 9.08 9.22 8.88
HP_EEG_WITH_SPIKE_WAVE_COMPLEXES 8.11 8.33 8 7.86 8.36 8.29 8.49 8.42 8.29 8.48 7.89 8.27 8.29 8.28 8.52 8.34 7.99 8.06 8.31 8.5 8.02 8.16 8.43 8.45 8.3 8.16
HP_EEG_WITH_BURST_SUPPRESSION 7.92 8.27 8.22 7.79 7.95 8.13 7.97 8.2 8.04 7.81 8.19 8.14 8 8.03 8.43 7.9 7.95 8.05 7.96 8.19 8.45 8.4 8.2 8.4 8.06 8.25
HP_DELAYED_FINE_MOTOR_DEVELOPMENT 7.31 7.14 6.79 7.18 7.59 7.72 8.09 7.91 7.25 7.72 7.09 7.69 7.34 7.39 7.59 7.28 7.59 7.44 7.39 8.21 7.95 7.82 7.04 7.38 7.67 7.56
HP_RECEPTIVE_LANGUAGE_DELAY 8.02 8.51 8.21 8.2 8.48 8.39 8.34 8.64 8.65 8.55 7.9 8.31 8.6 8.58 8.54 8.32 8.4 8.45 8.4 8.5 8.61 8.66 8.61 8.67 8.9 8.52
HP_INTELLECTUAL_DISABILITY_SEVERE 7.37 7.5 7.76 7.49 7.8 7.85 7.76 7.74 7.89 7.82 7.58 7.72 7.92 7.89 7.78 7.74 7.55 7.46 7.72 7.83 7.52 7.76 7.85 8.01 7.8 7.69
HP_TENDON_XANTHOMATOSIS 5.84 5.32 6.06 6.08 5.01 5.17 5.46 5.49 5.34 5.18 5.81 5.45 5.57 5.4 5.24 5.4 6.02 5.36 5.74 5.3 5.82 5.23 5.27 4.95 5.48 5.4
HP_ABNORMAL_CIRCULATING_PROTEIN_CONCENTRATION 6.3 6.31 6.4 6.4 6.46 6.49 6.4 6.35 6.39 6.54 6.35 6.38 6.36 6.39 6.35 6.39 6.38 6.36 6.41 6.38 6.4 6.29 6.53 6.41 6.42 6.42
HP_INCREASED_NUCHAL_TRANSLUCENCY 7.24 7.34 7.38 7.34 7.41 7.45 7.55 7.37 7.65 7.64 7.07 7.73 7.72 7.73 7.63 7.27 7.25 7.16 7.61 7.45 7.27 7.42 7.64 7.83 7.23 7.38
HP_ABNORMALITY_OF_THE_UMBILICAL_CORD 6.26 6.17 6.18 6.29 6.27 6.19 6.05 6.28 6.17 6.13 5.95 5.94 6.18 6.01 6.12 5.98 6.1 6.28 5.89 6.29 6.23 6.23 6.14 6.24 6.27 6.25
HP_AVASCULAR_NECROSIS 6.07 6.23 6.41 6.24 6.46 6.5 6.41 6.24 6.51 6.41 6.37 6.33 6.47 6.39 6.28 6.29 6.25 6.16 6.16 6.38 6.14 6.22 6.61 6.66 6.31 6.38
HP_ABNORMAL_CIRCULATING_SERINE_FAMILY_AMINO_ACID_CONCENTRATION 7.27 7.37 6.81 7.27 7.41 7.7 6.98 6.73 7.36 6.9 7.01 7.4 7.15 7.1 7.15 7.24 6.97 7.32 7.23 6.81 7.2 6.91 6.95 6.97 6.9 7.07
HP_ABNORMAL_CIRCULATING_GLYCINE_CONCENTRATION 7.63 7.59 7.29 7.4 7.45 7.79 7.54 7.23 7.64 7.15 7.02 7.42 7.18 7.37 7.83 7.53 7.24 7.53 7.4 7.4 7.54 7.68 7.26 7.31 7.82 7.4
HP_ABNORMAL_CIRCULATING_ASPARTATE_FAMILY_AMINO_ACID_CONCENTRATION 6.8 6.61 6.93 7.19 7.57 7.58 7.47 7.3 7.19 8.25 7.24 7.19 7.55 7.65 7.28 7.58 6.89 6.71 6.58 7.7 6.65 7.06 7.41 7.37 7.42 7.07
HP_ABNORMAL_CIRCULATING_GLUTAMINE_FAMILY_AMINO_ACID_CONCENTRATION 6.4 7 6.93 6.53 7.79 7.07 6.72 6.66 7.22 7.07 6.7 7.11 7.03 6.86 6.34 6.33 6.71 6.71 6.71 6.84 6.52 6.54 6.67 7.37 6.45 6.38
HP_ABNORMAL_CIRCULATING_PYRUVATE_FAMILY_AMINO_ACID_CONCENTRATION 7.27 7 8.14 7.59 7.44 7.4 7.51 7.46 7.54 7.61 7.86 7.45 7.5 7.65 7.78 7.53 7.07 7.26 7.57 7.6 7.52 7.66 7.53 7.73 7.51 7.38
HP_ZONULAR_CATARACT 6.41 6.13 6.1 6.41 5.89 6.17 6.23 6.34 6.28 6.15 6.12 6.32 5.91 6.25 6.29 5.91 6.22 6.13 6.2 6.07 6.38 6.22 6.37 6.07 6.41 6.23
HP_ABNORMAL_BLOOD_INORGANIC_CATION_CONCENTRATION 6.65 6.66 6.58 6.49 6.86 6.93 6.81 6.85 6.72 6.69 6.61 6.75 6.86 6.85 6.64 6.66 6.68 6.71 6.98 6.9 6.68 6.62 6.78 6.92 6.68 6.85
HP_ABNORMAL_BLOOD_MONOVALENT_INORGANIC_CATION_CONCENTRATION 5.8 5.75 5.64 5.85 5.47 5.2 5.85 5.55 5.67 5.69 5.76 5.43 5.4 5.34 5.59 5.35 5.64 5.68 5.45 5.74 5.8 5.57 5.51 5.37 5.51 5.65
HP_ABNORMAL_BLOOD_SODIUM_CONCENTRATION 5.49 5.26 5.28 5.72 4.83 4.81 4.89 4.86 5.23 5.1 5.22 5.07 4.85 4.91 5.09 5.08 5.25 5.13 4.93 5.03 5.35 5.21 5.12 5.08 5.11 5.24
HP_ABNORMAL_CIRCULATING_NUCLEOBASE_CONCENTRATION 5.79 5.7 5.8 6 5.46 5.3 5.57 5.46 5.63 5.65 5.66 5.23 5.37 5.4 5.32 5.43 5.93 5.71 5.43 5.49 5.52 5.65 5.52 5.36 5.51 5.63
HP_ABNORMALITY_OF_THE_UPPER_URINARY_TRACT 6.41 6.42 6.53 6.45 6.5 6.52 6.51 6.51 6.44 6.53 6.44 6.47 6.5 6.45 6.37 6.52 6.45 6.41 6.42 6.46 6.48 6.48 6.43 6.52 6.51 6.55
HP_ABNORMALITY_OF_THE_LOWER_URINARY_TRACT 6.68 6.73 6.89 6.76 6.92 6.98 6.93 6.95 6.93 6.96 6.85 6.96 6.9 6.89 6.92 6.86 6.72 6.71 6.8 6.95 6.82 6.93 7.03 7.07 6.92 6.89
HP_ABNORMALITY_OF_THE_EXTERNAL_NOSE 6.8 6.85 6.99 6.94 7.01 7.11 7.02 7.08 6.97 7.08 6.85 7.08 7.16 7.11 7.12 7.03 6.84 6.9 6.98 7.09 6.99 7.08 7.04 7.19 7.07 7.05
HP_ABNORMAL_RENAL_PELVIS_MORPHOLOGY 6.85 6.88 7.13 6.94 7 7.18 7.14 7.18 7.14 7.21 6.96 7.19 7.22 7.25 7.1 7.2 7.1 6.92 6.98 7.1 7.05 7.15 7.23 7.28 7.19 7.25
HP_ABNORMALITY_OF_THE_FETAL_CARDIOVASCULAR_SYSTEM 6.6 6.51 6.68 6.42 6.42 6.41 6.07 6.44 6.32 6.46 6.23 6.21 6.52 6.38 6.27 6.25 6.17 6.34 6.28 6.51 6.29 6.4 6.35 6.46 6.26 6.31
HP_DILATATION_OF_THE_BLADDER 5.25 4.86 4.77 5.04 4.74 4.47 5.16 4.59 5.06 4.87 4.97 4.7 4.62 4.69 4.28 4.66 5.28 5.23 4.9 4.8 5.19 4.68 5.31 4.44 5.11 5.24
HP_ABNORMAL_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION 6.55 6.89 7.31 7.02 7.2 7.17 7.03 6.84 6.96 7.19 7.27 7.13 7.16 7.47 6.73 7.17 6.85 6.9 7.05 7.22 6.84 7 7.16 7.28 7.18 7.21
HP_ABNORMAL_CIRCULATING_FATTY_ACID_ANION_CONCENTRATION 6.35 6.3 6.71 6.37 6.46 6.43 6.37 6.55 6.64 6.33 6.61 6.22 6.78 6.64 6.02 6.74 6.89 6.17 6.47 6.85 6.14 6.77 6.46 6.36 6.6 6.71
HP_ANEMIA_OF_INADEQUATE_PRODUCTION 6.18 6.08 6.42 6.32 6.18 6.18 6.24 6.37 6.3 6.19 6.14 6.04 6.17 6.1 6.11 6.18 6.21 6.12 5.9 6.13 6.19 6.12 6.28 6.39 6.21 6.15
HP_ABNORMAL_MYELOID_LEUKOCYTE_MORPHOLOGY 6.18 6.2 6.11 6.18 6.22 6.14 6.22 6.2 6.25 6.16 6.12 6.22 6.26 6.28 6.14 6.25 6.22 6.31 6.26 6.27 6.3 6.19 6.31 6.33 6.19 6.31
HP_B_LYMPHOCYTOPENIA 5.67 5.78 5.84 6.03 5.36 5.56 5.5 5.39 5.5 5.36 5.57 5.38 5.63 5.63 5.44 5.31 5.55 5.68 5.51 5.5 5.35 5.31 5.33 5.41 5.27 5.53
HP_ABNORMALITY_OF_LIPOPROTEIN_CHOLESTEROL_CONCENTRATION 6.25 6.06 6.26 6.48 6.58 6.38 6.28 6.32 6.15 6.67 6.2 6.41 6.22 6.09 6.02 6.02 6.36 6.04 6.16 6.27 6.14 6.1 6.03 5.94 6.21 6.42
HP_HYPERLIPOPROTEINEMIA 6.2 5.86 6.15 6.15 6.34 5.88 6.21 6.06 6.05 5.98 6.03 6.04 6.06 6.02 5.74 5.9 6.34 6.02 5.87 6.11 6.3 6 5.72 5.84 6.17 6.08
HP_HYPOLIPOPROTEINEMIA 6.29 6.26 6.28 6.91 6.89 6.53 6.36 6.36 6.54 6.82 6.5 6.81 6.35 6.17 6.47 6.27 6.61 6.53 6.29 6.43 6.14 6.27 6.42 6.5 6.35 6.63
HP_POLYGENIC_INHERITANCE 5.37 5.47 5.42 6.21 4.99 4.85 5.2 5.02 5.11 4.99 5.3 4.78 4.84 5.02 5.09 5.04 5.29 5.16 5.08 5.14 5.18 5.09 5.06 4.67 5.03 4.89
HP_GONOSOMAL_INHERITANCE 6.59 6.76 6.89 6.67 6.9 7.2 6.91 6.9 7.17 6.98 6.76 6.98 7.03 6.95 6.9 6.83 6.86 6.63 6.85 7.11 6.66 6.95 7.23 7.43 6.95 6.77
HP_ABNORMALITY_OF_THE_EXTRINSIC_PATHWAY 6.52 6.83 7.02 6.79 6.58 6.55 6.76 6.65 6.72 6.53 6.58 6.41 6.4 6.7 6.94 6.77 6.41 6.83 6.44 6.48 6.71 6.6 6.69 6.72 6.81 6.47
HP_ABNORMALITY_OF_THE_INTRINSIC_PATHWAY 6.86 7.04 7.36 6.93 7.01 6.78 7.12 7.34 6.89 6.87 6.9 6.59 6.71 6.79 7.28 7.1 7.43 7.38 6.58 6.89 7.1 6.95 7.02 7.43 7.5 7.02
HP_ABNORMALITY_OF_THE_COMMON_COAGULATION_PATHWAY 5.87 5.9 5.8 6.18 5.76 5.43 5.6 5.8 5.78 5.42 5.66 5.53 5.9 5.65 5.76 5.47 5.63 5.73 5.56 5.64 5.77 5.88 5.77 5.67 6.05 5.98
HP_ABNORMAL_MORPHOLOGY_OF_THE_ABDOMINAL_MUSCULATURE 6.57 6.48 6.85 6.79 6.93 6.96 6.67 6.85 6.73 6.8 6.6 6.64 6.66 6.79 6.85 6.61 6.6 6.49 6.54 6.79 6.58 6.85 7.03 6.8 6.88 6.73
HP_ABNORMALITY_OF_THE_CEREBRAL_SUBCORTEX 7.39 7.5 7.72 7.53 7.69 7.74 7.71 7.75 7.7 7.71 7.48 7.68 7.73 7.75 7.73 7.65 7.51 7.47 7.61 7.79 7.52 7.74 7.72 7.87 7.72 7.64
HP_ABNORMAL_CORPUS_STRIATUM_MORPHOLOGY 7.43 7.51 7.82 7.47 7.7 7.77 7.46 7.45 7.9 7.64 7.52 7.52 7.61 7.75 7.77 7.62 7.69 7.64 7.53 7.79 7.82 7.94 7.88 7.74 7.67 7.47
HP_ABNORMAL_CIRCULATING_DICARBOXYLIC_ACID_CONCENTRATION 6.34 6.29 6.5 6.6 6.41 6.42 6.38 6.31 6.37 6.29 6.38 6.26 6.35 6.39 6.37 6.33 6.3 6.26 6.29 6.45 6.14 6.39 6.34 6.14 6.26 6.49
HP_ABNORMAL_CIRCULATING_MONOCARBOXYLIC_ACID_COCENTRATION 5.21 5.22 4.9 4.79 4.45 4.47 4.58 4.75 4.63 4.62 4.7 4.51 4.46 4.54 4.72 4.71 4.96 4.81 4.72 4.35 4.75 4.37 4.98 4.49 4.6 4.72
HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_IONIZING_RADIATION 7.12 7.19 6.81 7.25 7.32 7.47 7.2 6.69 7.28 7.15 6.84 7.37 7.09 7.08 7.25 7.25 7.14 7.07 7.17 7.36 7.18 6.94 7.29 7.89 7.37 7.13
HP_INCREASED_BONE_MINERAL_DENSITY 6.49 6.59 6.51 6.63 6.82 6.7 6.28 6.54 6.56 6.67 6.59 6.5 6.54 6.58 6.49 6.47 6.6 6.56 6.61 6.56 6.41 6.46 6.55 6.54 6.72 6.59
HP_OSTEOPETROSIS 7.01 7.02 7.56 7.18 7.86 7.7 7.94 7.74 7.15 7.89 7.04 7.8 7.71 7.81 7.79 7.46 7.61 7.75 7.32 8 7.74 7.81 7.36 8.22 7.9 7.75
HP_HIGH_MYOPIA 6.28 6.09 6.24 5.89 6.5 6.59 6.03 6.02 6.35 6.49 6.19 6.51 6.36 6.09 6.05 5.94 6.13 5.97 6.17 6.11 5.89 6.05 6.46 6.44 6.06 6.31
HP_ABNORMAL_SYSTEMIC_ARTERIAL_MORPHOLOGY 6.63 6.6 6.67 6.7 6.87 6.87 6.78 6.79 6.78 6.86 6.66 6.85 6.88 6.72 6.75 6.76 6.79 6.62 6.74 6.79 6.86 6.9 6.87 6.96 6.86 6.89
HP_ABNORMAL_MORPHOLOGY_OF_THE_MUSCULATURE_OF_THE_NECK 7.19 7.56 7.53 7.59 7.43 7.39 7.71 7.87 7.34 7.9 7.36 7.76 7.56 7.72 7.66 7.78 7.5 7.73 7.34 7.67 7.55 7.81 7.53 7.66 7.88 7.93
HP_TEMPORAL_PATTERN 7.91 8.11 8.88 7.99 8.85 8.65 8.35 8.14 8.43 8.56 8.27 8.41 8.69 8.46 8.58 8.37 8.18 7.84 8.29 8.47 7.91 8.42 8.22 8.77 8.77 8.23
HP_ABNORMAL_CIRCULATING_CARBOHYDRATE_CONCENTRATION 7.06 7.01 7.91 7.46 6.88 7.11 7.1 7.28 7.38 7.24 7.03 7.18 7.07 7.17 7.15 7.35 7.02 6.86 6.95 7.19 7.26 7.52 6.98 7.29 7.2 7.36
HP_ABNORMAL_GLUCOSE_HOMEOSTASIS 6.3 6.4 6.54 6.5 6.43 6.5 6.44 6.47 6.49 6.54 6.42 6.37 6.49 6.5 6.41 6.5 6.38 6.39 6.4 6.55 6.41 6.46 6.49 6.49 6.5 6.5
HP_ABNORMAL_BLOOD_GLUCOSE_CONCENTRATION 6.35 6.48 6.81 6.75 6.7 6.81 6.67 6.71 6.67 6.65 6.53 6.5 6.76 6.75 6.61 6.72 6.6 6.53 6.63 6.79 6.62 6.75 6.72 6.8 6.71 6.7
HP_ABNORMALITY_OF_CIRCULATING_ENZYME_LEVEL 6.58 6.7 6.74 6.68 6.81 6.85 6.67 6.74 6.79 6.86 6.75 6.8 6.78 6.75 6.67 6.7 6.77 6.59 6.75 6.73 6.68 6.57 6.94 6.78 6.75 6.73
HP_ABNORMAL_CARDIOVASCULAR_SYSTEM_PHYSIOLOGY 6.46 6.45 6.62 6.57 6.57 6.57 6.58 6.54 6.55 6.62 6.51 6.57 6.56 6.52 6.5 6.58 6.57 6.46 6.48 6.58 6.55 6.62 6.64 6.65 6.6 6.61
HP_APLASIA_HYPOPLASIA_OF_THE_VAGINA 5.34 5.35 5.55 6.1 5.01 4.77 5.19 5.05 5.32 5.26 5.22 4.96 5.16 5.08 5.43 4.91 5.27 5.56 4.83 5 5.24 4.9 4.81 4.92 4.98 5.3
HP_ABNORMAL_FALLOPIAN_TUBE_MORPHOLOGY 5.53 5 5.96 6.15 5.26 5.1 5.46 5.55 5.56 5.54 5.54 5.38 5.37 5.36 5.55 5.73 5.51 5.5 5.34 5.46 5.43 5.46 5.69 5.41 5.07 5.39
HP_ABNORMALITY_OF_BLOOD_CIRCULATION 6.32 6.28 6.38 6.34 6.32 6.38 6.25 6.21 6.29 6.27 6.36 6.35 6.4 6.35 6.18 6.26 6.25 6.25 6.16 6.37 6.4 6.35 6.34 6.35 6.31 6.31
HP_ABNORMAL_BLOOD_TRANSITION_ELEMENT_CATION_CONCENTRATION 5.59 5.57 5.84 5.84 5.45 5.36 5.6 5.26 5.32 5.45 5.85 5.25 5.18 5.29 5.43 5.32 5.73 5.71 5.27 5.07 5.62 5.64 5.35 4.9 6.09 5.98
HP_ABNORMALITY_OF_IRON_HOMEOSTASIS 5.67 5.58 6.19 5.91 5.99 5.47 5.82 5.27 5.38 5.83 5.9 5.29 5.27 5.37 5.57 5.71 5.86 5.66 5.27 5.06 5.72 5.8 5.6 4.81 6.14 6.08
HP_ABNORMALITY_OF_FLUID_REGULATION 6.2 6.14 6.19 6.2 6.15 6.06 6.1 6.13 6.17 6.16 6.23 6.08 6.19 6.11 6.08 6.15 6.1 6.02 6.06 6.12 6.2 6.12 6.23 6.18 6.15 6.31
HP_AMYLOIDOSIS 5.85 5.89 5.93 5.72 5.48 5.39 5.5 5.52 5.47 5.63 5.7 5.27 5.65 5.49 5.31 5.51 5.74 5.71 5.47 5.38 5.94 6.01 5.53 5.27 5.67 5.91
HP_ABNORMAL_RENAL_CORTEX_MORPHOLOGY 6.45 6.38 6.43 6.21 6.5 6.55 6.32 6.21 6.22 6.32 6.28 6.35 6.42 6.34 6.24 6.31 6.41 6.29 6.46 6.38 6.18 6.2 6.36 6.35 6.31 6.48
HP_ABNORMALITY_OF_RENAL_EXCRETION 5.44 5.32 5.15 5.41 4.81 4.78 5.15 5.05 5.21 4.88 5.21 4.85 4.93 4.95 4.84 5.05 5.37 5.35 4.98 5 5.36 5 4.98 4.65 5.01 4.91
HP_DECREASED_URINE_OUTPUT 5.46 5.35 5.15 5.15 4.81 4.76 5.15 5.15 5.21 4.89 5.35 4.77 5.03 4.8 4.68 5.13 5.61 5.41 4.95 5 5.35 5.12 4.96 4.5 5.34 5.39
HP_ABNORMALITY_OF_RENAL_RESORPTION 5.49 5.54 5.28 5.5 5.11 5.15 5.41 5.36 5.39 4.96 5.41 5.23 4.97 5.12 5.27 5.12 5.45 5.23 5 5.25 5.38 5.34 5.1 4.82 5.07 4.82
HP_ABNORMALITY_OF_THE_HELIX 6.82 6.85 7.11 7.01 7.1 7.27 7 6.98 7.25 7.14 6.87 7.13 7.19 7.05 6.97 7.14 6.97 6.76 7 7.06 6.93 7.05 7.16 7.31 7.07 7.09
HP_ABNORMALITY_OF_THE_INTRAHEPATIC_BILE_DUCT 5.55 5.86 5.94 5.91 5.94 5.77 5.6 5.15 5.98 5.31 5.59 5.93 5.86 5.07 5.4 5.95 5.95 5.39 5.27 5.57 5.18 5.71 5.87 5.96 5.69 5.57
HP_ABNORMAL_BLOOD_POTASSIUM_CONCENTRATION 5.8 5.75 5.57 5.88 5.41 5.19 5.79 5.51 5.54 5.64 5.79 5.46 5.36 5.32 5.63 5.17 5.74 5.7 5.28 5.6 5.86 5.62 5.42 5.38 5.52 5.61
HP_ABNORMALITY_OF_CIRCULATING_ADRENOCORTICOTROPIN_LEVEL 5.5 5.42 5.71 6.07 5.56 5.46 5.75 5.77 5.76 5.66 5.99 5.69 5.56 5.52 5.8 5.86 5.53 5.62 5.42 5.43 5.9 5.86 5.56 5.52 5.68 5.98
HP_ABNORMAL_NUMBER_OF_PERMANENT_TEETH 6.25 6.31 6.2 6.43 6.25 5.99 6.21 6.29 6.19 6.01 6.33 6.14 5.94 6 5.75 5.87 6.63 6.3 5.97 6.26 6.68 6.1 6.36 5.99 6.79 6.65
HP_ABNORMALITY_OF_DENTAL_STRUCTURE 6.44 6.37 6.42 6.41 6.22 6.36 6.32 6.37 6.3 6.35 6.45 6.43 6.28 6.4 6.28 6.45 6.3 6.4 6.35 6.4 6.3 6.43 6.33 6.44 6.23 6.35
HP_ABNORMALITY_OF_INCISOR_MORPHOLOGY 6.92 7.23 7.19 7.37 7.24 7.57 7.49 7.44 7.44 7.53 7.12 7.86 7.41 7.37 7.51 7.07 7.18 7.23 7.29 7.46 7.05 7.56 7.63 7.67 7.65 7.42
HP_ABNORMAL_NUMBER_OF_INCISORS 5.7 5.87 5.74 6 5.94 5.89 5.86 5.88 6.02 6.04 5.69 5.63 6.16 6.16 5.69 5.86 5.79 5.8 6 5.92 5.96 5.46 6.24 6 5.78 5.79
HP_CONICAL_INCISOR 5.4 5.43 5.8 5.75 5.1 5.38 5.47 5.27 5.99 5.44 5.3 5.49 5.26 5.23 5.44 5.24 5.02 5.21 5.11 5.21 5.17 5.07 5.73 5.43 5.07 4.82
HP_INCREASED_NUMBER_OF_TEETH 6.55 6.51 6.15 6.27 6.56 6.4 6.42 6.37 6.19 6.4 6.2 6.26 6.5 6.5 6.37 6.36 6.48 6.19 6.28 6.44 6.32 6.24 6.61 6.43 6.31 6.49
HP_ABNORMALITY_OF_DENTAL_COLOR 6.28 6.23 6.25 6.32 6.31 6.34 6.73 6.35 6.58 6.15 6.26 6.44 6.52 6.51 6.43 6.27 6.09 6.62 5.85 6.85 6.04 6.5 6.11 6.21 6.38 6.11
HP_INCISOR_MACRODONTIA 8.14 8.59 8.45 8.28 8.74 8.82 8.62 8.94 8.97 8.72 8.6 8.69 8.89 8.99 8.84 8.92 8.52 8.43 8.83 8.89 8.46 8.88 8.91 9.04 9.01 8.58
HP_PERIPHERAL_DEMYELINATION 7.15 7.16 7.49 6.79 7.76 7.78 7.47 7.74 7.68 7.62 7.02 7.45 7.68 7.52 7.52 7.36 7.39 7.17 7 7.87 7.09 7.35 7.41 7.65 7.59 7.62
HP_EPILEPTIC_SPASM 7.94 8.06 8.14 7.96 8.36 8.48 8.41 8.27 8.12 8.32 8.02 8.34 8.23 8.37 8.5 8.31 8.07 8.05 8.31 8.32 8.1 8.29 8.43 8.43 8.3 8.25
HP_SPEECH_APRAXIA 7.76 8.32 8.17 8.11 8.38 8.26 8.54 8.7 8.55 8.52 8.25 8.43 8.44 8.58 8.77 8.49 8.23 8.27 8.39 8.59 8.48 8.56 8.89 8.83 8.87 8.45
HP_INTESTINAL_ATRESIA 6.53 6.42 6.7 6.5 6.54 6.32 6.67 6.49 6.53 6.56 6.22 6.57 6.55 6.4 6.59 6.32 6.45 6.4 6.25 6.45 6.62 6.78 6.42 6.58 6.56 6.34
HP_ABNORMAL_LEFT_VENTRICULAR_OUTFLOW_TRACT_MORPHOLOGY 5.09 5.12 5.11 5.11 5.1 4.96 5.32 5.14 4.81 5.06 5.52 5.02 5.18 4.87 4.82 5.09 5.53 5.51 5.12 4.96 5.51 5.24 4.97 5.06 5.07 5.35
HP_ABNORMALITY_OF_BLOOD_VOLUME_HOMEOSTASIS 5.73 5.56 5.37 5.63 5.72 5.5 5.78 5.51 5.74 5.75 5.46 5.84 5.71 5.61 5.6 5.46 5.81 5.6 5.21 5.61 5.6 5.74 5.67 5.59 5.74 5.49
HP_RECURRENT_SINUSITIS 5.34 5.28 5.31 5.24 4.84 4.93 5.21 5.33 5.18 5.32 5.3 4.94 5.18 5.08 5.25 5.35 5.25 5.41 5.25 5.05 5.35 5.15 4.96 4.96 5 5.29
HP_CHRONIC_SINUSITIS 5.77 5.47 5.6 5.45 5.16 5.4 5.53 5.44 5.49 5.85 5.47 5.65 5.42 5.33 5.49 5.83 5.55 5.84 5.39 5.35 5.55 5.59 5.27 5.11 5.22 5.58
HP_ABNORMALITY_OF_IMMUNE_SERUM_PROTEIN_PHYSIOLOGY 5.77 5.37 5.76 5.57 5.85 5.41 5.28 5.48 5.92 5.4 5.67 5.75 5.66 5.55 5.17 5.49 5.87 5.34 5.36 5.4 5.57 5.51 5.49 5.37 5.72 5.66
HP_ABNORMALITY_OF_THE_NASAL_DORSUM 6.36 6.36 6.55 6.57 6.5 6.53 6.4 6.39 6.31 6.66 6.42 6.35 6.42 6.39 6.43 6.43 6.46 6.22 6.32 6.33 6.4 6.39 6.41 6.54 6.48 6.47
HP_CONCAVE_NASAL_RIDGE 7.61 7.16 7.7 7.89 7.25 7.43 7.74 7.95 7.82 7.9 6.82 7.29 7.72 7.51 7.78 7.46 7.49 7.29 7.4 7.7 7.06 7.47 7.57 7.92 7.59 7.09
HP_ABNORMALITY_OF_SKIN_PHYSIOLOGY 5.84 5.69 5.77 5.83 5.72 5.57 5.78 5.8 5.81 5.73 5.87 5.58 5.75 5.65 5.65 5.61 5.83 5.73 5.6 5.68 5.92 5.86 5.56 5.47 5.78 5.84
HP_ABNORMALITY_OF_EPIDERMAL_MORPHOLOGY 5.7 5.53 5.43 5.46 5.58 5.58 5.44 5.29 5.55 5.33 5.51 5.29 5.66 5.55 5.39 5.21 5.54 5.5 5.29 5.39 5.49 5.58 5.61 5.65 5.74 5.5
HP_INCREASED_SENSITIVITY_TO_IONIZING_RADIATION 6.89 6.74 6.74 7.24 6.9 7.06 6.96 6.68 6.8 6.92 6.82 6.97 6.9 6.83 6.92 6.9 7.04 6.76 6.84 7.12 6.99 6.8 6.95 7.45 6.96 6.93
HP_SYMPTOMATIC_SEIZURES 5.97 5.83 5.79 6.15 5.81 6.22 5.91 6.06 5.56 5.56 5.69 5.73 5.9 5.57 5.87 5.88 5.58 5.69 6.44 5.83 5.64 5.6 5.51 6.13 5.71 5.5
HP_DIALEPTIC_SEIZURE 7.84 8.09 8.21 7.86 8.47 8.59 8.55 8.32 8.6 8.52 8 8.35 8.33 8.51 8.55 8.42 8.12 8.06 8.31 8.56 8.13 8.38 8.65 8.61 8.53 8.25
HP_TYPICAL_ABSENCE_SEIZURE 9.28 9.27 9.32 8.69 9.65 9.91 9.97 9.65 9.92 9.96 9.65 9.67 9.88 9.95 9.81 9.59 9.35 9.59 9.62 9.87 9.26 9.53 9.91 10.17 9.54 9.28
HP_MYOCLONIC_ABSENCE_SEIZURE 8.92 8.97 8.8 9.02 8.88 9.43 9.21 8.66 9.14 9.16 8.63 8.49 8.96 9.05 8.87 8.73 8.22 8.75 9.37 9.04 8.16 8.4 9.05 9.05 8.3 8.42
HP_FOCAL_MOTOR_SEIZURE 8.73 8.94 8.57 8.4 9.21 9.32 9.23 9.09 9.17 9.19 8.9 9.01 9.31 9.36 9.18 9 8.4 8.75 9.13 9.21 8.78 8.99 9.07 9.36 8.93 8.58
HP_FOCAL_SENSORY_SEIZURE 9.19 9.18 8.46 9.19 9.32 9.45 9.53 9.78 9.1 9.19 8.83 9.55 9.34 9.38 9.33 9.31 9.42 8.8 9.4 9.69 8.89 9.01 8.75 9.24 9.4 9.16
HP_FOCAL_MYOCLONIC_SEIZURE 7.94 7.53 8.18 7.76 8.13 8.06 7.81 7.87 8 7.94 8.31 7.7 8.22 7.78 8.19 7.66 7.85 8.05 8.22 8.18 7.7 7.98 8 8.03 7.75 7.52
HP_FOCAL_TONIC_SEIZURE 8.52 9.03 8.37 7.65 8.92 9.3 9.33 8.82 9.17 9.1 8.31 9.1 9.02 9.09 8.99 8.61 8.21 8.24 8.89 9.06 8.51 8.43 8.8 9.36 8.8 8.26
HP_GENERALIZED_CLONIC_SEIZURE 8.01 8.59 8.38 7.79 8.75 8.97 8.9 8.69 9.11 8.95 8.55 8.54 8.8 8.92 8.91 8.53 8.16 8.13 8.5 8.83 8.45 8.48 8.71 9.25 8.53 8.45
HP_SIMPLE_FEBRILE_SEIZURE 8.1 8.66 8.14 7.71 8.84 8.92 8.51 8.42 8.59 8.75 8 8.52 8.49 8.47 8.67 8.57 8.02 8.08 8.83 8.53 8.28 8.43 8.48 8.8 8.34 8.42
HP_COMPLEX_FEBRILE_SEIZURE 8.94 9.07 8.71 9.53 9.32 9.45 9.53 9.67 9.17 9.19 8.8 9.04 9.32 9.36 9.63 9.25 8.92 9.17 9.42 9.69 9.26 9.21 8.84 9.36 8.85 8.86
HP_EEG_WITH_FOCAL_EPILEPTIFORM_DISCHARGES 8.22 8.15 8.14 8.02 8.53 8.48 8.41 8.25 8.5 8.37 8.26 8.35 8.29 8.48 8.51 8.28 8.19 8.19 8.35 8.41 7.96 8.38 8.46 8.46 8.33 8.24
HP_EEG_WITH_FOCAL_SHARP_WAVES 8.78 8.87 8.08 8.52 9.17 9.44 9.21 9.36 8.74 9.14 8.57 9.09 9.23 9.35 9.43 9.12 8.95 8.47 8.66 9.52 9.02 8.71 8.71 9.1 9.05 8.99
HP_EEG_WITH_ABNORMALLY_SLOW_FREQUENCIES 8.86 8.87 9.32 9.06 9.04 9.46 9.59 9.13 9.33 9.44 9.15 9.27 9.41 9.41 9.4 9.14 8.66 8.97 9.24 9.52 8.87 8.9 9.51 9.39 9.3 8.88
HP_ABNORMAL_SHAPE_OF_THE_OCCIPUT 6.58 6.59 6.94 6.78 7.01 6.92 6.9 6.84 6.84 6.82 6.63 6.84 6.97 6.88 6.85 6.78 6.82 6.8 6.82 6.98 6.81 7 6.89 7.01 6.91 6.84
HP_ABNORMAL_SHAPE_OF_THE_FRONTAL_REGION 6.68 6.78 6.97 6.85 6.91 7 6.89 7 6.79 7.04 6.85 6.92 6.98 6.85 6.91 6.93 6.83 6.82 6.85 7.02 7 6.97 6.98 7.02 6.95 7.08
HP_PROMINENT_FOREHEAD 7.37 7.28 7.46 7.2 7.58 7.75 7.72 7.76 7.6 7.68 7.34 7.67 7.71 7.73 7.67 7.71 7.65 7.31 7.54 7.75 7.56 7.73 7.82 7.81 7.83 7.6
HP_APLASIA_HYPOPLASIA_OF_THE_EYELID 6.41 6.36 6.57 7.03 6.45 6.35 6.33 6.68 6.7 6.36 6.49 6.72 6.69 6.52 6.37 6.93 6.23 6.62 6.37 6.44 6.15 6.43 6.57 6.27 6.51 6.38
HP_HORIZONTAL_EYEBROW 8.47 8.52 8.15 8.74 8.41 8.48 9.08 8.94 8.83 8.76 8.76 8.8 8.89 9.14 8.71 8.67 8.88 8.35 8.32 8.95 8.31 8.55 9.01 8.85 9.02 8.44
HP_BROAD_EYEBROW 6.69 6.74 7.33 7.46 7.12 6.86 7.09 6.95 7.19 7.54 6.93 7.25 7.28 6.91 7.09 7.07 6.55 6.7 7.11 7.34 6.8 7.07 7.11 7.22 6.89 7.02
HP_ANISOCYTOSIS 6.14 6.07 6.24 6.73 5.99 5.68 5.56 5.88 5.89 5.79 5.8 5.61 5.95 5.83 6.17 5.6 5.47 5.94 5.9 5.97 6.33 5.97 6.14 5.75 5.44 5.83
HP_RECURRENT_MYCOBACTERIAL_INFECTIONS 5.45 5.39 5.4 5.47 5.13 5.18 5.48 5.19 5.37 5.77 5.47 5.63 5.36 5.18 5.49 5.73 5.5 5.75 5.27 5.13 5.5 5.41 5.27 5.11 5.27 5.36
HP_VASCULAR_SKIN_ABNORMALITY 6.3 6.24 6.34 6.37 6.31 6.16 6.18 6.15 6.25 6.25 6.35 6.27 6.29 6.3 6.06 6.24 6.26 6.22 6.12 6.25 6.3 6.29 6.32 6.27 6.3 6.36
HP_ABNORMALITY_OF_THE_URINARY_SYSTEM_PHYSIOLOGY 6.23 6.26 6.38 6.36 6.3 6.3 6.32 6.38 6.29 6.3 6.28 6.29 6.25 6.21 6.23 6.25 6.2 6.25 6.24 6.33 6.24 6.26 6.29 6.36 6.25 6.38
HP_ABNORMALITY_OF_URINE_CALCIUM_CONCENTRATION 6.1 5.81 5.64 5.92 5.58 5.33 5.69 5.83 5.63 5.6 5.73 5.25 5.6 5.51 5.47 5.28 5.88 5.71 5.57 5.62 6.04 5.73 5.41 5.24 5.71 5.79
HP_ABNORMALITY_OF_URINE_CATECHOLAMINE_CONCENTRATION 7.36 7.22 8.01 7.65 7.63 7.6 7.31 7.79 7.21 7.53 7.9 7.64 7.61 7.52 7.72 7.65 7.53 7.32 7.73 7.7 7.17 7.85 7.39 7.38 7.82 7.63
HP_ABNORMALITY_OF_HINDBRAIN_MORPHOLOGY 7.15 7.21 7.42 7.41 7.39 7.45 7.39 7.37 7.45 7.46 7.31 7.41 7.48 7.47 7.39 7.38 7.23 7.14 7.35 7.45 7.2 7.35 7.45 7.58 7.47 7.38
HP_PROMINENT_DIGIT_PAD 8.26 8.62 8.37 8.34 8.95 9.15 9.26 8.97 8.99 8.62 8.68 8.68 8.91 8.82 8.89 9.01 8.85 8.68 8.79 8.96 8.76 9.01 8.93 9.05 9.04 8.74
HP_BROAD_THUMB 7.4 7.28 7.33 7.09 7.55 7.68 7.51 7.81 7.57 7.67 7.41 7.51 7.84 7.83 7.53 7.62 7.66 7.29 7.55 7.71 7.44 7.78 7.69 7.82 7.86 7.63
HP_ABNORMALITY_OF_LONG_BONE_MORPHOLOGY 6.5 6.47 6.68 6.65 6.67 6.66 6.58 6.62 6.54 6.63 6.55 6.64 6.63 6.58 6.51 6.62 6.53 6.47 6.49 6.6 6.55 6.64 6.7 6.71 6.64 6.74
HP_ABNORMALITY_OF_FONTANELLES 6.3 6.31 6.27 6.2 6.44 6.54 6.23 6.34 6.29 6.25 6.22 6.3 6.4 6.27 6.09 6.21 6.23 6.12 6.3 6.24 6.21 6.17 6.39 6.34 6.2 6.29
HP_ABNORMALITY_OF_CRANIAL_SUTURES 6.61 6.65 6.79 6.77 6.91 6.92 6.78 6.93 6.75 6.82 6.73 6.86 6.93 6.89 6.86 6.83 6.82 6.76 6.81 6.96 6.79 7.01 6.83 7.02 6.98 7.03
HP_FACIAL_SHAPE_DEFORMATION 5.6 5.63 5.15 5.03 5.35 5.34 4.61 5.67 5.63 5.17 5.85 5.24 5.15 5.08 5.52 5.6 5.63 5.65 5.21 5.1 5.6 5.64 5.65 5.74 5.65 5.39
HP_ABNORMALITY_OF_MOUTH_SIZE 7.11 7.17 7.12 7.12 7.17 7.32 7.24 7.31 7.3 7.36 7.12 7.37 7.4 7.37 7.34 7.27 7.25 7.23 7.23 7.33 7.21 7.41 7.38 7.57 7.37 7.38
HP_ABNORMALITY_OF_MOUTH_SHAPE 7.23 7.41 7.19 7.26 7.68 7.63 7.64 7.49 7.59 7.64 7.16 7.63 7.64 7.69 7.6 7.5 7.36 7.32 7.41 7.61 7.19 7.54 7.55 7.67 7.5 7.57
HP_ABNORMALITY_OF_UPPER_LIP_VERMILLION 7.18 7.4 7.46 7.31 7.49 7.54 7.55 7.46 7.59 7.59 7.28 7.58 7.72 7.73 7.61 7.51 7.44 7.25 7.42 7.46 7.33 7.54 7.69 7.74 7.55 7.47
HP_MILD_GLOBAL_DEVELOPMENTAL_DELAY 6.88 6.84 6.94 7.26 6.93 7.09 7.12 6.94 6.69 7.02 7.08 7.32 7.01 7.07 6.89 6.89 6.94 7.1 7.02 6.95 6.97 7.21 6.89 7.08 6.85 7.03
HP_MODERATE_GLOBAL_DEVELOPMENTAL_DELAY 7.14 7.41 7.28 7.73 7.83 7.67 7.05 7.16 7.57 6.94 6.91 7.23 7.13 7.02 7.36 7.35 6.9 6.8 7.4 7.39 7.14 7.48 7.31 7.71 7.57 7.25
HP_SEVERE_GLOBAL_DEVELOPMENTAL_DELAY 7.58 7.55 8.08 7.86 7.84 8.06 8.06 8.06 8.04 8.03 7.86 7.97 8.17 8.17 8.12 8 7.66 7.74 7.9 8.02 7.66 8.03 8.09 8.18 8 7.93
HP_GENERALIZED_ABNORMALITY_OF_SKIN 6.26 6.25 6.37 6.36 6.32 6.24 6.23 6.19 6.29 6.29 6.33 6.25 6.33 6.31 6.09 6.27 6.29 6.28 6.17 6.28 6.3 6.29 6.34 6.33 6.3 6.36
HP_LOCALIZED_SKIN_LESION 6.38 6.44 6.52 6.49 6.55 6.52 6.44 6.48 6.54 6.62 6.47 6.53 6.59 6.53 6.39 6.47 6.47 6.39 6.44 6.46 6.48 6.48 6.6 6.58 6.56 6.6
HP_REGIONAL_ABNORMALITY_OF_SKIN 6.87 6.89 7.12 7.02 7.04 7.16 7.08 7.03 7.17 7.1 6.93 7.2 7.2 7.16 7.12 7.12 7 6.95 7.11 7.17 7.05 7.07 7.16 7.35 7.17 7.13
HP_GENERALIZED_HYPOPIGMENTATION_OF_HAIR 6.13 6.23 6.1 6.4 6.05 6.09 6.35 6.25 5.93 5.94 6.05 6.08 6.28 5.99 6.03 6.09 6.19 6.17 5.84 6.14 6.23 6.22 6.13 5.88 6.15 6.31
HP_DRY_HAIR 6.23 6.47 6.61 6.27 6.51 6.2 6.2 6.18 6.26 6.29 6.52 6.53 6.02 6.31 6.21 6.51 6.42 6 6.23 6.22 6.13 6.03 6.14 6.16 6.08 6.17
HP_ACQUIRED_ABNORMAL_HAIR_PATTERN 6.58 6.36 6.2 6.59 6.23 5.88 6.29 6.07 6.28 6.33 6.4 6.45 6.03 5.66 6.34 6.08 6.46 6.19 6.1 6.16 6.48 5.9 6.19 6.05 6.1 6.39
HP_ABNORMAL_HAIR_QUANTITY 6.61 6.63 6.76 6.79 6.84 6.87 6.78 6.85 6.73 6.87 6.69 6.84 6.82 6.81 6.86 6.77 6.72 6.63 6.75 6.83 6.78 6.84 6.82 6.93 6.77 6.85
HP_WHITE_HAIR 5.6 5.58 5.79 5.86 5.59 5.51 5.75 5.67 5.73 5.53 5.63 5.42 5.51 5.73 5.81 5.66 5.56 5.51 5.32 5.47 5.67 6.07 5.45 5.59 6.05 5.93
HP_PATCHY_HYPOPIGMENTATION_OF_HAIR 6.08 6.32 6.27 6.65 6.45 6.37 6.24 6.17 6.45 6.62 6.17 6.33 6.37 6.12 6.11 6.5 6.42 6.37 6.22 6.26 6.1 5.93 6.62 6.48 6.62 6.44
HP_MORPHOLOGICAL_ABNORMALITY_OF_THE_VESTIBULE_OF_THE_INNER_EAR 7.78 7.77 7.98 7.6 8.34 7.95 7.65 7.53 7.91 7.34 7.63 7.4 7.68 7.36 8 7.87 7.96 7.07 7.2 8.37 7.08 7.17 8.33 8.05 7.56 7.78
HP_APLASIA_OF_THE_SEMICIRCULAR_CANAL 7.93 7.78 8.03 7.74 8.52 8.05 8.53 7.84 8.61 8.05 8.34 8.24 8.58 8.62 8.01 7.91 7.99 7.31 7.71 8.55 7.13 7.25 8.57 8.2 8.65 7.98
HP_ABNORMALITY_OF_THE_INTERNAL_AUDITORY_CANAL 6.46 6.27 6.98 6.86 6.45 6.54 6.61 6.67 6.19 6.42 6.59 6.17 6.59 6.34 6.23 6.93 6.23 6.81 6.53 6.63 6.28 6.82 6.57 6.5 6.87 6.44
HP_NARROW_INTERNAL_AUDITORY_CANAL 6.5 6.27 6.99 7.09 6.55 6.54 6.43 6.71 6.32 6.36 6.54 6.08 6.45 6.38 6.19 6.81 6.73 6.85 6.68 6.67 6.41 6.76 6.77 6.45 6.66 6.73
HP_MORPHOLOGICAL_ABNORMALITY_OF_THE_INNER_EAR 6.14 6.2 6.55 6.39 6.23 6.54 6.24 6.39 6.06 6.3 6.33 6.17 6.29 6.37 6.37 6.39 6.24 6.28 6.37 6.27 6.12 6.29 6.37 6.41 6.3 6.34
HP_ABNORMAL_CNS_MYELINATION 7.37 7.47 7.99 7.75 7.57 7.68 7.68 7.61 7.75 7.72 7.52 7.55 7.66 7.63 7.61 7.61 7.6 7.38 7.56 7.78 7.44 7.61 7.61 7.84 7.73 7.61
HP_PROPORTIONATE_TALL_STATURE 6.84 6.72 7.67 7.06 6.74 6.86 7.03 6.87 7.1 7.39 6.79 7.03 6.93 7.14 6.99 7.23 6.36 6.61 6.94 7.42 7.17 7.08 7.61 7.31 7.13 7.14
HP_ABNORMAL_BLOOD_CHLORIDE_CONCENTRATION 4.75 4.76 4.65 5.3 4.49 4.36 4.57 4.64 5.04 4.51 4.83 4.39 4.48 4.51 4.81 4.6 4.64 5.18 4.72 4.39 4.74 4.52 4.55 4.15 4.52 4.4
HP_FETAL_ULTRASOUND_SOFT_MARKER 6.88 6.92 7.38 7.17 7.1 7.18 7.03 6.94 7.09 7.21 6.88 7.13 7.21 7.14 6.91 7.02 6.85 6.86 7.02 7.1 6.92 7.05 7.1 7.25 7.18 7.09
HP_ABNORMALITY_OF_COORDINATION 7.24 7.27 7.59 7.5 7.48 7.61 7.53 7.53 7.52 7.59 7.42 7.45 7.57 7.52 7.51 7.53 7.33 7.26 7.5 7.65 7.32 7.55 7.58 7.73 7.54 7.48
HP_ANKLE_CLONUS 7.76 7.83 8.25 8.05 8.25 8.33 8.46 8.3 8.28 8.43 8.3 8.42 8.43 8.32 8.26 8.44 8.2 7.7 8.05 8.28 7.99 8.24 8.53 8.6 8.19 8.21
HP_CONGENITAL_MICROCEPHALY 7.72 7.83 7.54 7.83 7.91 7.93 7.97 7.79 7.8 7.85 7.71 7.68 8.05 7.84 7.73 8.02 7.41 7.53 7.48 8.15 7.54 7.72 7.9 8.11 7.72 7.58
HP_FUNCTIONAL_ABNORMALITY_OF_THE_MIDDLE_EAR 6.35 6.3 6.25 6.32 6.43 6.5 6.38 6.38 6.45 6.53 6.4 6.5 6.5 6.5 6.37 6.7 6.39 6.43 6.44 6.28 6.34 6.52 6.38 6.49 6.56 6.5
HP_ESOPHAGEAL_CARCINOMA 6.54 6.73 6.46 6.52 7.05 6.81 7.1 6.9 7.09 6.65 6.35 6.71 7.26 6.85 6.56 6.78 6.93 6.79 6.72 7.29 6.86 6.48 7.04 7.28 6.97 7.07
HP_YOUNG_ADULT_ONSET 6.48 6.63 7.06 6.67 7.58 6.34 7.02 6.77 7.2 7.16 6.57 6.74 7.16 6.58 6.39 6.78 7.11 6.93 7.12 7.22 6.91 6.88 7.27 7.44 7.27 7.02
HP_CHILDHOOD_ONSET 5.95 6.07 6 5.84 6.03 5.91 5.85 5.7 5.97 6.02 6.08 5.91 5.78 6 5.63 5.87 6.02 6.14 6.04 6 6.04 5.91 6.07 5.94 6.04 6.15
HP_FACIAL_TICS 9.27 9.44 8.78 9.53 9.34 9.69 9.94 9.71 9.59 9.45 9.13 9.55 9.44 9.39 9.93 9.58 9.22 9.58 9.53 9.86 9.4 9.34 9.24 9.54 9.08 8.87
HP_NASAL_REGURGITATION 5.7 5.71 6.35 6 6.19 5.91 7.22 6.49 6.44 8.06 6.1 6.11 6.66 6.28 5.88 5.83 6.58 5.79 6.05 5.63 5.88 5.91 6.16 6.9 6.98 6.4
HP_NASOGASTRIC_TUBE_FEEDING_IN_INFANCY 8.39 8.66 8.55 8.2 9.18 9.03 9.09 8.98 9.07 8.97 8.38 9.15 9.08 8.77 9.17 8.67 9 8.82 8.9 8.89 8.65 8.69 9.11 9.28 9.04 8.62
HP_GASTROSTOMY_TUBE_FEEDING_IN_INFANCY 7.37 7.53 7.6 7.74 7.82 8.05 7.9 7.9 7.95 8.03 7.55 7.87 8.05 8.06 7.79 7.77 7.67 7.58 7.76 8.07 7.76 7.81 7.92 8.15 7.9 7.84
HP_ABNORMALITY_OF_SMALL_INTESTINAL_VILLUS_MORPHOLOGY 6 5.77 5.99 5.99 6.22 6.05 6.12 6.12 6.37 6.24 6.09 6.07 6.4 6.29 6.11 6.34 5.96 6.05 6.18 6.45 6.42 6.31 6.3 6.45 5.9 6.03
HP_CHILDHOOD_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT 6.03 6.22 5.75 5.94 6.64 6.93 6.42 6.4 6 6.54 6.21 6.72 6.55 6.37 6.39 6.35 6.26 6.54 6.43 6.3 6.29 5.78 6.35 6.54 6.04 6.33
HP_ABNORMAL_LACRIMAL_DUCT_MORPHOLOGY 6.38 6.22 5.65 5.85 6.33 6.22 5.93 6.09 5.98 6.12 5.89 6.19 5.93 6.11 6 6.07 5.89 6.02 6.02 6.11 5.92 6.19 6.18 6.15 6.09 5.92
HP_ANTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER 5.54 5.38 5.73 5.83 6.03 5.62 5.91 5.7 5.51 5.74 5.83 5.71 5.9 5.62 5.33 5.45 6.25 5.51 5.64 5.73 5.75 5.9 5.99 5.31 5.85 5.63
HP_ABNORMALITY_OF_CORNEAL_THICKNESS 5.86 5.88 6.08 6.14 5.87 5.81 5.74 5.77 5.98 6.07 5.99 6.09 5.93 5.88 6.03 5.99 5.95 5.98 5.83 6.01 6.06 6.14 5.9 5.92 5.9 6.13
HP_ABNORMAL_CORNEAL_ENDOTHELIUM_MORPHOLOGY 5.54 5.38 5.73 5.83 5.31 5.2 6.19 5.7 5.51 5.63 5.45 5.4 5.76 5.62 5.33 5.45 5.72 5.51 5.64 5.73 5.75 5.9 5.99 5.31 5.85 5.63
HP_ABNORMALITY_OF_CORNEAL_STROMA 6.05 6.02 6.19 6.17 6.28 6.36 6.35 6.36 6.19 6.21 6.13 6.28 6.35 6.09 6.1 6.03 6.26 6.1 5.92 6.33 6.26 6.25 6.37 6.45 6.14 6.25
HP_CENTRAL_OPACIFICATION_OF_THE_CORNEA 6.04 6.01 6.16 6.17 6.3 6.26 6.22 6.29 6.05 6 6.27 6.31 6.35 5.79 6.01 5.93 6.37 6.01 5.72 6.06 6.31 6.19 6.37 5.7 5.94 6.25
HP_ABNORMAL_CORNEAL_EPITHELIUM_MORPHOLOGY 5.92 5.94 5.76 5.82 5.64 5.79 5.89 5.91 5.98 5.84 5.83 5.89 5.63 5.72 5.67 5.77 5.85 5.65 5.82 5.76 5.7 5.89 5.78 5.54 5.88 5.76
HP_CORNEAL_NEOVASCULARIZATION 6.11 6.04 5.98 6.59 6.45 6.55 6.41 6.34 6.51 6.54 6.36 6.53 6.58 6.53 6.05 6.14 6.46 6.19 6.19 6.3 6.23 6.3 6.43 6.44 6.02 6.4
HP_CYSTOID_MACULAR_EDEMA 6.4 5.89 5.91 6.2 6 5.7 6.37 6.34 6.44 6.1 5.98 6.23 5.94 5.89 6.35 5.67 5.94 5.77 5.78 6.13 6.45 6 6.19 6.3 6.5 6.37
HP_CHOROIDAL_NEOVASCULARIZATION 5.32 5.39 4.92 5.62 4.71 4.75 4.95 4.62 5.01 4.84 5.09 4.62 4.92 4.96 4.89 4.67 4.75 5.19 5.11 4.77 5.26 4.83 5.38 4.9 4.5 4.66
HP_DRUSEN 5.79 5.57 5.78 5.99 5.73 6 5.54 5.53 5.68 5.91 5.7 5.72 5.66 5.67 5.41 5.29 5.42 5.67 5.64 6.02 5.41 5.39 5.91 5.76 5.32 5.27
HP_ABNORMALITY_OF_LENS_SHAPE 5.25 5.18 5.52 5.32 5.31 5.36 5.15 5.3 5.35 5.13 5.63 5.13 5.15 5.18 5.17 5.11 5.31 5.57 5 5.32 5.72 5.19 5.3 5.04 5.28 5.07
HP_ABNORMAL_ATRIAL_ARRANGEMENT 5.47 5.41 5.16 5.29 5.08 5.18 5.45 5.18 5.08 5.69 5.3 5.63 5.32 5.16 5.33 5.73 5.41 5.75 5.25 5 5.45 5.39 5.05 5.1 5.07 5.32
HP_ABNORMAL_CONNECTION_OF_THE_CARDIAC_SEGMENTS 6.11 6.15 6.05 6.15 5.9 6.04 6.03 6.22 6.11 6.13 6.03 6.09 6.19 6.04 6.06 6.22 5.99 6.11 6.04 6.13 6.24 6.07 6.05 6.06 6.1 6.11
HP_COMMON_ATRIUM 6.04 6.01 5.77 6.28 5.81 5.42 5.96 5.87 6 5.41 6.14 5.73 5.83 5.4 5.47 5.79 5.83 5.93 5.27 5.27 5.68 6.01 5.68 5.41 5.53 5.73
HP_ABNORMAL_BRANCHING_PATTERN_OF_THE_AORTIC_ARCH 6.69 6.59 6.12 6.25 6.83 6.22 6.46 6.59 6.13 6.39 6.66 6.5 6.28 6.12 6.5 6.72 6.69 6.86 6.3 5.94 6.77 6.64 5.94 6.11 6.25 6.63
HP_CONGENITAL_MALFORMATION_OF_THE_GREAT_ARTERIES 6.51 6.47 6.62 6.56 6.68 6.73 6.64 6.6 6.67 6.68 6.53 6.71 6.65 6.57 6.59 6.64 6.61 6.52 6.49 6.66 6.64 6.61 6.81 6.88 6.77 6.66
HP_INTERRUPTED_AORTIC_ARCH 6.24 6.47 6.49 6.75 6.16 6.08 6.56 6.74 6.34 6.33 6.28 6.61 5.84 6.27 6.71 6.51 6.5 6.88 6.16 6.14 6.36 7.08 6.39 5.78 6.63 6.51
HP_ABNORMAL_ELECTROPHYSIOLOGY_OF_SINOATRIAL_NODE_ORIGIN 7.18 7.3 7.54 7.15 7.39 7.44 7.47 7.53 7.58 7.62 7.49 7.66 7.58 7.69 7.6 7.65 7.45 7.48 7.68 7.65 7.15 7.63 7.81 7.74 7.74 7.33
HP_SINUS_TACHYCARDIA 7.48 7.35 8.9 8.12 8 7.83 7.85 8.14 8.07 7.62 8.18 7.67 7.96 7.75 8.1 7.73 7.68 7.95 7.98 8.06 7.45 8.06 8.5 8.04 7.88 7.72
HP_SICK_SINUS_SYNDROME 6.91 7.24 7.36 6.69 7.05 7.42 7.16 7.24 7.2 7.38 7.27 7.35 7.5 7.57 7.5 7.49 7.12 7.25 7.38 7.31 6.94 7.29 7.81 7.69 7.58 7.25
HP_FIRST_DEGREE_ATRIOVENTRICULAR_BLOCK 5.89 6.05 6.23 6.24 5.41 6.08 6.45 5.84 5.87 6.32 6.1 6.52 5.97 5.97 5.99 6.26 6.33 6.44 6.27 6.4 6.7 5.74 6.79 6.36 6.01 6.14
HP_BUNDLE_BRANCH_BLOCK 6.35 6.48 6.86 6.38 6.87 6.61 6.96 7.04 6.75 7.04 6.56 6.99 7.16 7.19 6.8 6.75 7.07 6.74 6.78 6.83 6.84 6.42 7.53 7.15 6.87 7.01
HP_RIGHT_BUNDLE_BRANCH_BLOCK 6.91 6.89 6.97 6.99 7.04 7.12 7.26 7.29 7.56 7.35 7.02 7.07 7.4 7.44 7.55 7.31 7.17 6.97 7.07 7.53 7.23 7.31 7.62 7.57 7.63 7.32
HP_ABNORMALITY_OF_THE_PULMONARY_VEINS 5.78 5.46 5.83 5.67 5.15 5.36 5.64 5.47 5.65 5.68 5.56 5.63 5.45 5.37 5.49 5.82 5.61 5.91 5.37 5.18 5.56 5.43 5.34 5.16 5.49 5.58
HP_CONGENITAL_MALFORMATION_OF_THE_RIGHT_HEART 5.77 5.47 5.62 5.54 5.15 5.31 5.57 5.43 5.29 5.69 5.47 5.64 5.42 5.18 5.49 5.73 5.55 5.84 5.27 5.2 5.57 5.48 5.27 5.2 5.43 5.43
HP_ABNORMALITY_OF_JOINT_MOBILITY 6.62 6.66 6.8 6.78 6.91 6.95 6.82 6.88 6.9 6.89 6.74 6.85 6.91 6.83 6.84 6.74 6.81 6.68 6.84 6.88 6.73 6.83 6.96 6.99 6.88 6.89
HP_ABNORMAL_CENTRAL_SENSORY_FUNCTION 7.12 7.19 6.81 7.24 7.32 7.47 7.2 6.69 7.28 7.15 6.84 7.37 7.09 7.08 7.25 7.25 7.14 7.07 7.17 7.36 7.18 6.66 7.29 7.89 7.37 7.13
HP_ABNORMALITY_OF_ADRENAL_MORPHOLOGY 6.5 6.39 6.16 6.39 6.36 6.52 6.44 6.43 6.34 6.11 6.36 6.57 6.44 6.2 6.26 6.32 6.32 6.27 6.27 6.23 6.4 6.44 6.31 6.66 6.55 6.85
HP_ABNORMALITY_OF_ADRENAL_PHYSIOLOGY 6.28 6.36 6.36 6.2 6.36 6.54 6.55 6.31 6.24 6.43 6.3 6.43 6.47 6.43 6.35 6.42 6.33 6.22 6.18 6.68 6.4 6.46 6.42 6.65 6.19 6.45
HP_CENTRAL_ADRENAL_INSUFFICIENCY 6.39 6.52 6.74 6.26 6.92 6.89 7.13 6.94 7.14 6.8 6.31 7.03 6.84 6.84 7.11 6.91 6.44 6.85 6.89 7.33 6.91 6.87 7.03 6.91 6.94 7.18
HP_ABNORMALITY_OF_THE_POSTERIOR_PITUITARY 5.88 5.7 6.17 6.19 5.95 5.77 5.94 5.92 5.91 6 6 5.77 6.01 6.01 5.99 5.94 5.85 5.84 5.85 5.85 6.22 6.07 6.08 5.81 5.79 6.05
HP_POSTERIOR_PITUITARY_DYSGENESIS 5.48 5.19 5.34 5.59 5.02 4.95 5.16 5.3 5.25 5 5.68 5.16 5.2 5.36 5.48 5.07 5.24 5.45 5.25 4.98 5.55 5.33 4.96 4.98 5.09 5.37
HP_PITUITARY_GROWTH_HORMONE_CELL_ADENOMA 6.55 6.88 6.81 6.56 6.57 6.92 7.02 7.13 7.28 7.11 6.79 7.23 6.92 6.8 6.98 7.33 6.69 6.92 6.78 7.13 7.18 7.28 7.42 7.4 7.14 7.02
HP_ABNORMALITY_OF_THE_PARATHYROID_MORPHOLOGY 6.6 6.44 6.62 6.45 5.8 6.38 6.99 6.66 7.29 7.06 6.25 6.75 5.87 6.1 7.04 7.18 5.98 6.66 7.04 7.37 6.37 6.45 7.24 7.29 6.9 6.96
HP_ABNORMAL_THYROID_MORPHOLOGY 6.09 6.33 6.29 6.25 6.64 6.5 6.35 6.33 6.48 6.69 6.35 6.68 6.34 6.21 6.18 6.49 6.13 6.3 6.4 6.31 6.13 6.11 6.59 6.46 6.39 6.41
HP_CENTRAL_HYPOTHYROIDISM 6.07 6.15 6.27 6.19 6.13 6.35 6.21 6.13 6.27 6.43 6.26 6.41 6.46 6.4 6.17 6.32 6.06 6.21 6.18 6.2 6.38 6.46 6.37 6.55 6.17 6.34
HP_NEOPLASM_BY_HISTOLOGY 6.67 6.61 6.8 6.64 6.84 6.76 6.72 6.84 6.67 6.81 6.62 6.75 6.78 6.71 6.81 6.84 6.69 6.59 6.82 6.83 6.77 6.82 6.81 6.96 6.76 6.87
HP_EMBRYONAL_RENAL_NEOPLASM 6.14 6.15 5.86 6.1 5.94 6.16 6.17 6.35 6.14 6.01 6.15 6.16 6.39 5.94 6.16 6.05 5.87 5.97 6.17 6.02 6.19 6.18 6.09 6.23 6.11 6.09
HP_ABNORMALITY_OF_FACIAL_SOFT_TISSUE 6.77 6.85 6.98 6.82 6.99 7.11 6.99 6.96 6.94 7.04 6.84 7.08 7.04 7.01 7.04 6.96 6.95 6.92 7.05 7.17 6.94 7 7.04 7.01 7.1 7.01
HP_MIDFACE_RETRUSION 6.81 6.74 7.05 6.99 7.13 7.18 7.15 7.21 7.27 7.32 6.95 7.19 7.24 7.19 7.17 7.24 7.05 6.85 7.07 7.15 7.12 7.25 7.51 7.38 7.18 7.24
HP_HAMARTOMA_OF_TONGUE 6.36 6.45 6.21 6.53 6.57 6.42 6.13 6.24 6.09 6.38 6.61 6.37 6.27 6.52 6.26 6.59 6.72 6.66 6.41 6.22 6.67 6.44 6.38 6.32 6.62 6.33
HP_TYPE_1_MUSCLE_FIBER_ATROPHY 6.82 6.77 6.31 6.68 6.79 6.74 6.37 6.38 6.77 6.79 6.89 7.05 6.72 6.61 6.62 6.74 7.16 6.69 6.79 6.6 6.68 7.03 6.95 6.88 7.46 7.05
HP_BASAL_ENCEPHALOCELE 5.53 5.48 5.49 5.69 5.46 5.24 5.68 5.25 5.44 5.61 5.62 5.37 5.63 5.56 5.57 5.57 5.76 5.48 5.68 5.57 5.7 5.31 5.46 5.42 5.68 5.53
HP_ABNORMALITY_OF_FACIAL_SKELETON 6.54 6.56 6.66 6.64 6.69 6.72 6.64 6.69 6.63 6.71 6.59 6.66 6.65 6.59 6.63 6.6 6.62 6.56 6.62 6.62 6.62 6.7 6.76 6.7 6.72 6.7
HP_ABNORMAL_ORAL_MUCOSA_MORPHOLOGY 6.16 6.23 6.32 6.3 6.21 6.1 6.22 6.35 6.27 6.24 6.25 6.22 6.28 6.3 6.12 6.22 6.21 6.1 6.08 6.29 6.41 6.23 6.24 6.33 6.36 6.45
HP_MOYAMOYA_PHENOMENON 7.1 6.9 7.35 7.15 7.2 7.54 7.36 7.17 7.71 7.8 7.22 7.74 7.41 7.56 7.37 7.24 7.51 7.57 7.41 7.32 7.31 7.34 7.86 8.01 7.71 7.67
HP_ABNORMALITY_OF_T_CELL_PHYSIOLOGY 5.51 5.4 5.64 5.58 5.27 5.23 5.59 5.46 5.51 5.31 5.42 5.08 5.33 5.38 5.46 5.42 5.54 5.61 5.31 5.36 5.59 5.65 5.04 5.08 5.49 5.38
HP_ABNORMAL_STERNAL_OSSIFICATION 7.01 6.84 7.51 6.7 7.38 7.52 7.43 7.47 7.16 7.29 6.91 7.7 7.46 7.33 7.3 7.39 7.93 7.96 7.24 7.57 7.54 7.72 7.24 7.45 7.69 7.53
HP_ABNORMALITY_OF_THE_WING_OF_THE_ILIUM 6.24 6.32 6.18 6.21 6.67 6.64 6.54 6.72 6.48 6.64 6.5 6.63 6.41 6.48 6.46 6.65 6.5 6.46 6.48 6.42 6.38 6.46 6.76 6.68 6.46 6.39
HP_ABNORMAL_PLATELET_FUNCTION 6.53 6.6 6.83 6.56 6.91 6.96 6.6 6.95 6.77 6.86 7.05 6.72 6.72 6.92 6.66 6.61 6.4 6.59 6.75 6.62 6.73 6.95 6.95 6.88 6.65 6.82
HP_ABNORMAL_PLATELET_MORPHOLOGY 6.59 6.25 5.93 6.04 6.6 6.5 6.03 6.02 6.29 6.5 6.26 6.28 6.32 6.56 6.04 6.12 6.31 6.44 6.57 6.12 6.3 6.3 6.48 6.33 6.28 6.36
HP_ABNORMAL_PLATELET_VOLUME 6.23 5.83 6.12 5.56 5.73 5.42 5.58 5.53 5.82 5.82 6.29 5.28 5.29 5.56 5.68 5.59 6.2 5.56 5.47 5.32 5.57 6.09 5.36 5.55 6.1 5.23
HP_HEMORRHAGE_OF_THE_EYE 6.38 6.28 6.22 6.38 6.17 6.42 6.28 6.17 6.29 6.27 6.24 6.4 6.32 6.35 6.34 6.15 6.31 6.27 6.31 6.48 6.4 6.47 6.26 6.33 6.24 6.12
HP_PROLONGED_BLEEDING_FOLLOWING_PROCEDURE 5.57 5.48 5.38 5.3 5.01 4.96 5.22 4.98 5.27 5.01 5.15 4.6 4.94 4.58 4.79 4.6 5.1 5.09 5.1 4.54 5.32 5.19 5.23 4.85 5.24 5.03
HP_POST_PARTUM_HEMORRHAGE 5.29 5.19 5.07 5.23 4.98 4.8 4.88 4.79 5.23 4.92 5.14 4.46 4.82 4.4 4.72 4.57 4.71 4.86 5.01 4.39 5.18 5 5.08 4.77 5.17 4.82
HP_ABNORMAL_LEUKOCYTE_COUNT 6.13 6.14 6.04 6.16 6.15 6.16 6.1 6.19 6.23 6.12 6.06 5.99 6.27 6.28 6.08 6.12 6.13 6.11 6.02 6.15 6.07 6.09 6.25 6.33 6.1 6.22
HP_NEUTROPHILIA 5.9 5.87 5.98 6.05 5.44 5.9 6 6.17 6.18 6.01 5.65 5.86 5.66 5.85 6.19 5.87 5.71 5.56 5.47 6.15 6.06 6.09 6.01 6.22 6.27 6.12
HP_ABNORMALITY_OF_CIRCULATING_FIBRINOGEN 5.66 5.7 5.78 5.97 5.56 5.43 5.6 5.95 5.78 5.4 5.43 5.54 5.9 5.65 5.76 5.47 5.63 5.73 5.56 5.97 5.77 5.83 5.76 5.75 5.92 6.23
HP_ABNORMAL_HEMOGLOBIN 5.88 5.74 6.28 6.11 5.64 5.69 5.85 5.54 5.81 5.64 6.08 5.81 5.87 5.81 5.94 6.13 6.07 5.73 5.46 5.43 5.74 5.73 6.08 6 5.75 5.8
HP_PERSISTENCE_OF_HEMOGLOBIN_F 7.1 7.4 7.15 7 7.64 7.6 6.99 6.85 7.2 7.67 7.79 7.26 7.41 7.58 7.2 6.93 7.82 7.62 7.21 6.94 7.15 6.97 6.95 7.1 6.7 7.17
HP_ABNORMALITY_OF_METACARPOPHALANGEAL_JOINT 6.27 6.74 6.61 5.87 6.67 6.59 6.97 6.77 6.65 6.69 6.24 6.52 6.9 6.61 6.99 6.76 6.83 6.21 6.12 6.61 6.47 6.45 6.43 7.05 6.88 6.74
HP_CARDIOVASCULAR_CALCIFICATION 6.41 6.36 6.08 5.98 6.89 6.74 6.31 6.11 6.15 6.53 6.1 6.41 6.4 5.83 6.07 6.24 6.5 6.47 6.32 6.07 6.28 6.32 6.64 6.25 6.42 6.34
HP_ABNORMAL_ACTIVITY_OF_MITOCHONDRIAL_RESPIRATORY_CHAIN 7.34 7.43 8.15 7.89 7.49 7.65 7.48 7.56 7.74 7.72 7.91 7.44 7.63 7.64 7.62 7.68 7.4 7.53 7.81 7.8 7.5 7.7 7.59 7.87 7.62 7.56
HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_I 7.07 7.15 8.14 7.7 7.32 7.62 7.31 7.48 7.71 7.59 7.8 7.29 7.46 7.38 7.39 7.61 7.08 7.15 7.42 7.81 7.48 7.59 7.35 7.75 7.59 7.36
HP_SHORT_DIGIT 6.8 6.83 6.94 6.91 7.04 7.19 7.04 7.07 6.93 7.1 6.91 7.1 7.18 7.12 7.11 7.06 6.94 6.9 7.05 7.09 7 7.11 7.15 7.27 7.06 7.09
HP_ABNORMALITY_OF_THE_SUPERIOR_CEREBELLAR_PEDUNCLE 5.99 6.19 5.9 6.02 6.36 6.19 6.24 6.1 5.97 6.26 6.22 6.34 6.03 6.17 6.36 6.75 6.03 6.25 6.27 6.11 6.19 6.58 5.84 5.98 6.34 6.69
HP_HYPOPLASTIC_FIFTH_TOENAIL 8.25 8.32 8.1 7.78 8.52 8.49 8.8 8.94 8.23 8.33 7.94 8.34 8.37 8.47 8.59 8.86 7.79 8.11 8.09 8.6 8.32 8.43 8.23 8.51 8.79 8.58
HP_RESPIRATORY_TRACT_INFECTION 6.18 6.16 6.15 6.21 6.19 6.16 6.14 6.18 6.16 6.2 6.22 6.13 6.24 6.28 6.1 6.22 6.18 6.15 6.11 6.23 6.21 6.26 6.18 6.16 6.22 6.36
HP_ASPIRATION_PNEUMONIA 6.29 6.26 6.27 6.5 6.44 6.37 6.31 6.34 6.45 6.69 6.32 6.62 6.6 6.52 6.63 6.39 6.47 6.45 6.27 6.33 6.39 6.44 6.41 6.56 6.63 6.34
HP_SUBSTANTIA_NIGRA_GLIOSIS 8.55 8.11 7.97 7.99 8.85 8.65 8.35 8.54 8.32 8.26 7.74 8.38 8.42 8.29 8.5 8.37 7.99 8.21 8.62 8.74 7.51 8.42 8.18 8.14 8.77 8.57
HP_NON_OBSTRUCTIVE_AZOOSPERMIA 5.09 5.16 5.03 4.86 4.72 4.68 4.68 4.71 4.85 4.61 4.84 4.91 4.96 4.76 4.87 4.93 5.01 5.06 5.36 4.98 5.02 5.03 4.89 4.67 4.6 4.59
HP_OBSTRUCTIVE_AZOOSPERMIA 4.78 4.96 4.53 4.67 4.44 4.34 4.07 4.5 4.14 4.31 4.54 4.6 4.7 4.31 4.62 4.48 4.56 4.86 4.71 4.64 4.74 4.67 4.31 4.39 4.5 4.25
HP_FEEDING_DIFFICULTIES 7.08 7.15 7.39 7.37 7.33 7.45 7.44 7.39 7.41 7.44 7.26 7.41 7.47 7.48 7.43 7.41 7.19 7.15 7.38 7.44 7.21 7.4 7.41 7.55 7.47 7.36
HP_MYELOFIBROSIS 6.57 6.2 5.5 5.74 5.9 5.91 5.5 5.58 6 6.11 5.95 5.99 5.9 6.17 5.6 6.04 6.07 6.15 6.13 5.79 5.92 5.73 5.76 5.72 6 5.83
HP_ABNORMALITY_OF_NEUTROPHIL_PHYSIOLOGY 6.21 6.12 6.44 6.34 5.73 6.05 6.14 6.55 6.34 6.36 5.61 5.9 5.71 6.31 6.58 6.73 5.89 6.42 5.89 6.48 5.99 6.23 6.02 6.52 6.66 6.34
HP_ABNORMAL_NEUTROPHIL_COUNT 6.27 6.35 6.47 6.34 6.44 6.56 6.4 6.48 6.54 6.37 6.46 6.28 6.56 6.53 6.38 6.46 6.34 6.4 6.33 6.51 6.3 6.45 6.46 6.52 6.42 6.53
HP_ABNORMALITY_OF_NEUTROPHIL_MORPHOLOGY 6.28 5.95 5.85 6.2 6.67 6.43 5.79 6.1 6.23 6.47 6.17 6.08 6.35 6.57 5.92 6.21 6.31 6.11 6.3 6.17 5.7 6.2 6.72 6.12 6 6.06
HP_PARANOIA 6.5 6.75 6.27 6.39 6.84 6.68 6.78 6.65 6.71 6.76 6.4 6.76 6.62 6.57 6.79 6.55 6.72 6.74 6.52 7.04 6.24 6.48 6.71 6.48 6.6 6.84
HP_RIGHT_AORTIC_ARCH 6.01 6.14 5.62 5.89 6.08 5.92 6.11 6.41 5.81 5.77 6.03 6.1 6.11 5.85 5.69 6.37 6.11 6.16 5.74 5.59 5.88 6.18 5.73 5.95 5.95 6.14
HP_HEPATOCELLULAR_ADENOMA 5.84 5.55 5.34 5.74 5.48 5.02 5.52 5.17 5.68 5.18 5.42 5.1 5.37 5.43 5.27 5.39 5.37 5.37 5.06 5.1 5.34 5.26 5.2 5.14 5.52 5.14
HP_LIPOMA 7.19 7.22 7.23 8.28 8.06 7.44 7.2 7.23 7.98 7.62 8.09 7.7 8.03 7.56 7.58 7.27 7.14 7.07 7.49 7.55 7.15 7.12 8.15 8.03 7.37 7.13
HP_DECREASED_FERTILITY_IN_MALES 5.45 5.45 5.2 5.47 5.08 5.13 5.3 5.09 5.24 5.35 5.2 5.28 5.32 5.16 5.33 5.4 5.41 5.53 5.25 5.14 5.36 5.29 5.05 5.03 5.07 5.3
HP_PENDULAR_NYSTAGMUS 5.71 5.85 5.74 5.67 5.56 5.72 5.65 5.52 5.51 6.01 5.84 5.73 5.71 5.84 5.71 5.91 5.69 5.91 5.63 5.69 6.01 5.75 6.1 5.85 5.62 5.69
HP_OROMANDIBULAR_DYSTONIA 6.31 6.9 6.36 7.49 6.61 6.87 6.46 6.34 6.55 6.69 6.43 6.69 6.67 6.75 6.58 6.56 6.79 6.94 6.9 6.59 6.38 6.22 6.4 6.62 6.68 6.62
HP_CUTANEOUS_MELANOMA 6.5 6.5 6.92 6.98 6.96 7.02 6.85 7.21 6.58 6.7 6.49 6.67 6.75 6.89 6.42 7.02 6.66 6.77 6.86 6.93 6.39 6.87 6.65 6.48 6.66 6.73
HP_BONE_CYST 7.19 7.19 8.03 7.81 8.06 7.44 7.53 7.28 7.91 7.62 7.3 7.77 7.82 7.58 7.67 7.66 7.51 7.34 7.49 7.87 7.58 7.81 8.15 8.03 7.48 7.22
HP_PERSONALITY_DISORDER 8.8 8.75 9.32 8.91 8.83 8.71 9.07 9.22 8.77 9.07 9.27 9.19 8.74 8.82 8.92 8.83 8.68 9 8.62 9.09 9.04 8.89 9.16 9.05 8.8 8.59
HP_ABNORMALITY_OF_SKELETAL_MUSCLE_FIBER_SIZE 6.14 6.2 6.22 6.24 6.58 6.47 6.21 6.29 6.53 6.43 6.37 6.5 6.36 6.01 6.31 6.38 6.2 5.98 6.25 6.28 6.21 6.23 6.81 6.28 6.42 6.43
HP_ABNORMAL_PANCREAS_MORPHOLOGY 5.97 6.1 5.86 5.99 5.76 5.83 6.04 6.08 5.84 5.82 5.95 5.87 5.82 5.97 6.03 5.83 6.04 6.02 5.82 5.97 6.21 6.17 5.77 5.76 6.12 6.05
HP_ABNORMALITY_OF_PANCREAS_PHYSIOLOGY 6.04 6.17 6.15 6.31 6.16 6.19 5.97 6.03 6.04 6.21 6.03 5.91 6.17 6.01 5.96 6.09 5.97 6.03 5.88 6.3 6.1 6.08 6.03 6.1 6.19 6.26
HP_ABNORMALITY_OF_EXOCRINE_PANCREAS_PHYSIOLOGY 5.84 5.78 5.5 5.78 5.53 5.23 5.68 5.55 5.71 5.36 5.42 5.34 5.57 5.47 5.45 5.39 5.59 5.65 5.16 5.46 5.5 5.47 5.33 5.21 5.65 5.74
HP_ABNORMALITY_OF_ENDOCRINE_PANCREAS_PHYSIOLOGY 6.01 6.19 6.11 6.26 5.84 5.78 6.01 6.04 6.39 6.32 6 5.97 6.21 6.28 5.96 6.22 5.98 6.2 5.96 6.35 6.54 6.22 5.91 6.33 6.35 6.3
HP_ABNORMAL_PANCREAS_SIZE 5.84 5.62 5.35 5.83 5.4 5.04 5.85 5.29 5.74 5.2 5.67 5.11 5.37 5.43 5.41 5.39 5.55 5.55 5.06 5.1 5.5 5.37 5.33 5.14 5.52 5.36
HP_ABNORMAL_CIRCULATING_CREATININE_CONCENTRATION 6.47 6.3 6.08 6.21 6.57 6.63 6.2 6.16 6.16 6.15 6.08 6.37 6.24 6.17 6.07 6.16 6.66 6.44 6.44 6.15 6.47 6.42 6.24 6.29 6.28 6.46
HP_ABNORMALITY_OF_THE_MITOCHONDRION 7.07 7.02 7.86 7.65 7.31 7.4 7.3 7.47 7.37 7.51 7.25 7.27 7.37 7.54 7.31 7.47 7.24 7.11 7.34 7.39 7.3 7.6 7.42 7.67 7.34 7.3
HP_HYPOPLASIA_OF_THE_PONS 7 6.89 7.09 6.88 7.07 7.05 6.98 7.12 6.77 6.84 6.96 6.6 7.08 6.84 7.22 6.68 6.79 6.77 7.34 7.07 6.79 6.88 6.55 6.85 6.94 6.96
HP_ABNORMALITY_OF_CIRCULATING_GLUCOCORTICOID_LEVEL 6.01 5.94 6.03 5.99 5.7 5.63 6.06 5.93 6.03 5.57 5.99 5.86 6.1 6.13 6.06 6.09 5.92 5.8 5.73 6 5.93 6.07 5.77 5.76 5.72 6.02
HP_HEPATITIS 5.84 5.68 5.77 6 5.89 5.8 5.72 5.55 5.79 5.71 5.71 5.74 5.72 5.48 5.55 5.48 5.69 5.75 5.49 5.69 5.81 5.78 5.76 5.55 5.78 5.55
HP_ABNORMAL_CIRCULATING_ALBUMIN_CONCENTRATION 6.43 6.31 6.17 6.03 6.37 6.6 6.51 6.5 6.29 6.54 5.89 6.44 6.32 6.1 6.11 6.27 6.13 6.29 6.42 6.28 6.22 6.05 6.72 6.37 6.57 6.42
HP_METHYLMALONIC_ACIDURIA 6.35 6.49 7.73 7.41 6.88 6.55 7.47 7.3 7.36 6.66 7.33 6.43 6.97 7.1 6.2 6.96 6.78 6.35 6.47 7.13 6.42 7.48 6.72 6.97 7.42 7.29
HP_ANTERIOR_UVEITIS 5.46 5.33 5.21 5.39 4.66 4.69 5.13 4.99 4.83 4.7 5.12 4.65 4.78 4.72 4.81 5.02 5.16 5.28 5.37 5.17 5.48 4.79 4.55 4.53 4.94 4.78
HP_STOMACH_CANCER 5.73 5.58 6.2 6.05 6.25 5.86 6.41 6.5 6.11 5.98 5.92 5.99 6.12 5.9 6.2 6.02 5.63 5.68 5.49 5.91 5.63 5.99 6.41 6.46 5.75 5.86
HP_ABNORMAL_NUMBER_OF_ERYTHROID_PRECURSORS 6.85 6.47 6.88 6.18 6.47 6.56 6.73 6.15 6.5 6.33 6.78 6.23 6.41 6.28 6.44 6.45 6.64 6.46 6.66 5.9 6.83 6.29 6.39 6.4 5.98 5.91
HP_ERYTHROID_HYPOPLASIA 6.9 6.08 7.15 5.58 7.05 5.94 5.72 5.06 6.57 6.27 7.17 6.22 6.32 6.26 6.14 6.76 6.67 6.55 7 5.77 7.15 5.37 6.45 6.33 5.81 5.89
HP_ABNORMAL_MEGAKARYOCYTE_MORPHOLOGY 6.18 5.99 5.97 5.74 5.73 5.6 5.57 5.88 5.95 5.94 6.35 5.87 5.98 5.95 5.73 5.79 6.06 5.65 5.87 5.98 5.73 5.63 6.01 6.2 5.94 5.83
HP_ABNORMAL_MONOCYTE_MORPHOLOGY 6.14 6.22 6.66 6.6 5.95 6.25 6.27 6.27 6.43 6.07 6.32 6.12 6.15 6.26 6.44 6.16 6.3 6.65 5.67 6.22 5.82 6.64 6.04 6.12 6.37 6.15
HP_HEMOPHAGOCYTOSIS 5.08 5.33 5.31 5.47 4.44 4.81 4.85 5.11 4.97 4.73 4.9 5.24 4.79 4.56 5.31 4.52 4.85 5.13 4.82 5.1 5.25 5.45 5.04 4.97 4.79 5.06
HP_SUBCORTICAL_CEREBRAL_ATROPHY 5.92 6.06 6.1 6.47 6.41 6.36 6.38 6.45 6.42 6.61 6.28 6.57 6.46 6.32 6.36 6.19 6.45 6.21 6.04 6.46 6.09 6.44 6.26 6.64 6.68 6.48
HP_OLIGODACTYLY 7.06 7.26 7.16 6.96 7.16 7.29 7.31 7.19 7.56 7.45 6.95 7.46 7.63 7.69 7.15 7.27 7.29 7.12 7 7.32 7.06 7.26 7.16 7.46 7.11 7.35
HP_STEREOTYPICAL_HAND_WRINGING 9.33 9.36 8.83 8.67 9.3 9.65 9.36 9.85 9.47 9.36 8.9 9.32 9.74 9.69 9.71 9.43 9.33 9.25 9.54 9.58 9.37 9.39 9.36 9.8 9.57 9.23
HP_GLIOBLASTOMA_MULTIFORME 7.01 6.89 7.15 7.41 7.51 7.68 7.16 7.11 7.4 7.48 7.26 7.12 7.62 7.35 7.17 7.41 7.25 6.92 7.39 7.28 7.11 6.88 7.48 7.59 7.36 7.17
HP_ABNORMAL_NATURAL_KILLER_CELL_MORPHOLOGY 5.21 5.06 4.98 5.31 4.87 5.03 4.98 5.12 4.89 4.89 5.42 4.93 5.2 4.93 5.13 5.25 5.25 4.81 5.11 5.13 5.2 5.13 4.89 5 5.15 5.42
HP_ABNORMAL_NATURAL_KILLER_CELL_PHYSIOLOGY 5.66 5.6 5.56 5.49 5.12 5.25 5.37 5.33 5.78 5.44 5.19 5.54 5.29 5.31 5.41 5.26 5.19 5.5 5.35 5.58 5.25 5.45 5.3 5.25 5.33 5.22
HP_HODGKIN_LYMPHOMA 5.54 5.16 5.47 5.76 5.37 5.22 5.43 5.19 5.71 5.3 5.42 5.68 5.75 5.47 5.63 5.34 5.64 5.51 5.57 5.61 5.28 5.12 5.81 5.11 5.49 5.46
HP_T_CELL_LYMPHOMA 5.42 5.46 5.04 5.6 5.37 5.37 5.02 5.03 5.17 5.03 5.1 5.11 5.27 5.38 5.23 5.23 5.62 5.68 5.37 5.09 5.28 5.77 5.06 4.87 5.49 5.46
HP_B_CELL_LYMPHOMA 6.25 6.37 6.49 6.42 7.25 6.75 7.03 7.27 6.25 6.99 6.41 6.81 6.89 6.48 6.58 6.93 6.91 6.5 6.73 7.21 6.69 6.96 7.05 6.97 6.51 7.07
HP_ABNORMALITY_OF_PROTHROMBIN 6.39 6.26 6.68 6.65 6.55 6.38 6.48 5.8 6.27 6.35 6.37 6.14 6.29 6.38 6.45 5.95 6.14 5.89 6.19 6.27 6.3 6.25 6.35 6.2 6.21 6.07
HP_ONYCHOMYCOSIS 5.35 5.2 5.15 5.42 4.92 5.02 5.55 5.01 5.31 5.02 5.35 4.54 5.03 4.97 5.3 5.31 4.98 5.09 4.81 4.94 5.16 5.1 4.74 4.65 4.93 4.91
HP_ABNORMAL_SPERM_MOTILITY 5.34 5.37 5.13 5.05 4.97 5.13 5.3 5.09 5.06 5.66 5.2 5.48 5.18 5.11 5.25 5.64 5.4 5.71 5.22 5 5.44 5.35 5.03 5.01 4.99 5.21
HP_REDUCED_SPERM_MOTILITY 5.27 5.54 5.12 4.74 4.7 4.73 5.14 4.91 4.98 4.9 5.19 5.1 4.5 4.97 5.09 5.17 5.32 5.73 5.11 4.99 5.26 5.13 4.78 4.73 4.97 5.15
HP_ABNORMAL_RENAL_MORPHOLOGY 6.47 6.46 6.53 6.47 6.56 6.6 6.53 6.56 6.45 6.54 6.47 6.54 6.56 6.52 6.45 6.56 6.48 6.43 6.46 6.52 6.51 6.52 6.48 6.58 6.56 6.6
HP_ABNORMAL_RENAL_PHYSIOLOGY 6.23 6.25 6.3 6.26 6.23 6.23 6.25 6.3 6.2 6.26 6.19 6.25 6.15 6.11 6.11 6.16 6.15 6.19 6.17 6.2 6.19 6.18 6.22 6.27 6.14 6.3
HP_ABNORMAL_GLOMERULAR_FILTRATION_RATE 5.68 5.45 5.41 5.82 5.11 4.99 5.28 4.98 5.24 5.36 5.55 5.11 5.41 5.18 5.06 5.11 5.65 5.42 5.11 5.33 5.18 5.17 5.34 5.19 5.39 5.14
HP_ARACHNOID_HEMANGIOMATOSIS 9.05 9.31 9.49 8.89 9.27 9.07 9.55 9.2 9.1 9.17 9.05 8.98 9.39 9.44 9.25 9.01 9.01 8.77 9.21 9.58 9.01 9.12 9.22 9.29 9.14 8.89
HP_URETHRAL_STRICTURE 5.63 5.65 5.45 5.74 5.45 5.37 5.3 5.17 5.44 5.39 5.58 5.38 5.35 5.36 5.21 5.28 5.46 5.55 5.43 5.28 5.47 5.25 5.22 4.89 5.34 5.34
HP_CSF_PLEOCYTOSIS 6.93 6.98 7.27 7.41 7.65 7.71 7.57 7.44 7.94 7.8 7.63 7.52 7.59 7.98 7.47 7.61 7.41 7.51 7.15 7.52 7.33 7.52 7.96 8.1 7.75 7.6
HP_SHORTENED_QT_INTERVAL 7.7 7.58 7.36 6.74 7.51 7.66 7.59 7.88 7.58 7.77 7.48 7.94 7.59 7.78 7.72 7.72 7.64 7.66 7.88 7.89 7.62 7.63 7.48 7.74 7.71 7.66
HP_INCREASED_INTRAMYOCELLULAR_LIPID_DROPLETS 6.91 6.4 7.32 7.43 6.75 6.98 7.31 7.34 7.01 6.82 6.87 6.81 7.08 7.15 7.23 7.41 6.74 6.8 6.85 6.95 7.17 7.2 7.03 7.39 7.35 7.08
HP_ABNORMAL_SEX_DETERMINATION 5.3 4.92 5.27 5.27 4.85 4.52 4.95 4.73 5.19 4.67 5.1 4.76 4.73 4.83 4.92 4.71 4.96 4.89 4.65 4.78 5.06 4.9 4.76 4.63 4.8 5.04
HP_SEX_REVERSAL 5 4.75 4.9 5.08 4.59 4.38 4.85 4.66 4.92 4.5 4.91 4.56 4.46 4.39 4.79 4.54 4.53 4.71 4.41 4.5 4.77 4.64 4.45 4.41 4.54 4.55
HP_OCULOMOTOR_NERVE_PALSY 6.6 6.29 6.67 6.42 6.58 6.64 7.05 6.69 6.61 6.69 6.61 7.03 6.86 6.58 6.59 6.89 6.53 6.46 6.51 6.93 6.91 6.66 6.6 7.01 7.17 7
HP_ABNORMAL_ST_SEGMENT 5.85 5.88 6.18 6.18 5.4 5.72 5.97 5.72 5.75 5.92 6.09 5.77 5.95 5.54 5.93 5.82 5.72 5.83 5.62 5.58 5.96 5.69 5.94 5.71 5.92 5.9
HP_ST_SEGMENT_DEPRESSION 5.03 4.88 4.74 5.63 4.71 4.53 4.84 4.72 4.84 4.96 5.22 4.74 4.6 4.57 4.64 4.79 5.01 4.71 4.82 4.73 4.9 4.81 4.78 4.4 4.69 4.79
HP_ST_SEGMENT_ELEVATION 6.86 6.95 7.31 6.38 7.48 7.61 7.21 7.29 7.65 7.84 7.28 7.68 7.65 7.71 7.55 7.4 7.17 7.06 7.71 7.53 7.03 7.28 7.96 7.7 7.73 7.32
HP_ABNORMAL_RESPIRATORY_SYSTEM_MORPHOLOGY 6.29 6.3 6.35 6.43 6.35 6.35 6.28 6.34 6.32 6.36 6.34 6.34 6.36 6.4 6.31 6.38 6.31 6.32 6.25 6.31 6.34 6.4 6.35 6.41 6.39 6.46
HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_PHYSIOLOGY 5.4 5.36 5.15 5.16 4.98 5.14 5.27 5.14 5.14 5.47 5.13 5.46 5.19 5.09 5.23 5.53 5.37 5.69 5.23 5 5.44 5.34 5.13 5.07 4.97 5.15
HP_ABNORMAL_MUSCLE_GLYCOGEN_CONTENT 6.77 6.88 6.99 6.99 6.96 7.34 7.05 6.99 6.89 6.94 6.86 7.26 6.9 6.88 7.02 6.88 7.18 7.03 7.18 6.99 7.1 6.97 6.78 6.91 6.94 6.96
HP_ABNORMAL_HYPOTHALAMUS_PHYSIOLOGY 6.02 5.73 6.1 6.21 5.8 5.82 5.94 6.13 6.15 6.18 6.24 6.04 6.24 6.36 6.16 5.94 6.11 6.09 6.01 6.21 6.15 6.18 6.19 5.83 5.78 6.14
HP_ABNORMAL_HYPOTHALAMUS_MORPHOLOGY 6.41 6.58 6.46 6.3 6.72 6.87 6.68 6.67 6.56 6.41 6.89 6.62 6.61 6.68 6.44 6.71 6.95 6.92 6.77 6.22 7.07 6.92 6.58 6.75 6.57 6.63
HP_NEOPLASM_OF_HEAD_AND_NECK 6.63 6.64 6.76 6.57 6.86 6.6 6.84 6.93 6.73 6.78 6.64 6.81 7.09 6.61 6.82 6.81 6.73 6.43 6.52 6.84 6.51 6.86 6.91 6.73 6.74 6.8
HP_ABNORMAL_AORTIC_ARCH_MORPHOLOGY 6.41 6.58 6.27 6.28 6.72 6.35 6.64 6.66 6.7 6.39 6.54 6.7 6.34 6.39 6.54 6.62 6.61 6.76 6.25 6.66 6.61 6.64 6.85 6.12 6.62 6.63
HP_FIBROUS_TISSUE_NEOPLASM 7.46 7.47 7.69 7.74 7.97 7.78 7.6 7.54 7.91 7.65 7.68 7.94 7.82 8.04 7.9 7.91 7.51 7.37 7.69 7.89 7.35 7.38 8.24 8.04 7.8 7.4
HP_MYELOID_LEUKEMIA 6.9 7.13 6.7 6.62 7.84 7.9 6.72 6.95 6.92 7.32 7.26 7.3 7.46 7.39 7.09 7.29 7.37 6.99 7.2 7.2 6.79 7.05 7.09 7.34 6.98 7.01
HP_PYELONEPHRITIS 6.51 6.91 5.5 6.26 6.57 6.63 6.41 6.92 6.53 7.04 6.33 7.43 6.24 6.57 6.59 6.33 6.96 6.79 6.53 6.21 7.02 6.99 6.1 6.96 6.86 6.89
HP_ABNORMAL_AUTONOMIC_NERVOUS_SYSTEM_PHYSIOLOGY 7.17 7.15 7.1 7.07 7.32 7.35 7.53 7.31 7.36 7.34 7.28 7.33 7.4 7.5 7.65 7.23 7.1 7.02 7.28 7.65 7.25 7.13 6.96 7.37 7.4 7.3
HP_ABNORMAL_ENERGY_EXPENDITURE 5.34 5.27 5.54 6.04 4.84 4.74 5.03 4.92 4.98 4.87 5.32 4.57 4.69 4.71 5.23 5.23 5.3 5.13 5.09 4.97 5.22 4.95 5 4.63 4.85 4.72
HP_ABNORMAL_GLYCOSYLATION 7.29 7.36 7.91 7.62 7.74 7.9 7.79 7.95 7.75 7.67 7.56 7.66 7.67 7.76 7.71 7.58 7.53 7.42 7.73 7.84 7.33 7.69 7.71 8 7.75 7.76
HP_ABNORMAL_PROTEIN_GLYCOSYLATION 7.41 7.44 8.05 7.71 7.81 7.95 7.89 7.99 7.91 7.8 7.72 7.84 7.85 7.85 7.77 7.65 7.56 7.51 7.84 7.93 7.45 7.88 7.94 8.18 7.85 7.84
HP_FLAT_FACE 6.44 6.25 6.63 6.44 6.8 6.49 6.31 6.6 6.34 6.58 6.54 6.57 6.5 6.6 6.43 6.56 6.49 6.14 6.31 6.28 6.5 6.58 6.59 6.75 6.59 6.64
HP_HEMIANOPIA 6.07 6.05 6.62 6.42 6.1 6.51 6.73 6.67 6.33 6.45 6.31 6.68 6.29 6.43 6.5 6.49 6.48 6.29 6 6.68 6.69 6.57 6.6 6.98 6.56 6.6
HP_FATIGUE 6.08 6.19 6.23 6.29 6.22 6.27 6.08 6.13 6.23 6.22 6.21 6.18 6.16 6.1 6.04 6.12 6.06 6.15 6.07 6.12 6.11 6.14 6.32 6.22 6.27 6.27
HP_ABNORMAL_ENZYME_COENZYME_ACTIVITY 6.4 6.39 6.67 6.61 6.54 6.65 6.49 6.5 6.54 6.61 6.47 6.49 6.49 6.47 6.44 6.48 6.48 6.43 6.49 6.53 6.31 6.46 6.55 6.53 6.56 6.6
HP_RHINITIS 5.43 5.35 5.15 5.33 5.09 5.16 5.53 5.32 5.18 5.65 5.37 5.31 5.24 5.16 5.37 5.52 5.45 5.68 5.1 5 5.51 5.39 5.12 5.07 5.15 5.3
HP_BRONCHITIS 5.94 5.67 5.9 5.65 5.65 5.54 5.69 5.55 5.68 5.88 5.78 5.7 5.57 5.88 5.58 6.06 5.94 6.12 5.6 5.45 5.88 5.88 5.63 5.45 5.94 5.92
HP_ALLERGY 6.13 6.19 6.07 6.3 6.68 6.52 6.17 6.3 6.02 6.45 6.1 6.36 6.57 6.45 6.36 6.39 6.41 6.5 6.68 6.28 5.99 6.45 6.55 6.38 6.66 6.91
HP_ABNORMAL_ALDOLASE_LEVEL 6.25 6.21 6.47 6.51 6.49 6.56 6.45 6.28 6.51 6.53 6.56 6.04 6.5 6.18 6.25 6.59 6.69 6.34 6.46 6.05 6.2 6.59 6.61 6.63 6.38 6.61
HP_PURE_RED_CELL_APLASIA 6.06 5.49 7.15 5.58 5.76 5.51 5.72 5.51 6.43 4.8 7.14 5.28 6.01 5.95 5.49 5.74 5.93 6.55 5.47 5.82 5.36 5.08 6.25 6.17 5.81 5.86
HP_PREMATURE_PUBARCHE 5.53 5.61 6.2 6 5.67 5.31 5.41 5.61 5.74 5.76 5.42 5.53 5.6 5.55 5.58 5.28 5.89 5.23 5.32 5.27 5.44 5.49 5.46 5.8 5.72 5.77
HP_ABNORMAL_BLOOD_GAS_LEVEL 6.12 5.93 5.8 6.28 5.56 5.45 5.94 6.12 5.87 5.6 5.95 5.9 5.85 5.77 5.51 5.77 6 5.98 5.66 5.74 6.02 5.76 5.78 5.75 5.67 5.73
HP_APLASIA_HYPOPLASIA_OF_THE_CEREBRAL_WHITE_MATTER 8.61 8.61 8.7 8.54 8.99 9.23 9.34 9.29 9.12 9.19 8.52 8.83 9.22 9.15 9.48 9.09 8.7 8.52 8.73 9.21 8.54 8.7 9.1 9.43 9.24 9.02
HP_CEREBRAL_WHITE_MATTER_HYPOPLASIA 8.61 8.61 8.7 8.54 8.99 9.23 9.34 9.29 9.12 9.19 8.52 8.83 9.22 9.15 9.48 9.09 8.7 8.52 8.73 9.21 8.54 8.7 9.1 9.43 9.24 9.02
HP_CHRONIC_FATIGUE 5.73 6.14 5.79 6.15 6.32 6.29 5.91 6.24 6.14 6.17 5.81 5.87 6.41 5.84 5.95 6.11 5.59 6.15 5.84 6.19 5.96 6.14 6.6 5.88 6.04 5.94
HP_ABNORMAL_SOCIAL_BEHAVIOR 7.78 7.88 8.26 7.94 8.09 8.09 8.2 8.15 8.12 8.2 8.02 8.15 8.2 8.18 8.29 8.26 8.01 7.89 8.14 8.2 8.05 8.16 8.2 8.4 8.24 8.07
HP_ABNORMAL_BILIARY_TRACT_MORPHOLOGY 5.79 5.81 5.96 6.13 5.92 5.93 6.08 5.96 5.91 6.13 5.86 5.96 6 5.88 5.87 6.16 6.15 5.84 5.9 5.89 6.01 5.97 5.91 6.03 5.91 5.98
HP_BRAIN_ATROPHY 7.54 7.6 7.93 7.77 7.89 8.01 7.92 7.85 7.91 7.99 7.7 7.88 7.94 7.91 7.92 7.85 7.61 7.58 7.77 7.96 7.62 7.82 7.9 8.06 7.9 7.78
HP_ABNORMAL_MYELINATION 7.53 7.62 8.05 7.77 7.84 7.89 7.89 7.91 7.93 7.91 7.69 7.84 7.92 7.94 7.83 7.78 7.7 7.61 7.8 7.96 7.62 7.77 7.89 8.06 7.94 7.84
HP_DELAYED_MYELINATION 7.66 7.77 8.08 7.91 7.93 8.01 8.2 8.14 8.09 8 7.77 7.88 8.04 8.17 8.13 8.03 7.72 7.86 7.85 8.21 7.68 7.88 8.02 8.25 8.07 7.88
HP_CHRONIC_CONSTIPATION 8.1 8.11 7.7 7.82 8.67 8.57 8.55 8.14 8.41 8.17 7.91 8.41 8.69 8.65 8.36 8.47 7.97 8.14 8.47 8.6 7.89 7.9 8.34 8.52 8.55 8.23
HP_RESTLESS_LEGS 9.25 9.26 9.16 8.65 9.46 9.42 9.47 9.69 9.38 9.41 9.06 9.4 9.45 9.62 9.62 9.68 9.39 9.69 9.38 9.69 9.42 9.65 9.39 9.52 9.7 9.79
HP_INFANTILE_SPASMS 7.69 7.49 8 7.82 7.71 7.98 8.07 8.15 7.9 7.91 7.88 7.73 7.93 8 8.13 8.07 7.71 7.85 7.96 8.17 7.75 7.91 7.9 8.05 8.03 8
HP_THICK_VERMILION_BORDER 7.35 7.47 7.61 7.31 7.51 7.73 7.6 7.63 7.71 7.82 7.54 7.64 7.73 7.8 7.76 7.71 7.52 7.31 7.58 7.69 7.47 7.6 7.94 8.07 7.81 7.6
HP_ECLABION 7 6.9 7.05 7.06 7.11 7.16 6.99 7.14 6.91 6.91 6.92 7.08 7.16 7.02 7.17 6.94 7 7.05 7.35 7.23 7.08 7.15 6.85 7.09 7.18 7.21
HP_DECREASED_CIRCULATING_LEVEL_OF_SPECIFIC_ANTIBODY 5.54 5.4 5.31 5.35 5.19 5.21 5.13 5.38 5.17 5.3 5.54 5.08 4.98 5.35 5.68 5.25 5.61 5.35 5.33 5.32 5.28 5.9 5.15 5.11 5.49 5.42
HP_PANNICULITIS 6.57 6.36 6.57 7.07 5.94 6.07 6.33 5.86 6.07 5.4 6.32 5.87 5.9 5.5 5.74 6.24 5.97 6.4 5.95 5.97 5.59 6.25 5.91 5.9 6.05 5.66
HP_ABNORMALITY_OF_THE_BRAINSTEM_WHITE_MATTER 5.99 6.19 5.9 6.02 6.36 6.19 6.24 6.1 5.97 6.26 6.22 6.34 6.03 6.17 6.36 6.75 6.03 6.25 6.27 6.11 6.19 6.58 5.84 5.98 6.34 6.69
HP_ABNORMALITY_OF_THE_PITUITARY_GLAND 6.18 6.15 6.29 6.26 6.14 6.33 6.3 6.27 6.26 6.25 6.26 6.29 6.33 6.35 6.17 6.28 6.16 6.13 6.06 6.24 6.23 6.31 6.27 6.32 6.24 6.33
HP_ABNORMAL_SIZE_OF_PITUITARY_GLAND 6.28 6.1 6.63 6.62 6.27 6.65 6.63 6.48 6.25 6.58 6.43 6.59 6.49 6.41 6.54 6.52 6.49 6.43 6.25 6.64 6.61 6.49 6.51 6.62 6.27 6.6
HP_METAMORPHOPSIA 8.79 8.83 8.44 8.1 9.17 9.07 8.87 8.86 8.79 9.16 8.15 9.15 8.71 8.52 8.32 8.46 9.08 8.25 9 9.34 8.66 8.5 8.75 9.15 8.97 8.61
HP_LOWER_LIMB_PAIN 5.88 5.42 5.85 5.57 5.17 5.23 5.42 5.53 5.63 5.08 5.76 5.38 5.64 5.34 5.54 5.63 5.43 5.78 5.07 5.68 5.83 5.4 5.66 5.58 5.71 5.74
HP_HIP_FLEXOR_WEAKNESS 5.36 5 5.08 5.43 5.32 4.96 4.98 5.11 5.17 4.83 5.13 4.78 5.04 4.78 4.83 4.97 5.05 4.97 5.17 4.9 5.06 4.84 4.98 4.72 4.73 4.78
HP_PAIN 6.14 6.19 6.23 6.28 6.23 6.24 6.17 6.21 6.25 6.27 6.2 6.25 6.26 6.13 6.04 6.15 6.21 6.15 6.08 6.15 6.2 6.25 6.33 6.26 6.27 6.34
HP_DYSESTHESIA 6.95 7.11 7.09 6.48 7.97 7.46 8.15 7.68 8.01 7.85 6.96 7.61 7.94 7.78 7.82 7.49 7.21 6.73 7.7 7.67 7.17 7.07 7.29 7.85 7.71 7.58
HP_NON_HODGKIN_LYMPHOMA 5.81 6.07 5.8 5.99 5.79 5.96 5.56 5.66 5.71 5.79 5.7 5.68 5.99 5.83 5.54 5.91 6.03 5.99 5.95 5.82 5.94 5.88 5.88 5.75 5.72 6.13
HP_ABNORMAL_INVOLUNTARY_EYE_MOVEMENTS 7 6.99 7.36 7.21 7.23 7.28 7.24 7.27 7.28 7.3 7.22 7.23 7.33 7.34 7.3 7.33 7.12 6.99 7.23 7.32 7.08 7.28 7.29 7.48 7.29 7.22
HP_FATTY_REPLACEMENT_OF_SKELETAL_MUSCLE 6.82 6.68 7.14 6.79 6.93 7 7.01 6.88 7.15 6.92 6.84 7.21 6.97 7.01 7.27 6.96 6.72 6.82 6.85 7.25 6.92 6.99 7.06 6.83 6.88 6.95
HP_ABSENT_THUMBNAIL 8.27 8.59 8.45 8.38 8.92 8.97 8.9 8.82 9.19 9.05 8.81 8.76 9.34 9.19 9.12 8.95 8.54 8.27 8.31 8.83 9.27 9.41 9.31 9.25 8.89 8.57
HP_ABNORMAL_NEPHRON_MORPHOLOGY 6.51 6.47 6.37 6.29 6.4 6.47 6.29 6.36 6.23 6.34 6.3 6.32 6.3 6.29 6.19 6.31 6.25 6.34 6.47 6.38 6.23 6.1 6.33 6.36 6.23 6.45
HP_ABNORMAL_URINARY_ELECTROLYTE_CONCENTRATION 5.7 5.54 5.46 5.75 5.29 5.15 5.42 5.39 5.52 5.37 5.45 5.22 5.22 5.23 5.29 5.16 5.61 5.64 5.28 5.26 5.76 5.52 5.27 5.09 5.33 5.52
HP_ALBUMINURIA 6.46 6.7 6.47 6.44 6.43 6.63 6.41 6.84 6.53 6.81 6.33 7.17 6.24 6.57 6.6 6.31 6.66 6.79 6.53 6.88 6.64 6.93 5.91 6.59 6.6 6.69
HP_ABNORMAL_URINE_POTASSIUM_CONCENTRATION 5.27 4.78 4.77 5.47 4.58 4.39 4.73 4.66 4.93 4.55 4.92 4.58 4.53 4.6 4.68 4.77 5.11 5.13 4.83 4.54 4.9 4.85 4.51 4.46 4.74 4.65
HP_ABNORMAL_URINE_PHOSPHATE_CONCENTRATION 5.43 5.45 5.11 5.61 5.17 5.27 5.03 4.9 5.46 5.02 5.41 5.23 4.99 5.2 5.07 5.01 5.69 5.49 5.11 5.07 5.62 5.14 5.05 4.85 5.18 4.91
HP_ABNORMAL_URINE_SODIUM_CONCENTRATION 4.97 4.86 4.77 4.92 4.45 4.36 4.53 4.69 4.63 4.39 4.77 4.53 4.36 4.46 4.59 4.66 4.8 4.96 4.58 4.64 4.82 4.69 4.5 4.55 4.93 4.46
HP_HYPERNATRIURIA 4.81 4.81 4.65 4.78 4.21 4.31 4.51 4.67 4.34 4.35 4.74 4.4 4.33 4.31 4.56 4.42 4.48 4.93 4.57 4.39 4.79 4.63 4.41 4.35 4.52 4.34
HP_ABNORMAL_URINE_MAGNESIUM_CONCENTRATION 7.04 6.71 6.21 6.44 6.18 5.46 6.28 6.22 5.72 6.26 6.49 5.66 5.91 6.11 5.72 6.23 6.79 6.38 6.07 5.62 6.51 6.14 5.87 5.18 5.74 5.89
HP_ABNORMAL_URINE_CYTOLOGY 6.63 6.6 6.48 6.43 6.76 6.61 6.46 6.48 6.73 6.87 6.52 6.61 6.48 6.48 6.31 6.32 6.61 6.37 6.43 6.34 6.3 6.33 6.63 6.69 6.55 6.48
HP_CHRONIC_KIDNEY_DISEASE 6.29 6.18 5.84 5.92 5.85 5.98 6.02 5.9 5.74 6.11 5.98 6.08 5.82 5.91 5.91 5.83 6.06 6.27 6.05 5.94 6.08 5.97 5.86 5.79 5.79 6
HP_ABNORMAL_INTRAOCULAR_PRESSURE 5.53 5.73 5.52 5.73 5.26 5.61 5.91 5.6 5.6 5.52 5.66 5.71 5.91 5.64 5.36 5.44 5.72 5.73 5.7 5.9 6.09 5.82 6 5.46 5.88 5.62
HP_ABNORMAL_INFLAMMATORY_RESPONSE 6.1 6.07 6.09 6.17 6.04 6.03 6.05 6.09 6.03 6.03 6.1 5.95 6.03 5.99 5.97 6.01 6.09 6.04 6 6.07 6.14 6.07 6.01 5.96 6.13 6.23
HP_PERISYLVIAN_POLYMICROGYRIA 5.84 5.69 6.07 6.17 5.78 5.74 5.87 5.89 6 6.07 6 5.6 6.18 6.16 5.88 5.87 5.87 5.73 6 5.99 6.33 5.69 6.22 5.83 5.78 5.89
HP_ABNORMAL_BRAIN_POSITRON_EMISSION_TOMOGRAPHY 7.52 7.73 8.65 8.44 8.37 8.18 8.36 8.05 8.13 8.17 7.99 8.37 8.1 8.28 8.1 8.04 7.76 7.72 7.88 8.21 7.79 8.15 8.24 8.41 8.34 8.17
HP_ABNORMALITY_OF_THE_PINEAL_GLAND 6.01 6.65 6.36 6.9 6.7 6.91 6.78 6.68 6.63 6.82 6.34 6.84 6.7 6.8 6.83 6.22 6.74 6.22 6.44 6.94 7.31 6.75 6.82 7.1 6.83 6.45
HP_ABNORMAL_THALAMIC_MRI_SIGNAL_INTENSITY 6.53 6.68 6.97 7.02 6.9 6.86 6.85 6.68 6.57 6.94 6.48 6.5 6.45 6.5 6.54 6.9 7.04 6.88 6.61 6.86 6.85 6.62 6.64 6.74 6.63 6.87
HP_SMALL_BASAL_GANGLIA 6.45 7 7.49 7.77 7.42 7.63 6.32 7.04 7.02 6.87 6.97 6.98 7.39 7.28 6.86 6.42 6.67 6.08 6.58 7.09 7.14 7.54 7.16 7.4 7.41 7.44
HP_ABNORMAL_LARGE_INTESTINE_PHYSIOLOGY 7.2 7.06 6.91 6.59 7.19 7.09 7.25 7.31 7.24 7.1 6.7 7.18 7.05 7.1 6.93 6.78 6.87 6.76 7.23 7.33 7.08 7.13 7.32 7.31 7.32 7.36
HP_ABNORMAL_SUBARACHNOID_SPACE_MORPHOLOGY 7.45 7.47 7.55 7.43 7.8 8.05 7.86 8.06 7.89 7.69 7.58 7.79 7.91 8 7.77 7.58 7.46 7.49 7.78 7.96 7.56 7.84 8.11 8.24 7.92 7.7
HP_WIDENED_SUBARACHNOID_SPACE 7.78 7.95 8 7.85 8.26 8.28 8.32 8.2 8.18 8.27 7.76 8.22 8.2 8.24 8.45 8.19 7.71 7.86 8.16 8.25 7.99 8.11 8.42 8.51 8.16 8.08
HP_ABNORMAL_METABOLIC_BRAIN_IMAGING_BY_MRS 7.82 8 8.37 7.9 7.81 7.84 8.31 8.48 8.21 8.03 8.04 8.22 8.03 8.15 8.34 8 7.96 7.69 7.95 8.1 7.9 8.14 8.29 8.41 8.54 8.23
HP_MILD_HEARING_IMPAIRMENT 7.31 7.38 7.65 7.05 7.52 7.69 7.9 7.95 7.89 7.7 7.26 7.52 7.8 7.87 7.7 7.54 7.31 7.41 7.49 7.87 7.45 7.63 8.21 8.27 7.87 7.46
HP_PROFOUND_HEARING_IMPAIRMENT 6.03 5.8 6.53 6.08 5.66 5.71 6.27 5.53 6.39 5.67 6.18 5.47 5.19 5.9 5.94 6.31 5.79 5.79 5.31 5.55 5.82 5.85 5.93 5.39 6.01 5.49
HP_FUNCTIONAL_ABNORMALITY_OF_THE_GASTROINTESTINAL_TRACT 6.9 6.89 7.09 7.08 7.13 7.2 7.12 7.1 7.13 7.19 6.9 7.14 7.21 7.21 7.1 7.06 7.03 6.95 7.15 7.19 7.01 7.05 7.16 7.27 7.22 7.09
HP_VENOUS_MALFORMATION 6.88 7.01 7.38 7.54 7.48 7.5 6.88 6.35 7.27 7.24 7.52 7.01 7.49 7.46 7.17 7.21 6.6 6.95 7.31 7.18 6.77 6.71 7.69 7.38 7.15 6.8
HP_HEART_BLOCK 6.81 6.88 6.88 6.66 6.79 6.81 6.91 6.89 6.74 7.01 6.6 6.99 6.91 6.98 6.93 6.81 7.1 6.87 6.94 6.95 6.85 6.9 7.07 7.04 6.86 6.92
HP_CUTANEOUS_SYNDACTYLY 6.54 6.62 6.54 6.64 6.95 6.8 6.61 6.85 6.75 6.87 6.81 6.84 7.09 6.92 6.66 6.85 6.68 6.71 6.9 6.71 6.54 6.96 6.81 6.83 6.61 6.92
HP_THORACIC_AORTIC_ANEURYSM 6.63 6.74 6.62 6.56 6.93 6.77 6.76 6.67 6.9 6.99 6.74 7.03 6.84 6.7 6.76 6.72 6.89 6.68 6.84 6.73 6.91 6.8 7.07 6.97 7.1 7.01
HP_ANORECTAL_ANOMALY 6.21 6.28 6.39 6.51 6.36 6.43 6.38 6.57 6.4 6.42 6.34 6.37 6.47 6.4 6.33 6.33 6.24 6.27 6.19 6.38 6.38 6.36 6.44 6.57 6.34 6.42
HP_MACULE 6.6 6.71 7.15 7.41 6.94 6.95 7.15 7.14 7.29 7.06 6.72 6.99 6.96 7.02 7 7.08 6.83 6.8 7.04 7.2 7.01 7.29 7.24 7.37 7.26 7.13
HP_COUGH 6.03 5.93 5.93 5.88 5.74 5.53 5.9 5.96 5.8 6.02 5.98 6.01 5.65 5.75 5.84 6.06 5.83 6.13 5.86 5.78 6.14 5.84 5.65 5.36 6.09 6.03
HP_PROFOUND_GLOBAL_DEVELOPMENTAL_DELAY 7.11 7.23 7.31 7.28 7.56 7.5 7.67 7.69 7.37 7.68 7.38 7.43 7.52 7.64 7.51 7.42 7.39 7.4 7.65 7.58 7.18 7.51 7.58 7.82 7.48 7.52
HP_PAPILLOMA 6.3 6.14 6.45 6.46 6.23 6.36 6.26 6.54 6.17 6.24 6.14 6.41 6.4 6.31 6.13 6.26 6.27 6.16 6.26 6.29 6.25 6.42 6.41 6.51 6.28 6.39
HP_ABDOMINAL_OBESITY 5.87 6.15 6.92 6.33 6.36 6.21 6.94 6.45 6.32 6.85 6.32 6.8 6.72 6.39 6.46 6.44 6.32 6.23 6 7.01 6.52 6.51 6.48 6.94 6.94 6.91
HP_SHORT_PALPEBRAL_FISSURE 6.58 6.62 6.89 6.7 6.86 6.86 6.67 6.65 6.83 6.81 6.6 6.69 6.75 6.62 6.83 6.76 6.83 6.46 6.56 6.79 6.73 6.86 6.83 6.93 6.76 6.92
HP_ABNORMAL_BRAINSTEM_MRI_SIGNAL_INTENSITY 7.06 7.09 8.09 7.62 7.4 7.31 7.13 7.51 7.71 7.68 7.96 7.35 7.52 7.29 7.57 7.66 7.03 7.27 7.52 7.82 7.42 7.75 7.5 7.45 7.46 7.36
HP_FOCAL_T2_HYPERINTENSE_BRAINSTEM_LESION 7.28 7.39 8.49 8.22 7.76 7.86 7.72 7.6 7.93 8.01 8.06 8.18 7.93 7.84 8 7.86 7.96 7.83 7.9 7.92 7.89 8.18 7.89 7.88 7.82 7.57
HP_ABNORMAL_BASAL_GANGLIA_MRI_SIGNAL_INTENSITY 7.27 7.47 8.29 7.65 7.42 7.7 7.54 7.6 7.15 7.71 7.7 7.51 7.46 7.54 7.46 7.41 7.83 7.34 7.91 7.92 7.39 8.08 7.35 7.5 7.51 8.02
HP_ABNORMAL_NEURON_MORPHOLOGY 7.48 7.6 8.28 8.12 8.11 8.08 7.93 7.72 8.07 7.98 8.03 7.9 7.98 7.94 8.03 7.93 7.66 7.44 7.69 7.87 7.62 8.06 8.12 8.28 8.11 7.8
HP_CEREBRAL_WHITE_MATTER_ATROPHY 7.83 8.08 8.12 7.91 7.93 8.09 8.47 8.26 8.29 8.4 8.08 8.13 8.07 8.09 8.16 8.25 7.94 7.39 7.91 8.21 7.84 7.89 8.39 8.53 8.15 8.12
HP_ORTHOPNEA 5.17 4.88 4.75 4.99 4.52 4.52 4.84 4.72 4.58 4.47 4.95 4.71 4.55 4.44 4.64 4.64 4.58 4.68 4.67 4.73 4.97 4.61 4.63 4.4 4.63 4.67
HP_ABNORMAL_PLACENTAL_SIZE 6.22 6.26 5.99 6.27 6.58 6.3 6.32 6.43 6.51 6.51 6.31 6.39 6.28 5.98 6.07 6.48 6.56 5.95 6.19 6.19 6.17 5.85 6.34 6.53 6.18 6.27
HP_ABNORMAL_ARM_SPAN 6.55 6.46 6.2 6.29 6.83 6.63 6.08 6.42 6.53 6.7 6.37 6.69 6.24 6.06 6.52 6.26 6.58 6.32 6.2 6.39 6.45 6.5 6.46 6.66 6.75 6.76
HP_NEOPLASM_OF_THE_EAR 7.12 7.14 6.81 6.8 7.32 7.47 7.38 7.41 7.28 7.43 7.1 7.64 7.7 7.67 7.28 7.33 7.62 7.37 7.17 7.46 7.07 6.98 7.29 7.46 7.64 7.45
HP_NARROW_JAW 6.54 7.22 6.67 5.9 7.9 8.07 7.34 8 7.05 8.18 7.17 7.76 7.57 7.01 7.01 6.22 7.01 7.47 7.41 7.9 5.88 6.45 6.61 7.46 7.29 7.67
HP_CORNEAL_ULCERATION 6.02 6.18 5.79 6.06 5.83 5.8 5.88 6.05 5.97 6.3 6.18 6.15 5.88 5.9 5.96 5.91 6.01 5.87 5.89 5.66 5.93 5.84 6.1 5.79 5.85 6.13
HP_ABNORMAL_NASAL_BASE 7.67 7.86 8 7.64 8.03 8.2 8.34 7.91 8.15 8.3 8.03 7.89 8.18 8.2 8.1 8.3 7.62 7.85 8.13 8.29 7.74 7.73 7.98 8.19 8.33 7.76
HP_HYPOPLASTIC_FEMALE_EXTERNAL_GENITALIA 6.1 6.2 6.48 6.51 6.13 6.19 6.6 6.5 6.3 6.68 6.13 6.43 6.42 6.57 6.66 6.42 6.43 6.41 6.34 6.11 6.51 6.52 6.21 6.62 6.41 6.28
HP_RETINAL_VASCULAR_TORTUOSITY 6.35 6.51 6.6 6.77 6.17 6.42 6.41 6.48 6.32 6.17 6.52 6.3 6.22 6.42 6.46 6.45 6.31 6.28 6.32 6.4 6.68 6.42 6.33 6.32 6.48 6.62
HP_SKIN_APPENDAGE_NEOPLASM 8.69 9 8.16 8.29 9.34 9.29 9.13 8.83 9.36 9.15 8.55 9.12 9.51 9.29 9 8.71 9.07 8.83 9.18 9.27 8.64 8.64 9.23 9.41 9.11 8.71
HP_ABNORMAL_GERM_CELL_MORPHOLOGY 5.28 5.29 4.87 4.92 4.72 4.78 5.04 4.86 4.98 4.81 4.99 4.76 4.62 4.68 4.82 5.14 5.28 5.27 5.4 4.9 5.13 4.87 4.72 4.28 4.72 4.59
HP_ABNORMAL_SPERM_HEAD_MORPHOLOGY 4.65 4.68 4.18 4.37 4.13 3.9 4.37 4.2 4.4 4.18 4.31 4.22 3.88 3.96 4.28 4.46 4.72 4.8 4.4 4.02 4.72 4.11 3.94 3.7 4.12 4.03
HP_ABNORMAL_SPERM_TAIL_MORPHOLOGY 5.37 5.54 5.29 5.47 5.13 5.18 5.53 5.33 5.06 5.67 5.39 5.64 5.32 5.19 5.23 5.81 5.41 5.84 5.64 5.45 5.54 5.41 5.05 4.87 4.99 5.36
HP_ABNORMAL_MALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY 5.78 5.72 5.82 5.96 5.62 5.5 5.69 5.64 5.76 5.83 5.73 5.68 5.67 5.59 5.96 5.82 5.75 5.84 5.72 5.74 5.79 5.69 5.61 5.48 5.61 5.74
HP_ABNORMAL_LABIA_MINORA_MORPHOLOGY 6.14 6.45 6.91 6.17 6.13 6.62 6.65 6.61 6.34 6.55 6.19 6.56 6.82 6.71 6.88 6.45 6.4 6.68 6.42 6.66 6.71 6.55 6.58 6.71 6.81 7.12
HP_ABNORMAL_LABIA_MAJORA_MORPHOLOGY 6.1 6.2 6.22 6.48 6.03 6.08 6.34 6.2 6.14 6.44 6.1 6.35 6.09 6.56 6.09 6.18 6.36 6.16 6.32 6.01 6.2 6.15 5.95 6.16 6.15 6.29
HP_ESODEVIATION 6.77 6.99 7.12 7.08 7.07 7.26 7.2 7.06 7.15 7.16 6.92 7.15 7.26 7.02 7.12 6.94 7.01 7.02 7.14 7.1 6.92 7.16 7.07 7.31 7.28 6.96
HP_EXODEVIATION 7.11 7.13 7.63 7.31 7.01 7.36 7.66 7.71 7.36 7.31 7.28 7.48 7.63 7.52 7.56 7.72 7.26 7.09 7.35 7.52 7.14 7.69 7.57 7.69 7.63 7.38
HP_ABNORMAL_ERYTHROCYTE_PHYSIOLOGY 5.29 5.09 5.09 6.26 5.06 4.84 5.14 5.16 5.23 5.25 5.33 5.08 4.83 4.82 5.26 5.06 5.32 5.49 4.85 5.07 5.13 5.01 5.18 4.75 5.36 5.03
HP_HYPOPIGMENTED_MACULE 6.44 6.61 6.48 6.39 6.47 6.86 6.76 6.54 6.58 6.79 6.43 6.62 6.63 6.75 6.64 6.89 6.3 6.75 6.75 6.82 6.96 6.83 6.65 6.83 7.03 6.98
HP_UNUSUAL_FUNGAL_INFECTION 5.51 5.42 5.34 5.62 5.34 5.13 5.6 5.42 5.51 5.26 5.63 5 5.33 5.31 5.5 5.39 5.34 5.65 5.11 5.33 5.59 5.31 5.29 5.07 5.27 5.38
HP_BONE_FRACTURE 7.31 7.14 7.72 7.18 7.59 7.72 8.09 7.91 7.25 7.83 7.19 7.7 7.72 7.67 7.59 7.28 7.59 7.44 7.46 8.21 7.96 7.82 7.25 7.99 7.67 7.56
HP_ABNORMAL_URINE_PROTEIN_LEVEL 6.34 6.26 6.34 6.22 6.08 6.41 6.26 6.21 6.21 6.36 6.04 6.25 6.18 6.09 6.11 6.14 6.2 6.25 6.33 6.28 6.22 6.13 6.18 6.1 6.17 6.36
HP_REFLEX_SEIZURE 8.17 8.53 8.38 8.96 8.78 9.16 8.32 8.82 8.39 8.17 8.55 8.49 8.26 8.18 8.61 8.31 8.26 8.27 8.9 8.83 8.28 8.68 8.43 8.46 8.3 8.45
HP_MOTOR_SEIZURE 7.82 7.98 8.06 7.86 8.15 8.29 8.32 8.2 8.12 8.2 7.95 8.21 8.23 8.26 8.39 8.13 7.95 7.95 8.15 8.27 7.9 8.15 8.24 8.36 8.25 8.1
HP_CLONIC_SEIZURE 7.98 8.46 8.31 7.73 8.73 8.63 8.61 8.61 8.75 8.43 8.33 8.35 8.49 8.48 8.76 8.42 8.11 8.1 8.4 8.76 8.28 8.44 8.41 8.85 8.41 8.35
HP_ABNORMAL_VASCULAR_MORPHOLOGY 6.52 6.48 6.6 6.56 6.63 6.68 6.63 6.58 6.6 6.64 6.54 6.63 6.64 6.58 6.53 6.61 6.58 6.5 6.49 6.62 6.59 6.63 6.68 6.76 6.65 6.63
HP_ABNORMAL_ERYTHROCYTE_SEDIMENTATION_RATE 5.46 5.36 5.38 5.78 4.99 5.02 5.62 5.78 5.51 5.34 5.37 5.11 5.2 5.11 5.28 5.45 5.34 5.65 5.32 5.46 5.75 5.63 4.96 5.02 5.51 5.56
HP_ABNORMALITY_OF_DIGESTIVE_SYSTEM_MORPHOLOGY 6.27 6.3 6.38 6.38 6.32 6.32 6.28 6.34 6.34 6.3 6.35 6.33 6.35 6.35 6.29 6.39 6.25 6.28 6.29 6.28 6.41 6.36 6.41 6.37 6.32 6.38
HP_ABNORMAL_MEAN_CORPUSCULAR_VOLUME 6.92 7 7.1 6.79 7.6 7.52 6.96 6.63 7.17 7.14 7.15 7.04 6.92 7.52 6.98 6.93 7.26 6.68 7.1 6.68 6.68 6.78 7.18 6.84 6.67 6.7
HP_INCOMITANT_STRABISMUS 8.06 8.55 8.12 8.12 8.51 8.64 8.57 8.94 8.88 8.62 8.16 8.34 8.87 8.62 8.96 9.05 8.22 8.44 8.48 8.88 8.54 8.73 8.88 8.87 9.02 8.6
HP_BLOODY_DIARRHEA 6.28 6.36 5.99 6 6.21 6.22 6.03 6.21 5.96 5.81 6.12 6.28 6.08 5.81 5.87 6 6.21 5.99 6 6.03 6.39 6.36 6.16 6.26 6.33 6.37
HP_EPIDERMAL_ACANTHOSIS 5.39 5.44 5.24 5.28 5.17 5.23 5.35 5.14 5.52 5.31 5.41 5.04 5.63 5.34 5.35 5.08 5.11 5.47 5.04 5.09 5.22 5.27 5.55 5.43 5.09 5.42
HP_EYELID_MYOCLONUS 9.32 9.27 8.75 8.59 10.02 9.87 9.98 9.7 10.02 9.87 9.46 9.87 9.93 10 9.81 9.72 9.37 9.61 9.71 9.98 9.22 9.6 9.91 10.22 9.81 9.36
HP_DYSGENESIS_OF_THE_HIPPOCAMPUS 7.81 8.33 8.38 7.29 8.75 8.29 8.32 8.82 8.39 7.91 8.55 8.17 7.77 8.04 8.61 8.31 8.26 8.27 8.5 8.83 7.88 8.66 8.12 8.46 8.3 8.45
HP_CAPILLARY_MALFORMATION 6.33 6.67 7.03 7.01 6.97 7.14 7.2 7.21 6.76 7.31 6.88 6.9 7.02 7.14 7.49 7.27 7.03 6.99 6.8 7.23 7.15 7.25 7.11 7.03 6.95 7.2
HP_SOUND_SENSITIVITY 7.15 6.9 7.16 7.13 7.41 7.16 7.2 7.78 7.15 7.35 7.17 7.37 7.55 7.73 7.34 7.77 7.25 7.3 7.61 7.47 7.18 7.42 7.07 7.6 7.35 7.58
HP_HYPERGRANULOSIS 5.15 4.94 5.04 5.25 4.54 4.77 5.08 4.95 4.95 4.73 5.18 4.84 4.89 4.54 5 4.74 4.68 5.4 4.75 4.75 5.08 4.77 4.82 4.6 4.95 4.78
HP_FETAL_DISTRESS 7.07 7.39 8.14 7.6 7.71 7.64 7.54 7.57 7.93 7.77 7.57 7.91 7.82 7.48 7.95 7.71 7.93 7.82 7.42 7.87 7.81 8.01 7.75 7.88 7.74 7.57
HP_ABNORMAL_CIRCULATING_ESTROGEN_LEVEL 5.81 5.82 6.16 6.15 5.6 5.72 5.97 6.07 5.82 6.02 5.98 6.13 6.08 6.03 6.06 6.1 6.02 5.93 5.8 5.98 6.06 6.32 6.04 5.84 5.97 6.26
HP_CONSTITUTIONAL_SYMPTOM 6.25 6.27 6.34 6.38 6.35 6.35 6.28 6.33 6.33 6.43 6.26 6.31 6.33 6.25 6.28 6.26 6.27 6.25 6.25 6.26 6.28 6.31 6.42 6.39 6.42 6.46
HP_CHILLS 6.07 5.93 5.89 6.19 5.79 6 5.85 5.91 6.16 5.85 5.85 5.86 5.74 5.81 5.95 5.84 5.56 5.58 5.5 5.97 6.27 6 6.06 6.01 6.27 6.11
HP_ABNORMALITY_OF_HEPATOBILIARY_SYSTEM_PHYSIOLOGY 6.58 6.57 6.98 6.9 6.71 6.81 6.64 6.7 6.61 6.62 6.77 6.66 6.74 6.72 6.59 6.74 6.66 6.49 6.69 6.78 6.61 6.74 6.77 6.77 6.54 6.65
HP_ABNORMAL_TEMPER_TANTRUMS 8.48 8.49 8.26 7.65 8.77 8.68 8.82 8.97 8.26 8.41 7.87 8.27 8.77 8.7 8.71 8.75 8.05 8.4 8.43 8.72 8.3 8.93 7.98 8.7 9.16 8.83
HP_LEFT_VENTRICULAR_SYSTOLIC_DYSFUNCTION 6.09 6.04 6.1 5.7 6.55 5.97 6.01 6.05 5.99 6.09 6.05 6.21 5.98 5.75 5.84 5.94 5.86 5.74 5.94 6.12 6.01 5.96 6.02 6.08 6.24 6.5
HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_GENERALIZED_ONSET 8.2 8.36 8.51 8.96 8.75 8.88 8.77 9.07 8.62 8.59 8.55 8.54 8.84 8.67 9.02 9.14 8.41 8.27 8.75 9.33 8.7 9.27 8.65 8.96 8.68 8.58
HP_CUTANEOUS_CYST 5.89 5.66 5.95 6.45 6.34 5.88 6.24 6.4 6.07 5.44 6.09 5.91 5.7 5.51 5.56 5.3 6.08 5.98 5.99 5.87 6.34 5.34 6.2 6.18 5.38 5.75
HP_ABNORMALITY_OF_ESOPHAGUS_PHYSIOLOGY 7.28 7.34 7.42 7.45 7.6 7.62 7.62 7.53 7.58 7.63 7.29 7.63 7.68 7.68 7.62 7.5 7.43 7.34 7.58 7.78 7.4 7.59 7.63 7.74 7.64 7.48
HP_ABNORMALITY_OF_SKIN_ADNEXA_PHYSIOLOGY 6.05 5.86 5.94 6.07 5.89 5.79 5.87 6.02 6.06 6 6.16 6.05 5.95 5.98 5.93 5.93 5.99 5.99 5.81 5.94 6.04 5.9 5.91 5.87 5.96 6.04
HP_MALAR_RASH 5.89 5.65 5.68 6.02 5.66 5.56 5.59 5.68 5.94 5.75 5.71 5.26 5.29 5.57 5.68 5.74 5.6 5.89 5.85 5.56 5.7 5.8 5.82 5.22 5.85 5.49
HP_OVARIAN_CARCINOMA 6.45 6.24 6.06 6.19 6.32 6.64 6.24 6.37 6.32 6.27 6.11 6.25 6.4 6.47 6.23 6.32 6.39 6.4 6.01 6.47 6.03 6.2 6.6 6.36 6.23 6.38
HP_ABNORMAL_ARTERIAL_PHYSIOLOGY 6.21 6.22 6.26 6.29 6.4 6.26 6.18 6.12 6.58 6.22 6.34 6.29 6.38 6.22 6.01 6.15 6.17 6.21 6.03 6.29 6.21 6.2 6.35 6.37 6.24 6.18
HP_DELAYED_ABILITY_TO_SIT 7.99 7.81 7.86 7.36 8.36 8.33 8.1 7.87 8.33 8.07 7.71 8.16 8.26 8.6 8.33 8.28 8 7.93 8.32 8.15 7.92 8.05 8.21 8.39 8.24 7.99
HP_RED_EYE 6.04 6.19 5.94 6.05 5.77 5.94 6.01 6.08 6.13 5.96 6.04 5.92 6.09 5.8 5.86 6.01 5.9 5.94 6 5.83 5.92 5.94 6 6.02 6.1 6.13
HP_ABNORMAL_CELLULAR_PHENOTYPE 6.32 6.36 6.56 6.62 6.55 6.6 6.46 6.55 6.46 6.55 6.48 6.5 6.61 6.56 6.43 6.45 6.41 6.41 6.47 6.51 6.4 6.51 6.53 6.74 6.56 6.63
HP_PSYCHOMOTOR_RETARDATION 6.84 6.72 7.44 7.42 6.97 6.9 7.07 7.22 7 7.12 7.21 6.96 7.04 7.06 7.14 7.12 6.83 6.8 6.99 7.19 6.92 7.12 7.27 7.21 7.16 7.07
HP_INTERICTAL_EEG_ABNORMALITY 7.95 7.98 8.04 7.88 8.36 8.31 8.34 8.18 8.07 8.23 7.92 8.15 8.18 8.32 8.24 8.12 7.88 8 8.25 8.3 7.85 8.08 8.31 8.36 8.09 8.03
HP_PULMONARY_INTERSTITIAL_HIGH_RESOLUTION_COMPUTED_TOMOGRAPHY_ABNORMALITY 5.99 5.93 6.13 6.59 6.67 6.63 5.67 6.02 5.78 6.63 6.22 6.26 5.96 6.38 6.17 6.41 6.55 6.46 6.12 6.17 6.36 6.77 6.12 6.38 6.15 6.57
HP_STARING_GAZE 8.23 8.1 7.97 7.76 8.21 8.55 8.43 8.38 7.85 8.51 8.3 8.26 8.38 8.28 8.33 8.4 7.71 7.89 8.46 8.26 7.89 8.48 8.32 8.16 8.03 7.96
HP_ABNORMAL_VISUAL_FIXATION 7.15 7.46 7.05 6.89 7.4 7.09 7.16 6.95 7.08 6.77 7.25 7.02 7.21 7.54 6.75 6.57 7.29 7.38 7.25 6.91 7.07 7.66 6.95 7.25 7.41 7.29
HP_DIFFUSE_ALVEOLAR_HEMORRHAGE 7.16 7.23 6.8 7.19 6.81 6.54 6.64 6.78 7.46 7.2 7.12 7.92 7.17 6.95 7.63 7.04 8.1 7.92 6.15 6.7 7.05 6.77 7.23 7.78 7.88 7.97
HP_ABNORMAL_LARYNX_MORPHOLOGY 6.78 6.63 6.67 6.67 6.92 6.94 6.93 7 6.79 6.98 6.71 6.91 6.88 6.96 6.89 7.05 6.84 6.8 6.99 6.99 6.95 6.97 6.96 7 6.92 7.2
HP_ABNORMAL_LARYNX_PHYSIOLOGY 7.61 7.82 8.21 8.11 7.96 8.17 8.1 8.12 8.06 8.04 8.24 8.03 7.99 8.12 8.15 7.96 7.7 7.52 7.84 7.88 7.7 8.13 8.21 8.42 8.16 7.94
HP_ABNORMAL_BRONCHUS_MORPHOLOGY 5.98 5.93 5.91 5.82 5.75 5.74 5.68 5.84 5.81 5.98 5.91 5.71 5.79 5.9 5.68 6.11 5.88 6.09 5.67 5.72 5.94 5.77 5.7 5.57 6 5.99
HP_ABNORMAL_BRONCHUS_PHYSIOLOGY 6.86 7.18 7.12 7.16 6.5 6.68 7.2 6.92 7.29 6.76 6.72 6.85 6.93 7.02 6.82 6.56 6.83 6.93 6.87 7.3 6.48 6.84 6.82 7.42 6.79 6.77
HP_ABNORMAL_CRY 6.7 7.06 6.76 6.58 7.14 7.07 7.12 7.02 6.9 7.2 7.14 7.22 7.03 6.87 6.93 6.81 6.92 6.81 7.27 7 6.68 6.69 7.13 6.9 7.28 7.21
HP_INCREASED_LACTATE_DEHYDROGENASE_LEVEL 6.52 6.49 6.5 6.33 6.72 6.88 6.43 6.28 6.6 6.45 6.43 6.38 6.38 6.46 6.27 6.01 6.52 6.2 6.27 6.35 6.35 6.26 6.54 6.42 6.66 6.83
HP_PHARYNGITIS 5.41 5.33 5.83 5.79 5.29 5.02 6 6.12 5.78 5.73 5.69 5.11 5.81 5.73 5.51 5.53 6.18 5.84 4.85 6 6.41 5.98 5.44 5.59 5.53 5.38
HP_ABNORMAL_CSF_METABOLITE_LEVEL 7.07 7.15 8.21 7.83 7.58 7.72 7.54 7.55 7.77 7.71 7.88 7.47 7.59 7.63 7.63 7.61 7.6 7.25 7.42 7.49 7.45 7.66 7.58 7.63 7.62 7.57
HP_ABNORMAL_CSF_PROTEIN_LEVEL 7.28 7.24 6.81 7.08 7.01 6.71 7.51 7.07 7.05 7.61 6.6 7.1 6.55 6.72 7.52 7.23 7.16 7.11 7.29 7.67 7.23 7.35 6.89 7.07 7.3 6.93
HP_ABNORMAL_CELL_MORPHOLOGY 5.89 5.99 6.14 6.76 6.35 6.35 6.03 5.97 6.03 6.2 6.06 6.19 6.09 6.02 6.28 6.18 6.33 6.02 6.08 6.01 6.3 6.16 6.11 6.24 6.27 6.14
HP_ABNORMALITY_OF_BLADDER_MORPHOLOGY 6.02 5.8 5.78 6.02 5.77 5.76 5.85 5.59 5.9 5.71 5.82 5.74 5.74 6 5.85 5.74 5.87 6.12 5.72 5.53 6.03 6.11 6.04 5.49 6 5.95
HP_OVERWEIGHT 5.85 5.66 5.51 5.92 5.5 5.28 5.76 5.32 5.71 5.24 5.44 5.32 5.55 5.46 5.36 5.42 5.5 5.54 5.32 5.27 5.63 5.47 5.4 5.25 5.58 5.35
HP_ABNORMAL_T_CELL_SUBSET_DISTRIBUTION 5.48 5.39 5.25 5.36 5.36 5.06 5.22 5.31 5.42 5.22 5.59 4.95 5.08 5.15 5.22 5.18 5.26 5.48 5.04 5.01 5.47 5.28 5.06 5.02 5.27 5.28
HP_ABNORMAL_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION 5.96 5.95 5.93 6.35 5.65 5.93 5.81 5.52 5.55 5.61 6.09 5.84 5.95 5.73 5.48 5.23 5.91 5.89 5.83 6.05 6.09 6.18 5.76 5.68 5.79 6.44
HP_INCREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION 5.74 5.84 5.63 6.44 5.09 5.4 5.8 5.46 5.35 5.3 5.62 5.78 5.58 5.27 5.66 5.08 5.64 5.74 5.47 5.75 5.99 5.88 5.28 5.61 5.48 6.2
HP_ABNORMAL_MORPHOLOGY_OF_THE_CHOROIDAL_VASCULATURE 5.97 5.82 6.27 5.87 6.33 6.08 6.22 6.03 6.01 6.14 6.05 5.92 6.43 6.18 6.09 6.26 5.8 6.02 5.95 6.28 6.08 6.35 6 6.1 5.9 5.9
HP_ABNORMAL_LEFT_ATRIUM_MORPHOLOGY 5.93 5.74 5.84 6.22 5.38 4.9 5.35 5.04 5.08 5.39 6.25 5.29 4.88 5.11 4.93 5 6.06 6.1 5.61 4.91 5.53 5.27 5.35 4.88 5.45 5.62
HP_ABNORMAL_RIGHT_ATRIUM_MORPHOLOGY 4.81 4.68 5.07 5.47 4.68 4.55 4.89 4.77 4.75 5.17 5.29 4.97 4.68 4.58 4.7 4.72 4.79 4.67 4.72 4.69 5.04 4.78 4.94 4.64 4.71 4.85
HP_FOCAL_EMOTIONAL_SEIZURE 9.18 9.17 8.74 8.49 9.48 9.48 9.85 9.79 9.74 9.75 9.18 9.41 9.84 9.93 9.54 9.53 9.25 9.6 9.43 9.98 9.22 9.54 9.58 9.94 9.68 9.46
HP_ABSCESS 5.59 5.44 5.79 5.81 5.35 5.23 5.49 5.57 5.67 5.37 5.62 5.4 5.62 5.58 5.46 5.38 5.63 5.69 5.36 5.43 5.73 5.62 5.28 5.07 5.57 5.76
HP_ABNORMAL_URETER_MORPHOLOGY 6.34 6.24 6.34 6.36 6.44 6.5 6.31 6.39 6.33 6.36 6.27 6.62 6.49 6.39 6.39 6.38 6.45 6.35 6.29 6.45 6.31 6.39 6.6 6.58 6.3 6.31
HP_ABNORMAL_URETER_PHYSIOLOGY 6.79 6.83 6.65 6.67 7.01 7 6.97 6.94 6.82 6.87 6.7 6.85 6.84 6.84 6.92 6.63 6.81 6.6 6.74 6.91 6.98 6.8 6.95 7.12 6.85 6.89
HP_ABNORMAL_FEMALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY 6.1 6.05 6.31 6.19 6.1 6.07 6.2 6.14 6.17 6.14 6.23 6.05 6.05 6.13 6.1 6.12 6.12 6.1 6.09 6.18 6.12 6.18 6.11 6.14 6.15 6.25
HP_FEMALE_SEXUAL_DYSFUNCTION 6.4 5.95 6.62 6.34 6.32 6.35 6.51 6.44 6.94 6.31 6.43 6.47 6.86 6.82 6.25 6.15 6.23 6.35 6.25 6.76 6.16 6.22 6.73 6.56 6.04 6.6
HP_DYSPAREUNIA 5.98 5.42 6.09 5.99 5.74 5.44 5.94 6.13 6.56 5.75 6.25 6.04 5.88 6.25 6.15 5.87 5.99 5.97 6 6.22 5.94 5.86 5.64 5.55 5.93 6.05
HP_ENCHONDROMA 6.57 6.44 7.13 7.22 6.72 7.17 6.99 6.66 7.64 7.76 7.28 6.75 7.36 7.37 6.91 7.43 7.39 6.89 6.96 7.37 6.37 6.45 7.58 7.4 7.06 7.08
HP_HIP_SUBLUXATION 7.12 7.13 6.4 7.19 7.6 7.83 6.85 7.23 7.45 7.58 7.36 7.5 7.41 7.43 7.37 7.19 7.23 6.77 7.26 7.18 7.22 6.8 7.57 7.69 7.27 7.28
HP_FLEXION_CONTRACTURE_OF_DIGIT 6.27 6.34 6.33 6.39 6.4 6.42 6.33 6.41 6.43 6.4 6.3 6.37 6.39 6.44 6.36 6.35 6.34 6.34 6.33 6.34 6.36 6.29 6.53 6.46 6.54 6.48
HP_ABNORMALITY_OF_LATERAL_VENTRICLE 7.98 8.18 8.18 8.07 8.5 8.64 8.52 8.3 8.36 8.34 8.12 8.39 8.53 8.45 8.43 8.46 8.16 8.17 8.24 8.44 8.24 8.4 8.55 8.61 8.35 8.31
HP_COLPOCEPHALY 7.75 7.88 7.78 7.84 8.36 8.32 8.09 8.14 8.22 8.31 7.94 8.34 8.31 8.24 8.35 7.84 8.15 7.86 8.14 8.11 8.06 7.95 8.4 8.38 8.19 8.13
HP_AUTOIMMUNE_ANTIBODY_POSITIVITY 5.42 5.3 5.19 5.3 5.1 4.92 5.14 5.13 5.04 5.03 5.36 4.86 5.03 5.09 5.21 5.17 5.13 5.31 4.93 4.82 5.27 5.24 4.86 4.82 5.02 4.97
HP_PRIMITIVE_NEUROECTODERMAL_TUMOR 7.13 7.18 7.38 7.41 7.41 7.7 7.43 7.33 7.42 7.55 7.24 7.58 7.64 7.71 7.39 7.43 7.25 6.97 7.39 7.52 7.12 7.05 7.58 7.88 7.37 7.39
HP_ABNORMAL_DRINKING_BEHAVIOR 5.43 5.3 5.15 5.46 4.81 4.8 5.16 5 5.34 4.99 5.21 4.97 4.97 5 5.16 5.05 5.28 5.32 5 5.04 5.36 5 4.99 4.82 5.07 4.95
HP_CLINODACTYLY 6.69 6.75 6.89 6.87 6.91 7 6.86 7 6.91 6.94 6.8 6.96 7.03 6.91 7.04 6.91 6.82 6.8 6.88 6.98 6.98 7.07 6.99 7.08 7.01 7.03
HP_ABNORMAL_MUSCLE_FIBER_PROTEIN_EXPRESSION 6.35 6.38 6.19 6.51 6.86 6.5 6.31 6.28 6.52 6.53 6.37 6.99 6.4 6.01 6.12 6.44 6.69 6.34 6.33 6.38 6.21 6.23 6.92 6.61 6.58 6.61
HP_ABNORMALITY_OF_THE_ENDOMETRIUM 7.43 7.49 7.98 8.08 8.06 7.9 7.52 7.53 7.92 7.87 7.8 7.72 8.03 7.91 7.73 7.48 7.49 7.07 7.61 7.6 7.21 7.38 8.15 8.08 7.8 7.33
HP_ORAL_CAVITY_BLEEDING 5.84 5.8 6.17 5.66 5.69 5.34 5.65 6.06 5.66 5.32 5.31 5.46 5.73 5.65 5.78 5.45 5.56 5.52 5.41 5.59 5.98 6.02 5.77 5.57 6.49 6.25
HP_CHOLANGITIS 5.53 5.52 4.94 4.97 5.51 5.39 5.09 5.14 5.44 5.35 5.26 4.83 5.37 5.35 5.37 5.12 5.24 5.63 5.19 5.07 5.57 5.38 5.09 5.21 5 5.06
HP_ABNORMAL_VASCULAR_PHYSIOLOGY 6.41 6.37 6.46 6.41 6.51 6.39 6.34 6.47 6.58 6.35 6.36 6.42 6.49 6.49 6.24 6.33 6.55 6.45 6.3 6.4 6.47 6.36 6.48 6.46 6.44 6.44
HP_NIGHT_SWEATS 7.32 7.25 7.15 6.91 7.35 7.61 7.31 6.99 7.24 7.25 6.86 7.33 7.48 7.52 7.18 7.33 6.96 6.99 7.36 7.67 6.95 7.58 7.23 7.29 7.4 7.23
HP_ABNORMALITY_OF_PERIPHERAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY 7.31 7.36 7.71 7.27 7.84 7.85 7.68 7.72 7.54 7.67 7.41 7.72 7.68 7.79 7.54 7.61 7.51 7.26 7.59 7.77 7.39 7.4 7.66 7.75 7.52 7.6
HP_ABNORMALITY_OF_CENTRAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY 7.54 7.61 7.9 7.76 7.89 8.04 7.92 7.93 7.9 7.9 7.7 7.89 7.92 7.86 7.94 7.89 7.63 7.61 7.85 7.98 7.69 7.86 7.95 8.05 7.9 7.84
HP_TETRAPLEGIA_TETRAPARESIS 6.56 7.16 7.91 7.74 6.77 7.23 7.18 7.31 7.15 7.52 6.93 7.01 7.37 7.28 7.43 7.23 7.14 7.15 7.34 7.42 7.15 7.08 7.3 7.65 7.35 6.98
HP_KINETIC_TREMOR 7.66 7.49 8.08 7.98 8.05 8.19 8.2 8.34 8.32 8.27 8 8.38 8.43 8.31 8.34 8.42 7.99 7.95 8.11 8.27 7.6 8.17 8.22 8.36 8.42 8.19
HP_TITUBATION 7.53 7.46 7.95 7.95 7.66 7.67 7.53 7.85 7.76 8.02 7.83 7.99 7.6 7.74 7.83 7.72 7.66 7.45 7.53 7.59 7.71 7.79 7.78 7.71 7.8 7.76
HP_TREMOR_BY_ANATOMICAL_SITE 7.53 7.46 7.83 7.52 7.87 7.85 7.54 7.64 7.72 8.01 7.57 7.83 7.66 7.73 7.8 7.68 7.54 7.48 7.64 7.62 7.62 7.89 7.79 7.86 7.83 7.69
HP_FATIGABLE_WEAKNESS_OF_BULBAR_MUSCLES 7.12 7.23 7.23 7.72 7.01 7 6.96 6.88 6.82 7.51 6.93 7.1 6.63 6.74 6.98 7.02 7.49 6.86 7.02 6.77 7.12 7.17 7.06 6.82 7.27 6.88
HP_FATIGABLE_WEAKNESS_OF_SWALLOWING_MUSCLES 7.65 7.76 8.35 8.15 8.32 8.36 8.2 8.16 8.35 8.23 8.29 8.08 8.07 8.22 8.18 8.21 7.76 7.56 8.17 7.89 7.92 8.2 8.38 8.54 8.16 8.04
HP_FATIGABLE_WEAKNESS_OF_RESPIRATORY_MUSCLES 6.52 6.68 6.98 7.13 6.77 6.67 6.7 6.3 6.66 6.78 6.64 6.52 6.34 6.56 6.71 6.53 6.42 6.67 6.67 6.42 6.68 6.8 6.98 6.73 6.91 6.43
HP_FATIGABLE_WEAKNESS_OF_SKELETAL_MUSCLES 5.76 5.55 6.19 5.95 5.74 5.48 5.93 5.65 5.91 5.46 5.94 5.66 5.46 5.43 5.56 5.68 5.5 5.79 5.49 5.54 5.63 5.39 5.45 5.19 5.65 5.29
HP_FATIGUABLE_WEAKNESS_OF_PROXIMAL_LIMB_MUSCLES 5.73 5.68 6.11 5.91 5.74 5.57 5.79 5.69 5.75 5.42 5.99 5.74 5.54 5.57 5.51 5.56 5.5 5.87 5.6 5.44 5.5 5.43 5.46 5.28 5.72 5.28
HP_COLLECTIONISM 8.57 8.68 9.23 8.5 8.9 8.96 9.57 8.91 9.33 9 8.79 8.8 8.92 8.94 8.22 8.64 8.66 8.17 8.4 9.25 8.33 8.27 9.26 8.99 8.94 8.68
HP_INAPPROPRIATE_CRYING 8.78 8.98 7.98 7.83 8.93 8.89 9.27 9.76 9.11 9.13 8.64 9.07 8.27 8.61 9.26 9.12 8.94 8.47 8.66 8.78 9.02 8.72 8.88 9.12 9.34 9.08
HP_PERSEVERATION 8.98 8.81 9.27 9 9.05 9.03 9.57 8.98 9.27 9.13 9.03 8.89 9.05 9.17 8.87 8.73 8.75 8.43 8.94 9.33 8.61 8.93 9.26 9.04 9.29 8.84
HP_ABNORMALITY_OF_MUSCLE_SIZE 6.88 6.95 7.25 7.07 7.15 7.24 7.18 7.22 7.21 7.28 7.15 7.15 7.24 7.17 7.19 7.16 7.05 6.86 7.14 7.2 7.08 7.09 7.35 7.39 7.18 7.14
HP_HAND_MUSCLE_WEAKNESS 6.49 6.24 6.2 6.11 6.38 6.59 6.27 6.36 6.45 6.76 6.27 6.67 6.58 6.5 6.47 6.51 6.39 6.57 6.28 6.41 6.35 6.43 6.46 6.64 6.51 6.6
HP_PORTAL_VEIN_THROMBOSIS 6.23 6.26 5.37 5.81 6.54 6.58 5.68 5.37 6.13 6.2 5.73 6.01 5.95 5.95 5.6 5.61 6.12 6.01 6.15 5.76 5.61 5.35 6.19 6.03 5.6 6.04
HP_SPLANCHNIC_VEIN_THROMBOSIS 5.76 5.78 5.11 5.57 5.22 4.91 5.06 5.02 5.28 5.12 5.33 5.14 5.39 5.06 4.97 5.01 5.33 5.49 5.11 4.82 5.21 5.15 5.14 4.85 5.36 5
HP_LARGE_INTESTINAL_POLYPOSIS 7.45 7.65 8.2 8.08 8.09 8.17 7.72 7.98 8 7.93 7.8 7.77 8.16 7.98 8.21 7.66 7.62 7.3 8.21 8.12 7.58 8.25 8.15 8.08 8.38 8.01
HP_MICROPHALLUS 6.25 6.44 6.4 6.43 6.48 6.7 6.51 6.91 6.43 6.71 6.54 6.6 6.65 6.57 6.11 6.23 6.51 6.08 6.49 7.08 6.25 6.4 6.33 6.23 6.53 6.67
HP_ELEVATED_RED_CELL_ADENOSINE_DEAMINASE_LEVEL 6.87 5.79 7.18 6.29 6.41 5.73 6.33 5.73 6.89 5.42 7.72 5.93 6.29 6.11 6.45 6.85 7.5 7.12 6.23 5.63 7.46 6.01 6.35 6.32 5.86 5.88
HP_ABNORMAL_ERYTHROCYTE_ENZYME_LEVEL 6.81 6.17 7.15 6.58 6.8 7.18 6.79 6.82 6.8 6.66 6.77 6.39 6.64 6.26 6.62 6.88 6.88 7.02 7 6.82 6.73 6.8 6.45 6.5 6.53 6.71
HP_SMALL_SCROTUM 8.98 8.9 8.53 8.37 9.27 9.25 9.4 9.01 9.16 9.23 8.89 9 9.32 9.29 9.14 9.1 9.08 8.88 8.93 8.96 8.76 9.08 9.24 9.25 9.13 8.98
HP_UPPER_EXTREMITY_JOINT_DISLOCATION 6.68 6.74 6.67 6.67 7.04 7.02 6.93 6.91 6.64 7.24 6.87 6.68 7.04 7.15 7.1 6.72 7.02 6.67 6.66 6.81 7.01 7.18 7.05 7.15 7.04 7.09
HP_LOWER_EXTREMITY_JOINT_DISLOCATION 6.51 6.59 6.66 6.67 6.72 6.85 6.67 6.85 6.73 6.73 6.79 6.63 6.78 6.71 6.8 6.69 6.56 6.55 6.58 6.66 6.68 6.64 6.87 6.8 6.77 6.85
HP_WEAKNESS_OF_FACIAL_MUSCULATURE 6.75 6.87 6.89 6.66 7.01 7.11 7 6.92 6.97 7.03 6.8 7.1 7.04 6.94 7.01 6.83 6.95 6.9 6.95 7.13 6.84 6.94 7.05 6.93 7.01 6.88
HP_RETINAL_THINNING 5.34 5 5.04 5.19 4.63 4.75 5.05 4.96 5.02 4.96 5.11 4.85 4.78 4.91 5.08 4.91 5.13 5.17 4.88 4.77 5.13 4.87 4.83 4.76 4.93 4.88
HP_ABNORMAL_CIRCULATING_GONADOTROPIN_LEVEL 5.56 5.36 5.61 5.63 5.44 5.07 5.38 5.36 5.31 5.29 5.41 5.43 5.31 5.08 5.44 5.21 5.37 5.42 5.39 5.3 5.39 5.29 5.26 5.1 5.08 5.28
HP_DECREASED_CIRCULATING_GONADOTROPIN_LEVEL 6.67 6.7 6.81 6.62 6.72 6.64 7.04 6.67 7.02 6.69 6.54 6.57 6.71 6.58 6.59 6.55 6.95 6.9 6.51 6.92 6.71 6.58 6.6 7.01 6.7 6.75
HP_DECREASED_CIRCULATING_LUTEINIZING_HORMONE_LEVEL 7.12 7.22 6.81 7.24 7.32 7.47 7.2 6.69 7.28 7.15 6.84 7.37 7.09 7.08 7.25 7.25 7.14 7.07 7.17 7.36 7.18 6.66 7.29 7.89 7.37 7.13
HP_ABNORMAL_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL 5.68 5.63 5.71 6.1 5.59 5.51 5.78 5.9 5.75 5.65 5.96 5.84 5.67 5.82 5.96 5.92 5.78 5.75 5.69 5.58 5.67 6.14 5.39 5.67 5.6 5.96
HP_ABNORMAL_CIRCULATING_ANDROGEN_LEVEL 5.96 5.75 5.9 6.11 5.67 5.51 5.94 6.01 5.92 5.93 5.98 5.96 5.89 5.94 5.99 5.88 5.98 5.94 6 5.93 5.95 5.83 5.78 5.7 5.73 6.05
HP_INCREASED_CIRCULATING_ANDROGEN_LEVEL 6.36 6.49 6.19 6.33 6.56 6.6 6.59 6.76 6.6 6.52 6.28 6.72 6.74 6.48 6.62 6.26 6.1 6.07 6.34 6.86 6.58 6.53 6.94 6.62 6.64 6.46
HP_DECREASED_CIRCULATING_ANDROGEN_LEVEL 5.95 5.7 5.86 5.89 5.61 5.45 5.91 5.79 5.85 5.86 5.94 5.89 5.67 5.73 5.97 5.86 5.87 5.92 5.84 5.83 5.91 5.68 5.64 5.64 5.61 5.96
HP_ABNORMAL_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1_LEVEL 6.29 5.69 6.48 6.26 6.26 6.14 6.18 5.93 6.08 6.15 6.27 5.96 5.85 5.96 6.04 6.15 6.04 6.15 5.73 5.76 5.99 6.21 5.59 5.72 6.04 6.22
HP_DECREASED_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1 6.28 5.69 6.27 6.07 5.57 5.57 5.68 5.79 5.77 5.89 5.81 5.64 5.52 5.41 5.81 6 5.81 6.02 5.54 5.45 5.64 5.83 5.45 5.3 5.65 5.38
HP_ABNORMAL_SERUM_INTERFERON_LEVEL 6.58 6.48 7.27 7.41 6.93 6.97 6.92 6.64 7.18 6.88 6.84 6.89 6.81 7.01 6.69 6.92 7.14 7.13 6.45 6.54 6.85 6.84 7.07 7.09 7.09 7
HP_ABNORMAL_PLATELET_AGGREGATION 6.07 5.97 5.9 5.83 5.77 5.81 5.8 5.78 5.81 5.8 6.21 5.53 5.76 5.85 5.55 5.86 6.1 5.9 5.61 5.73 6.21 6.16 5.49 5.66 6.22 6.03
HP_PANCREATIC_ENDOCRINE_TUMOR 6.64 6.89 6.76 6.47 6.91 7.05 7.07 6.94 6.81 6.91 6.56 6.82 6.96 6.9 6.87 6.92 6.62 7.13 6.88 7.14 7 6.99 6.76 7.01 7.3 6.98
HP_PRIMARY_PERITONEAL_CARCINOMA 4.91 4.87 5.25 5.69 5.12 4.99 5.21 5.45 5.37 5.17 5.26 5.23 5.34 5.39 4.91 5.09 5.39 5.13 5.08 5.77 5.11 5.05 5.68 5.49 5.01 5.01
HP_SOFT_TISSUE_SARCOMA 7.02 7.06 7.14 7.17 7.22 7.34 7.26 7.21 7.29 7.15 6.87 7.16 7.23 7.32 7.29 7.21 6.93 6.95 7.11 7.33 7 7.01 7.38 7.65 7.39 7.19
HP_ABNORMAL_VISUAL_ELECTROPHYSIOLOGY 6.29 6.35 6.31 6.44 6.37 6.47 6.42 6.46 6.44 6.6 6.3 6.56 6.5 6.47 6.37 6.47 6.39 6.4 6.45 6.48 6.34 6.46 6.64 6.54 6.5 6.46
HP_ABNORMAL_FULL_FIELD_ELECTRORETINOGRAM 5.42 5.2 5.33 5.39 4.88 4.85 5.29 5.24 5.34 5 5.31 4.86 4.99 4.96 5.16 5.12 5.25 5.31 5.02 4.94 5.41 5.02 5.02 4.82 5.08 4.94
HP_ABNORMAL_DARK_ADAPTED_ELECTRORETINOGRAM 5.32 5 5.03 5.08 4.53 4.51 4.93 4.6 4.68 4.75 5.06 4.84 4.56 4.71 4.89 4.53 4.83 4.76 4.76 4.42 4.88 4.52 4.48 4.46 4.6 4.81
HP_REDUCED_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM_A_WAVE 5.35 5 5.05 5.3 4.61 4.73 5.01 4.88 5.15 4.88 5.15 4.86 4.72 4.87 4.99 4.69 4.85 5.16 4.82 4.71 4.98 4.78 4.48 4.59 5.07 4.81
HP_MACULAR_THICKENING 6.4 5.97 6.14 6.44 6.15 6.23 6.4 6.34 6.45 6.36 6.42 6.34 6.49 6.4 6.62 6.93 5.97 5.95 6.28 6.2 6.45 6.33 6.68 6.43 6.5 6.5
HP_YELLOW_WHITE_LESIONS_OF_THE_MACULA 5.03 4.91 4.72 4.79 4.49 4.39 4.68 4.5 4.75 4.78 5.01 4.53 4.43 4.52 4.61 4.82 4.77 4.75 4.8 4.53 5.04 4.64 4.6 4.35 4.33 4.39
HP_YELLOW_WHITE_LESIONS_OF_THE_RETINA 5.75 5.7 5.36 5.75 5.73 5.55 5.35 5.57 5.61 5.33 5.68 5.51 5.56 5.51 5.38 5.43 5.87 5.75 5.61 5.41 5.78 5.48 5.71 5.67 5.48 5.41
HP_HETERONYMOUS_HEMIANOPIA 6.89 7.02 6.97 7.94 7.11 7.35 7.29 7.14 7.29 7.15 7.26 7.27 7.03 7.06 7.41 7.26 7.04 7.07 7.11 7.45 7.2 6.92 7.63 7.99 7.46 7.22
HP_VISUAL_ACUITY_TEST_ABNORMALITY 7.12 7.19 6.81 7.24 7.32 7.47 7.2 6.69 7.28 7.15 6.84 7.37 7.09 7.08 7.25 7.25 7.14 7.07 7.17 7.36 7.18 6.82 7.29 7.89 7.37 7.13
HP_COLOR_VISION_TEST_ABNORMALITY 4.7 4.83 4.87 4.89 4.19 4.22 4.94 4.87 4.85 4.41 4.87 4.42 4.4 4.35 4.31 4.58 4.63 4.94 4.37 4.22 5.13 4.43 5.22 4.03 4.54 4.18
HP_ABNORMAL_VISUAL_FIELD_TEST 7.16 7.4 6.97 7.94 7.69 7.57 7.4 7.05 7.63 7.4 7.26 7.57 7.37 7.49 7.41 7.26 7.38 7.36 7.33 7.46 7.2 6.8 7.72 8.09 7.5 7.22
HP_ABNORMAL_POSTERIOR_SEGMENT_IMAGING 5.68 5.89 6.12 5.71 5.74 5.94 5.97 5.53 6.1 5.73 6.05 5.72 5.59 5.56 5.68 5.73 5.61 5.86 5.93 5.81 5.5 5.26 5.88 5.81 5.77 5.48
HP_ABNORMAL_FUNDUS_AUTOFLUORESCENCE_IMAGING 6.29 6.25 6.64 6.09 6.11 6.44 6.46 5.73 6.71 6.6 6.47 6.44 6.1 6.17 6.17 6.4 6.13 6.16 6.19 6.51 6.01 5.87 6.8 6.69 6.39 6.07
HP_ABNORMAL_OPTICAL_COHERENCE_TOMOGRAPHY 5.19 5.06 5.19 5.02 4.76 4.6 5.27 5.19 5.08 4.79 4.74 4.68 4.59 5.06 5.04 5.02 4.84 5.17 4.71 4.59 4.98 4.73 5.13 4.5 4.79 4.55
HP_ABNORMAL_MORPHOLOGY_OF_MYOCARDIAL_TRABECULAE 7.14 6.93 6.79 7.07 6.91 6.88 6.94 6.75 6.78 6.61 6.46 6.71 6.84 6.56 6.66 6.45 7.04 6.7 7.05 6.92 6.65 6.83 6.61 6.74 6.85 6.97
HP_CENTRAL_NERVOUS_SYSTEM_CYST 6.78 6.68 6.92 6.97 6.77 6.91 6.9 6.95 6.74 6.9 6.88 6.9 6.82 6.87 6.99 7.06 6.7 6.81 6.89 6.99 6.76 6.92 6.93 6.89 6.95 6.85
HP_CARCINOMA 6.09 6.58 6.34 6.5 7.32 6.49 6.7 6.29 6.94 7.09 6.48 6.76 6.94 6.91 6.28 7.06 6.14 6.75 5.83 6.38 6.11 6.22 6.87 7.09 6.29 6.61
HP_RENAL_FIBROSIS 5.56 5.47 5.65 5.8 5.7 5.15 5.42 5.33 5.64 5.5 5.78 5.65 5.31 5.43 5.12 5.9 5.16 4.92 5.44 5.5 5.2 4.7 5.48 5.36 5.07 5.72
HP_EAR_PAIN 6.36 6.17 6.63 6.52 6.07 6.48 6.66 6.57 6.25 6.57 6.53 6.5 6.45 6.5 6.54 6.52 6.74 6.43 6.25 6.78 6.61 6.54 6.51 6.74 6.36 6.6
HP_ABNORMAL_SERUM_INTERLEUKIN_LEVEL 4.86 4.72 4.93 4.98 4.6 4.46 4.59 4.62 4.58 4.25 4.98 4.58 4.47 4.38 4.61 4.34 5.2 4.98 4.58 4.24 4.97 4.68 4.59 4.48 4.54 4.84
HP_PHOTOPSIA 9.1 8.98 8.99 9.34 9.27 9.37 9.25 9.51 8.91 9.22 8.9 9.47 9.34 9.38 9.41 9.28 9.22 9.49 9.39 9.52 9.12 9.2 9.04 9.47 9.43 9.28
HP_ABNORMAL_JAW_MORPHOLOGY 6.59 6.65 6.8 6.76 6.85 6.9 6.71 6.85 6.77 6.85 6.69 6.79 6.81 6.76 6.79 6.71 6.71 6.68 6.74 6.78 6.69 6.78 6.91 6.9 6.84 6.82
HP_ABNORMAL_C_PEPTIDE_LEVEL 5.87 5.87 6.24 6.55 5.53 5.28 5.85 5.31 5.74 5.52 5.77 5.61 5.66 5.59 5.55 5.55 5.73 5.64 5.17 5.41 5.92 5.8 5.52 5.21 5.65 5.36
HP_SCAPHOCEPHALY 6.59 6.59 7.37 6.47 6.75 6.92 6.68 6.95 6.79 6.74 6.61 6.68 6.9 7.01 6.85 7.01 7.07 7.2 6.82 7.2 6.85 7.05 6.89 6.77 6.64 6.99
HP_ABNORMAL_TONGUE_MORPHOLOGY 6.29 6.45 6.53 6.56 6.62 6.58 6.61 6.48 6.6 6.72 6.56 6.62 6.56 6.56 6.4 6.56 6.56 6.48 6.47 6.51 6.59 6.53 6.51 6.56 6.63 6.6
HP_ABNORMAL_TONGUE_PHYSIOLOGY 7.66 7.16 7.7 8.03 8.09 7.94 7.62 7.47 7.74 7.7 7.7 7.86 7.62 7.66 8.13 7.44 7.33 6.84 7.48 7.65 7.23 7.68 8.05 7.92 7.32 7.53
HP_ABSENT_FOVEAL_REFLEX 4.99 4.87 5.28 5.11 4.68 4.46 5.09 5.2 5.25 4.64 5.21 4.59 4.82 4.89 5 4.93 4.83 5.15 4.59 4.41 5.27 4.74 4.97 4.64 4.81 4.36
HP_WHEEZING 5.46 5.36 5.15 5.2 5.09 5.14 5.33 5.09 5.06 5.67 5.25 5.4 5.26 5.07 5.25 5.65 5.35 5.67 5.23 5 5.4 5.33 5.03 5.02 5.03 5.13
HP_ABNORMAL_BREATH_SOUND 5.66 5.55 5.53 5.55 5.55 5.31 5.57 5.52 5.57 5.93 5.69 5.64 5.42 5.4 5.47 5.73 5.58 5.71 5.35 5.29 5.53 5.41 5.27 5.12 5.55 5.58
HP_CRACKLES 5.66 5.7 5.64 5.83 5.39 4.96 5.32 5.29 5.04 5.1 5.63 5.42 5.26 5.4 5.27 5.35 5.09 5.38 5.15 5.34 5.54 5.28 5.2 4.8 5 5.32
HP_CHOKING_EPISODES 6.87 7.24 7.69 7.33 7.98 8.54 8.38 8.33 7.4 8.46 8.28 8.26 8.29 8.1 8.23 8.34 7.43 7.72 7.75 7.98 7.82 8.2 8.19 7.83 7.79 7.74
HP_HETEROTAXY 5.86 5.54 5.35 6.27 5.21 5.07 5.62 5.44 5.8 5.41 5.61 5.57 5.48 5.1 5.47 5.47 5.8 5.93 5.25 5.27 5.49 5.37 5.68 5.04 5.63 5.48
HP_ADDICTIVE_BEHAVIOR 6.71 6.87 6.66 7.14 6.69 6.6 6.52 6.78 7.22 7.02 7 7.37 7.04 6.83 7.61 6.83 7.09 6.98 6.37 6.62 6.78 6.8 7.21 7.62 7.46 7.2
HP_ABNORMAL_CARDIAC_VENTRICULAR_FUNCTION 6.04 6.08 6.04 6.12 6.22 6.07 6.08 6.08 6.18 6.13 6.25 6.34 6.12 6 5.98 6.07 6.37 6.19 6.03 6.07 6.14 5.97 6.31 5.94 6.06 6.14
HP_ABNORMALITY_OF_PULMONARY_CIRCULATION 6.47 6.48 6.5 6.53 6.48 6.39 6.51 6.53 6.39 6.5 6.37 6.43 6.35 6.48 6.27 6.29 6.56 6.47 6.32 6.44 6.42 6.3 6.55 6.34 6.56 6.44
HP_ABNORMALITY_ON_PULMONARY_FUNCTION_TESTING 6.14 5.86 6.04 6.11 5.74 5.84 6.07 6.12 5.98 6.15 6.02 6.1 6.07 6.06 6.12 5.97 6.11 5.94 5.85 6.24 6.17 6.22 6.02 5.98 6 6.12
HP_RAYNAUD_PHENOMENON 6.53 6.36 6.18 6.41 6.62 6.5 6.31 6.11 6.88 6.63 6.35 6.45 6.4 5.92 6.02 6.26 6.31 6.47 6.26 6.38 5.96 6.07 6.34 6.43 6.27 6.22
HP_HYPERINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI 7.08 6.9 8.18 7.76 7.36 7.58 7.55 7.6 7.6 7.7 7.92 7.98 7.65 7.59 7.58 7.76 7.15 7.46 7.36 7.69 7.88 7.75 7.66 7.83 7.5 7.6
HP_PERIVENTRICULAR_WHITE_MATTER_HYPERDENSITIES 8.86 9.24 9.6 9.28 8.76 9.12 9.69 9.5 9.02 9.14 9.33 9.19 9.06 9.21 9.55 9.46 8.61 9.11 9.43 9.54 9.29 9.36 9.76 9.31 9.46 9.31
HP_ABNORMAL_PERISTALSIS 6.5 6.81 6.35 6.66 6.93 6.74 6.72 6.63 6.98 6.44 6.54 7.03 6.79 6.56 6.35 6.44 7.01 6.79 6.72 6.85 6.85 6.86 7.45 6.67 6.7 7.02
HP_GLOMERULAR_DEPOSITS 5.64 5.8 5.85 5.79 5.43 5.56 5.91 5.57 5.64 5.62 5.62 5.72 5.29 5.17 5.41 5.29 5.61 5.77 5.82 5.57 5.87 5.38 5.42 5.18 5.65 5.68
HP_ABNORMALITY_OF_CARDIOVASCULAR_SYSTEM_ELECTROPHYSIOLOGY 6.44 6.55 6.71 6.61 6.69 6.61 6.65 6.66 6.69 6.82 6.6 6.73 6.66 6.61 6.63 6.65 6.68 6.53 6.65 6.63 6.66 6.64 6.85 6.8 6.65 6.75
HP_ABNORMAL_MORPHOLOGY_OF_THE_GREAT_VESSELS 6.59 6.55 6.64 6.64 6.74 6.77 6.68 6.72 6.71 6.82 6.59 6.71 6.68 6.64 6.63 6.71 6.65 6.55 6.6 6.7 6.75 6.7 6.81 6.86 6.79 6.77
HP_ABNORMAL_SYSTEMIC_BLOOD_PRESSURE 6.23 6.24 6.27 6.29 6.3 6.31 6.24 6.23 6.18 6.29 6.34 6.29 6.25 6.21 6.07 6.17 6.22 6.28 6.26 6.22 6.28 6.31 6.23 6.3 6.19 6.36
HP_ANKYLOSIS 6.41 6.38 6.18 6.9 6.56 6.42 6.35 6.32 6.72 7.12 6.72 6.72 6.79 6.53 6.43 6.67 6.83 6.51 6.33 6.38 6.56 6.31 6.81 6.92 6.74 6.52
HP_BONE_MARROW_HYPERCELLULARITY 6.64 6.67 6.41 6.04 6.62 6.41 6.33 6.77 6.63 6.77 6.07 6.59 6.65 6.65 6.36 6.83 6.42 6.26 6.33 6.3 6.67 6.48 7.15 6.89 6.73 6.48
HP_CHRONIC_INFECTION 6.9 7.23 7.37 7.18 7.68 7.68 7.59 7.91 7.15 7.49 7.12 7.85 7.35 6.95 7.59 7.28 7.59 7.44 7.31 7.38 7.55 7.8 7.25 7.78 7.72 7.93
HP_IMPAIRMENT_OF_ACTIVITIES_OF_DAILY_LIVING 7.23 7.22 7.25 7.18 7.49 7.57 7.62 7.47 7.7 7.58 7.38 7.56 7.68 7.67 7.57 7.43 7.36 7.21 7.4 7.66 7.41 7.55 7.72 7.77 7.58 7.42
HP_ABNORMAL_OVARIAN_MORPHOLOGY 6.32 6.37 6.46 6.49 6.23 6.29 6.37 6.37 6.47 6.55 6.39 6.34 6.44 6.5 6.34 6.47 6.07 6.41 6.37 6.39 6.26 6.4 6.26 6.64 6.16 6.41
HP_ABNORMAL_OVARIAN_PHYSIOLOGY 6.18 5.99 6.17 6.02 5.86 6.03 6.07 6.14 5.84 6.18 6.25 6.05 5.95 5.91 6.01 6.12 5.95 6.18 6.18 6.07 6.07 6.05 5.69 5.89 5.97 6.21
HP_ABNORMAL_ENDOCRINE_PHYSIOLOGY 5.42 5.4 5.38 5.11 4.74 4.78 5.04 4.99 5.39 5.29 5.36 5.06 4.88 4.73 4.98 5.03 5.21 5.41 5.3 5.2 5.31 5.12 5.31 5.2 5.03 4.98
HP_ABNORMAL_THYROID_STIMULATING_HORMONE_LEVEL 6.2 5.88 5.89 5.84 6.09 6.1 5.83 5.77 6.09 6.1 6.13 6.73 6.2 5.95 5.81 5.81 5.61 5.74 6.11 6.14 5.79 5.83 5.79 6.17 5.9 6.66
HP_ABNORMAL_UTERUS_MORPHOLOGY 6.47 6.41 6.6 6.39 6.4 6.58 6.44 6.61 6.54 6.42 6.3 6.58 6.48 6.46 6.35 6.5 6.15 6.24 6.3 6.26 6.43 6.44 6.61 6.7 6.31 6.49
HP_TRICEPS_WEAKNESS 5.39 5.01 5.05 5.57 5.31 4.88 5.05 5.08 5.19 4.76 5.01 4.73 5.06 5.03 4.88 4.97 4.9 5.21 5.15 4.96 5.14 4.82 4.91 4.71 4.79 4.74
HP_RECURRENT_GASTROENTERITIS 5.89 5.68 5.63 5.56 5.57 6.05 5.76 5.39 6.31 5.51 5.74 5.9 5.6 6.12 5.44 5.65 5.89 5.68 5.33 5.45 5.89 5.33 5.49 5.37 5.88 5.94
HP_IMPAIRED_OROPHARYNGEAL_SWALLOW_RESPONSE 6.76 6.76 6.7 7.4 7.02 7.02 6.76 6.75 6.64 6.95 6.74 7.2 6.8 6.95 6.68 6.5 6.75 6.66 7.24 6.76 6.79 6.66 7 7.32 6.49 6.82
HP_NUCHAL_RIGIDITY 6.77 6.84 7.07 7.07 7.24 7.17 7.08 7.22 7.22 7.21 7.4 7.04 6.94 7.29 7.11 7.23 6.84 6.89 6.91 7.46 7.01 7.41 7.38 7.38 7.07 7.02
HP_PRODUCTIVE_COUGH 5.52 5.46 5.36 5.45 5.18 5.36 5.59 5.43 5.24 5.84 5.38 5.63 5.42 5.31 5.5 5.77 5.52 5.79 5.37 5.3 5.54 5.53 5.25 5.11 5.36 5.58
HP_FLUSHING 7.59 7.38 9.05 8.43 8.13 7.9 8.17 8.16 8 7.62 8.36 7.71 8.22 7.88 8.26 7.79 7.82 7.86 8.1 8.18 7.54 8.25 8.38 8.03 8.42 7.9
HP_CUTANEOUS_ABSCESS 5.98 5.57 5.97 6.01 6.03 5.66 5.96 5.8 6.02 5.85 5.84 5.66 6.1 5.97 5.87 5.68 5.73 5.7 5.88 5.57 6.13 6.18 5.92 5.63 5.72 5.82
HP_LEFT_ATRIAL_ENLARGEMENT 5.86 5.74 5.84 6.22 5.38 4.9 5.35 5.04 5.08 5.39 6.25 5.29 4.88 5.11 4.93 5 6.06 6.1 5.61 4.91 5.53 5.27 5.35 4.88 5.45 5.62
HP_ECCHYMOSIS 5.82 5.7 5.49 5.57 5.53 5.38 5.56 5.29 5.51 5.21 5.49 5.53 5.61 5.34 5.54 5.42 5.63 5.62 5.36 5.34 5.66 5.37 5.53 5.16 5.71 5.89
HP_MACULAR_PURPURA 5.86 5.7 5.68 5.57 5.58 5.32 5.57 5.47 5.72 5.36 5.78 5.47 5.62 5.61 5.62 5.45 5.87 5.63 5.45 5.52 5.68 5.61 5.45 5.26 5.71 5.76
HP_ANKLE_WEAKNESS 5.54 5.05 5.05 5.87 5.31 4.88 5.05 5.08 5.19 4.76 5.01 4.73 5.06 5.03 4.88 4.97 4.9 5.21 5.15 4.96 5.14 4.82 4.91 4.71 4.79 4.74
HP_ABNORMAL_CELL_PROLIFERATION 5.46 5.28 5.22 5.31 5.04 5.07 5.42 5.3 5.13 4.99 5.17 4.93 5.18 4.95 5.28 5.12 5.25 5.35 4.92 4.92 5.2 5.13 4.88 4.81 5.15 5.38
HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_MITOGEN 5.33 5.11 5.1 5.23 4.92 4.86 5.05 5.1 4.87 4.98 5.1 4.69 4.87 4.86 4.97 4.9 5.15 5.15 4.91 4.8 5.08 4.89 4.86 4.55 4.87 4.77
HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_T_CELLS 5.7 5.53 5.72 5.92 5.69 5.81 5.73 5.42 5.71 5.46 5.73 5.55 5.51 5.49 5.6 5.51 5.85 5.64 5.43 5.45 5.88 5.66 5.61 5.39 5.55 5.66
HP_ABNORMAL_PROPORTION_OF_CD8_POSITIVE_T_CELLS 5.1 4.98 5.12 5.32 5.17 4.93 4.61 4.86 5.15 4.76 5.01 4.82 4.74 5.17 4.59 5.18 5.41 5.08 4.85 4.84 5.13 5.2 4.72 4.68 5.14 5.11
HP_ABNORMAL_CD4_CD8_RATIO 5.87 5.66 5.98 6.05 6.18 6.05 6.09 5.86 6.07 6.08 5.85 6.07 6.46 6.29 5.75 6.1 6.36 5.84 6.03 6.06 6.4 5.82 6.11 6.03 5.72 5.91
HP_IMPAIRED_ANTIGEN_SPECIFIC_RESPONSE 5.54 5.4 5.31 5.28 5.19 5.21 5.13 5.37 5.13 5.3 5.42 5.08 4.98 5.22 5.49 5.23 5.5 5.35 5.33 5.32 5.24 5.5 5.15 5.07 5.49 5.42
HP_ABNORMAL_LYMPHOCYTE_PHYSIOLOGY 5.89 5.86 5.85 5.89 5.86 5.74 5.86 5.8 5.87 5.78 5.89 5.79 5.83 5.81 5.65 5.65 5.92 5.83 5.84 5.84 5.87 5.86 5.72 5.71 5.81 5.88
HP_ABNORMAL_SPEECH_PROSODY 8.12 8.15 7.75 7.47 8.91 8.81 8.37 8.33 8.37 8.38 7.58 8.26 8.5 8.51 8.19 8.4 8.17 8.05 8.59 8.5 8.13 8.29 8.11 8.49 8.44 8.57
HP_IMPAIRMENT_IN_PERSONALITY_FUNCTIONING 7.37 7.47 7.69 7.62 7.75 7.78 7.72 7.6 7.7 7.77 7.49 7.77 7.75 7.82 7.67 7.63 7.52 7.37 7.66 7.82 7.46 7.68 7.77 7.99 7.66 7.62
HP_STATUS_EPILEPTICUS_WITHOUT_PROMINENT_MOTOR_SYMPTOMS 7.78 8.09 8.37 8.92 8.37 8.27 7.99 8.34 8.11 7.8 8.05 8.07 7.98 8.07 8.37 8.36 7.8 7.92 8.18 8.35 7.8 8.21 8.08 8.22 7.92 7.69
HP_ABNORMAL_MITRAL_VALVE_PHYSIOLOGY 6.61 6.66 6.65 6.53 6.81 6.6 6.64 6.85 6.69 6.98 6.66 6.74 6.66 6.52 6.69 6.59 6.81 6.48 6.55 6.56 6.68 6.64 6.98 6.82 6.67 6.79
HP_ABNORMAL_THYROID_HORMONE_LEVEL 6.69 6.45 6.5 6.17 6.13 5.91 6.65 6.07 6.34 6.55 6.19 6.56 6.46 6.43 6.17 6.45 6.4 6.64 6.42 6.92 6.71 6.58 6.58 6.71 6.7 6.34
HP_CARDIAC_CONDUCTION_ABNORMALITY 6.97 7.1 7 6.9 7.02 7.2 7.21 7.04 7.17 7.25 6.91 7.1 7.27 7.22 7.18 7.08 7.34 6.98 7.07 7.12 7.07 7.2 7.53 7.23 7.34 7.28
HP_ABNORMAL_QT_INTERVAL 6.3 6.26 6.43 6.42 5.87 5.71 6.17 6.11 5.93 6.37 6.27 5.93 6.01 5.87 6.76 6.44 6.31 6.67 6.19 6.07 6.67 6.6 6.17 6.33 6.35 6.7
HP_ABNORMAL_AORTIC_VALVE_CUSP_MORPHOLOGY 6.62 6.57 6.76 6.52 6.86 6.75 6.73 7.13 6.77 6.9 6.58 7.07 6.84 6.7 6.67 6.74 6.94 6.8 6.74 6.8 7.1 6.98 7.19 7.03 7 7.01
HP_ABNORMAL_PR_INTERVAL 6.03 6 6.27 6.5 6 6.06 6.18 6.02 6.11 6.24 6.07 6.14 6.31 6.17 6.4 5.84 6.09 6.11 5.97 6.27 6.11 6.34 6.29 6.44 6.26 6.45
HP_ABNORMALITY_OF_FUNDUS_PIGMENTATION 5.57 5.31 5.75 5.47 5.33 5.1 5.47 5.44 5.41 5.19 5.68 5.19 5.39 5.21 5.37 5.26 5.43 5.53 5.02 5.2 5.65 5.47 5.41 5.26 5.22 5.06
HP_IMPAIRED_TANDEM_GAIT 8.22 8.55 8.37 8.34 8.49 8.24 8.75 8.89 8.88 8.88 8.42 8.86 8.87 8.62 9.01 9.02 8.43 8.24 8.48 8.88 8.76 8.78 8.94 9.19 9.02 8.94
HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_PHYSIOLOGY 6.66 6.74 6.83 6.65 6.85 6.7 6.69 6.91 6.83 7.03 6.78 6.98 6.78 6.57 6.74 6.74 6.87 6.56 6.83 6.61 6.85 6.72 7.05 6.89 6.76 6.89
HP_ABNORMAL_TRICUSPID_VALVE_PHYSIOLOGY 6.6 6.51 6.61 6.67 6.72 6.5 6.58 6.42 6.92 6.53 6.77 6.79 6.5 6.56 6.72 6.58 6.92 6.4 6.88 6.46 6.22 6.37 7.04 6.72 6.52 6.55
HP_ABNORMAL_AORTIC_VALVE_PHYSIOLOGY 6.56 6.59 6.69 6.63 6.66 6.52 6.58 6.61 6.64 6.65 6.53 6.64 6.57 6.48 6.53 6.58 6.71 6.53 6.33 6.58 6.82 6.73 6.66 6.66 6.65 6.75
HP_ABNORMAL_HEART_VALVE_PHYSIOLOGY 6.62 6.59 6.86 6.76 6.83 6.72 6.71 6.86 6.78 6.91 6.77 6.79 6.79 6.58 6.77 6.74 6.85 6.64 6.67 6.75 6.87 6.9 6.96 6.86 6.79 6.86
HP_ABNORMAL_PULMONARY_VALVE_PHYSIOLOGY 6.66 6.57 7.03 6.83 7.01 6.96 7.08 7.16 6.91 7.07 6.91 6.95 7.04 6.94 6.94 6.89 6.96 6.65 6.82 6.93 7.04 7.06 7.19 6.94 6.85 6.82
HP_ABNORMAL_HEART_SOUND 6.13 5.96 6.31 6.23 5.92 5.87 5.96 5.92 6 5.81 6.02 6.12 5.95 5.78 5.63 5.79 5.99 5.85 5.65 5.53 5.78 6.06 6.15 5.89 6.07 6.14
HP_OPPORTUNISTIC_INFECTION 5.04 5.1 5.29 5.29 4.92 4.88 5.05 5.12 5.16 4.97 5 4.76 4.93 4.88 4.77 4.83 4.9 5.09 4.72 4.9 5 4.94 4.91 4.81 5.09 4.84
HP_SEVERE_VIRAL_INFECTION 5.38 5.18 5.88 5.9 4.83 5.3 5.21 5.43 5.85 5.14 5.15 5.45 5.45 5.35 5.5 5.49 5.3 5.37 5.38 5.48 5.37 5.32 5.26 5.4 5.33 5.55
HP_COMPENSATORY_HEAD_POSTURE 5.35 5 5.05 5.3 4.61 4.73 5.01 4.88 5.15 4.88 5.15 4.86 4.72 4.87 4.99 4.69 4.85 5.16 4.82 4.71 4.98 4.78 4.48 4.59 5.07 4.81
HP_CLINICAL_COURSE 6.81 6.82 7.07 6.99 7.06 7.12 7.04 7.04 7.01 7.06 6.95 7 7.09 7.05 7.02 7.03 6.9 6.86 7 7.09 6.83 7.05 7.04 7.14 7.03 7.03
HP_ABNORMAL_ORAL_PHYSIOLOGY 6.91 7.12 7.32 7.34 7.38 7.36 7.41 7.33 7.6 7.4 7.11 7.42 7.46 7.52 7.52 7.34 7.13 7.04 7.37 7.38 7.16 7.49 7.62 7.78 7.43 7.39
HP_ABNORMAL_WAIST_TO_HIP_RATIO 5.43 5.26 5.34 5.67 5 4.82 5.08 4.99 5.47 5.14 5.42 4.87 4.93 5.08 5.27 5.37 5.37 5.29 5.06 5.01 5.32 5.07 5.08 4.71 5.07 4.9
HP_ABNORMAL_REFLEX 7.09 7.17 7.43 7.22 7.28 7.4 7.33 7.34 7.41 7.42 7.26 7.37 7.46 7.46 7.37 7.35 7.16 7.06 7.31 7.39 7.2 7.33 7.46 7.6 7.41 7.33
HP_ABNORMAL_LIBIDO 5.49 5.35 5.72 5.58 5.43 5.09 5.51 5.64 5.85 5.34 5.82 5.4 5.52 5.39 5.88 5.39 5.73 5.49 5.5 5.45 5.91 5.63 5.36 5.1 5.58 6.12
HP_ABNORMAL_HEART_RATE_VARIABILITY 6.07 6.15 6.17 6.59 6.54 6.17 6.09 5.92 6.27 6.56 6.29 6.15 6.6 6.4 5.97 6.19 6.24 6.13 6.12 6.25 6.39 6.39 6.31 6.23 6.27 6.23
HP_ABNORMAL_LIVER_PHYSIOLOGY 7 6.55 6.46 6.91 6.14 6.48 6.72 5.49 5.78 5.92 6.51 6.2 6.06 6.27 6.41 5.73 5.44 6.03 7.16 6.8 5.97 5.34 6.97 6.39 5.63 5.89
HP_ABNORMAL_EYELID_PHYSIOLOGY 7.45 7.39 7.52 7.67 7.36 7.41 7.15 7.3 6.93 7.59 7.59 7.41 7.29 7.07 7.7 7.52 7.48 7.49 7.31 7.45 7.54 8.1 7.49 7.6 7.5 7.37
HP_AGYRIA 7.72 7.53 7.93 6.92 8.38 8.2 8.26 7.99 8.2 7.93 7.38 7.79 8.07 8.3 7.98 7.88 8.05 8.01 8.17 8.21 7.73 8.14 8.01 8.13 8.27 7.76
HP_ABNORMAL_LDL_CHOLESTEROL_CONCENTRATION 6.29 6.13 6.2 6.63 6.84 6.5 6.31 6.32 6.24 6.73 6.2 6.59 6.29 6.21 6.07 6.03 6.36 6.18 6.2 6.38 6.14 6.1 6.35 6.25 6.26 6.52
HP_ABNORMAL_HDL_CHOLESTEROL_CONCENTRATION 5.92 5.73 6.18 6.48 6 6.01 6.1 5.92 5.59 5.87 5.96 5.54 6.16 5.75 5.97 5.55 5.73 5.56 5.6 5.81 5.77 5.94 5.52 5.53 5.61 5.98
HP_MICROGRAPHIA 7.53 7.7 7.46 7.72 8.07 8.12 7.24 7.37 7.01 7.71 7.35 7.79 7.64 7.91 7.85 7.66 7.68 7.49 7.8 8.01 7.69 8.38 7.78 7.64 7.51 7.34
HP_ABNORMAL_CRANIAL_NERVE_PHYSIOLOGY 6.61 6.61 6.79 6.62 6.66 6.95 6.86 6.75 6.94 6.85 6.57 6.88 6.78 6.75 6.74 6.62 6.68 6.72 6.72 6.9 6.6 6.68 6.99 6.88 6.8 6.8
HP_DELAYED_ABILITY_TO_WALK 7.99 8.08 8.26 8.07 8.44 8.5 8.46 8.41 8.33 8.45 8.17 8.27 8.42 8.49 8.44 8.43 8 8.14 8.3 8.51 8.26 8.35 8.36 8.58 8.39 8.32
HP_ABNORMAL_CONUS_TERMINALIS_MORPHOLOGY 7.47 7.53 7.6 8.17 8.01 7.78 7.73 7.56 8.04 7.83 8 7.8 8.14 8.12 8 8.15 8.09 7.91 7.99 7.76 7.52 7.46 8.05 8.37 7.66 7.9
HP_ELEVATED_SERUM_ASPARTATE_AMINOTRANSFERASE 6.77 6.56 7.35 7.19 6.4 6.59 6.69 7.01 6.58 6.73 6.46 6.85 6.44 6.65 7.11 6.55 6.73 5.97 6.5 6.81 6.74 6.89 6.64 7.07 6.77 6.62
HP_ELEVATED_SERUM_ALANINE_AMINOTRANSFERASE 6.22 5.74 7.04 6.64 6.21 6.24 6.46 6.4 6.45 6.39 6 6.4 6.33 6.14 6.21 6.07 6.34 5.77 6.04 6.49 5.85 6.05 6.29 6.51 6.67 6.41
HP_ABNORMAL_URINE_CARBOHYDRATE_LEVEL 6.18 6.37 6.93 7.08 6.52 6.6 6.68 6.65 6.5 6.53 6.57 6.62 6.59 6.44 6.6 6.41 6.47 6.43 6.29 6.67 6.58 6.76 6.91 6.73 6.64 6.76
HP_ABNORMAL_URINE_CARBOXYLIC_ACID_LEVEL 6.28 6.23 6.85 6.76 6.59 6.34 6.28 6.32 6.54 6.52 6.6 6.21 5.97 6.2 6.42 6.33 6.22 6.05 6.38 6.63 6.07 6.46 6.49 6.48 6.41 6.58
HP_ABNORMAL_PULMONARY_THORACIC_IMAGING_FINDING 6.19 6.58 6.38 6.29 6.32 6.63 6.19 6.02 6.52 6.36 6.31 6.26 6.32 6.58 6.13 6.15 6.42 6.36 6.34 6.38 6.35 6.07 6.36 6.35 6.15 6.31
HP_HETEROTROPIA 6.69 6.95 7.15 7.16 7.01 7.18 7.2 7.19 7.17 7.14 6.95 7.07 7.27 7.05 7.18 7.15 7.01 6.93 7.14 7.18 6.99 7.16 7.18 7.4 7.19 6.96
HP_ABNORMAL_SPUTUM 5.67 5.46 5.34 5.54 5.18 5.23 5.61 5.51 5.47 5.69 5.51 5.63 5.43 5.3 5.49 5.66 5.61 5.84 5.39 5.35 5.57 5.54 5.36 5.14 5.44 5.55
HP_DECREASED_VIGILANCE 8.3 8.36 7.35 7.93 9.02 8.86 8.42 8.53 8.28 8.42 8.23 8.32 8.4 8.7 8.37 8.51 8.23 8.29 8.45 8.7 8.16 8.35 8.29 8.51 8.3 8.34
HP_UNUSUAL_INFECTION 6.18 6.18 6.16 6.27 6.19 6.19 6.21 6.19 6.19 6.22 6.24 6.13 6.24 6.26 6.12 6.22 6.15 6.15 6.08 6.25 6.2 6.2 6.24 6.22 6.25 6.37
HP_KERATOSIS_PILARIS 7.37 7.2 7.76 8.43 6.99 7.07 7.58 7.5 7.82 7.71 7.58 7.63 8.07 7.97 7.85 7.89 7.36 7.01 7.42 7.48 7.23 7.46 8.11 8.13 7.59 7.73
HP_JOINT_SUBLUXATION 6.72 6.83 6.34 6.46 6.94 6.92 7.26 7.02 6.66 6.92 6.79 6.75 6.98 7.03 6.85 7.32 7.08 7.32 7.07 7.13 7.14 7.44 6.89 6.65 6.77 7.37
HP_APHTHOUS_ULCER 5.2 5.17 5.73 5.59 5.29 5.14 5.43 5.45 5.34 5.11 5.75 5.17 5.27 5.24 5.33 5.15 5.58 5.27 4.74 5.22 5.39 5.5 5.02 5 5.51 5.3
HP_UNUSUAL_INFECTION_BY_ANATOMICAL_SITE 5.46 5.41 5.62 5.51 5.28 5.27 5.61 5.48 5.52 5.34 5.38 5.04 5.38 5.34 5.46 5.24 5.61 5.3 5.27 5.35 5.55 5.64 5.24 5.08 5.25 5.27
HP_SEVERE_INFECTION 5.22 5.08 5.11 5.37 4.84 4.88 5 4.99 5.18 4.99 5.13 5.16 4.95 4.96 4.82 5.15 5.05 5.33 4.8 4.85 5.24 4.98 4.98 4.89 5.05 4.86
HP_ABNORMAL_CIRCULATING_METABOLITE_CONCENTRATION 6.35 6.38 6.51 6.49 6.51 6.54 6.45 6.43 6.47 6.58 6.44 6.47 6.46 6.47 6.41 6.43 6.44 6.4 6.46 6.5 6.42 6.44 6.52 6.51 6.53 6.51
HP_ABNORMAL_CEREBROSPINAL_FLUID_METABOLITE_CONCENTRATION 7.35 7.26 8.12 7.11 7.84 8.12 8.13 8.01 7.96 8.06 7.97 8.2 7.92 8.49 8.08 8.52 7.98 7.84 7.98 7.53 7.76 7.86 8.2 8.35 7.91 8.03
HP_ABNORMAL_TISSUE_METABOLITE_CONCENTRATION 7.13 7.16 7.31 7.04 7.31 7.48 7.16 7.01 6.99 7.21 6.88 7.43 7.2 7.42 7.23 7.33 7.2 7.35 7.48 7.45 7.18 7.26 7.16 7.54 7.4 7.35
HP_ABNORMAL_METABOLISM 6.57 6.56 6.78 6.82 6.87 6.68 6.91 6.86 6.98 6.8 6.54 6.96 6.93 6.79 6.82 6.66 6.48 6.43 6.6 6.94 6.61 6.66 6.94 7.01 6.86 6.77
HP_ABNORMAL_IMMUNE_SYSTEM_MORPHOLOGY 6.14 6.19 6.12 6.18 6.22 6.13 6.14 6.17 6.21 6.13 6.09 6.08 6.21 6.2 6.03 6.1 6.14 6.15 6.02 6.15 6.19 6.18 6.28 6.21 6.17 6.22
HP_INCREASED_BLOOD_PRESSURE 6.4 6.38 6.4 6.35 6.48 6.53 6.46 6.47 6.38 6.52 6.44 6.39 6.41 6.41 6.22 6.4 6.48 6.43 6.47 6.49 6.42 6.4 6.39 6.49 6.4 6.49
HP_ABNORMAL_GRANULOCYTE_COUNT 6.24 6.31 6.21 6.29 6.4 6.54 6.4 6.48 6.42 6.36 6.25 6.27 6.51 6.49 6.35 6.39 6.34 6.38 6.33 6.49 6.3 6.22 6.39 6.48 6.36 6.43
HP_REDUCED_FORCED_VITAL_CAPACITY 5.99 5.8 6.19 6.08 5.72 5.69 5.97 5.98 5.95 6.27 6.03 6.02 5.85 5.85 6.1 5.99 5.75 5.98 5.59 5.74 6.21 6.09 6.06 5.55 6.09 5.93
HP_ABNORMAL_GROWTH_HORMONE_LEVEL 6.37 6.39 6.51 6.44 6.46 6.67 6.62 6.55 6.44 6.55 6.44 6.57 6.62 6.55 6.56 6.52 6.35 6.34 6.43 6.72 6.61 6.55 6.6 6.68 6.59 6.6
HP_ACIDEMIA 6.57 6.61 7.59 7.41 7.21 7.12 7.47 7.18 6.88 6.74 7.33 6.94 7.21 7.1 7.06 7.15 6.48 6.81 6.82 6.92 6.42 7.24 6.95 6.97 6.98 7.03
HP_PERIVENTRICULAR_NODULAR_HETEROTOPIA 7.87 7.99 7.8 7.72 8.04 8.09 8.13 8.49 8.23 8.08 7.37 8.23 8.45 8.15 8.41 7.99 8.2 8.01 8.13 8.36 8.09 8.27 8.17 8.36 8.63 8.3
HP_ABNORMAL_C_REACTIVE_PROTEIN_LEVEL 5.43 5.4 5.07 5.28 4.88 4.57 4.85 4.99 5.02 4.76 5.15 4.76 4.77 4.93 4.84 5.03 5.07 5.34 5.03 4.82 5.35 5.05 4.68 4.63 4.88 4.84
HP_PULMONARY_CYST 7.35 7.43 7.4 7.45 7.87 7.91 8.15 8.39 7.55 8.46 7.03 7.33 7.24 7.73 7.95 7.72 7.97 7.3 7.54 8.12 8.15 8.25 7.54 7.98 7.94 8.49
HP_ABSENT_SPERM_FLAGELLA 5.28 5.49 5.19 5 4.97 5.08 5.36 5.25 4.98 5.42 5.36 5.37 5.17 5.13 5.21 5.49 5.28 5.55 5.55 5.34 5.41 5.36 4.94 4.81 4.98 5.13
HP_STATUS_EPILEPTICUS_WITH_PROMINENT_MOTOR_SYMPTOMS 9.46 9.53 10.05 10.25 9.92 9.92 10.04 9.41 10.16 10.47 9.63 9.25 10.03 10.05 9.82 9.48 8.98 9.24 9.67 9.82 9.59 9.49 10.16 10.11 9.33 8.91
HP_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA 7.43 7.51 8.15 8.74 7.69 7.73 7.64 7.81 7.74 7.67 7.85 7.74 7.74 7.95 7.93 8.1 7.4 7.49 7.86 7.76 7.59 7.72 7.96 7.95 7.48 7.53
HP_GENERALIZED_ONSET_MOTOR_SEIZURE 7.82 8 8.04 7.81 8.15 8.25 8.31 8.21 8.19 8.2 7.89 8.28 8.23 8.22 8.43 8.11 7.95 8.01 8.15 8.22 8.02 8.16 8.24 8.36 8.25 8.16
HP_FOCAL_NON_MOTOR_SEIZURE 9.15 9.1 8.7 8.56 9.33 9.46 9.78 9.67 9.62 9.65 9.08 9.39 9.57 9.46 9.3 9.28 9.23 9.46 9.4 9.86 9.1 9.34 9.53 9.63 9.54 9.16
HP_TONIC_SEIZURE 8.75 9.15 8.57 8.38 9.02 9.39 9.37 9.25 9.26 9.34 8.84 9.24 9.32 9.31 9.29 9.08 8.47 8.83 9.11 9.32 9.02 9.31 9.42 9.5 9.03 8.64
HP_MYOCLONIC_SEIZURE 7.74 7.85 7.98 7.77 8.12 8.17 8.16 8.14 8.05 8.06 7.81 8.07 8.18 8.17 8.15 7.97 7.85 7.86 8.12 8.19 7.82 7.98 8.11 8.35 8.13 7.99
HP_INFECTION_RELATED_SEIZURE 8.13 8.26 8.04 7.79 8.54 8.68 8.52 8.3 8.33 8.21 7.89 8.34 8.27 8.28 8.32 8.18 7.87 8.07 8.39 8.64 7.92 8.16 8.42 8.46 8.3 8.21
HP_ABNORMAL_URINE_PH 6.69 6.64 7.38 7.08 6.83 6.98 6.94 6.88 6.89 6.92 6.93 6.88 6.97 7 6.53 6.97 6.77 6.64 6.78 7.01 6.65 6.98 6.85 6.98 7.04 7
HP_MALE_REPRODUCTIVE_SYSTEM_NEOPLASM 5.84 6.05 6.07 6.31 6.34 6.2 6.24 6.57 6.15 6.24 6.15 6.29 6.22 6.13 6.44 6.16 5.98 5.86 5.96 6.17 6.46 6.27 6.64 6.76 6.18 6.3
HP_FEMALE_REPRODUCTIVE_SYSTEM_NEOPLASM 6.98 7.15 7.15 6.72 7.32 7.37 7.14 7.27 6.94 7.09 6.85 7.16 7.16 7.27 7.34 7.27 6.83 6.75 7.02 7.29 7.06 7.19 7.27 7.22 7.37 7.33
HP_PSYCHOGENIC_NON_EPILEPTIC_SEIZURE 9.08 8.97 8.93 8.65 9.27 9.2 9.42 9.31 9.16 9.23 8.89 9.07 9.24 9.39 9.2 9.24 9.05 8.88 8.95 9.22 9.01 9.12 9.24 9.25 9.34 9.02
HP_ABNORMAL_MACROSCOPIC_URINE_APPEARANCE 6.3 6.49 6.87 6.4 6.59 6.49 6.69 6.21 6.86 6.83 6.62 6.62 6.26 6.43 6.58 6.67 6.5 6.35 6.54 6.51 5.94 6.18 6.91 6.89 6.42 6.18
HP_APLASIA_HYPOPLASIA_OF_THE_THYROID_GLAND 5.3 4.94 5.22 5.27 4.99 4.92 5.16 5.14 4.95 5.13 5.36 4.98 4.7 4.71 4.78 4.66 5.29 5.07 5.13 4.79 5.12 4.97 5.14 4.61 4.92 5.01
HP_INCREASED_SULFUR_AMINO_ACID_LEVEL_IN_URINE 7.39 7.2 7.52 7.95 8.04 8.02 7.84 7.62 8.15 8.44 8.1 7.62 8.3 8.48 8.25 8.74 7.51 7.2 7.4 7.99 7.25 8.06 7.78 8.16 8.12 8.26
HP_INCREASED_URINARY_NON_PROTEINOGENIC_AMINO_ACID_LEVEL 5.49 5.41 5.35 5.61 4.9 4.61 5.1 5.2 5.24 5.08 5.55 4.96 4.84 5.17 4.99 5.02 5.24 5.4 5.03 4.9 5.37 5.21 4.97 4.81 4.92 5.11
HP_INCREASED_SERINE_FAMILY_AMINO_ACID_IN_URINE 6.46 6.27 6.76 6.49 6.57 6.45 6.67 6.7 5.96 6.62 6.42 6.76 6.32 6.6 6.2 6.6 6.74 7.05 6.76 6.76 6.86 6.79 6.19 6.55 6.19 6.52
HP_INCREASED_PROTEINOGENIC_AMINO_ACID_LEVEL_IN_URINE 6.35 6.3 6.56 6.58 6.48 6.55 6.67 6.66 6.38 6.3 6.3 6.52 6.55 6.39 6.2 6.27 6.71 6.48 6.42 6.77 6.42 6.77 6.18 6.16 6.57 6.58
HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_CONCENTRATION 6.68 6.61 6.92 7.08 7.03 7.03 6.95 6.73 6.55 6.9 6.7 6.84 6.97 6.86 6.55 6.93 6.77 6.77 6.63 6.81 6.65 6.81 6.75 6.97 6.71 6.96
HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_CONCENTRATION 7.27 7 8.17 7.81 7.45 7.58 7.66 7.6 7.54 7.9 7.87 7.57 7.73 8 7.78 7.71 7.07 7.26 7.7 7.74 7.52 7.7 7.66 7.75 7.74 7.57
HP_ABNORMAL_CIRCULATING_NON_PROTEINOGENIC_AMINO_ACID_CONCENTRATION 5.37 5.35 4.97 4.95 4.84 4.62 5.22 5.06 4.9 4.9 4.78 4.81 4.84 5.02 4.97 5.09 5.43 5.04 4.92 4.93 5.34 5.4 4.89 4.84 5.05 5.27
HP_ABNORMAL_RIGHT_VENTRICULAR_FUNCTION 5.25 4.88 5.3 5.48 4.85 4.71 4.94 4.83 4.84 5.2 5.22 5.21 4.77 4.76 4.83 4.79 4.56 4.78 4.54 4.73 4.9 4.95 5.18 4.89 4.74 4.92
HP_ABNORMAL_SHOULDER_PHYSIOLOGY 6.26 6.21 6.09 5.96 6.04 6.3 6.37 6.33 6.66 6.32 6.16 6.61 6.38 6.14 6.06 5.85 6.45 6.5 6.11 6.45 6.13 6.06 6.72 6.63 6.62 6.67
HP_ABNORMAL_RENAL_ECHOGENICITY 6.23 6.24 6.1 6.22 6.61 6.71 6.24 6.16 5.94 6.24 5.98 6.41 6.38 6.09 6.34 6.16 6.13 6.43 6.43 6.33 6.11 6.42 6.29 6.27 6.01 6.46
HP_ABNORMAL_PHARYNX_MORPHOLOGY 5.94 5.83 5.94 6.06 5.93 5.95 6.05 5.95 6.03 6.1 6.03 5.87 6.1 6.15 5.96 6.13 6.09 6.18 5.94 6.08 6.22 6.13 6 5.92 6.06 6.06
HP_NON_MOTOR_SEIZURE 8.15 8.33 8.38 7.95 8.71 8.73 8.85 8.53 8.88 8.68 8.24 8.54 8.7 8.64 8.8 8.68 8.16 8.15 8.5 8.68 8.28 8.49 8.79 8.81 8.65 8.35
HP_ACUTE_PHASE_RESPONSE 5.55 5.55 5.3 5.77 5.03 4.94 5.36 5.25 5.33 5.18 5.33 5.05 5.1 5.05 5.24 5.11 5.3 5.5 5.15 5.19 5.7 5.34 5.07 4.89 5.1 5.3
HP_NEURALGIA 7.16 7.4 6.97 7.94 7.69 7.57 7.4 7.05 7.63 7.4 7.26 7.57 7.37 7.49 7.41 7.26 7.38 7.36 7.33 7.46 7.2 6.8 7.72 8.09 7.5 7.22
HP_EPILEPTIC_AURA 8.86 8.87 8.23 8.57 9.3 9.44 9.21 9.59 9.11 9.14 8.57 9.39 9.23 9.35 9.23 9.14 9.13 8.13 9.36 9.52 8.69 9.01 8.79 9.33 9.05 8.58
HP_ABNORMAL_URINE_METABOLITE_LEVEL 6.3 6.3 6.47 6.48 6.44 6.5 6.41 6.4 6.38 6.41 6.32 6.39 6.36 6.26 6.3 6.31 6.28 6.29 6.38 6.39 6.25 6.29 6.31 6.42 6.42 6.47
HP_TISSUE_ISCHEMIA 6.21 6.23 6.34 6.29 6.35 6.3 6.18 6.13 6.55 6.27 6.36 6.28 6.38 6.22 6.01 6.15 6.17 6.21 6.08 6.35 6.29 6.14 6.42 6.34 6.22 6.18
HP_NEUROINFLAMMATION 4.99 4.95 5.04 5.17 5.37 5.22 4.79 4.88 5.17 4.55 5.04 4.91 4.98 5.38 5.14 5.23 5.61 4.98 4.99 5.17 5.28 5.9 4.59 4.58 5.49 5.46
HP_TUBE_FEEDING 7.53 7.6 7.77 7.82 7.84 8.05 7.93 7.78 7.99 8.01 7.66 7.89 8 8 7.78 7.78 7.68 7.62 7.78 8 7.7 7.78 7.94 8.14 7.94 7.74
HP_ABNORMAL_CIRCULATING_BILIRUBIN_CONCENTRATION 6.07 5.84 5.93 6.14 5.9 5.8 6.08 5.66 5.78 5.92 6.09 6.05 5.72 5.72 5.86 5.88 5.46 6.03 5.8 5.81 5.71 5.78 6.1 5.4 5.64 5.89
HP_PRE_CAPILLARY_PULMONARY_HYPERTENSION 6.53 6.58 6.65 6.75 6.87 6.68 6.71 6.88 6.61 6.84 6.57 6.66 6.59 6.75 6.68 6.56 6.72 6.77 6.57 6.91 6.61 7.05 6.83 6.87 6.71 6.84
HP_MORTALITY_AGING 6.58 6.7 6.88 6.78 6.9 7.07 6.78 6.73 6.79 6.9 6.68 6.84 7.03 6.96 6.77 6.75 6.79 6.79 6.82 6.89 6.64 6.87 6.88 6.91 6.8 6.81
HP_CHROMOSOME_BREAKAGE 6.01 5.9 6.32 6.42 5.97 6.11 6.36 6.35 6.16 6.31 6.08 6.11 6.29 6.16 6.08 6.28 6.15 6.01 5.95 6.19 6.16 6.34 6.42 6.58 5.96 6.34
HP_FINGER_CLINODACTYLY 6.53 6.62 6.64 6.76 6.77 6.87 6.67 6.85 6.7 6.81 6.6 6.72 6.77 6.69 6.76 6.63 6.69 6.55 6.69 6.75 6.72 6.85 6.81 6.95 6.77 6.81
HP_DECREASED_ADIPOSE_TISSUE 6.22 6.31 6.2 6.59 6.36 6.58 6.25 6.22 6.42 6.59 6 6.44 6.42 6.07 5.94 6.24 5.88 6.16 6.33 6.22 6.2 6.2 6.43 6.4 6.2 6.42
HP_ABNORMAL_LOWER_LIMB_BONE_MORPHOLOGY 6.55 6.6 6.69 6.65 6.76 6.87 6.66 6.79 6.65 6.75 6.69 6.74 6.79 6.73 6.76 6.74 6.68 6.66 6.75 6.71 6.68 6.81 6.81 6.82 6.79 6.83
HP_ABNORMAL_UPPER_LIMB_BONE_MORPHOLOGY 6.59 6.62 6.69 6.7 6.82 6.73 6.67 6.85 6.74 6.87 6.73 6.76 6.82 6.76 6.7 6.77 6.63 6.65 6.66 6.71 6.7 6.83 6.98 6.92 6.74 6.84
HP_ABNORMAL_FOREARM_BONE_MORPHOLOGY 6.04 6.06 5.96 6.17 6.2 6.24 6.24 6.25 6.14 6.17 6.13 6.06 6.12 6.06 6.08 6.08 6.01 6 5.91 6.17 5.92 6.12 6.26 6.49 6.07 5.83
HP_HYPOPITUITARISM 6.38 6.32 6.51 6.41 6.46 6.65 6.57 6.55 6.48 6.49 6.43 6.56 6.68 6.59 6.51 6.49 6.41 6.42 6.43 6.77 6.47 6.53 6.6 6.68 6.58 6.57
HP_AXONAL_DEGENERATION 7.33 7.19 7.88 7.2 7.43 7.4 7.32 7.52 7.46 7.75 7.4 7.47 7.07 7.04 7.09 7.22 7.76 6.9 7.08 7.56 6.69 6.9 7.45 7.44 7.15 7.8
HP_HAPPY_DEMEANOR 7.62 8.16 8.78 8.59 8.67 8.89 8.73 8.7 9.08 9.06 9.44 8.79 8.99 8.71 8.86 8.68 8.64 8.28 8.39 8.64 8.7 8.74 9.4 9.32 8.68 8.21
HP_TOE_WALKING 6.59 6.79 6.5 6.66 6.64 6.89 6.63 6.64 6.77 6.98 6.53 7.03 6.66 6.7 6.9 6.59 6.85 6.57 6.78 6.63 6.37 6.59 6.83 6.9 6.92 6.9
HP_ABNORMAL_CIRCULATING_RENIN 5.05 4.75 4.64 4.96 4.43 4.44 4.58 4.5 4.6 4.28 4.66 4.44 4.43 4.48 4.51 4.35 4.68 4.82 4.5 4.62 4.86 4.61 4.45 4.39 4.52 4.36
HP_ABNORMAL_CIRCULATING_ALDOSTERONE 5.02 4.9 5.19 5.29 4.73 4.61 4.69 4.71 4.89 4.44 4.69 4.48 4.69 4.53 4.79 4.48 4.84 4.8 4.75 4.62 5.01 4.72 4.71 4.51 4.85 4.49
HP_ABNORMAL_PROLACTIN_LEVEL 6.07 6.05 6.42 6.42 6.09 6.32 6.28 6.31 6.18 6.19 6.26 6.42 6.19 6.14 6.17 6.32 6.45 6.28 6 6.18 6.24 6.43 6.08 6.21 6.12 6.39
HP_ABNORMAL_VITAMIN_B12_LEVEL 6.66 6.63 6.93 7.19 7.05 7.51 7.49 7.24 6.95 6.79 7.12 7.09 7.48 7.54 7.45 7.39 6.63 6.7 6.72 7.49 6.25 7.35 6.77 6.93 7.33 7.47
HP_ABNORMAL_NERVE_CONDUCTION_VELOCITY 7.37 7.4 7.94 7.37 7.9 7.96 7.74 7.92 7.64 8.02 7.64 7.89 7.94 7.85 7.69 7.77 7.61 7.3 7.76 8 7.48 7.48 7.86 8.03 7.84 7.75
HP_ABNORMAL_SERUM_IRON_CONCENTRATION 5.59 5.57 5.84 5.97 5.45 5.22 5.6 5.11 5.32 5.24 5.88 5.12 5.09 5.29 5.41 5.32 5.44 5.48 5.09 4.93 5.4 5.64 5.35 4.72 5.07 5.39
HP_ABNORMAL_MOTOR_NERVE_CONDUCTION_VELOCITY 7.75 7.5 7.99 7.36 8.08 8.05 8.15 8.1 8.3 8.27 7.72 8 8.35 8.14 7.84 8.17 7.94 7.44 7.76 8.15 7.76 7.6 8.23 8.6 8.28 7.92
HP_ABNORMAL_SENSORY_NERVE_CONDUCTION_VELOCITY 7.33 7.05 7.69 7.17 7.17 7.31 7.38 7.25 7.35 7.61 7.37 7.51 7.27 7.36 7.24 7.35 7.06 7.26 7.44 7.46 6.96 7.06 7.49 7.7 7.31 7.09
HP_ABNORMAL_CIRCULATING_FERRITIN_CONCENTRATION 5.56 5.35 5.63 5.75 5.14 5.2 5.35 5.32 5.4 5.24 5.47 5.31 5.04 5.29 5.49 5.17 5.39 5.58 5.1 5.13 5.65 5.44 5.27 5.03 5.42 5.68
HP_DEGENERATION_OF_THE_STRIATUM 7.94 8.03 8.19 7.46 8.25 8.37 8.48 8.29 8.33 8.47 8.48 8.39 8.1 8.39 8.48 7.98 8.36 8.36 8.37 8.37 8.18 8.35 8.46 8.7 8.37 8.25
HP_ELEVATED_URINARY_CARBOXYLIC_ACID 6.3 6.18 6.24 6.21 6.59 6.34 6.61 6.35 6.76 6.52 6.36 5.91 5.85 6.1 6.22 5.76 6.31 6.05 6.11 6.63 5.98 5.97 6.49 6.24 6.41 6.58
HP_GENERALIZED_OSTEOPOROSIS 6.08 6.14 5.94 5.89 6.47 6.32 6.08 5.96 6.18 6.4 6.16 6.1 6.19 6.03 5.83 5.91 6.31 6.28 5.84 6.18 6.08 5.83 6.55 6.61 6.35 6.29
HP_ABNORMAL_PELVIS_BONE_MORPHOLOGY 6.77 6.77 6.31 6.64 6.91 6.89 6.81 6.93 6.73 6.96 6.76 7.08 7.06 6.91 6.9 6.94 6.53 6.8 7.06 6.9 6.77 7.03 6.99 7.18 7.24 7.04
HP_ABNORMALITY_OF_HAIR_GROWTH 6.86 6.56 6.78 6.72 6.97 6.8 6.6 6.85 6.66 6.9 7.08 6.76 7.2 7.16 6.96 7.22 6.69 6.96 6.79 6.94 6.75 7.03 7.13 6.8 6.61 6.66
HP_SCALING_SKIN 6.23 5.74 5.85 6.05 5.79 5.92 6.11 5.93 6.11 6.36 6.33 6.12 6.38 5.81 5.97 6.01 6.75 6.08 6.1 6.23 6.14 6.26 6.34 6 6.53 6.64
HP_INCREASED_HEAD_CIRCUMFERENCE 7.1 7.12 7.38 7.13 7.31 7.44 7.37 7.34 7.4 7.49 7.29 7.4 7.39 7.41 7.31 7.36 7.21 7.07 7.34 7.36 7.25 7.45 7.5 7.54 7.37 7.36
HP_DECREASED_HEAD_CIRCUMFERENCE 7.12 7.24 7.45 7.41 7.38 7.52 7.47 7.44 7.46 7.46 7.27 7.43 7.52 7.52 7.48 7.39 7.2 7.17 7.37 7.46 7.23 7.41 7.46 7.63 7.49 7.4
HP_MILD_MICROCEPHALY 7.09 7.29 8.09 7.79 7.58 7.28 7.4 7.6 7.54 7.25 7.53 7.2 7.58 7.34 7.89 7.38 7.18 7.06 7.09 7.5 7.6 7.6 8.33 7.65 7.35 7.16
HP_ABNORMAL_CONSUMPTION_BEHAVIOR 6.38 6.58 6.55 6.43 6.53 6.56 6.59 6.47 6.45 6.65 6.41 6.64 6.49 6.41 6.4 6.54 6.57 6.52 6.43 6.69 6.42 6.59 6.6 6.7 6.64 6.62
HP_ABNORMAL_SKIN_MORPHOLOGY_OF_THE_PALM 6.85 6.89 7.08 6.94 7.01 7.12 7.08 7.03 7.18 7.16 6.88 7.13 7.16 7.21 7.17 7.13 6.99 6.9 7 7.22 7.02 7.05 7.16 7.23 7.17 7.13
HP_ABNORMAL_INSULIN_LEVEL 6.01 6.01 6.15 6.27 6.08 6.18 5.98 6.12 6.22 6.12 6.09 6.18 6.29 6.16 6.03 6.18 5.97 6.1 6.09 6.13 6.17 6.1 6.05 6.24 5.93 6.27
HP_HYPOINSULINEMIA 5.64 5.63 5.3 5.54 5.5 5.03 5.49 5.22 5.62 5.22 5.38 5.25 5.51 5.46 5.36 5.42 5.46 5.33 5.12 5.18 5.33 5.19 5.18 5.17 5.52 5.25
HP_ELEVATED_HEMOGLOBIN_A1C 5.43 5.26 5.32 5.58 5.03 4.98 5.46 5.09 5.56 5.14 5.34 5.01 5.24 5.23 5.1 5.37 5.36 5.29 5 5.01 5.32 5.09 5.17 4.79 5.07 5.14
HP_PULMONARY_HEMORRHAGE 6.91 6.98 6.69 6.81 6.86 6.76 6.58 6.77 7.16 6.99 6.87 7.16 7.04 6.91 7.16 6.94 7.07 6.98 6.65 6.7 6.89 6.98 7.21 7.32 7.35 6.99
HP_ABNORMAL_SIZE_OF_THE_CLITORIS 6.69 6.58 7.1 7.02 6.92 7.11 6.9 6.68 6.89 7.05 6.88 6.91 6.89 7.23 6.72 6.74 6.35 6.68 7 7.03 6.81 6.63 7.15 7.2 6.87 6.86
HP_IMPAIRED_GLUCOSE_TOLERANCE 5.63 5.49 5.33 5.77 5.5 5.03 5.52 5.22 5.64 5.22 5.44 5.25 5.51 5.46 5.36 5.42 5.46 5.47 5.12 5.18 5.42 5.39 5.26 5.17 5.55 5.25
HP_ADENOCARCINOMA_OF_THE_INTESTINES 6.87 6.33 7.18 6.86 7.18 6.22 6.82 6.35 7.07 6.68 7.12 6.5 6.75 6.58 6.45 7 6.41 6.65 6.42 6.1 7.16 6.47 6.66 6.79 6.11 6.03
HP_ADENOCARCINOMA_OF_THE_LARGE_INTESTINE 6.81 5.49 7.15 6.72 5.99 5.51 5.72 5.84 6.57 5.83 7.07 5.63 6.01 5.95 6.14 6.76 5.85 6.25 5.67 5.47 7.15 5.59 6.25 6.17 5.81 5.86
HP_NEOPLASM_OF_THE_PITUITARY_GLAND 7.47 7.57 7.82 7.63 7.96 7.81 7.53 7.54 7.55 7.72 7.6 7.71 7.65 7.74 7.54 7.73 7.51 7.27 7.56 7.56 7.22 7.48 7.92 8.03 7.58 7.54
HP_NASOGASTRIC_TUBE_FEEDING 7.54 7.52 7.76 7.75 7.71 8.06 7.84 7.65 7.9 7.77 7.6 7.44 7.73 7.8 7.67 7.64 7.52 7.49 7.8 7.86 7.45 7.56 7.62 8 7.89 7.63
HP_MALE_SEXUAL_DYSFUNCTION 6.59 6.38 6.68 6.64 6.41 6.61 6.93 6.68 6.82 6.72 6.53 6.65 6.9 6.92 6.83 6.64 6.84 6.51 6.51 6.94 6.93 6.92 6.8 7.11 6.55 6.86
HP_ABNORMAL_MORPHOLOGY_OF_THE_OLFACTORY_BULB 5.91 5.95 6.04 6.47 5.95 5.9 5.79 5.92 5.87 6.2 6.2 5.79 6.08 6.31 5.86 5.87 6.22 5.93 5.91 6.09 6.3 6.02 6.29 5.85 5.79 5.89
HP_ABNORMAL_SUBSTANTIA_NIGRA_MORPHOLOGY 8.38 8.11 7.5 7.99 7.49 7.43 7.11 7.07 7.5 7.47 7.52 7.32 7.3 7.5 7.84 7.42 7.56 7.53 7.77 7.73 7.51 7.49 6.93 7.48 7.24 7.2
HP_ABNORMAL_MORPHOLOGY_OF_THE_RADIUS 6.15 6.16 6.24 6.42 6.38 6.42 6.34 6.34 6.21 6.37 6.57 6.27 6.25 6.48 6.43 6.2 6.44 6.11 6.01 6.22 6.11 6.36 6.36 6.6 6.21 5.85
HP_CONGENITAL_MALFORMATION_OF_THE_LEFT_HEART 6.39 6.24 6.37 6.2 6.09 6.17 6.17 6.61 6.09 5.95 6.01 5.77 6.07 6.17 6.05 6.03 6.06 6.21 5.95 6.08 6.24 6.5 5.84 5.77 6.15 6.13
HP_NARROW_PALPEBRAL_FISSURE 6.66 6.64 6.49 6.65 6.78 6.65 6.66 6.93 6.66 6.88 6.72 6.69 6.88 6.76 6.64 6.86 6.84 6.81 6.88 6.94 6.87 6.8 6.81 6.68 6.79 7.04
HP_ABNORMALITY_OF_THE_THORACIC_CAVITY 6.86 6.92 6.96 6.59 7.36 7.4 7.17 6.96 7.05 7 6.76 6.86 7.22 7.08 6.89 7.21 7.05 6.85 7.28 7.18 7.08 6.96 7.35 7.32 7.5 7.17
HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS 6.53 6.52 6.26 6.48 6.2 6.29 6.41 6.4 6.67 6.7 6.07 6.2 6.29 6.05 6.05 6.24 6.56 6.43 6.17 6.21 6.26 6.37 6.67 6.42 6.75 6.94
HP_ABNORMAL_LACTATE_DEHYDROGENASE_LEVEL 6.52 6.61 6.66 6.46 6.59 6.92 6.57 6.5 6.6 6.65 6.59 6.58 6.49 6.5 6.41 6.58 6.63 6.44 6.65 6.37 6.44 6.57 6.73 6.62 6.8 6.99
HP_ABNORMAL_LEVELS_OF_ALPHA_FETOPROTEIN 6.4 6.89 6.93 6.74 6.77 6.58 6.72 6.65 6.97 6.98 6.81 7.07 6.86 6.75 6.5 6.74 6.95 6.7 6.52 6.8 6.8 7.06 7.04 7.13 6.91 7.07
HP_ABNORMALITY_OF_THE_TESTIS_SIZE 5.94 5.95 6.11 6.05 5.74 5.77 5.8 5.89 5.92 5.86 5.81 5.87 5.87 5.84 6.08 5.85 5.87 5.8 5.88 5.99 5.84 5.76 6.01 5.98 5.89 5.89
HP_SEROSITIS 5.41 5.03 5.71 5.45 5.29 4.97 5.05 5.37 5.32 5.07 5.43 5.05 5.03 5.22 5.34 5.24 5.61 5.27 5.32 5.17 5.28 5.5 5.19 4.58 5.49 5.31
HP_THIN_EYEBROW 6.38 6.3 6.4 6.21 6.68 6.38 6.27 6.54 6.57 6.71 6.32 6.59 6.34 6.37 6.85 6.41 6.56 6.29 6.37 6.31 6.59 6.48 6.54 6.51 6.61 6.58
HP_SPARSE_EYEBROW 6.71 6.84 7.13 7.03 7.04 6.96 6.79 7.12 6.9 7.1 6.88 7.05 6.91 6.94 7.17 6.91 6.9 6.61 6.87 6.98 6.83 7 6.82 7.03 6.95 7.13
HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS 4.69 4.76 4.47 4.43 4.18 3.88 4.14 4.28 4.43 4.21 4.16 4.26 3.98 4.02 4.23 4.16 4.1 4.83 4.31 4.17 4.89 4.39 3.88 3.97 4.19 4.38
HP_LIMB_MYOCLONUS 9.18 9.09 8.83 8.88 8.93 9.16 9.38 9.47 9.24 9.24 9.03 9.07 9.22 9.35 9.74 9.48 8.94 8.88 9.24 9.4 9.27 9.12 8.9 9.38 9.12 8.58
HP_PAIN_IN_HEAD_AND_NECK_REGION 6.07 6 6.42 6.19 5.97 6.37 6.25 5.99 6.06 6.44 6.2 6.07 6.02 6.09 5.99 5.93 6.45 6.13 6.01 6.63 6.08 6.34 6.08 6.04 5.84 6.09
HP_ABNORMAL_CERVICAL_SPINE_MORPHOLOGY 5.92 6.04 5.67 6.1 5.52 5.36 5.59 5.67 5.74 5.54 5.94 5.39 5.72 5.94 5.33 5.71 5.98 5.92 5.81 5.45 5.85 5.77 5.68 5.55 6.15 6.24
HP_EARLY_ONSET_OF_SEXUAL_MATURATION 6.63 6.72 7.15 7.04 6.94 7.05 6.96 7 7 7.16 6.86 7 6.99 7.03 7.08 7.05 6.85 6.8 6.83 7.08 7.06 7.05 7.15 7.32 7.17 7.28
HP_NEOPLASM_OF_THE_PERIPHERAL_NERVOUS_SYSTEM 7.19 7.19 7.06 7.24 7.32 7.44 7.2 7.33 7.28 7.36 7.26 7.37 7.46 7.39 7.34 7.29 7.14 7.27 7.17 7.46 7.02 7.1 7.29 7.34 7.42 7.3
HP_INTRACRANIAL_MENINGIOMA 7.12 7.19 6.81 7.24 7.32 7.47 7.2 6.69 7.28 7.15 6.84 7.37 7.09 7.08 7.25 7.25 7.14 7.07 7.17 7.36 7.18 6.66 7.29 7.89 7.37 7.13
HP_NEOPLASM_OF_THE_EYE 7.36 7.37 8.22 7.81 8.09 7.71 7.67 7.84 7.91 7.63 7.94 7.73 8.06 7.61 7.96 7.69 7.63 7.5 7.85 7.99 7.5 7.85 8.19 8.06 7.88 7.66
HP_NEOPLASM_OF_THE_BREAST 6.45 6.44 6.8 6.9 6.46 6.66 6.59 6.54 6.56 6.66 6.48 6.53 6.58 6.48 6.25 6.44 6.32 6.42 6.3 6.45 6.07 6.45 6.79 6.93 6.42 6.61
HP_NUCLEAR_CATARACT 6.19 6.11 6.09 6.49 5.85 6.08 6.19 6.23 5.93 6.12 6.04 6.28 5.67 6.11 6.14 5.79 6.08 6.13 5.98 5.98 6.16 5.95 5.92 5.82 6.31 6.02
HP_CEREBRAL_PALSY 6.82 6.44 6.84 6.61 6.58 6.88 6.75 6.66 6.56 6.33 6.79 6.56 6.5 6.38 6.64 6.69 6.56 6.47 6.43 6.95 6.51 6.77 6.51 6.84 6.56 6.5
HP_OVERFRIENDLINESS 7.36 6.82 7.13 7.12 7.14 6.82 6.99 7.46 6.73 6.96 7.05 6.83 7.02 7.12 6.93 7.25 7.03 6.93 7.5 7.01 7.13 6.86 6.77 7.29 6.91 7.06
HP_ARTERIOVENOUS_MALFORMATION 5.86 5.75 5.64 6 5.91 5.85 5.82 5.8 5.94 5.92 5.73 5.65 6.08 5.98 5.85 5.73 5.69 5.59 5.78 5.85 5.72 5.7 5.97 5.89 5.83 5.71
HP_NEOPLASM_OF_THE_THYROID_GLAND 6.79 7.15 7.14 7.3 7.41 7.22 7.2 6.95 7.34 7.32 7.07 7.35 7.24 7.07 7.04 7.3 6.93 6.95 7.04 7.2 7.06 7.12 7.62 7.67 7.11 7
HP_TICS 7.28 7.63 6.82 7.89 7.66 7.65 7.39 7.45 7.25 7.3 7.46 7.52 7.46 7.75 7.67 7.49 7.39 7.45 7.53 7.18 7.48 7.79 7.83 7.71 7.67 7.38
HP_ABNORMALITY_OF_THE_PUBIC_HAIR 5.34 5.11 5.78 5.39 5.06 4.84 5.23 5.37 5.23 5.26 5.22 5.17 5.16 5.03 5.43 5.17 5.27 5.45 5.02 5.13 5.53 5.35 4.98 5.07 5.01 5.28
HP_ABNORMALITY_OF_THE_AXILLARY_HAIR 5.34 5.27 5.62 5.36 5.06 5.12 5.3 5.45 5.32 5.26 5.22 5.17 5.49 5.08 5.43 5.26 5.37 5.49 5.23 5.19 5.47 5.38 5.05 5.11 5.07 5.29
HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS 6.61 6.65 6.91 6.78 6.87 6.68 6.71 6.88 6.7 6.85 6.87 6.78 6.9 6.8 6.89 6.74 6.6 6.6 6.61 6.73 6.95 6.93 6.94 6.92 6.65 6.86
HP_SYNOSTOSIS_OF_JOINTS 6.15 6.21 6.27 6.3 6.37 6.35 6.42 6.47 6.32 6.41 6.35 6.27 6.48 6.52 6.48 6.44 6.42 6.32 6.28 6.49 6.52 6.46 6.46 6.55 6.46 6.5
HP_SARCOMA 7.02 7.06 7.14 7.05 7.3 7.37 7.18 7.12 7.29 7.15 6.9 7.15 7.26 7.32 7.28 7.21 7.07 6.95 7.25 7.33 7.03 7.01 7.38 7.6 7.36 7.19
HP_LEIOMYOSARCOMA 6.98 6.81 7.14 6.68 7.16 7.37 7.2 7.27 7.64 7.36 6.78 7.16 7.16 7.27 7.34 7.27 7.14 6.57 6.96 7.29 7.06 7.05 7.35 7.27 7.37 7.61
HP_METAPHYSEAL_DYSPLASIA 6.18 6.37 6.5 6.27 6.12 6.43 6.33 6.71 6.29 6.6 6.26 6.65 6.18 6.22 6.5 6.49 6.51 6.45 6.01 6.13 6.2 6.6 6.16 6.33 6.38 6.41
HP_SENILE_PLAQUES 8.77 8.87 9.43 9 8.9 9.16 9.47 9.27 9.44 9.03 8.86 9.13 9.26 9.27 9.04 9.04 8.75 8.36 8.81 9.37 8.83 9.17 9.3 9.38 9.57 9.25
HP_ECTRODACTYLY 6.98 6.74 6.96 6.72 7.44 7.4 7.47 7.63 7.25 7.35 6.86 7.29 7.6 7.39 7.49 7.38 7.06 7.11 7.18 7.55 7.25 7.59 7.49 7.58 7.26 7.48
HP_PREAXIAL_POLYDACTYLY 6.49 6.53 6.74 6.52 6.62 6.7 6.48 6.45 6.59 6.57 6.75 6.73 6.47 6.58 6.67 7.18 6.53 6.75 6.66 6.2 6.68 6.77 6.46 6.53 6.66 6.67
HP_POSTAXIAL_POLYDACTYLY 6.63 6.64 7.16 6.99 6.85 7.14 6.73 6.75 6.74 6.93 6.96 6.81 6.74 6.84 6.87 7.23 6.56 6.76 6.97 6.85 6.65 6.96 6.9 6.9 6.75 6.95
HP_MESOAXIAL_POLYDACTYLY 6.51 6.59 6.17 6.23 6.82 6.92 6.62 7.02 6.65 6.38 6.8 6.68 6.69 6.7 6.85 6.86 6.72 6.92 6.19 6.22 6.89 6.82 6.38 6.65 6.59 6.66
HP_ABNORMAL_TENDON_MORPHOLOGY 6.57 6.6 6.75 6.78 6.87 6.91 6.8 6.85 6.82 6.87 6.64 6.82 6.88 6.79 6.83 6.7 6.74 6.66 6.74 6.83 6.62 6.75 6.9 6.92 6.84 6.82
HP_SYNOSTOSIS_INVOLVING_DIGITS 6.71 6.98 6.05 6.35 6.78 6.87 6.81 6.93 6.45 6.88 6.72 7.14 6.98 6.8 6.86 6.93 6.91 6.87 6.9 6.97 7.19 7.26 6.59 7 7.28 7.28
HP_SYNOSTOSIS_OF_METACARPALS_METATARSALS 6.71 7.28 7.02 6.23 6.89 6.87 7.49 7.39 7.46 6.88 6.19 7.14 7.41 7.06 7.42 6.93 7.53 6.54 6.33 7.34 7.32 7.26 6.59 7.62 7.29 7.34
HP_SYNOSTOSIS_OF_CARPALS_TARSALS 5.96 5.85 5.98 5.85 5.77 6.1 6.35 6.34 6.13 6.08 6.14 6.27 6.36 6.52 6.1 6.56 6.46 5.97 5.88 6.25 6.42 6.26 6.28 6.48 6.34 6.21
HP_LIP_PIT 5.13 4.84 4.78 5.47 4.91 4.66 4.68 4.69 4.81 4.58 4.92 4.61 4.41 4.48 4.63 4.81 5.05 5.17 4.77 4.72 4.95 4.5 4.46 4.23 4.75 4.74
HP_NEOPLASM_OF_THE_COLON 6.6 6.5 6.98 6.73 6.79 6.67 6.78 6.6 6.6 6.84 6.86 6.84 6.58 6.49 6.8 6.85 6.53 6.56 6.48 6.63 6.82 6.85 6.89 6.81 6.64 6.8
HP_DIFFUSE_CEREBELLAR_ATROPHY 7.32 7.36 7.31 7.43 7.54 7.17 7.2 7.56 7.32 7.49 7.38 7.34 7.41 7.4 7.11 7.32 7.16 7.08 7.28 7.5 7.18 7 7.66 7.54 7.33 7.16
HP_SKIN_PIT 6.3 6.34 6.11 6.28 6.35 6.52 6.15 6.25 6.29 6.46 6.14 6.42 6.48 6.37 6.3 6.3 6.31 6.3 6.46 6.46 6.37 6.44 6.46 6.39 6.23 6.33
HP_PERIAURICULAR_SKIN_PITS 6.5 6.57 6.36 6.43 6.89 7.02 6.26 6.59 6.71 6.99 6.38 7 6.74 6.91 6.38 6.71 6.72 6.44 6.66 6.63 6.75 6.67 6.8 6.5 6.78 6.59
HP_EMG_IMPAIRED_NEUROMUSCULAR_TRANSMISSION 6.39 6.05 6.35 5.97 6.23 6.17 6.26 6.12 5.96 6.17 6.1 5.93 5.98 6.28 5.94 6.02 5.98 6.39 6.05 6.29 6.25 6.09 6.16 5.98 6.27 6.34
HP_MUSCLE_FIBER_ATROPHY 6.54 6.85 6.51 6.76 7.01 6.96 6.71 6.55 6.77 7.03 6.79 7.05 6.85 6.72 6.59 6.41 7 6.66 7.2 6.75 6.44 6.54 6.86 6.9 7.13 7.05
HP_INCREASED_ENDOMYSIAL_CONNECTIVE_TISSUE 6.28 5.42 5.23 5.7 5.72 5.69 5.76 5.64 5.95 5.63 5.76 6.16 5.86 5.55 5.16 5.57 5.62 5.28 5.61 5.76 6.04 5.97 6.35 5.87 5.55 5.72
HP_MUSCLE_FIBER_INCLUSION_BODIES 5.79 5.75 6.11 5.8 5.74 5.77 6 5.84 5.78 5.98 6.05 5.86 5.73 5.81 5.86 5.99 5.69 5.87 5.65 5.68 5.75 5.67 5.83 5.46 5.99 5.56
HP_CEREBRAL_INCLUSION_BODIES 8.14 8.19 7.79 7.63 8.85 8.65 8.06 8.14 8.32 8.26 7.63 8.38 8.38 8.35 8.26 8.14 8.16 7.91 8.4 8.39 7.91 8.28 8.22 8.21 8.29 8.23
HP_LEWY_BODIES 8.32 8.23 7.74 7.56 8.87 8.72 8.21 8.33 8.32 8.36 7.89 8.4 8.4 8.4 8.31 8.26 8.17 8.06 8.48 8.5 8.01 8.32 8.23 8.45 8.44 8.4
HP_ABNORMALITY_OF_THE_DENTATE_NUCLEUS 6.64 6.68 7.12 6.6 7.2 7.26 6.87 6.82 6.86 7.08 6.32 7.25 6.51 6.49 6.58 7.05 7.65 7.19 7.2 7.07 7.22 7.26 6.9 6.74 7.21 7.21
HP_JUVENILE_ASEPTIC_NECROSIS 6.07 6.21 6.47 6.43 6.46 6.35 6.5 6.77 6.51 6.61 6.61 6.02 6.78 6.47 6.33 7 6.7 6.55 6.02 5.99 6.1 6.55 6.92 6.72 6.34 6.38
HP_SCLERODERMA 6.06 5.87 6.15 5.98 6.1 5.82 6.04 6.03 6.17 6.18 5.99 5.72 6.11 5.77 5.65 5.88 6.25 6.04 5.78 6.27 5.84 5.93 5.89 6.15 6.2 6.01
HP_IMMUNOLOGIC_HYPERSENSITIVITY 6.02 6.11 5.97 6.16 5.95 6.16 6.03 5.84 6.2 6.14 6.09 5.92 6.27 6.19 5.95 5.94 5.99 6.11 6.05 5.99 6.05 6.07 6.14 6.03 5.96 6.03
HP_UNILATERAL_CLEFT_PALATE 5.28 5.39 5.74 5.72 5.09 4.92 4.86 4.97 5.34 4.99 5.24 5.09 5 5.12 5.27 5.09 5.03 5.04 4.88 4.84 5.16 5.05 5.2 5.12 5.02 5.04
HP_NON_MIDLINE_CLEFT_LIP 5.55 5.7 5.82 6.22 5.65 5.3 5.44 5.74 5.53 5.44 5.8 5.49 5.61 5.53 5.54 5.8 5.38 5.41 5.55 5.19 5.48 5.53 5.69 5.41 5.36 5.46
HP_BILATERAL_CLEFT_LIP 5.41 5.43 5.8 5.75 5.33 5.05 4.95 5.22 5.53 5.02 5.47 5.34 5.26 5.53 5.44 5.24 5.03 5.19 5.03 4.96 5.17 5.1 5.47 5.18 5.07 4.82
HP_NON_MIDLINE_CLEFT_PALATE 5.44 5.97 5.8 6.16 5.33 5.68 4.95 5.51 5.63 5.33 5.48 5.34 5.68 5.65 5.44 5.49 5.05 5.19 5.11 5.21 5.32 5.1 5.47 5.55 5.16 5.33
HP_CONTRACTURES_OF_THE_JOINTS_OF_THE_UPPER_LIMBS 6.43 6.47 6.46 6.54 6.64 6.62 6.51 6.66 6.55 6.53 6.43 6.54 6.56 6.56 6.43 6.53 6.52 6.41 6.45 6.49 6.5 6.54 6.78 6.65 6.61 6.61
HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_5TH_TOE 8.26 8.44 8.26 7.48 8.59 8.71 8.83 9.01 8.43 8.45 8.17 8.56 8.56 8.52 8.61 8.89 8.76 8.39 8.1 8.79 8.46 8.5 8.41 8.57 8.86 8.63
HP_ABNORMALITY_OF_LOWER_LIMB_JOINT 6.67 6.67 6.9 6.8 6.9 6.94 6.9 6.95 6.91 6.9 6.87 6.85 7.03 6.89 6.91 6.93 6.81 6.76 6.95 6.91 6.87 6.88 7.02 7.04 7 6.98
HP_JOINT_CONTRACTURES_INVOLVING_THE_JOINTS_OF_THE_FEET 6.24 6.55 6.1 5.78 6.5 6.14 6.36 6.37 6.53 5.98 6.06 6.24 6.36 6.24 5.98 6.26 6.33 6.12 6.28 6.5 6.35 6.08 6.72 6.25 6.41 6.47
HP_DEVIATION_OF_TOES 7.46 7.37 7.52 7.17 7.54 7.73 7.68 7.81 7.85 7.7 7.44 7.53 7.81 7.98 7.69 7.77 7.46 7.31 7.58 7.89 7.56 7.63 7.89 7.97 7.87 7.59
HP_ABNORMALITY_OF_VITAMIN_METABOLISM 6.19 6.11 6.12 6.24 5.92 6.38 6.28 6.34 6.08 6.15 6.09 6.09 6.18 6.2 6.18 6.1 6.12 6.2 6.25 6.14 5.89 6.07 5.62 6.04 6.14 6.29
HP_ABNORMALITY_OF_VITAMIN_D_METABOLISM 5.6 5.64 5.28 5.59 5.39 5.23 5.24 5.08 5.19 5.2 5.43 5.17 5.04 5.24 4.91 5.17 5.46 5.22 5.1 5.06 5.4 5.21 5.13 4.98 5.06 5.27
HP_LOW_LEVELS_OF_VITAMIN_D 5.75 5.78 5.29 5.73 5.92 6.37 5.85 5.93 5.36 5.74 5.92 5.69 5.22 5.51 5.16 5.58 5.76 5.48 5.45 5.8 5.58 5.74 5.42 5.69 5.84 6.04
HP_ABNORMALITY_OF_VITAMIN_E_METABOLISM 5.92 5.73 5.42 5.48 4.83 4.92 5.24 5.27 5.54 4.95 5.42 5.17 5.18 5.58 5.19 5.39 5.62 5.67 5.45 5.3 5.91 5.36 5.13 5.19 5.08 5
HP_DYSURIA 6.18 6 7.05 6.66 6.44 6.51 7.05 6.94 6.81 7.16 6.97 7.03 6.97 6.35 6.8 7.23 6.23 5.78 6.11 7.39 6.93 7.57 6.81 6.09 7.17 7.3
HP_ANURIA 5.4 5.35 5.15 5.03 5 4.76 5.15 5.05 5.21 4.89 5.66 5.04 5.08 4.8 4.68 4.8 5.61 5.41 4.95 5 5.6 5.13 4.98 4.39 5.65 5.42
HP_ABNORMAL_BLOOD_PHOSPHATE_CONCENTRATION 5.85 5.81 6.3 6.04 5.66 5.89 5.97 6.28 5.95 6.01 6.25 6.03 5.87 5.73 6.05 5.98 5.81 5.98 5.84 5.95 5.92 5.93 5.59 6.04 6.02 6.16
HP_ABNORMAL_CALCIUM_PHOSPHATE_REGULATING_HORMONE_LEVEL 6.67 6.92 6.62 6.68 7.09 7.26 7.09 6.9 7.05 7.19 6.95 6.86 7.16 7.04 7.34 7.26 6.54 6.92 7.04 7.46 6.55 6.9 7.24 7.29 6.97 6.96
HP_INFLAMMATORY_ABNORMALITY_OF_THE_EYE 6.04 6.19 6.03 6.05 5.77 5.83 6.06 6.04 6.01 5.94 5.92 5.92 5.81 5.8 5.86 6 5.9 5.99 5.88 5.83 6.05 5.95 5.88 5.86 6.11 6
HP_ABNORMALITY_OF_THE_SUPRAORBITAL_RIDGES 6.81 6.67 7.16 7.01 6.96 7.15 7.01 6.95 7.05 7.31 6.98 7.01 7.22 7.34 6.94 7.08 6.87 6.86 6.93 7.06 7.06 7.05 7.4 7.42 7.03 6.94
HP_PALPEBRAL_EDEMA 6.55 7.17 7.05 6.66 6.58 7.18 7.13 7.37 7.04 7.16 7.13 7.04 7.32 7.44 7.26 7.2 6.98 7.25 7.35 7.28 7.07 7.12 7.63 7.57 7.17 7.21
HP_FEMORAL_HERNIA 5.95 6.05 5.93 6.29 6.22 5.86 5.88 5.73 6.1 6.03 6.23 5.92 5.89 6.1 5.84 5.74 6.12 6.11 5.95 5.94 6.07 5.79 6.08 5.94 5.84 5.77
HP_ABNORMAL_LOCALIZATION_OF_KIDNEY 6.66 6.59 7.11 6.93 6.86 6.88 6.68 7.01 6.79 6.68 6.94 6.7 6.82 6.69 6.85 6.79 6.65 6.63 6.85 6.83 6.97 6.84 6.95 7 6.64 6.86
HP_COGNITIVE_IMPAIRMENT 7.23 7.28 7.44 7.41 7.45 7.51 7.49 7.32 7.44 7.52 7.3 7.43 7.57 7.52 7.46 7.4 7.16 7.25 7.47 7.61 7.22 7.38 7.47 7.71 7.46 7.35
HP_NEOPLASM_OF_THE_HEART 6.35 6.25 5.97 5.88 6.13 6.53 6.24 6.23 6.65 6.35 6.43 6.59 6.74 6.49 6.16 6.38 6.58 6.62 6.61 6.59 6.51 6.47 7.06 6.59 6.21 6.3
HP_ARTERIAL_STENOSIS 6.37 6.38 6.44 6.36 6.65 6.58 6.35 6.48 6.65 6.55 6.41 6.47 6.56 6.39 6.35 6.44 6.57 6.44 6.35 6.45 6.62 6.41 6.73 6.59 6.5 6.57
HP_ASYMMETRIC_GROWTH 7.07 7.18 7.57 7.81 8.02 7.71 7.57 7.74 7.76 7.67 7.29 7.51 7.87 7.88 7.83 7.38 7.12 6.82 7.37 7.74 7.34 7.62 7.85 8.07 7.35 7.45
HP_LOWER_LIMB_ASYMMETRY 8.22 7.94 8.06 8.1 8.39 8.74 8.63 8.4 8.4 8.32 8.21 8.1 8.36 8.24 8.34 8.17 7.97 8.23 8.08 8.32 8.03 8.35 8.38 8.59 8.09 7.99
HP_UPPER_LIMB_ASYMMETRY 8.98 9.16 8.89 8.6 8.96 9.3 9.42 9.07 9.1 9.15 8.48 8.76 8.99 8.96 8.92 8.35 8.74 8.87 8.89 9.27 8.47 8.69 9.05 9.49 8.92 8.32
HP_SPINAL_CORD_LESION 7.08 7.21 7.52 7 7.36 7.35 7.58 7.38 7.66 7.31 7.62 7.46 7.45 7.6 7.49 7.51 7.15 7.31 7.38 7.61 7.27 7.58 7.71 7.71 7.48 7.3
HP_NEOPLASM_OF_THE_ENDOCRINE_SYSTEM 6.79 6.91 7.06 6.9 7.28 7.32 7.11 7.26 7.27 7.32 7.01 7.18 7.15 7.07 7.04 7.3 7 6.95 7.02 7.29 7.04 7.12 7.35 7.31 7.11 7.12
HP_ABNORMALLY_OSSIFIED_VERTEBRAE 6.14 5.94 5.76 5.92 5.45 5.86 5.61 5.74 5.74 5.83 5.88 5.71 6.01 5.95 5.83 5.91 5.67 5.92 6.1 5.83 5.56 5.66 5.93 5.59 6.26 6.2
HP_CARCINOID_TUMOR 6.57 6.62 6.48 6.67 6.92 6.86 6.73 6.59 7 7.11 6.31 7.01 6.63 6.42 6.53 6.81 6.74 6.76 6.69 6.94 6.96 6.71 7.03 7.11 7.14 6.98
HP_CARDIAC_DIVERTICULUM 7.42 7.52 7.74 7.82 7.8 7.81 7.49 7.46 7.46 7.68 7.45 7.71 7.64 7.74 7.5 7.51 7.44 7.03 7.56 7.56 7.16 7.12 7.86 8 7.39 7.23
HP_BILIARY_TRACT_NEOPLASM 5.3 5.34 5.03 5.07 4.72 4.51 4.5 4.6 4.86 4.66 4.93 4.65 4.46 4.62 4.72 5.06 4.81 5.17 4.91 4.45 4.79 4.48 4.69 4.47 4.48 4.63
HP_AMAUROSIS_FUGAX 7.43 7.51 7.65 7.74 7.93 7.9 7.47 7.4 7.44 7.65 7.53 7.69 7.61 7.57 7.43 7.48 7.16 7.02 7.63 7.55 7.16 7.19 7.86 7.92 7.38 7.33
HP_LIPOATROPHY 6.17 6.32 5.98 6.14 6.39 5.93 6.12 5.85 5.88 6.09 6.04 6.35 5.91 5.99 5.98 6.06 6.07 6.28 6.24 6.02 6.13 5.96 6.43 5.77 6 6.11
HP_MUCOSAL_TELANGIECTASIAE 6.91 6.67 7.13 7.33 7.69 7.3 7.3 6.92 7.37 7.06 7.18 7.34 7.02 7.13 6.91 6.81 7.33 7.04 7.43 7.43 6.7 7.06 7.12 7.3 7.3 6.97
HP_ENDOCARDITIS 5.89 6.44 6.5 6.25 5.72 5.77 6.06 5.83 6.13 5.41 6.32 5.84 6.18 5.72 5.51 5.93 5.85 5.78 5.63 5.33 5.69 5.9 5.75 5.84 5.72 6.03
HP_TELANGIECTASIA_OF_THE_SKIN 5.95 6.04 6.26 6 5.77 5.98 6.04 6.13 6.02 5.97 6.13 5.98 5.9 5.79 5.82 5.96 6.07 6.04 5.95 6.09 6.13 5.98 5.99 6.06 6.12 6.16
HP_ABNORMALITY_OF_THE_PREPUTIUM 5.61 5.54 5.6 5.97 5.59 5.83 5.75 5.79 5.93 5.81 5.36 5.68 6.05 5.65 5.95 5.72 5.62 5.51 5.8 6.1 5.74 5.7 5.83 6.03 5.78 5.75
HP_UROGENITAL_FISTULA 6.07 5.98 6.02 6.31 5.99 6.04 6.04 6.3 6.13 6.07 6.25 6 6.09 6.08 6.16 6.13 6.05 6.19 6.1 6.2 6.16 6.24 6.01 6 6.25 6.22
HP_RECTAL_FISTULA 6.11 6.05 6.98 6.35 6.37 6.43 6.31 6.61 6.3 6.3 6.45 6.31 6.45 6.18 6.2 6.55 6.36 6.45 6.37 6.52 6.51 6.39 6.57 6.74 6.66 6.34
HP_CALCIFICATION_OF_CARTILAGE 6.05 5.83 6.11 6.04 5.55 5.73 5.89 6.25 6.18 5.55 6.02 5.79 5.79 6.41 5.21 6.33 6.71 5.82 6.19 5.48 6.32 6.25 6.11 5.81 6.23 6.59
HP_PULMONARY_EDEMA 5.63 5.53 5.42 5.84 5.39 4.9 5.32 5.12 5.1 5.1 5.39 5.15 5.26 5.31 5.27 5.38 5.09 5.41 4.95 5.17 5.51 5.47 5.14 4.85 5 5.32
HP_TOXEMIA_OF_PREGNANCY 5.75 5.51 6.12 6.21 5.27 5.22 5.42 5.28 5.58 5.37 5.88 5.21 5.2 5.5 5.43 5.55 5.76 5.48 5.39 5.4 5.42 5.74 5.37 5.2 5.72 5.68
HP_NEOPLASM_OF_THE_LARYNX 5.4 5.81 5.46 5.96 5.41 5.53 5.37 5.6 5.88 5.63 5.49 5.61 5.93 5.74 5.43 5.47 5.4 5.61 5.49 5.87 5.5 5.51 5.48 5.59 5.48 5.55
HP_NEOPLASM_OF_THE_RESPIRATORY_SYSTEM 6.32 6.44 6.52 6.41 6.84 6.5 6.31 6.4 6.56 6.76 6.49 6.85 6.6 6.44 6.5 6.55 6.25 6.32 6.34 6.36 6.24 6.64 6.81 6.93 6.6 6.61
HP_DYSMENORRHEA 6.18 6.38 6.55 6.66 6.58 6.51 6.33 6.82 6.8 6.87 6.37 6.95 6.65 6.13 6.5 6.44 6.67 5.97 6.33 6.68 6.69 6.87 6.58 6.74 6.78 6.88
HP_METRORRHAGIA 7.16 7.23 6.8 7.19 6.81 6.54 6.64 7 7.46 7.2 7.12 7.92 7.17 6.95 7.63 7.04 8.1 7.92 6.15 6.7 7.05 6.78 7.23 7.78 7.88 7.97
HP_DEATH_IN_EARLY_ADULTHOOD 7.19 6.9 7.25 7.51 7.41 7.27 7.2 7.26 7.2 7.32 7.2 7.37 7.55 7.32 7.03 7.39 7.14 6.95 7.38 7.2 7.08 7.05 7.38 7.6 6.99 7.08
HP_MYOSITIS 6.38 6.6 6.61 6.41 6.32 6.58 6.33 6.08 6.41 6.24 6.32 6.16 6.31 6.19 6.27 6.24 6.15 6.29 6.25 6.14 6.05 6.25 6.35 6.35 6.26 6.31
HP_OVARIAN_NEOPLASM 6.49 6.44 6.47 6.75 6.88 6.8 6.68 6.6 6.6 6.81 6.49 6.75 6.62 6.54 6.52 6.55 6.41 6.49 6.61 6.51 6.43 6.48 6.85 6.96 6.62 6.61
HP_GERMINOMA 8.68 8.56 8.41 8.52 9.21 9.13 9.06 9.02 9.63 9.26 8.73 9.37 9.04 9.16 8.79 8.48 8.39 7.99 8.63 8.85 8.4 8.44 9.53 9.42 8.92 8.7
HP_ENLARGED_THORAX 6.38 6.38 6.92 6.86 6.89 6.65 6.66 6.75 6.83 6.93 6.49 6.75 6.64 6.64 6.47 6.63 6.35 6.35 6.34 6.49 6.26 6.45 6.89 6.92 6.56 6.6
HP_CHRONIC_HEPATIC_FAILURE 5.95 6.14 5.94 6.03 6.38 6.22 6.2 6.16 6.31 6.21 5.88 6.17 6.22 6.12 6.46 6.18 6.17 6.1 5.84 6.04 6.06 6.22 5.87 5.96 6.3 6.34
HP_DISPLACEMENT_OF_THE_URETHRAL_MEATUS 6.51 6.55 6.78 6.67 6.78 6.76 6.64 6.72 6.72 6.73 6.61 6.71 6.82 6.71 6.77 6.62 6.54 6.55 6.58 6.77 6.54 6.55 6.81 6.92 6.59 6.61
HP_NEOPLASM_OF_THE_ADRENAL_GLAND 6.82 6.92 7.13 6.97 7.88 7.69 7.15 7.47 7.27 7.62 7.33 7.26 7.52 7.39 7.5 7.49 7.4 7.14 7.61 7.5 7.01 7.73 7.58 7.34 7.55 7.39
HP_ESOPHAGITIS 6.6 6.68 6.93 6.63 6.9 6.78 6.18 6.53 6.88 6.94 7.13 7.03 6.57 6.61 6.77 6.59 6.48 6.9 6.63 6.63 6.91 6.9 7.27 7.15 7.14 7
HP_NEUROENDOCRINE_NEOPLASM 7.37 7.32 7.69 7.52 7.88 7.76 7.53 8.12 7.64 7.62 7.99 7.65 7.7 7.56 7.95 7.66 7.64 7.37 7.86 7.94 7.33 7.87 7.64 7.43 7.84 7.65
HP_NEOPLASM_OF_THE_ADRENAL_CORTEX 6.04 5.95 5.63 5.79 5.49 5.3 5.72 5.64 5.85 5.07 5.78 5.23 5.69 5.6 5.32 5.2 5.69 5.44 5.19 5.41 5.5 5.56 5.35 5.13 5.53 5.68
HP_ABNORMALITY_OF_NAIL_COLOR 6.2 6.27 6.98 6.44 6.26 6.15 6.42 6.66 6.11 6.28 6.33 6.58 6.4 6.41 6.52 6.77 6.46 6.33 6.16 6.2 6.71 6.62 6.45 6.31 6.3 6.51
HP_THYROIDITIS 5.83 5.74 5.54 5.63 5.74 5.44 5.72 5.59 5.36 5.44 5.61 5.33 5.33 5.42 5.45 5.35 5.61 5.65 5.5 5.41 5.71 5.7 5.41 5.16 5.64 5.65
HP_NEOPLASM_OF_THE_TONGUE 6.6 6.48 6.63 6.64 6.6 6.58 6.61 6.43 6.26 6.79 6.71 6.79 6.56 6.57 6.46 6.57 6.81 6.71 6.68 6.33 6.69 6.59 6.46 6.65 6.65 6.6
HP_NEOPLASM_OF_THE_ORAL_CAVITY 6.44 6.43 6.47 6.64 6.6 6.5 6.42 6.34 6.26 6.68 6.57 6.5 6.41 6.48 6.23 6.55 6.62 6.52 6.46 6.32 6.51 6.44 6.47 6.49 6.58 6.6
HP_VAGINAL_NEOPLASM 6.24 5.8 6.02 6.2 5.71 5.8 6.16 6.14 6 5.84 5.92 6.21 5.55 5.39 6.33 5.49 5.49 5.94 6.21 6.01 6.4 6.14 5.73 5.43 5.52 5.78
HP_TYPE_I_DIABETES_MELLITUS 5.84 6.09 6.13 6.01 5.62 5.81 6.2 6.01 6.3 5.73 6 5.98 5.99 6.12 5.96 5.5 6.15 5.96 5.74 6.04 6.12 5.98 5.63 5.82 6 6.09
HP_CELLULITIS 5.89 5.62 5.73 5.76 5.6 5.38 5.8 5.8 5.73 5.36 5.67 5.6 5.71 5.58 5.86 5.6 5.76 5.72 5.39 5.47 5.75 5.65 5.31 5.09 5.71 5.63
HP_ABNORMALITY_OF_THE_CEREBRAL_VASCULATURE 6.47 6.36 6.48 6.46 6.59 6.6 6.42 6.45 6.52 6.58 6.48 6.52 6.55 6.45 6.32 6.44 6.63 6.4 6.42 6.4 6.49 6.51 6.46 6.55 6.56 6.6
HP_DYSKINESIA 8.14 8.16 8.38 8.07 8.52 8.53 8.47 8.27 8.39 8.52 8.19 8.44 8.4 8.51 8.44 8.26 8.12 8.13 8.37 8.5 8.15 8.38 8.49 8.53 8.36 8.25
HP_ABNORMAL_TRABECULAR_BONE_MORPHOLOGY 5.57 5.52 5.75 5.78 5.38 5.43 5.59 5.61 5.57 5.53 5.69 5.42 5.52 5.57 5.44 5.5 5.65 5.62 5.32 5.5 5.68 5.93 5.41 5.37 5.86 5.79
HP_PREMATURE_SKIN_WRINKLING 6.92 6.74 7.12 7.12 6.94 6.66 6.69 6.95 7.37 7.16 6.85 6.85 7.03 7.24 7.01 7.08 7 6.62 6.79 7.06 7.18 7.16 7.26 6.93 7.09 7.41
HP_LACK_OF_SKIN_ELASTICITY 6.43 6.4 6.72 6.65 6.9 6.77 6.26 6.43 6.68 6.8 6.51 6.73 6.54 6.39 6.3 6.56 6.32 6.35 6.33 6.31 6.38 6.32 7.04 6.87 6.94 6.91
HP_ABNORMAL_SHARPEY_FIBER_MORPHOLOGY 6.32 5.81 5.64 5.84 6.18 5.8 6.11 5.36 5.73 5.75 6.25 5.25 5.43 5.2 5.72 5.18 5.69 5.69 5.42 5.25 6.12 5.65 5.96 6.11 5.18 4.94
HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_CORNEA 6.45 6.46 6.72 6.68 6.66 6.59 6.66 6.64 6.68 6.7 6.6 6.65 6.69 6.62 6.54 6.6 6.47 6.45 6.63 6.63 6.54 6.71 6.72 6.8 6.64 6.71
HP_TIBIAL_TORSION 8.15 8.79 8.56 9.28 8.75 8.77 9.26 8.82 8.88 9.06 8.55 8.41 8.68 8.66 9.06 8.73 8.42 8.86 8.97 9.36 8.28 8.68 8.87 8.78 8.53 8.45
HP_SCARRING 5.99 5.91 5.95 6.14 5.79 5.77 5.8 5.84 5.93 5.86 6.01 5.89 5.83 6.01 5.71 5.84 5.98 5.93 5.79 5.94 5.94 5.89 5.92 5.84 5.79 5.86
HP_ABNORMAL_ARACHNOID_MATER_MORPHOLOGY 6.94 7.02 7.33 7.53 7.27 7.33 6.94 7.31 7.36 7.31 7.05 7.46 7.35 7.3 7.42 7.47 7.22 7.08 7.29 7.15 7.1 7.14 7.46 7.61 7.1 7
HP_TONGUE_THRUSTING 8.35 8.6 8.34 8.36 8.75 8.89 9 9.29 8.93 8.91 8.9 8.93 8.53 8.59 9.5 9.08 8.79 8.43 8.99 8.72 9.09 8.73 9.15 9.04 9.01 8.73
HP_CEREBRAL_VISUAL_IMPAIRMENT 7.71 7.9 7.97 7.99 8.01 8.23 8.25 8.15 8.04 8.18 7.83 8.01 8.23 8.21 8.16 8.02 7.72 7.79 7.97 8.22 7.85 7.97 8.14 8.25 8.01 7.95
HP_ABNORMAL_GLIAL_CELL_MORPHOLOGY 7.28 7.43 7.59 7.62 7.69 7.73 7.51 7.47 7.5 7.65 7.36 7.5 7.63 7.67 7.5 7.48 7.52 7.25 7.63 7.57 7.3 7.49 7.62 7.88 7.55 7.39
HP_ABNORMAL_ASTROCYTE_MORPHOLOGY 7.11 7.18 7.26 7.44 7.67 7.7 7.19 7.17 7.24 7.54 7.18 7.41 7.49 7.22 7.26 7.29 7.47 6.91 7.46 7.37 7.05 6.96 7.3 7.43 7.51 7.35
HP_ABNORMAL_THORACIC_SPINE_MORPHOLOGY 6.49 6.29 6.5 6.6 6.72 6.68 6.53 6.54 6.6 6.55 6.72 6.64 6.66 6.59 6.65 6.58 6.73 6.79 6.54 6.68 6.67 6.72 6.81 6.85 6.79 6.92
HP_ABNORMAL_LUMBAR_SPINE_MORPHOLOGY 6.29 6.25 6.45 6.52 6.81 6.56 6.68 6.74 6.32 6.55 6.51 6.48 6.46 6.49 6.49 6.36 6.54 6.13 6.42 6.69 6.49 6.69 6.09 6.56 6.7 7.07
HP_SELF_INJURIOUS_BEHAVIOR 7.79 7.85 8.1 7.96 8.36 8.24 8.32 8.38 8.15 8.21 8.08 8.35 8.3 8.43 8.57 8.37 8 8.05 8.15 8.32 8.23 8.44 8.24 8.44 8.43 8.23
HP_HYPOPLASIA_OF_THE_EAR_CARTILAGE 5.65 5.56 6.05 6.16 5.48 5.5 5.63 5.64 5.6 5.58 5.6 5.77 5.44 5.28 5.7 5.77 5.63 5.58 5.72 5.5 5.61 5.51 5.59 5.59 5.61 5.95
HP_MEDIASTINAL_LYMPHADENOPATHY 5.93 6.14 5.63 5.89 5.36 5.51 5.8 6.4 5.78 5.6 6.22 5.68 6.09 6.43 5.47 5.61 6.02 6.32 6.05 5.72 6.01 5.92 5.56 5.58 5.77 5.73
HP_GASTROINTESTINAL_STROMA_TUMOR 7.37 7.32 6.87 7.09 7.84 7.44 7.53 7.59 7.58 6.91 6.86 7.52 7.46 7.45 7.47 7.66 6.99 7.14 7.61 8.02 6.5 6.97 7.91 7.71 7.47 6.8
HP_HYPERCOAGULABILITY 5.29 5.39 5.09 5.62 5.18 4.84 5.44 5.19 5.46 5.25 5.44 5.08 5.39 5.17 5.51 5.4 5.44 5.49 5.39 5.13 5.77 5.29 5.18 5 5.54 5.48
HP_LICHENIFICATION 5.75 5.56 5.28 5.61 5.45 5.22 5.38 5.62 5.41 5.16 5.75 5.1 5.17 5.34 5.13 5.21 5.44 5.48 5.36 5.05 5.4 5.22 5.21 4.86 5.41 5.61
HP_GERM_CELL_NEOPLASIA 6.16 6.32 6.13 6.15 6.59 6.66 6.65 6.65 6.53 6.64 6.38 6.62 6.74 6.64 6.88 6.62 6.25 6.03 6.44 6.38 6.5 6.5 6.35 6.69 6.53 6.26
HP_LARGE_FACE 6.82 6.99 7.13 6.84 7 7.28 7.15 7.19 7.11 7.16 7.05 7.2 7.29 7.15 7.28 7.37 7.14 6.99 7.11 7.2 7.15 7.27 7.31 7.45 7.33 7.33
HP_PANCREATIC_FIBROSIS 6.23 6.24 6.57 6.53 6.34 6.22 6.09 6.15 5.74 6.15 6.26 6.35 5.9 6.01 6.09 6.52 6.06 6.35 6.14 6.05 6.21 6.37 6.08 6.14 6.15 6.26
HP_NEOPLASM_OF_THE_PARATHYROID_GLAND 6.71 6.65 6.87 6.71 7.42 7.46 7.07 6.76 7.46 7.41 6.76 6.89 7.05 7.2 7.17 7.31 6.94 6.97 7.4 7.44 6.96 6.71 7.41 7.34 7.45 7.2
HP_HYPERTENSIVE_CRISIS 5.9 5.94 5.79 6.33 5.59 5.24 6.93 6.61 6.72 5.45 6.04 5.57 5.61 5.45 5.95 5.64 5.99 5.61 6.71 6.89 5.98 5.95 5.52 5.4 5.7 5.74
HP_ABNORMAL_SOFT_PALATE_MORPHOLOGY 6.38 6.36 6.44 6.56 6.55 6.45 6.39 6.48 6.47 6.54 6.53 6.44 6.57 6.5 6.4 6.58 6.47 6.37 6.41 6.44 6.49 6.37 6.5 6.6 6.54 6.47
HP_ABNORMAL_EATING_BEHAVIOR 6.95 7.18 7.03 6.79 7.59 7.71 7.29 7.5 7.4 7.98 7.23 7.63 7.6 7.63 7.36 7.44 7.1 7.22 7.41 7.52 7.19 7.49 7.39 7.65 7.44 7.56
HP_VASCULAR_NEOPLASM 6.9 6.81 7.13 7.22 7.28 7.33 7.2 7.31 7.24 7.24 7.13 7.16 7.42 7.33 7.28 7.3 7.14 7.05 7.2 7.27 7.07 7.3 7.31 7.4 7.37 7.31
HP_NEOPLASM_OF_THE_RECTUM 7.44 7.5 7.72 7.8 8.02 7.94 7.52 7.57 7.71 7.68 7.25 7.71 7.72 7.74 7.5 7.61 7.52 7.11 7.62 7.77 7.16 7.29 7.92 8 7.54 7.35
HP_ABNORMALITY_OF_THE_HUMERORADIAL_JOINT 6.35 6.47 6.67 6.72 6.61 6.39 6.54 6.6 6.45 6.61 6.75 6.34 6.68 6.58 6.52 6.68 6.56 6.51 6.37 6.36 6.5 6.47 6.43 6.62 6.54 6.67
HP_CHEST_PAIN 6.7 6.81 6.66 6.65 6.91 7.1 6.85 6.91 6.93 7.1 6.74 7.03 6.94 6.73 6.79 6.9 7.11 6.95 7.1 7.04 6.94 7.07 7.21 7.05 7.13 6.97
HP_ATELECTASIS 5.82 5.78 5.77 5.61 5.6 5.44 5.68 5.55 5.69 6.02 5.78 5.71 5.48 5.46 5.54 5.96 5.61 5.84 5.48 5.38 5.72 5.73 5.56 5.25 5.59 5.66
HP_ESOPHAGEAL_NEOPLASM 6.98 6.82 6.87 7.09 7.23 7.37 7.38 7.27 7.35 6.97 6.75 6.91 7.43 7.02 7.04 7.49 7.11 6.9 7.11 7.39 6.8 6.97 7.23 7.35 7.18 7.14
HP_SCHIZOPHRENIA 5.9 6.13 5.94 6.15 5.75 6.01 6.29 6.45 6 5.89 6.15 5.78 5.78 6.02 6.15 5.87 6 5.96 5.75 5.96 6.22 6.07 5.79 5.7 6.02 5.97
HP_MANIA 7.28 7.13 6.6 6.77 7.88 7.9 7 7 7.17 7.61 6.6 7.45 7.5 7.39 6.93 6.78 7.07 6.76 7.3 7.46 7.03 6.78 7.32 7.34 7.3 7.27
HP_ABNORMALITY_OF_SALIVATION 7.23 7.32 7.7 7.65 7.66 7.65 7.83 7.72 7.72 7.68 7.41 7.63 7.73 7.75 7.66 7.76 7.44 7.33 7.63 7.87 7.52 7.71 7.9 8.15 7.83 7.5
HP_GANGRENE 5.33 5.51 5.43 5.79 5.19 5.02 5.6 5.78 5.31 5.21 5.43 5.18 5.42 5.34 5.57 5.42 5.61 5.4 5.28 5.51 5.77 5.83 5.04 4.97 5.49 5.48
HP_CLUBBING_OF_FINGERS 6 5.93 6.32 6.71 6.42 6.42 6.22 6.51 5.97 6.42 6.57 6.39 6.28 6.41 6.19 6.48 6.4 6.62 6 6.08 6.58 6.77 6.56 6.77 6.28 6.48
HP_CLUBBING_OF_TOES 5.39 5.33 5.25 5.96 5.08 5.07 5.21 4.89 5.21 5.21 4.95 5.43 4.84 4.97 5.16 4.99 5.54 5.26 5.58 5.07 5.33 5.21 5.15 5.03 5.21 5.43
HP_VISCERAL_ANGIOMATOSIS 7.01 6.89 7.13 8.01 7.99 7.68 7.1 7.09 7.94 7.48 7.18 7.29 7.91 7.64 7.5 7.35 7.27 7.03 7.51 7.46 7.18 7.08 7.86 7.73 7.38 7.31
HP_ABNORMALITY_OF_THE_LYMPHATIC_SYSTEM 6.21 6.21 6.17 6.26 6.22 6.22 6.17 6.24 6.17 6.21 6.27 6.22 6.26 6.19 6.21 6.21 6.18 6.27 6.13 6.18 6.23 6.22 6.22 6.17 6.26 6.31
HP_ABNORMALITY_OF_THE_TONSILS 5.43 5.33 5.79 5.97 5.29 5.09 5.51 5.55 5.37 5.25 6.03 5.34 5.48 5.43 5.51 5.53 5.61 5.61 5.31 5.37 5.78 5.83 5.39 5.12 5.59 5.47
HP_ABNORMAL_LYMPHATIC_VESSEL_MORPHOLOGY 6.65 6.57 6.2 5.81 6.87 6.63 6.11 6.49 6.4 6.14 6.04 6.12 6.61 6.64 6.36 6.31 6.29 6.45 6.52 6.04 6.46 6.98 6.6 6.6 6.14 6.28
HP_ABNORMAL_PLACENTA_MORPHOLOGY 6.18 6.26 5.8 6.11 6.22 6.46 6.31 6.32 6.04 5.87 6.37 5.94 6.15 6.01 5.85 5.78 6.51 5.94 6.19 5.99 6.14 5.77 5.88 6.15 6.12 6.22
HP_HYPEROSTOSIS 6.74 6.77 6.83 7.16 7.32 7.19 6.98 7.23 7.27 7.31 6.87 7.01 7.41 7.42 7.37 7.19 7.15 7.02 7.24 7.27 7.21 7.12 7.53 7.57 7.27 7.25
HP_EXOSTOSES 6.82 6.44 5.98 6.49 6.65 6.24 6.34 6.37 6.45 6.41 6.57 6.27 6.47 6.62 6.47 6.74 6.49 6.04 6.44 6.25 6.34 6.45 6.92 6.72 6.34 6.48
HP_UROGENITAL_SINUS_ANOMALY 5.55 5.65 5.7 6.1 5.31 5.23 5.71 5.73 5.58 5.6 5.58 5.69 5.81 5.51 5.79 5.52 5.63 5.84 5.29 5.51 5.65 5.7 5.41 5.52 5.63 5.63
HP_BREAST_APLASIA 5.11 5.21 6.1 6.05 5.17 5.38 5.68 5.27 5.51 5.39 5.79 5.39 5.18 5.09 4.85 5.22 5.41 5.13 5.27 5.33 5.47 5.38 5.5 5.18 5.38 5.06
HP_INSOMNIA 7.21 7.06 7.13 7.12 7.78 7.47 7.42 7.46 7.41 7.69 7.09 7.4 7.52 7.69 7.19 7.5 7.5 7.22 7.59 7.63 7.13 7.16 7.16 7.53 7.35 7.23
HP_HYPERSOMNIA 5.11 4.94 4.96 5.03 4.82 4.48 4.88 4.91 4.81 4.89 5.15 4.72 4.62 4.7 4.67 4.63 4.64 4.94 4.68 4.67 4.98 4.9 4.75 4.46 4.92 4.73
HP_PROSTATE_NEOPLASM 5.75 6.05 6.14 6.65 6.3 6.05 6.16 6.4 6.13 6.2 6.06 6.17 6.08 5.89 6.17 6.05 5.82 5.51 5.96 5.98 6.17 6.1 6.44 6.48 6.05 6.08
HP_HERNIA 6.49 6.5 6.59 6.5 6.57 6.66 6.64 6.7 6.64 6.63 6.49 6.66 6.67 6.56 6.61 6.58 6.69 6.48 6.44 6.62 6.68 6.68 6.82 6.75 6.68 6.71
HP_ORCHITIS 5.35 5.58 5.83 5.39 5.54 5.55 5.43 5.22 5.68 5.07 5.66 5.4 5.64 5.78 5.44 5.58 5.73 5.09 5.17 5.29 5.6 5.9 5.39 5.27 5.81 5.8
HP_TOENAIL_DYSPLASIA 5.27 5.44 5.16 5.52 5.37 5.12 5.34 5.65 5.43 5.18 5.71 5.49 5.44 5.31 5.39 5.3 5.38 4.94 5.25 4.93 5.45 5.44 5.24 4.93 5.43 5.62
HP_FINGERNAIL_DYSPLASIA 5.19 5.08 5.51 5.68 4.95 5.04 5.3 5.29 5.27 4.99 5.48 5.08 5.61 5.29 5.44 4.9 5.3 5.35 5.04 5.43 5.57 5.26 5.35 5.25 5.19 5.35
HP_ABNORMALITY_OF_THE_PERIUNGUAL_REGION 5.54 5.46 5.37 5.46 5.16 5.21 5.38 5.01 5.26 5.36 5.21 5.1 5.41 5.39 5.4 5.29 5.25 5.54 5.17 5.28 5.56 5.29 5.09 5.44 5.14 5.27
HP_SEPSIS 5.89 5.54 5.68 5.56 5.39 5.18 5.63 5.68 5.54 5.36 5.71 5.4 5.42 5.65 5.49 5.51 5.7 5.72 5.45 5.47 5.58 5.65 5.67 5.15 5.51 5.45
HP_LONG_FINGERS 6.83 6.91 7.19 7.02 6.95 7.06 7.16 7.13 7.28 7.16 7.09 7.14 7.22 7.15 7.18 7.13 7.13 7.06 7.11 7.11 7.13 7.26 7.24 7.36 7.17 7.23
HP_RENOVASCULAR_HYPERTENSION 7.15 6.9 7.25 7.13 7.38 7.66 7.33 7.79 7.68 7.58 6.92 7.37 7.55 7.65 7.65 7.64 7.25 7.3 7.58 7.47 7.18 7.47 7.62 7.74 7.51 7.48
HP_INTESTINAL_FISTULA 6.11 6.05 6.98 6.35 6.37 6.43 6.31 6.61 6.3 6.3 6.45 6.31 6.45 6.18 6.2 6.55 6.36 6.45 6.37 6.52 6.51 6.65 6.57 6.74 6.66 6.34
HP_GLOMERULOPATHY 6.35 6.3 6.35 6.13 5.77 6.27 6.03 6.02 6.02 6.03 5.81 5.92 6.2 5.91 6.02 5.93 5.99 5.63 6.01 5.97 6.05 5.94 5.94 6.1 6.1 6.22
HP_CHEILITIS 6.06 5.74 5.96 6.16 5.75 5.52 5.88 5.5 5.72 5.7 5.97 6.06 5.97 5.59 5.72 5.79 6.13 5.96 5.66 5.92 5.94 5.79 5.72 5.81 6.02 5.91
HP_LYMPHOCYTOSIS 5.69 6.03 5.53 5.78 5.48 5.47 6.31 6.66 6.35 5.49 5.63 4.99 5.87 6.14 5.51 5.28 6 6.02 5.75 6.34 5.82 5.84 5.18 5.19 5.55 5.86
HP_NEOPLASM_OF_THE_SMALL_INTESTINE 7.68 7.7 8.34 8.39 8.15 8.05 8.3 8.08 8.22 8.03 7.81 7.74 8.69 8.59 8.08 8.1 7.73 7.28 8.42 8.24 7.25 7.94 8.47 8.29 8.1 7.39
HP_NEOPLASM_OF_THE_LARGE_INTESTINE 6.81 6.58 7.09 6.8 7.05 6.95 6.95 6.95 7.2 6.94 6.86 6.91 6.94 6.8 6.87 6.97 6.73 6.75 6.74 6.87 7.04 6.94 7.16 7.09 6.9 6.85
HP_BENIGN_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM 7.08 6.9 7.16 7.24 7.32 7.4 7.31 7.31 7.28 7.3 7.18 7.37 7.57 7.32 7.43 7.37 7.17 7.14 7.3 7.46 7.16 7.19 7.35 7.43 7.37 7.3
HP_MALIGNANT_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM 7.08 7.15 7.15 7.27 7.41 7.57 7.3 7.27 7.38 7.54 7.24 7.38 7.62 7.35 7.26 7.36 7.25 6.97 7.29 7.42 7.06 6.96 7.34 7.63 7.39 7.26
HP_APLASIA_HYPOPLASIA_OF_THE_EYEBROW 6.52 6.49 6.7 6.67 6.86 6.73 6.64 6.94 6.6 6.9 6.59 6.76 6.72 6.52 6.91 6.72 6.71 6.47 6.55 6.78 6.64 6.8 6.75 6.74 6.74 6.92
HP_SEPTO_OPTIC_DYSPLASIA 5.56 5.13 5.43 5.68 5.1 4.96 5.25 5.25 5.34 5.12 5.57 5.15 5.21 5.36 5.75 5.23 5.16 5.38 5.13 4.98 5.32 5.31 5.01 5.1 5.05 5.4
HP_NEOPLASM_OF_THE_MALE_EXTERNAL_GENITALIA 5.8 5.87 5.86 6.1 6.25 6.01 6.15 6.68 6 6.22 6.2 6.54 6.36 6.35 6.33 6.13 5.98 5.86 5.87 6.13 6.43 6.59 6.42 6.36 6.67 6.6
HP_ABNORMAL_EMOTION_AFFECT_BEHAVIOR 7.51 7.63 7.92 7.75 7.94 8.06 8 7.9 7.93 7.93 7.71 7.84 8.04 8.08 7.91 7.88 7.63 7.64 7.8 7.91 7.69 7.94 7.96 8.11 7.92 7.81
HP_ABNORMAL_FEAR_ANXIETY_RELATED_BEHAVIOR 7.37 7.41 7.7 7.67 7.89 7.84 7.72 7.7 7.69 7.74 7.54 7.8 7.81 7.84 7.7 7.78 7.53 7.28 7.64 7.75 7.51 7.74 7.91 8.04 7.7 7.68
HP_DUODENAL_STENOSIS 5.41 5.45 5.24 5.71 4.99 5.02 5.17 4.85 5.31 4.82 4.89 5.21 4.81 4.87 5.19 4.97 5.08 5.24 5.53 5.04 5.34 5.02 4.92 4.69 5.01 5.23
HP_ABNORMALITY_OF_THE_PALM 6.75 6.88 7.1 6.93 6.95 7.11 7.06 7.04 6.98 7.08 6.88 7.09 7.16 7.15 7.15 7.04 6.91 6.89 6.94 7.16 7 7.01 7.16 7.13 7.11 7.11
HP_ABNORMALITY_OF_THE_PLANTAR_SKIN_OF_FOOT 6.26 6.55 6.43 6.66 6.46 6.42 6.47 6.48 6.33 6.51 6.5 6.4 6.6 6.36 6.57 6.41 6.45 6.4 6.51 6.66 6.54 6.51 6.5 6.56 6.7 6.67
HP_THICK_HAIR 6.42 6.62 6.88 6.97 6.71 6.8 6.86 6.98 6.95 7.04 6.79 6.93 6.76 6.88 6.96 6.64 6.73 6.41 6.62 6.91 6.7 6.86 7.22 7.37 6.75 6.55
HP_ENLARGED_OVARIES 6.77 6.65 7.4 7.81 7.39 7.05 6.81 7.04 7.33 7.22 6.97 6.98 7.13 6.86 7.23 7.05 6.74 6.68 6.97 7.09 7.14 7.33 7.24 7.4 7.37 7.13
HP_ABNORMALITY_OF_GLOBE_LOCATION 6.82 6.83 6.99 6.88 7.03 7.17 6.94 7.03 6.97 7.08 6.91 7 7.1 7.03 6.97 7 6.92 6.92 7.02 7.02 6.98 7.01 7.09 7.2 7.06 7.08
HP_ABNORMALITY_OF_GLOBE_SIZE 6.18 6.24 6.3 6.43 6.31 6.48 6.3 6.39 6.26 6.39 6.31 6.48 6.29 6.35 6.41 6.38 6.22 6.26 6.15 6.33 6.26 6.44 6.4 6.41 6.42 6.4
HP_ABNORMAL_RENAL_MEDULLA_MORPHOLOGY 6.58 6.55 6.34 6.33 6.55 6.43 6.31 6.38 6.21 6.47 6.39 6.45 6.36 6.24 6.31 6.32 6.36 6.63 6.48 6.35 6.26 6.42 6.31 6.35 6.26 6.58
HP_ABNORMAL_SHAPE_OF_THE_PALPEBRAL_FISSURE 5.94 5.76 5.94 5.99 5.74 5.91 5.75 5.79 5.93 5.8 5.31 5.62 6 5.84 5.89 5.73 5.59 5.42 5.8 5.93 5.66 5.66 6.19 6.03 5.63 5.61
HP_ABNORMAL_SIZE_OF_THE_PALPEBRAL_FISSURES 6.84 6.83 7.08 6.97 7 7.16 6.92 7.14 7.08 7.06 6.85 7.04 7.2 7.16 7.17 7.11 7.03 6.93 6.99 7.06 7.06 7.05 7.16 7.29 7.18 7.11
HP_NEOPLASM_OF_FATTY_TISSUE 7.19 7.22 8.03 7.99 7.55 7.44 7.2 7.23 7.94 7.62 7.4 7.7 7.39 7.56 8 7.66 7.14 7.07 7.49 7.55 7.15 7.12 8.14 8.05 7.55 7.13
HP_CORNEAL_EROSION 5.52 5.49 5.28 5.67 5.18 5.22 5.59 5.44 5.51 5.3 5.36 5.28 5.02 5.22 5.19 5.21 5.44 5.43 5.14 5.07 5.4 5.31 5.21 4.83 5.15 5.23
HP_DOWN_SLOPING_SHOULDERS 7.15 6.99 7.16 7.13 7.08 7.16 7.2 7.14 6.98 7.16 7.17 7.37 7.23 7.03 7.34 6.76 7 6.57 7.15 7.08 7.08 6.92 7.23 7.6 7.18 7.38
HP_OCULAR_PAIN 5.9 5.82 5.66 5.77 5.94 6.66 6.05 5.96 6 6.24 5.83 5.87 6.1 5.89 5.5 5.89 6.23 6.13 6.03 6.25 5.63 6 5.72 6.11 6.14 6.26
HP_PAPULE 6.53 6.37 6.56 6.41 6.31 6.3 6.22 6.14 6.56 6.27 6.37 6.3 6.3 6.19 6.27 6.24 6.11 5.97 6.06 6.37 6.2 6.07 6.43 6.49 6.29 6.13
HP_SKIN_PLAQUE 5.62 5.59 5.29 5.79 5.34 5.07 5.5 5.41 5.56 5.24 5.44 5.12 5.12 5.34 5.47 5.21 5.44 5.55 5.31 5.48 5.49 5.05 5.18 4.99 5.27 5.23
HP_SKIN_NODULE 6.41 6.61 6.69 6.71 6.7 6.91 6.91 6.68 6.94 6.95 6.61 6.54 6.79 7.08 6.55 6.64 6.69 6.83 6.96 6.94 6.48 6.66 7.06 7.01 6.61 6.46
HP_SKIN_VESICLE 5.73 5.78 5.74 5.88 5.52 5.56 5.89 5.78 5.76 5.53 5.87 5.53 5.56 5.77 5.64 5.84 5.66 5.6 5.59 5.55 5.87 6.11 5.69 5.36 6.1 6.12
HP_PUSTULE 5.6 5.48 5.22 5.86 5.13 5.12 5.55 5.39 5.57 5.44 5.37 5.22 5.27 5.23 5.49 5.25 5.34 5.57 5.21 5.27 5.62 5.49 5.17 5.08 5.24 5.5
HP_EPIDERMOID_CYST 7.73 7.76 7.31 7.31 7.4 7.6 7.49 7.64 7.32 7.68 7.44 7.64 7.5 7.42 7.75 7.77 7.32 7.59 7.74 7.84 7.84 7.77 7.57 7.9 7.84 7.68
HP_SKIN_EROSION 5.83 5.75 5.49 5.8 5.41 5.4 5.59 5.44 5.46 5.3 6.02 5.23 5.35 5.48 5.3 5.45 5.4 5.77 5.57 5.58 5.65 5.13 5.47 5.06 5.11 5.44
HP_SKIN_ULCER 6.31 6.17 6.06 6.29 6.16 6.04 6.07 5.88 6.13 6.06 6.24 6.13 6.11 6.15 5.91 5.97 6.19 6.12 6.02 6.08 6.13 6.08 6.12 5.89 6.16 6.28
HP_VERRUCAE 5.66 5.35 5.58 5.43 5.23 5.22 5.57 5.51 5.6 5.56 5.27 5.08 5.45 5.16 5.48 5.33 5.47 5.57 5.33 5.75 5.53 5.31 5.28 5.21 5.25 5.03
HP_SMALL_HAND 7.21 7.37 7.55 7.32 7.69 7.81 7.64 7.53 7.62 7.93 7.08 7.83 7.74 7.69 7.66 7.47 7.43 7.16 7.45 7.48 7.37 7.56 7.83 7.92 7.66 7.68
HP_COLORECTAL_POLYPOSIS 7.37 7.32 8.01 7.9 8.13 7.66 7.52 7.91 8 7.65 8.09 7.72 8.22 7.91 8.26 7.66 7.14 7.07 7.61 8.01 7.21 8.1 8.38 8.08 7.8 7.13
HP_CHORIORETINAL_DEGENERATION 5.3 5.29 5.92 5.56 5.11 4.82 5.33 5.49 5.44 5.2 5.4 5.07 5.12 5.23 5.31 5.36 5.13 5.5 5.53 4.93 5.37 5.39 5.42 5.25 5.2 5.22
HP_RECURRENT_SPONTANEOUS_ABORTION 4.91 4.69 4.59 5.17 4.51 4.34 4.55 4.44 4.75 4.52 4.59 4.36 4.56 4.28 4.42 4.53 4.6 4.8 4.71 4.53 4.94 4.37 4.65 4 4.23 4.41
HP_LIMB_TREMOR 7.71 8.25 8.05 7.76 8.49 8.47 8.42 8.48 8.06 8.46 7.67 8.35 8.61 8.55 8.78 8.45 8.08 8.03 8.45 8.44 8.05 8.37 8.37 8.68 8.54 8.18
HP_ORAL_MUCOSAL_BLISTERS 5.31 5.36 5.28 5.55 4.6 4.64 5.02 4.9 4.91 4.92 5.4 4.79 4.93 4.94 4.95 4.98 4.99 5.48 5.12 4.95 5.29 4.74 5.01 4.63 5.06 4.99
HP_DECREASED_ABSENT_ANKLE_REFLEXES 7.33 7.16 7.27 7.15 7.35 7.37 7.18 7.29 7.48 7.43 7.44 7.45 7.29 7.52 7.53 6.86 7.24 7.16 7.02 7.49 7.17 7.44 7.74 7.73 7.41 7.6
HP_SPARSE_OR_ABSENT_EYELASHES 6.17 6.25 6.02 6.12 6.34 6.07 6.22 6.4 6.16 6.36 6.33 6.25 6.19 6.08 6.14 6.29 6.23 6.29 6.05 6.28 6.14 6.23 6.42 6.38 6.3 6.48
HP_METABOLIC_ALKALOSIS 5.01 4.78 4.59 5.1 4.58 4.4 4.54 4.45 4.67 4.36 4.64 4.35 4.4 4.6 4.46 4.47 4.68 4.71 4.54 4.5 4.83 4.38 4.53 4.3 4.18 4.41
HP_RECURRENT_UPPER_AND_LOWER_RESPIRATORY_TRACT_INFECTIONS 5.13 4.73 4.68 5.27 4.41 4.43 4.59 4.54 4.61 4.29 4.61 4.4 4.3 4.46 4.67 4.36 4.85 4.93 4.36 4.5 4.79 4.62 4.62 4.3 4.21 4.24
HP_CHRONIC_HEPATITIS 5.94 5.66 6.13 6.16 5.96 5.99 6.19 5.83 6.11 5.9 6.17 5.91 6.14 5.95 5.71 5.83 6.38 6.07 5.73 6.06 6.36 5.82 6.03 5.84 5.74 5.68
HP_EPILEPTIC_ENCEPHALOPATHY 8.44 8.55 8.53 8.48 8.81 9.09 9.15 8.77 8.97 9.11 8.55 8.59 8.92 9.06 9.04 8.97 8.17 8.57 8.87 9.24 8.23 8.61 8.87 9.31 8.82 8.52
HP_ORAL_PHARYNGEAL_DYSPHAGIA 7.78 7.97 7.9 7.77 8.09 8.17 8.19 8.26 8.08 8.27 7.69 8.34 8.23 8.22 8.21 8.27 7.74 7.86 8.21 8.22 8.13 8.29 8.11 8.32 8.27 8.27
HP_AGENESIS_OF_LATERAL_INCISOR 5.28 5.39 5.4 5.56 5.09 4.92 4.86 5 5.34 4.99 5.24 5.09 5 5.12 5.27 5.09 4.97 5.14 4.91 4.78 5.16 5.05 5.2 5.12 5.02 4.75
HP_ABNORMALITY_OF_THE_PERIPHERAL_NERVOUS_SYSTEM 6.5 6.58 6.56 6.61 6.61 6.7 6.57 6.63 6.59 6.66 6.47 6.56 6.66 6.6 6.66 6.67 6.49 6.55 6.4 6.48 6.41 6.71 6.62 6.8 6.7 6.58
HP_ABNORMALITY_OF_MASTICATORY_MUSCLE 5.19 5.13 5 5.29 4.98 4.83 4.88 4.77 5.02 4.85 5.29 4.72 4.99 4.92 4.99 4.93 4.98 5.12 4.88 4.83 5.14 4.9 4.81 4.72 4.93 4.78
HP_RECURRENT_EAR_INFECTIONS 6.92 6.86 7.19 7.09 6.77 6.93 7.11 7.33 6.65 7.21 7.26 6.93 7.01 7.07 7.27 6.98 7.42 7.16 6.98 7.1 7.44 7.18 6.81 6.68 7.07 7.33
HP_CLEFT_LIP 6.07 6.27 6.19 6.29 6.1 6.07 6.08 6.24 6.11 6.17 6.22 6.18 6.16 6.22 6.14 6.31 6.23 6.11 6.11 6.05 6.34 6.29 6.2 6.1 6.2 6.24
HP_SUBMUCOUS_CLEFT_OF_SOFT_AND_HARD_PALATE 6.65 6.63 7.14 6.78 6.93 6.96 6.66 7.04 7.13 7.01 6.6 6.92 7.17 6.99 7.26 6.98 7.01 6.93 6.75 7.01 6.79 6.94 7.22 7.01 7.07 7.05
HP_ABNORMAL_LIVER_MORPHOLOGY 6.46 6.48 6.64 6.65 6.56 6.6 6.52 6.52 6.51 6.63 6.47 6.56 6.6 6.55 6.45 6.5 6.49 6.42 6.51 6.57 6.48 6.49 6.56 6.56 6.59 6.68
HP_ABNORMAL_NEURAL_TUBE_MORPHOLOGY 6.23 6.24 6.18 6.43 6.3 6.32 6.24 6.39 6.33 6.27 6.29 6.17 6.26 6.33 6.21 6.24 6.17 6.27 6.25 6.2 6.34 6.31 6.31 6.34 6.26 6.34
HP_PHYSICAL_URTICARIA 5.05 4.89 5.1 5.03 4.6 4.54 4.58 4.84 4.76 4.72 4.8 4.37 4.67 4.6 4.61 4.68 4.84 4.61 4.68 4.38 4.64 4.72 4.46 4.18 4.49 4.61
HP_ABNORMAL_CIRCULATING_IGA_LEVEL 4.98 5.06 5.02 5.07 4.76 4.75 4.89 4.97 4.91 4.68 4.97 4.7 4.65 4.75 4.8 4.78 4.97 5.05 4.73 4.67 4.95 4.98 4.56 4.54 4.78 4.74
HP_ABNORMAL_CIRCULATING_IGE_LEVEL 5.49 5.46 5.3 5.38 5.3 5.21 5.21 5.21 5.38 5.19 5.4 4.93 5.28 5.34 5.26 5.23 5.39 5.41 5.22 5.13 5.5 5.38 5.17 5.05 5.46 5.35
HP_ABNORMAL_CIRCULATING_IGG_LEVEL 5.39 5.37 5.63 5.35 5.29 5.23 5.31 5.37 5.35 5.18 5.15 4.97 5.29 5.22 5.17 5.21 5.39 5.34 5.11 5.4 5.2 5.31 5.24 5.07 5.27 5.46
HP_ABNORMAL_CIRCULATING_IGM_LEVEL 5.3 5.11 5.2 5.31 4.84 4.93 5.15 5.19 4.99 4.97 5.35 4.88 4.96 4.86 4.96 5.01 4.98 5.32 4.81 4.76 5.16 5.12 4.78 4.77 5.05 4.95
HP_BRAIN_IMAGING_ABNORMALITY 7.61 7.93 8.14 8.1 8.17 8.14 8.54 8.36 8.31 8.43 8.07 8.34 8.26 8.24 8.33 8.39 8.06 7.84 8.02 8.38 8 8.32 8.27 8.55 8.48 8.22
HP_PEDIATRIC_ONSET 6.68 6.7 6.99 6.88 7 7 6.97 7.01 6.92 6.88 6.91 6.84 6.91 6.88 6.86 6.93 6.79 6.8 6.87 6.95 6.69 6.83 6.9 7.04 6.84 6.75
HP_NEGATIVISM 6.42 6.4 6.22 6.03 6.05 6.17 6.61 6.85 6.33 6.07 5.93 5.94 6.18 6.32 6.97 6.09 6.3 6.31 5.86 6 6.34 5.98 6.01 6.24 6.41 6.18
HP_ABNORMAL_CARDIAC_TEST 6.15 6.1 6.31 6.34 5.93 6.08 6.08 6.09 5.97 6.27 6.13 6.26 5.97 5.97 6.32 6.12 6.16 6.24 6.04 6.18 6.11 6 6.18 6.22 6.2 6.44
HP_ABNORMALITY_OF_CARTILAGE_OF_EXTERNAL_EAR 6.76 6.47 6.06 7.03 6.75 6.46 6.62 6.73 6.92 7.11 6.63 6.82 6.41 6.87 6.01 7.09 7.07 6.62 6.87 6.33 7.12 6.9 7.01 6.84 6.64 6.42
HP_ABNORMALITY_OF_HEAD_BLOOD_VESSEL 6.71 6.62 6.6 6.9 6.87 7 6.79 6.83 6.67 6.62 6.61 6.7 6.85 6.56 6.53 6.59 6.62 6.53 6.95 6.78 6.82 6.52 6.73 6.82 6.65 6.66
HP_ABNORMALITY_OF_ODONTOID_TISSUE 6.29 6.23 6.5 6.41 6.16 6.2 6.27 6.26 6.23 6.18 6.49 6.15 6.22 6.34 6.28 6.44 6.28 6.34 6.3 6.33 6.12 6.29 6.32 6.22 6.12 6.14
GOBP_MITOCHONDRIAL_GENOME_MAINTENANCE 6.74 7.37 7.35 7.25 6.81 7.35 7.02 7.62 7.36 7.14 7.38 7.13 7.19 7.38 7.21 7.26 6.72 6.73 7.14 7.22 7.15 7.55 7.38 7.47 7.38 7.2
GOBP_REPRODUCTION 5.85 5.81 5.89 5.94 5.7 5.64 5.73 5.72 5.77 5.77 5.9 5.76 5.72 5.71 5.84 5.84 5.76 5.84 5.79 5.7 5.86 5.73 5.73 5.67 5.78 5.91
GOBP_SINGLE_STRAND_BREAK_REPAIR 6.36 6.69 6.63 6.38 6.92 6.74 6.79 6.76 6.91 6.89 6.34 6.92 7.2 7.09 7 6.75 6.47 6.54 6.67 6.56 6.6 6.62 7.28 7.45 6.82 6.32
GOBP_REGULATION_OF_DNA_RECOMBINATION 5.99 5.91 6.16 6.1 6.06 6.08 5.74 6.21 5.9 6.08 6.16 6.18 6.04 6.04 5.87 6.03 6.21 6.05 5.86 5.95 6.15 6.16 5.83 6.35 6.18 6.31
GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY 5.92 6 6.03 6.4 5.8 5.81 6.34 6.49 6.17 6.22 6.2 6.17 6.19 6.11 6.08 6.1 6.18 6.2 5.91 5.99 6.05 6.57 6.22 6.25 6.05 6.22
GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY 6.09 6.32 6.76 6.07 6.11 6.01 6.25 6.54 5.97 6.28 6.62 5.65 6.29 6.16 6.49 6.28 6.27 5.99 6.01 6.1 6.47 6.2 6.62 6.28 6.51 6.69
GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS 6.25 6.19 6.65 6.91 6.56 6.5 6.54 6.61 6.67 6.82 6.69 6.79 6.53 6.46 6.67 6.92 6.24 6.51 6.3 6.4 6.58 6.61 6.82 6.75 6.35 6.4
GOBP_TRANSITION_METAL_ION_TRANSPORT 6.82 6.67 7.06 6.99 7.06 7.18 6.92 7.06 7.11 6.97 6.79 6.96 7 7.08 6.8 6.9 7.08 6.93 7.14 7.15 6.99 7.11 6.89 7.2 7.29 7.24
GOBP_UREA_CYCLE 5.49 5.12 5.18 5.1 5.29 5.25 5.32 5.56 5.41 5.15 4.85 4.92 5.11 5.08 5.25 5.62 5.23 5.16 4.99 4.99 5.25 5.59 4.98 5.34 5.11 5.31
GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION 6.1 6.18 6.22 6.24 6.13 6.19 6.21 6.36 6.28 6.45 6.13 6.36 6.2 6.17 6.43 6.21 6.28 6 6 6.24 6.18 6.22 6.38 6.64 6.28 6.3
GOBP_CELL_CYCLE_CHECKPOINT 6.24 6.39 6.38 6.39 6.4 6.44 6.2 6.39 6.16 6.35 6.43 6.25 6.23 6.2 6.23 6.52 6.35 6.24 6.4 6.26 6.42 6.5 6.25 6.37 6.44 6.51
GOBP_DNA_REPLICATION_CHECKPOINT 5.72 5.43 5.54 5.85 5.37 5.13 5.49 5.65 5.64 5.21 5.61 5.64 5.28 5.32 5.59 5.57 5.73 5.37 5.92 5.23 5.49 5.84 5.21 5.38 5.55 5.74
GOBP_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE 6.42 6.18 6.68 6.36 6.05 6.26 7.06 6.94 6.53 6.62 6.64 6.1 6.59 6.37 6.64 7.03 6.52 6.27 6.29 6.83 6.38 6.48 6.54 6.65 6.76 6.54
GOBP_SULFUR_AMINO_ACID_METABOLIC_PROCESS 6.37 6.5 6.69 7.34 6.62 6.4 6.62 6.54 6.49 6.66 6.7 6.8 6.46 6.39 6.51 6.52 6.89 6.48 6.42 6.65 6.95 6.66 6.36 6.64 6.57 6.56
GOBP_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS 7.05 7.19 7.03 7.34 6.62 6.35 6.67 6.54 6.52 6.66 7 7.07 6.82 6.39 6.96 6.52 7.3 6.68 7.25 6.77 7.04 6.81 6.88 7 6.57 6.58
GOBP_SULFUR_AMINO_ACID_CATABOLIC_PROCESS 6.36 6.5 6.65 7.37 6.65 6.33 6.67 6.83 6.52 6.58 6.56 6.87 6.82 6.39 6.51 6.18 6.89 6.33 6.42 6.76 7.04 6.66 6.88 6.83 6.39 6.52
GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II 6.34 6.31 6.38 6.39 6.31 6.4 6.43 6.45 6.39 6.41 6.38 6.37 6.52 6.48 6.44 6.48 6.49 6.32 6.35 6.38 6.44 6.51 6.48 6.52 6.42 6.45
GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_ORIENTATION 6.88 6.4 6.47 6.4 7.11 6.84 6.42 6.3 6.23 6.56 7.1 6.44 6.27 6.49 6.07 6.69 6.28 6.42 6.42 6.43 6.46 6.56 6.61 6.53 6.22 6.77
GOBP_RRNA_MODIFICATION 6.39 6.52 6.77 6.94 6.35 6.46 6.41 6.66 6.45 6.23 6.35 6.34 6.33 6.32 6.27 6.18 6 6.4 6.29 6.35 6.36 6.3 6.45 6.56 6.29 6.58
GOBP_MAPK_CASCADE 6.37 6.31 6.48 6.46 6.36 6.44 6.46 6.52 6.51 6.48 6.51 6.4 6.47 6.47 6.54 6.51 6.48 6.4 6.28 6.43 6.57 6.51 6.6 6.57 6.5 6.56
GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY 7.24 7.44 7.46 7.42 7.33 7.39 7.31 7.3 7.18 7.37 7.42 7.14 7.41 7.23 7.57 7.41 7.42 7.17 7.23 7.37 7.24 7.31 7.47 7.35 7.29 7.47
GOBP_ACTIVATION_OF_MAPKKK_ACTIVITY 5.46 5.91 6.67 5.98 6.21 6.16 6.57 6.48 6.18 6.16 6.26 6.09 6.19 6.14 6.12 6.49 6.52 6.46 5.84 6.12 6.59 6.57 6.47 6.47 6.17 6.09
GOBP_ACTIVATION_OF_MAPKK_ACTIVITY 6.98 7.08 7.14 6.91 7.52 7.45 7.11 7.35 7.36 7.47 7.15 7.49 7.48 7.49 7.09 7.16 7.21 7.1 7.32 7.47 6.92 7.3 7.27 7.54 7.26 7.47
GOBP_ACTIVATION_OF_MAPK_ACTIVITY 6.32 6.19 6.22 6.27 6.21 6.19 6.28 6.38 6.5 6.35 6.36 6.31 6.33 6.4 6.35 6.43 6.41 6.42 6.33 6.4 6.53 6.33 6.48 6.42 6.26 6.45
GOBP_INACTIVATION_OF_MAPK_ACTIVITY 7.04 7.1 7.26 7.29 7.47 6.9 6.86 6.88 7.32 7.16 6.98 7.1 7.16 7.47 6.86 6.8 7.13 6.78 7.43 7.14 7.12 7.06 7.66 7.58 6.89 7.05
GOBP_PROTEIN_POLYUBIQUITINATION 7.23 7.24 7.68 7.62 7.52 7.55 7.55 7.55 7.68 7.58 7.51 7.4 7.56 7.56 7.54 7.52 7.33 7.26 7.49 7.56 7.29 7.36 7.61 7.8 7.58 7.52
GOBP_MEIOTIC_SPINDLE_ORGANIZATION 5.28 4.74 5.23 4.89 5.37 5.37 5.2 5.5 5.38 5.24 4.88 5.18 4.88 5.03 5.36 5.61 5.07 5 4.86 5.2 5 5.35 5.88 5.99 5.12 5.05
GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION 6.8 6.81 6.99 6.79 7.02 6.97 6.85 6.91 6.77 7.04 6.89 7.01 7.02 6.91 7 7.06 6.79 6.84 6.81 6.83 6.87 6.97 6.9 7.09 6.95 6.89
GOBP_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY 6.65 7.11 7.22 7.37 7.05 7.04 7.04 7.31 7.2 7.22 6.93 7.13 7.01 7.09 7.36 7.56 6.7 6.96 7.31 7.34 7.08 7.16 7.3 7.5 7.3 7.28
GOBP_SPLICEOSOMAL_COMPLEX_ASSEMBLY 8.05 7.95 8.34 8.25 8.57 8.59 8.36 8.46 8.49 8.65 8.19 8.69 8.44 8.48 8.69 8.66 8.27 8.17 8.25 8.57 8.17 8.52 8.79 8.84 8.74 8.56
GOBP_MITOCHONDRIAL_FISSION 7.36 7.82 7.28 7.55 8.29 8.01 8.25 7.95 8.29 8.48 7.89 8.28 8.11 8.13 7.92 8.04 7.83 7.47 7.82 8.01 7.62 7.98 8.42 8.44 8.3 8
GOBP_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS 6.54 6.78 6.51 6.72 6.8 7 6.96 7.05 7.05 7 6.54 6.86 7.25 6.97 7.14 7.01 6.83 6.86 6.87 7.09 6.73 6.85 7.04 7.09 6.91 6.98
GOBP_POLYSACCHARIDE_CATABOLIC_PROCESS 6.69 6.7 6.62 6.72 6.8 7.23 6.59 6.78 7.05 6.66 6.31 6.86 6.82 6.88 6.5 6.63 6.83 6.85 6.87 6.68 6.73 6.87 6.58 6.64 6.85 6.74
GOBP_MITOTIC_CELL_CYCLE 6.68 6.73 6.96 6.9 6.78 6.93 6.87 6.91 6.8 6.95 6.79 6.9 6.9 6.9 6.94 6.97 6.72 6.78 6.73 6.93 6.76 6.96 6.96 7.05 6.92 6.97
GOBP_MITOTIC_CYTOKINESIS 6.69 6.68 7.57 7.13 7.02 6.88 7.02 6.83 6.97 7.01 7.05 6.98 7.15 7.04 7.18 7.21 6.67 6.75 6.85 6.99 6.71 6.97 7.07 7.43 7.29 7.03
GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY 7.61 7.75 7.85 7.78 7.73 7.81 7.68 7.47 7.72 7.72 7.51 7.71 7.74 7.81 7.68 7.5 7.53 7.32 7.48 7.79 7.41 7.63 7.9 7.88 7.69 7.41
GOBP_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING 7.55 7.78 7.94 7.8 7.85 7.82 7.81 7.78 7.72 7.82 7.66 7.7 7.74 7.9 7.91 7.74 7.64 7.38 7.78 7.81 8.21 7.9 8 8 8 7.89
GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC 7.38 7.26 7.52 7.79 7.52 7.49 7.56 7.33 7.61 7.4 7.41 7.5 7.5 7.55 7.1 7.45 6.83 7.19 7.21 7.56 6.94 7.26 7.16 7.31 7.36 7.19
GOBP_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES 6.69 6.7 7 6.66 6.98 6.82 6.88 6.92 6.91 7.01 6.86 6.92 7.08 7.07 6.98 6.98 6.96 6.88 6.83 7 7.14 7.35 6.99 7.01 7.11 6.91
GOBP_RESPONSE_TO_OXYGEN_RADICAL 5.77 5.76 5.79 6.15 5.77 5.8 5.91 5.73 5.73 5.75 6.07 5.69 5.92 5.83 6.21 5.9 5.99 5.85 5.75 6.51 6.14 5.74 6.28 6.11 6.61 6.31
GOBP_PROTEIN_DENEDDYLATION 8.11 8.44 9.68 9.58 8.08 8.37 8.63 8.36 8.66 8.69 8.85 8.34 8.45 8.61 8.66 8.83 7.95 7.72 8.28 8.53 7.96 8.41 8.69 8.77 8.69 8.4
GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS 7.37 7.62 7.81 7.68 7.76 7.83 7.83 7.81 7.78 7.82 7.62 7.81 7.69 7.69 7.89 7.9 7.66 7.54 7.77 7.9 7.59 7.85 7.83 7.93 7.87 7.81
GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME 7.87 8.1 8.45 8.27 8.51 8.47 8.53 8.38 8.63 8.74 8.39 8.47 8.46 8.6 8.47 8.54 8.27 8.13 8.37 8.53 7.96 8.27 8.52 8.7 8.58 8.43
GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME 7.86 8.11 8.41 8.21 8.58 8.6 8.59 8.48 8.68 8.86 8.05 8.57 8.68 8.68 8.59 8.54 8.28 8.17 8.37 8.48 7.96 8.52 8.5 8.67 8.61 8.42
GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY 6.6 6.64 6.8 7.28 6.73 6.72 6.61 6.94 6.7 6.97 6.81 7.03 6.92 6.94 6.99 7.1 6.63 6.75 7.04 6.86 7 6.95 6.9 7.06 6.89 7.12
GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION 5.99 6.01 6.28 6.32 6.05 6.39 5.9 6.24 6.09 6.24 6.2 5.91 5.98 6.16 6.24 6.07 6.28 5.99 6.17 6.16 6.27 6.25 6.06 6.06 6.1 5.94
GOBP_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION 6.91 6.92 7.18 7.33 6.96 6.88 7.25 7.18 7.04 7.03 7.49 7.04 7.15 6.91 7.47 7.46 6.92 7.14 7.29 7.15 7.31 7.5 7.32 7.37 7.13 7.5
GOBP_AUTOPHAGY_OF_MITOCHONDRION 7.69 8.04 8.29 7.97 8.17 8.1 8.12 8.31 8.18 8.22 8.19 8.07 8.28 8.4 8.22 8.25 7.97 7.97 8.23 8.15 8.09 8.2 8.31 8.44 8.32 8.34
GOBP_MITOPHAGY 8.31 8.55 8.43 8.09 8.34 8.56 8.05 8.14 8.3 8.47 8.18 8.35 8.42 8.51 8.24 8.27 8.29 8.17 8.45 8.28 8.21 8.23 8.37 8.6 8.31 8.26
GOBP_MATURATION_OF_5_8S_RRNA 6.72 6.72 6.92 6.97 6.62 6.71 6.74 6.71 6.76 6.71 6.92 6.92 6.87 6.69 6.87 6.74 6.63 6.62 6.67 6.73 6.32 6.56 6.67 6.86 6.97 6.82
GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA 6 5.94 6.12 6.36 6.13 6.01 6.11 6.25 6.14 6.29 6.23 6.16 6.22 6.24 6.29 6.28 6.07 5.93 6.02 6.05 6.31 6.36 6.17 6.36 6.15 6.47
GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA 6.67 6.59 7.38 7.17 7.09 7.21 7.16 7.59 7.52 7.2 7.25 7.27 7.2 7.27 7.23 7.78 6.74 6.95 7.32 6.88 6.58 6.99 7.38 7.72 7.02 7.05
GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA 6 6.43 6.76 6.94 6.28 6.11 6.74 6.71 6.7 6.58 6.62 6.57 6.65 6.39 6.87 6.69 6.63 6.61 6.37 6.41 6.32 6.56 6.62 6.52 6.67 6.72
GOBP_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING 6.08 6.44 6.56 6.68 6.41 6.35 6.48 6.58 6.21 6.57 6.55 6.55 6.63 6.42 6.77 6.7 6.42 6.48 6.51 6.41 6.31 6.65 6.44 6.59 6.78 6.73
GOBP_MATURATION_OF_LSU_RRNA 6.81 6.71 7.4 7.2 6.96 7.21 7.16 7.59 7.51 7.2 7.74 7.26 7.2 7.27 7.23 7.88 6.74 6.94 7.32 6.9 6.58 6.99 7.25 7.72 7.08 7.18
GOBP_ENDONUCLEOLYTIC_CLEAVAGE_INVOLVED_IN_RRNA_PROCESSING 6 5.81 6.11 6.24 6.22 6.08 6.19 5.81 6.16 6.44 6.18 6.57 6.37 6.39 6.49 6.02 6.27 6.15 6.01 6.05 5.89 6.36 6.33 6.26 5.87 5.95
GOBP_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY 6.6 6.76 7.86 7.04 7.12 7.13 7.39 7.3 7.66 7.53 7.6 7.36 7.11 7.52 7.43 7.6 7.52 7.24 7.14 7.27 7.53 7.32 7.69 7.94 7.7 7.35
GOBP_EMBRYONIC_AXIS_SPECIFICATION 5.91 5.86 5.68 5.57 5.59 5.44 5.49 5.78 5.54 5.62 5.77 5.25 5.67 5.58 5.63 5.86 5.65 5.52 5.51 5.49 5.88 5.84 5.4 5.6 5.66 5.82
GOBP_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES 4.96 5.33 5.21 6.07 4.72 4.63 4.54 4.67 4.81 4.7 4.79 4.99 4.47 4.73 4.54 4.8 4.91 5.12 4.88 4.77 5.16 4.85 4.93 4.93 4.76 4.89
GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_DAMAGE_RECOGNITION 8.14 8.42 9.61 9.34 8.37 8.52 8.71 8.65 8.92 8.67 8.74 8.51 8.49 8.82 8.77 8.8 8.34 7.94 8.32 8.59 8.39 8.51 8.67 8.85 8.91 8.78
GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_DUPLEX_UNWINDING 7.61 7.82 8.34 7.83 8.19 8.31 7.95 8.03 8.05 8.21 7.89 8.06 8.23 7.85 8.16 8.17 7.68 7.54 8.22 8.16 7.58 7.87 8.31 8.36 8.36 8.04
GOBP_TELOMERE_MAINTENANCE_VIA_RECOMBINATION 6.52 6.19 6.47 7.29 6.53 6.74 6.44 6.45 6.89 6.62 6.27 6.58 6.27 6.33 6.33 6.3 6.48 6.12 6.18 6.53 6 6.02 6.8 7.15 6.35 6.14
GOBP_RECOMBINATIONAL_REPAIR 6.04 6.07 6.36 6.43 6.12 6.19 6.21 6.12 6.12 6.25 6.16 6.25 6.05 6.06 6.21 6.19 6.21 6.06 5.96 6.16 6.12 6.09 6.31 6.49 6.17 6.24
GOBP_NON_RECOMBINATIONAL_REPAIR 6.32 6.24 6.45 6.54 6.48 6.57 6.56 6.54 6.49 6.37 6.51 6.52 6.64 6.41 6.48 6.24 6.31 6.27 6.33 6.51 6.34 6.41 6.62 6.82 6.42 6.65
GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_BREAK_INDUCED_REPLICATION 5.74 5.51 5.44 5.89 5.08 4.75 5.21 5.6 5.21 5.11 5.68 5.27 5.12 5.17 5.19 5.34 5.25 5.4 5.3 5.28 5.56 5.22 5.11 5.43 5.51 5.91
GOBP_DNA_DOUBLE_STRAND_BREAK_PROCESSING 6.11 5.96 6.81 6.79 6.41 6.57 6.52 6.18 6.26 6.21 6.51 6.47 6.05 5.97 6.48 6.09 6.23 6.45 6.51 6.28 6.21 6.18 6.22 6.35 6.43 6.51
GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR 6.48 6.41 7.16 7.31 6.66 6.81 6.62 6.76 6.54 6.73 6.69 6.62 6.92 6.76 6.5 7.01 6.47 6.47 6.74 6.68 6.68 6.83 6.63 6.72 6.81 6.59
GOBP_DNA_CATABOLIC_PROCESS_ENDONUCLEOLYTIC 5.87 5.75 6 5.96 5.76 5.8 5.54 6.09 5.57 5.83 6.24 5.98 5.63 5.59 5.73 5.93 5.45 5.8 5.91 6.12 5.67 5.87 5.51 5.62 5.95 6.01
GOBP_SISTER_CHROMATID_SEGREGATION 6.19 6.25 6.4 6.52 6.26 6.24 6.41 6.39 6.41 6.51 6.26 6.44 6.22 6.21 6.54 6.34 6.37 6.19 6.15 6.32 6.2 6.37 6.44 6.68 6.37 6.34
GOBP_CELL_MORPHOGENESIS 7.01 7.14 7.23 6.95 7.32 7.37 7.42 7.5 7.35 7.39 7.22 7.42 7.55 7.53 7.5 7.45 7.24 7.23 7.31 7.46 7.26 7.47 7.39 7.61 7.44 7.37
GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION 7.13 7.19 7.3 6.97 7.36 7.42 7.51 7.58 7.4 7.51 7.29 7.48 7.61 7.61 7.58 7.55 7.25 7.28 7.35 7.56 7.31 7.54 7.44 7.69 7.52 7.46
GOBP_CYTOKINESIS 6.82 6.9 7.29 6.94 7.04 6.93 7.02 7.12 6.89 7.08 7.05 6.98 7.15 7.09 7.18 7.32 6.74 6.86 7 7.03 6.76 7.26 7.11 7.43 7.29 7.12
GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS 7.42 7.53 7.73 7.58 7.62 7.65 7.56 7.46 7.6 7.52 7.47 7.58 7.6 7.64 7.76 7.48 7.52 7.32 7.41 7.66 7.36 7.51 7.71 7.68 7.47 7.47
GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS 6.4 6.8 7.43 7.51 6.75 7 6.63 7.15 7 6.73 7 6.77 6.92 6.99 6.72 6.96 6.5 6.71 6.94 6.98 6.72 7.22 6.97 7 6.94 6.88
GOBP_MITOCHONDRIAL_RNA_PROCESSING 6.83 6.84 7.45 7.48 6.98 7.11 6.66 7.22 7.1 6.79 7.01 6.82 6.91 6.95 6.7 6.98 6.95 6.91 6.98 7.07 6.89 7.11 7.15 7.05 7.02 7.06
GOBP_RNA_5_END_PROCESSING 6.13 5.92 6.79 6.76 6.22 6.56 6.86 6.61 6.51 6.29 6.47 6.38 6.37 6.39 6.73 6.75 6.27 6.15 6.09 6.56 6.32 6.58 6.62 6.52 6.66 6.58
GOBP_RESPONSE_TO_ACID_CHEMICAL 6.67 6.65 7.13 7.05 6.99 7.04 6.88 6.94 7.09 7.03 7.18 6.86 6.85 6.8 7.1 7 7.15 6.84 6.7 6.87 6.99 7.06 6.99 7.13 7.1 7.03
GOBP_FORMATION_OF_EXTRACHROMOSOMAL_CIRCULAR_DNA 6.39 6.18 6.11 6.53 6.73 6.75 6.12 6.07 6.38 6.44 6.29 6.24 6.72 6.52 6.1 6.39 6.29 6.17 6.54 6.46 6.24 6 6.36 6.53 6.37 6.76
GOBP_SKELETAL_SYSTEM_DEVELOPMENT 5.87 5.75 5.92 5.92 5.77 5.66 5.89 5.92 5.91 5.85 6 5.82 5.85 5.88 5.88 5.86 5.91 5.9 5.83 5.83 5.96 5.95 5.85 5.79 5.86 5.96
GOBP_OSSIFICATION 6.1 6.11 6.3 6.14 6.03 6.04 6.22 6.23 6.28 6.21 6.27 6.27 6.28 6.21 6.25 6.28 6.24 6.12 6.05 6.11 6.39 6.41 6.26 6.15 6.24 6.29
GOBP_NEUROTRANSMITTER_UPTAKE 6.68 6.74 6.27 6.5 6.52 6.42 7.59 7.23 6.84 7.37 6.4 6.11 6.88 7.28 6.94 6.76 6.41 6.75 6.96 7.37 6.5 7.15 7.15 6.73 6.78 6.74
GOBP_REGULATION_OF_NEUROTRANSMITTER_LEVELS 7.35 7.43 7.77 7.44 7.69 7.77 7.93 7.75 7.63 7.94 7.63 7.82 7.83 7.91 7.9 7.79 7.44 7.73 7.74 7.88 7.63 7.67 7.69 7.93 7.68 7.58
GOBP_ACTION_POTENTIAL 7.32 7.4 7.42 7 7.67 7.56 7.57 7.51 7.64 7.69 7.48 7.73 7.64 7.73 7.72 7.72 7.36 7.43 7.79 7.76 7.26 7.57 7.57 7.85 7.72 7.42
GOBP_RNA_METHYLATION 6.49 6.55 6.94 7.12 6.85 6.83 6.49 6.63 6.64 6.57 6.66 6.69 6.77 6.79 6.47 6.63 6.44 6.43 6.76 6.68 6.61 6.5 6.6 6.74 6.64 6.76
GOBP_PSEUDOURIDINE_SYNTHESIS 5.75 5.65 6.28 6.28 5.61 5.48 5.98 6.03 5.95 5.93 5.85 5.89 5.56 5.78 5.98 6.09 5.89 5.74 5.9 5.92 5.86 6.23 6.14 5.84 5.69 6.28
GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY 5.47 5.37 5.31 5.43 5.07 5.11 5.23 5.27 5.18 5.4 5.4 5.28 5.22 5.18 5.24 5.5 5.29 5.44 5.34 5.03 5.44 5.3 5.02 4.88 4.96 5.22
GOBP_OVARIAN_FOLLICLE_DEVELOPMENT 5.91 5.77 6.4 6.09 5.91 5.6 5.76 6.07 5.79 5.76 5.93 5.97 5.79 5.58 5.94 5.85 5.9 5.99 6.03 5.82 6.12 6.04 5.91 5.72 5.89 6.12
GOBP_LUTEINIZATION 7.03 7.01 6.84 6.38 7.09 7.08 7.34 6.83 7.58 7.06 6.51 6.62 7.48 7.83 6.77 7.34 7.31 7.04 7.34 7.16 6.82 6.83 7.84 7.4 6.96 6.85
GOBP_OOCYTE_MATURATION 5.3 5.19 5.1 5.42 4.83 4.65 4.77 5.29 4.82 4.88 4.92 5.23 4.67 4.62 5.07 5 5.07 5.43 5.07 5.01 5.23 4.99 4.92 5.08 4.73 5.12
GOBP_RESPONSE_TO_PROTOZOAN 5.3 5.41 5.05 5.23 4.83 4.83 5.13 5.12 5.13 4.68 4.93 4.88 5.14 4.92 4.89 5.06 5.15 5.36 5.18 5.15 5.12 5.08 4.73 4.76 5.22 5.08
GOBP_BRANCHING_INVOLVED_IN_BLOOD_VESSEL_MORPHOGENESIS 6 6.08 6.16 6.03 6.05 5.83 6.05 6.13 6.02 5.8 6.07 5.77 6.2 6.01 5.93 5.96 5.96 5.93 5.91 6.09 6.19 6.06 5.76 5.74 6.05 6.26
GOBP_VASCULOGENESIS 6.52 6.51 6.69 6.47 6.4 6.61 6.58 6.65 6.56 6.7 6.47 6.46 6.56 6.55 6.27 6.53 6.59 6.65 6.59 6.58 6.59 6.62 6.55 6.6 6.41 6.58
GOBP_GANGLIOSIDE_METABOLIC_PROCESS 7.99 7.75 8.21 8.08 7.71 7.83 8.11 8.37 8.05 8.05 8.09 8.21 8.07 7.86 8.18 8.02 7.73 8.01 7.81 8.17 8.01 8.17 7.7 8.32 8.19 7.99
GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS 7.57 7.58 8.24 7.9 7.81 8.03 8.3 8.53 8.33 8.22 8.09 8.29 8.24 8.18 8.32 8.45 7.51 8.1 8.13 8.29 8.1 8.33 8.02 8.49 8.45 7.95
GOBP_MICROTUBULE_BUNDLE_FORMATION 5.73 5.55 5.81 5.39 5.33 5.48 5.61 5.65 5.64 5.95 5.65 5.77 5.47 5.43 5.88 5.94 5.63 6.15 5.53 5.55 5.55 5.7 5.66 5.37 5.59 5.71
GOBP_OSTEOBLAST_DIFFERENTIATION 6.25 6.35 6.44 6.17 6.49 6.47 6.57 6.41 6.51 6.62 6.44 6.48 6.6 6.58 6.48 6.6 6.52 6.4 6.44 6.43 6.47 6.67 6.57 6.65 6.56 6.56
GOBP_UROGENITAL_SYSTEM_DEVELOPMENT 5.94 6.01 5.97 6.01 6.02 5.97 6.05 6.11 6.06 6.09 5.89 6.11 6.06 5.96 6.1 6.1 6.06 5.93 5.96 6 6.14 6.12 6.13 6.1 6.14 6.25
GOBP_METANEPHROS_DEVELOPMENT 5.83 5.87 5.8 5.99 5.77 5.6 5.92 5.9 5.87 6.15 5.81 5.72 5.91 5.91 5.99 5.93 5.86 5.71 5.81 5.81 6.08 5.8 6.09 5.7 5.82 5.95
GOBP_TEMPERATURE_HOMEOSTASIS 6.32 6.22 6.5 6.38 6.4 6.65 6.59 6.73 6.58 6.49 6.4 6.49 6.71 6.61 6.68 6.58 6.56 6.52 6.42 6.64 6.56 6.93 6.6 6.72 6.58 6.63
GOBP_FEVER_GENERATION 5.26 5.12 4.88 5.03 4.7 4.31 4.63 4.73 4.63 4.58 4.65 4.52 4.53 4.65 4.83 4.57 4.78 4.97 4.87 4.72 5.06 4.56 4.75 4.3 4.57 4.64
GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION 6.47 6.47 6.74 6.5 6.73 6.68 6.68 6.77 6.67 6.69 6.52 6.69 6.8 6.68 6.68 6.62 6.65 6.47 6.45 6.66 6.77 6.78 6.8 6.76 6.83 6.87
GOBP_REGULATION_OF_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY 6.69 6.61 6.35 6.38 6.59 6.74 6.38 6.85 6.77 6.55 6.3 6.55 6.87 6.82 6.62 6.41 6.2 6.34 6.45 6.45 6.35 6.49 6.61 7.23 6.65 6.62
GOBP_ACROSOME_ASSEMBLY 4.74 4.82 4.7 4.88 4.44 4.14 4.74 4.67 4.55 4.26 4.72 4.44 4.2 4.47 4.05 4.42 5.06 4.9 4.25 4.45 4.72 4.26 4.33 4.02 4.57 4.39
GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS 5.98 5.98 6.3 6.17 5.41 5.56 5.7 5.93 5.92 5.73 5.95 6.01 5.6 5.72 5.71 5.65 5.66 6.07 5.71 5.78 6.02 6.04 5.95 5.75 5.85 5.99
GOBP_CELLULAR_GLUCOSE_HOMEOSTASIS 6.71 6.67 7.12 7.01 6.84 6.94 6.97 7 6.92 7.18 6.92 6.86 6.84 6.89 7.09 7.07 7.06 7.03 6.78 7.01 6.99 7.16 6.89 6.89 7.12 7.17
GOBP_TRNA_5_LEADER_REMOVAL 6.38 5.92 7.26 6.76 6.03 6.77 7 6.61 6.51 6.29 6.52 6.38 6.14 6.24 6.73 6.75 6.16 5.93 6.09 6.56 6.29 6.58 6.65 6.82 6.66 6.52
GOBP_GASTRIC_ACID_SECRETION 5.78 5.57 5.5 5.51 5.01 5.26 5.72 5.55 5.41 5.32 5.31 5.6 5.61 5.24 5.39 5.12 5.35 5.5 5.17 5.74 5.59 5.36 5.57 4.94 5.57 5.44
GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT 6.43 6.47 6.57 6.51 6.64 6.65 6.64 6.71 6.59 6.65 6.54 6.62 6.69 6.59 6.55 6.64 6.65 6.61 6.56 6.76 6.54 6.71 6.61 6.79 6.62 6.74
GOBP_GASTRULATION_WITH_MOUTH_FORMING_SECOND 6.18 6.1 6.15 6.41 6.32 6.45 6.44 6.23 6.68 6.65 6.55 6.29 6.68 6.55 6.51 6.83 6.31 6.81 6.34 6.4 6.38 6.49 6.47 6.58 6.19 6.31
GOBP_FORMATION_OF_PRIMARY_GERM_LAYER 5.77 5.64 5.75 5.77 5.4 5.34 5.56 5.56 5.53 5.47 5.5 5.42 5.59 5.58 5.59 5.61 5.7 5.49 5.51 5.41 5.97 5.71 5.76 5.41 5.59 5.66
GOBP_ENDODERM_FORMATION 5.65 5.51 5.22 5.35 5.15 5.01 5.14 5.19 5.16 4.98 5.15 4.98 5.09 5.08 4.98 5.09 5.19 5.35 5.31 4.96 5.5 5.22 5.11 4.93 5 5.22
GOBP_CELL_FATE_SPECIFICATION 5.29 5.19 5.49 5.53 4.98 4.96 5.3 5.13 5.28 4.97 5.39 5.15 5.21 5.21 5.27 5.16 5.33 5.24 5 4.91 5.34 5.27 5.26 5.07 5.13 5.07
GOBP_CELL_FATE_DETERMINATION 5.79 5.73 5.63 6.08 5.56 5.43 5.74 5.63 5.68 5.53 5.67 5.55 5.45 5.37 5.69 5.55 5.66 5.57 5.77 5.66 5.77 5.74 5.79 5.24 5.48 5.7
GOBP_MESODERMAL_CELL_FATE_COMMITMENT 5.22 5.34 5.23 5.31 4.53 4.76 5.3 4.84 5.35 4.96 5.39 4.71 5.11 5.12 5.27 5.15 5.39 5.21 4.98 4.98 5.56 5.19 4.99 4.59 5.02 4.95
GOBP_ENDODERMAL_CELL_FATE_COMMITMENT 6.04 6.03 5.86 6.28 6.12 5.4 5.86 5.87 5.87 6.12 5.95 6.23 5.89 5.87 5.93 6 5.68 6.53 6.67 5.82 6.19 6.37 5.97 5.53 5.62 6.08
GOBP_FORMATION_OF_CYTOPLASMIC_TRANSLATION_INITIATION_COMPLEX 9.06 9.1 9.61 9.49 9.17 9.12 9.35 9.23 9.64 9.44 9.4 9.01 9.42 9.39 9.49 9.35 9.22 8.9 9 9.33 8.95 9.06 9.5 9.36 9.57 9.05
GOBP_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM 6.99 7.02 7.36 7.17 7.15 7.23 7.15 7.32 7.15 7.4 7.12 6.99 7.1 7.24 7.19 7.33 6.99 6.96 7.22 7.31 6.96 7.05 7.29 7.35 7.34 7.27
GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION 6.05 5.99 6.09 6.02 6.07 6.22 6.43 6.19 6.28 6.33 6.05 6.13 6.22 6.18 6.54 6.31 6.39 6.29 5.79 6 6.17 5.99 6.08 6.33 6.17 6.21
GOBP_NEURAL_CREST_CELL_MIGRATION 5.98 5.86 6.16 6.05 5.96 6 6.23 6.12 6.01 6.1 6.07 5.85 6.07 6.18 6.04 6.19 5.99 6.06 5.9 6.04 6.11 6.3 6.08 5.85 6.08 6.09
GOBP_SOMITOGENESIS 5.79 5.86 5.83 5.77 5.8 5.7 5.85 5.71 5.87 5.8 5.77 5.93 5.87 5.79 5.81 5.85 5.75 5.62 5.65 5.81 5.91 5.98 5.81 5.72 5.68 6
GOBP_ORGAN_INDUCTION 4.76 4.72 4.99 5.17 4.42 4.43 4.83 4.61 4.79 4.67 4.84 4.47 4.71 4.67 4.82 4.7 4.58 5.11 4.77 4.51 4.78 4.66 4.59 4.44 4.76 4.65
GOBP_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE 5.86 5.89 5.79 5.85 5.79 5.63 5.97 6 5.87 5.87 5.83 5.75 5.85 5.93 5.89 5.84 5.87 5.71 5.74 5.77 6.03 5.84 5.83 5.72 5.88 5.96
GOBP_NEURON_MIGRATION 6.9 6.96 7.17 7.05 7.14 7.24 7.24 7.29 7.19 7.22 7.14 7.23 7.4 7.52 7.65 7.29 6.92 7.07 7 7.28 7.12 7.44 7.22 7.59 7.18 7.2
GOBP_MEMBRANE_RAFT_ASSEMBLY 6.69 6.57 7.45 7.06 6.99 7.1 7.31 6.76 6.93 6.99 7.32 7.37 6.9 7.06 6.27 6.6 7.21 6.8 6.86 7.32 7.04 7.05 7.61 7.21 7.39 7.48
GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY 5.42 5.25 5.23 5.93 5.26 5.22 4.97 5.14 5.63 5.78 4.94 5.2 5.17 5.24 5.57 5.45 5.29 5.08 5.49 5.34 5.36 5.18 5.05 5.03 5.11 5.18
GOBP_IMMUNOLOGICAL_SYNAPSE_FORMATION 5.46 5.28 5.28 5.42 5.09 5.2 5.1 5.11 5.15 5.27 4.9 5.01 5.21 5.06 5.44 5.31 5.18 5.13 4.82 5.1 5.55 5.34 4.84 5.16 5.05 5.3
GOBP_MYELOID_DENDRITIC_CELL_ACTIVATION 5.3 5.27 5.12 5.64 5.07 5.11 5.1 5.28 5.33 5.01 4.93 4.89 5.29 4.94 5.14 5.13 5.03 5.18 5.15 5.09 5.14 5.08 4.99 4.79 5.22 5.3
GOBP_MICROGLIAL_CELL_ACTIVATION 5.68 5.84 5.44 6.01 5.33 5.48 4.91 5.16 5.35 5.15 5.41 4.93 5.53 5.12 5.26 5.35 5.17 5.46 5.31 5.04 5.8 5.69 5.31 5.13 5.42 5.77
GOBP_CELL_ACTIVATION 6.1 6.06 6.16 6.25 6.02 5.98 6.01 6.05 6.06 6.06 6.06 6 6 6 5.99 6.02 6.1 5.99 5.89 5.97 6.21 6.23 6.01 5.93 6.16 6.32
GOBP_LEUKOCYTE_HOMEOSTASIS 5.84 6.14 6.18 6.35 5.96 6.08 5.81 6.11 5.85 5.9 6.28 6.12 6.34 6.52 6.01 6.15 6.24 6.05 6.1 6 6.3 6.39 6.42 6.11 6.12 6.22
GOBP_PLASMA_MEMBRANE_REPAIR 6.82 6.86 6.99 6.33 7.6 7.75 7.74 7.7 7.58 7.77 7.36 7.97 8.07 7.81 7.78 7.7 7.89 7.22 7.45 7.69 7.9 8.33 8 8.18 8.61 8.58
GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION 6.5 6.71 6.84 6.63 6.35 6.75 6.69 6.89 6.67 5.99 6.21 6.33 6.7 6.45 6.75 6.65 6.58 6.38 6.67 6.77 6.93 7.21 6.4 6.72 6.66 7.1
GOBP_NEUTROPHIL_HOMEOSTASIS 7.58 7.98 7.95 7.02 7.61 8.01 7.78 7.87 7.93 7.49 7.49 7.75 8.21 8.24 7.88 8.28 8.27 8.09 7.68 8.09 8.29 8 7.71 7.88 8.13 8.15
GOBP_B_CELL_HOMEOSTASIS 5.88 6.16 6.36 6.74 6.05 6.1 5.97 6.27 5.81 6.13 6.42 6.15 6.49 6.52 6.21 6.26 6.35 6.07 6.29 6.12 6.19 6.46 6.58 6.3 6.18 6.57
GOBP_B_CELL_APOPTOTIC_PROCESS 5.92 6.17 6.19 6.58 6.02 6.13 6.14 6.22 5.6 5.71 5.77 6.04 5.63 6.43 5.97 6.15 6.24 5.99 6.02 6.03 6.07 6.51 5.81 5.83 5.84 6.5
GOBP_NATURAL_KILLER_CELL_PROLIFERATION 5.02 4.8 5.06 5.44 4.49 4.03 4.36 4.94 4.5 4.44 5.12 4.53 4.27 4.34 4.21 4.56 4.63 4.86 4.62 4.56 5.21 4.41 4.4 4.11 4.47 4.53
GOBP_CYTOKINE_PRODUCTION 5.86 5.78 5.78 5.89 5.64 5.54 5.71 5.73 5.83 5.67 5.9 5.62 5.7 5.69 5.69 5.74 5.82 5.73 5.56 5.59 5.93 5.83 5.67 5.58 5.84 5.84
GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION 5.71 5.68 5.79 5.79 5.44 5.5 5.65 5.67 5.77 5.54 5.83 5.5 5.64 5.57 5.66 5.63 5.7 5.65 5.47 5.55 5.77 5.79 5.55 5.35 5.68 5.71
GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION 5.69 5.56 5.58 5.73 5.45 5.28 5.49 5.49 5.55 5.35 5.61 5.45 5.53 5.48 5.48 5.42 5.53 5.53 5.36 5.3 5.69 5.64 5.41 5.26 5.62 5.73
GOBP_SEROTONIN_SECRETION 5.45 5.74 5.12 5.43 4.84 4.94 5.46 5.22 5.14 4.98 5.47 5.19 5.09 4.88 5.56 5.13 5.1 5.41 5.1 5.14 5.71 5.06 5.3 4.95 5.14 5
GOBP_HISTAMINE_SECRETION 6.03 5.99 5.84 5.94 6.44 5.9 5.43 5.46 5.47 5.43 5.85 5.76 5.79 6.05 5.56 5.71 6.18 5.62 6.01 5.72 5.69 5.9 5.58 5.61 5.76 5.96
GOBP_MESONEPHROS_DEVELOPMENT 6.07 6.06 6.02 6.03 5.86 5.78 6.1 6.17 6.23 6.16 6.2 6.09 6.24 6.04 6.16 6.21 5.98 5.95 5.97 5.9 6.24 6.2 6.09 6.01 6.1 6.25
GOBP_BLASTOCYST_DEVELOPMENT 6.39 6.48 6.64 6.64 6.73 6.65 6.64 6.76 6.6 6.57 6.56 6.55 6.64 6.61 6.6 6.62 6.51 6.42 6.67 6.82 6.33 6.69 6.56 6.8 6.48 6.77
GOBP_BLASTOCYST_FORMATION 6.23 6.46 6.57 6.58 6.56 6.6 7.06 6.94 6.17 6.75 6.28 6.46 6.64 6.52 6.85 6.63 6.51 6.42 6.33 6.85 6.17 6.54 6.5 6.55 6.48 6.82
GOBP_TROPHECTODERMAL_CELL_DIFFERENTIATION 6.64 6.94 7 6.73 7.19 7.04 7.37 7.63 7.36 7.08 6.77 7.43 7.35 7.15 7.57 7.59 7.15 6.95 6.98 7.19 7.57 7.75 7.27 7.42 7.46 7.51
GOBP_BLASTOCYST_GROWTH 6.42 6.57 6.83 6.6 6.84 7.08 7.11 7.34 6.83 7.18 6.7 6.84 7.28 6.97 7.46 7.39 6.62 6.86 6.77 7.25 6.77 7 7.29 7.18 6.94 7.13
GOBP_INNER_CELL_MASS_CELL_PROLIFERATION 5.82 5.9 5.45 5.85 5.87 6.02 5.75 6.1 5.72 5.79 5.47 5.58 6.24 5.85 5.54 6.12 5.42 5.75 5.89 5.91 5.64 5.5 5.87 6.08 5.65 6.16
GOBP_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA 6.37 6.45 7.24 7.23 6.33 6.17 6.68 6.68 6.48 6.59 6.46 6.19 6.54 6.62 7.06 6.94 6.53 6.43 6.51 6.36 6.51 6.62 6.62 6.39 6.26 6.5
GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION 6.37 6.32 6.44 6.17 6.28 6.43 6.35 6.44 6.42 6.33 6.35 6.33 6.44 6.46 6.33 6.39 6.61 6.48 6.25 6.3 6.59 6.65 6.31 6.5 6.48 6.49
GOBP_NEURAL_TUBE_FORMATION 6.43 6.37 6.37 6.41 6.53 6.64 6.52 6.48 6.42 6.66 6.43 6.58 6.37 6.54 6.51 6.59 6.45 6.48 6.52 6.52 6.33 6.51 6.42 6.8 6.56 6.54
GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY 6.94 6.64 7.85 7.46 6.67 6.61 6.88 7.25 6.84 6.71 7.49 6.9 6.67 6.95 6.77 7.04 7.2 7.13 6.75 7.01 6.91 6.95 7.03 6.83 6.98 7.31
GOBP_PHAGOLYSOSOME_ASSEMBLY 7.3 7.5 7.82 7.59 7.83 8.02 7.69 7.59 7.57 7.87 7.6 7.74 7.94 8.1 7.43 7.62 7.54 7.47 7.64 7.64 7.43 7.68 7.88 7.82 7.49 7.45
GOBP_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY 5.11 4.9 4.64 5.15 4.33 4.41 4.91 4.57 4.64 4.7 5.12 4.71 4.7 4.42 4.42 4.42 5.08 4.96 4.78 4.67 5.15 4.72 4.58 4.15 4.52 4.71
GOBP_RECEPTOR_RECYCLING 7.34 7.4 7.94 7.35 7.69 7.81 7.86 7.95 7.86 7.72 7.81 8.03 7.8 7.64 7.94 7.84 7.63 7.25 7.69 7.97 7.33 7.68 8.03 8.24 7.81 7.47
GOBP_ENDOTHELIAL_CELL_DEVELOPMENT 6.59 6.57 6.95 6.8 6.81 6.85 6.8 6.7 6.93 6.53 6.93 6.66 6.9 6.84 6.55 6.86 6.93 6.52 6.55 6.63 6.73 6.71 6.99 6.93 7.01 6.87
GOBP_ENDOTHELIAL_CELL_MORPHOGENESIS 6.04 5.79 5.78 5.83 6.22 6.02 5.55 5.72 5.99 5.76 5.77 5.84 5.71 5.38 5.51 5.38 5.8 5.69 5.39 5.35 5.65 5.32 5.53 5.62 5.39 5.61
GOBP_PLACENTA_DEVELOPMENT 6.25 6.17 6.48 6.45 6.11 6.42 6.63 6.56 6.33 6.3 6.33 6.43 6.33 6.4 6.5 6.37 6.68 6.28 6.32 6.37 6.47 6.54 6.24 6.43 6.29 6.44
GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT 6.08 6.23 6.14 6.21 6.1 6.31 6.46 6.18 6.42 6.17 6.07 6.08 6.21 6.21 6.35 6 6.62 6.12 6.23 6.08 6.46 6.42 5.69 5.83 6.2 6.37
GOBP_MATERNAL_PLACENTA_DEVELOPMENT 7.52 8.07 8.4 7.99 8.25 7.97 7.55 8.27 7.35 7.18 7.68 7.81 7.97 7.93 7.67 8.04 7.49 7.95 8.26 7.96 8.9 9.32 7.49 7.53 7.66 8.32
GOBP_TISSUE_HOMEOSTASIS 6.06 6.05 6.19 6.34 6.13 6.03 6.17 6.2 6.13 6.21 6.2 6.22 6.21 6.19 6.12 6.21 6.25 6.11 6.01 6.18 6.29 6.28 6.13 6.1 6.28 6.34
GOBP_RETINA_HOMEOSTASIS 5.81 5.47 5.81 5.83 5.71 5.52 5.56 5.39 5.69 5.6 5.97 5.67 5.55 5.5 5.44 5.5 5.67 5.75 5.57 5.38 5.76 5.66 5.48 5.41 5.7 5.74
GOBP_CELL_KILLING 5.19 5.04 4.84 5.04 4.71 4.53 4.64 4.79 4.9 4.64 4.99 4.7 4.61 4.56 4.68 4.73 4.93 5.03 4.78 4.73 5.15 4.82 4.63 4.49 4.77 4.95
GOBP_LEUKOCYTE_MEDIATED_CYTOTOXICITY 5.31 5.2 5.06 5.42 5.03 4.84 4.91 5.07 5.14 4.87 5.17 4.96 4.79 4.77 4.88 4.8 5.03 5.13 4.86 4.87 5.26 5.12 4.79 4.78 4.9 5.05
GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY 5.29 4.92 4.79 4.93 4.83 4.62 4.73 4.96 5 4.71 4.93 4.68 4.59 4.65 4.68 4.72 4.96 5.06 4.78 4.83 5.15 4.57 4.63 4.4 4.77 4.89
GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_CYTOTOXICITY 5.27 5.2 5.38 5.45 5.28 4.87 4.98 5.29 5.14 5.05 4.94 4.97 4.67 4.81 4.72 5.2 5.03 5.1 5 4.98 5.29 5.69 4.96 5 5.12 5.53
GOBP_T_CELL_MEDIATED_CYTOTOXICITY 5.32 5.2 5.26 5.43 4.93 4.84 5.1 5.23 5.07 4.92 5.01 5.1 4.73 4.8 4.9 4.73 5 5.15 4.95 5 5.23 5.22 4.75 4.94 4.92 5.09
GOBP_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY 5.3 4.96 4.77 5.11 4.82 4.57 4.85 5.02 4.91 4.7 4.76 4.68 4.57 4.46 4.66 4.71 4.91 5.03 4.81 4.87 5.14 4.61 4.51 4.43 4.79 4.99
GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY 5.57 5.24 5.39 5.44 5.28 4.92 5.35 5.66 5.17 5.04 5.35 5.14 4.97 5.02 4.98 4.78 5.55 5.27 5.39 5.05 5.25 5.27 5.05 4.96 5.2 5.4
GOBP_REGULATION_OF_RECEPTOR_RECYCLING 6.73 6.97 7.75 7.05 7.46 7.33 7.47 7.63 7.63 7.64 7.74 7.42 7.5 7.32 7.57 7.68 7.35 6.91 7.47 7.66 6.91 7.32 7.78 7.88 7.18 7.2
GOBP_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING 8.57 8.15 8.41 7.34 9.31 9.11 9.22 8.4 9.09 8.67 8.06 9.15 8.88 8.87 7.98 8.41 8.38 8.52 8.54 9.16 8.23 8.11 8.76 8.96 8.68 8.64
GOBP_REGULATION_OF_PROTEIN_PHOSPHORYLATION 6.41 6.33 6.5 6.45 6.35 6.4 6.48 6.51 6.49 6.46 6.39 6.35 6.51 6.46 6.53 6.52 6.46 6.39 6.28 6.4 6.57 6.58 6.5 6.53 6.48 6.56
GOBP_POSITIVE_REGULATION_OF_PROTEIN_PHOSPHORYLATION 6.27 6.23 6.32 6.26 6.17 6.19 6.3 6.34 6.18 6.26 6.26 6.18 6.24 6.24 6.33 6.28 6.37 6.25 6.14 6.18 6.45 6.45 6.23 6.24 6.26 6.38
GOBP_ENDOTHELIAL_CELL_PROLIFERATION 5.97 5.73 6.06 5.98 5.8 5.83 6.1 5.92 5.78 5.89 5.87 5.58 5.9 5.84 5.96 5.88 6.02 5.77 5.7 5.75 6.05 6.09 5.82 5.86 5.92 6
GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION 5.99 5.77 6.96 6.49 6.33 6.14 6.27 5.9 6.13 6.18 6.26 6.22 6.34 6.3 6.23 6.2 6.06 6.03 5.71 5.81 6.09 6.78 6.85 5.96 6.33 6.96
GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION 6.07 5.95 6.21 5.82 5.93 5.85 6.2 6.25 6.03 5.92 6 5.64 6 5.95 5.95 5.94 6.09 5.95 5.79 5.77 6.25 6.29 5.91 5.97 6.08 6.11
GOBP_POSTSYNAPTIC_MEMBRANE_ORGANIZATION 8.01 8.31 8.19 8.09 8.5 8.65 8.17 8.25 7.89 8.33 7.93 8.17 8.32 8.45 8.32 8.28 8.33 8.02 8.33 8.13 7.99 7.98 8.24 8.42 8.25 8.06
GOBP_VASCULATURE_DEVELOPMENT 6.09 6.11 6.16 6.12 6.11 6.12 6.19 6.19 6.15 6.14 6.09 6.08 6.22 6.18 6.16 6.14 6.28 6.08 5.97 6.12 6.31 6.39 6.28 6.11 6.19 6.34
GOBP_LYMPH_VESSEL_DEVELOPMENT 6 6.18 5.77 6.01 6.19 6.08 6.22 6.23 6.02 6.03 6.04 6.28 6.2 6.18 6.01 6 6.25 5.76 6 5.89 6.32 6.18 6.16 6.18 6.19 6.25
GOBP_LYMPHANGIOGENESIS 5.89 5.56 5.76 5.85 5.97 5.62 5.8 6.18 5.79 5.74 5.82 5.92 5.9 5.99 5.88 5.93 5.83 5.63 5.71 5.82 5.75 6.06 5.99 5.77 5.75 6.14
GOBP_REGULATION_OF_CELL_MATRIX_ADHESION 7.24 7.26 7.25 6.78 7.56 7.56 7.42 7.49 7.53 7.3 7.17 7.5 7.63 7.54 7.45 7.42 7.43 7.31 7.32 7.46 7.51 7.51 7.7 7.63 7.63 7.52
GOBP_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION 7.32 7.35 7.14 6.61 7.4 7.36 6.89 7.46 7.04 7.3 6.96 7.18 7.15 7.01 7.07 7.25 7.48 7.44 7.3 7.36 7.3 7.06 7.45 7.38 7.26 7.51
GOBP_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION 6.73 6.68 6.65 6.49 7.06 7.1 6.97 7.05 7.26 7.14 6.51 7.07 7.4 7.25 7.02 6.63 7.13 6.54 6.62 7 6.74 7.16 6.99 7.15 7.17 7.38
GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION 8.66 8.34 8.56 8.02 8.92 9.2 9.05 9.33 8.98 8.63 8.4 8.51 9.33 9.37 8.96 9.45 7.81 8.48 9.21 9.14 7.82 8.51 8.96 9.23 8.71 8.04
GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC 7.33 7.32 7.72 6.72 7.68 8.04 7.93 7.28 7.51 8 7.41 7.66 7.38 7.9 7.69 7.52 7.06 7.58 7.72 8.02 6.86 7.15 7.59 7.96 7.37 7.05
GOBP_STARTLE_RESPONSE 7.17 7.53 7.77 6.73 7.68 8.52 7.93 7.59 7.66 7.67 7.41 7.8 7.67 8.01 7.69 7.86 7.45 7.94 7.98 8.02 7.7 7.87 7.58 8.11 7.53 7.36
GOBP_SUCKLING_BEHAVIOR 7.88 7.87 8.79 8.61 8.43 7.71 7.77 8.51 8.66 7.79 8.41 7.82 8.08 7.84 8.34 8.29 7.86 7.89 8.38 8.95 7.92 8.18 8.7 9.04 8.49 8.52
GOBP_BLOOD_VESSEL_REMODELING 5.75 5.93 5.84 6.03 5.77 5.86 6.08 6.12 5.79 5.75 6.04 6.02 6.02 5.99 5.85 5.93 5.85 5.65 5.67 5.82 6.14 6.06 5.99 5.83 6.12 6.14
GOBP_RESPONSE_TO_AMPHETAMINE 6.73 7.07 6.98 7.5 7.25 7.32 7.37 7.32 7.66 7.4 7.28 7.33 7.34 7.55 8.03 6.86 6.8 6.43 7.54 7.15 7.06 6.88 7.36 8.11 7 7.07
GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME 5.6 6.05 5.21 4.88 5.23 4.89 5.28 5.38 5.39 5.4 5.25 5.12 5.19 5.22 5.57 5.79 5.06 5.6 5.19 5.38 5.65 5.78 5.17 5.3 5.51 5.91
GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE 5.18 5.35 4.72 4.83 4.63 4.71 4.68 4.65 4.85 4.7 5.01 4.77 4.44 4.65 4.7 4.87 4.73 5.29 4.73 4.79 4.93 4.97 4.99 4.48 4.76 4.82
GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN 4.73 4.63 4.52 4.57 4.22 3.95 4.41 4.45 4.4 4.33 4.47 4.29 4.11 4.31 4.21 4.41 4.64 4.76 4.5 4.39 4.73 4.29 4.42 4.17 4.32 4.49
GOBP_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD 4.72 4.63 4.66 4.68 4.22 3.95 4.57 4.46 4.3 4.36 4.51 4.29 4.11 4.31 4.21 4.41 4.73 4.76 4.39 4.39 4.73 4.19 4.07 4.17 4.32 4.49
GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM 6.14 6.2 6.15 6.17 6.19 6.12 6.23 6.23 6.25 6.28 6.2 6.19 6.25 6.3 6.24 6.21 6.21 6.17 6.09 6.15 6.24 6.33 6.29 6.18 6.2 6.3
GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET 6.49 6.52 6.61 6.46 6.85 7.21 6.87 6.83 6.87 7.05 6.49 6.8 7.07 6.94 6.77 6.74 6.81 6.53 6.7 7.01 6.65 6.76 7.26 6.8 6.6 6.65
GOBP_RESPONSE_TO_DIETARY_EXCESS 5.79 5.56 5.95 5.97 5.49 5.32 5.62 5.41 5.37 5.28 5.89 5.16 4.96 5.29 5.45 5.12 5.44 5.83 5.38 5.39 6.18 5.55 5.23 5.58 5.38 5.49
GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION 6.54 6.35 6.84 6.54 6.05 6.6 6.86 6.88 6.62 6.2 6.27 6.3 6.48 6.37 6.32 6.29 6.28 6.78 5.9 6.35 6.69 6.41 6.93 6.52 6.95 6.67
GOBP_REGULATION_OF_HEART_RATE 6.24 6.18 6.28 6.36 6.04 6.34 6.39 6.26 5.93 6.5 6.44 6.38 6.09 6.03 6.8 6.48 6.43 6.33 6.41 6.26 6.31 6.27 6.57 6.68 6.06 6.45
GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT 7.82 8.01 8.38 7.99 8.36 8.52 8.32 8.7 8.36 8.15 8.09 8.16 8.35 8.38 8.48 8.31 8.31 8.14 8.43 8.62 8.25 8.46 8.34 8.46 8.3 8.32
GOBP_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION 7.11 7.56 7.76 6.9 7.2 8.56 8.17 8.06 7.75 7.92 7.3 7.08 8.07 7.95 7.69 7.94 6.79 7.95 8.02 8.32 7.43 7.9 7.87 7.99 7.94 7.5
GOBP_SPROUTING_ANGIOGENESIS 6.35 6.23 6.39 6.13 6.26 6.16 6.24 6.34 6.25 6.21 6.04 6.11 6.39 6.28 6.33 6.25 6.25 6.08 6.17 6.27 6.59 6.34 6.44 6.18 6.33 6.4
GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS 6.69 6.68 6.74 6.44 6.87 6.91 6.7 6.87 6.86 6.62 6.88 6.87 6.93 7.04 7.09 6.99 6.54 6.29 6.75 6.88 7.13 7.09 6.93 6.92 6.65 6.66
GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS 5.74 5.37 5.35 5.94 5.44 5.35 5.58 5.2 5.2 5.32 5.66 5.41 5.63 5.55 5.82 5.41 5.56 5.46 5.43 5.33 5.56 5.33 5.79 5.05 5.51 5.79
GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION 7.82 7.72 7.14 7.38 7.98 7.92 7.79 7.99 7.81 7.39 7.18 7.4 7.96 7.89 7.99 8.03 8.03 7.6 7.51 8.19 8.12 7.9 7.29 7.67 7.58 7.93
GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION 6.07 5.93 6.17 6.36 5.92 5.75 6.09 5.89 6.08 6.2 6.29 5.81 6.22 6.39 6.05 6.19 6.53 6.26 6 6.18 6.39 6.47 6.08 5.85 5.76 6.13
GOBP_CHONDROCYTE_DIFFERENTIATION 6.02 6.09 6.01 6.14 6.07 5.67 6.06 6.15 6.06 6.07 6.18 6.07 5.94 6.08 6.03 6.13 6.1 6.16 5.91 5.97 6.32 6.25 6.13 5.94 6.35 6.15
GOBP_CHONDROCYTE_DEVELOPMENT 5.87 5.64 5.87 6.1 5.65 5.61 5.88 6.08 6 5.66 6.08 5.56 5.61 5.8 5.88 5.84 5.84 6 6.05 5.86 5.85 5.94 5.95 5.83 5.86 5.97
GOBP_EPITHELIAL_CELL_DEVELOPMENT 6.25 6.26 6.3 6.18 6.25 6.27 6.42 6.39 6.33 6.32 6.28 6.3 6.38 6.37 6.32 6.23 6.46 6.12 6.2 6.27 6.44 6.42 6.32 6.37 6.34 6.3
GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION 6.01 5.94 5.79 6.23 5.72 5.62 5.93 5.85 6.06 5.89 5.9 5.77 5.85 5.93 5.83 5.77 5.93 5.89 5.88 5.61 5.92 5.91 6.01 5.79 5.8 5.73
GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT 6.51 6.52 6.59 6.62 6.97 6.64 6.7 6.81 6.66 6.76 6.34 6.5 6.79 6.61 6.74 6.59 6.62 6.31 6.55 6.76 6.7 6.79 6.45 6.82 6.7 6.79
GOBP_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION 5.96 5.91 5.79 6.13 5.6 5.48 5.91 5.8 6.05 5.67 5.92 5.77 5.78 5.65 5.83 5.69 5.85 5.69 5.94 5.5 5.92 5.9 6 5.7 5.73 5.58
GOBP_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT 6.49 6.54 6.8 6.99 7.06 6.89 6.76 6.93 6.92 6.84 6.79 6.77 6.98 6.65 6.89 6.68 6.67 6.55 6.64 7 6.54 6.94 6.45 7.08 6.7 6.76
GOBP_EPITHELIAL_CELL_MATURATION 5.81 6.06 5.73 5.99 5.61 5.29 5.67 5.52 5.82 5.39 5.81 5.7 5.54 5.5 5.53 5.48 5.75 5.52 5.09 5.17 5.78 5.63 5.57 5.23 5.78 5.57
GOBP_OSTEOBLAST_DEVELOPMENT 5.75 5.93 6.17 6.14 5.95 5.9 6.09 5.89 6.08 6.15 6.25 6.21 6.22 6.31 5.88 6.1 6.18 6.26 5.91 6.02 6.23 6.39 5.95 5.85 5.85 6.06
GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION 6.22 7.16 7.11 7.84 6.46 6.94 6.87 7.33 7.01 6.78 7.34 6.77 6.82 7.45 6.53 7.06 6.88 7.12 7.17 7.04 6.94 7.18 6.61 6.75 6.48 6.62
GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE 6.15 6 6.26 6.14 5.93 6.1 6.17 5.93 6.14 5.87 6.14 5.99 5.85 6.07 6.01 6 5.94 6.19 6.03 5.8 6 5.92 6.14 5.93 5.96 5.84
GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE 6.28 5.98 6.26 5.85 6.31 6.06 6.14 6.01 6.4 6.33 5.98 5.99 6.26 6.54 6.01 6 5.98 5.95 6.03 5.78 6 5.73 6.34 6.34 6.26 6.51
GOBP_REGULATION_OF_RECEPTOR_INTERNALIZATION 7.77 7.74 7.99 7.67 8.11 8.33 8.06 7.92 7.92 8.08 7.81 7.82 8.34 8.36 8.23 8.08 7.9 7.64 7.94 8.11 7.81 8.02 8.27 8.37 7.98 7.98
GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION 9.41 9 9.07 8.59 9.83 9.68 9.59 9.67 10.13 9.81 9.3 9.53 9.52 9.8 9.62 9.06 9.27 8.51 9.43 9.81 9.34 8.97 9.92 9.84 9.21 8.99
GOBP_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION 6.93 7 7.59 7.2 7.58 7.53 7.75 7.46 7.28 7.46 7 7.43 7.37 7.35 8.08 7.58 7.09 6.65 7.3 7.81 7.39 7.31 7.18 7.53 7.08 7.36
GOBP_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS 6.11 5.83 6.08 5.34 5.49 6.23 6.32 5.72 6.31 5.58 6.28 6.03 5.75 6.02 6 5.96 5.7 5.85 5.64 5.83 5.65 6.26 6.09 5.92 6.09 5.63
GOBP_TRNA_WOBBLE_BASE_MODIFICATION 6.18 6.06 6.82 6.58 6.24 6.3 6.28 5.81 6.21 6.32 6.39 6.03 6.3 6.16 6.44 6.35 6.27 6.21 6.19 5.84 5.75 6.48 6.19 6.22 5.9 6.24
GOBP_STORE_OPERATED_CALCIUM_ENTRY 6.61 6.2 6.22 6.37 5.72 5.84 6.07 5.61 5.46 5.98 5.94 5.91 6.07 6.13 5.93 5.31 6.21 6.42 5.67 5.6 6.1 6.07 5.56 5.53 6 5.94
GOBP_CYTOPLASMIC_TRANSLATION 7.45 7.81 8.34 8.15 7.74 8.14 8.05 8.08 7.91 7.98 7.78 7.8 8 7.88 8.14 8.05 7.82 7.76 7.77 7.91 7.91 8.13 8.05 8.21 8.02 8.23
GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION 8.04 8.43 8.61 8.9 8.58 8.61 8.45 8.56 8.73 8.71 8.36 8.48 8.57 8.55 8.62 8.62 8.28 8.13 8.28 8.49 8.35 8.71 8.87 8.89 8.7 8.66
GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS 6.09 6.22 6.1 6.11 6.49 6.41 6.31 6.29 6.26 6.31 6.41 6.48 6.45 6.29 6.14 6.24 6.14 6.36 6.29 6.38 6.37 6.51 6.41 6.71 6.37 6.59
GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE 7.16 7.27 7.74 7.53 7.49 7.45 7.55 7.35 7.75 7.3 7.21 7.04 7.6 7.54 7.44 7.34 7.37 7.13 7.27 7.47 7.17 7.26 7.6 7.6 7.53 7.44
GOBP_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY 6.08 6.13 6.01 6.26 6.17 6.03 6.09 6.01 6.1 6.03 6.08 6.08 5.99 5.96 6 6.01 6.08 6.03 5.82 5.94 6.11 6.05 5.84 5.9 6.12 6.09
GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 6.06 6.08 6 6.23 6.07 5.96 5.91 5.76 6.07 5.86 6.03 5.86 5.89 5.9 5.86 5.86 5.95 5.94 5.67 5.9 6.1 6.03 5.8 5.77 6.08 5.95
GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA 4.67 3.88 4.48 4.75 3.8 3.76 4.13 3.84 3.99 3.78 3.74 3.9 3.86 3.89 4.17 3.96 3.98 4.05 4.07 4.24 4.36 4.27 3.75 3.89 4.32 3.97
GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY 5.02 5.2 4.87 4.96 4.48 4.57 4.5 4.63 4.51 4.56 4.93 4.72 4.48 4.45 4.42 4.52 4.89 4.99 4.61 4.56 5.06 4.54 4.61 4.33 4.7 4.86
GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST 5.71 5.2 5.55 5.65 4.91 5.28 5.38 5.18 5.36 5.51 6.04 4.9 4.98 4.95 5.16 5.3 5.83 5.5 5.47 5.33 5.48 5.27 5.29 4.79 5.41 5.16
GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN 5.91 5.79 5.84 5.98 5.62 5.5 5.57 5.63 5.63 5.38 5.72 5.45 5.63 5.58 5.63 5.69 5.78 5.72 5.48 5.54 5.93 5.84 5.44 5.47 5.77 5.93
GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION 6.86 6.86 7.38 7.16 6.82 7.03 6.87 7.13 7.15 7.14 7.05 6.99 7.2 7.22 7.22 7.2 7.08 6.93 6.89 7.23 6.99 7.05 7.44 7.44 7.39 7.02
GOBP_ADAPTIVE_IMMUNE_RESPONSE 5.44 5.28 5.2 5.29 5.01 4.97 5.09 5.11 5.14 4.96 5.21 4.96 5.04 4.97 5.06 5.01 5.19 5.2 5 4.99 5.21 5.1 4.95 4.82 5.13 5.18
GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE 4.82 4.64 4.6 5.05 4.05 4.17 4.35 4.27 4.51 4.13 4.34 4.2 4.22 4.48 4.46 4.51 4.6 4.64 4.32 4.37 4.57 4.56 4.06 4.11 4.58 4.47
GOBP_IMMUNE_EFFECTOR_PROCESS 6.09 6.07 6.17 6.21 6.16 6.01 5.98 6.03 6.07 6.05 6.1 6.01 6 5.94 5.96 6.02 6.1 5.99 5.89 5.99 6.19 6.19 5.95 5.97 6.24 6.29
GOBP_ACTIVATION_OF_IMMUNE_RESPONSE 6.23 6.27 6.33 6.26 6.25 6.05 6.14 6.24 6.16 6.2 6.23 6.07 6.09 6.22 6.06 6.13 6.33 6.29 5.97 6.16 6.39 6.22 6.14 5.98 6.41 6.43
GOBP_LYMPHOCYTE_HOMEOSTASIS 5.64 5.68 5.73 6.32 5.6 5.77 5.64 5.32 5.6 5.52 5.74 5.62 5.65 5.87 5.85 5.76 5.6 5.36 5.33 5.47 5.64 5.9 5.51 5.53 5.73 6.01
GOBP_MYELOID_CELL_HOMEOSTASIS 6.83 6.72 6.88 6.87 6.88 6.98 6.99 7.04 6.97 6.83 6.94 6.9 7.07 7.01 7.09 6.91 6.94 6.81 6.6 7.04 6.88 7.02 7.15 7.33 7.13 7.24
GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 6.24 6.18 6.38 6.41 6.33 6.2 6.13 6.25 6.18 6.18 6.16 6.09 6.18 6.15 6.18 6.23 6.2 6.16 6.01 6.23 6.36 6.4 6.13 6.12 6.49 6.58
GOBP_MYELOID_LEUKOCYTE_ACTIVATION 6.47 6.37 6.68 6.67 6.5 6.45 6.46 6.48 6.44 6.31 6.36 6.3 6.45 6.37 6.39 6.47 6.45 6.32 6.19 6.35 6.48 6.59 6.44 6.35 6.72 6.72
GOBP_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 5.63 5.73 5.88 5.67 5.21 5.25 5.46 5.41 5.68 5.32 5.49 5.28 5.39 5.41 5.52 5.43 5.55 5.73 5.33 5.35 5.71 5.45 5.31 5.31 5.69 5.88
GOBP_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 5.81 6.17 5.73 5.71 5.54 5.86 5.4 5.45 5.92 5.53 5.68 5.39 5.85 5.51 5.6 5.66 5.63 5.58 5.38 5.82 5.71 5.78 5.63 5.51 5.46 5.82
GOBP_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 5.61 5.44 5.5 5.57 5.25 5.23 5.4 5.48 5.45 5.19 5.42 5.18 5.37 5.29 5.32 5.31 5.36 5.48 5.24 5.23 5.54 5.5 5.22 5 5.32 5.49
GOBP_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 5.43 5.2 5.17 5.34 4.92 4.93 5.12 5.27 5.17 4.87 5.02 4.91 5.19 5.03 5.08 5.02 5.14 5.26 5.07 4.98 5.28 5.13 4.97 4.83 5.05 5.18
GOBP_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE 5.53 5.38 5.29 5.44 5.15 5.12 5.32 5.42 5.22 4.98 5.29 5.1 5.29 5.18 5.18 5.11 5.25 5.37 5.15 5.16 5.41 5.3 5.1 4.95 5.21 5.28
GOBP_T_HELPER_CELL_LINEAGE_COMMITMENT 5.43 5.14 5.06 5.39 4.72 4.81 4.92 4.94 5.16 4.64 4.88 4.67 4.98 4.74 4.92 4.73 4.98 5.18 4.81 4.77 5.14 5.07 4.63 4.49 4.61 4.81
GOBP_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 5.92 5.97 5.93 5.97 5.86 5.96 5.89 5.92 5.95 6.01 6.12 6.11 6.02 5.95 5.75 5.86 6.14 6.09 5.83 5.91 6.2 6.09 5.9 5.98 5.88 5.92
GOBP_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE 5.84 5.96 5.88 5.87 5.21 5.09 5.83 5.78 5.63 5.19 5.41 5 5.45 5.4 5.61 5.56 6.11 5.82 5.22 5.25 6.05 5.89 5.39 5.51 5.53 5.37
GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION 6.29 6.69 6.58 6.47 6.84 6.84 6.71 6.56 6.48 6.75 6.49 6.37 7.14 7.16 6.9 6.81 6.6 6.63 6.65 6.84 6.79 6.68 7.23 7.15 6.36 6.6
GOBP_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 4.74 4.67 4.29 4.28 4.28 3.86 4.32 4.32 4.09 4.09 4.42 4.29 4.02 4.18 4 3.91 4.52 4.53 4.34 4.07 4.68 4.29 4.02 3.78 4.21 4.3
GOBP_PRO_B_CELL_DIFFERENTIATION 7.39 7.55 7.36 7.45 7.76 7.74 7.7 8.04 7.43 7.87 6.97 7.84 7.61 7.7 7.89 7.89 7.62 7.61 7.59 7.7 8.06 7.89 7.81 8.06 8.02 8.03
GOBP_MATURE_B_CELL_DIFFERENTIATION 5.81 5.94 5.83 5.94 5.43 5.09 5.74 5.64 5.61 5.22 5.58 5.02 5.23 5.3 5.58 5.61 5.99 5.75 5.23 5.23 6.05 5.56 5.4 5.41 5.54 5.28
GOBP_RESPONSE_TO_TUMOR_CELL 5.42 5.45 5.28 5.47 5.03 5.11 5.11 5.75 5.09 5.08 5.47 5.24 5.56 5.5 5.39 5.22 5.44 5.59 5.56 5.42 5.58 5.47 5.24 5.36 5.3 5.53
GOBP_T_CELL_LINEAGE_COMMITMENT 5.43 5.15 5.06 5.4 4.8 4.92 5.08 5 5.19 4.84 5.25 4.84 5 4.93 5 4.78 5.01 5.19 4.89 4.85 5.22 5.09 4.97 4.74 4.98 4.95
GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE 5.47 5.41 5.58 5.48 5.36 5.25 5.42 5.43 5.5 5.35 5.5 5.27 5.44 5.34 5.28 5.35 5.34 5.49 5.31 5.22 5.56 5.47 5.24 5.26 5.67 5.65
GOBP_T_CELL_CYTOKINE_PRODUCTION 5.43 5.44 5.13 5.37 5.36 5.12 5.24 5.32 5.3 5.08 5.34 5.25 5.36 5.21 5.18 5.11 5.14 5.48 5.07 5.09 5.38 5.27 5.1 5.01 5.26 5.47
GOBP_DENDRITIC_CELL_CYTOKINE_PRODUCTION 5.63 5.79 5.71 5.8 5.86 5.89 5.68 5.75 6.05 6.08 6.08 5.88 6.1 5.75 5.87 5.62 5.95 5.59 6.13 5.96 5.8 6.14 5.96 6.04 6.16 6.07
GOBP_IMMUNOGLOBULIN_PRODUCTION 5.95 5.94 5.76 5.97 5.86 5.7 5.93 5.8 5.95 5.93 5.86 6.12 5.84 5.91 5.8 5.85 6.06 6.01 5.83 5.85 6.05 5.91 5.86 5.78 5.88 5.84
GOBP_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE 5.94 5.94 5.76 5.97 6.38 5.92 5.99 5.93 6.04 6.01 6.12 6.12 6.28 5.95 5.74 5.85 6.14 6.16 5.94 5.99 6.22 5.91 5.88 6.1 5.9 5.84
GOBP_DENDRITIC_CELL_CHEMOTAXIS 5.27 4.86 4.97 4.99 4.83 4.64 4.37 4.48 4.76 4.52 4.75 4.5 4.58 4.45 4.57 4.68 4.7 4.74 4.69 4.28 4.97 4.66 4.49 4.73 4.63 4.89
GOBP_IMMUNE_RESPONSE_TO_TUMOR_CELL 5.07 4.71 4.72 4.96 4.39 4.25 4.67 4.95 4.7 4.37 4.59 4.22 4.31 4.35 4.34 4.32 4.53 4.97 4.74 4.69 4.59 4.39 4.25 4.02 4.18 4.41
GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY 5.05 4.82 4.6 4.74 4.42 4.42 4.54 4.25 4.8 4.45 4.57 4.42 4.15 4.33 4.57 4.61 4.89 4.95 4.22 4.47 4.95 5 4.25 4.17 4.75 4.83
GOBP_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY 7.5 7.35 7.5 7.13 7.86 7.89 7.56 7.66 7.74 7.63 7.7 7.74 7.94 7.91 7.81 7.77 7.36 7.37 7.69 7.62 7.34 7.65 7.91 7.91 7.72 7.83
GOBP_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS 5.41 5.3 5.23 5.52 5.13 4.84 5.26 5.29 5.16 5.07 5.42 5.12 4.89 4.98 5.16 5.09 5.19 5.38 5.01 5.17 5.36 5 5.04 4.79 4.99 5.03
GOBP_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS 5.41 5.38 5.16 5.59 4.96 4.86 5.21 5.28 5.1 4.92 5.41 5.14 5.05 5.01 5.11 4.99 5.15 5.39 5.07 5.11 5.37 4.99 4.95 4.84 4.9 5.02
GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE 5.63 5.58 5.59 5.63 5.39 5.34 5.49 5.57 5.63 5.35 5.67 5.56 5.53 5.39 5.52 5.53 5.61 5.65 5.54 5.46 5.77 5.55 5.39 5.3 5.68 5.68
GOBP_LEUKOCYTE_MEDIATED_IMMUNITY 6.11 6.06 6.18 6.24 6.11 6.01 5.95 6.07 6.06 6.07 6.06 5.94 6 5.91 5.97 6.02 6.09 6 5.91 5.99 6.2 6.25 5.92 5.96 6.28 6.42
GOBP_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY 6.56 6.48 6.83 6.74 6.67 6.62 6.66 6.68 6.64 6.48 6.61 6.57 6.56 6.59 6.69 6.62 6.61 6.44 6.46 6.56 6.7 6.73 6.65 6.72 6.88 6.92
GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY 5.48 5.41 5.32 5.46 5.08 5.09 5.22 5.28 5.3 5.06 5.29 5.2 5.3 5.12 5.18 5.12 5.32 5.39 5.12 5.11 5.38 5.26 5.11 4.94 5.31 5.22
GOBP_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN 5.17 5.05 4.96 4.98 4.72 4.68 4.83 4.88 4.87 4.7 4.84 4.81 4.62 4.71 4.5 4.79 4.9 5.07 4.97 4.85 5.14 4.72 4.62 4.57 5.03 4.86
GOBP_T_CELL_MEDIATED_IMMUNITY 5.43 5.39 5.39 5.44 5.2 5.04 5.23 5.3 5.26 5.04 5.32 5.24 5.33 5.16 5.15 5.06 5.22 5.31 5.15 5.11 5.38 5.28 5.04 4.98 5.27 5.2
GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS 5.59 5.44 5.4 5.51 5.22 5.22 5.3 5.41 5.35 5.16 5.37 5.27 5.35 5.29 5.25 5.19 5.39 5.39 5.26 5.2 5.41 5.37 5.18 5.06 5.39 5.39
GOBP_GERMINAL_CENTER_FORMATION 5.66 5.6 5.56 5.67 4.97 5.13 5.48 5.51 5.61 5.44 5.42 5.54 5.46 5.41 5.75 5.89 5.55 5.73 5.31 5.2 5.41 5.55 5.4 5.25 5.54 5.38
GOBP_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION 5.14 4.96 5.21 5.2 4.77 4.55 5.07 5.01 4.94 4.88 4.96 4.92 4.8 4.82 4.67 4.75 5.33 5.23 4.88 5.01 5.35 4.85 4.63 4.71 5.19 4.65
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I 7.19 7.47 8.35 8.31 7.68 7.69 7.8 7.58 8.06 7.76 7.78 7.62 7.78 7.73 7.57 7.89 7.65 7.19 7.45 7.73 7.51 7.81 8.15 7.92 7.79 7.84
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB 6.11 5.92 5.88 6.54 6 6.55 5.23 5.85 5.62 5.71 6.23 6.39 6.01 5.51 5.05 4.89 6.06 5.51 6.15 5.34 6.26 5.57 5.45 5.58 6.41 6.06
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN 6.36 6.75 6.61 6.93 6.74 6.82 6.67 6.58 6.94 6.55 6.89 6.69 6.49 6.58 6.04 6.52 6.81 6.58 6.58 6.75 6.3 6.63 6.42 6.65 6.62 6.87
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II 8.1 8.14 9.02 9.04 8.52 8.54 8.7 8.76 8.61 8.34 8.55 8.35 8.45 8.48 8.76 8.78 8.29 8.32 8.37 8.65 8.48 8.54 8.52 8.75 8.56 8.45
GOBP_TOLERANCE_INDUCTION 5.5 5.39 5.08 5.05 5.22 5.07 4.88 5.11 5.62 5.06 5.27 5.01 5.15 5.11 5.05 5.23 5.3 5.12 4.91 5 5.43 5.22 4.97 5.01 5.43 5.18
GOBP_T_CELL_TOLERANCE_INDUCTION 5.5 5.39 5.08 5.46 5.36 4.94 5.17 5.12 5.46 5.27 5.57 5.09 5.15 4.89 5.05 5.23 5.1 5.09 4.84 5.02 5.59 5.24 4.94 4.82 5.26 5.18
GOBP_IMMUNE_SYSTEM_DEVELOPMENT 6.13 6.16 6.19 6.32 6.11 6.12 6.07 6.12 6.2 6.19 6.2 6.12 6.19 6.19 6.1 6.18 6.22 6.1 6.05 6.06 6.22 6.27 6.24 6.08 6.21 6.35
GOBP_LEUKOCYTE_DIFFERENTIATION 5.77 5.77 5.81 5.97 5.58 5.5 5.63 5.7 5.76 5.5 5.67 5.48 5.63 5.56 5.72 5.68 5.8 5.63 5.47 5.52 5.84 5.76 5.56 5.45 5.73 5.83
GOBP_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE 5.47 5.14 5.61 6.03 4.74 4.58 5.07 5.02 5.4 4.89 5.28 4.74 5.13 4.98 5.63 5.42 5.56 5.2 4.91 4.9 5.73 5.65 4.96 4.64 5.53 5.35
GOBP_HYPERSENSITIVITY 5.38 5.3 5.34 5.61 4.59 4.89 5.37 5.18 4.98 4.81 5.02 5.1 4.69 4.92 4.82 5.01 5.11 5.15 5.15 5.1 5.39 4.89 4.83 4.66 4.99 5.01
GOBP_ACUTE_INFLAMMATORY_RESPONSE 5.33 5.08 5.02 5.14 4.7 4.66 4.86 4.98 4.88 4.75 5.09 4.83 4.86 4.86 4.81 4.85 5.03 5.15 4.91 4.77 5.15 4.9 4.74 4.54 4.82 4.98
GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE 5.63 5.45 5.22 5.58 5.31 5.11 5.4 5.13 5.37 5.14 5.4 4.96 5.37 5.23 5.35 5.36 5.3 5.36 5.05 5.27 5.29 5.37 5.33 5.19 5.14 5.06
GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE 5.96 5.45 5.38 5.59 5.47 5.44 5.5 5.2 5.88 5.72 5.75 5.07 5.67 5.48 5.87 5.36 5.44 5.57 5.33 5.58 5.47 5.86 5.71 5.3 5.61 5.37
GOBP_CHRONIC_INFLAMMATORY_RESPONSE 5.16 4.95 5.23 4.95 4.51 4.15 4.43 4.61 4.88 4.59 5.06 4.57 4.54 4.64 4.78 4.64 5.1 5.2 4.74 4.67 5.31 5.21 4.73 4.18 5.11 5.18
GOBP_MONOCYTE_CHEMOTAXIS 5 4.9 4.76 5.19 4.29 4.35 4.84 4.59 4.81 4.56 4.76 4.72 4.5 4.45 4.7 4.6 4.7 4.96 4.73 4.55 4.97 4.81 4.64 4.38 4.59 4.48
GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION 6.09 6.52 7.09 6.72 6.62 6.49 6.7 6.29 6.94 7.09 6.48 6.76 6.54 6.79 5.92 6.88 6.14 6.75 6.54 6.38 6.32 6.17 6.87 7.09 6.63 6.61
GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION 5.92 6.11 6.28 6.29 5.89 5.88 5.89 6.04 6.17 6.07 5.92 5.74 5.99 5.91 6.09 5.98 6.07 5.96 5.8 5.86 6.17 6.05 6.02 5.77 6.04 6.21
GOBP_PLATELET_DEGRANULATION 6.3 6.29 6.52 6.24 6.55 6.38 6.01 6.21 6.09 6.23 6.45 6.16 6.24 6.01 6.13 6.37 6.57 6.13 6.28 6.18 6.48 6.43 6.42 6.33 6.36 6.43
GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION 5.22 4.97 5.21 5.34 4.78 4.77 4.92 5 4.98 5.08 5.07 4.88 4.8 4.9 5.04 5 5.11 5.09 4.75 4.89 5.43 5.07 4.96 4.86 5.13 5.03
GOBP_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION 5.13 4.96 5.19 5.17 4.7 4.4 4.77 4.59 4.88 4.87 4.86 4.88 4.79 4.72 4.76 4.89 4.91 5.06 4.76 4.82 5.14 4.9 4.55 4.53 4.98 4.76
GOBP_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION 6.25 6.26 5.78 6.19 6.07 5.64 6.05 6.23 5.94 5.93 6.12 6 5.84 6.15 5.77 5.87 6.21 6.03 5.81 5.9 6.12 6.05 5.83 5.78 6.21 6.03
GOBP_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION 7.1 6.69 5.76 5.56 7.52 6.85 6.05 6.59 5.94 6.91 6.1 6.62 6.3 6.15 6.73 6.56 6.54 6.16 6.46 5.99 6.12 5.67 6.8 6.6 6.59 6.65
GOBP_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION 6.16 5.96 5.81 6.3 5.96 5.49 6.06 5.7 5.94 5.54 6.16 5.8 5.73 5.78 5.66 5.72 6.17 5.96 5.68 5.57 6.15 6.09 5.72 5.52 5.81 5.9
GOBP_REGULATION_OF_TOLERANCE_INDUCTION 5.43 5.39 5.08 5.05 5.22 5.07 5.1 5.11 5.62 5.27 5.27 5.05 5.15 5.11 5.05 5.23 5.3 5.12 4.85 5 5.58 5.24 4.97 5.1 5.43 5.18
GOBP_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION 5.32 5.35 5.05 4.99 5.1 5 4.96 5.1 5.54 5.17 5.08 5.07 4.96 5 5.05 5.03 5.24 5.24 4.85 4.94 5.28 5.23 4.95 5.06 5.34 5.02
GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE 5.35 5.16 5.05 5.4 4.82 4.74 4.94 5.02 4.93 4.82 5.17 4.95 4.93 4.91 4.91 4.97 4.98 5.25 5.06 4.83 5.19 4.97 4.86 4.76 4.91 4.89
GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE 5.26 5.24 5.22 5.89 4.69 4.83 5.09 5.24 5.04 5.28 5.06 4.96 5.18 4.9 4.88 5.47 5.05 5.09 4.96 4.99 5.25 5 5.11 4.73 4.61 4.74
GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE 5.31 5.11 4.88 5.25 4.73 4.6 4.78 4.83 4.74 4.62 4.77 4.69 4.7 4.84 4.85 4.91 4.79 5.13 5.06 4.72 5.06 4.72 4.85 4.63 4.91 4.84
GOBP_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE 5.2 4.95 5.22 5.35 4.87 4.9 5.04 4.64 4.89 5.18 5.27 4.81 5.06 4.89 5.04 4.98 4.68 4.89 4.92 4.74 4.97 5.08 4.76 4.64 5.05 5.06
GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS 6.03 5.98 5.99 6.06 5.87 5.77 5.86 5.91 5.94 5.84 5.96 5.78 5.89 5.84 5.88 5.86 6.02 5.93 5.78 5.83 6.08 6.02 5.78 5.74 5.99 6.15
GOBP_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS 5.83 5.75 5.93 6.02 5.59 5.51 5.71 5.75 5.8 5.64 5.79 5.59 5.64 5.58 5.77 5.76 5.73 5.63 5.59 5.59 5.94 5.83 5.61 5.56 5.83 6.04
GOBP_POSITIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS 5.93 5.94 5.88 5.98 5.84 5.65 5.77 5.83 5.84 5.69 5.86 5.7 5.81 5.72 5.74 5.76 6.01 5.9 5.66 5.69 6 5.89 5.71 5.58 5.89 6.06
GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION 5.76 5.65 5.71 5.85 5.57 5.32 5.58 5.41 5.57 5.32 5.65 5.45 5.59 5.56 5.53 5.46 5.81 5.49 5.31 5.35 5.76 5.63 5.42 5.29 5.7 5.74
GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION 5.59 5.51 5.93 5.48 5.82 5.45 5.58 5.42 5.28 5.16 5.45 5.51 5.48 5.47 5.49 5.37 5.61 5.44 5.2 5.24 6.01 5.53 5.5 5.34 5.5 5.97
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION 5.73 5.56 5.7 5.73 5.3 5.21 5.49 5.31 5.6 5.37 5.65 5.32 5.52 5.52 5.49 5.51 5.81 5.48 5.28 5.3 5.75 5.65 5.45 5.24 5.7 5.73
GOBP_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS 5.92 5.72 5.82 5.57 5.82 5.65 5.58 5.48 5.76 5.38 5.75 5.56 5.65 5.58 5.55 5.71 5.86 5.62 5.29 5.44 5.8 5.75 5.59 5.47 5.75 5.76
GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS 5.88 5.59 6.74 5.98 6.37 6.14 5.65 5.57 5.38 5.34 5.38 5.68 5.73 6.21 5.61 5.63 5.74 5.52 5.34 5.63 6.57 6.4 5.34 5.39 5.74 6.59
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS 5.93 5.79 5.75 5.52 5.68 5.55 5.55 5.36 5.76 5.42 5.84 5.48 5.64 5.58 5.54 5.69 5.92 5.7 5.31 5.33 5.78 5.77 5.63 5.55 5.75 5.75
GOBP_REGULATION_OF_CELLULAR_EXTRAVASATION 5.32 5.32 5.39 5.52 5.1 4.93 5.21 5.14 5.32 5.13 5.25 4.95 5.2 5.2 5.29 4.94 5.37 5.04 5.09 4.91 5.42 5.33 5.16 4.89 5.39 5.38
GOBP_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION 5.49 5.44 5.74 5.97 5.13 5.13 5.54 5.5 5.8 5.21 5.87 5.38 5.47 5.26 5.7 5.45 5.66 5.14 5.21 5.5 6.05 5.75 5.4 5.26 5.79 5.87
GOBP_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS 5.63 5.48 5.47 5.6 5.28 5.25 5.32 5.37 5.45 5.25 5.45 5.26 5.34 5.29 5.31 5.3 5.46 5.49 5.33 5.26 5.54 5.46 5.22 5.1 5.51 5.6
GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS 5.62 5.62 5.66 5.65 5.29 5.26 5.49 5.45 5.61 5.43 5.56 5.29 5.45 5.39 5.37 5.41 5.49 5.49 5.17 5.35 5.61 5.63 5.34 5.28 5.69 5.75
GOBP_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS 5.63 5.51 5.46 5.62 5.27 5.23 5.3 5.41 5.34 5.17 5.42 5.27 5.33 5.31 5.31 5.27 5.44 5.5 5.33 5.22 5.54 5.45 5.17 5.01 5.35 5.56
GOBP_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE 5.58 5.45 5.51 5.51 5.3 5.25 5.44 5.43 5.48 5.24 5.56 5.25 5.35 5.32 5.31 5.33 5.4 5.5 5.29 5.24 5.61 5.45 5.24 5.2 5.58 5.61
GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE 5.25 5.21 5.2 5.37 5 5.08 5.28 5.3 5.34 4.98 5.09 5.09 5.18 5.18 5.09 5.1 5.12 5.32 5.01 5.07 5.43 5.23 4.97 4.87 5.34 5.36
GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE 5.67 5.62 5.6 5.71 5.47 5.35 5.46 5.44 5.35 5.25 5.6 5.34 5.39 5.39 5.39 5.41 5.54 5.57 5.33 5.27 5.84 5.56 5.38 5.26 5.68 5.59
GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY 5.44 5.39 5.34 5.44 5.13 4.98 5.21 5.21 5.3 5.05 5.32 5.02 5.23 5.13 5.19 5.15 5.2 5.42 5.07 5.16 5.39 5.27 5.05 4.95 5.3 5.22
GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY 5.21 5.19 5.17 5.22 4.95 4.88 5.1 5.09 5.18 4.87 4.86 4.78 5.1 4.83 5.06 5.11 4.91 5.05 4.97 5.1 5.14 5.21 4.96 4.93 5.12 4.96
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY 5.52 5.4 5.39 5.44 5.24 4.97 5.21 5.31 5.22 5.06 5.42 5.24 5.3 5.1 5.17 5.12 5.29 5.49 5.12 5.16 5.39 5.26 5.07 4.93 5.26 5.2
GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY 5.36 5.28 5.07 5.38 5.02 4.93 5.13 5.09 5.14 4.98 5.16 4.96 5.01 4.89 5.05 4.9 5.12 5.28 5.01 5.01 5.17 5.1 4.96 4.8 5.03 5.03
GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY 5.21 5.19 5.04 5.17 4.97 4.87 4.92 5.02 5.18 4.87 4.86 4.93 5.02 4.83 5.06 5.11 5 5.05 4.99 5 5.06 5.22 4.96 5 4.98 4.86
GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY 5.38 5.2 5.07 5.29 5 4.89 5.09 5.04 5.11 4.87 5.12 4.88 4.97 4.86 4.98 4.84 5.06 5.21 5.01 4.98 5.17 5.09 4.83 4.83 5.01 5.03
GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY 5 4.85 4.92 4.86 4.7 4.57 4.61 4.88 4.56 4.55 4.7 4.67 4.57 4.72 4.6 4.52 4.83 4.76 4.76 4.85 4.93 4.79 4.55 4.43 4.59 4.69
GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY 5.71 5.51 5.45 5.44 5.32 4.98 5.46 5.43 5.3 5.08 5.42 5.29 5.36 5.21 5.08 5.2 5.41 5.48 5.36 5.09 5.44 5.27 5.15 5 5.54 5.56
GOBP_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY 5.63 5.62 5.62 5.65 5.3 5.16 5.49 5.44 5.67 5.21 5.75 5.29 5.36 5.32 5.54 5.37 5.42 5.66 5.21 5.34 5.79 5.58 5.31 5 5.34 5.55
GOBP_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY 5.27 5.62 5.23 5.51 5.28 5.07 5.73 5.32 5.72 5.78 5.47 5.29 5.43 5.34 5.97 5.62 5.4 5.61 5.03 5.11 5.59 5.24 5.42 5.1 5.54 5.18
GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY 5.78 5.62 5.64 5.78 5.32 5.23 5.42 5.44 5.63 5.17 5.86 5.27 5.33 5.3 5.39 5.22 5.44 5.71 5.28 5.36 5.84 5.6 5.24 4.95 5.3 5.59
GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY 5.01 4.77 4.48 4.89 4.34 4.36 4.5 4.46 4.51 4.44 4.52 4.41 4.31 4.34 4.39 4.44 4.89 4.76 4.54 4.33 4.82 4.45 4.41 4.3 4.42 4.48
GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY 5.68 5.57 5.07 5.57 5.02 5.32 4.86 5.14 4.82 4.93 4.97 4.86 5.05 4.97 4.85 4.58 5.1 5.06 5.08 5.29 5.32 5.11 4.9 4.79 5.05 5.24
GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY 4.96 4.99 4.48 4.87 4.59 4.46 4.5 4.44 4.68 4.49 4.72 4.44 4.36 4.46 4.35 4.41 4.91 5.01 4.6 4.4 4.8 4.49 4.57 4.31 4.5 4.5
GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE 5.18 5.16 5.06 5.14 4.96 4.98 5.22 5.16 5.18 4.92 4.96 5.06 5.09 5 5.06 4.89 5.05 5.19 4.97 5 5.28 5.23 4.97 4.81 5.23 5.12
GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE 5.7 5.75 5.63 5.48 5.53 5.61 5.46 5.49 5.35 5.56 5.6 5.86 5.61 5.54 5.39 5.59 5.54 5.5 5.95 5.43 5.74 5.55 5.39 5.42 5.69 5.77
GOBP_NEGATIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION 5.13 5.08 5.01 4.76 5.06 4.87 4.84 4.87 5.18 4.72 4.8 4.61 5.09 5.01 4.83 4.62 4.89 4.94 4.93 4.93 4.82 5.13 4.78 4.97 4.72 4.72
GOBP_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION 5.71 5.62 5.58 5.39 5.5 5.56 5.48 5.43 5.35 5.35 5.6 5.68 5.44 5.48 5.24 5.54 5.54 5.5 5.33 5.22 5.44 5.42 5.39 5.42 5.86 5.77
GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY 6.44 6.39 6.46 6.8 6.93 6.26 6.94 6.9 7.15 6.55 6.68 6.54 6.44 6.85 6.8 6.61 6.76 6.98 6.56 7.04 7.19 7.03 7.09 7.08 6.77 6.85
GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 5.64 5.67 5.7 5.56 5.54 5.47 5.21 5.34 5.5 5.13 5.75 5.12 5.25 5.32 5.26 5.28 5.53 5.52 5.39 5.16 5.89 5.29 5.35 5.44 5.81 5.76
GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 6.12 6.16 6.41 6.54 6.22 6.29 6.28 6.16 6.13 6.2 6.32 6.37 6.21 6.24 6.35 6.45 6.17 6.18 6.28 6.49 6.1 6.24 6.34 6.34 6.29 6.46
GOBP_INNATE_IMMUNE_RESPONSE_ACTIVATING_SIGNAL_TRANSDUCTION 7.11 7.06 7.77 7.6 7.32 7.36 7.35 7.23 7.75 7.36 7.28 6.96 7.58 7.5 7.31 7.34 7.23 7.04 7.14 7.31 6.96 7.21 7.6 7.59 7.51 7.36
GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION 5.83 5.98 6.15 6.21 5.75 5.88 5.89 6.02 6.13 5.79 5.82 5.62 5.95 5.87 5.86 5.8 6.07 5.67 5.66 5.76 6.07 5.94 5.83 5.74 5.87 6.13
GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION 5.59 5.47 5.84 5.85 5.53 5.25 5.71 5.63 5.72 5.38 5.51 5.26 5.63 5.59 5.79 5.76 5.46 5.46 5.43 5.53 5.77 5.65 5.33 5.53 5.69 5.91
GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION 5.79 5.98 6.06 6.22 5.73 5.57 5.64 6.02 6.2 5.71 5.78 5.62 6.16 5.87 6.04 5.65 6.1 6.02 5.66 5.76 6.2 6.23 5.83 5.61 5.84 6.34
GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY 6.41 6.46 6.5 6.4 6.37 6.42 6.4 6.47 6.4 6.44 6.36 6.24 6.46 6.48 6.4 6.41 6.48 6.4 6.24 6.41 6.52 6.43 6.37 6.49 6.63 6.58
GOBP_PEPTIDE_SECRETION 6.33 6.37 6.81 6.56 6.61 6.44 6.73 6.85 6.66 6.69 6.5 6.67 6.52 6.53 6.82 6.73 6.56 6.67 6.46 6.63 6.55 6.87 6.64 6.61 6.6 6.5
GOBP_REGULATION_OF_PEPTIDE_SECRETION 6.38 6.34 6.78 6.53 6.53 6.41 6.68 6.78 6.58 6.66 6.46 6.67 6.49 6.44 6.77 6.73 6.4 6.69 6.39 6.6 6.49 6.85 6.54 6.61 6.58 6.48
GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION 6.05 5.78 6.27 6.3 6.24 6.1 6.1 6.4 6.17 6.22 6.35 6.05 6.2 6.26 6.39 6.3 6.22 6.2 6.06 5.79 6.12 6.32 6.17 6.16 6.14 6.34
GOBP_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION 6.24 6.11 6.66 6.38 6.37 6.2 6.31 6.26 6.42 6.3 6.26 6.34 6.17 6.17 6.68 6.65 6.32 6.56 6.34 6.57 6.4 6.76 6.36 6.38 6.22 6.37
GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE 5.47 5.37 5.29 5.44 5.13 5.11 5.24 5.32 5.18 5.08 5.31 5.08 5.23 5.18 5.18 5.1 5.3 5.3 5.08 5.16 5.34 5.22 5.1 4.93 5.26 5.23
GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE 5.23 5.05 4.92 4.96 4.75 4.81 4.75 4.94 4.84 4.77 4.79 4.72 4.79 4.74 4.72 4.75 4.83 5 4.92 4.9 4.99 5.02 4.65 4.53 4.79 4.86
GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE 5.71 5.51 5.45 5.56 5.28 5.12 5.45 5.44 5.3 5.14 5.42 5.27 5.33 5.3 5.24 5.14 5.41 5.48 5.33 5.22 5.49 5.42 5.15 4.95 5.3 5.52
GOBP_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE 5.24 5.05 5 5.27 4.83 4.73 4.93 4.97 4.86 4.86 5.14 4.58 4.98 4.8 4.87 4.84 4.94 5.14 4.86 4.74 5.16 5.09 4.77 4.68 5.21 5.27
GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE 5.18 4.93 5.04 5.19 4.74 4.42 4.5 4.74 4.86 4.75 5 4.56 4.89 4.65 4.7 4.78 4.86 5 4.76 4.71 5.05 4.99 4.61 4.5 5.08 5
GOBP_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE 5.39 5.41 5.3 5.46 5.08 5 5.53 5.41 5.19 5.13 5.5 5.17 5.29 5.15 5.19 5.38 5.14 5.38 5.16 5.19 5.6 5.3 5.07 4.93 5.28 5.53
GOBP_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE 5.36 5.28 5.59 5.45 4.99 4.99 5.17 5.26 5.28 5.36 5.71 5.25 5.11 5.22 5.23 5.3 5.09 5.37 5.16 5.19 5.28 5.3 5.07 4.93 5.25 5.27
GOBP_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE 5.36 5.44 5.03 5.44 5.19 4.98 5.59 5.41 4.98 4.81 4.98 4.91 5.34 4.86 5.16 5.41 5.11 5.37 5.08 5.17 5.77 5.27 4.89 4.93 5.29 5.77
GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS 6.26 6.25 6.46 6.53 6.26 6.22 6.33 6.24 6.28 6.33 6.38 6.28 6.07 6.18 6.07 6.15 6.27 6.22 6.16 6.15 6.15 6.24 6.01 6.06 6.31 6.37
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS 6.24 6.11 5.97 6.48 5.78 5.69 6.02 6 6.11 6.17 6.11 6.08 5.89 5.78 5.86 6.01 5.93 5.88 6.05 5.95 6.1 5.97 5.87 5.88 6.1 6.25
GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS 6.36 6.33 6.51 6.42 6.33 6.27 6.39 6.45 6.22 6.34 6.4 6.31 6.04 6.24 6.09 6.25 6.4 6.26 6.22 6.3 6.09 6.25 5.98 6.04 6.55 6.33
GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL 5.04 4.65 4.35 4.71 4.29 3.98 4.55 4.66 4.39 4.21 4.38 4.19 4.26 4.13 4.12 4.15 4.52 4.79 4.49 4.17 4.55 4.31 4.23 3.89 4.13 4.24
GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL 5.04 4.65 4.17 4.68 4.18 3.85 4.33 4.42 4.26 4.21 4.36 4.16 3.99 4.12 4.01 4.15 4.51 4.68 4.49 4.17 4.44 4.22 4.07 3.78 4.13 4.1
GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS 5.44 5.39 5.26 5.74 4.91 4.77 5.23 5.3 5.15 5.01 5.41 5.1 4.91 4.9 5.17 5.06 5.19 5.76 5.55 5.24 5.34 5 4.94 4.71 5.03 4.99
GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS 5.27 4.96 4.92 5.76 4.7 4.71 5.1 5.35 5.16 4.87 4.86 4.97 4.79 4.74 5.14 4.89 5.18 5.43 5.6 5.17 5.14 4.9 4.55 4.53 4.73 4.71
GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS 5.91 5.15 5.45 5.73 5.13 4.97 5.26 5.32 5.14 5.15 5.66 5.23 5.03 4.98 5.21 5.21 5.19 6.06 5.56 5.31 5.54 5.56 5.04 4.79 5.18 5.14
GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS 5.91 5.78 5.45 6.01 5.23 4.84 5.21 5.32 5.16 5.41 5.42 5.48 5.68 4.98 5.73 5.21 5.18 5.53 5.56 5.15 5.41 5.09 5.42 5.09 5.18 5
GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY 5.69 5.69 5.67 5.71 5.38 5.5 5.37 5.33 5.78 5.32 5.48 5.21 5.62 5.41 5.41 5.41 5.55 5.68 5.35 5.35 5.51 5.5 5.33 5.31 5.66 5.9
GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY 6.04 5.86 5.76 5.89 6.25 5.93 5.86 6.17 6.09 5.91 5.91 5.91 6.03 5.89 6.35 5.89 6.06 5.68 5.98 6.22 6.06 6.03 6 6.19 6.63 6.51
GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS 5.87 5.8 5.57 6.11 5.58 5.41 5.26 5.12 5.32 5.04 5.29 5.25 5.62 5.42 5.23 5.71 5.6 5.36 5.19 5.35 5.43 5.87 5.33 5.47 5.73 5.58
GOBP_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS 5.9 6.16 5.57 6.11 5.58 5.41 6.52 6.66 5.35 6.34 5.77 5.92 5.63 5.42 6.09 5.71 6.13 6.22 6.02 6.03 5.94 6.51 5.83 5.96 5.8 6.1
GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE 5.31 5.02 4.96 5.06 4.76 4.6 4.72 4.87 4.87 4.7 4.93 4.78 4.68 4.76 4.7 4.82 4.87 5.13 4.94 4.72 5.08 4.85 4.64 4.52 4.96 4.85
GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE 5.25 5.47 5.63 5.86 5.13 5.01 5.46 5.26 5.73 5.48 5.15 5.23 5.17 5.09 5.75 5.48 5.46 5.33 4.94 5.14 5.64 5.53 5.38 5.36 6 5.54
GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE 5.22 4.79 4.88 4.99 4.4 4.23 4.32 4.88 4.58 4.51 4.65 4.65 4.42 4.4 4.47 4.69 4.72 4.75 4.76 4.61 4.64 4.72 4.5 4.31 4.64 4.63
GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN 5.07 4.73 4.8 4.89 4.43 4.22 4.42 4.69 4.57 4.45 4.58 4.72 4.27 4.39 4.37 4.59 4.87 5 4.8 4.59 4.7 4.76 4.51 4.47 4.68 4.65
GOBP_RESPONSE_TO_ISCHEMIA 7.28 7.26 7.73 7.11 7.6 7.48 7.58 7.67 7.88 7.68 7.1 7.4 7.91 7.43 7.19 7.31 7.7 7.29 7.66 7.58 7.39 7.33 8.07 8.29 7.83 7.5
GOBP_REGIONALIZATION 5.68 5.62 5.66 5.79 5.48 5.43 5.53 5.55 5.6 5.53 5.73 5.55 5.56 5.58 5.64 5.57 5.5 5.62 5.48 5.54 5.75 5.65 5.52 5.52 5.54 5.58
GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION 5.93 5.9 6.01 6.04 5.79 5.74 5.85 5.82 5.87 5.9 6.05 5.92 5.88 5.79 5.96 5.95 5.88 5.93 5.86 5.74 6 5.94 5.83 5.79 5.9 6.02
GOBP_HEART_MORPHOGENESIS 6 5.98 6.05 6.13 6.01 5.89 6.07 6.1 6.09 6.12 6.02 6.03 6.02 6.03 5.98 6.01 6 5.97 5.93 5.89 6.14 6.13 6.01 5.89 6.02 6.14
GOBP_SKELETAL_MUSCLE_CONTRACTION 5.34 5.56 5.74 5.75 5.35 5.12 5.6 5.49 5.48 5.52 5.4 5.06 5.27 5.33 5.53 5.22 5.47 5.61 5.29 5.48 5.21 5.6 5.38 5.04 5.24 5.21
GOBP_MUSCLE_SYSTEM_PROCESS 6.25 6.16 6.18 6.22 6.1 6 6.17 6.26 6.15 6.2 6.28 6.25 6.14 6.1 6.25 6.18 6.41 6.27 6.13 6.13 6.39 6.28 6.39 6.07 6.24 6.35
GOBP_CIRCULATORY_SYSTEM_PROCESS 6.17 6.18 6.24 6.23 6.2 6.17 6.26 6.28 6.16 6.21 6.18 6.22 6.19 6.21 6.31 6.15 6.28 6.09 6.09 6.2 6.35 6.42 6.24 6.2 6.32 6.36
GOBP_RENAL_SYSTEM_PROCESS 5.97 6.05 5.64 6.22 5.76 5.7 6.01 5.96 5.9 6.13 5.87 6.07 5.85 5.93 6.36 5.99 6.17 5.91 5.92 6.03 6.2 6.28 6.17 5.91 6.05 6.28
GOBP_HEART_PROCESS 6.5 6.53 6.51 6.56 6.46 6.52 6.57 6.55 6.36 6.6 6.4 6.46 6.39 6.46 6.75 6.53 6.63 6.56 6.41 6.58 6.54 6.55 6.75 6.68 6.64 6.51
GOBP_RESPIRATORY_SYSTEM_PROCESS 6.57 6.4 6.98 6.51 6.59 6.52 6.65 6.27 6.45 6.64 6.81 6.6 6.48 6.61 6.32 6.45 6.4 6.25 6.42 6.7 6.29 6.21 6.58 6.6 6.7 6.34
GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM 6.32 6.41 6.36 6.25 6.39 6.45 6.42 6.49 6.48 6.27 6.34 6.29 6.43 6.43 6.32 6.2 6.35 6.2 6.24 6.46 6.53 6.62 6.35 6.48 6.6 6.67
GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL 5.3 5.47 5.06 5.09 4.92 5.15 5.07 4.97 5.22 5.14 5.35 5.16 4.84 5.05 5.05 5.46 5.24 5.38 4.92 5.17 5.44 5.47 5.09 5.03 5.11 5.01
GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE 5.23 5.35 4.74 4.87 4.74 4.79 4.71 4.8 4.84 4.52 4.94 4.82 4.5 4.67 4.64 4.77 4.71 5.43 4.75 4.82 5.12 4.98 4.87 4.41 5.07 5.05
GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE 5.55 5.58 5.29 5.42 5.08 5.15 5.46 5.25 5.4 5.14 5.42 5.16 5.18 5.11 5.39 5.42 5.31 5.49 5.15 5.36 5.57 5.5 5.3 5.06 5.42 5.24
GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN 4.96 4.63 4.57 4.57 4.3 4.15 4.55 4.45 4.56 4.33 4.51 4.35 4.11 4.46 4.5 4.45 4.64 5.11 4.56 4.39 4.73 4.45 4.58 4.2 4.32 4.49
GOBP_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE 5.3 5.63 5.06 5.22 4.78 4.91 5.57 4.82 5.79 5.14 5.04 4.83 5.15 4.94 5.15 5.48 5.29 5.32 4.9 5.04 5.6 5.56 5.44 4.95 5.55 5.09
GOBP_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE 5.68 5.61 5.5 5.77 5.55 5.5 5.78 5.58 5.84 5.55 5.51 5.34 5.55 5.5 5.76 5.36 5.59 5.91 5.55 5.74 6.02 5.62 5.46 5.35 5.38 5.53
GOBP_RENAL_WATER_HOMEOSTASIS 6.63 6.65 6.86 6.67 6.38 6.59 6.64 6.77 6.44 6.99 6.5 6.82 6.74 6.65 6.54 6.46 6.74 6.41 6.24 6.44 6.74 6.27 6.52 6.18 7.01 6.95
GOBP_REGULATION_OF_GLOMERULAR_FILTRATION 6.52 6.76 7.3 6.51 6.35 7.05 7.06 7.01 6.91 6.59 6.65 6.91 6.61 6.6 6.9 6.96 6.3 6.49 7.08 6.76 7.15 7.56 6.76 7.21 6.56 7.14
GOBP_HEART_FIELD_SPECIFICATION 5.61 5.53 5.49 5.35 4.87 4.99 5.27 5.27 5.05 4.96 5.65 5.04 5.05 5.12 5.16 5.36 5.21 5.53 5.56 4.96 5.39 5.48 5.07 5.34 5.4 5.43
GOBP_SECONDARY_HEART_FIELD_SPECIFICATION 6.04 6.03 5.56 5.43 5.82 5.4 5.27 5.45 5.05 5.71 5.65 6.01 5.4 5.49 5.69 5.55 5.65 5.53 5.93 5.82 5.39 5.7 5.39 5.53 5.47 5.97
GOBP_EMBRYONIC_HEART_TUBE_MORPHOGENESIS 5.94 5.89 6.04 6.2 5.95 5.89 5.8 6.03 5.67 6.2 6.07 6.23 5.92 5.95 5.88 6 5.7 5.84 5.93 6.05 6.12 6.21 5.88 5.7 5.73 6.12
GOBP_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS 6.99 6.65 6.54 6.28 7.29 7.56 6.3 6.97 7.09 7.07 6.19 7.33 6.62 6.66 6.88 6.51 6.18 5.95 6.17 6.16 6.5 6.55 6.63 6.48 6.31 6.53
GOBP_OUTFLOW_TRACT_MORPHOGENESIS 6.15 6.42 6.37 6.13 6.31 6.24 6.35 6.34 6.4 6.33 6.36 6.3 6.4 6.54 6.37 6.35 6.7 6.22 6.3 6.16 6.59 6.38 6.34 6.34 6.19 6.4
GOBP_REGULATION_OF_ANIMAL_ORGAN_FORMATION 5.03 5 5.38 5.31 4.87 4.75 5.42 5.17 5.08 4.96 5.31 4.95 4.94 4.87 5.16 5.36 5.21 5.53 5.03 4.96 5.26 5.17 4.8 4.76 5.01 5.3
GOBP_ENDOCARDIUM_DEVELOPMENT 6.61 6.6 6.51 6.22 7.27 7.26 7 6.84 6.95 7.32 6.53 7.15 7.41 7.1 6.29 7.09 6.92 6.4 6.87 7 6.67 7.42 7.12 7.05 6.5 6.81
GOBP_ENDOTHELIUM_DEVELOPMENT 6.51 6.42 6.61 6.46 6.48 6.58 6.79 6.71 6.64 6.41 6.47 6.49 6.62 6.59 6.44 6.4 6.79 6.41 6.38 6.49 6.67 6.77 6.73 6.65 6.68 6.77
GOBP_MORPHOGENESIS_OF_AN_ENDOTHELIUM 6.61 6.42 6.1 6.31 6.66 7.04 6.44 6.98 6.52 6.48 6.2 6.71 6.64 6.56 6.5 6.77 6.65 6.27 6.55 6.62 6.67 6.9 7.3 6.75 6.29 6.35
GOBP_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT 5.49 5.55 5.58 5.63 5.55 5.16 5.4 5.43 5.36 5.69 5.9 5.7 5.44 5.37 5.56 5.36 5.26 5.7 5.53 5.39 5.76 5.88 5.44 5.32 5.27 5.57
GOBP_HEART_VALVE_DEVELOPMENT 6.38 6.28 6.34 6.34 6.33 6.06 6.11 6.4 6.32 6.19 6.36 6.2 6.23 6.28 6.15 6.28 6.79 6.39 6 6.03 6.67 6.66 6.2 6.25 6.62 6.66
GOBP_ATRIOVENTRICULAR_VALVE_DEVELOPMENT 6.49 6.61 6.48 6.42 6.82 6.71 6.64 6.74 6.67 6.79 6.59 6.23 6.92 7.23 6.22 6.56 6.98 6.93 7.03 6.92 6.63 6.82 6.59 6.77 6.57 6.96
GOBP_MITRAL_VALVE_DEVELOPMENT 5.93 5.7 6.24 6.34 5.86 5.53 6 5.91 6.1 5.97 5.99 6.09 6 6.04 5.85 6.21 6 6.04 5.49 5.7 6.12 6.28 5.65 5.89 6.02 6.16
GOBP_PULMONARY_VALVE_DEVELOPMENT 6.59 6.61 6.48 6.17 6.44 6.39 6.56 6.75 6.61 6.99 6.5 6.59 6.7 6.84 6.34 6.31 6.92 6.62 6.7 6.86 7.05 7.21 6.8 6.81 7.09 7.35
GOBP_AORTIC_VALVE_MORPHOGENESIS 6.02 5.89 5.82 6.04 5.76 5.51 5.74 5.75 5.71 5.58 5.78 5.89 5.7 5.93 5.49 5.85 5.93 5.71 5.72 5.77 6.13 5.8 5.65 5.59 5.97 5.8
GOBP_PULMONARY_VALVE_MORPHOGENESIS 6.49 6.61 6.44 6.11 6.33 6.39 6.56 6.75 6.61 6.99 6.45 6.59 6.7 6.84 6.25 6.31 6.91 6.62 6.7 6.86 6.96 6.89 6.62 6.81 6.78 6.89
GOBP_HEART_VALVE_FORMATION 6.13 5.86 6.24 6.2 5.86 5.53 6.1 6.3 6.1 5.97 5.99 6.2 6.06 6.04 6.15 6.21 6 6.04 5.49 5.7 6.53 6.28 5.65 5.95 6.45 6.48
GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT 6.07 6.32 6.44 6.05 6.1 6.06 6.2 6.53 6.13 6 6.33 6.27 6.18 6.61 6.15 6.35 6.32 6.41 6.06 5.98 6.59 6.64 5.9 6.48 6.5 6.34
GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION 6.49 6.68 6.68 6.74 7.06 7.02 6.68 6.74 6.79 6.79 6.59 6.35 7.07 7.23 6.47 6.74 6.98 6.93 7.03 6.92 6.65 7.06 7.19 6.93 7.04 7.02
GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS 6.04 6.25 6.42 6.08 6.15 6.12 6.25 6.58 6.28 6.41 6.32 6.3 6.61 6.7 6.22 6.44 6.33 6.32 5.96 6.05 6.6 6.47 6.03 6.49 6.61 6.43
GOBP_CARDIAC_CHAMBER_DEVELOPMENT 6.06 6.25 6.22 6.16 6.16 6.04 6.23 6.15 6.25 6.17 6.19 6.2 6.21 6.17 6.04 6.28 6.29 6.33 6.1 6.06 6.2 6.33 6.15 6.16 6.03 6.29
GOBP_CARDIAC_CHAMBER_MORPHOGENESIS 6 6 6.1 6.12 6.02 5.8 6.11 6.06 6.2 6.07 6.09 6.07 6.13 6.1 5.99 6.01 6.21 6.03 6.01 5.85 6.12 6.2 6.07 5.93 5.96 6.2
GOBP_CARDIAC_CHAMBER_FORMATION 5.93 5.76 5.78 6.1 5.92 5.64 5.74 5.83 5.49 5.79 6.07 5.9 5.65 5.43 5.77 5.74 5.64 5.75 5.8 5.54 5.74 5.99 5.89 5.43 5.82 6.1
GOBP_CARDIAC_VENTRICLE_MORPHOGENESIS 6 6.04 6.02 6.12 6.07 5.91 6.11 6.13 6.13 6.14 6.09 6.12 6.19 6.1 5.97 6.01 6.21 6.12 6.04 5.82 6.04 6.18 5.98 5.87 5.94 6.2
GOBP_CARDIAC_ATRIUM_MORPHOGENESIS 5.63 5.46 5.86 6.05 5.55 5.51 5.91 5.87 5.67 5.79 5.95 5.61 6 6.2 5.85 6 5.64 5.67 5.4 5.82 5.55 5.64 5.9 5.7 5.87 5.87
GOBP_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS 7.82 7.79 7.47 7.06 8.16 8.36 8.01 7.95 7.68 7.39 7.81 7.41 7.82 8 7.41 7.92 7.53 7.57 8.15 7.91 8.22 8.05 8.23 8.02 7.75 7.95
GOBP_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS 5.5 5.56 5.59 6.05 5.73 5.58 5.97 5.91 5.6 5.52 5.71 5.41 5.74 5.32 5.43 5.48 5.42 5.53 5.13 5.58 5.64 5.5 5.9 5.21 5 5.29
GOBP_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS 7.66 7.65 6.98 6.84 8.38 8.32 8.27 8.2 7.97 7.39 7.29 7.85 8.32 8.15 7.41 7.55 8.32 7.47 7.6 8.68 8.22 8.19 7.77 7.88 8.14 7.95
GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT 5.85 5.85 5.76 5.87 5.73 5.63 5.97 6.03 5.93 5.74 5.98 6.11 6.17 5.89 5.91 5.96 6.25 5.68 6 5.73 5.94 5.77 5.9 5.68 5.92 6.08
GOBP_CARDIAC_ATRIUM_DEVELOPMENT 5.63 5.46 5.86 6.05 5.55 5.51 5.91 5.87 5.67 5.79 5.95 5.61 5.92 5.95 5.85 6 5.64 5.67 5.4 5.82 5.55 5.64 5.9 5.7 5.87 5.88
GOBP_CARDIAC_VENTRICLE_DEVELOPMENT 6.35 6.38 6.22 6.17 6.16 6.11 6.32 6.17 6.36 6.34 6.2 6.25 6.36 6.46 6.16 6.3 6.39 6.4 6.22 6.14 6.25 6.35 6.25 6.4 6.04 6.37
GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION 5.98 6.2 7.41 6.98 5.96 6.08 6.45 6.32 6.28 6.35 6.49 6.41 6.24 6.19 6.4 6.15 6.5 6.15 6.2 6.2 6.74 6.21 6.28 6.49 6.34 6.39
GOBP_ENDOCARDIAL_CUSHION_FORMATION 6.07 6.53 6.51 6.17 6.85 6.78 6.35 6.64 6.64 6.63 6.44 6.34 6.98 7.01 6.38 6.6 6.92 6.83 6.65 6.85 6.64 6.7 7.12 6.8 6.65 6.81
GOBP_CARDIAC_SEPTUM_DEVELOPMENT 6.67 6.62 6.48 6.24 6.86 6.75 6.71 6.64 6.64 6.63 6.46 6.5 6.72 6.82 6.38 6.58 6.69 6.61 6.62 6.68 6.55 6.65 6.58 6.64 6.52 6.6
GOBP_VENTRICULAR_SEPTUM_DEVELOPMENT 6.72 6.72 6.51 6.34 6.96 6.94 6.9 6.64 6.82 6.66 6.54 6.66 7.17 7.22 6.51 6.71 6.74 6.77 6.69 6.86 6.67 6.7 6.73 6.8 6.65 6.71
GOBP_ATRIAL_SEPTUM_DEVELOPMENT 5.72 5.55 6.24 6.37 5.54 5.64 5.9 5.81 5.73 5.95 6.01 5.71 5.9 5.88 5.84 5.94 5.9 5.87 5.68 5.86 5.81 5.99 5.84 5.72 5.8 6.02
GOBP_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS 6.53 6.38 6.33 6.49 6.94 6.61 6.49 6.34 6.72 7.16 6.52 7 6.4 6.72 6.31 6.97 7.2 6.68 6.99 6.38 6.83 6.96 6.81 6.93 6.74 7.08
GOBP_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY 7.26 7.19 7.87 7.29 7.48 7.7 7.94 7.53 7.59 7.6 6.91 7.28 7.33 7.24 7.7 7.15 7.06 7.29 7.34 7.93 7.24 7.31 7.83 7.81 8.01 7.54
GOBP_WNT_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT 4.65 4.72 5 5.2 4.5 4.25 4.47 4.33 4.63 4.3 4.84 4.4 4.57 4.56 4.64 4.44 4.37 4.65 4.54 4.28 4.63 4.56 4.37 4.29 4.62 4.62
GOBP_TYPE_B_PANCREATIC_CELL_DEVELOPMENT 6.31 6.34 6.59 6.46 6.87 6.78 6.54 6.81 6.44 6.76 6.34 6.5 6.78 6.61 6.74 6.59 6.62 6.31 6.55 6.75 6.47 6.79 6.25 6.7 6.38 6.44
GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT 7.26 7.24 7.09 7.03 7.11 7.26 7.29 7.38 7.26 7.21 6.88 6.93 7.19 7.41 7.57 7.17 6.89 6.9 7.15 7.33 7.14 7.15 7.13 7.36 7.18 7.08
GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS 6.08 5.64 5.93 5.66 5.31 5.13 5.67 6.09 5.56 5.58 5.9 5.29 5.4 5.35 5.67 5.74 5.62 5.83 5.42 5.4 5.98 5.45 5.07 5.04 5.54 5.69
GOBP_METANEPHROS_MORPHOGENESIS 6.09 5.86 5.84 6.1 5.6 5.4 6.08 6.12 6.28 6.15 6.19 6.03 5.84 5.91 6.17 6.42 5.93 6 5.53 5.95 6.08 5.8 6.08 5.54 5.82 5.8
GOBP_CILIUM_MOVEMENT 5.48 5.37 5.31 5.45 5.08 5.15 5.28 5.25 5.17 5.46 5.44 5.28 5.23 5.2 5.33 5.64 5.34 5.58 5.35 4.99 5.44 5.37 5.03 4.92 5.07 5.25
GOBP_REGULATION_OF_CILIUM_MOVEMENT 5.09 4.7 5.05 5.08 4.57 4.47 4.87 4.47 4.7 4.66 4.83 4.75 4.43 4.42 4.81 4.88 4.5 4.77 4.5 4.46 4.74 4.76 4.44 4.12 4.63 4.67
GOBP_EPITHELIAL_CELL_MORPHOGENESIS 5.84 5.44 5.41 5.75 5.54 5.34 5.46 5.17 5.97 5.71 5.81 5.8 5.55 5.12 5.26 5.42 5.35 5.37 5.7 5.58 5.26 5.31 5.07 5.44 5.33 5.27
GOBP_AXIS_ELONGATION 6.27 6.23 6.17 6.1 6.24 6.48 6.43 6.48 6.49 6.3 6.29 6.58 6.71 6.4 6.61 6.45 6.15 6.29 6.34 6.34 6.39 6.73 6.87 6.64 6.31 6.71
GOBP_NEURAL_RETINA_DEVELOPMENT 5.86 5.99 6.14 6.29 5.96 5.88 6.32 6.19 6.28 6.33 5.89 5.89 6.22 6.23 6.18 6.2 6.3 6.1 5.79 5.94 6.19 5.96 6.19 6.45 5.96 6.13
GOBP_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS 5.77 5.6 5.84 6.11 5.42 5.57 5.67 5.87 5.7 5.55 5.72 5.54 5.57 5.7 5.82 5.48 5.7 5.85 5.96 5.98 6.04 6.22 5.44 5.8 6.23 5.93
GOBP_GROWTH_PLATE_CARTILAGE_DEVELOPMENT 5.74 5.39 5.21 6.1 5.19 5.64 5.44 5.85 5.4 5.55 5.17 5.55 5.37 5.43 5.65 5.39 5.56 5.93 5.74 5.73 5.86 6.33 5.15 5 5.63 6.7
GOBP_DETECTION_OF_CALCIUM_ION 9.01 9.3 9.06 8.62 9.3 9.56 9.42 9.09 8.75 9.32 9.04 9.38 9.45 9.56 9.26 9.32 8.67 9.25 9.33 9.43 9.02 8.83 9.34 9.79 9.42 9.49
GOBP_CARBOHYDRATE_METABOLIC_PROCESS 6.56 6.59 6.9 6.9 6.79 6.81 6.76 6.69 6.76 6.84 6.67 6.75 6.8 6.88 6.74 6.68 6.7 6.72 6.74 6.82 6.61 6.75 6.81 6.82 6.75 6.72
GOBP_POLYSACCHARIDE_METABOLIC_PROCESS 6.48 6.68 6.54 6.67 6.74 6.98 6.8 6.73 6.95 6.79 6.56 6.85 6.97 6.92 6.73 6.7 6.78 6.83 6.83 6.94 6.72 6.84 6.92 6.93 6.83 6.74
GOBP_DISACCHARIDE_METABOLIC_PROCESS 4.68 4.76 4.75 5.08 4.44 4.17 4.88 4.41 5.16 4.33 4.7 4.69 4.66 4.08 4.66 4.32 4.49 4.7 4.29 4.45 4.78 4.6 4.32 4.5 4.52 4.43
GOBP_MONOSACCHARIDE_METABOLIC_PROCESS 6.47 6.55 6.9 6.9 6.78 6.79 6.78 6.81 6.76 6.74 6.54 6.56 6.71 6.79 6.7 6.71 6.74 6.72 6.51 6.76 6.58 6.7 6.72 6.76 6.78 6.69
GOBP_FRUCTOSE_METABOLIC_PROCESS 5.17 5.42 5.8 6.19 5.56 5.02 5.85 5.55 5.74 5.58 5.62 5.47 5.56 5.56 5.3 5.45 5.25 5.08 4.92 5.4 5.4 4.93 5.49 5.5 5.47 5.37
GOBP_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS 7.81 7.81 7.77 7.56 7.8 8.03 8.24 7.34 8.42 8.58 7.96 7.95 8.34 8.2 8.17 8.11 8 7.66 7.95 7.83 7.27 7.45 8.58 8.5 7.87 7.33
GOBP_FUCOSE_METABOLIC_PROCESS 5.66 5.78 5.56 5.76 5.41 5.26 5.56 5.28 5.39 5.2 5.23 5.18 5.27 5.32 5.69 5.4 5.37 5.25 5.35 5.43 5.42 5.52 5.25 5.3 5.56 5.88
GOBP_GLUCOSE_METABOLIC_PROCESS 6.52 6.63 6.93 6.78 6.74 6.82 6.86 6.92 6.93 6.95 6.6 6.84 6.79 6.93 6.75 6.79 6.81 6.84 6.67 6.87 6.67 6.81 6.86 6.79 6.85 6.75
GOBP_GLUCOSE_CATABOLIC_PROCESS 6.46 6.36 7.12 6.78 6.15 6.05 6.55 6.41 6.42 6.5 6.21 6.32 6.08 6.22 6.47 6.47 6.68 6.62 6.22 6.51 6.35 6.72 6.13 6.22 6 5.98
GOBP_GALACTOSE_METABOLIC_PROCESS 6.46 6.53 6.9 6.98 6.78 6.52 6.59 6.52 7.05 6.4 6.57 6.49 6.47 6.88 6.6 6.31 6.47 6.61 6.6 6.76 6.56 6.68 6.31 6.04 6.64 6.44
GOBP_INOSITOL_METABOLIC_PROCESS 6.53 6.64 6.79 6.91 6.14 6.63 6.84 6.67 6.66 6.47 6.59 6.98 6.57 6.8 6.77 6.47 6.42 6.84 6.7 6.89 6.55 6.96 6.52 6.71 6.73 6.37
GOBP_AMINOGLYCAN_METABOLIC_PROCESS 6.27 6.21 6.36 6.36 6.59 6.3 6.34 6.37 6.27 6.27 6.22 6.4 6.35 6.28 6.33 6.31 6.27 6.08 6.22 6.45 6.27 6.35 6.41 6.52 6.46 6.46
GOBP_AMINOGLYCAN_BIOSYNTHETIC_PROCESS 6.58 6.42 6.87 6.62 6.75 6.76 6.6 6.53 6.55 6.58 6.57 6.81 6.94 6.6 6.61 6.65 6.59 6.38 6.66 6.59 6.53 6.74 6.78 6.92 6.7 6.76
GOBP_AMINOGLYCAN_CATABOLIC_PROCESS 6.13 5.96 5.84 5.86 6 5.83 5.71 5.77 5.77 5.69 5.8 5.88 5.72 5.8 5.57 5.79 6.08 5.89 5.87 5.68 6.22 6.01 5.94 5.82 5.91 6.01
GOBP_PROTEOGLYCAN_METABOLIC_PROCESS 6.96 7.04 7.12 6.93 7.04 7.13 7.24 7.31 7.19 7.02 6.93 6.97 7.31 7.33 7.29 7.39 7.01 7.16 7.1 7.18 7.09 7.32 7.06 7.38 7.23 7.13
GOBP_AMINO_SUGAR_METABOLIC_PROCESS 6.46 6.52 6.59 6.6 6.64 6.35 6.4 6.28 6.25 6.47 6.58 6.32 6.55 6.47 6.27 6.28 6.52 6.36 6.76 6.61 6.22 6.17 6.57 6.41 6.48 6.43
GOBP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS 6.54 6.39 6.96 6.87 6.71 7.19 6.89 6.63 7.08 6.8 6.86 6.53 6.78 6.67 6.89 6.37 6.42 6.28 6.61 7.2 6.31 6.27 7.28 7.12 6.66 6.47
GOBP_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS 6.51 6.52 6.98 6.81 6.64 6.48 6.47 6.42 6.38 6.54 6.83 6.55 6.6 6.57 6.44 6.55 6.49 6.58 6.86 6.8 6.35 6.17 6.94 6.57 6.42 6.25
GOBP_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS 6.48 6.55 6.99 7.01 6.33 6.33 6.61 6.42 6.22 6.58 6.86 6.43 6.5 6.66 6.32 6.39 6.53 6.35 6.86 6.86 6.33 6.1 7.01 6.73 6.33 6.23
GOBP_N_ACETYLNEURAMINATE_METABOLIC_PROCESS 6.63 6.78 6.97 6.69 6.71 7.12 6.83 6.14 6.92 6.84 6.85 6.19 6.78 6.94 6.22 6.22 6.4 6.34 6.75 6.97 6.51 6.25 7.01 6.73 6.38 6.65
GOBP_URONIC_ACID_METABOLIC_PROCESS 5.62 5.48 4.3 4.92 4.58 4.94 4.73 5.33 5.05 4.44 5.02 5.38 4.15 4.05 4.62 4.92 5.21 6.01 5.83 5.47 5.81 4.9 4.66 4.9 4.43 4.74
GOBP_ALCOHOL_METABOLIC_PROCESS 6.31 6.37 6.45 6.53 6.49 6.5 6.44 6.39 6.46 6.63 6.44 6.45 6.46 6.37 6.48 6.29 6.36 6.33 6.35 6.34 6.36 6.44 6.48 6.47 6.5 6.47
GOBP_ETHANOL_METABOLIC_PROCESS 4.93 4.92 5.44 5.2 4.71 4.57 5.09 4.79 5.08 5.01 5.15 5.02 5 4.1 4.87 4.92 4.93 4.95 4.75 4.57 4.54 4.81 4.63 4.46 5.23 5.14
GOBP_ETHANOL_CATABOLIC_PROCESS 4.77 4.49 4.93 4.83 4.48 4.35 4.91 5.06 4.99 4.9 5.13 4.76 4.64 4.39 4.48 4.6 4.8 4.69 4.55 4.62 4.85 4.57 4.9 4.57 5.06 4.66
GOBP_ETHANOL_OXIDATION 5.09 5.14 5.52 5.83 5.05 4.71 5.63 5.5 5.39 5.26 5.87 5.23 5.35 4.49 5.23 5.14 5.39 5.15 5.04 4.78 4.99 5.07 5.67 4.81 5.43 5.86
GOBP_CELLULAR_GLUCAN_METABOLIC_PROCESS 6.47 6.68 6.67 6.89 6.74 6.96 6.91 6.91 6.98 7.02 6.69 6.88 6.99 6.92 6.84 6.85 6.82 6.86 6.88 6.97 6.75 6.86 7.07 7.04 6.84 6.81
GOBP_CELLULAR_ALDEHYDE_METABOLIC_PROCESS 6.45 6.23 6.88 6.38 6.56 6.43 6.27 6.46 6.27 6.66 6.75 6.47 6.5 6.34 6.2 6.59 6.47 6.06 6.33 6.4 6.2 6.29 6.42 6.57 6.33 6.36
GOBP_ORGANIC_ACID_METABOLIC_PROCESS 6.46 6.45 6.97 6.83 6.58 6.61 6.62 6.57 6.6 6.66 6.64 6.61 6.65 6.64 6.54 6.6 6.59 6.53 6.53 6.67 6.58 6.64 6.58 6.72 6.68 6.67
GOBP_ACETYL_COA_METABOLIC_PROCESS 7.34 7.39 6.76 6.86 7.74 7.78 7.41 7.42 7.39 7.66 7.29 7.9 7.68 7.49 7.64 7.27 7.39 7.56 7.53 7.65 7.22 7.57 7.33 7.61 7.63 7.82
GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS 7.86 8.12 8.51 8.22 8.5 8.33 8.7 8.25 8.4 8.2 8.07 8.3 8.29 8.44 8.54 8.47 8.12 7.95 8.3 8.54 7.57 8.19 8.36 8.3 8.69 8.35
GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE 8.44 8.55 8.88 8.47 8.91 8.75 8.74 8.53 8.88 8.66 8.46 8.67 8.52 8.75 8.88 8.63 8.59 8.37 8.52 8.8 8.26 8.47 9.08 9.29 8.82 8.53
GOBP_LACTATE_METABOLIC_PROCESS 8.18 8.04 8.26 7.5 7.89 8.22 7.95 7.76 8 7.98 8.16 7.91 8.2 8.11 7.94 8.21 7.86 7.7 8.51 8.66 7.74 8.37 7.85 8.34 8.16 7.79
GOBP_PYRUVATE_METABOLIC_PROCESS 7.51 7.42 7.73 7.74 7.65 7.81 7.88 7.48 7.77 7.67 7.54 7.66 7.66 7.81 7.59 7.6 7.43 7.48 7.69 7.75 7.23 7.6 7.76 7.76 7.63 7.63
GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY 7.02 7.09 7.54 7.49 7.28 7.36 7.22 7.4 7.29 7.25 7.41 7.26 7.3 7.38 7.22 7.39 7.12 7.12 7.23 7.36 7.17 7.32 7.28 7.44 7.32 7.3
GOBP_TRICARBOXYLIC_ACID_CYCLE 8.91 8.82 9.06 8.6 9.04 8.84 9 8.74 8.93 8.89 8.56 8.84 8.88 9 8.98 8.67 8.87 8.56 8.9 8.99 8.71 8.67 8.98 9.22 8.78 8.54
GOBP_2_OXOGLUTARATE_METABOLIC_PROCESS 7.3 8.02 7.9 7.63 7.93 8.5 8 7.64 7.64 7.76 7.91 7.78 8.47 8.47 7.77 7.82 7.76 7.64 7.77 7.91 7.8 7.83 7.89 7.55 8.03 7.9
GOBP_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS 6.82 6.91 7.12 7.07 6.96 6.96 7.04 7 6.97 7.05 6.75 6.92 7.04 6.98 7.07 7.01 6.93 6.98 6.84 7.01 6.91 6.94 6.94 6.95 6.91 6.96
GOBP_REGULATION_OF_GLUCONEOGENESIS 6.81 6.63 6.63 6.53 6.51 6.66 6.23 6.34 6.57 6.45 6.48 6.56 7.17 7.09 6.55 6.61 6.6 6.58 6.52 6.6 6.62 6.7 6.79 6.99 6.52 6.63
GOBP_ENERGY_RESERVE_METABOLIC_PROCESS 6.44 6.58 6.73 6.72 6.66 6.91 6.86 6.82 6.97 7 6.6 6.86 6.88 6.91 6.84 6.89 6.74 6.86 6.87 6.94 6.69 6.84 6.99 6.99 6.83 6.74
GOBP_OXIDATIVE_PHOSPHORYLATION 7.8 8.06 9.33 8.76 8.02 7.9 8.3 8.61 8.11 8.39 8.71 8.37 8.23 8.31 8.61 8.93 8.26 8.08 8.04 8.46 8.34 8.71 8.37 8.61 8.47 8.57
GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE 8.83 8.81 9.76 9.52 8.83 8.8 9.07 9.23 8.91 9.02 9.33 8.81 8.99 8.99 9.44 9.66 8.91 8.83 8.84 9.04 9.1 9.22 8.82 8.98 9 9.25
GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN 9.13 9.73 9.72 9.76 7.94 8.25 9.04 9.59 9.17 9.36 9.28 8.96 9.87 9.59 9.75 9.64 8.92 8.95 9.55 9.21 9.21 9.92 9.42 9.71 9.23 9.15
GOBP_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS 7.08 7.05 7.18 7.06 7.14 7.21 7.2 7.08 7.23 7.1 6.93 6.91 7.01 7.21 7.15 7.22 7.09 7.12 7.1 7.13 7.01 6.95 7.11 7.28 7.02 7.05
GOBP_PURINE_NUCLEOBASE_METABOLIC_PROCESS 6.62 6.98 7.31 7.16 6.93 7.14 7.06 6.87 6.96 7.21 6.63 6.72 6.78 6.73 6.96 7.35 6.79 7.07 6.75 7.04 7.01 7.17 6.68 6.82 7.21 7.21
GOBP_CAMP_BIOSYNTHETIC_PROCESS 7.07 6.86 6.62 6.62 7.2 7.26 7.53 7.75 7.26 7.49 7.11 7.68 7.43 7.62 7.69 7.47 7.5 7.05 7.21 7.4 7.51 7.33 7.35 7.4 7.69 7.64
GOBP_IMP_BIOSYNTHETIC_PROCESS 6.79 6.63 6.95 7.02 6.81 6.83 6.93 6.98 6.82 6.85 6.67 7 6.84 6.78 6.87 6.75 6.88 6.87 6.69 6.76 6.78 6.99 6.36 6.98 6.85 7.01
GOBP_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS 6.36 6.13 5.92 6.31 6.75 6.68 6.11 6.04 6.22 6.26 5.83 5.82 6.29 6.12 5.99 6.26 5.79 5.71 5.97 6.23 5.82 5.89 6.34 6.04 6.23 6.28
GOBP_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS 5.22 5.23 5.53 5.44 5.02 4.94 5.05 5.07 5.29 4.77 5.33 5.13 5.1 5 5.12 5.19 5.38 5.27 5.09 4.98 5.41 5.32 5.04 4.89 5.29 5.15
GOBP_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS 6.28 6.27 6.51 6.56 6.42 6.43 6.01 6.24 6.21 6.17 6.2 6.44 6.07 6.32 6.12 6.36 5.99 6.37 6.08 6.38 6.24 6.2 6.17 6.39 6.34 6.54
GOBP_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS 6.4 6.55 6.87 6.76 6.77 6.73 6.59 6.75 6.56 6.59 6.62 6.52 6.75 6.8 6.75 6.74 6.33 6.67 6.58 6.73 6.44 6.74 6.45 6.63 6.67 6.79
GOBP_UMP_BIOSYNTHETIC_PROCESS 6.08 6.06 6.17 6.52 6.15 6.08 5.64 6.19 5.84 5.93 5.81 5.99 5.99 5.9 6.04 6.06 5.71 5.76 5.93 5.83 5.96 5.83 6.12 5.99 5.8 5.99
GOBP_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS 5.61 5.53 5.83 5.68 5.28 5.46 5.8 5.42 5.64 5.49 5.67 5.47 5.72 5.74 5.65 5.81 5.55 5.54 5.45 5.14 5.39 5.67 5.62 5.66 5.51 5.85
GOBP_DNA_METABOLIC_PROCESS 6.33 6.31 6.63 6.68 6.47 6.52 6.46 6.51 6.44 6.48 6.5 6.49 6.52 6.45 6.43 6.46 6.36 6.29 6.42 6.54 6.44 6.48 6.47 6.63 6.47 6.58
GOBP_DNA_REPLICATION 5.9 6.02 6.33 6.32 5.93 6.09 6 6.11 5.98 6.15 6.13 6.04 6.01 6.01 6.12 6.23 5.97 6.02 5.95 5.99 6 6.2 6.14 6.18 6.15 6.25
GOBP_DNA_DEPENDENT_DNA_REPLICATION 5.76 5.92 6.09 6.12 5.79 5.95 5.82 6.05 5.86 5.87 6.02 5.95 5.82 5.63 6 6.05 5.78 5.68 5.8 5.75 5.77 6.03 6.06 6.16 6.05 6.21
GOBP_DNA_LIGATION 6.35 6.39 6.58 6.25 6.16 6.01 6.48 6.38 6.52 6.06 6.21 6.21 6.27 6.03 6.32 6.28 6.05 6.43 6.27 6.05 6.31 6.03 6.37 6.41 6.42 6.15
GOBP_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION 5.97 6.02 6.14 6.47 5.78 6.09 6.08 6.18 5.94 6.11 6.3 6.09 6.07 5.96 5.97 6.15 6.17 5.97 6.12 5.97 5.97 6.02 6.28 6.06 5.91 6.06
GOBP_DNA_REPLICATION_INITIATION 5.71 5.86 6.11 6.34 5.8 5.88 5.76 5.96 6.16 5.87 5.88 5.96 5.83 5.72 5.88 5.77 5.8 5.64 5.6 5.82 5.6 5.55 6.13 6.19 5.82 6.18
GOBP_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION 5.72 5.89 5.9 6.31 5.85 6.14 5.82 6.04 5.92 5.89 5.59 5.83 5.74 6.01 6.21 6.23 5.72 5.8 5.8 5.82 5.95 5.99 6.01 6.11 6.04 6.2
GOBP_REGULATION_OF_DNA_REPLICATION 5.95 6.13 6.55 6.74 6.16 6.16 6.07 6.28 6.16 6.2 6.27 6.27 6.09 6.15 6.27 6.43 5.99 6.1 6.14 6.21 6.41 6.37 6.32 6.17 6.19 6.4
GOBP_RNA_DEPENDENT_DNA_BIOSYNTHETIC_PROCESS 7.09 7.35 7.68 7.29 7.57 7.38 7.39 7.3 6.99 7.73 7.36 7.38 7.29 7.26 7.39 7.18 7.18 7.13 7.34 7.36 7.22 7.38 7.45 7.52 7.43 7.76
GOBP_DNA_REPAIR 6.48 6.39 6.81 6.8 6.65 6.66 6.63 6.65 6.52 6.72 6.67 6.71 6.68 6.65 6.6 6.7 6.48 6.46 6.52 6.69 6.49 6.68 6.62 6.77 6.65 6.73
GOBP_REGULATION_OF_DNA_REPAIR 6.25 6.34 6.83 6.68 6.54 6.52 6.63 6.59 6.57 6.7 6.61 6.59 6.67 6.4 6.46 6.7 6.46 6.43 6.28 6.55 6.45 6.46 6.86 6.75 6.74 6.66
GOBP_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR 7.52 7.72 8.14 7.96 7.76 7.91 7.78 7.9 7.89 7.94 7.88 7.92 8.07 7.85 8.03 7.98 7.57 7.43 7.56 7.96 7.58 8.05 8.05 8.21 8.03 7.96
GOBP_BASE_EXCISION_REPAIR 6 5.88 6.41 6.41 5.79 5.95 6.01 6.01 6.02 5.82 6.1 5.9 5.87 5.85 6.05 6.08 5.8 5.95 5.95 5.91 5.94 6.2 5.94 6.29 6.04 6.02
GOBP_BASE_EXCISION_REPAIR_AP_SITE_FORMATION 5.73 5.71 6.29 6.5 5.53 5.7 5.8 5.78 5.86 5.72 5.95 5.77 5.83 5.84 5.73 5.89 5.8 5.95 5.8 5.68 5.68 5.73 5.86 5.94 5.55 5.85
GOBP_NUCLEOTIDE_EXCISION_REPAIR 7.03 7.26 7.79 7.7 7.37 7.33 7.39 7.54 7.5 7.52 7.28 7.45 7.3 7.2 7.77 7.44 7.09 7.11 7.18 7.62 7.2 7.49 7.48 7.82 7.59 7.64
GOBP_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_STABILIZATION 7.45 7.31 7.83 7.62 7.55 7.99 7.47 7.72 7.77 7.71 7.42 7.84 7.96 7.68 7.88 7.69 7.32 7.35 7.56 7.79 7.37 7.66 7.72 8.03 7.85 7.75
GOBP_NUCLEOTIDE_EXCISION_REPAIR_PREINCISION_COMPLEX_ASSEMBLY 7.56 7.7 7.99 7.91 8.1 8.21 7.88 7.96 7.95 7.94 7.91 8.05 8.12 7.88 8.09 8.05 7.61 7.5 7.96 8.1 7.54 7.98 8.14 8.27 8.33 8.02
GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING 6.27 6.33 7.1 6.97 6.08 6.38 6.56 6.61 6.04 6.66 6.35 6.2 6.03 6.11 6.35 6.92 5.99 6.08 6.42 6.64 6.23 6.47 6.47 6.55 6.38 6.43
GOBP_MISMATCH_REPAIR 6.1 6.06 6.57 6.64 5.94 5.96 5.82 6 5.99 5.83 6.26 6.01 5.79 6.01 5.99 5.99 5.85 6.09 5.95 5.99 5.8 6.31 5.91 6.22 6.05 6.23
GOBP_POSTREPLICATION_REPAIR 6.93 7.04 7.59 7.72 7.28 7.45 7.39 7.16 7.09 7.28 7.53 7.4 7.32 7.27 7.22 7.19 7.18 6.95 7.14 7.32 7.09 7.47 7.31 7.41 7.47 7.33
GOBP_DOUBLE_STRAND_BREAK_REPAIR 6.1 6.11 6.41 6.47 6.19 6.22 6.28 6.31 6.26 6.25 6.28 6.3 6.35 6.19 6.17 6.2 6.21 6.16 6.03 6.26 6.24 6.19 6.31 6.5 6.32 6.34
GOBP_DNA_MODIFICATION 6.02 6.02 6.13 6.4 6.04 6.14 5.85 5.96 5.86 5.88 6.07 5.94 5.99 6.05 5.89 5.96 5.94 5.99 6 5.84 6.12 5.95 6 6.29 5.95 6.07
GOBP_DNA_METHYLATION 6.33 6 6.06 6.03 6.08 6.18 5.85 6.08 5.74 5.99 6.08 5.89 6.06 6.03 6.21 6.2 6.07 5.87 6.01 5.63 6.18 5.98 5.8 6.28 6.06 6.13
GOBP_DNA_DEALKYLATION_INVOLVED_IN_DNA_REPAIR 6.54 6.79 6.82 7.18 6.79 6.68 6.83 6.5 6.79 6.7 6.64 6.67 6.88 6.39 6.51 6.57 6.43 6.64 6.6 6.86 6.65 6.84 6.67 6.93 6.82 7.02
GOBP_DNA_CATABOLIC_PROCESS 5.82 5.76 6.16 6.06 5.73 5.85 5.73 6.14 5.57 5.82 6.11 6.01 5.69 5.65 5.81 6.01 5.6 5.81 5.86 5.97 5.77 5.88 5.52 5.62 6.04 6.05
GOBP_APOPTOTIC_DNA_FRAGMENTATION 5.68 5.87 6.2 6.21 5.74 5.79 5.73 5.93 5.63 5.77 6.35 6.01 5.69 5.72 5.81 5.87 5.6 5.62 5.87 6.21 5.77 5.88 5.52 5.54 5.75 5.96
GOBP_DNA_RECOMBINATION 5.94 5.94 6.04 6.17 5.9 5.92 5.93 6.05 5.85 6.07 5.96 6.04 5.92 5.85 5.92 5.85 6.02 5.89 5.91 6.03 5.85 5.99 6.01 6.15 6.07 6
GOBP_MITOTIC_RECOMBINATION 6.21 6.19 6.47 6.88 6.39 6.4 6.27 6.2 6.58 6.42 6.27 6.58 6.05 6.14 6.11 6.3 6.38 6.25 6.18 6.29 6.11 6.02 6.45 6.89 6.22 6.07
GOBP_DNA_PACKAGING 6 5.99 6.08 6.11 6.13 6.22 6.15 6.33 6.08 6.17 6.15 6.14 6.18 6.12 6.22 6.08 6.06 6.05 6.09 6.13 6.16 6.2 6.13 6.28 6.22 6.26
GOBP_CHROMATIN_ORGANIZATION 6.84 6.87 6.95 6.93 7.15 7.17 7.04 7.07 7.06 7.13 7 7.16 7.11 7.15 7.11 7.14 6.93 6.82 7.06 7.2 6.92 7.16 7.14 7.36 7.12 7.17
GOBP_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY 6.34 6.44 6.56 6.55 6.59 6.68 6.7 6.85 6.72 6.84 6.74 6.72 6.77 6.72 6.65 6.72 6.47 6.55 6.5 6.69 6.69 6.71 6.78 6.92 6.65 6.77
GOBP_NUCLEOSOME_ASSEMBLY 6.21 6.15 6.36 6.3 5.93 6.44 6.29 6.44 6 6.2 6.47 6.2 6.35 6.28 6.39 6.3 6.25 6.3 6.16 6.16 6.47 6.39 6.11 6.4 6.52 6.5
GOBP_CHROMATIN_REMODELING 6.52 6.58 6.71 6.86 6.92 6.81 6.85 6.87 6.83 6.97 6.79 6.9 6.91 6.85 6.83 6.93 6.66 6.6 6.66 6.88 6.71 6.95 6.95 7.2 6.89 6.87
GOBP_CHROMATIN_SILENCING 6.83 6.82 7.54 7.39 7.23 7.11 6.95 7.17 7.06 7.02 7.16 7.01 7.11 7.15 7.31 7.37 6.86 6.97 7.13 6.97 7.15 7.13 7.16 7.23 7.16 7.35
GOBP_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_ASSEMBLY 6.26 6.5 6.49 6.7 6.67 6.71 6.93 6.88 6.82 6.97 6.35 7.01 6.89 6.89 6.69 6.9 6.57 6.41 6.55 6.7 6.61 6.76 6.85 7.25 6.82 6.73
GOBP_CHROMATIN_SILENCING_AT_TELOMERE 5.7 6.05 6.46 5.65 6.91 6.69 5.84 7.17 5.87 6.73 5.73 6.85 6.63 6.46 7.16 6.87 6.75 6.89 6.1 6.63 6.6 6.79 6.11 6.6 6.59 7.37
GOBP_REGULATION_OF_GENE_EXPRESSION_BY_GENETIC_IMPRINTING 6.65 6.76 6.66 6.61 7.53 7.77 7.1 7.44 6.92 7.6 6.59 7.31 7.08 7 7.27 7.33 7.09 6.46 6.89 7.52 6.91 7.08 7.32 7.34 7.02 7.26
GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION 6.85 6.92 7.13 7.21 7.16 7.15 7.19 7.31 7.25 7.18 7.11 7.33 7.37 7.27 7.37 7.3 7.1 7.08 7.04 7.3 7.22 7.38 7.27 7.61 7.42 7.38
GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION 7.41 7.43 7.76 7.4 7.61 7.53 7.68 7.74 7.72 7.7 7.33 7.62 7.63 7.61 7.74 7.76 7.45 7.47 7.71 7.62 7.52 7.73 7.68 7.83 7.71 7.66
GOBP_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION 7.56 7.64 7.99 7.88 7.91 8.09 7.69 7.9 7.81 7.99 7.81 7.93 7.92 7.82 8.03 7.97 7.6 7.52 7.71 7.9 7.58 8.06 8.01 8.11 8.04 7.99
GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I 7.06 7.22 6.99 7.08 6.98 7.23 6.92 7.01 7.29 7.16 6.97 7.06 7.27 7.28 6.91 6.92 7.08 6.92 7 7.13 7.24 6.91 7.16 7.6 7.28 7.22
GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III 6.03 6.15 6.41 6.4 6.3 6.21 6.08 6.5 6.39 6.43 6.11 6.55 5.93 6.04 6.37 6.32 6.22 6.15 6.23 6.36 6.59 6.61 6.11 6.39 6.35 6.32
GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_I 6.8 6.98 7.12 7.21 7.23 7.48 7.18 7.09 7.29 7.26 7.04 7.2 7.39 7.29 7.12 6.98 7.08 7.02 7.28 7.3 7.18 7.3 7.17 7.49 7.31 7.29
GOBP_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_I_PROMOTER 7.51 7.4 7.53 7.56 7.7 7.96 7.68 7.78 7.66 7.8 7.28 7.8 7.79 7.72 7.87 7.72 7.36 7.48 7.76 7.62 7.45 7.66 7.67 7.85 7.77 7.93
GOBP_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_I_PROMOTER 7.54 7.31 7.53 7.56 7.7 8.02 7.68 7.68 7.7 7.8 7.31 7.68 8 7.72 7.72 7.84 7.18 7.48 7.81 7.5 7.36 7.63 7.67 7.85 7.56 7.73
GOBP_TERMINATION_OF_RNA_POLYMERASE_I_TRANSCRIPTION 7.58 7.4 7.67 7.82 7.95 8.36 7.71 7.78 7.82 7.94 7.56 7.84 8.12 7.84 7.9 8.05 7.36 7.55 8.07 7.8 7.45 7.8 7.9 7.96 7.82 7.9
GOBP_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER 6.88 7.08 7.29 7.25 7.31 7.26 7.31 7.38 7.29 7.29 7.26 7.39 7.37 7.28 7.47 7.35 7.27 7.11 7.09 7.36 7.36 7.48 7.32 7.61 7.46 7.4
GOBP_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER 7.9 7.94 8.39 8.23 8.34 8.36 8.03 8.34 8.21 8.27 8.13 8.07 8.36 8.47 8.22 8.42 7.9 7.94 8.31 8.37 7.84 8.3 8.24 8.3 8.31 8.25
GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION 7.34 7.39 7.74 7.31 7.39 7.41 7.51 7.71 7.64 7.6 7.24 7.47 7.46 7.38 7.59 7.55 7.39 7.42 7.49 7.6 7.52 7.67 7.66 7.51 7.65 7.57
GOBP_MRNA_SPLICE_SITE_SELECTION 8.34 8.55 8.38 8.27 8.72 8.87 8.71 8.63 8.8 8.91 8.24 8.92 8.63 8.76 8.83 8.83 8.82 8.6 8.86 8.75 8.41 8.79 8.87 9.03 8.84 8.66
GOBP_MRNA_CLEAVAGE 7.08 7.05 7.76 7.23 7.42 7.36 7.2 7.6 7.68 7.79 7.1 7.64 7.51 7.43 8.03 7.77 7.52 7.38 7.12 7.68 7.52 7.86 7.84 7.83 7.76 7.5
GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III 6.48 6.42 6.95 6.97 6.59 6.51 6.64 6.77 6.47 6.69 6.78 6.82 6.54 6.77 6.91 6.88 6.51 6.34 6.71 6.85 6.7 7.14 6.74 6.86 6.81 7.05
GOBP_MITOCHONDRIAL_TRANSCRIPTION 6.93 7.16 8 7.84 6.71 7.1 7.05 7.43 7.12 7.24 7.47 7.12 7.09 7.46 7.38 7.2 6.78 6.92 7.17 7.17 7.2 7.5 7.06 7.55 7 6.91
GOBP_RNA_PROCESSING 6.85 6.99 7.25 7.23 7.21 7.25 7.1 7.16 7.16 7.25 7.14 7.24 7.13 7.19 7.18 7.22 6.89 6.93 7.13 7.25 7.02 7.18 7.24 7.36 7.2 7.22
GOBP_MRNA_PROCESSING 7.28 7.46 7.69 7.58 7.69 7.67 7.64 7.66 7.63 7.7 7.47 7.66 7.61 7.6 7.82 7.78 7.52 7.39 7.56 7.79 7.43 7.74 7.7 7.88 7.69 7.66
GOBP_TRNA_METABOLIC_PROCESS 6.31 6.14 6.72 6.7 6.39 6.41 6.37 6.32 6.39 6.33 6.43 6.32 6.38 6.35 6.36 6.43 6.21 6.21 6.32 6.32 6.18 6.35 6.36 6.43 6.3 6.42
GOBP_TRNA_MODIFICATION 6.29 6.07 6.59 6.55 6.08 6.23 6.05 5.99 6.21 6.16 6.14 6.13 6.1 5.99 6.16 6.13 5.99 6.15 6.17 6.06 6.14 6.13 6.19 6.11 6.01 6.22
GOBP_RNA_CATABOLIC_PROCESS 7.44 7.53 7.84 7.78 7.69 7.78 7.66 7.62 7.71 7.75 7.71 7.68 7.69 7.77 7.86 7.7 7.56 7.42 7.64 7.71 7.54 7.74 7.91 7.91 7.68 7.65
GOBP_RNA_LOCALIZATION 7.42 7.52 7.84 7.74 7.75 7.83 7.76 7.6 7.67 7.76 7.65 7.74 7.66 7.8 7.77 7.72 7.53 7.28 7.68 7.71 7.44 7.79 7.81 7.9 7.77 7.76
GOBP_RNA_EXPORT_FROM_NUCLEUS 7.42 7.47 7.79 7.58 7.78 7.82 7.6 7.6 7.68 7.9 7.49 7.74 7.66 7.81 7.74 7.72 7.45 7.35 7.59 7.71 7.36 7.68 7.84 7.9 7.71 7.74
GOBP_MRNA_EXPORT_FROM_NUCLEUS 7.42 7.46 7.83 7.58 7.75 7.82 7.56 7.65 7.68 7.9 7.49 7.74 7.63 7.76 7.87 7.72 7.45 7.29 7.59 7.71 7.36 7.74 7.84 7.96 7.68 7.76
GOBP_TRANSLATIONAL_INITIATION 7.49 7.62 7.95 7.9 7.69 7.55 7.73 7.67 7.77 7.91 7.77 7.68 7.7 7.77 7.92 7.97 7.71 7.68 7.6 7.71 7.52 7.8 7.89 7.94 7.78 7.72
GOBP_TRANSLATIONAL_ELONGATION 7.02 6.97 7.98 7.74 7.12 7.2 7.28 7.4 7.48 7.33 7.57 7.25 7.23 7.38 7.58 7.74 7.02 6.98 7.01 7.36 7.12 7.48 7.38 7.58 7.24 7.21
GOBP_TRANSLATIONAL_TERMINATION 6.82 6.92 8.12 7.72 7.12 7.12 7.3 7.42 7.54 7.3 7.57 7.36 7.29 7.43 7.57 7.83 7.07 6.98 6.98 7.31 7.06 7.44 7.35 7.52 7.21 7.25
GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION 7.62 7.74 8.08 8.14 8.13 8.2 8.12 8.02 8.37 8.27 8 8.26 8.35 8.31 8.41 8.24 7.94 7.73 7.87 8.14 7.77 8.21 8.05 8.37 8.41 8.23
GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION 7.1 6.54 7.27 7.26 7.09 7.01 6.63 6.99 7.17 6.91 7.31 7.14 6.9 6.94 7.39 7.01 6.71 6.8 6.89 6.71 7.03 7.12 7.09 7.1 6.72 6.83
GOBP_PROTEIN_FOLDING 7.26 7.33 7.85 7.74 7.35 7.38 7.53 7.6 7.57 7.63 7.66 7.5 7.71 7.68 7.76 7.75 7.41 7.36 7.32 7.59 7.43 7.61 7.72 7.75 7.67 7.66
GOBP_DE_NOVO_PROTEIN_FOLDING 7.04 6.97 7.64 7.93 7.55 7.58 7.41 7.68 7.56 7.61 7.51 7.53 7.68 7.71 7.7 7.85 7.58 7.6 7.52 7.71 7.53 7.78 7.71 7.84 7.25 7.78
GOBP_SIGNAL_PEPTIDE_PROCESSING 7.37 7.6 8.02 8.06 7.61 7.69 7.47 7.77 7.47 7.54 7.56 7.29 7.46 7.64 7.57 7.08 7.22 7.31 7.58 7.83 7.39 7.56 7.73 7.66 7.82 7.6
GOBP_PROTEIN_PHOSPHORYLATION 6.47 6.42 6.6 6.53 6.49 6.54 6.57 6.58 6.56 6.55 6.51 6.52 6.62 6.59 6.59 6.6 6.51 6.48 6.43 6.51 6.62 6.67 6.61 6.61 6.59 6.64
GOBP_PROTEIN_DEPHOSPHORYLATION 7.33 7.4 7.73 7.57 7.62 7.72 7.58 7.67 7.7 7.76 7.48 7.66 7.71 7.74 7.73 7.65 7.66 7.51 7.48 7.63 7.5 7.66 7.83 7.92 7.7 7.54
GOBP_PROTEIN_ADP_RIBOSYLATION 6.87 6.75 7.32 6.68 6.96 6.78 7.07 6.71 6.94 7.03 6.8 7.03 6.96 7.09 7.04 6.88 7.12 6.62 6.43 7 6.88 6.9 7.22 6.89 6.83 6.8
GOBP_PROTEIN_ACETYLATION 7.14 7.25 7.35 7.33 7.55 7.55 7.42 7.65 7.37 7.57 7.41 7.39 7.48 7.44 7.47 7.45 7.43 7.08 7.23 7.54 7.27 7.54 7.58 7.73 7.57 7.46
GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION 7.59 7.7 7.81 7.5 7.71 7.64 7.53 7.93 7.64 7.72 7.58 7.48 7.23 7.84 7.25 7.43 7.92 7.44 7.43 7.69 7.64 7.89 7.84 7.73 7.53 7.94
GOBP_PROTEIN_METHYLATION 6.71 6.77 6.8 6.86 7.04 7.04 7.05 6.96 7 7.05 6.73 6.97 6.91 6.89 7.2 7.13 6.87 6.73 7 6.99 6.86 7.13 7.05 7.2 7.01 7.06
GOBP_PROTEIN_DEMETHYLATION 6.79 6.72 6.41 6.82 7.41 7.22 6.97 7.09 6.98 7 6.6 7.08 7.24 7.23 6.97 6.88 6.88 6.66 7.2 6.99 6.82 7.03 7.09 7.25 6.9 7.21
GOBP_PROTEIN_N_LINKED_GLYCOSYLATION 7.31 7.14 7.48 7.29 7.53 7.58 7.58 7.51 7.42 7.4 7.23 7.37 7.41 7.6 7.62 7.58 7.32 7.28 7.44 7.71 7.17 7.49 7.09 7.45 7.66 7.39
GOBP_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS 7.16 7.03 7 7 7.03 7.53 7.28 7.12 7.41 7.24 6.93 7.37 7.36 7.32 7.39 7.23 7.15 7.2 7.51 7.44 6.9 7.09 7.02 7.45 7.39 7.39
GOBP_N_GLYCAN_PROCESSING 8.84 8.7 8.98 8.47 9.12 9.22 9.17 8.89 9.33 9.32 8.61 8.74 9.16 9.12 8.81 8.92 7.88 8.09 8.83 8.91 8.36 8.78 9.43 9.42 8.82 8.81
GOBP_PROTEIN_O_LINKED_GLYCOSYLATION 6 6.03 6.11 6.02 6.33 6.31 6.03 6.05 6.29 6.27 6.05 6.11 6.19 6.13 6.02 6.29 5.93 5.92 6.17 5.91 5.92 6.14 6.02 6.2 6.07 5.92
GOBP_GPI_ANCHOR_METABOLIC_PROCESS 7.24 7.51 7.19 7.01 7.02 7.27 7.16 6.74 7.15 7.21 6.78 6.86 7.21 6.94 6.77 6.57 6.79 6.9 6.99 7.21 6.65 6.84 6.95 7.19 7.28 7.09
GOBP_PROTEOLYSIS 6.47 6.48 6.76 6.71 6.62 6.67 6.6 6.64 6.62 6.7 6.58 6.61 6.62 6.65 6.67 6.62 6.52 6.47 6.52 6.63 6.57 6.62 6.72 6.74 6.64 6.69
GOBP_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS 6.51 6.61 6.63 6.31 6.97 6.83 6.32 6.32 6.86 6.71 6.5 6.7 6.83 6.82 6.46 6.55 6.84 6.73 6.49 6.61 6.52 6.69 6.76 6.69 6.82 6.77
GOBP_PROTEIN_MONOUBIQUITINATION 7.07 6.99 7.62 7.65 7.22 7.28 7.32 7.44 7.48 7.52 7.29 7.29 7.4 7.52 7.53 7.52 7.22 7.15 7.61 7.47 7.19 7.58 7.64 7.47 7.48 7.69
GOBP_PROTEIN_QUALITY_CONTROL_FOR_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEINS 7.59 7.59 7.54 7.91 7.93 8.22 8.16 7.89 8.22 8.02 7.78 7.67 8.18 8.18 8 7.66 7.44 7.51 7.85 8.02 7.6 7.69 8.18 8.27 7.93 7.91
GOBP_GLYCOPROTEIN_CATABOLIC_PROCESS 6.14 6.28 6.28 6.74 6.07 6.19 6.33 6.27 6.21 6.19 6.12 6.24 6.1 6.07 6.29 5.99 6.17 6.05 6.08 6.27 6.3 6.18 6.2 6.37 6.34 6.42
GOBP_PROTEIN_DEGLYCOSYLATION 7.61 7.29 7.54 7.77 7.69 7.91 7.28 7.71 7.94 7.79 7.78 7.7 7.87 7.73 7.98 8.05 7.43 7.29 7.41 7.26 7.38 7.66 8.12 7.93 7.83 7.71
GOBP_PEPTIDE_METABOLIC_PROCESS 7.12 7.16 7.68 7.5 7.37 7.39 7.38 7.35 7.42 7.42 7.41 7.34 7.34 7.39 7.46 7.39 7.21 7.11 7.29 7.48 7.22 7.4 7.47 7.58 7.45 7.38
GOBP_CELLULAR_AMINO_ACID_METABOLIC_PROCESS 6.66 6.63 7.15 7.04 6.74 6.89 6.8 6.77 6.74 6.8 7.04 6.84 6.8 6.79 6.6 6.71 6.73 6.78 6.73 6.81 6.7 6.79 6.75 6.83 6.8 6.7
GOBP_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS 7.64 7.95 8.82 8.57 8.17 8.36 8.36 8.23 8.72 8.46 8.57 8.34 8.42 8.48 8.65 8.5 7.94 7.88 7.9 8.39 7.98 8.18 8.78 8.77 8.42 8.28
GOBP_ARGININE_METABOLIC_PROCESS 6.07 5.93 6.83 6.46 5.84 5.74 6.01 6.13 6.11 6.11 6.38 5.69 5.88 6.03 5.91 6.33 6.18 6.1 6.02 6.03 6.28 6.2 6.38 5.94 6.45 6.34
GOBP_ARGININE_CATABOLIC_PROCESS 6.23 6.34 7.22 6.98 6.41 6.31 6.52 6.58 6.53 6.5 6.71 6.46 6.49 6.42 6.43 6.81 6.54 6.94 6.54 6.75 6.93 6.96 7.07 6.96 6.94 6.57
GOBP_CYSTEINE_METABOLIC_PROCESS 7.27 7.19 6.69 7.42 6.62 6.4 6.44 6.54 6.49 6.66 6.56 6.88 6.76 6.39 6.51 6.52 7.28 6.89 6.88 6.76 7.04 6.77 6.36 6.64 6.39 6.56
GOBP_GLUTAMATE_METABOLIC_PROCESS 7.03 7.19 7.33 7.11 6.62 6.98 7.05 7.15 7.02 7.44 7.49 7.53 7.72 7.55 7.28 7.42 7.3 7.1 7.32 6.94 7.17 7.48 7.83 7.39 7.65 7.26
GOBP_GLUTAMINE_METABOLIC_PROCESS 6.81 7.22 7.53 6.83 7.01 7.08 6.82 6.91 6.71 6.62 7.01 7.02 6.83 6.75 7.18 6.76 6.76 7.06 6.94 6.9 6.75 7.08 6.75 6.88 6.94 6.84
GOBP_GLYCINE_METABOLIC_PROCESS 5.44 5.8 5.33 6.23 5.22 5.16 5.53 5.03 5.68 5.44 5.79 5.38 5.59 5.46 5.44 5.7 5.43 5.23 5.62 5.48 5.22 5.44 5.48 5.52 5.61 5.48
GOBP_LYSINE_METABOLIC_PROCESS 8.41 8.17 8.04 7.46 8.4 8.71 8.5 8.07 8.29 8.46 8.22 8.48 8.71 8.55 8.38 8.54 7.41 7.7 8.32 8.34 7.34 7.66 8.25 8.26 8.08 8.29
GOBP_METHIONINE_METABOLIC_PROCESS 6.86 6.88 7.26 7.1 7.09 6.9 7.16 6.8 6.8 6.63 7.11 6.79 6.4 6.73 6.48 6.6 7.13 6.58 6.68 7 6.76 7.05 6.61 6.67 7.24 6.89
GOBP_L_SERINE_METABOLIC_PROCESS 6.78 6.78 8.04 8.48 6.99 7.25 7.47 6.94 7.51 7.09 7.16 6.86 7.43 7.19 6.54 6.56 7.36 7.23 7.12 7.58 7.05 7.12 7 7.33 7.06 6.46
GOBP_TRYPTOPHAN_METABOLIC_PROCESS 4.77 4.64 4.33 4.46 4.4 4.01 3.93 4.38 4.03 4.27 4.4 4.21 4.11 3.91 4.13 4.25 4.68 4.58 4.75 4.26 4.36 4.3 3.97 3.97 4.1 4.34
GOBP_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS 6.2 6.2 6.67 6.71 6.16 6.35 6.26 6.39 6.24 6.13 6.47 6.22 6.26 6.38 6.14 6.18 6.24 6.24 6.15 6.29 6.34 6.33 6.2 6.26 6.35 6.35
GOBP_CELLULAR_BIOGENIC_AMINE_METABOLIC_PROCESS 6.07 5.99 6.54 6.4 5.87 6.12 6.11 6.03 5.93 6.09 6.25 6.11 6 6.11 6.07 6.2 5.92 6.04 5.85 6.07 6.22 6.26 6.18 6.07 6.01 6.09
GOBP_AMINO_ACID_BETAINE_METABOLIC_PROCESS 5.72 5.88 6.29 6.15 6.15 5.8 5.54 5.56 5.2 5.27 6.12 5.76 6 6.67 5.24 5.89 5.39 6.41 5.56 5.83 5.5 5.9 5.11 5.71 5.64 5.75
GOBP_INDOLALKYLAMINE_METABOLIC_PROCESS 4.77 4.55 4.33 4.44 4.15 4.23 4.21 4.19 4.14 4.15 4.35 4.3 4.1 4.01 4.27 4.06 4.48 4.53 4.44 4.07 4.36 4.26 4.09 3.92 4.25 4.18
GOBP_THYROID_HORMONE_GENERATION 5.34 5.1 4.91 5.15 4.65 4.64 5.08 4.85 5.08 4.8 5.05 4.78 4.8 4.78 4.88 4.81 5.04 4.92 4.7 4.64 5.04 4.94 4.84 4.55 4.78 4.67
GOBP_POLYAMINE_METABOLIC_PROCESS 7.39 7.25 8.49 8.4 7.77 7.57 8.02 8.01 8.12 8.04 8.19 8.05 8.23 8.21 8.24 8.21 7.99 7.51 7.83 7.84 8.05 7.91 8.16 8.24 8.09 7.86
GOBP_POLYAMINE_BIOSYNTHETIC_PROCESS 7.66 7.37 8.62 8.75 8.31 8.28 8.38 8.33 8.78 8.71 8.38 8.45 8.9 8.33 8.45 8.22 8.12 7.57 7.91 8.1 8.1 7.98 8.96 8.9 8.35 7.93
GOBP_PROTEIN_TARGETING 7.22 7.38 7.83 7.69 7.61 7.67 7.58 7.62 7.59 7.61 7.69 7.51 7.71 7.69 7.66 7.65 7.37 7.39 7.54 7.58 7.46 7.59 7.63 7.84 7.64 7.57
GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS 8.37 8.41 8.98 8.92 8.89 9.05 8.8 8.06 9.12 8.75 8.77 8.55 8.91 9.1 8.7 8.47 8.25 8.28 8.66 8.62 7.97 8.18 8.99 9.02 8.79 8.28
GOBP_PROTEIN_TARGETING_TO_MEMBRANE 7.19 7.32 7.65 7.55 7.49 7.44 7.42 7.47 7.3 7.49 7.52 7.37 7.42 7.57 7.55 7.55 7.22 7.36 7.21 7.33 7.33 7.46 7.49 7.72 7.55 7.5
GOBP_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE 7.01 6.67 7.39 7.48 6.51 6.85 6.92 7.05 6.81 6.69 7.33 6.23 6.93 6.93 6.84 7.03 7.03 6.82 7.07 6.73 7.08 6.93 6.87 6.78 6.95 7
GOBP_POSTTRANSLATIONAL_PROTEIN_TARGETING_TO_ENDOPLASMIC_RETICULUM_MEMBRANE 8.76 9.01 9.21 9.02 9.07 9.11 9.37 8.93 9.34 8.76 8.82 9.16 9.16 8.87 9.12 9.04 8.86 9.01 9.14 9.16 8.68 8.9 9.04 8.74 8.89 8.91
GOBP_PROTEIN_TARGETING_TO_LYSOSOME 8.47 8.67 9.06 8.61 8.96 8.8 8.87 8.32 8.87 8.92 8.78 8.79 8.9 8.99 8.62 8.58 8.54 8.43 8.84 8.74 8.19 8.72 8.99 9.04 8.79 8.68
GOBP_PROTEIN_TARGETING_TO_VACUOLE 8.09 8 8.15 7.9 8.59 8.52 8.19 8.09 8.34 8.42 8.15 8.31 8.38 8.39 8.01 8.02 7.96 7.71 7.99 8.41 7.9 8.19 8.44 8.47 8.37 8.05
GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION 7.34 7.43 8.28 8.01 7.83 7.91 7.83 8.03 7.8 7.99 7.9 7.68 7.95 7.87 7.93 7.96 7.58 7.52 7.57 8.15 7.57 7.94 7.92 8.02 7.94 7.82
GOBP_LIPID_METABOLIC_PROCESS 6.54 6.54 6.75 6.75 6.59 6.67 6.65 6.64 6.61 6.74 6.56 6.66 6.74 6.63 6.64 6.6 6.57 6.56 6.52 6.64 6.58 6.67 6.64 6.7 6.7 6.76
GOBP_FATTY_ACID_METABOLIC_PROCESS 6.3 6.3 6.63 6.66 6.37 6.43 6.44 6.45 6.42 6.48 6.47 6.45 6.55 6.4 6.39 6.54 6.41 6.29 6.32 6.58 6.42 6.51 6.45 6.53 6.49 6.63
GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS 6.34 6.34 6.52 6.67 6.19 6.14 6.4 6.23 6.31 6.41 6.49 6.28 6.41 6.09 6.26 6.4 6.36 6.04 6.33 6.14 6.25 6.48 6.37 6.21 6.57 6.56
GOBP_FATTY_ACID_BETA_OXIDATION 6.59 6.55 6.86 6.78 6.6 6.83 6.75 6.77 6.64 6.75 6.76 6.84 6.75 6.7 6.6 6.95 6.57 6.66 6.67 6.89 6.74 6.84 6.67 6.8 6.81 7.07
GOBP_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS 6.5 6.24 6.73 6.52 6.48 6.41 6.69 6.73 6.31 6.67 6.76 6.86 6.76 6.4 6.95 6.97 6.47 6.47 6.36 6.71 6.91 6.85 7.19 7.2 6.56 6.45
GOBP_NEUTRAL_LIPID_METABOLIC_PROCESS 6.19 6.37 6.4 6.69 6.46 6.57 6.43 6.4 6.18 6.44 6.47 6.37 6.52 6.51 6.32 6.2 6.31 6.2 6.24 6.45 6.46 6.44 6.38 6.58 6.58 6.47
GOBP_TRIGLYCERIDE_METABOLIC_PROCESS 6.08 6.14 6.26 6.27 6.15 6.18 5.97 5.95 5.86 6.08 6.15 5.91 6.16 5.99 6.07 6.12 6.05 5.89 5.9 6.08 6.33 6.35 5.67 6.25 5.86 6.25
GOBP_MEMBRANE_LIPID_METABOLIC_PROCESS 7.12 7.14 7.32 7.18 7.19 7.43 7.39 7.31 7.27 7.31 7 7.14 7.29 7.16 7.18 7.17 7.08 6.9 7.16 7.45 6.97 7.11 7.19 7.29 7.28 7.28
GOBP_PHOSPHOLIPID_METABOLIC_PROCESS 6.88 6.91 7.25 7.07 7.06 7.17 7.17 7.1 7.13 7.05 6.93 7.08 7.27 7.3 7.17 7.09 7.08 6.9 7.02 7.24 6.95 7.1 7.13 7.28 7.23 7.17
GOBP_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS 6.99 7.1 8.09 7.67 7.19 7.45 7.59 7.69 7.54 7.2 7.66 7.19 7.79 7.73 7.68 7.34 6.89 7.13 7.19 7.5 7.59 7.35 7.39 7.6 7.96 7.57
GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS 6.98 7.05 7.35 7.16 7.17 7.26 7.23 7.18 7.21 7.14 7.01 7.15 7.33 7.32 7.24 7.15 7.15 7 7.06 7.27 6.99 7.2 7.2 7.31 7.27 7.29
GOBP_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS 7.19 7.34 7.8 7.83 7.56 7.82 7.5 7.71 7.6 7.64 7.4 7.37 7.82 7.82 7.42 7.54 7.71 7.38 7.43 7.81 7.45 7.69 7.32 7.64 7.94 7.68
GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS 6.21 6.12 6.3 6.21 6.44 6.41 6.55 6.47 6.45 6.12 6.13 6.15 6.36 6.43 5.99 6.11 6.24 5.97 6.15 6.29 6.1 6.02 6 6.25 6.23 6.03
GOBP_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS 7.33 7.55 7.56 7.56 7.55 7.92 7.74 7.45 7.6 7.86 7.36 7.65 7.78 7.9 7.58 7.53 7.38 7.38 7.64 7.68 7.36 7.55 7.85 7.87 7.73 7.58
GOBP_GLYCEROL_ETHER_METABOLIC_PROCESS 7.14 6.99 6.94 6.98 7.15 7.58 7.27 7.12 7.43 7.79 6.69 7.36 7.53 7.42 7.03 6.92 6.84 6.66 7.01 7.29 6.61 6.93 7.2 7.44 7.28 7.44
GOBP_SPHINGOLIPID_METABOLIC_PROCESS 7.17 7.32 7.56 7.6 7.52 7.67 7.8 7.73 7.59 7.41 7.33 7.42 7.67 7.58 7.55 7.54 7.11 7.13 7.42 7.71 7.14 7.39 7.66 7.71 7.6 7.47
GOBP_CERAMIDE_METABOLIC_PROCESS 6.98 7.13 7.7 7.13 7.49 7.63 7.6 7.53 7.59 7.31 7.21 7.23 7.33 7.34 7.56 7.46 7.12 6.93 7.39 7.73 7.14 7.3 7.41 7.63 7.61 7.33
GOBP_GLYCOSYLCERAMIDE_METABOLIC_PROCESS 7.75 7.66 7.98 7.45 7.89 8.05 8.19 7.75 8.14 7.38 7.52 7.59 7.93 8.03 7.8 7.9 7.38 7.11 7.92 8.15 7.15 7.59 7.91 7.91 7.63 7.36
GOBP_SPHINGOMYELIN_METABOLIC_PROCESS 7.27 7.35 7.72 6.74 7.83 7.89 8.07 8.2 7.88 7.77 7.36 7.94 8.06 8 7.51 7.63 7.82 7.39 7.29 8.15 7.56 7.8 7.91 7.87 7.83 8.05
GOBP_GLYCOSPHINGOLIPID_METABOLIC_PROCESS 7.35 7.35 7.81 7.7 7.7 7.89 8.03 7.75 7.79 7.71 7.4 7.59 7.79 7.75 7.9 7.78 7.38 7.39 7.58 8 7.4 7.6 7.74 7.88 7.7 7.61
GOBP_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS 7.19 7.32 7.98 7.7 7.7 7.99 7.99 7.75 8.02 7.38 7.29 7.44 7.79 7.75 7.8 7.9 7.24 6.89 7.67 8.1 7.15 7.59 7.66 7.88 7.61 7.36
GOBP_ICOSANOID_METABOLIC_PROCESS 5.96 5.97 5.71 5.85 5.28 5.19 5.6 5.44 5.6 5.24 5.67 5.71 5.5 5.37 5.58 5.47 5.56 5.82 5.46 5.33 5.94 5.71 5.51 5.2 5.59 5.65
GOBP_LEUKOTRIENE_METABOLIC_PROCESS 5.96 5.94 5.59 5.83 5.18 5.23 5.6 5.4 5.69 5.24 5.72 5.35 5.09 5.34 5.64 5.47 5.71 5.65 5.36 5.33 5.98 5.47 5.42 5.11 5.59 5.67
GOBP_PROSTANOID_METABOLIC_PROCESS 6.19 6.19 6.59 6.3 6.03 5.67 5.8 6.23 5.93 5.62 6.28 6.08 6.12 5.79 5.66 6.02 5.93 5.95 5.75 5.73 6.19 6.31 6.22 5.96 6.45 6.5
GOBP_STEROID_BIOSYNTHETIC_PROCESS 6.44 6.32 6.61 6.67 6.4 6.4 6.36 6.4 6.52 6.63 6.47 6.45 6.48 6.27 6.41 6.5 6.5 6.18 6.26 6.38 6.34 6.44 6.61 6.43 6.56 6.45
GOBP_BILE_ACID_BIOSYNTHETIC_PROCESS 6.13 5.98 5.77 5.85 6.14 6.4 6.36 5.49 5.78 5.92 5.89 5.94 5.95 5.81 6.01 5.73 5.48 5.68 6.01 6.02 5.79 5.37 5.88 5.46 5.63 5.89
GOBP_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS 5.64 5.63 5.78 5.76 5.75 5.32 5.76 5.72 5.82 5.72 5.93 5.37 5.6 5.68 5.7 5.7 5.75 5.7 5.66 5.46 5.62 5.85 5.55 5.54 5.78 5.69
GOBP_ANDROGEN_BIOSYNTHETIC_PROCESS 7.1 6.38 6.45 6.6 6.83 6.75 6.29 6.19 6.63 6.41 6.78 6.08 6.43 6.65 6.63 6.07 6.51 6.23 6.31 6.69 5.92 5.7 6.55 6.26 6.1 6.11
GOBP_ESTROGEN_BIOSYNTHETIC_PROCESS 5.36 5.16 5.43 5.4 4.57 4.64 5.45 4.8 5.22 4.94 5.12 4.79 4.96 4.8 5.09 4.83 4.79 5.22 5.01 4.95 5.46 5.05 5.06 5.05 4.96 4.71
GOBP_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS 5.17 4.94 5.1 5.02 4.7 4.77 4.89 4.67 4.72 4.32 4.8 4.49 4.62 4.61 4.56 4.35 4.84 5.09 4.67 4.68 5 4.81 4.52 4.54 4.97 5.16
GOBP_STEROID_CATABOLIC_PROCESS 5.65 5.83 5.24 6.69 5.64 5.05 5.56 5.35 5.22 5.36 5.52 5.06 5.43 5.17 5.36 5.43 5.48 5.59 5.58 5.69 5.71 5.39 5.35 4.86 5.84 5.48
GOBP_CHOLESTEROL_CATABOLIC_PROCESS 5.71 5.74 5.34 6.16 6.05 5.08 5.65 5.76 5.55 5.22 5.65 5.39 5.17 5.16 5.39 5.51 5.41 5.67 5.8 6.13 5.96 5.62 5.77 4.9 6 5.49
GOBP_ISOPRENOID_METABOLIC_PROCESS 5.76 5.67 5.74 5.95 5.38 5.29 5.56 5.6 5.62 5.64 5.78 5.44 5.61 5.48 5.55 5.61 5.59 5.63 5.51 5.37 5.72 5.56 5.66 5.35 5.62 5.65
GOBP_TERPENOID_METABOLIC_PROCESS 5.55 5.5 5.53 5.57 5.11 4.97 5.35 5.29 5.41 5.25 5.45 5.3 5.34 5.12 5.47 5.31 5.45 5.5 5.13 5.03 5.52 5.31 5.37 4.9 5.42 5.22
GOBP_ONE_CARBON_METABOLIC_PROCESS 6.17 6.24 6.37 7.36 6.09 6.24 6.24 6.29 6.47 6.37 6.34 6.31 6.42 6.49 6.2 6.18 6.24 6.3 6.07 6.35 6.28 6.18 6.3 6.29 6.45 6.62
GOBP_NADH_METABOLIC_PROCESS 7.18 7.2 7.63 7.62 7.23 7.65 7.33 6.96 7.87 7.59 7.93 7.42 7.41 7.59 7.06 7.49 6.95 6.49 6.95 7.15 6.45 6.94 7.89 7.5 6.84 7.04
GOBP_NADP_METABOLIC_PROCESS 6.81 6.46 7.19 7 7.48 7.53 7.04 6.76 7.46 7.54 6.89 7 7.17 7 6.63 6.76 6.71 6.41 6.88 6.77 6.24 6.46 7.27 7.31 6.86 6.81
GOBP_NADPH_REGENERATION 6.82 6.44 7.13 6.97 7.51 7.66 6.99 6.66 7.3 7.49 6.76 6.75 7.11 6.88 6.39 6.7 6.59 6.61 6.88 6.97 6.37 6.47 6.97 7.22 7.07 7.14
GOBP_UBIQUINONE_METABOLIC_PROCESS 6.18 6.8 7.1 7.27 5.97 6.39 6.3 6.89 6.61 6.65 6.83 6.43 6.79 6.48 6.71 7.3 6.73 6.4 6.16 6.15 6.76 6.93 6.66 6.62 6.95 6.68
GOBP_GLUTATHIONE_METABOLIC_PROCESS 6.68 6.48 7.44 7.34 6.47 6.48 6.94 6.89 6.6 6.66 6.87 6.83 6.54 6.62 7.01 6.95 6.94 6.87 6.61 6.71 7.03 6.67 6.81 7 7.07 7.1
GOBP_ATP_BIOSYNTHETIC_PROCESS 6.96 7.29 7.24 7.08 6.85 6.87 6.87 6.67 6.98 7 7.4 7.26 6.83 7.4 6.65 7.24 6.89 6.71 7.57 6.86 6.62 6.77 7.07 7.37 6.57 6.63
GOBP_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.28 6.28 6.97 6.85 5.96 6.11 6.28 6.29 6.3 6.37 6.53 6.47 6.38 6.41 6.27 6.29 6.22 6.48 6.1 6.23 6.34 6.39 6.32 6.3 6.46 6.56
GOBP_VITAMIN_METABOLIC_PROCESS 6.15 6.23 6.38 6.63 5.9 5.99 6.06 6.22 6.15 6 6.27 6.16 6.31 6.24 5.99 6.13 6.22 6.07 6.03 6.06 6.14 6.16 6.15 6.11 6.25 6.34
GOBP_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS 6.28 6.38 7.08 7.04 6.46 6.49 6.55 6.81 6.55 6.42 6.62 6.51 6.65 6.57 6.36 6.56 6.67 6.49 6.36 6.49 6.35 6.55 6.48 6.76 6.68 6.62
GOBP_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS 5.44 5.27 5.36 5.32 4.96 4.94 5.07 4.92 5.25 4.99 4.99 4.9 5.04 5.19 5.3 5.16 5.3 5.35 5.06 4.93 5.34 5.21 4.84 4.85 5.12 4.98
GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.4 6.69 7.1 6.98 6.94 6.51 6.81 6.86 6.76 6.78 6.7 6.41 6.95 6.72 6.6 6.79 6.7 6.59 6.67 6.84 6.52 6.58 6.8 7.07 7.42 6.97
GOBP_SULFUR_COMPOUND_METABOLIC_PROCESS 6.79 6.69 7.21 7.01 6.96 7.04 7.05 7.01 6.95 7.09 7.01 6.91 7 7.07 6.96 6.97 7.06 6.86 6.84 7.07 6.95 6.93 7.07 7.05 7.19 7.03
GOBP_SUPEROXIDE_METABOLIC_PROCESS 5.75 5.52 5.5 5.78 5.1 5.28 5.42 5.28 5.42 5.23 5.45 5.19 5.43 5.34 5.43 5.39 5.4 5.68 5.25 5.46 5.41 5.58 5.35 5.26 5.71 5.65
GOBP_CATION_TRANSPORT 6.43 6.41 6.56 6.58 6.43 6.49 6.57 6.65 6.58 6.53 6.44 6.4 6.55 6.47 6.52 6.47 6.53 6.45 6.44 6.58 6.51 6.62 6.59 6.66 6.55 6.53
GOBP_POTASSIUM_ION_TRANSPORT 6.63 6.61 6.61 6.53 6.65 6.69 6.68 6.84 6.6 6.67 6.48 6.55 6.71 6.81 6.71 6.71 6.51 6.81 6.54 6.75 6.5 6.73 6.75 6.74 6.62 6.56
GOBP_SODIUM_ION_TRANSPORT 6.74 6.78 6.64 6.58 6.57 6.77 7.07 6.96 6.81 6.84 6.51 6.66 7.01 6.95 6.87 6.58 6.78 6.82 6.68 7.02 6.9 6.77 6.75 6.84 6.95 6.83
GOBP_CALCIUM_ION_TRANSPORT 6.29 6.21 6.32 6.49 6.07 6.13 6.29 6.4 6.3 6.27 6.22 6.19 6.27 6.29 6.39 6.26 6.3 6.25 6.12 6.26 6.42 6.48 6.29 6.39 6.38 6.33
GOBP_PHOSPHATE_ION_TRANSPORT 6.29 6.12 6.58 6.09 5.84 6.08 6.57 6.76 6.45 6.39 6.36 6.55 6.2 6.25 7.22 6.74 6.28 6.22 6.41 6.49 6.37 6.27 6.66 7.02 6.79 6.18
GOBP_CHLORIDE_TRANSPORT 6.1 5.99 5.94 5.94 5.73 5.86 5.78 5.89 5.73 6.06 5.96 5.63 5.67 5.83 5.7 5.9 5.9 5.85 6.11 5.78 6.01 5.48 5.65 5.57 5.82 6.21
GOBP_COPPER_ION_TRANSPORT 5.95 6.62 6.86 6.9 6.7 6.71 6.51 6.79 6.18 6.52 6.68 6.5 6.39 7.03 6.45 6.99 7.11 6.27 6.83 6.32 6.28 7.06 6.98 7.19 7.34 7.84
GOBP_IRON_ION_TRANSPORT 7.29 7.46 7.54 7.45 7.65 7.6 7.11 7.13 7.39 7.62 7.02 7.3 7.09 7.18 7.23 7.61 7.4 7.35 7.55 7.33 7.09 7.41 6.94 7.45 7.67 7.76
GOBP_MANGANESE_ION_TRANSPORT 6.18 6.19 5.63 6.1 6.41 6.48 6.25 5.99 6.06 6.42 6.2 6.07 6.71 6.79 5.68 5.85 6.7 6.3 6.4 6.49 6.34 6.26 6 6.18 6.44 6.58
GOBP_ZINC_ION_TRANSPORT 6.86 6.79 6.82 7.03 7.12 7.24 6.94 7 7.12 6.98 6.87 6.99 7.23 7.31 6.79 6.63 7.04 6.93 7.21 7.11 7.01 6.94 7 7.33 7.11 7.09
GOBP_WATER_TRANSPORT 5.49 5.23 5.03 5.64 4.78 4.69 4.97 4.85 5.09 5.02 5.18 4.9 5.01 4.98 4.82 4.94 5.01 5.32 4.9 5.04 5.1 5.21 5.01 4.67 4.89 4.9
GOBP_DICARBOXYLIC_ACID_TRANSPORT 7.01 7.11 7.43 7.13 7.14 7.5 7 7.23 7.08 7.37 7.15 7.24 7.15 7.28 7.21 7.13 6.84 6.87 7.15 7.09 6.98 6.7 6.95 7.19 7.06 7.03
GOBP_NEUROTRANSMITTER_TRANSPORT 7.48 7.53 7.8 7.48 7.86 7.96 8 7.99 7.72 7.98 7.68 7.99 7.87 7.96 8.02 7.82 7.53 7.78 7.77 7.95 7.7 7.82 7.77 7.97 7.77 7.61
GOBP_SEROTONIN_TRANSPORT 5.28 5.55 5.09 5.38 4.84 4.8 5.16 5.12 4.96 4.84 5.16 4.92 4.92 4.85 5.27 5.06 5.05 5.31 5.1 4.93 5.2 4.88 5 4.79 5.1 4.96
GOBP_MITOCHONDRIAL_TRANSPORT 7.01 7.19 7.97 7.84 7.44 7.51 7.53 7.6 7.48 7.4 7.62 7.44 7.52 7.63 7.63 7.72 7.35 7.25 7.53 7.59 7.43 7.59 7.45 7.73 7.55 7.53
GOBP_MITOCHONDRIAL_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT 7.37 7.6 7.47 7.5 7.02 7.03 7.19 7.14 7.5 7.45 7.17 7.53 7.12 7.05 7.47 7.68 7.02 7.69 7.79 7.36 7.53 6.99 7.43 7.59 7.49 7.39
GOBP_CARNITINE_SHUTTLE 7.22 7.28 7.02 6.44 7.6 7.72 7.3 7.42 7.27 7.47 7.13 7.92 7.7 7.75 7.51 7.22 7.48 7.26 7.23 7.31 7.24 7.6 7.61 7.78 7.64 7.44
GOBP_DRUG_TRANSMEMBRANE_TRANSPORT 4.95 4.74 4.59 4.79 4.33 4.25 4.58 4.64 4.56 4.38 4.5 4.41 4.49 4.36 4.66 4.43 4.73 4.89 4.43 4.28 4.79 4.4 4.6 4.21 4.35 4.52
GOBP_OLIGOPEPTIDE_TRANSPORT 7.85 7.77 7.61 7.38 8.13 8.38 7.84 7.95 7.66 7.93 7.83 7.95 7.97 8 7.99 8.01 7.66 7.19 8.21 7.97 7.42 8.04 7.68 8.09 8.27 7.77
GOBP_EXTRACELLULAR_TRANSPORT 6.52 6.22 6.64 6.49 6.36 6.53 6.24 6.25 6.08 6.65 6.34 6.33 6.25 6.15 6.7 6.68 6.45 6.48 6.53 6.46 6.62 6.32 6.13 6.19 6.21 6.26
GOBP_NUCLEOTIDE_TRANSPORT 5.79 6.27 6.4 6.15 6.31 6.08 6.09 6.32 6.75 6.33 6.25 6.74 6.7 6.24 6.48 6.64 5.84 6 6.48 6.57 6.19 6.36 6.03 6.94 6 5.94
GOBP_AMINO_ACID_TRANSPORT 7.21 7.19 7.53 7.19 7.2 7.45 7.44 7.52 7.29 7.37 7.09 7.19 7.21 7.48 7.57 7.34 6.95 7.11 7.38 7.39 7.18 7.31 7.33 7.51 7.31 7.21
GOBP_CELLULAR_ION_HOMEOSTASIS 6.14 6.16 6.19 6.31 5.93 5.91 6.16 6.2 6.15 6.07 6.15 6.07 6.09 6.12 6.25 6.04 6.23 6.16 5.97 6.12 6.26 6.28 6.12 6.09 6.21 6.29
GOBP_CELLULAR_COPPER_ION_HOMEOSTASIS 6.26 6.58 7.03 7 6.73 6.79 6.4 7.46 6.46 6.23 6.87 6.86 6.51 7.08 6.71 6.74 6.99 6.14 6.82 6.47 6.4 7.66 6.68 7.66 7.31 6.89
GOBP_CELLULAR_IRON_ION_HOMEOSTASIS 7.13 6.82 7.26 7.29 7.23 7.08 6.93 6.91 7.11 6.9 6.8 6.99 7.03 7.03 6.78 6.92 7.26 6.83 7.16 7.06 7 7.16 6.82 7.2 7.13 7.2
GOBP_CELLULAR_SODIUM_ION_HOMEOSTASIS 5.98 6.41 7.42 5.45 5 5.49 6.4 6.55 6.14 5.8 5.82 5.38 5.9 5.73 5.88 6.53 6.63 7.19 6.39 6.9 6.12 5.44 5.16 5.79 7.21 5.86
GOBP_CELL_VOLUME_HOMEOSTASIS 6.99 6.88 6.62 6.82 6.9 6.75 6.77 6.8 6.72 6.97 6.52 6.6 6.92 7.03 6.81 7.01 7.12 7.12 6.82 6.98 7.23 7.02 7.02 7.05 6.81 6.86
GOBP_REGULATION_OF_PH 7.15 6.98 7.7 7.45 7.33 7.19 7.32 7.25 7.42 7.35 7.37 7.23 7.57 7.65 7.2 6.98 7.14 7.29 7.25 7.54 7.03 7.48 7.32 7.48 7.6 7.27
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT 7.35 7.43 7.89 7.71 7.68 7.76 7.66 7.74 7.67 7.77 7.66 7.69 7.77 7.73 7.77 7.76 7.46 7.42 7.57 7.74 7.51 7.7 7.81 7.99 7.74 7.66
GOBP_EXOCYTOSIS 6.82 6.85 7.26 6.98 7.06 7.12 7.11 7.19 7.1 7.11 7.01 6.97 7.06 7.04 7.22 7.23 7 6.95 6.89 7.15 6.99 7.2 7.16 7.26 7.22 7.26
GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT 7.81 7.77 8.62 8.38 8.27 8.25 8.31 8.16 8.37 8.46 8.3 8.06 8.22 8.33 8.38 8.22 7.83 7.7 8.12 8.33 7.87 8.21 8.46 8.53 8.23 8.2
GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM 7.52 7.74 8.28 8.17 8.06 8.21 8.29 8.19 8.07 8.19 8.22 8.1 8.18 8.26 8.24 8.09 7.78 7.59 7.66 8.22 7.91 8.21 8.24 8.54 8.22 7.75
GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT 7.65 7.74 8.69 8.51 8.22 8.35 8.36 8.08 8.74 8.46 8.12 8.21 8.29 8.36 8.1 8.06 7.77 7.58 8.34 8.34 7.9 8.18 8.65 8.82 8.28 7.92
GOBP_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT 7.64 7.77 8 7.86 8.22 8.24 7.94 7.94 7.98 7.96 7.88 7.99 8.06 8.03 7.91 7.87 7.71 7.64 7.87 8.1 7.73 7.96 8 8.24 8.11 7.73
GOBP_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT 7.5 7.56 7.94 7.83 8.26 8.2 7.86 7.98 7.94 8.04 7.88 7.9 7.96 7.94 7.95 7.87 7.63 7.6 7.82 7.95 7.64 7.86 7.91 8.17 7.87 7.67
GOBP_GOLGI_TO_ENDOSOME_TRANSPORT 7.43 7.71 7.87 8.06 8.16 8.17 7.96 8.21 7.99 7.97 8.06 8.02 8.26 8.41 7.83 8.02 7.59 7.61 8.01 8.1 7.82 8.46 8.08 8.08 7.94 7.87
GOBP_GOLGI_TO_VACUOLE_TRANSPORT 8.32 8.05 7.99 8.1 8.46 8.66 7.9 7.86 8.3 8.14 7.87 8.15 8.25 8.25 7.77 7.87 7.92 7.85 7.98 8.28 7.85 8.09 7.95 8.29 8.32 8.38
GOBP_ENDOCYTOSIS 6.98 7.08 7.34 7.08 7.34 7.43 7.38 7.38 7.34 7.4 7.12 7.38 7.37 7.36 7.27 7.39 7.26 7.1 7.2 7.41 7.03 7.26 7.44 7.54 7.32 7.3
GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS 7.22 7.25 7.42 7.18 7.65 7.67 7.58 7.5 7.43 7.6 7.25 7.56 7.46 7.65 7.36 7.56 7.32 7.36 7.58 7.83 7.26 7.25 7.54 7.68 7.45 7.36
GOBP_VESICLE_BUDDING_FROM_MEMBRANE 7.87 7.77 8.48 8.33 8.2 8.22 8.27 8.16 8.33 8.5 8.18 8.06 8.19 8.18 8.45 8.21 7.8 7.57 7.88 8.2 7.87 8.21 8.51 8.52 8.34 8.21
GOBP_VESICLE_TARGETING 7.87 7.74 8.35 8.3 8.05 8.09 8.22 8.07 8.12 8.33 8 7.99 8.12 8.09 8.11 8.07 7.79 7.58 7.86 8.13 7.87 8.21 8.33 8.48 8.23 8.12
GOBP_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS 7.4 7.2 7.66 7.44 7.97 8.02 8.09 8.17 7.77 7.84 7.36 7.7 7.95 7.71 7.67 7.56 7.35 7.41 7.56 8.15 7.75 7.91 7.38 7.96 7.61 7.71
GOBP_PINOCYTOSIS 6.61 6.39 6.88 6.58 7.07 6.76 7.09 7.05 6.79 6.69 6.72 6.76 6.84 7.03 6.65 6.81 6.81 6.81 6.84 6.97 6.9 7.18 6.93 7.15 7.26 7.3
GOBP_PHAGOCYTOSIS 6.43 6.48 6.84 6.58 6.57 6.51 6.32 6.44 6.5 6.35 6.33 6.41 6.47 6.54 6.3 6.35 6.5 6.42 6.27 6.24 6.75 6.67 6.64 6.39 6.68 6.63
GOBP_PHAGOCYTOSIS_RECOGNITION 5.35 5.09 5.08 5.29 4.74 4.63 4.91 4.8 4.82 4.99 5.4 4.87 5.01 4.87 5.03 5.4 5.22 5.05 5.02 4.78 5.23 4.79 4.78 4.38 4.89 4.98
GOBP_APOPTOTIC_PROCESS 6.54 6.56 6.85 6.71 6.69 6.73 6.74 6.77 6.74 6.77 6.7 6.74 6.79 6.77 6.77 6.79 6.75 6.65 6.59 6.81 6.82 6.93 6.88 6.89 6.85 6.84
GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS 5.89 6 6.16 6.32 5.6 5.74 5.87 5.89 5.98 5.86 5.95 5.82 5.85 5.9 6.12 6.23 5.97 5.88 5.87 5.73 6.1 6.13 5.89 5.8 6.13 6.33
GOBP_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS 6.01 6.07 6.39 6.35 6.02 5.9 6.07 6.23 5.71 5.85 6.41 6.08 5.8 5.76 5.97 6.19 6.24 5.88 6.25 6.26 6.03 6.29 5.77 5.62 5.95 6.08
GOBP_INFLAMMATORY_CELL_APOPTOTIC_PROCESS 6.31 6.55 6.57 6.77 6.6 6.6 6.92 6.97 6.77 6.55 6.76 6.68 6.96 6.66 6.91 6.57 6.5 6.72 6.25 6.81 6.91 7.15 6.77 7.03 6.77 6.71
GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION 6.97 6.53 6.74 6.81 7.65 7.64 6.76 6.99 7.46 7.53 7.33 7.48 7.03 7.31 7.06 7.18 6.73 7.14 7.36 6.98 6.96 7.01 7.15 7.06 7.06 6.69
GOBP_MUSCLE_CONTRACTION 6.11 6.01 5.88 6.04 5.75 5.82 6.01 6.11 5.98 6.04 6.04 6.01 5.95 5.9 6.03 5.94 6.26 6.1 5.97 6 6.13 5.98 6.21 5.82 5.94 6.12
GOBP_REGULATION_OF_MUSCLE_CONTRACTION 6.07 6.05 5.81 6.03 5.62 5.64 5.94 6.01 5.88 5.89 6.1 5.87 5.77 5.7 5.96 5.84 5.99 5.99 5.96 5.83 5.96 5.8 5.93 5.72 5.8 6.15
GOBP_SMOOTH_MUSCLE_CONTRACTION 6.18 6.15 5.8 5.87 5.78 5.89 6.16 6.1 6.08 6.14 6.18 5.78 6.02 5.91 5.96 5.89 6.29 6.21 6.07 6.05 6.17 5.91 6.34 5.98 5.9 5.87
GOBP_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION 6.17 6.13 5.73 5.86 5.68 5.64 5.91 5.8 5.99 5.85 5.96 5.59 5.66 5.55 5.71 5.69 6.06 6.04 5.89 5.91 6.03 5.76 5.88 5.69 5.75 5.68
GOBP_STRIATED_MUSCLE_CONTRACTION 6.07 6.04 6.18 6.25 5.8 5.8 6.09 6.23 5.96 6.2 6.1 6.11 5.97 6 6.32 6.2 6.25 6.1 6.04 6.02 6.11 6 6.18 5.85 5.93 6.29
GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION 6.05 5.85 6.07 6.2 5.61 5.69 6.07 6.21 5.83 6.15 6.3 6.11 5.93 5.97 6.51 6.29 5.95 5.99 5.96 5.98 5.98 5.8 6.48 6.08 5.87 6.33
GOBP_SYNCYTIUM_FORMATION 6.64 6.6 6.94 6.55 6.85 6.61 6.7 6.52 6.65 6.61 6.23 6.61 6.85 6.61 6.5 6.36 7.05 6.92 6.46 6.52 6.77 6.48 6.77 6.71 7.06 6.89
GOBP_DEFENSE_RESPONSE 5.76 5.66 5.65 5.74 5.41 5.36 5.5 5.51 5.55 5.37 5.63 5.39 5.49 5.44 5.52 5.47 5.7 5.64 5.43 5.42 5.74 5.62 5.42 5.29 5.6 5.65
GOBP_ACUTE_PHASE_RESPONSE 4.96 4.72 4.75 4.86 4.18 4.17 4.45 4.29 4.5 4.41 4.62 4.37 4.42 4.46 4.36 4.42 4.49 4.67 4.69 4.36 4.63 4.32 4.47 4.04 4.43 4.45
GOBP_INFLAMMATORY_RESPONSE 5.6 5.49 5.44 5.58 5.22 5.06 5.31 5.3 5.35 5.16 5.42 5.16 5.31 5.23 5.33 5.31 5.48 5.5 5.26 5.19 5.56 5.42 5.23 5.04 5.42 5.43
GOBP_COMPLEMENT_ACTIVATION 5.29 4.99 4.86 5.06 4.61 4.56 4.76 4.7 4.81 4.68 5 4.77 4.67 4.66 4.66 4.64 4.86 5.09 4.85 4.68 5.09 4.87 4.64 4.31 4.9 4.79
GOBP_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY 5.23 4.83 4.83 4.98 4.63 4.59 5.03 4.59 4.86 4.69 5.03 4.77 4.7 4.72 4.65 4.68 4.77 5.13 4.48 4.49 4.85 4.62 4.45 4.59 4.97 4.79
GOBP_HUMORAL_IMMUNE_RESPONSE 5.09 4.93 4.82 4.95 4.38 4.25 4.62 4.57 4.58 4.37 4.8 4.5 4.42 4.39 4.48 4.5 4.84 4.98 4.56 4.5 4.9 4.65 4.38 4.16 4.55 4.57
GOBP_CELLULAR_DEFENSE_RESPONSE 5.31 5.04 5.22 5.15 4.62 4.61 4.92 4.8 4.97 4.67 5 4.83 4.81 4.68 4.9 4.63 4.86 5.13 4.82 4.6 5.21 5.21 4.72 4.48 5.1 4.95
GOBP_RESPONSE_TO_OSMOTIC_STRESS 7.01 6.73 6.99 6.82 7.04 6.94 6.86 6.98 6.98 6.86 6.76 7.03 6.71 6.71 6.83 6.81 7.11 6.68 6.59 6.88 7.02 6.99 6.9 6.75 6.93 7.04
GOBP_HYPOTONIC_RESPONSE 7.32 6.48 7.29 6.86 7.32 7.35 6.34 6.55 7.03 7.17 6.75 7.27 6.74 6.82 6.67 6.92 7.36 6.61 6.21 6.56 6.94 6.87 6.92 6.92 6.33 6.68
GOBP_HYPEROSMOTIC_RESPONSE 7.01 6.89 7.46 7.51 7.04 7.08 7.06 7.18 7.16 7.29 7.01 7.2 7.32 7.12 7.3 7.6 6.71 7.22 6.85 7.17 7.21 7.01 7.08 6.61 7.44 7.53
GOBP_CELLULAR_RESPONSE_TO_DNA_DAMAGE_STIMULUS 6.56 6.57 6.88 6.9 6.68 6.78 6.71 6.81 6.62 6.77 6.72 6.74 6.75 6.71 6.73 6.79 6.55 6.56 6.64 6.83 6.65 6.84 6.8 6.84 6.77 6.82
GOBP_RESPONSE_TO_OXIDATIVE_STRESS 6.67 6.71 7.12 6.97 6.97 6.94 6.89 6.99 6.95 7.02 6.87 6.94 7.05 7.05 6.99 7.01 6.9 6.81 6.74 7.01 6.93 7.08 7.05 7.09 7.07 6.98
GOBP_ER_OVERLOAD_RESPONSE 7.17 7.17 8.18 7.68 6.69 7.01 7.71 7.75 7.6 7.72 7.89 7.16 7.71 7.73 6.8 7.23 7.12 7.54 7.21 7.69 7.56 7.63 6.81 7.97 7.48 7.58
GOBP_ER_NUCLEUS_SIGNALING_PATHWAY 7.61 7.76 7.83 8.08 7.9 7.91 7.9 7.83 7.91 7.85 7.52 7.37 8.03 7.84 7.97 7.72 7.39 7.5 7.54 7.88 7.69 7.92 7.89 8.41 7.83 7.91
GOBP_RESPONSE_TO_STEROL_DEPLETION 7.38 7.4 7.56 7.44 7.83 7.95 7.86 7.85 7.8 7.94 6.93 7.32 7.96 7.78 7.7 7.33 7.13 7.09 7.49 7.98 7.71 7.32 7.48 7.85 7.67 7.94
GOBP_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION 7.18 7.11 8.6 8.71 7.36 7.17 7.27 8.09 7.36 7.28 8.13 7.08 7.5 7.57 8.04 8.02 7.8 7.5 7.28 7.94 7.98 7.95 7.44 7.37 7.46 7.71
GOBP_NUCLEUS_ORGANIZATION 7.08 7.17 7.58 7.66 7.56 7.5 7.52 7.36 7.49 7.58 7.55 7.32 7.4 7.51 7.54 7.48 7.25 7.2 7.34 7.38 7.31 7.66 7.64 7.68 7.57 7.48
GOBP_NUCLEAR_ENVELOPE_ORGANIZATION 7.85 7.77 8.31 8.48 8.01 8.16 8.26 8.04 8.25 8.38 8.01 8.14 8.35 8.33 8.24 8.16 8.29 7.85 7.93 8.31 8.04 8.12 8.36 8.54 8.31 8
GOBP_NUCLEAR_PORE_ORGANIZATION 7.42 7.63 8.25 8.61 8.18 8.14 8.09 7.87 7.99 7.98 7.83 7.88 8.07 8.13 7.8 7.83 7.55 7.37 8.12 7.76 7.41 8.12 8.08 8.2 7.94 7.86
GOBP_MITOCHONDRION_ORGANIZATION 7.23 7.27 8.03 7.79 7.5 7.64 7.72 7.77 7.75 7.67 7.72 7.7 7.71 7.71 7.8 7.82 7.47 7.37 7.56 7.8 7.5 7.79 7.78 7.92 7.84 7.68
GOBP_MITOCHONDRIAL_MEMBRANE_ORGANIZATION 7.13 7.14 7.97 7.9 7.51 7.74 7.75 7.63 7.77 7.61 7.72 7.72 7.88 7.73 7.93 7.92 7.44 7.52 7.72 7.92 7.45 7.63 7.95 8 8.03 7.71
GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION 7.09 7 8 7.92 7.51 7.74 7.75 7.63 7.58 7.6 7.72 7.65 7.83 7.73 7.99 8.19 7.48 7.62 7.72 7.93 7.14 7.63 7.83 8 7.55 7.66
GOBP_PLASMA_MEMBRANE_ORGANIZATION 7.08 7.02 7.03 6.94 7.44 7.54 7.31 7.5 7.5 7.34 7.23 7.65 7.36 7.26 7.19 7.26 7.41 6.91 7.28 7.54 6.99 7.26 7.58 7.58 7.46 7.42
GOBP_CYTOSKELETON_ORGANIZATION 6.73 6.77 6.86 6.7 6.92 6.94 6.86 6.93 6.84 6.97 6.79 6.98 6.93 6.88 6.99 6.96 6.82 6.86 6.8 6.87 6.87 6.95 6.97 7.05 6.98 6.93
GOBP_ACTIN_FILAMENT_ORGANIZATION 6.73 6.84 6.99 6.75 7.04 7.05 6.97 7.15 6.92 7.1 6.86 7.1 7.03 7 7.06 7.03 7 6.9 6.93 7.06 7.03 7.01 7.1 7.15 7.18 7.15
GOBP_MICROTUBULE_BASED_PROCESS 6.72 6.79 6.97 6.8 6.89 6.9 6.83 6.86 6.73 7.03 6.91 6.99 6.93 6.9 6.98 7.05 6.71 6.81 6.8 6.86 6.81 6.95 6.89 7.06 6.95 6.9
GOBP_MICROTUBULE_BASED_MOVEMENT 6.43 6.52 6.65 6.56 6.51 6.72 6.53 6.56 6.36 6.79 6.75 6.7 6.5 6.5 6.66 6.81 6.45 6.61 6.62 6.57 6.55 6.61 6.6 6.56 6.63 6.7
GOBP_MICROTUBULE_DEPOLYMERIZATION 7.54 7.43 7.97 7.49 7.78 8.12 7.78 8.08 7.82 7.91 7.68 7.93 7.96 8.04 8.3 8.09 7.5 7.56 7.58 8.1 7.98 8.18 7.83 7.98 7.78 7.95
GOBP_MICROTUBULE_NUCLEATION 7.74 7.61 7.77 8.14 8.86 8.46 7.77 7.76 8.04 8.34 8.08 8.22 8.23 8.32 8.2 8.25 8.3 8.4 8.41 8.62 8.28 8.55 8.52 8.66 8.19 7.98
GOBP_CYTOPLASM_ORGANIZATION 5.85 5.86 6.04 5.48 5.38 5.47 6.03 5.68 5.88 5.56 5.81 5.32 5.72 5.64 5.61 5.35 6.14 6.16 5.65 5.45 6.32 6.25 5.43 6.38 6.28 6.11
GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION 7.79 7.69 8.06 7.9 7.9 7.72 7.54 7.64 7.92 7.89 7.81 7.69 8.11 7.82 7.67 7.76 7.87 7.81 7.43 8.01 7.79 8.04 8.04 7.93 8.07 8.24
GOBP_GOLGI_ORGANIZATION 7.54 7.56 7.86 7.88 8.12 8.03 7.75 7.63 7.8 8.13 7.83 7.87 8.12 8.1 7.86 7.84 7.7 7.48 7.76 7.9 7.54 7.92 8.1 8.17 8 7.59
GOBP_PEROXISOME_ORGANIZATION 6.85 6.58 7.09 7.09 7.02 7.14 6.96 6.72 6.99 7.1 6.92 7.06 7.15 7.27 6.79 6.99 6.89 6.8 7.02 7.1 6.78 6.89 7.09 7.16 7.02 6.95
GOBP_ENDOSOME_ORGANIZATION 7.5 7.38 8.27 8.11 7.63 7.99 8.01 7.92 8.03 7.84 7.72 7.74 7.98 7.95 7.99 7.67 7.23 7.57 7.75 8.03 7.49 7.76 8 8.08 7.79 7.61
GOBP_VACUOLE_ORGANIZATION 7.63 7.68 8.19 8.09 7.78 8.05 7.88 7.88 7.77 7.84 7.76 7.72 7.93 8.01 7.77 7.82 7.72 7.53 7.69 7.96 7.67 7.84 7.92 8.01 7.94 7.81
GOBP_VACUOLAR_TRANSPORT 7.82 7.98 8.22 8.11 8.14 8.31 8.15 8.01 8.11 8.21 7.92 7.99 8.15 8.18 8.02 7.96 7.77 7.72 7.98 8.22 7.77 7.86 8.09 8.25 8.15 7.95
GOBP_VACUOLAR_ACIDIFICATION 8.1 8.2 8.87 8.45 8.02 8.17 8.16 8.13 8.46 8.27 8.22 8.32 8.02 8.22 8.08 8.19 7.98 7.92 7.89 8.34 7.81 7.92 8.18 8.51 8.11 8.01
GOBP_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE 8.22 8 7.98 8.27 8.13 8.19 7.85 7.91 7.67 8.11 7.7 8.21 7.92 7.84 7.9 7.8 7.63 7.58 8.47 7.71 7.65 7.94 7.94 7.98 8.14 7.81
GOBP_LYSOSOMAL_TRANSPORT 8.04 8.03 8.42 8.14 8.25 8.54 8.45 8.19 8.38 8.35 8.15 8.17 8.32 8.46 8.12 7.98 8.02 8 8.05 8.45 7.79 7.87 8.25 8.46 8.3 8.09
GOBP_CELL_CELL_JUNCTION_ASSEMBLY 6.6 6.49 6.83 6.4 6.45 6.58 6.8 6.53 6.62 6.54 6.42 6.37 6.38 6.47 6.5 6.53 6.58 6.41 6.33 6.63 6.5 6.66 6.79 6.8 6.8 6.74
GOBP_CELL_CYCLE 6.65 6.73 6.95 6.9 6.8 6.91 6.83 6.88 6.83 6.91 6.8 6.87 6.89 6.91 6.89 6.97 6.71 6.71 6.76 6.92 6.8 6.95 6.95 7.04 6.87 6.92
GOBP_CELL_CYCLE_ARREST 6.6 6.68 6.93 6.83 6.71 6.82 6.76 6.92 6.84 6.78 6.82 6.91 6.81 7.02 6.93 6.88 6.8 6.69 6.78 6.88 6.87 7.06 6.96 6.99 6.86 7.02
GOBP_SPINDLE_ORGANIZATION 6.95 6.88 7.01 6.79 7.11 7.07 7 6.96 6.91 7.08 6.89 7.22 7.07 7 7.14 6.98 6.85 6.86 6.98 6.97 6.84 7.07 6.94 7.21 7.11 6.97
GOBP_MITOTIC_SPINDLE_ORGANIZATION 7.07 6.99 7.25 6.77 7.18 7.19 7.06 7.16 6.98 7.19 7.26 7.37 7.16 7.14 7.26 7.24 7.07 7.01 7.1 7.06 7.19 7.23 7.11 7.42 7.32 7.12
GOBP_CHROMOSOME_SEGREGATION 6.05 6.07 6.34 6.39 6.05 6.17 6.19 6.15 5.95 6.26 6.15 6.25 6.11 6.11 6.07 6.13 6.14 5.96 5.96 6.16 6.03 6.13 6.22 6.3 6.2 6.15
GOBP_SISTER_CHROMATID_COHESION 6.95 6.87 6.92 7.13 7.1 7.27 7.09 6.98 7.19 7.41 6.87 7.53 7.17 6.96 7.14 7.17 7.03 6.78 6.9 7.29 6.99 7.06 7.08 7.48 6.87 6.9
GOBP_REGULATION_OF_SISTER_CHROMATID_COHESION 7.08 7.38 7.38 7.55 7.69 7.63 7.31 6.88 7.56 7.59 7.01 7.77 7.34 7.48 7.3 7.32 7.53 6.81 7.11 7.32 6.98 6.86 7.76 7.73 7.11 7.02
GOBP_MITOTIC_SISTER_CHROMATID_COHESION 7.45 7.54 7.61 7.73 7.43 7.64 7.58 7.63 7.44 7.68 7.5 7.79 7.31 7.5 7.89 7.54 7.62 7.54 7.11 7.74 7.49 7.85 7.6 7.67 7.69 7.58
GOBP_MITOTIC_CHROMOSOME_CONDENSATION 5.76 6.05 5.59 5.43 6.03 5.75 6.11 6 6.08 5.97 5.64 6.07 6.18 6.12 5.63 5.69 5.75 5.86 5.74 6 5.95 5.53 6.09 6.18 5.98 5.88
GOBP_MITOTIC_NUCLEAR_ENVELOPE_DISASSEMBLY 7.12 6.83 7.23 7.22 7.09 7.85 7.57 7.24 7.41 7.83 7.8 7.89 7.23 7.11 7.36 7.16 7.69 7.27 7.37 7.57 7.44 7.63 7.75 8.03 7.54 7.08
GOBP_MITOTIC_METAPHASE_PLATE_CONGRESSION 6.07 6.12 6.57 6.36 6.01 6.23 6.58 6.23 6.28 6.43 6.61 6.56 6.11 6.17 6.44 6.21 6.22 5.82 5.96 6.06 6.31 6.53 6.29 6.53 6.22 6.22
GOBP_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION 5.84 5.89 5.81 5.8 5.64 5.72 5.71 5.84 5.72 5.91 5.82 5.89 5.65 5.71 5.9 5.87 5.99 5.9 5.77 5.66 5.81 6.07 5.95 5.91 5.9 6.09
GOBP_MITOTIC_CELL_CYCLE_CHECKPOINT 6.18 6.29 6.34 6.35 6.26 6.26 6.19 6.39 6.12 6.22 6.42 6.15 6.08 6.17 6.18 6.48 6.24 6.24 6.25 6.23 6.42 6.46 6.12 6.22 6.43 6.62
GOBP_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT 6.28 6.65 6.55 6.45 6.75 6.68 6.3 6.37 6.34 6.48 6.54 6.15 6.06 6.26 6.6 6.73 6.68 6.08 6.25 6.68 6.56 7.13 6.67 6.6 6.73 7.03
GOBP_REGULATION_OF_EXIT_FROM_MITOSIS 5.98 5.9 6.17 5.78 5.89 5.89 5.8 5.89 6.02 5.68 6.04 6.01 5.93 5.89 5.77 6.26 5.98 5.87 5.86 5.58 5.76 6.18 5.95 5.99 6.39 6.01
GOBP_NUCLEAR_MIGRATION 8.39 8.54 8.32 8.06 9.28 9.19 8.77 8.92 9.23 9.12 8.25 8.74 8.99 8.95 8.93 8.47 8.66 8.38 8.62 8.85 7.97 8.35 9.18 9.32 9.04 8.8
GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS 4.91 5.05 4.92 5.04 4.49 4.27 4.49 4.85 4.42 4.35 4.78 4.78 4.52 4.33 4.63 4.56 4.79 5.06 4.95 4.61 5.01 4.62 4.31 4.36 4.47 4.6
GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION 5.01 4.88 4.75 4.95 4.31 4.38 4.43 4.74 4.46 4.41 4.72 4.55 4.44 4.31 4.49 4.35 4.82 5.01 4.87 4.65 5 4.55 4.34 4.3 4.39 4.53
GOBP_MALE_MEIOSIS_I 5.03 5.01 4.82 5.33 4.33 4.37 4.84 4.85 4.65 4.48 4.76 4.46 4.5 4.2 4.81 4.47 4.8 5.23 4.71 4.57 5.04 4.63 4.45 4.26 4.47 4.5
GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION 6.09 6.14 6.8 6.72 5.93 5.69 6.49 5.79 6.2 6.26 6.13 6.01 6.12 6.21 6.07 5.94 6.14 6.19 5.83 6.35 5.43 5.94 6.44 6.68 6.07 6.08
GOBP_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES 6.32 6.35 6.15 6.03 6.46 6.53 6.53 6.33 6.48 6.59 6.19 6.34 6.4 6.53 6.36 6.43 6 6.29 6.57 6.47 6.05 6.16 6.63 6.37 6.42 6.29
GOBP_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES 5.83 5.66 5.65 5.94 5.55 5.23 5.61 5.54 5.78 5.98 5.64 5.74 5.88 5.68 5.37 5.39 5.7 5.75 5.45 5.65 6.16 5.88 6.14 5.64 5.83 5.85
GOBP_NEURON_CELL_CELL_ADHESION 8.38 8.92 8.23 7.76 8.73 9.16 8.87 8.37 8.98 8.93 7.94 8.44 9.21 9.27 8.69 8.87 8.41 8.58 8.89 9.12 7.84 7.73 8.68 9.14 8.86 8.18
GOBP_LEUKOCYTE_CELL_CELL_ADHESION 5.66 5.6 5.63 5.67 5.37 5.27 5.49 5.45 5.53 5.35 5.53 5.29 5.51 5.36 5.56 5.54 5.58 5.57 5.37 5.42 5.66 5.67 5.38 5.25 5.57 5.71
GOBP_CELL_MATRIX_ADHESION 6.59 6.46 6.55 6.44 6.53 6.55 6.6 6.71 6.52 6.54 6.34 6.44 6.62 6.54 6.47 6.39 6.31 6.4 6.41 6.29 6.66 6.71 6.7 6.52 6.77 6.7
GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION 6.04 6.01 6.07 6.05 5.97 5.95 6.14 6.18 6.11 6.05 6.05 5.99 5.99 6.06 6.04 6.01 6.14 6.09 5.84 6.04 6.33 6.26 6.16 6.01 6.32 6.25
GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY 7.12 7.1 7.54 7.12 7.43 7.48 7.56 7.54 7.3 7.52 7.43 7.34 7.57 7.49 7.53 7.63 7.35 7.27 7.32 7.52 7.39 7.59 7.56 7.7 7.46 7.31
GOBP_ESTABLISHMENT_OF_TISSUE_POLARITY 6.95 7.1 7.39 7.26 7.17 7.26 7.16 7.33 7.18 7.43 7.18 6.98 7.24 7.31 7.09 7.35 7.07 6.95 7.24 7.31 6.88 7.01 7.31 7.44 7.4 7.21
GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY 6.53 6.54 6.64 6.55 6.69 6.69 6.71 6.73 6.63 6.75 6.51 6.65 6.75 6.72 6.75 6.79 6.67 6.6 6.6 6.74 6.73 6.83 6.89 6.75 6.78 6.81
GOBP_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY 5.23 4.67 4.54 5.09 4.31 4.16 4.6 4.43 4.66 4.43 4.85 4.45 4.35 4.48 4.54 4.83 4.72 4.76 4.61 4.43 4.56 4.47 4.33 4.13 4.56 4.57
GOBP_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY 6.73 6.65 6.88 6.65 6.93 6.93 6.83 6.97 6.85 6.94 6.73 6.86 6.92 6.97 6.95 6.9 6.76 6.84 6.78 6.95 6.88 6.97 7.02 6.98 7.01 7
GOBP_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY 6 5.71 5.51 5.93 5.33 5.63 5.83 5.82 5.71 5.75 5.85 5.62 5.79 5.77 5.84 6.01 5.39 6.03 5.74 5.22 5.77 5.74 5.66 5.55 5.59 5.7
GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 7.13 7.18 7.26 7.16 7.44 7.37 7.25 7.1 7.52 7.17 7.09 7.39 7.46 7.49 7.25 7.26 7.19 7.32 7.26 7.41 7.08 7.14 7.37 7.54 7.33 7.28
GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY 7.16 6.98 7.4 7.5 7.5 7.23 7.23 6.85 7.68 7.05 7.03 7.31 7.4 7.4 7.12 7.07 6.98 6.88 7.31 7.25 7 7.21 7.59 7.62 7.09 7.08
GOBP_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY 6.84 6.64 6.93 6.83 7.11 7.08 6.89 6.6 6.96 6.99 6.76 6.83 7.15 7.2 6.73 6.71 6.69 6.61 6.99 7.01 6.83 6.87 7.01 6.9 6.96 6.94
GOBP_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY 6.41 6.44 6.47 6.44 6.31 6.47 6.63 6.53 6.44 6.48 6.33 6.45 6.63 6.61 6.55 6.6 6.51 6.29 6.34 6.43 6.61 6.7 6.72 6.68 6.54 6.64
GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY 6.62 6.75 6.69 6.62 6.81 6.73 6.82 6.8 6.62 6.66 6.53 6.66 6.89 6.82 6.87 6.94 6.9 6.75 6.71 6.86 6.93 6.94 7.12 6.85 7.05 7.08
GOBP_SMAD_PROTEIN_COMPLEX_ASSEMBLY 7.48 7.56 8.14 6.98 8.15 8.03 8.06 7.64 8.52 7.67 7.68 7.59 8.33 8.43 7.96 7.85 7.68 7.58 8.27 7.79 7.41 7.96 8.22 8.62 8.23 8.04
GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 5.37 5.27 5.09 5.27 4.84 4.76 5.01 5.02 5.05 4.91 5.18 4.97 4.93 4.92 5.03 4.95 5.2 5.3 5.02 4.86 5.28 4.99 4.87 4.71 4.92 5.04
GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER 5.34 5.37 5.36 5.34 4.8 4.95 5.24 5.29 5.27 5.29 5.47 5.15 5.37 5.33 5.25 5.28 5.47 5.39 5.24 5.31 5.72 5.41 5.31 4.97 5.34 5.52
GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 5.92 5.8 5.74 5.92 5.57 5.57 5.95 6.09 5.8 5.82 6.07 5.79 5.76 5.8 5.93 5.76 6.02 6.07 5.87 5.96 6 5.89 5.86 5.77 5.93 6.09
GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 5.66 5.57 5.59 5.81 5.41 5.35 5.72 5.86 5.62 5.67 5.82 5.47 5.55 5.56 5.78 5.47 5.84 5.83 5.51 5.63 5.81 5.59 5.44 5.41 5.62 5.61
GOBP_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY 6.17 5.94 5.75 6 5.86 5.97 5.96 6.25 5.84 5.93 5.87 5.59 5.92 5.9 5.93 5.88 6.12 5.97 5.97 5.96 6.09 5.79 6.02 5.85 6.07 5.95
GOBP_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY 8.16 8.54 9.03 8.2 8.56 9.18 9.22 8.92 9.06 9.04 8.51 8.72 8.91 8.94 9.53 8.61 9.24 8.87 8.93 9.18 8.58 8.37 8.82 9.02 8.87 8.64
GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 6.67 6.96 7.09 6.37 6.95 7.35 7.23 7.18 7.02 7.29 6.93 7.12 7.3 7.42 7.33 7.37 6.7 6.86 7.24 7.37 6.96 7.16 7.43 7.26 7.07 6.99
GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY 6.77 6.99 6.52 6.49 6.57 6.97 6.29 6.3 7.23 6.76 6.65 6.41 6.97 6.91 6.47 6.53 6.42 6.67 6.68 6.36 6.22 6.73 6.89 7.03 6.99 6.44
GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 5.41 5.42 5.2 5.29 4.99 5.19 5.19 5.28 5.29 5.27 5.4 5.15 5.22 5.27 5.32 5.26 5.49 5.56 5.21 5.2 5.46 5.41 5.12 5.08 5.3 5.37
GOBP_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY 5.3 4.92 5.06 5.21 4.66 4.77 5.07 5.06 4.85 5.14 5.04 5.07 4.88 4.79 5.16 4.91 5.06 5.53 4.79 4.76 5.22 5.23 4.97 4.86 4.75 5.09
GOBP_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 6.7 6.76 7.22 6.68 6.49 6.69 6.75 6.87 6.63 7 6.91 7.29 6.56 6.75 7.28 7.05 6.86 7.24 6.74 6.58 6.74 7.11 6.93 7.06 7.01 6.82
GOBP_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY 5.21 5.07 4.95 4.94 4.55 4.56 5 4.71 4.86 4.72 4.87 4.71 4.52 4.61 4.65 4.69 5.14 4.83 4.97 5.06 5.03 4.67 4.54 4.67 4.71 4.95
GOBP_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY 8.6 8.96 8.94 8.23 8.74 9 9.13 9.07 8.86 8.99 8.4 8.85 8.92 9 9.08 8.58 8.7 8.77 8.94 9.21 8.93 8.87 9.12 9.09 9.14 8.89
GOBP_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY 7.64 8.09 7.59 7.46 7.8 7.63 8.1 9.08 7.71 7.97 8.4 8.25 8.03 8.14 8.54 8.27 8.39 8.81 8.14 8.36 8.65 8.73 7.8 7.83 8.87 8.69
GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY 8.46 8.73 9.01 9.11 8.59 9.18 9.65 9.05 8.95 9.67 8.25 8.32 8.84 8.76 9.62 9.1 8.26 8.45 8.81 8.78 8.2 8.5 9.12 9.18 8.67 8.45
GOBP_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY 7.86 8.12 8.08 7.86 8 8.25 8.33 8.48 8.02 8.27 7.73 8.31 8.36 8.43 8.44 8.46 7.8 8.12 8.03 8.28 8.17 8.41 7.98 8.24 8.34 8.35
GOBP_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY 6.51 6.65 6.83 6.9 6.61 6.54 6.93 7.08 6.53 7.17 6.7 6.78 7 6.89 7.11 7.34 6.23 6.67 7.03 7.04 6.72 6.67 6.59 6.64 6.66 6.77
GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY 5.51 5.45 5.66 5.57 5.09 5.06 5.47 5.45 5.31 5.3 5.53 5.12 5.25 5.05 5.62 5.34 5.34 5.57 5.43 5.39 5.36 5.21 5.26 5.16 5.2 5.36
GOBP_NOTCH_SIGNALING_PATHWAY 6.56 6.58 6.68 6.6 6.72 6.69 6.59 6.67 6.58 6.77 6.56 6.74 6.74 6.83 6.65 6.84 6.69 6.74 6.65 6.68 6.73 6.97 6.77 6.77 6.69 6.67
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET 7.07 7.09 6.83 6.72 7.41 7.53 7.35 7.59 7.2 7.33 7.03 7.38 7.59 7.44 7.47 7.33 7.39 7.46 7.2 7.65 7.62 7.58 7.34 7.25 7.05 7.43
GOBP_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY 7.46 7.55 6.58 6.23 7.14 7.37 7.17 7.79 7.19 7.11 7.38 7.24 7.43 7.52 7.02 7.48 7.67 7.31 7.14 7.58 7.29 7.49 6.85 6.94 6.95 7.82
GOBP_SMOOTHENED_SIGNALING_PATHWAY 6.62 6.48 6.76 6.82 6.67 6.82 6.71 6.93 6.5 6.72 6.62 6.73 6.67 6.69 6.78 6.8 6.6 6.92 6.71 6.7 6.68 6.82 6.87 6.74 6.79 6.79
GOBP_INTEGRIN_MEDIATED_SIGNALING_PATHWAY 6.14 6.05 6.16 6.23 6.26 6.08 6.14 6.19 6.25 6.12 6.01 6.07 6.08 6.01 6.14 6.06 6.26 6.04 6.08 6.17 6.5 6.32 6.44 6.17 6.31 6.43
GOBP_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING 6.41 6.39 6.58 6.46 6.48 6.3 6.4 6.41 6.53 6.41 6.36 6.39 6.32 6.36 6.36 6.43 6.46 6.4 6.31 6.41 6.37 6.44 6.31 6.59 6.63 6.55
GOBP_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY 5.43 5.58 5.5 5.6 5.34 5.51 5.43 5.36 5.37 5.33 5.5 5.59 5.34 5.3 5.43 5.48 5.35 5.69 5.4 5.15 5.57 5.54 5.54 5.35 5.37 5.45
GOBP_I_KAPPAB_PHOSPHORYLATION 7.06 6.91 7.19 6.74 7.32 7.39 6.83 6.92 7.62 6.36 7.12 6.79 7.62 7.52 7.4 6.56 7.04 6.52 7.18 6.9 6.85 7.07 7.3 7.59 7.43 7.42
GOBP_JNK_CASCADE 6.42 6.44 6.62 6.45 6.37 6.59 6.63 6.58 6.8 6.68 6.62 6.94 6.8 6.72 6.62 6.61 6.52 6.42 6.47 6.4 6.61 6.66 7.01 7.07 6.72 6.64
GOBP_ACTIVATION_OF_JNKK_ACTIVITY 6.89 7.05 6.78 6.86 7.38 7.45 7.56 7.54 7.36 7.68 6.79 7.66 7.49 7.49 7.34 7.24 7.24 7.37 7.26 7.51 6.92 7.16 7.19 7.63 7.24 7.36
GOBP_ACTIVATION_OF_JUN_KINASE_ACTIVITY 6.45 6.55 6.78 6.35 6.99 6.92 6.95 7.01 6.97 7.05 6.64 7.12 7.07 7.17 6.72 6.73 6.55 6.64 6.9 7.14 6.69 6.54 7.09 7.16 6.75 6.79
GOBP_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN 5.56 5.32 5.38 5.68 4.91 5.03 5.2 5.21 5.18 4.98 5.31 5.04 5.2 4.94 5.13 5.08 5.34 5.34 5.19 4.98 5.43 5.13 4.96 4.8 5.3 5.53
GOBP_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION 5.99 5.9 6.54 6.43 5.58 5.52 6.42 6.29 6.03 6.35 6.34 6.11 5.51 5.8 6.64 6.05 6.24 5.98 5.87 5.84 6.03 5.61 6.25 6.18 6.07 6.03
GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION 6.93 7.03 7.08 6.95 7.32 7.35 7.16 7.28 7.07 7.25 6.97 7.29 7.22 7.3 7.35 7.29 7.05 7.05 7.12 7.28 7.06 7.2 7.15 7.39 7.13 7.2
GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION 6.93 7.06 7.11 7 7.33 7.38 7.16 7.27 7.07 7.25 7.09 7.28 7.24 7.28 7.36 7.28 7.11 7.05 7.07 7.25 7.01 7.21 7.16 7.33 7.17 7.23
GOBP_RHO_PROTEIN_SIGNAL_TRANSDUCTION 6.39 6.37 6.3 6.35 6.29 6.24 6.43 6.74 6.41 6.38 6.27 6.43 6.4 6.32 6.68 6.41 6.53 6.3 6.32 6.58 6.52 6.44 6.46 6.39 6.5 6.52
GOBP_CELL_CELL_SIGNALING 6.63 6.63 6.82 6.67 6.73 6.83 6.86 6.96 6.8 6.84 6.67 6.77 6.88 6.87 6.94 6.82 6.71 6.79 6.75 6.87 6.8 6.88 6.81 6.89 6.86 6.85
GOBP_NEUROTRANSMITTER_SECRETION 7.65 8.01 7.95 7.86 8.06 8.14 8.21 8.39 8.02 8.22 8.06 8.33 8.16 8.22 8.49 8.26 7.81 8.1 8.24 8.16 7.89 8.41 8.02 8.36 8.24 8.05
GOBP_SYNAPTIC_TRANSMISSION_CHOLINERGIC 5.95 6 5.27 6.04 5.42 5.21 5.76 5.72 5.87 5.5 5.77 5.45 5.43 5.48 5.49 5.42 5.55 5.55 5.66 5.27 5.64 5.48 5.54 5.35 5.53 5.44
GOBP_ENSHEATHMENT_OF_NEURONS 7.79 7.74 7.95 7.63 8.42 8.22 8.23 8.03 8.23 8.02 7.87 8.1 8.29 8.2 7.83 8.01 7.97 7.59 8.03 8.34 7.84 7.91 8.15 8.29 8.1 8.08
GOBP_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION 6.56 6.82 6.98 6.65 6.44 6.8 7.42 6.99 6.65 7.68 6.39 6.7 6.88 6.75 6.97 6.37 6.63 7.01 6.78 7.04 6.95 6.87 6.56 7.14 6.99 6.82
GOBP_GAMETE_GENERATION 5.83 5.67 5.92 5.9 5.62 5.56 5.68 5.67 5.7 5.75 5.9 5.77 5.64 5.62 5.85 5.88 5.7 5.78 5.72 5.55 5.81 5.7 5.66 5.63 5.72 5.84
GOBP_GERM_CELL_DEVELOPMENT 5.76 5.53 5.69 5.65 5.32 5.21 5.41 5.33 5.38 5.4 5.64 5.41 5.23 5.43 5.64 5.49 5.48 5.52 5.46 5.31 5.47 5.37 5.27 5.24 5.39 5.5
GOBP_SPERM_AXONEME_ASSEMBLY 6.3 5.86 5.97 6.02 6.28 6.07 6.64 6.24 6.03 6.81 6.79 6.33 6.23 6.34 6.32 7.23 5.84 6.66 6.16 6.33 6.07 6.52 5.89 6.05 6.25 6.55
GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION 5.87 5.6 6.02 5.55 5.59 5.5 5.86 6.23 5.71 6.34 6.51 6.02 5.74 6.03 6.34 6.01 6.03 6.08 6.09 5.5 5.82 6.22 5.52 5.54 6.49 6.62
GOBP_FEMALE_GAMETE_GENERATION 5.76 5.62 5.74 5.62 5.37 5.33 5.53 5.67 5.56 5.4 5.66 5.49 5.55 5.45 5.81 5.64 5.56 5.52 5.68 5.52 5.66 5.7 5.39 5.42 5.72 5.55
GOBP_INSEMINATION 5.56 5.43 5.16 5.23 4.69 4.92 5.36 4.73 5.17 4.92 5.26 4.9 5.04 5.03 5.3 5.1 5.27 5.12 4.96 5.14 5.18 5.08 5.57 4.87 5.1 4.83
GOBP_SINGLE_FERTILIZATION 5.14 5.03 5.02 5.17 4.66 4.54 4.86 4.88 4.88 4.6 4.91 4.73 4.6 4.75 4.78 4.82 4.97 5.23 4.83 4.74 5.14 4.81 4.76 4.57 4.76 4.84
GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA 4.99 5.03 4.91 5.32 4.51 4.36 4.6 4.82 4.56 4.6 4.91 4.73 4.67 4.61 4.56 4.65 4.88 5.05 4.68 4.66 4.98 4.71 4.59 4.45 4.63 4.67
GOBP_ACROSOME_REACTION 5.6 5.34 5.22 5.48 4.95 5.04 5.21 5.25 5.17 5.07 5.3 5.23 4.99 4.98 5.24 5.05 5.11 5.4 4.97 4.93 5.33 5.21 4.97 4.85 5.21 5.08
GOBP_FUSION_OF_SPERM_TO_EGG_PLASMA_MEMBRANE_INVOLVED_IN_SINGLE_FERTILIZATION 4.78 4.79 4.63 4.68 4.46 4.06 4.41 4.52 4.67 4.2 4.32 4.15 4.47 4.54 4.44 4.3 4.64 5.21 4.65 4.16 4.64 4.26 4.33 4.1 4.25 4.47
GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE 6.6 6.7 6.89 6.84 6.77 6.94 6.83 6.92 6.73 6.9 6.74 6.86 6.86 6.91 6.88 6.95 6.74 6.79 6.67 6.87 6.82 6.99 6.95 7 6.9 6.97
GOBP_BLASTODERM_SEGMENTATION 5.8 5.6 5.57 5.43 5.3 5.31 5.4 5.36 5.23 5.44 5.64 5.27 5.53 5.56 5.45 5.34 5.37 5.48 5.32 5.32 5.36 5.47 5.24 5.39 5.74 5.78
GOBP_TRIPARTITE_REGIONAL_SUBDIVISION 5.34 5.43 5.55 5.37 5.01 5.11 5.19 5.05 5.08 4.98 5.42 5.17 5.26 5.11 4.99 4.91 5.3 5.48 4.94 5.08 5.33 5.38 5.06 5.11 4.96 5.3
GOBP_GASTRULATION 5.84 5.71 5.91 5.92 5.73 5.62 5.86 5.84 5.77 5.87 5.82 5.56 5.91 5.8 5.89 5.83 5.8 5.7 5.71 5.81 6.08 6.07 5.97 5.79 5.81 5.86
GOBP_SEGMENT_SPECIFICATION 5.39 5.41 5.75 5.75 5.16 5.09 5.48 5.15 5.35 5.37 5.51 5.19 5.26 5.1 5.49 5.28 5.07 5.35 5.3 5.48 5.73 5.57 5.08 5.03 5.61 5.31
GOBP_PATTERN_SPECIFICATION_PROCESS 5.7 5.65 5.7 5.83 5.49 5.46 5.59 5.58 5.6 5.56 5.74 5.6 5.61 5.58 5.67 5.61 5.55 5.63 5.52 5.55 5.75 5.68 5.55 5.54 5.57 5.61
GOBP_ECTODERM_DEVELOPMENT 5.98 5.91 6.15 6.31 6.65 6.18 6.09 6.09 6.27 6.2 6.29 5.78 6.28 6.42 5.92 6.19 6.25 5.97 5.93 6.25 6.39 6.26 6.25 5.85 5.81 6.02
GOBP_NEUROBLAST_PROLIFERATION 7.54 7.67 7.55 6.95 7.71 7.89 7.65 7.92 7.54 7.34 7.41 7.48 7.76 7.77 7.83 7.83 7.71 7.34 7.62 7.92 7.68 7.79 7.45 7.63 7.57 7.47
GOBP_AXONAL_FASCICULATION 7.38 7.35 7.33 6.92 7.56 7.5 7.88 7.78 7.5 7.92 7.43 7.72 7.73 7.75 7.9 7.87 7.12 7.73 7.5 7.95 7.32 7.44 7.52 7.87 7.85 7.72
GOBP_SYNAPSE_ASSEMBLY 7.13 7.3 7.21 6.9 7.51 7.61 7.68 7.69 7.37 7.72 7.34 7.7 7.68 7.76 7.88 7.74 7.35 7.68 7.61 7.83 7.36 7.56 7.46 7.78 7.56 7.56
GOBP_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT 6.83 6.94 7.1 7.02 7.15 7.18 7.16 7.24 7.19 7.23 6.95 7.19 7.24 7.26 7.25 7.17 7.09 7 7.02 7.24 6.99 7.19 7.21 7.31 7.12 7.2
GOBP_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT 6.96 6.9 6.66 6.74 7.24 7.11 7.01 7.21 7.22 7.08 6.97 7.36 6.92 7.2 6.97 7.23 7.16 6.89 6.89 7.22 7.15 7.12 7.04 7.14 7.36 7.36
GOBP_SENSORY_ORGAN_DEVELOPMENT 5.99 5.93 5.94 6.03 5.85 5.83 5.97 5.98 5.95 5.97 6 5.91 5.95 5.96 5.95 5.94 6 5.97 5.88 5.87 6.08 5.99 5.9 5.92 5.95 6.02
GOBP_SALIVARY_GLAND_DEVELOPMENT 5.98 5.86 5.98 6.03 6.63 6.03 6.05 6.27 6.06 6.28 6.28 6.16 6.16 6.16 5.94 6.14 6.59 6.33 6.01 6.41 6.35 6.61 6.32 5.83 6.05 6.27
GOBP_ENDODERM_DEVELOPMENT 5.75 5.62 5.53 5.83 5.4 5.21 5.55 5.46 5.39 5.27 5.38 5.18 5.5 5.48 5.38 5.27 5.42 5.62 5.46 5.27 5.97 5.54 5.8 5.32 5.29 5.38
GOBP_MIDGUT_DEVELOPMENT 6.11 5.59 5.57 5.59 5.4 5.39 5.82 5.75 5.73 5.07 5.17 5.17 5.23 5.68 5.46 5.46 6.09 5.98 5.46 5.63 5.49 5.32 5.1 5.44 5.26 5.49
GOBP_MESODERM_DEVELOPMENT 5.79 5.56 5.92 5.89 5.71 5.61 5.82 5.83 5.8 5.8 5.81 5.59 5.87 5.8 5.89 5.89 5.63 5.52 5.75 5.74 5.86 5.83 5.81 5.77 5.64 5.77
GOBP_MESODERMAL_CELL_FATE_SPECIFICATION 5.16 5.22 5.32 5.34 4.71 4.86 5.39 4.94 5.33 5.05 5.35 5.07 5.14 5.22 5.34 5.43 5.32 5.31 4.88 4.99 5.54 5.18 5.18 4.68 5.05 5.16
GOBP_HEART_DEVELOPMENT 6.25 6.35 6.39 6.38 6.4 6.43 6.34 6.34 6.45 6.41 6.34 6.35 6.45 6.43 6.4 6.45 6.46 6.34 6.39 6.33 6.5 6.5 6.44 6.46 6.51 6.52
GOBP_ADULT_HEART_DEVELOPMENT 5.2 4.61 4.93 5.08 4.87 4.8 5.09 4.77 5.13 5.05 5.36 4.88 4.96 4.83 4.91 4.88 5.16 4.88 5.11 4.71 5.44 5.12 4.85 4.65 4.74 4.91
GOBP_MUSCLE_ORGAN_DEVELOPMENT 6.02 6.05 6.13 6.01 5.95 5.9 6.08 6.09 6.09 6.16 6.06 6.16 6.02 6.11 5.98 6.02 6.25 6.09 6.05 6.06 6.16 6.21 6.17 5.99 6.04 6.15
GOBP_MYOBLAST_FUSION 6.45 6.6 6.63 6.28 6.48 6.56 6.53 6.36 6.58 6.44 6.12 6.43 6.85 6.61 6.2 6.35 6.84 6.76 6.46 6.52 6.74 6.33 6.77 6.71 7.06 6.89
GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT 6.87 6.87 7.19 6.73 6.95 7.16 7.38 7.23 7.03 7.3 7.13 7.42 7.14 7.12 7.12 7.13 6.91 7.02 7.33 7.06 7.32 6.92 7.29 7.47 7.3 7.14
GOBP_SEX_DETERMINATION 5.29 5.09 5.66 5.53 5.03 4.89 5.34 5.18 5.36 5.11 5.56 4.96 5.06 5.08 5.52 5.33 5.4 5.24 5.11 5.13 5.3 5.13 5.13 4.89 5.1 5.35
GOBP_SEX_DIFFERENTIATION 5.93 5.94 6.08 6.1 5.86 5.77 5.86 6.03 5.91 5.92 6.06 5.89 5.94 5.79 5.91 5.86 5.95 5.92 5.8 5.79 6.11 6.05 6.01 5.83 5.89 6.03
GOBP_DOSAGE_COMPENSATION 7.02 7.14 7.71 7.43 7.64 7.98 7.66 7.54 7.73 7.98 7.29 7.9 7.77 7.65 7.92 7.61 7.26 6.97 7.59 7.73 7.32 7.35 7.92 8.28 7.66 7.7
GOBP_EMBRYO_IMPLANTATION 6.78 6.74 7.17 6.58 6.66 7.03 7.33 6.97 6.91 6.98 6.64 6.99 7.23 7.01 7.05 7.21 6.99 6.89 6.71 7.28 6.41 7 7.11 7.4 7.33 7.25
GOBP_PARTURITION 4.99 5.57 5.26 5.26 4.92 4.87 5.11 5.3 5.27 5.03 5.53 5.11 5.08 5.15 5.27 5.17 4.68 5.16 5.1 5.1 5.13 5.08 5.2 4.9 5.21 4.79
GOBP_AGING 6.45 6.54 6.75 6.89 6.92 6.69 6.66 6.6 6.72 6.89 6.7 6.79 6.76 6.72 6.77 6.72 6.67 6.67 6.58 6.64 6.86 6.83 6.94 6.92 6.82 6.76
GOBP_CELL_AGING 6.48 6.59 6.65 7.04 7.06 6.95 6.7 6.76 6.72 6.97 6.7 6.95 7.01 7.04 7.11 7.02 6.81 6.79 6.68 6.71 6.91 6.86 7.08 7.07 6.89 6.85
GOBP_RESPONSE_TO_NUTRIENT 5.96 5.94 6.16 6.21 6 6.09 6.14 6.11 6.07 6.21 6.06 6.11 6.16 6.17 5.88 6.14 6.17 6.01 5.88 6 5.98 6.23 6.17 6.03 5.89 6.32
GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM 6.57 6.4 6.65 6.45 6.59 6.49 6.56 6.27 6.38 6.6 6.57 6.6 6.69 6.63 6.36 6.39 6.4 6.25 6.55 6.52 6.2 6.42 6.46 6.52 6.4 6.34
GOBP_DIGESTION 5.44 5.37 5.22 5.6 4.97 4.91 5.2 5.02 5.09 5.03 5.36 5.07 5.04 5.04 5.25 4.99 5.27 5.31 5.1 4.99 5.04 5.06 5.05 4.8 5.14 4.96
GOBP_EXCRETION 5.33 5.24 5.21 5.31 4.77 4.87 5.19 4.85 5.13 4.96 5.26 4.77 4.75 4.84 5.09 4.97 5.34 5.23 5.05 4.87 5.41 5.03 4.98 4.82 4.93 4.85
GOBP_BODY_FLUID_SECRETION 6.2 6.04 6.03 6.26 5.75 5.82 5.97 6.15 5.81 5.95 6.08 5.83 6 5.87 5.87 5.7 5.99 6.1 5.98 5.92 5.99 6.17 6.07 5.84 5.7 6.11
GOBP_LACTATION 6.56 6.57 6.95 6.55 6.94 6.76 6.68 6.68 6.72 6.59 6.3 6.21 6.27 6.78 6.42 6.56 6.44 6.61 6.65 6.75 6.2 6.43 6.71 6.99 6.36 6.22
GOBP_BLOOD_COAGULATION_INTRINSIC_PATHWAY 5.46 5.42 4.98 5.17 5.07 4.96 4.89 4.71 5.13 5.01 5.18 4.64 4.86 4.94 4.79 4.76 5.05 5.32 5.01 4.78 5.09 5.04 4.74 4.48 4.94 4.79
GOBP_SENSORY_PERCEPTION 5.13 5.03 4.71 4.96 4.43 4.41 4.74 4.65 4.69 4.57 4.85 4.68 4.53 4.56 4.63 4.58 4.85 4.98 4.73 4.55 4.96 4.68 4.52 4.35 4.57 4.62
GOBP_PHOTOTRANSDUCTION 5.35 5.1 5.45 5.39 4.86 4.67 5.24 5.14 5.33 5.12 5.31 4.8 4.88 4.89 5.18 5.2 4.97 5.36 4.93 4.86 5.33 4.94 4.94 4.77 5.08 4.89
GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT 5.35 5.14 5.47 5.43 5.03 4.5 5.21 5.12 5.3 5.04 5.21 4.75 4.96 4.89 5.31 5.2 4.96 5.4 4.89 4.81 5.29 4.78 4.73 4.72 5 4.84
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS 4.56 4.51 4.06 4.24 3.9 3.79 4.06 4.07 4.09 3.86 4.24 4.06 3.88 3.87 3.98 3.9 4.25 4.54 4.13 4.02 4.36 4.05 3.85 3.78 3.91 4.02
GOBP_SENSORY_PERCEPTION_OF_SMELL 4.47 4.42 3.98 4.17 3.8 3.73 3.94 3.98 3.99 3.76 4.11 4 3.83 3.79 3.9 3.81 4.18 4.44 4.07 3.99 4.29 3.97 3.77 3.72 3.84 3.94
GOBP_BEHAVIOR 6.82 7 7.15 6.92 7.09 7.16 7.32 7.4 7.27 7.25 7.18 7.25 7.39 7.38 7.53 7.36 6.98 7.05 7.14 7.28 7.1 7.23 7.34 7.5 7.28 7.26
GOBP_LEARNING 7.94 8.2 8.05 7.79 8.45 8.52 8.39 8.35 8.12 8.29 7.85 8.44 8.23 8.42 8.57 8.38 7.98 8.23 8.56 8.49 8.02 8.28 8.29 8.62 8.12 8.32
GOBP_MEMORY 7.45 7.89 7.86 7.48 7.8 7.94 7.71 7.89 7.85 7.93 7.75 7.77 7.92 7.94 8.16 7.84 7.65 7.65 8.14 7.89 7.84 8.05 7.98 8.14 7.86 7.73
GOBP_LONG_TERM_MEMORY 7.61 8.17 7.86 7.83 8.76 8.45 8.26 8.67 8.44 8.44 8.03 8.61 8.05 8.34 8.69 8.36 8.58 8.16 8.87 8.78 8.35 8.54 8.46 8.26 8.16 8.57
GOBP_MATING_BEHAVIOR 7.17 7.32 7.09 6.75 7.25 7.32 7.37 7.28 7.66 7.75 7.41 7.8 7.66 7.55 7.72 7.86 6.84 7.44 7.77 7.15 7.1 7.19 7.74 8.23 7.18 7.16
GOBP_MATING 6.36 6.23 6.57 6.43 6.09 6.53 6.54 6.46 6.45 6.49 6.57 6.41 6.43 6.44 6.68 6.57 6.37 6.36 6.47 6.32 6.66 6.66 6.4 6.42 6.5 6.55
GOBP_COPULATION 5.86 5.59 5.21 5.29 4.85 4.98 5.57 4.82 5.27 5.11 5.49 4.97 5.12 5.09 5.35 5.21 5.3 5.24 4.99 5.3 5.2 5.27 5.57 4.94 5.11 4.84
GOBP_RHYTHMIC_BEHAVIOR 6.97 7.13 7.31 6.96 7.27 7.55 7.47 7.55 7.56 7.4 6.99 7.12 7.66 7.77 7.61 7.49 7.11 7.4 7.57 7.95 7.25 7.26 7.36 7.92 7.61 7.13
GOBP_CIRCADIAN_RHYTHM 6.83 6.99 7.35 7.12 7.3 7.27 7.35 7.3 7.39 7.17 7.03 7.29 7.47 7.51 7.28 7.45 7.21 7.09 7.26 7.33 7.19 7.38 7.46 7.59 7.5 7.37
GOBP_GROOMING_BEHAVIOR 6 6.06 6.05 5.77 6.01 6.54 5.72 6.15 5.91 5.88 6.3 6.03 5.76 5.85 5.63 5.83 5.88 5.8 5.49 5.97 5.99 6.01 5.95 6.18 5.99 6.23
GOBP_LOCOMOTORY_BEHAVIOR 7.53 7.84 7.64 7.63 7.89 8.09 7.71 7.82 7.83 7.92 7.69 7.78 7.86 7.92 8.09 7.85 7.68 7.69 7.91 8.01 7.61 7.85 7.78 7.93 7.67 7.67
GOBP_FEEDING_BEHAVIOR 5.77 5.75 5.95 5.97 5.52 5.4 5.74 5.86 5.73 5.54 5.89 5.52 5.6 5.51 5.85 5.73 5.72 5.87 5.56 5.7 5.97 5.63 5.59 5.22 5.7 5.61
GOBP_VISUAL_BEHAVIOR 7.84 7.89 8.25 7.98 8.01 8.87 8.79 8.71 7.91 8.27 8.36 8.44 8.17 8.09 8.6 8.32 8.02 8.2 8.92 8.56 8 8.53 8.33 8.6 8.13 8.55
GOBP_CHEMOSENSORY_BEHAVIOR 5.1 5.45 5.25 5.12 5.32 5.24 5.02 4.76 5.2 4.86 5.25 4.95 4.82 5.15 5.3 5.12 5.06 5.13 5.32 4.87 5.52 4.82 4.86 4.59 4.57 4.97
GOBP_REGULATION_OF_HEART_CONTRACTION 6.63 6.61 6.61 6.58 6.49 6.61 6.62 6.6 6.59 6.66 6.52 6.6 6.55 6.6 6.81 6.59 6.78 6.76 6.57 6.64 6.62 6.59 6.77 6.69 6.77 6.63
GOBP_TRNA_PROCESSING 6.3 6.07 6.71 6.63 6.17 6.33 6.23 6.21 6.28 6.23 6.27 6.25 6.13 6.19 6.27 6.21 6.14 6.15 6.2 6.13 6.29 6.2 6.29 6.27 6.25 6.23
GOBP_CELL_RECOGNITION 5.64 5.61 5.45 5.75 5.31 5.19 5.23 5.48 5.44 5.27 5.53 5.27 5.37 5.32 5.46 5.44 5.42 5.38 5.48 5.38 5.6 5.57 5.31 5.17 5.25 5.41
GOBP_NEURON_RECOGNITION 7.32 7.23 7.25 6.84 7.28 7.37 7.86 7.75 7.31 7.72 7.17 7.68 7.33 7.59 7.79 7.45 7.03 7.44 7.29 7.73 7.27 7.41 7.33 7.73 7.69 7.37
GOBP_MOTOR_NEURON_AXON_GUIDANCE 5.91 5.92 6.14 5.88 5.81 5.78 6.31 6.19 6.33 6.18 5.81 5.82 6.05 6.38 6.6 6.38 5.75 6.05 5.62 6.05 5.94 6.33 6 6.39 6.25 6.05
GOBP_MITOCHONDRIAL_FUSION 7.39 7.14 7.32 6.91 7.74 7.7 7.61 7.5 8.13 7.61 7.2 7.43 7.62 7.69 7.99 8.17 7.1 7.36 7.65 7.52 7.5 7.63 7.83 8.18 8.15 7.66
GOBP_AXO_DENDRITIC_TRANSPORT 9.07 9.15 9.32 8.94 9.58 9.58 9.72 9.17 9.56 9.6 9.38 9.24 9.63 9.62 9.62 9.49 9.17 8.98 9.27 9.44 8.91 9.26 9.64 9.67 9.43 9.12
GOBP_ANTEROGRADE_AXONAL_TRANSPORT 8.94 9.04 9.35 9.04 9.36 9.4 9.72 9.19 9.38 9.59 9.39 9.2 9.5 9.55 9.66 9.46 9.02 8.94 9.17 9.19 8.68 9.17 9.61 9.51 9.39 9.01
GOBP_RETROGRADE_AXONAL_TRANSPORT 9.76 9.94 9.72 9.55 9.75 9.99 9.81 9.71 9.95 9.9 9.86 9.52 10.03 9.86 9.85 10.06 9.71 9.71 9.99 9.63 9.87 10.19 9.91 9.74 10.02 10.13
GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION 6.92 7.06 7.19 7.04 7.31 7.29 7.21 7.37 7.21 7.23 6.99 7.24 7.44 7.31 7.36 7.22 7.12 7.08 7.08 7.36 7.17 7.23 7.28 7.48 7.3 7.27
GOBP_NEGATIVE_REGULATION_OF_DNA_REPLICATION 5.63 5.82 6.12 5.8 5.5 5.62 5.47 5.87 5.67 5.48 5.96 5.75 5.49 5.5 5.64 6.05 5.57 5.79 5.64 5.85 5.83 5.98 5.44 5.7 5.78 6.32
GOBP_STEROID_METABOLIC_PROCESS 6.09 5.99 6.15 6.24 6.03 6.1 6.01 6.12 6.06 6.19 6.09 6.2 6.1 5.92 5.97 6.01 6.07 5.99 5.91 5.98 5.98 6.18 6.22 6.03 6.04 6.22
GOBP_BILE_ACID_METABOLIC_PROCESS 6.15 5.87 5.84 5.98 5.91 5.81 5.64 5.78 5.84 5.86 5.84 6.07 5.71 5.63 6.12 5.78 5.46 5.58 5.58 5.48 5.79 5.4 6.07 5.63 5.71 5.85
GOBP_C21_STEROID_HORMONE_METABOLIC_PROCESS 5.53 5.47 5.78 5.62 5.27 5.22 5.64 5.62 5.81 5.24 5.84 5.21 5.54 5.64 5.7 5.63 5.68 5.59 5.36 5.4 5.53 5.7 5.51 5.5 5.73 5.68
GOBP_ANDROGEN_METABOLIC_PROCESS 6.3 5.9 6.64 6.77 6 5.91 6.09 6.05 6.3 6.23 6.46 5.83 6.14 6.11 6.09 6.51 6.35 5.98 5.82 6.05 6.19 6.46 5.73 5.86 6.04 6.18
GOBP_ESTROGEN_METABOLIC_PROCESS 5.51 5.21 5.15 5.16 4.48 4.92 5.3 4.84 5.13 4.73 5.07 4.82 5.23 4.65 4.97 4.93 4.89 5.4 5.27 5.04 5.61 5.05 4.83 4.84 4.95 4.84
GOBP_GLUCOCORTICOID_METABOLIC_PROCESS 5.26 5.06 5.16 5.12 4.72 4.8 4.89 4.71 4.84 4.97 5.07 4.56 4.67 4.65 4.79 4.66 4.86 5.13 4.84 4.76 5.01 5.02 4.9 4.63 5.05 5.18
GOBP_MINERALOCORTICOID_METABOLIC_PROCESS 5.19 5.06 5.14 5.05 4.68 4.75 4.92 4.68 4.51 4.45 4.91 4.49 4.52 4.41 4.52 4.31 4.6 5.19 4.68 4.71 5.06 4.79 4.46 4.27 4.97 5.19
GOBP_REGULATION_OF_BLOOD_PRESSURE 5.66 5.59 5.64 5.68 5.52 5.34 5.69 5.58 5.56 5.49 5.65 5.44 5.53 5.48 5.55 5.56 5.67 5.5 5.32 5.55 5.74 5.68 5.46 5.3 5.6 5.58
GOBP_OPSONIZATION 5 4.73 4.7 4.56 3.99 3.84 4.21 4.34 4.28 3.94 4.9 4.22 4.32 3.88 3.93 4.19 4.36 4.85 4.64 4.21 4.53 4.07 4.18 3.73 3.99 4.57
GOBP_SULFATE_TRANSPORT 5.56 5.36 5.28 5.39 4.98 4.93 5.04 5.24 5.15 5.33 5.15 5.05 4.97 4.96 5.03 5.31 5.04 5.15 4.89 5.02 5.45 5.02 4.67 4.46 5.05 5.25
GOBP_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 6.24 6.12 6.45 6.26 6.22 6.48 6.38 6.4 6.14 6.44 6.22 6.32 6.44 6.26 6.48 6.29 6.39 6.52 6.41 6.6 6.3 6.43 6.47 6.38 6.51 6.56
GOBP_CELL_POPULATION_PROLIFERATION 6.09 6.11 6.17 6.17 5.99 6.03 6.13 6.14 6.1 6.11 6.1 6.09 6.16 6.09 6.09 6.07 6.18 6.09 6 6.05 6.25 6.26 6.14 6.09 6.13 6.24
GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION 5.96 5.93 5.9 5.99 5.72 5.73 5.88 5.86 5.93 5.85 5.89 5.76 5.86 5.91 5.96 5.83 6.02 5.94 5.78 5.79 6.08 6.05 5.9 5.75 5.89 5.98
GOBP_NEGATIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION 6.2 6.23 6.41 6.33 6.13 6.14 6.28 6.27 6.28 6.22 6.27 6.24 6.27 6.32 6.2 6.33 6.32 6.25 6.13 6.21 6.39 6.42 6.37 6.22 6.39 6.39
GOBP_INSULIN_RECEPTOR_SIGNALING_PATHWAY 7.48 7.35 7.54 7.56 7.88 7.97 7.72 7.78 7.7 7.76 7.54 7.69 7.83 7.88 7.78 7.61 7.61 7.37 7.63 7.63 7.57 7.91 7.85 8 7.83 7.89
GOBP_INTRACELLULAR_MRNA_LOCALIZATION 7.52 7.63 7.94 8.03 8.02 8.14 7.97 7.54 8.03 7.49 7.77 7.84 8.16 8.14 8.24 7.53 7.25 7.1 7.53 7.94 7.74 7.76 7.9 7.81 7.65 7.3
GOBP_ISOPRENOID_BIOSYNTHETIC_PROCESS 6.23 5.64 6.61 6.24 5.85 5.61 6.22 6.23 6.52 6.15 6.27 6.14 6.31 5.79 6.09 6.38 6.15 5.99 5.84 5.91 6.3 6.28 6.22 6.03 6.41 6.5
GOBP_ASSOCIATIVE_LEARNING 8.43 8.71 8.36 8.09 8.76 8.87 8.7 8.71 8.63 8.53 8.36 8.63 8.65 8.61 9 8.86 8.04 8.58 8.92 8.78 8.5 8.67 8.6 8.89 8.61 8.67
GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT 7.23 7.39 8.16 7.82 8.05 8.05 7.19 7.35 7.52 7.84 7.52 7.55 7.76 7.86 7.44 7.37 7.23 7.11 7.59 7.38 7.16 7.47 7.82 7.78 7.49 7.58
GOBP_HISTONE_MRNA_METABOLIC_PROCESS 7.13 7.14 7.84 7.59 7.34 7.52 7.2 7.44 7.57 7.41 7.46 7.7 7.4 7.31 7.61 7.46 7.32 7.29 7.38 7.52 7.36 7.75 7.8 7.74 7.27 7.49
GOBP_DETERMINATION_OF_ADULT_LIFESPAN 6.14 6.28 6.31 6.15 6.19 6.01 5.87 5.91 6.37 6.22 6.78 6.18 6.28 6.14 6.12 6.46 6.38 6.22 6.33 6.15 6.98 6.58 6.19 6.58 6.17 6.61
GOBP_ADULT_FEEDING_BEHAVIOR 5.51 5.48 6.1 6 5.26 4.67 5.61 5.6 5.39 5.2 5.76 5.33 5.26 5.23 5.75 5.73 5.56 5.34 5.07 5.64 5.47 5.26 5.2 4.95 5.6 5.43
GOBP_ADULT_LOCOMOTORY_BEHAVIOR 7.17 7.54 7.13 7.43 7.33 7.81 7.56 7.71 7.51 7.82 7.44 7.68 7.51 7.66 7.85 7.86 7.15 7.15 7.71 7.73 7.21 7.51 7.55 7.84 7.53 7.25
GOBP_GLIAL_CELL_MIGRATION 7.57 7.26 8.06 7.51 7.89 7.97 8.13 7.91 7.66 7.94 7.54 7.62 8.19 8.12 8.2 7.86 7.83 7.47 7.49 7.89 7.77 7.95 7.82 8 7.64 7.71
GOBP_ASYMMETRIC_CELL_DIVISION 7.06 7.02 7.55 6.81 6.74 6.96 7.01 7.1 7.33 7.22 7.31 7.39 7.33 7.27 7.64 7.93 7.34 7.35 6.83 6.81 7.8 7.77 7.56 7.75 7.7 7.46
GOBP_REGULATION_OF_CELL_SHAPE 6.87 6.92 7.12 6.74 6.96 7.05 7.13 7.34 7.01 7 6.89 7.08 7.13 7.18 7.3 7.16 7.22 6.94 7.1 7.21 6.97 7.22 7.05 7.19 7.19 7.17
GOBP_REGULATION_OF_CELL_SIZE 7.31 7.34 7.54 7.1 7.6 7.66 7.92 7.9 7.53 7.72 7.24 7.77 7.91 7.81 7.76 7.77 7.39 7.49 7.61 7.89 7.48 7.63 7.46 7.83 7.62 7.7
GOBP_RNA_SPLICING 7.25 7.46 7.7 7.56 7.73 7.71 7.6 7.66 7.61 7.71 7.47 7.65 7.61 7.56 7.78 7.78 7.51 7.4 7.57 7.74 7.46 7.79 7.66 7.85 7.71 7.68
GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 6.58 6.72 7.04 6.79 6.77 6.84 6.83 6.98 6.77 6.91 6.79 6.72 7.07 6.99 7.07 7 6.81 6.88 6.89 6.98 6.9 6.9 7.09 7.22 6.9 6.89
GOBP_EPIDERMIS_DEVELOPMENT 5.33 5.26 5.14 5.34 4.84 4.76 5.13 4.93 5.06 4.88 5.27 4.89 4.93 4.91 5.03 4.87 5.16 5.31 4.98 4.84 5.27 5 4.9 4.63 4.96 4.9
GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY 6.81 6.59 6.82 6.91 6.67 6.92 6.73 7.02 6.49 6.75 6.7 6.68 6.71 6.67 6.64 6.62 6.81 6.99 6.82 6.88 6.65 6.61 6.9 6.65 6.73 6.95
GOBP_REGULATION_OF_NOTCH_SIGNALING_PATHWAY 6.83 6.91 6.99 6.81 7.09 7.25 7.23 7.24 6.96 7.13 6.94 7.29 7.4 7.26 7.03 7.09 6.98 7.01 6.94 7.18 7.26 7.36 7.35 7.14 7.06 7.33
GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE 6.34 5.86 6.55 6.32 6.26 6.23 5.89 6.23 6.41 6.68 6.61 6.52 6.03 6.01 6.14 6.21 6.35 6.43 6.1 5.59 6.18 6.43 6.29 6.04 6.12 5.72
GOBP_LIPID_BIOSYNTHETIC_PROCESS 6.82 6.86 7.12 7.01 6.98 7.03 7.04 6.93 7.04 7.03 6.84 6.95 7.12 7.02 7.02 6.91 6.88 6.76 6.89 7.06 6.91 6.96 7.05 7.17 7.11 7.1
GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS 6.1 6.14 6.51 6.58 6.14 5.88 6.02 6.36 6.23 6.2 6.27 6.17 6.17 6.07 6.24 6.16 6.29 6.37 6.06 6.02 6.34 6.29 6.11 6.04 6.41 6.53
GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE 6.29 6.47 6.52 6.63 6.34 6.34 6.41 6.53 6.5 6.46 6.45 6.36 6.55 6.53 6.51 6.64 6.41 6.36 6.22 6.44 6.57 6.65 6.64 6.67 6.57 6.7
GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS 7.23 7.35 7.99 7.71 8.01 7.89 7.83 7.63 7.91 7.67 7.99 7.9 7.41 7.78 7.75 8.25 7.33 7.31 7.89 7.47 7.62 7.65 7.95 7.62 7.74 7.74
GOBP_APOPTOTIC_MITOCHONDRIAL_CHANGES 6.98 7 7.85 7.5 7.29 7.17 7.72 7.27 7.49 7.52 7.2 7.54 7.31 7.16 7.41 7.07 7.28 7.04 7.28 7.38 7.45 7.21 7.06 7.8 7.35 7.31
GOBP_CARBOHYDRATE_TRANSPORT 6.41 6.44 6.42 6.64 6.5 6.41 6.54 6.62 6.39 6.59 6.4 6.64 6.5 6.76 6.58 6.55 6.46 6.54 6.38 6.6 6.45 6.5 6.29 6.53 6.26 6.47
GOBP_CELLULAR_AMINO_ACID_BIOSYNTHETIC_PROCESS 6.78 6.93 7.36 7.14 7.17 7.06 6.91 7.01 6.96 6.92 7.12 7.18 7.02 7.06 7.05 6.85 6.89 6.98 7.13 7.12 6.9 7.03 6.92 7.2 6.81 6.93
GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS 7.15 7.24 7.54 7.41 7.4 7.52 7.47 7.33 7.44 7.55 7.27 7.32 7.6 7.52 7.45 7.25 7.24 7.27 7.32 7.52 7.12 7.27 7.52 7.6 7.43 7.45
GOBP_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE 5.56 5.58 6.08 6.13 5.84 6.05 5.96 6.05 5.66 6.39 5.84 6 5.75 5.72 5.93 6.37 5.73 5.63 5.61 6.31 6.26 6.07 5.8 5.84 5.94 6.32
GOBP_MACROMOLECULE_CATABOLIC_PROCESS 7.19 7.28 7.69 7.58 7.52 7.54 7.49 7.47 7.52 7.51 7.45 7.45 7.56 7.6 7.53 7.49 7.38 7.32 7.44 7.57 7.35 7.52 7.6 7.67 7.58 7.46
GOBP_AEROBIC_RESPIRATION 7.89 8.1 9.03 8.54 8.27 8.36 8.42 8.65 8.43 8.53 8.42 8.5 8.44 8.44 8.64 8.62 8.23 8.1 8.43 8.6 8.53 8.54 8.63 8.76 8.52 8.35
GOBP_FATTY_ACID_CATABOLIC_PROCESS 6.41 6.54 7.04 7.02 6.6 6.83 6.75 6.77 6.8 6.75 6.76 6.84 6.74 6.67 6.67 6.95 6.57 6.66 6.66 6.88 6.74 6.84 6.77 7.03 6.81 7.07
GOBP_CELLULAR_AMINO_ACID_CATABOLIC_PROCESS 6.3 6.3 6.9 6.66 6.42 6.39 6.47 6.53 6.29 6.47 6.55 6.48 6.53 6.43 6.35 6.54 6.41 6.59 6.47 6.66 6.8 6.73 6.33 6.41 6.57 6.43
GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS 6.52 6.43 7.03 6.79 6.53 6.57 6.51 6.76 6.44 6.55 6.58 7.01 6.62 6.61 6.46 6.62 6.72 6.81 6.83 6.85 6.91 6.76 6.58 6.6 6.67 6.73
GOBP_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS 6.84 7.06 7.9 7.65 7.45 7.06 7.72 7.38 7.52 8.05 7.93 8.22 8.32 7.95 7.2 7.79 7.75 7.43 7.57 7.39 7.92 7.91 7.93 7.4 8.19 8.34
GOBP_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS 7.03 7.34 7.48 7.14 7.45 7.63 7.59 7.38 7.52 7.6 7.24 7.53 7.74 7.57 7.33 7.66 7.38 7.37 7.57 7.61 7.24 7.59 7.5 7.44 7.42 7.84
GOBP_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS 7.04 7.63 7.48 7.22 7.78 7.66 7.54 7.26 7.65 7.42 7.23 7.43 7.93 7.73 7.39 7.64 7.37 7.21 7.48 7.65 7.13 7.6 7.5 7.49 7.3 7.52
GOBP_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS 6.53 7.06 7.15 6.9 7.12 7.06 7.49 7.38 7.19 7.68 7.24 7.78 8.32 7.95 7.2 7.79 7.35 7.06 7.57 7.39 7.16 7.63 7.41 7.05 7.42 7.9
GOBP_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS 6.21 6.23 6.65 7.16 6.46 6.35 6.25 6.32 6.3 6.58 6.53 6.3 6.37 6.26 6.28 6.18 6.38 6.44 6.31 6.58 6.66 6.63 6.07 6.35 6.39 6.43
GOBP_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS 6.44 6.45 6.72 7.3 6.47 6.39 6.56 6.47 6.61 6.48 6.47 6.35 6.75 6.26 6.45 6.27 6.89 6.89 6.53 6.67 6.63 6.72 6.59 6.66 6.32 6.35
GOBP_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS 6.14 6.23 6.03 7.16 6.46 6.33 6.21 6.07 6 6.3 6.43 6.3 6.37 6.26 6 6.08 6.38 5.66 6.36 6.77 6.94 6.66 5.74 6.07 6.29 6.44
GOBP_AROMATIC_AMINO_ACID_FAMILY_METABOLIC_PROCESS 5 4.87 4.8 4.69 4.44 4.19 4.77 4.64 4.68 4.51 4.6 4.49 4.36 4.14 4.63 4.59 4.76 4.62 4.68 4.34 4.65 4.45 4.51 4.29 4.51 4.56
GOBP_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS 5.05 4.81 4.54 4.87 4.44 4.12 4.54 4.64 4.75 4.6 4.62 4.46 4.36 4.11 4.63 4.59 4.76 4.59 4.68 4.34 4.8 4.4 4.38 4.29 4.51 4.56
GOBP_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS 6.91 6.99 7.7 7.24 7.48 7.39 7.31 7.55 7.41 7.24 7.2 7.35 7.61 7.32 7.3 7.55 7 7.1 7.18 7.53 7.07 7.66 7.42 7.72 7.58 7.68
GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS 6.76 6.95 8.15 7.34 6.86 6.85 7.17 7.11 7.05 7.06 7.9 7.34 7.26 6.92 7.07 7.14 6.7 7.13 7.08 7.32 6.93 7.53 7.08 7.3 6.88 6.79
GOBP_METHIONINE_BIOSYNTHETIC_PROCESS 7.05 7.34 7.49 7.34 7.88 7.69 7.7 7.15 7.23 7.23 7.21 7.07 6.92 7.07 7.33 7.04 7.8 6.68 7.25 7.87 7.29 7.59 6.89 7.3 8 7.21
GOBP_GLYCOPROTEIN_METABOLIC_PROCESS 6.82 6.79 6.94 6.89 7.02 7.01 7.06 7.01 6.99 6.86 6.77 6.88 7.05 6.97 6.96 6.87 6.85 6.74 6.86 6.98 6.72 6.84 6.97 7.03 6.95 6.92
GOBP_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS 6.83 6.8 6.95 6.89 7.03 7.07 7.12 7.01 7.07 6.92 6.82 6.9 7.13 7.01 6.97 6.92 6.88 6.76 6.88 7.03 6.73 6.91 7.03 7.08 6.99 7.02
GOBP_VITAMIN_BIOSYNTHETIC_PROCESS 5.79 6.23 6.42 7.3 6.45 6.5 6.1 6.49 6.44 6.5 6.36 6.23 6.53 6.58 6.35 6.85 6.55 6.11 6.23 6.14 6.09 6.38 6.82 6.82 6.77 6.4
GOBP_VITAMIN_CATABOLIC_PROCESS 5.49 5.22 4.94 5.3 4.8 4.5 4.89 4.9 4.89 4.78 4.82 4.9 4.71 5 5.03 4.84 4.87 5.03 4.52 4.53 5.03 4.94 4.72 4.37 4.8 4.74
GOBP_NUCLEOBASE_METABOLIC_PROCESS 6.5 6.75 6.74 6.83 6.84 6.99 7.02 6.77 6.74 6.85 6.32 6.49 6.71 6.52 6.8 6.73 6.41 6.43 6.65 6.66 6.58 6.98 6.58 6.72 6.77 6.77
GOBP_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS 6.45 6.52 7.1 7.69 7.1 7.14 7.05 7.13 6.96 6.99 6.77 7.05 6.84 6.91 6.91 7.04 6.96 7.07 6.75 7.23 6.9 7.11 6.68 6.85 6.69 7.13
GOBP_NUCLEOSIDE_METABOLIC_PROCESS 6.09 6.21 6.62 6.74 6.59 6.7 6.08 6.44 6.41 6.32 6.62 6.49 6.5 6.36 6.28 6.51 6.33 6.48 6.44 6.38 6.21 6.46 6.21 6.66 6.56 6.63
GOBP_RIBONUCLEOSIDE_METABOLIC_PROCESS 6.12 6.55 6.82 6.8 6.68 6.96 6.77 6.67 6.72 6.82 6.8 6.62 6.72 6.56 6.57 6.87 6.75 6.63 6.65 6.67 6.49 6.62 6.6 6.76 7.02 6.72
GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS 6.5 6.69 6.87 6.76 6.84 6.89 7.05 6.78 6.78 6.85 6.62 6.63 6.83 6.89 6.81 6.87 6.86 6.65 6.77 6.96 6.54 6.74 6.72 6.92 6.8 6.75
GOBP_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS 6.61 6.84 7.26 7.07 6.87 6.86 7.05 7.03 6.75 6.85 6.69 6.78 6.84 6.86 6.88 6.9 6.85 6.66 6.83 7.04 6.75 6.75 6.58 6.98 6.81 6.75
GOBP_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS 5.52 5.24 6.06 5.79 5.36 5.21 5.73 5.34 5.35 5.51 5.63 5.13 5.31 5.34 5.44 5.58 5.65 5.16 5.09 4.8 5.61 5.51 5.36 4.92 5.49 5.39
GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS 6.86 7.05 7.72 7.45 7.28 7.24 7.15 7.19 7.03 7.13 7.05 7.31 7.18 7.36 6.97 7.29 7.12 6.96 7.08 7.46 6.85 7.23 6.96 7.3 7.15 7.27
GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS 6.96 7.47 7.95 7.69 7.13 7.24 7.13 7.29 7.03 7.03 7.69 7.26 7.18 7.01 7.19 7.46 7.03 7.02 7.15 7.46 6.85 7.23 7.13 7.39 7.15 7.27
GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS 5.6 5.72 5.6 5.79 5.68 5.61 5.56 5.44 5.52 5.79 5.77 5.57 5.44 5.6 5.61 5.6 5.65 5.53 5.85 5.55 5.65 5.67 5.5 5.44 5.44 5.57
GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS 6.21 6.06 6.09 6.38 6.32 6.49 5.71 6.29 5.89 6.06 5.8 6.06 6.03 5.97 6.24 6.29 5.77 5.74 5.95 5.95 5.92 5.88 6.14 6.22 6.16 6.42
GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS 7.32 7.21 7.39 7.49 7.4 7.56 7.43 7.4 7.42 7.47 7.43 7.46 7.3 7.48 7.42 7.51 7.36 7.22 7.49 7.52 7.2 7.39 7.44 7.51 7.39 7.35
GOBP_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS 6.17 6.02 6.38 6.5 6.19 6.23 6.59 6.65 6.31 6.39 6.33 6.53 6.73 6.4 6.42 6.66 6.25 6.55 6.14 6.37 6.93 6.57 6.4 6.34 6.49 6.57
GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS 6.57 6.93 7.24 7.05 6.9 7.16 7 6.96 6.86 7.13 7.01 7.08 7.09 7.06 6.65 7.14 6.95 6.76 6.86 6.81 6.74 6.77 6.91 6.93 6.97 6.95
GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS 6.78 7.17 7.76 7.37 6.88 7.2 7.08 7.02 6.84 7.01 7.21 7.28 7.06 7.28 6.86 7.36 6.92 6.89 7.27 6.99 6.88 7 7.01 7.07 6.89 7.05
GOBP_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS 5.53 5.4 5.51 5.83 5.44 5.44 5.43 5.79 5.59 5.41 5.64 5.55 5.39 5.76 5.77 5.5 5.3 5.64 5.68 5.64 5.6 5.85 5.37 5.57 5.73 5.77
GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS 6.6 6.93 7.19 7.3 6.87 7 6.87 7.01 6.59 6.67 7.12 6.85 6.97 6.81 6.83 6.96 6.59 6.83 7.15 6.78 6.75 7 6.63 6.67 6.77 7.19
GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS 6.45 6.55 6.87 6.74 6.84 6.83 6.67 6.76 6.56 6.64 6.69 6.65 6.91 6.8 6.75 6.93 6.44 6.8 6.9 6.76 6.55 6.99 6.55 6.63 6.73 6.95
GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS 5.9 6.17 6.27 6.58 7.12 7.34 7.08 7.09 6.99 7.13 7.36 6.86 7.18 7.34 6.65 6.88 6.88 6.51 6.75 7.13 5.94 6.34 6.74 6.68 6.97 6.75
GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS 6.61 6.84 7.26 7.07 6.81 6.86 7.05 7.23 6.75 6.85 6.69 6.78 6.84 6.86 6.91 6.9 6.89 6.73 6.83 7.04 6.75 6.99 6.44 6.98 6.74 7.05
GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS 6.71 6.93 6.88 6.77 6.84 7.05 7.05 6.94 6.87 6.85 6.74 6.94 6.86 6.93 6.87 6.88 6.89 6.8 6.9 7.12 6.7 6.93 6.74 6.93 6.8 7.02
GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS 5.56 5.22 5.56 5.64 5.16 5.16 5.71 5.26 5.13 5.63 5.68 5.35 5.16 5.4 5.23 5.82 5.67 5.23 5.18 4.9 5.56 5.76 5.5 5.36 5.51 5.64
GOBP_NUCLEOSIDE_CATABOLIC_PROCESS 5.38 5.24 5.71 5.55 5.09 5.03 5.05 5.14 5.35 4.91 5.52 5.13 5.1 5 5.42 5.35 5.38 5.35 5.01 4.98 5.35 5.23 4.86 4.72 5.3 5.15
GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS 5.6 5.72 6.06 5.79 5.68 5.61 5.38 5.44 5.46 5.66 5.61 5.53 5.44 5.6 5.21 5.49 5.47 5.65 5.85 5.55 5.65 5.64 5.31 5.44 5.31 5.39
GOBP_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS 6.49 6.37 6.37 6.61 6.48 6.77 6.62 6.37 6.31 6.77 6.47 6.75 6.71 6.4 6.71 6.16 6.57 6.43 6.57 6.42 6.48 6.33 6.27 6.55 6.59 6.7
GOBP_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS 5.72 5.53 5.46 5.78 5.45 5.42 5.88 5.91 5.72 5.79 5.78 5.26 5.61 5.49 5.95 5.6 6.05 5.7 5.55 5.67 5.93 5.95 5.42 5.51 5.83 5.79
GOBP_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS 6.78 7.09 7.42 7.3 7.01 7.2 6.97 6.87 6.88 7.09 7.48 7.26 7.09 7.28 6.7 7.23 6.96 6.83 7.05 6.83 6.77 6.89 6.99 7.08 7.02 6.99
GOBP_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS 6.42 6.17 6.27 6.03 7.12 6.58 7 6.64 6.56 7 6.28 6.46 6.64 6.52 6.36 6.69 6.69 6.31 6.24 6.51 5.92 6.34 6.72 6.66 6.82 6.66
GOBP_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS 6.75 7.05 7.24 7.05 6.84 6.87 6.87 6.76 6.61 6.79 7.01 7.04 6.91 7.21 6.75 7.21 6.76 6.8 7.15 6.81 6.62 6.83 6.91 6.75 6.67 6.95
GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS 6.75 7.31 7.5 7.86 6.84 7.16 7.06 7.26 6.61 6.7 7.55 7.04 7.03 6.82 6.92 6.99 6.73 6.87 7.48 6.81 6.94 7 6.55 6.71 6.73 7.42
GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS 6.54 6.93 7.34 7.33 6.77 7 6.87 7.01 6.51 6.67 7.12 6.85 6.97 6.81 6.83 6.96 6.59 6.83 7.19 6.78 6.75 7 6.38 6.66 6.7 7.19
GOBP_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS 7.88 7.83 7.57 7.57 9.3 8.78 8.13 8.51 8.14 8.43 7.83 7.93 7.89 8.19 7.99 7.98 8.11 7.71 8.28 8.42 8.14 8.13 8.2 8.19 7.88 7.96
GOBP_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS 6.28 6.42 6.75 6.74 6.65 6.61 6.02 6.69 6.31 6.32 6.62 6.49 6.33 6.74 6.57 6.6 6.32 6.66 6.58 6.43 6.32 6.51 6.19 6.4 6.48 6.76
GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS 5.63 5.69 6.07 5.84 5.43 5.68 5.87 5.81 5.84 5.82 5.82 5.77 5.83 5.81 5.73 5.92 5.71 5.53 5.71 5.55 5.53 5.73 5.84 5.85 5.7 5.88
GOBP_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS 6.29 6.55 6.87 6.76 6.7 6.73 6.59 6.75 6.41 6.59 6.62 6.52 6.75 6.8 6.75 6.74 6.33 6.67 6.58 6.73 6.44 6.74 6.21 6.61 6.56 6.79
GOBP_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS 6.68 6.59 7.22 6.81 6.71 6.83 6.71 6.6 6.66 6.65 6.88 6.69 6.74 6.72 6.93 6.74 6.56 6.8 6.86 6.91 6.57 6.43 7.05 6.76 6.68 6.74
GOBP_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS 6.67 6.56 7.26 6.96 6.51 6.74 6.82 6.42 6.79 6.65 6.9 6.62 6.7 6.79 7.12 6.78 6.51 6.7 6.86 6.86 6.37 6.28 7.08 6.79 6.69 6.27
GOBP_COBALAMIN_METABOLIC_PROCESS 6.18 6.3 6.5 6.57 6.15 6.01 6.55 6.51 6.36 6.1 5.95 6.18 6.65 6.27 6.02 6.1 6.42 5.9 6.25 6.44 5.98 6.07 6.08 6.11 6.58 6.54
GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS 7.14 7.14 7.16 7.11 7.25 7.53 7.54 7.18 7.31 7.31 6.83 7.02 7.33 7.14 7.16 6.94 7.11 6.83 7.08 7.57 6.86 6.99 7.1 7.23 7.33 7.25
GOBP_GLUCAN_BIOSYNTHETIC_PROCESS 6.44 6.65 6.62 6.9 6.78 7 6.97 7.16 7.05 7.05 6.54 6.86 7.25 6.97 7.16 7.16 6.83 6.91 6.88 7.16 6.78 6.87 7.18 7.12 6.91 6.98
GOBP_RIBONUCLEOTIDE_CATABOLIC_PROCESS 6.22 6.15 6.53 6.44 6.49 6.47 6.66 6.71 6.79 6.92 6.29 6.78 6.97 6.63 6.69 6.62 6.54 6.53 6.43 6.4 6.69 6.79 6.41 6.74 6.8 6.74
GOBP_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS 5.66 5.84 6.22 6.18 5.71 5.99 5.97 6.01 5.97 6.05 5.96 5.99 5.91 6.02 5.79 6.04 5.84 5.86 5.94 5.86 5.66 5.96 6.05 6.31 5.92 6.14
GOBP_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS 6.96 7.41 7.95 7.77 7.36 7.46 7.51 6.97 7.17 7.57 7.95 7.45 7.27 7.55 7.26 7.21 7.07 6.73 7.39 7.6 6.81 6.83 7.53 7.75 7.3 6.83
GOBP_RESPONSE_TO_TEMPERATURE_STIMULUS 6.83 6.92 7.42 7.17 7.14 7.2 7.28 7.22 7.36 7.25 6.97 7.03 7.27 7.22 7.31 7.36 7.08 6.93 7.07 7.2 7.29 7.46 7.35 7.35 7.26 7.2
GOBP_CELLULAR_RESPONSE_TO_STARVATION 6.92 7 7.29 7.13 7.18 7.11 7.16 7.27 7.19 7.17 7.12 7.13 7.29 7.18 7.5 7.24 7.17 6.99 7.1 7.36 7.15 7.38 7.11 7.47 7.24 7.2
GOBP_RESPONSE_TO_PH 5.83 5.61 5.56 5.59 5.13 4.98 5.22 5.52 5.37 5.1 5.56 5.28 5.09 5.2 5.28 5.41 5.72 5.35 5.39 5.44 5.68 5.57 5.27 5.28 5.37 5.26
GOBP_MRNA_TRANSCRIPTION 7.56 7.45 7.33 7.58 7.97 7.78 7.81 7.54 7.86 8.19 7.82 8.26 7.97 7.73 7.79 7.71 7.97 7.42 7.69 7.89 7.43 7.6 7.8 7.98 8.18 7.91
GOBP_SNRNA_TRANSCRIPTION 6.98 7.41 7.9 7.74 7.56 7.54 7.3 7.68 7.64 7.79 7.77 7.63 7.68 7.55 7.78 7.84 7.5 7.24 7.21 7.56 7.29 7.83 7.53 7.78 7.73 7.52
GOBP_RRNA_TRANSCRIPTION 6.63 6.71 6.85 6.78 6.7 6.84 6.7 7.17 6.64 6.86 6.67 6.81 6.55 6.64 7.06 7.1 6.79 6.45 6.66 7.05 6.6 7.08 6.86 7.17 6.91 7.21
GOBP_AMINE_METABOLIC_PROCESS 6.56 6.7 7.21 6.93 6.4 6.54 6.73 6.72 6.79 6.79 7.03 6.58 6.66 6.86 6.82 6.84 6.53 6.56 6.67 6.72 6.57 6.89 6.8 6.94 6.86 6.67
GOBP_AMINE_BIOSYNTHETIC_PROCESS 5.81 5.76 5.98 6.25 5.44 5.27 5.63 5.78 5.52 5.65 6.04 5.52 5.63 5.71 5.85 5.85 5.69 5.41 5.49 5.37 5.6 5.9 5.67 5.27 5.3 5.43
GOBP_AMINE_CATABOLIC_PROCESS 6.15 5.88 6.18 6.33 5.97 6.1 6.11 5.8 5.92 6.08 6.91 6.11 6.01 6.3 6.16 6.19 6.01 6.01 5.9 6.02 6.51 5.88 5.94 5.83 6.35 6.4
GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS 6.25 6.37 6.86 6.71 6.79 6.57 6.59 6.52 6.56 6.53 6.66 6.62 6.64 6.62 6.5 6.45 6.37 6.1 6.37 6.75 6.15 6.46 6.49 6.58 6.5 6.43
GOBP_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS 6.26 6.41 8.01 6.64 7.64 7.63 7.81 7.46 8.16 8.05 7.52 7.44 7.93 8.03 8.21 8 7.08 6.89 7.67 7.33 6.99 7.59 8.39 7.71 7.63 7.28
GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS 6.15 6.06 7.12 6.65 6.8 6.52 6.57 6.52 6.67 6.53 6.66 6.75 6.74 6.98 6.34 6.41 6.76 6.63 6.94 6.85 6.4 6.43 6.51 6.6 6.5 6.43
GOBP_RESPONSE_TO_RADIATION 6.43 6.42 6.65 6.69 6.37 6.51 6.52 6.68 6.46 6.65 6.41 6.48 6.57 6.58 6.57 6.56 6.45 6.35 6.52 6.61 6.39 6.58 6.62 6.72 6.63 6.64
GOBP_PHOSPHOLIPID_CATABOLIC_PROCESS 6.57 6.44 6.6 6.71 6.89 6.81 6.87 6.77 6.67 6.91 6.66 6.75 6.84 6.67 6.62 6.82 6.84 6.52 6.37 6.64 6.81 6.78 6.64 6.73 6.53 6.71
GOBP_TOXIN_METABOLIC_PROCESS 6.02 5.81 5.66 6.16 6.26 6.36 5.93 5.78 5.62 6.13 5.99 5.95 5.83 5.93 6.02 5.37 6.38 5.69 5.78 5.75 5.75 5.75 6.13 6.01 5.86 5.79
GOBP_RESPONSE_TO_HEAT 7.29 7.2 7.78 7.65 7.47 7.47 7.44 7.4 7.5 7.42 7.49 7.38 7.39 7.5 7.53 7.45 7.32 7.14 7.22 7.32 7.3 7.53 7.48 7.59 7.4 7.35
GOBP_RESPONSE_TO_COLD 6.44 6.48 7.12 6.69 6.58 6.62 6.77 6.74 6.95 6.95 6.27 6.45 6.89 6.8 6.9 6.76 6.43 6.5 6.76 6.86 7.26 7.19 6.93 6.86 6.42 6.74
GOBP_RESPONSE_TO_XENOBIOTIC_STIMULUS 5.81 5.64 6.02 6.28 5.6 5.5 5.65 5.65 5.77 5.76 5.72 5.83 5.68 5.45 5.71 5.6 5.58 5.69 5.6 5.44 5.68 5.55 5.46 5.4 5.82 5.84
GOBP_RESPONSE_TO_UV 6.52 6.42 6.66 6.84 6.73 6.72 6.62 6.86 6.74 6.76 6.56 6.84 6.81 6.95 6.62 6.7 6.53 6.41 6.72 6.71 6.45 6.63 6.81 7.01 6.71 6.77
GOBP_RESPONSE_TO_WATER 6.17 6.19 6.19 6.29 6.09 6.2 6.49 6.02 6.06 6.26 6.26 6.2 5.87 5.97 6 5.78 6.26 6.06 5.89 6.27 6.36 5.91 6.11 5.98 5.9 5.98
GOBP_RESPONSE_TO_LIGHT_STIMULUS 6.5 6.48 6.74 6.76 6.52 6.69 6.75 6.89 6.67 6.77 6.52 6.61 6.84 6.92 6.92 6.77 6.49 6.45 6.73 6.76 6.51 6.75 6.71 6.92 6.75 6.75
GOBP_NAD_BIOSYNTHETIC_PROCESS 5.76 5.86 5.81 5.65 5.26 5.3 5.57 5.62 5.55 5.64 5.81 5.44 5.59 5.64 5.62 5.64 5.93 5.83 5.74 5.58 5.79 5.42 5.4 5.62 5.62 5.62
GOBP_CARNITINE_METABOLIC_PROCESS 5.82 6.03 6.4 6.29 6.15 6.15 5.75 5.58 5.72 5.79 6.47 6.14 6.23 6.75 5.6 5.94 6.2 6.47 6.04 6.05 6.2 6.02 5.62 6.1 5.9 5.79
GOBP_RNA_MODIFICATION 6.24 6.13 6.49 6.61 6.21 6.23 6.18 6.31 6.22 6.22 6.27 6.22 6.24 6.16 6.21 6.21 6.01 6.17 6.17 6.08 6.29 6.22 6.24 6.27 6.25 6.39
GOBP_FERTILIZATION 5.21 5.07 5.02 5.18 4.66 4.54 4.86 4.88 4.88 4.6 4.92 4.78 4.62 4.78 4.78 4.81 5 5.26 4.88 4.74 5.16 4.81 4.71 4.55 4.75 4.84
GOBP_DETECTION_OF_ABIOTIC_STIMULUS 5.49 5.48 5.45 5.44 5.31 5.12 5.5 5.51 5.41 5.26 5.38 5.1 5.3 5.25 5.43 5.21 5.38 5.52 5.09 5.07 5.4 5.27 5 5.04 5.28 5.16
GOBP_DETECTION_OF_LIGHT_STIMULUS 5.33 5.17 5.18 5.32 4.82 4.73 5.15 5.03 5.22 4.94 5.23 4.83 4.85 4.93 5.12 5.12 4.94 5.29 4.91 4.81 5.26 4.91 4.87 4.79 5.04 4.87
GOBP_DETECTION_OF_CHEMICAL_STIMULUS 4.56 4.5 4.06 4.23 3.9 3.79 4.04 4.07 4.09 3.86 4.22 4.08 3.88 3.87 3.98 3.9 4.26 4.53 4.14 4.03 4.36 4.05 3.84 3.78 3.9 4.02
GOBP_DETECTION_OF_BIOTIC_STIMULUS 5.38 5.18 4.99 5.04 4.99 4.71 4.82 4.85 5.23 4.72 4.94 4.73 4.96 4.91 4.91 4.93 4.84 5.11 5.17 5.08 5.15 4.75 4.6 4.72 4.97 5.1
GOBP_RESPONSE_TO_BIOTIC_STIMULUS 5.86 5.78 5.82 5.89 5.66 5.51 5.69 5.69 5.72 5.52 5.79 5.61 5.63 5.59 5.58 5.68 5.86 5.78 5.5 5.6 5.9 5.84 5.55 5.45 5.74 5.83
GOBP_RESPONSE_TO_WOUNDING 6.25 6.23 6.34 6.41 6.21 6.13 6.22 6.29 6.28 6.16 6.24 6.2 6.25 6.29 6.28 6.28 6.32 6.21 6.16 6.22 6.45 6.4 6.36 6.17 6.31 6.34
GOBP_RESPONSE_TO_MECHANICAL_STIMULUS 6.29 6.26 6.49 6.25 6.1 6.11 6.17 6.23 6.28 6.2 6.16 6.18 6.19 6.33 6.31 6.33 6.34 6.15 6.19 6.1 6.46 6.43 6.2 6.11 6.31 6.43
GOBP_RESPONSE_TO_VIRUS 5.95 5.98 6.03 5.9 6.13 5.91 5.98 6.02 6.1 6.08 6.17 6.03 6.03 6.01 5.95 6 6.06 5.98 6.02 5.99 6.06 6.05 5.93 5.98 6.05 6.08
GOBP_RESPONSE_TO_BACTERIUM 5.5 5.39 5.39 5.49 5.06 4.92 5.17 5.22 5.21 5.04 5.36 5.04 5.2 5.08 5.22 5.17 5.39 5.39 5.11 5.09 5.49 5.37 5.05 4.94 5.28 5.34
GOBP_RESPONSE_TO_FUNGUS 5.1 5.14 4.93 4.99 4.51 4.25 4.87 4.44 4.83 4.59 4.93 4.41 4.52 4.55 4.81 4.99 4.78 4.92 4.65 4.7 4.94 4.68 4.4 4.27 4.71 4.81
GOBP_RESPONSE_TO_ABIOTIC_STIMULUS 6.53 6.53 6.81 6.74 6.54 6.66 6.68 6.77 6.72 6.73 6.56 6.62 6.72 6.71 6.7 6.72 6.62 6.57 6.63 6.68 6.6 6.73 6.77 6.81 6.77 6.74
GOBP_RESPONSE_TO_TOXIC_SUBSTANCE 6.13 6.23 6.52 6.45 6.1 6.22 6.31 6.39 6.35 6.26 6.39 6.18 6.34 6.35 6.35 6.24 6.37 6.22 6.02 6.4 6.32 6.46 6.46 6.4 6.61 6.43
GOBP_PHOTOPERIODISM 7.06 7.45 6.77 6.97 7.37 7.35 7.51 7.54 7.25 7.34 7.48 7.2 7.53 7.59 7.14 7.57 7.73 7.55 7.55 7.58 7.4 7.42 7.05 7.55 7.24 7.55
GOBP_ENTRAINMENT_OF_CIRCADIAN_CLOCK 7.44 7.76 7.18 7.35 7.44 7.9 7.57 8.1 7.65 7.66 7.7 7.74 7.66 7.66 7.72 7.72 7.77 7.9 7.65 7.74 7.5 7.72 7.73 7.69 7.67 7.82
GOBP_UV_PROTECTION 6.75 6.93 7.56 7.25 6.91 6.93 7.17 7.16 7.2 6.95 6.68 6.92 7.02 7.2 7.17 7.11 6.92 7.04 7.11 7.25 6.73 7.36 6.71 7.33 7.31 7.28
GOBP_RESPONSE_TO_SALT_STRESS 5.87 6.07 6.19 6.21 5.73 5.77 6.14 5.85 5.71 5.52 5.4 6.04 5.85 5.78 5.47 5.61 6.24 5.99 5.51 6.06 5.59 5.79 5.77 6.03 5.86 5.8
GOBP_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.07 6.03 6.53 6.36 5.87 6.13 6.11 6 6.06 6 6.16 6.14 6.18 6.02 6.23 6.21 6.1 6.04 5.67 6.26 6.22 6.57 6.28 6.18 6.2 6.07
GOBP_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS 5.77 5.75 5.68 6.01 4.95 5.12 5.35 5.71 5.3 5.25 5.68 5.26 5.13 5.65 5.4 5.48 5.42 5.37 5.4 5.22 5.38 5.59 5.35 5.19 4.78 5.18
GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS 6.51 6.55 6.79 6.63 6.73 6.73 6.77 6.78 6.78 6.8 6.62 6.7 6.84 6.8 6.82 6.8 6.7 6.66 6.63 6.75 6.77 6.86 6.89 6.86 6.82 6.82
GOBP_RESPONSE_TO_HORMONE 6.53 6.55 6.88 6.67 6.86 6.89 6.78 6.85 6.89 6.83 6.7 6.77 6.84 6.87 6.83 6.8 6.75 6.68 6.67 6.86 6.78 6.86 6.9 6.88 6.86 6.82
GOBP_RESPONSE_TO_CARBOHYDRATE 6.41 6.46 6.82 6.72 6.69 6.65 6.67 6.78 6.8 6.86 6.78 6.68 6.6 6.67 6.75 6.71 6.6 6.73 6.56 6.7 6.8 6.82 6.82 6.68 6.7 6.67
GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY 6.82 6.73 6.98 6.84 6.98 7.09 6.97 7.04 7.02 7.12 6.85 6.96 7.04 7.02 7.06 7 7.02 6.84 6.89 6.96 6.82 6.99 7.08 7.32 6.95 6.91
GOBP_EMBRYO_DEVELOPMENT 6.02 6.03 6.09 6.14 6.05 6.04 6.08 6.14 6.08 6.08 6.09 6.06 6.06 6.04 6.05 6.01 6.1 6.07 6 6.01 6.17 6.15 6.1 6.03 6.11 6.16
GOBP_POST_EMBRYONIC_DEVELOPMENT 6.69 6.71 6.57 6.66 7.06 6.78 6.81 6.92 7.06 6.97 6.49 6.81 7.01 7.04 6.65 6.57 6.83 6.78 6.54 6.91 6.71 6.77 7.06 6.88 6.86 6.81
GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING 6.05 6.15 6.18 6.18 6.22 6.16 6.2 6.21 6.16 6.21 6.22 6.15 6.21 6.2 6.18 6.15 6.24 6.17 6.06 6.13 6.19 6.19 6.16 6.17 6.19 6.32
GOBP_AXIS_SPECIFICATION 5.91 5.8 6.06 6.06 5.83 5.63 5.83 5.91 5.71 6.14 5.96 6.06 6.01 5.93 5.88 6.01 5.9 5.94 5.79 5.7 5.96 6.13 5.86 5.89 5.8 6.05
GOBP_SPECIFICATION_OF_SYMMETRY 5.72 5.77 5.68 5.99 5.4 5.4 5.7 5.75 5.45 5.82 5.76 5.72 5.54 5.51 5.77 5.69 5.53 5.58 5.75 5.38 5.84 6 5.71 5.54 5.56 5.72
GOBP_EMBRYONIC_PATTERN_SPECIFICATION 6.04 6.06 6.17 5.8 6.12 6.24 6.09 5.96 6.27 6.12 6.19 6.06 6.14 6.03 6.06 6.02 6.18 5.94 5.93 6.09 6.19 6.3 5.97 6.22 6.04 6.03
GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS 6.13 6.22 5.84 5.66 5.89 6.05 5.76 5.64 5.67 5.73 5.46 5.9 5.76 5.69 5.8 6.19 6.02 5.95 5.72 6 5.84 5.8 5.97 5.85 5.87 6.08
GOBP_ANIMAL_ORGAN_MORPHOGENESIS 5.98 5.99 5.98 6.12 5.87 5.83 5.98 6.07 6 6 6.05 5.91 5.95 5.94 6 6 6.01 5.98 5.9 5.91 6.14 6.09 6.01 5.85 5.98 6.12
GOBP_NEGATIVE_REGULATION_OF_BIOSYNTHETIC_PROCESS 6.45 6.45 6.59 6.56 6.59 6.61 6.57 6.62 6.53 6.61 6.53 6.6 6.68 6.63 6.59 6.63 6.61 6.5 6.5 6.63 6.62 6.73 6.62 6.7 6.64 6.63
GOBP_POSITIVE_REGULATION_OF_BIOSYNTHETIC_PROCESS 6.4 6.4 6.52 6.53 6.47 6.5 6.51 6.59 6.52 6.57 6.46 6.49 6.57 6.57 6.55 6.57 6.52 6.41 6.38 6.54 6.55 6.65 6.58 6.64 6.57 6.59
GOBP_REGULATION_OF_CATABOLIC_PROCESS 7.33 7.4 7.73 7.6 7.66 7.69 7.64 7.63 7.68 7.69 7.55 7.7 7.75 7.73 7.7 7.7 7.45 7.38 7.54 7.71 7.5 7.73 7.75 7.84 7.71 7.64
GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS 7.19 7.35 7.53 7.46 7.46 7.6 7.39 7.37 7.58 7.66 7.44 7.55 7.63 7.65 7.58 7.57 7.38 7.34 7.49 7.53 7.35 7.62 7.62 7.67 7.64 7.55
GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS 7.18 7.33 7.5 7.46 7.52 7.53 7.48 7.55 7.6 7.55 7.42 7.54 7.62 7.59 7.58 7.55 7.37 7.21 7.34 7.58 7.41 7.58 7.67 7.77 7.61 7.46
GOBP_EPIDERMAL_CELL_DIFFERENTIATION 5.2 5.11 5 5.26 4.61 4.53 5 4.8 4.88 4.67 5.1 4.79 4.76 4.65 4.88 4.69 4.93 5.17 4.72 4.65 5.14 4.84 4.64 4.48 4.77 4.69
GOBP_HORMONE_TRANSPORT 6.3 6.19 6.38 6.33 6.23 6.14 6.46 6.4 6.35 6.38 6.35 6.21 6.26 6.31 6.51 6.45 6.31 6.41 6.35 6.33 6.32 6.53 6.29 6.36 6.26 6.42
GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION 5.68 5.65 5.68 6 5.53 5.4 5.49 5.59 5.55 5.62 5.71 5.58 5.78 5.5 5.63 5.56 5.53 5.53 5.19 5.46 5.68 5.65 5.41 5.54 5.69 5.82
GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION 5.57 5.52 5.59 5.74 5.33 5.4 5.53 5.47 5.56 5.56 5.66 5.54 5.61 5.62 5.62 5.53 5.45 5.53 5.45 5.51 5.52 5.56 5.47 5.53 5.42 5.44
GOBP_DORSAL_VENTRAL_PATTERN_FORMATION 5.7 5.64 5.8 5.93 5.56 5.5 5.65 5.62 5.61 5.4 5.8 5.45 5.63 5.59 5.75 5.69 5.53 5.69 5.54 5.49 5.87 5.88 5.66 5.68 5.7 5.84
GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION 5.08 4.98 5.1 5.26 4.64 4.56 4.84 4.98 4.95 4.85 5 4.69 4.89 4.74 4.76 4.84 4.85 4.89 4.77 4.76 4.98 4.85 4.85 4.46 4.75 4.84
GOBP_CELL_CELL_RECOGNITION 5.01 5.03 4.92 5.05 4.59 4.49 4.71 4.73 4.89 4.6 4.79 4.72 4.69 4.69 4.7 4.69 4.85 5.07 4.71 4.74 5.08 4.81 4.76 4.57 4.72 4.91
GOBP_RESPONSE_TO_EXTRACELLULAR_STIMULUS 6.3 6.34 6.6 6.49 6.33 6.54 6.52 6.53 6.48 6.52 6.3 6.43 6.62 6.51 6.45 6.6 6.48 6.42 6.33 6.52 6.67 6.73 6.47 6.58 6.61 6.62
GOBP_OOCYTE_DIFFERENTIATION 5.63 5.5 5.59 5.53 5.23 5.02 5.31 5.33 5.43 5.34 5.51 5.28 5.03 5.15 5.6 5.18 5.27 5.5 5.4 5.12 5.37 5.32 5.12 5.11 5.18 5.32
GOBP_GLIAL_CELL_DIFFERENTIATION 6.78 6.9 7.12 6.9 7.22 7.27 7.17 7.27 7.27 7.28 6.93 7.26 7.46 7.32 7.18 7.28 7.23 7.02 7 7.48 7.1 7.3 7.19 7.34 7.17 7.42
GOBP_CARDIOBLAST_DIFFERENTIATION 6.03 5.85 5.69 6.2 5.72 5.89 5.93 5.81 6.09 6.01 6.15 6.3 5.91 5.88 5.71 6.01 5.68 5.78 6.14 5.78 5.94 5.77 6.04 5.66 6.11 6.12
GOBP_RESPONSE_TO_INORGANIC_SUBSTANCE 6.53 6.52 6.87 6.73 6.59 6.71 6.73 6.75 6.76 6.78 6.61 6.57 6.76 6.67 6.78 6.72 6.69 6.6 6.6 6.76 6.77 6.69 6.77 6.8 6.71 6.74
GOBP_RESPONSE_TO_METAL_ION 6.84 6.69 7.05 6.92 6.87 6.82 6.82 6.92 6.91 6.89 6.76 6.92 6.91 6.89 6.96 6.75 6.87 6.78 6.67 7.01 6.85 6.97 6.95 6.91 6.96 7.01
GOBP_RESPONSE_TO_IRON_ION 6.36 6.33 6.58 6.32 6.23 6.36 6.65 6.85 6.27 6.64 6.52 6.38 6.88 6.76 6.65 6.62 6.78 6.66 6.46 6.83 6.71 6.7 6.62 6.88 7.06 6.96
GOBP_RESPONSE_TO_MANGANESE_ION 7 6.95 7.79 6.79 7.51 7.4 7.38 7.09 7.93 7.64 7.3 7.63 7.88 7.63 7.43 7.42 7.38 6.81 7.56 7.17 7.49 7.45 7.76 7.59 7.57 7.34
GOBP_RESPONSE_TO_ZINC_ION 5.98 5.76 6.63 6.59 5.74 5.8 6.11 5.99 6.13 6.12 5.99 5.6 5.74 5.7 6.13 5.95 5.95 6.21 5.65 5.77 6.42 5.93 6.17 5.68 5.92 6.32
GOBP_SPECIFICATION_OF_ANIMAL_ORGAN_IDENTITY 5.61 5.53 5.49 5.31 4.95 4.99 5.33 5.37 5.05 5.07 5.56 5 5.1 4.87 5.27 5.36 5.33 5.53 5.32 4.96 5.39 5.34 5.07 5.04 5.3 5.03
GOBP_REGULATION_OF_PROTON_TRANSPORT 6.27 6.39 7.07 6.46 6.34 6.69 6.65 6.95 6.32 6.49 6.48 6.24 6.33 6.27 6.7 6.65 6.26 6.69 6.59 6.78 6.36 6.72 6.53 6.54 6.48 6.41
GOBP_RESPONSE_TO_X_RAY 6.04 6.36 6.15 6.43 6.24 6.48 6.62 6.58 5.9 6.05 6.27 6.08 6.49 6.4 6.25 6.22 6.18 5.75 6.48 5.82 6.19 6.39 6.62 6.44 5.89 6.24
GOBP_BODY_MORPHOGENESIS 6.97 7.22 6.85 6.61 7.19 7.11 7.13 7.29 7.14 7.09 7.12 7.21 7.01 7.26 6.98 7.33 7.11 7.06 6.96 7.33 7.06 7.15 7.14 7.27 7 7.25
GOBP_EMBRYONIC_BODY_MORPHOGENESIS 7.35 7.25 7.58 6.95 7.24 7.49 7.71 7.62 7.19 7.59 7.27 7.24 7.47 7.47 7.6 8.1 7.17 7.45 7.78 7.5 7.44 7.26 7.38 7.53 7.29 7.5
GOBP_RESPONSE_TO_IONIZING_RADIATION 6.32 6.45 6.57 6.76 6.4 6.48 6.35 6.49 6.37 6.55 6.45 6.49 6.53 6.52 6.25 6.46 6.45 6.29 6.48 6.41 6.34 6.57 6.62 6.71 6.43 6.58
GOBP_RESPONSE_TO_UV_B 5.94 6.08 5.7 6.12 5.61 5.53 5.67 5.57 5.76 5.71 6.03 5.76 5.7 5.78 5.42 5.81 5.96 5.9 5.88 5.57 6.2 6.08 6.21 5.33 6.08 6.22
GOBP_RESPONSE_TO_UV_C 6.61 6.56 6.46 6.66 7.15 7.06 6.49 6.75 6.47 6.82 6.5 6.59 6.88 6.9 6.74 6.7 6.71 6.37 7.06 6.94 6.29 6.78 6.57 6.5 6.8 6.75
GOBP_RESPONSE_TO_LITHIUM_ION 5.57 5.73 5.88 5.66 5.8 5.55 5.8 5.82 6.05 5.59 5.86 5.66 5.65 5.36 5.63 5.83 5.65 5.86 5.65 5.82 5.68 5.73 5.82 5.68 5.64 5.44
GOBP_VASCULAR_TRANSPORT 7.26 7.45 7.29 7.26 7.71 7.61 7.81 7.54 7.66 7.54 7.21 7.48 7.87 7.93 7.54 7.19 7.65 7.21 7.42 7.74 7.31 7.36 7.63 7.93 7.72 7.57
GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_TRANSMEMBRANE_ELECTROCHEMICAL_GRADIENT 5.98 6.45 6.57 6.35 5.77 5.77 6.14 6.55 5.6 5.71 5.82 6.04 5.9 5.73 5.88 6.33 6.53 5.99 6.39 6.26 6.12 5.87 5.51 5.79 6.25 6.5
GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION 7.38 7.42 7.74 7.74 7.74 7.87 7.72 7.68 7.71 7.77 7.71 7.74 7.8 7.79 7.67 7.69 7.59 7.45 7.59 7.81 7.43 7.73 7.89 8.01 7.73 7.62
GOBP_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY 8.06 8.06 9.46 9.05 8.11 8.12 8.43 8.49 8.2 8.32 8.78 8.43 8.31 8.48 9.1 9 8.27 8.35 8.12 8.32 8.34 8.76 8.34 8.57 8.39 8.72
GOBP_MULTICELLULAR_ORGANISM_AGING 6.14 6.19 6.31 6.15 6.19 6.01 5.87 5.91 6.37 6.22 6.53 6.18 5.98 6.1 6.12 6.46 6.38 6.22 6.33 6.15 6.19 6.43 5.9 6.22 6.17 6.33
GOBP_RESPONSE_TO_LEAD_ION 7.62 7.5 8 7.89 7.81 8.05 7.99 8.29 7.52 8.01 8.28 8.05 7.73 7.58 8.25 8.09 8.24 7.7 7.88 8.32 8.42 8.53 7.69 7.89 8.07 8.03
GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS 6.13 5.9 6.01 6.08 5.92 5.94 5.85 5.98 5.95 5.74 5.91 5.74 6.01 5.81 6.12 5.84 5.74 5.8 5.56 5.8 5.66 6.23 5.46 5.7 6.01 5.94
GOBP_MEMBRANE_INVAGINATION 6.37 6.21 6.96 6.35 6.37 6.35 6.05 6.19 6.28 6.13 6.22 6.05 6.1 5.86 6.15 6.23 6.1 6.28 5.88 5.92 6.11 6.46 6.39 6.45 6.51 6.35
GOBP_RESPONSE_TO_GAMMA_RADIATION 6.62 6.65 6.62 6.9 6.9 6.74 6.34 6.58 6.56 6.73 6.61 6.56 6.86 6.67 6.54 6.62 6.48 6.64 6.68 6.41 6.35 6.62 7.06 7.29 6.6 6.72
GOBP_HISTONE_MONOUBIQUITINATION 6.91 7.09 7.51 7.39 7.22 7.1 7.28 7.24 7.44 7.49 7.22 7.29 7.4 7.52 7.32 7.47 7.22 7.01 7.37 7.47 7.19 7.45 7.68 7.6 7.4 7.62
GOBP_RESPONSE_TO_ACIDIC_PH 5.31 5.16 5.26 5.21 5.08 4.75 4.94 5.27 5.33 4.72 4.96 5.22 4.67 4.64 4.98 4.94 5.49 5.35 5.06 4.79 5.4 5.17 4.89 4.69 5.17 5.12
GOBP_HISTONE_H3_K36_METHYLATION 7.07 6.94 7.24 6.8 7.42 7.74 6.82 7.27 7.28 7.35 6.95 7.67 7.16 7.22 7.28 7.33 7.35 6.63 7.68 7.25 6.81 6.98 7.31 7.46 7.12 7.45
GOBP_REGULATION_OF_CELL_FATE_COMMITMENT 5.16 4.9 5.06 5.42 4.72 4.81 4.88 4.94 5.04 4.95 5.27 4.76 4.94 4.87 5.01 5.07 4.97 5.2 4.81 4.65 4.98 4.85 4.8 4.59 4.91 4.95
GOBP_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT 5.25 5 5.39 5.42 4.73 4.82 4.9 4.99 5.19 4.97 5.64 5.1 5.14 5.24 5.13 5.21 5.24 5.2 5 4.92 5.12 5.18 5.08 4.76 4.97 5.02
GOBP_CENTRIOLE_CENTRIOLE_COHESION 6.72 7.12 6.01 6.44 7.04 7.13 6.51 6.71 6.42 6.52 6.4 6.93 6.83 6.77 6.56 6.38 6.38 6.6 6.8 6.77 6.36 6.55 6.53 6.75 6.43 6.44
GOBP_EXIT_FROM_MITOSIS 6.73 7 7.09 7.48 7.11 7.32 7.37 7.58 7.1 7.49 6.88 6.76 7.04 7.55 7.87 7.84 6.78 6.97 6.98 7.15 6.94 7.72 7.74 8.22 7.18 7.28
GOBP_POSITIVE_REGULATION_OF_HEART_RATE 5.9 6.1 5.71 5.84 5.41 5.46 5.82 5.73 5.66 5.72 6.05 5.7 5.72 5.87 5.68 5.63 5.83 5.86 5.71 5.98 5.93 5.87 5.64 5.57 5.76 5.65
GOBP_MESENCHYMAL_CELL_PROLIFERATION 5.77 5.73 5.98 6.05 5.58 5.5 5.92 5.69 5.91 5.79 6.03 5.53 5.75 5.98 5.89 5.85 5.93 5.83 5.63 5.56 6.21 6.04 5.66 5.62 5.71 5.74
GOBP_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION 6.24 6.08 6.38 6.43 5.94 5.82 6.19 6.1 6.18 6.31 6.44 6.05 6.25 6.41 6.08 6.37 6.57 6.51 6.03 6.22 6.51 6.84 6.17 5.92 5.81 6.36
GOBP_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY 5.49 5.51 5.33 5.52 5.14 5.08 5.32 5.21 5.27 5.14 5.4 5.22 5.21 5.02 5.21 5.23 5.39 5.48 5.14 5.17 5.41 5.29 5.17 4.91 5.31 5.29
GOBP_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY 6.69 6.59 7.23 6.75 6.95 6.92 6.99 6.85 7.08 7.02 6.65 6.84 7.07 7.05 6.99 6.77 6.69 6.7 6.87 6.98 6.85 6.77 6.93 6.95 6.78 6.85
GOBP_REGULATION_OF_GASTRULATION 5.51 5.26 5.39 5.76 4.9 4.89 5.09 5.09 5.49 4.93 5.42 5.08 4.81 4.83 5.17 4.91 4.93 5.17 5.1 4.75 5.29 5.09 4.93 4.69 4.86 4.81
GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS 7.42 7.52 8.03 7.91 7.75 7.85 7.89 7.84 7.94 7.87 7.79 7.86 7.86 7.88 7.84 7.84 7.66 7.54 7.67 7.87 7.6 7.76 7.97 8.09 7.92 7.74
GOBP_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS 7.81 8.29 9.53 8.77 8.27 8.66 8.33 8.15 8.86 8.52 8.76 8.48 8.84 8.9 8.72 8.62 8.17 7.96 7.86 8.47 7.98 8.36 8.81 8.66 8.39 8.21
GOBP_REGULATION_OF_AUTOPHAGY 7.41 7.51 7.92 7.64 7.88 7.8 7.95 7.86 7.77 7.94 7.63 7.8 7.91 7.86 7.93 7.92 7.67 7.49 7.6 7.93 7.58 7.9 8.01 8.09 8.06 7.82
GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY 7.18 7.19 7.88 7.52 7.32 7.55 7.39 7.38 7.7 7.65 7.52 7.3 7.81 7.65 7.77 7.79 7.2 7.28 7.34 7.57 7.51 7.67 7.77 7.76 8.01 7.65
GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY 7.17 7.37 7.69 7.52 7.66 7.41 7.48 7.69 7.68 7.63 7.41 7.63 7.62 7.49 7.69 7.44 7.42 7.31 7.35 7.59 7.42 7.62 7.73 7.66 7.71 7.38
GOBP_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY 6.14 6.27 5.89 6.02 6.37 6.29 6.19 6.43 6.43 6.3 6.09 6.43 6.56 6.38 6.54 5.95 6.27 6.12 6.21 6.21 6.57 5.86 6.37 6.24 6.03 5.99
GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL 6.71 6.67 6.71 6.8 6.67 6.69 6.66 6.88 6.65 6.81 6.97 6.69 6.84 7.01 6.59 6.48 6.71 6.69 6.64 6.58 6.62 6.66 7.06 6.88 6.68 6.75
GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL 7.59 7.58 8.04 7.41 8.05 7.68 6.9 6.98 7.31 7.51 7.25 7.57 7.24 7.15 6.75 7.49 7.51 6.79 7.21 6.88 7.02 6.99 8.06 7.51 7.11 7.04
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL 6.11 6.24 6.21 6.49 5.77 5.69 6.14 5.87 5.88 5.52 6.08 6 5.81 5.62 5.96 5.74 6.41 6.09 5.93 5.93 6.07 6.21 5.76 5.83 6.12 6.33
GOBP_REGULATION_OF_TRANSPOSITION 4.9 5.05 5.02 4.91 4.38 4.35 4.5 4.84 4.46 4.23 4.75 4.61 4.27 4.49 4.68 4.53 4.91 5 4.84 4.77 5.01 4.63 4.19 4.46 4.81 4.72
GOBP_REGULATION_OF_PLATELET_ACTIVATION 5.58 5.61 5.26 5.61 5.54 5.38 5.4 5.68 5.37 5.33 5.15 5.15 5.51 5.41 5.31 5.64 5.57 5.33 5.3 5.35 5.66 5.46 5.32 5.52 5.48 5.73
GOBP_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION 5.63 5.79 6.11 5.95 5.54 5.38 5.66 5.76 5.65 5.74 5.61 5.54 5.67 5.87 6.3 5.89 5.92 5.63 5.45 5.56 5.96 6.05 5.79 5.86 5.96 6
GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS 6.28 6.22 6.33 6.32 6.21 6.2 6.33 6.39 6.27 6.31 6.27 6.21 6.27 6.28 6.33 6.35 6.37 6.27 6.16 6.21 6.46 6.44 6.25 6.34 6.27 6.44
GOBP_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS 6.7 6.81 7.12 6.95 6.96 7.03 6.95 7 7.02 7.08 6.92 7.12 7.11 7.12 7.14 7.08 6.84 6.89 6.92 7.09 6.99 7.19 7.24 7.29 7.01 7.05
GOBP_REGULATION_OF_CELL_CYCLE_PROCESS 6.69 6.73 6.9 6.91 6.78 6.93 6.85 6.91 6.83 6.91 6.82 6.86 6.88 6.94 6.89 7.02 6.72 6.78 6.79 6.93 6.83 6.99 6.96 7.05 6.88 6.98
GOBP_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS 6.83 6.81 7.45 7.05 7.04 7.07 7.15 7.18 7.28 7.27 7.14 7.18 7.29 7.24 7.18 7.18 7.15 6.82 6.96 7.2 6.91 7.05 7.34 7.42 7.34 7.13
GOBP_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS 5.9 5.61 5.78 6 5.97 5.65 5.74 5.81 5.81 5.87 6.15 5.86 5.66 5.79 5.72 5.95 5.83 5.79 5.42 5.78 5.88 6.18 5.56 5.5 5.73 5.99
GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION 5.99 5.91 6.54 6.37 6.09 6.33 6.05 6.5 6.29 6.36 6.44 6.35 6.2 6.17 6.39 6.34 6.25 6.05 5.89 6.28 6.32 6.31 6.51 6.65 6.5 6.31
GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION 5.26 5.35 5.38 5.45 5.08 4.91 4.98 5.19 5.14 5.03 5.15 4.92 5.33 5.25 5.17 5.13 5.34 5.34 5.27 5 5.34 5.3 5.15 4.81 5.41 5.42
GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION 5.25 5.28 5.3 5.39 4.97 4.82 4.97 5.15 5.07 5.03 5.11 4.86 5.31 5.17 5.1 5.08 5.25 5.12 5.02 4.98 5.31 5.23 5.15 4.76 5.22 5.38
GOBP_MIRNA_METABOLIC_PROCESS 7.41 7.76 7.49 7.63 7.68 7.78 7.63 7.55 7.48 7.33 7.43 7.63 7.76 7.65 7.47 7.78 7.52 7.59 7.59 7.79 7.32 7.67 7.21 7.58 7.79 7.26
GOBP_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY 7.31 7.19 7.4 7.19 8.06 7.98 7.5 7.66 7.7 7.65 7.74 7.77 7.96 7.88 7.58 7.67 7.29 7.11 7.49 7.62 7.21 7.59 7.85 8.04 7.75 7.61
GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY 7.68 7.95 7.94 7.68 8.47 8.15 8.22 8.23 8.18 8.28 7.87 7.95 8.18 8.13 8.05 8.36 8 8.01 7.91 8.39 8.03 8.03 8.15 8.43 8.57 8.4
GOBP_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION 6.39 6.37 6.67 6.38 6.69 6.5 6.32 6.74 6.59 6.56 6.42 6.73 6.65 6.6 6.51 6.45 6.53 6.21 6.37 6.44 6.6 6.66 6.76 6.66 6.63 6.67
GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION 6.39 6.32 6.67 6.27 6.61 6.47 6.26 6.68 6.51 6.4 6.29 6.22 6.45 6.6 6.43 6.32 6.53 6.23 6.33 6.41 6.58 6.5 6.61 6.56 6.54 6.5
GOBP_POSTTRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION 7.43 7.48 7.79 7.78 7.69 7.77 7.7 7.65 7.76 7.82 7.7 7.74 7.78 7.79 7.71 7.71 7.49 7.37 7.61 7.75 7.46 7.72 7.87 7.9 7.74 7.66
GOBP_PROGRAMMED_CELL_DEATH_INVOLVED_IN_CELL_DEVELOPMENT 5.75 6.24 6.24 6.17 5.92 5.66 6.1 6.39 6.13 6.46 6.4 6.18 5.99 6.45 6.19 6.02 6.25 6.27 5.91 5.91 6.57 6.04 6.55 6.2 6.29 6.28
GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION 6.18 6.19 6.29 6.23 6.18 6.09 6.19 6.18 6.13 6.16 6.2 6.09 6.16 6.11 6.15 6.21 6.25 6.11 6.07 6.12 6.21 6.33 6.14 6.07 6.24 6.32
GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION 6.81 6.79 7.15 7.11 7.02 7 6.99 7.03 6.99 7.03 7.03 6.98 7.03 7.07 6.99 7.06 6.88 6.83 6.95 7.02 6.94 7.05 7.05 7.16 7.04 7.09
GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION 6.62 6.54 6.84 6.51 6.96 6.98 6.79 6.97 6.89 6.73 6.57 6.93 7.05 6.97 6.81 6.7 6.72 6.5 6.64 6.75 6.81 6.79 6.91 6.86 6.91 6.87
GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION 6.5 6.38 6.69 6.56 6.84 6.74 6.64 6.87 6.76 6.7 6.52 7.02 6.96 6.73 6.65 6.75 6.53 6.24 6.41 6.78 6.67 7.23 7 7.07 6.74 7.02
GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION 6.5 6.53 6.82 6.48 6.93 6.94 6.79 6.86 6.79 6.69 6.43 6.75 6.7 6.82 6.79 6.59 6.69 6.51 6.55 6.56 6.77 6.69 6.83 6.7 6.84 6.74
GOBP_REGULATION_OF_MITOCHONDRIAL_FUSION 7.08 7.22 7.33 6.54 7.26 7.44 7.09 7.12 7.59 7.46 6.4 7.16 7.38 7.47 7.76 7.53 7.17 7.14 6.99 7.09 6.72 7.57 7.43 7.75 7.64 7.42
GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION 7.08 7.09 7.31 7.21 7.4 7.38 7.31 7.34 7.36 7.48 7.1 7.34 7.43 7.4 7.41 7.42 7.29 7.15 7.25 7.41 7.21 7.31 7.5 7.63 7.34 7.37
GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION 6.78 6.89 7.12 7.05 7.11 7.13 7.02 7.14 7.03 7.17 6.83 7 6.97 7.07 7.22 7.08 6.86 6.92 6.88 7.06 7.03 7.2 7.17 7.23 7.07 7.2
GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 7.49 7.68 7.5 7.29 8.2 8.36 8.07 7.69 7.78 7.59 7.6 7.93 7.8 7.86 7.47 7.52 7.98 7.67 7.91 7.97 7.5 7.57 7.71 7.65 7.74 7.77
GOBP_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 7.99 7.85 8.51 8.46 8.71 8.64 8.61 8.16 8.86 8.65 8.52 8.4 8.82 8.72 8.47 8.72 8.29 8.12 8.34 8.46 8.13 8.39 8.61 8.7 8.46 8.41
GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING 7.64 7.96 8.25 7.95 8.44 8.64 8.4 8.6 7.89 8.31 8.63 8.16 8.04 8.15 8.62 8.79 8.22 7.81 8.36 8.14 8.24 8.53 8.83 8.32 8.6 8.33
GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING 7.64 7.96 8.73 8.24 8.78 9.02 8.6 8.79 8.54 8.65 8.76 8.11 8.32 8.58 8.94 8.96 8.38 7.77 8.73 7.95 8.13 8.51 8.98 8.45 8.86 9.03
GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS 6.66 6.55 6.81 6.68 6.81 6.91 6.85 6.87 6.88 6.93 6.51 6.81 7.13 6.92 6.77 6.93 6.93 6.88 6.64 6.98 6.61 6.79 6.71 6.98 6.59 6.59
GOBP_MUSCLE_CELL_APOPTOTIC_PROCESS 6.5 6.58 6.85 6.77 6.99 7.1 6.91 6.86 7.08 7.02 6.51 7.03 7.13 7.03 7.1 6.97 6.85 6.88 6.69 6.98 6.88 7.05 7.01 7.25 6.78 6.81
GOBP_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS 6.9 6.95 7.38 7.34 7.04 7.26 6.91 7.07 7.08 7.12 7.63 7.43 7.41 7.25 7.04 7.06 7.78 7.17 6.78 7.51 7.13 7.2 7.28 7.21 7.35 7.33
GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS 6.62 6.94 7.89 7.03 7.45 7.31 7.49 7.54 7.69 7.98 7.57 7.85 7.77 7.57 8.07 7.87 7.52 7.12 7.55 7.33 7.5 7.71 7.92 8.17 7.92 7.93
GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS 6.79 6.81 7.33 6.89 6.97 7.17 6.88 6.89 7.06 7.07 7.52 7.38 7.26 7.2 6.99 6.97 7.71 7.03 6.74 7.16 6.95 7.14 7.22 7.09 7.3 7.14
GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE 6.38 6.11 5.85 6.65 5.89 5.43 5.63 5.16 5.92 5.81 5.81 6.1 5.74 5.19 5.67 5.29 6.06 5.9 5.89 5.89 6.31 6.05 5.83 5.57 5.71 5.58
GOBP_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS 6.55 6.59 6.7 6.81 6.57 6.66 6.78 6.61 6.64 6.83 6.52 6.59 6.65 6.66 6.59 6.68 6.76 6.82 6.51 6.71 6.8 6.78 6.72 6.72 6.78 6.69
GOBP_POSITIVE_REGULATION_OF_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS 6.25 6.34 6.13 6.25 6.29 6.54 6.69 6.52 6.61 6.63 6.13 6.42 6.58 6.43 6.23 6.42 6.47 6.22 6.33 6.47 6.51 6.1 6.54 6.5 6.44 6.47
GOBP_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS 5.6 5.41 5.67 5.65 5.56 5.53 5.52 5.69 5.51 5.48 5.56 5.31 5.25 5.23 5.79 5.59 5.54 5.63 5.23 5.5 5.66 5.45 5.68 5.03 5.36 5.67
GOBP_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS 5.97 5.51 7.18 6.61 5.6 5.65 5.62 5.3 5.51 5.38 5.64 5.45 5.18 5.11 5.55 5.55 5.51 5.61 5.27 5.22 5.75 5.4 5.52 5.03 5.26 5.56
GOBP_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS 5.6 5.37 5.67 5.65 5.49 5.35 5.62 5.85 5.57 5.68 5.73 5.66 5.7 5.36 5.9 5.88 5.62 5.65 5.42 5.53 5.64 5.85 5.68 5.21 5.45 5.78
GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY 6.61 6.53 6.37 6.55 6.36 6.55 6.41 6.78 6.7 6.52 6.15 6.36 6.62 6.59 6.14 6.67 7.25 6.82 6.88 7.12 7.07 6.81 6.72 6.42 6.94 6.95
GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION 6.25 6.32 6.44 6.4 6.32 6.48 6.42 6.44 6.68 6.33 6.36 6.33 6.57 6.61 6.38 6.57 6.62 6.48 6.22 6.49 6.67 6.7 6.49 6.7 6.5 6.6
GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION 6.49 6.68 6.48 6.17 6.81 6.61 6.83 6.56 6.88 6.7 6.4 6.34 6.73 6.61 6.38 6.59 6.92 6.6 6.65 6.98 7.03 6.91 6.95 6.8 6.61 6.81
GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION 5.98 6.12 6.19 6.41 6.25 6.27 6.39 6.3 6.21 6.16 6.14 6.19 6.35 6.43 6.36 6.2 5.95 5.67 5.78 5.84 6.3 6.1 6.27 6.36 6.05 6.39
GOBP_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT 6.93 6.9 6.9 6.78 7.27 7.22 7.21 7.36 7.11 7.26 6.89 7.22 7.31 7.26 7.28 7.23 7.15 6.97 7 7.39 6.96 7.16 7.13 7.22 7.08 7.21
GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT 6.58 6.67 6.89 6.72 6.88 7.09 6.91 7.19 6.92 7.08 6.78 6.82 7.16 7.1 6.87 6.92 6.83 6.85 6.68 7.04 6.85 6.89 6.89 7.05 6.8 6.93
GOBP_PROTEIN_KINASE_A_SIGNALING 6.12 5.87 7.31 7.18 6.24 6.17 7.21 6.98 7.04 6.71 6.67 6.82 6.74 6.63 6.78 6.52 6.37 6.32 6.32 7.13 6.99 6.44 6.52 6.5 6.9 6.95
GOBP_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING 6.62 6.82 7.95 7.29 6.48 6.45 7.32 7.22 7.21 7.08 7.75 6.97 6.91 6.91 7.22 7.47 6.7 6.97 6.68 7.26 7.06 7.3 6.99 7.31 7.1 7.18
GOBP_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION 5.6 5.51 6 5.98 5.41 4.75 5.47 5.84 5.01 5.35 5.7 5.65 5.15 5.11 5.55 5.55 5.63 5.48 5.31 5.28 6.3 5.42 5.52 5.31 5.59 5.31
GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION 5.56 5.31 5.29 5.45 5.2 4.7 4.99 5.24 4.92 5.03 5.69 5.4 4.82 4.73 4.96 5.26 5.4 5.22 4.95 4.81 5.69 5.21 4.78 4.69 5.22 5.05
GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION 5.96 5.87 7.1 6.48 6.14 6.54 5.86 6.34 6.49 6.45 6.13 6.42 6.54 6.56 6.39 6.42 6.31 6.32 5.91 6.03 6.62 6.4 6.27 6.52 6.51 6.63
GOBP_REGULATION_OF_CGMP_MEDIATED_SIGNALING 5.38 5.36 5.9 5.85 5.22 5.67 6.05 5.11 5.39 5.7 5.36 5.69 5.19 5.59 5.37 5.6 5.24 5.75 5.38 5.76 5.36 4.99 6.38 5.7 5.32 5.25
GOBP_REGULATION_OF_PLASMINOGEN_ACTIVATION 5.51 5.49 5.37 5.3 5.59 5.47 5.49 5.55 5.6 5.38 5.91 5.39 5.37 5.58 5.47 5.01 5.53 5.47 4.93 5.53 5.8 5.39 5.74 5.13 5.48 5.73
GOBP_REGULATION_OF_MACROPHAGE_CHEMOTAXIS 6.25 6.5 6.65 6.58 6.24 5.76 5.84 5.94 6.16 5.66 6 5.57 6 5.66 5.93 6.69 6.1 5.62 5.89 6.16 6.7 6.42 6.2 6.09 6.52 6.56
GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS 6.25 6.5 6.65 6.58 6.24 5.76 5.84 5.94 6.16 5.66 6 5.56 6 5.66 5.93 6.69 6.1 5.56 5.89 6.16 6.7 6.42 6.2 6.09 6.52 6.56
GOBP_FIBROBLAST_MIGRATION 7.71 7.91 8.04 7.67 8.36 8.26 8.16 8.12 8.58 8.25 7.86 8.38 8.33 8.36 8.24 8.21 8.17 7.75 8.12 8.04 8.09 8.28 8.58 8.77 8.28 8.26
GOBP_REGULATION_OF_FIBROBLAST_MIGRATION 7.72 7.95 8.08 7.68 8.39 8.41 8.21 8.16 8.59 8.34 7.97 8.41 8.38 8.37 8.25 8.27 8.18 7.8 8.32 8.23 8.12 8.44 8.68 8.77 8.59 8.34
GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION 7.73 7.97 8.44 7.95 8.69 8.55 8.52 8.22 8.68 8.61 8.08 8.67 8.42 8.72 8.56 8.61 8.48 8.62 8.45 8.54 8.59 8.53 8.89 8.79 8.59 8.26
GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT 7.85 8.08 8.39 7.97 8.36 8.51 8.42 8.8 8.37 8.15 8.22 8.47 8.51 8.45 8.55 8.37 8.45 8.23 8.67 8.84 8.36 8.62 8.23 8.6 8.42 8.45
GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT 7.6 7.91 7.99 7.99 8.36 8.52 7.93 8.08 7.71 7.82 7.86 7.74 7.8 8.38 8.24 8.08 7.49 7.64 8.43 8.02 7.81 7.9 7.94 8.33 7.67 7.94
GOBP_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION 7.33 7.35 7.29 7.01 7.46 7.27 7.68 7.58 7.49 7.84 7.59 7.89 7.73 7.76 7.82 7.73 7.65 7.44 7.77 7.89 7.3 7.47 7.75 8 7.62 7.68
GOBP_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION 7.46 7.54 7.42 7.09 7.9 7.78 7.74 7.74 7.86 7.9 7.6 7.94 7.75 7.8 7.95 7.8 7.67 7.48 7.84 7.92 7.3 7.5 7.94 8.05 7.88 7.81
GOBP_NEGATIVE_REGULATION_OF_CELL_MORPHOGENESIS_INVOLVED_IN_DIFFERENTIATION 6.91 6.75 6.6 6.71 6.86 6.68 6.97 6.96 6.87 6.78 7 6.78 7.45 7.16 7.31 7.14 6.95 6.57 6.97 6.95 7.04 7.13 7.18 7.27 6.7 6.93
GOBP_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION 6.59 6.6 7.16 7.01 6.52 6.88 6.91 6.91 6.95 7.06 6.76 7.09 7.36 7.35 6.99 7.07 7.53 7 6.64 7.12 7.74 7.61 7.42 7.35 7.09 7.15
GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION 6.07 6.32 6.26 6.1 6.42 6.46 6.64 6.71 6.73 6.89 6.29 6.83 6.88 6.63 6.54 6.61 6.42 6.46 6.23 6.63 6.34 6.83 6.84 6.87 6.58 6.64
GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION 7.61 7.49 7.8 7.87 8.54 8.27 8.02 8.24 7.93 8.1 7.92 8.06 8.43 8.4 8.28 8.09 8.11 8.01 8.08 8.39 7.98 8.4 7.94 8.56 8.54 8.43
GOBP_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY 6.36 6.36 6.45 6.41 6.42 6.54 6.13 6.56 6.38 6.29 6.28 6.61 6.36 6.22 6.36 6.24 6.4 6.28 6.45 6.46 6.46 6.58 6.18 6.62 6.4 6.61
GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY 5.99 6 6.18 6.28 5.88 5.94 5.85 6.06 5.99 5.94 6.11 6.12 6.15 5.85 5.75 5.64 6.06 5.82 5.91 6.04 6.09 6.35 5.72 5.86 5.75 6.07
GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION 6.79 6.76 6.69 6.54 6.88 7.11 6.91 7.01 6.94 7.14 6.72 7.03 7.13 7.12 7.01 6.79 7.03 6.77 7.02 7.01 6.99 7.02 7.09 7.08 7.05 7.08
GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION 6.55 6.48 6.65 6.31 6.53 6.7 6.8 6.76 6.39 6.81 6.49 6.6 6.73 6.68 6.75 6.62 6.61 6.54 6.42 6.59 6.7 6.75 6.72 6.46 6.68 6.58
GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION 6.93 6.87 6.81 6.47 7.22 7.2 6.91 7.25 6.91 7.3 6.72 7.03 7.16 7.08 7.13 7.23 7.03 6.83 7.17 7.08 7.22 6.99 7.29 7.13 7.17 7.17
GOBP_REGULATION_OF_HORMONE_LEVELS 5.99 5.95 6.02 6 5.65 5.69 5.94 5.88 5.93 5.9 5.92 5.78 5.9 5.91 5.92 5.96 5.97 5.95 5.84 5.84 5.94 5.89 5.84 5.82 5.79 5.92
GOBP_T_CELL_CHEMOTAXIS 5.59 5.48 5.31 5.35 5.11 5.06 5.1 5.31 4.89 5.01 4.77 4.97 5.25 4.94 5.32 5 5.89 5.55 4.97 4.74 5.34 5.35 5.13 5.07 5.15 5.17
GOBP_REGULATION_OF_T_CELL_CHEMOTAXIS 4.86 5.05 4.79 5.48 4.63 4.49 4.77 4.48 4.76 4.35 4.77 4.72 4.57 4.55 4.64 4.37 6.66 6.09 4.54 4.61 5.55 4.67 4.43 4.83 4.69 4.62
GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION 7.42 7.49 7.94 7.84 7.95 7.88 7.94 8.01 7.97 8.05 7.85 7.94 8.08 7.84 8.04 7.97 7.68 7.71 7.65 8.03 7.79 8.04 8.12 8.28 8.2 7.94
GOBP_POSITIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION 7.41 7.6 7.91 7.72 7.74 7.72 8.06 7.96 8.1 8.04 7.81 7.91 8.13 7.76 8.06 8.11 7.61 7.75 7.65 7.93 7.82 8.07 8.17 8.2 8.17 7.79
GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRION_ORGANIZATION 7.78 7.86 8.26 8.19 8.05 8.17 8.2 8.39 8.46 8.4 8.01 8.05 8.47 7.9 8.2 8.28 8.06 7.83 8.12 8.09 7.82 8.25 8.36 8.51 8.64 8.49
GOBP_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION 6.54 6.4 6.56 7.23 6.38 6.69 6.44 6.38 6.41 6.78 5.97 6.44 6.2 6.25 6.77 5.9 6.63 6.55 6.43 6.21 6.51 6.55 6.2 6.69 6.06 6.71
GOBP_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT 6.64 6.87 7.38 7.13 6.94 6.94 7.24 7.16 7.2 7.17 6.89 7.25 7 7.19 7.36 7.19 6.91 6.87 6.74 7.13 7.14 6.92 7.2 7.41 7.01 6.76
GOBP_POSITIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT 6.71 6.93 7.41 7.1 7.3 7.17 7.56 7.38 7.27 7.3 6.92 7.25 7.31 7 7.58 7.39 6.94 6.86 7.12 7.25 7.3 6.75 7.28 7.58 7.19 6.78
GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT 7.26 7.18 7.38 7.2 7.53 7.72 7.5 7.28 7.61 7.47 7.62 7.37 7.44 7.71 7.44 7.14 7.48 7.09 7.51 7.58 7.25 7.57 7.37 7.55 7.47 7.46
GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION 5.55 5.54 5.53 5.71 5.29 5.25 5.65 5.51 5.82 5.87 5.61 5.29 5.29 5.65 5.53 5.72 5.79 5.75 5.64 5.51 5.58 5.48 5.74 5.02 5.43 5.59
GOBP_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION 5.42 5.16 5.15 5.68 5.19 5.01 5.25 5.08 5.46 5.71 5.13 5.29 5.22 5.03 5.53 5.35 5.57 5.54 5.48 5.5 5.09 5.28 5.15 4.91 5.12 5.08
GOBP_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION 5.92 5.62 5.76 5.66 5.27 5.33 5.56 5.3 5.86 5.58 5.79 4.91 5.12 5.5 5.04 5.59 5.33 5.36 5.44 5.3 5.94 5.48 5.74 5.02 5.43 5.71
GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING 7.01 7.15 7.61 7.23 7.43 7.33 7.27 7.23 6.99 7.52 7.26 7.26 7.24 7.24 7.22 7.16 7.12 7.01 7.3 7.3 7.22 7.37 7.37 7.47 7.27 7.75
GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION 6.12 6.29 5.78 6 5.55 5.58 5.81 5.94 5.83 5.81 5.87 5.85 5.88 5.62 5.57 5.88 5.97 5.67 5.71 5.93 6.06 6.21 5.67 5.62 6.31 5.93
GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION 4.71 4.66 4.46 4.89 4.45 4.18 4.44 4.67 4.45 4.36 4.71 4.66 4.51 4.26 4.45 4.31 4.49 4.74 4.57 4.26 4.71 4.55 4.2 4.07 4.39 4.59
GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION 6.79 6.77 6.66 6.99 6.51 6.42 6.91 6.75 7.64 7.01 7.14 7.57 7.02 7.3 6.89 7.11 7.73 7.09 6.6 7.1 7.29 7.05 7.17 7.63 7.11 7.3
GOBP_RETINA_LAYER_FORMATION 5.86 5.93 6.07 6.29 5.85 5.88 5.78 5.61 5.94 6.13 5.76 5.76 6.14 6.18 6 6.05 5.72 6 5.79 5.94 5.7 5.88 5.97 5.87 5.51 5.73
GOBP_REGULATION_OF_CHROMATIN_ASSEMBLY 6.05 6.18 6.28 6.3 6.45 6.7 6.33 6.65 6.65 6.54 6.15 6.46 6.8 6.75 6.6 6.36 6.08 6.08 6.42 6.29 6.21 6.41 6.56 7.08 6.61 6.51
GOBP_POSITIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION 5.81 5.61 6 6.02 5.49 5.29 5.52 5.46 5.75 5.38 5.96 5.23 5.31 5.45 5.43 5.71 5.35 5.64 5.54 5.41 5.71 5.72 5.69 5.6 5.46 5.4
GOBP_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS 6.44 6.59 7.09 6.9 6.76 6.57 6.91 6.86 6.41 6.71 6.66 6.41 6.9 7.25 6.44 6.61 6.55 6.32 6.35 6.64 6.76 6.94 6.54 6.74 6.82 6.69
GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS 6.42 6.68 6.76 6.88 6.83 6.72 7 6.89 6.51 6.72 6.7 6.63 6.87 7.11 6.31 6.61 6.53 6.18 6.66 6.72 6.7 6.74 6.59 6.64 6.9 6.66
GOBP_REGULATION_OF_CHOLESTEROL_ESTERIFICATION 6.55 6.48 6.8 6.39 6.73 6.62 6.73 6.49 6.52 6.57 6.62 6.39 6.68 6.44 6.36 6.12 6.83 6.25 6.64 6.39 6.56 6.71 6.43 6.87 6.32 6.58
GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX 6.57 6.57 6.7 6.67 7.12 6.87 7.14 7.05 7.14 7 6.71 7.05 7.07 7.16 6.52 6.49 6.39 6.27 6.95 7.05 6.91 6.83 7.56 7.63 6.87 6.84
GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX 7.02 6.85 7.08 6.75 7.3 7.15 7.46 7.4 7.33 7.26 6.79 7.32 7.32 7.26 7.15 6.67 6.76 6.39 7.09 7.38 6.99 7.01 7.69 7.82 7.25 7.1
GOBP_LIPID_LOCALIZATION 6.37 6.41 6.65 6.49 6.47 6.5 6.51 6.64 6.46 6.55 6.47 6.44 6.62 6.61 6.49 6.45 6.37 6.43 6.38 6.37 6.48 6.45 6.52 6.65 6.57 6.64
GOBP_CHOLESTEROL_STORAGE 6.14 6.96 7.29 6.83 7.19 7.07 7.35 6.99 7.03 7.04 6.47 6.8 6.9 7.14 6.63 6.73 6.76 6.43 6.96 6.96 6.62 6.79 7.06 7.42 6.96 7.18
GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION 7.68 7.92 8.96 8.45 8.32 8.62 8.09 8.7 8.05 8.35 8.62 8.12 8.11 8.22 8.65 8.9 8.34 7.64 8.52 8.07 8.02 8.58 8.85 8.36 8.49 8.52
GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING 7.64 7.91 8.82 8.24 8.04 8.25 8.04 8.6 7.97 8.31 8.19 8.08 8.04 8.15 8.62 8.44 8.02 7.5 8.36 8.16 7.85 8.5 8.72 8.18 8.32 8.31
GOBP_REGULATION_OF_LIPID_STORAGE 6.14 6.44 6.7 6.6 6.46 6.58 6.32 6.51 6.54 6.71 6.41 6.57 6.68 6.52 6.51 6.43 6.39 6.34 6.4 6.39 6.56 6.65 6.67 6.77 6.66 6.72
GOBP_POSITIVE_REGULATION_OF_LIPID_STORAGE 6.11 6.44 6.32 6.46 6.34 6.25 6.21 6.3 6.44 6.33 6.25 6.38 6.54 6.29 6.45 6.24 6.07 5.96 6.2 6.34 6.41 6.46 6.51 6.66 6.55 6.67
GOBP_NEGATIVE_REGULATION_OF_LIPID_STORAGE 6.05 6.36 6.94 6.59 6.35 6.62 6.29 6.64 6.5 6.64 6.3 6.57 6.68 6.76 6.57 6.56 6.53 6.38 6.28 6.44 6.51 6.74 6.59 6.72 6.74 6.82
GOBP_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE 6.02 5.69 7.2 6.94 6.01 5.96 5.67 6.12 6.31 6.23 6.08 6.17 6.01 6.17 6.42 6.27 6.19 5.58 5.71 5.93 6.47 6.47 6.12 6.55 6.51 6.72
GOBP_POSITIVE_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS 6.57 6.52 7.01 6.15 6.69 6.69 6.36 6.87 6.05 6.7 6.47 6.58 7 6.62 6.71 6.73 6.57 6.57 6.8 6.49 6.6 6.9 6.61 7.15 6.79 6.28
GOBP_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS 5.28 5.24 5.34 5.37 5.06 4.75 4.86 4.93 5.38 4.82 5.07 4.99 4.82 4.95 4.75 5.03 5.14 5.44 5.14 4.63 5.31 5.27 5.04 4.83 4.82 5.03
GOBP_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS 6.69 6.65 6.86 6.91 6.7 6.88 6.82 6.88 6.91 6.97 6.54 6.84 6.73 6.8 6.74 6.74 6.81 6.91 6.67 6.94 6.8 6.84 6.82 6.79 6.83 6.74
GOBP_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS 6.35 6.54 6.45 6.59 6.75 6.87 6.86 6.72 6.85 6.74 6.22 6.71 6.71 6.68 6.72 6.83 6.68 6.45 6.39 6.69 6.67 6.4 6.92 6.79 6.8 6.67
GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL 7.73 7.75 7.87 7.96 8.33 8.38 7.51 7.8 7.53 7.68 7.77 7.66 7.68 7.79 7.68 7.44 7.78 7.77 8.04 8.01 7.73 7.57 7.39 7.61 7.5 7.61
GOBP_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS 5.34 5.28 4.88 4.48 4.64 4.8 4.92 4.91 5.03 4.79 5.09 4.68 5.18 4.85 5.14 5.08 4.78 5.04 5.04 4.81 4.72 5.18 4.72 4.33 5.15 5.5
GOBP_REGULATION_OF_PHOSPHATASE_ACTIVITY 7.39 7.38 7.51 7.33 7.59 7.7 7.41 7.46 7.49 7.73 7.52 7.65 7.45 7.48 7.64 7.53 7.47 7.24 7.43 7.66 7.45 7.61 7.71 7.7 7.49 7.46
GOBP_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY 6.94 6.75 6.61 6.49 6.83 6.8 6.35 6.89 6.7 6.49 6.74 6.86 6.52 6.94 6.82 6.81 6.55 6.79 6.83 6.85 6.86 7.09 6.86 6.72 6.94 6.91
GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS 6.35 6.4 6.31 6.29 6.43 6.23 6.6 6.36 6.58 6.51 6.4 6.69 6.5 6.38 6.55 6.36 6.73 6.55 6.38 6.29 6.47 6.58 6.57 6.65 6.42 6.52
GOBP_MACROPHAGE_CYTOKINE_PRODUCTION 6.44 6.54 6.93 7.65 7.72 7.02 7.06 7.15 7.71 7.01 6.65 7.25 7.61 7.32 7.37 7.24 7 6.67 6.11 7.4 7.02 6.87 7.52 7.38 7.18 7.19
GOBP_REGULATION_OF_NECROTIC_CELL_DEATH 7.34 6.92 7.71 7.24 7.21 7.58 7.56 7.33 7.22 7.74 7.44 7.95 7.51 7.3 6.83 7.09 7.83 7.4 7.65 7.93 7.45 7.21 7.27 7.66 7.57 7.33
GOBP_REGULATION_OF_CELL_DEATH 6.49 6.51 6.79 6.67 6.6 6.65 6.67 6.74 6.66 6.73 6.65 6.66 6.73 6.74 6.69 6.72 6.66 6.56 6.57 6.65 6.8 6.9 6.81 6.84 6.77 6.82
GOBP_POSITIVE_REGULATION_OF_CELL_DEATH 6.48 6.46 6.8 6.64 6.63 6.62 6.62 6.71 6.83 6.77 6.54 6.75 6.8 6.77 6.71 6.81 6.74 6.65 6.51 6.65 6.83 6.95 6.95 6.87 6.83 6.84
GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING 7.21 6.99 6.69 6.63 6.9 6.7 7.13 7.12 6.75 6.59 6.73 6.99 6.97 6.95 6.74 7.2 7.31 7.15 7.13 6.56 7.11 7.1 6.65 6.81 7.52 7.72
GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS 6.61 6.73 6.88 6.88 6.68 6.84 6.81 6.88 6.75 6.9 6.8 6.84 6.78 6.9 6.85 6.97 6.7 6.49 6.72 6.73 6.74 6.97 6.93 7.01 6.86 6.98
GOBP_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY 6.06 6.08 6.51 6.58 6.19 6.16 6.34 6.26 6.24 6.29 6.25 6.22 6.38 6.33 6.34 6.39 6.32 6.11 6.2 6.19 6.38 6.42 6.11 6.16 6.23 6.43
GOBP_REGULATION_OF_AMINO_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE 9.38 9.9 10.56 9.82 9.74 10.19 9.82 9.97 10.42 9.97 10.11 9.65 10.47 10.72 10.23 9.92 8.65 9.01 10.12 10.51 9.13 9.93 10.66 10.97 9.19 9.04
GOBP_REGULATION_OF_METAL_ION_TRANSPORT 6.37 6.28 6.51 6.69 6.44 6.2 6.52 6.47 6.37 6.44 6.58 6.29 6.44 6.42 6.5 6.44 6.5 6.33 6.2 6.28 6.5 6.62 6.74 6.48 6.51 6.39
GOBP_MAGNESIUM_ION_HOMEOSTASIS 7.41 7.42 8 7.48 7.99 8 7.15 7.13 7.58 7.3 7.85 7.59 7.81 7.9 7.62 7.26 7.33 7.49 7.94 7.75 7.83 7.98 7.61 7.59 7.64 7.4
GOBP_REGULATION_OF_GLUCAN_BIOSYNTHETIC_PROCESS 6.69 6.85 6.85 7.1 7.33 7.15 7.07 7.6 7.14 7.29 6.92 6.95 7.34 7.07 7.36 7.29 6.94 7.09 6.88 7.33 7.3 7.73 7.28 7.58 6.96 7.08
GOBP_TRANSPORT_ALONG_MICROTUBULE 7.87 7.99 8.56 8.04 8.36 8.34 8.47 8.33 8.31 8.53 8.14 8.46 8.34 8.43 8.61 8.42 8.12 8.02 8.13 8.35 8.08 8.37 8.52 8.64 8.15 8.09
GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT 7.4 7.53 7.59 7.17 7.73 7.78 7.68 7.84 7.57 7.74 7.54 7.73 7.71 7.75 7.78 7.77 7.54 7.58 7.61 7.83 7.51 7.74 7.66 7.87 7.71 7.78
GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT 7.7 7.85 7.88 7.53 8 8.02 8.15 8.12 7.82 8.05 7.86 8.07 7.93 7.97 8.02 8.16 7.9 7.83 7.9 8.01 7.82 8.05 7.92 8.08 8.27 8.22
GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT 7.17 7.46 7.54 7.34 7.42 7.49 7.58 7.75 7.44 7.71 7.33 7.68 7.65 7.69 7.76 7.55 7.35 7.44 7.53 7.69 7.48 7.63 7.49 7.83 7.65 7.51
GOBP_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE 5.8 6.25 5.69 5.98 5.84 5.38 5.78 5.92 6.02 5.68 5.97 5.56 6.22 5.95 5.8 5.78 6.49 5.75 5.68 6.18 6.46 5.89 5.73 5.3 6.15 6.3
GOBP_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE 5.79 5.82 5.48 5.98 5.25 5.32 5.58 5.71 5.55 5.35 5.77 5.39 5.7 5.6 5.59 5.76 6.14 5.54 5.43 5.51 6.05 5.56 5.47 5.31 5.43 5.51
GOBP_RESPONSE_TO_AUDITORY_STIMULUS 6.96 7.35 7.5 7.43 7.31 7.28 7.68 7.56 7.4 7.71 7.43 7.59 7.7 7.52 7.46 7.34 7.25 7.31 7.45 7.68 7.22 7.21 7.51 7.82 7.64 7.34
GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_BY_EIF2_ALPHA_PHOSPHORYLATION 7.01 7.1 7.57 7.18 7.8 7.76 7.57 7.46 7.76 7.54 7.57 7.17 7.71 7.73 7.48 7.36 7.55 7.08 7.53 7.83 7.22 7.54 7.71 7.82 7.58 7.4
GOBP_ASTROCYTE_DEVELOPMENT 6.08 6.37 6.59 6.74 6.89 6.87 6.68 6.76 6.28 6.77 6.61 6.42 6.74 7.2 6.78 6.63 6.53 6.54 6.22 6.58 6.46 6.89 6.64 6.78 6.64 7.17
GOBP_OLIGODENDROCYTE_DEVELOPMENT 7.9 7.78 8.15 7.75 8.45 8.24 8.16 8.2 8.17 8.02 7.64 8.02 8.07 7.97 7.76 7.75 7.88 7.33 7.69 8.4 7.62 7.8 7.84 8.22 7.86 7.98
GOBP_GLIAL_CELL_PROLIFERATION 7.15 7.26 7.56 6.98 7.42 7.48 7.56 7.41 7.27 7.34 6.91 7.39 7.6 7.43 7.26 7.22 7.09 7.21 7.13 7.46 7.08 7.16 7.29 7.7 7.56 7.5
GOBP_REGULATION_OF_GLIOGENESIS 6.43 6.4 6.52 6.49 6.54 6.42 6.71 6.56 6.4 6.63 6.48 6.24 6.8 6.59 6.55 6.6 6.5 6.15 6.34 6.32 6.46 6.94 6.63 6.48 6.55 6.61
GOBP_NEGATIVE_REGULATION_OF_GLIOGENESIS 6.63 6.68 6.66 6.49 6.89 7.22 6.91 6.77 6.93 7.03 6.53 6.24 7.62 7.25 6.55 6.65 7.03 6.83 6.63 6.73 6.46 6.97 6.8 6.48 6.76 6.61
GOBP_POSITIVE_REGULATION_OF_GLIOGENESIS 6.54 6.44 6.59 6.47 6.55 6.38 6.64 6.65 6.56 6.62 6.48 6.57 6.59 6.59 6.61 6.64 6.68 6.2 6.48 6.74 6.7 6.97 6.55 6.7 6.6 6.91
GOBP_PRIMARY_NEURAL_TUBE_FORMATION 6.16 6.32 6.36 6.35 6.53 6.64 6.5 6.48 6.38 6.66 6.35 6.57 6.37 6.51 6.48 6.32 6.45 6.48 6.49 6.49 6.22 6.48 6.42 6.58 6.35 6.53
GOBP_NEURAL_CREST_FORMATION 6.78 6.63 6.61 6.1 6.91 6.48 6.84 6.94 6.39 6.75 6.44 6.8 6.44 6.47 6.48 6.22 6.81 6.76 6.52 6.35 6.73 6.48 6.9 7 6.16 6.49
GOBP_NEURAL_CREST_CELL_DIFFERENTIATION 6.15 6.22 6.4 6.18 6.31 6.24 6.3 6.26 6.28 6.41 6.36 6.3 6.44 6.43 6.37 6.29 6.35 6.31 6.3 6.24 6.32 6.38 6.38 6.22 6.16 6.34
GOBP_SCHWANN_CELL_DIFFERENTIATION 7.56 7.36 7.17 6.92 8.01 8.07 7.76 7.55 7.87 7.85 7.28 7.84 7.97 8.02 7.46 7.52 7.93 7.39 7.35 8.1 7.69 7.77 7.41 7.65 7.78 7.8
GOBP_SCHWANN_CELL_DEVELOPMENT 7.67 7.71 7.66 7.43 8.39 8.16 8.16 7.94 8.21 7.95 7.71 8.06 8.19 8.09 7.86 7.85 8.22 7.86 7.81 8.38 7.93 8.09 7.88 8.19 8.2 8.01
GOBP_DOPAMINE_SECRETION 6.86 7.11 6.93 6.79 6.8 7.72 7.45 7.74 7.31 7.37 7.26 6.95 7.59 7.79 7.46 7.52 7.02 7.58 7.61 7.9 6.74 7.29 6.95 7.18 7.37 6.98
GOBP_GLUTAMATE_SECRETION 7.8 8.04 8.29 8.18 7.86 8.15 8.08 8.39 8.02 7.91 7.89 8.08 8.03 8.01 8.38 8.27 7.81 8.05 8.14 8.17 7.96 7.91 7.8 8 7.97 7.86
GOBP_REGULATION_OF_GLUTAMATE_SECRETION 6.21 6.5 7.37 5.97 6.2 6.5 6.8 6.6 6.2 6.96 6.68 6.34 6.75 6.81 7.37 7.1 6.13 6.49 6.87 6.55 5.83 6.24 6.23 6.55 6.46 6.62
GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING 6.47 6.59 6.63 6.61 6.62 6.7 6.78 6.76 6.63 6.69 6.53 6.66 6.75 6.8 6.83 6.61 6.74 6.33 6.36 6.47 6.71 6.75 6.8 6.87 6.95 6.86
GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING 6.45 6.57 6.63 6.64 6.59 6.68 6.73 6.69 6.58 6.68 6.4 6.6 6.73 6.66 6.78 6.54 6.63 6.25 6.35 6.45 6.65 6.72 6.63 6.48 6.76 6.74
GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING 7.07 7.25 7.27 7.59 7.29 7.44 7.58 7.54 7.34 7.17 7.38 7.71 7.37 7.44 7.33 7.13 7.34 7.1 7.01 7.25 7.17 7.77 7.11 7.9 7.54 7.55
GOBP_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_SIGNALING 6.12 6.15 6.34 6.18 6.07 6.1 6.06 5.91 6.17 6.2 6.17 5.67 6.07 6.07 6.15 5.97 6.25 5.97 6.08 5.84 6.34 6.06 6.03 5.96 6.17 6.19
GOBP_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND 6.39 6.39 6.62 6.49 6.45 6.48 6.54 6.55 6.54 6.58 6.4 6.47 6.63 6.6 6.57 6.54 6.58 6.51 6.39 6.5 6.62 6.67 6.62 6.64 6.67 6.64
GOBP_RESPONSE_TO_ISOQUINOLINE_ALKALOID 7.03 7.16 7.91 7.99 7.5 8.18 7.93 8 7.71 7.75 7.52 7.74 7.8 8.01 8.2 8.05 7.75 7.58 7.77 8.04 7.9 7.9 7.58 7.95 7.63 7.56
GOBP_RESPONSE_TO_PURINE_CONTAINING_COMPOUND 6.14 6.14 6.23 6.21 6.1 6.18 6.38 6.12 6.43 6.34 6.14 6.15 6.37 6.21 6.51 6.31 6.19 6.35 6.06 6.11 6.48 6.44 6.46 6.29 6.25 6.15
GOBP_RESPONSE_TO_AMINE 6.66 6.73 6.97 6.8 7.18 6.9 6.81 6.9 6.91 7.21 6.87 7.05 7 6.8 7.37 6.51 6.5 6.4 6.48 6.52 6.75 6.37 6.78 6.66 6.78 6.65
GOBP_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION 8.21 8.43 8.19 7.87 8.18 8.26 8.81 8.74 8.4 8.26 7.74 8.1 8.25 8.24 8.43 8.41 8.58 8.35 8.09 8.78 8.35 8.42 8.47 8.54 8.38 8.05
GOBP_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY 6.88 7.14 7.81 7.02 7.42 7.36 7.14 7.45 7.01 7.43 6.79 7.28 7.6 7.46 7.57 6.85 7.03 6.86 7.13 7.37 7.42 7.51 7.39 7.53 7.61 7.47
GOBP_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY 7.68 7.51 8.04 7.71 8.13 7.97 8.45 7.8 8.46 7.91 7.58 7.88 7.97 8.08 7.93 7.79 7.45 7.29 7.81 8.26 7.41 8.08 8.62 7.9 8.49 8.52
GOBP_REGULATION_OF_MUSCLE_HYPERTROPHY 7.21 7.26 7.89 7.4 7.62 7.69 7.47 7.68 7.66 7.63 7.01 7.41 7.7 7.78 7.75 7.51 7.26 7.14 7.51 7.71 7.41 7.61 7.83 7.71 7.88 7.68
GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ADAPTATION 7.39 7.29 7.96 7.25 7.78 7.67 7.5 8.09 7.93 8.03 7.41 7.75 8.11 8.08 7.98 8.3 7.52 7.69 7.7 7.65 7.84 8.12 8.35 8.33 8.23 7.91
GOBP_MUSCLE_CELL_MIGRATION 6.71 6.71 7 6.71 7.12 6.89 7.05 6.85 7.01 7 6.86 7.02 7.02 7.04 6.88 6.9 6.85 6.86 6.82 6.97 6.84 6.93 6.92 6.99 6.74 7.05
GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION 5.02 4.95 5.05 5.38 4.96 5.23 5.7 6 5.48 5.58 5.16 5.1 5.68 5.64 6.51 5.17 5.53 5.62 5.93 5.63 5.11 5.66 6.48 6.08 5.36 5.1
GOBP_TONIC_SMOOTH_MUSCLE_CONTRACTION 6.15 6.2 5.76 5.59 6.34 6.48 6.09 6.12 6.57 6.14 6.42 6.45 6.56 6.33 5.54 5.88 6.3 6.17 6.16 6.23 6.33 6.15 6.37 6.24 6.02 5.86
GOBP_PHASIC_SMOOTH_MUSCLE_CONTRACTION 6.16 6.04 5.76 5.84 5.58 5.38 5.69 5.66 5.65 5.41 6.07 5.62 5.44 5.38 5.65 5.51 5.73 5.91 5.42 5.33 5.93 5.64 5.58 5.36 5.77 5.64
GOBP_RESPONSE_TO_ACTIVITY 6.32 6.23 6.35 6.38 6.31 6.25 6.23 6.44 6.49 6.33 6.53 6.58 6.39 6.35 6.34 6.62 6.61 6.2 6.41 6.46 6.37 6.77 6.36 6.42 6.79 6.48
GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION 6.67 6.81 7.56 6.76 7.49 7.25 6.74 7.62 7.15 7.24 7.38 7.81 7.88 7.93 7.59 7.48 8.15 7.86 7.56 7.63 7.82 7.99 7.62 7.39 7.28 8.02
GOBP_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION 5.47 5.96 5.46 5.78 5.22 4.82 5.53 5.32 5.67 5.04 5.47 5.11 5.31 5.12 5.5 5.29 5.38 5.51 5.13 5.21 5.65 5.24 5.54 4.94 5.3 5.25
GOBP_RESPONSE_TO_MUSCLE_ACTIVITY 7.03 6.92 6.35 5.88 7.55 6.94 6.52 6.44 7.08 7.34 6.06 6.75 6.47 5.81 6.55 6.44 6.8 6.29 6.64 6.19 6.37 6.13 6.87 6.72 6.1 6.48
GOBP_RESPONSE_TO_INACTIVITY 6.63 6.3 6.49 5.41 6.71 6.61 6.49 6.34 6.64 6.62 6.52 6.65 6.34 6.72 6.31 6.97 6.84 6.61 6.99 6.28 6.66 6.96 6.54 6.68 6.73 7.08
GOBP_STRIATED_MUSCLE_CELL_PROLIFERATION 6.88 6.98 6.93 7 6.96 7.26 7.05 7.1 7.06 6.94 6.81 6.98 7.16 7.27 6.88 7.16 6.9 6.89 7.13 7.04 6.86 7 7.06 7.16 7.4 7.41
GOBP_SKELETAL_MUSCLE_CELL_PROLIFERATION 7.05 7.15 7.41 7.13 7.35 7.51 6.59 7 7.08 7.2 7.69 7.21 7.21 7.22 7.01 7.29 7.3 7.26 7.31 6.93 6.63 7.11 6.84 7.11 7.53 7.43
GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION 6.13 6.29 6.68 6.55 6.41 6.53 6.22 6.39 6.67 6.69 6.98 6.27 6.72 6.72 6.29 6.68 6.53 6.47 6.37 6.55 6.4 6.74 6.19 6.33 6.58 6.69
GOBP_RESPONSE_TO_MUSCLE_INACTIVITY 6.04 5.7 5.78 5.3 5.99 5.69 5.75 5.56 5.85 5.8 5.95 5.72 5.6 5.78 5.63 6 5.94 5.96 5.91 5.5 5.85 5.92 5.61 5.6 5.79 5.81
GOBP_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION 6.44 6.21 6.53 5.72 5.99 6.23 6.58 6.27 6.45 6.35 6.32 6.42 6.24 6.41 5.92 6.27 6.63 6.39 6.33 6.28 6.46 6.66 6.24 6.38 6.5 6.61
GOBP_STRIATED_MUSCLE_ADAPTATION 6.34 5.81 6.19 6.23 6.07 5.74 6.07 5.74 5.96 5.86 6.25 6.23 5.73 5.83 5.97 6.28 6.6 6.26 6.22 5.93 6.01 5.83 6.08 6.27 6.19 6.31
GOBP_MUSCLE_ATROPHY 6.25 6.12 6.61 6.89 5.41 5.86 6.68 6.19 6.25 6.07 6.11 6.19 6.14 6.1 5.53 5.57 6.42 6.17 5.67 6.28 6.26 6.36 5.94 6.09 6.26 6.15
GOBP_MUSCLE_HYPERTROPHY 6.88 6.92 6.88 7.01 7.31 7.31 7.2 7.39 7.34 7.39 6.79 7.25 7.43 7.37 7.43 7.12 7.06 6.9 7.12 7.44 7.18 7.31 7.35 7.51 7.45 7.43
GOBP_MYOTUBE_DIFFERENTIATION 6.26 6.22 6.49 6.33 6.22 6.22 6.21 6.31 6.31 6.27 6.31 6.24 6.34 6.35 6.31 6.19 6.48 6.42 6.29 6.3 6.39 6.31 6.51 6.31 6.3 6.42
GOBP_MYOTUBE_CELL_DEVELOPMENT 6.12 5.91 6.29 6.04 5.81 5.81 6.05 6.01 5.91 6.17 6.38 6.11 5.94 6.01 6.18 6.08 6.02 6.02 5.91 5.98 6.23 6.2 6.07 5.76 5.99 6.1
GOBP_SMOOTH_MUSCLE_CELL_MIGRATION 6.93 6.93 6.85 6.61 7.33 6.92 7.36 7.14 7.08 7.16 6.89 6.97 7.02 7.04 6.82 6.83 6.86 6.86 6.85 6.89 6.83 6.96 7.06 7 6.66 7.01
GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION 6.66 6.53 6.55 6.37 6.71 6.55 6.35 6.42 6.64 6.62 6.45 6.65 6.62 6.72 6.5 6.51 6.62 6.61 6.33 6.19 6.74 6.74 6.87 6.72 6.51 6.47
GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION 7.68 7.87 7.93 7.4 8.22 8.08 8.19 7.89 8.24 8.11 8.06 8.13 8.63 8.38 8.08 8.24 7.65 7.98 8.29 8.02 7.75 8.18 8.41 8.48 8.1 7.7
GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS 7.3 7.46 7.33 6.93 7.35 7.56 7.39 7.81 7.6 7.48 7.2 7.39 7.79 7.59 7.57 7.64 7.55 7.46 7.47 7.57 7.26 7.58 7.59 7.78 7.75 7.59
GOBP_GAS_TRANSPORT 5.8 5.77 5.93 6.21 5.46 5.44 5.68 5.56 5.92 5.58 5.79 5.37 5.56 5.55 6.33 5.78 5.83 5.64 5.5 5.41 6 5.56 5.67 5.27 5.56 5.98
GOBP_OXYGEN_TRANSPORT 5.79 5.79 5.8 6.16 5.59 5.29 5.61 5.37 5.83 5.46 5.76 5.33 5.45 5.39 6.26 5.76 5.78 5.63 5.43 5.33 5.84 5.48 5.6 5.02 5.44 5.89
GOBP_MAGNESIUM_ION_TRANSPORT 7.85 7.89 8.33 7.91 8.05 8.13 8.2 8.21 8.21 8.21 7.98 8.37 8.31 8.22 8.35 8.06 7.95 7.76 8.04 7.93 7.95 8.24 8.53 8.33 8.18 8.37
GOBP_ORGANIC_CATION_TRANSPORT 5.91 5.88 5.81 5.92 5.65 5.6 5.92 5.8 5.96 5.64 5.76 5.6 5.82 5.84 5.63 5.48 5.8 6 5.76 5.49 5.66 5.85 5.61 5.72 5.99 5.54
GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT 5.28 5.47 5.24 5.44 5.12 4.71 5.13 4.8 5.26 4.8 5.41 5.19 4.83 4.91 4.93 5.07 5.23 5.37 5.12 5 5.2 4.81 5.16 4.6 4.76 4.91
GOBP_INORGANIC_ANION_TRANSPORT 6.12 6 6.04 5.98 5.78 5.89 5.92 5.99 5.88 6.04 6.02 5.6 5.68 5.95 5.82 5.89 5.96 5.88 6.18 5.88 6.07 5.79 5.99 5.85 5.94 6.12
GOBP_BICARBONATE_TRANSPORT 5.95 5.78 5.88 5.89 5.58 5.31 5.45 5.54 5.63 5.4 5.51 5.14 5.4 5.47 5.26 5.31 5.48 5.38 5.43 5.14 5.45 5.23 5.27 4.99 5.51 5.75
GOBP_ORGANIC_ANION_TRANSPORT 6.02 5.92 5.89 6.02 5.68 5.68 5.81 5.87 5.83 5.57 5.86 5.67 5.73 5.78 5.74 5.65 5.83 5.87 5.74 5.67 5.85 5.74 5.64 5.75 5.84 5.92
GOBP_MONOCARBOXYLIC_ACID_TRANSPORT 6.06 5.77 5.9 5.96 5.73 5.69 5.83 6.15 5.94 5.68 5.86 5.78 5.91 6.05 5.97 5.89 5.97 5.85 5.96 5.73 5.86 5.86 5.7 5.83 5.85 6.05
GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT 5.05 4.92 4.86 5.02 4.24 4.33 4.61 4.58 4.66 4.37 4.98 4.45 4.6 4.38 4.6 4.42 4.81 5.01 4.57 4.42 5.03 4.64 4.5 4.09 4.44 4.63
GOBP_PROSTAGLANDIN_TRANSPORT 5.13 4.92 5 4.89 4.72 4.38 4.84 4.74 4.77 4.45 4.61 4.47 4.79 4.67 4.9 4.67 5.04 4.9 4.72 4.67 4.79 4.77 4.65 4.37 4.77 4.8
GOBP_C4_DICARBOXYLATE_TRANSPORT 7.91 7.52 7.84 7.52 7.7 7.85 7.89 7.9 7.54 7.9 7.44 7.81 8.18 8.3 8.25 7.98 7.66 7.75 7.57 7.45 7.67 7.69 7.66 8.32 7.68 7.72
GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT 6.24 6.22 6.38 6.21 6.38 6.38 6.32 6.39 6.34 6.34 6.45 6.33 6.45 6.67 6.31 6.21 6.24 6.2 6.16 6.23 6.44 6.41 6.38 6.4 6.6 6.54
GOBP_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT 6.9 7.19 6.92 6.89 6.92 7.15 7.24 7 6.69 6.66 7.47 6.98 6.91 6.88 7.23 6.99 6.65 6.77 7.15 7.27 6.81 7.21 6.61 7.15 7.23 7.59
GOBP_POLYOL_TRANSPORT 6.12 5.67 5.72 6.1 5.38 5.36 5.72 5.53 5.85 5.61 5.61 5.42 5.48 5.27 5.69 5.58 5.83 5.73 5.68 5.38 5.46 5.47 5.53 5.16 5.5 5.9
GOBP_ACIDIC_AMINO_ACID_TRANSPORT 7.96 8.15 8.3 8.13 8.39 8.36 8.27 8.42 8.35 8.33 8.05 8.37 8.48 8.39 8.5 8.35 8.01 8.06 8.4 8.49 8.16 8.45 8.01 8.42 8.66 8.44
GOBP_AROMATIC_AMINO_ACID_TRANSPORT 7.27 7.75 7.58 7.67 7.49 7.61 7.84 7.97 7.98 7.74 6.94 7.49 8.11 7.93 7.58 7.76 7.85 7.19 7.33 8.01 7.54 7.83 7.72 8 7.91 7.52
GOBP_BASIC_AMINO_ACID_TRANSPORT 5.84 6 5.65 6.58 5.32 5.7 6.05 5.57 5.82 5.5 5.73 5.5 5.66 5.99 5.49 5.45 5.5 6.4 6.09 6.06 5.6 5.36 5.89 5.54 6.25 6.51
GOBP_NEUTRAL_AMINO_ACID_TRANSPORT 7.01 6.92 7.17 7.56 7.08 7.33 7.29 7.24 7.31 6.72 6.87 6.92 7.16 7.48 7.57 7.34 6.93 6.9 7 7.29 7.09 6.95 7.14 7.36 7.5 7.13
GOBP_L_AMINO_ACID_TRANSPORT 6.77 6.92 6.93 7.08 7.08 7.08 6.84 7.23 7.08 6.79 6.4 6.62 6.9 7.34 7.26 6.76 6.71 6.75 7.11 7.29 6.6 6.58 7.06 7.3 7.05 7.03
GOBP_L_ALANINE_TRANSPORT 7.79 7.57 7.37 7.74 7.64 7.9 7.57 7.44 8.19 7.8 7.16 7.63 7.57 7.99 7.58 7.65 7.63 7.72 7.52 7.53 7.41 6.81 7.46 7.51 8.01 7.57
GOBP_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT 7.98 8.11 7.72 7.1 8.16 8.91 8.85 8.65 8.33 8.19 7.76 8.76 8.74 8.68 7.97 8.12 7.81 8.22 8.66 8.62 8.52 8.79 8.01 7.98 8.61 8.31
GOBP_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT 7.94 7.77 8.44 9.08 8.23 8.49 8.25 8.43 8.7 8.62 8.08 8.51 8.42 8.22 8.68 8.07 8.12 8.06 7.71 8.46 8.22 8.28 7.99 8.43 8.58 8.53
GOBP_GLYCINE_TRANSPORT 8 7.81 7.17 7.6 8.19 8.25 7.97 7.66 8.4 8.58 7.43 7.82 8.23 8.44 8.05 7.92 8.32 7.82 7.94 7.77 7.28 7.04 7.63 7.52 8.1 7.89
GOBP_AMINE_TRANSPORT 6.31 6.31 6.72 6.5 6.26 6.42 6.82 6.81 6.81 6.87 6.46 6.11 6.53 6.63 7.03 6.58 6.37 6.71 6.56 6.85 6.32 6.62 6.54 6.7 6.62 6.44
GOBP_MONOAMINE_TRANSPORT 6.29 6.26 6.56 6.43 6.11 6.21 6.75 6.73 6.37 6.51 6.35 5.95 6.38 6.35 6.73 6.29 6.31 6.51 6.32 6.23 6.27 6.39 6.32 6.35 6.39 6.29
GOBP_ORGANIC_ACID_TRANSPORT 6.21 6.16 6.3 6.31 6.15 6.12 6.14 6.24 6.09 6.18 6.15 6.11 6.04 6.17 6.14 6.1 6.14 6.22 6.17 6.11 6.22 6.27 6.11 6.25 6.25 6.35
GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT 6.17 6.1 6.27 6.22 6.03 6.14 6.29 6.41 6.15 6.22 6.17 5.94 6.24 6.1 6.22 6.18 6.21 6.05 6.13 6.01 6.22 6.25 6.11 6.17 6.26 6.23
GOBP_PURINE_NUCLEOTIDE_TRANSPORT 5.79 6.02 5.88 6.04 5.78 5.77 5.98 6.14 6.18 6.07 6.24 5.52 5.48 5.31 6 5.88 5.55 6 6.05 5.79 6.18 5.9 5.65 5.64 5.84 5.82
GOBP_ATP_TRANSPORT 5.79 5.44 5.87 5.76 5.78 5.64 5.98 6.14 6.18 6.07 5.7 5.52 5.48 5.15 6 5.88 5.55 6 5.71 5.79 6.18 5.9 5.61 5.64 5.84 5.81
GOBP_DOPAMINE_TRANSPORT 6.38 6.65 6.69 6.47 6.42 6.76 7.14 6.81 6.89 6.92 6.49 6.11 6.79 6.8 7.18 6.47 6.41 6.7 6.61 7.09 6.32 6.64 6.65 6.73 6.61 6.35
GOBP_NOREPINEPHRINE_TRANSPORT 6.11 5.87 5.82 6.05 5.53 5.17 5.68 5.79 5.57 6 6.14 5.59 5.53 5.62 5.71 5.52 5.7 6.02 5.62 5.5 6.17 5.72 5.59 5.26 5.45 5.13
GOBP_DRUG_TRANSPORT 5.12 4.98 4.76 4.98 4.52 4.51 4.71 4.68 4.62 4.41 4.6 4.47 4.55 4.45 4.77 4.49 4.88 4.95 4.71 4.56 4.84 4.44 4.81 4.4 4.4 4.77
GOBP_FATTY_ACID_TRANSPORT 6.34 6.35 6.93 6.76 6.39 6.55 6.69 6.86 6.53 6.45 6.61 6.42 6.72 6.56 6.84 6.71 6.48 6.57 6.49 6.76 6.48 6.53 6.5 6.8 6.55 6.61
GOBP_LONG_CHAIN_FATTY_ACID_TRANSPORT 5.78 5.64 5.86 6.05 5.65 5.52 5.67 5.6 5.7 5.51 5.79 5.68 5.53 5.58 5.63 5.6 5.95 5.9 5.41 5.51 5.89 5.88 5.57 5.35 5.85 5.85
GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE 6.42 6.69 7.03 6.43 6.44 6.7 6.81 7.11 6.62 6.76 6.45 6.89 6.85 6.75 6.73 6.73 7 6.69 6.26 6.82 6.93 6.96 7.18 7.05 7.38 7.33
GOBP_PHOSPHOLIPID_TRANSPORT 6.39 6.48 6.47 6.4 6.52 6.65 6.53 6.53 6.45 6.63 6.55 6.42 6.77 6.93 6.49 6.41 6.39 6.61 6.29 6.29 6.51 6.58 6.57 6.6 6.89 7.06
GOBP_STEROL_TRANSPORT 6.37 6.39 6.47 6.47 6.65 6.56 6.41 6.64 6.53 6.82 6.3 6.59 6.69 6.52 6.47 6.47 6.38 6.34 6.35 6.3 6.5 6.48 6.62 6.48 6.59 6.82
GOBP_PEROXISOMAL_MEMBRANE_TRANSPORT 6.92 6.73 7.31 7.21 7.43 7.42 7.1 6.98 7.25 7.29 7.37 7.36 7.38 7.58 7.05 7.33 7.18 6.97 7.38 7.43 7.14 7.13 7.47 7.72 7.23 7.21
GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT 7.27 7.27 7.69 7.52 7.6 7.62 7.43 7.48 7.5 7.55 7.47 7.5 7.43 7.51 7.43 7.53 7.34 7.14 7.38 7.59 7.22 7.57 7.55 7.66 7.47 7.57
GOBP_COENZYME_A_METABOLIC_PROCESS 6.9 6.79 7.7 7.65 7.13 7.02 7.23 7.09 6.91 7.24 7.23 7.4 7.26 7.23 7.45 7.38 6.85 6.98 7.09 7.43 6.98 7.22 7.04 7.19 7.07 7.48
GOBP_COENZYME_A_BIOSYNTHETIC_PROCESS 6.52 6.48 7.7 7.52 7 6.57 7.08 7.09 6.8 7.24 7.23 7.4 7.12 7.23 7.45 7.38 6.85 6.87 6.66 7.43 6.81 7.22 7.04 7.16 6.95 7.48
GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION 6.78 7.1 6.96 7.18 6.85 7.2 7.12 6.82 7.07 7.36 6.71 7.46 7.01 7.26 6.82 6.74 7.2 7.11 6.9 7.23 7.01 6.92 7.02 7.05 7.11 6.99
GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS 7.34 7.47 8.29 8.12 7.82 7.75 7.99 7.94 7.99 7.86 8.06 7.77 7.97 8 8.04 7.97 7.57 7.58 7.78 7.99 7.62 8.02 8.06 8.19 7.85 7.78
GOBP_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS 7.43 7.59 8.62 8.05 7.94 8.24 8.14 7.8 8.55 8.2 8.19 8.04 8.66 8.48 8.15 8.5 8.44 7.95 8.25 8.11 7.61 8.22 8.33 8.64 8.32 8.23
GOBP_LIPID_CATABOLIC_PROCESS 6.24 6.34 6.41 6.62 6.2 6.44 6.35 6.38 6.29 6.47 6.47 6.44 6.34 6.33 6.19 6.41 6.33 6.21 6.21 6.34 6.4 6.35 6.34 6.37 6.33 6.43
GOBP_DETECTION_OF_TEMPERATURE_STIMULUS 6.26 6.15 6.06 5.99 5.88 5.76 6.06 6.77 6.16 6.32 5.89 5.44 6.39 6.24 6.32 5.82 6.25 6.1 5.69 5.85 6.46 5.74 6.03 5.59 5.85 5.71
GOBP_CELL_GROWTH 6.87 6.92 7.23 6.99 7.13 7.18 7.19 7.29 7.21 7.17 7.01 7.25 7.28 7.31 7.28 7.21 7.12 7.07 7.13 7.17 7.08 7.31 7.27 7.35 7.38 7.32
GOBP_VESICLE_ORGANIZATION 7.38 7.39 7.88 7.88 7.78 7.97 7.86 7.74 7.76 7.84 7.72 7.74 7.87 7.89 7.69 7.66 7.54 7.46 7.63 7.85 7.51 7.73 7.89 8.04 7.77 7.68
GOBP_CARBOHYDRATE_BIOSYNTHETIC_PROCESS 6.46 6.58 6.63 6.72 6.61 6.82 6.78 6.65 6.91 6.79 6.54 6.83 6.88 6.92 6.7 6.64 6.62 6.8 6.69 6.82 6.62 6.7 6.9 6.83 6.72 6.68
GOBP_CARBOHYDRATE_CATABOLIC_PROCESS 6.69 6.62 7.1 7.11 6.8 6.92 6.8 6.8 6.92 6.84 6.55 6.84 6.8 6.93 6.69 6.68 6.83 6.83 6.88 6.9 6.72 6.86 6.77 6.73 6.76 6.82
GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS 6.39 6.34 6.69 6.52 6.43 6.41 6.35 6.44 6.41 6.26 6.49 6.35 6.44 6.38 6.39 6.42 6.41 6.28 6.34 6.64 6.38 6.51 6.43 6.47 6.45 6.44
GOBP_ORGANIC_ACID_CATABOLIC_PROCESS 6.33 6.38 6.85 6.76 6.44 6.56 6.57 6.51 6.39 6.55 6.54 6.55 6.62 6.56 6.41 6.59 6.5 6.45 6.51 6.7 6.67 6.67 6.58 6.52 6.54 6.54
GOBP_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY 5.37 5.2 5.49 5.47 5.22 4.51 5.24 5.14 5.41 5.17 5.36 4.8 5.03 4.89 5.38 5.2 4.97 5.44 4.9 4.86 5.41 4.79 4.8 4.82 5.01 4.84
GOBP_MRNA_METABOLIC_PROCESS 7.35 7.47 7.76 7.67 7.68 7.7 7.63 7.63 7.64 7.69 7.52 7.66 7.63 7.61 7.8 7.76 7.52 7.38 7.54 7.74 7.43 7.7 7.73 7.85 7.67 7.65
GOBP_RRNA_METABOLIC_PROCESS 6.36 6.49 6.85 6.76 6.5 6.51 6.69 6.65 6.66 6.76 6.74 6.78 6.65 6.65 6.76 6.69 6.36 6.45 6.62 6.65 6.47 6.62 6.62 6.79 6.69 6.62
GOBP_SNRNA_METABOLIC_PROCESS 6.65 6.75 7.41 7.05 6.83 6.94 6.63 6.85 6.68 6.75 6.96 6.68 6.87 6.76 6.64 6.84 6.49 6.59 6.84 7 6.56 6.72 6.79 6.83 6.82 6.83
GOBP_SNO_S_RNA_METABOLIC_PROCESS 7.09 7.31 7.86 7.87 7.25 7.34 7.82 7.33 7.37 7.38 7.43 7.53 7.55 7.45 7.42 7.24 6.87 6.76 7.09 7.5 6.84 7.14 7.59 7.38 7.14 7.17
GOBP_RRNA_CATABOLIC_PROCESS 6.75 7.24 7.53 7.67 7.13 7.28 7.55 7.23 7.19 7.27 7.37 7.38 7.04 7.18 7.03 7.06 6.78 6.77 7.13 7.43 6.59 6.76 7.09 7.33 7.2 7.2
GOBP_SYNAPTIC_VESICLE_EXOCYTOSIS 7.8 8.04 7.93 7.86 8.43 8.25 8.58 8.49 8.12 8.35 8.08 8.49 8.22 8.28 8.59 8.53 7.89 8.22 8.39 8.17 8 8.51 8.11 8.45 8.28 8.2
GOBP_SYNAPTIC_VESICLE_PRIMING 8.99 8.97 8.56 8.65 8.92 9.2 9.57 9.33 8.98 9.44 8.75 9.14 9.2 9.43 9.5 9.35 8.68 8.97 9.41 9.82 8.82 9.29 9.27 9.58 9.42 8.83
GOBP_TERPENOID_BIOSYNTHETIC_PROCESS 5.33 5.4 5.6 5.72 5.11 4.99 5.38 4.92 5.41 5.16 5.47 4.65 5.18 4.96 5.27 5.1 5.55 5.61 4.86 4.82 4.81 5.17 4.95 4.93 4.93 4.85
GOBP_STEROL_METABOLIC_PROCESS 6.47 6.4 6.57 6.59 6.86 6.65 6.58 6.67 6.88 7.02 6.58 6.69 6.91 6.58 6.56 6.49 6.69 6.5 6.4 6.63 6.41 6.56 6.72 6.8 6.66 6.83
GOBP_STEROL_BIOSYNTHETIC_PROCESS 7.32 7.36 7.48 7.29 7.66 7.65 7.73 7.55 7.68 7.81 7.2 7.54 7.65 7.6 7.59 7.53 7.41 7.13 7.4 7.64 7.35 7.43 7.73 7.96 7.9 7.58
GOBP_GLYCOSIDE_METABOLIC_PROCESS 6.13 6.14 6.35 6.36 6.33 6.12 5.8 6.13 6.07 5.8 5.84 5.87 6.37 5.84 5.93 6.06 6.09 5.72 5.81 5.97 5.99 6.1 6.07 6.03 6.16 6.28
GOBP_SNRNA_PROCESSING 6.72 6.89 7.42 7.17 7.03 7.24 6.74 6.91 6.76 6.85 7.03 6.76 6.88 6.86 6.81 6.98 6.74 6.61 7 7.02 6.57 6.75 7.01 6.92 6.86 6.94
GOBP_SYNAPTIC_VESICLE_MATURATION 8.32 8.16 9 8.83 9.04 8.7 9.06 9.12 9.02 9.37 8.52 8.81 9.27 9.49 9.27 9.19 8.45 8.31 8.42 8.6 8.75 8.96 8.66 9.29 9.27 9.27
GOBP_ENDOSOMAL_TRANSPORT 7.56 7.65 8.14 8.1 7.96 8.09 8.12 7.91 7.91 8 7.94 7.99 8.05 8.05 8.01 7.99 7.88 7.56 7.81 8.08 7.7 7.91 8.1 8.2 7.97 7.83
GOBP_IRON_SULFUR_CLUSTER_ASSEMBLY 7.73 7.77 8.1 7.9 7.18 7.82 7.1 7.45 7.93 7.61 7.69 7.75 7.75 7.65 7.72 7.76 7.3 7.61 7.8 7.63 7.74 7.75 7.6 7.66 7.65 7.2
GOBP_TELOMERE_CAPPING 7.09 7.35 7.61 7.59 7.4 7.33 7.15 7.2 7.45 7.48 7.25 7.49 7.24 7.26 7.16 7.16 7.12 7.17 7.3 7.3 7.41 7.36 7.37 7.47 7.27 7.54
GOBP_MACROAUTOPHAGY 7.87 8.03 8.28 8.2 8.15 8.15 8.15 8.03 8.1 8.23 8.06 8.09 8.12 8.1 8.15 8.13 7.85 7.78 8.18 8.18 7.81 8.05 8.2 8.37 8.18 7.96
GOBP_POSITIVE_REGULATION_OF_MACROAUTOPHAGY 7.69 8.07 7.7 7.7 8 8.05 8.12 7.94 8.1 8.17 7.81 8.03 8.09 8.03 8.09 7.96 7.85 7.74 8.05 8.09 7.64 7.92 8.17 8.26 8.16 8.04
GOBP_REGULATION_OF_MACROAUTOPHAGY 7.89 8.11 8.21 7.99 8.18 8.21 8.22 8.05 8.12 8.32 8.17 8.26 8.15 8.13 8.25 8.14 7.99 7.91 8.23 8.24 7.78 8.16 8.35 8.47 8.32 8.09
GOBP_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY 7.95 8.15 8.12 8.19 8.32 8.3 8.29 8.26 8.05 8.35 8.06 8.05 8.28 8.16 8.27 8.03 8.03 7.73 7.97 8.31 8.2 8.29 8.14 8.4 8.38 8.08
GOBP_RNA_INTERFERENCE 7.84 7.76 7.92 7.68 7.99 7.96 8.21 7.96 8.18 8.25 8 7.63 8.08 7.88 7.65 8.51 7.47 7.33 7.68 8.25 7.45 7.72 8.11 7.66 8.08 7.92
GOBP_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE 7.05 6.9 6.43 6.34 6.72 6.92 6.65 6.56 6.59 6.4 5.9 6.44 6.59 6.6 6.24 6.21 6.59 6.57 6.52 6.55 6.1 6.39 6.39 6.34 6.7 6.55
GOBP_GAP_JUNCTION_ASSEMBLY 6.05 6.12 5.2 6.17 5.41 5.8 5.91 6.25 6.02 5.66 5.86 6.25 5.87 5.48 5.73 5.78 5.5 5.65 6.05 5.71 6.47 6.48 6.04 5.78 6.48 6.55
GOBP_O_GLYCAN_PROCESSING 5.38 5.36 5.49 5.58 4.97 5.04 5.51 5.63 5.3 5.23 5.37 5.05 5.28 5.28 5.77 5.32 5.17 5.1 5.01 5.25 5.63 5.24 5.46 5.22 5.28 5.37
GOBP_DEPHOSPHORYLATION 7.04 7.13 7.42 7.22 7.32 7.34 7.26 7.33 7.3 7.43 7.26 7.27 7.35 7.35 7.38 7.22 7.19 7.11 7.24 7.4 7.13 7.34 7.41 7.51 7.3 7.3
GOBP_NEURON_REMODELING 7.18 7.2 6.84 6.87 7.09 7.3 7.23 7.16 6.8 7.11 7.36 6.96 7.11 7.14 7.05 7.17 7.44 7.36 7.15 7.45 7.5 7.62 6.85 7.32 7.1 6.89
GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM 5.98 6.04 6.09 6.03 6 6.04 6.1 6.09 6.1 6.17 6.21 6.04 6.17 6.09 6.01 6.14 6 6.02 5.95 5.96 6.17 6.33 6.06 5.98 6.02 6.18
GOBP_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES 5.23 5.15 5.04 5.2 4.59 4.66 4.8 4.98 4.89 4.88 5.34 4.69 4.74 4.84 4.78 4.76 5.08 5.57 4.95 5 4.99 4.76 4.78 4.68 4.88 4.95
GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES 6.45 6.46 6.36 6.08 6.73 7.02 6.7 6.52 6.82 6.83 6.19 6.59 6.71 6.8 6.93 6.77 5.98 6.3 6.98 6.67 6.17 6.26 6.93 6.85 6.64 6.57
GOBP_DENDRITE_DEVELOPMENT 7.6 7.76 7.88 7.54 7.99 8.14 8.16 8.07 7.94 8.12 7.71 8.12 8.16 8.12 8.09 8.05 7.88 7.79 7.98 8.15 7.81 7.98 8.06 8.26 7.96 7.97
GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS 6.09 6.39 6.04 6.15 6.51 6.49 6.48 6.29 6.39 6.41 6.34 6.5 6.52 6.4 6.18 6.28 6.14 6.4 6.46 6.38 6.39 6.69 6.42 6.73 6.36 6.61
GOBP_SOMATIC_RECOMBINATION_OF_IMMUNOGLOBULIN_GENE_SEGMENTS 6.17 6.43 6.04 6.36 6.54 6.56 6.54 6.29 6.26 6.42 6.41 6.53 6.53 6.43 6.19 6.24 6.19 6.49 6.5 6.4 6.44 6.76 6.42 6.74 6.34 6.67
GOBP_GENE_SILENCING 7.09 7.15 7.54 7.42 7.56 7.39 7.28 7.2 7.47 7.48 7.3 7.38 7.28 7.46 7.38 7.42 7.28 7.14 7.32 7.38 7.26 7.57 7.49 7.58 7.57 7.41
GOBP_CELL_MIGRATION 6.35 6.31 6.39 6.36 6.35 6.36 6.34 6.36 6.34 6.31 6.3 6.29 6.39 6.4 6.37 6.39 6.46 6.3 6.25 6.29 6.53 6.54 6.5 6.44 6.5 6.49
GOBP_CYTOSOLIC_TRANSPORT 7.99 7.92 8.14 8.1 8.24 8.38 8.37 8.07 8.26 8.14 7.99 8.29 8.29 8.25 8.06 8 8.04 7.82 7.98 8.27 7.89 8.12 8.13 8.27 8.13 8.02
GOBP_PROTEIN_PROCESSING 6.06 5.93 6.09 6.24 5.92 5.91 5.98 6.06 6.02 6.02 6.09 6.09 6.11 6.03 5.98 5.95 6.28 5.97 5.92 6.01 6.15 6.13 6.05 5.82 6 6.13
GOBP_PROTEIN_AUTOPROCESSING 5.64 5.62 5.79 6.18 5.46 5.58 5.72 5.48 5.26 5.4 5.58 5.46 5.55 5.78 5.45 5.46 5.86 5.77 5.2 5.68 5.65 5.72 5.4 5.18 5.24 5.46
GOBP_BASE_CONVERSION_OR_SUBSTITUTION_EDITING 5.25 5.2 5.16 5.1 4.84 4.53 4.82 4.85 5.08 4.37 4.91 4.91 4.95 4.69 4.97 4.8 5.14 5.19 4.96 4.82 5.32 5.13 4.58 4.58 5.09 5.13
GOBP_CYTIDINE_TO_URIDINE_EDITING 4.69 5.03 4.71 4.28 4.3 4.12 4.38 4.63 4.33 4.23 4.47 4.59 4.08 4.34 4.4 4.43 4.85 4.97 4.61 4.43 5.08 4.43 4.04 4.14 4.67 4.62
GOBP_MRNA_MODIFICATION 6.7 6.68 6.97 7.03 6.8 6.89 6.38 6.87 6.59 6.42 6.69 6.55 6.88 6.7 6.47 6.85 6.65 6.95 6.59 6.92 6.77 6.99 6.62 6.65 6.92 6.81
GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX 6.88 6.89 7.31 7.02 7.31 7.37 7.04 6.84 6.96 7.21 7.27 7.21 7.34 7.5 6.85 7.25 7.16 6.99 7.34 7.5 6.84 7 7.16 7.54 7.18 7.21
GOBP_COVALENT_CHROMATIN_MODIFICATION 6.9 6.98 7.11 7.04 7.33 7.27 7.15 7.24 7.13 7.27 7.05 7.22 7.21 7.22 7.28 7.29 7.13 6.95 7.2 7.3 7 7.24 7.26 7.44 7.19 7.3
GOBP_HISTONE_METHYLATION 6.61 6.68 6.65 6.7 6.9 6.96 6.81 6.94 6.76 6.9 6.64 6.87 6.86 6.72 7.04 6.91 6.75 6.57 6.65 6.85 6.78 7 6.99 7.08 6.96 7.02
GOBP_HISTONE_PHOSPHORYLATION 7.09 6.81 7.46 7.61 7.38 7.23 7.04 7.23 7.09 7.23 7.24 7.7 7.16 7.12 7.37 7.45 7.25 7.08 7.22 7.3 7.13 7.63 7.57 7.74 7.54 7.52
GOBP_HISTONE_UBIQUITINATION 7.36 7.34 7.65 7.63 7.89 7.97 7.71 8.03 7.68 7.9 7.74 7.82 7.86 8.12 8.38 8.24 7.5 7.69 7.86 7.9 7.75 7.9 7.88 8.11 7.97 8.24
GOBP_HISTONE_DEACETYLATION 6.83 6.93 7.09 6.9 7.29 7.44 7.19 7 7.16 7.21 6.92 7.11 7.24 7.2 7.15 7.28 7.02 6.81 7.14 7.32 6.98 6.98 7.19 7.43 6.94 7.08
GOBP_HISTONE_DEUBIQUITINATION 7.67 7.59 7.22 7.21 8.02 8.03 7.76 7.66 7.75 7.9 7.69 7.87 7.98 8.16 7.74 7.63 7.54 7.7 7.92 8.1 7.61 7.68 7.68 7.93 7.77 7.7
GOBP_RAC_PROTEIN_SIGNAL_TRANSDUCTION 7.36 7.58 7.89 7.68 7.98 8.19 8.09 7.91 8.18 8.2 7.79 8.07 8.22 8.1 8.05 7.88 7.81 7.76 7.92 8.41 7.39 7.61 8.19 8.47 8.27 7.89
GOBP_PROTEIN_SUMOYLATION 7.33 7.32 7.79 7.6 7.69 7.76 7.37 7.45 7.63 7.52 7.48 7.52 7.58 7.77 7.54 7.59 7.3 7.16 7.45 7.75 7.18 7.68 7.46 7.68 7.65 7.37
GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS 6.89 7.05 7.16 7.34 7.32 7.37 6.9 7.22 6.88 7.3 6.71 7.07 6.94 7.05 7.34 7.17 6.92 6.74 7.05 6.98 6.93 7.25 7.13 7.31 7.24 7.32
GOBP_CYTOCHROME_COMPLEX_ASSEMBLY 6.93 6.93 7.66 7.68 6.9 7.13 6.88 7.47 7.18 6.93 7.06 7.09 6.94 7.08 6.9 6.94 6.85 6.38 7.06 7.17 6.69 6.98 6.75 7.49 6.74 6.56
GOBP_PROTEIN_NITROSYLATION 6.19 6.09 6.67 6.72 6.39 6.84 6.23 6.98 7.23 7.49 7.08 7.11 6.05 6.4 7.67 7.96 6.34 6.83 6.57 6.22 7.26 7.15 7.32 7.3 8.06 7.84
GOBP_PROTEIN_IMPORT 7.23 7.25 7.58 7.67 7.63 7.51 7.44 7.48 7.54 7.48 7.53 7.6 7.59 7.64 7.35 7.52 7.3 7.29 7.48 7.5 7.3 7.57 7.56 7.71 7.6 7.47
GOBP_PLASMA_MEMBRANE_PHOSPHOLIPID_SCRAMBLING 6.48 6.75 6.17 6.29 6.23 6.06 6.28 6.46 6 5.95 6.57 6.19 6.37 6.48 5.93 6.06 6.32 6.55 6.01 6.38 6.46 6.66 5.83 5.89 6.69 6.92
GOBP_DRUG_METABOLIC_PROCESS 5.56 5.34 5.28 5.24 4.75 4.69 5.19 5.03 4.98 4.84 5.17 5.11 5.2 4.76 5.05 4.99 5.02 5.44 5.07 4.79 5.51 4.79 4.59 4.69 4.98 5.09
GOBP_STEM_CELL_DIVISION 6.48 6.84 6.84 7.15 6.93 7.06 6.75 6.76 6.97 7.24 6.85 7.02 7.32 7.23 7.2 7.03 6.77 6.63 6.74 7.19 6.7 6.87 7.28 7.23 7.13 6.82
GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS 7.66 7.54 7.58 7.48 8.07 7.67 8.08 8.31 7.58 7.91 7.54 8.08 7.91 8.05 8.07 8.09 7.73 8.01 8.05 8 7.9 7.91 7.67 8.12 7.76 7.95
GOBP_REGULATION_OF_EXOCYTOSIS 7.28 7.34 7.58 7.26 7.57 7.6 7.68 7.62 7.59 7.74 7.54 7.72 7.67 7.76 7.74 7.62 7.43 7.42 7.58 7.68 7.65 7.72 7.71 7.88 7.52 7.53
GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS 7.32 7.35 7.14 6.92 7.42 7.26 7.75 8.01 7.42 7.55 7.26 7.68 7.67 7.59 7.93 7.73 7.29 7.73 7.61 7.8 7.79 7.82 7.39 7.72 7.71 7.67
GOBP_PEPTIDYL_LYSINE_METHYLATION 6.43 6.51 6.63 6.7 6.76 6.73 6.56 6.85 6.53 6.73 6.51 6.72 6.65 6.68 6.83 6.62 6.6 6.47 6.6 6.71 6.69 6.79 6.86 7.05 6.77 6.84
GOBP_PEPTIDYL_LYSINE_TRIMETHYLATION 6.42 6.64 6.65 6.5 7.09 6.96 6.69 6.86 6.72 6.69 6.38 6.56 6.64 6.65 6.78 6.98 6.53 6.54 6.59 6.62 6.7 6.72 7.03 7.29 7.04 6.74
GOBP_PEPTIDYL_LYSINE_DIMETHYLATION 7.48 6.94 7.33 7.13 6.67 7.54 6.56 6.6 6.76 6.82 6.93 6.81 6.99 6.89 6.83 6.58 6.71 6.62 7.68 6.78 6.69 7.05 6.83 7.05 6.85 7.02
GOBP_PROTEIN_HYDROXYLATION 6.43 6.57 7.19 6.7 7.23 7.03 6.62 7.1 7.26 6.72 6.93 7.16 7.53 7.02 6.84 6.98 7.29 7.09 6.67 7.06 6.86 6.69 7.25 7.53 6.79 6.91
GOBP_KERATAN_SULFATE_BIOSYNTHETIC_PROCESS 6.14 6.12 6.96 6.86 6.81 6.8 6.8 7.01 6.55 6.84 6.75 6.77 6.87 6.17 6.41 6.4 7.3 6.05 6.1 6.82 6.64 7.17 6.79 7.04 6.55 6.72
GOBP_PEPTIDE_CROSS_LINKING 5.09 5.02 4.72 5.07 4.73 4.51 4.8 4.61 4.81 4.46 4.86 4.52 4.59 4.54 4.54 4.42 4.71 4.99 4.65 4.53 5 4.67 4.79 4.48 4.72 4.59
GOBP_PROTEIN_OXIDATION 5.86 5.26 5.28 5.69 5.21 5.24 5.47 5.38 5.31 5.35 5.57 5.33 5.53 5.42 5.29 5.42 5.61 5.39 5.44 5.17 5.57 5.55 5.28 4.99 5.4 5.44
GOBP_PEPTIDYL_AMINO_ACID_MODIFICATION 6.69 6.67 6.96 6.85 6.92 6.96 6.87 6.9 6.89 6.94 6.85 6.89 6.92 6.85 6.95 6.97 6.83 6.75 6.85 6.99 6.86 6.97 6.98 7.08 6.91 6.96
GOBP_PEPTIDYL_ARGININE_MODIFICATION 6.33 5.86 6.24 5.93 6.08 5.89 6 6.25 5.67 6.12 5.94 6.19 5.92 6.04 6.23 6.25 5.94 5.87 6.01 5.91 6.51 6.31 5.8 5.83 6.29 6.48
GOBP_PEPTIDYL_ASPARAGINE_MODIFICATION 7.63 7.84 8.25 8.12 8.18 8.33 8.04 7.97 8.05 8.03 7.86 7.94 8.25 8.25 8.11 8.18 7.76 7.69 8.15 8.25 7.49 8.08 8 8.32 7.96 8.05
GOBP_PEPTIDYL_CYSTEINE_MODIFICATION 7.23 7.18 7.24 7.26 7.18 7.54 7.29 7.68 7.4 7.52 7.53 7.65 7.62 7.55 7.59 7.96 7.17 7.34 7.45 7.35 7.38 7.35 7.34 7.46 7.6 7.56
GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION 6.86 7.04 6.65 6.65 6.55 6.33 6.48 6.17 6.55 6.19 6.76 6.41 6.46 6.79 6.59 6.5 6.71 6.88 6.79 6.39 7.1 6.66 6.09 6.59 6.23 6.28
GOBP_PEPTIDYL_LYSINE_MODIFICATION 6.85 6.89 7.17 7.07 7.19 7.17 7.05 7.1 7.09 7.11 6.98 7.06 7.06 7.07 7.15 7.2 7.03 6.77 7.05 7.2 6.92 7.05 7.08 7.35 7.09 7.11
GOBP_PEPTIDYL_METHIONINE_MODIFICATION 6.84 6.94 6.81 6.86 7.38 7.23 7.26 6.82 6.88 6.97 7.35 7.38 7.19 7.25 7.14 6.89 7.04 6.93 7 7.21 6.9 7.47 7.2 7.55 7 7.37
GOBP_PEPTIDYL_PROLINE_MODIFICATION 6.89 6.87 7.2 7.23 7.14 7.13 7.25 7.18 7.07 7.18 7.24 7.1 7.3 7.02 7.36 7.34 6.94 7.21 7.17 7.15 7.24 7.36 7.33 7.4 7.13 7.5
GOBP_PEPTIDYL_SERINE_MODIFICATION 6.96 6.93 7.31 7.15 7.34 7.36 7.2 7.27 7.36 7.26 7.29 7.3 7.34 7.45 7.36 7.33 7.26 7.18 7.25 7.4 7.13 7.45 7.45 7.59 7.37 7.31
GOBP_PEPTIDYL_THREONINE_MODIFICATION 7.34 7.28 7.73 7.61 7.87 7.78 7.75 7.9 7.63 7.83 7.55 7.87 7.81 7.93 7.78 7.88 7.68 7.47 7.63 7.78 7.84 7.96 7.92 7.95 7.75 7.94
GOBP_PEPTIDYL_TYROSINE_MODIFICATION 6.07 6.08 6.25 6.14 5.97 5.99 6.09 6.18 6.18 6.17 6.1 5.93 6.07 6.18 6.18 6.12 6.17 6.12 5.94 6 6.2 6.1 6.1 6.12 6.1 6.27
GOBP_PROTEIN_PHOSPHOPANTETHEINYLATION 7.02 7.13 7.44 7.26 7.35 7.35 7.31 7.14 7.19 7.35 7.16 7.28 7.36 7.33 7.25 7.22 7.11 7.12 7.24 7.29 7.05 7.35 7.41 7.54 7.17 7.27
GOBP_PEPTIDYL_ARGININE_METHYLATION 6.8 6.81 7.18 6.71 6.89 7.21 7.41 7.36 7.24 7.39 6.94 7.37 7.14 7.32 7.7 7.53 7.05 6.98 7.04 7.08 7.06 7.41 7.12 7.61 7.41 7.14
GOBP_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION 7.68 7.59 7.51 7.49 7.68 7.81 7.37 7.82 7.38 7.52 7.55 7.72 7.8 7.91 7.59 7.81 7.35 7.56 7.79 7.51 7.49 7.48 7.34 7.46 7.54 7.56
GOBP_PROTEIN_CHROMOPHORE_LINKAGE 5.09 5.29 5.26 5.64 5.21 4.56 4.79 5.04 5.2 5.05 5.72 4.94 4.73 4.99 5.28 5.03 4.98 5.07 5.04 4.9 5.39 5.02 5.19 4.58 4.97 4.92
GOBP_PROTEIN_PALMITOYLATION 7.68 7.59 7.95 7.54 7.85 7.88 7.75 7.94 7.8 7.66 7.62 7.75 7.95 8.06 7.8 7.81 7.59 7.85 7.82 7.65 7.53 7.62 7.6 7.92 7.76 7.62
GOBP_PEPTIDYL_LYSINE_ACETYLATION 7.14 7.11 7.35 7.33 7.55 7.42 7.37 7.51 7.37 7.35 7.41 7.38 7.41 7.4 7.47 7.45 7.44 7.08 7.16 7.52 7.27 7.54 7.55 7.75 7.57 7.31
GOBP_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION 7.43 7.08 8.02 7.7 7.36 6.99 6.73 6.89 7.22 7.05 7.55 6.91 7.08 7.27 7.07 7.54 7.29 7.36 7.57 7.22 7.06 7.26 7.21 7.29 7.17 6.88
GOBP_ETHER_METABOLIC_PROCESS 6.65 6.71 6.93 6.9 7.03 7.17 7.08 6.97 6.69 7.19 6.44 7.23 7.41 7.14 6.75 6.44 6.59 6.49 6.35 7.18 6.49 6.86 6.64 6.99 6.75 7.33
GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS 5.77 5.78 5.7 5.89 5.54 5.41 5.67 5.8 5.77 5.67 5.66 5.41 5.44 5.38 5.75 5.61 5.69 5.64 5.47 5.44 5.66 5.58 5.65 5.51 5.65 5.64
GOBP_VIRAL_LATENCY 6.39 6.07 6.65 7.01 7.23 6.55 6.7 6.85 6.47 6.61 6.83 6.56 6.27 6.6 6.27 6.75 6.29 6.78 6.67 6.6 6.1 6.37 6.78 6.61 6.38 6.47
GOBP_MODULATION_BY_VIRUS_OF_HOST_PROCESS 7.23 6.85 7.67 7.09 7.29 7.33 7.18 7.24 7.11 7.35 7.37 7.32 7.38 7.22 7.67 7.39 7.47 7.61 7.46 7.49 7.51 7.98 7.47 7.64 7.84 7.85
GOBP_MODULATION_BY_VIRUS_OF_HOST_CELLULAR_PROCESS 7.28 7.34 8.35 7.76 7.33 7.34 7.42 7.48 7.24 7.45 7.52 7.36 7.38 7.26 7.52 7.48 7.52 7.55 7.76 7.59 7.51 7.84 7.73 7.66 7.68 8.1
GOBP_VIRAL_LIFE_CYCLE 6.63 6.53 6.96 6.9 6.74 6.88 6.91 6.92 6.92 6.75 6.78 6.78 6.95 7.03 6.72 6.8 6.74 6.71 6.8 6.71 6.75 6.95 6.95 7.08 7.04 7.14
GOBP_VIRION_ASSEMBLY 7.36 7.36 8.48 8.55 7.51 7.51 7.91 8.07 7.73 7.9 7.9 7.87 7.98 7.95 7.8 7.79 7.58 7.35 7.67 7.7 7.65 7.76 8.14 8.08 7.79 7.67
GOBP_VIRAL_RELEASE_FROM_HOST_CELL 6.93 6.59 7.18 7.01 6.68 6.88 6.94 6.92 7.14 7.04 6.97 6.65 6.93 7.17 7.27 7.13 6.51 6.8 6.92 7.03 6.82 7.19 7.41 7.35 7.09 7.21
GOBP_VIRAL_GENOME_REPLICATION 6.6 6.63 6.83 6.77 7.11 6.91 6.78 6.73 6.93 6.87 6.83 6.87 7.17 7.03 6.59 6.71 6.85 6.71 6.88 6.69 6.82 7.08 6.74 6.88 6.92 7.18
GOBP_VIRAL_GENE_EXPRESSION 7.15 7.13 7.37 7.54 7.17 7.26 7.33 7.32 7.22 7.27 7.31 7.2 7.21 7.27 7.38 7.36 7.29 7.12 7.16 7.33 7.22 7.37 7.36 7.4 7.32 7.34
GOBP_VIRAL_TRANSLATION 8.08 8.58 8.38 8.21 8.38 8.39 8.21 8.59 8.66 8.67 8.27 8.41 8.38 8.14 8.45 8.8 8.28 8.13 8.21 8.64 8.61 8.79 8.55 8.73 8.7 8.88
GOBP_REPRODUCTIVE_BEHAVIOR 7.17 7 7.09 6.75 7.1 7.32 7.37 7.16 7.66 7.75 7.41 7.8 7.43 7.4 7.69 6.97 6.84 6.94 7.19 7.1 7.1 7.09 7.74 7.76 7.18 7.16
GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS 6.71 6.29 6.9 6.92 6.39 6.38 6.33 6.38 6.33 6.85 6.44 6.95 6.38 6.37 7.01 6.76 7.07 6.84 6.27 6.52 6.79 6.7 6.1 6.47 6.65 6.62
GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS 6.82 6.81 7.13 6.94 7.07 7.05 7.13 7.04 7.05 7.18 6.92 7.18 7.16 7.19 7.12 7.06 7.02 6.87 6.89 6.99 6.97 6.98 7.22 7.4 7.31 7.18
GOBP_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS 6.23 6.48 6.62 6.62 6.71 6.78 6.74 6.69 6.86 6.93 6.64 6.78 6.87 7.08 6.72 6.62 6.73 6.6 6.34 6.85 6.74 6.75 6.99 7.1 7.12 6.87
GOBP_REGULATION_OF_STEROID_METABOLIC_PROCESS 6.51 6.52 6.61 6.62 6.69 6.45 6.44 6.64 6.81 6.8 6.52 6.93 6.97 6.58 6.57 6.5 6.72 6.53 6.35 6.57 6.5 6.44 6.77 6.89 6.79 6.65
GOBP_CYTOKINE_MEDIATED_SIGNALING_PATHWAY 6.08 5.97 6.04 6.15 5.94 5.81 5.92 5.96 5.96 5.85 6.06 5.87 5.88 5.85 5.9 5.85 6.06 6.03 5.83 5.83 6.12 6.1 5.74 5.64 6.03 6.16
GOBP_TRANSMISSION_OF_NERVE_IMPULSE 7.17 7.15 6.52 6.44 7.13 7.13 7.26 7.04 7.22 6.95 6.83 7 6.89 6.79 6.75 6.62 6.79 6.72 6.97 7.63 6.5 6.56 6.87 6.78 6.97 6.8
GOBP_NEURONAL_ACTION_POTENTIAL 7.32 7.15 6.46 6.25 7.13 7.13 7.26 6.86 7.22 6.86 7.43 6.66 7.52 7.59 6.75 7.21 6.74 7.08 7.31 7.63 6.69 6.81 6.87 6.84 6.91 6.8
GOBP_REGULATION_OF_VASOCONSTRICTION 5.6 5.59 5.47 5.52 5.15 5.29 5.64 5.37 5.56 5.45 5.85 5.33 5.64 5.49 5.52 5.53 5.55 5.65 5.29 5.54 5.87 5.68 5.54 5.39 5.6 5.46
GOBP_SENSORY_PERCEPTION_OF_PAIN 6.25 6.21 6.07 6.08 6.03 5.98 6.03 6.35 6.16 6.27 6.09 5.76 6.36 6.09 6.24 6.08 6.17 6.2 6.06 6.1 6.16 6.13 5.93 6.15 5.97 6.2
GOBP_PENTOSE_METABOLIC_PROCESS 6.79 6.66 7.4 7.4 7.25 7.26 6.77 7.05 6.9 6.89 6.78 6.74 6.88 6.94 6.53 6.71 6.64 6.72 6.73 6.89 6.7 6.7 7.07 7.01 6.97 7.03
GOBP_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS 6.08 6.18 6.29 6.35 5.91 5.94 5.9 6.19 6.14 6 6.65 6.06 6.29 6.32 6.28 6.37 5.97 6.36 6.18 6.64 6.71 6.85 6.03 6.42 6.65 6.48
GOBP_ARACHIDONIC_ACID_METABOLIC_PROCESS 5.68 5.61 5.39 5.53 5 5.1 5.25 5.13 5.21 5.13 5.29 5.34 5.34 4.93 5.3 5.17 5.17 5.72 5.27 5.12 5.65 5.13 5.11 4.87 5.37 5.47
GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS 6.3 6.03 6.37 6.33 5.3 6.16 6.29 6.45 6.13 5.73 5.82 5.82 6.43 5.7 6.15 6.26 6.25 6.29 5.5 6.18 6.59 6.63 5.71 5.95 5.93 6.15
GOBP_CYCLOOXYGENASE_PATHWAY 6.32 5.88 6.48 6.01 5.37 5.36 5.48 6.04 5.76 5.56 6.01 5.91 5.86 5.85 5.76 6.1 5.74 5.83 5.6 5.73 5.84 6.6 5.79 5.72 6 5.64
GOBP_LIPOXYGENASE_PATHWAY 5.32 5.07 5.35 5.34 4.74 4.91 4.87 4.93 4.84 4.74 5.22 4.93 4.92 4.69 4.93 5.01 4.87 5.05 5.09 4.91 5.01 4.77 4.84 4.62 4.91 5.02
GOBP_EPOXYGENASE_P450_PATHWAY 5.53 5.31 5.04 4.98 4.25 4.49 5.16 4.95 4.58 4.34 5.11 4.86 4.71 4.45 4.89 4.7 5.01 5.45 4.92 4.75 5.5 4.75 4.37 4.53 4.92 4.94
GOBP_GLYCOLIPID_CATABOLIC_PROCESS 6.63 6.55 7.37 7.04 6.57 6.99 6.96 6.89 6.83 6.81 7.03 7.13 7.03 7.19 6.8 6.9 6.44 6.78 7.24 7.13 6.8 6.89 6.96 7.41 6.68 6.59
GOBP_ALDITOL_METABOLIC_PROCESS 5.3 6.27 5.79 6.27 5.85 5.56 5.67 5.75 5.6 5.9 5.84 5.78 5.95 5.24 5.47 5.52 5.76 5.59 6 5.77 5.95 5.57 5.81 5.29 5.64 5.8
GOBP_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS 6.44 6.59 7.19 6.9 6.76 6.72 6.91 6.86 6.47 6.72 6.74 6.41 7.03 7.25 6.47 6.61 6.59 6.32 6.35 6.67 6.91 6.95 6.64 6.76 6.99 6.72
GOBP_TRIGLYCERIDE_CATABOLIC_PROCESS 5.14 4.74 4.97 5.02 4.9 4.61 4.72 4.77 5.22 4.52 5.02 4.54 4.71 4.89 4.6 4.75 4.82 4.91 4.95 4.68 4.97 4.71 4.86 4.73 4.65 4.89
GOBP_PEPTIDYL_PROLINE_HYDROXYLATION 6.5 6.46 7.45 6.87 7.63 7.39 6.9 6.92 7.5 7.43 7.04 7.32 7.56 7.31 6.91 6.59 7.39 7.27 6.63 7.07 7.03 6.81 7.51 7.82 6.99 7.2
GOBP_OXALATE_TRANSPORT 5.25 5.03 4.48 5.16 4.67 4.48 4.51 4.74 4.84 4.6 4.79 4.77 4.78 4.63 4.66 4.54 4.87 4.79 4.68 4.73 4.9 4.58 4.39 4.42 4.61 4.69
GOBP_UREA_METABOLIC_PROCESS 5.49 5.12 5.12 5.1 4.69 4.97 5.19 5.34 5.41 4.97 4.85 4.92 5.06 4.78 5.25 5.22 5.23 5.16 4.99 4.99 5.25 5.16 4.98 5.04 5.11 5.14
GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS 6.7 6.71 7.06 6.97 6.89 6.94 6.97 6.81 6.9 6.96 6.78 6.87 6.95 6.97 6.81 6.79 6.84 6.79 6.79 6.95 6.78 6.91 6.92 6.97 6.94 6.96
GOBP_NAD_METABOLIC_PROCESS 6.53 6.35 6.45 6.54 6.75 6.71 6.15 6.33 6.36 6.15 6.21 6.6 6.21 6.13 6.47 6.21 6.69 6.31 6.44 6.3 6.36 6.92 6.15 6.32 6.21 6.39
GOBP_CALCIUM_MEDIATED_SIGNALING 6.14 6.18 6.11 6.11 6.08 5.89 6.07 6.22 6.11 5.91 6.05 6.05 5.93 5.84 6.14 5.97 6.18 6.04 6.01 6.01 6.26 6.18 6.2 5.91 5.99 6.21
GOBP_B_CELL_MEDIATED_IMMUNITY 5.63 5.62 5.45 5.56 5.28 5.23 5.37 5.32 5.39 5.18 5.47 5.28 5.34 5.3 5.28 5.41 5.44 5.65 5.27 5.27 5.59 5.49 5.24 5.1 5.42 5.65
GOBP_CELLULAR_HOMEOSTASIS 6.29 6.23 6.6 6.51 6.2 6.22 6.37 6.33 6.31 6.35 6.31 6.22 6.25 6.3 6.36 6.34 6.35 6.34 6.29 6.34 6.42 6.51 6.31 6.33 6.43 6.47
GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE 4.9 4.79 4.71 4.75 4.24 4.08 4.42 4.42 4.53 4.21 4.73 4.37 4.31 4.28 4.41 4.36 4.76 4.8 4.41 4.37 4.77 4.51 4.23 4.07 4.37 4.37
GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE 4.8 4.8 4.53 4.7 4.23 4.03 4.57 4.4 4.49 4.16 4.41 4.22 4.17 4.04 4.4 4.24 4.46 4.78 4.38 4.31 4.69 4.49 4.19 4.13 4.38 4.23
GOBP_SECONDARY_METABOLIC_PROCESS 5.63 5.71 5.92 5.76 5.59 5.38 5.72 5.89 5.62 5.52 5.56 5.63 5.55 5.6 5.67 5.39 5.69 5.61 5.53 5.44 5.56 5.51 5.44 5.81 5.74 5.61
GOBP_POLYOL_METABOLIC_PROCESS 6.28 6.45 6.54 6.62 6.21 6.52 6.58 6.38 6.48 6.55 6.54 6.47 6.42 6.45 6.57 6.28 6.36 6.47 6.46 6.36 6.44 6.57 6.49 6.52 6.59 6.46
GOBP_ONE_CARBON_COMPOUND_TRANSPORT 5.31 5.19 4.94 5.41 4.37 4.44 4.9 4.74 4.89 4.73 5.08 4.69 4.7 4.74 4.89 4.57 4.85 5.26 4.66 4.7 4.76 4.6 4.74 4.38 4.65 4.96
GOBP_CYTOLYSIS 4.86 4.74 4.51 4.69 4.06 3.92 4.3 4.25 4.39 4.13 4.53 4.37 4.28 4.11 4.24 4.25 4.56 4.86 4.46 4.26 4.7 4.24 4.14 3.98 4.51 4.71
GOBP_L_ASCORBIC_ACID_METABOLIC_PROCESS 6.98 7.02 8.43 8.28 7.15 6.92 6.96 7.14 7.23 7.13 7.29 6.74 7.12 6.9 7.01 7.01 7.05 7.31 6.66 7.16 7.17 7.1 7.15 7.25 7.22 7.05
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION 7.31 7.37 8.32 7.88 7.63 7.66 7.83 7.57 7.94 7.77 7.53 7.42 7.66 7.73 7.58 7.9 7.67 7.28 7.45 7.73 7.48 7.8 8.04 7.99 7.78 7.65
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN 6.18 6.18 6.28 6.71 6.39 6.55 6.47 6.06 6.45 6.21 6.19 6.21 6.4 6.33 5.77 6.16 6.55 6.12 6.23 6.46 6.26 6.36 6.08 6.02 6.58 6.26
GOBP_AXONAL_TRANSPORT_OF_MITOCHONDRION 8.48 8.84 9.44 9.06 8.65 8.94 9.19 8.76 9.04 9.19 8.72 8.83 8.95 8.89 9.31 9.01 8.87 8.71 8.81 9.07 8.26 8.54 9.72 9.42 9.28 9.03
GOBP_LIPID_STORAGE 6.63 6.61 7.18 6.81 7.03 6.96 6.87 6.88 6.83 6.97 6.77 6.92 6.97 7.09 6.69 6.73 6.76 6.67 6.67 6.83 6.91 6.87 6.94 7.17 7.01 7.01
GOBP_SECOND_MESSENGER_MEDIATED_SIGNALING 6.28 6.16 6.28 6.46 6.25 6.33 6.38 6.31 6.29 6.43 6.24 6.25 6.25 6.12 6.36 6.22 6.27 6.24 6.25 6.17 6.45 6.35 6.47 6.33 6.24 6.34
GOBP_CAMP_MEDIATED_SIGNALING 6.76 6.7 7.33 7.14 6.89 6.82 7.18 7.02 6.97 6.95 6.98 6.91 7.1 7.19 7.09 7.06 6.87 6.91 6.96 7.23 6.97 6.94 7.33 7.06 7.12 7.2
GOBP_CGMP_MEDIATED_SIGNALING 5.46 5.66 5.48 5.69 5.35 5.38 6.05 5.4 5.58 5.81 5.36 5.69 5.41 5.59 5.88 5.71 5.54 5.62 5.61 5.46 5.56 5.27 6.28 6.11 5.46 5.53
GOBP_CYCLIC_NUCLEOTIDE_MEDIATED_SIGNALING 6.4 6.25 6.76 6.97 6.48 6.58 6.8 6.53 6.57 6.82 6.68 6.59 6.64 6.52 6.82 6.52 6.66 6.56 6.62 6.79 6.59 6.54 6.84 6.56 6.47 6.53
GOBP_SEXUAL_REPRODUCTION 5.77 5.66 5.83 5.87 5.56 5.48 5.61 5.62 5.58 5.6 5.81 5.62 5.53 5.57 5.74 5.77 5.62 5.65 5.65 5.51 5.73 5.65 5.56 5.55 5.62 5.72
GOBP_TRANSLESION_SYNTHESIS 6.89 6.89 7.58 7.64 6.99 7.06 6.98 6.99 6.72 7.22 7.13 7.17 7.06 7.16 6.93 7.02 6.87 6.92 7.01 7.06 6.77 7.45 7.09 7.33 7.13 7.13
GOBP_HEMOGLOBIN_METABOLIC_PROCESS 6.58 6.75 7.25 6.62 6.53 6.94 7.27 7.08 7.55 6.85 6.67 6.62 7.48 7.82 6.83 7.4 6.72 6.4 7.22 7.27 6.4 6.65 7.54 7.15 7.06 6.94
GOBP_SPINAL_CORD_DEVELOPMENT 6.17 6.08 6.08 6.33 6.16 6.12 6.14 6.17 6.2 6.34 6.13 6.22 6.27 6.48 6.12 6.21 6.32 5.99 6.01 6.19 6.15 6.27 6.16 6.34 6.01 6.42
GOBP_SPINAL_CORD_PATTERNING 5.89 5.71 5.87 6.34 5.77 5.82 6 6.1 6.17 6.2 5.99 6.09 6.26 6.37 5.92 6.14 6.45 5.84 5.96 6.22 6.22 6.36 5.93 5.88 5.86 6.31
GOBP_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION 5.64 5.37 5.77 5.65 5.43 5.19 5.59 5.19 5.66 5.07 5.63 5.37 5.39 5.62 5.71 5.41 5.5 5.42 5.21 5.33 5.54 5.51 5.55 5.16 5.61 5.69
GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD 5.66 5.37 5.77 5.85 5.45 5.2 5.54 5.22 5.55 5.33 5.63 5.42 5.47 5.57 5.58 5.52 5.56 5.42 5.38 5.38 5.52 5.53 5.55 5.15 5.41 5.52
GOBP_DORSAL_SPINAL_CORD_DEVELOPMENT 5.77 5.47 5.72 5.93 5.33 5.22 5.41 5.2 5.59 5.38 5.59 5.41 5.34 5.47 5.33 5.54 5.71 5.39 5.44 5.28 5.39 5.53 5.47 5.11 5.33 5.45
GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT 5.68 5.42 5.77 5.95 5.76 5.32 5.69 5.66 5.71 5.67 5.72 5.45 5.92 5.92 5.78 5.6 5.81 5.61 5.56 5.58 5.59 5.72 5.75 5.39 5.56 5.69
GOBP_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION 5.31 4.95 5.21 5.18 5.11 4.93 5.1 5.05 5.22 5.06 5.54 4.98 5.27 5.41 5.12 4.77 5.1 4.96 5 4.91 5.02 4.93 4.89 4.52 4.67 4.74
GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION 5.69 5.49 5.77 5.81 6.01 5.54 5.58 5.83 5.76 6.07 5.81 5.61 5.92 5.96 5.78 5.72 5.81 5.61 5.83 5.68 5.47 5.72 5.75 5.5 5.49 5.78
GOBP_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION 5.7 5.38 5.79 6.04 5.33 5.22 5.32 5.14 5.59 5.36 5.53 5.18 5.34 5.47 5.16 5.54 5.54 5.34 5.27 5.28 5.39 5.53 5.47 5.11 5.26 5.36
GOBP_NEURAL_TUBE_PATTERNING 5.97 5.86 6.11 5.93 5.6 5.9 5.96 5.89 5.8 6.04 6.01 5.77 6.02 5.96 5.81 5.94 5.99 6 5.83 6.18 6.08 6.11 5.76 5.85 5.76 6.26
GOBP_CELL_DIFFERENTIATION_IN_HINDBRAIN 6.77 6.8 7.2 7.47 7.81 6.99 7.42 7.54 7.58 7.32 7.05 7.31 7.61 7.19 7.57 7.36 7.25 7.57 7.14 7.37 7.77 7.71 7.11 7.2 6.95 7.22
GOBP_CELL_PROLIFERATION_IN_HINDBRAIN 5.66 5.18 5.8 6.19 5.33 5.21 5.56 5.63 5.62 5.4 6.07 5.15 5.61 5.68 5.78 5.5 5.45 5.52 5.24 5.69 5.76 6.19 5.65 5.62 5.31 5.99
GOBP_CELL_MIGRATION_IN_HINDBRAIN 7.46 7.53 6.82 6.67 7.65 7.34 7.17 7.59 7.23 7.67 7.41 7.68 7.6 7.66 7.73 7.64 7.63 7.23 7.43 7.57 7.7 7.79 7.46 7.03 7.55 7.92
GOBP_DIENCEPHALON_DEVELOPMENT 5.51 5.45 5.81 5.86 5.39 5.18 5.63 5.65 5.46 5.52 5.62 5.36 5.42 5.62 5.73 5.43 5.6 5.43 5.4 5.29 5.48 5.47 5.55 5.21 5.42 5.39
GOBP_TELENCEPHALON_DEVELOPMENT 6.86 7 7.2 7.07 7.35 7.39 7.37 7.48 7.3 7.37 7.2 7.44 7.54 7.52 7.52 7.41 7.18 7.1 7.17 7.36 7.07 7.41 7.32 7.58 7.27 7.37
GOBP_DENTATE_GYRUS_DEVELOPMENT 6.52 6.24 6.59 6.54 6.99 6.97 6.95 6.92 6.81 6.67 6.8 7 7.03 6.92 6.49 6.71 6.98 6.42 6.77 6.74 6.68 6.98 6.52 6.71 6.56 6.7
GOBP_PALLIUM_DEVELOPMENT 6.9 6.94 7.27 7.23 7.61 7.38 7.29 7.29 7.38 7.39 7.37 7.45 7.55 7.47 7.43 7.45 7.24 7.13 7.22 7.36 7.06 7.35 7.31 7.66 7.2 7.37
GOBP_SUBPALLIUM_DEVELOPMENT 6.45 6.59 7.42 6.66 7.02 7.04 7.03 7.32 6.79 7.12 6.97 6.92 6.82 7.32 7.37 7.57 7.02 7.13 6.7 7.19 7.16 7.19 7.46 7.09 6.82 7.17
GOBP_CRANIAL_NERVE_DEVELOPMENT 5.75 5.58 5.66 5.71 5.7 5.85 5.84 5.59 6.07 5.76 5.65 5.6 5.53 6.05 5.82 5.57 5.46 5.51 5.46 5.56 5.7 5.82 5.85 5.72 5.74 5.54
GOBP_OPTIC_NERVE_DEVELOPMENT 6.5 6.63 6.2 6.77 7 6.91 6.99 7.37 6.8 6.8 6.69 6.75 6.89 6.84 6.85 6.56 7.04 7.2 6.76 7.3 7.14 7.25 6.86 6.8 6.65 7.01
GOBP_HINDBRAIN_MORPHOGENESIS 7.12 7.24 7.02 7.18 7.81 7.51 8.05 7.73 7.58 7.53 7.07 7.85 7.78 7.7 7.64 7.85 7.57 7.69 7.59 7.68 7.77 7.97 7.75 7.97 7.95 7.58
GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT 7.87 7.59 7.78 7.53 8.01 8.24 7.94 7.8 7.46 8.05 7.75 8.26 7.95 7.78 7.79 8.21 7.96 7.93 8.23 8.02 7.68 7.88 7.92 8.18 7.96 7.55
GOBP_CRANIAL_NERVE_MORPHOGENESIS 5.34 5.34 5.16 5.38 4.95 4.76 5.13 4.98 5.13 4.85 5.28 4.91 5.18 4.73 4.94 4.89 5.2 5.41 5.02 5.08 5.3 5.25 5 4.7 5.02 5.2
GOBP_FACIAL_NERVE_MORPHOGENESIS 5.86 5.75 5.62 5.65 6.12 6.37 5.82 5.62 6.34 6.31 5.72 5.52 5.93 6.18 5.68 5.81 5.4 5.84 5.89 5.96 5.65 5.78 5.89 6.26 5.73 5.78
GOBP_LATERAL_VENTRICLE_DEVELOPMENT 6.64 6.97 7.13 6.71 6.73 6.79 7.24 7.2 7.19 7.28 6.73 7.19 7.04 7.37 7.27 7 6.59 6.71 6.89 7.17 7.06 6.78 7.28 7.44 6.98 7.47
GOBP_NERVE_DEVELOPMENT 5.78 5.64 5.77 5.78 5.8 5.83 6.06 5.89 6.21 6.04 5.78 5.68 5.74 6.07 6.07 5.94 5.6 5.73 5.7 5.62 5.93 5.9 6.06 5.93 5.79 5.77
GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT 7.68 7.89 8.1 7.94 8.16 8.11 8.18 8.71 8.29 8.06 8.03 8.19 8.17 7.97 8.6 8.32 8.04 8.12 7.84 8.4 8.11 8.28 8.05 8.59 8.06 8.23
GOBP_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT 7.54 7.83 8.57 8.79 7.81 7.85 8.12 7.73 8.33 7.82 8 7.85 7.96 7.92 8.09 7.94 8.09 7.66 7.58 8.1 8.25 8.16 8.21 8.24 8.34 7.92
GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS 7.65 7.92 7.73 7.7 8.34 8.22 8.31 8.04 8.36 8 7.5 8.22 8.1 7.98 8.19 7.94 8.01 8.1 7.86 8.08 8.27 8.08 7.96 8.47 8.34 8.08
GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION 8.55 8.66 8.94 8.52 8.94 8.79 8.85 9.03 8.43 8.59 8.65 8.45 8.69 8.67 9.02 8.89 8.18 8.21 8.47 8.87 8.8 9.15 8.1 8.77 9.03 8.85
GOBP_CEREBELLAR_CORTEX_DEVELOPMENT 6.77 6.8 7.2 7.45 7.43 7.18 7.28 7.73 7.41 7.53 7.43 7.85 7.78 7.7 7.64 7.85 7.5 7.56 7.14 7.68 7.77 7.97 7.75 7.97 7.63 7.58
GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS 7.1 7.24 7.2 7.43 7.81 7.51 8.05 7.73 7.58 7.53 7.43 7.85 7.78 7.7 7.64 7.85 7.5 7.66 7.59 7.68 7.77 7.97 7.75 7.97 7.95 7.58
GOBP_CEREBELLAR_CORTEX_FORMATION 7.78 8.15 8.07 7.94 8.43 8.34 8.44 8.04 8.41 7.94 8 8.27 8.43 8.67 8.27 7.99 8.1 7.95 7.91 8.16 8.43 8.2 8.1 8.34 8.62 8.22
GOBP_DEVELOPMENTAL_MATURATION 6.36 6.36 6.53 6.59 6.31 6.37 6.55 6.5 6.35 6.42 6.28 6.26 6.49 6.59 6.59 6.45 6.43 6.47 6.27 6.49 6.58 6.6 6.28 6.5 6.49 6.6
GOBP_CEREBELLAR_PURKINJE_CELL_DIFFERENTIATION 8.22 8.66 8.5 8.7 8.86 8.89 8.65 8.54 8.66 8.43 8.66 8.77 8.61 8.59 8.67 8.44 8.3 8.26 8.19 8.52 8.61 8.63 8.65 8.99 8.82 8.61
GOBP_STRIATUM_DEVELOPMENT 8.06 8.13 8.4 7.9 8.31 8.49 8.89 8.5 8.65 8.56 8.28 8.48 8.56 8.77 8.88 8.6 7.86 8.35 8.38 8.71 8.11 8.32 8.51 8.91 8.51 8.33
GOBP_LIMBIC_SYSTEM_DEVELOPMENT 6.54 6.58 7.12 6.77 6.97 6.97 7.05 7.19 7.15 7.05 7.14 7.18 6.98 7.11 6.98 7.23 6.93 6.91 6.77 6.99 6.92 7.17 6.85 7.07 6.97 7.17
GOBP_SUBSTANTIA_NIGRA_DEVELOPMENT 10.09 10.23 10.38 10.1 10.55 10.4 10.73 10.33 10.61 9.99 9.93 10.49 10.43 10.33 10.15 10.1 10.37 10.24 10.26 10.53 9.8 10.08 10.42 10.65 10.08 10.02
GOBP_HIPPOCAMPUS_DEVELOPMENT 6.72 6.88 7.3 7.23 7.23 7.22 7.27 7.3 7.26 7.31 7.34 7.28 7.37 7.31 7.3 7.33 7.31 6.97 7.12 7.28 7.03 7.42 7.24 7.49 7.18 7.3
GOBP_GLIAL_CELL_DEVELOPMENT 7.34 7.16 7.55 7.45 7.92 7.79 7.47 7.49 7.73 7.6 7.29 7.47 7.8 7.47 7.59 7.51 7.48 7.19 7.17 7.64 7.48 7.6 7.44 7.73 7.71 7.74
GOBP_THALAMUS_DEVELOPMENT 7.01 6.96 6.71 7.21 7.09 7.55 7.28 7.12 7.27 7.6 7.14 7.55 7.85 7.97 7.66 7.57 7.34 7.03 6.96 8.04 7.23 7.79 8.1 8.24 7.34 6.83
GOBP_CEREBRAL_CORTEX_CELL_MIGRATION 7.01 7.01 7.18 7.36 7.89 7.69 8.01 7.91 7.5 7.9 7.61 7.62 7.65 7.91 8.2 7.87 7.2 7.33 7.55 7.45 7.39 7.85 7.32 8 7.43 7.52
GOBP_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION 7.01 6.86 7.37 7.44 7.89 7.51 8.01 7.85 7.5 7.9 7.54 7.62 7.65 7.91 7.86 7.85 7.67 7.34 7.3 7.45 7.7 7.51 7.3 8 7.18 7.47
GOBP_CELL_PROLIFERATION_IN_FOREBRAIN 6.55 6.58 6.76 6.76 6.67 6.92 7.05 7 6.79 6.81 6.98 7.07 6.82 6.88 6.92 7.08 6.7 6.81 6.82 6.83 6.72 6.95 6.92 7.06 6.59 7.03
GOBP_HYPOTHALAMUS_DEVELOPMENT 5.81 5.71 6.54 5.98 6.09 5.77 6.19 5.96 6.33 5.9 5.92 5.77 5.84 5.95 5.97 6.06 6.18 5.95 5.54 5.7 6.24 6.3 5.6 6.05 6.12 6.05
GOBP_PYRAMIDAL_NEURON_DIFFERENTIATION 7.65 8.03 8.49 7.49 8.25 8.26 8.31 8.97 8.43 8.48 7.93 8.16 8.36 8.61 8.64 8.39 7.98 7.85 8.22 8.68 8.24 8.57 8.31 8.65 8.48 8.57
GOBP_FOREBRAIN_REGIONALIZATION 5.69 5.7 5.93 5.86 5.73 5.39 5.64 5.89 5.68 5.55 6.05 5.57 5.55 5.56 5.31 5.62 5.6 5.93 5.87 5.41 6.29 5.52 5.62 5.07 5.45 5.63
GOBP_FOREBRAIN_GENERATION_OF_NEURONS 6.39 6.44 6.4 6.16 6.68 6.39 6.77 6.59 6.59 6.5 6.13 5.91 6.82 6.92 6.61 6.61 6.58 6.42 6.35 6.67 6.82 6.69 6.41 6.33 6.21 6.57
GOBP_FOREBRAIN_NEURON_DEVELOPMENT 6.42 6.54 7.08 6.22 6.79 6.75 6.92 7.12 6.76 7.33 6.73 6.81 6.36 6.7 6.82 6.53 6.57 7.06 6.51 7.2 6.9 6.84 6.45 6.83 7.18 6.59
GOBP_FOREBRAIN_CELL_MIGRATION 7.01 7.01 7.2 7.02 7.68 7.69 7.81 7.85 7.5 7.39 7.47 7.62 7.62 7.69 7.76 7.85 7.2 7.33 7.49 7.45 7.56 7.65 7.32 7.98 7.43 7.47
GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION 5.6 5.7 6.15 5.98 5.51 5.34 5.84 6.37 5.67 5.58 5.73 5.6 5.96 5.79 6.19 5.95 6.34 5.93 5.66 5.89 5.91 6.26 5.58 5.85 5.95 6.05
GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION 6.39 6.45 6.73 6.46 6.38 6.36 6.83 7.2 6.41 6.9 6.24 6.23 6.69 6.78 7.36 6.61 6.5 6.53 6.35 6.82 6.5 6.87 6.51 6.47 6.81 6.72
GOBP_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING 6.29 6.18 6.33 6.47 6.03 6.27 6.21 6.24 6.24 6.32 6.55 6.5 6.32 6.5 6.15 6.43 6.49 6.23 6.25 6.3 6.38 6.45 6.25 6.17 6.16 6.6
GOBP_NEURAL_TUBE_DEVELOPMENT 6.28 6.32 6.32 6.35 6.37 6.48 6.35 6.34 6.38 6.56 6.35 6.56 6.33 6.51 6.33 6.37 6.45 6.32 6.49 6.21 6.33 6.39 6.34 6.48 6.36 6.51
GOBP_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION 5.66 5.01 5.8 6.19 5.33 5.21 5.56 5.19 5.5 5.31 5.8 5.15 5.61 5.68 5.78 5.5 5.03 5.04 5.11 5.69 5.19 6.19 5.61 5.62 4.92 5.31
GOBP_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS 7.87 7.83 8 7.69 8.32 8.33 8.38 8.39 8.35 8.15 8.45 8.45 8.78 8.65 8.48 8.28 8.07 8.24 8.69 8.63 8.25 8.46 8.4 8.41 8.16 8.14
GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION 6.62 6.72 6.71 6.58 6.69 6.94 6.9 7.21 6.91 7.12 6.65 6.72 7.21 7.03 7.06 6.74 6.68 6.66 6.72 6.88 6.83 6.86 6.81 6.9 6.78 6.9
GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT 7.72 7.78 8.06 7.78 8.01 8.3 8.37 8.07 8.31 8.2 8.11 8.15 8.19 8.42 8.46 8.31 7.91 7.94 8.13 8.43 8.12 8.25 8.31 8.46 8.06 8.15
GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS 8.37 8.46 8.51 8.13 8.92 8.86 8.75 8.9 8.88 8.86 8.62 8.74 9.08 9.06 8.8 8.84 8.33 8.67 8.97 8.91 8.53 8.56 8.93 9.04 8.61 8.48
GOBP_PITUITARY_GLAND_DEVELOPMENT 5.22 5.12 5.23 5.4 5.16 4.83 5.03 5.03 5.15 5.01 5.44 4.94 5.04 5.14 5.12 4.91 5.07 5.05 5.01 4.91 5 5.05 4.9 4.56 4.84 4.81
GOBP_ADENOHYPOPHYSIS_DEVELOPMENT 5.15 4.79 5.21 5.92 4.9 4.84 4.96 4.65 4.89 5.05 5.52 4.96 4.74 5.12 5.14 4.89 5.1 5.16 4.68 4.46 5 5 4.62 4.52 4.78 4.73
GOBP_CEREBRAL_CORTEX_DEVELOPMENT 7.15 7.15 7.66 7.44 7.89 7.89 7.68 7.72 7.72 7.94 7.61 7.84 7.97 8.04 7.99 7.87 7.49 7.34 7.84 7.96 7.7 7.82 7.75 8 7.54 7.58
GOBP_OLFACTORY_LOBE_DEVELOPMENT 6.7 6.6 6.95 6.32 7.35 7.21 6.95 6.89 7.47 6.91 6.19 6.78 7.76 7.49 7.06 7.13 6.64 6.39 6.15 7.5 6.88 7.14 7.09 7.04 6.86 7.22
GOBP_NEUROGENESIS 6.89 6.98 7.16 6.95 7.2 7.32 7.31 7.33 7.25 7.32 7.1 7.3 7.39 7.38 7.36 7.31 7.15 7.08 7.14 7.37 7.1 7.27 7.32 7.5 7.29 7.31
GOBP_TELENCEPHALON_GLIAL_CELL_MIGRATION 7.57 7.35 7.96 7.51 8.22 8.15 8.38 7.97 8.31 8.03 7.61 8.16 8.57 8.23 8.2 8.2 7.83 7.63 7.91 8.44 7.78 8.02 8.34 8.23 7.69 7.71
GOBP_METENCEPHALON_DEVELOPMENT 6.88 7.03 7.05 7.43 7.28 7.2 7.23 7.72 7.26 7.44 7.1 7.74 7.63 7.62 7.6 7.5 7.38 7.29 7.26 7.57 7.32 7.55 7.26 7.29 7.59 7.53
GOBP_CORPUS_CALLOSUM_DEVELOPMENT 7.68 7.61 7.32 7.72 8.43 8.39 7.52 7.86 7.91 7.54 7.54 7.88 8.16 7.97 8.18 7.87 7.76 7.47 8.41 7.93 7.36 7.83 7.85 7.85 7.96 7.76
GOBP_CELL_CYCLE_PROCESS 6.58 6.65 6.89 6.85 6.75 6.84 6.79 6.81 6.73 6.86 6.75 6.84 6.81 6.86 6.84 6.91 6.66 6.6 6.71 6.85 6.73 6.93 6.91 6.98 6.83 6.84
GOBP_MEMBRANE_DOCKING 7.2 7.22 7.64 7.52 7.63 7.66 7.61 7.48 7.38 7.48 7.43 7.45 7.44 7.38 7.37 7.5 7.2 7.27 7.42 7.47 7.27 7.61 7.48 7.57 7.58 7.54
GOBP_REGULATION_OF_CELL_CELL_ADHESION 5.67 5.64 5.68 5.71 5.48 5.38 5.6 5.6 5.59 5.43 5.6 5.37 5.6 5.52 5.73 5.64 5.61 5.62 5.43 5.46 5.75 5.74 5.52 5.4 5.65 5.77
GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION 5.66 5.7 5.71 5.84 5.57 5.38 5.69 5.75 5.87 5.58 5.71 5.52 5.59 5.5 5.92 5.74 5.58 5.66 5.48 5.52 6.01 5.87 5.67 5.61 5.72 6.01
GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION 5.53 5.49 5.46 5.56 5.33 5.25 5.47 5.41 5.46 5.28 5.41 5.23 5.39 5.34 5.45 5.41 5.52 5.37 5.22 5.35 5.55 5.52 5.34 5.15 5.48 5.56
GOBP_CELLULAR_COMPONENT_DISASSEMBLY 7.04 7.01 7.7 7.49 7.32 7.22 7.33 7.38 7.41 7.29 7.39 7.31 7.34 7.37 7.41 7.42 7.25 7.07 7.14 7.37 7.21 7.53 7.41 7.48 7.45 7.3
GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM 5.7 5.48 5.6 5.58 5.27 5.21 5.33 5.32 5.37 5.35 5.6 5.33 5.23 5.39 5.58 5.4 5.41 5.48 5.46 5.25 5.46 5.37 5.27 5.19 5.39 5.41
GOBP_DIGESTIVE_SYSTEM_PROCESS 5.84 5.6 5.5 5.83 5.23 5.38 5.42 5.34 5.47 5.4 5.54 5.48 5.47 5.19 5.58 5.31 5.51 5.51 5.21 5.42 5.54 5.54 5.37 5.17 5.48 5.42
GOBP_OVULATION_CYCLE_PROCESS 6.24 6.47 6.55 6.67 6 6.18 6.69 6.52 6.78 6.6 6.26 6.41 6.57 6.65 6.42 6.5 6.25 6.02 6.33 6.24 6.77 6.39 7.04 6.41 6.62 6.51
GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS 6.69 6.68 6.92 6.68 6.82 6.87 6.92 6.99 6.88 6.86 6.76 6.81 6.97 7.03 6.87 6.89 6.87 6.74 6.71 6.92 6.88 6.95 6.87 7.07 6.95 6.97
GOBP_REGULATION_OF_CELL_MORPHOGENESIS 7.08 7.17 7.23 6.92 7.43 7.38 7.56 7.54 7.41 7.43 7.35 7.48 7.64 7.64 7.55 7.64 7.39 7.26 7.41 7.56 7.21 7.4 7.39 7.63 7.39 7.49
GOBP_BIOLOGICAL_ADHESION 6.23 6.13 6.17 6.18 6.2 6.1 6.14 6.18 6.14 6.12 6.1 6.15 6.14 6.13 6.13 6.19 6.21 6.13 6.08 6.07 6.31 6.27 6.27 6.06 6.2 6.26
GOBP_GLAND_MORPHOGENESIS 5.86 5.95 5.97 5.92 5.89 5.77 6.09 6.07 6.04 6.15 5.96 5.85 5.98 5.96 5.97 6.02 5.96 5.68 5.73 5.79 6.2 6.1 6.05 5.8 6.13 6.12
GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS 6.81 6.88 7.31 7.17 6.98 7.05 7.03 7.06 7.04 7.17 7.06 7.18 7.06 7.11 7.11 7.12 6.78 6.79 7.03 7.02 6.88 7.1 7.08 7.36 7.08 7.08
GOBP_DNA_STRAND_ELONGATION 5.86 5.94 6.12 6.51 5.9 6.18 6.1 6.07 6.11 6.42 6.28 5.96 6.03 6.11 6.21 6.23 5.99 6.01 5.8 6.31 6.23 6.19 6.09 6.14 6.05 6.21
GOBP_EXTRACELLULAR_MATRIX_DISASSEMBLY 5.61 5.43 5.47 5.59 5.22 5.07 5.45 5.36 5.45 5.14 5.39 5.18 5.26 5.23 5.44 5.28 5.55 5.5 5.15 5.27 5.57 5.61 5.33 5.16 5.28 5.38
GOBP_ELECTRON_TRANSPORT_CHAIN 7.36 7.63 8.72 8.26 7.77 7.75 7.95 7.86 7.94 7.83 8.16 7.7 7.86 7.76 8.01 8.09 7.71 7.83 7.7 8.04 7.72 8.24 8.16 8.06 7.93 7.86
GOBP_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN 8.13 8.22 9.48 9.05 8.23 8.17 8.72 8.96 8.43 8.62 8.92 8.48 8.54 8.64 9.06 9.31 8.61 8.46 8.32 8.56 8.49 8.73 8.53 8.69 8.52 8.7
GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION 5.43 5.25 5.46 5.88 4.98 4.78 5.26 5.14 5.24 4.97 5.46 4.87 5.19 5.28 5.27 5.34 5.09 5.25 4.85 4.81 5.34 5.03 5.26 5.18 5.23 5.31
GOBP_CD40_SIGNALING_PATHWAY 5.62 5.33 4.87 5.43 4.94 4.67 4.67 4.91 4.56 4.76 4.89 4.81 4.77 4.38 4.78 4.88 4.85 4.94 4.91 4.76 5 5.23 4.47 4.41 4.63 5.43
GOBP_POSITIVE_REGULATION_OF_SIGNALING 6.43 6.42 6.61 6.52 6.47 6.45 6.55 6.58 6.51 6.55 6.48 6.47 6.53 6.52 6.59 6.56 6.5 6.44 6.41 6.51 6.55 6.64 6.61 6.57 6.61 6.6
GOBP_NEGATIVE_REGULATION_OF_SIGNALING 6.53 6.53 6.65 6.63 6.7 6.72 6.73 6.76 6.7 6.74 6.61 6.63 6.74 6.78 6.75 6.68 6.66 6.62 6.59 6.69 6.73 6.79 6.8 6.78 6.82 6.81
GOBP_ADAPTATION_OF_SIGNALING_PATHWAY 5.94 5.6 6.51 6.25 5.9 6.07 6.26 6.09 5.62 6.46 5.75 5.49 6.35 5.92 5.81 5.79 6.2 6.11 5.45 5.92 5.96 6.22 5.78 5.39 5.99 6.16
GOBP_SIGNAL_RELEASE 6.55 6.52 6.84 6.65 6.61 6.76 6.82 6.92 6.76 6.79 6.7 6.71 6.84 6.8 6.89 6.85 6.6 6.81 6.61 6.85 6.69 6.86 6.72 6.84 6.82 6.71
GOBP_METAL_ION_TRANSPORT 6.44 6.4 6.51 6.6 6.3 6.34 6.5 6.57 6.52 6.44 6.4 6.35 6.42 6.43 6.45 6.42 6.5 6.39 6.36 6.46 6.52 6.59 6.48 6.64 6.51 6.51
GOBP_CELLULAR_ANION_HOMEOSTASIS 5.6 5.22 4.79 5.5 4.64 4.58 5.16 4.76 4.99 4.9 5.39 4.66 4.75 4.88 5.07 4.95 4.91 4.96 4.75 4.7 4.97 5.03 5.04 4.54 4.65 4.52
GOBP_CELLULAR_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS 7.32 7.09 7.77 7.44 7.54 7.39 7.57 7.27 7.79 7.55 7.46 7.45 7.59 7.68 7.4 7.51 7.32 7.39 7.36 7.67 7.53 7.48 7.74 7.83 7.69 7.56
GOBP_CELLULAR_POTASSIUM_ION_HOMEOSTASIS 8.79 8.58 8.4 8.1 9.47 9.35 8.35 8.93 8.98 8.92 8.62 8.55 8.8 9.08 8.72 8.4 8.49 7.75 8.89 8.86 8.2 8.52 9.47 9.04 8.19 8.39
GOBP_ESTABLISHMENT_OF_CELL_POLARITY 7.12 7.13 7.51 6.95 7.44 7.58 7.53 7.38 7.27 7.55 7.35 7.43 7.6 7.51 7.5 7.47 7.42 7.29 7.29 7.46 7.4 7.62 7.66 7.72 7.42 7.29
GOBP_MAINTENANCE_OF_CELL_POLARITY 6.49 6.4 6.85 6.96 6.14 5.97 6.32 6.06 6.39 6.44 6.45 6.32 6.07 5.91 6.54 6.56 6.61 6.81 5.81 6.07 6.54 6.49 6.29 6.33 6.71 6.49
GOBP_ACTIN_FILAMENT_BASED_PROCESS 6.73 6.81 6.85 6.74 6.96 6.99 6.9 7.05 6.89 7 6.83 7.03 6.96 6.96 7.04 6.92 6.86 6.89 6.83 6.93 6.87 6.96 7.04 7.08 7.06 7.05
GOBP_CELL_PROJECTION_ORGANIZATION 6.99 7.06 7.28 7.03 7.27 7.35 7.32 7.38 7.17 7.32 7.19 7.3 7.38 7.38 7.38 7.4 7.17 7.19 7.19 7.38 7.17 7.37 7.33 7.51 7.32 7.3
GOBP_CELL_PROJECTION_ASSEMBLY 6.74 6.79 7.04 6.9 6.99 7.07 6.91 6.93 6.9 6.98 6.93 7.01 6.89 6.88 7 7.16 6.9 6.91 6.94 7.01 6.94 7.05 6.97 7.13 7.05 7.02
GOBP_LAMELLIPODIUM_ASSEMBLY 7.19 7.36 7.56 7.4 7.84 7.86 7.5 7.56 7.65 7.55 7.41 7.6 7.61 7.5 7.58 7.59 7.34 7.33 7.41 7.55 7.27 7.58 7.85 7.76 7.39 7.4
GOBP_MICROVILLUS_ASSEMBLY 8.52 8.44 7.95 7.75 9.19 8.93 9.05 8.37 8.85 8.66 8.5 8.75 9.21 9.27 8.83 8.8 8.17 8.36 8.92 8.53 8.21 8.2 8.97 8.95 8.87 8.69
GOBP_ACTIN_FILAMENT_DEPOLYMERIZATION 7.1 7.19 7.14 7.68 7.43 7.61 7.69 7.69 7.66 7.72 7.28 7.76 7.61 7.84 7.61 7.29 7.25 7.2 7.6 7.5 7.24 7.31 7.75 8.03 7.55 7.36
GOBP_ACTIN_FILAMENT_BASED_MOVEMENT 6.33 6.2 6.31 6.24 6.2 6.1 6.32 6.28 6.6 6.43 6.4 6.38 6.25 6.1 6.61 6.47 6.5 6.44 6.34 6.4 6.44 6.45 6.66 6.49 6.42 6.44
GOBP_MUSCLE_FILAMENT_SLIDING 5.09 5.19 4.85 5.02 4.76 4.49 4.88 4.97 4.99 4.64 5.04 4.66 4.6 4.58 4.88 4.94 5 5 4.67 4.71 4.94 4.77 4.82 4.38 4.57 4.63
GOBP_PEPTIDE_HORMONE_SECRETION 6.33 6.22 6.62 6.49 6.38 6.42 6.68 6.84 6.46 6.67 6.42 6.64 6.45 6.4 6.79 6.56 6.4 6.69 6.4 6.6 6.49 6.73 6.39 6.54 6.51 6.5
GOBP_INSULIN_SECRETION 6.44 6.46 6.82 6.61 6.61 6.5 6.74 6.92 6.66 6.78 6.65 6.74 6.68 6.68 6.89 6.82 6.59 6.85 6.51 6.82 6.72 6.91 6.69 6.68 6.72 6.74
GOBP_MYELOID_CELL_DIFFERENTIATION 6.47 6.4 6.57 6.61 6.55 6.61 6.46 6.72 6.6 6.6 6.36 6.51 6.61 6.6 6.5 6.61 6.47 6.5 6.33 6.51 6.56 6.68 6.57 6.55 6.64 6.67
GOBP_REGULATION_OF_ENDOCYTOSIS 7.38 7.59 7.94 7.72 7.91 7.9 7.88 7.81 7.74 7.84 7.5 7.79 7.76 7.88 7.97 7.82 7.71 7.62 7.71 7.97 7.58 7.82 7.74 8.1 7.81 7.72
GOBP_NATURAL_KILLER_CELL_ACTIVATION 5.37 5.22 5.03 5.18 4.8 4.78 4.73 5 4.93 4.9 5.12 4.97 4.78 4.68 4.75 4.74 5.13 5.28 4.76 4.73 5.33 5.04 4.56 4.58 4.76 5.05
GOBP_WATER_HOMEOSTASIS 5.66 5.53 5.38 5.83 5.5 5.37 5.5 5.26 5.65 5.49 5.35 5.14 5.43 5.38 5.47 5.12 5.44 5.55 5.48 5.58 5.5 5.27 5.23 5.55 5.4 5.3
GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY 6.83 6.72 6.98 6.76 6.96 7.04 7.04 7.04 6.94 6.97 6.87 6.99 6.99 7.04 6.94 6.94 6.92 6.8 6.91 7.08 7.03 6.98 6.95 7.15 6.99 7.01
GOBP_SPHINGOLIPID_BIOSYNTHETIC_PROCESS 7.15 7.33 7.46 7.32 7.68 7.82 7.83 7.82 7.77 7.32 7.31 7.44 7.75 7.63 7.56 7.61 7.12 7.09 7.38 7.77 7.1 7.42 7.66 7.81 7.61 7.36
GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX 6.36 6.55 8.05 7.3 6.66 6.35 6.51 7.33 7.04 6.96 7.82 6.68 6.64 7.05 6.88 7.46 6.88 6.81 6.75 6.89 6.8 6.82 7.03 7.1 6.98 6.97
GOBP_REGULATION_OF_CELL_ADHESION 6.06 6.02 6.04 6.03 6 5.93 6.03 6.07 6.08 6.03 5.95 5.96 6.01 6.05 6.07 6.05 6.1 6.02 5.89 5.97 6.32 6.2 6.1 5.96 6.14 6.21
GOBP_PANCREATIC_JUICE_SECRETION 5.89 5.56 6.07 6.74 5.43 5.84 6.34 6.21 6.3 6.2 5.97 6.04 6.17 6.02 6.51 6.45 6.07 5.97 6.13 5.9 6.5 6.68 6.01 6.09 6.02 6.5
GOBP_REGULATION_OF_PROTEOLYSIS 6.39 6.37 6.57 6.54 6.42 6.41 6.46 6.47 6.41 6.56 6.34 6.43 6.47 6.46 6.46 6.46 6.47 6.37 6.36 6.4 6.43 6.46 6.43 6.51 6.47 6.55
GOBP_PROTEIN_CATABOLIC_PROCESS 7.28 7.36 7.81 7.77 7.65 7.66 7.6 7.61 7.67 7.66 7.53 7.59 7.7 7.69 7.67 7.57 7.52 7.44 7.54 7.67 7.45 7.6 7.74 7.81 7.7 7.56
GOBP_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS 7.05 7.12 7.32 7.01 7.13 7.37 7.39 7.6 7.31 7.42 6.97 7.02 7.43 7.37 7.47 7.57 7.23 7.28 7.36 7.55 7.21 7.48 7.45 7.53 7.54 7.34
GOBP_PLATELET_ACTIVATION 6.32 6.03 6.41 6.22 6.36 6.19 6.12 6.22 6.01 6.03 6.13 6.15 5.99 6.24 6.07 6.01 6.27 6.13 6.32 6.14 6.34 6.35 6.11 6.03 6.44 6.32
GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY 6.98 6.88 7.16 6.92 7.17 7.37 7.18 7.3 7.35 7.34 7.04 7.2 7.33 7.28 7.15 7.2 7.09 6.97 7.08 7.28 7.16 7.05 7.43 7.44 7.49 7.21
GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY 6.72 6.63 6.98 6.76 6.94 7.01 6.93 7 6.85 6.9 6.81 6.81 6.82 6.9 6.72 6.65 6.83 6.68 6.87 6.85 6.78 6.9 6.9 7.04 6.9 6.97
GOBP_NEURON_DIFFERENTIATION 6.93 7.02 7.22 6.99 7.22 7.34 7.35 7.42 7.27 7.36 7.13 7.32 7.44 7.45 7.43 7.36 7.18 7.15 7.23 7.42 7.16 7.35 7.36 7.55 7.32 7.33
GOBP_B_CELL_DIFFERENTIATION 5.81 5.94 5.69 5.86 5.42 5.53 5.73 5.55 5.67 5.34 5.47 5.38 5.57 5.5 5.63 5.48 5.55 5.52 5.41 5.49 5.97 5.74 5.4 5.44 5.54 5.56
GOBP_COLLAGEN_FIBRIL_ORGANIZATION 5.69 5.53 5.48 5.44 5.59 5.38 5.57 5.44 5.51 5.37 5.54 5.35 5.44 5.29 5.41 5.42 5.41 5.43 5.42 5.34 5.68 5.44 5.81 5.11 5.35 5.36
GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS 7.22 7.43 7.09 6.93 7.06 7.5 7.33 7.74 7.28 7.41 7.07 7.3 7.53 7.42 7.51 7.51 7.23 7.36 7.36 7.55 7.16 7.48 7.43 7.48 7.54 7.28
GOBP_HEPARIN_METABOLIC_PROCESS 7.31 7.53 6.97 6.88 7.53 8.03 7.47 7.86 6.92 7.64 7.15 7.4 7.37 7.38 7.62 7.28 7.17 7.47 7.79 7.85 6.8 7.45 6.98 6.9 7.6 7.5
GOBP_DERMATAN_SULFATE_METABOLIC_PROCESS 7.35 7.91 7.32 7.49 7.71 8.2 7.49 7.49 7.24 8.09 7.39 7.45 7.8 7.77 7.67 7.99 7.67 8.06 8.02 8.25 7.77 8.14 7.54 7.55 7.81 7.81
GOBP_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS 6.69 6.57 7.23 6.75 6.84 6.96 6.87 6.47 6.84 6.94 6.64 6.86 7 7 6.98 6.71 7.23 6.73 6.77 6.86 7.03 6.73 6.99 6.95 7.35 7.16
GOBP_CHONDROITIN_SULFATE_CATABOLIC_PROCESS 7.86 7.91 7.46 7.38 8.14 8.3 7.9 8.43 7.91 8.18 7.63 8.05 7.99 7.95 7.93 7.99 8.01 8.21 8.09 8.43 8.24 8.29 8.16 8.13 8.25 8.25
GOBP_HYALURONAN_METABOLIC_PROCESS 5.77 5.66 5.47 5.78 5.66 5.33 5.51 5.56 5.5 5.39 5.33 5.25 5.33 5.39 5.28 5.75 5.75 5.7 5.54 5.52 5.79 6.02 5.55 5.11 5.48 5.77
GOBP_HYALURONAN_BIOSYNTHETIC_PROCESS 5.22 5.28 5.56 5.59 5.27 4.87 5.42 5.79 5.56 5.04 5.24 5.17 5.33 5.39 5.28 5.63 5.38 5.3 5.23 5.44 5.79 6.35 5.36 4.9 5.48 5.77
GOBP_HYALURONAN_CATABOLIC_PROCESS 6.12 5.73 5.99 6.36 5.93 5.57 5.51 5.59 5.63 5.39 5.67 5.18 5.54 5.72 5.28 5.78 5.93 5.86 5.39 5.52 6.02 6.28 5.66 5.37 5.71 5.8
GOBP_KERATINOCYTE_DIFFERENTIATION 5.08 5.08 4.84 5.19 4.49 4.46 4.9 4.71 4.78 4.54 4.98 4.65 4.69 4.54 4.79 4.58 4.85 5.09 4.63 4.58 5.1 4.73 4.58 4.44 4.68 4.61
GOBP_T_CELL_DIFFERENTIATION 5.63 5.46 5.55 5.66 5.36 5.24 5.46 5.48 5.48 5.28 5.54 5.3 5.46 5.36 5.42 5.41 5.52 5.46 5.32 5.34 5.53 5.49 5.33 5.22 5.48 5.49
GOBP_MEGAKARYOCYTE_DIFFERENTIATION 6.83 6.98 6.65 6.85 7.24 7.27 7.19 7.08 7.11 7.3 6.89 6.89 6.85 7.14 6.68 7.22 6.93 6.77 7.2 6.93 6.86 6.78 6.99 7.14 6.97 7.37
GOBP_MONOCYTE_DIFFERENTIATION 6.71 6.77 6.94 6.76 6.89 6.96 7.14 6.87 7.06 6.91 6.77 7.02 7.21 7.1 6.96 7.06 7.11 6.77 6.48 7.11 7.01 7.09 6.98 6.68 6.88 7.18
GOBP_MACROPHAGE_DIFFERENTIATION 5.39 5.37 5.44 5.67 5.47 5.08 5.43 5.63 5.54 5.1 5.36 5.3 5.36 5.21 5.4 5.48 5.25 5.34 5.36 5.41 5.52 5.52 5.01 5.23 5.47 5.57
GOBP_MALE_SEX_DETERMINATION 5.06 5.04 5.11 5.23 4.69 4.76 5.11 5.06 5.07 4.85 5.22 4.83 4.88 4.93 5.11 5.05 5.04 5.18 4.97 4.78 5.21 4.93 4.91 4.75 4.94 4.75
GOBP_MYOFIBRIL_ASSEMBLY 6.14 5.89 5.5 5.85 5.86 5.68 6.03 5.77 6.04 6.16 6.06 6.1 6.04 5.78 5.76 6.05 6.4 6.2 6.04 6 6.19 6.21 6.14 5.68 5.92 6.31
GOBP_GROWTH_HORMONE_SECRETION 7.28 7.42 7.25 6.79 7.36 7.51 7.67 7.75 7.27 7.57 7.34 7.71 7.44 7.69 7.83 7.74 7.19 7.23 7.42 7.7 7.43 7.5 7.38 7.44 7.26 7.55
GOBP_LIPID_MODIFICATION 6.78 6.76 7.08 7.07 7.03 7.1 7.03 7.06 7.04 7.04 6.9 7.18 7.15 7.19 7.07 7.09 7.04 6.9 7.04 7.01 6.91 7.1 7.26 7.33 7.2 7.2
GOBP_LIPID_GLYCOSYLATION 6.03 6.21 6.44 6.55 6.79 6.57 6.9 6.76 6.45 6.65 6.21 6.53 7.25 6.39 6.61 6.73 7.12 7.72 6.15 6.6 6.32 6.23 6.42 6.58 6.66 6.67
GOBP_CHROMOSOME_CONDENSATION 5.71 5.49 5.59 5.51 5.53 5.35 5.35 5.64 5.83 5.53 5.63 5.34 5.63 5.58 5.61 5.69 5.62 5.59 5.8 5.47 5.56 5.42 5.67 5.39 5.34 5.5
GOBP_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM 5.69 5.65 5.01 5.85 5.48 5.36 5.13 4.95 5.45 5.55 5.66 5.74 5.48 5.15 5.38 4.99 5.48 5.24 5.51 5.62 5.22 4.88 5.44 5.17 5.56 5.35
GOBP_REGULATION_OF_OSSIFICATION 6.25 6.15 6.51 6.22 6.03 6.16 6.31 6.35 6.42 6.7 6.45 6.53 6.26 6.17 6.4 6.59 6.24 6.29 6.05 6.16 6.7 6.8 6.69 6.87 6.5 6.29
GOBP_NEGATIVE_REGULATION_OF_OSSIFICATION 5.9 6.03 5.75 5.94 5.41 5.5 5.85 5.76 5.97 5.69 5.98 5.57 5.64 5.51 5.77 5.51 5.78 5.67 5.68 5.56 6.1 5.89 5.54 5.6 5.83 5.63
GOBP_BONE_MINERALIZATION 5.92 5.65 6.06 6.05 5.59 5.52 5.84 5.84 5.87 5.77 6.21 5.82 5.75 5.79 5.91 5.63 6 5.95 5.55 5.76 6.03 5.94 5.82 5.77 5.86 6.11
GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH 6.87 7.06 7.19 6.93 7.33 7.31 7.19 7.14 7.21 7.18 6.84 7.18 7.41 7.43 7.32 7.18 7.04 7.1 7.19 7.18 6.99 7.2 7.23 7.29 7.4 7.32
GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH 6.61 6.54 7.14 6.81 6.82 6.69 6.81 6.93 6.85 6.96 6.82 6.92 7 7.03 6.93 6.85 6.74 6.67 6.53 6.71 6.81 6.84 7.09 7.01 6.89 6.95
GOBP_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS 6.86 7.06 6.51 5.53 7.12 7.14 6.62 6.52 7.15 6.53 6.62 6.83 7.29 7.02 5.84 6.41 6.09 6.83 7.1 7.09 5.91 6.64 6.64 7.36 6.35 5.71
GOBP_OSTEOCLAST_DIFFERENTIATION 6.59 6.53 6.55 6.58 6.68 6.66 6.28 6.52 6.38 6.4 6 6.41 6.59 6.43 6.4 6.22 6.1 6.16 6.33 6.22 6.73 6.51 6.2 6.31 6.32 6.49
GOBP_MELANOCYTE_DIFFERENTIATION 5.94 6.11 6.1 5.86 5.45 5.87 6.09 6.05 6.34 6.19 6.04 6.18 6.34 6.48 6.17 6.02 5.93 6.23 6.05 5.95 5.97 5.94 6.3 6.46 6.34 6.22
GOBP_STABILIZATION_OF_MEMBRANE_POTENTIAL 5.79 5.58 5.36 5.78 5.11 5.4 5.8 5.4 5.35 5.25 5.48 5.33 5.29 5.29 5.42 5.09 5.26 5.47 5.3 5.28 5.61 5.63 5.28 5.46 5.37 5.26
GOBP_ADRENAL_GLAND_DEVELOPMENT 5.95 5.95 6.34 6.19 5.73 5.76 6.1 5.87 6.06 5.77 6.09 5.59 5.87 5.65 6.02 5.76 6.23 5.59 5.7 5.98 6.1 6.13 5.73 5.72 5.98 6.04
GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 6.42 6.55 6.63 7.03 6.45 6.46 6.3 6.74 6.42 6.24 6.61 6.42 6.52 6.36 6.29 6.52 6.47 6.41 6.43 6.43 6.69 6.63 6.36 6.23 6.65 6.77
GOBP_MEMBRANE_DISASSEMBLY 7.72 7.62 8.17 8.08 7.81 7.96 7.82 7.78 7.72 7.94 8.38 8.1 8.15 7.97 7.95 8.23 8.29 8.14 7.68 7.94 8.16 8.34 7.91 8.29 7.96 8
GOBP_SLEEP 6.18 6.17 6.38 6.12 6.05 6.22 6.9 6.77 6.16 7.11 6.27 6.09 6.64 6.52 7.18 6.86 5.73 6.28 6.75 6.36 6.46 6.5 6.74 6.58 6.06 6.39
GOBP_UBIQUITIN_DEPENDENT_ERAD_PATHWAY 7.77 7.98 8.35 8.02 8.31 8.14 8.34 8.23 8.28 8.16 8.23 8.21 8.34 8.4 8.23 8.47 8.1 7.96 8.01 8.4 8.02 8.06 8.57 8.54 8.51 8.32
GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION 5.54 5.28 4.96 5.17 4.92 4.62 4.79 4.86 4.95 4.89 5.03 4.84 4.87 4.88 4.72 4.85 5.03 5.33 4.99 4.76 5.26 5.2 4.87 4.59 5.22 5.21
GOBP_TRNA_METHYLATION 6.31 6.38 6.91 7.11 6.67 6.52 6.39 6.34 6.38 6.48 6.43 6.33 6.64 6.34 6.41 6.48 6.31 6.25 6.67 6.21 6.53 6.43 6.52 6.55 6.59 6.6
GOBP_MATURATION_OF_SSU_RRNA 6.1 6.12 6.29 6.53 6.3 6.15 6.13 6.41 6.16 6.44 6.35 6.31 6.37 6.3 6.49 6.61 6.27 6.08 6.13 6.17 6.32 6.46 6.27 6.52 6.43 6.51
GOBP_REGULATION_OF_BONE_MINERALIZATION 6.05 5.77 6.18 6.11 5.49 5.53 5.94 5.93 6 5.96 6.2 5.96 5.64 5.74 6.16 5.94 5.79 5.68 5.72 5.68 6.24 6.49 5.74 6.05 5.8 5.79
GOBP_POSITIVE_REGULATION_OF_BONE_MINERALIZATION 5.91 5.71 6.44 6.14 5.6 6.13 5.94 6.12 5.89 6.25 6.2 5.88 5.67 5.74 6.3 5.94 5.73 5.97 5.65 5.96 6.04 6.29 5.87 6.05 6.1 6.03
GOBP_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION 5.82 5.73 5.49 5.81 5.19 5.15 5.8 5.66 5.83 5.69 5.65 5.45 5.64 5.25 5.5 5.44 5.34 5.35 5.49 5.48 5.85 5.65 5.24 4.93 5.8 5.6
GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY 6.15 6.31 6.28 6.36 6.22 6.34 6.35 6.51 6.39 6.53 6.24 6.42 6.4 6.4 6.54 6.22 6.14 6.13 6.17 6.16 6.6 6.49 6.52 6.38 6.26 6.48
GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY 6.58 6.63 6.68 6.62 6.95 6.82 6.77 6.64 6.84 6.62 6.62 6.74 7.1 7.12 6.73 6.96 6.97 6.8 6.68 6.69 6.95 6.95 7.46 6.94 7.13 7.01
GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY 6.43 6.41 6.39 6.27 6.31 6.38 6.84 6.56 6.58 6.46 6.49 6.28 7.01 7.27 6.88 6.84 7.03 6.83 6.63 6.35 6.99 7.05 6.52 6.34 6.79 6.58
GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY 6.61 6.45 6.24 6.58 6.69 6.58 6.58 6.77 6.63 6.82 6.26 6.85 6.98 6.6 6.51 6.33 6.23 6.07 6.25 6.19 6.52 6.54 6.81 6.61 6.28 6.47
GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION 6.66 6.76 7.13 6.8 7.02 6.95 6.99 7.46 6.96 7.04 6.88 7.18 7.22 7.27 6.98 7.01 7.07 6.93 6.74 7.39 6.88 6.8 7.19 7.17 7.21 6.98
GOBP_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY 7 7.18 7.22 7.21 7.44 7.53 7.46 7.45 7.35 7.51 7.31 7.3 7.41 7.37 7.67 7.53 7.52 7.27 7.4 7.58 7.25 7.42 7.56 7.49 7.58 7.37
GOBP_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY 7.22 7.54 7.57 7.67 7.92 7.89 7.89 7.56 7.92 7.8 7.57 7.87 7.91 7.95 7.75 7.55 7.6 7.36 7.73 7.9 7.37 7.65 8.15 7.99 7.92 7.45
GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY 6.98 7.07 6.82 6.9 7.36 7.47 7.32 7.3 7.28 7.49 6.95 7.26 7.21 7.26 7.6 7.48 7.54 7.23 7.28 7.41 7.14 7.32 7.31 7.42 7.19 7.2
GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY 6.71 6.7 6.95 6.86 6.89 7.05 6.82 7.04 7.03 6.91 6.81 6.95 7.04 7.02 7.02 7.05 6.98 6.73 6.8 6.96 6.84 7.08 7.11 7.1 6.98 6.97
GOBP_ADULT_BEHAVIOR 6.73 6.99 7.11 6.99 6.94 7.11 7.46 7.63 7.22 7.52 7.08 7.14 7.33 7.41 7.83 7.51 6.75 7.13 6.97 7.4 7 7.06 7.31 7.42 7.35 7.16
GOBP_MALE_GENITALIA_DEVELOPMENT 5.02 5.12 4.99 4.71 4.92 4.63 4.83 4.89 4.96 4.64 4.85 4.78 4.69 4.79 4.78 4.76 4.68 5.13 4.84 4.65 5.14 4.75 4.66 4.55 4.65 4.63
GOBP_FEMALE_GENITALIA_DEVELOPMENT 5.87 6.45 5.56 6.19 5.77 5.77 5.35 5.65 5.42 5.52 5.44 6.04 5.62 5.54 5.69 5.55 6.14 5.3 5.33 6 5.42 5.7 5.51 5.47 5.47 6.5
GOBP_COLLAGEN_CATABOLIC_PROCESS 5.47 5.35 5.12 5.22 4.99 4.91 5.15 5.03 5.09 4.89 5.11 4.82 5.05 4.98 5.32 5.06 4.96 5.03 5.03 5.02 5.33 5.27 4.94 5.14 4.95 4.93
GOBP_NUCLEAR_BODY_ORGANIZATION 5.81 6.01 5.99 7.38 6.3 6.12 6.35 6.58 6.33 6.18 5.86 6.2 6.11 6.05 6.33 6 6.22 5.99 6.18 5.92 6.99 6.68 6.45 6.29 7.1 6.86
GOBP_NEUTROPHIL_CHEMOTAXIS 5.59 5.35 5.5 5.41 4.9 4.94 5.08 5.18 5.13 5.03 5.32 4.86 5.06 5.05 5.22 5.24 5.51 5.51 5.02 5.1 5.55 5.47 4.92 4.89 5.52 5.42
GOBP_LEUKOCYTE_CHEMOTAXIS 5.76 5.56 5.71 5.67 5.28 5.15 5.47 5.39 5.51 5.17 5.53 5.33 5.5 5.38 5.49 5.41 5.77 5.63 5.18 5.29 5.91 5.65 5.29 5.21 5.69 5.67
GOBP_REGULATION_OF_VITAMIN_METABOLIC_PROCESS 5.23 5.02 5.32 5.67 5.04 5.01 5.29 4.81 5.54 5.12 5.17 5.5 5.48 5.38 5.49 5.23 5.59 5.27 4.87 5.32 5.12 5.23 5.35 5.47 5.71 4.93
GOBP_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT 7.83 7.71 8.11 7.89 8.05 8.23 8.27 8.27 8.24 8.46 8.04 8.33 8.27 8.18 8.35 8.28 8.02 7.96 8 8.24 7.98 8.18 8.45 8.55 8.11 7.95
GOBP_OVULATION 5.83 5.66 5.49 5.54 5.38 5.25 5.59 6.04 5.79 5.78 5.81 5.78 5.52 5.39 5.34 5.42 5.8 5.92 5.51 5.68 6.17 6.18 5.96 5.87 5.93 5.67
GOBP_SEQUESTERING_OF_TRIGLYCERIDE 5.91 5.42 5.62 5.59 5.13 5.26 5.45 5.36 5.54 5.37 5.72 5.54 5.33 5.59 5.55 5.64 5.69 5.51 5.29 5.77 5.76 6.39 5.56 5.99 5.77 6.63
GOBP_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS 6.02 6.28 6.94 6.23 6.28 6.6 6.59 6.57 6.38 6.81 6.26 6.38 6.63 6.81 6.41 6.33 6.55 6.65 5.98 6.56 6.14 6.39 6.83 6.64 6.56 6.43
GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS 5.75 5.7 6.08 5.92 5.59 6.48 5.67 5.72 5.9 5.71 6.01 5.69 5.47 5.69 5.68 6.09 5.92 6.02 5.75 5.74 5.84 6.25 5.83 5.47 5.82 6.16
GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH 6.93 7.05 7.29 7.09 7.33 7.27 7.21 7.28 7.34 7.24 6.93 7.2 7.46 7.26 7.38 7.27 7.14 7.07 7.02 7.36 7.18 7.22 7.29 7.42 7.29 7.19
GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION 6.96 7.05 6.56 7.18 7.35 7.51 6.63 6.69 7 7.17 6.65 6.66 7.46 7.34 7.29 6.74 7.14 6.8 6.88 7.35 7.03 7.02 7.41 7.32 7.01 7.13
GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION 6.46 6.33 6.39 6.35 6.97 6.98 6.69 6.92 6.84 6.84 6.32 6.56 6.61 6.43 6.97 6.61 6.8 6.45 6.24 6.88 6.88 6.73 6.73 7.01 6.7 7.04
GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION 6.86 7.08 7.38 7.05 7.31 7.19 7.2 7.19 7.38 7.44 7.13 7.27 7.36 7.03 7.45 7.12 6.97 7.05 6.98 7.25 7.2 7.04 7.23 7.49 7.24 7.18
GOBP_PROSTATE_GLAND_DEVELOPMENT 5.66 5.77 5.54 5.48 5.55 5.51 5.95 5.59 5.8 5.71 5.8 5.23 5.79 5.53 5.81 6.14 5.45 5.51 5.34 5.3 5.8 5.86 5.88 5.2 5.7 5.42
GOBP_GRANULOCYTE_DIFFERENTIATION 5.88 5.51 5.88 6.02 5.75 5.6 5.89 5.94 6.2 5.79 5.95 5.65 6.1 5.82 5.86 5.98 6.07 5.84 5.59 5.86 5.95 6.01 5.74 5.74 6.11 6.22
GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION 6.01 6.11 5.88 6.02 6.19 6.05 6.08 6.16 6.22 6.08 6.09 5.83 6.19 6.24 6.09 6.12 6.42 6.44 5.66 6.12 6.19 6.23 6.25 6.26 6.69 6.82
GOBP_EPITHELIAL_CELL_DIFFERENTIATION 5.81 5.7 5.68 5.77 5.49 5.34 5.67 5.52 5.69 5.36 5.76 5.45 5.55 5.43 5.55 5.51 5.68 5.7 5.45 5.48 5.77 5.59 5.44 5.27 5.54 5.56
GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION 6.05 6.01 5.8 5.83 5.72 5.62 5.91 5.92 5.78 5.8 6.02 5.88 5.89 5.87 5.91 5.86 6.09 6 5.66 5.81 6.05 6.09 5.8 5.58 5.85 5.89
GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION 6.51 6.15 6.21 6.14 6.16 6.24 6.47 6.19 6.23 6.34 6.38 6.22 6.3 6.26 6.03 6.17 6.5 6.07 6.09 6.19 6.36 6.33 6.17 5.97 6.07 6.35
GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION 5.7 5.5 5.56 5.64 5.34 5.03 5.33 5.38 5.41 5.28 5.67 5.36 5.27 5.19 5.34 5.53 5.49 5.57 5.31 5.12 5.6 5.37 5.29 4.94 5.29 5.07
GOBP_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION 7.5 7.12 6.86 6.55 7.24 7.41 7.34 7.34 7.18 7.54 7.02 7.71 7.6 7.42 7.65 7.24 7.18 7.46 7.3 7.29 6.98 7.24 7.6 7.59 7.58 7.55
GOBP_CORTICAL_CYTOSKELETON_ORGANIZATION 7.44 7.38 7.94 7.73 7.96 7.78 7.89 8.15 7.7 7.76 7.71 8.14 8.03 8.05 7.64 7.64 7.92 7.28 7.39 8.26 7.48 7.54 7.77 7.81 7.79 7.66
GOBP_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION 7.51 7.41 7.99 7.74 8.13 7.95 7.96 8.13 7.95 8.23 7.74 8.23 8.11 8.13 7.68 7.54 7.93 7.47 7.58 8.32 7.55 7.67 8.4 8.07 8.03 7.83
GOBP_THYROID_GLAND_DEVELOPMENT 5 4.8 5 4.99 4.82 4.47 4.94 4.91 4.71 4.99 5.04 4.7 4.6 4.49 4.78 4.66 4.62 5.15 4.67 4.61 4.98 4.97 4.61 4.4 4.92 4.73
GOBP_MAMMARY_GLAND_DEVELOPMENT 6.07 5.89 6.09 6.01 5.77 5.74 5.84 6.08 5.89 5.99 5.94 5.85 5.95 5.88 5.97 5.95 5.91 5.98 5.77 5.74 6 6.03 5.81 5.64 5.85 6.02
GOBP_REGULATION_OF_B_CELL_PROLIFERATION 5.72 5.87 5.75 5.74 5.48 5.42 5.3 5.51 5.76 5.31 5.81 5.26 5.62 5.56 5.57 5.66 5.62 5.7 5.38 5.42 5.83 5.92 5.53 5.5 5.74 6.02
GOBP_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION 5.38 5.7 6.13 5.74 5.53 5.28 5.19 5.32 5.77 5.26 5.69 5.12 5.37 5.9 5.39 5.73 5.46 5.44 5.08 5.43 5.73 5.8 5.6 5.65 5.75 6.1
GOBP_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION 5.77 5.94 5.74 5.82 5.36 5.35 5.19 5.57 5.76 5.24 5.75 5.25 5.65 5.56 5.58 5.24 5.85 5.71 5.54 5.36 5.94 5.93 5.31 5.41 5.62 5.99
GOBP_FOREBRAIN_DEVELOPMENT 6.71 6.71 6.96 6.76 7.09 7.05 7.14 7.2 6.97 7.15 6.95 7.08 7.05 7.16 7.2 7.09 6.85 6.88 6.77 7.06 6.89 7.1 7.02 7.08 7.05 7.06
GOBP_MIDBRAIN_DEVELOPMENT 6.97 7.14 7.48 7.45 7.26 7.46 7.29 7.24 7.22 7.2 7.07 7.12 7.47 7.59 7.68 7.42 7 7.25 7.09 7.27 7.06 7.43 7.61 7.57 7.65 7.39
GOBP_HINDBRAIN_DEVELOPMENT 6.51 6.52 6.76 6.66 6.56 6.78 6.91 6.74 6.91 6.72 6.83 6.68 6.99 7 6.93 6.86 6.84 6.73 6.56 6.73 6.85 6.96 6.74 6.83 6.57 6.57
GOBP_NOTOCHORD_DEVELOPMENT 5.25 5.03 5.53 5.6 5.41 5.05 5.04 5.12 5.05 5.11 5.5 5.12 5.13 5.2 5.32 5.14 5.12 5.09 5.03 5.01 5.32 5.5 5 4.82 5.12 5.33
GOBP_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 6.42 5.93 5.65 5.74 5.73 5.84 5.88 5.82 5.9 5.31 5.68 5.36 5.74 5.48 5.73 5.6 6.05 5.96 5.48 5.4 6.35 5.98 5.77 5.67 6.11 6.22
GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 6.22 6.04 6.07 5.79 6.39 6.54 6.42 6.36 6.63 6.25 6.31 6.35 6.23 6.37 6.26 6.23 6.36 6.22 6.2 6.37 6.33 6.64 6.38 6.12 6.93 6.88
GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 6.31 5.78 5.74 5.8 5.78 5.5 5.89 5.82 5.76 5.43 5.6 5.72 5.8 5.65 5.53 5.49 5.92 5.99 5.69 5.47 6.46 5.93 6.14 5.66 6.01 6.1
GOBP_ASTRAL_MICROTUBULE_ORGANIZATION 8.87 8.83 9.04 8.01 9.14 9.17 9.06 8.85 9.2 9.35 8.76 9.35 9.39 9.23 9.31 9.03 9.2 8.91 8.89 9.17 9.07 8.98 9.2 9.15 9.23 8.89
GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE 7.15 7.31 7.9 7.49 7.5 7.51 7.66 7.77 7.66 7.59 7.43 7.58 7.79 7.75 7.63 7.69 7.58 7.42 7.38 7.66 7.52 7.73 7.71 7.95 7.76 7.6
GOBP_RESPONSE_TO_CAFFEINE 7.61 7.86 8.43 8.45 8.32 8.17 8.31 7.99 8.35 7.96 8.29 7.91 8.52 8.75 7.93 7.92 7.6 7.83 8.32 7.91 7.57 7.96 8.6 8.42 8.17 7.79
GOBP_PANCREAS_DEVELOPMENT 5.96 5.93 5.95 5.83 5.87 5.81 5.93 5.8 5.97 6.06 5.88 5.8 5.85 6.09 5.85 6 6.01 5.78 5.96 6 5.9 6.02 5.81 5.7 5.76 6.03
GOBP_ENDOCRINE_PANCREAS_DEVELOPMENT 6.12 6.04 6.14 6.21 6.1 5.93 6.05 5.97 6.09 6.24 6 6.08 6.01 6.35 6.04 6.3 6.38 5.99 6.1 6.11 6.2 6.34 6.14 5.86 6.01 6.28
GOBP_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION 6.49 6.55 6.56 6.72 6.59 6.69 6.52 6.7 6.6 6.71 6.47 6.6 6.78 6.58 6.81 6.89 6.46 6.42 6.48 6.6 6.46 6.7 6.9 6.84 6.62 6.71
GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION 6.82 6.74 6.81 6.62 7.06 7.1 6.93 7.13 7 7.14 6.83 7.25 6.99 7.02 6.85 6.94 7.25 6.89 7.17 7.02 6.88 6.91 7.29 7.32 7.21 7.21
GOBP_PRIMARY_MIRNA_PROCESSING 7 7.27 7.49 6.73 7.93 7.46 7.58 6.77 7.8 7.5 7.23 6.81 7.26 7.39 7.5 7.47 7.07 7.55 8.06 6.98 7.25 7.26 7.8 8.15 7.6 7.57
GOBP_CHROMATIN_REMODELING_AT_CENTROMERE 5.58 5.54 5.3 5.35 5.33 5.14 5.55 5.44 5.18 5.25 5.56 5.41 5.3 5.47 5.21 5.4 5.29 5.55 5.29 5.47 5.67 5.31 5.01 5.33 5.23 5.34
GOBP_REGULATION_OF_HISTONE_MODIFICATION 6.94 6.94 7.08 6.87 7.4 7.33 7.31 7.33 7.26 7.38 6.94 7.34 7.24 7.45 7.46 7.51 7.31 7.07 7.19 7.39 7.06 7.37 7.53 7.54 7.2 7.43
GOBP_NEGATIVE_REGULATION_OF_HISTONE_MODIFICATION 6.81 6.58 6.71 6.93 7.24 7.16 7.03 6.9 6.99 7.04 6.78 6.93 7.22 7.33 7.2 7.26 6.77 6.8 7.03 7.02 6.86 6.96 7.32 7.36 7.08 6.94
GOBP_REGULATION_OF_HISTONE_METHYLATION 6.73 6.74 6.54 6.48 7.08 6.96 7.05 7.13 7.01 7.04 6.58 6.92 7.16 7.05 7.08 7.12 6.68 6.6 6.85 7.09 6.83 7 7.06 7.23 7.11 7.24
GOBP_NEGATIVE_REGULATION_OF_HISTONE_METHYLATION 6.81 6.99 6.45 6.67 7.24 7.08 7.05 6.9 6.99 7.04 6.53 7.12 7.22 7.33 7.04 7.02 6.77 6.66 7.05 7.02 6.86 6.85 7.15 7.21 7.08 7.07
GOBP_POSITIVE_REGULATION_OF_HISTONE_METHYLATION 6.74 6.74 6.79 6.94 7.09 7.06 7.19 7.16 7.06 7.2 6.65 7.33 7.22 7.07 7.16 7.16 6.77 6.71 6.91 7.17 6.9 7.14 7.17 7.25 7.11 7.31
GOBP_REGULATION_OF_HISTONE_DEACETYLATION 7.25 7.2 7.38 6.92 7.39 7.51 7.24 7.37 7.08 7.26 6.92 7.32 7.75 7.73 7.37 7.61 7.31 7.3 7.42 7.36 7.1 7.55 7.44 7.63 7.19 7.18
GOBP_POSITIVE_REGULATION_OF_HISTONE_DEACETYLATION 7.36 7.29 7.42 7.17 7.89 7.96 7.28 7.48 7.31 7.34 6.98 7.33 7.79 7.79 7.5 7.67 7.42 7.31 7.48 7.4 7.3 7.59 7.49 7.77 7.2 7.3
GOBP_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT 6.01 5.94 5.48 5.85 5.73 5.95 5.84 6.09 5.83 5.9 5.95 5.97 5.97 5.9 5.92 5.95 5.98 5.8 5.76 5.68 5.97 5.91 5.86 5.75 6.03 6.19
GOBP_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE 6.52 6.56 6.77 6.51 6.76 6.7 6.65 6.74 6.8 6.71 6.69 6.88 6.86 6.76 6.67 6.76 6.6 6.64 6.59 6.53 6.73 6.76 7.01 7.01 6.86 6.77
GOBP_REGENERATION 6.42 6.38 6.74 6.69 6.59 6.58 6.61 6.79 6.61 6.38 6.48 6.3 6.66 6.53 6.5 6.64 6.62 6.52 6.48 6.57 6.72 6.62 6.72 6.65 6.82 6.95
GOBP_ANIMAL_ORGAN_REGENERATION 6.06 5.87 6.06 6.05 5.8 5.92 5.79 5.79 5.83 5.81 5.89 5.64 6.16 6.11 5.97 5.88 6.14 5.91 5.97 5.88 6.3 6.35 6.16 6.21 6.17 6.43
GOBP_NEURON_PROJECTION_REGENERATION 7.86 8.14 8.19 7.65 8.24 8.1 7.98 8.01 8.06 8.19 7.79 8.14 8.26 8.27 8.16 8.17 8.4 8.25 7.82 8.33 8.12 8.46 8.36 8.07 8.45 8.22
GOBP_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION 7.53 7.58 7.76 7.62 8.07 8.27 7.9 7.96 7.88 8.07 7.75 8.07 8.08 8.05 8.2 8.11 8.03 7.73 7.87 8.04 7.98 8.2 8.26 8.21 7.96 7.95
GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION 7.7 7.79 8 7.74 8.53 8.44 8.15 8.53 8.36 8.41 8.02 8.53 8.27 8.35 8.48 8.28 8.42 8.06 8.03 8.37 8.33 8.49 8.5 8.49 8.32 8.35
GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION 7.91 7.86 8.13 7.74 8.79 8.85 8.21 8.64 8.52 8.5 8.13 8.81 8.54 8.57 8.54 8.4 8.46 8.17 8.08 8.82 8.55 8.58 8.56 8.66 8.74 8.76
GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION 7.7 7.68 7.97 7.83 8.6 8.42 8.03 8 8.04 8.55 8.09 8.7 8.31 8.37 8.66 8.62 8.44 8.21 8.18 8.47 8.43 8.55 8.88 8.69 8.26 8.14
GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION 7.89 8.31 8.18 7.85 8.74 8.88 8.36 8.64 8.66 8.62 8.25 8.76 8.32 8.49 8.85 8.62 8.52 8.46 8.57 8.7 8.76 8.72 8.92 8.86 8.68 8.73
GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION 7.7 7.68 8.02 7.65 8.6 8.31 8.14 8.52 8.33 8.26 7.8 8.63 8.27 8.38 8.35 8.28 8.09 7.75 7.79 8.42 8.25 8.42 8.47 8.39 8.26 8.26
GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION 8.76 9.14 8.86 8.89 9.34 9.17 9.29 9.07 9.78 9.43 9.12 9.2 9.33 9.32 9.37 9.1 9.07 8.91 9.3 9.19 9.16 9.06 9.66 9.68 9.17 8.97
GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION 7.66 7.38 7.64 7.77 8.01 7.84 8.02 7.87 7.91 8.18 7.72 8.09 8.1 8.23 7.91 8.04 8.13 7.63 8.01 7.89 7.84 7.99 8.01 8.31 8.02 7.84
GOBP_RNA_3_END_PROCESSING 7.28 7.28 7.72 7.5 7.63 7.66 7.61 7.52 7.61 7.67 7.41 7.56 7.54 7.62 7.84 7.63 7.26 7.27 7.44 7.66 7.3 7.56 7.72 7.81 7.64 7.57
GOBP_MRNA_3_END_PROCESSING 7.52 7.65 7.84 7.61 7.91 8.05 7.98 7.83 7.92 8.08 7.56 7.82 7.96 8.1 8.1 8.13 7.7 7.52 7.81 7.94 7.62 7.88 8.07 8.28 7.87 7.97
GOBP_RRNA_3_END_PROCESSING 7.07 7 7.43 7.45 6.81 7.29 7.21 7 7.17 7.01 6.92 7.16 7.19 6.71 6.98 7.25 6.78 6.69 6.96 6.92 6.3 6.66 7.03 6.81 7.12 7.05
GOBP_SNO_S_RNA_3_END_PROCESSING 7.9 7.98 8.15 8 8.03 7.93 8.14 7.83 8.03 7.7 7.65 8.16 7.98 8.14 8.12 7.94 6.87 7.33 7.6 7.76 7.1 7.57 8.25 7.89 7.33 7.29
GOBP_DEVELOPMENTAL_INDUCTION 5.53 5.65 5.49 5.37 5.09 4.99 5.46 5.27 5.4 5.37 5.56 5.04 5.05 5.12 5.35 5.42 5.21 5.48 5.51 5.08 5.34 5.48 5.07 5.11 5.36 5.43
GOBP_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS 7.16 7.63 8.17 7.97 7.56 7.73 7.82 7.64 8.07 8.17 7.98 7.89 7.73 7.77 7.67 7.96 7.6 7.26 7.65 7.67 7.6 7.4 8.05 8.22 7.78 7.61
GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS 7.54 7.74 8.36 8.05 7.91 7.93 8.08 8.1 8.16 8.17 8.25 8.15 8.07 8.09 8.15 8.28 7.65 7.66 7.82 8.07 7.6 7.82 8.36 8.28 8.09 7.79
GOBP_RRNA_METHYLATION 6.75 6.83 7.25 7.35 7.15 7.25 6.67 6.75 7.05 6.79 7.15 6.83 7 7.04 6.35 6.51 6.67 6.73 6.99 6.82 6.54 6.62 6.8 7.04 6.75 6.78
GOBP_PSEUDOPODIUM_ORGANIZATION 6.25 6.18 6.1 5.92 5.99 6.38 6.43 6.59 6.24 6.23 6.16 6.08 6.44 6.11 6.24 5.76 6.37 5.94 6.11 6.53 5.86 6.05 6.26 6.32 6.44 6.44
GOBP_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY 6.45 6.24 6.27 6.46 6.56 6.63 6.46 6.79 6.35 6.35 6.23 6.09 6.45 6.17 6.45 5.81 6.79 6.05 6.32 6.79 5.91 6.66 6.46 6.4 6.57 6.61
GOBP_REGULATION_OF_CYCLASE_ACTIVITY 6.69 6.97 6.83 6.38 6.54 6.7 6.68 6.5 6.73 6.95 6.72 6.72 6.79 6.77 6.68 6.41 6.34 6.57 6.86 6.45 6.21 6.66 6.59 6.89 6.92 6.48
GOBP_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY 7.36 7.35 6.96 6.79 7.21 7.35 6.73 7.04 6.73 7.25 7.28 7.32 6.96 7.26 7.72 6.86 7.06 7.64 7.52 7.12 7.06 7.28 6.99 7.23 7.06 7.31
GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY 5.12 5.3 4.61 5.09 4.73 4.49 5.11 5 4.84 4.72 4.83 4.47 4.52 4.8 4.75 5.33 4.93 5.4 4.97 4.75 4.88 4.52 4.57 4.33 4.92 4.82
GOBP_RETINAL_GANGLION_CELL_AXON_GUIDANCE 7.28 7.22 7.68 6.8 7.27 7.51 7.41 7.53 7.49 7.36 7.26 7.3 7.49 7.71 7.38 7.61 6.86 7.31 7.4 7.33 7.09 7.85 7.27 7.75 7.21 7.14
GOBP_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS 7.47 7.41 7.36 7.6 7.5 7.35 7.62 7.8 7.84 7.25 6.79 7.28 7.71 7.72 7.46 7.36 7.41 7.52 7.23 7.64 7.51 7.58 7.28 7.54 7.79 7.6
GOBP_LYMPHOCYTE_COSTIMULATION 5.22 5.24 5.32 4.96 4.79 4.84 4.87 5.04 5.13 4.76 5.12 4.8 4.99 4.77 4.95 4.84 5.14 5.15 4.77 4.81 5.03 5.16 4.87 4.87 5.03 5.39
GOBP_REPLICATION_FORK_PROCESSING 5.83 5.79 5.61 5.52 5.69 5.77 5.59 5.75 5.16 5.75 5.63 5.52 5.52 5.52 5.46 5.85 5.31 5.24 5.52 5.28 5.54 5.66 5.24 5.83 5.72 5.78
GOBP_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS 7.35 7.44 7.78 7.6 7.73 7.73 7.73 7.7 7.71 7.76 7.59 7.72 7.77 7.75 7.73 7.75 7.47 7.39 7.57 7.75 7.51 7.74 7.84 7.91 7.83 7.67
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS 7.26 7.45 7.7 7.6 7.7 7.67 7.52 7.47 7.67 7.71 7.58 7.69 7.79 7.74 7.68 7.67 7.46 7.39 7.51 7.59 7.43 7.68 7.73 7.76 7.89 7.64
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY 6.96 7.13 7.45 7.11 7.3 7.39 7.45 7.54 7.45 7.39 7.46 7.73 7.57 7.66 7.92 7.72 7.39 7.14 7.03 7.52 7.23 7.75 7.75 7.91 7.64 7.49
GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY 6.96 7.07 7.36 7.13 7.32 7.23 7.22 7.28 7.33 7.34 7.21 7.21 7.27 7.14 7.39 7.16 7.05 7.12 7.22 7.33 7.22 7.27 7.19 7.49 7.21 7.24
GOBP_REGULATION_OF_VESICLE_FUSION 7.79 8.35 8.57 8.24 9.11 9.01 9.38 8.54 8.58 8.62 8.21 8.69 8.77 8.78 8.75 8.32 8.86 8.41 8.27 8.64 8.5 8.41 8.4 8.59 8.5 8.47
GOBP_REGULATION_OF_CELL_KILLING 5.27 5.03 4.81 4.98 4.84 4.77 4.75 4.97 4.99 4.73 5.02 4.72 4.65 4.73 4.72 4.73 4.98 5.1 4.81 4.82 5.15 4.74 4.65 4.51 4.79 4.95
GOBP_NEGATIVE_REGULATION_OF_CELL_KILLING 5.24 5.08 5.31 5.21 5.08 4.72 4.8 5.15 4.85 4.96 4.98 4.95 4.62 4.63 4.68 4.97 4.97 5.06 4.88 4.93 5.22 5.3 4.81 4.71 4.86 5.24
GOBP_POSITIVE_REGULATION_OF_CELL_KILLING 5.25 5.04 4.79 5.14 4.88 4.82 4.8 5.02 5.03 4.78 4.98 4.74 4.69 4.76 4.76 4.72 5.03 5.13 4.84 4.81 5.15 4.88 4.68 4.62 4.85 4.96
GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION 7.2 7.34 7.5 7.13 7.6 7.64 7.59 7.68 7.49 7.63 7.47 7.68 7.63 7.69 7.73 7.65 7.45 7.37 7.48 7.72 7.4 7.59 7.55 7.82 7.53 7.56
GOBP_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION 7.16 7.44 7.5 7.26 7.49 7.48 7.59 7.7 7.42 7.63 7.39 7.69 7.58 7.58 7.67 7.55 7.25 7.3 7.42 7.71 7.48 7.7 7.48 7.84 7.63 7.52
GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION 7.33 7.47 7.53 7.19 7.86 7.84 7.79 7.82 7.65 7.81 7.54 7.81 7.73 7.77 7.86 7.78 7.53 7.53 7.56 7.89 7.49 7.62 7.79 7.91 7.75 7.81
GOBP_REGULATION_OF_DEFENSE_RESPONSE 6.02 5.95 6.04 6.21 5.84 5.65 5.88 5.92 5.98 5.79 6.04 5.79 5.89 5.82 5.8 5.89 5.91 5.89 5.77 5.74 5.99 6 5.69 5.65 5.93 6.08
GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE 6.14 5.96 6.04 6.21 5.75 5.69 6.03 6.02 6.07 5.87 6.1 5.81 5.89 5.82 5.92 6.01 5.96 5.82 5.81 5.94 6.14 5.99 5.79 5.76 5.93 6.1
GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE 6.07 6.14 6.28 6.33 6.06 5.88 5.95 6.04 6.03 5.88 5.98 5.88 5.89 5.84 5.86 5.87 5.99 5.99 5.86 5.94 5.99 6.05 5.71 5.76 6.09 6.2
GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION 7.67 7.81 8.57 8.34 8.39 8.53 8.18 8.29 8.4 8.59 8.22 8.35 8.4 8.45 8.45 8.42 8.12 7.72 8.09 8.17 7.79 8.14 8.56 8.59 8.36 8.1
GOBP_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS 6.59 6.54 6.81 6.71 6.7 6.78 6.74 6.82 6.78 6.8 6.68 6.81 6.88 6.76 6.82 6.79 6.68 6.6 6.65 6.74 6.79 6.79 6.92 6.9 6.81 6.8
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS 6.86 6.96 7.27 7.09 7.29 7.22 7.08 7.2 7.22 7.22 7.06 7.26 7.27 7.31 7.23 7.19 7 7 7.14 7.17 7.03 7.32 7.39 7.46 7.12 7.12
GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS 6.46 6.45 6.57 6.48 6.46 6.47 6.62 6.66 6.58 6.61 6.49 6.49 6.55 6.61 6.59 6.6 6.56 6.42 6.42 6.51 6.66 6.68 6.62 6.65 6.64 6.71
GOBP_KERATINIZATION 4.89 4.77 4.51 4.91 4.36 4.13 4.7 4.47 4.57 4.26 4.65 4.4 4.45 4.25 4.42 4.33 4.61 4.75 4.4 4.32 4.82 4.51 4.34 4.18 4.39 4.34
GOBP_REGULATION_OF_MRNA_3_END_PROCESSING 7.64 8.04 7.94 7.86 8.11 8.44 8.27 8.35 8.01 8.37 7.99 8.2 8.07 8.28 8.26 8.35 8.02 7.82 7.88 8.42 7.91 8.29 8.43 8.54 8.24 8.1
GOBP_POSITIVE_REGULATION_OF_MRNA_3_END_PROCESSING 7.45 7.88 7.83 7.53 7.21 7.68 7.76 7.42 7.68 7.87 7.82 7.82 7.67 7.91 8.14 8.24 7.67 7.44 7.71 7.9 7.41 7.9 8.07 8.26 7.85 7.36
GOBP_NUCLEAR_ENVELOPE_REASSEMBLY 7.99 7.71 9.11 9.16 8.28 8.26 8.4 8.38 8.5 8.59 8.81 8.42 8.33 8.26 8.8 8.63 8.49 7.79 8.04 8.48 8.14 8.25 8.84 8.64 8.52 8.52
GOBP_CHROMATIN_DISASSEMBLY 7.97 8.21 8.26 7.76 8.52 8.26 8.56 8.35 8.38 8.44 7.71 8.56 8.18 8.43 8.59 8.67 7.89 8.33 8.09 8.41 8.26 8.5 8.24 8.46 8.71 8.26
GOBP_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION 7.4 7.55 7.84 7.58 7.79 7.85 7.84 7.73 7.73 7.89 7.57 7.84 7.79 7.86 7.89 7.92 7.52 7.47 7.7 7.85 7.49 7.79 7.89 8.04 7.75 7.73
GOBP_RUFFLE_ORGANIZATION 6.73 6.95 7.39 7.19 7.3 7.21 7.23 7.41 7.18 7.19 6.91 7.12 7.44 7.38 7.3 7.18 7.29 7.09 6.95 7.41 7.31 7.3 7.35 7.43 7.33 7.23
GOBP_ACTIN_CYTOSKELETON_REORGANIZATION 6.82 6.86 6.87 6.78 7.16 7.06 6.86 7 6.92 6.95 6.99 7.03 7 7.07 7.05 6.92 7.02 7.01 7.07 7.09 6.87 7.05 6.75 7.09 7.25 7.2
GOBP_DNA_INTEGRITY_CHECKPOINT 6.25 6.45 6.46 6.45 6.45 6.46 6.27 6.49 6.18 6.35 6.51 6.37 6.3 6.26 6.35 6.59 6.36 6.3 6.43 6.37 6.48 6.52 6.25 6.5 6.59 6.69
GOBP_G2_DNA_DAMAGE_CHECKPOINT 5.95 6.07 6.31 6.44 6.26 5.87 5.64 5.63 5.74 6.02 6.42 6.12 5.81 6.04 6.08 6.08 6.04 5.59 6 5.65 6.42 6.41 6.01 6.22 6.51 6.49
GOBP_INTRA_S_DNA_DAMAGE_CHECKPOINT 5.83 5.89 5.67 5.87 5.58 5.78 5.58 5.9 5.82 5.7 6.13 5.84 5.8 5.91 5.71 6.36 5.92 5.96 6.06 5.83 6 6.12 5.35 5.61 5.93 6.33
GOBP_MEMBRANE_RAFT_ORGANIZATION 7.42 7.65 7.45 7.11 8.06 8.04 8.12 7.75 7.87 7.3 7.37 7.83 7.52 7.42 7.22 7.13 7.73 7 7.47 8.08 7.53 7.55 7.77 7.96 7.76 7.9
GOBP_HEMIDESMOSOME_ASSEMBLY 5.92 5.77 5.61 5.92 5.95 5.53 5.72 5.73 6.02 5.72 5.95 6.03 5.76 5.88 5.76 5.88 6.12 6.07 5.89 5.87 5.97 6.07 6.08 5.78 6.05 5.96
GOBP_CELL_SUBSTRATE_ADHESION 6.53 6.48 6.5 6.43 6.5 6.46 6.6 6.7 6.49 6.41 6.38 6.59 6.47 6.51 6.5 6.52 6.55 6.48 6.43 6.43 6.7 6.78 6.69 6.54 6.78 6.76
GOBP_RECEPTOR_INTERNALIZATION 7.4 7.61 7.98 7.67 8.04 8.1 8.07 7.85 7.92 8.04 7.92 7.82 8.21 8.2 8.19 8.05 7.62 7.64 7.88 8.07 7.71 8.02 8.16 8.31 7.98 7.98
GOBP_ZYMOGEN_ACTIVATION 5.42 5.3 5.35 5.55 4.98 5.04 5.42 5.19 5.21 5.03 5.59 5.14 5.28 4.98 5.16 5.01 5.3 5.27 5.04 4.98 5.63 5.25 5.17 4.87 5.33 5.7
GOBP_PLASMINOGEN_ACTIVATION 5.4 5.2 4.98 4.96 5.01 4.91 5.09 4.85 5.16 5.01 5.22 5.13 5.14 5.16 4.93 4.57 5.3 5.26 4.93 4.74 5.37 5.18 5.11 4.87 5.1 5.04
GOBP_KILLING_OF_CELLS_OF_OTHER_ORGANISM 4.91 4.83 4.69 4.76 4.33 4.22 4.39 4.49 4.55 4.2 4.54 4.47 4.18 4.4 4.55 4.54 4.72 4.86 4.53 4.47 4.82 4.54 4.34 4.1 4.51 4.51
GOBP_REGULATION_OF_MYELINATION 7.83 7.46 8.02 7.31 8.34 8.03 7.68 7.84 7.79 7.95 7.52 7.9 8.26 8.27 7.83 7.99 7.68 7.16 7 8.2 7.83 7.59 7.85 8.29 7.86 7.83
GOBP_POSITIVE_REGULATION_OF_MYELINATION 8.17 7.61 7.74 6.81 8.44 8.07 7.97 7.73 8.08 7.65 7.32 7.65 8.29 8.35 7.75 7.67 8.11 7.19 7.38 8.35 7.84 7.66 7.9 8.06 8.08 7.73
GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS 6.72 6.82 7.24 6.95 6.69 6.97 7.34 7.41 6.94 7.34 6.91 7.17 7.05 6.99 7.54 7.17 6.97 7.05 6.93 7.08 7.1 6.97 6.89 7.14 7.12 7.06
GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS 5.43 5.43 5.94 6.03 5.33 4.87 5.57 5.77 5.33 5.23 5.05 4.83 5.07 4.94 5.45 5 5.55 5.32 5.09 5.04 5.41 5.44 5.64 4.94 5.23 5.21
GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS 7.05 6.96 7.63 6.4 7.5 7.78 7.13 7.29 7.31 7.34 7.04 7.46 7.4 7.31 7.4 7.13 7.29 6.86 6.84 7.58 7.35 7.26 7.17 7.45 7.5 7.53
GOBP_REGULATION_OF_PROTEIN_STABILITY 7.49 7.54 7.82 7.68 7.87 7.91 7.89 7.86 7.91 7.88 7.78 7.88 7.94 7.87 7.82 7.79 7.73 7.6 7.67 7.96 7.58 7.92 8.01 8.04 7.95 7.9
GOBP_PROTEIN_DESTABILIZATION 7.39 7.39 7.65 7.65 7.53 7.73 7.84 7.75 7.64 7.53 7.44 7.78 7.76 7.69 7.6 7.47 7.34 7.38 7.55 7.87 7.41 7.59 7.5 7.65 7.6 7.64
GOBP_HEAT_GENERATION 5.48 5.54 5.2 5.57 4.95 4.63 4.82 4.91 4.9 4.68 4.71 4.84 4.94 4.68 5.11 4.88 5.08 5.26 4.87 4.86 5.47 4.92 5 4.43 4.87 4.96
GOBP_REGULATION_OF_HEAT_GENERATION 5.47 5.59 4.89 5.42 4.84 4.38 4.84 5.06 4.85 4.61 4.65 5.11 5.22 4.67 5.32 4.85 5.06 5.31 5.01 4.75 5.63 4.77 5.05 4.54 5.12 5.27
GOBP_POSITIVE_REGULATION_OF_HEAT_GENERATION 5.26 5.12 4.7 5.09 4.46 4.16 4.63 4.75 4.5 4.49 4.57 4.52 4.5 4.61 4.83 4.63 4.55 5.14 4.87 4.62 5.06 4.42 4.75 4.3 4.49 4.64
GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY 6.03 5.97 5.94 6.35 5.92 5.72 5.66 5.84 5.89 5.26 5.72 5.41 5.61 5.81 5.96 5.76 6.01 5.82 5.62 5.73 6.19 6.27 5.7 5.61 6.04 5.93
GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY 5.84 5.71 5.8 6.33 5.55 5.17 5.58 5.82 5.78 5.17 5.89 5.41 5.5 5.34 5.96 5.57 6.01 6.29 5.74 5.79 6 6.28 5.6 5.63 5.27 5.44
GOBP_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS 6.7 6.76 6.95 6.85 6.99 6.97 6.92 6.96 6.84 6.79 6.71 6.79 6.97 6.8 7.09 6.92 6.8 6.67 6.74 6.93 6.94 7.12 6.97 6.93 7.01 7.06
GOBP_CELLULAR_RESPONSE_TO_NUTRIENT 5.78 5.96 5.7 6.53 5.97 5.92 5.79 5.52 5.97 6.12 5.78 5.5 5.77 5.43 5.52 5.77 6.1 5.56 5.4 5.69 5.89 6.17 6 5.48 5.83 6.02
GOBP_PROTECTION_FROM_NON_HOMOLOGOUS_END_JOINING_AT_TELOMERE 6.36 6.5 6.49 7 6.01 6.47 6.67 6.32 6.84 6.47 6.32 6.47 6.45 6.16 6.53 6.22 6.35 6.29 6.01 6.59 6.36 6.48 6.66 6.92 6.37 6.15
GOBP_TOR_SIGNALING 7.21 7.21 7.61 7.68 7.47 7.53 7.29 7.35 7.4 7.57 7.28 7.23 7.45 7.48 7.55 7.33 7.25 7.27 7.33 7.37 7.18 7.41 7.56 7.5 7.51 7.31
GOBP_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS 5.57 5.33 5.43 5.42 5.75 5.24 5.63 5.63 5.58 5.72 5.79 5.35 5.16 5.23 5.49 5.34 5.66 5.5 5.36 5.27 5.49 5.61 5.34 4.91 5.47 5.72
GOBP_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION 7.59 7.65 7.65 7.1 7.9 7.48 7.93 7.61 7.89 7.68 7.17 7.72 7.98 7.97 7.71 7.67 7.35 7.14 7.53 7.71 7.58 7.71 7.82 8.1 7.75 7.42
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION 5.72 5.77 5.75 6.07 5.62 6.14 5.81 5.66 6.27 6.42 5.78 6.01 5.49 5.37 5.96 5.75 5.92 5.92 5.54 5.71 5.63 5.91 5.76 5.89 5.88 6.72
GOBP_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION 7.59 7.67 7.62 7.1 7.1 7.48 7.73 7.43 7.5 7.5 7.17 7.4 7.64 7.58 7.88 7.67 6.87 7.09 7.78 7.69 7.58 7.71 7.66 7.63 7.41 7.32
GOBP_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY 7.31 7.53 7.8 7.94 7.63 7.9 8.12 7.97 7.45 7.65 7.72 7.78 7.77 8.15 8.15 7.78 7.82 7.79 7.57 7.99 7.84 7.99 7.94 7.99 8.12 7.77
GOBP_RESPONSE_TO_CORTICOSTEROID 6.07 5.91 6.27 6.07 5.73 5.71 5.85 5.79 5.96 5.89 5.97 5.83 6.07 6.11 6.01 6.01 6.01 6.1 5.84 5.82 6.38 6.39 5.83 5.98 6.14 6.28
GOBP_REGULATION_OF_FATTY_ACID_BETA_OXIDATION 6.27 6.14 6.37 6.19 6.27 6.57 6.69 6.86 6.64 6.56 6.52 6.63 6.62 6.7 6.55 6.56 6.76 6.43 6.34 6.76 6.76 6.8 6.35 6.56 7.09 6.63
GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION 5.94 5.92 5.67 5.71 5.82 6.03 5.84 6 6.06 6.09 5.97 5.99 6.13 6.24 6.17 6.15 6.28 6.21 5.98 5.87 6.08 6.02 6.05 6.11 6.03 5.92
GOBP_REGULATION_OF_TOR_SIGNALING 7.15 7.19 7.53 7.67 7.3 7.45 7.2 7.31 7.34 7.51 7.15 7.12 7.34 7.35 7.53 7.25 7.24 7.08 7.22 7.3 7.15 7.42 7.47 7.45 7.27 7.2
GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING 6.94 6.99 7.15 7.7 7.14 7.34 7.07 7.31 7.13 6.97 6.82 6.95 7.24 7.34 7.4 7.21 7.43 7.19 6.66 7.26 7.15 7.44 7.52 7.41 7.22 7.09
GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING 7.22 7.3 7.88 7.73 7.73 7.65 7.31 7.38 7.66 7.65 7.4 7.7 7.47 7.81 7.65 7.54 7.17 7.08 7.49 7.44 7.21 7.54 7.59 7.82 7.71 7.64
GOBP_ARF_PROTEIN_SIGNAL_TRANSDUCTION 7.96 8.09 7.82 7.68 8 8.29 8.38 8.4 8.28 8.48 8.04 8.38 8.49 8.68 8.41 8.32 8.37 8 8 8.5 8.03 8.27 8.5 8.66 8.45 8.3
GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION 6.41 6.11 6.66 6.33 6.33 6.13 6.44 6.86 6.52 6.62 6.28 6.59 6.14 6.31 6.7 6.58 6.37 6.54 6.36 6.57 6.4 6.66 6.26 6.33 6.48 6.4
GOBP_RESPONSE_TO_MAGNESIUM_ION 6.57 6.52 7.44 6.26 6.69 6.69 6.88 6.92 6.76 7.06 6.54 6.58 7 6.62 6.87 6.73 6.57 6.57 6.72 6.49 6.6 6.9 7.09 7.15 7.42 7.31
GOBP_MITOCHONDRIAL_DNA_METABOLIC_PROCESS 6.07 6.67 6.9 6.83 5.77 6.66 6.96 7.26 7.25 6.96 6.73 7.13 6.93 6.94 7.21 6.93 6.53 6.73 6.32 6.97 7.15 7.31 7.14 7.17 7.2 7.2
GOBP_CARDIOLIPIN_METABOLIC_PROCESS 6.57 6.88 7.77 7.48 7.07 7.17 6.97 6.88 6.67 6.96 7.61 6.94 7.21 7.05 7.41 7.46 7.22 6.93 6.89 7.23 6.97 7.28 7.03 7.07 6.98 7.27
GOBP_REGULATION_OF_NUCLEASE_ACTIVITY 6.78 6.78 7.11 7.36 6.73 6.47 7.17 6.83 6.96 6.79 7.32 6.52 6.9 6.6 6.7 6.63 6.7 6.39 6.17 6.69 6.4 6.4 7.08 7.02 7.14 6.5
GOBP_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY 6.07 6 5.89 6.22 5.95 5.99 5.78 5.83 5.93 6.03 6.13 6.02 6.21 5.93 5.92 5.9 6.17 5.9 5.81 6.06 5.96 6.25 5.86 6.07 6.02 5.92
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING 6.59 6.5 6.57 6.77 7.1 7.11 6.92 7 6.91 7.06 7.06 7.03 6.98 6.8 6.55 6.99 6.99 6.6 6.8 6.66 6.88 7.06 6.63 6.92 6.94 7.24
GOBP_POSITIVE_REGULATION_OF_PROTEIN_BINDING 7.08 7.11 7.27 7.13 7.72 7.42 7.44 7.45 7.39 7.54 7.8 7.82 7.41 7.5 7.32 7.47 7.68 7.31 7.13 7.6 7.63 7.64 7.79 7.81 7.77 7.84
GOBP_RESPONSE_TO_FOOD 5.85 5.79 6.35 6.3 5.83 5.81 5.92 6.14 5.83 6.26 6.25 6.23 5.86 5.73 6.45 6.44 5.85 6.25 6.1 5.88 6.07 6.27 5.79 6.15 6.25 6.46
GOBP_REGULATION_OF_RESPONSE_TO_FOOD 6.22 6.13 8.12 6.97 6.25 6.54 6.46 6.55 6.39 6.88 6.61 6.49 6.59 6.5 7.31 7.1 6.57 6.74 6.16 6.52 6.85 6.78 6.28 6.66 6.82 6.93
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_FOOD 6.05 5.98 8.03 6.56 5.83 6.19 6.38 6.28 6.04 6.61 6.41 6.39 6.31 6.27 6.71 6.61 6.39 6.58 6.1 6.04 6.7 6.57 6.08 6.37 6.56 6.77
GOBP_REGULATION_OF_APPETITE 6.05 5.92 6.57 6.56 5.62 6.19 6.38 6.14 6.04 6.32 6.25 6.2 6.12 6.05 6.45 6.44 6.19 6.58 6.13 5.96 6.56 6.27 5.94 6.15 6.27 6.57
GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS 6.12 6.06 6.18 6.23 6 5.88 6.09 6.11 6.11 5.98 6.1 5.91 5.97 5.93 5.98 6.02 6.14 6 5.9 5.97 6.15 6.17 5.88 5.93 6.09 6.14
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS 6.16 6.01 6.16 6.24 5.91 5.81 6.13 6.14 6.07 6.02 6.1 5.9 5.99 5.99 6.04 6.03 6.04 5.99 5.89 6.02 6.2 6.28 5.93 5.94 6.14 6.15
GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS 6.07 6.04 6.07 6.18 6.06 5.86 5.84 5.99 6.07 5.83 5.94 5.79 5.89 5.82 5.88 5.88 6.1 5.99 5.84 5.79 6.01 6.1 5.74 5.74 6 6.06
GOBP_REGULATION_OF_RESPONSE_TO_EXTRACELLULAR_STIMULUS 6.38 6.27 7.56 6.88 6.31 6.55 6.51 6.77 6.49 7.01 6.76 6.56 6.63 6.56 7.68 7.07 6.67 6.72 6.19 6.99 6.82 6.82 6.42 6.8 6.97 6.97
GOBP_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY 6.44 6.42 6.58 6.4 6.33 6.32 6.6 6.55 6.53 6.51 6.41 6.5 6.45 6.43 6.49 6.56 6.49 6.44 6.34 6.44 6.62 6.57 6.57 6.61 6.67 6.73
GOBP_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY 7.62 8.1 8.41 7.88 8.33 8.1 8.28 8.26 8.55 8.27 7.94 8.32 8.37 8.34 8.48 8.43 7.75 7.95 8.43 8.59 7.9 7.98 8.56 8.68 8 7.79
GOBP_TRANSPOSITION 4.9 5.05 4.99 4.91 4.38 4.35 4.43 4.72 4.46 4.23 4.75 4.61 4.27 4.49 4.57 4.53 4.84 4.99 4.74 4.77 4.92 4.63 4.19 4.46 4.81 4.72
GOBP_TELOMERE_ORGANIZATION 6.46 6.4 6.73 7.01 6.51 6.79 6.54 6.53 6.57 6.7 6.64 6.46 6.55 6.44 6.46 6.5 6.41 6.27 6.5 6.61 6.37 6.56 6.74 6.81 6.56 6.65
GOBP_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION 5.74 5.94 6.71 6.83 5.76 6.06 5.87 6.18 5.96 5.87 6.04 5.95 5.77 5.76 6.07 6.07 5.87 5.76 5.84 5.94 5.85 6.24 5.94 6.14 6.1 6.21
GOBP_REGULATION_OF_TELOMERE_MAINTENANCE 7.52 7.6 7.78 7.63 7.69 8.01 7.92 7.62 7.71 7.94 7.44 7.83 7.88 7.81 7.74 7.62 7.58 7.4 7.68 7.72 7.41 7.6 7.98 8.02 7.92 7.83
GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE 7.58 7.6 7.47 7.71 7.41 7.84 7.29 7.36 7.53 7.53 7.27 7.67 7.42 7.38 7.28 7.37 7.35 7.3 7.55 7.38 7.41 7.39 7.5 7.61 7.54 7.77
GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE 7.46 7.63 8 7.71 7.66 8.07 7.98 7.63 7.71 8.03 7.79 7.76 8 7.85 7.92 7.65 7.61 7.44 7.72 7.82 7.56 7.81 8.31 8.07 8.08 7.87
GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE 6.92 6.77 6.72 7.29 7.34 7.3 6.69 6.54 6.68 7.1 7.25 6.52 6.85 6.76 6.56 6.61 6.48 6.42 6.95 6.9 6.8 6.84 7.1 7.23 7.16 6.82
GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC 8.18 8.31 7.72 7.75 8.18 8.2 8.18 8.17 8.24 8.1 7.91 8.33 8.28 8.28 8.19 8.43 7.55 7.74 8.37 8.58 7.61 7.86 8.17 8.32 7.76 7.97
GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC 7.54 7.31 6.96 6.89 6.01 6.84 7.33 6.68 6.73 6 6.68 6.31 6.52 5.61 6.45 6.02 6.14 6.77 6.99 6.85 6.9 6.78 5.98 6.57 6.38 6.23
GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY 6.53 6.64 6.87 6.64 6.97 7.02 6.94 7.3 6.83 7.19 6.97 7.27 7.04 6.97 7.25 7.17 7.35 6.97 6.87 7.02 7.04 6.92 7.28 7.27 7.25 7.35
GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY 5.9 5.97 6.39 6.29 6.22 6.28 6.37 6.34 6.44 6.37 5.99 6.23 6.31 6.61 6.62 6.1 6.34 6.12 6.05 6.13 6.49 6.35 6.19 6.3 6.79 6.75
GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY 6.49 6.44 6.81 6.63 6.95 6.78 6.91 7.25 6.73 7.06 6.8 7.14 6.99 6.82 6.78 6.91 7.34 7.01 6.66 6.63 6.81 6.91 7.1 7.04 7.18 7.31
GOBP_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT 8.54 8.58 7.91 7.89 8.47 8.56 8.07 8.29 8.29 8.42 8.15 8.41 8.21 8.13 8.14 8.46 7.96 8.02 8.59 8.64 7.77 7.96 8.55 8.73 7.97 8.34
GOBP_SECRETORY_GRANULE_LOCALIZATION 10.53 10.63 10.22 9.75 10.29 10.73 10.84 10.71 10.9 10.84 10.8 10.54 10.7 10.91 11.03 10.88 9.39 10.29 10.48 10.59 10.29 10.59 10.99 11.13 10.52 9.99
GOBP_METHYLATION 6.44 6.51 6.78 6.8 6.75 6.68 6.62 6.72 6.54 6.69 6.62 6.69 6.64 6.66 6.64 6.73 6.5 6.47 6.6 6.68 6.67 6.69 6.71 6.77 6.66 6.73
GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION 7.19 7.21 7.53 7.28 7.63 7.83 7.69 7.56 7.56 7.67 7.61 7.74 7.68 7.8 7.77 7.79 7.35 7.39 7.52 7.65 7.41 7.53 7.75 7.83 7.62 7.58
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION 6.51 6.6 6.56 6.83 7.06 7.11 7.08 7.16 7.12 7.24 6.7 7.02 6.93 6.76 7.27 6.74 6.93 6.8 6.46 7.03 7.03 7.2 7.31 7.32 7.02 7.27
GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION 7.29 7.31 7.53 7.32 7.66 7.94 7.57 7.58 7.61 7.75 7.62 7.76 7.75 7.68 7.85 7.78 7.39 7.38 7.52 7.65 7.46 7.48 7.8 7.85 7.63 7.57
GOBP_GONADOTROPIN_SECRETION 5.6 5.67 5.76 5.29 5.03 4.96 5.42 5.31 5.5 5.03 5.68 5.27 5.15 5.21 5.63 5.16 5.2 5.34 5.26 5.13 5.6 5.31 5.34 5.25 5.28 4.98
GOBP_MYELIN_ASSEMBLY 8.43 8.73 8.31 8.03 9.09 8.89 8.89 8.94 9.27 9.17 8.64 9.02 8.97 8.8 9.25 8.87 8.78 8.1 8.7 9.25 8.37 8.57 9.23 9.29 9.01 8.87
GOBP_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM 8.82 9.08 8.92 8.45 9.44 9.5 9.35 9.29 9.36 9.35 8.52 9.07 9.13 9.17 9.2 8.83 8.47 8.44 8.97 9.45 8.51 8.65 9.29 9.51 9.08 8.83
GOBP_REGULATION_OF_ICOSANOID_SECRETION 5.03 4.86 4.89 4.88 4.64 4.38 4.8 4.74 4.65 4.56 4.58 4.63 4.57 4.57 4.76 4.67 4.68 4.84 4.69 4.59 4.69 4.6 4.64 4.23 4.64 4.63
GOBP_REGULATION_OF_PROSTAGLANDIN_SECRETION 4.9 4.86 5.03 4.88 4.73 4.38 4.84 4.74 4.76 4.56 4.63 4.47 4.95 4.59 4.9 4.67 4.86 4.9 4.69 4.7 4.69 4.77 4.78 4.29 4.64 4.63
GOBP_ICOSANOID_SECRETION 5.19 5.03 5.02 5.06 4.72 4.38 4.84 5 4.82 4.65 4.88 4.63 4.61 4.73 4.76 4.89 5 4.85 4.73 4.66 5.01 4.75 4.73 4.33 4.8 4.94
GOBP_PROSTAGLANDIN_SECRETION 5.02 4.89 5.02 4.89 4.63 4.31 4.85 4.88 4.77 4.5 4.6 4.49 4.73 4.63 4.83 4.62 4.95 4.8 4.7 4.67 4.74 4.69 4.71 4.33 4.7 4.72
GOBP_ALANINE_TRANSPORT 7.79 7.57 7.37 7.73 7.64 7.9 7.75 7.7 8.19 7.8 7.16 7.63 8.05 8.16 7.58 7.65 7.86 8.18 7.87 8.01 7.89 7.44 7.48 7.51 8.01 7.57
GOBP_SERINE_TRANSPORT 6.79 6.73 6.59 6.41 6.73 6.74 7.14 7.23 6.69 6.32 6.43 6.53 6.7 6.92 6.78 6.9 6.53 6.78 6.87 6.89 6.86 6.99 6.67 6.96 6.58 7.05
GOBP_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION 5.98 6.15 5.93 6.1 5.99 5.69 5.88 6.08 5.96 5.85 6.21 6.06 5.84 5.8 5.94 6 5.84 5.77 5.71 5.89 6.05 6.18 5.85 5.85 6.33 6.13
GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION 5.58 5.14 5.44 5.93 5.47 5.24 5.49 5.19 5.79 5.53 5.82 5.68 5.47 5.59 5.45 5.78 5.35 5.4 5.34 5.44 5.26 5.1 5.5 5.47 5.35 5.69
GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION 5.96 6.17 6.16 6.02 6.32 6.18 6.27 6.61 6.01 5.95 6.44 6.37 6.35 6.34 6.32 6.36 6.32 6.4 5.93 6.11 6.6 6.43 6.38 6.41 6.46 6.15
GOBP_ALDOSTERONE_METABOLIC_PROCESS 5.45 5.24 5.44 5.22 5.08 4.8 5.37 5.08 5.01 4.89 5.63 4.72 4.58 4.75 5.16 4.61 5.02 5.19 5.21 4.9 5.06 5.16 4.79 4.47 5.23 5.54
GOBP_REGULATION_OF_HORMONE_METABOLIC_PROCESS 6.02 5.78 5.78 5.92 5.81 5.71 5.74 5.81 5.81 5.87 6.09 5.86 5.59 5.66 5.71 5.76 5.79 5.8 5.56 5.78 5.86 5.83 5.51 5.39 5.73 5.84
GOBP_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS 5.45 5.12 5.44 5.24 5.04 4.82 5.27 5.14 5.16 5.06 5.86 4.8 4.91 5.13 5.32 5 5.36 5.19 4.86 4.9 5.06 5.19 5.01 4.68 5.22 5.54
GOBP_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS 6.95 6.55 7.05 6.14 6.87 6.96 6.74 6.67 6.55 6.46 7.09 6.93 6.95 6.92 6.8 6.99 6.38 6.83 7.11 6.58 6.41 6.69 6.9 7.15 7.08 6.64
GOBP_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE 6.34 6.47 6.51 6.1 6.16 6.4 6.31 6.32 6.49 6.12 6.37 6.49 6.26 6.6 6.2 6.57 6.79 6.8 6.57 6.46 6.91 6.03 6.28 6.36 6.92 6.75
GOBP_RESPONSE_TO_ESTRADIOL 6.31 6.11 6.15 6.43 6.24 6.2 6.58 6.45 6.5 6.66 6.34 6.36 6.43 6.12 6.5 6.5 6.53 6.31 6.18 6.58 6.38 6.58 6.45 6.42 6.51 6.38
GOBP_INTRACELLULAR_LIPID_TRANSPORT 7.22 7.38 7.39 7.48 7.76 7.65 7.67 7.46 7.71 7.69 7.49 7.81 7.94 8.01 7.49 7.66 7.62 7.38 7.47 7.61 7.49 7.77 8.04 8.28 7.71 7.61
GOBP_INTRACELLULAR_STEROL_TRANSPORT 7.51 7.68 7.64 7.6 7.97 8.08 8.17 8.14 8.07 8.14 7.76 8.03 8.24 8.05 7.95 8 8.21 7.83 7.86 7.97 8.23 8.13 8.19 8.45 8.4 8.63
GOBP_REGULATION_OF_LIPID_TRANSPORT 5.98 6.02 6.05 6.18 5.94 5.97 5.94 6.03 6 6.05 6.16 5.88 5.99 6.07 6.07 6.13 6.13 5.95 5.91 5.86 6.03 6.17 5.99 5.87 5.84 6.22
GOBP_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT 5.84 6.59 6.02 6.62 5.99 5.94 5.91 6.18 6.14 6.09 6.24 5.73 6.19 6.22 6.05 6.08 6.09 5.79 5.86 6.06 5.77 6.05 6.27 5.87 5.77 6.15
GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT 6.01 5.91 5.92 6.02 5.68 5.55 5.76 5.86 5.63 5.61 6.06 5.88 5.67 5.76 5.86 5.87 5.87 5.95 5.56 5.72 5.95 6.13 5.65 5.67 5.75 6.11
GOBP_REGULATION_OF_STEROL_TRANSPORT 5.96 5.87 6.1 6.21 5.96 5.95 6.03 5.85 6.02 6.04 6.18 5.68 6.2 5.91 6.02 6.02 6.11 5.89 5.89 6.01 6.07 6.27 5.94 6.01 5.66 6.01
GOBP_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT 5.51 5.3 4.98 5.5 4.69 4.68 4.86 5.12 5.11 4.78 5.32 4.76 4.88 4.94 4.89 4.89 5.42 5.3 5.15 4.78 5.18 4.91 4.73 4.41 4.72 4.95
GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT 6.19 6.55 6.52 6.22 7.08 6.66 6.58 6.85 6.89 6.97 6.44 6.92 6.89 6.44 6.08 6.45 6.31 6.23 6.94 6.71 6.82 6.35 6.84 6.63 6.47 6.77
GOBP_REGULATION_OF_INTRACELLULAR_TRANSPORT 7.54 7.53 8 7.84 7.81 7.9 7.98 7.96 7.79 8 7.88 7.91 7.96 7.93 7.9 7.96 7.71 7.69 7.64 7.94 7.75 8.04 8.05 8.03 7.95 7.83
GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT 7.22 7.15 7.69 7.86 7.35 7.44 7.48 7.79 7.58 7.77 7.63 7.31 7.58 7.73 7.54 7.57 7.37 7.15 7.22 7.49 7.28 7.9 7.93 7.62 7.6 7.69
GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT 7.62 7.71 8.15 7.96 7.83 7.99 8.04 8.07 7.97 8.06 7.96 8 8.09 8.1 8.14 8.05 7.87 7.84 7.82 8.11 7.86 8.09 8.16 8.08 8.07 7.91
GOBP_DNA_GEOMETRIC_CHANGE 6.46 6.37 6.76 6.91 6.84 6.75 6.55 6.56 6.41 6.77 6.81 6.73 6.76 6.61 6.41 6.65 6.39 6.46 6.62 6.61 6.47 6.6 6.53 6.7 6.6 6.78
GOBP_REGULATION_OF_TRANSPORTER_ACTIVITY 7.32 7.33 7.59 7.17 7.62 7.56 7.65 7.73 7.52 7.57 7.38 7.72 7.5 7.69 7.93 7.78 7.36 7.48 7.63 7.67 7.43 7.58 7.61 7.89 7.5 7.5
GOBP_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY 7.08 7.05 7.23 7.23 7.27 7.42 7.24 7.03 7.42 7.48 7.15 7.14 7.36 7.23 6.75 7.39 7.11 7.03 7.21 7.06 6.64 7.06 7.58 7.68 7.11 7.04
GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY 6.53 6.67 7.25 7.03 7.15 7.19 7.21 7.41 6.94 7.23 6.98 7.43 7.15 6.97 7.27 7.19 6.68 6.79 7.06 7.1 6.92 6.99 6.93 7.36 7.07 7.18
GOBP_LYSOSOME_LOCALIZATION 6.09 6.27 6.48 6.29 6.1 5.96 6.44 6.59 6.18 6.2 6.1 5.92 6.07 6.22 6.5 6.29 6.36 6.42 6.06 6.08 6.43 6.29 6.16 6.33 6.59 6.48
GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS 7.72 7.8 8.2 8.06 8.2 8.26 8.23 8.07 8.17 8.18 7.87 8.19 8.14 8.13 8.05 8.04 8.1 7.95 7.97 8.3 7.78 7.97 8.24 8.43 8.23 8.07
GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS 8.02 8.26 8.49 8.1 8.33 8.38 8.41 8.39 8.42 8.45 8.23 8.42 8.15 8.29 8.21 8.14 8.52 8.33 8.23 8.54 8.24 8.47 8.38 8.62 8.6 8.42
GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS 7.59 7.59 8.01 7.92 8.2 8.09 8.17 7.95 8.01 8.15 7.82 8.08 8.11 7.96 7.93 7.9 7.93 7.6 7.86 7.94 7.62 7.94 8.17 8.37 7.99 8.04
GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION 7.01 7.09 7.47 7.38 7.34 7.38 7.29 7.38 7.36 7.37 7.27 7.3 7.39 7.45 7.3 7.39 7.1 7.11 7.24 7.37 7.13 7.32 7.41 7.56 7.4 7.24
GOBP_ENDOCYTIC_RECYCLING 7.39 7.46 7.38 7.3 7.53 7.5 7.48 7.67 7.62 7.65 7.84 7.85 7.83 7.76 7.84 7.64 7.61 7.64 7.65 7.72 7.47 7.56 7.84 7.84 7.74 7.51
GOBP_REGULATION_OF_CYTOKINESIS 6.55 6.63 6.8 6.35 6.59 6.76 6.67 6.73 6.71 6.92 6.67 6.6 6.69 6.67 6.62 6.9 6.51 6.82 6.5 6.8 6.63 6.93 6.61 6.83 6.59 6.43
GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS 5.89 5.77 6.26 5.66 5.93 5.8 5.64 5.63 5.54 5.52 5.87 5.62 5.74 5.73 5.72 5.72 5.77 5.64 5.79 5.59 5.61 5.91 5.66 5.94 5.84 5.59
GOBP_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS 7.97 7.95 8.84 8.52 8.77 8.19 8.98 8.65 8.9 8.96 8.69 8.57 8.51 8.69 8.84 8.9 8.53 8.4 8.39 8.29 8.81 8.93 9.18 8.85 9.16 8.95
GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION 6.54 6.16 5.83 6.15 6.53 6.22 6.29 6.41 6.41 6.12 6.49 6.44 6.19 6.24 5.97 6.32 6.26 5.76 6.25 6.13 6.06 5.94 6.07 6.02 6.39 6.5
GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION 6.71 6.57 6.83 6.74 6.6 6.64 6.58 6.82 6.62 6.71 6.86 6.66 6.78 6.51 6.64 6.62 6.5 6.36 6.8 6.9 6.39 6.51 6.73 6.84 6.77 6.64
GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION 7.66 7.61 7.66 7.92 7.85 7.91 7.8 8.03 7.88 7.59 7.61 7.76 7.77 7.84 7.58 7.72 7.84 7.73 7.65 8.07 7.62 7.78 7.76 7.88 7.77 7.73
GOBP_RAP_PROTEIN_SIGNAL_TRANSDUCTION 8.25 8.6 7.8 7.09 8.97 8.94 8.81 8.52 8.67 8.65 8.19 8.62 8.75 8.81 8.6 8.58 8.05 8.34 8.75 8.71 8.31 8.3 8.81 8.97 8.64 8.4
GOBP_CDC42_PROTEIN_SIGNAL_TRANSDUCTION 6.71 7.4 6.65 6.48 6.91 7.88 7.7 7.74 7.6 7.47 7.62 7.38 7.39 7.56 7.49 7.66 6.57 7.17 7.27 7.59 6.99 7.91 7.72 8.28 7.8 7.68
GOBP_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN 5.54 5.56 4.98 5.17 5.5 5.48 4.78 4.88 5.37 5.07 5.4 4.83 5.19 5.25 5.26 5.05 4.83 5.33 5.34 5.17 5.84 5.04 5.21 5.08 5.14 5.77
GOBP_RESPONSE_TO_PEPTIDOGLYCAN 5.45 5.48 5.7 5.63 5.07 5.08 4.86 5.13 5.47 5.16 5.31 4.86 5.24 5.23 5.2 5.36 5.05 5.24 5.05 5.17 5.42 5.42 5.16 5.16 4.97 5.29
GOBP_RESPONSE_TO_MURAMYL_DIPEPTIDE 6.36 6.23 6.48 6.16 6.52 6.54 6.9 6.91 6.72 7.07 6.6 7.16 6.95 6.7 6.77 6.86 6.61 6.38 6.36 6.73 6.33 6.78 7.15 7.1 6.7 6.88
GOBP_MULTICELLULAR_ORGANISM_REPRODUCTION 5.87 5.8 5.94 5.98 5.7 5.67 5.69 5.69 5.75 5.78 5.92 5.81 5.72 5.71 5.88 5.89 5.8 5.85 5.78 5.7 5.86 5.8 5.7 5.68 5.78 5.87
GOBP_CYTOKINETIC_PROCESS 6.53 6.46 7.11 6.93 6.78 6.82 7 6.71 6.76 6.69 6.73 6.86 6.95 7.02 7.11 6.9 6.48 6.49 6.54 6.77 6.49 6.83 7.25 7.44 6.91 6.7
GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL 7.71 7.73 8.03 7.84 7.96 8.18 8.07 8.01 7.92 8.1 8.08 8.2 7.95 8.11 8.18 8.14 7.99 7.78 7.96 8.04 7.86 8.13 8.13 8.28 8.23 8
GOBP_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY 7.69 7.94 8.8 8.66 8.13 8.06 8.04 8.12 7.67 8 8.06 7.87 7.98 7.95 8.05 8.08 7.47 7.62 8.18 7.77 7.69 8.03 8.1 8.23 7.79 7.47
GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY 7.46 7.75 8.79 8.66 7.89 7.93 7.75 7.86 7.49 7.55 8.02 7.55 7.44 7.51 7.96 7.72 7.39 7.52 7.65 7.49 7.49 7.63 7.89 8.08 7.51 7.35
GOBP_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY 6.94 6.81 7.49 6.88 6.86 7.17 7.11 7.27 7 7.23 7.18 7.37 7.16 7.13 7.3 7.07 7.11 7.01 7.23 7.54 7.56 7.6 7.67 7.49 7.48 7.49
GOBP_RESPONSE_TO_RETINOIC_ACID 5.69 5.51 5.7 5.72 5.57 5.32 5.55 5.48 5.6 5.37 5.64 5.36 5.46 5.41 5.55 5.74 5.51 5.5 5.47 5.5 5.71 5.83 5.55 5.43 5.57 5.58
GOBP_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM 8.41 8.56 8.74 8.6 8.74 9 8.93 8.62 8.96 8.94 8.49 8.86 8.93 8.96 8.76 8.77 8.48 8.3 8.7 8.93 8.35 8.6 8.89 9.05 8.96 8.65
GOBP_MICROVILLUS_ORGANIZATION 7.79 7.95 7.7 7.08 8.59 8.56 8.28 7.82 8.65 8.36 7.88 8.63 7.98 8.16 7.78 7.89 7.96 7.69 7.97 8.1 7.6 7.67 8.5 8.29 8.12 7.55
GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION 7.61 7.16 7.42 6.23 7.22 7.86 8.2 7.21 7.62 7.78 7.7 7.93 7.86 7.64 7.66 7.4 7.48 6.56 7.34 7.91 6.41 6.69 7.81 8.08 6.59 7.45
GOBP_REGULATION_OF_CELLULAR_COMPONENT_SIZE 6.95 7.08 7.28 7.02 7.33 7.36 7.48 7.48 7.29 7.39 7.13 7.39 7.51 7.56 7.51 7.42 7.21 7.14 7.24 7.47 7.24 7.42 7.29 7.59 7.31 7.29
GOBP_REGULATION_OF_CELL_PROJECTION_SIZE 5.94 5.7 5.56 5.78 5.94 5.57 5.44 5.54 5.61 5.51 5.94 5.87 5.7 5.54 5.62 5.44 6.2 5.59 5.74 5.78 5.63 5.68 5.49 5.37 5.54 5.77
GOBP_MITOCHONDRIAL_TRANSLATION 6.59 6.71 7.76 7.65 6.93 7.04 7.07 7.2 7.01 7.21 7.39 7.02 7.15 7.17 7.21 7.34 6.88 6.74 6.74 7.21 6.96 7.08 7.02 7.3 6.95 6.94
GOBP_RESPONSE_TO_PROGESTERONE 6.35 6.18 6.39 6.2 6.24 6.12 6.26 6.25 6.36 6.25 6.1 5.87 6.35 6.3 6.19 6.07 6.02 6.1 6.12 6.44 6.44 6.67 6.22 6.22 6.34 6.51
GOBP_CHEMOKINE_PRODUCTION 5.54 5.56 5.58 5.97 5.32 5.11 5.07 5.19 5.33 5.26 5.48 5.01 5.34 5.25 5.26 5.41 5.3 5.43 5.31 5.14 5.58 5.37 5.14 5.11 5.5 5.63
GOBP_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION 5.07 4.87 5.26 4.88 4.74 4.73 4.72 4.63 4.89 4.74 4.7 4.6 4.88 4.67 4.68 4.79 4.65 4.71 4.58 4.63 4.62 4.79 4.66 4.56 4.54 4.82
GOBP_TYPE_I_INTERFERON_PRODUCTION 6.6 6.46 6.58 6.54 6.53 6.5 6.4 6.57 6.58 6.55 6.72 6.6 6.4 6.43 6.53 6.57 6.4 6.36 6.57 6.53 6.26 6.31 6.57 6.69 6.48 6.53
GOBP_INTERFERON_ALPHA_PRODUCTION 6.46 6.21 6.34 6.43 6.34 6.07 6.13 6.04 6.44 6.18 6.68 6.26 6.21 6.35 5.86 6.13 6.21 5.59 5.98 6.15 6.32 6.01 5.93 6.08 5.88 6.03
GOBP_INTERFERON_BETA_PRODUCTION 6.08 6.21 6.28 6.21 6.3 6.02 6.09 6.16 6.15 6.18 6.22 6.26 6.16 6.13 5.86 5.9 6.21 5.89 6.25 6.35 6.18 6.03 6.02 6.08 6.09 5.95
GOBP_INTERFERON_GAMMA_PRODUCTION 5.31 5.05 5.07 5.31 4.84 4.82 4.99 4.96 5.09 4.8 5.01 4.75 4.97 4.86 4.93 4.96 4.99 5.25 4.97 4.9 5.16 5 4.85 4.58 5.01 5.01
GOBP_INTERLEUKIN_1_BETA_PRODUCTION 5.33 5.34 5.06 5.16 4.96 4.86 4.75 4.87 5.04 5.02 5 4.72 4.78 4.9 5 5.04 4.85 5.16 5.02 4.88 5.09 5.07 4.83 4.78 5 4.91
GOBP_INTERLEUKIN_1_PRODUCTION 5.33 5.35 5.1 5.23 4.99 4.86 4.79 4.87 5.09 5.02 5.04 4.72 4.82 4.93 5 5.04 4.87 5.16 5.02 4.88 5.09 5.07 4.83 4.78 5.01 4.92
GOBP_INTERLEUKIN_10_PRODUCTION 5.27 5.11 4.96 5.39 4.88 4.87 4.86 4.97 5.14 4.87 5.02 4.67 4.78 4.75 4.94 5.03 4.83 5.06 4.93 4.86 4.94 4.86 4.8 4.57 4.96 4.96
GOBP_INTERLEUKIN_12_PRODUCTION 5.18 5.11 4.98 5.17 4.85 4.9 5.02 4.98 4.93 4.95 5 4.67 4.87 4.8 4.97 4.89 4.86 5.2 4.92 4.83 5.21 5.07 4.86 4.69 5.2 5.26
GOBP_INTERLEUKIN_13_PRODUCTION 5.36 5.43 5.27 5.44 5.19 4.98 5.59 5.28 5.07 4.81 4.98 5.15 5.36 4.86 5.16 5.3 5.46 5.38 5.08 5.22 5.77 5.42 4.89 4.93 5.08 5.6
GOBP_INTERLEUKIN_17_PRODUCTION 5.31 4.89 4.92 5.11 4.84 4.85 4.8 5.1 4.94 4.98 4.93 4.65 5.04 4.8 5.14 4.91 4.83 4.98 4.78 4.77 4.77 5.07 4.97 4.56 5.14 5.06
GOBP_INTERLEUKIN_2_PRODUCTION 5.81 5.68 5.65 5.64 5.5 5.25 5.48 5.48 5.63 5.38 5.6 5.29 5.53 5.34 5.44 5.51 5.58 5.63 5.32 5.39 5.58 5.64 5.35 5.3 5.54 5.56
GOBP_INTERLEUKIN_4_PRODUCTION 5.41 5.4 5.21 5.42 5.25 4.96 5.2 5.32 5.22 4.82 4.97 4.78 5.36 5.03 5.17 5.16 5.11 5.38 5.24 5.16 5.32 5.07 4.87 4.69 5.13 5.34
GOBP_INTERLEUKIN_5_PRODUCTION 5.37 5.39 5.12 5.39 5.04 4.96 4.96 4.98 5.26 4.77 4.97 5.01 4.96 4.84 4.9 5.25 5.29 5.38 5.16 5.07 5.33 5.14 4.83 4.94 4.79 4.89
GOBP_INTERLEUKIN_6_PRODUCTION 5.54 5.51 5.37 5.61 5.35 5.11 5.1 5.21 5.46 5.32 5.42 5.21 5.46 5.34 5.31 5.32 5.35 5.43 5.14 5.17 5.54 5.39 5.24 5.24 5.37 5.53
GOBP_INTERLEUKIN_8_PRODUCTION 5.45 5.33 5.26 5.41 4.95 4.94 5.02 5.02 5.33 5.07 5.43 4.98 5.29 5.14 5.26 5.2 5.06 5.37 5.04 4.87 5.45 5.39 5.14 4.96 5.14 5.29
GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION 5.86 5.73 5.86 6.33 5.5 5.37 5.85 5.57 5.95 5.32 6.12 5.42 5.41 5.44 5.51 5.71 5.68 5.49 5.47 6.13 5.78 5.87 5.88 5.59 5.53 5.36
GOBP_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION 5.53 5.47 5.47 5.77 5.1 5.45 5.54 5.96 5.58 5.29 5.75 5.55 5.71 5.59 5.54 5.3 5.86 5.7 5.38 5.29 5.24 5.53 5.51 5.03 5.59 5.73
GOBP_NEGATIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION 5.23 5.1 4.68 4.96 4.89 4.94 4.75 4.88 4.98 4.58 4.86 4.67 4.78 4.72 4.82 4.55 5.1 5.26 4.94 5.02 5.06 4.88 4.55 4.53 4.69 4.84
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION 6.08 5.73 6.2 5.96 5.66 5.54 5.6 5.79 5.93 5.42 5.21 5.48 5.99 5.69 5.66 5.5 5.63 5.58 5.31 5.64 5.84 5.77 5.34 5.3 5.3 5.98
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION 5.92 5.69 5.49 4.93 5.51 5.43 5.02 5.28 5.67 5.11 5.14 4.81 5.47 5.32 5.23 5.25 5.46 5.37 5.13 5.21 5.3 5.52 5.26 5.16 5.01 5.19
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION 5.11 4.92 4.84 5.14 4.71 4.56 4.82 4.84 4.67 4.54 4.79 4.67 4.62 4.53 4.56 4.7 4.76 4.77 4.81 4.8 4.86 4.83 4.44 4.36 4.55 4.86
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION 4.97 5.02 4.92 4.93 4.84 4.71 4.69 4.88 4.84 4.55 4.86 4.61 4.71 4.63 4.97 4.75 4.83 5.2 4.9 4.87 5.18 4.86 4.86 4.53 4.98 4.96
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION 5.38 5.65 5.36 5.52 5.48 5.35 5.44 5.27 5.61 5.41 5.26 4.99 5.51 5.45 5.5 5.32 5.08 5.46 5.27 5.29 5.6 5.51 5.14 5.24 5.44 5.75
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION 5.84 5.68 5.64 5.56 5.34 4.96 5.27 5.32 5.46 5.35 5.66 5.27 5.15 5.18 5.44 5.31 5.51 5.63 5.08 5.22 5.59 5.83 5.18 5.05 5.26 5.53
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION 5.58 5.49 5.38 5.52 5.32 5.18 5.3 5.27 5.69 5.41 5.28 5.29 5.45 5.26 5.5 5.3 5.39 5.6 5.17 5.19 5.58 5.32 5.25 5.27 5.52 5.38
GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION 5.92 5.73 5.83 5.97 4.91 5.53 5.88 5.57 5.61 5.29 6.12 5.38 5.64 5.32 5.75 5.82 5.92 5.37 5.43 5.52 5.62 6.05 5.76 5.39 5.53 5.64
GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION 5.54 5.37 5.02 5.52 5.03 4.97 5.03 4.99 5.17 5.05 5.36 4.82 5.26 5 5.16 5.04 5.15 5.26 5.07 5.11 5.44 5.17 4.99 5.1 5.29 5.45
GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION 5.03 4.85 5.06 5.06 4.82 4.77 5.02 5.09 4.92 4.95 5 4.67 4.98 4.8 4.92 4.85 4.64 4.67 4.7 4.7 4.63 4.77 4.8 4.57 5.08 4.97
GOBP_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION 6.51 6.44 6.83 6.74 7.09 6.62 6.77 6.82 6.52 6.55 6.9 6.88 6.88 6.8 6.88 6.57 6.76 6.52 6.79 6.93 6.78 7.07 6.74 6.84 6.42 6.74
GOBP_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION 6.25 6.39 6.34 6.33 6.34 6.21 6.13 6.17 6.48 6.24 6.33 6.29 6.21 6.2 6.04 6.13 6.21 5.9 6.28 6.47 6.2 6.05 6.31 6.19 6.12 6.26
GOBP_POSITIVE_REGULATION_OF_INTERFERON_GAMMA_PRODUCTION 5.44 5.05 5.19 5.45 4.84 4.89 5.08 5.05 5.09 4.94 5.26 4.77 5.05 4.96 5.05 5.05 4.99 5.28 4.99 4.88 5.22 5.09 5.02 4.73 5.25 5.33
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION 4.98 5.06 4.94 5.29 4.68 4.71 4.67 4.71 4.91 4.55 4.91 4.61 4.69 4.83 4.88 4.8 4.83 4.81 4.98 4.73 4.98 4.81 4.68 4.57 4.97 4.86
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION 5.44 5.14 4.94 5.42 4.91 4.91 4.81 4.89 5.03 4.91 5.06 4.63 4.88 4.77 4.99 5.02 4.78 5.16 4.95 4.84 5.05 4.85 4.83 4.63 4.99 4.94
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION 5.27 4.93 4.89 5.08 4.81 4.78 4.83 4.87 4.93 4.92 4.94 4.64 4.86 4.78 4.9 4.96 4.83 5.07 4.91 4.72 5.12 4.84 4.66 4.65 5.03 5.08
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION 5.06 4.82 4.46 4.93 4.37 4.15 4.57 4.46 4.85 4.43 4.86 4.4 4.24 4.5 4.3 4.56 4.74 4.68 4.52 4.38 4.61 4.32 4.37 3.95 4.53 4.37
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION 5.67 5.56 5.63 5.41 5.53 5.47 5.48 5.64 5.63 5.45 5.36 5.68 5.61 5.48 5.48 5.61 5.63 5.52 5.36 5.43 5.49 5.66 5.55 5.42 5.6 5.59
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION 5.4 5.26 5.01 5.37 5.14 4.95 5.15 5.05 4.95 4.79 4.93 4.65 5.06 4.92 4.99 5.07 5.06 5.23 5.04 4.91 5.07 4.85 4.83 4.55 5.06 5.11
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION 5.48 5.42 5.29 5.52 5.27 4.99 5.03 5.11 5.32 5.09 5.43 4.98 5.36 5.27 5.25 5.29 5.18 5.34 5.11 5.14 5.34 5.23 5.14 5.08 5.2 5.27
GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION 5.47 5.35 5.22 5.48 5.06 4.94 5.23 5.09 5.33 5.14 5.51 4.98 5.36 5.3 5.31 5.3 5 5.46 5.04 4.9 5.49 5.33 5.17 4.96 5.52 5.31
GOBP_REGULATION_OF_MONOOXYGENASE_ACTIVITY 6.09 6.06 6.61 6.61 6.14 5.95 5.91 6.29 6.24 6.4 6.61 6.6 6.03 6.17 6.44 6.36 6.22 6.18 6 6.14 6.11 5.97 6.13 6.13 6.51 6.36
GOBP_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY 6.33 6.58 6.35 6.74 6.57 6.98 6.17 6.64 6.71 6.8 6.36 6.9 6.71 6.66 5.96 6.53 6.58 6.36 6.67 6.3 6.5 6.6 6.94 6.89 6.72 6.64
GOBP_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY 5.86 5.75 5.64 5.3 5.08 5.29 5.44 5.29 5.4 5.37 5.56 5.61 5.37 5.48 5.35 5.39 5.47 5.62 5.51 5.34 5.54 5.28 5.22 4.8 5.36 5.43
GOBP_NEGATIVE_REGULATION_OF_ATPASE_ACTIVITY 6.53 6.77 6.63 7.61 6.64 6.29 6.73 6.49 6.8 6.56 6.56 6.77 6.75 6.66 7.02 7.04 6.88 6.72 6.56 6.71 6.77 6.6 8.02 7.1 6.99 6.54
GOBP_POSITIVE_REGULATION_OF_ATPASE_ACTIVITY 7.53 7.33 7.63 7.79 7.73 7.86 7.37 7.35 7.78 7.86 7.8 7.79 7.86 7.9 7.6 7.82 7.72 7.04 7.68 7.56 7.51 7.38 7.9 7.86 7.72 7.48
GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION 7.11 7.23 7.69 7.38 7.9 8.17 7.53 7.46 7.74 8.05 7.84 7.85 7.91 7.82 7.96 7.66 7.6 7.52 7.6 7.53 7.43 8.06 7.9 8.26 8.12 8.04
GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION 6.32 5.9 6.65 6.65 6.7 6.56 6.48 6.45 6.27 6.61 6.71 6.54 6.51 6.4 6.21 7.11 6.83 6.03 6.17 6.41 6.8 7.07 6.47 6.69 5.9 6.95
GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION 7.97 7.86 8.17 7.58 8.12 8.21 8.3 8.31 7.81 8.25 8.16 7.96 8.36 8.08 8.05 7.86 7.67 8.16 8.32 8.37 8.05 8.19 7.92 8.3 8.34 8.46
GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS 6.36 6.35 6.78 6.72 6.45 6.45 6.5 6.49 6.46 6.53 6.52 6.51 6.58 6.44 6.43 6.54 6.48 6.4 6.35 6.59 6.54 6.55 6.44 6.57 6.55 6.6
GOBP_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY 7.59 7.23 7.17 7.29 7.8 8.03 7.59 7.93 7.37 7.34 7.42 7.7 7.97 7.99 7.77 7.73 7.49 7.47 7.9 7.95 7.21 7.56 7.25 7.77 7.2 7.38
GOBP_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_PARTICLE_METABOLIC_PROCESS 8.66 9.2 9.32 9.1 8.84 8.83 9.32 9.71 9.14 8.69 9.01 8.87 9.15 9.17 9.61 9.56 9.27 9.32 9.12 9.34 9.41 9.49 8.9 9.3 9.55 9.54
GOBP_RECEPTOR_CATABOLIC_PROCESS 8.2 8.43 8.39 8.42 8.54 8.43 7.93 8.16 8.72 8.09 8.47 8.31 8.11 8.75 8.76 8.44 7.75 7.71 8.21 8.34 7.9 8.26 8 8.51 8.72 8.34
GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION 6.06 6.03 6.24 6.18 5.64 5.84 5.86 5.86 6.09 5.76 5.75 5.82 5.93 5.89 5.96 5.8 5.83 5.77 5.91 5.97 6.23 5.85 5.82 5.79 6.2 6.13
GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION 6.3 6.49 6.53 6.77 6.2 6.66 6.67 6.73 6.59 6.21 6.24 6.12 6.33 6.21 6.42 6.6 6.81 6.35 6.49 6.93 6.89 7.16 6.16 6.61 6.48 6.96
GOBP_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION 5.85 5.93 5.74 5.83 5.61 5.86 5.91 6.11 6.06 5.43 5.72 5.55 5.64 5.58 5.61 5.86 5.73 5.57 5.59 5.58 6.18 6.52 5.44 5.51 5.31 5.98
GOBP_GLOMERULUS_DEVELOPMENT 6.09 6.14 6.05 5.99 6.1 6.16 6.27 6.16 6.21 6.35 6.07 6.31 6.49 6.42 6.37 6.31 6.46 6.41 6.05 6.15 6.48 6.21 6.53 6.48 6.34 6.38
GOBP_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT 5.61 5.53 5.63 5.45 6.2 6.24 6.34 6.12 6.21 6.04 5.83 6.02 6.47 5.95 6.33 6.2 5.85 5.56 5.81 5.89 5.97 5.85 6.63 6.39 6.15 5.58
GOBP_RESPONSE_TO_INSULIN 6.77 7.02 7.43 7.23 7.29 7.26 7.17 7.2 7.38 7.29 7.21 7.25 7.25 7.31 7.36 7.27 7.13 6.94 7.15 7.3 7.15 7.22 7.44 7.47 7.32 7.34
GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS 7.13 7.14 7.54 7.47 7.65 7.58 7.56 7.38 7.6 7.59 7.36 7.39 7.53 7.56 7.59 7.51 7.29 7.11 7.48 7.46 7.37 7.4 7.65 7.74 7.66 7.52
GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS 6.69 6.67 7.13 6.88 7.05 7.03 6.93 6.91 7.02 7.03 6.89 6.93 6.94 7.02 7.06 6.99 6.97 6.83 6.83 7 6.9 7 7.09 7.11 6.96 7
GOBP_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY 7.2 7.34 7.91 7.81 7.55 7.71 7.71 7.51 7.7 7.68 7.62 7.89 7.73 7.71 7.86 7.51 7.43 6.98 7.12 7.67 7.38 7.74 7.97 7.82 7.74 7.48
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION 6.94 7.07 7.37 7.19 7.23 7.21 7.24 7.31 7.23 7.25 7.18 7.29 7.31 7.27 7.26 7.32 7.17 7.12 7.13 7.29 7.15 7.32 7.31 7.41 7.33 7.35
GOBP_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS 6.51 6.63 6.71 6.82 6.75 6.96 7.02 7.11 6.95 7.02 6.5 6.85 7.1 6.92 7.01 7.08 6.78 6.89 6.76 6.97 6.73 6.84 7.16 6.86 6.83 6.73
GOBP_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS 6.56 6.65 6.4 6.74 7.12 7 6.99 7.29 7.01 7.05 6.54 6.93 7.31 6.97 7.22 7.2 6.81 6.91 6.8 7.07 6.82 6.85 7.28 7.34 6.91 6.98
GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS 6.98 6.89 7.18 7.04 7.15 7.23 7.09 7.2 7.12 7.1 7.2 7.23 7.15 7.11 7.16 7.23 7.07 6.9 7.03 7.11 7.05 7.11 7.15 7.22 7.11 7.06
GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT 6.07 6.18 5.99 6.14 6.03 5.99 5.98 6.32 6.2 6.53 6.27 6.04 6.04 6.13 6.4 6.31 6.47 6.18 6.08 6.04 6.07 6.24 6.33 6.31 6.22 6.49
GOBP_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT 7.34 7.47 7.65 7.57 7.42 7.58 7.91 7.65 7.8 7.78 7.62 7.74 7.96 7.92 7.9 7.54 7.12 7.58 7.66 8.02 7.91 7.76 7.57 7.89 7.76 7.69
GOBP_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT 5.5 5.51 5.5 5.72 5.08 4.87 5.46 5.58 5.32 5.14 5.49 5.42 5.33 5.48 5.37 5 5.34 5.34 5.27 5.15 5.54 5.8 5.16 5.22 5.63 5.65
GOBP_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION 6.29 6.4 6.53 6.25 6.49 6.46 6.38 6.39 6.1 6.27 6.13 6.54 6.3 6.25 6.2 6.42 6.01 6.15 6.12 6.41 6.29 6.72 6.23 6.51 6.38 6.89
GOBP_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION 6.06 6.07 6.23 6.25 5.98 6.1 6.49 6.65 6.44 6.15 6.05 6.05 6.21 6.29 6.33 6.01 6.32 6.26 6.03 6.33 6.89 6.88 6.79 6.35 6.83 7.04
GOBP_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION 7.59 7.76 7.86 7.83 7.89 8.05 8.27 7.84 7.97 7.99 7.74 7.99 8 8.13 8.04 7.9 7.79 7.62 8.01 8.04 7.86 7.99 7.9 8.29 8.04 7.89
GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY 5.95 5.96 6.32 6.06 5.95 5.9 6.09 6.07 6.13 5.92 6.22 5.77 6.15 6.05 5.85 6.05 5.83 5.93 5.8 6.13 6.38 6.03 6.02 6.15 5.76 6.03
GOBP_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY 5.98 6 6.28 6.2 5.99 6 6.12 6.05 6.18 6.3 6.23 5.94 6.22 6.05 6.22 6.12 6.16 6.1 5.86 6.23 6.39 6.12 6.02 6 5.95 6.06
GOBP_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY 6.77 6.81 6.7 6.45 6.49 6.69 6.58 6.77 6.54 6.6 6.86 6.39 6.56 6.68 6.27 6.57 6.79 6.82 6.65 6.61 6.7 6.53 6.57 6.42 6.32 6.45
GOBP_REGULATION_OF_SUPEROXIDE_ANION_GENERATION 6.06 5.61 6.44 6.24 5.74 5.79 5.76 5.6 6.23 5.72 5.66 5.56 5.84 5.7 6.29 6.19 5.72 5.98 5.36 5.86 6.47 6.79 6.02 5.92 6.81 6.28
GOBP_SECRETION_BY_TISSUE 5.9 5.84 6.07 6.58 5.61 5.84 6.44 6.21 6.3 6.2 5.97 6.04 6.17 6.02 6.51 6.45 6.07 6.31 6.13 5.93 6.5 6.54 6.59 6.09 5.8 6.5
GOBP_INOSITOL_TRISPHOSPHATE_METABOLIC_PROCESS 6.46 6.13 6.01 6.05 5.9 6.27 6.64 6.17 6.55 6.08 5.96 5.75 6.49 6.68 5.94 6.04 5.76 6.27 5.93 6.36 5.92 6.01 6.68 6.16 5.94 6.12
GOBP_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS 6.16 5.55 5.82 5.89 5.98 6.22 5.79 5.8 6 5.68 5.73 5.65 5.77 5.78 5.75 5.67 5.74 5.72 5.75 5.83 5.92 6.09 5.92 5.5 5.81 6.16
GOBP_COLLAGEN_METABOLIC_PROCESS 5.54 5.45 5.43 5.51 5.26 5.07 5.3 5.37 5.36 5.23 5.42 5.17 5.22 5.21 5.49 5.47 5.39 5.46 5.18 5.29 5.64 5.51 5.41 5.19 5.35 5.48
GOBP_COLLAGEN_BIOSYNTHETIC_PROCESS 5.54 5.36 5.49 5.55 5.59 5.38 5.42 5.48 5.51 5.38 5.49 5.28 5.33 5.32 5.57 5.55 5.51 5.55 5.19 5.3 5.68 5.49 5.53 5.02 5.38 5.56
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER 7.97 7.86 8.27 7.58 8.12 8.21 8.3 8.31 7.81 8.25 8.23 7.96 8.36 8.08 8.22 7.86 7.67 8.16 8.32 8.37 8.1 8.19 7.92 8.3 8.34 8.47
GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS 6.71 6.74 6.99 6.74 7.03 7.1 7.15 7.2 7 7.11 6.86 7.11 7.1 6.97 7.16 7.02 7.02 6.91 6.84 7.13 7.07 7.02 7.1 7.19 7.18 7.18
GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY 7.1 7.17 7.81 7.6 7.37 7.45 7.5 7.63 7.57 7.46 7.49 7.45 7.45 7.55 7.6 7.64 7.2 7.17 7.22 7.44 7.24 7.65 7.65 7.73 7.51 7.4
GOBP_PROTEIN_DNA_COMPLEX_DISASSEMBLY 7.51 8.2 7.61 7.39 8.38 8.19 8.42 8.31 8.08 8.17 7.68 8.28 7.66 8.38 8.06 7.93 7.52 7.8 7.77 8.35 8.1 7.88 8.22 8.29 8.23 8
GOBP_CELLULAR_COMPONENT_MORPHOGENESIS 7.18 7.21 7.36 7.05 7.5 7.53 7.58 7.65 7.45 7.6 7.26 7.6 7.63 7.69 7.61 7.58 7.39 7.37 7.43 7.64 7.33 7.6 7.51 7.73 7.57 7.49
GOBP_CELL_PART_MORPHOGENESIS 7.32 7.37 7.5 7.1 7.69 7.67 7.76 7.78 7.62 7.69 7.46 7.73 7.76 7.8 7.76 7.77 7.45 7.49 7.57 7.8 7.48 7.79 7.71 7.89 7.69 7.61
GOBP_MUSCLE_CELL_PROLIFERATION 6.44 6.41 6.48 6.46 6.62 6.52 6.3 6.36 6.75 6.63 6.43 6.49 6.75 6.69 6.51 6.53 6.61 6.38 6.46 6.26 6.46 6.46 6.72 6.52 6.54 6.64
GOBP_REGULATION_OF_MAST_CELL_ACTIVATION 5.66 5.75 5.88 5.67 5.21 5.25 5.44 5.41 5.68 5.18 5.42 5.21 5.39 5.41 5.41 5.4 5.5 5.73 5.35 5.35 5.56 5.45 5.31 5.31 5.66 5.83
GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION 5.43 5.98 6 5.54 5.05 4.95 5.54 5.12 5.41 4.84 5.1 4.76 5.11 5.39 5 5.13 5.3 5.85 5 5.16 5.83 5.21 5.07 4.99 5.53 5.8
GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION 5.54 5.69 5.61 5.57 5.53 5.35 5.45 5.5 5.32 5.16 5.38 5.13 5.65 5.45 5.43 5.4 5.44 5.66 5.46 5.4 5.89 5.57 5.4 5.31 5.61 5.96
GOBP_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 5.69 5.8 5.92 5.83 5.21 5.25 5.46 5.41 5.78 5.32 5.44 5.21 5.39 5.41 5.46 5.41 5.6 5.85 5.35 5.35 5.56 5.45 5.31 5.31 5.73 5.9
GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE 5.69 5.69 5.63 6.23 5.59 5.37 5.83 5.75 5.68 5.64 5.46 5.35 5.72 5.6 5.56 5.52 6.48 5.98 5.46 5.4 6.08 5.83 5.69 5.52 5.96 6.18
GOBP_TETRAPYRROLE_METABOLIC_PROCESS 6.28 6.45 7.06 6.85 6.6 6.49 6.7 6.83 6.57 6.64 6.51 6.34 6.8 6.6 6.4 6.63 6.49 6.38 6.47 6.67 6.35 6.56 6.61 6.9 6.74 6.8
GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS 6.66 7.04 7.47 7.02 6.97 7.14 6.97 7.13 7.22 7.07 6.84 7.16 7.26 7.21 7.08 6.92 7.27 6.75 6.73 7.05 6.68 7.11 6.85 7.45 7.46 7.54
GOBP_MYELOID_CELL_APOPTOTIC_PROCESS 6.31 6.53 6.57 6.77 6.6 6.6 6.74 6.97 6.62 6.62 6.76 6.67 7.01 6.99 6.91 6.57 6.53 6.72 6.25 6.71 6.91 7.15 7.06 7.03 6.7 6.63
GOBP_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS 6.31 6.53 6.57 6.62 7 6.66 6.74 6.76 6.62 6.64 6.49 6.67 7.2 7.04 7.41 7.43 6.53 6.72 6.33 6.39 6.91 6.7 7.11 7.31 6.58 6.63
GOBP_REGULATION_OF_ORGANELLE_ORGANIZATION 6.96 7.05 7.32 7.18 7.32 7.31 7.21 7.3 7.12 7.29 7.1 7.26 7.25 7.26 7.29 7.26 7.18 7.09 7.14 7.35 7.21 7.34 7.3 7.42 7.27 7.3
GOBP_REGULATION_OF_CHROMOSOME_ORGANIZATION 6.83 6.88 7 7.04 7.12 7.21 7.05 7.14 6.98 7.26 6.91 7.1 7.06 7.13 7.15 7.15 6.87 6.86 6.97 7.13 6.94 7.14 7.19 7.26 7.12 7.18
GOBP_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION 5.83 5.93 5.97 5.76 5.71 5.77 5.64 5.81 5.51 5.84 5.65 5.79 5.59 5.56 5.6 5.7 5.63 5.52 5.76 5.49 5.44 5.69 5.5 5.7 5.72 6.08
GOBP_CELLULAR_PIGMENTATION 6.71 6.73 7.14 7.36 6.72 7.03 6.91 6.99 7.12 7.14 7.06 7.08 7.01 7.07 7.19 7.07 6.67 7 6.55 7.06 6.78 7.16 7.25 7.44 7.02 7.01
GOBP_T_CELL_DIFFERENTIATION_IN_THYMUS 5.8 5.78 5.83 5.93 5.51 5.61 5.76 5.82 5.99 5.74 6.08 5.81 6.08 5.95 5.92 5.75 5.87 5.85 5.61 5.6 5.9 5.89 5.89 5.78 5.78 5.89
GOBP_IMMATURE_T_CELL_PROLIFERATION 5.38 5.43 5.59 5.44 5.13 4.75 5.05 5.11 5.27 5.15 5.84 5.13 5.22 5.23 5.61 5.07 5.49 5.31 5.16 5.09 5.45 5.03 5.02 4.64 5.04 5.28
GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS 5.83 6 6.18 6.27 5.92 5.95 6.18 6.07 6 6.08 6.26 6.09 6.15 6.3 6.31 6.6 6.19 5.99 5.86 6.24 6.18 6.41 6.19 6.25 5.78 6.43
GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY 7.37 7.65 8.96 8.8 7.93 7.81 8.2 8.13 8.05 8.06 8.56 8.22 8.03 8.19 8.41 8.5 8.02 7.97 8.07 8.15 8.12 8.5 8.06 8.36 8.03 8.3
GOBP_NEGATIVE_REGULATION_OF_RNA_SPLICING 7.63 8.22 8.47 8.34 8.64 8.64 8.46 8.69 8.31 8.43 7.94 8.68 8.38 8.17 8.27 8.54 8.44 8.23 8.3 8.65 8.19 8.7 8.54 8.68 8.67 8.88
GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING 8.5 9 8.71 8.49 8.81 8.85 8.91 8.84 8.95 9.04 8.75 8.93 9.24 9.28 9.24 9.21 8.79 8.92 8.93 8.97 8.61 9.02 9.16 9.13 9.18 9.09
GOBP_REGULATION_OF_HISTONE_PHOSPHORYLATION 7.34 7.16 7.89 8.16 8.08 8.2 7.38 7.86 7.72 8.21 7.8 8.1 8.04 7.93 8.21 8.13 7.8 7.47 7.82 7.8 7.42 8.43 8.33 8.05 7.78 8.01
GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION 6.37 6.37 6.42 6.35 6.4 6.46 6.35 6.59 6.53 6.58 6.51 6.6 6.53 6.5 6.55 6.51 6.51 6.4 6.51 6.38 6.6 6.67 6.37 6.52 6.51 6.81
GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION 6.26 6.41 6.57 6.91 6.45 6.51 6.27 6.49 6.94 6.92 6.89 6.87 6.68 6.76 6.78 6.43 6.54 6.55 6.88 6.77 6.59 6.62 6.93 6.72 6.72 6.9
GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION 6.3 6.32 6.34 6.08 6.2 6.2 6.34 6.44 6.19 6.21 6.29 6.36 6.32 6.16 6.5 6.49 6.38 6.25 6.26 6.14 6.57 6.66 6.16 6.33 6.11 6.64
GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN 4.21 4.2 3.97 4.2 3.77 3.69 3.85 4.24 4.01 3.58 3.89 4.24 3.79 3.7 3.79 3.85 4.08 4.36 4.11 3.88 4.37 3.95 3.74 3.61 3.79 3.9
GOBP_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY 7.02 7.21 7.26 7.36 7.45 7.59 7.49 7.56 7.41 7.58 7.27 7.36 7.46 7.4 7.74 7.54 7.56 7.31 7.42 7.61 7.29 7.5 7.55 7.48 7.61 7.37
GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY 6.61 6.58 6.81 7.19 7.3 7.4 7.17 7.26 7.1 7.05 6.73 6.96 7.11 7.11 7.18 7.3 7.11 6.89 7.06 7.06 6.97 6.91 7.09 7.42 7.18 7.02
GOBP_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY 6.99 7.51 7.53 7.71 7.84 7.75 7.87 7.55 7.88 7.75 7.5 7.68 7.88 7.94 7.72 7.55 7.56 7.3 7.73 7.87 7.33 7.57 8.13 7.91 7.9 7.41
GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY 6.38 6.11 6.98 7.19 6.27 6.23 7.15 7.22 6.48 6.32 6.25 6.25 6.63 6.51 6.71 6.8 6.56 6.58 6.04 6.77 6.79 6.66 6.62 6.85 7.2 6.73
GOBP_V_D_J_RECOMBINATION 6.18 6.54 6.46 5.89 6.73 6.99 6.78 6.94 6.3 6.48 7.01 6.73 6.79 6.62 6.64 6.52 5.93 6.36 6.65 6.84 6.33 6.66 6.38 6.8 6.63 6.65
GOBP_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT 7.37 7.38 7.97 7.79 7.71 7.78 7.87 7.93 7.68 7.81 7.75 7.83 7.83 7.78 7.86 7.86 7.62 7.48 7.56 7.86 7.62 8.06 7.88 7.91 7.94 7.74
GOBP_HISTONE_H3_K9_DEMETHYLATION 6.75 6.72 6.54 6.82 7.23 6.97 6.61 6.98 6.96 6.98 6.64 7.08 7.06 6.87 7.16 6.68 6.88 6.66 7 6.85 6.9 7.01 6.87 7.17 6.73 7.21
GOBP_REGULATION_OF_HISTONE_UBIQUITINATION 7.91 8.15 7.98 7.91 8.16 8.27 8.15 8.22 8.14 8.12 8.14 7.99 8.16 8.22 8.3 8.38 8.12 7.97 8.48 8.13 8.22 8.25 8.06 8.38 8.33 8.32
GOBP_RESPONSE_TO_VITAMIN_A 5.53 5.33 5.28 5.9 4.88 4.89 5.05 5.23 5.28 5.51 5.43 5.22 5.17 5.24 5.46 5.36 5.48 5.19 5.34 5.11 5.32 5.26 5.43 4.89 5.2 5.13
GOBP_RESPONSE_TO_HYDROPEROXIDE 6.57 6.96 7.18 6.88 6.96 7.25 6.78 7.04 7.11 6.97 7.36 7.15 7.58 7.69 7.32 7.46 7.21 6.8 7.1 7.13 6.86 7.08 7.69 7.49 7.62 7.26
GOBP_RESPONSE_TO_VITAMIN_E 6.41 6.49 6.83 6.45 7.16 7.13 7.17 7.31 6.11 7.03 6.41 6.62 6.69 6.71 6.86 6.93 6.94 6.68 6.73 7.21 6.54 6.96 6.93 6.77 6.57 7.07
GOBP_RESPONSE_TO_ATP 5.86 5.93 5.6 6 5.81 5.65 5.77 5.84 5.74 5.72 5.87 5.75 5.66 5.66 5.74 5.68 6.1 5.93 5.76 5.59 5.88 5.8 5.51 5.83 5.81 5.75
GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY 6.39 6.42 6.31 6.47 6.27 6.28 6.16 6.25 6.31 6.31 6.45 6.22 6.28 6.35 6.31 6.37 6.4 6.19 6.18 6.28 6.38 6.36 6.21 6.21 6.4 6.49
GOBP_LEPTIN_MEDIATED_SIGNALING_PATHWAY 6.35 6.6 8.01 8.1 7.15 7.16 6.95 7.48 7.41 7.24 7.11 7.16 7.24 7.15 7.8 7.44 6.47 6.75 6.73 7.06 6.91 6.82 7.75 7.45 7.02 6.9
GOBP_IRON_IMPORT_INTO_CELL 5.66 5.59 5.89 6.24 5.57 5.92 5.72 5.52 5.75 5.78 5.69 5.52 6.01 6.12 5.47 5.57 6.02 6.03 5.74 5.9 5.85 5.83 5.5 5.5 5.72 5.91
GOBP_REGULATION_OF_PROTEIN_SUMOYLATION 7.27 7.35 7.55 7.47 7.81 7.92 7.86 7.9 7.94 7.6 7.28 7.5 7.86 7.62 7.7 7.76 7.58 7.13 7.58 8.09 7.21 7.9 7.45 7.64 7.97 7.59
GOBP_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION 7.01 7.34 7.15 7.1 7.79 7.72 7.08 7.08 7.01 7.35 7.14 6.91 7.15 6.76 7.15 7.39 7.5 6.91 7.45 8.04 6.86 7.01 6.77 7.35 7.65 7.35
GOBP_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS 7.61 7.9 8.59 8.42 8.06 8.2 8.26 8.15 8.41 8.4 8.4 8.24 8.33 8.3 8.48 8.27 7.74 7.66 7.85 8.28 7.74 8.07 8.62 8.69 8.35 7.97
GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION 5.43 5.27 6.04 5.68 5.39 5.44 5.55 5.66 5.63 5.32 5.6 5.68 5.28 5.26 5.76 5.81 5.54 5.46 5.6 5.28 5.47 5.76 5.22 5.43 5.66 5.35
GOBP_RESPONSE_TO_VITAMIN 5.87 5.87 5.8 5.99 5.94 5.86 5.85 5.73 6.05 6.05 5.77 5.62 5.79 5.74 5.57 5.85 6.07 5.64 5.71 5.79 5.92 6.04 5.96 5.88 5.8 6.08
GOBP_RESPONSE_TO_VITAMIN_D 5.67 5.57 5.59 5.62 5.81 5.68 5.67 5.52 5.96 6.12 5.28 5.27 5.8 5.43 5.44 5.74 6.1 5.67 5.32 5.69 5.84 5.85 5.91 5.28 5.6 6.02
GOBP_LEYDIG_CELL_DIFFERENTIATION 6.54 6.99 6.75 6.57 7.05 7.2 6.94 6.65 6.98 7.1 6.7 7.19 7.11 7.15 6.95 6.93 7.15 6.93 6.42 6.94 6.77 6.99 7.19 7.33 7.1 6.99
GOBP_CHOLESTEROL_EFFLUX 6.14 6.55 6.3 6.48 6.09 6.51 6.42 6.65 6.27 6.46 6.29 6.36 6.61 6.44 6.15 6.31 6.3 6.05 6.33 6.44 6.49 6.5 6.25 6.41 6.57 6.74
GOBP_SECRETORY_GRANULE_ORGANIZATION 6.19 6.76 6.8 6.3 6.16 6.02 6.34 5.99 6.19 7 6.79 6.49 6.2 5.93 6.92 6.6 6.38 6.52 6.27 6.28 6.28 6.66 6.79 7.3 6.65 6.09
GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE 7.12 7.21 7.53 7.47 7.43 7.45 7.39 7.43 7.41 7.39 7.33 7.41 7.44 7.48 7.43 7.44 7.27 7.25 7.36 7.44 7.27 7.5 7.5 7.61 7.46 7.39
GOBP_CARBOHYDRATE_HOMEOSTASIS 6.38 6.48 6.86 6.65 6.29 6.34 6.59 6.74 6.59 6.65 6.4 6.61 6.37 6.53 6.75 6.62 6.42 6.55 6.38 6.61 6.71 6.73 6.4 6.61 6.74 6.75
GOBP_HISTONE_H2A_UBIQUITINATION 7.44 7.48 7.73 7.74 7.92 8.15 7.6 7.98 7.88 8.06 7.76 7.98 7.97 8.14 8.33 8.21 7.6 7.72 7.88 7.83 7.51 7.94 8.03 8.36 8.07 8.17
GOBP_HISTONE_H2B_UBIQUITINATION 6.68 6.61 6.81 6.7 7.27 6.97 7.28 7.16 7.44 7.49 6.73 7.41 7.4 7.28 7.44 7.38 6.99 7.01 7.04 7.33 7.27 7.47 7.68 7.65 7.28 7.43
GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE 7.02 6.98 7.39 6.77 7.26 7.16 6.99 7.18 7.06 6.98 6.76 7.11 7.03 7.21 6.79 7.12 6.65 6.88 7.06 7.03 7.2 7.41 7.11 7.38 7.28 7.45
GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE 6.52 6.45 6.49 6.92 6.26 6.49 6.15 5.96 6.13 6.4 6.56 6.46 6.03 6.35 6.35 6.19 5.72 6.27 6.66 6.23 6.19 6.08 6.44 6.44 6.04 5.85
GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS 6.41 6.56 6.81 6.49 6.05 6.03 6.47 6.3 6.28 6.41 6.32 6.18 6.47 6.13 6.67 6.45 6.28 6.43 6.13 6.2 6.56 6.5 6.71 6.22 6.36 6.39
GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS 6.16 6.18 6.56 6.31 5.91 5.83 6.19 6.3 6.06 5.97 6.28 6.41 6.29 5.92 5.87 6.26 6.05 6.2 5.85 6.06 6.41 6.41 6.25 5.96 6.45 6.39
GOBP_REGULATION_OF_WATER_LOSS_VIA_SKIN 5.44 5.38 5.13 5.27 4.98 4.92 4.83 4.97 5.16 4.96 5.08 4.86 5.02 4.89 5 4.79 5.16 5.08 4.9 4.91 5.04 4.85 4.9 4.62 4.87 4.8
GOBP_TRANSFERRIN_TRANSPORT 8.52 8.38 9.24 8.49 9.07 9.01 8.97 8.9 9.01 9.15 9.02 9.01 8.93 8.97 9.2 8.91 8.52 8.32 8.64 8.87 8.58 8.97 9.16 9.39 8.88 8.44
GOBP_RESPONSE_TO_TESTOSTERONE 6.31 6.22 6.74 7.22 6.38 6.38 6.34 6.19 6.46 6.38 6.27 6.15 6.21 6.16 6.54 6.38 6.49 6.72 6.37 6.23 6.34 6.43 6.71 6.31 6.25 6.45
GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION 6.81 6.82 7.16 6.9 6.86 6.6 7.07 7.29 7 6.75 6.67 6.91 6.79 6.69 6.94 6.95 7.29 7.3 6.58 7.11 7.41 7.13 7 6.97 7.14 7.4
GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION 6.68 6.81 7.2 6.7 6.82 6.52 6.83 7.27 6.92 6.7 6.54 6.81 6.99 6.82 6.87 6.94 7.2 7.3 6.72 7.12 7.5 7.21 6.95 6.66 6.86 7.31
GOBP_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION 6.63 6.31 7.29 6.85 5.81 6.66 7.48 7.31 7.08 7.11 6.75 6.83 7.04 7.36 7.35 6.58 6.35 6.82 6.8 6.88 6.91 6.78 7.82 6.94 6.84 6.68
GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION 6.22 6.01 7.02 6.45 5.64 5.64 6.56 6.56 5.89 5.76 6.25 5.62 5.78 5.99 6.35 6.32 6.07 6.13 5.94 6.04 6.37 6.07 5.86 5.59 6.69 6.71
GOBP_MEMBRANE_PROTEIN_PROTEOLYSIS 6.77 6.73 7.05 6.92 7.05 7.06 6.62 6.86 7.04 7.06 6.55 6.97 7.03 7.02 6.79 6.81 6.84 6.88 6.82 6.88 6.9 7.04 7.15 6.99 7.09 7.12
GOBP_INTEGRIN_ACTIVATION 6.26 5.85 5.9 5.71 5.72 5.94 5.57 6.03 5.63 5.77 5.51 5.79 5.52 5.59 5.35 5.72 5.89 5.84 6.08 6 6.24 5.57 5.68 5.5 5.81 5.79
GOBP_REGULATION_OF_INTEGRIN_ACTIVATION 5.51 5.5 5.42 5.1 5.64 5.14 4.98 5.87 5.37 4.91 5.23 5.72 5 4.98 4.82 5.41 5.86 5.48 5.96 5.68 5.88 5.56 5.26 5.3 5.62 5.69
GOBP_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION 5.51 5.5 5.42 5.1 5.64 5.57 4.98 5.87 5.27 4.89 5.23 5.86 5.04 4.99 4.82 5.53 5.86 5.48 6.04 5.76 6.09 5.65 5.26 5.63 5.62 5.69
GOBP_CELL_ADHESION_MEDIATED_BY_INTEGRIN 5.86 5.72 5.79 5.86 5.86 5.72 5.73 5.63 5.76 5.8 5.73 5.94 5.89 5.74 5.65 5.79 5.97 5.64 5.56 5.79 5.94 5.78 5.75 5.8 6.1 5.99
GOBP_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN 5.73 5.71 5.84 6.08 5.69 5.66 5.75 5.56 5.7 5.76 5.71 5.75 5.7 5.79 5.6 5.74 5.86 5.52 5.52 5.75 5.94 5.83 5.66 5.76 6.01 5.99
GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN 5.76 5.94 5.71 6.02 6.23 6.06 6.13 5.66 6.16 6.01 5.91 6.36 6.19 5.85 5.45 5.79 6.23 5.77 5.71 5.79 5.94 5.9 5.85 6.02 6.1 6.05
GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN 5.28 5.55 5.88 5.8 5.22 5.46 5.75 5.47 5.7 5.62 5.52 5.68 5.7 5.71 5.67 5.71 5.63 5.36 5.22 5.68 6.04 5.92 5.66 5.85 6.06 5.99
GOBP_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN 5.9 5.94 5.83 5.86 6.38 6.12 6.13 5.66 5.53 6.01 5.66 6.46 6.54 5.85 6.18 5.83 6.07 6.31 5.56 5.78 5.94 5.87 6.52 6.1 6 5.98
GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN 5.63 5.63 5.68 5.4 5.81 5.6 5.76 5.33 5.44 5.39 5.5 5.77 5.83 5.51 5.75 5.62 5.78 5.82 5.27 5.64 5.76 5.7 5.72 5.58 5.65 5.72
GOBP_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY 6.74 6.89 7.27 7.04 7.13 7.08 7.08 7.06 7.22 7.15 7.04 7.23 7.16 7.19 7.21 7.2 6.88 6.98 7.04 7.13 7.02 7.31 7.36 7.45 7.07 7.07
GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_INCISION 6.8 6.76 7.46 7.47 7.26 7.13 7 6.97 6.99 6.9 7.18 6.92 7.02 6.9 6.91 7.04 6.96 6.85 7.14 7.31 6.64 7.04 6.79 7.02 6.84 6.9
GOBP_OSTEOBLAST_PROLIFERATION 5.79 6.11 6.16 6.25 6.08 6.28 6.43 6.46 6.33 6.37 6.26 6.39 6.75 6.49 6.52 6.2 6.31 6.16 5.87 6.31 6.41 6.62 6.75 6.94 6.37 6.46
GOBP_REGULATION_OF_OSTEOBLAST_PROLIFERATION 5.75 6.13 6.15 6.08 6.24 6.28 6.57 6.56 6.39 6.39 6.27 6.48 6.99 6.59 6.47 6.22 6.31 6.26 5.77 6.02 6.45 6.83 7.02 7 6.34 6.49
GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION 5.24 5.21 5.35 5.22 4.85 5.16 5.3 4.67 5.34 4.66 4.98 5.01 4.99 4.99 4.97 5.06 4.86 4.97 4.59 5.1 5.29 5.2 5.04 4.7 5.2 5.37
GOBP_PHOSPHOLIPID_EFFLUX 5.9 5.76 5.68 5.92 5.31 5.36 5.61 5.67 5.56 5.4 5.96 5.51 5.66 5.6 5.64 5.4 5.79 5.53 5.54 5.29 5.71 5.75 5.35 5.23 5.63 5.65
GOBP_RESPONSE_TO_GLUCAGON 6.31 5.94 5.67 6.53 6.87 6.64 6.89 6.39 5.94 6.32 5.97 6.2 5.9 6.02 6.3 6.03 6.34 6.26 6.02 5.97 6.4 6.07 6.09 5.87 6.35 6.48
GOBP_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY 7.14 7.14 6.49 7.07 6.76 6.84 6.43 6.2 7.21 7.14 7.15 7.13 6.99 6.83 6.99 6.54 7 6.59 6.91 6.28 6.9 6.49 7.26 6.92 7.14 6.77
GOBP_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS 6.72 6.7 7.08 6.95 7 6.95 6.92 6.83 6.98 7.17 6.93 7.06 7.01 7.11 6.76 6.75 6.88 6.83 6.85 6.92 6.62 6.89 6.99 6.97 7.15 7.12
GOBP_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS 7.12 7.27 8.04 7.57 7.79 7.62 7.96 7.76 7.75 7.67 7.61 7.85 7.75 7.81 7.84 7.62 7.43 7.6 7.47 7.82 7.13 7.57 7.94 8.04 7.82 7.82
GOBP_P_BODY_ASSEMBLY 8.37 8.72 7.56 8.94 8.31 8.12 8.45 8.4 8.23 7.88 8.61 7.79 8.15 7.95 7.88 7.66 8.13 8 8.01 8.03 7.45 8.03 8.56 8.08 7.83 7.88
GOBP_RESPONSE_TO_LIPID 6.11 6.08 6.24 6.26 6.02 6.07 6.06 6.16 6.2 6.11 6.1 6 6.14 6.11 6.1 6.22 6.26 6.11 6.01 6.05 6.31 6.3 6.12 6.06 6.34 6.35
GOBP_STRESS_GRANULE_ASSEMBLY 9.05 9.3 9.09 9.06 9.26 9.31 8.97 8.74 9.46 9.13 9.11 9.05 8.99 9.21 8.49 9.04 8.59 9.33 9.66 8.91 8.68 9.33 9.55 9.5 8.88 8.83
GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS 8.18 7.83 7.76 7.9 7.98 8.1 7.95 8.01 7.7 8.09 7.85 7.93 7.85 7.93 8.09 8.11 8.01 7.91 7.97 8.04 7.94 8.16 8 8.07 8.12 7.9
GOBP_RESPONSE_TO_CYTOKINE 6.25 6.17 6.34 6.31 6.23 6.18 6.17 6.21 6.26 6.2 6.22 6.12 6.19 6.17 6.12 6.14 6.28 6.25 6.05 6.18 6.3 6.35 6.16 6.12 6.28 6.44
GOBP_ERYTHROCYTE_HOMEOSTASIS 6.71 6.62 6.88 6.87 6.73 6.98 6.99 6.91 6.97 6.83 6.85 6.9 7.04 7.01 7.03 6.86 6.87 6.78 6.57 6.96 6.84 6.91 7.14 7.25 7.11 7.1
GOBP_REGULATION_OF_TISSUE_REMODELING 6.01 6.15 6.31 6.25 5.84 5.84 6.04 6.02 6.11 6.07 6 5.65 6.08 5.95 6.15 6.02 5.96 5.75 5.7 6.15 6.56 6.42 6.02 6.03 6.22 6.31
GOBP_NEGATIVE_REGULATION_OF_TISSUE_REMODELING 5.8 6.14 5.97 6.11 5.82 5.74 6.04 6.01 6.06 5.59 5.76 5.48 5.95 5.93 6.28 6.01 5.54 5.63 5.61 5.67 6.04 6 5.7 6 6.02 6.4
GOBP_POSITIVE_REGULATION_OF_TISSUE_REMODELING 5.48 4.85 5.06 5.44 4.66 4.69 5.49 5.18 4.99 4.98 5.27 4.67 4.98 4.46 4.92 4.73 4.9 5.3 4.62 4.56 5.21 5.07 4.61 4.56 5.27 5.06
GOBP_HOMOTYPIC_CELL_CELL_ADHESION 6.56 6.2 6.45 6.65 6.42 6.47 6.21 6.32 6.46 6.22 6.29 6.29 6.25 6.46 6.33 6.41 6.34 6.19 6.49 6.41 6.69 6.45 6.58 6.42 6.49 6.56
GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION 6.21 6.09 6.42 6.79 6.33 6.28 6 6.36 6.44 6.12 5.8 5.84 6.17 6.39 6.3 6.06 6.31 5.93 5.67 6.41 6.26 6.37 6.21 6.09 6.32 6.11
GOBP_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION 6.6 6.29 6.56 7.36 6.48 6.3 6.39 6.53 6.51 6.31 6.29 6.36 6.29 6.4 6.47 6.15 6.6 6.31 6.05 6.58 6.95 6.59 6.61 6.41 6.64 6.35
GOBP_HETEROTYPIC_CELL_CELL_ADHESION 5.55 5.63 5.3 5.48 5.33 5.2 5.39 5.16 5.37 5.27 5.43 5.18 5.21 5.35 5.2 5.32 5.46 5.52 5.41 5.29 5.62 5.74 5.38 5.04 5.35 5.59
GOBP_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION 5.22 4.79 4.51 4.75 4.36 4.31 4.86 4.63 4.73 4.41 5.18 4.52 4.78 4.46 4.46 4.67 4.62 4.65 4.9 4.7 4.56 4.77 4.73 4.33 4.47 4.67
GOBP_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION 4.71 4.44 4.37 4.67 4.26 4.11 4.04 4.32 4.45 4.3 4.39 4.41 3.93 4.13 4.21 4.28 4.36 4.52 4.63 4.42 4.39 4.19 4.43 3.94 4.05 4.33
GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 5.93 5.94 5.86 5.98 5.75 5.74 5.7 5.57 5.72 5.53 5.99 5.44 5.55 5.73 5.57 5.75 5.81 5.63 5.35 5.32 6.05 5.66 5.55 5.43 5.76 5.78
GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 6.03 6.06 6.03 6.3 5.99 5.88 5.87 5.76 5.89 5.86 6.08 5.57 5.65 6 6 5.85 6.01 5.86 5.9 5.57 6.05 6.16 5.78 5.71 6.2 6.11
GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 6.09 6.12 5.71 5.97 5.74 5.29 5.7 5.5 5.58 5.53 6.36 5.78 5.54 5.69 5.37 5.46 6 5.77 5.32 5.38 6.14 5.65 5.3 5.36 5.64 5.7
GOBP_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY 5.63 5.42 4.98 5.43 5.02 4.94 4.75 5.05 5.35 5.04 5.29 4.83 5.29 5.25 5.13 5.38 4.94 5.4 5.16 5.05 5.43 5.04 4.99 4.96 5.52 5.43
GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY 5.55 5.38 4.98 5.04 4.8 4.91 4.71 4.93 5.33 4.97 5.07 4.8 5.24 5.15 5.13 5.21 4.83 5.41 5.1 5.01 5.25 4.92 4.91 4.74 5 4.82
GOBP_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY 5.68 5.87 5.72 5.88 5.37 5.86 5.3 5.48 5.95 5.55 5.7 5.36 6.03 5.69 5.58 5.75 5.37 5.44 5.4 5.49 5.58 5.88 5.88 5.8 5.67 5.86
GOBP_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY 6.01 5.8 6.52 6.44 5.86 5.93 5.47 5.76 5.85 5.32 5.91 5.53 5.54 5.57 5.59 5.86 6.1 5.69 5.27 5.35 5.96 6.01 5.58 5.53 6.09 6.05
GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY 5.63 5.8 6.52 6.58 5.41 6.13 5.47 5.12 5.84 5.32 5.54 5.29 5.62 5.53 5.13 5.71 5.6 5.49 5.19 5.35 5.48 5.56 5.36 5.41 5.43 5.35
GOBP_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY 5.73 6.04 5.63 5.85 6.01 5.72 5.18 5.42 5.99 5.33 5.29 5.11 5.73 5.75 5.34 5.67 5.32 5.46 5.4 5.37 5.9 5.51 5.38 5.63 5.57 5.66
GOBP_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY 5.93 6.21 5.85 6.01 6.07 5.72 5.6 5.57 6.07 6.03 6.06 6.04 5.9 6 5.73 5.82 5.67 5.85 5.56 5.97 6.09 5.83 5.83 5.78 5.68 5.95
GOBP_ACTIVATION_OF_PROTEIN_KINASE_A_ACTIVITY 7.61 7.72 7.93 7.77 8.07 8.07 8.09 8.5 8.55 8.14 7.86 7.64 8.52 8.39 8.6 8.41 7.69 7.62 8.17 8.26 8.02 8.54 8.47 8.5 8.14 7.87
GOBP_LIPID_TRANSLOCATION 6.5 6.54 6.37 6.38 7.05 6.78 6.48 6.46 6.61 6.59 6.5 6.66 6.84 6.92 6.15 6.31 6.37 6.45 6.45 6.36 6.48 6.47 6.39 6.34 6.84 6.68
GOBP_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORT 6.55 6.57 6.6 6.67 6.59 6.86 6.67 6.86 6.65 6.92 6.43 6.84 6.7 6.94 6.98 6.85 6.75 6.58 6.41 6.67 6.49 6.58 6.9 7.05 6.52 6.7
GOBP_REGULATION_OF_TRANSCRIPTION_ELONGATION_FROM_RNA_POLYMERASE_II_PROMOTER 7.78 7.78 8.27 7.48 8.01 8.2 8.04 8.03 7.77 8.15 8.14 7.91 8.21 7.95 8.14 7.76 7.64 7.84 8.29 8.3 7.93 8.12 7.91 8.28 8.29 8.3
GOBP_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS 7.54 7.53 7.79 7.73 7.79 7.89 7.85 7.79 7.83 7.91 7.7 7.84 8 7.89 7.84 7.7 7.56 7.46 7.68 7.86 7.46 7.8 7.89 7.97 7.83 7.78
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS 7.79 7.93 8.04 7.87 8.15 8.22 8.25 8.09 8.26 8.26 8.01 8.14 8.33 8.32 8.25 8.22 8.01 7.69 8.09 8.13 7.78 8.2 8.24 8.38 8.35 8.3
GOBP_POSITIVE_REGULATION_OF_CELLULAR_AMIDE_METABOLIC_PROCESS 7.46 7.57 7.72 7.54 7.76 7.86 7.85 7.79 7.81 8.01 7.57 7.83 8.01 7.91 7.89 7.74 7.49 7.33 7.67 7.81 7.49 7.87 7.94 8.07 7.9 7.83
GOBP_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY 7.53 7.86 7.38 7.12 7.89 7.9 7.87 7.86 7.68 8.21 7.72 8.16 7.88 7.9 7.88 7.82 7.87 7.45 7.63 7.98 7.52 7.89 7.77 8.02 7.89 7.82
GOBP_RESPONSE_TO_MONOSACCHARIDE 6.41 6.48 7 6.78 6.76 6.8 6.72 6.94 6.85 6.89 6.88 6.81 6.69 6.68 6.79 6.79 6.67 6.85 6.71 6.78 6.83 6.88 6.85 6.71 6.88 6.74
GOBP_PRIMARY_ALCOHOL_METABOLIC_PROCESS 5.53 5.31 5.69 6 5.4 5.18 5.74 5.5 5.51 5.65 5.54 5.43 5.6 5.32 5.33 5.4 5.46 5.45 5.17 5.08 5.52 5.48 5.56 5.23 5.49 5.75
GOBP_PRIMARY_ALCOHOL_BIOSYNTHETIC_PROCESS 5.6 5.46 5.47 5.62 5.97 5.65 5.74 5.81 5.65 5.87 6.09 5.75 5.59 5.35 5.71 5.76 5.68 5.79 5.42 5.46 5.86 5.7 5.51 5.27 5.6 5.75
GOBP_PRIMARY_ALCOHOL_CATABOLIC_PROCESS 4.77 4.49 4.93 4.83 4.48 4.35 4.85 5.06 4.99 4.71 5.13 4.76 4.64 4.39 4.48 4.6 4.8 4.69 4.51 4.62 4.85 4.57 4.9 4.57 5.06 4.66
GOBP_DIOL_METABOLIC_PROCESS 7.22 6.98 7.72 7.27 7.06 7.04 7.3 6.81 7.12 7.22 7.41 6.84 6.98 6.88 7.68 7.05 7.1 6.58 7.29 7.05 7.05 6.86 7.41 7.2 6.77 6.79
GOBP_DIOL_BIOSYNTHETIC_PROCESS 6.49 6.35 7.72 6.61 7.03 6.6 6.95 6.81 6.81 7.22 7.41 6.84 6.13 6.8 7.68 7.05 6.35 6.26 6.47 6.81 6.36 6.8 7.62 7.2 6.73 6.64
GOBP_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION 7.57 7.52 8.01 7.79 7.63 7.83 7.76 7.59 7.65 7.85 7.77 7.68 7.85 7.88 7.73 7.86 7.68 7.64 7.57 7.64 7.71 7.91 7.97 7.87 7.75 7.93
GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION 7.58 7.53 8.17 7.81 7.96 8.04 7.76 7.66 7.65 7.85 7.77 7.68 8.03 7.88 7.93 8.3 7.68 7.98 7.57 7.66 7.71 7.91 7.97 7.92 7.75 7.93
GOBP_CELL_JUNCTION_ASSEMBLY 6.99 6.95 7.16 6.79 7.36 7.35 7.37 7.38 7.27 7.35 7.14 7.25 7.32 7.26 7.46 7.36 7.24 7.13 7.28 7.36 7.3 7.35 7.35 7.5 7.4 7.36
GOBP_CELL_JUNCTION_ORGANIZATION 7.14 7.15 7.36 7.04 7.47 7.47 7.51 7.52 7.42 7.6 7.23 7.48 7.51 7.55 7.63 7.51 7.41 7.29 7.4 7.56 7.42 7.55 7.46 7.72 7.59 7.49
GOBP_CELL_JUNCTION_MAINTENANCE 6.73 6.49 7.5 7.42 6.68 6.64 6.72 6.45 6.88 6.46 6.49 6.64 6.98 7.05 7.23 7.32 6.55 6.64 6.3 7.07 6.74 7.15 6.65 7.06 6.65 6.58
GOBP_ADHERENS_JUNCTION_ORGANIZATION 7.22 7.29 7.27 7.32 7.22 7.26 7.93 7.65 7.37 7.35 7.25 7.29 7.67 7.66 7.52 7.37 7.21 7.52 7.45 7.6 7.6 7.54 7.21 7.27 7.35 7.47
GOBP_ADHERENS_JUNCTION_ASSEMBLY 7.91 8.37 7.7 7.66 8.17 8.27 8.43 8.46 8.09 7.74 7.57 7.91 8.38 8.37 8.03 8.05 8.42 7.8 8.41 8.6 8.06 8.01 7.98 8.3 8.15 8.3
GOBP_RESPONSE_TO_TYPE_I_INTERFERON 6.15 6.24 6.43 6.3 6.4 6.28 6.26 6.38 6.29 6.54 6.68 6.44 6.2 5.96 6.08 6.05 6.27 5.76 6.06 6.36 6.15 6.23 6.08 6 6.26 6.38
GOBP_RESPONSE_TO_INTERFERON_GAMMA 5.7 5.7 5.6 5.69 5.72 5.59 5.65 5.57 5.75 5.4 5.7 5.3 5.6 5.5 5.37 5.45 5.88 5.64 5.33 5.64 5.73 5.61 5.35 5.3 5.75 5.76
GOBP_GLIAL_CELL_APOPTOTIC_PROCESS 7.43 7.16 7.3 7.02 7.84 7.86 7.92 7.64 7.7 7.27 7.74 7.59 7.8 7.72 7.65 7.64 6.92 7.24 7.81 7.57 7.44 7.48 7.93 7.96 7.46 7.75
GOBP_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS 7.43 7.22 7.44 7.09 7.84 7.86 7.94 7.75 7.7 7.27 7.76 7.59 7.8 7.72 7.65 7.91 6.92 7.24 7.9 7.57 7.54 7.64 7.93 7.96 7.46 7.75
GOBP_NAD_BIOSYNTHESIS_VIA_NICOTINAMIDE_RIBOSIDE_SALVAGE_PATHWAY 6.09 5.86 5.55 5.65 5.24 5.3 5.57 5.62 5.55 5.57 5.86 5.47 5.1 5.32 5.77 5.64 5.93 5.89 5.74 5.58 5.79 5.42 5.4 5.23 5.77 5.79
GOBP_PROTEIN_CONTAINING_COMPLEX_REMODELING 5.3 5.24 5.09 5.45 5.02 4.66 4.98 4.96 5.36 5.08 5.29 4.95 4.97 4.96 5.06 5 5.32 5.33 5.11 4.89 5.2 5.27 4.97 4.57 5.03 5.14
GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING 5.21 5.21 4.98 5.26 4.71 4.59 4.93 5.01 5.36 4.65 5.04 4.81 4.61 4.77 4.75 4.81 5.14 5.33 5.06 4.58 5.15 5.12 4.6 4.42 4.82 4.99
GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING 5.18 5.21 4.79 5.2 4.77 4.51 4.87 4.86 4.77 4.9 5.25 4.71 4.44 4.84 4.7 4.7 5.18 5.04 4.56 4.66 4.99 4.99 4.75 4.19 4.8 4.79
GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING 5.11 5.22 4.79 5.71 4.73 4.57 4.87 5.16 5.22 4.65 5.25 4.78 4.65 4.54 4.62 4.85 5.18 5.28 5.02 4.68 4.79 4.91 4.43 4.26 4.65 5.18
GOBP_CHYLOMICRON_ASSEMBLY 5.44 5.48 4.98 5.3 4.71 4.93 5.22 5.35 5.29 4.52 5.17 4.81 4.97 4.99 4.96 4.81 5.14 5.33 5.23 4.58 5.15 5.12 4.6 4.34 5.13 5.44
GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY 5.51 5.51 5.5 5.84 5.51 5.37 6.05 5.81 5.74 5.39 5.74 4.89 5.7 5.8 5.37 5.41 5.42 5.38 5.29 5.65 5.65 5.27 4.95 5.17 5.71 5.87
GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY 5.94 5.78 5.85 6.21 6.01 6.01 6.1 5.92 5.66 5.87 6.2 6.11 6.16 5.77 6.15 5.78 6.26 5.98 5.84 5.88 5.79 6.35 5.54 5.67 5.68 5.98
GOBP_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE 6.33 6.46 6.37 6.3 6.69 6.22 6.38 6.41 6.25 6.62 6.32 6.39 6.49 6.11 6.25 6.17 6.52 6.17 5.86 6.31 6.58 6.28 6.55 6.14 6.28 6.42
GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE 7 7.17 6.95 6.87 7.21 7.18 7.2 6.92 7.42 7.08 7.12 7.4 7.12 7.22 6.87 7.14 7.09 6.73 7.23 6.99 7 6.74 7.19 7.34 7.15 6.88
GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE 5.49 5.48 5.03 5.96 4.83 5.21 5.53 5.35 5.36 5.18 5.79 5.1 5.34 5.22 5.32 5.15 5.32 5.44 5.33 5 5.31 5.12 5.06 4.86 5.41 5.44
GOBP_LIPID_DROPLET_ORGANIZATION 6.51 6.42 7.21 7.11 6.59 6.62 6.5 6.78 6.86 6.5 6.68 6.4 7.22 6.97 6.92 7.1 6.47 6.9 6.69 6.8 6.96 6.87 6.61 6.92 6.57 6.98
GOBP_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS 6.3 6.58 6.82 6.93 7.04 6.92 7.02 6.86 7.31 7.5 6.51 6.89 7.08 7.03 7.44 7.42 6.72 6.73 6.79 6.83 6.86 6.71 7.29 7.4 6.87 6.76
GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS 6.29 6.64 7.28 6.78 6.93 6.84 7.15 7.02 7.31 7.5 6.92 7.51 7.15 7.4 7.48 7.55 6.85 6.86 7.08 6.87 7.5 7.2 7.56 7.67 7.43 7.5
GOBP_PROTEIN_LOCALIZATION_TO_CELL_SURFACE 7.32 7.59 7.23 7.44 7.77 7.77 7.46 7.72 7.43 7.65 7.4 7.77 7.74 7.6 7.58 7.43 7.3 7.44 7.52 7.57 7.4 7.5 7.62 7.82 7.5 7.6
GOBP_CHROMATIN_ORGANIZATION_INVOLVED_IN_REGULATION_OF_TRANSCRIPTION 6.73 6.61 6.94 7.21 7.08 6.89 6.95 7.12 7 7.02 7.14 7.1 6.92 7.09 7.07 7.07 6.75 6.89 6.84 6.95 7.03 6.98 6.97 7.23 6.92 7.27
GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS 6.18 6.21 6.53 6.66 6.33 6.53 6.63 6.6 6.41 6.32 6.31 6.49 6.68 6.35 6.49 6.61 6.17 6.51 6.32 6.43 6.47 6.57 6.31 6.61 6.28 6.72
GOBP_RESPONSE_TO_FLUID_SHEAR_STRESS 7.11 6.78 7.14 6.99 7.19 7.4 7.08 6.95 7.24 7.06 7.39 7.39 7.23 7.17 6.87 7.08 7.42 7.08 7.09 6.99 7.25 7.41 7.52 7.34 7.11 7.15
GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_EXONUCLEOLYTIC_3_5 7.41 7.24 7.44 7.22 7.33 7.6 7.55 7.23 7.32 7.24 7.37 7.58 7.46 7.36 7.04 7.44 6.83 6.88 7.29 7.57 6.67 6.76 7.04 7.2 7.2 7.2
GOBP_STEROID_ESTERIFICATION 6.26 6.51 6.8 7.31 7.01 6.85 6.96 7 6.73 7.09 6.62 6.71 6.6 6.61 6.56 6.52 6.73 6.68 6.64 6.84 6.8 6.93 6.54 6.67 6.55 6.78
GOBP_LIPID_OXIDATION 6.62 6.55 7.08 7.01 6.66 6.88 6.85 6.82 6.75 6.83 6.83 6.95 6.76 6.81 6.81 7.08 6.61 6.71 6.72 6.89 6.8 6.88 6.95 7.06 7.02 7.22
GOBP_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING 6.58 6.51 6.53 6.45 6.51 6.44 6.43 6.7 6.43 6.34 6.43 6.65 6.59 6.77 6.74 6.63 6.79 6.52 6.44 6.56 6.72 6.89 6.64 6.53 6.8 6.82
GOBP_MICROTUBULE_ANCHORING 7.89 7.53 7.72 7.39 8.41 8.27 7.97 7.75 8.08 7.78 7.52 7.97 8.29 8.23 7.98 8.18 8.11 7.88 8.23 7.96 7.72 7.86 8.3 8.16 8.29 7.72
GOBP_MICROTUBULE_ANCHORING_AT_CENTROSOME 8.21 8.07 8.28 7.99 9.07 8.9 8.09 7.81 8.6 8.33 8.38 8.6 8.67 8.51 8.29 8.44 8.32 8.27 8.82 8.34 7.97 8.33 8.82 8.59 8.44 8.18
GOBP_NCRNA_PROCESSING 6.34 6.41 6.79 6.71 6.47 6.44 6.45 6.52 6.46 6.55 6.64 6.52 6.51 6.45 6.49 6.62 6.32 6.35 6.49 6.44 6.35 6.49 6.52 6.6 6.57 6.59
GOBP_PROTEIN_LOCALIZATION_TO_PHAGOPHORE_ASSEMBLY_SITE 7.38 7.44 7.75 7.85 7.76 7.79 7.58 7.69 7.63 7.69 7.96 7.59 7.49 7.3 7.78 7.69 7.65 7.93 7.73 7.68 7.89 7.86 7.49 7.62 7.61 7.57
GOBP_PROTEIN_LOCALIZATION_TO_KINETOCHORE 5.48 5.21 5.99 6.19 5.25 5.3 5.57 5.59 5.44 5.32 5.65 5.75 5.45 5.25 5.65 5.55 5.62 5.5 5.28 5.43 5.66 5.48 5.5 5.76 5.33 5.39
GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME 6.53 6.77 6.96 6.95 7.1 7.13 6.74 6.88 6.68 7.06 6.92 6.76 6.96 7.04 6.9 7.05 6.63 6.38 6.95 6.9 6.74 6.86 6.88 7.04 7.11 6.82
GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS 6.96 7.08 7.31 7.23 7.17 7.36 7.27 7.32 7.27 7.23 7.24 7.34 7.4 7.31 7.19 7.24 7.25 7.15 7.16 7.3 7.08 7.26 7.34 7.48 7.44 7.32
GOBP_TOOTH_MINERALIZATION 5.52 5.47 5.16 5.52 5.47 4.99 5.35 5.32 5.43 5.1 5.49 5.44 5.31 4.9 5.37 5.45 5.14 5.41 5.14 5.24 5.88 5.66 5.75 4.72 5.41 5.47
GOBP_CENTROMERE_COMPLEX_ASSEMBLY 5.65 5.57 5.37 5.51 5.34 5.45 5.62 5.46 5.29 5.74 5.57 5.54 5.57 5.47 5.33 5.68 5.32 5.7 5.46 5.54 5.9 5.38 5.43 5.59 5.28 5.6
GOBP_PIRNA_METABOLIC_PROCESS 4.71 4.49 4.49 4.51 4.11 3.96 4 4.36 4.27 3.94 4.38 4.24 3.78 3.93 4.17 4.19 4.4 4.77 4.53 4.24 4.73 4.23 4.14 4.21 4.02 4.12
GOBP_CELLULAR_RESPONSE_TO_HEAT 7.34 7.51 7.83 7.86 7.75 7.71 7.56 7.48 7.59 7.63 7.54 7.7 7.72 7.8 7.66 7.6 7.45 7.28 7.5 7.58 7.41 7.68 7.79 7.74 7.55 7.66
GOBP_RESPONSE_TO_TUMOR_NECROSIS_FACTOR 6.23 6.14 6.27 6.38 6.19 6.17 6.1 6.18 6.19 6.14 6.25 6.1 6.19 6.18 6.08 6.22 6.27 6.16 6.1 6.11 6.23 6.35 6.12 6.01 6.23 6.36
GOBP_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES 6.53 6.62 7 6.64 6.98 6.93 6.88 6.92 6.91 7.01 6.87 6.92 7.11 7.09 7.08 7.15 7.11 6.87 6.83 7 7.14 7.43 6.97 7 7.11 7.04
GOBP_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS 6.16 6.01 6.99 6.51 6.45 6.16 6.7 6.49 6.88 6.31 7.53 6.29 6.57 6.05 6.45 6.76 7.05 6.88 5.88 6.61 7.12 6.94 6.77 6.48 7.1 6.86
GOBP_CELLULAR_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY 7.06 7.11 7.63 7.4 7.34 7.33 7.34 7.44 7.36 7.41 7.47 7.45 7.34 7.37 7.44 7.49 7.24 7.16 7.33 7.39 7.26 7.48 7.44 7.61 7.51 7.43
GOBP_CELLULAR_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION 6.94 7 6.89 7.13 7.22 7.2 6.91 7.5 7.17 7.3 7.15 7.13 7.42 7.53 7.46 7.62 7.24 7.36 7.32 7.46 7.03 7.69 7.27 7.47 7.35 7.54
GOBP_CELLULAR_CARBOHYDRATE_BIOSYNTHETIC_PROCESS 6.44 6.57 6.4 6.53 6.61 6.88 6.78 6.68 6.91 6.66 6.4 6.83 6.75 6.88 6.77 6.63 6.71 6.83 6.72 7.01 6.58 6.64 6.64 6.72 6.78 6.71
GOBP_PHOSPHATIDYLCHOLINE_CATABOLIC_PROCESS 6.17 6.05 6.41 6.69 6.5 6.64 6.77 6.56 6.41 6.68 6.38 6.55 6.79 6.52 6.5 6.28 6.26 6.26 5.98 6.49 6.62 6.73 6.64 6.53 6.38 6.32
GOBP_CELLULAR_RESPONSE_TO_UV 6.48 6.41 6.66 6.76 6.33 6.59 6.55 6.65 6.52 6.69 6.3 6.52 6.59 6.59 6.53 6.49 6.47 6.37 6.64 6.64 6.32 6.51 6.61 6.72 6.54 6.61
GOBP_CORTISOL_METABOLIC_PROCESS 5.36 5.19 5.19 4.83 4.63 4.77 4.96 4.7 4.51 4.32 5.11 4.49 4.42 4.38 4.62 4.75 4.88 5.17 5 4.73 5.02 5.14 4.4 4.55 5.12 5.39
GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS 5.47 5.44 5.98 5.82 5.35 5.44 5.69 5.5 5.52 5.62 5.67 5.53 5.43 5.44 5.6 5.51 5.67 5.61 5.33 5.48 5.58 5.59 5.53 5.56 5.73 5.74
GOBP_NCRNA_METABOLIC_PROCESS 6.34 6.44 6.79 6.73 6.5 6.47 6.44 6.47 6.47 6.59 6.67 6.53 6.59 6.46 6.49 6.62 6.34 6.37 6.54 6.49 6.34 6.49 6.51 6.6 6.55 6.57
GOBP_NCRNA_CATABOLIC_PROCESS 6.68 6.79 7.46 7.2 6.9 7 6.93 7.07 6.96 7.04 7.31 7.1 6.99 7.15 6.96 6.92 6.76 6.7 6.82 7.07 6.59 6.72 7.05 7.09 7.05 7.1
GOBP_RESPONSE_TO_PROSTAGLANDIN 5.78 5.81 5.85 5.98 5.63 5.39 5.68 5.84 5.63 5.41 6 5.88 5.71 5.54 5.67 5.75 6.18 5.56 5.35 5.72 6.08 6.28 5.9 5.42 5.75 6.41
GOBP_RESPONSE_TO_PROSTAGLANDIN_E 5.83 5.99 6.65 6.26 6.24 6.46 6.63 6.56 5.65 6.18 6.04 6.66 5.9 6.2 6.2 5.83 6.31 5.63 5.71 5.79 5.97 6.12 6.23 5.85 5.89 6.71
GOBP_RESPONSE_TO_GONADOTROPIN 5.89 5.62 5.51 5.69 5.4 4.93 5.55 5.29 5.35 5.2 5.81 5.34 5.4 5.21 5.34 5.3 5.4 5.71 5.32 5.12 5.69 5.37 5.14 4.94 5.3 5.16
GOBP_DNA_REPLICATION_INDEPENDENT_NUCLEOSOME_ORGANIZATION 5.68 5.61 5.68 5.56 5.59 6.02 5.87 5.53 5.68 5.77 5.59 5.64 5.9 5.68 5.51 5.72 5.47 5.71 5.59 5.64 5.92 5.64 5.81 5.91 5.71 5.95
GOBP_NUCLEOSOME_ORGANIZATION 6.45 6.52 6.73 6.83 6.7 6.74 6.74 6.87 6.65 6.86 6.8 6.8 6.65 6.6 6.8 6.81 6.45 6.59 6.62 6.76 6.72 6.63 6.86 6.92 6.64 6.88
GOBP_CELLULAR_HORMONE_METABOLIC_PROCESS 5.54 5.34 5.49 5.59 5.18 4.96 5.43 5.31 5.37 5.23 5.3 5.03 5.35 5.12 5.46 5.14 5.38 5.41 5.27 5.1 5.5 5.33 5.32 4.9 5.4 5.27
GOBP_IRON_ION_TRANSMEMBRANE_TRANSPORT 6.68 7.03 7.04 7.11 7.27 6.76 6.93 6.89 7.47 6.86 6.93 6.99 7.08 7.2 6.42 6.77 7.31 6.83 7.16 7.06 6.97 7.25 6.87 7.35 7.11 7.52
GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT 6.86 6.95 7.16 6.8 7.04 7.05 7.07 7.2 7.15 7.1 7 7 7.14 7.19 7.14 7.16 6.98 7 7.05 7.08 7.02 7.1 7.15 7.32 7.09 7.12
GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT 7.32 7.28 7.52 7.48 7.4 7.47 7.41 7.23 7.57 7.51 7.43 7.53 7.44 7.44 7.36 7.39 7.36 7.21 7.52 7.39 7.29 7.27 7.49 7.68 7.5 7.28
GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT 6.66 6.67 7.18 6.86 7.3 7.06 7.09 7.28 7.03 7.23 7.02 7.09 7.15 6.97 7.36 7.19 6.87 6.81 7.03 7.01 6.8 6.75 7 7.34 7.19 7.04
GOBP_HISTONE_ARGININE_METHYLATION 6.8 6.81 6.76 6.51 6.89 7.21 7.41 7.36 7.24 7.39 6.91 7.37 7.14 7.32 7.7 7.53 7.05 6.98 7.04 7.08 7.06 7.41 7.12 7.61 7.41 7.14
GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 7.06 7.17 7.78 7.51 7.5 7.45 7.62 7.66 7.52 7.47 7.44 7.54 7.51 7.59 7.64 7.57 7.42 7.3 7.36 7.56 7.45 7.59 7.62 7.78 7.69 7.6
GOBP_MITOCHONDRIAL_PROTEIN_PROCESSING 6.39 6.28 7.25 7.07 6.8 6.82 6.37 6.63 7.17 7.07 6.61 6.78 6.58 6.74 6.77 6.35 6.48 6.3 6.66 6.38 6.69 6.92 6.64 6.75 7.18 6.93
GOBP_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE 6.32 6.69 6.87 6.5 6.81 6.61 6.83 7.02 6.89 6.98 6.65 6.97 7.2 6.97 7.1 7.07 7.07 6.84 6.75 6.98 6.83 6.97 7.02 7 6.61 7.21
GOBP_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION 7.14 7.45 7.84 7.83 7.89 8.05 7.93 7.81 8.05 8.25 7.74 8.07 8 8.08 8.03 7.67 7.56 7.36 7.92 8.19 7.14 7.45 8.26 8.47 7.79 7.39
GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION 6.25 6.17 6.21 6.22 6.02 6.11 6.33 6.73 6.25 6.17 6.22 6.33 6.18 6.31 6.7 6.41 6.39 6.23 6.16 6.15 6.5 6.35 6.38 6.42 6.47 6.49
GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION 6.94 7.44 6.81 6.5 7.48 8.02 7.62 7.37 7.91 7.81 6.72 7.03 7.24 7.81 7.67 7.64 7.03 7.54 7.42 7.74 7.6 7.56 7.73 8.16 7.89 7.66
GOBP_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION 5.35 5.38 5.2 5.27 5.07 5.18 5.19 5.27 5.22 5 5.33 5.22 4.99 5.27 5.42 5.2 5.33 5.54 5.27 4.98 5.41 5.17 5.11 5.08 5.19 5.37
GOBP_SPERM_EGG_RECOGNITION 4.98 5.03 4.92 5.08 4.59 4.36 4.6 4.72 4.86 4.59 4.77 4.69 4.6 4.6 4.68 4.65 4.85 5.02 4.7 4.69 4.97 4.77 4.66 4.49 4.65 4.8
GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT 6 5.99 6.17 6.2 6.03 5.9 5.97 6.15 5.74 6.2 6.19 6.27 6.02 5.99 5.99 6.01 5.87 5.84 6 6.05 6.19 6.21 5.99 5.85 5.79 6.26
GOBP_CARDIOCYTE_DIFFERENTIATION 6.55 6.54 6.57 6.36 6.73 6.59 6.72 6.74 6.85 6.72 6.53 6.6 6.97 6.96 6.56 6.72 6.75 6.56 6.6 6.73 6.85 6.95 6.95 6.77 6.61 6.71
GOBP_NEGATIVE_REGULATION_OF_HISTONE_ACETYLATION 6.01 6 6.22 6.52 6.08 6.13 6.22 6.26 6.35 6.18 6 6.14 6.13 6.14 6.34 6.43 5.94 6.06 5.8 5.94 6.05 6.34 6.56 6.75 6.34 6.45
GOBP_AXONEME_ASSEMBLY 5.4 5.34 5.12 5.17 4.97 5.13 5.27 5.09 5.04 5.52 5.22 5.57 5.19 5.14 5.22 5.65 5.32 5.62 5.3 5 5.44 5.34 5.04 5.07 4.97 5.18
GOBP_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY 6.51 6.45 7.1 7.15 6.18 6.01 6.31 6.19 6.53 6.54 6.37 6.16 6.13 5.9 6.49 6.38 6.36 6.46 6.17 6.33 6.34 6.27 6.23 6.46 6.45 6.2
GOBP_SPERM_CHROMATIN_CONDENSATION 5.33 4.87 4.8 5.1 4.54 4.26 4.55 4.82 4.6 4.18 4.85 4.8 4.62 4.71 4.53 4.79 5.02 5.47 5.1 4.65 5.05 4.64 4.49 4.26 4.56 4.56
GOBP_RESPONSE_TO_NICOTINE 5.99 6.02 6 6.53 5.96 5.78 5.99 5.89 6.25 6.31 6.19 6.15 5.92 6.11 6.2 5.86 6.38 6.42 5.88 6.06 6.44 6.3 6.02 5.98 6.2 6.17
GOBP_APPENDAGE_MORPHOGENESIS 5.81 5.71 5.89 5.96 5.71 5.89 5.9 5.85 5.7 5.87 5.9 5.79 5.82 5.78 5.9 5.88 5.8 5.82 5.82 5.85 5.91 5.83 5.83 5.84 5.78 5.85
GOBP_GENITALIA_MORPHOGENESIS 5.02 5.08 4.83 4.81 4.75 4.86 4.94 4.8 4.68 4.7 4.81 4.85 4.73 4.7 4.75 4.7 4.8 5.21 4.89 4.65 5.03 4.7 4.79 4.83 4.65 4.63
GOBP_EMBRYONIC_APPENDAGE_MORPHOGENESIS 5.81 5.78 5.94 5.81 5.57 5.64 5.76 5.75 5.6 5.82 5.82 5.72 5.62 5.69 5.78 5.85 5.68 5.63 5.74 5.85 5.87 5.71 5.66 5.73 5.74 5.81
GOBP_EMBRYONIC_FORELIMB_MORPHOGENESIS 5.02 5.09 5.12 5.22 4.96 4.78 4.83 4.99 5.14 5.01 5.2 4.73 4.99 5.11 5.09 5.04 5.06 4.99 4.86 4.81 5.04 5.03 4.95 4.55 4.92 5.05
GOBP_EMBRYONIC_HINDLIMB_MORPHOGENESIS 5.26 5.12 5.35 5.58 5.16 5.03 5.3 5.24 5.34 5.34 5.56 5.1 5.18 5.36 5.27 5.3 5.18 5.23 4.9 4.96 5.46 5.29 5.11 5.09 5.33 5.08
GOBP_FORELIMB_MORPHOGENESIS 5.1 5.09 5.12 5.22 4.96 4.78 4.83 5.01 5.14 5.01 5.2 4.77 4.99 5.11 5.09 5.03 5.06 4.99 4.86 4.81 5.04 4.94 4.95 4.55 4.92 5
GOBP_HINDLIMB_MORPHOGENESIS 5.21 5.1 5.23 5.45 5.04 4.99 5.17 5.2 5.17 5.17 5.48 5.06 5.06 5.09 5.25 5.08 5.15 5.21 4.91 4.81 5.28 5.12 5.04 4.9 5.01 5.05
GOBP_TUBE_FORMATION 6.07 6.2 6.18 6.1 6.24 6.23 6.33 6.16 6.29 6.33 6.26 6.47 6.29 6.31 6.11 6.21 6.19 6.2 6.17 6.16 6.2 6.38 6.15 6.31 6.19 6.45
GOBP_REGULATION_OF_TUBE_SIZE 5.99 5.86 5.79 5.84 5.81 5.74 5.88 5.89 5.83 5.85 6.04 5.7 5.9 5.94 5.91 5.81 5.89 5.86 5.79 5.96 6.13 6.02 5.93 5.7 5.96 5.96
GOBP_EMBRYONIC_HEMOPOIESIS 6.44 6.25 6.97 7.11 6.38 6.37 6.87 6.82 6.64 6.79 6.82 6.36 6.47 6.68 6.96 6.88 7.22 6.67 6.34 6.69 6.9 7.01 7.13 7 6.46 6.6
GOBP_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY 8.32 8.43 8.08 7.8 8 8.4 8.33 8.48 8.17 8.27 8.07 8.31 8.36 8.43 8.44 8.46 8.1 8.22 8.6 8.38 8.17 8.41 7.98 8.24 8.34 8.35
GOBP_TUBE_MORPHOGENESIS 6.06 6.04 6.07 6.05 6.05 6.06 6.1 6.12 6.09 6.13 6.06 6.05 6.18 6.08 6.13 6.08 6.18 6.03 5.95 6.01 6.22 6.28 6.18 6.04 6.17 6.29
GOBP_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC 8.19 8.15 7.96 7.71 7.99 8.4 8.3 8.25 8.29 8.02 7.89 8.14 8.26 8.43 8.21 8.32 7.66 8.11 8.61 8.28 7.96 8 8.02 8.24 7.97 7.93
GOBP_MULTICELLULAR_ORGANISM_GROWTH 6.95 7.04 7.02 6.85 7.32 7.45 7.31 7.37 7.29 7.24 7.28 7.18 7.1 7.22 7.3 7.39 7.05 7.09 7.06 7.3 7.15 7.13 7.34 7.51 7.2 7.19
GOBP_ORGAN_GROWTH 6.47 6.44 6.49 6.33 6.66 6.67 6.45 6.66 6.64 6.62 6.52 6.59 6.77 6.69 6.55 6.6 6.71 6.47 6.46 6.52 6.66 6.55 6.82 6.81 6.8 6.86
GOBP_PROTEIN_MANNOSYLATION 7.62 7.54 8.02 7.22 8.11 8.13 7.97 7.91 7.84 7.56 7.29 7.67 7.96 7.49 7.7 7.52 7.69 7.29 7.85 7.88 7.51 7.4 7.73 7.87 7.73 7.43
GOBP_PROTEIN_O_LINKED_MANNOSYLATION 7.8 7.86 7.7 7.26 8.17 8.17 8.02 8.01 7.64 7.73 7.1 7.69 7.62 7.49 7.77 7.42 7.82 7.4 7.98 7.98 7.57 7.35 7.7 7.87 7.77 7.59
GOBP_ENDOCRINE_SYSTEM_DEVELOPMENT 5.86 5.64 5.8 5.82 5.55 5.47 5.83 5.67 5.71 5.67 5.79 5.48 5.7 5.62 5.73 5.56 5.67 5.5 5.46 5.47 5.65 5.67 5.66 5.46 5.55 5.61
GOBP_EXOCRINE_SYSTEM_DEVELOPMENT 6.08 6.05 5.96 6 6.63 6.03 6.16 6.27 6.06 6.28 6.28 6.34 6.16 6.16 5.97 6.15 6.59 6.22 6.06 6.41 6.35 6.61 6.32 5.94 6.05 6.31
GOBP_SEGMENTATION 5.78 5.69 5.76 5.71 5.71 5.61 5.58 5.56 5.71 5.67 5.73 5.68 5.74 5.71 5.65 5.76 5.59 5.6 5.56 5.62 5.75 5.66 5.51 5.67 5.69 5.79
GOBP_TUBE_DEVELOPMENT 6.07 6.06 6.07 6.12 6.05 6.07 6.14 6.13 6.11 6.14 6.08 6.06 6.14 6.07 6.12 6.1 6.19 6.04 5.98 6.03 6.23 6.27 6.23 6.04 6.15 6.28
GOBP_REGULATION_OF_DEPHOSPHORYLATION 7.46 7.48 7.6 7.33 7.66 7.84 7.5 7.7 7.65 7.75 7.42 7.75 7.57 7.57 7.73 7.64 7.6 7.42 7.49 7.8 7.48 7.77 7.74 7.92 7.64 7.61
GOBP_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION 7.79 7.72 7.96 7.89 8.04 8.15 8.07 8.25 8.09 8.14 7.89 8.08 8.08 8.11 8.18 8.25 7.98 7.93 7.92 8.21 7.93 8.28 8.02 8.3 8.16 8.03
GOBP_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION 6.82 7.05 7.19 7.04 7.06 7.32 7.07 7.38 7.2 7.48 7.16 7.27 7.34 7.21 7.56 7.16 6.99 6.97 7.24 7.46 7.3 7.34 7.41 7.46 7.23 7.33
GOBP_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION 7.28 7.51 7.66 7.18 7.78 7.93 7.71 7.75 7.68 7.67 7.36 7.94 7.89 7.85 7.73 7.7 7.69 7.74 7.54 8.04 7.76 7.88 7.69 7.91 7.74 7.58
GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION 7.73 7.77 7.94 7.66 8.06 8.16 8.06 8.46 8.04 8.17 7.81 8.05 8.15 8.17 8.14 8.23 7.99 8.18 8.14 8.23 8.15 8.34 7.9 8.06 8.02 8.19
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION 7.7 7.48 7.95 7.89 7.65 7.86 7.83 7.86 7.74 7.79 7.69 7.9 7.79 7.97 7.9 8.1 7.83 7.49 7.69 8.09 7.79 7.97 8.03 8.23 7.37 7.46
GOBP_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS 6.16 6.12 6.07 6.19 6.21 6.25 6.17 6.46 6.29 6.17 6.02 6.18 6.1 6.29 5.91 6.17 6.4 6.13 6.18 6.31 6.37 6.25 6.65 6.37 6.22 6.06
GOBP_HAIR_CELL_DIFFERENTIATION 6.15 6.07 6.32 5.82 5.97 6.23 6.42 5.92 6.26 5.96 6.36 6.2 6.37 6.29 6.01 5.97 6.24 6.01 5.91 6.2 6.21 6.4 6.27 6.23 6.06 6.29
GOBP_HIPPO_SIGNALING 6.63 6.54 6.68 6.42 7.03 6.78 6.75 6.91 6.97 7 6.8 7.11 7.01 6.82 7.12 7 6.99 6.63 6.89 6.83 6.8 6.94 7.16 7.05 6.92 6.96
GOBP_REGULATION_OF_HIPPO_SIGNALING 6.54 6.42 6.68 6.28 6.41 6.49 6.44 6.56 6.53 6.53 6.76 6.74 6.73 6.64 6.82 6.71 6.85 6.72 6.8 6.54 6.45 6.81 6.83 6.66 6.71 6.83
GOBP_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING 6.64 6.43 6.82 6.29 6.51 6.71 6.5 6.72 6.65 6.62 6.81 6.88 6.92 6.72 6.99 6.86 7.09 7.07 6.91 6.62 6.48 6.94 7.15 6.92 6.87 6.86
GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION 6.98 7.02 7 6.99 7.31 7.26 7.02 7.28 7.14 7.18 7.02 7.1 7.16 7.37 7.18 7.22 7.12 7.14 7.24 7.08 7.11 7.35 7.24 7.41 7.11 7.12
GOBP_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS 7.2 7.71 8.08 7.7 8.12 8.38 8.27 8.15 8.17 8.15 7.97 8.08 8.67 8.69 8.2 8.36 7.99 7.8 8.05 8.36 7.32 7.98 8.6 8.49 7.89 7.92
GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS 7.2 7.71 8.05 7.7 8.08 8.07 8.26 8.15 8.03 8.15 7.96 8.03 8.29 8.1 8.2 8.36 7.93 7.83 7.97 8.15 7.35 7.98 8.19 8.36 7.92 7.92
GOBP_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS 7.14 7.83 8.21 7.48 8.42 8.57 8.53 8.19 8.62 8.53 8.02 8.34 8.71 8.77 8.34 8.53 8.08 7.84 8.32 8.48 7.52 7.9 8.63 8.68 8.4 7.93
GOBP_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY 6.44 6.55 6.95 6.71 6.72 6.68 6.83 7.07 6.75 6.93 6.55 6.83 7.02 7.02 7.11 6.99 6.69 6.57 6.5 6.86 6.85 7.07 7.37 7.18 7.07 6.89
GOBP_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY 6.13 6.42 6.63 5.53 5.46 6.12 6.7 6.76 5.93 6.02 6.26 6.08 6.76 6.16 6.73 6.69 5.93 5.95 6.33 6.71 6.04 6.7 6.95 6.32 6.45 5.62
GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE 7.84 8.05 8.07 7.96 7.89 8.42 8.21 8.32 8.75 8.39 8.07 8.77 8.49 8.48 8.35 8.6 8.35 7.87 8.28 8.51 8.08 8.26 8.74 8.71 8.7 8.08
GOBP_THIOESTER_METABOLIC_PROCESS 6.83 6.95 7.18 7.01 7.19 7.26 7.28 7.25 7.26 7.41 7.13 7.42 7.17 7.23 7.3 7.2 7.2 7.05 7.09 7.54 6.98 7.4 7.26 7.44 7.27 7.29
GOBP_THIOESTER_BIOSYNTHETIC_PROCESS 7.36 7.84 8.17 7.94 8.1 8.15 8.26 8.19 8.16 8.18 7.98 8.06 8.29 8.26 8.34 8.41 8.03 7.91 8 8.25 7.56 8.03 8.35 8.33 8.12 8.01
GOBP_HISTONE_SERINE_PHOSPHORYLATION 6.01 5.91 6.42 6.29 5.65 5.63 5.93 6.12 6.09 5.94 5.88 5.94 6.05 6.03 6.27 5.99 5.63 6.01 5.9 5.6 5.73 6.35 5.88 6.02 5.66 5.87
GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE 8.16 8.42 8.31 8.11 8.54 8.57 8.92 8.47 8.71 8.82 8.26 8.56 8.56 8.77 8.73 8.73 8.26 8.58 8.48 8.44 8.21 8.48 8.65 8.95 8.71 8.37
GOBP_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT 6.33 6.26 6.58 6.09 6.41 6.64 6.93 6.97 6.88 6.84 6.66 6.86 7.02 7.11 7.22 7.15 6.36 6.83 6.49 6.86 6.59 6.65 7.08 7.33 6.93 6.23
GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM 7.93 8.21 8.56 8.79 8.61 8.79 8.7 8.53 8.76 8.88 8.49 8.66 9.06 8.92 8.49 8.48 8.37 8.33 8.45 9.03 8.25 8.27 8.62 8.97 8.62 8.57
GOBP_RESPONSE_TO_INTERFERON_ALPHA 6.1 6.7 6.77 6.05 6.89 6.55 6.72 6.69 6.72 6.98 7.25 7.29 6.67 6.7 6.6 6.67 6.62 5.78 6.14 6.59 6.88 6.94 6.58 7.04 6.65 7.06
GOBP_RESPONSE_TO_INTERFERON_BETA 6.59 6.7 7.66 7.2 6.82 6.62 6.78 6.93 6.55 7.15 7.52 6.99 6.84 6.87 7.05 6.79 6.93 6.71 6.52 6.85 6.79 7.31 7.01 7.07 7.07 7.1
GOBP_CELLULAR_RESPONSE_TO_INTERFERON_BETA 6.19 6.3 7.74 7.42 6.97 6.94 6.95 7.47 6.77 7.39 7.03 7.07 7.28 7.25 7.28 7.49 7.2 6.57 6.59 7.02 6.87 7.53 7.12 7.09 7.14 7.39
GOBP_VESICLE_CARGO_LOADING 7.94 7.66 8.96 8.72 8.07 8.22 8.15 8.07 8.08 8.27 8.42 7.76 8.33 8.46 8.46 7.91 8.06 7.54 7.68 7.97 8.18 7.93 8.19 8.06 7.98 8.21
GOBP_VITAMIN_TRANSMEMBRANE_TRANSPORT 6.28 6.38 6.09 6.71 5.96 6 5.46 6.03 5.88 5.96 5.64 5.69 5.85 5.92 5.69 5.55 6.14 5.78 5.76 5.75 5.73 5.7 5.81 6.1 5.81 6.17
GOBP_SNARE_COMPLEX_ASSEMBLY 8.2 8.41 8.33 8.43 8.82 8.85 8.57 8.33 8.7 8.48 8.3 8.55 8.38 8.45 8.39 7.96 8.43 8.1 8.32 8.53 7.68 7.88 8.55 8.84 8.22 7.72
GOBP_DNA_DEALKYLATION 5.83 5.98 5.85 6.06 5.49 5.92 5.58 5.75 5.91 5.72 5.92 5.75 6.06 5.95 5.78 5.65 5.73 5.62 5.9 5.77 5.63 5.43 5.75 5.77 5.67 5.82
GOBP_HISTONE_H2A_MONOUBIQUITINATION 7.19 7.34 7.68 7.72 7.89 7.97 7.32 7.59 7.64 7.58 7.54 7.26 7.86 7.87 7.34 7.53 7.39 7.08 7.61 7.58 7.19 7.54 7.88 7.74 7.72 7.94
GOBP_REGULATION_OF_CHROMATIN_BINDING 6.04 5.86 6.07 6.06 5.87 5.87 5.99 5.95 6.35 5.88 6.05 5.66 6.26 6.21 5.89 5.94 6.33 6.08 5.86 5.9 5.83 6.06 5.92 6.09 6.36 6.59
GOBP_POSITIVE_REGULATION_OF_CHROMATIN_BINDING 5.93 5.64 5.82 5.97 5.46 5.43 5.68 5.56 5.51 5.51 6.04 5.39 5.33 5.31 5.16 5.86 6.21 5.74 5.47 5.33 5.8 5.58 5.5 5.25 5.95 6.4
GOBP_NON_CANONICAL_WNT_SIGNALING_PATHWAY 7.18 7.2 7.29 7.15 7.47 7.37 7.38 7.37 7.26 7.63 7.37 7.21 7.39 7.54 7.21 7.41 7.23 6.95 7.24 7.53 7.01 7.13 7.43 7.33 7.33 7.28
GOBP_CALCIUM_MEDIATED_SIGNALING_USING_INTRACELLULAR_CALCIUM_SOURCE 5.74 6.08 5.98 5.91 6.06 5.76 6.4 5.64 6.16 5.72 5.72 5.73 5.99 5.79 5.42 5.69 5.87 5.73 5.68 5.96 5.68 5.88 5.95 5.73 6.13 5.67
GOBP_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY 7.41 7.59 7.91 7.89 8.2 8.17 8.07 8.65 7.9 8.28 7.89 7.6 8.21 7.84 7.83 8.34 6.88 7.19 7.3 8.48 7.7 7.9 8.02 8 7.11 6.95
GOBP_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY 5.14 5.08 4.66 5.02 5.81 5.82 4.9 5.16 4.98 5.04 5.17 4.79 5.43 5.3 5.29 5.29 5.18 5.04 5.07 5.59 5.23 5.18 5.54 5.37 5.23 5.46
GOBP_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY 5.9 5.99 6.19 6.31 5.88 6.12 5.72 5.92 6.01 5.63 5.96 5.51 5.94 6.24 5.74 5.9 5.51 6.02 5.79 5.83 5.94 6.45 5.88 5.84 5.63 5.7
GOBP_CERAMIDE_TRANSPORT 6.42 6.23 6.87 6.68 6.58 6.39 6.31 6.14 6.53 6.1 6.52 6.1 6.71 6.8 6.24 6.26 6.24 6.36 6.28 5.9 6.75 6.58 6.42 6.56 6.76 6.29
GOBP_MAINTENANCE_OF_BLOOD_BRAIN_BARRIER 6.71 6.7 6.96 7.12 7.32 6.93 7.45 7.28 7.34 6.79 6.84 6.99 7.12 7.29 6.81 6.65 7.5 6.49 6.64 7.32 7.11 7.5 7.33 7.13 7.23 7.36
GOBP_ENTRY_OF_BACTERIUM_INTO_HOST_CELL 8.22 8.34 8.28 7.85 8.23 8.6 8.56 8.67 7.89 8.79 8.34 8.46 8.08 7.83 8.56 8.13 8.4 8.47 8.3 8.88 8.37 8.4 8.74 8.53 8.13 8.33
GOBP_MULTICELLULAR_ORGANISMAL_SIGNALING 7.17 7.09 6.96 6.77 7.48 7.35 7.26 7.05 7.39 7.35 6.95 7.25 7.42 7.44 7.18 6.86 7.16 7.13 7.31 7.62 7.01 7.08 7.46 7.48 7.35 7.16
GOBP_EXPLORATION_BEHAVIOR 8.23 8.41 8 7.87 8.54 8.77 8.63 8.61 8.64 8.61 7.9 8.1 8.93 9.07 8.71 8.75 8.04 8.59 8.87 9.02 8.3 8.42 8.44 8.96 8.87 8.61
GOBP_LOCOMOTORY_EXPLORATION_BEHAVIOR 9.37 9.61 9.77 9.18 9.11 9.66 9.88 9.6 9.6 9.63 9.31 9.51 9.93 9.96 9.41 9.83 9.47 9.37 9.74 9.73 9.27 9.46 9.5 9.65 9.85 9.72
GOBP_CELLULAR_RESPONSE_TO_DRUG 6.07 6.07 6.13 6.06 5.99 5.83 6 6.03 6.11 6.21 6.1 6.1 5.95 6 6.07 6.09 6.14 5.98 6.11 6.09 6.19 5.95 6.14 5.81 5.93 6.28
GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION 5.56 5.44 5.44 5.57 5.27 5.23 5.47 5.45 5.45 5.2 5.36 5.25 5.42 5.27 5.29 5.24 5.38 5.43 5.34 5.21 5.46 5.3 5.21 5.08 5.27 5.38
GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT 6.96 6.96 6.96 6.78 6.76 7.13 7.27 7.38 7.3 7.25 6.89 7.23 7.24 7.32 7.2 7.28 7.07 7.27 7.21 7.2 7.09 7.15 7.1 7.41 7.37 7.2
GOBP_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR 6.96 7.35 7.36 7.62 7.99 8.02 7.69 7.75 8.2 8.2 7.32 8.05 7.95 8.04 7.99 7.53 7.72 6.97 7.13 8.14 7.33 7.33 7.82 7.71 7.9 7.5
GOBP_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_ASSEMBLY 6.92 6.78 7.17 6.94 6.93 7.14 6.77 6.56 6.61 6.86 7.07 6.93 6.62 6.78 6.9 7.02 6.71 6.74 7.18 6.82 6.62 7.18 6.8 6.92 6.96 6.99
GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_CYTOKINE_PRODUCTION 5.29 5.13 5.08 5.37 4.73 4.57 4.76 4.8 4.91 4.6 5.07 4.99 4.86 4.86 4.83 4.76 5.05 5.2 4.71 4.75 5.25 5.01 4.82 4.71 4.91 5.05
GOBP_T_HELPER_2_CELL_CYTOKINE_PRODUCTION 5.36 5.19 5.03 5.39 4.72 4.81 4.92 4.71 5.21 4.61 4.88 4.83 4.69 4.86 5.04 4.67 5 5.37 4.7 4.85 5.13 4.88 4.81 4.54 4.8 5.03
GOBP_REGULATION_OF_LYSOSOMAL_LUMEN_PH 8.39 8.21 8.7 8.51 8.08 8.17 8.24 8.25 8.04 8.16 8.22 8.32 8.02 8.07 8.13 8.19 8.01 8.11 7.89 8.38 7.81 7.92 8.07 8.3 8.3 8.01
GOBP_ENDOTHELIAL_CELL_CHEMOTAXIS 6.18 5.93 6.16 6.22 6.26 5.99 6.23 6.9 6.25 6.06 6.13 6.08 6.79 6.66 6.63 6.51 6.23 6.04 5.97 6.44 6.57 6.77 6.52 6.46 5.95 6.35
GOBP_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS 7.08 7.18 7.38 7.53 7.12 7.14 7.3 7.32 7.08 7.24 7.32 7.12 7.08 6.99 7.25 7.36 7.23 7.56 7.33 7.17 7.4 7.45 6.95 7.08 7.23 7.35
GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS 6.48 6.39 7 6.51 5.98 5.91 6.6 6.95 6.63 6.79 6.26 6.59 6.04 6.31 6.76 6.71 6.56 6.94 6.45 6.6 6.44 6.76 6.28 6.42 6.55 6.38
GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY 6.48 6.53 6.63 6.22 7.02 6.87 6.75 6.73 6.87 7.18 5.98 7.02 6.52 6.43 6.8 6.62 6.41 6.11 6.33 6.74 6.8 6.42 6.53 6.78 6.32 6.95
GOBP_REGULATION_OF_URINE_VOLUME 5.31 5.27 5.55 5.85 5.82 5.54 5.64 5.42 5.6 5.12 5.57 5.57 5.54 5.76 5.39 5.61 5.76 5.59 5.15 5.19 5.54 5.04 5.56 5.57 5.73 5.24
GOBP_POSITIVE_REGULATION_OF_URINE_VOLUME 6.15 6.19 5.64 6.35 6.39 5.67 5.77 5.58 5.6 5.45 6.53 5.87 5.64 5.76 5.39 5.66 6.75 6.2 6.41 6.09 6.19 6.43 5.56 5.68 5.96 6.33
GOBP_RENAL_SODIUM_EXCRETION 6.29 6.19 5.94 6.09 6.46 5.83 5.97 6.12 5.98 5.88 6.41 5.99 5.88 6.02 6.24 6.24 6.48 6.51 6.56 6.12 6.2 6.79 6.02 6.07 6.35 6.36
GOBP_POSITIVE_REGULATION_OF_RENAL_SODIUM_EXCRETION 6.42 6.2 6.24 6.33 6.54 6 6.17 6.66 6.36 6.32 6.53 6.11 6.13 6.29 7.09 6.81 6.74 6.83 6.71 6.15 6.21 7.15 6.4 6.46 6.75 6.39
GOBP_MODULATION_OF_PROCESS_OF_OTHER_ORGANISM 6.48 6.55 6.71 6.51 6.74 6.72 6.54 6.66 6.72 6.81 6.34 6.41 6.85 6.79 6.64 6.63 6.88 6.41 6.44 6.75 6.82 6.97 6.81 6.77 6.88 7.19
GOBP_HOMOLOGOUS_RECOMBINATION 5.08 5.39 5.07 5.43 5 4.74 4.95 4.96 4.73 4.71 4.91 4.99 4.66 4.44 4.78 4.82 5.17 5.36 4.96 4.77 5.24 4.96 4.68 4.65 4.93 5.12
GOBP_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION 5.71 5.92 6.08 6.11 5.88 5.77 5.71 5.68 5.79 6.06 6.01 5.67 6 6.02 5.73 5.97 5.75 5.81 5.79 5.82 5.95 5.9 5.78 5.85 5.53 5.74
GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT 6.11 6 6.26 6.09 6.13 6.07 6.08 6.18 6.36 6.28 6.04 6.27 6.11 5.97 6.29 6.29 6.09 6.03 5.97 5.92 6.2 6.24 6.44 6.14 6.2 6.28
GOBP_MEGAKARYOCYTE_DEVELOPMENT 7.31 7.47 6.87 7.27 7.84 8.13 7.99 7.75 7.58 7.71 7.26 7.52 7.46 7.45 7.79 7.53 7.94 7.42 7.68 8.02 7.03 6.97 7.38 7.71 7.47 7.43
GOBP_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY 5.31 5.34 5.4 5.67 4.86 4.77 5.61 5.36 5.31 5.17 5.48 5.2 4.76 4.87 5.56 5.14 5.24 5.45 4.87 5.08 5.53 5.24 5.19 4.65 5.28 5.21
GOBP_RESPONSE_TO_POTASSIUM_ION 7.32 6.4 7.14 6.46 7.84 7.67 7.76 7.72 7.59 7.88 7.54 7.82 7.14 6.87 8 6.97 7.67 6.94 6.44 7.91 6.33 7.14 7.79 7.98 7.3 7.05
GOBP_CELLULAR_RESPONSE_TO_POTASSIUM_ION 7.47 7.71 7.53 7.44 8.38 8.04 8.53 8.33 8.45 8 8.05 8.15 8.42 8.84 8.17 8.2 7.94 7.79 8.29 8.4 7.84 8.05 8.16 8.41 7.94 7.97
GOBP_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY 7.31 7.16 7.82 7.6 7.94 7.72 7.49 7.68 7.94 7.79 7.24 7.75 7.99 8.02 7.76 7.7 7.67 7.36 7.6 7.73 7.68 7.69 7.8 8.24 7.85 7.74
GOBP_ENTEROENDOCRINE_CELL_DIFFERENTIATION 6.14 6.07 6.31 6.36 6.25 6.09 6.24 6.19 6.09 6.53 5.94 6.38 6.31 6.51 6.38 6.32 6.55 6.07 6.32 6.35 6.38 6.51 6.14 6.25 5.94 6.29
GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION 6.63 6.68 6.78 6.44 7.01 6.74 7.05 6.85 6.93 7.22 6.53 7.26 7.41 7.46 7.1 6.89 7 6.78 6.64 6.95 6.99 6.97 7.19 7.26 7.19 7.11
GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS 5.62 5.61 5.42 6.57 5.1 5.34 5.67 6.11 5.24 5.37 5.45 5.61 5.41 5.43 5.94 5.55 5.62 5.57 5.51 5.61 5.41 5.27 5.52 5.04 5.42 5.15
GOBP_AORTA_DEVELOPMENT 6.79 6.68 6.44 6.35 7.33 7.03 6.9 6.86 6.93 7.22 6.53 7.08 7.16 6.96 6.59 6.86 7.24 6.79 6.52 6.88 7.02 7.05 6.97 7.01 6.92 6.71
GOBP_DORSAL_AORTA_DEVELOPMENT 7.08 7.65 7.22 6.74 8.17 8.05 7.95 8.27 8.05 7.3 7.54 7.88 8.32 8.15 7.18 7.36 8.19 7.78 7.97 8.45 8.36 8.61 7.71 7.62 8.2 8.09
GOBP_AORTA_MORPHOGENESIS 6.79 6.75 6.81 6.44 7.33 7.03 7.1 7.28 6.98 7.22 6.6 7.15 7.61 7.46 6.82 6.89 7.41 7.09 6.63 7.06 7.66 7.32 6.98 7.13 7.05 7.09
GOBP_SKELETAL_MUSCLE_CELL_DIFFERENTIATION 6.36 6.42 6.48 6.43 6.58 6.55 6.83 6.6 6.48 6.62 6.53 6.64 6.67 6.84 6.8 6.7 6.71 6.49 6.69 6.94 6.49 6.65 6.54 6.82 6.7 6.79
GOBP_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS 6.68 6.43 6.52 6.13 6.62 6.66 6.38 6.87 6.49 6.38 6.31 6.35 6.66 6.75 6.73 6.95 6.4 6.24 6.57 6.86 7.01 6.8 6.51 6.47 6.68 6.8
GOBP_STEROID_HORMONE_SECRETION 5.37 5.77 5.34 5.29 5.51 5.37 5.38 5.73 5.88 5.22 5.61 5.29 5.6 5.49 5.78 5.52 5.57 5.52 5.42 5.46 5.65 5.65 5.62 5.46 5.43 5.21
GOBP_CORTICOSTEROID_HORMONE_SECRETION 5.34 5.61 5.65 5.99 5.51 5.69 5.45 6.22 5.77 5.43 5.62 5.26 5.55 5.6 5.92 5.58 5.63 5.57 5.37 5.52 5.57 5.53 5.68 5.6 5.48 5.52
GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN 7.19 7.35 7.9 7.81 7.54 7.56 7.71 7.76 7.66 7.71 7.63 7.7 7.81 7.79 7.79 7.82 7.64 7.51 7.4 7.69 7.55 7.85 7.84 7.95 7.73 7.76
GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN 7.18 7.32 7.85 7.51 7.51 7.53 7.7 7.75 7.66 7.63 7.52 7.69 7.78 7.73 7.73 7.73 7.58 7.45 7.36 7.69 7.52 7.75 7.79 7.93 7.71 7.83
GOBP_PEPTIDYL_THREONINE_DEPHOSPHORYLATION 7.04 7.15 6.95 7.58 7.35 7.12 7.11 7.14 7.34 7.31 6.9 7.14 7.64 7.45 7.49 7.08 7.41 7.2 7.33 7.47 7.12 7.03 7.2 7.33 7.21 7.07
GOBP_ENDODERMAL_CELL_DIFFERENTIATION 5.69 5.59 5.2 5.29 5.15 5.05 5.11 5.08 5.08 4.92 5.15 4.99 5.09 5.01 4.95 5.06 5.25 5.24 5.28 4.95 5.51 5.06 5.01 4.77 4.95 5.22
GOBP_CHONDROCYTE_PROLIFERATION 5.8 5.53 6.34 5.87 6.2 5.69 5.94 6.12 6.21 6.15 5.83 5.82 5.84 5.91 6.09 6.01 5.85 5.88 5.14 5.57 6.04 5.8 6.71 5.85 5.82 5.58
GOBP_RESPONSE_TO_MUSCLE_STRETCH 7.43 7.27 7.39 7.48 7.44 7.22 7.27 7.18 7.57 7.77 7.03 7.74 8 7.98 7.77 7.66 7.25 7.18 7.35 7.64 7.61 8.14 7.56 7.54 7.63 7.39
GOBP_TETRAHYDROFOLATE_INTERCONVERSION 6.33 6.21 6.29 6.5 5.82 6.04 6.04 6.23 6.11 6.2 6.34 6.23 6.04 6.32 5.98 6.18 5.98 6.45 6.07 6.06 6.17 6.25 6.2 5.99 6.31 6.41
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS 7.2 7.08 7.45 7.52 7.32 7.18 7.53 7.76 7.43 7.35 7.54 7.37 7.36 7.51 7.65 7.47 7.57 7.39 7.09 7.55 8.01 7.98 7.36 7.71 7.5 7.54
GOBP_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR 6.71 6.67 6.65 6.58 6.82 7.03 5.84 5.94 7.05 6.24 6.14 6.06 7.54 7.25 6.64 6.79 6.1 5.98 6.23 6.92 6.97 7 6.2 6.77 6.52 6.9
GOBP_PROTEIN_LOCALIZATION_TO_ENDOSOME 7.58 7.63 8.4 8 8.01 8.31 8.49 8.55 8.38 8.81 8.22 8.77 8.42 8.38 8.17 7.82 7.98 8.08 7.93 8.71 7.83 8.08 8.68 8.84 8.55 8.36
GOBP_OSTEOCLAST_DEVELOPMENT 5.78 6.24 5.21 5.85 5.77 5.73 5.71 5.62 5.53 6.07 5.51 6.05 5.91 5.83 6.1 5.72 5.84 5.64 6.32 6.07 5.97 5.76 6.02 5.38 6.22 5.72
GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION 5.28 5.31 5.45 5.82 5.4 5.35 5.11 5.18 5.94 5.13 5.26 5.15 5.4 5.29 4.96 5.17 5.53 5.09 4.84 5.24 5.59 5.64 5.23 5.3 5.35 5.23
GOBP_FUCOSYLATION 5.39 5.78 5.45 5.61 5.29 5.26 5.41 5.16 5.39 5.2 5.17 5.18 5.23 5.32 5.69 5.18 5.37 5.25 5.11 5.21 5.42 5.52 5.25 5.3 5.49 5.62
GOBP_REPLACEMENT_OSSIFICATION 5.81 5.77 6 5.94 5.88 5.77 6.15 6.15 6.07 6 6.15 5.93 6.3 6.14 6.06 6 6.07 5.92 5.99 6.07 6.22 6.43 6 6.01 5.87 6.15
GOBP_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS 7.69 7.67 7.3 8.49 8.52 8.41 7.47 7.47 7.93 8.02 7.64 7.9 7.92 7.96 7.75 7.64 7.68 7.33 7.89 7.55 7.18 7.49 8.11 8.03 7.68 7.88
GOBP_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS 8.36 8.48 8.74 8.38 9.23 9.13 8.81 8.43 9.04 8.95 8.83 8.62 8.92 9.02 8.41 8.75 8.54 8.38 8.59 8.53 8.66 8.79 8.78 9.03 9.03 8.94
GOBP_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR 7.19 6.65 7.38 6.93 7.17 7.23 7.36 7.14 7.49 7.3 6.84 7.28 7.44 7.32 6.82 6.96 7.17 6.92 7.14 7.37 7.25 7 7.67 7.1 7.31 6.9
GOBP_HISTONE_H3_K9_TRIMETHYLATION 5.97 5.73 6.03 6.31 5.67 5.96 6.12 5.77 6.52 5.95 5.91 5.79 6.2 5.96 6.02 5.95 5.67 5.61 5.43 5.62 5.93 6.11 6.82 6.8 6.26 5.89
GOBP_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING 5.31 5.18 5.03 5.33 4.74 4.43 4.91 4.89 4.86 4.68 5.09 4.65 4.57 4.84 4.74 5.09 5.1 5.07 4.76 4.71 5.12 4.75 4.73 4.62 4.8 4.83
GOBP_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING 5.31 5.08 5.03 5.2 4.65 4.38 4.85 4.77 4.83 4.65 5.09 4.65 4.49 4.45 4.7 4.89 4.85 4.85 4.73 4.69 5.1 4.8 4.73 4.56 4.8 4.79
GOBP_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING 5.45 5.3 5.14 5.51 4.87 4.5 4.92 5.11 4.85 4.87 5.37 4.9 4.64 4.92 4.72 5.13 5.18 5.29 4.95 4.77 5.17 4.9 4.77 4.63 4.9 4.94
GOBP_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING 5.9 5.81 5.96 5.91 4.86 4.83 5.5 5.43 5.2 5.11 5.63 5.3 5.06 5.29 5.1 5.19 5.44 5.63 4.9 5.23 5.76 5.69 5.09 5.06 5.5 5.32
GOBP_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING 5.45 5.3 5.11 5.34 4.86 4.5 4.89 5.07 4.85 4.87 5.29 4.81 4.59 4.92 4.72 5.13 5.17 5.01 4.86 4.77 5.11 4.85 4.82 4.63 4.8 4.85
GOBP_OUTER_DYNEIN_ARM_ASSEMBLY 4.73 4.64 4.67 4.63 4.33 4.37 4.82 4.42 4.58 4.63 4.78 4.6 4.72 4.48 4.81 5.31 4.44 4.71 4.56 4.77 4.79 4.85 4.4 4.29 4.83 4.8
GOBP_MULTIVESICULAR_BODY_ORGANIZATION 7.12 7.24 8.46 8.58 7.52 7.59 7.91 7.52 7.69 7.49 7.89 7.7 7.35 7.49 7.79 7.66 7.26 7.16 7.35 7.67 7.57 7.67 7.89 8.08 7.74 7.42
GOBP_RNA_CAPPING 7.6 7.91 8.64 8.23 8.12 8.31 7.81 8.34 8.08 8.27 8.15 8.07 8.26 8.47 8.36 8.46 7.9 7.9 8.13 8.16 7.72 8.3 8.24 8.3 8.35 8.36
GOBP_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS 6.82 6.52 7.85 7.36 7.48 7.09 7.04 6.66 7.32 7.43 7.85 7.51 6.67 7 6.32 6.88 7.22 6.86 7.51 7.19 7.18 6.94 7.65 7.65 7.38 7.01
GOBP_RESPONSE_TO_INCREASED_OXYGEN_LEVELS 6.61 6.45 7.19 6.77 6.72 6.6 6.36 6.34 6.85 6.72 6.66 6.61 6.35 6.6 6.34 6.58 6.92 6.83 6.94 6.9 6.65 6.75 6.67 6.86 6.68 6.73
GOBP_INTERSTRAND_CROSS_LINK_REPAIR 5.66 5.69 5.75 6.04 5.63 5.56 5.7 5.86 5.94 5.8 5.68 5.7 5.81 5.76 5.8 5.75 5.65 5.69 5.79 5.75 5.7 5.71 5.73 6.05 5.75 5.76
GOBP_LYMPH_VESSEL_MORPHOGENESIS 5.95 5.98 5.76 5.87 6.03 6.07 6.08 6.21 5.96 5.81 5.98 6.11 6.02 6.05 5.91 6 6.01 5.68 5.89 5.82 5.88 6.08 6.1 6.06 5.85 6.16
GOBP_RESPONSE_TO_STEROL 6.34 6.57 6.65 6.68 6.89 6.59 6.67 6.34 6.63 6.67 6.45 6.38 6.62 6.97 6.45 6.59 6.54 6.73 6.84 6.36 6.53 6.76 6.94 6.58 6.78 6.78
GOBP_CELLULAR_RESPONSE_TO_STEROL 7.02 6.74 6.85 6.95 6.95 6.81 6.97 6.98 6.69 6.78 6.69 6.6 6.76 7.14 6.81 6.65 6.63 7.07 7.06 6.85 6.53 6.72 6.95 6.66 6.78 7.01
GOBP_DENDRITIC_CELL_MIGRATION 5.56 5.4 5.23 5.36 5.1 5.05 5.15 5.31 5.57 5.32 4.78 4.85 5.23 5.01 5.51 5.23 5.31 5.4 5.14 5.13 5.74 5.36 5.08 5.15 4.93 5.09
GOBP_POST_ANAL_TAIL_MORPHOGENESIS 5.74 5.62 5.81 5.57 5.71 5.51 5.63 5.5 5.71 5.75 5.79 5.73 5.74 5.75 5.85 5.74 5.67 5.63 5.48 5.46 5.58 5.67 5.62 5.51 5.57 5.75
GOBP_PLATELET_MORPHOGENESIS 6.55 6.57 7.06 6.95 7.16 7.13 6.91 7.14 7.26 7.22 7.27 7.01 7.08 7.16 6.98 6.97 6.95 6.61 7.01 7.28 6.58 6.86 7.15 7.35 7.05 6.87
GOBP_SODIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE 8.38 8.15 8.4 8.1 8.36 8.38 8.3 8.09 7.97 8.15 8.09 8.16 8.35 8.71 8.09 8.4 8.37 8.18 8.74 8.86 8.38 8.59 7.95 7.92 8.02 8.09
GOBP_TRAIL_ACTIVATED_APOPTOTIC_SIGNALING_PATHWAY 5.79 5.31 5.36 5.33 5.27 5.11 5.3 5.64 5.34 5.37 5.45 5.23 5.1 5.39 5.04 5.54 5.45 5.17 5.3 5.31 5.62 5.34 5.29 4.84 5.18 5.42
GOBP_SYNAPTIC_VESICLE_RECYCLING 8.06 8.01 8.26 8.17 8.18 8.65 8.27 8.43 8.17 8.37 8.12 8.48 8.33 8.34 8.72 8.51 8.17 8.06 8.13 8.22 7.82 8.28 8.57 8.44 8.54 8.18
GOBP_CELL_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS 6.76 6.81 7.76 7.56 7.24 7.13 7.26 7.07 7.18 7.09 7.49 7.14 7.2 7.17 7.5 7.48 6.99 7.06 7.1 7.2 7 7.29 7.82 7.47 7.43 7.24
GOBP_CELL_DEATH_IN_RESPONSE_TO_HYDROGEN_PEROXIDE 6.53 6.48 7.25 6.64 7.12 6.93 6.54 6.81 6.59 7.01 6.87 6.66 6.93 6.9 7.31 7.71 6.79 6.6 7.03 6.54 7.07 8.04 7.86 7.01 6.89 7.01
GOBP_NEURON_DEATH_IN_RESPONSE_TO_OXIDATIVE_STRESS 7.81 8.33 8.6 7.97 8.33 8.49 8.39 8.33 8.51 8.46 8.25 8.26 8.8 8.57 8.68 8.73 8.16 8.14 8.28 8.52 8.63 8.51 8.52 8.58 8.72 8.78
GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 6.48 6.7 7.48 6.91 7.7 7.32 7.42 7.44 7.67 7.24 7.41 6.98 7.38 7.18 7.3 6.81 7.42 7.07 7.48 7.5 7.52 7.63 7.62 7.66 7.48 7.49
GOBP_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE 7.01 7.3 7.86 7.47 7.51 7.53 7.83 7.81 7.65 7.44 7.44 7.63 7.79 7.82 7.64 7.64 7.58 7.53 7.39 7.69 7.6 7.89 7.54 8 7.8 7.52
GOBP_ERAD_PATHWAY 7.52 7.53 8.06 7.77 8.06 7.97 7.96 8.1 7.94 7.91 8.04 7.91 7.87 7.88 8.04 8.09 7.68 7.54 7.81 7.98 7.63 7.89 8.04 8.14 7.95 7.94
GOBP_PROTEIN_DEMANNOSYLATION 7.72 7.56 7.64 7.84 8.07 8.33 7.53 7.8 8.14 7.9 7.85 7.85 8.11 8.09 8.02 8.09 7.48 7.45 7.71 7.54 7.43 7.68 8.14 8.17 7.88 7.81
GOBP_OPIOID_RECEPTOR_SIGNALING_PATHWAY 6.82 6.92 6.54 6.24 6.95 6.64 6.87 7.28 7.17 6.89 6.69 6.77 7.02 7.12 7.19 7.2 6.53 6.54 7.03 6.87 7.17 7.07 6.69 7.15 6.96 7.17
GOBP_NETRIN_ACTIVATED_SIGNALING_PATHWAY 6.43 6.67 6.6 6.66 7.37 7.35 6.93 7.04 7.1 7.27 6.26 7.12 7.06 6.98 7 6.61 6.83 6.62 6.92 7.27 6.72 6.68 7.04 7.1 6.66 6.6
GOBP_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND 6.29 6.46 6.36 6.97 6.18 6.21 6.77 6.93 6.75 6.64 6.53 6.36 6.72 6.73 6.48 6.8 6.64 6.41 6.49 6.36 6.61 6.81 6.9 6.9 6.8 6.68
GOBP_NIK_NF_KAPPAB_SIGNALING 6.94 6.88 7.14 7.05 6.8 6.77 6.82 6.78 6.88 6.9 6.83 6.72 6.85 7.23 6.73 6.95 6.8 6.55 6.59 6.55 6.63 7 7.06 7.06 7.18 7
GOBP_COLLAGEN_ACTIVATED_TYROSINE_KINASE_RECEPTOR_SIGNALING_PATHWAY 5.19 4.89 5.2 5.44 4.95 4.91 5.32 5.46 5.27 4.95 5.09 4.7 5.15 4.95 5.19 5.03 4.79 5.38 5.09 4.91 5.3 5.1 5.53 4.89 5.08 5.14
GOBP_COLLAGEN_ACTIVATED_SIGNALING_PATHWAY 5.37 5.08 5.21 5.41 4.89 4.94 5.19 5.29 5.23 4.91 5.12 4.75 5.07 4.84 5.16 5.02 4.9 5.26 5.08 4.91 5.25 5.05 5.44 4.86 5.04 5.06
GOBP_P38MAPK_CASCADE 6.48 6.45 6.03 6.18 6.39 6.22 6.2 6.48 6.56 6.41 6.59 6.21 6.33 6.36 6.33 6.29 6.52 6.41 6.13 6.38 6.59 6.76 6.41 6.68 6.8 6.83
GOBP_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION 7.21 6.87 6.76 6.4 7.81 7.66 7.54 6.95 7.68 7.02 7.18 7.53 7.35 7.56 6.46 6.84 6.77 6.44 7.85 7.85 7.66 7.52 7.33 7.61 7.41 7.21
GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY 6.45 6.2 6.54 6.01 6.67 6.81 6.29 6.85 6.42 6.44 6.31 6.38 6.7 6.85 6.63 6.95 6.3 6.13 6.98 6.28 6.57 6.75 6.5 6.8 6.63 6.52
GOBP_NODAL_SIGNALING_PATHWAY 5.49 5.55 5.72 5.23 5.49 5.42 5.81 5.42 5.88 5.51 5.82 5.32 5.6 5.68 5.45 5.52 5.53 5.73 5.43 5.72 5.81 5.83 5.44 5.35 5.47 5.43
GOBP_FC_RECEPTOR_SIGNALING_PATHWAY 7.53 7.47 7.82 7.55 7.88 7.98 8.05 7.9 7.98 7.9 7.75 7.81 7.95 7.91 7.98 8 7.66 7.53 7.77 7.95 7.57 7.85 8.05 8.11 7.79 7.83
GOBP_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY 7.35 7.41 7.85 7.62 7.86 7.89 8.03 7.85 7.98 7.99 7.62 7.79 7.92 7.86 7.92 7.76 7.65 7.3 7.56 7.73 7.47 7.66 8.05 8.15 7.79 7.74
GOBP_INTERLEUKIN_7_MEDIATED_SIGNALING_PATHWAY 5.7 5.79 5.39 5.77 5.34 5.28 5.66 5.67 5.55 5.42 5.51 5.26 5.46 5.48 5.79 5.65 5.44 5.65 5.23 5.34 5.64 5.44 5.44 5.18 5.56 5.51
GOBP_ERBB_SIGNALING_PATHWAY 7.19 7.19 7.28 7.31 7.58 7.66 7.43 7.37 7.58 7.35 7.16 7.47 7.5 7.61 7.44 7.39 7.29 7.35 7.31 7.46 7.24 7.39 7.67 7.73 7.43 7.4
GOBP_ERBB2_SIGNALING_PATHWAY 6.82 7.17 7.19 7.76 7.57 7.68 7.18 7.03 7.69 7.36 7.42 7.35 7.66 7.9 7.35 7.25 7.21 7.07 7.23 7.46 7.22 7.19 7.76 7.87 7.49 7.29
GOBP_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY 6.9 6.63 7.91 7.4 8.16 7.55 7.7 6.8 7.75 7.72 8.23 7.99 7.33 7.54 6.98 6.99 7.77 6.82 7.5 7.67 7.48 7.2 8.74 7.94 7.75 7.33
GOBP_NEUROTROPHIN_SIGNALING_PATHWAY 7.31 7.49 7.71 7.17 7.59 8.41 7.82 7.99 8.04 7.83 7.32 7.84 8.27 8.11 8.09 7.67 7.72 7.45 7.67 7.8 7.99 7.92 8.03 7.92 7.9 7.9
GOBP_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY 7.08 7.49 7.71 6.91 7.59 8.57 8.46 7.99 8.33 7.83 7.45 7.84 8.4 8.34 8.25 8.04 7.27 7.46 7.67 8.35 8.12 7.92 8.13 8.27 8.28 7.9
GOBP_BILE_ACID_SIGNALING_PATHWAY 4.77 4.66 4.58 4.79 4.48 4.03 4.26 4.28 4.36 4.51 4.39 4.35 4.18 4.31 4.29 4.26 4.5 4.65 4.57 4.12 4.77 4.34 4.21 4.16 4.3 4.54
GOBP_TORC1_SIGNALING 7.15 7.3 7.78 7.86 7.05 7.45 7.16 7.25 7.24 7.53 7.15 7.18 7.24 7.35 7.53 7.54 7.07 7.08 7.22 7.24 7.08 7.44 7.39 7.43 7.52 7.32
GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY_IN_RESPONSE_TO_VIRUS 6.14 6.12 6.28 6.58 6.6 6.22 6.53 6.37 6.48 6.44 6.22 6.44 6.19 6.24 6.64 6.17 6.5 5.72 6.23 6.09 6.78 6.96 6.77 6.84 6.75 6.5
GOBP_RIG_I_SIGNALING_PATHWAY 6.14 6.32 5.92 6.24 6.78 6.26 6.34 6.64 6.69 6.25 6.18 6.35 6.11 5.92 6.35 6.09 6.23 6.41 6.27 6.31 6.58 6.43 6.53 6.75 6.38 6.85
GOBP_REGULATION_OF_VIRAL_INDUCED_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY 6.29 6.42 6.81 6.71 6.78 6.26 6.86 6.64 6.89 6.45 6.34 6.49 6.32 6.55 6.72 7.07 6.87 6.7 6.4 6.5 7.32 7 7.11 7.09 7.04 7.07
GOBP_REGULATION_OF_RIG_I_SIGNALING_PATHWAY 6.14 6.32 5.92 6.24 6.78 6.26 6.34 6.64 6.69 6.25 6.12 6.35 6.09 5.88 6.16 6.09 6.22 6.41 6.08 6.25 6.58 6.43 6.48 6.75 6.38 6.9
GOBP_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE 5.34 5.22 5.69 5.27 4.59 5.03 5.03 5.14 5.09 4.61 5.04 4.72 5.3 4.71 5.42 5.19 5.3 5.58 5.31 5.06 5.41 5.27 4.64 4.63 5.18 5.15
GOBP_VIRAL_RNA_GENOME_REPLICATION 6.93 6.8 7.48 7.53 7.03 7.05 7 7.34 7.28 6.89 7.34 7 7.25 7.25 7.27 7.36 6.79 6.74 7.08 7.17 6.74 7.27 7.23 7.5 7.13 7.15
GOBP_VIRAL_BUDDING_VIA_HOST_ESCRT_COMPLEX 7.05 6.7 8.38 7.53 7.02 7.05 7.09 7.17 7.52 7.3 7.27 6.98 7.15 7.17 7.61 7.36 6.77 6.8 7.13 7.37 7.03 7.43 7.54 7.62 7.49 7.21
GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION 6.93 6.79 6.51 6.74 7.41 7.21 6.55 6.37 6.52 6.67 7.15 6.52 6.69 7.05 6.44 6.84 6.48 6.84 6.73 6.55 6.49 6.61 6.74 6.87 6.54 6.8
GOBP_GROWTH 6.66 6.65 6.93 6.74 6.95 6.92 6.93 6.98 6.92 6.97 6.77 6.88 6.99 7.01 6.92 6.93 6.8 6.81 6.76 6.95 6.87 6.98 7 7.01 7.03 7.05
GOBP_REGULATION_OF_GROWTH 6.63 6.6 6.93 6.78 6.89 6.83 6.85 6.93 6.88 6.93 6.72 6.88 6.92 6.97 6.92 6.88 6.74 6.72 6.69 6.91 6.85 6.93 6.97 7 7 6.99
GOBP_LOCOMOTION 6.33 6.3 6.37 6.35 6.32 6.33 6.34 6.34 6.32 6.32 6.33 6.28 6.37 6.39 6.37 6.44 6.42 6.34 6.25 6.3 6.5 6.49 6.46 6.39 6.48 6.48
GOBP_NEGATIVE_REGULATION_OF_LOCOMOTION 6.7 6.71 6.84 6.6 7.06 6.82 6.81 7.05 6.88 7 6.68 6.89 7.01 6.93 6.86 6.8 6.79 6.54 6.56 6.86 6.77 6.96 7.01 7.03 6.92 6.98
GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH 6.54 6.58 6.65 6.74 7.14 7.16 7.27 7.12 7.19 7.11 6.84 6.87 7.01 7.19 7.49 7.38 6.61 6.92 6.62 7.06 7 6.82 7.19 7.22 7.11 7.17
GOBP_POSITIVE_REGULATION_OF_LOCOMOTION 6.36 6.35 6.55 6.42 6.4 6.48 6.36 6.51 6.53 6.42 6.34 6.32 6.45 6.5 6.39 6.5 6.53 6.37 6.31 6.38 6.61 6.66 6.54 6.47 6.52 6.47
GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH 6.28 6.15 6.43 6.48 6.44 6.29 6.17 6.71 6.7 6.63 6.66 6.64 6.67 6.8 6.52 6.67 6.5 6.58 6.12 6.51 6.85 6.58 7.02 6.85 6.62 6.75
GOBP_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT 5.7 5.01 5.59 6.19 5.54 4.89 5.3 5.35 5.51 5.57 6.23 4.96 4.94 5.12 5.83 5.07 5.68 5.17 5.56 5.08 5.88 5.17 5.17 4.65 4.92 5.39
GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION 5.22 4.86 5.05 5.26 5.06 4.65 4.71 4.78 5.12 4.78 5.44 4.77 4.58 4.87 5.1 4.87 5.09 5.14 4.9 4.89 5.12 4.74 5.01 4.7 4.72 4.87
GOBP_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC 6.93 7.02 7.18 7.31 7.4 7.47 7.14 7.27 7.06 7.35 7.07 7.39 7.23 7.35 7.31 7.29 7.08 6.97 7.28 7.33 7.15 7.25 7.3 7.38 7.23 7.34
GOBP_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 5.53 5.44 5.78 5.99 5.57 5.65 5.91 5.84 5.67 5.6 5.51 5.39 5.98 5.91 6.07 5.66 5.86 5.64 5.7 5.57 5.8 5.78 5.9 5.19 5.91 5.79
GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 5.53 5.44 5.78 6.15 5.57 5.65 5.8 5.75 5.67 5.91 5.75 5.39 5.98 5.91 6.08 5.5 5.86 5.64 5.7 5.54 5.8 6.02 6.12 5.07 5.55 5.73
GOBP_PROTEIN_REFOLDING 7.6 8.09 8.95 8.76 8.86 8.84 8.8 9.04 8.63 8.89 8.78 8.81 8.91 9.05 9.09 9.1 8.51 8.31 8.4 8.89 8.52 9.15 9.15 9.37 8.98 8.67
GOBP_FLUID_TRANSPORT 5.66 5.53 5.41 5.86 5.34 5.2 5.57 5.42 5.4 5.4 5.45 5.4 5.21 5.01 5.39 5.31 5.72 5.51 5.48 5.14 5.36 5.27 5.16 5.08 5.3 5.58
GOBP_EPITHELIAL_FLUID_TRANSPORT 6.05 5.86 5.45 5.87 5.98 5.49 5.49 5.29 5.36 5.43 6.03 5.76 5.42 5.38 5.16 5.49 6.32 5.8 5.95 5.62 5.76 5.83 5.28 5.3 5.63 6.04
GOBP_WOUND_HEALING 6.1 6.03 6.18 6.24 6.1 6.06 6.09 6.18 6.09 6.06 6.13 6.08 6.08 6.05 6.06 6.11 6.23 6.11 6.02 6.02 6.31 6.23 6.16 5.98 6.17 6.17
GOBP_GLIOGENESIS 6.83 6.9 7.18 6.95 7.32 7.32 7.2 7.29 7.27 7.28 6.95 7.32 7.51 7.34 7.23 7.28 7.21 7.02 7 7.45 7.14 7.38 7.21 7.37 7.17 7.43
GOBP_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS 7.33 7.38 7.61 7.74 7.08 7.28 7.03 7.32 7.17 7.05 7.08 6.93 7.7 7.89 8.22 7.59 6.61 6.99 6.99 7.47 7.3 7.89 6.99 7.21 7.15 7.46
GOBP_INTRACILIARY_TRANSPORT 6.44 6.6 7.05 6.79 6.59 6.74 6.44 6.55 6.53 6.8 6.94 6.84 6.54 6.72 6.65 6.92 6.43 6.65 6.91 6.59 6.51 6.88 6.69 6.81 6.89 6.79
GOBP_CELL_MIGRATION_INVOLVED_IN_GASTRULATION 4.97 5.05 5.02 5.54 4.73 4.41 4.88 4.96 4.61 4.69 5.14 4.62 4.7 4.61 4.67 4.98 4.97 4.99 4.63 4.57 5.16 4.75 4.4 4.55 4.75 5
GOBP_T_HELPER_1_TYPE_IMMUNE_RESPONSE 5.44 5.37 5.13 5.48 4.91 4.98 5.49 5.41 5.17 5.02 5.42 4.92 5.23 5.07 5.13 5.04 5.3 5.39 5.13 5.16 5.21 5.14 5.1 4.88 5.27 5.52
GOBP_TYPE_2_IMMUNE_RESPONSE 5.36 5.39 5.33 5.44 4.94 4.99 5.34 5.35 5.22 5 5.15 5.17 5.26 5.08 5.19 5.38 5.14 5.32 5.16 5.13 5.46 5.28 5.07 4.93 5.27 5.51
GOBP_T_CELL_PROLIFERATION 5.52 5.44 5.42 5.62 5.23 5.08 5.37 5.28 5.5 5.27 5.42 5.19 5.33 5.12 5.44 5.26 5.5 5.36 5.14 5.22 5.49 5.41 5.21 5.12 5.32 5.52
GOBP_B_CELL_PROLIFERATION 5.44 5.22 5.38 5.12 5.01 4.9 4.98 5.14 5.3 5.03 5.29 4.93 5.09 5.13 5.13 5.16 5.1 5.32 5.01 4.94 5.28 5.17 5.05 4.84 5.21 5.28
GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION 5.43 5.15 5.25 5.35 4.88 4.89 5.07 5.11 5.15 5.04 5.18 4.9 5.19 4.96 5.16 5.06 5.13 5.09 4.91 4.92 5.21 5.09 4.97 4.85 5.11 5.35
GOBP_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION 5.28 5.12 5.27 5.33 4.74 4.78 5.06 5.02 5.13 5.08 5.18 4.82 5.06 4.76 5.05 4.96 5.03 5.01 4.79 4.79 5.1 5 5.02 4.75 4.94 5.16
GOBP_T_CELL_ACTIVATION 5.64 5.5 5.63 5.67 5.36 5.26 5.46 5.47 5.53 5.35 5.53 5.32 5.47 5.4 5.53 5.45 5.61 5.52 5.33 5.38 5.58 5.56 5.36 5.25 5.54 5.62
GOBP_B_CELL_ACTIVATION 5.82 5.94 5.77 5.84 5.52 5.55 5.75 5.65 5.82 5.61 5.68 5.64 5.64 5.59 5.76 5.72 5.63 5.7 5.56 5.58 5.97 5.87 5.59 5.52 5.76 5.86
GOBP_MACROPHAGE_ACTIVATION 5.54 5.61 5.7 5.82 5.37 5.3 5.42 5.24 5.36 5.21 5.55 5.28 5.53 5.32 5.29 5.49 5.35 5.52 5.29 5.27 5.76 5.78 5.51 5.24 5.53 5.75
GOBP_MONOCYTE_ACTIVATION 7.61 7 6.65 6.8 6.16 6.72 6.28 7.07 6.85 6.91 6.78 7.16 5.99 6.17 6.6 6.79 6.88 7.48 5.96 6.65 7.39 7.16 6.99 5.76 7.64 7.84
GOBP_ENDOTHELIAL_CELL_ACTIVATION 6.26 6.33 6.69 7.6 6.49 6.22 6.17 6.42 6.31 6.56 6.59 6.32 6.47 6.6 6.33 6.85 6.55 6.6 6.34 6.31 6.35 6.59 6.88 6.71 6.59 6.7
GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION 5.51 5.57 5.35 5.71 5.29 5.01 5.42 5.37 5.72 5.31 5.59 5.24 5.2 5.22 5.57 5.26 5.51 5.56 5.16 5.34 5.6 5.53 5.17 5.16 5.4 5.51
GOBP_NEUROTRANSMITTER_METABOLIC_PROCESS 6.17 6.06 6.4 6.43 6.19 6.17 6.58 6.42 6.35 6.26 6.91 6.28 6.66 6.28 6.41 6.15 6.16 6.01 5.9 6.61 6.53 6.63 6.16 6.5 6.82 6.28
GOBP_NEUROTRANSMITTER_CATABOLIC_PROCESS 6.61 6.56 7.36 6.93 6.45 6.77 6.88 7.13 7.29 7.02 7.23 7.26 7.32 7.33 6.82 6.91 6.66 6.73 7 7.02 6.99 7 6.72 7.04 7.01 6.67
GOBP_NEUROTRANSMITTER_BIOSYNTHETIC_PROCESS 5.99 5.77 6.18 5.22 5.73 5.25 6.26 5.8 6.35 6.11 6.1 6.11 5.87 5.84 5.6 5.83 6.39 5.42 5.59 5.29 5.43 5.91 5.72 6.03 6.76 6.1
GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI 7.71 7.82 8.14 8.2 8.13 8.31 8.45 7.99 8.09 8.11 7.9 8.11 8.2 8.2 8.06 8 8.04 7.64 7.9 8.27 7.7 8.05 8.09 8.2 8.12 8.01
GOBP_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION 6.94 7 7.29 6.89 7.12 7.04 7.06 7.32 6.85 7.01 6.84 7.13 7.02 7 7.5 6.98 7.07 7.04 6.78 7.19 7.14 7.3 7.11 7.41 7.01 7.36
GOBP_LIPOPROTEIN_METABOLIC_PROCESS 7.14 7.21 7.54 7.45 7.19 7.27 7.16 7.14 7.3 7.33 7.15 6.96 7.21 7.24 7.29 7.07 7.03 7.03 7.2 7.22 6.96 7.24 7.07 7.29 7.27 7.2
GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS 7.37 7.31 7.69 7.54 7.34 7.7 7.39 7.39 7.45 7.39 7.21 7.23 7.45 7.48 7.45 7.17 7.2 7.33 7.47 7.59 7.11 7.32 7.13 7.39 7.48 7.47
GOBP_LIPOPROTEIN_CATABOLIC_PROCESS 7.6 7.74 9.6 8.95 8.43 8.56 8.25 8.08 8.72 8.31 8.96 7.84 8.24 8.29 8.38 8.63 8 7.88 8.04 8.11 7.77 8.21 8.78 8.58 8.35 7.95
GOBP_HEME_METABOLIC_PROCESS 6.48 6.85 7.38 7.1 6.95 7.05 6.89 7 7.09 7.04 6.78 6.82 7 6.9 6.92 6.92 6.92 6.65 6.72 6.94 6.57 6.56 6.83 7.26 7.48 7.54
GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS 7.39 7.4 7.87 7.76 7.73 7.81 7.7 7.74 7.7 7.76 7.63 7.83 7.87 7.84 7.73 7.78 7.69 7.55 7.59 7.83 7.62 7.81 7.88 7.98 7.83 7.71
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS 7.58 7.71 8.11 7.83 8.09 7.98 7.96 8.02 7.91 8.03 7.78 8.15 8.01 8.01 7.88 7.9 8.02 7.73 7.86 8.13 8 8 8.18 8.07 8.25 8.04
GOBP_XENOBIOTIC_CATABOLIC_PROCESS 6.16 5.76 8.08 6.76 5.63 5.51 5.82 6.07 6.15 6.63 7.03 6.6 6.34 6.15 6.54 6.68 5.61 5.62 5.72 5.63 6.74 6.66 6.48 5.8 6.92 6.33
GOBP_CELLULAR_KETONE_METABOLIC_PROCESS 6.41 6.58 7.14 6.94 6.78 6.81 6.87 6.88 7.11 6.98 6.93 6.86 6.94 7.09 6.82 6.74 6.76 6.69 6.52 6.93 6.65 6.8 7.16 7.14 7.11 6.92
GOBP_KETONE_BIOSYNTHETIC_PROCESS 5.9 5.78 5.91 5.9 5.91 5.39 5.74 5.81 5.77 5.62 5.88 5.75 5.61 5.7 5.72 5.77 5.76 5.79 5.43 5.78 5.78 5.72 5.55 5.57 5.73 5.75
GOBP_KETONE_CATABOLIC_PROCESS 5.84 6.49 5.79 5.39 5.31 5.66 5.69 5.39 5.98 5.24 5.51 5.73 6.01 6.14 5.35 5.74 5.95 6.17 5.68 5.73 6.62 5.91 5.69 5.23 6.08 5.92
GOBP_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS 5.53 5.89 6.83 6.47 5.74 6.18 6.36 6.37 6.07 6.25 6.24 6.77 6.22 6.18 6.16 6.06 5.81 6.29 6.38 6.18 6.42 6.14 6.05 6.21 6.05 5.88
GOBP_RESPONSE_TO_COCAINE 7.3 7.12 7.63 7.25 7.65 7.9 7.88 7.83 7.42 7.7 7.32 7.65 7.59 7.7 7.93 7.41 7.39 7.36 7.51 7.74 7.14 7.12 7.64 7.89 7.18 7.16
GOBP_TISSUE_REGENERATION 6.27 6.29 6.57 6.69 6.64 6.57 6.57 6.41 6.65 6.44 6.2 6.26 6.17 6.28 6.37 6.48 6.46 6.48 6.29 6.32 6.42 6.3 6.59 6.35 6.53 6.65
GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_OF_EMBRYONIC_EPITHELIUM 5.82 5.89 5.98 5.72 5.69 5.53 6.09 5.82 5.78 5.36 6.04 5.54 5.8 5.77 5.6 5.61 6.04 5.66 5.67 5.65 6.04 6.04 5.56 5.61 5.68 5.92
GOBP_RIBOSOME_BIOGENESIS 6.41 6.49 6.86 6.91 6.51 6.5 6.6 6.67 6.66 6.75 6.72 6.78 6.63 6.65 6.74 6.69 6.37 6.47 6.58 6.65 6.48 6.69 6.66 6.79 6.69 6.62
GOBP_RIBOSOME_ASSEMBLY 6.07 6.22 6.76 6.71 6.05 6.08 6.42 6.65 6.21 6.35 6.58 6.57 6.29 6.3 6.49 6.31 6.27 6.26 5.93 6.41 6.44 6.57 6.6 6.36 6.51 6.51
GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS 6.18 6.42 6.78 6.78 6.53 6.32 6.42 6.65 6.35 6.57 6.77 6.62 6.5 6.61 6.76 6.76 6.53 6.47 6.57 6.65 6.47 6.79 6.59 6.69 6.55 6.52
GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS 6.1 6.32 6.31 6.3 6.26 6.12 6.12 6.43 6.12 6.28 6.36 6.24 6.33 6.25 6.4 6.43 6.19 6.03 6.1 6.13 6.31 6.38 6.26 6.49 6.18 6.49
GOBP_ERROR_PRONE_TRANSLESION_SYNTHESIS 7.04 7.01 7.58 7.64 7.46 7.56 7.19 7.03 6.57 6.99 7.4 7.07 7.33 7.14 6.79 7.07 7.05 6.73 7.49 7.06 6.7 7.23 7.03 7.05 7.13 6.93
GOBP_PURINE_NUCLEOSIDE_METABOLIC_PROCESS 6.77 7.07 7.84 7.56 7.24 7.35 7.11 7.07 6.95 7.28 7.6 7.28 7.19 7.42 7.03 7.35 7.11 6.99 7.07 7.25 6.91 7 7.31 7.36 7.51 7.31
GOBP_MOLTING_CYCLE 5.79 5.75 5.6 5.85 5.45 5.55 5.82 5.76 5.69 5.78 5.73 5.6 5.69 5.71 5.79 5.76 5.78 5.72 5.58 5.58 5.97 5.95 5.62 5.49 5.69 5.81
GOBP_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS 5.94 6.23 6.31 6.44 6.2 6.01 6.09 6.17 5.93 6.25 6.02 6.17 6.37 6.04 6.06 6.31 6.33 5.87 5.72 5.82 6.31 6.38 6.26 6.29 6.42 6.5
GOBP_VASOCONSTRICTION 5.86 5.62 5.63 5.59 5.38 5.47 5.77 5.61 5.66 5.72 5.88 5.42 5.72 5.76 5.63 5.56 5.76 5.8 5.39 5.74 5.93 5.73 5.6 5.48 5.67 5.6
GOBP_VASODILATION 6.41 6.23 7.16 6.57 6.45 7.03 6.42 6.49 7.21 6.41 6.68 6.29 6.69 6.3 6.45 6.76 6.41 6.4 6.29 6.61 6.5 6.64 6.93 6.72 6.79 6.74
GOBP_NEGATIVE_REGULATION_OF_PHOSPHORYLATION 6.7 6.8 7.13 7 7.05 7.03 6.97 7 7.03 7.08 7 7.1 7.11 7.18 7.11 7.13 6.84 6.91 6.92 7.05 6.94 7.15 7.28 7.29 6.94 7.04
GOBP_TAXIS 6.17 6.07 6.23 6.22 6.13 5.99 6.13 6.18 6.12 6.13 6.08 5.98 6.07 6.11 6.27 6.24 6.14 6.08 5.91 6.11 6.32 6.34 6.13 6.06 6.15 6.2
GOBP_KERATAN_SULFATE_METABOLIC_PROCESS 6.49 6.41 7.73 7.52 6.99 7.44 7.25 7.43 6.99 7.32 7.29 7.07 7.28 7.07 6.9 7.5 7.35 6.77 6.98 7.57 7.33 7.44 7.26 7.12 7.23 7.3
GOBP_KERATAN_SULFATE_CATABOLIC_PROCESS 6.38 5.96 6.81 6.61 6.28 6.02 6.46 6.33 5.79 5.96 6.51 6.87 5.81 5.7 5.65 5.96 6.58 5.99 5.68 6.04 6.79 6.97 6.31 6.53 5.78 5.77
GOBP_VITAMIN_D_METABOLIC_PROCESS 5.09 4.87 4.71 4.84 4.58 4.44 4.89 4.69 4.74 4.72 4.73 4.52 4.46 4.62 4.77 4.85 4.89 4.81 4.62 4.59 4.81 4.88 4.76 4.55 4.81 4.41
GOBP_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS 5.23 5.02 5.32 6.07 5.39 5.49 5.3 4.81 5.33 5.23 5.17 5.33 5.48 5.38 5.49 5.44 5.42 5.26 5.36 5.27 5.12 5.23 5.15 5.49 5.59 5.4
GOBP_VITAMIN_D_BIOSYNTHETIC_PROCESS 5.14 4.87 4.96 5.14 4.9 4.86 4.93 4.8 4.99 5.02 4.77 4.6 5.04 5.19 5.19 5.05 4.92 4.71 4.87 4.69 4.9 4.99 4.84 4.88 5.12 4.63
GOBP_REGULATION_OF_MEMBRANE_POTENTIAL 7.12 7.15 7.43 7.11 7.4 7.24 7.37 7.54 7.34 7.46 7.28 7.33 7.44 7.48 7.58 7.4 7.17 7.13 7.44 7.53 7.23 7.28 7.3 7.64 7.38 7.32
GOBP_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS 6.59 6.6 7.16 7.1 6.73 6.77 7.05 6.95 6.91 7.03 7.07 7.18 6.84 6.94 7.09 6.98 7.11 6.9 6.89 6.88 6.99 6.93 6.86 6.93 6.98 6.95
GOBP_THYROID_HORMONE_METABOLIC_PROCESS 5.34 5.12 4.96 5.28 4.66 4.79 5.28 4.87 5.15 4.89 5.15 4.83 4.92 4.8 5.08 5 5.11 4.98 4.7 4.66 5.05 4.97 4.86 4.56 5.09 4.84
GOBP_CRISTAE_FORMATION 7.3 7 7.53 7.56 7.72 7.77 7.53 7.56 7.54 7.61 7.5 7.41 7.74 7.86 7.81 8.04 7.04 7.57 7.67 7.95 7.47 7.9 7.81 8.1 7.55 7.6
GOBP_DOPAMINE_BIOSYNTHETIC_PROCESS 6.05 5.99 6.26 7.76 5.54 5.29 5.67 6.16 5.54 6.11 6.01 5.9 5.85 5.84 6.94 6.27 6.1 5.64 5.64 5.41 5.56 6.15 5.9 5.27 5.3 5.23
GOBP_DOPAMINE_METABOLIC_PROCESS 6.56 6.89 6.81 6.51 6.42 6.69 6.54 6.73 6.78 6.35 6.63 6.25 7.03 6.87 7.06 6.84 6.4 6.6 7.21 6.77 6.81 7.17 6.37 7.12 6.91 6.87
GOBP_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS 5.11 5.02 5.01 5.17 4.8 4.68 5 4.77 4.99 4.96 4.66 4.72 5.04 4.31 4.68 4.7 5 5.03 5.18 4.63 5.09 4.62 4.75 4.5 4.52 4.62
GOBP_PIGMENT_METABOLIC_PROCESS 6.35 6.38 7.1 6.67 6.85 6.86 6.81 6.79 6.68 6.82 6.59 6.43 6.78 6.79 6.68 6.65 6.79 6.52 6.63 6.6 6.38 6.52 6.64 6.91 6.53 6.6
GOBP_HORMONE_METABOLIC_PROCESS 5.6 5.43 5.45 5.51 5.2 5.07 5.47 5.37 5.35 5.21 5.41 5.17 5.29 5.16 5.36 5.25 5.38 5.48 5.27 5.17 5.45 5.32 5.29 5.07 5.36 5.27
GOBP_HORMONE_BIOSYNTHETIC_PROCESS 5.46 5.32 5.43 5.4 5.13 4.97 5.43 5.35 5.37 5.21 5.53 5 5.27 5.25 5.4 5.23 5.28 5.37 5.21 5.28 5.41 5.24 5.36 5.27 5.39 5.39
GOBP_HORMONE_CATABOLIC_PROCESS 7.61 7.15 7.96 7.12 7.15 8.12 7.63 7.12 8 7.25 7.66 7.2 8 7.72 7.58 7.7 7.34 6.98 7.61 7.9 7.07 7.22 8.1 7.97 7.7 6.83
GOBP_PROGESTERONE_METABOLIC_PROCESS 6.09 6.02 6.33 6 5.97 5.36 5.74 6.23 5.91 5.79 6.09 5.75 5.89 5.7 5.72 5.76 6.19 5.86 5.15 5.46 5.7 5.71 6.22 5.57 6.18 5.75
GOBP_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS 6.82 7.47 8.49 8.53 7.41 7.68 7.95 7.73 7.67 7.96 8.12 7.63 7.59 7.72 7.84 8.34 7.84 7.82 7.55 8.04 7.89 7.99 7.59 7.39 8.22 8.06
GOBP_RIBONUCLEOSIDE_CATABOLIC_PROCESS 5.34 5.41 5.71 5.55 5.02 4.84 5.03 5.07 5.21 4.72 5.29 5.13 4.91 4.71 4.9 5.19 5.38 5.47 4.99 4.98 5.35 5.22 4.64 4.61 5.22 5.15
GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT 5.91 5.93 6.09 5.95 6.06 6.2 6.32 5.77 6.28 6.13 6.25 6 5.86 5.9 6.09 6.12 6.04 6.1 5.79 5.94 6.03 5.97 5.9 6.03 6.09 5.76
GOBP_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT 5.83 5.96 6.08 5.99 6.01 6.05 5.98 5.6 6.11 6.2 5.97 6.01 5.86 5.87 6.05 5.95 6.01 5.97 5.79 5.94 6.07 5.9 5.94 6.01 5.98 5.91
GOBP_EAR_MORPHOGENESIS 5.62 5.46 5.46 5.69 5.53 5.2 5.49 5.43 5.6 5.39 5.84 5.34 5.39 5.51 5.41 5.39 5.45 5.68 5.36 5.48 5.5 5.44 5.51 5.19 5.54 5.41
GOBP_INNER_EAR_MORPHOGENESIS 5.5 5.43 5.35 5.54 5.36 5.13 5.46 5.29 5.6 5.2 5.78 5.1 5.38 5.33 5.38 5.25 5.44 5.54 5.34 5.2 5.44 5.32 5.12 5.11 5.39 5.22
GOBP_MIDDLE_EAR_MORPHOGENESIS 5.39 5.39 5.82 5.85 5.55 5.4 5.77 5.58 5.6 5.45 5.89 5.34 5.64 5.76 5.39 5.87 5.1 5.46 5.14 5.57 5.5 5.64 5.56 5.54 5.82 5.69
GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH 5.65 5.49 5.7 5.72 5.47 5.31 5.64 5.72 5.63 5.61 5.8 5.26 5.42 5.54 5.63 5.63 5.79 5.71 5.4 5.57 5.68 5.61 5.47 5.18 5.53 5.58
GOBP_ODONTOGENESIS 5.65 5.58 5.64 5.68 5.46 5.32 5.65 5.54 5.64 5.57 5.66 5.35 5.4 5.48 5.54 5.63 5.71 5.59 5.32 5.47 5.71 5.75 5.52 5.17 5.46 5.43
GOBP_REGULATION_OF_ODONTOGENESIS 5.27 5.31 5.3 5.31 5.1 4.78 5.34 4.86 5.32 5.02 5.33 4.71 5.21 5.18 5.09 4.77 5.07 5.46 4.51 4.81 4.99 5.16 5.2 5.07 5.07 4.8
GOBP_MECHANORECEPTOR_DIFFERENTIATION 6.15 6.15 5.85 5.98 5.97 6.2 5.92 6.08 6.07 6 6.15 6.03 5.83 6.07 5.91 5.86 6.24 6.01 5.93 5.9 6.1 6.02 6.03 6.09 5.95 6.08
GOBP_INNER_EAR_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION 6.17 6.25 6.44 6.05 6.11 6.42 6.51 6.08 6.33 6.32 6.42 6.21 6.39 6.53 6.37 6.1 6.5 6.12 6.12 6.29 6.28 6.56 6.29 6.28 6.37 6.48
GOBP_GAMMA_DELTA_T_CELL_DIFFERENTIATION 5.69 5.56 6.03 5.67 5.77 5.88 5.67 5.68 5.54 5.37 5.4 5.5 5.81 5.59 5.52 5.52 5.99 5.72 5.41 5.48 5.62 5.85 5.49 5.52 5.69 6.07
GOBP_RESPONSE_TO_DRUG 6.17 6.18 6.37 6.41 6.15 6.16 6.27 6.21 6.35 6.26 6.26 6.18 6.39 6.36 6.27 6.29 6.11 6.25 6.2 6.19 6.34 6.29 6.36 6.28 6.24 6.39
GOBP_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN 4.57 4.4 4.22 4.27 4.15 3.82 4.01 4.3 4.13 3.83 4.24 4.38 3.9 3.96 3.91 3.87 4.24 4.48 4.38 3.97 4.7 4.08 3.85 3.78 3.89 3.95
GOBP_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN 5.38 5.05 5.1 5.39 4.84 4.75 5.08 4.74 5.01 4.78 5.27 4.92 4.81 4.85 4.76 4.73 4.97 5.18 4.96 4.56 5.13 4.9 4.73 4.48 4.85 5.11
GOBP_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN 6.7 6.58 6.81 6.62 7.18 7.13 7.48 6.88 7.28 7.34 6.92 7.26 7.09 7.08 7.25 7.25 7.54 6.81 7.17 7.36 7.16 7.06 7.45 7.84 7.32 7.25
GOBP_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS 5.49 5.76 6.66 6.24 5.27 5.29 4.88 4.93 5.92 5.24 6.26 5.44 5.35 5.72 4.84 5.38 5.29 5.16 5.25 5 6.65 5.31 5.9 5.4 5.82 5.82
GOBP_HYPEROSMOTIC_SALINITY_RESPONSE 6.22 6.19 5.92 6.34 6 5.88 6.18 5.48 5.85 5.8 5.61 5.85 6.32 6.24 5.42 5.31 6.39 5.94 6.09 5.97 5.58 5.53 5.97 6.22 5.83 5.61
GOBP_HEMOGLOBIN_BIOSYNTHETIC_PROCESS 6.93 7.04 7.84 7.6 7.07 7.69 7.75 8.09 8.32 7.77 7.43 7.92 8.14 8.26 7.87 8.11 7.45 7.34 7.86 8.3 6.63 7.27 7.63 7.95 7.85 7.61
GOBP_RESPONSE_TO_HYDROGEN_PEROXIDE 6.69 6.55 6.99 6.71 6.96 6.66 6.96 7.16 6.84 6.97 6.87 6.78 7.01 6.9 7.08 7.02 6.99 6.88 6.75 7.13 7.05 7.53 6.97 7 7.1 7.01
GOBP_NEURON_MATURATION 7.45 7.45 7.67 7.63 7.97 7.95 7.67 7.59 7.56 7.73 7.66 7.75 7.91 7.98 7.85 7.78 7.53 7.59 7.72 7.94 7.5 7.69 7.63 7.75 7.54 7.57
GOBP_SUPEROXIDE_ANION_GENERATION 5.47 5.35 5.34 5.61 5.03 4.98 5.2 5.16 5.22 4.98 5.45 5.1 5.33 5.34 5.39 5.38 5.33 5.65 5.09 5.38 5.41 5.58 4.98 5.2 5.44 5.41
GOBP_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.37 6.35 7 6.93 6.3 6.37 6.32 6.45 6.49 6.38 6.59 6.56 6.38 6.52 6.36 6.4 6.35 6.48 6.31 6.35 6.36 6.55 6.33 6.41 6.55 6.58
GOBP_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS 6.68 6.43 7.34 7.48 6.81 6.69 7 6.88 6.86 7.03 7.09 7.08 6.62 6.86 7.2 7.13 6.78 6.67 6.71 6.58 6.9 6.69 6.98 6.7 6.64 6.8
GOBP_RETINOL_METABOLIC_PROCESS 5.23 5.1 5.34 5.2 4.75 4.54 5.09 4.79 5.04 5.01 5.1 4.52 5.34 4.71 5.01 5.01 5.06 5.07 4.74 4.57 5.27 5.04 4.65 4.45 5.01 5.09
GOBP_RETINOIC_ACID_METABOLIC_PROCESS 5.11 5.05 4.63 4.87 4.7 4.49 4.57 4.77 4.67 4.34 4.87 4.54 4.68 4.4 4.39 4.66 4.68 5.01 4.64 4.46 4.71 4.49 4.3 4.16 4.61 4.72
GOBP_RETINAL_METABOLIC_PROCESS 5.61 5.55 5.62 5.56 5.44 5.2 5.5 5.6 5.58 5.25 5.11 5.25 5.68 5 5.37 5.36 5.54 5.69 4.9 4.85 5.18 5.57 5.67 5.55 5.77 5.42
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I 7.16 7.71 8.38 8.33 7.83 7.73 8.05 8.03 8.19 8.17 7.98 7.81 7.98 7.86 7.92 8.2 7.66 7.23 7.46 8.01 7.6 7.91 8.46 8.27 8.1 7.91
GOBP_HOMEOSTATIC_PROCESS 6.27 6.23 6.46 6.48 6.24 6.34 6.4 6.39 6.32 6.4 6.34 6.31 6.32 6.34 6.4 6.33 6.36 6.28 6.24 6.36 6.43 6.5 6.4 6.42 6.44 6.48
GOBP_RESPONSE_TO_STARVATION 6.79 6.96 7.04 6.98 7.08 7.03 6.97 6.97 6.94 6.87 6.92 6.92 7.02 6.97 7.23 6.98 6.99 6.87 6.81 7.1 7.03 7.22 6.97 7.01 7.21 7.09
GOBP_FEAR_RESPONSE 6.67 6.83 7.02 6.87 6.37 6.71 7.09 6.97 7.54 6.93 6.88 7 7.1 7.12 7.32 7.12 6.75 7.06 7.04 6.89 7.24 7 6.99 7.04 7.03 7
GOBP_REGULATION_OF_HAIR_CYCLE 5.52 5.33 5.52 5.47 5.17 5.42 5.55 5.39 5.65 5.55 5.29 5.37 5.38 5.49 5.57 5.15 5.52 5.54 5.46 5.31 5.67 5.3 5.35 4.95 5.49 5.31
GOBP_REGULATION_OF_CELL_FATE_SPECIFICATION 5.03 4.99 5.22 5.23 4.7 4.83 4.88 4.84 5.04 4.96 5.31 4.83 4.94 5.12 5.26 5.42 4.97 5.21 4.94 4.65 5.17 4.85 4.89 4.73 5.01 4.97
GOBP_RETINAL_CONE_CELL_DIFFERENTIATION 5.58 5.93 5.92 5.95 5.96 5.77 6.32 5.61 6.68 6.33 5.76 6 5.86 5.9 6 5.58 6.5 5.74 5.79 5.94 5.7 5.88 6.08 6.33 6.12 6.21
GOBP_MUSCLE_CELL_DIFFERENTIATION 6.51 6.53 6.65 6.55 6.74 6.64 6.7 6.74 6.85 6.66 6.54 6.71 6.73 6.7 6.66 6.59 6.72 6.57 6.6 6.71 6.69 6.81 6.86 6.76 6.65 6.73
GOBP_MUSCLE_CELL_FATE_COMMITMENT 4.76 4.69 4.83 5.13 4.69 4.44 4.78 4.62 4.9 4.86 5.01 4.66 4.9 4.73 4.77 4.63 4.72 4.65 4.84 4.61 4.69 4.85 4.61 4.48 4.83 4.7
GOBP_OVULATION_CYCLE 6.24 6.46 6.72 6.65 6.01 6.13 6.46 6.54 6.65 6.43 6.26 6.36 6.57 6.4 6.32 6.49 6.27 6.12 6.28 6.25 6.74 6.45 7 6.57 6.94 6.76
GOBP_FIBRINOLYSIS 4.91 4.84 4.51 4.66 4.37 4.37 4.68 4.57 4.7 4.32 4.8 4.4 4.28 4.46 4.64 4.4 4.6 4.59 4.68 4.27 4.8 4.64 4.47 4.2 4.5 4.41
GOBP_EMBRYONIC_DIGIT_MORPHOGENESIS 5.74 5.77 5.93 6.05 5.55 5.65 6.09 5.82 5.58 5.52 5.97 5.77 5.62 5.74 5.79 5.87 5.71 5.7 5.34 5.69 5.91 5.87 5.76 5.82 5.76 5.84
GOBP_DRUG_CATABOLIC_PROCESS 5.53 5.37 5.21 5.21 4.52 4.58 5.22 4.97 4.92 4.86 5.23 5.23 5.23 4.63 5.3 5.03 5.03 5.45 5.07 5.07 5.56 4.8 4.58 4.66 5.11 5.09
GOBP_DEFENSE_RESPONSE_TO_BACTERIUM 4.99 4.87 4.76 4.96 4.5 4.28 4.67 4.55 4.64 4.44 4.79 4.5 4.52 4.47 4.63 4.59 4.78 4.89 4.6 4.49 4.93 4.68 4.5 4.23 4.57 4.65
GOBP_HYDROGEN_PEROXIDE_METABOLIC_PROCESS 5.92 5.78 5.98 6.16 5.37 5.49 5.75 5.91 5.91 5.46 5.84 5.55 5.65 5.81 6.08 5.68 5.71 5.75 5.53 5.52 5.73 5.88 5.44 5.56 5.81 5.87
GOBP_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS 5.44 5.33 5.49 6.2 4.9 4.77 5.3 5.37 5.41 5.12 5.6 5.24 5.39 5.03 5.98 5.29 5.15 5.38 5.13 5.37 5.42 5.61 5.37 5.25 5.49 5.47
GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE 6.05 6.61 6.84 6.58 6.54 7.17 7.08 7.12 6.89 7.11 6.28 6.3 6.64 6.6 7.18 7.34 6.28 6.77 6.75 6.64 6.59 6.95 6.93 7.81 7.37 6.82
GOBP_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE 6.22 6.64 6.52 6.33 6.3 7.26 7.21 7.44 6.37 7.12 6.27 6.2 6.91 6.86 7.01 7.11 6.25 6.83 6.91 6.88 6.08 6.84 6.84 7.24 6.59 6.61
GOBP_REGULATION_OF_CIRCADIAN_RHYTHM 7.18 7.46 7.47 7.28 7.52 7.84 7.82 7.75 7.72 7.6 7.57 7.77 7.74 7.87 7.75 7.64 7.53 7.56 7.7 7.74 7.5 7.65 7.8 7.96 7.76 7.69
GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM 5.42 5.66 5.89 5.77 5.09 4.77 6.07 6.1 5.1 5.52 5.49 5.78 5.18 5.27 6.07 5.42 5.43 5.93 5.18 4.95 5.56 5.7 5.23 5.15 5.43 5.38
GOBP_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM 5.95 6.02 6.13 6.69 6.32 6.21 6.22 6.73 6.38 6.54 6.16 6.04 6.27 6.2 6.49 6.36 6.19 6 6.06 6.5 6.02 6.15 6.39 6.46 5.91 6.13
GOBP_EATING_BEHAVIOR 5.81 5.96 5.95 5.96 5.49 5.16 5.46 5.45 5.59 5.56 6.1 5.55 5.52 5.42 5.66 5.56 5.51 5.77 5.22 5.41 5.87 5.47 5.57 5.14 5.6 5.31
GOBP_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS 5.78 5.74 5.83 6.4 5.07 5.17 5.22 5.19 5.63 5.2 5.76 5.56 5.38 5 5.45 5.28 5.19 5.44 5.44 5.13 5.92 5.18 5.44 4.88 5.42 5.52
GOBP_REGULATION_OF_SULFUR_METABOLIC_PROCESS 8.31 8.26 8.12 8.38 9.01 8.97 8.51 8.11 8.81 8.24 7.99 8.52 8.49 8.58 7.91 7.6 8.49 8.37 8.46 8.73 7.51 8.1 8.97 8.66 8.6 8.28
GOBP_DNA_DAMAGE_RESPONSE_DETECTION_OF_DNA_DAMAGE 6.52 6.51 7.36 7.36 6.57 6.78 6.56 6.61 6.49 6.78 6.85 7.01 6.56 6.53 6.5 7.02 6.92 6.4 6.95 6.68 6.23 6.74 6.96 6.72 6.81 6.66
GOBP_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE 6.47 6.64 6.65 7.03 6.57 6.62 6.51 6.67 6.42 6.59 6.71 6.45 6.54 6.53 6.45 6.59 6.51 6.47 6.43 6.6 6.69 6.63 6.38 6.36 6.68 6.77
GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR 6.13 6.42 6.41 6.43 6.27 6.41 6.39 6.44 6.4 6.51 6.41 6.24 6.61 6.6 6.41 6.46 6.46 6.39 6.11 6 6.76 6.51 7.06 6.77 6.7 6.86
GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION 6.28 6.36 6.47 6.07 6.11 5.72 6.25 6.48 5.83 5.8 6.34 5.8 5.89 5.83 6.07 6.03 6.26 5.8 5.7 5.79 6.72 6.2 5.67 5.64 6.51 6.69
GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT 8.73 8.54 9.62 9.36 8.38 8.63 8.95 9.13 8.71 8.78 9.23 8.68 8.71 8.88 9.33 9.51 8.68 8.63 8.63 8.87 8.73 9.09 8.72 8.88 8.74 9.06
GOBP_MRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II 7.64 7.49 7.37 7.51 8.1 7.78 7.98 7.65 7.91 8.31 7.72 8.26 7.98 7.81 7.83 7.72 8.06 7.53 7.84 7.89 7.61 7.81 7.85 8.01 8.26 7.98
GOBP_NUCLEOLAR_LARGE_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_I 7.31 7.49 6.76 6.78 6.69 7.72 7.33 7.78 7.3 7.67 6.33 6.81 6.58 6.51 7.8 7.46 7.45 7.14 7.11 7.08 7.32 7.78 7.15 7.73 7.53 7.52
GOBP_XENOBIOTIC_TRANSPORT 6.18 6.08 5.76 5.92 5.76 5.83 6.05 5.98 5.89 6.1 5.7 5.71 5.99 6.11 5.72 5.84 6.08 6 5.81 6.15 6.21 6.14 5.89 5.85 6.06 5.77
GOBP_ACTIVATION_OF_JANUS_KINASE_ACTIVITY 5.69 5.37 5.99 5.68 5.27 4.9 5.49 5.35 5.18 4.98 5.62 4.92 5.15 5.36 5.17 5.25 4.89 5.34 5.36 5.21 5.53 5.21 5.25 5.09 5.72 5.65
GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS 7.9 8.29 8.56 8.14 8.54 8.72 8.82 8.99 8.49 8.46 8.44 8.32 8.86 8.8 8.48 8.36 8.44 8.1 8.07 8.59 7.99 8.7 8.75 8.66 8.69 8.53
GOBP_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS 7.63 8.08 8.41 8.25 8.07 8.47 8.47 8.51 8 8.49 7.75 8.36 8.72 8.63 8.06 8.01 8.17 7.56 7.87 8.75 8.13 8.29 8.35 8.63 8.09 7.99
GOBP_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS 8.23 8.53 8.63 8.17 8.98 9.03 8.99 9.09 9.13 8.7 8.61 8.71 8.95 9.12 8.88 8.67 8.56 8.52 8.62 8.81 8.55 8.89 9 8.86 9.17 8.63
GOBP_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR 6.84 6.91 7 7.41 7.05 6.65 6.9 6.95 7.26 7.51 6.73 7.43 7.24 6.8 6.87 7.1 7.33 6.79 6.74 6.88 7.02 6.99 7.42 7.51 7.11 6.89
GOBP_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT 7.54 7.71 7.88 7.84 8.42 8.24 7.94 8.02 7.71 7.96 7.88 7.87 7.83 7.97 7.91 8 7.65 7.67 7.87 7.93 7.68 7.7 7.73 8.08 7.73 7.73
GOBP_CAMERA_TYPE_EYE_DEVELOPMENT 6 5.96 5.99 6.13 5.92 5.89 6.09 6.15 6.01 6.02 5.99 5.99 6.03 6.05 5.97 6.01 6.08 5.97 5.87 5.92 6.12 6.02 6.04 5.99 5.96 6.09
GOBP_MYELOID_DENDRITIC_CELL_DIFFERENTIATION 5.42 5.55 5.75 5.71 5.41 5.46 5.71 6.05 5.59 5.01 5.04 5.65 5.62 5.4 5.53 5.53 5.52 5.55 5.31 5.42 5.62 5.9 5.66 5.27 6.04 6.16
GOBP_T_CELL_HOMEOSTASIS 5.31 5.39 5.39 5.6 5.36 5.29 5.46 5.21 5.45 5.41 5.31 5.1 5.5 5.46 5.5 5.24 5.3 5.14 5.29 5.29 5.6 5.82 5.11 5.25 5.43 5.76
GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION 5.66 5.75 5.83 6.17 5.3 5.13 5.45 5.35 5.34 5.18 5.41 5.14 5.53 5.25 5.39 5.49 5.34 5.49 5.26 5.27 5.8 5.95 5.68 5.28 5.45 5.93
GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION 5.96 5.91 6.16 6.18 5.31 4.94 5.46 5.26 5.52 5.17 5.58 5.24 5.07 5.11 5.28 5.43 5.42 5.57 5.24 5.28 6.02 5.95 5.35 5.46 5.98 6.04
GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION 5.14 4.94 4.88 5.4 4.83 4.75 4.7 4.73 5.03 4.89 5.05 4.87 5.15 4.47 4.82 4.86 4.98 5.01 4.85 4.71 5.16 4.97 4.9 4.98 4.86 5.25
GOBP_AMINO_ACID_ACTIVATION 6.67 6.65 7.15 6.99 6.85 6.89 6.52 6.39 6.63 6.68 6.95 6.56 6.83 6.78 6.45 6.83 6.56 6.79 6.76 6.69 6.2 6.57 6.4 6.61 6.56 6.59
GOBP_PEPTIDE_BIOSYNTHETIC_PROCESS 7.1 7.16 7.71 7.52 7.37 7.38 7.38 7.35 7.42 7.43 7.43 7.36 7.34 7.44 7.51 7.41 7.25 7.16 7.31 7.46 7.22 7.41 7.48 7.58 7.42 7.35
GOBP_ATP_DEPENDENT_CHROMATIN_REMODELING 6.52 6.61 6.75 6.8 6.96 6.75 6.68 6.78 6.46 6.94 6.82 6.96 6.8 6.7 6.72 7.05 6.66 6.89 6.57 6.69 6.71 6.67 6.69 7.05 6.69 6.68
GOBP_DNA_METHYLATION_INVOLVED_IN_GAMETE_GENERATION 4.97 4.82 4.73 5.04 4.28 4.02 4.34 4.53 4.44 4.27 4.52 4.55 4.22 4.22 4.37 4.28 4.56 4.98 4.82 4.63 4.93 4.28 4.21 4.27 4.32 4.3
GOBP_PENILE_ERECTION 5.9 5.78 6.11 5.67 5.45 5.78 5.72 5.1 5.44 5.74 6.13 5.26 5.87 5.64 5.84 5.53 5.45 5.31 5.65 5.75 5.64 5.64 5.83 5.59 5.37 4.86
GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY 6.49 6.53 6.7 6.61 6.68 6.68 6.71 6.8 6.64 6.69 6.57 6.68 6.69 6.62 6.77 6.67 6.61 6.58 6.52 6.63 6.69 6.75 6.74 6.73 6.77 6.8
GOBP_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY 6.39 6.38 6.56 6.52 6.45 6.5 6.44 6.52 6.56 6.47 6.51 6.43 6.59 6.5 6.55 6.42 6.45 6.41 6.34 6.43 6.6 6.56 6.62 6.55 6.6 6.54
GOBP_REGULATION_OF_GTPASE_ACTIVITY 6.82 6.95 7.1 6.84 7.21 7.3 7.16 7.31 7.13 7.24 6.99 7.28 7.33 7.32 7.29 7.29 7.18 7 7.08 7.23 7.11 7.35 7.19 7.38 7.19 7.21
GOBP_AMINO_ACID_IMPORT 7.55 7.75 7.74 7.67 7.49 7.61 8.02 7.9 8.2 7.87 7.43 7.68 8.23 8.22 7.97 7.92 7.85 7.82 7.64 8.2 7.67 7.59 7.73 8.06 8.21 7.79
GOBP_CELLULAR_METABOLIC_COMPOUND_SALVAGE 6.44 6.93 7.77 7.2 7.11 7.14 7.06 7.03 6.93 7.06 6.94 6.57 6.95 6.67 6.89 6.98 6.79 6.71 6.96 7.24 6.57 6.67 6.73 7.05 7.46 7.24
GOBP_PURINE_CONTAINING_COMPOUND_SALVAGE 6.74 7.04 7.95 7.69 7.33 7.34 7.15 7.12 7.67 7.29 7.69 7.26 7.18 7.01 6.94 7.51 6.94 7.02 7.29 7.46 6.81 6.75 6.93 7.51 7.66 7.28
GOBP_RECEPTOR_METABOLIC_PROCESS 7.56 7.64 8.1 7.79 8.17 8.15 8 7.95 8 8.02 7.85 8.06 8.21 8.23 8.17 8.09 7.7 7.68 7.89 8.11 7.71 7.89 8.13 8.36 8.07 7.95
GOBP_RECEPTOR_CLUSTERING 7.74 8.06 8.2 8.43 8.15 8.31 8.13 8.28 7.89 8.31 8.09 8.28 8.16 8.31 8.47 8.39 8.11 7.92 8.13 8.14 8.03 8.36 8.24 8.38 8.42 8.29
GOBP_REGULATION_OF_VASCULAR_PERMEABILITY 5.73 5.73 6.15 6.11 5.76 5.84 6.05 6.22 6.05 5.87 6.02 6.04 6.07 5.92 5.74 6.06 5.82 6 5.86 6.08 6.2 6.51 6.01 5.77 6 6.06
GOBP_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY 7.8 7.84 7.62 7.51 7.99 8.23 8.52 7.97 8.14 7.81 7.86 7.99 8.33 8.48 8.41 8.49 7.6 8.15 8.21 8.08 7.14 7.86 8.18 8.24 8.03 7.61
GOBP_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY 5.84 5.89 5.9 6.32 5.87 6.27 6.35 6.41 6.01 6.03 6.27 6.2 6.5 6.09 6.61 6.47 5.7 5.94 6.18 5.91 6.16 6.78 6.16 6.3 6.04 6.18
GOBP_POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING 6.48 6.43 6.53 6.43 6.6 6.38 6.44 6.41 6.58 6.41 6.48 6.39 6.38 6.43 6.38 6.42 6.48 6.48 6.35 6.41 6.47 6.46 6.62 6.7 6.69 6.59
GOBP_NEGATIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_SIGNALING 6.01 5.96 5.87 5.91 5.74 5.94 6.06 5.97 6.01 6.31 5.81 6.12 6.25 5.99 6.03 6.12 6.34 5.9 6.06 5.92 6.02 6.25 6.09 6.13 6.09 6.3
GOBP_SURFACTANT_HOMEOSTASIS 5.25 5.52 5.99 6.18 5.53 5.85 5.92 6.13 5.24 5.52 5.4 5.59 5.35 5.43 6.03 5.7 6 5.48 5.25 6.04 6.07 6.34 5.7 5.46 6.03 6.19
GOBP_STRESS_FIBER_ASSEMBLY 6.9 6.91 7.17 7.12 7.37 7.22 7.09 7.38 7.27 7.28 7.47 7.37 7.22 7.32 7.38 7.44 7.46 7.24 7.33 7.42 7.19 7.5 7.4 7.6 7.48 7.42
GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY 7.2 7.04 7.33 7.39 7.47 7.29 7.33 7.25 7.44 7.29 7.26 7.37 7.35 7.34 7.61 7.62 7.21 7.38 7.34 7.08 7.46 7.48 7.71 7.68 7.54 7.35
GOBP_PEPTIDE_CATABOLIC_PROCESS 5.6 5.63 6.54 6.54 5.99 5.64 6.14 6.02 6.02 5.84 5.81 6.11 5.84 5.49 6.14 5.77 5.91 5.71 5.81 5.89 6.09 5.78 5.8 5.74 5.77 6.25
GOBP_NUCLEOTIDE_SALVAGE 6.17 6.55 6.53 6.62 7.09 6.94 6.86 7.23 6.42 7.06 6.45 6.55 7 6.67 6.88 6.9 6.91 6.56 6.95 7.3 6.57 6.67 6.48 6.87 6.74 7.35
GOBP_NUCLEOSIDE_SALVAGE 5.95 6.42 6.87 6.66 6.84 6.83 6.59 6.94 6.12 6.7 6.62 6.46 7.03 6.82 6.92 6.93 6.33 6.73 6.9 6.81 6.44 6.5 6.21 6.71 6.67 6.76
GOBP_RESPONSE_TO_LEUCINE 7.63 7.93 7.86 7.94 8.37 8.12 8.03 7.58 8.2 8.09 8.21 7.99 8.09 8.29 7.77 7.97 7.82 7.65 8.13 7.69 7.49 7.75 8.41 8.17 8.02 7.78
GOBP_MYELIN_MAINTENANCE 7.82 8.35 8.32 8.42 8.79 8.6 8.43 8.6 8.93 8.66 8.47 8.63 8.64 8.73 8.5 8.26 8.67 8.41 8.17 8.64 8.12 8.25 9.14 8.75 8.69 8.75
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY 7.14 7.2 7.13 7.21 7.35 7.51 7.13 7.19 7.35 7.35 7.37 7.12 7.5 7.43 7.46 7.28 7.14 7.12 7.06 7.36 7.14 7.25 7.48 7.65 7.4 7.25
GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY 7.14 7.23 7.31 7.1 7.21 7.09 7.19 7.36 7.48 7.29 7.19 7.48 7.5 7.22 7.23 7.34 6.94 7.3 7.15 7.42 7.15 7.02 7.53 7.46 7.25 6.98
GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY 7.17 7.21 7.27 7.18 7.35 7.51 7.44 7.5 7.67 7.44 7.3 7.5 7.61 7.53 7.44 7.36 7.24 7.17 7.17 7.37 7.21 7.24 7.51 7.82 7.45 7.36
GOBP_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE 6.58 6.77 6.56 7.29 6.12 6.64 6.69 6.39 7.11 6.66 6.48 6.52 6.49 6.17 6.63 6.24 6.48 6.42 6.18 6.9 6.47 6.58 6.71 7.01 6.42 6.26
GOBP_PROTEASOME_ASSEMBLY 7.62 7.85 8.36 8.62 8.36 8.25 8.4 8.04 8.04 7.99 7.95 8.01 7.86 7.72 8.53 7.85 7.6 7.89 7.72 8.67 7.57 7.9 8.05 8.29 8.1 8.13
GOBP_ERYTHROCYTE_MATURATION 6.17 6.07 7.12 6.66 6.45 6.16 6.7 6.49 7.25 6.44 6.72 6.29 6.71 6.2 6.45 6.56 6.83 7.02 5.88 6.61 6.48 6.84 6.51 6.48 6.67 6.67
GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT 5.25 5.49 5.91 5.74 5.19 5.12 5.44 5.61 5.51 5.32 5.41 5.04 5.25 5.23 5.51 5.15 5.69 5.88 5.23 5.5 5.44 5.74 5.48 5.51 5.77 6.03
GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY 7 7.1 7.4 7.18 7.34 7.38 7.4 7.4 7.41 7.38 7.41 7.44 7.5 7.48 7.5 7.44 7.2 7.16 7.22 7.41 7.25 7.42 7.35 7.63 7.34 7.37
GOBP_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS 6.5 6.6 6.24 6.62 6.58 6.86 6.76 6.62 6.75 6.82 6.47 6.83 7 6.92 6.69 6.76 6.59 6.69 6.5 6.65 6.7 6.72 7.04 6.86 6.67 6.63
GOBP_REGULATION_OF_POTASSIUM_ION_TRANSPORT 7.42 7.53 7.83 6.93 7.65 7.61 7.82 7.62 7.69 7.8 7.64 7.82 7.56 7.67 7.73 7.79 7.46 7.73 7.96 7.87 7.46 7.68 7.92 7.93 7.76 7.59
GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT 7.08 6.02 6.29 6.49 6.77 6.77 6.5 6.77 6.56 6.67 6.9 6.33 6.71 7.06 6.09 6.68 7.32 6.55 6.23 6.75 6.46 6.24 7.3 7 6.2 5.96
GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT 7.37 7.53 7.44 7.03 7.68 7.44 7.65 7.54 7.51 7.9 7.62 7.7 7.45 7.74 7.78 7.86 7.43 7.68 7.76 7.71 7.36 7.67 7.33 7.78 7.66 7.59
GOBP_REGULATION_OF_ION_TRANSPORT 6.65 6.65 6.88 6.76 6.74 6.86 6.93 6.98 6.86 6.86 6.84 6.84 6.89 6.97 6.91 6.92 6.84 6.81 6.78 6.93 6.84 6.96 6.89 6.93 6.88 6.98
GOBP_POSITIVE_REGULATION_OF_ION_TRANSPORT 6.63 6.65 7 6.8 6.74 6.87 6.88 6.92 6.84 6.86 6.83 6.86 6.85 6.95 6.86 6.89 6.87 6.81 6.82 6.93 6.86 6.96 6.86 6.94 7.02 7.04
GOBP_NEGATIVE_REGULATION_OF_ION_TRANSPORT 6.65 6.57 7.03 6.79 6.91 6.96 7.08 7.01 7.06 7.08 6.89 6.94 7.07 7.09 6.9 6.91 6.78 6.79 6.81 6.98 6.86 6.91 7.08 7.05 7.04 6.95
GOBP_ANOIKIS 6.63 6.58 6.75 6.48 6.34 6.59 6.88 7.25 6.85 6.77 6.56 7 7.01 7.04 6.99 6.81 6.95 6.78 6.43 7.19 7.17 6.95 7.06 7.34 7.19 7.13
GOBP_APOPTOTIC_CELL_CLEARANCE 6.92 6.53 7.15 6.74 6.85 6.53 6.67 7.08 6.54 6.21 6.27 6.55 6.32 6.78 6.75 6.7 6.71 6.42 6.58 6.43 6.82 7.28 7.09 6.1 6.95 7.33
GOBP_RESPONSE_TO_ALKALOID 6.78 6.85 7.43 7.03 7.09 7.28 7.22 7.55 6.93 7.43 7.26 7.22 7.42 7.28 7.18 7.19 7.23 6.97 7.07 7.25 7.14 7.28 7.16 7.38 7.22 7.08
GOBP_APICAL_JUNCTION_ASSEMBLY 6.08 6.12 6.06 6.09 5.93 5.84 6.09 6.13 5.87 5.94 6.16 6.02 6.05 6.06 5.84 6.03 6.33 6.29 5.96 6.04 6.11 6.21 5.79 5.74 6.29 6.09
GOBP_REGULATION_OF_LEUKOCYTE_DEGRANULATION 5.69 5.73 5.84 5.84 5.21 5.25 5.37 5.35 5.68 5.32 5.42 5.07 5.54 5.41 5.41 5.41 5.55 5.73 5.31 5.35 5.51 5.5 5.31 5.26 5.73 5.9
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION 5.83 5.73 5.87 6.23 5.73 5.53 5.46 5.64 5.9 6.13 5.48 5.76 5.94 5.69 5.66 5.63 6.1 5.85 5.46 5.59 6.12 5.69 5.56 5.37 6.26 6.13
GOBP_RESPONSE_TO_DSRNA 5.7 5.73 5.84 5.8 5.47 5.8 5.55 5.3 6 5.86 5.94 5.79 5.45 5.49 5.39 5.32 5.8 5.38 5.98 5.7 5.54 5.42 5.88 5.42 5.52 5.66
GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.52 5.41 5.4 5.44 5.18 5.18 5.43 5.41 5.34 5.02 5.32 5.15 5.36 5.23 5.19 5.16 5.25 5.38 5.22 5.16 5.41 5.27 5.13 4.97 5.26 5.3
GOBP_POSITIVE_T_CELL_SELECTION 5.48 5.18 5.33 5.43 4.96 4.93 5.08 5.03 5.17 5 5.32 4.93 5 4.94 5.08 5.21 5.06 5.29 5.01 4.88 5.39 5.17 4.97 4.94 5.04 5.09
GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT 5.52 5.19 5.29 5.43 4.82 4.93 5.12 5.05 5.21 4.97 5.42 4.92 5.02 5.07 5.08 5.11 5 5.3 5.01 4.86 5.21 5.15 4.98 4.93 5.02 5.06
GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.47 5.29 5.23 5.44 5.21 5.07 5.39 5.37 5.17 5.05 5.33 5.03 5.29 5.22 5.19 5.17 5.12 5.36 5.2 5.22 5.48 5.27 5.1 4.94 5.23 5.33
GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.61 5.64 5.35 5.5 5.36 5.24 5.48 5.41 5.4 5.4 5.7 5.28 5.39 5.31 5.25 5.41 5.35 5.57 5.27 5.4 5.55 5.3 5.33 5.13 5.26 5.53
GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.47 5.38 5.23 5.5 5.21 4.97 5.34 5.41 5.15 5.11 5.33 5.03 5.29 5.22 5.21 5.24 5.14 5.36 5.22 5.16 5.6 5.36 5.1 4.95 5.27 5.43
GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.31 5.48 5.47 5.68 5.6 5.4 5.31 5.34 5.95 5.38 5.49 5.31 5.65 5.56 5.55 5.25 5.83 5.11 5.22 5.47 5.61 5.78 5.24 5.37 5.62 5.99
GOBP_NEGATIVE_T_CELL_SELECTION 5.21 5.11 5.38 5.27 5.28 5.13 4.79 5.02 5.18 5.07 4.98 4.93 4.94 4.95 4.96 5.21 5.21 5.52 5 4.92 5.29 4.96 4.96 4.72 5.12 5.37
GOBP_POSITIVE_REGULATION_OF_DNA_BINDING 5.87 6.07 6.29 6.36 5.79 5.7 5.83 6.16 5.93 5.83 6.3 6.16 6.11 5.99 5.98 5.93 6.06 6.28 5.82 6 5.99 6.22 6.04 5.84 5.94 6.25
GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING 6.44 6.17 6.59 6.55 6.32 6.42 6.48 6.72 6.84 6.66 6.54 6.66 6.71 6.6 6.56 6.68 6.66 6.42 6.5 6.43 6.69 6.95 6.44 6.88 6.63 6.54
GOBP_REGULATION_OF_PROTEIN_BINDING 6.73 6.68 6.73 6.79 7.11 7.1 6.98 7 7.04 7.07 7.08 7.21 7.11 7.01 6.91 7.04 7.21 6.85 7.01 7.11 7.01 7.13 7.1 7.22 7.28 7.22
GOBP_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY 7 7.15 7.18 7.13 7.45 7.53 7.2 7.42 7.27 7.38 7.21 7.33 7.37 7.3 7.57 7.39 7.5 7.09 7.28 7.48 7.18 7.39 7.35 7.44 7.42 7.33
GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION 6.15 6.2 6.64 6.78 6.45 6.56 6.52 6.44 6.41 6.53 6.17 6.06 6.15 6.17 6.43 6.51 6.53 6.66 6.29 6.33 6.37 6.23 6.57 6.42 5.86 6.23
GOBP_REGULATION_OF_MAP_KINASE_ACTIVITY 6.39 6.31 6.43 6.38 6.26 6.24 6.36 6.49 6.56 6.48 6.43 6.31 6.55 6.43 6.48 6.51 6.41 6.52 6.33 6.33 6.56 6.51 6.6 6.47 6.45 6.42
GOBP_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY 6.11 6.18 6.12 6.24 6.09 6.12 6.21 6.32 6.17 6.28 6.32 6.21 6.22 6.3 6.35 6.28 6.38 6.3 6.15 6.19 6.49 6.39 6.25 6.26 6.2 6.35
GOBP_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY 6.72 6.96 7.13 7.17 7.09 6.89 6.87 6.96 7.19 7.15 7 7.23 7.16 7.43 6.94 7.08 6.87 7 6.96 6.98 7.03 7.21 7.41 7.51 6.97 7.05
GOBP_REGULATION_OF_MAPK_CASCADE 6.25 6.16 6.2 6.27 6.18 6.18 6.23 6.3 6.26 6.24 6.29 6.2 6.24 6.3 6.3 6.25 6.27 6.24 6.13 6.22 6.51 6.33 6.24 6.27 6.25 6.35
GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE 6.78 7.05 7.26 6.98 7.31 7.23 7.1 7.28 7.31 7.16 6.99 7.25 7.27 7.43 7.26 7.22 6.99 7.06 7.1 7.34 7.37 7.4 7.41 7.6 7.48 7.18
GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE 6.06 5.98 6.05 6.18 5.89 5.93 6.05 6.1 6.07 6.03 6.1 6 5.98 5.99 6.12 6.02 6.1 6.09 5.92 6.05 6.2 6.15 5.98 5.9 5.99 6.08
GOBP_MACROMOLECULE_METHYLATION 6.54 6.61 6.79 6.85 6.82 6.8 6.65 6.76 6.68 6.75 6.64 6.79 6.78 6.72 6.77 6.85 6.6 6.52 6.68 6.74 6.69 6.76 6.87 6.97 6.7 6.84
GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY 6.19 6.21 6.08 6.25 6.13 6.09 6.19 6.23 6.24 6.21 6.19 6.15 6.27 6.35 6.08 6.31 6.37 6.03 6.07 6.13 6.39 6.51 6.16 6.27 6.26 6.34
GOBP_RESPONSE_TO_PEPTIDE_HORMONE 6.57 6.62 7.24 6.96 6.99 7.04 6.9 6.89 6.99 7.04 6.85 6.85 6.94 7.03 6.96 6.97 6.88 6.8 6.77 6.98 6.85 6.98 7.08 7.05 7 6.82
GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS 6.71 6.93 7.71 6.35 7.3 7.17 7.63 7.75 7.31 7.1 7.69 7.29 6.29 7 7.58 7.45 6.99 7.56 7.12 7.3 6.31 5.52 6.59 7.32 7.52 6.43
GOBP_REGULATION_OF_CELLULAR_RESPIRATION 6.81 6.97 7.14 7.63 7.84 7.66 7.2 7.52 7.31 7.64 7.69 7.29 7.76 7.63 7.58 7.45 7.14 7.07 7.16 7.32 7.21 7.18 7.24 7.32 7.37 7.1
GOBP_REGULATION_OF_ATPASE_ACTIVITY 7.2 7.17 7.48 7.58 7.51 7.57 7.13 7.34 7.74 7.66 7.65 7.7 7.51 7.58 7.62 7.62 7.42 7.03 7.52 7.5 7.33 7.38 7.93 7.66 7.67 7.34
GOBP_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY 7.15 7.14 7.41 7.57 7.51 7.44 7.31 7.5 7.31 7.34 7.49 7.31 7.32 7.46 7.36 7.42 7.12 7.15 7.26 7.32 7.17 7.44 7.3 7.45 7.38 7.32
GOBP_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS 7.42 7.39 7.42 7.49 7.63 7.6 7.5 7.47 7.53 7.55 7.51 7.57 7.49 7.62 7.56 7.57 7.29 7.26 7.52 7.37 7.18 7.61 7.44 7.68 7.54 7.4
GOBP_PIGMENTATION 6.3 6.41 6.66 6.59 6.26 6.4 6.52 6.76 6.48 6.49 6.64 6.43 6.56 6.48 6.84 6.62 6.36 6.43 6.36 6.4 6.31 6.58 6.54 6.65 6.62 6.73
GOBP_PIGMENT_ACCUMULATION 6.93 7.13 7.01 7.2 7.05 7.07 6.83 7.02 7.3 7.31 7.12 7.34 7.26 7.36 7.63 7.4 7.34 7.16 6.52 6.65 6.97 7.28 7.24 7.51 7.13 7.32
GOBP_REGULATION_OF_RNA_SPLICING 7.9 8.07 8.23 8.14 8.56 8.5 8.36 8.36 8.32 8.52 8.06 8.39 8.41 8.34 8.41 8.53 8.24 7.94 8.24 8.29 8.03 8.54 8.37 8.51 8.53 8.45
GOBP_HISTONE_EXCHANGE 5.67 5.57 5.42 5.53 5.39 5.45 5.62 5.46 5.38 5.74 5.62 5.54 5.81 5.62 5.34 5.68 5.46 5.7 5.49 5.58 5.84 5.38 5.43 5.59 5.39 5.6
GOBP_PROTEIN_KINASE_B_SIGNALING 6.2 6.25 6.59 6.33 6.21 6.13 6.25 6.4 6.33 6.36 6.31 6.32 6.35 6.33 6.4 6.48 6.24 6.22 6.15 6.19 6.53 6.59 6.49 6.45 6.43 6.43
GOBP_MUSCLE_ADAPTATION 6.63 6.59 6.57 6.62 6.94 6.61 6.82 6.71 6.72 7.01 6.53 6.77 6.68 6.89 6.81 6.85 6.99 6.68 6.82 7 6.83 6.98 6.81 6.87 7.06 7.08
GOBP_SKELETAL_MUSCLE_ADAPTATION 5.22 5.34 5.11 5.2 4.78 4.53 4.93 4.77 5.13 4.97 5.28 4.78 4.85 4.68 5.46 5.14 5.41 5.54 5.07 4.9 4.89 5.04 4.78 5.01 4.96 4.78
GOBP_REGULATION_OF_MUSCLE_ADAPTATION 6.88 7.03 6.88 6.97 7.38 7.31 7.2 7.3 7.33 7.26 6.79 7.27 7.41 7.29 7.53 7.12 7.04 6.9 7.19 7.45 7.1 7.26 7.35 7.45 7.53 7.47
GOBP_REGULATION_OF_JUN_KINASE_ACTIVITY 6.42 6.36 6.24 6.33 6.29 6.53 6.5 6.48 6.73 6.73 6.57 6.65 6.89 6.41 6.28 6.24 6.46 6.28 6.46 6.32 6.54 6.48 6.91 6.69 6.24 6.51
GOBP_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY 6.48 6.39 6.34 6.33 6.33 6.58 6.4 6.58 6.77 6.71 6.61 6.78 6.86 6.67 6.54 6.61 6.56 6.34 6.59 6.51 6.6 6.45 7.07 7.07 6.21 6.64
GOBP_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY 6.35 6.47 6.57 6.77 6.67 6.71 6.79 6.57 6.98 6.95 6.49 6.88 7 6.99 6.74 6.72 6.21 6.21 6.31 6.24 6.29 6.63 7.13 7.04 6.43 6.51
GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 6.19 6.55 7.16 7.7 7.07 6.98 6.08 6.13 6.48 6.73 6.93 6.56 6.58 6.59 6.5 7.37 6.42 6.47 6.57 6.7 6.27 6.7 6.38 6.36 6.94 6.57
GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 6.11 6.39 6.65 7.04 6.86 6.98 5.87 6 6.09 6.59 6.92 6.53 6.5 6.17 6.02 6.32 6.21 6.37 6.57 6.21 6.01 6.63 6.36 6.23 6.07 6.3
GOBP_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 7.71 7.88 8.51 8.45 7.97 7.89 8.25 7.91 8.22 8.01 8.21 7.68 8.24 8.33 8.33 7.9 8.15 7.86 8.49 8.3 8.06 7.97 7.95 8.38 8.28 8.21
GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS 7.08 7.1 7.7 7.48 7.38 7.5 7.56 7.6 7.42 7.59 7.44 7.46 7.51 7.53 7.8 7.45 7.27 6.94 7.22 7.55 7.3 7.74 7.52 7.77 7.8 7.6
GOBP_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS 7.19 7.5 7.9 7.73 7.8 7.66 7.44 7.68 7.63 7.78 7.67 7.71 7.68 7.71 7.75 7.6 7.22 7.48 7.36 7.47 7.2 7.75 7.33 7.74 7.55 7.78
GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION 6.41 6.45 6.53 6.36 6.56 6.38 6.35 6.58 6.48 6.41 6.42 6.49 6.62 6.53 6.52 6.51 6.52 6.2 6.38 6.39 6.73 6.7 6.54 6.46 6.65 6.77
GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION 6.09 6.15 5.95 6.09 6.23 6.09 6.15 6.26 6.05 5.95 6.05 6.1 6.15 6.02 6.09 5.99 6.28 5.93 6.09 5.99 6.35 6.35 6.24 6.02 6.34 6.35
GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION 5.96 6.25 6.45 5.96 6.21 6.19 6.07 6.16 5.98 6.01 6.18 6.51 6.41 6.3 6.19 6.2 5.91 6.16 6.05 5.95 6.39 6.58 6.55 6.27 6.38 6.42
GOBP_ENDOTHELIAL_CELL_MIGRATION 6.36 6.42 6.64 6.36 6.57 6.43 6.35 6.7 6.58 6.53 6.34 6.49 6.62 6.58 6.5 6.4 6.52 6.2 6.33 6.44 6.68 6.69 6.62 6.63 6.72 6.79
GOBP_PROTEIN_ACYLATION 7.24 7.34 7.62 7.49 7.69 7.7 7.53 7.73 7.56 7.65 7.52 7.68 7.63 7.74 7.71 7.6 7.49 7.23 7.38 7.63 7.39 7.63 7.62 7.76 7.66 7.66
GOBP_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY 6.77 6.87 7.06 6.77 7.16 7.2 7.14 7.2 7.05 7.12 6.9 7.17 7.25 7.2 7.22 7.2 7.11 6.88 6.99 7.1 7.02 7.34 7.11 7.35 7.18 7.21
GOBP_REGULATION_OF_LIPID_KINASE_ACTIVITY 6.33 6.35 6.59 6.9 6.62 6.37 6.78 6.58 6.28 6.6 6.55 6.7 6.74 6.61 6.82 6.61 6.5 6.46 6.45 6.57 6.8 6.78 6.42 6.72 6.78 6.91
GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY 6.04 6.2 6.52 6.41 5.89 6.13 6.65 6.4 6.18 6.43 6.38 6.41 6.14 6.43 6.41 6.06 5.87 6.14 6.16 6.17 6.43 6.35 6.24 6.34 6.24 6.34
GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS 7.63 7.71 7.82 7.48 7.94 8.13 8.06 7.8 7.97 8.14 7.74 8.08 8.2 8.15 8.31 8.1 7.76 7.68 7.75 8.03 7.82 8.03 7.89 8.34 8.27 7.67
GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS 7.72 7.71 7.82 7.48 7.91 7.78 8.04 7.75 7.97 8.14 7.89 8.26 8.07 8.1 8.31 8.02 7.76 7.68 7.57 7.87 7.56 8.02 7.89 8.34 8.27 7.67
GOBP_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 5.29 5.12 5.18 5.46 5 4.79 5.06 5.19 5.04 4.95 5.14 4.83 4.85 4.77 5.14 4.89 4.99 5.15 5 4.76 5.17 5.04 4.93 4.66 5.01 5
GOBP_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 5.5 5.42 5.51 5.69 4.9 4.86 5.26 5.29 5.01 5.04 5.58 5.51 4.9 4.99 5.23 5.15 5.05 5.79 5.06 4.72 5.22 5.2 5.07 4.8 5.24 5.15
GOBP_PEROXISOMAL_TRANSPORT 6.55 6.56 7.08 7.13 7 6.97 6.94 6.59 6.94 6.91 6.88 6.88 7.1 7.27 6.67 6.9 6.7 6.8 6.99 7.03 6.72 6.77 7.02 6.99 6.49 6.54
GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE 6.47 6.71 6.4 7.42 6.64 6.52 6.65 6.88 5.88 6.64 6.32 6.47 7.25 7.07 6.71 6.27 6.3 6.25 6.29 6.7 6.29 6.18 6.27 6 6.22 6.22
GOBP_EAR_DEVELOPMENT 5.9 5.77 5.71 5.85 5.71 5.64 5.77 5.81 5.9 5.81 5.89 5.72 5.8 5.79 5.79 5.85 5.82 5.89 5.77 5.79 5.9 5.72 5.69 5.78 5.79 5.77
GOBP_NOSE_DEVELOPMENT 6.06 5.98 5.93 5.93 6.12 6.15 6.41 6.13 6.09 6.19 5.98 6.47 6.25 6.24 6.01 6 6.25 5.92 6.03 6.34 6.09 5.9 6.33 6.31 6.2 6.13
GOBP_TONGUE_DEVELOPMENT 6.37 6.43 6.4 6.16 6.17 6.15 6.62 6.82 6.3 6.19 6.57 6.58 6.01 6.19 6.48 6.28 6.74 6.52 5.93 6.34 6.83 6.73 6.4 6.31 6.59 6.7
GOBP_SKIN_DEVELOPMENT 5.44 5.37 5.23 5.43 4.92 4.84 5.15 5.02 5.16 4.9 5.33 4.98 4.98 4.99 5.12 4.9 5.18 5.38 5.03 4.88 5.3 5.09 4.92 4.69 5.09 5.02
GOBP_SKIN_MORPHOGENESIS 7.06 6.92 7.22 6.31 7.85 7.36 6.82 6.49 7.08 7.3 6.81 7.28 6.86 6.75 6.67 7 7.65 7.37 6.52 7 7.43 7.51 7.04 7.13 8.24 7.74
GOBP_CELLULAR_AMIDE_METABOLIC_PROCESS 6.99 7.08 7.48 7.36 7.27 7.27 7.28 7.24 7.29 7.26 7.23 7.19 7.26 7.27 7.31 7.27 7.09 6.98 7.19 7.37 7.08 7.29 7.32 7.43 7.26 7.27
GOBP_AMIDE_BIOSYNTHETIC_PROCESS 7.09 7.16 7.71 7.49 7.38 7.42 7.42 7.4 7.45 7.41 7.42 7.38 7.39 7.45 7.51 7.43 7.24 7.16 7.31 7.49 7.2 7.41 7.46 7.6 7.46 7.36
GOBP_KERATINOCYTE_PROLIFERATION 5.57 5.51 5.59 5.66 5.22 4.86 5.3 5.22 5.25 5.3 5.26 5.11 5.42 5.29 5.39 5.48 5.55 5.49 5.37 5.3 5.4 5.23 5.38 4.86 5.38 5.48
GOBP_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_OXIDATIVE_STRESS 7.89 7.92 7.54 7.51 8.31 8.55 8.32 8.14 8.32 8.48 7.68 8.26 8.1 8.08 8.13 7.98 8.16 8.02 8.11 8.04 7.88 8.02 8.01 8.41 8.35 7.94
GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS 7.46 7.68 8.06 8.1 7.87 7.78 8.05 8.03 8.19 8.2 7.91 7.88 8.07 8.08 8.13 8 7.85 7.87 7.55 8.01 7.88 7.96 8.17 8.35 8.14 7.93
GOBP_CELLULAR_PROTEIN_COMPLEX_DISASSEMBLY 7.12 7.19 7.98 7.71 7.35 7.45 7.63 7.69 7.67 7.51 7.57 7.5 7.55 7.62 7.76 7.85 7.24 7.31 7.3 7.53 7.24 7.69 7.75 7.83 7.58 7.43
GOBP_RESPONSE_TO_ESTROGEN 5.89 5.73 6.04 5.94 5.8 5.44 5.93 5.72 5.72 5.58 5.92 5.54 5.63 5.73 5.79 5.77 5.87 5.8 5.61 5.8 5.9 5.77 5.66 5.48 5.66 5.9
GOBP_NCRNA_3_END_PROCESSING 6.65 6.75 7.42 7.17 6.7 6.88 6.74 6.91 6.76 6.83 6.84 6.76 6.88 6.89 6.81 6.99 6.74 6.61 7 7.02 6.57 6.75 7.04 7 6.86 6.95
GOBP_RNA_POLYADENYLATION 7.41 7.3 7.82 7.53 7.83 7.95 7.82 7.77 7.92 7.79 7.48 7.79 7.76 7.91 8.03 7.77 7.55 7.38 7.62 7.82 7.69 7.85 7.93 8.11 7.72 7.64
GOBP_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS 7.43 7.51 8.01 7.95 7.8 7.89 7.82 7.74 7.91 7.82 7.78 7.82 7.86 7.89 7.8 7.82 7.61 7.53 7.67 7.85 7.58 7.68 7.94 8.07 7.83 7.67
GOBP_INOSITOL_PHOSPHATE_METABOLIC_PROCESS 6.47 6.62 6.49 6.71 6.19 6.54 6.76 6.54 6.66 6.73 6.59 6.81 6.57 6.73 6.62 6.47 6.42 6.69 6.56 6.87 6.56 6.72 6.5 6.58 6.7 6.7
GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS 6.83 6.66 7.32 6.95 6.55 6.67 6.83 6.96 6.75 6.72 7.12 7.11 6.75 6.66 7.04 6.96 7.07 6.89 6.87 6.76 6.97 6.94 6.87 6.95 6.96 6.92
GOBP_DICARBOXYLIC_ACID_CATABOLIC_PROCESS 7.04 8.17 8.01 7.7 7.4 7.92 8.16 7.96 7.6 7.75 8.13 7.95 8.09 8.1 7.87 7.97 7.53 7.6 7.67 8.13 8.16 8.36 8.06 7.65 8.07 8.21
GOBP_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS 6.92 6.89 7.46 7.48 6.32 6.46 6.47 6.43 6.23 6.3 7.27 6.59 6.51 6.57 6.64 6.5 6.57 6.95 6.79 6.48 7.13 6.82 6.45 6.49 6.65 6.3
GOBP_LINOLEIC_ACID_METABOLIC_PROCESS 6.81 6.97 7.25 7.58 8.74 8.29 7.66 7.45 6.44 8.2 7.02 6.97 7.81 7.7 7.52 6.84 7.93 6.86 7.55 8.4 6.98 7.5 7.14 7.13 6.81 7.41
GOBP_ENGULFMENT_OF_APOPTOTIC_CELL 6.18 6.03 6.82 6.29 6.28 6.02 5.5 5.81 6.12 5.46 5.72 5.55 5.99 5.81 6.15 5.84 5.78 5.94 5.49 5.69 5.8 6.23 5.83 5.7 6.01 5.94
GOBP_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY 7.75 7.76 8.01 8.02 7.97 8.13 8.01 8.05 7.97 8.14 7.9 8.07 7.95 8.1 8.18 8.25 7.97 7.83 7.8 8.18 7.91 8.22 8.11 8.37 8.11 7.98
GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION 7.18 7.21 7.71 7.46 7.37 7.33 7.45 7.43 7.5 7.58 7.45 7.34 7.55 7.52 7.47 7.34 7.32 7.35 7.34 7.51 7.24 7.49 7.54 7.69 7.53 7.47
GOBP_REVERSE_CHOLESTEROL_TRANSPORT 5.9 5.9 5.45 6.22 5.53 5.65 5.91 5.73 5.55 5.55 6.08 5.39 5.9 5.6 5.64 5.3 5.86 5.44 5.7 5.34 5.64 5.83 5.32 5.11 5.65 5.84
GOBP_REGULATION_OF_MULTI_ORGANISM_PROCESS 5.45 5.54 5.62 6.13 5.28 4.87 5.31 5.32 5.35 5.07 5.36 5.29 5.06 4.92 5.37 5.25 5.52 5.61 5.27 5.41 5.39 6.07 5.34 5.22 5.23 5.05
GOBP_NEGATIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS 4.84 4.86 5.01 5.43 4.73 4.34 4.89 4.54 4.78 5 4.85 4.84 4.6 4.53 4.81 4.8 4.65 4.6 4.62 5.01 5.08 5.19 4.83 4.48 4.69 4.79
GOBP_POSITIVE_REGULATION_OF_MULTI_ORGANISM_PROCESS 6.37 6.06 7.15 6.49 5.66 6.07 5.89 6.15 5.84 5.91 6.57 6.06 6.26 6.06 6.28 6.51 6.26 6.38 6.07 6.12 6.34 6.84 6.09 6.3 6.55 6.42
GOBP_REGULATION_OF_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION 6.39 6.4 6.53 6.61 6.65 6.56 6.59 6.57 6.48 6.53 6.49 6.57 6.87 6.82 6.39 6.62 6.58 6.59 6.5 6.6 6.62 6.72 6.68 6.57 6.72 6.89
GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION 6.74 6.05 7.05 7.28 6.59 6.58 7.05 6.66 6.83 6.44 6.36 6.3 6.86 6.79 6.64 7.01 6.41 6.61 6.2 6.75 6.86 6.98 6.97 6.87 6.68 6.54
GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION 6.9 6.75 6.95 6.79 6.91 6.96 7.11 7.1 7.03 7.02 7.15 6.75 6.94 6.94 7.11 7.19 6.85 6.36 6.57 7.35 6.83 7.3 7.06 6.96 6.93 7.29
GOBP_PROTEIN_CONTAINING_COMPLEX_SUBUNIT_ORGANIZATION 6.84 6.89 7.32 7.15 7.08 7.13 7.11 7.14 7.14 7.18 7.1 7.16 7.12 7.14 7.21 7.22 7 6.98 7.03 7.18 7.07 7.2 7.18 7.34 7.19 7.21
GOBP_REGULATION_OF_CAMP_MEDIATED_SIGNALING 6.33 5.9 6.8 7.12 6.25 6.62 6.73 6.28 6.51 6.81 6.67 6.48 6.81 6.63 6.8 6.52 6.54 6.56 6.47 6.77 6.53 6.54 6.94 6.52 6.3 6.56
GOBP_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING 5.79 5.58 5.57 5.97 5.43 5.25 5.2 5.51 5.24 5.63 5.43 5.42 5.51 5.12 5.66 5.15 5.46 5.5 5.49 5.18 5.4 5.13 5.41 5.18 5.04 5.2
GOBP_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING 7.17 6.51 7.98 8.12 7.12 7.26 6.84 7.39 7.05 7.15 6.95 6.99 7.42 7.49 7.88 7.36 6.93 6.92 7.39 6.95 6.95 8.06 7.57 7.07 7.29 7.67
GOBP_CELLULAR_COMPONENT_MAINTENANCE 7.36 6.85 7.57 7.47 7.49 7.72 7.56 7.54 7.07 7.66 6.99 7.32 7.65 7.65 7.93 7.71 7.44 7.49 7.42 7.72 7.36 7.56 7.39 7.88 7.16 7.29
GOBP_HISTONE_H3_ACETYLATION 6.71 7 7.37 7.32 7.12 7.08 7.11 7.43 7.24 7.15 7.45 7.17 7.37 7.23 7.5 7.25 7.44 6.65 6.98 7.35 7.14 7.32 7.36 7.37 7.46 7.36
GOBP_HISTONE_H4_ACETYLATION 7.19 7.56 7.52 7.96 7.75 7.57 7.44 7.62 7.56 7.66 7.68 7.68 7.57 7.6 7.7 7.68 7.49 7.09 7.35 7.6 7.71 7.74 7.71 7.86 7.61 7.47
GOBP_HISTONE_H2A_ACETYLATION 6.47 6.62 6.99 6.9 7.05 7.15 6.92 6.93 6.88 7.21 7.02 6.83 7 7.16 7.03 7.36 6.68 6.52 6.93 7.03 6.56 6.71 7.25 7.54 6.9 6.89
GOBP_HISTONE_H3_K9_ACETYLATION 6.07 6.59 6.15 6.63 6.6 6.18 6.84 7.22 6.58 6.62 6.16 6.48 6.85 6.6 6.58 6.44 6.94 6.22 6.02 6.96 6.43 6.61 6.4 6.63 6.74 6.84
GOBP_HISTONE_H4_K16_ACETYLATION 7.26 7.04 7.64 7.93 7.4 7.31 7.21 7.49 7.5 7.4 7.72 7.33 7.81 7.54 7.7 7.83 7.58 7.27 7.31 7.58 7.85 7.8 7.91 7.89 7.48 7.25
GOBP_MODULATION_BY_SYMBIONT_OF_HOST_PROCESS 7.28 6.96 8 7.23 7.33 7.32 7.18 7.33 7.24 7.24 7.48 7.28 7.38 7.26 7.52 7.48 7.52 7.68 7.39 7.5 7.52 7.98 7.73 7.66 7.79 7.64
GOBP_REGULATION_OF_DNA_METHYLATION 6.34 6.44 6.87 6.55 6.59 6.68 6.92 6.69 6.48 7.01 6.41 7.11 6.77 6.72 6.73 6.98 6.67 6.25 6.68 6.43 7.21 6.66 6.34 6.56 6.93 6.72
GOBP_REGULATION_OF_SYSTEM_PROCESS 6.4 6.41 6.51 6.42 6.35 6.43 6.6 6.56 6.55 6.51 6.39 6.39 6.47 6.43 6.73 6.57 6.53 6.43 6.41 6.4 6.5 6.52 6.57 6.65 6.57 6.56
GOBP_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS 5.66 5.56 5.5 5.83 5.08 5.01 5.42 5.34 5.52 5.11 5.54 5.35 5.26 5.12 5.37 5.12 5.46 5.51 5.14 5.21 5.64 5.47 5.36 5.03 5.3 5.14
GOBP_REGULATION_OF_ENDOCRINE_PROCESS 5.48 5.61 5.7 5.72 5.47 5.41 5.64 5.92 5.72 5.48 5.73 5.24 5.6 5.55 5.78 5.65 5.57 5.56 5.34 5.53 5.5 5.52 5.69 5.35 5.5 5.26
GOBP_REGULATION_OF_EXCRETION 6.15 6.19 5.64 5.85 6.39 5.67 5.77 5.58 5.6 5.45 6.3 5.87 5.64 5.76 5.39 5.66 6.21 6.2 6.41 6.09 6.19 6.43 5.64 5.68 5.96 6.33
GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS 8.13 8.21 7.77 7.76 8.68 8.17 8.07 8.25 8.29 8.28 7.89 8.5 8.21 7.84 7.83 8.34 7.86 8.05 8.87 8.78 7.49 7.29 8.02 8 7.97 8.07
GOBP_MODULATION_BY_SYMBIONT_OF_HOST_CELLULAR_PROCESS 7.36 7.15 8.32 7.87 7.4 7.33 7.3 7.41 7.42 7.35 7.62 7.14 7.44 7.48 7.49 7.85 7.62 7.64 7.66 7.65 7.51 7.82 7.75 7.69 7.55 7.71
GOBP_REGULATION_OF_ANION_TRANSPORT 6.68 6.72 7.07 6.85 6.93 6.98 7 7.05 7.01 6.96 6.92 6.95 7.04 7.07 7.04 7.05 6.93 6.88 6.83 7.02 6.87 7.09 6.97 7.06 7.06 7.08
GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS 6.99 7.12 7.29 7.1 7.35 7.36 7.29 7.35 7.29 7.35 7.22 7.37 7.37 7.34 7.47 7.37 7.22 7.09 7.17 7.38 7.21 7.43 7.4 7.59 7.34 7.38
GOBP_REGULATION_OF_VACUOLE_ORGANIZATION 7.86 8.12 8.53 8.31 8.22 8.38 8.41 8.17 8.09 8.47 8.15 7.9 8.16 8.08 8.23 8.19 7.86 7.72 8.21 8.26 8.21 8.3 8.25 8.44 8.18 8.11
GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS 7.01 7.11 7.18 7.01 7.39 7.37 7.31 7.31 7.25 7.34 7.2 7.38 7.24 7.24 7.49 7.32 7.2 7.13 7.17 7.36 7.14 7.34 7.33 7.54 7.31 7.37
GOBP_POSITIVE_REGULATION_OF_VACUOLE_ORGANIZATION 7.73 8.21 8.53 7.98 8.15 8.51 8.46 8.21 8.29 8.47 8.15 8.07 8.69 8.77 8.52 8.45 7.86 7.78 8.24 8.62 7.67 8.28 8.29 8.69 8.16 8.17
GOBP_MEMBRANE_BIOGENESIS 7.53 7.62 7.81 7.91 8.19 8.25 7.84 7.81 7.86 7.88 7.81 7.98 7.75 7.85 7.82 7.84 7.96 7.73 7.79 8.08 7.61 7.62 8.26 8.3 7.79 8.06
GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION 6.34 6.3 6.51 6.45 6.33 6.38 6.39 6.44 6.46 6.44 6.39 6.41 6.54 6.48 6.49 6.43 6.45 6.39 6.32 6.34 6.54 6.54 6.5 6.52 6.48 6.51
GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION 6.49 6.51 6.68 6.58 6.67 6.66 6.68 6.77 6.67 6.67 6.55 6.71 6.68 6.62 6.75 6.64 6.6 6.57 6.52 6.63 6.66 6.75 6.72 6.74 6.72 6.76
GOBP_HISTONE_H3_K14_ACETYLATION 6.56 6.99 6.84 7.62 7.08 6.85 7.47 7.87 7.41 7.06 7.54 7.16 7.5 7.09 7.88 7.44 7.46 6.6 6.93 7.29 7.81 7.44 7.52 7.45 7.46 7.48
GOBP_LIPID_DIGESTION 5.04 4.74 4.69 4.89 4.59 4.37 4.5 4.42 4.52 4.56 4.93 4.46 4.6 4.31 4.46 4.47 4.73 4.69 4.59 4.49 4.78 4.66 4.32 4.24 4.3 4.54
GOBP_CELLULAR_LIPID_CATABOLIC_PROCESS 6.41 6.42 6.8 6.75 6.64 6.75 6.66 6.67 6.57 6.73 6.66 6.72 6.67 6.57 6.53 6.63 6.56 6.5 6.5 6.67 6.66 6.62 6.62 6.72 6.5 6.71
GOBP_CELLULAR_LIPID_METABOLIC_PROCESS 6.59 6.59 6.87 6.84 6.68 6.75 6.76 6.72 6.71 6.79 6.66 6.75 6.81 6.8 6.74 6.7 6.64 6.63 6.65 6.76 6.67 6.81 6.7 6.82 6.81 6.91
GOBP_CELLULAR_PROTEIN_CATABOLIC_PROCESS 7.39 7.46 7.91 7.83 7.72 7.78 7.76 7.71 7.82 7.78 7.64 7.71 7.77 7.78 7.77 7.72 7.58 7.49 7.61 7.78 7.56 7.68 7.89 7.95 7.8 7.67
GOBP_CELLULAR_CARBOHYDRATE_METABOLIC_PROCESS 6.54 6.64 6.75 6.82 6.7 6.72 6.75 6.66 6.76 6.79 6.54 6.83 6.75 6.8 6.7 6.61 6.76 6.78 6.73 6.86 6.65 6.76 6.72 6.74 6.78 6.72
GOBP_CELLULAR_MACROMOLECULE_CATABOLIC_PROCESS 7.32 7.38 7.77 7.7 7.64 7.65 7.58 7.55 7.65 7.64 7.52 7.56 7.65 7.67 7.66 7.57 7.47 7.37 7.53 7.64 7.43 7.57 7.73 7.75 7.66 7.54
GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS 6.93 7.11 7.5 7.33 7.25 7.45 7.33 7.34 7.29 7.45 7.21 7.37 7.39 7.35 7.39 7.08 7.32 7.16 7.29 7.57 7.09 7.43 7.47 7.65 7.56 7.42
GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS 6.43 6.41 6.85 7.03 6.61 6.4 6.72 6.85 6.36 6.62 6.54 6.86 6.58 6.4 6.71 6.55 6.89 6.44 6.37 6.66 6.99 6.88 6.61 6.82 6.41 6.54
GOBP_CELLULAR_CARBOHYDRATE_CATABOLIC_PROCESS 6.59 6.63 6.51 6.64 6.84 7.06 6.5 6.55 6.87 6.74 6.34 6.74 6.78 6.87 6.41 6.31 6.72 6.68 6.79 6.67 6.71 6.86 6.49 6.54 6.88 6.81
GOBP_SMALL_MOLECULE_METABOLIC_PROCESS 6.45 6.45 6.85 6.77 6.57 6.58 6.61 6.59 6.56 6.64 6.56 6.58 6.64 6.6 6.55 6.56 6.56 6.5 6.51 6.64 6.51 6.59 6.54 6.65 6.63 6.64
GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS 6.13 6.27 6.66 6.58 6.18 6.36 6.34 6.38 6.21 6.36 6.42 6.36 6.43 6.38 6.29 6.39 6.32 6.29 6.32 6.38 6.41 6.48 6.31 6.33 6.37 6.41
GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS 6.43 6.44 6.74 6.68 6.5 6.52 6.57 6.52 6.53 6.57 6.57 6.58 6.67 6.5 6.55 6.57 6.47 6.52 6.45 6.61 6.54 6.61 6.52 6.68 6.58 6.58
GOBP_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS 6.19 5.99 6.93 6.48 6.37 6.55 6.42 6.62 6.46 6.79 6.65 6.56 6.63 6.9 6.9 6.89 6.23 6.52 6.34 6.67 6.41 6.64 6.79 6.99 6.2 6.34
GOBP_RESPONSE_TO_LEPTIN 6.22 6.37 6.71 6.32 6.44 6.61 6.23 6.51 6.5 6.88 6.54 6.56 6.56 6.78 6.84 6.86 6.29 6.49 6.37 6.53 6.4 6.57 6.71 6.89 6.17 6.44
GOBP_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN 6.25 6.22 6.17 6.1 6.38 6.16 6.45 6.45 6.08 6.1 6.22 6.1 6.31 6.47 6.38 6.13 6.36 6.16 5.99 6.32 6.5 6.44 6.23 5.85 6.59 6.32
GOBP_TYPE_B_PANCREATIC_CELL_PROLIFERATION 7.06 6.78 7.34 7.35 6.78 6.64 7.1 7.4 6.95 7.22 6.49 6.99 6.98 7.15 7.14 6.97 7.5 7.27 6.61 7.09 7.5 7.58 7.1 7 6.94 7.15
GOBP_FIBROBLAST_APOPTOTIC_PROCESS 5.83 6.21 6.37 6.77 6.2 6.46 6.67 6.6 6.39 6.21 6.27 6.55 6.48 6.4 6.42 6.57 6.31 5.91 6.66 6.01 6.82 6.74 6.33 6.61 5.91 6.5
GOBP_PROTEIN_LOCALIZATION_TO_CYTOSKELETON 7.02 7.02 7.32 7.12 7.43 7.43 7.04 7.27 6.98 7.4 7.25 7.53 7.43 7.46 7.49 7.54 7.13 7.25 7.51 7.12 7.09 7.3 7.39 7.42 7.15 7.15
GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION 6.97 7.07 7.35 7.32 7.32 7.28 7.25 7.25 7.27 7.33 7.27 7.27 7.34 7.3 7.28 7.25 7.18 7.04 7.18 7.37 7.18 7.33 7.45 7.46 7.39 7.42
GOBP_ADHESION_OF_SYMBIONT_TO_HOST 5.36 5.11 4.95 5.43 4.83 4.61 5.19 5.45 4.95 4.51 5.35 5.16 4.94 5.1 5.03 4.67 5.35 5.04 4.4 4.93 5.65 5.6 4.84 4.48 5.54 5.39
GOBP_ENTRY_INTO_HOST 6.28 6.15 6.43 6.32 6.34 6.28 6.27 6.49 6.25 6.26 6.17 6.21 6.36 6.4 6.25 6.39 6.25 6.16 6.29 6.39 6.41 6.43 6.39 6.3 6.31 6.51
GOBP_MOTILE_CILIUM_ASSEMBLY 6.44 6.5 7.67 6.76 6.74 6.95 6.68 6.79 6.68 6.87 6.96 6.98 6.72 6.82 7.14 7.52 6.35 6.72 6.83 6.81 6.76 7.08 7.18 7.32 7.15 7.16
GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_INTO_CELL 6.76 6.86 7.41 7.1 7.2 7.4 7.81 7.29 7.36 8 7.18 7.56 7.73 7.64 7.51 7.29 7.18 7.21 7.45 7.47 7.28 7.18 7.65 8.14 7.67 7.67
GOBP_NLRP3_INFLAMMASOME_COMPLEX_ASSEMBLY 5.29 4.97 4.98 5.2 4.67 6.06 4.79 4.49 5.37 5.02 4.56 5.06 5.67 4.43 6.04 5.59 4.71 5.2 5.75 4.51 5.08 4.68 5.81 5.08 4.61 4.51
GOBP_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS 5.6 5.53 6.1 5.67 4.99 5.41 5.8 5.93 5.26 5.21 5.41 5.41 5.41 5.34 5.84 5.16 5.63 5.47 5.38 5.41 5.4 5.29 5.19 5.41 5.65 5.33
GOBP_ADHESION_OF_SYMBIONT_TO_HOST_CELL 5.36 5.11 4.95 5.43 4.83 4.61 5.19 5.45 4.95 4.51 5.35 5.16 4.94 5.1 5.03 4.61 5.35 5.04 4.4 4.93 5.65 5.6 4.84 4.48 5.54 5.39
GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS 5.9 5.83 5.78 5.84 5.56 5.54 5.7 5.69 5.69 5.65 5.82 5.59 5.65 5.66 5.69 5.61 5.72 5.84 5.77 5.72 5.75 5.6 5.68 5.45 5.66 5.8
GOBP_DNA_METHYLATION_OR_DEMETHYLATION 5.83 5.69 5.94 5.85 5.61 5.98 5.58 5.76 5.68 5.75 5.78 5.61 5.91 5.91 5.78 5.65 5.73 5.61 5.9 5.63 5.61 5.66 5.67 6.12 5.72 5.89
GOBP_PROTEIN_TRANSMEMBRANE_IMPORT_INTO_INTRACELLULAR_ORGANELLE 6.46 6.56 7.31 7.01 7.13 7.11 6.94 6.88 6.94 6.96 7.04 6.94 7.1 7.35 6.85 7.25 6.88 6.92 6.89 6.93 6.81 6.93 7.02 7.1 6.95 6.97
GOBP_MULTI_ORGANISM_CELLULAR_PROCESS 6.12 5.98 7.05 6.77 6.22 6.34 6.28 6.73 6.26 6.32 6.83 6.55 6.32 6.59 6.32 6.7 6.27 6.48 6.74 6.6 6.58 7.06 7.11 6.61 6.51 7.17
GOBP_CELL_CYCLE_PHASE_TRANSITION 6.65 6.73 6.93 7 6.78 6.95 6.85 6.89 6.84 6.9 6.85 6.9 6.82 7 6.89 7.04 6.7 6.77 6.75 6.97 6.81 6.96 6.95 7.04 6.87 6.98
GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT 6.39 6.45 6.55 6.39 6.37 6.46 6.3 6.72 6.19 6.35 6.53 6.25 6.4 6.2 6.48 6.63 6.27 6.31 6.4 6.43 6.53 6.52 6.15 6.58 6.65 6.96
GOBP_CILIUM_ORGANIZATION 6.51 6.57 6.83 6.67 6.57 6.71 6.62 6.52 6.45 6.71 6.68 6.73 6.55 6.6 6.64 6.91 6.5 6.66 6.68 6.62 6.67 6.82 6.63 6.7 6.71 6.69
GOBP_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE 6.04 5.89 6.05 5.96 5.64 5.79 5.67 5.89 5.76 5.92 5.8 5.69 5.66 5.68 5.9 6.02 6 5.88 5.85 5.6 5.98 6.05 5.72 5.87 6.09 6.09
GOBP_CELL_CYCLE_DNA_REPLICATION 5.66 5.83 6.04 6.25 5.61 5.52 5.71 5.91 5.68 5.66 5.73 5.76 5.57 5.49 5.91 5.88 5.66 5.63 5.6 5.63 5.64 5.97 5.74 5.94 5.99 6.15
GOBP_MODULATION_BY_HOST_OF_VIRAL_PROCESS 7.32 7.15 7.83 7.72 7.7 7.51 7.42 7.58 7.65 7.79 7.99 7.72 7.54 7.84 7.41 7.59 7.67 7.08 7.67 7.53 7.48 7.93 7.73 7.66 7.68 7.85
GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS 5.54 4.98 4.53 4.79 4.89 4.61 4.47 4.17 4.53 4.23 4.57 4.1 4.55 4.14 4.44 4.54 4.8 4.86 4.94 4.15 4.52 4.35 4.11 4.46 4.34 4.24
GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS 8.42 8.42 8.68 9.03 8.2 8.43 8.23 8.08 8.64 8.35 8.32 8.51 8.37 8.44 8.54 7.96 8.09 7.99 8.11 8.3 8.28 8.37 8.77 8.77 8.36 8.08
GOBP_AUTOPHAGY_OF_NUCLEUS 7.43 7.4 8.14 8.03 7.49 7.63 7.72 7.57 7.67 7.59 7.96 7.59 7.65 7.74 7.78 8.04 7.72 7.94 7.77 7.87 7.95 7.78 7.62 7.64 7.74 7.46
GOBP_MITOTIC_G2_M_TRANSITION_CHECKPOINT 6.07 6.2 6.4 6.4 6.47 6.63 5.89 6.07 6.24 6.42 6.33 6.14 6.04 6.23 6.37 6.3 6.11 6.03 6.21 6.22 6.42 6.47 6.37 6.44 6.56 6.85
GOBP_MITOTIC_G1_S_TRANSITION_CHECKPOINT 6.87 6.73 6.61 6.45 6.45 6.46 6.51 6.88 6.5 6.63 6.61 6.42 6.56 6.53 6.5 6.92 6.88 6.49 6.43 6.6 6.72 6.76 6.81 6.67 6.71 7.03
GOBP_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION 8.04 8.01 8.33 8.21 8.26 8.22 8.38 8.07 8.26 8.54 8.5 8.54 8.42 8.56 8.63 8.14 7.76 7.35 8.01 8.16 8.24 8.19 8.34 8.69 8.48 8.21
GOBP_CELL_CYCLE_G2_M_PHASE_TRANSITION 6.98 6.97 7.28 7.18 7.28 7.2 7.11 7.16 7.26 7.34 7.13 7.16 7.27 7.33 7.27 7.31 7.13 7.09 7.19 7.3 7.19 7.25 7.38 7.6 7.38 7.31
GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION 6.42 6.44 6.67 6.46 6.45 6.59 6.48 6.49 6.5 6.62 6.55 6.48 6.59 6.61 6.48 6.63 6.42 6.45 6.54 6.52 6.63 6.68 6.81 6.72 6.62 6.71
GOBP_ESTROUS_CYCLE 6.21 6.11 6.77 6.05 5.56 5.89 6.21 6.47 6.05 5.77 6.11 5.86 5.85 5.81 5.86 5.82 6.09 6.1 6.07 6.04 6.47 6.45 6.06 5.97 6.72 6.81
GOBP_LIPOPROTEIN_LOCALIZATION 5.24 5.08 4.94 5.27 4.68 4.82 4.74 5.2 5.01 5.25 5.29 4.96 4.99 4.86 4.95 5.55 5.32 5.48 5.02 5.22 5.26 5.23 5.22 4.77 5.14 4.9
GOBP_DNA_DEPENDENT_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY 5.67 5.75 5.48 5.58 5.63 5.61 5.38 5.68 5.27 5.5 5.43 5.53 5.29 5.39 5.44 5.81 5.51 5.58 5.49 5.25 5.53 5.69 5.21 5.63 5.67 5.71
GOBP_DNA_DEAMINATION 4.96 5.2 5.49 5.25 4.53 4.81 4.94 5.05 4.95 4.37 4.91 4.67 4.98 4.69 5.16 4.89 5.22 5.32 5.06 4.93 5.32 5.17 4.58 4.62 5.12 5.13
GOBP_ACTIN_NUCLEATION 7.3 7.49 7.72 7.67 7.59 7.83 7.76 7.59 7.62 7.83 7.71 7.68 7.67 7.88 7.73 7.86 7.63 7.46 7.57 7.64 7.71 7.91 7.85 7.87 7.75 7.9
GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS 7.12 7.15 7.45 7.26 7.2 7.38 7.37 7.28 7.29 7.31 7.13 7.23 7.4 7.45 7.35 7.17 7.18 7.18 7.23 7.37 7.08 7.25 7.29 7.47 7.34 7.37
GOBP_G0_TO_G1_TRANSITION 6.93 7.01 7.21 7.42 7.02 6.86 7.12 7.25 7.06 7.2 7.4 7.01 6.99 7.12 7.25 7.33 7.08 6.86 7.18 7.34 7.19 7.09 7.13 7.14 7.24 7.31
GOBP_PLASMA_MEMBRANE_FUSION 5.12 4.98 4.85 4.79 4.73 4.49 4.68 4.76 4.79 4.33 4.51 4.34 4.84 4.66 4.71 4.7 4.69 5.21 4.7 4.53 4.95 4.54 4.46 4.47 4.57 4.67
GOBP_TRANSCYTOSIS 7.73 7.96 8.08 7.59 9.1 8.73 9 8.32 9.01 9.05 8.08 9.12 9.01 9.28 8.58 8.8 8.21 8.34 8.12 8.59 8.08 8.42 9.16 9.1 8.89 8.28
GOBP_T_CELL_SELECTION 5.48 5.2 5.24 5.37 4.96 4.93 5.08 5.03 5.17 4.97 5.25 4.88 4.98 4.94 5.12 5.12 5.06 5.24 4.98 4.9 5.33 5.09 4.96 4.82 5.04 5.09
GOBP_POSITIVE_THYMIC_T_CELL_SELECTION 5.44 5.44 5.38 5.75 5.19 5.22 5.09 5.38 5.16 5.2 5.3 5.35 5.07 4.94 5.09 5.35 5.19 5.4 5.4 5.16 5.87 5.77 4.96 5.22 5.32 5.57
GOBP_THYMIC_T_CELL_SELECTION 5.51 5.61 5.38 5.31 5.19 5.17 5.37 5.36 5.24 5.18 5.3 5.05 5.07 4.94 5.2 5.31 5.19 5.45 5.24 5.23 5.7 5.29 4.96 4.86 5.32 5.46
GOBP_T_HELPER_1_CELL_DIFFERENTIATION 5.66 5.58 5.65 5.97 5.27 5.35 5.52 5.6 5.52 5.36 5.7 5.37 5.6 5.54 5.36 5.41 6.12 5.63 5.2 5.36 5.42 5.62 5.62 5.1 5.37 5.53
GOBP_T_HELPER_2_CELL_DIFFERENTIATION 5.36 5.44 5.55 5.44 5.19 5.12 5.59 5.42 5.3 5.14 5.32 5.18 5.34 5.25 5.28 5.42 5.18 5.37 5.22 5.27 5.77 5.42 5.1 4.97 5.29 5.92
GOBP_REGULATORY_T_CELL_DIFFERENTIATION 5.41 5.62 5.08 5.59 5.1 4.94 5.54 5.25 5.48 5.27 5.35 5.09 5.34 5.03 5.05 5.23 5.52 5.26 5.08 5.11 5.41 5.49 4.94 5.01 5.26 5.32
GOBP_REGULATION_OF_VIRAL_GENOME_REPLICATION 6.15 5.98 5.96 5.93 6.39 6.28 6.09 6.26 6.19 6.44 6.31 6.29 6.25 6.5 6.09 6.28 6.28 6.06 6.05 6.39 6.06 6.24 6.15 6.25 6.22 6.47
GOBP_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION 7.48 7.6 7.73 7.94 7.48 7.55 7.73 7.83 7.95 7.79 7.48 7.98 7.91 7.89 8.08 7.99 7.1 7.33 7.42 7.64 7.91 7.81 8.23 8.03 7.4 7.67
GOBP_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION 5.78 5.58 5.48 5.55 5.72 5.59 5.49 5.49 5.72 5.62 5.97 5.59 5.52 5.62 5.43 5.34 5.86 5.68 5.69 5.45 5.73 5.56 5.26 5.34 5.63 5.66
GOBP_INNATE_IMMUNE_RESPONSE 5.75 5.69 5.7 5.83 5.5 5.43 5.57 5.53 5.62 5.4 5.66 5.47 5.5 5.49 5.44 5.45 5.74 5.63 5.39 5.47 5.74 5.64 5.47 5.37 5.62 5.72
GOBP_REGULATION_OF_INNATE_IMMUNE_RESPONSE 6.4 6.48 6.79 6.68 6.49 6.45 6.46 6.45 6.37 6.46 6.64 6.45 6.3 6.43 6.24 6.41 6.43 6.3 6.26 6.38 6.22 6.35 6.33 6.22 6.68 6.49
GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS 5.89 5.77 6.13 6.09 5.85 5.66 5.71 5.89 6.04 6.13 6.1 5.92 5.82 5.93 5.83 6.23 5.95 5.93 6 5.67 6.1 5.71 5.92 5.68 5.76 5.87
GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION 5.66 5.32 5.11 5.24 4.92 5.01 5.15 5 5.46 5.08 5.82 4.88 5.04 5.27 5.28 4.98 5.1 5.51 4.89 4.71 5.39 5.32 5.21 4.72 5.1 5.06
GOBP_PROTEIN_NEDDYLATION 7.48 7.64 8.68 8.01 7.29 7.83 7.95 8.11 8.09 8.21 7.92 7.83 7.94 7.67 7.97 7.83 6.94 7.49 7.42 7.17 7.59 7.9 8.57 8.34 7.6 7.83
GOBP_AZOLE_TRANSMEMBRANE_TRANSPORT 5.8 5.77 5.98 6.16 5.82 6.05 5.59 5.82 5.73 5.59 5.81 5.58 5.88 5.91 5.69 5.44 5.69 5.54 5.93 5.92 5.72 5.97 5.54 6.03 5.96 6.21
GOBP_CELLULAR_EXTRAVASATION 5.69 5.54 5.73 5.97 5.39 5.47 5.65 5.53 5.52 5.33 5.63 5.47 5.63 5.5 5.79 5.57 5.71 5.36 5.33 5.53 6.04 5.83 5.41 5.29 5.79 5.9
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION 4.99 5.16 5.08 5.2 4.84 4.59 4.59 4.85 4.68 4.61 4.84 4.95 4.62 4.54 4.68 4.84 4.93 5.14 5.11 4.72 5.07 4.67 4.69 4.58 4.68 4.73
GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS 5.91 5.96 6.15 6.06 5.86 5.77 5.86 6.04 5.93 5.93 6.04 5.89 5.91 5.79 5.97 5.86 5.98 5.92 5.77 5.79 6.07 6.04 6.02 5.87 5.9 6.09
GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION 4.94 5.05 4.87 4.99 4.57 4.4 4.51 4.78 4.51 4.35 4.77 4.84 4.55 4.39 4.66 4.64 4.79 5.07 5 4.63 5.01 4.58 4.34 4.45 4.61 4.63
GOBP_NEURONAL_ION_CHANNEL_CLUSTERING 8.58 8.6 8.38 8.12 9.15 9.07 9.2 9.08 8.66 9.31 8.55 8.92 8.87 8.6 9.05 8.76 7.73 7.94 8.49 8.84 7.77 8.14 8.89 9.36 8.78 9.01
GOBP_CELL_FATE_COMMITMENT 5.64 5.52 5.61 5.84 5.36 5.19 5.6 5.48 5.6 5.4 5.64 5.46 5.42 5.48 5.61 5.49 5.56 5.47 5.36 5.38 5.62 5.49 5.49 5.18 5.44 5.49
GOBP_APICAL_PROTEIN_LOCALIZATION 8.15 9 8.43 7.96 8.42 9.02 9.64 8.53 8.91 9.4 7.81 8.41 9 9.13 9.06 8.73 7.96 8.33 8.74 9.25 7.45 7.11 8.87 8.78 8.78 7.83
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION 7.16 7.25 7.66 7.5 7.51 7.57 7.46 7.5 7.5 7.55 7.44 7.49 7.51 7.53 7.5 7.51 7.28 7.28 7.45 7.52 7.3 7.51 7.59 7.75 7.59 7.5
GOBP_MAINTENANCE_OF_PROTEIN_LOCATION 7.48 7.43 7.78 7.63 7.8 7.7 7.55 7.56 7.76 7.86 7.71 7.77 7.69 7.77 7.76 7.62 7.68 7.58 7.63 7.72 7.71 7.78 7.78 7.92 7.81 7.55
GOBP_REGULATION_OF_ISOTYPE_SWITCHING 6.25 6.69 5.99 6.68 7.32 6.62 6.6 6.3 5.95 6.65 6.2 6.76 6.52 6.58 5.8 6.57 6.51 6.57 6.46 6.38 6.67 6.83 6.8 6.85 6.29 6.84
GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY 7.98 8.15 8.52 7.47 7.81 7.85 8.13 7.54 7.71 7.82 8 7.85 8.12 8.08 8.09 7.94 7.99 7.95 7.59 7.98 6.99 8.2 8.06 8.06 8.13 8.1
GOBP_SARCOMERE_ORGANIZATION 5.85 5.75 5.12 5.4 5.31 5.4 5.68 5.33 5.54 5.85 5.73 5.52 5.48 5.65 5.63 5.83 6.02 5.68 5.66 5.3 5.34 5.37 5.47 5.28 5.56 5.86
GOBP_CELL_CELL_JUNCTION_ORGANIZATION 6.64 6.54 6.85 6.47 6.53 6.6 6.78 6.6 6.66 6.69 6.46 6.5 6.59 6.62 6.69 6.64 6.58 6.43 6.37 6.65 6.71 6.83 6.86 6.97 6.86 6.84
GOBP_CELL_CELL_JUNCTION_MAINTENANCE 6.23 6.23 6.38 6.29 5.93 6.24 5.84 6.1 5.71 6.09 5.93 5.81 6.04 6 6.67 6.36 6.1 5.84 5.71 6.39 6.29 6.3 6.2 6.11 6.16 6.04
GOBP_EXTERNAL_ENCAPSULATING_STRUCTURE_ORGANIZATION 5.7 5.48 5.43 5.56 5.38 5.26 5.54 5.48 5.49 5.37 5.49 5.34 5.44 5.36 5.45 5.46 5.53 5.5 5.34 5.35 5.71 5.49 5.56 5.21 5.48 5.56
GOBP_MRNA_CIS_SPLICING_VIA_SPLICEOSOME 6.95 7.59 6.96 7.01 7.37 7.59 7.06 6.98 7.1 7.42 7.31 7.66 7.2 7.25 6.91 7.18 7.13 7.16 7.26 7.18 6.95 7.45 7.36 7.7 7.34 7.1
GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT 7.46 7.74 8.72 8.63 7.89 7.93 7.93 8.05 7.7 7.75 8.03 7.81 7.6 7.65 8.04 8.04 7.39 7.45 7.7 7.67 7.59 7.88 8.05 8.16 7.76 7.54
GOBP_CELLULAR_RESPIRATION 7.87 8.05 9.05 8.66 8.18 8.17 8.31 8.53 8.35 8.47 8.53 8.37 8.38 8.42 8.64 8.72 8.14 8.07 8.28 8.47 8.31 8.57 8.38 8.65 8.45 8.36
GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS 6.19 6.32 5.81 5.82 5.64 5.65 5.62 6.01 5.74 5.56 5.68 5.82 5.62 5.4 5.55 5.53 6.26 6.47 6.25 5.43 6.3 5.98 5.6 5.54 6.04 6.58
GOBP_FAT_CELL_DIFFERENTIATION 6.46 6.55 6.63 6.55 6.56 6.51 6.65 6.73 6.61 6.74 6.48 6.56 6.72 6.87 6.62 6.72 6.63 6.54 6.45 6.67 6.72 6.83 6.54 6.79 6.61 6.65
GOBP_MYOBLAST_DIFFERENTIATION 6.05 6.19 6.45 6.2 6.56 6.64 6.34 6.4 6.4 6.65 6.23 6.51 6.53 6.52 6.37 6.4 6.59 6.42 6.27 6.31 6.42 6.65 6.39 6.7 6.31 6.41
GOBP_BONE_RESORPTION 6.21 6.24 6.35 6.29 5.89 5.95 6.18 6.34 6.17 6.26 6.12 6.05 6.1 6.12 6.51 6.23 6.1 6.29 5.9 6.18 6.8 6.29 6.02 6.03 6.52 6.16
GOBP_CELL_REDOX_HOMEOSTASIS 6.06 5.9 7.22 6.6 5.98 5.62 6.11 6.19 6.32 6.45 6.25 6.25 6.32 6.11 6.46 6.39 6.2 6.31 6.21 6.1 6.35 6.51 6.02 6.36 6.56 6.46
GOBP_RESPONSE_TO_ETHANOL 6.31 6.18 6.65 6.34 6.2 6.54 6.78 6.57 6.64 6.49 6.29 6.32 6.45 6.28 6.72 6.53 6.37 6.43 6.29 6.46 6.33 6.6 6.55 6.57 6.69 6.7
GOBP_RESPONSE_TO_ETHER 6.05 5.99 6.66 6.59 5.98 6.2 6.58 6.16 6.74 6.26 6.26 6.28 5.94 6 6.94 6.62 6.25 6.43 5.52 6.61 6.86 6.88 5.9 6.03 7 6.28
GOBP_LOCOMOTOR_RHYTHM 8.57 8.59 7.86 7.98 8.92 9.04 9.12 8.86 8.75 8.84 8.29 8.56 9.03 8.99 8.85 8.84 8.31 8.57 8.73 9.04 8.23 8.65 8.85 8.67 8.46 8.56
GOBP_PHOTORECEPTOR_CELL_MAINTENANCE 5.86 5.63 5.84 5.95 5.78 5.64 5.63 5.45 5.75 5.92 6.04 5.72 5.69 5.69 5.6 5.8 5.85 5.84 5.78 5.56 5.86 5.76 5.62 5.54 5.75 5.74
GOBP_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS 7.58 7.88 7.5 7.39 8.03 8.14 8.03 7.87 8.11 8.1 7.67 7.95 8.1 8.17 7.92 7.85 7.99 7.5 7.86 8.05 7.56 7.97 8.02 8.47 8.14 8.06
GOBP_MAST_CELL_ACTIVATION 5.62 5.67 5.83 5.58 5.19 5.23 5.4 5.39 5.6 5.18 5.49 5.25 5.32 5.4 5.44 5.4 5.47 5.48 5.32 5.32 5.64 5.42 5.3 5.29 5.6 5.89
GOBP_REGULATION_OF_B_CELL_DIFFERENTIATION 5.46 5.48 5.48 5.24 5.05 5.18 5.1 5.16 5.51 5.34 4.99 4.86 5.39 5.53 5.37 5.23 5.1 5.05 5.12 5.33 5.44 5.53 5.41 5.34 5.35 5.14
GOBP_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION 5.31 5.48 5.73 4.96 5.6 5.72 5.07 5.21 5.76 5.38 4.98 4.69 5.65 5.56 5.55 5.24 5.06 5.08 5.22 5.47 5.61 5.78 5.24 5.47 5.62 5.99
GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION 5.53 5.39 5.4 5.62 5.24 5.12 5.33 5.42 5.31 5.27 5.38 5.23 5.34 5.23 5.31 5.41 5.41 5.38 5.19 5.26 5.59 5.46 5.13 5.1 5.28 5.5
GOBP_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION 5.5 5.35 5.08 5.56 4.91 4.89 5.76 5.32 5.94 5.27 5.35 5.09 5.15 4.89 5.05 5.23 5.52 5.38 5 5.11 5.45 5.52 4.94 5.01 5.26 5.18
GOBP_REGULATION_OF_CELL_DIFFERENTIATION 6.47 6.47 6.57 6.55 6.56 6.65 6.67 6.71 6.64 6.66 6.53 6.57 6.67 6.68 6.64 6.63 6.65 6.52 6.49 6.61 6.69 6.67 6.66 6.66 6.64 6.72
GOBP_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION 6.3 6.32 6.5 6.41 6.41 6.48 6.49 6.45 6.49 6.49 6.38 6.42 6.58 6.56 6.5 6.55 6.53 6.43 6.3 6.4 6.64 6.53 6.51 6.5 6.51 6.6
GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION 6.33 6.36 6.41 6.45 6.35 6.43 6.54 6.63 6.47 6.48 6.35 6.32 6.56 6.48 6.55 6.55 6.54 6.36 6.3 6.43 6.54 6.6 6.55 6.53 6.48 6.6
GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION 6.56 6.57 6.8 6.74 6.87 6.67 6.86 6.86 6.89 6.91 6.62 6.92 6.94 6.92 6.75 6.86 6.73 6.6 6.59 6.84 6.83 6.93 6.95 6.91 6.87 6.77
GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION 6.19 6.39 6.68 6.56 6.7 6.64 6.79 6.88 6.83 6.91 6.5 6.94 6.72 6.94 6.93 6.73 6.7 6.57 6.47 6.78 6.82 6.94 7.04 7.02 6.95 6.7
GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION 6.73 6.65 6.98 6.88 6.99 6.9 7.07 6.96 7.21 7.17 7.16 7.15 7.16 7.09 7.19 7.09 6.81 6.73 6.7 7.05 7.11 6.99 7.24 7.21 7.01 7.18
GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION 6.6 6.44 6.33 6.15 6.16 6.44 6.59 6.6 6.26 6.33 6.35 6.3 6.28 6.42 6.34 6.22 6.68 6.4 6.4 6.25 6.78 6.77 6.42 6.16 6.89 6.72
GOBP_POSITIVE_REGULATION_OF_EPIDERMAL_CELL_DIFFERENTIATION 5.43 5.35 5.33 5.7 5.28 4.92 5.13 5.02 4.99 4.93 5.72 5.12 5.01 5.15 4.99 5.45 5.09 5.42 5.03 4.74 5.38 4.87 5.22 4.79 5.14 4.97
GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION 5.58 5.44 5.4 5.63 4.94 4.84 5.2 5.31 5.15 5.17 5.42 5.15 5.35 5.08 5.09 5.48 5.61 5.54 5.2 5.01 5.47 5.22 5.27 4.82 5.25 5.16
GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION 5.54 5.38 5.73 5.83 5.57 4.92 5.33 5.7 5.22 5.2 5.83 5.2 5.01 5.15 5.33 5.65 5.37 5.51 5.31 4.9 5.51 5.35 5.45 4.79 5.19 5.19
GOBP_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION 5.63 5.48 5.45 5.65 5.29 5.19 5.49 5.47 5.38 5.35 5.44 5.29 5.38 5.32 5.35 5.42 5.52 5.38 5.35 5.34 5.64 5.54 5.36 5.22 5.37 5.53
GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION 5.57 5.43 5.19 5.43 5.16 5.19 5.26 5.27 5.3 5.33 5.39 5.26 5.36 5.24 5.21 5.36 5.27 5.27 5.14 5.24 5.35 5.29 5.14 5.22 5.26 5.24
GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION 5.67 5.63 5.66 5.66 5.36 5.25 5.65 5.61 5.51 5.4 5.6 5.32 5.44 5.36 5.52 5.52 5.77 5.54 5.48 5.42 5.74 5.63 5.53 5.28 5.61 5.95
GOBP_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION 5.43 5.18 5.11 5.43 5.14 4.97 5.39 5.37 5.12 5 5.3 5.03 5.22 5.2 5.17 5.09 5.12 5.29 5.14 5.13 5.32 5.24 4.97 4.93 5.17 5.26
GOBP_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION 5.54 5.37 5.04 5.42 5.32 5.18 5.32 5.32 5.21 5.14 5.54 5.23 5.34 5.25 5.19 5.31 5.14 5.27 5.19 5.27 5.43 5.24 5.1 4.95 5.2 5.3
GOBP_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION 5.44 5.37 5.17 5.44 5.19 4.98 5.46 5.42 4.98 5.02 5.32 5.15 5.23 5.21 5.18 5.41 5.18 5.3 5.19 4.77 5.67 5.42 5.1 4.93 5.27 5.5
GOBP_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION 5.41 5.62 5.55 6.12 5.31 5.18 5.59 5.84 5.17 5.35 5.67 5.18 5.36 5.34 5.8 5.42 5.46 5.38 5.22 5.46 6.05 5.83 5.56 4.97 6.48 5.98
GOBP_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION 6.48 6.37 6.46 6.61 6.54 6.61 6.31 6.78 6.6 6.6 6.27 6.47 6.64 6.66 6.48 6.65 6.59 6.54 6.36 6.4 6.47 6.67 6.6 6.58 6.64 6.72
GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION 6.15 6.21 6.31 6.21 6.24 6.13 5.89 6.07 6.13 6.16 5.94 6.06 6.15 6.4 5.93 5.98 6.24 5.84 6.12 6.07 6.17 6.03 6.25 6.23 6.31 6.44
GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION 6.14 6.21 6.31 6.41 6.14 6.18 6.11 6.23 6.34 6.28 6.13 6 6.28 6.28 6.27 6.44 6.39 6.06 6.22 6.02 6.34 6.5 6.38 6.22 6.34 6.51
GOBP_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION 7.06 6.62 6.79 7.04 7.17 7.5 7.21 7.42 6.85 7.44 7.37 7.25 7.58 7.39 7.3 7.3 6.87 6.69 7.17 7.12 7.2 7.13 7.25 7.68 7.14 7.54
GOBP_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION 7.59 7.41 6.49 6.53 6.74 6.86 6.87 6.96 7.06 6.94 6.75 6.7 7 7.07 6.59 6.88 7.17 7.13 6.99 6.85 7.98 7.92 6.79 6.93 7.25 7.42
GOBP_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION 6.89 6.54 6.94 7 6.86 7.24 7.35 7.45 6.85 7.22 7.41 7.07 7.53 7.35 7.32 7.38 6.78 6.8 6.96 7.46 7.13 7.09 7.33 7.45 7.28 7.57
GOBP_REGULATION_OF_MACROPHAGE_DIFFERENTIATION 5.51 5.72 5.75 5.99 5.4 5.22 5.47 5.79 5.54 5.16 5.56 5.47 5.36 5.29 5.53 5.56 5.37 5.41 5.6 5.43 6.05 5.78 5.31 5.4 5.63 5.74
GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION 5.76 5.97 5.99 6.22 5.64 5.88 5.49 6.01 5.84 5.71 5.82 5.82 6.16 5.87 5.54 5.65 6.1 5.73 6.14 5.46 6.3 6.05 5.89 5.77 5.84 6.09
GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION 6.51 6.91 6.44 6.8 7.06 6.95 6.7 6.9 6.82 6.76 6.8 6.72 6.61 6.85 6.64 6.94 6.85 6.68 6.59 6.58 6.39 6.4 6.73 7.11 6.84 7.05
GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION 6.06 5.98 6.31 6.2 5.89 6.02 6.88 6.76 6.84 6.21 6.03 6.18 6.82 6.69 6.64 6.63 6.87 6.54 6.33 6.92 6.47 6.5 6.31 5.69 6.03 6.45
GOBP_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION 7.26 6.8 6.97 7.95 6.84 7.07 7.86 7.44 7.2 7.11 7.02 7.3 7.36 7.1 7.39 7.27 7.57 7.38 7.08 7.81 7.12 7.11 7.12 6.95 7.27 6.89
GOBP_REGULATION_OF_MYOBLAST_DIFFERENTIATION 5.73 5.93 6.11 6 5.71 5.67 5.76 5.84 6 5.84 5.75 5.77 5.79 5.7 5.97 6.1 6.34 6.28 5.92 5.86 6.28 6.1 6.2 5.83 6.1 5.92
GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION 5.47 5.76 6.04 6.05 5.24 5.23 5.59 5.73 5.63 5.56 5.6 5.54 5.49 5.55 5.65 5.63 6.24 5.91 5.52 5.58 6.28 5.78 5.9 5.29 5.79 5.87
GOBP_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION 5.86 5.75 5.76 5.94 5.7 5.61 5.82 5.98 5.86 5.96 5.73 5.72 5.82 6.19 6.08 6.27 6.34 6.51 6.39 6.07 6.22 6.18 6.24 6.16 6.18 5.98
GOBP_REGULATION_OF_NEURON_DIFFERENTIATION 6.49 6.54 6.57 6.64 6.97 6.91 6.89 6.98 6.79 6.87 6.59 6.84 7.01 7.02 6.92 6.73 6.81 6.6 6.68 6.96 6.89 7.05 6.9 7.01 6.7 6.78
GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION 6.54 6.59 6.71 6.57 7.11 7.22 6.88 7.02 6.82 7.03 6.49 6.98 7.15 7.16 6.96 6.86 7.03 6.6 6.7 7.13 6.99 7.12 6.89 7.06 6.83 6.81
GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION 6.33 6.4 6.37 6.63 6.45 6.47 6.73 6.78 6.4 6.43 6.48 6.44 6.73 6.58 6.73 6.32 6.63 6.37 6.53 6.56 6.64 6.88 6.59 6.47 6.6 6.6
GOBP_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION 6.54 6.42 6.5 6.13 6.54 6.61 6.62 6.45 6.57 6.66 6.4 6.55 6.65 6.6 6.51 6.61 6.59 6.42 6.46 6.53 6.62 6.67 6.59 6.66 6.57 6.58
GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION 6.09 6.13 6.23 6.03 6.1 6.04 6.35 6.34 6.33 6.15 6.09 6.16 6.34 6.35 6.31 6.22 6.31 5.94 6.2 6.02 6.31 6.51 6.26 6.48 6.23 5.97
GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION 6.47 6.47 6.51 6.13 6.54 6.64 6.62 6.76 6.53 6.66 6.45 6.56 6.66 6.59 6.34 6.7 6.67 6.72 6.56 6.69 6.63 6.67 6.75 6.62 6.56 6.58
GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION 6.11 6.25 6.37 6.28 6.17 6.33 5.88 6.02 6.2 6.25 5.94 5.9 5.97 5.87 6.24 5.93 6.03 5.83 5.67 5.93 5.91 6.26 6.07 5.98 6.1 6.47
GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION 5.83 6.1 6.31 6.21 5.72 5.86 5.71 5.63 5.95 6.24 5.94 6.18 5.91 5.83 6.15 5.8 6 5.63 5.54 5.79 5.63 5.73 6.02 5.94 6.14 6.44
GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION 5.65 5.37 5.86 5.8 5.33 5.19 5.44 5.61 5.68 5.47 5.29 5.14 5.58 5.5 5.5 5.27 5.22 5.3 5.21 5.43 5.8 5.96 5.51 5.2 5.26 5.64
GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT 5.58 5.46 5.46 5.68 5.23 4.96 5.3 5.31 5.25 5.22 5.46 5.19 5.62 5.26 5.23 5.52 5.61 5.51 5.36 5.19 5.48 5.57 5.38 4.93 5.35 5.43
GOBP_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT 4.76 4.56 4.62 4.8 4.6 4.44 4.51 5.24 4.29 4.47 5.04 5.06 4.71 4.39 4.18 4.75 4.56 4.88 4.92 4.49 5.02 4.66 4.32 4.26 4.56 4.59
GOBP_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT 5.54 5.38 5.33 5.75 5.28 4.92 5.22 5.02 5.11 4.93 5.72 5.12 5.09 5.15 4.99 5.45 5.25 5.42 5.07 4.9 5.38 4.87 5.22 4.79 5.14 4.97
GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION 6.58 6.55 6.62 6.71 6.71 6.91 6.83 6.97 6.86 6.89 6.48 6.33 7.24 7.15 6.84 7 6.68 6.4 6.66 6.74 6.78 7.05 6.71 6.88 6.7 6.97
GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION 6.41 6.2 6.51 6.44 6.54 6.9 6.76 6.37 6.33 6.75 6.23 6.11 7.6 7.24 6.55 6.6 6.36 6.25 6.13 6.32 6.34 6.68 6.64 6.45 6.53 6.48
GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION 6.63 6.68 6.84 6.79 6.96 6.91 6.91 7.21 6.93 7.38 6.53 7.06 7.31 7.16 7.06 7.22 7.03 6.56 6.96 7.47 6.96 7.2 6.73 7.11 6.78 7.01
GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS 5.63 5.61 5.8 5.74 5.25 5.6 6.08 5.64 6.26 5.77 5.79 5.06 5.91 5.77 5.56 5.97 5.93 5.74 5.12 5.63 5.35 5.27 5.51 5.83 6.14 6.37
GOBP_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS 6.55 6.59 5.96 6.53 6.49 6.36 5.97 6.12 6.17 6.11 6.12 6.08 6.34 5.96 6.01 6.14 6.46 6.57 6.13 6.15 6.41 6.64 6.48 6.37 6.2 6.44
GOBP_POSITIVE_REGULATION_OF_GLUCONEOGENESIS 7.42 7.58 7.12 7.05 7.12 6.96 7.97 7.37 7.59 7.43 7.17 7.61 7.24 7.8 7.66 7.66 6.8 7.41 7.41 7.54 7.32 7.96 7.54 7.93 7.78 7
GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS 5.42 5.76 5.59 5.83 5.58 5.43 5.47 5.83 5.22 5.59 5.44 5.48 5.48 5.48 5.24 5.23 5.73 5.5 5.57 5.28 5.65 5.8 5.5 5.31 5.61 5.98
GOBP_POSITIVE_REGULATION_OF_CILIUM_ASSEMBLY 6.85 7.27 7.23 7.33 7.15 7.38 7.37 6.94 6.7 7.22 7.1 7.24 7.12 7.11 7.28 7.42 7.07 6.88 7.14 6.99 6.94 7.11 7.54 7.26 7.31 7.24
GOBP_POSITIVE_REGULATION_OF_TRANSLATION 7.39 7.49 7.72 7.51 7.61 7.76 7.78 7.75 7.78 7.99 7.54 7.74 7.72 7.84 7.82 7.67 7.46 7.29 7.63 7.76 7.45 7.65 7.89 8 7.77 7.76
GOBP_RESPIRATORY_BURST 5.48 4.97 5.31 5.54 4.87 4.9 5.08 5.06 5.08 5.18 5.54 4.88 5.3 4.93 5.32 5.25 5.25 5.35 4.97 5.12 5.08 5.31 4.9 4.84 5.15 5.27
GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS 7.3 7.35 7.73 7.68 7.63 7.56 7.58 7.71 7.7 7.64 7.52 7.7 7.75 7.73 7.67 7.75 7.45 7.24 7.49 7.67 7.51 7.68 7.74 7.9 7.72 7.63
GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR 6.08 6.12 7.44 7.43 6.92 6.74 6.65 6.89 6.91 6.96 7.25 7.2 7.08 6.67 6.62 6.97 6.25 6.8 6.44 6.51 6.6 6.97 7.07 7.03 6.66 6.71
GOBP_POSITIVE_REGULATION_OF_DNA_REPAIR 6.25 6.53 6.77 6.68 6.65 6.57 6.79 6.62 6.65 6.81 6.66 6.78 6.67 6.54 6.47 6.7 6.54 6.49 6.22 6.63 6.53 6.46 7.08 6.91 6.88 6.7
GOBP_POSITIVE_REGULATION_OF_DNA_REPLICATION 5.5 5.27 6.12 5.77 5.43 5.45 5.68 5.76 5.51 5.46 5.79 5.58 5.98 5.53 6.02 6.2 5.67 5.72 5.61 5.4 5.54 5.73 5.5 5.55 5.7 5.88
GOBP_POSITIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY 5 4.77 4.8 5.64 4.88 4.5 4.99 5.08 4.86 4.67 4.76 4.55 4.75 4.33 5.76 4.78 4.85 5.28 4.72 4.52 4.88 5.16 4.5 4.49 4.61 4.38
GOBP_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 6.55 6.82 7.21 7.31 6.86 7.31 7.58 7.42 7.31 7.37 6.78 6.82 7.35 7.49 7.06 7.27 6.83 7.34 7.27 7.38 6.65 7.19 7.34 7.25 7.28 7.01
GOBP_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 6.22 6.21 6.24 6.37 5.67 6.14 6.48 6.65 6.04 6.28 6.01 6.1 6.23 6.4 6.7 6.07 6.32 6.64 5.98 6.39 6.15 6.34 5.93 6 6.64 6.58
GOBP_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY 6.72 6.58 6.79 6.57 7.04 7.22 6.88 7.03 6.91 6.82 6.72 7.25 7.43 7.26 6.91 6.97 6.93 7.03 6.87 7.13 7.25 7.61 7.31 6.99 6.66 6.55
GOBP_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY 6.79 6.72 6.87 6.7 6.9 6.87 7.17 6.95 6.89 6.95 6.68 7.01 6.91 6.83 6.83 7.07 6.79 6.75 6.63 7.04 6.83 7.12 7.03 7.13 6.93 7.11
GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY 7.35 7.22 6.98 7.21 7.16 7.61 7.13 7.13 7.63 7.41 7.24 7.3 7.43 7.53 7.45 7.19 7.02 7.3 7.79 7.57 6.9 7.14 7.55 7.51 7.34 7.17
GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION 7.44 7.61 7.62 7.24 8.03 8.04 7.98 7.94 7.89 7.87 7.47 7.87 7.95 7.93 7.93 7.89 7.54 7.96 7.83 7.98 7.92 7.91 7.84 8.02 7.82 7.81
GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE 5.77 5.62 5.64 5.87 5.57 5.64 5.75 5.82 5.83 5.81 5.54 5.35 5.77 5.83 5.76 5.48 5.68 5.76 5.71 5.74 5.92 5.74 5.57 5.37 5.55 5.77
GOBP_POSITIVE_REGULATION_OF_BLOOD_PRESSURE 5.64 5.68 5.34 5.55 5.26 5.23 5.79 5.68 5.49 5.42 5.96 5.32 5.53 5.42 5.58 5.58 5.42 5.42 5.31 5.73 5.65 5.6 5.43 5.44 5.6 5.38
GOBP_POSITIVE_REGULATION_OF_OSSIFICATION 6.1 6.22 6.8 6.27 6.31 6.28 6.31 6.48 6.4 6.7 6.45 6.58 6.26 6.1 6.63 6.56 6.25 6.57 6.15 6.33 6.6 6.8 6.57 6.7 6.61 6.38
GOBP_NEGATIVE_REGULATION_OF_BONE_RESORPTION 5.7 5.74 5.77 6 5.46 5.58 5.66 5.66 5.87 5.4 5.45 5.04 5.5 5.72 5.99 5.74 5.54 5.69 5.54 5.54 5.87 5.43 5.54 5.59 6 5.95
GOBP_POSITIVE_REGULATION_OF_BONE_RESORPTION 7.13 7.45 6.87 7.1 7.48 7.68 7.15 7.05 6.85 6.77 6.89 7.33 7.7 7.9 6.98 7.2 7.29 7.49 7.4 7.52 7.5 7.8 7.47 7.59 7.64 7.4
GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION 5.89 5.81 5.89 5.87 5.74 5.7 5.89 5.83 5.93 5.71 5.73 5.61 5.89 5.83 5.89 5.87 5.94 5.85 5.65 5.82 5.99 5.89 5.76 5.68 5.89 5.99
GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE 6.54 6.68 6.88 6.81 6.71 6.79 6.67 6.85 6.75 6.77 6.73 6.84 6.78 6.86 6.9 6.88 6.68 6.56 6.71 6.73 6.76 6.99 6.92 6.95 6.85 6.97
GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE 6.53 6.51 6.65 6.44 6.58 6.76 6.67 6.62 6.5 6.65 6.54 6.64 6.56 6.6 6.59 6.74 6.66 6.56 6.46 6.63 6.69 6.75 6.73 6.74 6.65 6.72
GOBP_POSITIVE_REGULATION_OF_CELL_SIZE 7.54 7.73 8.48 8.31 7.99 7.98 8.18 8.04 8.16 8.06 8.45 8.07 8.06 8.18 8.46 8.29 8.09 7.82 7.95 8.14 8.09 8.22 8.24 8.48 8.31 7.98
GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY 6.37 6.47 6.62 6.61 6.67 6.81 7.02 6.95 6.82 6.94 6.39 6.86 6.91 6.89 6.86 6.76 6.44 6.46 6.55 6.82 6.35 6.82 6.97 7.32 6.82 6.98
GOBP_NEGATIVE_REGULATION_OF_ENDOCYTOSIS 7.07 6.9 7.45 7.37 7.34 7.07 7.24 7.49 7.04 7.04 6.96 7.18 6.9 7.23 6.82 6.81 7.26 6.82 6.96 7.36 6.91 7.28 7.46 7.62 7.29 7.28
GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS 7.39 7.6 7.97 7.71 7.99 7.99 7.99 7.84 7.72 7.92 7.39 7.72 7.92 7.9 7.76 7.7 7.79 7.48 7.72 8.03 7.49 7.73 7.88 8.1 7.99 7.72
GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC 6.88 7.1 6.96 7.33 7.4 7.39 7.05 7.17 7 7.12 7.06 7.32 7.21 7.15 7.25 7.19 6.87 6.94 7.2 7.09 7.04 7.1 7.04 7.26 7.11 7.27
GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC 8.05 7.99 7.68 7.44 8.36 8.14 7.95 7.87 8.02 8.26 7.66 8.26 8.19 8.08 7.67 7.99 7.86 7.82 8.14 8.29 7.73 7.68 7.98 8.2 8.11 7.84
GOBP_NEGATIVE_REGULATION_OF_GLYCOLYTIC_PROCESS 5.96 5.87 6.16 6.03 5.95 6 5.86 6.34 6.41 6.15 6.09 6.42 6.32 6.29 6.39 6.28 6.76 6.61 5.91 6.03 6.62 6.96 6.22 6.52 6.51 6.63
GOBP_POSITIVE_REGULATION_OF_GLYCOLYTIC_PROCESS 7.8 7.04 6.85 6.9 7.33 7.64 7.69 7.6 8.29 7.67 6.45 6.84 7.31 6.97 7.59 7.39 6.74 6.86 7.57 8.04 7.13 6.75 7.34 7.76 6.83 6.62
GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE 6.12 6.01 5.92 6.2 5.38 5.54 5.54 5.67 5.9 5.53 5.73 5.78 5.55 5.52 5.54 5.85 5.64 5.54 5.71 5.66 5.84 5.71 5.57 5.53 5.97 5.97
GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING 6.09 6.1 5.88 6.34 5.94 5.92 6.05 6.06 5.86 5.58 6.03 6.02 5.93 5.96 5.66 5.91 5.89 6.14 5.69 5.92 6.15 6.41 5.72 5.43 5.96 5.96
GOBP_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS 6.3 6.38 6.24 6.21 6.58 6.39 6.44 6.63 6.47 6.4 6.25 6.37 6.6 6.4 6.29 6.56 6.55 6.22 6.2 6.45 6.53 6.6 6.22 6.53 6.35 6.5
GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS 6.36 6.34 6.58 6.61 6.5 6.57 6.64 6.77 6.36 6.61 6.54 6.46 6.66 6.62 6.49 6.63 6.55 6.45 6.33 6.46 6.63 6.64 6.44 6.54 6.78 6.66
GOBP_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION 5.15 4.79 5.02 5.04 5.02 4.78 4.73 4.65 5.14 4.83 5.42 4.71 4.57 5.05 5.09 4.84 5.07 4.79 4.74 4.48 5 4.81 5.13 4.55 4.82 4.82
GOBP_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL 7.62 7.14 7.25 7.27 7.79 7.72 7.08 7 6.76 7.35 7.14 6.91 7.09 6.74 7.08 7.07 7.2 7.13 7.45 7.09 6.86 6.86 6.8 6.71 7.05 7.07
GOBP_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION 5.75 5.61 5.82 5.85 5.57 5.65 5.68 5.82 5.6 5.89 6.09 5.68 5.67 5.73 5.93 5.88 5.77 5.73 5.77 5.71 5.79 6.04 5.99 5.84 5.85 6.02
GOBP_PH_REDUCTION 7.72 8.05 8.13 8.12 7.66 8.05 7.95 8 8 8.1 7.89 8.29 7.86 7.84 8 7.75 7.8 7.57 7.71 8.01 7.62 7.65 7.95 8.3 7.89 7.83
GOBP_REGULATION_OF_PROTEIN_KINASE_ACTIVITY 6.49 6.52 6.71 6.62 6.59 6.6 6.68 6.76 6.69 6.65 6.66 6.72 6.7 6.69 6.75 6.75 6.6 6.57 6.52 6.66 6.8 6.75 6.91 6.77 6.74 6.75
GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY 6.43 6.44 6.54 6.42 6.37 6.4 6.6 6.63 6.54 6.53 6.4 6.48 6.45 6.48 6.57 6.56 6.51 6.42 6.33 6.43 6.66 6.63 6.57 6.61 6.62 6.71
GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS 5.8 5.73 5.76 6.02 5.65 5.54 5.63 5.67 5.8 5.68 5.72 5.53 5.64 5.58 5.64 5.73 5.83 5.68 5.51 5.69 5.72 5.74 5.65 5.58 5.68 5.75
GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS 6.59 6.52 6.94 6.88 6.79 6.76 6.72 6.78 6.8 6.84 6.74 6.79 6.77 6.73 6.76 6.68 6.62 6.66 6.69 6.72 6.73 6.8 6.73 6.79 6.73 6.82
GOBP_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE 5.28 5.2 5.48 5.25 4.53 4.81 4.97 5.05 5.05 4.49 4.91 4.67 5.08 4.69 5.16 4.89 5.22 5.37 5.15 4.97 5.38 5.19 4.58 4.62 5.12 5.13
GOBP_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY 7.24 7.17 7.3 7.06 7.32 7.49 7.42 7.59 7.07 7.46 7.11 7.08 7.14 7.25 7.49 7.42 7.61 7.46 7.42 7.42 7.29 7.34 7.27 7.3 7.39 7.32
GOBP_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY 5.85 6.03 6.16 6.47 5.88 5.93 5.97 6.09 5.84 6.31 6.28 6.32 6.07 6.2 6.02 6.06 6.23 6.1 5.94 6.03 6.15 6.28 5.98 6.04 5.75 6.38
GOBP_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY 8.59 8.59 8.38 8.55 8.74 8.93 8.91 8.72 9.2 8.82 8.84 8.72 8.89 8.8 9.07 8.83 8.45 8.43 8.85 8.76 8.45 8.69 9.24 9.14 8.57 8.44
GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION 5.42 5.47 5.29 5.23 4.99 5.13 5.45 5.11 5.37 5.13 5.43 5.07 5.53 5.33 5.2 5.37 5.38 5.4 5.12 5.39 5.55 5.46 5.34 5.09 5.39 5.42
GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION 6.17 6.64 7.29 6.7 7.42 6.94 6.23 6.36 7.13 7 6.6 6.88 6.77 6.66 6.58 6.82 6.43 6.45 6.2 6.43 6.53 6.65 7.01 6.97 6.55 6.91
GOBP_POSITIVE_REGULATION_OF_DNA_RECOMBINATION 6.04 5.76 5.99 6.38 6.28 6.19 6.35 6.29 5.95 5.93 6.2 6.45 6.52 6.29 5.8 6 6.21 6.11 5.84 6.38 6.11 6.19 5.78 5.87 6.17 6.15
GOBP_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS 6.47 6.58 6.16 6.53 6.5 6.54 6.04 6.34 6.41 6.17 6.13 6.42 6.34 6.56 6.39 6.29 6.76 6.77 6.28 6.28 6.81 6.95 6.35 6.53 6.51 6.54
GOBP_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS 6.26 6.43 6.09 6.3 6.46 6.6 6.49 6.57 6.62 6.65 6.16 6.47 6.62 6.49 6.54 6.5 6.49 6.29 6.33 6.39 6.51 6.26 6.56 6.51 6.47 6.55
GOBP_NEGATIVE_REGULATION_OF_EXOCYTOSIS 7.19 6.7 6.72 6.35 7.02 6.88 7.36 6.79 6.93 7.3 6.53 6.96 6.93 7.17 7.37 7.11 6.61 6.84 6.85 7.03 6.8 7.22 7.25 7.43 7.26 7.17
GOBP_POSITIVE_REGULATION_OF_EXOCYTOSIS 7.12 7.36 7.45 7.27 7.46 7.52 7.67 7.65 7.61 7.65 7.46 7.7 7.45 7.56 7.77 7.64 7.55 7.38 7.38 7.7 7.72 7.75 7.72 7.93 7.73 7.54
GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS 6.19 6.38 6.37 6.19 6.78 6.66 6.77 6.76 6.8 6.97 6.26 6.27 6.84 6.49 6.55 6.6 6.47 5.91 6.35 6.97 6.76 6.8 6.67 6.8 7.14 6.84
GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS 5.69 5.82 5.86 5.83 5.52 5.44 5.63 5.77 5.55 5.76 5.6 5.51 5.6 5.61 5.64 5.52 5.77 5.72 5.58 5.48 5.71 5.75 5.58 5.54 5.59 5.53
GOBP_NEGATIVE_REGULATION_OF_GROWTH 6.56 6.47 6.88 6.73 6.59 6.6 6.79 6.93 6.85 6.91 6.73 6.88 6.99 6.9 6.84 6.85 6.72 6.59 6.49 6.7 6.79 6.85 6.91 6.96 6.85 6.95
GOBP_POSITIVE_REGULATION_OF_GROWTH 6.72 6.74 6.79 6.74 7.07 6.99 6.94 7.02 6.93 6.89 6.53 6.93 7.01 6.99 6.94 6.91 6.8 6.81 6.65 6.97 6.78 6.98 7.02 7 7.18 7.17
GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE 6.55 6.66 6.79 6.64 6.6 6.82 6.6 6.83 6.68 6.71 6.7 6.61 6.67 6.79 6.69 6.83 6.64 6.42 6.54 6.59 6.68 6.93 6.81 6.88 6.77 6.94
GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE 7.12 7.13 7.29 7.23 7.21 7.18 7.53 7.18 7.2 7.34 7.23 7.33 7.6 7.53 7.29 7.36 7.29 7.36 7.22 7.37 7.29 7.27 7.6 7.61 7.42 7.3
GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION 8.22 8.42 8.04 7.72 8.6 8.23 7.98 8.32 8.46 8.25 7.8 8.38 8.37 8.31 8.05 8.3 7.88 7.62 8.88 8.86 7.76 7.38 8.38 8.49 7.83 7.69
GOBP_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION 5.59 5.68 5.64 5.76 5.27 5.2 5.74 5.62 5.63 5.54 5.76 5.37 5.53 5.47 5.41 5.52 5.53 5.52 5.3 5.51 5.64 5.44 5.55 5.27 5.43 5.52
GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.41 6.44 6.54 6.54 6.51 6.54 6.54 6.59 6.52 6.59 6.51 6.58 6.65 6.57 6.55 6.61 6.57 6.46 6.44 6.54 6.6 6.68 6.59 6.69 6.63 6.6
GOBP_POSITIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.45 6.45 6.55 6.57 6.51 6.55 6.56 6.64 6.57 6.62 6.53 6.55 6.61 6.61 6.58 6.61 6.58 6.47 6.45 6.59 6.6 6.71 6.62 6.72 6.62 6.64
GOBP_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS 5.58 5.4 5.63 5.74 5.76 5.83 6.01 5.55 6.22 5.89 5.89 5.67 5.9 5.66 5.64 5.88 5.84 5.71 5.56 5.7 5.2 5.36 5.68 5.88 6.13 6.14
GOBP_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS 5.92 5.73 6.3 6.13 6 6.01 6.1 5.92 5.83 5.87 6.44 5.54 6.16 5.92 5.97 5.63 6.26 5.86 5.81 5.81 5.77 6.35 5.5 5.57 5.73 5.98
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I 6.74 6.86 6.56 6.75 6.72 6.85 6.69 6.68 7.25 7.01 6.77 6.68 6.94 6.89 6.7 6.71 6.5 6.74 6.81 6.62 7 6.65 7.05 7.2 7.16 6.92
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II 6.32 6.32 6.36 6.43 6.32 6.33 6.37 6.42 6.42 6.4 6.37 6.37 6.46 6.44 6.43 6.42 6.47 6.35 6.3 6.41 6.48 6.58 6.47 6.42 6.44 6.46
GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION 8.14 8.13 8.77 9 8.53 8.37 8.61 8.32 8.83 8.87 8.41 8.58 8.78 8.67 8.79 8.22 8.09 8.29 8.29 8.24 8.08 8.43 9.06 8.89 8.7 8.33
GOBP_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION 7.52 7.67 8.08 7.9 7.91 7.96 8.03 8.04 8.41 8.21 7.81 8.1 8.06 8.12 8.38 8.27 7.67 7.6 7.84 7.87 7.77 8.16 8.05 8.22 8.22 8.27
GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY 5.02 5.2 4.8 4.98 4.7 4.84 5.07 4.46 4.99 4.58 4.93 4.72 4.48 4.57 4.42 4.63 5.43 5.46 4.61 4.64 4.8 4.53 4.65 4.32 4.73 4.53
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS 7.71 7.63 7.41 7.34 8.33 8.28 8.73 8.83 7.58 8.25 7.51 8.28 8.15 8.17 8.33 8.31 7.87 8.49 8.27 8.76 8.14 8.38 7.88 8.42 8.34 8.41
GOBP_REGULATION_OF_TRANSLATION_NCRNA_MEDIATED 8.48 8.7 7.92 7.91 8.58 8.49 8.28 8.45 8.36 8.17 8.15 8.18 8.34 8.35 8.25 8.4 8.02 8.06 8.56 8.39 8.02 8.2 8.23 8.32 8.39 8.42
GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS 5.86 5.86 6.32 5.95 6.05 6.24 6.18 6.34 6.34 6.3 6.05 6.25 6.33 6.42 6.41 6.35 6.76 6.69 6.01 6.15 6.59 6.86 6.25 6.27 6.48 6.48
GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS 6.05 5.98 6.6 6.27 6.4 6.53 6.42 6.48 6.38 6.62 6.1 6.23 6.49 6.4 6.61 6.22 6.24 6.18 5.94 6.42 6.38 6.33 6.51 6.43 6.13 6.4
GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION 8.22 8.42 8.04 7.72 8.6 8.23 7.98 8.32 8.46 8.25 7.8 8.38 8.37 8.31 8.05 8.3 7.88 7.62 8.88 8.86 7.76 7.38 8.38 8.49 7.83 7.69
GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION 5.71 5.85 5.53 5.66 5.27 5.17 5.62 5.35 5.57 5.4 5.67 5.27 5.53 5.47 5.38 5.38 5.52 5.43 5.21 5.47 5.65 5.4 5.51 5.11 5.32 5.23
GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION 5.29 5.39 5.48 5.72 5.29 5.33 6.05 6.05 5.66 5.98 5.59 5.55 5.76 5.42 5.9 5.89 5.46 5.55 5.36 5.68 5.62 5.99 5.57 5.65 5.43 6.03
GOBP_REGULATION_OF_EMBRYONIC_DEVELOPMENT 6.33 6.03 5.94 6.06 6.22 6.42 6.07 6.07 5.92 6.05 6.09 6 5.9 5.95 6.04 6.03 6.34 6.31 6.1 5.99 6.21 6.32 6.08 6.12 6.06 6.16
GOBP_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION 5.49 5.54 5.07 5.56 5.36 4.94 4.97 4.98 5.46 4.58 5.71 5.18 5.15 5.32 4.84 5.25 5.1 5.09 4.84 5.08 5.41 5.24 4.72 5.01 5.26 5.18
GOBP_AMP_METABOLIC_PROCESS 7.33 7.29 7.93 7.66 6.8 7.23 7.13 7.29 7.41 7.29 7.69 7.46 7.18 7.44 7.31 7.48 7.3 7.5 7.08 7.6 7.66 7.72 7.08 7.3 7.15 7.27
GOBP_ATP_METABOLIC_PROCESS 7.37 7.47 8.06 7.84 7.69 7.74 7.69 7.72 7.69 7.87 7.85 7.7 7.65 7.77 7.84 7.87 7.61 7.49 7.69 7.83 7.49 7.9 7.76 7.94 7.76 7.7
GOBP_GMP_METABOLIC_PROCESS 7.29 7.09 7.3 7.16 8.05 7.9 7.58 7.83 7.4 7.37 6.8 7.49 7.81 7.39 7.25 7.51 7.98 7.39 7.16 7.77 7.47 7.28 7.68 7.53 7.69 7.74
GOBP_GTP_METABOLIC_PROCESS 6.81 7.14 7.81 7.59 7.19 7.36 7.18 7.02 6.92 7.34 7.88 7.31 7.19 7.45 6.75 7.55 7.51 7.4 7.48 7.42 7.35 7 7.36 7.14 7.79 7.6
GOBP_IMP_METABOLIC_PROCESS 6.79 6.63 6.95 7.02 6.81 6.83 6.93 6.98 6.82 6.85 6.67 7 6.84 6.78 6.87 6.75 6.88 6.87 6.69 6.76 6.78 6.99 6.36 6.98 6.85 7.01
GOBP_UTP_METABOLIC_PROCESS 6.78 7.07 8.15 8.04 6.68 7.08 7.38 7.16 6.51 7.14 7.84 7.53 6.92 7.23 7.23 7.66 7.05 7.4 7.55 7.23 7.42 7.5 6.89 6.77 7.39 7.55
GOBP_CAMP_METABOLIC_PROCESS 6.85 6.93 6.67 6.61 6.81 6.86 6.93 6.8 6.81 6.88 6.81 6.77 7.14 7.06 6.79 6.69 6.57 7.01 7.14 6.95 6.8 6.79 6.91 6.82 6.93 6.75
GOBP_CGMP_METABOLIC_PROCESS 5.41 5.2 5.22 5.51 5.28 4.98 5.14 5.14 5.46 5.03 5.67 5.45 4.94 4.89 5.24 5.13 5.5 5.42 5.57 4.86 5.32 5.02 6.02 4.79 5 4.82
GOBP_NUCLEOBASE_BIOSYNTHETIC_PROCESS 6.4 6.46 6.61 6.77 7.08 7.05 7.05 6.77 6.9 6.85 6.53 7.04 6.82 6.8 6.76 6.74 6.88 6.66 6.58 6.76 6.41 6.93 6.55 6.66 6.48 6.72
GOBP_PYRIMIDINE_RIBONUCLEOSIDE_METABOLIC_PROCESS 4.83 5.03 5.04 4.92 4.53 4.26 4.66 4.71 4.83 4.35 4.77 4.61 4.18 4.38 4.4 4.43 5.11 5.02 4.83 4.64 5.21 4.64 4.11 4.22 4.93 4.91
GOBP_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS 5.6 5.72 6.06 5.88 5.68 5.61 5.56 5.44 5.52 5.79 5.8 5.57 5.44 5.6 5.61 5.6 5.65 5.65 5.85 5.89 5.72 5.85 5.5 5.45 5.62 5.57
GOBP_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS 4.92 5.05 5.19 5.19 4.86 4.58 4.78 4.88 4.84 4.37 5.04 4.62 4.42 4.49 4.5 4.53 5.13 5.03 4.88 4.71 5.25 4.66 4.28 4.53 4.96 4.99
GOBP_PIGMENT_BIOSYNTHETIC_PROCESS 6.42 6.58 7.12 6.88 6.97 7.06 6.98 6.9 7.02 7.04 6.71 6.88 6.91 6.87 6.8 6.9 6.88 6.72 6.72 6.95 6.47 6.56 6.71 7.06 6.84 6.83
GOBP_ALCOHOL_CATABOLIC_PROCESS 6.01 6.32 6.54 6.49 6.14 6.3 6.29 6.3 6.06 6.52 6.27 6.17 6.39 6.16 6.21 6.19 6.43 6.21 6.03 6.08 6.31 6.44 6.46 6.11 6.28 6.6
GOBP_ALCOHOL_BIOSYNTHETIC_PROCESS 6.57 6.6 6.79 6.72 6.69 6.63 6.68 6.67 6.81 6.82 6.76 6.93 6.91 6.8 6.76 6.6 6.68 6.75 6.7 6.66 6.56 6.78 6.67 7.15 6.75 6.65
GOBP_POLYOL_BIOSYNTHETIC_PROCESS 6.07 6.31 6.13 6.23 6.02 6.22 6.29 6.2 6.04 6.01 5.95 5.99 5.92 5.84 5.89 5.9 6 5.91 6.02 6.03 6.12 6.16 5.92 6.11 5.94 6.17
GOBP_POLYOL_CATABOLIC_PROCESS 6.74 7.07 7.4 7.03 6.7 6.72 6.96 7.17 7.24 6.97 7.3 7.14 7.03 7.16 7.34 6.81 7.17 6.81 6.89 7.03 6.56 6.99 7.18 7.2 7.22 7.31
GOBP_ALDEHYDE_BIOSYNTHETIC_PROCESS 6.05 5.78 5.78 5.9 6.5 6.1 5.93 5.81 5.81 6.01 6.23 6.3 6.04 6.27 5.83 6.01 5.75 5.79 6.2 5.78 6.19 6.18 5.59 5.5 5.96 6.23
GOBP_ALDEHYDE_CATABOLIC_PROCESS 7.68 8 8.25 7.82 7.8 7.86 7.93 7.72 7.51 7.86 7.56 7.76 7.67 7.84 7.94 7.72 7.12 7.63 7.62 7.93 7.24 7.34 7.59 7.96 7.47 7.36
GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS 5.69 5.64 5.69 5.7 4.94 5.23 5.57 5.78 5.3 5.19 5.55 5.32 5.09 5.34 5.47 5.42 5.31 5.41 5.36 5.33 5.39 5.4 5.3 5.23 5.1 5.21
GOBP_REGULATION_OF_FATTY_ACID_OXIDATION 6.6 6.52 7.08 6.64 6.78 6.89 6.97 7.3 7.01 7.01 6.91 7.45 7.26 7.3 7.14 7.14 7.07 6.71 6.59 6.99 7.09 7 7.15 7.4 7.28 7.24
GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION 5.93 5.87 5.88 5.83 5.53 5.53 5.81 5.75 6.49 5.89 5.81 5.57 6.5 6.56 6.39 6.42 5.8 5.98 6.06 5.94 6.39 6.2 6.27 6.52 5.69 5.49
GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION 6.83 6.92 7.51 6.27 7.07 7.22 7.43 7.37 7.19 7.03 6.91 7.53 7.17 7.36 7.18 7.17 7.23 7.41 7.02 7.54 7.32 7.86 7.24 7.42 7.69 7.44
GOBP_GLUCOSE_IMPORT 6.57 6.85 7.35 7.1 6.7 6.97 7.07 7.2 7.14 7.25 6.83 6.97 7.07 7 7.37 7.08 6.9 6.87 6.62 7.01 6.86 7.06 7.15 7.32 7.05 6.78
GOBP_REGULATION_OF_GLUCOSE_IMPORT 6.57 6.9 7.41 7.17 7.19 7.07 7.56 7.29 7.24 7.25 6.92 7.25 7.25 7.19 7.51 7.39 6.92 6.87 6.62 7.25 7.29 7.06 7.28 7.58 7.19 6.78
GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT 6.74 6.83 7.92 7.08 7.53 7.54 7.5 7.55 7.47 7.76 7.11 7.26 7.87 8.09 7.7 7.68 7.28 7.38 7.31 7.55 6.84 7.63 7.86 7.33 7.16 7.33
GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT 6.71 6.93 7.41 7.1 7.3 7.17 7.56 7.38 7.27 7.3 6.92 7.25 7.31 7 7.58 7.39 6.94 6.86 7.12 7.25 7.3 6.75 7.28 7.58 7.19 6.78
GOBP_REGULATION_OF_JNK_CASCADE 6.42 6.39 6.52 6.51 6.36 6.54 6.63 6.48 6.61 6.53 6.62 6.78 6.55 6.54 6.54 6.58 6.52 6.36 6.43 6.33 6.56 6.59 6.89 6.87 6.65 6.61
GOBP_NEGATIVE_REGULATION_OF_JNK_CASCADE 6.54 6.83 7.26 6.59 7.24 7.09 7.07 6.96 7.35 7.34 6.88 7.12 7.09 7.67 7.19 7.43 6.73 7 7.06 7 6.92 6.86 7.58 7.71 7.19 6.86
GOBP_POSITIVE_REGULATION_OF_JNK_CASCADE 5.98 5.86 5.92 6.17 5.98 5.93 5.9 6.05 5.84 6.09 6.13 5.96 6.14 6.05 6.09 5.9 5.98 6.01 5.86 5.88 6.14 6.17 5.88 5.77 5.88 6.04
GOBP_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS 6.5 6.67 6.84 7.14 6.61 7.02 7.12 6.89 6.85 6.85 6.69 6.58 6.84 6.94 6.57 6.48 6.37 6.28 6.32 7.18 6.67 6.79 6.69 6.82 6.89 7.04
GOBP_DIACYLGLYCEROL_METABOLIC_PROCESS 6.82 6.72 6.94 6.9 6.96 6.96 7.3 7.18 7.01 7 6.91 7.4 7.15 7.09 7.18 6.93 7.17 7.29 7.06 7.27 6.79 7.14 6.97 7.1 7.21 7
GOBP_AMINO_SUGAR_CATABOLIC_PROCESS 6.28 6.36 6.72 6.31 6.71 6.27 5.99 5.74 5.89 6.04 6.43 5.95 6.24 6.45 5.5 6.15 6.18 6.26 6.64 6.08 6.11 6.07 6.06 6.28 5.97 6.39
GOBP_AMINO_SUGAR_BIOSYNTHETIC_PROCESS 6.48 6.55 6.97 6.69 6.33 6.33 6.61 6.42 6.22 6.58 6.85 6.43 6.5 6.66 6.32 6.39 6.44 6.35 6.75 6.86 6.33 6.1 7.01 6.73 6.33 6.23
GOBP_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS 6.68 6.8 7.03 6.97 6.74 6.8 6.78 6.71 7.22 7.04 6.72 6.74 7.14 7.13 6.76 6.81 6.73 6.86 6.68 6.84 6.68 6.9 6.92 7.06 6.74 6.72
GOBP_MONOSACCHARIDE_CATABOLIC_PROCESS 6.12 6 6.47 6.32 5.84 5.71 5.78 6.01 6.06 6.06 6.29 6.18 6.12 6.1 6.17 6.18 5.91 6.15 5.96 6 6.04 6.23 6 5.94 6.11 6.12
GOBP_DEOXYRIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS 7.51 7.98 9.52 8.64 8.03 8.16 8.29 7.46 8.54 8.07 8.53 7.83 7.65 7.95 7.7 8.03 7.6 7.09 7.96 8.4 7.05 7.18 8.47 8.64 7.71 7.2
GOBP_DEOXYRIBOSE_PHOSPHATE_CATABOLIC_PROCESS 5.52 5.4 6.06 5.88 5.34 5.47 5.75 5.72 5.53 5.64 5.8 5.58 5.7 5.72 5.68 5.81 5.65 5.43 5.34 5.3 5.56 5.79 5.76 5.75 5.72 5.85
GOBP_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS 6.83 7.01 7.58 7.3 7.1 7.25 7.22 7.25 7.25 7.27 7.13 7.29 7.21 7.23 7.16 7.21 7.14 7.05 7.1 7.48 7.06 7.05 7.14 7.42 7.19 7.43
GOBP_URATE_METABOLIC_PROCESS 5.61 5.3 5.35 5.69 5.05 5.06 5.11 4.77 5.09 4.95 5.4 4.85 5.34 5.11 4.94 5.3 5.53 5.22 4.88 4.93 5.33 4.96 5.15 4.92 4.96 5.35
GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT 6.68 6.66 6.86 7.1 7.15 7.18 7.29 7.05 7.04 7.31 7.14 7.32 7.03 7.16 7.33 7.34 7.45 6.91 7.11 7.41 7.08 7.35 7.31 7.28 7.48 7.27
GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS 6.29 6.4 6.46 6.69 6.52 6.52 6.66 6.65 6.58 6.75 6.44 6.66 6.75 6.51 6.59 6.5 6.37 6.37 6.37 6.48 6.48 6.56 6.51 6.64 6.55 6.66
GOBP_ICOSANOID_BIOSYNTHETIC_PROCESS 6.15 6.04 6.1 6.28 5.46 5.67 5.77 6.02 5.91 5.62 6.05 5.82 5.69 5.76 5.73 5.73 5.93 6.09 5.79 5.91 6.04 6.43 5.64 5.68 5.93 6.03
GOBP_PROSTANOID_BIOSYNTHETIC_PROCESS 6.15 6.19 6.1 5.85 5.91 5.67 5.77 5.85 5.82 5.62 6.26 5.87 5.69 5.79 5.66 5.66 5.93 5.95 5.93 5.91 6.04 6.43 5.64 5.68 5.96 5.65
GOBP_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS 6.13 6.33 6.11 6.32 5.71 5.81 6.09 5.97 6.08 6.03 5.91 6.13 6.17 5.98 5.87 6.41 6.25 5.79 6.1 5.67 6.01 5.53 5.59 5.79 5.67 5.86
GOBP_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS 6.27 6.41 6.44 6.78 6.52 6.57 6.55 6.45 6.17 6.49 6.49 6.37 6.74 6.83 6.44 6.23 6.51 6.01 6 6.45 6.69 6.68 6.54 6.58 6.53 6.61
GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS 5.9 5.69 5.57 5.9 5.61 5.65 5.58 5.55 5.56 5.32 5.98 5.51 5.68 5.54 5.47 5.43 5.53 5.5 5.7 5.37 5.61 5.79 5.35 5.5 5.65 5.77
GOBP_MONOACYLGLYCEROL_METABOLIC_PROCESS 6.71 6.74 7.75 6.13 7.05 6.89 7.21 7.12 7.09 6.78 7.08 7.3 6.63 6.83 6.62 6.48 6.2 6.44 6.75 6.69 6.36 6.83 6.86 7.4 6.98 6.41
GOBP_MEMBRANE_LIPID_CATABOLIC_PROCESS 6.78 6.37 6.6 6.71 6.52 6.52 6.57 6.52 6.35 6.46 6.66 6.45 6.8 6.39 6.33 6.45 6.55 6.25 6.37 6.06 6.27 6.43 6.51 6.3 6.27 6.43
GOBP_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS 7.14 7.21 7.27 7.06 7.34 7.53 7.54 7.43 7.34 7.31 6.97 7.17 7.33 7.25 7.19 7.17 7.1 6.95 7.15 7.48 7 7.23 7.2 7.38 7.43 7.31
GOBP_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS 6.41 6.46 6.65 6.85 6.82 6.63 6.77 6.84 6.7 6.78 6.64 6.62 6.84 6.86 6.57 6.45 6.51 6.58 6.29 6.68 6.73 6.83 6.58 6.59 6.67 6.7
GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS 6.37 6.55 6.7 7.01 6.66 6.62 6.55 6.67 6.54 6.86 6.49 6.41 6.74 6.51 6.6 6.39 6.56 6.57 6.38 6.91 6.48 6.53 6.67 6.99 6.53 6.93
GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS 6.5 6.51 6.67 6.61 6.52 6.49 6.6 6.58 6.63 6.34 6.63 6.63 6.36 6.48 6.62 6.46 6.61 6.54 6.34 6.61 6.43 6.57 6.42 6.59 6.53 6.54
GOBP_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS 6.47 6.37 6.43 6.6 6.92 6.84 6.89 6.83 6.68 6.94 6.63 6.8 6.98 6.68 6.64 6.63 6.81 6.62 6.39 6.83 7.08 6.91 6.66 6.88 6.59 6.83
GOBP_GLYCEROLIPID_METABOLIC_PROCESS 6.82 6.83 7.14 7.04 6.97 7.03 7.09 6.98 7.02 6.99 6.84 7 7.2 7.16 7.03 6.93 6.91 6.86 6.93 7.1 6.92 7.07 6.98 7.19 7.17 7.15
GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS 7.04 6.93 7.06 7.07 7.13 7.15 7.08 6.94 7.17 7.05 6.83 7.03 7.33 7.31 7.05 7.07 7.01 6.98 7.03 7.09 6.95 7.14 7.06 7.24 7.24 7.14
GOBP_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS 7.05 7.33 8.95 8.16 7.23 7.69 7.7 7.69 7.77 7.77 7.77 7.48 8.03 7.99 7.47 7.63 7.8 7.51 7.25 8.23 7.29 7.8 7.67 8.18 8 7.62
GOBP_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS 6.93 7.04 7.54 7.77 7.44 7.69 7.43 7.36 7.68 7.75 7.44 7.69 7.68 7.71 7.57 7.61 7.45 7.34 7.83 7.38 6.63 7.27 8 7.95 7.68 7.55
GOBP_GLYCEROLIPID_CATABOLIC_PROCESS 6.18 6.34 6.36 6.44 6.79 6.55 6.51 6.59 6.48 6.77 6.47 6.69 6.59 6.52 6.4 6.41 6.41 6.21 6.04 6.36 6.43 6.39 6.44 6.38 6.36 6.46
GOBP_SPHINGOSINE_BIOSYNTHETIC_PROCESS 7.34 7.81 7.72 6.23 8.13 8.23 8.15 7.36 8.43 8.4 7.52 8.09 8.09 7.87 7.71 7.7 7.48 7.65 8.05 8.15 7.14 7.23 7.88 8.58 8.11 7.33
GOBP_CERAMIDE_BIOSYNTHETIC_PROCESS 7.06 7.24 7.78 7.03 7.66 7.73 7.9 7.79 7.86 7.31 7.21 7.31 7.67 7.62 7.67 7.54 7.18 7.08 7.42 7.93 7.12 7.44 7.42 7.65 7.62 7.36
GOBP_CERAMIDE_CATABOLIC_PROCESS 6.63 6.55 7.37 7.04 6.57 6.99 6.96 6.89 6.83 6.81 7.03 7.13 7.03 7.19 6.8 6.9 6.44 6.78 7.24 7.13 6.77 6.89 6.96 7.41 6.68 6.59
GOBP_SPHINGOID_METABOLIC_PROCESS 7.57 7.89 7.54 7.36 7.66 7.68 8.14 7.6 8.26 7.81 7.72 7.74 7.69 7.44 7.82 7.66 7.4 7.67 7.64 8.05 7.26 7.43 7.65 7.85 7.8 7.3
GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION 5.97 5.99 6.12 5.99 6.15 6.25 6.43 6.17 6.28 6.29 6.24 6.08 6.31 6.2 6.19 6.25 6.3 6.22 5.96 6.14 6.14 6.01 6.03 6.29 6.14 6.14
GOBP_SALIVA_SECRETION 7.09 6.9 7.27 6.58 6.13 6.59 6.68 7.05 6.63 6.99 6.92 6.9 7.09 7.24 7.9 7.36 6.51 6.42 6.85 7.22 7.33 7.22 7.15 7.27 6.79 7.25
GOBP_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS 5.93 6 6.34 6.28 5.93 5.77 5.78 6.08 6.08 5.92 6.16 6.08 5.94 5.96 6.05 5.93 6.14 5.96 6.08 5.79 6.17 6.18 6.03 5.93 5.9 6.25
GOBP_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION 6.85 6.83 6.91 6.89 7.32 7.38 7.07 7.28 6.98 7.27 6.93 7.27 7.23 7.22 7.3 7.22 7.03 7.03 7.08 7.16 7.06 7.21 7.16 7.31 7.16 7.28
GOBP_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL 5.95 5.93 5.47 6 5.6 5.65 6.08 5.66 5.74 5.38 5.58 5.68 5.75 5.68 5.9 6 5.97 6 5.17 5.95 5.75 6.11 5.72 5.02 5.86 6.32
GOBP_REGULATION_OF_CENTRIOLE_REPLICATION 6.54 6.4 6.12 5.73 7.02 6.84 5.8 6.01 5.95 6.78 5.65 6.36 6.2 6.18 6.06 5.72 6.17 5.96 6.07 6.21 5.82 6.54 6.2 6.37 6.06 6.34
GOBP_REGULATION_OF_CENTROSOME_CYCLE 6.69 6.49 6.63 6.97 7.02 6.77 6.95 6.59 6.62 6.78 6.43 6.73 7.08 6.76 7 7.2 6.47 6.47 6.54 6.6 6.51 6.7 7.18 7.18 6.81 6.77
GOBP_REGULATION_OF_ORGAN_GROWTH 6.62 6.45 6.58 6.56 6.87 6.75 6.81 6.73 6.65 6.68 6.54 6.8 6.89 6.76 6.58 6.71 6.81 6.44 6.55 6.8 6.56 6.61 6.82 6.82 6.87 6.9
GOBP_NEGATIVE_REGULATION_OF_ORGAN_GROWTH 6.88 6.6 7.35 7.02 7.23 7.43 7.14 7.33 7.19 7.12 6.81 7.27 7.34 7.12 6.95 6.86 6.95 6.86 7.12 7.35 6.83 7 7.17 7.16 6.96 7.43
GOBP_POSITIVE_REGULATION_OF_ORGAN_GROWTH 6.63 6.68 6.51 6.28 6.96 6.94 6.93 6.83 6.64 6.91 6.53 6.84 6.68 6.57 6.55 6.6 6.88 6.75 6.58 7.04 6.99 6.55 6.67 6.8 6.91 7.2
GOBP_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY 6.76 6.91 7.36 7.36 7.58 7.87 7.59 7.55 7.6 7.29 7.18 7.27 7.47 7.37 7.59 7.44 7.14 7.09 7.45 7.47 7.28 7.31 7.52 7.7 7.66 7.43
GOBP_GAMMA_DELTA_T_CELL_ACTIVATION 5.31 5.41 5.38 5.17 5.28 4.91 5.07 5.21 5.18 5.16 4.94 4.98 5.05 4.84 5.19 5.24 5.44 5.52 5.22 5.17 5.35 5.68 5 5.11 5.23 5.59
GOBP_ALPHA_BETA_T_CELL_ACTIVATION 5.51 5.4 5.41 5.57 5.21 5.21 5.4 5.38 5.42 5.09 5.31 5.17 5.37 5.23 5.21 5.23 5.36 5.38 5.2 5.17 5.46 5.28 5.18 5.08 5.26 5.33
GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.56 5.44 5.48 5.6 5.31 5.25 5.46 5.47 5.46 5.2 5.46 5.25 5.4 5.27 5.29 5.25 5.46 5.49 5.34 5.21 5.52 5.43 5.23 5.13 5.28 5.38
GOBP_ALPHA_BETA_T_CELL_PROLIFERATION 5.29 5.05 5.2 5.63 5.03 4.91 5.19 5.13 5.15 5.06 5.07 4.93 5.16 4.88 5.07 5.21 5.18 5.28 4.95 4.89 5.39 5.26 4.91 4.85 5.1 5.46
GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION 5.47 5.38 5.28 5.44 5.29 5.11 5.4 5.41 5.32 5.09 5.3 5.07 5.29 5.23 5.21 5.25 5.31 5.38 5.2 5.22 5.5 5.3 5.12 4.98 5.23 5.46
GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION 5.63 5.52 5.42 5.65 5.39 5.25 5.52 5.55 5.38 5.4 5.4 5.23 5.42 5.34 5.43 5.42 5.42 5.59 5.43 5.38 5.69 5.51 5.34 5.13 5.45 5.62
GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION 5.61 5.67 5.48 5.5 5.47 5.24 5.6 5.41 5.52 5.4 5.75 5.28 5.39 5.35 5.28 5.41 5.51 5.8 5.27 5.4 5.82 5.3 5.52 5.29 5.51 5.65
GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.53 5.4 5.41 5.44 5.34 5.24 5.47 5.47 5.34 5.2 5.4 5.19 5.37 5.24 5.27 5.28 5.31 5.38 5.27 5.26 5.56 5.44 5.15 5.04 5.27 5.51
GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.66 5.62 5.48 5.66 5.53 5.25 5.59 5.59 5.4 5.41 5.6 5.29 5.46 5.34 5.44 5.49 5.46 5.71 5.48 5.39 5.77 5.52 5.46 5.24 5.6 5.87
GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION 5.61 5.64 5.42 5.5 5.36 5.24 5.48 5.41 5.4 5.4 5.7 5.28 5.39 5.31 5.25 5.41 5.44 5.57 5.27 5.4 5.55 5.3 5.33 5.13 5.26 5.53
GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION 5.21 4.99 5.19 5.44 4.84 4.87 5.02 5.09 5.13 4.98 5.03 4.92 4.98 4.8 4.92 5.14 5.03 5.26 4.9 4.87 5.29 5.1 4.86 4.77 5.08 5.41
GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION 5.63 5.48 5.73 5.64 5.6 5.72 5.33 5.5 5.31 5.35 5.27 5.48 5.65 5.56 5.49 5.5 5.81 5.56 5.38 5.47 5.61 5.78 5.24 5.47 5.62 5.99
GOBP_LYMPHOCYTE_ACTIVATION 5.77 5.74 5.76 5.84 5.58 5.52 5.61 5.64 5.79 5.51 5.67 5.51 5.63 5.56 5.67 5.65 5.75 5.7 5.48 5.51 5.82 5.77 5.57 5.45 5.76 5.85
GOBP_TETRAHYDROFOLATE_METABOLIC_PROCESS 6.28 6.12 6.47 6.77 5.88 6.11 6.28 6.29 6.38 6.37 6.43 6.4 6.29 6.39 6.14 6.21 5.99 6.48 6.1 6.23 6.33 6.33 6.32 6.03 6.46 6.47
GOBP_FOLIC_ACID_METABOLIC_PROCESS 6.33 6.34 6.98 6.95 6.13 6.24 6.45 6.47 6.34 6.38 6.57 6.67 6.47 6.52 6.32 6.4 6.59 6.51 6.44 6.23 6.74 6.53 6.38 6.35 6.53 6.6
GOBP_FEMALE_SEX_DIFFERENTIATION 6 6.02 6.23 6.26 5.91 5.79 5.77 6.06 6.03 5.91 6.15 6.1 5.98 5.93 6.01 5.93 6.14 5.94 6.09 5.85 6.15 6.14 6.03 5.9 5.89 6.28
GOBP_MALE_SEX_DIFFERENTIATION 5.73 5.69 5.89 5.91 5.64 5.66 5.81 5.89 5.83 5.83 5.93 5.6 5.65 5.71 5.81 5.77 5.68 5.67 5.44 5.69 5.79 5.79 5.8 5.53 5.77 5.82
GOBP_RESPONSE_TO_ANTIBIOTIC 6.32 6.15 6.41 6.54 6.15 6.38 6.3 6.37 6.42 6.3 6.41 6.11 6.44 6.77 6.59 6.5 6.71 6.16 6.51 6.38 6.52 7.05 6.42 6.68 6.67 6.57
GOBP_RESPONSE_TO_ORGANOPHOSPHORUS 6.08 6.06 6.13 6.1 5.98 6.04 6.19 6.04 6.19 6.11 6.07 6.04 6.33 6.09 6.27 6.19 6.11 6.1 5.96 6.02 6.24 6.02 6.24 5.97 6.15 6.13
GOBP_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE 6.45 6.43 7.09 6.93 7.07 7.02 6.78 6.78 6.62 6.67 6.82 6.62 6.65 6.62 7.08 6.88 6.93 6.61 6.7 6.79 6.91 6.67 6.89 7.27 6.96 6.81
GOBP_RESPONSE_TO_CADMIUM_ION 7.01 6.83 7.54 7.41 6.73 6.84 6.88 7.03 7.18 6.96 7.27 7.07 7.05 7.08 7.17 7.1 7.07 6.8 6.67 7.11 7.41 7.54 7.02 6.99 7.36 7.4
GOBP_RESPONSE_TO_COPPER_ION 6.79 6.71 6.88 7.09 5.88 6.35 6.87 7.3 6.72 6.73 6.91 7.16 6.75 6.71 7.31 6.81 6.99 6.87 6.34 7.14 7.14 7.36 6.34 6.37 7.3 7.42
GOBP_RESPONSE_TO_MERCURY_ION 6.12 5.7 6 6.34 5.7 5.27 5.68 5.6 5.58 5.98 6.32 5.23 5.32 5.7 5.39 5.58 5.94 5.71 5.59 5.71 5.68 5.66 5.7 5.21 5.38 5.42
GOBP_DECIDUALIZATION 7.48 7.86 7.79 7.31 7.76 7.45 7.52 7.79 7.33 7.11 7.17 7.62 7.78 7.86 7.45 7.73 7.48 7.55 7.65 7.85 7.9 8.24 7.28 7.48 7.6 7.83
GOBP_GDP_METABOLIC_PROCESS 8.03 7.86 7.19 7.66 8.6 8.55 8.08 8.19 8.11 8.05 7.29 7.84 8.02 7.81 7.57 7.53 8.13 7.55 7.73 8.08 7.7 7.77 8.35 8.04 7.65 7.75
GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS 7.06 7.09 7.04 7.08 7.06 7.14 6.96 6.88 7.22 6.97 6.75 7.11 7.12 6.86 7.11 6.8 6.66 6.59 6.92 6.66 6.33 6.7 7.17 7.06 7.22 6.81
GOBP_ACID_SECRETION 5.74 5.48 5.31 5.49 5.01 5.18 5.36 5.33 5.28 5.26 5.34 5.36 5.36 5.05 5.39 5.12 5.39 5.49 5.17 5.42 5.59 5.15 5.39 4.89 5.41 5.44
GOBP_VIRAL_BUDDING 7.01 6.49 8.38 7.53 7.02 6.92 7.09 7.17 7.01 7.04 7.27 6.98 7.15 7.09 7.27 7.21 6.72 6.78 7 7.03 6.82 7.43 7.54 7.49 7.09 7.14
GOBP_PROTEIN_AUTOPHOSPHORYLATION 7.02 6.72 7.04 6.91 7.1 7.36 7.12 7.23 7.07 7.23 7.03 7.29 7.29 7.32 7.11 7.19 7.31 7 7.21 7.25 7.2 7.38 7.33 7.47 7.39 7.3
GOBP_REGULATION_OF_VIRAL_TRANSCRIPTION 7.31 7.43 8.08 7.92 7.36 7.53 7.7 8.2 8 7.98 7.81 7.63 7.77 7.72 8.02 7.9 7.49 7.41 7.43 7.79 7.89 7.92 8.05 8.21 7.86 7.84
GOBP_MICROTUBULE_POLYMERIZATION 7.72 7.94 8 7.83 8.53 8.44 8.09 8.23 8.21 8.33 8.01 8.28 8.24 8.27 8.34 8.24 8.36 8.13 8.15 8.23 8.46 8.4 8.56 8.49 8.2 8
GOBP_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT 7.29 7.35 7.62 7.33 7.51 7.43 7.32 7.51 7.5 7.35 7.52 7.66 7.66 7.55 7.43 7.55 7.43 7.36 7.2 7.6 7.39 7.88 7.64 7.57 7.75 7.6
GOBP_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT 6.66 6.84 7.04 6.79 6.97 7.13 7.25 6.93 7.24 7.19 7.15 6.89 7.39 7.48 6.77 7.31 7.12 6.71 6.83 7.11 6.9 7.58 7.44 7.07 6.97 6.99
GOBP_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT 7.38 7.35 7.72 7.24 7.42 7.36 7.36 7.49 7.5 7.21 7.44 7.66 7.77 7.71 7.34 7.48 7.69 7.69 7.5 7.6 7.6 7.96 7.43 7.57 7.9 7.52
GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS 7.06 7.28 7.19 7.18 7.54 7.36 7.33 7.47 7.44 7.06 7.39 7.26 7.78 7.74 7.39 7.34 7.46 7.39 7.35 7.61 7.44 7.96 7.39 7.61 7.74 7.54
GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS 6.98 7.01 7.1 7.17 6.91 7.2 7.13 7.21 7.28 6.91 7.14 7.11 7.71 7.47 7.11 7.19 7.36 7.33 7.08 7.46 7.35 7.74 7.25 7.31 7.74 7.41
GOBP_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS 8.59 8.59 8.3 8.27 8.54 8.69 8.47 8.48 8.8 8.74 8.53 8.57 8.54 8.5 8.49 8.64 8.18 8.31 8.65 8.68 7.9 8.02 8.74 8.84 8.62 8.43
GOBP_LIPID_PHOSPHORYLATION 7.11 7.15 7.2 7.41 7.33 7.45 7.4 7.17 7.41 7.36 7.13 7.41 7.38 7.31 7.38 7.26 7.15 7.19 7.37 7.26 6.75 7.14 7.73 7.77 7.32 7.11
GOBP_CARBOHYDRATE_PHOSPHORYLATION 6.11 6.37 7.25 6.98 5.85 5.96 6.59 6.26 6.5 6.29 6.57 6.49 6.39 6.52 6.41 6.26 5.91 6.21 6.34 6.11 6.13 6.24 6.31 6.6 6.45 6.2
GOBP_PHOSPHORYLATED_CARBOHYDRATE_DEPHOSPHORYLATION 6.86 7.13 7.4 7.03 7.32 6.89 7.41 7.64 7.51 7.29 7.39 7.25 7.35 7.2 7.44 7.19 7.19 7 7.04 7.28 6.56 6.99 7.49 7.31 7.3 7.31
GOBP_PHOSPHOLIPID_DEPHOSPHORYLATION 7.29 7.51 7.34 7.6 7.36 7.58 7.48 7.64 7.64 7.58 7.4 7.25 7.72 7.45 7.49 7.44 7.54 7.46 7.59 7.45 7.41 7.64 7.7 7.84 7.68 7.72
GOBP_FILOPODIUM_ASSEMBLY 7.43 7.35 7.97 7.41 7.96 7.96 8.16 7.91 8.14 7.82 8.08 8.15 8.05 8.12 8.07 8.09 8.02 7.74 7.92 7.86 7.86 8.01 8.06 8.5 8.26 8.07
GOBP_BONE_REMODELING 6.12 6.19 6.36 6.27 6.08 6.01 6.2 6.28 6.23 6.2 6.1 6.2 6.18 6.2 6.41 6.18 6.08 6.18 5.83 6.16 6.56 6.51 6.15 6.04 6.42 6.4
GOBP_REGULATION_OF_BONE_REMODELING 6.41 6.53 6.55 6.45 6.33 6.48 6.69 6.35 6.39 6.4 6.12 6.18 6.37 6.4 6.47 6.22 6.06 6.04 6.33 6.18 6.8 6.64 6.2 6.37 6.52 6.84
GOBP_PHOSPHATIDYLINOSITOL_PHOSPHORYLATION 7.12 7.11 7.2 7.19 7.33 7.48 7.24 7.02 7.5 7.33 7.13 7.34 7.44 7.45 7.34 7.26 7.15 7.08 7.22 7.16 6.69 7.14 7.76 7.77 7.36 7.22
GOBP_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION 7.32 7.53 7.41 7.61 7.45 7.62 7.61 7.71 7.78 7.75 7.4 7.43 7.74 7.63 7.5 7.49 7.61 7.47 7.67 7.53 7.43 7.72 7.82 7.98 7.81 7.73
GOBP_REGULATION_OF_HORMONE_SECRETION 6.24 6.13 6.28 6.26 6.03 6.06 6.35 6.4 6.3 6.27 6.32 6.09 6.2 6.26 6.44 6.31 6.31 6.32 6.18 6.18 6.2 6.43 6.22 6.27 6.14 6.33
GOBP_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS 5.83 5.62 5.73 5.81 6.03 5.81 5.76 5.81 5.78 5.94 6.12 5.8 5.63 5.79 5.72 5.86 5.79 5.83 5.66 5.62 5.87 6 5.54 5.45 5.67 5.87
GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION 6.24 6.1 6.07 6.13 5.72 5.84 6.07 6.17 6.14 6.13 6.17 5.92 6.09 6.09 6.2 6.28 6.17 6.2 6.18 6.03 6.11 6.2 6.01 6.04 6.02 6.27
GOBP_NEGATIVE_REGULATION_OF_HORMONE_SECRETION 5.75 5.67 5.79 5.84 5.5 5.48 5.79 5.8 5.75 5.69 5.95 5.6 5.73 5.8 5.89 5.99 5.78 5.81 5.45 5.72 5.84 5.73 5.72 5.76 5.73 5.89
GOBP_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS 6.42 6.53 6.68 6.59 6.73 6.63 6.66 6.82 6.45 6.71 6.7 6.52 6.87 6.9 6.46 6.69 6.56 6.41 6.57 6.57 6.63 6.74 6.57 6.64 6.89 6.66
GOBP_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS 6.57 6.55 6.97 6.78 6.93 6.87 6.77 6.77 7.03 6.97 6.76 6.92 7 6.98 6.76 6.73 6.8 6.67 6.67 6.67 6.76 6.85 6.94 7.14 7.03 6.79
GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY 6.95 6.87 7.5 7.35 6.88 7.03 7.11 7.16 7.05 7.16 7.15 7.01 6.96 7.1 7.01 6.84 7.19 7.01 6.92 7.37 7 6.96 7.05 6.94 7.02 7.15
GOBP_SECRETION 6.51 6.51 6.87 6.69 6.69 6.7 6.8 6.84 6.76 6.75 6.63 6.66 6.68 6.68 6.85 6.78 6.64 6.63 6.6 6.77 6.7 6.83 6.77 6.88 6.83 6.83
GOBP_INTRACELLULAR_TRANSPORT 7.35 7.45 7.87 7.71 7.68 7.76 7.7 7.75 7.67 7.78 7.65 7.71 7.8 7.77 7.77 7.78 7.5 7.45 7.59 7.75 7.52 7.73 7.82 7.96 7.75 7.69
GOBP_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS 7 6.69 7.06 7.2 6.71 6.74 6.89 6.91 6.98 6.84 6.89 6.96 6.94 7.02 6.95 6.92 7.03 6.78 6.81 6.89 7 7.3 6.77 7.11 7.25 7.2
GOBP_PORE_COMPLEX_ASSEMBLY 7.22 7.34 7.49 7.18 7.5 7.7 7.83 7.78 7.53 7.95 7.57 7.6 7.77 7.63 7.9 7.5 7.5 7.32 7.32 7.56 7.49 7.73 7.92 8.22 8.34 8.18
GOBP_NUCLEOTIDE_PHOSPHORYLATION 7.32 7.32 7.54 7.66 7.33 7.55 7.43 7.45 7.41 7.59 7.54 7.46 7.29 7.51 7.57 7.6 7.35 7.28 7.54 7.43 7.23 7.54 7.46 7.52 7.49 7.43
GOBP_CARBOXYLIC_ACID_TRANSPORT 6.07 5.94 5.88 6.06 5.78 5.7 5.84 6.03 5.88 5.64 5.88 5.75 5.74 5.93 5.75 5.66 5.9 5.78 5.82 5.75 5.89 5.79 5.65 5.77 5.84 6.03
GOBP_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS 7.2 7.76 8.08 7.86 8.12 8.24 8.27 8.19 8.16 8.4 7.97 8.08 8.4 8.42 8.41 8.49 7.99 7.99 8.03 8.36 7.97 8.1 8.46 8.49 8.31 7.93
GOBP_VESICLE_TRANSPORT_ALONG_MICROTUBULE 8.29 8.55 9.01 8.61 8.91 9 9.4 8.94 8.93 8.99 8.9 8.81 8.9 9.07 9.01 9.07 8.58 8.66 8.79 8.9 8.49 8.57 9.1 9.22 8.75 8.39
GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN 7.53 7.82 8.54 8.33 8.09 8.19 8.3 8.15 8.37 8.24 8.06 7.9 8.19 8.23 8.31 8.37 7.85 7.96 7.92 8.32 7.74 8.13 8.37 8.4 8.21 8.03
GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 7.5 7.51 7.5 7.04 7.82 7.98 7.91 7.61 7.71 7.51 7.6 7.76 7.95 7.96 7.41 7.6 7.9 7.53 7.53 7.97 7.61 7.7 7.75 7.72 7.84 7.67
GOBP_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 6.17 5.96 6.01 6.05 5.55 5.48 5.75 5.73 5.65 5.8 5.9 6.25 5.59 5.63 5.8 6.09 6.18 6.34 5.88 5.77 6.25 5.67 5.65 5.57 5.77 5.7
GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 7.06 7.15 7.42 6.99 7.33 7.52 7.2 7.29 7.66 7.24 7.34 7.53 7.47 7.69 7.35 7.37 7.38 7.1 7.19 7.45 7 7.37 7.38 7.73 7.48 7.4
GOBP_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY 6.87 7.03 7.35 7.12 7.2 7.16 7.4 6.84 7.17 7.28 6.72 7.2 7.31 7.68 6.79 7.01 7.41 7.15 7.03 7.3 7.47 7.47 7.47 7.64 7.03 7.08
GOBP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY 5.76 5.51 5.37 5.28 5.63 5.71 5.48 5.75 5.16 5.46 5.37 5.47 5.55 5.38 5.47 5.48 5.44 5.68 5.54 5.4 5.34 5.32 5.04 5.44 5.51 5.56
GOBP_EPHRIN_RECEPTOR_SIGNALING_PATHWAY 7.96 8.09 8.17 7.84 8.26 8.47 8.4 8.27 8.26 8.29 8.22 8.36 8.43 8.52 8.58 8.57 8.08 8.2 8.3 8.42 7.92 8.32 8.28 8.65 8.38 8.36
GOBP_INOSITOL_PHOSPHATE_MEDIATED_SIGNALING 6.52 6.4 6.48 6.52 6.43 6.38 6.56 6.48 6.72 6.64 6.53 6.68 6.43 6.44 6.3 6.65 6.55 6.41 6.45 6.28 6.69 6.53 6.93 6.37 6.66 6.51
GOBP_INOSITOL_LIPID_MEDIATED_SIGNALING 6.56 6.63 6.78 6.69 6.71 6.87 6.95 6.88 6.68 6.87 6.69 6.83 6.91 6.95 6.95 6.97 6.76 6.65 6.43 6.78 6.85 6.76 6.86 6.9 7.02 7.09
GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME 8.04 8.34 8.41 8.41 8.61 8.64 8.5 8.52 8.52 8.81 8.09 8.57 8.56 8.53 8.59 8.55 8.4 8.17 8.38 8.52 8.05 8.64 8.61 8.64 8.61 8.62
GOBP_NEGATIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME 7.6 8.11 8.29 8.03 8.61 8.64 8.38 8.69 8.28 8.41 7.88 8.67 8.37 8.17 8.18 8.54 8.4 8.17 8.24 8.39 8.11 8.69 8.48 8.53 8.61 8.84
GOBP_POSITIVE_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME 8.35 8.41 8.64 8.57 8.61 8.83 8.74 8.56 8.52 8.89 8.72 8.69 8.79 8.87 8.96 8.79 8.24 8.68 8.89 8.86 8.27 8.7 8.48 8.81 8.85 8.85
GOBP_FOCAL_ADHESION_ASSEMBLY 7.64 7.83 7.69 7.52 8.13 8.33 8.28 8.22 7.97 8.08 7.8 8.06 8.24 8.43 8.17 8.16 7.82 7.7 7.89 8.15 8 8.32 8.27 8.38 8.37 8.26
GOBP_EMBRYONIC_EYE_MORPHOGENESIS 5.98 5.89 5.48 5.84 5.73 6.02 5.52 5.8 5.75 5.67 5.77 5.99 5.91 5.83 5.71 5.76 5.87 5.92 5.71 5.54 5.61 5.65 5.76 5.67 6.11 6.26
GOBP_DEVELOPMENTAL_PIGMENTATION 5.9 6.13 6.26 6.1 5.99 5.9 6.21 6.33 6.29 6.05 6.09 6.11 6.27 6.14 6.13 6.13 5.97 5.97 5.95 6.1 6.02 5.9 6.26 6.19 6.36 6.28
GOBP_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION 5.74 6.2 6.19 6.1 5.66 5.56 5.95 6.46 5.95 5.94 6.03 6.11 5.98 6.16 6.19 6.02 6.13 5.96 5.69 5.91 6.15 6.04 6.45 6.22 6.29 6.28
GOBP_CHROMATIN_MEDIATED_MAINTENANCE_OF_TRANSCRIPTION 8.24 8.17 7.93 7.44 8.36 8.65 8.48 8.89 8.38 8.37 7.71 8.4 8.65 8.52 8.59 7.99 8.65 8.88 8.44 8.88 8.46 8.11 8.22 8.46 8.49 8.54
GOBP_AUTOPHAGIC_CELL_DEATH 6.89 6.88 8.36 8.01 7.56 7.12 6.95 7.21 7.09 7.21 6.64 6.84 7.2 7.13 7.22 7.2 7.06 6.95 7.38 7.26 7.4 7.57 7.35 7.34 7.34 7.17
GOBP_ASTROCYTE_ACTIVATION 6.24 6.17 6.73 7.07 6.87 6.94 6.41 6.54 6.22 6.61 6.47 6.41 6.92 6.84 6.22 6.29 6.75 6.04 5.83 5.96 6.27 6.59 6.49 6.08 6.38 6.61
GOBP_FIBROBLAST_PROLIFERATION 6.23 6.27 6.58 6.33 5.98 6.23 6.3 6.15 6.24 6.38 6.23 6.26 6.21 6.39 6.08 6.2 6.1 6.17 6.15 6.08 6.16 6.22 6.31 6.26 6.28 6.41
GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION 6.08 6.01 5.9 5.71 5.66 5.78 5.65 5.84 5.73 5.85 5.99 5.54 5.88 5.9 6.03 6.05 5.93 5.93 6.09 5.62 6.16 5.91 5.74 5.54 5.73 6.15
GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION 6.18 6.29 6.75 6.6 6.06 6.31 6.34 6.21 6.27 5.89 6.27 6.35 6.21 6.4 5.97 6.12 6.24 6.29 5.98 6.16 6.11 6.23 6.5 6.4 6.31 6.42
GOBP_BEHAVIORAL_RESPONSE_TO_COCAINE 5.73 5.58 7.1 6.71 6.08 6.22 6.64 7.06 6.28 6.45 6.58 6.11 6.93 6.24 7.18 6.05 6.05 6.15 5.55 6.24 6.46 6.26 6.16 6.34 6.02 6.09
GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY 8.46 8.47 8.38 8.18 8.6 8.61 8.65 8.88 8.63 8.54 8.28 8.62 8.79 8.81 8.83 8.73 8.23 8.58 8.82 8.83 8.53 8.54 8.49 8.86 8.71 8.58
GOBP_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY 8.54 8.8 8.89 8.78 8.93 9.13 9.17 9.22 8.69 8.97 9.1 8.91 9.13 9.31 9.37 9.34 8.58 8.9 9 9.07 8.83 9.08 8.57 9.26 8.93 8.86
GOBP_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY 8.83 8.93 9.1 9.02 9.54 9.67 9.58 9.3 9.68 9.55 9.24 9.37 9.75 9.97 9.89 9.77 8.93 8.97 9.47 9.38 9.59 9.59 9.87 9.73 9.6 9.29
GOBP_GOLGI_VESICLE_TRANSPORT 7.62 7.74 8.2 8.09 8.2 8.24 8.15 8.07 8.1 8.18 8.01 8.05 8.17 8.19 8.1 8.03 7.79 7.66 7.9 8.2 7.77 8.05 8.19 8.41 8.13 7.92
GOBP_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI 8.01 7.81 8.43 8.37 8.14 8.23 8.32 8.11 8.3 8.51 8.23 8.05 8.16 8.21 8.42 8.23 7.85 7.69 8.12 8.32 7.93 8.24 8.51 8.56 8.29 8.21
GOBP_MALE_GAMETE_GENERATION 5.76 5.6 5.88 5.82 5.58 5.46 5.56 5.62 5.58 5.65 5.8 5.62 5.47 5.55 5.71 5.74 5.6 5.68 5.54 5.44 5.7 5.59 5.48 5.52 5.58 5.69
GOBP_SPERM_CAPACITATION 5.24 5.08 4.99 5.08 4.53 4.17 4.66 4.65 4.56 4.32 4.8 5.06 4.19 4.45 4.45 4.65 4.82 5.07 4.69 4.27 4.79 4.89 4.57 4.12 4.63 4.9
GOBP_NOREPINEPHRINE_SECRETION 6.25 6.06 6.76 6.72 5.66 5.64 5.98 6.16 5.96 6.02 6.56 5.92 5.79 5.99 6.17 6.44 6.31 6.72 5.78 6.04 6.81 6.24 5.86 5.82 5.93 5.81
GOBP_EOSINOPHIL_CHEMOTAXIS 5.02 4.92 4.72 4.93 4.13 3.95 4.4 4.48 4.03 4.08 4.61 4.48 4.15 4.32 4.58 4.29 4.55 4.51 4.42 4.05 4.82 4.23 4.45 3.99 4.59 4.29
GOBP_MACROPHAGE_CHEMOTAXIS 6.25 6.22 6.34 6.54 6.03 5.75 5.82 5.63 5.82 5.27 5.91 5.56 5.82 5.58 5.64 5.76 6.01 5.62 5.66 5.44 6.26 6.25 5.88 5.42 5.99 6.14
GOBP_LYMPHOCYTE_CHEMOTAXIS 5.14 4.96 4.76 5.19 4.67 4.57 4.92 4.58 4.79 4.61 4.74 4.62 4.7 4.67 4.66 4.52 5.05 5.19 4.69 4.52 5.14 4.69 4.76 4.52 4.66 4.65
GOBP_ELASTIC_FIBER_ASSEMBLY 5.96 5.51 5.47 5.52 5.87 5.77 5.73 5.56 5.77 5.89 5.92 5.66 5.69 5.64 5.75 5.48 5.78 5.92 5.81 5.61 6.1 5.9 6.44 5.88 5.86 5.65
GOBP_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS 7.66 7.67 8.14 7.92 8.2 8.38 8.2 7.87 7.93 8.23 7.84 8.05 8.24 8.34 8.22 8.09 7.98 7.84 7.92 8.28 7.68 7.99 8.32 8.34 8 7.96
GOBP_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS 7.37 7.34 7.57 7.39 7.99 8.14 7.93 7.56 7.69 7.92 7.07 7.55 8.04 7.9 7.93 7.41 7.44 7.08 7.82 7.99 7.31 7.24 7.67 8.24 7.19 7.58
GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS 7.66 7.64 8.8 8.3 8.2 8.63 8.55 8.35 8.49 8.81 8.26 8.74 8.39 8.34 8.27 7.85 8.02 7.84 7.92 8.54 7.98 8.22 8.85 8.83 8.51 8.6
GOBP_RESPONSE_TO_PAIN 5.92 5.85 5.79 5.98 5.63 5.61 5.91 5.78 5.79 5.49 5.72 5.56 5.53 5.64 5.76 5.75 5.68 5.9 5.7 5.45 5.82 5.77 5.58 5.44 5.71 5.81
GOBP_BEHAVIORAL_RESPONSE_TO_PAIN 5.98 5.96 5.9 6.31 5.68 5.59 5.91 5.82 5.93 5.5 5.77 5.58 5.57 5.83 5.76 5.82 5.69 5.93 5.63 5.37 5.84 5.8 5.69 5.51 5.79 5.89
GOBP_CLATHRIN_COAT_ASSEMBLY 9.37 9.52 9.73 9.59 9.33 9.19 9.48 9.77 9.31 9.63 9.46 9.43 9.51 9.48 9.73 9.77 9.52 9.57 9.48 9.77 9.3 9.69 9.58 9.53 9.61 9.73
GOBP_VESICLE_DOCKING 7.4 7.31 7.62 7.45 7.91 7.96 7.73 7.73 7.76 7.86 7.36 7.74 7.87 7.72 7.62 7.47 7.61 7.42 7.56 7.8 7.56 7.82 7.71 7.98 7.61 7.7
GOBP_ORGANELLE_FUSION 7.48 7.43 7.78 7.54 7.86 7.99 7.76 7.59 7.81 7.94 7.49 7.84 7.92 7.99 7.75 7.71 7.61 7.48 7.66 7.81 7.51 7.73 7.91 8.16 7.86 7.69
GOBP_ORGANELLE_FISSION 6.07 6.18 6.37 6.24 6.25 6.28 6.35 6.29 6.31 6.42 6.3 6.34 6.27 6.2 6.3 6.22 6.31 6.13 6.09 6.25 6.11 6.2 6.38 6.49 6.29 6.26
GOBP_LUNG_ALVEOLUS_DEVELOPMENT 5.89 6.06 5.71 6.08 5.77 5.73 5.95 5.59 5.82 5.62 6.01 5.7 5.66 5.49 5.81 5.57 5.82 5.82 5.76 5.37 5.9 5.89 6.04 5.41 5.7 5.6
GOBP_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES 5.63 5.52 5.51 5.52 5.32 4.9 5.45 5.21 5.34 5.28 5.75 5.28 5.2 5.26 5.36 5.22 5.06 5.59 5.23 5.01 5.44 5.6 5.01 5 5.25 5.42
GOBP_ORGANELLE_INHERITANCE 7.53 7.21 8.25 8.31 7.73 7.66 7.6 7.53 7.77 8.16 8.2 7.83 7.98 8.04 8 7.79 7.82 7.66 7.29 7.52 7.97 8.41 8.21 8.35 7.87 7.82
GOBP_MITOCHONDRION_DISTRIBUTION 7.61 7.8 8.38 8.01 8.42 8.43 8.45 8.41 8.12 8.55 7.85 8.12 8.15 8.38 8.5 8.37 8.27 8.09 7.99 8.18 8.02 8.56 8.45 8.27 8.37 8.38
GOBP_MESODERM_MORPHOGENESIS 5.94 5.73 6.07 5.88 5.74 5.61 6.02 6.11 5.83 5.95 5.86 5.81 5.87 5.89 6.05 5.97 5.82 5.57 5.75 5.78 6.18 5.95 5.98 5.87 5.78 5.98
GOBP_MESODERMAL_CELL_DIFFERENTIATION 5.94 5.69 5.65 5.56 5.27 5.27 5.7 5.52 5.78 5.49 5.5 5.38 5.6 5.78 5.79 5.71 5.75 5.44 5.36 5.22 5.91 5.74 5.67 5.25 5.41 5.48
GOBP_PARAXIAL_MESODERM_DEVELOPMENT 6 6.42 6.38 6.01 6.39 6.07 6.22 6.2 6.02 6.03 6.22 6.31 6.2 5.99 6.24 6.03 6.25 5.63 6 5.91 6.32 6.19 6.17 6.06 6.19 6.26
GOBP_PARAXIAL_MESODERM_MORPHOGENESIS 6.03 6.85 6.43 6.07 6.98 6.81 6.7 6.21 6.63 6.57 6.76 6.56 6.57 6.76 6.36 6.61 6.66 6.06 6.57 6.4 6.87 6.72 6.31 6.46 6.54 6.75
GOBP_LATERAL_MESODERM_DEVELOPMENT 5.85 5.71 6.01 5.57 5.4 5.21 5.94 5.71 5.7 5.84 5.89 5.49 5.77 6.09 5.89 5.77 5.8 6 5.92 5.6 6.13 6.35 5.54 5.47 5.64 6.04
GOBP_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY 5.9 5.92 7.13 6.62 6.05 6.16 6 6.23 6.36 6.02 6.62 6.29 6.37 6.2 6.28 6.63 6.31 5.98 5.88 6.41 6.37 7.2 6.22 6.28 6.43 6.5
GOBP_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY 6.01 6.12 6.91 6.52 5.94 5.63 6.15 6.36 6.22 6.08 6.79 6.37 6.54 6 6.16 6.66 6.98 5.85 5.87 6.26 6.56 7.21 6.5 6.23 6.47 6.58
GOBP_CELL_MATURATION 5.8 5.8 5.93 6.11 5.57 5.52 5.73 5.85 5.73 5.91 5.89 5.85 5.76 5.81 5.76 5.7 5.92 5.72 5.57 5.55 5.97 5.97 5.56 5.54 5.86 6.04
GOBP_OOGENESIS 5.7 5.57 5.77 5.76 5.36 5.2 5.53 5.67 5.49 5.4 5.64 5.42 5.63 5.52 5.83 5.44 5.44 5.52 5.72 5.46 5.54 5.52 5.27 5.42 5.46 5.52
GOBP_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT 5.51 5.44 5.63 5.78 5.56 5.23 5.35 5.56 5.41 5.37 5.67 5.27 5.38 5.48 5.28 5.46 5.45 5.43 5.34 5.47 5.64 5.47 5.57 5.04 5.36 5.57
GOBP_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT 5.47 5.04 5.55 5.22 5.23 4.84 5.3 5.65 5.38 5.36 5.56 5.27 5.11 5.24 5.19 5.46 5.4 5.27 5.17 5.24 5.43 5.36 5.04 4.93 5.26 5.43
GOBP_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT 5.83 5.64 5.7 5.98 5.75 5.45 5.6 5.8 6.06 5.67 5.68 5.47 5.65 5.65 5.35 5.48 5.67 5.71 5.51 5.49 5.65 5.74 5.67 5.51 5.45 5.69
GOBP_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT 5.83 5.71 5.59 5.53 5.23 5.15 5.35 5.29 5.4 5.37 5.56 5.36 5.34 5.48 5.29 5.33 5.35 5.73 5.51 5.24 5.38 5.27 5.09 4.7 5.36 5.69
GOBP_SYNAPTIC_VESICLE_TRANSPORT 7.69 7.99 8.83 8.41 8.88 8.69 8.66 8.6 8.62 8.95 8.25 8.64 8.74 8.72 8.71 8.46 8.35 8.11 7.9 8.39 8.04 8.28 8.85 8.89 8.51 8.16
GOBP_RHYTHMIC_PROCESS 6.76 6.88 7.13 7.01 7.21 7.18 7.26 7.24 7.3 7.12 6.99 7.25 7.37 7.48 7.23 7.35 7.1 7.02 7.13 7.27 7.14 7.22 7.34 7.4 7.35 7.31
GOBP_BLOOD_VESSEL_MORPHOGENESIS 6.07 6.02 6.12 6.07 6.04 6.07 6.12 6.1 6.06 6.06 6.07 6.04 6.18 6.06 6.08 6.08 6.25 6 5.89 6.02 6.26 6.32 6.24 6.04 6.14 6.29
GOBP_SPERMATID_DIFFERENTIATION 5.67 5.36 5.52 5.56 5.2 5.21 5.35 5.19 5.26 5.4 5.54 5.29 5.21 5.29 5.58 5.4 5.41 5.44 5.22 5.24 5.34 5.37 5.15 5.04 5.3 5.45
GOBP_POSITIVE_REGULATION_OF_BEHAVIOR 6.11 6.12 6.11 6.36 5.52 5.39 6.41 6.14 5.99 6.04 6.41 5.93 5.86 6.16 6.41 6.56 5.96 6.21 6.1 6 6.53 6.33 5.92 6.15 5.8 6.21
GOBP_NEGATIVE_REGULATION_OF_BEHAVIOR 5.85 6.03 5.93 6.03 5.47 5.36 6.05 6.1 5.66 5.93 6.07 5.56 5.65 5.45 6.02 6.13 5.85 5.92 5.85 5.7 5.83 5.7 5.56 5.27 5.65 5.9
GOBP_POSITIVE_REGULATION_OF_VIRAL_PROCESS 7.4 7.51 8.08 7.97 7.5 7.56 8.04 8.08 7.94 8.15 7.77 7.92 7.9 7.89 8.15 7.95 7.71 7.36 7.59 7.99 8 8.04 8.17 8.21 7.86 7.93
GOBP_NEGATIVE_REGULATION_OF_VIRAL_PROCESS 6.01 5.93 5.69 5.71 6.13 6.06 5.98 5.92 5.88 6.04 5.98 5.69 5.81 5.77 5.76 5.54 5.93 5.76 5.74 5.75 5.81 6.05 5.65 5.45 6.03 6.23
GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT 5.89 5.79 5.64 5.8 6.03 6.24 5.74 5.92 6.13 5.99 5.66 5.68 6.06 6.13 5.56 5.86 5.44 5.73 5.98 5.88 5.93 5.97 5.79 6.22 5.45 5.77
GOBP_LYMPH_NODE_DEVELOPMENT 5.22 5.28 5.29 5.73 5.08 4.97 5.26 5.15 5.25 4.98 5.23 4.95 5.03 5.03 5.21 5.03 5.26 5.27 4.91 5.31 5.39 5.56 5.04 4.73 5.08 5.35
GOBP_SPLEEN_DEVELOPMENT 5.64 5.7 5.83 6.05 5.33 5.51 5.77 5.9 5.96 5.71 6.01 5.62 5.85 5.87 5.75 5.84 5.54 5.47 5.36 5.55 5.9 6.1 5.85 5.69 6 6.09
GOBP_THYMUS_DEVELOPMENT 6.13 6.43 6.17 6.62 5.95 6.15 6.18 6.11 6.33 6.3 6.49 6.18 6.55 6.31 6.38 6.21 6.32 6.43 6.16 6.13 6.64 6.39 6.29 6.28 6.12 6.22
GOBP_RESPONSE_TO_STEROID_HORMONE 6.43 6.5 6.71 6.59 6.63 6.66 6.7 6.79 6.74 6.74 6.56 6.68 6.83 6.89 6.71 6.66 6.75 6.6 6.61 6.75 6.74 6.91 6.73 6.85 6.84 6.76
GOBP_DIGESTIVE_TRACT_MORPHOGENESIS 5.41 5.39 5.55 5.71 5.33 5.3 5.42 5.7 5.82 5.56 5.73 5.21 5.66 5.72 5.57 5.54 5.45 5.51 5.18 5.37 5.43 5.63 5.45 5.15 5.14 5.37
GOBP_REGULATION_OF_PINOCYTOSIS 7.79 8.07 7.92 7.35 8.21 8.54 8.43 8.18 8.28 7.93 8.19 8.1 8.2 8.07 7.76 7.72 8.16 8.16 8 8.22 7.82 8.11 8.06 8.49 8.13 7.72
GOBP_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS 6.29 6.09 6.17 6.05 6.13 5.65 6.09 5.95 6.34 6.17 6.41 5.88 6.05 6.35 6.15 6.32 6.11 6.22 5.99 5.68 6.51 6.39 6.05 5.7 5.79 6.04
GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS 5.88 5.67 5.67 5.8 5.57 5.33 5.61 5.57 5.62 5.47 5.84 5.68 5.57 5.54 5.65 5.5 5.72 5.76 5.49 5.55 5.77 5.64 5.55 5.42 5.6 5.66
GOBP_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT 6.04 5.88 6.07 6.23 5.72 5.74 6.09 5.89 6.09 5.86 6.19 5.77 5.94 6.02 5.92 6.19 6.07 5.97 5.91 5.57 6.24 6.38 6 5.61 5.8 6.04
GOBP_EMBRYONIC_ORGAN_DEVELOPMENT 5.9 5.87 5.92 5.9 5.73 5.59 5.79 5.82 5.8 5.77 5.99 5.79 5.82 5.8 5.81 5.88 5.94 5.92 5.76 5.72 5.97 5.86 5.76 5.68 5.81 5.87
GOBP_POST_EMBRYONIC_ANIMAL_ORGAN_DEVELOPMENT 6.34 6.41 5.66 5.86 6.38 6.67 5.97 6.07 5.79 6.12 5.91 6.33 6.4 5.95 5.91 6.25 6.54 5.95 6.27 6.16 6.02 5.87 5.97 5.88 6.2 6.47
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS 6.42 6.42 6.55 6.56 6.53 6.55 6.56 6.62 6.53 6.57 6.49 6.52 6.62 6.59 6.6 6.56 6.55 6.47 6.39 6.55 6.61 6.66 6.64 6.64 6.64 6.7
GOBP_DEVELOPMENTAL_CELL_GROWTH 7.44 7.53 7.57 7.26 7.85 8 7.96 7.91 7.82 7.91 7.53 7.83 7.94 7.93 7.94 7.89 7.54 7.65 7.74 7.95 7.61 7.85 7.86 7.95 7.81 7.81
GOBP_DEVELOPMENTAL_GROWTH 6.83 6.85 7.04 6.78 7.12 7.19 7.2 7.22 7.07 7.18 6.9 7.15 7.19 7.2 7.2 7.11 7.05 7.02 6.98 7.2 7.01 7.11 7.18 7.23 7.21 7.22
GOBP_EYE_MORPHOGENESIS 6.01 6 6.02 6.12 5.94 5.97 6.01 6.09 6.1 6.14 5.95 6.06 6.22 6.07 6.05 6.06 6.03 5.98 6.03 6 6.12 6.02 6 6.08 6.15 6.27
GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS 6.06 6.05 6.12 6.18 6.04 6.12 6.26 6.34 6.28 6.23 6.07 6.12 6.31 6.27 6.19 6.24 6.28 6.05 6.05 6.2 6.26 6.34 6.11 6.24 6.22 6.38
GOBP_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS 6.04 5.98 5.48 5.85 5.74 6.06 6.11 6.16 5.84 6.01 5.98 6.07 6.03 5.96 6.01 5.94 5.98 5.92 5.8 5.78 5.97 5.85 5.8 6.03 6.13 6.28
GOBP_EMBRYONIC_MORPHOGENESIS 5.9 5.83 5.9 5.9 5.72 5.64 5.8 5.83 5.78 5.85 5.94 5.77 5.84 5.79 5.86 5.81 5.81 5.87 5.76 5.79 6.02 5.93 5.8 5.7 5.8 5.85
GOBP_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT 5.55 5.52 5.45 5.53 5.23 5.22 5.5 5.12 5.39 5.42 5.54 5.33 5.4 5.35 5.34 5.49 5.51 5.54 5.74 5.48 5.55 5.3 5.36 5.15 5.62 5.59
GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH 6.88 6.91 7.12 6.87 7.22 7.25 7.2 7.24 7.19 7.18 6.9 7.27 7.34 7.26 7.24 7.21 7.05 7.04 7.01 7.28 7.06 7.12 7.2 7.3 7.26 7.3
GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH 6.98 7.04 6.94 6.8 7.29 7.34 7.31 7.31 7.29 7.24 6.84 7.37 7.55 7.34 7.26 7.32 7.22 7.11 7.02 7.21 7.09 7.16 7.19 7.39 7.21 7.28
GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH 6.63 6.66 7.07 6.8 6.94 7.02 7.02 7.35 7.07 7.04 6.84 7.05 7.16 7.11 6.97 6.95 6.9 6.87 6.82 7.16 6.9 6.97 7.05 7.13 7.19 7.17
GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT 5.65 5.7 5.7 5.61 5.36 5.29 5.75 5.86 5.71 6.07 5.57 5.57 5.52 5.88 5.67 5.74 5.87 5.79 5.92 5.68 6.24 6.11 5.95 5.74 5.78 5.9
GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT 5.65 5.7 5.55 5.6 5.23 5.29 5.75 5.51 5.83 6.07 5.57 5.47 5.93 5.95 5.67 5.59 5.87 5.68 5.98 5.68 6.03 5.69 5.95 5.74 5.78 5.85
GOBP_MUSCLE_ORGAN_MORPHOGENESIS 5.54 5.46 5.67 5.78 5.49 5.29 5.45 5.49 5.59 5.5 5.43 5.34 5.68 5.45 5.69 5.46 5.5 5.46 5.4 5.46 5.5 5.64 5.61 5.55 5.71 5.63
GOBP_ANIMAL_ORGAN_FORMATION 5.64 5.55 5.56 5.46 5.36 5.05 5.46 5.52 5.24 5.29 5.76 5.25 5.18 5.15 5.5 5.47 5.41 5.63 5.43 5.06 5.6 5.55 5.33 5.13 5.38 5.43
GOBP_ANATOMICAL_STRUCTURE_FORMATION_INVOLVED_IN_MORPHOGENESIS 6.04 6.02 6.05 6.03 6.01 5.99 6.04 6.07 6.01 6.11 6.04 6 6.05 6.01 6.01 6.03 6.14 6.05 5.93 5.98 6.17 6.21 6.13 5.98 6.1 6.22
GOBP_SMOOTH_MUSCLE_CELL_PROLIFERATION 6.47 6.36 6.49 6.41 6.7 6.49 6.26 6.34 6.89 6.69 6.45 6.62 6.74 6.69 6.53 6.45 6.68 6.3 6.5 6.26 6.51 6.49 6.87 6.57 6.48 6.51
GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION 6.67 6.63 6.6 6.29 6.73 6.67 6.54 6.54 6.98 6.75 6.49 6.75 6.91 6.82 6.58 6.59 6.73 6.44 6.82 6.52 6.78 6.66 6.93 6.68 6.54 6.51
GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION 5.75 5.83 6.1 6.22 5.96 6.04 6.08 5.56 5.77 5.83 5.77 5.57 6.13 5.87 5.55 5.53 5.9 5.71 5.45 5.61 5.99 5.99 6.28 5.5 5.75 5.77
GOBP_NEURON_FATE_COMMITMENT 5.66 5.69 5.8 5.86 5.45 5.18 5.64 5.6 5.68 5.47 5.8 5.52 5.55 5.59 5.73 5.48 5.74 5.43 5.4 5.47 5.55 5.71 5.55 5.21 5.54 5.53
GOBP_NEURON_FATE_SPECIFICATION 5.34 5.33 5.67 5.7 5.28 5.01 5.34 5.13 5.58 5.24 5.58 5.15 5.35 5.34 5.25 5.16 5.41 5.24 5.02 4.96 5.26 5.38 5.48 5.09 5.35 5.16
GOBP_NEURON_DEVELOPMENT 7.16 7.24 7.43 7.13 7.43 7.57 7.55 7.61 7.46 7.58 7.33 7.49 7.62 7.69 7.67 7.56 7.37 7.34 7.41 7.66 7.36 7.58 7.61 7.73 7.58 7.52
GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION 7.31 7.37 7.47 7.1 7.6 7.66 7.77 7.78 7.57 7.68 7.44 7.73 7.71 7.77 7.76 7.74 7.45 7.49 7.53 7.87 7.48 7.78 7.75 7.88 7.69 7.67
GOBP_COLLATERAL_SPROUTING 7.52 7.71 7.53 6.66 7.8 8.35 8.02 8.09 8.04 8.3 7.57 8.08 8.24 8.11 8.36 8.25 7.45 7.78 7.95 8.04 8.08 8.32 8.31 8.2 8.21 8.17
GOBP_REGULATION_OF_COLLATERAL_SPROUTING 7.54 7.71 8.02 6.66 7.78 8.27 8.02 8.09 7.81 8.43 7.47 7.79 8.16 8.11 8.38 8.36 7.18 7.59 7.53 8.04 7.89 8.03 8.09 8.2 8.02 8.17
GOBP_AXON_EXTENSION 7.44 7.67 7.62 7.36 8.01 8.07 8.02 7.97 7.89 8.05 7.63 8.05 8.04 8.11 8.03 7.98 7.68 7.84 7.81 8.08 7.84 7.87 7.9 8.17 8.03 7.91
GOBP_RESPONSE_TO_AXON_INJURY 7.83 8.07 8.2 7.66 8.17 8.05 8.27 8.08 7.96 8 7.84 7.78 8.17 8.1 8.36 8.15 7.85 8.06 7.71 8.4 7.76 8.37 8.3 8.21 8.29 7.85
GOBP_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS 6.15 6.42 6.82 6.49 6.46 6.15 6.08 6.21 6.49 6.37 6.74 6.11 6.55 6.24 6.24 6.47 6.49 6.54 6.16 6.13 6.53 6.7 6.71 6.48 6.59 6.71
GOBP_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS 5.72 5.43 5.42 5.56 5.35 5.05 5.31 5.38 5.36 5.37 5.67 5.34 5.4 5.27 5.45 5.28 5.4 5.67 5.26 5.31 5.49 5.3 5.21 4.99 5.34 5.26
GOBP_SKELETAL_SYSTEM_MORPHOGENESIS 5.79 5.64 5.9 5.94 5.67 5.61 5.85 5.79 5.78 5.74 6.01 5.77 5.69 5.74 5.84 5.83 5.76 5.9 5.81 5.73 5.91 5.94 5.72 5.74 5.71 5.87
GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT 5.7 5.5 5.52 5.61 5.5 5.32 5.57 5.48 5.5 5.41 5.76 5.55 5.51 5.53 5.65 5.51 5.48 5.63 5.42 5.53 5.66 5.47 5.53 5.2 5.38 5.42
GOBP_ASTROCYTE_DIFFERENTIATION 6.67 6.77 6.75 6.7 7.06 7.05 6.95 6.99 7.12 6.86 6.72 7.11 7.53 7.24 6.99 7.16 7.04 6.84 6.89 7.11 7.01 7.16 7.19 7.22 7.35 7.48
GOBP_OLIGODENDROCYTE_DIFFERENTIATION 6.86 6.95 7.29 6.96 7.34 7.32 7.36 7.47 7.29 7.38 6.91 7.08 7.47 7.24 7.18 7.17 7.49 7.05 7 7.57 7.06 7.16 7.22 7.42 7.17 7.37
GOBP_REGULATION_OF_ASTROCYTE_DIFFERENTIATION 7.12 7.13 6.9 6.9 7.42 7.26 7.36 7.97 6.93 7.43 6.53 7.42 7.92 7.51 7.57 7.34 7.58 6.83 7.13 7.47 8.12 7.79 7.18 7.7 7.61 7.71
GOBP_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION 7.77 7.68 7.72 7.06 8.02 8.16 8.28 8.77 8.12 8.13 7.47 8.07 8.24 7.89 8.22 7.88 7.91 7.29 7.48 8.44 8.15 7.81 8.12 8.45 8.36 8.8
GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION 6.63 6.68 6.84 6.79 6.96 6.91 6.76 7.21 6.93 7.38 6.49 6.24 7.16 7.14 6.64 6.86 6.68 6.55 6.7 6.75 6.86 7.06 6.8 7.01 6.78 7.01
GOBP_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION 6.62 6.6 6.84 6.85 6.96 6.91 6.71 7.21 6.79 7.38 6.48 7.06 6.8 6.67 6.64 6.63 6.68 6.25 6.7 6.75 6.86 7.06 6.73 7.01 6.78 7.01
GOBP_TISSUE_MORPHOGENESIS 6.07 6.15 6.12 6.14 6.11 6.06 6.12 6.16 6.2 6.19 6.11 6.11 6.2 6.18 6.13 6.2 6.17 6.1 6.06 6.08 6.23 6.21 6.25 6.12 6.14 6.23
GOBP_EPIDERMIS_MORPHOGENESIS 5.4 5.32 5.21 5.42 5.01 4.94 5.18 5.08 5.26 4.93 5.34 4.99 5.07 5.16 5.22 4.88 5.22 5.21 5.07 4.94 5.11 5.13 5.04 4.75 4.94 4.68
GOBP_GLAND_DEVELOPMENT 5.98 5.93 6.09 6.14 5.95 5.87 6.03 6.08 6.04 6.02 6.01 5.85 5.97 5.95 5.98 6 6.02 5.95 5.84 5.88 6.03 6.1 6 5.79 5.96 6.05
GOBP_APPENDAGE_DEVELOPMENT 5.95 6.06 5.99 6.14 6.02 6.06 6.11 6.01 5.82 6.11 6.07 5.91 6.04 6.31 6.05 6.19 5.98 5.97 5.94 6.02 6.09 6.31 6.04 6.1 6.02 6.12
GOBP_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT 6.27 6.42 6.39 6.28 6.49 6.43 6.31 6.25 6.49 6.42 6.38 6.37 6.54 6.48 6.31 6.51 6.49 6.43 6.28 6.24 6.51 6.42 6.51 6.48 6.5 6.56
GOBP_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT 5.18 5.23 4.74 5.1 4.63 4.28 4.66 4.57 4.67 4.64 4.92 4.62 4.74 4.53 4.55 4.54 4.81 4.66 4.69 4.48 4.79 4.68 4.51 4.36 4.7 4.55
GOBP_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT 6.69 6.42 6.8 6.65 7.16 7.08 6.9 6.78 7.15 7.1 6.87 7.32 7.35 7.05 6.3 6.72 7.45 6.73 6.45 6.75 6.75 7.02 7.11 7.11 6.74 6.87
GOBP_MUSCLE_FIBER_DEVELOPMENT 5.89 5.73 5.92 5.84 5.74 5.65 5.97 5.77 5.72 5.82 6.08 6.05 5.81 5.73 5.85 5.69 5.98 5.98 5.72 5.64 6.05 5.83 5.63 5.55 5.74 5.73
GOBP_PIGMENT_GRANULE_ORGANIZATION 6.53 6.78 6.97 6.47 6.58 6.73 6.75 6.84 6.76 7.06 6.83 6.77 6.93 6.98 6.98 6.98 6.37 6.59 6.54 6.98 6.73 7.16 7.06 6.91 6.91 7.01
GOBP_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE 5.87 5.8 5.79 5.85 5.71 5.61 5.96 5.99 5.87 5.8 5.82 5.64 5.84 5.91 5.85 5.83 5.85 5.71 5.77 5.81 6.14 5.85 5.68 5.7 5.87 5.87
GOBP_MESENCHYMAL_CELL_DIFFERENTIATION 6.23 6.22 6.41 6.22 6.26 6.24 6.29 6.35 6.34 6.36 6.36 6.3 6.38 6.43 6.33 6.39 6.43 6.42 6.2 6.24 6.45 6.48 6.37 6.36 6.26 6.36
GOBP_TISSUE_REMODELING 5.86 5.93 5.99 6.15 5.8 5.77 6.01 5.94 5.96 5.78 6 5.88 6.02 5.95 5.96 5.98 5.96 5.88 5.67 5.89 6.2 6.18 5.94 5.87 6.2 6.02
GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER 8.76 8.4 7.83 8.61 8.94 9.18 9.17 9 8.46 8.55 8.54 8.67 8.49 8.63 8.83 8.67 8.1 8.69 8.91 8.92 8.39 8.68 8.5 8.44 8.41 8.25
GOBP_ANIMAL_ORGAN_MATURATION 6.17 5.97 5.34 5.6 5.83 6.12 5.95 6.13 5.71 6.07 5.68 6.04 5.95 5.88 5.9 5.91 5.68 5.72 5.83 5.74 6.05 5.93 5.59 5.75 5.86 6.3
GOBP_GENITALIA_DEVELOPMENT 5.79 5.61 5.5 5.48 5.66 5.39 5.35 5.27 5.35 5.26 5.42 5.17 5.26 5.11 5.26 5.39 5.3 5.37 5.13 5.38 5.33 5.38 5.06 5.11 5.01 5.3
GOBP_DENDRITE_MORPHOGENESIS 7.76 7.95 7.85 7.44 8.22 8.43 8.26 8.09 8.07 8.27 7.87 8.14 8.34 8.26 8.2 8.32 7.95 8.05 8.35 8.28 7.86 8.05 8.18 8.32 8.16 8.1
GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS 7.67 7.62 7.73 7.3 7.89 8.17 8.02 8.01 7.88 8.01 7.65 8.07 7.74 7.82 8.02 8.09 7.67 7.65 7.87 8.09 7.79 7.97 7.97 8.23 7.96 7.88
GOBP_HAIR_FOLLICLE_MATURATION 6.1 6.07 7.1 5.48 6.5 6.68 6.62 6.91 5.78 6.76 6.17 6.85 6.06 6.17 6.82 6.51 6.83 6.93 6.08 6.57 6.48 6.84 6.51 6.7 6.65 6.7
GOBP_ERYTHROCYTE_DEVELOPMENT 6.42 6.38 6.88 6.66 6.55 6.59 6.63 6.47 6.98 6.56 6.49 6.47 6.68 6.59 6.52 6.36 6.55 6.65 6.3 6.51 6.55 6.47 6.71 7.03 6.73 6.47
GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE 6.37 6.38 6.74 6.33 6.92 6.63 6.82 6.76 6.39 6.93 6.78 6.73 6.72 6.78 6.87 6.6 6.57 6.48 6.31 6.71 6.72 6.61 6.59 6.58 6.53 6.64
GOBP_ARTERY_MORPHOGENESIS 6.15 6.22 6.34 6.17 6.26 6.08 6.22 6.21 6.33 6.11 6.07 6.28 6.55 6.42 6.05 6.28 6.28 6.23 6.03 6.13 6.47 6.42 6.27 6.46 6.19 6.4
GOBP_FOREBRAIN_MORPHOGENESIS 6 5.88 6.29 6.51 5.66 5.57 5.78 6.07 5.8 5.68 6.4 6.01 5.48 5.77 5.51 6.17 6.38 6.15 5.94 5.62 6.19 5.94 5.85 5.29 5.59 5.97
GOBP_BRAIN_MORPHOGENESIS 6.47 6.48 7.25 6.85 6.32 6.45 6.48 7.27 6.66 7.12 6.8 6.52 6.66 6.62 7.31 7.3 6.67 6.9 6.41 6.95 7.04 6.78 6.62 6.85 6.71 6.83
GOBP_NEURAL_NUCLEUS_DEVELOPMENT 8.34 8.71 8.7 8.32 8.99 9.01 9.1 9 8.96 9.18 8.75 8.48 8.94 8.92 9.08 9.4 8.42 8.61 8.86 9.29 8.52 8.94 8.53 9.1 8.98 9.03
GOBP_STEM_CELL_DIFFERENTIATION 6.46 6.58 6.79 6.47 6.67 6.66 6.81 6.86 6.85 6.85 6.81 6.8 6.73 6.9 6.75 6.65 6.73 6.49 6.63 6.71 6.65 6.72 6.92 7 6.85 6.66
GOBP_MULTICELLULAR_ORGANISMAL_HOMEOSTASIS 6.18 6.13 6.2 6.29 6.21 6.37 6.34 6.31 6.21 6.33 6.25 6.3 6.36 6.35 6.23 6.22 6.3 6.2 6.19 6.24 6.43 6.49 6.29 6.28 6.34 6.43
GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS 6.3 6.39 6.59 6.6 6.41 6.49 6.61 6.75 6.53 6.62 6.62 6.48 6.64 6.63 6.66 6.63 6.49 6.32 6.38 6.44 6.53 6.62 6.76 6.66 6.62 6.67
GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE 5.88 5.82 6.35 6.07 5.72 5.76 5.92 6.2 5.68 6.38 6.01 6.2 5.92 6.04 6.2 6.37 6.01 6.04 5.8 6.11 6.08 6.04 5.81 5.84 6.27 6.28
GOBP_CHEMICAL_HOMEOSTASIS_WITHIN_A_TISSUE 5.25 5.52 6.09 6.18 5.53 5.85 5.92 6.13 5.27 5.83 5.4 5.77 5.7 5.52 6.18 6.05 6 5.48 5.3 6.04 6.36 6.34 5.7 5.8 6.03 6.19
GOBP_CHEMICAL_HOMEOSTASIS 6.23 6.21 6.38 6.38 6.18 6.12 6.34 6.33 6.25 6.3 6.26 6.22 6.23 6.24 6.36 6.25 6.3 6.26 6.07 6.24 6.41 6.43 6.25 6.25 6.38 6.42
GOBP_SENSORY_SYSTEM_DEVELOPMENT 6 5.98 6 6.13 5.92 5.9 6 6.12 6.01 6.03 6 6.03 6.04 6.06 5.99 6 6.04 5.97 5.93 5.94 6.12 6.06 6.03 6.01 5.96 6.09
GOBP_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION 5.67 5.72 5.79 5.87 5.5 5.28 5.83 5.97 5.89 5.65 6.08 5.6 5.59 5.69 5.88 5.8 5.51 5.62 5.44 5.55 6.08 5.75 5.61 5.33 5.92 5.31
GOBP_CHROMOSOME_LOCALIZATION 6.14 6.15 6.62 6.49 6.27 6.27 6.61 6.31 6.43 6.54 6.42 6.58 6.25 6.16 6.43 6.36 6.25 6.03 6.02 6.35 6.24 6.36 6.48 6.55 6.3 6.33
GOBP_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS 5.69 5.78 5.56 6.15 5.6 5.68 5.04 5.56 5.63 5.67 5.68 5.28 5.6 5.32 5.27 5.42 5.53 5.32 5.47 5.27 5.75 5.5 5.34 5.55 5.42 5.82
GOBP_CATECHOLAMINE_SECRETION 6.59 6.68 6.87 6.65 6.52 6.81 7.23 7.2 7.09 7.01 6.84 6.38 7.24 7.32 7.28 7.08 6.62 7.05 6.72 7.18 6.59 6.79 6.88 6.89 6.89 6.7
GOBP_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION 8.38 8.5 8.87 8.51 8.45 8.49 8.87 8.65 8.75 8.67 8.41 8.66 8.51 8.57 8.58 8.74 8.42 8.23 8.68 8.72 8.62 8.69 8.93 9.07 8.52 8.72
GOBP_AMYLOID_BETA_METABOLIC_PROCESS 7.85 8.11 8.46 7.89 8.59 8.72 8.47 8.58 8.49 8.32 8.14 8.05 8.72 8.41 8.09 8.19 8.14 8.24 7.84 8.54 7.66 8.46 8.55 8.49 8.54 8.42
GOBP_ARACHIDONIC_ACID_SECRETION 5.2 4.98 5.02 5.17 4.73 4.47 4.8 4.94 4.83 4.72 5 4.69 4.59 4.81 4.66 5.06 5.09 4.84 4.75 4.66 5.05 4.71 4.73 4.28 4.8 4.99
GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS 6.69 6.57 7.29 6.94 6.99 7.04 7.01 6.78 7.28 7.21 6.76 6.86 7.4 7.37 7.25 6.91 7.23 6.73 6.81 7.15 7.13 7.15 7.5 7.35 7.35 7.31
GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS 6.86 7.07 7.32 7.01 7.04 7.13 7.24 7.41 7.24 7.53 6.9 7.3 7.41 7.37 7.46 7.56 7.45 7.16 7.21 7.18 7.21 7.58 7.43 7.44 7.65 7.42
GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS 7.32 7.43 7.66 7.58 7.53 7.91 7.55 7.59 7.42 7.9 7.63 7.69 7.73 7.55 7.69 7.78 7.62 7.61 7.6 7.92 7.59 8.18 7.59 7.68 7.75 7.57
GOBP_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS 5.98 5.84 5.31 5.85 5.45 5.7 5.82 5.75 5.92 5.48 5.59 5.45 5.37 5.57 5.7 5.38 5.75 5.91 5.41 5.66 5.77 5.88 5.44 5.66 5.8 5.72
GOBP_HOMOCYSTEINE_METABOLIC_PROCESS 5.6 5.62 6.37 6.42 6.3 6.11 6.25 6.45 5.95 6.02 6.01 6.2 5.78 6.37 5.64 5.94 5.83 5.95 5.68 5.92 6.19 6.07 6.08 6.03 6.14 6.44
GOBP_EPITHELIAL_CELL_PROLIFERATION 6.08 5.99 6.16 6.15 6.02 5.92 6.23 6.16 6.02 6.13 6.08 6.03 6.16 6.1 6.06 6.14 6.1 5.97 5.89 5.99 6.15 6.27 6.15 6.06 6.04 6.14
GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION 6.04 5.92 6.04 5.94 5.8 5.79 6.2 6.1 6.07 5.92 5.99 5.64 6.05 6.06 5.95 6.01 6.1 5.96 5.79 5.85 6.14 6.18 6.05 6.01 5.9 5.97
GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION 6.19 6.21 6.62 6.56 6.23 6.41 6.55 6.43 6.39 6.42 6.34 6.66 6.38 6.39 6.4 6.52 6.32 6.18 6.19 6.14 6.34 6.7 6.67 6.4 6.63 6.6
GOBP_REGULATION_OF_MRNA_PROCESSING 7.87 8.09 8.27 8.04 8.48 8.48 8.32 8.36 8.31 8.45 8.04 8.25 8.39 8.35 8.38 8.48 8.16 7.95 8.24 8.39 8.03 8.34 8.45 8.53 8.42 8.36
GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING 8.01 8.18 8.28 8.04 8.33 8.48 8.28 8.36 8.26 8.52 8.41 8.33 8.48 8.68 8.54 8.45 8.01 7.94 8.38 8.46 7.96 8.57 8.4 8.57 8.49 8.48
GOBP_NEGATIVE_REGULATION_OF_MRNA_PROCESSING 7.56 8.06 8.17 7.9 8.49 8.39 8.35 8.52 8.26 8.32 7.83 8.21 8.36 8.17 8.16 8.21 8.33 8.15 8.21 8.39 8.11 8.63 8.43 8.53 8.47 8.15
GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS 6.6 6.35 7.38 6.96 6.55 6.22 6.87 6.45 6.92 6.51 6.52 6.7 6.32 6.54 6.39 6.89 6.62 6.52 6.51 6.26 6.95 6.72 6.59 6.74 6.86 6.77
GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS 6.09 5.8 6.11 6.28 5.87 5.69 5.67 5.84 6.26 5.89 6.22 5.86 5.99 5.73 5.61 6.01 5.94 5.77 5.75 5.67 5.89 5.95 5.86 5.94 5.93 5.97
GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_VIRUS 7.93 8.34 8.54 8.02 8.28 8.43 8.69 8.66 8.52 8.23 8.01 8.41 8.45 8.56 8.56 8.56 7.99 8.13 8.31 8.66 8.46 8.24 8.05 8.48 8.71 8.42
GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST 5.71 5.33 5.55 5.65 4.91 5.28 5.38 5.18 5.36 5.38 5.95 4.98 4.98 4.95 5.16 5.3 5.44 5.38 5.13 5.33 5.48 5.27 5.21 4.79 5.41 5.16
GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE 5.74 5.59 5.54 5.69 5.3 5.12 5.46 5.41 5.46 5.3 5.54 5.25 5.36 5.23 5.46 5.39 5.53 5.53 5.36 5.27 5.64 5.56 5.35 5.15 5.53 5.6
GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE 5.84 5.73 5.83 5.97 5.3 5.19 5.86 5.75 5.5 5.51 5.66 5.35 5.47 5.53 5.66 5.55 5.75 5.66 5.6 5.4 5.77 5.79 5.43 5.36 5.62 5.6
GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE 5.6 5.38 5.38 5.57 5.13 4.97 5.19 5.27 5.26 5.15 5.41 5.05 5.28 5.04 5.28 5.3 5.48 5.39 5.27 5.04 5.71 5.49 5.14 4.93 5.43 5.6
GOBP_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION 6.03 5.99 6.13 6.07 5.86 5.79 5.93 5.92 6.03 5.84 5.98 5.69 5.9 5.88 5.98 5.86 5.99 6 5.81 5.81 6.14 6.06 5.9 5.87 6.04 6.16
GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION 5.9 5.62 5.81 5.78 5.52 5.36 5.66 5.67 5.75 5.42 5.65 5.33 5.66 5.52 5.66 5.62 5.65 5.79 5.5 5.52 5.95 5.71 5.51 5.42 5.74 5.83
GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION 6.73 6.48 6.72 6.61 7.07 6.97 6.8 6.83 6.83 7.04 6.85 7.1 6.94 6.66 6.63 6.7 6.77 6.64 6.72 7 6.87 6.96 7.08 7.04 6.79 6.78
GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS 7.42 7.58 8.53 7.85 7.61 7.43 8.41 8.09 7.77 7.77 7.52 7.61 8.06 8 7.76 7.66 7.86 7.78 7.46 8.57 7.56 7.98 7.67 8.33 7.83 7.81
GOBP_REGULATION_OF_PHAGOCYTOSIS 5.94 5.76 5.92 5.85 5.62 5.48 5.73 5.6 5.59 5.37 5.65 5.47 5.65 5.72 5.57 5.61 5.69 5.61 5.38 5.5 5.84 5.82 5.53 5.37 5.66 6.1
GOBP_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS 6.59 6.6 6.83 6.88 6.48 6.42 6.85 6.47 6.45 6.44 7.56 6.66 6.84 6.94 6.42 6.55 6.85 6.71 6.52 6.41 7.06 6.85 6.39 6.26 7.07 7.02
GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS 5.67 5.46 5.5 5.71 5.34 5.27 5.22 5.29 5.32 5.19 5.43 4.96 5.44 5.46 5.39 5.52 5.45 5.44 5.16 5.19 5.56 5.5 5.09 5.01 5.57 5.95
GOBP_REGULATION_OF_NEUROGENESIS 6.92 6.95 7.15 6.85 7.32 7.27 7.36 7.48 7.25 7.34 6.98 7.35 7.43 7.39 7.31 7.34 7.2 7.09 7.1 7.47 7.07 7.3 7.22 7.37 7.22 7.31
GOBP_POSITIVE_REGULATION_OF_NEUROGENESIS 7.15 7.12 7.16 6.95 7.41 7.41 7.5 7.62 7.35 7.43 6.98 7.39 7.6 7.51 7.54 7.47 7.3 7.21 7.25 7.62 7.1 7.33 7.28 7.59 7.21 7.38
GOBP_REGULATION_OF_AXONOGENESIS 7.28 7.28 7.4 6.99 7.55 7.64 7.58 7.82 7.43 7.66 7.26 7.71 7.68 7.7 7.76 7.74 7.35 7.33 7.43 7.87 7.26 7.47 7.46 7.76 7.62 7.55
GOBP_NEGATIVE_REGULATION_OF_AXONOGENESIS 6.73 6.85 7.19 6.85 7.19 7.22 7.36 7.71 7.14 7.28 7.16 7.65 7.36 7.51 7.44 7.45 7.11 7.05 7.31 7.47 6.92 7.24 7.27 7.31 7.53 7.23
GOBP_POSITIVE_REGULATION_OF_AXONOGENESIS 7.3 7.25 7.26 6.91 7.62 7.81 7.72 7.75 7.48 7.65 7.2 7.72 7.69 7.75 7.75 7.75 7.4 7.49 7.38 7.89 7.23 7.45 7.48 7.69 7.47 7.47
GOBP_REGULATION_OF_DENDRITE_DEVELOPMENT 7.57 7.6 7.71 7.51 7.89 8.02 7.99 7.85 7.82 7.98 7.6 8.06 7.75 7.88 7.95 7.85 7.79 7.64 7.82 8.03 7.71 7.94 7.82 8.22 7.87 7.71
GOBP_POSITIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS 7.73 7.63 7.76 7.72 8.04 8.32 8.13 8.05 7.89 8.09 7.69 8.07 7.75 7.8 8.12 8.35 7.67 7.79 8.05 8.12 7.45 8 7.99 8.26 7.96 7.93
GOBP_REGULATION_OF_IMMUNE_RESPONSE 5.9 5.84 5.82 5.86 5.61 5.52 5.69 5.65 5.76 5.59 5.74 5.59 5.65 5.62 5.66 5.62 5.83 5.77 5.56 5.55 5.87 5.71 5.56 5.43 5.79 5.94
GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE 5.6 5.52 5.49 5.59 5.21 5.12 5.32 5.29 5.46 5.24 5.5 5.23 5.34 5.23 5.27 5.32 5.47 5.36 5.11 5.22 5.43 5.3 5.3 5.22 5.41 5.53
GOBP_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE 6 5.98 5.94 6.05 5.87 5.8 5.82 5.93 5.85 5.74 5.92 5.79 5.86 5.82 5.74 5.73 6.09 5.98 5.68 5.73 6.06 5.95 5.73 5.72 6.07 6.14
GOBP_RNA_DESTABILIZATION 7.47 7.88 8.05 7.53 8.13 8.22 7.99 7.84 8.14 8.28 7.9 8.12 8.35 8.16 8.14 7.77 7.82 7.64 7.95 7.9 7.77 8.13 8.07 8.34 8.1 8.2
GOBP_REGULATION_OF_BEHAVIOR 6.54 6.64 6.89 6.38 6.62 7.25 7.15 7.16 7.07 7.18 6.55 6.51 7.11 7.19 7.22 7.01 6.57 6.77 7.03 7.3 6.87 7.19 7.06 7.15 7.05 7.05
GOBP_ACTIVATED_T_CELL_PROLIFERATION 5.36 5.27 5.13 5.46 4.83 4.88 5.06 5.04 5.23 5.08 5.23 4.97 5.15 4.89 5.05 5.05 5.09 5.07 4.82 4.92 5.18 5.06 4.99 4.84 5.09 5.19
GOBP_ION_HOMEOSTASIS 6.22 6.2 6.29 6.35 6.04 6.12 6.29 6.27 6.21 6.26 6.26 6.18 6.23 6.24 6.31 6.21 6.28 6.25 6.11 6.2 6.34 6.39 6.26 6.15 6.3 6.36
GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP 6.22 6.64 6.52 6.33 6.3 7.26 7.21 7.17 6.37 7.12 6.27 6.2 6.91 6.86 7.01 7.17 6.25 6.8 6.91 6.88 6.08 6.84 6.84 7.24 6.59 6.61
GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY 7.53 7.74 7.69 7.29 7.95 8.17 8.14 8.07 7.89 7.98 7.71 8.07 8.23 8.18 8.15 8.03 7.79 7.85 8.05 8.07 7.66 8 8.04 8.32 7.95 7.93
GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION 8.06 8.11 7.97 7.5 7.85 8.4 8.3 8.22 8.23 8.28 7.74 8.27 8.27 8.27 8.23 8.42 7.73 8.13 8.3 8.4 7.91 8.28 8.17 8.21 8.34 8.22
GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION 7.89 8.1 7.99 7.93 8.36 8.49 8.57 8.59 8.5 8.42 8.01 8.49 8.41 8.51 8.52 8.48 8.06 8.24 8.46 8.51 8.1 8.38 8.27 8.55 8.51 8.34
GOBP_SYNAPSE_ORGANIZATION 7.57 7.56 7.69 7.24 7.88 8.05 7.96 7.91 7.73 7.96 7.61 7.91 8.02 8.04 8.05 7.91 7.68 7.85 7.9 7.99 7.78 7.91 7.98 8.15 7.91 7.81
GOBP_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS 6.59 6.54 6.92 6.77 7.02 6.68 6.8 6.75 7.11 7.11 6.75 7.02 7.08 6.94 6.73 6.68 6.88 6.59 6.7 6.64 6.6 6.75 6.94 7.25 7 6.74
GOBP_COAGULATION 6.02 5.94 6.05 6.14 5.9 5.88 5.82 5.87 5.88 5.76 5.95 5.76 5.74 5.86 5.9 5.76 6 5.89 5.79 5.72 6.06 5.97 5.76 5.75 5.97 6.03
GOBP_REGULATION_OF_COAGULATION 5.46 5.38 5.25 5.34 4.95 4.86 5.3 5.03 5.22 5.09 5.31 5.15 5.08 4.97 5.05 5.04 5.15 5.38 5.17 5.02 5.45 5.25 5.05 5.04 5.18 5.23
GOBP_NEGATIVE_REGULATION_OF_COAGULATION 5.33 5.1 4.98 5.21 4.95 4.86 4.94 4.96 5.19 5.01 5.09 5.04 4.95 4.94 5 4.83 5.02 5.31 5.01 4.84 5.2 5.21 4.98 4.89 5.1 5.33
GOBP_POSITIVE_REGULATION_OF_COAGULATION 5.22 5.04 4.83 5.09 4.8 4.51 5.22 4.63 5.06 4.95 5.17 4.82 4.93 4.69 4.74 4.7 4.76 5.07 4.75 4.73 5.02 5.08 4.84 4.53 4.94 4.74
GOBP_PROTEIN_STABILIZATION 7.46 7.54 7.92 7.67 8.05 8.05 7.91 7.93 7.98 8.06 7.92 7.96 8 7.91 8.04 8.28 7.73 7.75 7.73 8.04 7.59 8.24 8.15 8.1 8.05 7.93
GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM 4.92 4.86 4.74 4.95 4.25 4.15 4.6 4.4 4.66 4.29 4.76 4.4 4.48 4.36 4.55 4.54 4.59 4.71 4.46 4.33 4.74 4.51 4.36 4.15 4.51 4.51
GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM 4.89 4.81 4.77 4.8 4.34 4.32 4.53 4.4 4.53 4.39 4.73 4.41 4.41 4.41 4.4 4.49 4.72 4.74 4.49 4.36 4.93 4.55 4.39 4.15 4.51 4.55
GOBP_DEFENSE_RESPONSE_TO_FUNGUS 5.09 4.96 4.73 4.95 4.21 4.07 4.44 4.25 4.59 4.38 4.81 4.21 4.14 4.27 4.58 4.56 4.73 4.85 4.51 4.45 4.87 4.6 4.23 4.13 4.59 4.63
GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING 6.13 6.24 6.31 6.51 6.18 5.93 6.19 6.3 6.23 5.86 6.1 6.02 5.99 5.79 6.25 5.96 6.18 6.09 5.86 5.94 6.33 6.28 6.22 5.9 6.17 6.35
GOBP_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING 6.22 6.31 6.11 6.26 6.55 6.33 6.36 6.47 6.8 6.77 6.19 6.57 6.26 5.8 6.62 6.46 6.21 6.39 6.28 6.04 6.74 6.43 6.06 5.93 6.66 6.55
GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING 6 6.2 6.2 6.51 5.66 5.47 5.79 5.81 5.88 5.44 5.63 5.65 5.78 5.69 5.75 5.44 5.85 5.46 5.31 5.65 5.89 5.99 5.9 5.72 5.49 5.91
GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY 6.38 6.45 6.41 6.35 6.46 6.42 6.36 6.61 6.39 6.44 6.37 6.2 6.47 6.45 6.39 6.36 6.43 6.4 6.33 6.45 6.4 6.4 6.31 6.49 6.45 6.44
GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY 6.48 6.62 6.77 6.74 6.78 6.98 6.67 6.92 6.86 6.88 6.84 6.57 6.76 6.92 6.67 6.72 6.6 6.58 6.75 6.78 6.57 6.55 6.74 6.89 6.89 6.72
GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY 5.63 5.69 5.65 5.41 5.49 5.33 5.43 5.41 5.47 5.35 5.37 5.26 5.39 5.52 5.47 5.5 5.5 5.52 5.2 5.5 5.79 5.66 5.42 5.46 5.72 5.92
GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY 5.84 5.98 5.79 5.76 5.55 5.51 5.7 5.7 5.46 5.32 5.67 5.73 5.54 5.54 5.48 5.6 5.71 5.86 5.6 5.59 6 5.83 5.58 5.59 5.76 6.07
GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY 6.23 6.67 6.25 5.72 6.62 6.39 5.89 6.1 5.94 5.78 6.09 6.28 5.62 5.99 5.65 5.77 6.26 6.23 5.63 5.73 6.11 5.67 5.74 5.68 6.27 6.19
GOBP_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY 5.78 5.93 5.65 6.1 5.28 5.31 5.73 5.49 5.35 5.27 5.62 5.68 5.43 5.3 5.39 5.41 5.51 5.8 5.47 5.4 5.99 5.78 5.56 5.44 5.54 6.01
GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY 5.92 5.95 5.92 5.73 6.34 6.03 6.01 6 5.35 5.45 5.8 6.2 5.81 5.67 5.7 5.44 5.84 5.85 6.08 5.87 5.97 5.89 5.53 5.79 5.64 6.17
GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY 5.79 6 5.86 6.01 5.39 5.28 5.77 5.7 5.76 5.54 5.91 5.58 5.39 5.46 5.61 5.55 5.9 5.86 5.3 5.47 6.08 5.65 5.67 5.56 6.36 6.21
GOBP_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY 5.79 5.83 6.02 6.29 5.16 5.28 5.77 5.7 5.97 5.56 5.91 5.74 5.7 5.45 5.76 5.53 5.9 5.91 5.42 5.47 6.2 6.24 5.85 5.7 6.54 6.12
GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY 5.84 5.89 5.64 5.44 5.49 5.68 5.45 5.69 5.22 5.24 5.57 5.93 5.64 5.39 5.52 5.15 5.54 5.6 5.72 5.69 5.84 5.63 5.26 5.49 5.39 6.1
GOBP_REGULATION_OF_T_CELL_ACTIVATION 5.57 5.48 5.47 5.64 5.28 5.18 5.4 5.41 5.43 5.27 5.42 5.26 5.37 5.33 5.44 5.41 5.52 5.39 5.22 5.34 5.58 5.52 5.28 5.18 5.43 5.56
GOBP_REGULATION_OF_B_CELL_ACTIVATION 5.83 5.87 5.77 5.79 5.53 5.52 5.73 5.63 5.83 5.81 5.88 5.42 5.64 5.8 5.71 5.76 5.62 5.68 5.54 5.53 5.97 6.04 5.7 5.61 5.76 6
GOBP_REGULATION_OF_CELL_ACTIVATION 5.75 5.69 5.73 5.77 5.44 5.38 5.49 5.57 5.66 5.4 5.52 5.36 5.56 5.51 5.61 5.62 5.63 5.61 5.45 5.46 5.77 5.71 5.46 5.32 5.61 5.85
GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION 5.63 5.66 5.68 5.74 5.29 5.24 5.46 5.45 5.58 5.36 5.54 5.28 5.43 5.38 5.45 5.45 5.51 5.5 5.3 5.39 5.75 5.59 5.36 5.31 5.49 5.6
GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION 5.71 5.62 5.68 5.67 5.44 5.36 5.49 5.49 5.59 5.35 5.47 5.31 5.61 5.51 5.57 5.59 5.67 5.58 5.45 5.46 5.75 5.7 5.49 5.29 5.65 5.89
GOBP_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION 5.83 5.68 5.76 5.45 5.49 5.07 5.48 5.32 5.72 5.47 5.74 5.29 5.46 5.51 5.54 5.76 5.42 5.52 5.32 5.35 5.64 5.37 5.59 5.53 5.54 5.58
GOBP_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION 5.84 5.94 5.77 5.84 5.54 5.52 5.63 5.75 5.8 5.62 5.88 5.72 5.83 5.82 5.66 5.72 5.99 5.75 5.68 5.52 6.09 6.07 5.72 5.46 5.77 6.01
GOBP_WHITE_FAT_CELL_DIFFERENTIATION 5.64 5.44 5.78 5.7 4.79 4.92 5.31 5.37 5.58 5.27 5.25 4.99 5.26 4.89 5.54 5.71 5.55 5.59 5.1 5.13 5.52 5.59 5.29 5.3 5.32 5.23
GOBP_BROWN_FAT_CELL_DIFFERENTIATION 6.19 6.18 5.86 5.91 6.02 6.18 5.86 6.09 5.99 5.99 6.23 6.24 6.12 6.28 5.94 6.15 6.28 6.05 6.08 6.18 6.41 6.13 6.12 5.86 6.29 6.38
GOBP_NERVOUS_SYSTEM_PROCESS 5.56 5.54 5.38 5.54 5.2 5.07 5.41 5.34 5.36 5.18 5.42 5.24 5.26 5.21 5.37 5.21 5.41 5.49 5.27 5.18 5.49 5.35 5.17 5.05 5.28 5.24
GOBP_REGULATION_OF_BODY_FLUID_LEVELS 5.99 5.86 5.96 6.1 5.82 5.8 5.81 5.85 5.85 5.78 5.89 5.75 5.79 5.84 5.88 5.73 5.95 5.84 5.76 5.75 5.98 5.99 5.76 5.74 5.87 5.98
GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT 6.01 5.72 5.88 5.84 6.15 5.96 5.7 5.88 6.04 5.59 5.79 5.92 5.91 5.64 5.77 5.69 6.05 5.82 5.9 5.85 5.72 5.83 5.78 5.91 5.87 6.13
GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE 6.18 5.84 6.67 6.47 6.4 6.39 6.56 6.45 6.33 6.27 5.89 6.43 6.6 6.39 6.35 6 6.34 5.92 5.95 6.26 5.99 6.22 6.05 6.59 6.55 6.46
GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE 6.66 7.03 6.86 7.7 7.06 6.73 7.53 7.61 6.77 7.43 6.58 7.77 7.41 7.24 7.83 7.47 7.09 7.5 7 6.92 7.52 7.59 7.22 7.78 7 6.97
GOBP_ENDOCRINE_PROCESS 5.44 5.58 5.45 5.26 5.15 5.26 5.44 5.31 5.49 5.13 5.51 5.23 5.32 5.41 5.36 5.47 5.36 5.47 5.18 5.38 5.53 5.52 5.46 5.09 5.5 5.07
GOBP_COGNITION 7.61 7.69 7.86 7.55 7.86 8.06 7.85 8.03 7.87 7.92 7.52 7.77 7.96 7.91 8 7.91 7.56 7.63 7.94 7.98 7.71 7.9 7.92 8.05 7.79 7.78
GOBP_INTESTINAL_ABSORPTION 5.57 5.16 5.1 5.67 4.93 4.81 4.99 4.89 5.2 5.03 5.03 4.89 4.95 4.81 5.05 5.21 4.96 5.21 4.98 4.86 5.01 5.05 4.81 4.75 4.89 4.72
GOBP_LEUKOCYTE_MIGRATION 5.74 5.63 5.73 5.82 5.42 5.28 5.59 5.48 5.55 5.3 5.62 5.36 5.53 5.41 5.53 5.45 5.74 5.65 5.31 5.35 5.88 5.65 5.42 5.29 5.7 5.68
GOBP_LEUKOCYTE_TETHERING_OR_ROLLING 5.64 5.78 5.66 5.97 5.73 5.68 5.64 5.43 5.75 5.46 5.39 5.46 5.81 5.77 5.64 5.5 5.4 5.35 5.41 5.65 5.52 5.43 5.48 5.3 5.52 5.57
GOBP_NEUROMUSCULAR_PROCESS 7.01 7.31 7.46 6.86 7.49 7.4 7.72 7.55 7.56 7.57 7.28 7.78 7.62 7.7 7.7 7.72 7.11 7.54 7.55 7.48 7.27 7.25 7.55 7.95 7.23 7.26
GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION 4.6 4.56 4.09 4.26 3.94 3.8 4.08 4.14 4.1 3.9 4.27 4.11 3.89 3.91 4.02 3.95 4.33 4.55 4.17 4.03 4.38 4.09 3.88 3.83 3.93 4.06
GOBP_SENSORY_PERCEPTION_OF_TASTE 5.08 4.93 4.53 4.91 4.51 4.45 4.55 4.57 4.6 4.56 4.87 4.66 4.56 4.46 4.45 4.41 4.7 4.93 4.8 4.44 4.91 4.57 4.45 4.2 4.41 4.55
GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND 5.34 5.24 5.09 5.15 5.34 5.2 4.78 5.08 4.77 5.01 4.95 4.99 5.03 5.25 4.93 4.69 5.32 5.19 4.83 4.97 5.02 4.5 4.88 4.77 5.07 4.84
GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE 5.08 5.03 4.33 4.8 4.45 4.23 4.28 4.44 4.47 4.44 4.87 4.49 4.46 4.39 4.27 4.28 4.7 4.84 4.8 4.4 4.72 4.48 4.34 4.09 4.35 4.5
GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE 5.1 5.07 4.42 4.84 4.55 4.55 4.4 4.58 4.51 4.6 4.88 4.63 4.59 4.43 4.3 4.35 4.76 4.92 4.89 4.43 4.88 4.41 4.41 4.18 4.45 4.53
GOBP_POSITIVE_CHEMOTAXIS 5.89 5.62 5.5 5.54 5.63 5.29 5.68 5.83 5.42 5.42 5.49 5.51 5.37 5.36 5.57 5.53 5.72 5.66 5.39 5.33 5.7 5.64 5.34 5.61 5.58 5.77
GOBP_NEGATIVE_CHEMOTAXIS 6.71 6.79 6.94 6.49 7.08 7.18 6.99 7.1 7.11 7.24 6.84 7.05 6.88 6.9 7.04 6.62 6.8 6.54 6.69 7.29 6.82 6.63 7.23 7.06 6.89 6.84
GOBP_REGULATION_OF_CHEMOTAXIS 6.18 6.08 6.18 6.05 6.22 5.99 6.11 6.21 6.12 6.01 6.03 5.87 6.1 6.18 6.29 6.09 6.1 5.98 5.86 6.04 6.2 6.34 6.16 6.1 6.01 6.14
GOBP_POSITIVE_REGULATION_OF_CHEMOTAXIS 6.07 5.94 5.94 5.8 6.03 5.76 5.82 5.84 6.09 5.62 5.86 5.68 5.77 5.81 5.93 5.88 6.04 5.76 5.51 5.74 5.84 6.24 5.83 5.74 5.76 5.9
GOBP_NEGATIVE_REGULATION_OF_CHEMOTAXIS 6.33 6.22 6.66 6.25 6.55 6.52 6.35 6.39 6.27 6.64 6.36 6.6 6.72 6.7 6.59 6.51 6.43 6.25 5.9 6.68 6.67 6.67 6.59 6.36 6.51 6.71
GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS 5.99 5.82 5.35 5.56 5.38 5.34 5.69 5.57 5.38 5.16 5.44 5.22 5.16 5.47 5.03 5.51 5.97 5.55 5.39 5.29 5.61 5.36 5.34 5.3 5.4 5.68
GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS 5.49 5.38 5.11 5.8 4.78 4.59 4.97 4.89 5.25 4.73 5.09 4.75 4.77 4.78 5.02 5.08 5.3 5.3 5.12 4.72 5.11 4.97 4.79 4.71 5.1 5.12
GOBP_PIGMENT_CELL_DIFFERENTIATION 6.3 6.26 6.28 6.41 6.66 6.4 6.51 6.98 6.51 6.6 6.25 6.35 6.76 6.81 6.4 6.65 6.53 6.43 6.32 6.28 6.73 6.58 6.89 6.65 6.47 6.42
GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS 6.17 5.93 5.93 5.98 5.84 5.7 6.03 6.33 6.09 6.16 5.8 5.43 6.02 6.17 6.11 5.81 6.11 6.07 5.69 5.91 6.43 5.92 5.99 5.55 5.82 5.66
GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS 5.54 5.35 5.45 5.53 5.24 4.91 5.44 5.24 5.37 5.21 5.49 5.09 5.17 5.23 5.28 5.21 5.41 5.42 5.18 5.03 5.46 5.38 5.2 5 5.22 5
GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS 5.98 5.85 5.85 5.98 5.78 5.79 6.02 5.89 6.05 5.96 6.17 6.05 5.95 5.89 6 5.93 6.03 6.01 5.9 5.86 6.13 6.1 5.87 5.91 5.96 6.09
GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION 6.28 6.19 6.07 5.99 5.99 5.99 6.18 6.99 6.16 6.25 6.07 5.54 6.41 6.42 6.59 6.48 6.25 6.12 6.05 6.12 6.5 6.57 6.47 5.97 5.94 5.86
GOBP_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION 5.12 4.82 4.78 5.06 4.63 4.46 4.8 4.63 4.74 4.7 5 4.53 4.71 4.76 4.81 4.73 4.77 4.9 4.47 4.52 4.86 4.75 4.71 4.54 4.58 4.49
GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN 7.03 6.98 6.68 6.47 7.95 8 7.54 7.61 7.17 7.69 6.86 7.39 7.19 7.43 7.45 7.43 6.89 6.71 7.05 7.44 7.4 7.59 7.09 7.03 7.33 7.25
GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION 6.26 6.23 6.06 5.53 6.01 6.22 6.06 6.42 6.16 6.19 6.15 5.64 6.39 6.24 6 6.1 6.25 6.1 6.05 6.1 6.4 6.1 6.13 5.91 5.79 5.74
GOBP_DETECTION_OF_MECHANICAL_STIMULUS 5.87 5.64 5.56 5.41 5.63 5.71 5.83 5.84 5.93 5.96 5.48 5.42 5.65 5.81 5.91 5.8 5.72 5.98 5.77 5.92 5.68 5.73 5.94 5.51 5.54 5.32
GOBP_REGULATION_OF_LIPID_CATABOLIC_PROCESS 6.15 6.14 6.27 6.42 6.07 6.46 6.23 6.27 6.36 6.27 6.31 6.17 6.27 6.36 6.13 6.34 6.41 6.11 6.08 5.95 6.41 6.21 6.01 6.14 6.17 6.28
GOBP_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS 6.27 6.17 6.24 6.21 5.99 6.21 5.78 6.21 6.47 6.08 6.2 5.62 5.94 6.24 6.07 6.25 6.24 5.91 6.35 6 5.8 5.95 5.64 6.04 5.92 5.7
GOBP_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS 5.93 5.73 5.62 5.83 5.5 5.53 5.81 5.67 5.59 5.72 5.81 5.54 5.72 5.75 5.58 5.31 5.8 5.64 5.81 5.71 5.65 5.63 5.5 5.53 5.61 5.7
GOBP_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY 6.12 6.15 7.15 6.61 6.25 6.43 6.37 6.4 6.66 6.48 6.94 6.75 6.71 6.66 6.84 6.87 6.34 6.45 6.34 6.51 6.16 6.55 7.19 6.41 6.64 6.46
GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY 6.19 6.31 7.12 6.82 6.04 6.34 6.13 6.67 6.84 6.9 6.61 6.37 6.61 6.54 7.53 7 6.27 6.69 6.09 6.58 5.92 6.26 6.94 7 6.08 6.05
GOBP_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY 5.67 5.74 6.15 5.77 5.84 5.56 5.86 5.8 5.65 5.62 5.85 5.53 5.92 5.72 5.94 5.68 5.97 5.74 5.64 5.67 6.03 5.97 5.72 5.53 5.68 5.83
GOBP_MICROTUBULE_SEVERING 7.06 6.7 6.76 6.61 7.02 6.88 7.02 7.31 7.01 7.3 6.66 6.96 6.93 7.17 7.01 6.49 6.54 6.43 6.85 7.03 6.68 6.73 6.97 7.23 7.44 7.21
GOBP_ACTIN_FILAMENT_SEVERING 6.2 6.15 6.56 6.33 6.36 6.63 6.53 6.93 6.27 6.76 6.14 6.56 6.45 6.32 7.12 6.74 6.4 6.43 6.16 6.26 6.83 6.65 6.06 7.14 6.6 7.12
GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING 6.89 7.03 7.55 7.52 7.21 7.4 7.36 7.62 7.82 7.72 7.57 6.78 7.14 7.47 7.74 7.41 7 6.61 6.96 7.58 7.3 7.79 7.49 7.67 7.51 7.84
GOBP_MRNA_TRANSPORT 7.33 7.43 7.77 7.62 7.65 7.77 7.56 7.6 7.62 7.75 7.49 7.73 7.52 7.71 7.71 7.64 7.39 7.24 7.57 7.71 7.35 7.74 7.73 7.83 7.66 7.72
GOBP_TRNA_TRANSPORT 7.42 7.39 7.75 7.84 7.63 7.5 7.35 7.3 7.37 7.25 7.51 7.57 7.25 7.48 7.31 7.53 7.2 7.2 7.26 7.28 7.04 7.44 7.37 7.56 7.54 7.35
GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS 6.23 6.46 6.56 6.21 6.33 6.14 6.05 5.87 6.66 6.44 6.48 6.43 6.56 6.36 6.07 6.12 6.87 6.6 6.23 6.28 6.37 6.25 6.54 6.54 6.54 6.73
GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS 5.63 5.58 6 6.03 6.22 5.98 5.86 5.81 6.29 5.76 6.16 6.05 6.08 5.83 5.86 5.86 6.49 5.8 6 6.01 6.34 5.95 5.47 6.04 5.91 5.56
GOBP_REGULATION_OF_SECRETION 6.42 6.37 6.72 6.57 6.53 6.53 6.7 6.76 6.68 6.69 6.49 6.45 6.58 6.53 6.8 6.76 6.54 6.67 6.49 6.61 6.51 6.78 6.64 6.67 6.72 6.66
GOBP_POSITIVE_REGULATION_OF_SECRETION 6.33 6.27 6.69 6.48 6.36 6.18 6.36 6.3 6.4 6.34 6.38 6.24 6.17 6.27 6.59 6.7 6.35 6.42 6.39 6.4 6.39 6.58 6.4 6.37 6.61 6.39
GOBP_NEGATIVE_REGULATION_OF_SECRETION 6.27 6.1 6.18 6.19 5.98 5.99 6.11 6.22 6.16 6.17 6.27 6.02 6.19 6.13 6.16 6.24 6.19 6.28 6.13 6.02 6.17 6.21 6 5.95 6.1 6.28
GOBP_REGULATION_OF_TRANSPORT 6.76 6.78 7.07 6.83 6.93 7 7.03 7.07 7.01 7.02 6.94 6.99 7.04 7.08 7.08 7.04 6.95 6.92 6.88 7.02 6.93 7.08 7.01 7.08 7.06 7.11
GOBP_POSITIVE_REGULATION_OF_TRANSPORT 6.71 6.77 7.12 6.88 6.9 6.96 6.97 7.01 6.93 6.97 6.94 6.98 7 7 7.03 6.97 6.93 6.91 6.85 7.03 6.91 7.06 6.96 7.13 7.11 7.16
GOBP_NEGATIVE_REGULATION_OF_TRANSPORT 6.58 6.57 7.01 6.75 6.77 6.78 6.94 6.95 6.97 6.95 6.72 6.86 6.95 7.05 6.8 6.82 6.73 6.78 6.65 6.76 6.7 6.88 7.03 7.01 7.01 6.92
GOBP_REGULATION_OF_DNA_METABOLIC_PROCESS 6.52 6.55 6.88 6.97 6.66 6.82 6.69 6.72 6.66 6.91 6.69 6.82 6.86 6.73 6.73 6.8 6.51 6.51 6.63 6.84 6.67 6.73 6.82 6.91 6.81 6.77
GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS 6.67 6.69 7.12 7.04 7.01 7.07 6.69 6.58 6.91 7.06 6.72 7 6.86 6.76 6.73 6.7 6.5 6.62 6.76 6.84 6.8 6.85 6.94 7.09 6.82 6.72
GOBP_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS 6.47 6.55 6.96 7.01 6.65 6.85 6.69 6.72 6.75 6.88 6.87 6.77 6.89 6.74 6.63 6.75 6.51 6.49 6.64 6.69 6.57 6.76 6.98 7.01 6.83 6.77
GOBP_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS 5.79 5.7 5.79 5.95 5.63 5.71 6.09 6.05 6.17 6.18 5.92 6.29 6.36 6.03 6.05 6.01 6.28 5.78 5.77 6 6.3 6.38 6.18 6 6.19 6.3
GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION 6.88 6.93 6.89 6.87 7.28 7.3 7.13 7.3 7.05 7.25 6.92 7.3 7.23 7.32 7.26 7.16 7.05 7.04 7.11 7.21 7.05 7.21 7.13 7.33 7.09 7.21
GOBP_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION 6.23 6.41 6.53 6.26 5.98 6.18 6.29 6.44 6.28 6.63 6.38 6.24 6.18 6.46 6.6 6.55 6.39 6.32 6.09 6.17 6.46 6.32 6.21 6.35 6.46 6.38
GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION 6.94 7.21 6.81 6.74 7.48 7.43 7.15 7.37 7.07 7.35 6.87 7.27 7.24 7.61 7.13 7.47 7.03 7.27 7.42 7.09 7.13 7.31 6.98 7.21 7.14 7.33
GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING 7.08 6.95 8.04 8.35 7.97 7.96 7.49 8.07 7.57 7.89 7.52 7.68 7.69 7.82 7.84 7.87 7.81 7.68 7.99 8.22 7.66 8.06 7.92 7.93 7.42 8.1
GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY 6.26 6.19 6.33 6.3 6.29 6.18 6.25 6.24 6.27 6.25 6.22 6.2 6.27 6.34 6.33 6.33 6.33 6.19 6.21 6.28 6.4 6.46 6.25 6.31 6.28 6.41
GOBP_POSITIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY 6.28 6.19 6.34 6.27 6.35 6.28 6.33 6.28 6.3 6.26 6.31 6.28 6.22 6.32 6.35 6.29 6.3 6.24 6.25 6.33 6.37 6.44 6.25 6.38 6.39 6.41
GOBP_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY 6.08 6.03 6.03 5.99 6.18 6.1 6.08 5.91 6.08 6.04 6.04 6.09 5.92 5.92 6.02 5.87 5.99 5.98 5.95 6.02 6.17 6.02 6 5.88 6.2 6.25
GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS 6.21 6.23 6.42 6.34 6.27 6.26 6.35 6.36 6.39 6.31 6.25 6.34 6.38 6.4 6.4 6.45 6.45 6.28 6.2 6.24 6.51 6.48 6.42 6.4 6.48 6.53
GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS 6.32 6.37 6.5 6.42 6.36 6.47 6.58 6.63 6.5 6.53 6.37 6.41 6.54 6.48 6.55 6.52 6.52 6.36 6.32 6.45 6.57 6.6 6.57 6.55 6.5 6.62
GOBP_REGULATION_OF_HELICASE_ACTIVITY 6.98 7.1 7.55 7.81 7.67 7.61 7.23 7.15 7.63 7.46 7.82 7.46 7.44 7.57 7.56 7.77 6.92 6.71 6.94 7.13 7.02 7.11 7.59 7.68 7.58 7.07
GOBP_REGULATION_OF_BINDING 6.62 6.61 6.72 6.8 6.85 6.94 6.86 6.88 6.96 7.03 6.79 6.98 7.03 6.93 6.77 6.87 6.83 6.78 6.78 6.88 6.84 6.99 6.97 7.01 6.87 6.93
GOBP_POSITIVE_REGULATION_OF_BINDING 6.71 6.76 6.89 6.95 6.96 7.07 6.88 6.89 7.11 7.04 6.92 7.11 7.01 6.95 6.87 6.83 7.05 6.83 6.59 7 6.85 7 7.07 7.28 6.94 6.91
GOBP_NEGATIVE_REGULATION_OF_BINDING 6.46 6.32 6.6 6.74 6.48 6.56 6.71 6.74 6.86 6.7 6.61 6.74 6.89 6.73 6.56 6.63 6.67 6.55 6.66 6.63 6.71 6.9 6.67 6.96 6.66 6.72
GOBP_REGULATION_OF_DNA_BINDING 6.17 6.17 6.56 6.5 6.23 6.35 6.44 6.42 6.42 6.44 6.42 6.51 6.47 6.53 6.48 6.55 6.58 6.42 6.1 6.34 6.53 6.61 6.34 6.6 6.45 6.51
GOBP_RNA_POLYMERASE_II_PREINITIATION_COMPLEX_ASSEMBLY 6.64 7.36 8.17 8.55 7.44 7.73 8.05 7.28 8.32 8.26 8.21 8.38 8.36 8.29 7.67 8 6.88 7.97 7.9 8.19 6.83 7.41 8.22 7.75 7.51 7.45
GOBP_REGULATION_OF_ACTIN_NUCLEATION 7.3 7.35 8.09 7.74 7.57 7.97 7.67 7.62 7.63 7.75 7.69 7.55 7.81 7.77 7.83 7.95 7.53 7.33 7.52 7.65 7.7 7.75 7.91 7.9 7.73 7.87
GOBP_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION 8.9 8.99 8.47 8.32 9.6 9.28 9.39 9.35 9.46 9.1 8.81 9.28 9.13 8.9 8.91 8.76 9.09 8.56 8.69 9.46 8.81 8.9 9.39 9.35 9.2 9.5
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION 6.86 6.87 7.2 7.05 7.12 7.21 7.09 7.25 7.11 7.26 7.1 7.18 7.23 7.24 7.27 7.24 7.11 6.99 7 7.3 7.07 7.3 7.27 7.39 7.22 7.28
GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION 7.07 7.11 7.28 7.12 7.4 7.42 7.37 7.37 7.29 7.43 7.16 7.38 7.4 7.39 7.42 7.39 7.27 7.16 7.25 7.44 7.18 7.34 7.41 7.53 7.37 7.43
GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY 6.58 7.03 8.53 8.73 7.48 7.27 7.82 7.62 7.78 7.84 8.28 8.01 7.73 7.74 8.13 7.75 7.24 7.26 7.47 7.52 7.09 7.64 8.2 7.82 7.8 7.66
GOBP_NK_T_CELL_ACTIVATION 5.02 4.85 4.67 5.37 4.49 4.24 5.37 5.18 4.97 4.96 4.94 4.32 4.98 4.46 4.92 4.73 4.63 4.98 4.62 4.56 5.21 5.07 4.51 4.56 4.84 5.06
GOBP_SMOOTH_MUSCLE_CELL_DIFFERENTIATION 6.73 6.66 6.82 6.53 7.04 6.92 7.03 6.85 6.96 6.98 6.8 7.09 7.22 7.39 7.1 7.1 7.01 6.79 6.91 6.98 6.95 7.31 7.22 7.34 7.17 7.08
GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION 6.32 6.34 6.49 6.38 6.45 6.5 6.42 6.37 6.49 6.51 6.44 6.48 6.45 6.43 6.39 6.46 6.55 6.43 6.41 6.34 6.52 6.48 6.61 6.52 6.4 6.55
GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION 6.69 6.68 6.68 6.76 7.08 6.94 6.94 6.85 6.93 6.97 6.7 6.95 7.14 7.04 7.11 6.85 6.88 6.67 6.7 6.98 6.91 6.98 7.2 7.04 7.03 7.08
GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION 6.66 6.61 6.51 6.5 6.75 6.66 6.92 6.81 6.91 6.82 6.6 6.76 6.92 6.85 6.95 6.82 7 6.61 6.64 6.62 6.85 6.96 7.15 6.77 6.91 7.05
GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION 6.4 6.47 6.61 6.7 6.99 6.66 6.92 6.81 6.87 6.85 6.51 6.92 7.17 6.97 6.73 6.55 6.58 6.48 6.65 6.91 6.71 6.89 7.04 7 6.54 6.76
GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION 7.13 7.05 7 6.86 7.84 7.96 8.09 7.9 7.73 7.51 7.15 7.73 7.71 7.96 7.59 7.64 8.33 7.35 7.53 8.02 7.71 7.75 7.96 7.71 7.85 7.89
GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION 6.94 6.81 6.78 6.68 7.01 6.74 7.05 6.85 7.41 7.35 7.06 7.26 7 7.58 7.21 7.3 7.2 7.35 6.8 6.95 7.62 7.69 7.85 7.71 7.68 7.81
GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION 6.82 7.01 6.95 7.25 7.62 7.53 8.02 7.96 7.79 7.37 7.17 7.63 7.59 7.71 7.78 7.68 8.13 6.99 7.71 7.62 7.7 7.89 7.75 7.58 7.99 8
GOBP_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION 6.36 6.26 6.2 6.18 6.52 6.28 6.06 6.26 6.49 6.52 6.38 6.31 6.43 6.58 6.35 6.37 6.33 6.31 6.13 6.23 6.28 6.38 6.5 6.4 6.27 6.38
GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION 6.56 6.45 6.5 6.09 6.63 6.54 6.01 6.34 6.61 6.6 6.52 6.42 6.45 6.56 6.39 6.56 6.76 6.43 6.07 6.18 6.62 6.4 6.29 6.37 6.51 6.63
GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION 5.99 5.85 5.84 5.86 5.68 5.63 5.97 5.89 5.87 6.2 6.18 5.87 5.91 5.88 5.96 6 5.93 5.93 6.03 6.09 6.19 6.21 5.97 5.68 5.88 6.08
GOBP_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS 5.85 5.79 6.05 6.52 5.92 5.77 5.77 5.82 5.88 5.9 6.07 6.02 6 5.92 5.58 5.84 5.81 5.93 5.92 5.94 5.88 6.03 6 5.88 5.93 6.39
GOBP_NUCLEAR_EXPORT 7.33 7.48 7.75 7.55 7.73 7.79 7.55 7.6 7.65 7.75 7.48 7.67 7.77 7.77 7.61 7.61 7.5 7.38 7.57 7.78 7.39 7.69 7.66 7.82 7.71 7.71
GOBP_NUCLEAR_TRANSPORT 7.29 7.36 7.68 7.53 7.6 7.61 7.48 7.59 7.57 7.56 7.45 7.58 7.64 7.68 7.53 7.54 7.38 7.32 7.49 7.62 7.36 7.67 7.62 7.74 7.67 7.64
GOBP_IMPORT_INTO_NUCLEUS 7.04 7.12 7.44 7.61 7.23 7.36 7.32 7.36 7.39 7.21 7.27 7.37 7.36 7.4 7.31 7.36 7.23 7.16 7.22 7.37 7.18 7.56 7.2 7.49 7.52 7.47
GOBP_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS 6.46 6.44 6.62 6.55 6.52 6.55 6.63 6.68 6.6 6.62 6.53 6.56 6.63 6.61 6.61 6.61 6.52 6.51 6.44 6.56 6.66 6.65 6.69 6.69 6.62 6.64
GOBP_VITAMIN_TRANSPORT 5.97 5.93 6 5.99 5.88 5.75 5.87 5.87 5.84 5.54 5.83 5.7 5.84 5.9 5.64 5.53 6.04 5.81 5.64 5.78 5.92 5.74 5.71 5.92 5.8 5.69
GOBP_PROTEIN_INSERTION_INTO_MEMBRANE 6.96 6.87 7.97 7.74 7.29 7.26 7.22 7.36 7.47 7.12 7.62 7.33 7.27 7.2 7.41 7.64 7.31 7.25 7 7.59 7.04 7.59 7.47 7.59 7.4 7.56
GOBP_SEQUESTERING_OF_CALCIUM_ION 6.69 6.89 6.68 6.74 6.88 6.93 6.79 6.95 6.76 6.97 6.92 6.91 6.9 7.03 6.78 6.7 6.72 6.8 6.85 6.72 6.66 6.77 7.04 7.1 6.98 6.98
GOBP_CARTILAGE_DEVELOPMENT 6.01 5.78 5.82 5.9 5.8 5.61 5.84 5.85 5.83 5.76 6.07 5.87 5.66 5.76 5.86 5.85 5.89 5.93 5.77 5.86 5.92 6.18 5.75 5.68 5.82 5.97
GOBP_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN 7.33 7.43 7.3 7.41 7.49 7.45 7.29 7.26 7.33 7.67 7.04 7.66 7.51 7.36 7.68 7.48 7.42 7.54 7.22 7.13 7.67 7.69 7.58 7.59 7.41 7.25
GOBP_SPINDLE_ASSEMBLY 7.03 6.81 7.08 6.95 7.26 7.18 7.13 7.09 7.01 7.29 6.89 7.3 7.14 7.07 7.24 7.1 6.78 6.79 6.94 7.02 6.96 7.13 7.1 7.35 7.21 7.02
GOBP_MAINTENANCE_OF_LOCATION 6.81 6.89 7.16 6.89 7.05 6.98 7.04 6.98 6.84 7.03 6.84 7.07 7.12 7.14 6.97 7.03 6.79 6.81 6.83 6.88 6.95 7.03 7.22 7.35 7.14 7.1
GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION 7.42 7.53 7.83 7.74 7.75 7.82 7.65 7.6 7.64 7.75 7.54 7.74 7.63 7.73 7.63 7.72 7.53 7.29 7.69 7.71 7.39 7.79 7.79 7.83 7.71 7.76
GOBP_SEQUESTERING_OF_METAL_ION 5.22 4.93 5.27 5.32 4.69 4.25 5 5.05 4.98 4.71 5.23 4.65 4.79 4.75 5.32 4.98 5.52 5.92 4.98 4.75 5.76 5.2 4.68 4.41 5.01 5.29
GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS 6.11 6.11 6.17 6.18 6.1 6.12 6.18 6.18 6.18 6.14 6.18 6.08 6.2 6.13 6.16 6.17 6.21 6.06 6.05 6.14 6.28 6.31 6.17 6.16 6.24 6.34
GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS 6.04 6.03 6.09 6.15 5.98 5.92 6.03 6.09 6.01 6.04 6.1 6 6.02 5.99 6.06 6.04 6.07 5.96 5.89 5.94 6.16 6.18 6.01 5.96 6.11 6.23
GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS 6.54 6.55 6.84 6.73 6.71 6.76 6.74 6.79 6.78 6.83 6.66 6.75 6.81 6.74 6.77 6.75 6.7 6.58 6.6 6.71 6.77 6.83 6.83 6.82 6.79 6.82
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS 6.73 6.73 7.01 6.94 7.08 7.02 7.01 6.99 7.01 7.05 6.83 7.03 7.1 7.08 7.07 7 6.87 6.81 6.9 7.03 6.91 7.09 7.18 7.24 7 6.99
GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION 5.75 5.68 5.71 5.77 5.44 5.37 5.57 5.58 5.75 5.44 5.6 5.47 5.56 5.52 5.62 5.63 5.69 5.66 5.48 5.48 5.8 5.74 5.49 5.32 5.72 5.85
GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION 5.6 5.62 5.47 5.66 5.31 5.2 5.32 5.42 5.58 5.33 5.57 5.27 5.37 5.33 5.37 5.41 5.51 5.48 5.19 5.4 5.61 5.54 5.33 5.29 5.5 5.56
GOBP_SPINDLE_MIDZONE_ASSEMBLY 5.37 5.17 5.43 5.38 4.7 4.7 5.14 4.87 5.13 5 5.41 4.95 5.14 4.84 5.17 5.04 5.03 5.41 4.91 4.92 5.16 5.31 4.52 4.56 5.05 5.25
GOBP_PROTEIN_POLYMERIZATION 7.08 7.18 7.48 7.28 7.51 7.51 7.49 7.49 7.41 7.61 7.47 7.65 7.6 7.5 7.66 7.6 7.25 7.19 7.38 7.5 7.3 7.48 7.53 7.73 7.54 7.45
GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION 6.35 6.45 6.61 6.6 6.47 6.58 6.71 6.75 6.7 6.75 6.46 6.56 6.71 6.56 6.6 6.6 6.54 6.65 6.53 6.79 6.67 6.77 6.65 6.75 6.64 6.71
GOBP_PROTEIN_HOMOOLIGOMERIZATION 6.19 6.22 6.34 6.28 6.32 6.45 6.51 6.54 6.38 6.53 6.29 6.38 6.53 6.33 6.53 6.24 6.32 6.36 6.37 6.52 6.46 6.38 6.58 6.67 6.45 6.43
GOBP_PROTEIN_DEPOLYMERIZATION 7.44 7.37 7.55 7.65 7.78 7.66 7.73 7.95 7.73 7.78 7.55 7.85 7.75 7.92 8.1 7.87 7.4 7.53 7.66 7.78 7.59 7.85 7.83 8.02 7.78 7.91
GOBP_PROTEIN_TETRAMERIZATION 6.15 6.44 6.39 6.5 6.31 6.49 6.74 6.87 6.69 6.77 6.44 6.51 6.61 6.54 6.54 6.53 6.73 6.29 6.43 6.7 6.68 6.85 6.53 6.78 6.62 6.73
GOBP_REGULATION_OF_CELLULAR_COMPONENT_MOVEMENT 6.45 6.46 6.56 6.44 6.56 6.58 6.53 6.68 6.59 6.62 6.4 6.56 6.63 6.59 6.54 6.61 6.53 6.41 6.38 6.54 6.67 6.67 6.73 6.65 6.62 6.69
GOBP_CHROMOSOME_ORGANIZATION 6.61 6.64 6.81 6.87 6.9 6.94 6.82 6.89 6.8 6.91 6.81 6.87 6.88 6.78 6.9 6.95 6.65 6.64 6.79 6.91 6.73 6.93 6.94 7.09 6.87 6.87
GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL 6.89 6.95 6.83 6.83 7.09 7.08 7.04 7.14 7 7 7.04 7.01 7.21 7.22 6.92 7.13 6.95 6.86 7.13 6.82 6.91 6.9 7.59 7.31 7.06 7.03
GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL 6.23 6.25 6.61 6.67 6.12 5.84 6.45 6.53 6.21 6.55 6.55 6.02 6.25 5.66 6.27 6.26 6.61 6.32 5.98 6.16 6.22 6.25 6.03 6.02 6.24 6.4
GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION 7.59 7.78 8.36 7.81 8.37 8.38 7.44 7.93 7.5 7.93 7.95 7.8 7.68 7.68 7.7 8.19 7.97 7.51 7.87 7.46 7.77 7.8 8.46 8.03 8.17 8.24
GOBP_PROTEIN_HOMOTETRAMERIZATION 5.82 5.93 6.06 6.19 5.68 5.89 5.97 5.97 6.31 6.42 6.4 6.04 6.3 6.49 6.47 6.02 6.33 5.98 5.59 6.37 6.23 6.33 6.31 6.41 6.29 6.19
GOBP_PROTEIN_HETEROTETRAMERIZATION 7.35 7.45 7.47 7.43 7.87 7.87 7.63 7.75 7.84 7.67 7.59 7.8 7.81 7.96 7.49 7.63 7.47 7.65 7.71 8.02 7.83 8.04 7.61 7.56 7.71 7.61
GOBP_PROTEIN_HETEROOLIGOMERIZATION 6.58 7.06 7.09 7.15 7.03 7.23 6.89 6.95 7.01 7.58 7.15 7.3 6.85 6.86 6.93 6.75 7.04 6.49 6.96 6.87 6.94 7.1 7.08 7.21 6.99 6.98
GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION 6.88 6.4 6.47 6.4 7.11 6.84 6.42 6.3 6.23 6.56 6.97 6.44 6.27 6.49 6.07 6.69 6.28 6.42 6.42 6.43 6.46 6.56 6.61 6.53 6.22 6.77
GOBP_CENTROSOME_DUPLICATION 6.69 6.49 6.56 6.86 7.08 6.88 6.74 6.76 6.62 6.78 6.43 6.92 7.08 6.86 6.77 6.86 6.51 6.55 6.77 6.62 6.43 6.64 7.03 7.04 6.56 6.69
GOBP_CENTROSOME_SEPARATION 5.35 5.49 5.18 5.6 5.51 5.62 5.52 5.65 5.49 5.64 5.31 5.54 5.68 5.67 5.42 5.51 5.66 5.23 5.56 5.61 5.67 5.47 5.47 5.52 5.5 5.82
GOBP_CELL_DIVISION 6.37 6.49 6.73 6.63 6.59 6.74 6.68 6.69 6.62 6.82 6.68 6.69 6.73 6.69 6.79 6.67 6.51 6.49 6.43 6.63 6.53 6.74 6.79 6.83 6.72 6.7
GOBP_REGULATION_OF_CELL_DIVISION 5.93 5.78 6.01 6.1 5.9 5.77 5.93 6.01 5.87 5.87 6.08 5.9 5.87 5.85 5.98 5.99 5.96 5.8 5.87 6.08 6.09 6.18 5.77 5.85 5.82 6.11
GOBP_CHROMOSOME_SEPARATION 5.96 5.84 6.05 6.12 5.64 5.79 5.68 5.89 5.8 5.95 5.8 5.73 5.75 5.68 5.87 5.89 5.91 5.76 5.79 5.66 5.91 5.7 5.79 5.96 5.89 6.02
GOBP_MEIOTIC_CHROMOSOME_SEPARATION 4.96 5.33 5.21 6.01 4.72 4.63 4.58 4.67 4.81 4.7 4.79 4.99 4.51 4.73 4.54 4.8 4.91 5.12 4.88 4.77 5.16 4.85 4.93 4.93 4.76 4.89
GOBP_METAPHASE_PLATE_CONGRESSION 5.93 5.93 6.4 6.32 5.91 6.17 6.24 6.15 6.16 6.25 6.23 6.34 6.03 6.07 6.3 6.21 6.03 5.77 5.91 6.04 5.99 6.18 6.22 6.21 6.14 6.18
GOBP_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE 5.53 5.47 5.93 6.19 5.47 5.58 5.66 5.82 5.82 5.81 6.2 5.75 5.45 5.25 5.56 5.72 5.98 5.54 5.52 5.41 5.79 5.97 5.87 5.54 5.48 5.39
GOBP_MEIOTIC_CELL_CYCLE 5.39 5.32 5.45 5.56 5.18 4.96 4.98 5.24 5.14 5.06 5.42 5.38 5.01 5.17 5.19 5.15 5.27 5.24 5.45 5.11 5.3 5.15 5.16 5.02 5.07 5.28
GOBP_REGULATION_OF_HYDROLASE_ACTIVITY 6.51 6.55 6.71 6.61 6.81 6.8 6.75 6.78 6.62 6.71 6.65 6.71 6.69 6.7 6.76 6.62 6.67 6.59 6.58 6.69 6.72 6.76 6.73 6.77 6.82 6.84
GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY 6.47 6.51 6.74 6.66 6.58 6.6 6.69 6.77 6.68 6.67 6.64 6.7 6.69 6.62 6.77 6.76 6.6 6.56 6.52 6.66 6.78 6.75 6.84 6.76 6.77 6.77
GOBP_REGULATION_OF_LYASE_ACTIVITY 6.13 6.66 6.48 6.38 6.22 6.45 6.45 6.5 6.16 6.27 6.58 6.11 6.46 6.57 6.38 6.39 6.28 6.1 6.51 6.3 6.21 6.43 6.33 6.52 6.67 6.39
GOBP_REGULATION_OF_LIGASE_ACTIVITY 5.62 5.95 6.37 6.63 5.85 6.01 6.13 6.18 6.09 6.04 6.32 6.27 6.17 6.19 6.25 6.39 6.28 5.87 5.95 6.05 6.27 6.33 6.35 6.55 6.62 6.14
GOBP_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY 6.07 6.11 6.26 6.35 6.03 6.01 6.08 6.29 5.95 6.16 6.12 5.99 6.04 6.03 6.29 6.17 6.3 6.1 5.92 6.13 6.15 6.21 6.2 6.13 6.18 6.29
GOBP_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY 6.61 6.61 6.85 6.75 6.95 6.93 6.83 6.89 6.78 6.84 6.73 6.8 6.87 6.86 6.88 6.81 6.76 6.76 6.78 6.85 6.79 6.97 6.86 6.99 6.95 6.94
GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY 6.22 6.17 6.31 6.27 6.07 6 6.2 6.15 6.06 6.16 6.16 6.14 6.17 6.1 6.08 6.13 6.3 6.21 6.14 6.2 6.23 6.21 6.1 6.04 6.22 6.26
GOBP_POSITIVE_REGULATION_OF_TRANSFERASE_ACTIVITY 6.41 6.43 6.56 6.51 6.47 6.45 6.64 6.66 6.59 6.62 6.48 6.51 6.55 6.52 6.65 6.61 6.55 6.45 6.4 6.51 6.61 6.65 6.53 6.61 6.64 6.71
GOBP_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY 6.71 6.8 7.14 7 7.07 6.98 6.97 6.98 7 7.04 6.95 7.06 7.08 7.1 7.04 7.1 6.79 6.85 6.89 7.02 6.93 7.08 7.17 7.29 6.93 6.99
GOBP_POSITIVE_REGULATION_OF_LYASE_ACTIVITY 6.75 6.62 6.66 6.38 6 6.48 6.71 6.76 6.03 6.89 6.49 6.46 6.36 6.46 6.6 6.32 6.66 6.25 6.47 6.55 6.29 6.33 6.54 6.77 6.8 6.68
GOBP_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY 6.69 6.97 7.01 6.65 6.54 6.7 6.45 6.33 6.85 6.27 6.72 6.72 6.75 6.77 6.68 6.67 6.21 6.57 6.61 6.45 6.24 6.75 6.69 6.74 6.89 6.48
GOBP_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY 6.11 6.11 6.12 6.35 5.9 5.86 5.92 6.18 5.8 5.79 6.29 5.88 5.81 6 6.21 5.92 6.21 6.1 5.82 6.03 6.03 6.39 6.14 6.03 6.05 6.07
GOBP_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY 5.7 5.58 5.61 5.73 5.18 5.22 5.67 5.54 5.55 5.69 5.5 4.98 5.34 5.25 5.37 5.49 5.52 5.59 5.33 5.31 5.45 5.21 5.87 5.45 5.31 5.44
GOBP_KINETOCHORE_ASSEMBLY 5.51 5.38 4.81 5.32 4.92 4.87 5.32 5.36 5.14 5.32 5.42 5.48 4.93 4.86 5.09 5.04 5.39 5.64 5.51 5.43 5.89 5.28 4.88 5.03 5.23 5.19
GOBP_KINETOCHORE_ORGANIZATION 5.49 5.31 5.1 5.35 5.17 5.43 5.68 5.46 5.51 5.39 5.54 5.41 5.3 5.2 5.06 5.09 5.46 5.55 5.46 5.33 5.67 5.07 5.43 5.18 5.38 5.08
GOBP_RESPONSE_TO_MINERALOCORTICOID 6.08 6.19 6.55 6.25 5.8 5.67 6.19 6.11 6.19 6.11 5.89 5.7 6.09 6.29 6.27 6.06 5.98 6.16 5.84 6.09 6.67 6.43 5.85 6.03 6.06 6.28
GOBP_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY 7.73 7.79 8.56 7.83 8.28 8.56 8.12 8 8.18 8.09 7.67 7.85 8.36 8.17 8.01 8.07 7.86 7.96 8.05 7.89 7.95 8.18 8.3 8.41 8.01 8.23
GOBP_NEURON_APOPTOTIC_PROCESS 7.17 7.19 7.79 7.54 7.54 7.64 7.55 7.56 7.6 7.65 7.51 7.65 7.65 7.61 7.77 7.53 7.24 7.18 7.28 7.56 7.42 7.65 7.73 7.77 7.69 7.67
GOBP_RESPONSE_TO_CORTICOSTERONE 6.05 5.91 6.34 6.26 5.56 5.49 6.03 6.04 5.94 5.98 5.89 5.61 6.09 6.13 6.27 5.93 5.73 6.1 5.63 5.74 6.67 6.36 5.83 5.55 6.05 6.27
GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY 6.41 6.47 7.04 6.88 6.87 7.12 7.2 6.98 6.84 7.29 6.85 7.26 7.35 7.44 7.2 7.15 6.81 7.08 6.69 6.99 6.64 7.1 7.07 7.48 7.18 7.07
GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY 6.98 6.96 7.47 7.55 7.24 7.17 7.35 7.16 7.37 7.33 7.33 7.37 7.52 7.6 7.21 7.16 6.94 7.21 7.3 7.17 7.18 7.24 7.67 7.74 7.54 7.12
GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY 5.45 5.62 5.76 5.53 6.43 5.77 5.7 5.7 5.93 5.86 5.92 5.42 5.88 5.9 5.31 5.94 5.17 5.72 5.57 5.64 5.42 6 6.03 6.07 5.95 6.64
GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE 5.37 5.06 5.27 5.62 5.11 4.81 4.9 4.99 5.14 5.03 5.49 5.02 4.71 5.08 5.15 4.96 5.25 5.23 4.95 5.02 5.27 4.97 5.15 4.93 4.97 5.08
GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE 5.15 4.79 5.26 5.26 5.02 4.78 4.84 4.65 5.14 4.83 5.42 4.83 4.69 5.05 5.09 4.84 5.07 4.79 4.74 4.48 5.24 4.91 5.13 4.55 4.82 4.82
GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE 5.32 5.01 5.28 5.51 5.02 4.52 4.84 4.95 5.11 4.83 5.42 5.15 4.69 4.69 5.11 4.98 5.1 5.19 4.95 5.18 5.23 4.91 4.97 4.84 4.73 4.93
GOBP_MYOBLAST_PROLIFERATION 6.03 5.9 6.58 6.45 5.65 5.36 6.03 6.07 5.8 6.24 6.2 5.86 6.13 5.98 6.4 6.02 6.04 6.53 6.17 6.25 6.25 6.33 6.07 6.28 6.05 6.26
GOBP_MYOBLAST_MIGRATION 6.51 6.65 7.33 7.24 6.99 6.87 6.97 6.71 6.49 6.86 6.84 7.07 7.02 7.49 6.93 7.41 6.81 6.85 6.74 7.04 7.02 6.73 6.71 6.98 7.39 7.13
GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS 7.73 7.14 7.88 7.77 7.82 7.92 7.37 7.62 7.84 7.85 7.84 7.53 7.75 7.83 7.77 7.92 7.79 7.35 7.83 7.84 7.73 8.17 7.98 7.96 7.6 7.56
GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION 5.7 5.7 5.71 5.85 5.44 5.46 5.77 5.69 5.73 5.62 5.78 5.52 5.64 5.65 5.77 5.63 5.82 5.74 5.52 5.62 5.87 5.72 5.59 5.44 5.75 5.6
GOBP_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION 9.54 9.66 9.81 8.45 9.46 10.06 10.24 9.38 9.98 9.95 9.75 9.93 10.09 10.2 10.04 10.22 9.77 9.84 10.43 9.97 9.7 9.81 9.87 10.59 9.88 9.68
GOBP_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION_INVOLVED_IN_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_SIGNALING_PATHWAY 5.47 5.38 5.5 5.61 5.07 5.32 5.18 5.4 5.33 5.11 5.42 5.22 5.34 5.48 5.39 5.32 5.62 5.56 5.16 5.1 5.42 5.33 5.11 5.22 5.51 5.37
GOBP_REGULATION_OF_FILOPODIUM_ASSEMBLY 8 8.43 8.53 7.86 8.48 8.56 8.61 8.35 8.7 8.88 8.23 8.64 8.74 8.88 8.68 8.86 8.57 8.27 8.44 8.61 8.28 8.65 8.92 9.06 8.86 8.56
GOBP_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY 8.11 8.53 8.42 7.75 8.48 8.54 8.61 8.37 8.67 8.88 8.29 8.56 8.81 8.88 8.66 8.95 8.57 8.16 8.38 8.51 8.19 8.66 8.89 9.08 8.88 8.62
GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION 6.93 6.91 7.31 7.07 7.29 7.22 7.21 7.34 7.12 7.28 7.25 7.32 7.26 7.26 7.31 7.27 7.14 7.08 7.1 7.33 7.18 7.32 7.27 7.42 7.31 7.29
GOBP_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION 6.76 6.87 7.4 7.21 7.14 7.05 7.22 7.31 7.25 7.32 7.1 7.24 7.1 7.22 7.48 7.28 7.14 7.01 6.88 7.25 7.17 7.25 7.36 7.41 7.14 7.25
GOBP_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION 6.93 6.9 7.16 7 7.34 7.26 7.23 7.35 7.36 7.35 7.27 7.37 7.47 7.17 7.51 7.41 7.22 7.09 7.12 7.36 7.08 7.22 7.29 7.6 7.42 7.36
GOBP_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY 6.93 6.9 6.93 6.64 7.32 7.25 7.2 7.34 6.88 7.15 6.92 7.37 7.09 7.08 7.25 7.25 7.48 7.18 7.17 7.36 6.99 6.94 7.29 7.6 7.53 7.38
GOBP_KERATINOCYTE_MIGRATION 7.52 7.49 7.18 6.61 7.58 7.84 7.55 7.31 7.35 7.18 7.19 7.69 7.97 7.78 7.22 7.41 6.83 7.73 8.13 7.67 6.4 7.16 7.06 7.42 7.66 7.29
GOBP_REGULATION_OF_KERATINOCYTE_MIGRATION 7.61 7.62 8.19 7.92 7.96 7.93 8.42 7.91 7.98 8.43 7.89 7.83 8.39 8.12 8.07 7.45 7.8 7.93 8.17 7.87 7.93 7.8 8.75 8.58 7.96 7.52
GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS 7.39 6.89 8.02 7.68 7.69 7.56 8.72 8.15 8.14 7.6 7.7 7.43 8.3 8.16 7.63 7.73 7.67 8.16 7.65 8.15 7.83 8.23 8.93 7.87 8.76 8.69
GOBP_HISTONE_H3_K9_METHYLATION 6.06 6.13 6.12 6.46 6.02 6.18 6.11 6.01 6.33 6.32 6.15 6.26 6.25 6.5 6.08 6.2 5.88 5.99 6.29 5.92 6.21 6.28 6.48 6.53 6.33 6.34
GOBP_HISTONE_H3_K4_METHYLATION 6.54 6.72 6.65 6.65 6.75 6.95 6.64 6.76 6.53 6.7 6.51 6.62 6.65 6.62 6.56 6.41 6.59 6.47 6.64 6.81 6.5 6.69 6.84 6.82 6.56 6.73
GOBP_REGULATION_OF_HISTONE_H3_K4_METHYLATION 6.42 6.51 5.88 5.83 6.31 6.54 6.6 6.76 6.07 6.55 6.2 6.45 6.52 6.57 6.4 6.41 6.25 6.15 6.27 6.7 6.36 6.49 6.22 6.08 6.45 6.71
GOBP_REGULATION_OF_HISTONE_H3_K9_METHYLATION 6.11 6.24 6.03 6.31 6.24 6.22 6.27 5.93 6.52 6.55 6.26 6.16 6.3 6.68 6.14 6.23 5.71 5.94 6.33 5.83 5.95 6.36 6.82 7.16 6.41 6.41
GOBP_POSITIVE_REGULATION_OF_HISTONE_H3_K4_METHYLATION 6.61 6.73 6.81 6.87 6.65 6.85 7.15 7.02 6.77 6.8 6.61 6.54 6.78 6.65 6.81 6.74 6.63 6.46 6.75 7 6.81 6.91 6.73 6.95 6.77 6.95
GOBP_NEGATIVE_REGULATION_OF_HISTONE_H3_K9_METHYLATION 5.49 5.84 6 6 5.69 5.9 5.96 5.97 5.91 6.09 5.69 5.94 5.98 6.02 5.91 5.79 5.67 5.54 5.66 5.75 5.71 5.87 5.95 6.65 6.21 5.89
GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE 7.17 7.55 8.25 6.72 7.68 8.52 7.93 7.28 7.61 8.26 7.41 7.8 7.67 8.01 7.63 7.86 6.71 7.94 7.72 8.03 6.58 7.31 7.68 8.1 7.53 7.16
GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT 7.6 7.78 8.24 7.6 8.19 8.37 8.22 8.25 8.18 8.31 8.08 8.27 8.13 8.22 8.44 8.39 7.79 8.02 8.3 8.16 7.89 8.45 8.14 8.5 8.24 8.06
GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT 8.78 8.79 9.13 8.84 9.29 9.27 9.34 9.03 9.65 9.55 9.29 9.49 9.41 9.56 9.19 8.88 8.98 8.23 9.12 9.49 8.49 8.79 9.91 9.66 9.21 9.3
GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT 8.19 8.1 8.44 7.45 8.85 8.78 8.57 8.25 8.93 8.63 8.08 8.51 8.42 8.22 8.69 8.87 7.81 8.06 8.39 8.46 7.82 8.28 8.96 8.77 8.58 8.04
GOBP_RESPONSE_TO_CAMP 6.24 6.29 6.56 6.27 6.31 6.18 6.39 6.09 6.48 6.45 6.19 6.37 6.41 6.21 6.58 6.51 6.39 6.56 6.06 6.3 6.61 6.55 6.52 6.35 6.25 6.45
GOBP_RESPONSE_TO_CALCIUM_ION 7.4 7.49 7.57 7.48 7.65 7.6 7.31 7.69 7.51 7.62 7.21 7.4 7.53 7.54 7.44 7.53 7.38 7.37 7.55 7.75 7.49 7.63 7.63 7.56 7.54 7.29
GOBP_RESPONSE_TO_FOLIC_ACID 6.19 5.98 6.08 6.16 5.93 5.99 5.89 6.01 6.22 5.61 5.64 5.54 5.72 6.07 5.52 5.78 5.98 5.4 5.73 5.71 5.82 5.99 5.93 5.97 6.18 6.25
GOBP_RESPONSE_TO_ELECTRICAL_STIMULUS 6.33 6.23 7.12 7.19 6.53 6.2 6.69 6.58 6.74 6.57 6.32 6.59 6.6 6.43 7.19 6.62 6.39 6.43 6.33 6.61 6.86 6.88 6.24 6.77 7.75 7.78
GOBP_PROTEIN_MATURATION 6.38 6.39 6.57 6.58 6.48 6.43 6.27 6.43 6.38 6.46 6.38 6.34 6.37 6.42 6.52 6.41 6.46 6.28 6.32 6.28 6.45 6.47 6.38 6.47 6.37 6.49
GOBP_DETECTION_OF_STIMULUS 4.93 4.79 4.38 4.57 4.17 4.01 4.3 4.38 4.36 4.12 4.57 4.35 4.11 4.15 4.24 4.18 4.54 4.75 4.44 4.25 4.66 4.3 4.11 4.04 4.22 4.3
GOBP_DEFENSE_RESPONSE_TO_VIRUS 5.87 5.84 5.85 5.83 6.06 5.8 5.64 5.85 6.03 5.82 6.04 5.91 5.89 5.85 5.69 5.86 5.98 5.73 5.68 5.7 5.85 6 5.79 5.81 5.81 5.95
GOBP_HISTAMINE_TRANSPORT 5.92 5.8 5.5 5.84 5.62 5.1 5.1 5.35 5.35 5.41 5.29 5.48 5.64 5.76 5.39 5.48 5.6 5.43 5.76 5.35 5.43 5.37 5.56 5.47 5.73 5.58
GOBP_SEROTONIN_UPTAKE 5.27 4.76 4.7 4.75 4.6 4.04 4.49 4.68 4.53 4.42 5.02 4.5 4.52 4.34 4.6 4.55 5 4.85 4.85 4.24 4.87 4.41 4.78 4.32 4.39 4.77
GOBP_ORGANELLE_LOCALIZATION 6.98 7.11 7.57 7.39 7.33 7.5 7.36 7.32 7.29 7.39 7.35 7.43 7.35 7.29 7.4 7.46 7.15 7.11 7.3 7.37 7.15 7.34 7.5 7.62 7.46 7.39
GOBP_GOLGI_LOCALIZATION 8.53 8.8 8.85 8.76 8.99 9.05 8.59 8.72 8.88 9.12 8.66 9.11 8.89 8.83 8.69 8.82 8.39 8.54 8.82 8.86 8.03 8.53 9.04 9.17 8.98 8.97
GOBP_MITOCHONDRION_LOCALIZATION 7.72 7.65 8.32 7.63 8.17 8.32 8.34 8.21 8.18 8.4 7.85 8.09 8.19 8.37 8.38 8.37 8.02 7.84 8.05 8.12 8.03 8.32 8.47 8.34 8.17 8.17
GOBP_NUCLEUS_LOCALIZATION 8.39 8.53 8.15 7.96 9.22 9.05 8.77 8.92 8.94 9.03 8.25 8.56 8.97 8.95 8.77 8.47 8.6 8.38 8.62 8.85 7.97 8.35 8.93 9.17 8.8 8.71
GOBP_VESICLE_LOCALIZATION 7.71 7.71 8.32 8.1 8.05 8.15 8.25 8.16 8.09 8.29 8.06 8.03 8.15 8.09 8.11 8.07 7.75 7.68 7.81 8.13 7.88 8.13 8.33 8.25 8.19 8.07
GOBP_MAINTENANCE_OF_LOCATION_IN_CELL 6.96 6.96 7.31 7.12 7.13 7.26 7.11 7.1 7.05 7.22 7.02 7.14 7.24 7.31 7.3 7.16 7.11 7.22 7.24 7.22 7.11 7.24 7.51 7.51 7.39 7.2
GOBP_SPINDLE_LOCALIZATION 6.98 7.18 6.99 7.16 7.7 7.73 7.74 7.7 7.7 7.77 7.42 8.03 7.54 7.61 7.28 7.41 7.42 7.22 7.36 7.69 7.63 7.78 7.7 7.79 7.51 7.66
GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION 8.48 8.84 9.45 9.14 8.65 8.94 9.19 8.93 9.04 9.19 8.72 8.83 8.95 8.89 9.31 9.01 8.87 8.33 8.81 9.07 8.38 8.7 9.72 9.42 9.28 9.03
GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION 6.93 7.16 7.71 7.46 7.32 7.5 7.38 7.32 7.36 7.49 7.36 7.47 7.38 7.31 7.5 7.48 7.14 7.09 7.06 7.37 7.12 7.38 7.55 7.66 7.48 7.35
GOBP_LOCALIZATION_WITHIN_MEMBRANE 7.69 7.93 8.16 8.07 8.12 8.16 8.23 8.24 7.92 8.19 8.05 8.27 8.17 8.35 8.43 8.32 8.1 7.86 8.02 8.12 8.01 8.33 8.23 8.37 8.32 8.23
GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_HOST 6.65 6.55 6.83 6.73 6.76 6.89 6.82 6.88 6.85 6.77 6.59 6.68 6.86 6.98 6.73 6.8 6.71 6.74 6.74 6.83 6.82 6.85 7.08 6.94 7.07 7.14
GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_SYMBIONT 6.38 6.45 6.71 6.58 6.59 6.58 6.5 6.46 6.42 6.4 6.36 6.23 6.8 6.69 6.32 6.56 6.17 6.2 6.27 6.43 6.57 6.8 6.48 6.73 6.51 6.56
GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS 7.01 7.1 7.53 6.94 7.15 7.59 7.46 7.67 7.21 7.46 7.37 7.42 7.46 7.75 7.77 7.72 7.54 7.49 7.53 7.78 7.5 7.79 7.73 7.71 7.42 7.47
GOBP_MULTI_ORGANISM_PROCESS 5.86 5.76 5.91 5.95 5.68 5.64 5.73 5.73 5.74 5.75 5.9 5.71 5.69 5.69 5.84 5.81 5.77 5.87 5.79 5.71 5.86 5.77 5.68 5.63 5.77 5.89
GOBP_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM 5.08 5.1 4.79 4.94 4.73 4.77 4.75 4.97 4.92 4.7 4.9 4.63 4.6 4.55 4.7 4.8 4.9 5.1 4.82 4.7 4.94 4.66 4.69 4.51 4.77 4.8
GOBP_POSITIVE_REGULATION_OF_KILLING_OF_CELLS_OF_OTHER_ORGANISM 5.04 4.94 4.63 4.92 4.45 4.64 4.73 4.86 4.85 4.52 4.55 4.58 4.49 4.51 4.66 4.42 4.68 4.88 4.76 4.66 4.73 4.59 4.67 4.44 4.74 4.78
GOBP_REGULATION_OF_CELL_CYCLE 6.73 6.77 7.01 6.93 6.91 6.96 6.88 6.93 6.89 6.96 6.88 6.95 6.99 7.04 6.99 7.06 6.76 6.81 6.82 6.99 6.93 7.09 7.04 7.08 7 7.02
GOBP_ACTIN_CROSSLINK_FORMATION 6.55 6.81 7.16 6.79 6.74 6.55 6.35 6.08 7.04 6.64 6.86 6.33 6.74 6.7 5.63 6.03 6.8 6.68 5.73 6.05 6.3 6.89 6.52 6.33 6.63 6.95
GOBP_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS 6.42 6.42 6.22 6.35 6.51 6.28 6.12 6.19 6.19 6.21 6.68 6.32 6.1 6.6 6.09 6.01 6.49 6.05 6.25 6.12 6.59 6.76 6.12 6.09 5.97 6.87
GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS 6.25 6.4 5.85 6.46 6.48 6.03 6.1 5.84 6.09 6.18 5.77 6.26 5.99 6.35 5.77 5.82 6.21 5.6 5.86 5.84 6.32 6.05 5.83 5.78 5.88 6.08
GOBP_RESPONSE_TO_REDOX_STATE 8.02 8.1 8.85 8.31 8.92 8.52 8.55 8.71 8.84 8.48 8.38 8.47 8.58 8.54 8.53 8.28 8.44 7.76 7.97 9.09 8.12 8.13 8.36 8.74 8.23 8.14
GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION 5.66 5.52 5.77 5.58 5.42 5.25 5.57 5.46 5.54 5.4 5.75 5.25 5.59 5.46 5.72 5.67 5.5 5.56 5.27 5.14 5.61 5.71 5.57 5.44 5.45 5.61
GOBP_NEGATIVE_REGULATION_OF_CELL_DIVISION 5.48 5.18 4.94 5.37 4.67 4.44 5.01 4.82 4.89 4.57 5.15 4.9 4.69 4.35 4.66 4.45 5.08 5.3 4.9 4.63 5.47 4.92 4.55 4.5 4.98 5
GOBP_REGULATION_OF_NUCLEAR_DIVISION 5.7 5.69 5.8 5.8 5.53 5.66 5.66 5.8 5.59 5.71 5.82 5.74 5.61 5.66 5.77 5.79 5.75 5.78 5.74 5.58 5.77 5.92 5.63 5.73 5.78 5.98
GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION 5.62 5.7 5.8 5.76 5.23 5.49 5.53 5.69 5.51 5.46 5.65 5.38 5.38 5.52 5.56 5.51 5.23 5.3 5.72 5.49 5.41 5.58 5.24 5.64 5.38 5.7
GOBP_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION 5.42 5.34 5.78 5.61 5.35 5.15 5.64 5.56 5.53 5.45 5.79 5.25 5.53 5.48 5.53 5.66 5.63 5.28 5.23 5.28 5.55 5.58 5.5 5.64 5.48 5.39
GOBP_RESPONSE_TO_MISFOLDED_PROTEIN 7.51 7.43 7.54 7.34 7.95 7.96 8.03 7.82 7.89 7.9 7.76 7.7 7.82 7.66 7.88 7.73 7.48 7.48 7.49 7.81 7.55 7.64 8.08 8 7.71 7.91
GOBP_MEDIUM_CHAIN_FATTY_ACID_METABOLIC_PROCESS 6.49 6.37 6.89 7.43 6.16 6.3 5.97 6.08 6.2 6.44 6.79 6.29 6.2 6.35 5.78 6.09 6.45 6.34 6.49 5.8 6.32 5.94 6.26 6.3 5.98 6.16
GOBP_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT 5.01 5.12 5.06 5.41 4.63 4.66 5.04 4.92 4.88 4.54 4.94 4.8 4.84 4.68 5.2 4.69 5.08 5.11 4.79 4.84 5 4.89 4.73 4.65 5.24 5.04
GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT 4.8 4.67 4.82 5.04 4.4 4.12 4.2 4.33 4.48 4.49 4.65 4.33 4.57 4.34 4.71 4.52 4.71 4.58 4.62 4.35 5 4.71 4.54 4.29 4.57 4.62
GOBP_MODULATION_OF_PROCESS_OF_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION 6.99 6.96 7.35 7.03 7.22 7.27 7.18 7.3 7.23 7.26 7.27 7.25 7.27 7.26 7.27 7.3 7.45 6.98 7.17 7.44 7.41 7.7 7.28 7.39 7.46 7.5
GOBP_MODULATION_BY_HOST_OF_SYMBIONT_PROCESS 6.83 6.92 7.13 6.88 7.2 7.27 7.18 7.3 7.23 7.26 7.2 7.22 7.18 7.18 7.03 7.2 7.37 6.78 6.88 7.33 7.15 7.58 7.28 7.13 7.43 7.4
GOBP_PROTEIN_AUTOUBIQUITINATION 6.91 7.05 7.19 7.21 7.39 7.38 7.52 7.76 7.38 7.48 7.19 7.29 7.48 7.56 7.54 7.32 7.08 7.01 7.29 7.59 7.25 7.47 7.32 7.69 7.24 7.17
GOBP_PIGMENT_GRANULE_LOCALIZATION 6.41 6.5 7.76 7.4 6.69 6.66 6.85 6.87 7.11 7.09 7.06 6.7 6.66 6.88 7.27 7.25 6.52 6.55 6.52 6.98 6.51 6.55 7.31 7.42 6.64 6.69
GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL 6.98 7.09 7.9 7.55 7.07 7.05 6.68 7.07 7.03 6.98 7.41 6.96 6.92 7.19 7.16 7.19 7.14 6.86 7.03 6.98 7.25 6.93 7.07 7.03 7.03 7.06
GOBP_MITOCHONDRIAL_DEPOLARIZATION 5.98 6.2 7.12 6.64 6.05 6.08 6.51 6.32 6.28 6.73 6.49 6.41 6.26 6.43 6.4 6.15 6.5 6.15 6.2 6.2 6.74 6.42 6.8 6.64 6.36 6.39
GOBP_KILLING_OF_CELLS_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION 5.08 5.3 4.72 4.9 4.72 4.11 4.54 4.66 4.55 4.26 5.13 4.61 4.42 4.47 4.67 4.73 4.89 5.03 4.69 4.2 5.05 4.52 4.28 4.1 4.51 4.62
GOBP_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY 6.97 6.86 7.11 6.62 7.59 7.46 7.19 7.27 7.69 7.2 7.49 7.47 7.59 7.69 7.32 7.44 7.61 7.02 7.25 7.45 7.33 7.81 7.48 7.61 7.43 7.43
GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING 6.02 5.94 6.29 6.24 5.81 5.74 5.98 6.24 6.1 6.13 6.18 6.16 6.02 5.99 6.33 6.22 6.02 6.01 6.01 6.01 6.25 6.37 6.09 6.01 6.18 6.24
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_B_SIGNALING 6.86 7.1 7.99 7.33 7.08 6.97 7.07 7.23 7.6 7.29 7.4 7.16 7.24 7.34 7.18 7.16 6.88 7.58 7.09 7.22 7.44 7.81 7.52 7.78 7.68 7.47
GOBP_MEMBRANE_DEPOLARIZATION 7.5 7.56 7.78 7.12 8.04 7.88 7.75 7.97 7.65 7.84 7.47 7.84 7.73 7.81 7.92 7.82 7.6 7.67 7.95 7.92 7.41 7.68 7.87 8.23 7.76 7.59
GOBP_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION 6.52 6.66 7.86 7.52 6.7 6.95 6.87 6.87 7.11 7.17 7.06 7 6.75 7.05 7.27 7.54 6.62 6.84 6.6 7.02 6.75 6.85 7.53 7.47 6.82 6.93
GOBP_REGULATION_OF_FIBRINOLYSIS 4.97 4.69 4.45 4.57 4.34 4.43 4.61 4.47 4.75 4.37 4.93 4.48 4.17 4.49 4.65 4.42 4.54 4.52 4.67 4.23 4.64 4.62 4.43 4.17 4.48 4.43
GOBP_NEGATIVE_REGULATION_OF_FIBRINOLYSIS 4.85 4.48 4.45 4.52 4.09 4.06 4.61 4.3 4.54 4.29 4.66 4.37 4.17 4.37 4.61 4.41 4.23 4.41 4.26 4.1 4.3 4.32 4.38 4.17 4.5 4.29
GOBP_SULFATION 5.88 5.95 7.23 6.44 6.17 6.52 6.62 6.26 6.59 6.62 6.48 6.37 6.76 6.6 6.55 6.45 6.09 6.29 6.24 6.22 6.21 6.74 7.07 6.84 6.58 6.05
GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT 6.1 6 6.08 6.74 6.07 5.69 6.09 6.43 6.1 6.35 6.53 6.22 6.3 6.32 6.09 6.09 6.02 5.9 5.98 6.15 6.21 6.17 6.74 6.74 6.38 6.28
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT 6.09 5.84 6.2 6.43 5.87 5.82 6.13 6 5.89 5.83 5.98 5.82 6.07 5.8 6.04 5.9 6.34 5.96 5.88 5.88 6.25 6.32 5.84 5.86 6.09 6.27
GOBP_REGULATION_OF_SENSORY_PERCEPTION 5.43 5.74 5.46 5.59 4.78 5.24 5.44 5.45 5.31 5.04 5.66 5.12 5.18 5.26 5.37 5.21 5.45 5.77 5.17 5.18 5.36 5.24 5.31 5.12 5.23 5.21
GOBP_SYNAPTIC_TRANSMISSION_GABAERGIC 8.56 8.41 8.26 7.9 8.62 8.87 8.95 8.72 8.65 8.43 8.2 8.33 8.84 8.73 8.6 8.71 7.78 8.25 8.66 8.84 7.9 8.37 8.6 8.78 8.53 8.34
GOBP_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION 6.51 6.66 6.27 6.33 6.22 6.24 7.7 6.81 6.84 7.48 6.33 6 6.02 6.1 7.01 6.31 5.84 6.36 6.68 6.48 6.1 5.91 7.15 6.73 5.95 5.87
GOBP_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT 7.37 7.76 7.88 7.5 7.75 8.01 8.02 7.84 8.11 7.9 7.8 7.84 8.02 8.05 8.04 8.3 7.07 7.47 7.93 8.33 7.7 7.24 7.92 8.01 7.44 7.31
GOBP_POSITIVE_REGULATION_OF_AMINE_TRANSPORT 6.13 6.13 7.02 6.3 5.87 5.63 6.68 6.53 6.11 6.17 6.28 5.67 5.85 6.11 6.73 6.34 5.93 6.05 6.22 5.98 5.99 5.97 5.77 6.12 6.13 6.35
GOBP_REGULATION_OF_AMINO_ACID_TRANSPORT 7.64 8.22 8.09 7.44 7.85 8.17 8.16 8.12 8.18 7.83 7.89 8.08 8.03 8.1 8.04 8.27 7.36 7.75 8.1 8.46 8.2 7.9 7.8 8.03 8.33 7.86
GOBP_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT 7.74 8.26 7.88 7.66 7.75 8.01 8.11 8.05 8.11 7.9 8.14 8.16 8.02 8.05 8.04 8.31 7.33 8.08 8.25 8.33 8.27 7.76 7.91 8.01 8.15 8.02
GOBP_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT 6.73 7.02 8.17 6.89 7.18 6.98 7.38 7.13 7.29 7.25 6.95 6.73 7.25 7.18 7.88 7.42 6.81 6.93 6.89 7.26 7.08 7.21 6.5 7.24 7.19 7.06
GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT 6.91 6.96 7.15 6.88 7.3 7.27 7.36 7.46 7.24 7.34 7 7.34 7.42 7.38 7.42 7.33 7.2 7.12 7.06 7.5 7.05 7.29 7.26 7.4 7.23 7.32
GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT 6.53 6.67 7.07 6.76 6.94 7.1 6.98 7.24 6.93 7.1 6.86 7 7.26 7.25 6.93 6.97 7.03 6.95 6.68 7.15 6.88 6.89 6.95 7.08 7.19 6.97
GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT 7.12 7.13 7.16 6.95 7.41 7.45 7.53 7.63 7.35 7.43 7.11 7.39 7.6 7.54 7.6 7.47 7.35 7.23 7.25 7.77 7.1 7.34 7.3 7.62 7.28 7.44
GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY 6.93 7.21 7.16 6.88 7.42 7.48 7.59 7.48 7.27 7.5 7.18 7.22 7.24 7.37 7.7 7.3 7.2 7.5 7 7.49 6.99 7.34 7.34 7.73 7.49 7.36
GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY 7.17 7.51 7.11 6.76 7.52 7.93 7.86 7.75 7.36 7.68 7.22 7.71 7.5 7.68 7.76 7.41 7.47 7.68 7.16 7.86 6.93 7.34 7.42 7.76 7.65 7.64
GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC 7.78 7.9 7.9 7.73 7.83 8.29 8.27 8.07 8.26 7.91 7.77 7.84 8.19 8.26 8.17 7.9 7.39 8.04 8.3 8.25 7.5 7.88 8.02 8.01 7.88 7.65
GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC 7.31 7.55 7.61 7.7 7.68 8.05 8.3 8.07 7.78 7.69 7.29 7.8 7.96 8.09 8.18 7.86 7.29 7.94 7.94 8.22 7.33 7.29 8.01 8.32 7.64 7.6
GOBP_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE 5.41 4.98 5.56 5.57 5 4.66 5.57 4.93 5.33 5.17 5.04 4.83 5.01 4.94 5.61 5.68 5.55 5.32 5.07 5.04 5.41 5.39 5.26 4.94 5.3 5.19
GOBP_REGULATION_OF_TELOMERASE_ACTIVITY 7.05 7.07 7.36 7.07 7.37 7.31 7.17 7.16 7.14 7.31 6.94 7.29 7.05 7.2 7.01 7.02 6.7 7.09 7.16 7.27 7.21 7.02 7.23 7.3 7.35 7.53
GOBP_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY 7.26 7.44 7.79 7.26 7.59 7.35 7.58 7.42 7.35 7.71 7.17 7.29 7.47 7.67 7.31 7.39 6.78 6.86 7.47 7.5 7.42 7.37 7.69 7.79 7.62 7.69
GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION 6.14 6.07 6.22 6.38 6.26 5.98 5.8 6.15 5.93 6.22 6.17 6.18 5.84 5.9 5.99 6.37 6.35 6.29 6.1 5.96 6.25 6.2 6.2 6.15 6.33 6.34
GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION 6.96 6.88 6.5 7.04 7.17 7.14 6.46 6.62 7 7.3 6.88 6.89 7.04 7.22 7.3 7.12 6.92 6.97 7.11 7.26 6.92 6.86 7.41 7.28 7.34 7.02
GOBP_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE 6.94 6.94 6.72 6.27 7.18 7.13 6.94 7.07 6.81 6.84 6.49 6.65 6.86 6.94 7.17 6.7 6.68 6.86 6.46 7.18 6.54 6.98 6.92 7.16 6.8 6.53
GOBP_MOVEMENT_IN_HOST_ENVIRONMENT 6.4 6.41 6.55 6.62 6.49 6.43 6.41 6.58 6.42 6.38 6.31 6.34 6.59 6.55 6.37 6.54 6.4 6.53 6.39 6.56 6.56 6.7 6.61 6.56 6.59 6.67
GOBP_MODULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST 6.04 6.04 5.56 5.84 6.15 6.1 6.11 5.97 6.13 5.92 5.82 5.93 5.9 6.08 5.92 5.89 6.1 5.88 6.09 6.36 5.8 6.01 6 5.79 5.98 6.23
GOBP_REGULATION_OF_PEPTIDASE_ACTIVITY 5.87 5.8 5.94 6.1 5.63 5.61 5.75 5.73 5.79 5.73 5.82 5.72 5.66 5.74 5.77 5.87 5.92 5.75 5.62 5.69 5.9 6.02 5.72 5.57 5.89 6
GOBP_ALDITOL_PHOSPHATE_METABOLIC_PROCESS 6.38 6.32 7.69 7.35 6.52 6.49 6.31 5.85 6.53 6.65 7.13 6.15 6.63 6.53 6.38 6.21 7.12 6.4 6.06 6.42 6.61 6.78 6.61 6.86 6.54 6.94
GOBP_CELLULAR_GLUCURONIDATION 5.04 4.93 4 4.38 4.08 3.76 3.93 4.22 3.85 3.82 4.25 4.22 3.74 3.8 3.87 4.16 4.43 4.63 4.42 4.28 4.62 3.87 4.02 3.94 3.81 3.91
GOBP_MUSCLE_CELL_DEVELOPMENT 6.26 6.22 6.39 6.12 6.38 6.23 6.24 6.31 6.33 6.44 6.41 6.42 6.31 6.19 6.32 6.39 6.6 6.32 6.28 6.18 6.51 6.42 6.46 6.42 6.34 6.48
GOBP_STRIATED_MUSCLE_CELL_DEVELOPMENT 6.08 5.91 5.98 5.86 5.88 5.76 6.03 5.83 5.87 6.19 6.14 6.15 5.92 5.82 5.95 6.02 6.06 6.13 5.97 5.95 6.17 6.14 5.99 5.72 5.91 6.1
GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY 6.18 5.74 4.89 5.48 6.85 6.16 6.2 5.92 6.24 6.75 5.71 6.41 6.37 5.95 5.67 6.05 5.98 5.57 5.86 5.94 5.05 5.24 7.07 5.92 5.58 5.99
GOBP_CARDIAC_CELL_DEVELOPMENT 6.84 6.78 6.71 6.4 6.98 6.89 6.96 6.79 6.91 6.9 6.57 6.95 7.1 6.97 6.77 6.88 6.88 6.82 6.66 6.97 7 6.96 7.19 7.08 6.89 6.94
GOBP_CARDIAC_MUSCLE_CELL_DIFFERENTIATION 6.55 6.54 6.75 6.5 6.81 6.6 6.81 6.82 6.92 6.73 6.6 6.68 7.05 6.9 6.63 6.69 6.74 6.54 6.69 6.91 6.83 6.89 7.07 6.79 6.58 6.82
GOBP_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS 5.54 5.46 5.67 5.84 5.49 5.51 5.62 5.84 5.63 5.52 5.43 5.4 5.87 5.62 5.73 5.55 5.6 5.53 5.4 5.51 5.55 5.7 5.66 5.55 5.85 5.83
GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION 6.6 6.31 6.39 6.26 7.48 6.94 6.9 6.63 7.58 6.81 6.19 6.9 7.61 6.96 6.01 6 6.72 6.09 6.48 6.63 5.88 5.64 6.95 7.04 6.36 6.71
GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH 6.88 7.18 7.43 7.15 7.49 7.69 7.22 7.45 7.27 7.21 6.91 7.3 7.47 7.54 6.97 6.95 6.92 6.98 7.25 7.66 7 7.26 7.13 7.44 7.43 7.47
GOBP_NEUROBLAST_DIVISION 7.43 7.29 7.55 6.66 6.97 7.04 7.17 7.59 7.23 7.11 7.41 7.23 7.1 7.36 7.41 7.37 6.95 7 7.14 7.41 7.68 7.79 7.13 7.22 7.35 7.23
GOBP_METAL_ION_HOMEOSTASIS 6.12 6.17 6.2 6.27 5.94 5.91 6.16 6.2 6.15 6.07 6.15 6.06 6.08 6.1 6.24 6.04 6.22 6.19 5.99 6.1 6.23 6.27 6.09 6.08 6.22 6.28
GOBP_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS 6.71 6.63 7.08 6.74 6.61 6.72 6.7 6.75 6.69 6.64 6.55 6.55 6.63 6.78 6.77 6.93 6.74 6.86 6.71 6.91 6.74 7.15 6.92 6.75 6.75 6.68
GOBP_ZINC_ION_HOMEOSTASIS 6.69 6.54 6.98 7.09 5.97 6.58 6.79 6.76 7.08 6.73 7.28 6.96 6.92 6.79 7.15 6.8 6.7 6.91 6.5 6.7 7.05 7.36 6.73 6.58 7.18 7.29
GOBP_COPPER_ION_HOMEOSTASIS 6.66 6.85 7.13 7.17 6.85 7.13 6.97 7.51 7.01 7.21 7.11 7.44 6.84 7.29 7.59 7.16 7.11 6.27 7.15 6.77 6.53 7.7 7.35 7.7 7.34 7.92
GOBP_IRON_ION_HOMEOSTASIS 7.29 7.22 7.55 7.38 7.32 7.6 7.1 7.07 7.39 7.56 7.27 7.28 7.09 7.18 7.08 6.94 7.3 7.08 7.38 7.33 7.09 7.41 7.13 7.45 7.61 7.6
GOBP_POTASSIUM_ION_HOMEOSTASIS 6.45 6.56 6.62 6.5 6.72 6.55 6.4 6.45 6.68 6.59 6.37 6.51 6.65 6.82 6.34 6.73 6.81 7.11 6.47 6.82 6.55 6.69 6.65 6.45 6.81 6.59
GOBP_TRANSITION_METAL_ION_HOMEOSTASIS 7.04 7 7.44 7.34 6.97 6.94 6.92 7.07 7.13 6.95 7.27 7.26 7 7.08 7.15 7.07 7.05 6.94 7.02 6.96 7.05 7.39 6.94 7.25 7.37 7.51
GOBP_SODIUM_ION_HOMEOSTASIS 5.57 5.42 5.3 5.4 4.91 4.79 5.36 4.98 5.13 5.11 5.42 4.85 4.96 5.03 5.29 5.06 5.57 5.44 4.9 5.02 5.45 5.3 5.16 4.82 5.08 5
GOBP_ANION_HOMEOSTASIS 5.8 5.54 5.25 5.63 5.47 5.27 5.32 5.23 5.34 5.07 5.49 5.23 4.97 5.24 5.29 5.36 5.45 5.54 5.29 5.07 5.45 5.31 5.12 4.82 5.16 4.91
GOBP_MONOVALENT_INORGANIC_ANION_HOMEOSTASIS 6.09 6.36 6.25 5.98 6.56 6.5 6.33 6.21 6.67 6.54 6.26 6.46 6.63 6.68 6 6.53 6.36 6.36 6.46 6.36 6.12 5.94 6.53 6.02 6.47 6.56
GOBP_TRANSMEMBRANE_TRANSPORT 6.47 6.45 6.61 6.66 6.54 6.56 6.63 6.67 6.6 6.63 6.52 6.55 6.6 6.58 6.55 6.53 6.61 6.53 6.49 6.68 6.52 6.58 6.54 6.71 6.62 6.62
GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS 6.49 6.58 6.92 6.86 6.7 6.77 6.78 6.72 6.7 6.83 6.69 6.72 6.76 6.66 6.73 6.7 6.69 6.66 6.7 6.76 6.55 6.75 6.72 6.86 6.74 6.74
GOBP_LIPID_HOMEOSTASIS 5.98 5.86 5.99 6.22 5.96 5.68 5.86 6.17 6.02 5.85 5.97 5.78 5.95 5.95 6.03 5.9 6.03 5.92 5.79 5.85 6.42 6.27 5.72 5.87 6.03 6.31
GOBP_FATTY_ACID_HOMEOSTASIS 6.71 7.3 7.91 7.26 7.08 6.96 7.9 7.37 7.59 7.43 7.17 7.33 7.24 7.8 7.66 7.54 6.8 7.3 6.78 7.54 7.13 7.69 7.54 8 7.78 7
GOBP_ACYLGLYCEROL_HOMEOSTASIS 5.42 5.25 5.73 5.71 5 4.72 5.47 5.42 5.53 5.16 5.54 5.26 5.35 5.11 5.27 5.13 5.46 5.5 5.14 5.19 5.77 5.63 5.36 4.93 5.61 5.69
GOBP_PHOSPHOLIPID_HOMEOSTASIS 5.61 5.31 5.38 5.97 4.56 4.69 5.16 5.04 5.58 4.77 5.32 4.87 4.87 4.95 5.25 5.01 5.18 5.36 4.91 4.88 5.54 5.18 5.07 4.74 5.14 5.05
GOBP_STEROL_HOMEOSTASIS 5.78 5.74 5.95 6.13 5.36 5.51 5.72 5.83 5.58 5.52 5.83 5.55 5.69 5.55 5.91 5.56 5.73 5.76 5.57 5.67 5.89 5.68 5.5 5.3 5.71 5.69
GOBP_RESPONSE_TO_HYPEROXIA 6.28 6.23 6.41 6.45 5.86 6.07 5.85 5.83 5.83 6.12 6.08 5.66 6.22 5.97 6 6.12 6.02 6.48 6.04 6.18 6.32 6.52 6.31 6.22 6.12 6.44
GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION 6.27 6.22 6.72 6.52 6.27 6.61 6.57 6.61 6.69 6.77 6.53 6.67 6.34 6.38 6.8 6.58 6.55 6.34 6.34 6.37 6.68 6.58 6.92 6.89 6.79 6.73
GOBP_RELAXATION_OF_CARDIAC_MUSCLE 8.79 8.58 9.12 8.66 9.34 9.35 9.04 9.22 9.37 9.12 8.71 8.7 9.03 9.08 9.25 9.18 8.49 8.04 8.94 9.32 8.76 9.09 9.33 9.07 8.7 9.02
GOBP_DIGESTIVE_SYSTEM_DEVELOPMENT 5.92 5.82 5.8 5.91 5.7 5.74 5.88 5.88 5.87 5.77 5.83 5.76 5.84 5.93 5.83 5.8 5.9 5.89 5.74 5.58 5.92 5.76 5.88 5.61 5.7 5.73
GOBP_REFLEX 5.75 5.44 6.43 6.29 5.61 5.97 5.96 5.72 6.51 5.6 5.74 5.62 5.57 5.77 5.74 5.71 6.02 5.99 5.38 5.86 5.77 6.01 5.92 5.92 5.62 5.66
GOBP_SERTOLI_CELL_DIFFERENTIATION 5.47 6.09 6.08 5.98 5.88 6.22 6.06 5.89 5.93 6.39 5.91 6.18 5.65 6.09 5.91 6.16 6.06 6.1 5.53 5.49 6.4 5.85 6.47 6.8 6.65 6.28
GOBP_SERTOLI_CELL_DEVELOPMENT 5.88 6.16 6.13 6.02 6.31 6.25 6.31 6.05 6.1 6.48 5.91 6.33 6.05 6.34 6.23 6.18 6.16 6.11 5.65 5.94 6.43 6.14 6.65 7.01 6.74 6.44
GOBP_RADIAL_GLIAL_CELL_DIFFERENTIATION 7.07 7.27 6.69 6.47 7.41 7.5 7.21 7.12 7.01 6.86 7.18 6.93 7.27 7.52 6.7 7.33 7.69 7.49 6.98 7.4 7.5 7.65 6.67 6.75 6.74 7.3
GOBP_ROOF_OF_MOUTH_DEVELOPMENT 6.15 6.36 6.17 6.18 6.02 6.06 6.5 6.29 6.45 6.19 6.25 6.05 6.28 6.5 6.21 6.45 6.06 6.07 6.16 6.24 6.29 6.31 6.31 6.34 6.18 6.26
GOBP_CONVERGENT_EXTENSION 5.91 6.08 6.11 6.04 6.18 6.46 6.2 6.42 5.78 6.37 6.25 6.43 6.06 5.91 6.14 6.07 6.39 6.25 5.93 6.17 6.18 6.48 6.03 6.16 6.02 6.42
GOBP_ANATOMICAL_STRUCTURE_REGRESSION 5.77 5.67 5.86 6.03 5.56 5.63 5.71 5.78 5.78 5.83 5.91 5.7 5.63 5.64 5.78 5.65 5.7 5.36 5.49 5.43 5.82 5.67 5.78 5.47 5.66 5.58
GOBP_PHARYNGEAL_SYSTEM_DEVELOPMENT 5.48 5.52 5.46 5.34 5.55 5.51 6.18 6.08 5.45 5.5 5.36 5.14 6.55 6.19 6.29 6.28 5.43 5.46 5.34 5.88 5.5 5.64 5.9 6.28 6.02 5.87
GOBP_CARDIAC_MUSCLE_CELL_PROLIFERATION 6.88 7.03 6.87 7.01 7.12 7.34 7.16 7.11 7.09 6.93 6.71 7.15 7.26 7.33 6.94 7.25 6.88 6.87 7.17 7.16 7.05 7 7.33 7.23 7.4 7.42
GOBP_PERICARDIUM_DEVELOPMENT 6.07 6.33 6.45 6.04 6.99 7.32 7.12 6.51 6.92 7.22 6.42 6.64 7.27 7.13 7.13 6.42 6.32 6.32 6.62 7.07 6.59 6.69 7.4 7.29 6.29 6.11
GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE 6.14 6.03 6.11 6.19 6.21 6.18 6.23 6.38 6.16 6.33 6.05 6.25 6.46 6.39 6.08 6.2 6.31 6.19 6.08 6.06 6.28 6.02 6.29 6.45 6.12 6.28
GOBP_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE 6.1 6.01 6.08 6.19 6.07 6.1 6.38 6.29 6.28 6.36 5.91 6.06 6.31 6.31 6.18 6.15 6.28 6.18 6.05 6.1 6.26 6 6.22 6.29 6.14 6.25
GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION 6.87 6.83 6.78 6.91 6.93 7.12 7.16 7.11 6.97 6.93 6.6 7.15 7.26 7.18 6.86 6.97 6.88 6.84 7.06 7.16 7 6.85 7.07 7.09 7.22 7.41
GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION 6.88 6.82 6.65 7.01 7 7.56 7.16 7.35 7.1 7.03 6.69 7.15 7.38 7.54 6.86 6.95 6.59 6.87 7.25 7.39 6.63 6.84 6.84 7.09 6.99 7.45
GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION 6.86 6.98 6.74 6.68 6.96 6.99 7.36 7.1 6.93 6.91 6.61 7.33 7.37 6.98 7.26 7.56 7.22 6.83 7 7.08 7.28 7 7.39 7.46 7.49 7.41
GOBP_REGULATION_OF_ACROSOME_REACTION 4.95 4.68 4.54 4.98 4.4 4.21 4.71 4.37 4.56 4.48 4.64 4.5 4.38 4.45 4.45 4.21 4.3 4.42 4.42 4.52 4.73 4.43 4.23 4.14 4.36 4.51
GOBP_CARDIAC_MUSCLE_CONTRACTION 6.17 6.13 6.36 6.55 5.93 5.94 6.33 6.32 6.12 6.32 6.39 6.37 6.12 6.11 6.62 6.44 6.5 6.31 6.2 6.25 6.43 6.45 6.44 6.45 6.34 6.45
GOBP_REGULATION_OF_PROTEIN_GLYCOSYLATION 7.04 7.53 7.39 6.89 7.36 7.42 7.49 7.63 7.72 7.9 7.29 7.63 7.48 7.49 7.99 7.79 7.33 7.42 7.41 7.83 7.63 7.59 7.67 7.87 8.1 7.59
GOBP_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING 6.07 6.02 6.76 5.95 6.07 6.09 6.19 6.53 6.13 6.1 6.04 6.08 6.3 6.02 6.32 6.2 6.24 6.06 6.24 6.22 6.49 6.63 6.31 6 6.07 6.17
GOBP_UTERUS_DEVELOPMENT 5.74 5.35 5.33 5.83 4.88 5 5.34 4.82 5.39 4.61 5.2 4.77 4.8 4.84 5.08 4.91 5.03 5.45 4.99 5 5.43 5.03 5.51 4.59 4.86 4.91
GOBP_VAGINA_DEVELOPMENT 6.99 6.68 6.13 6.5 6.31 6.85 5.97 6.65 6.24 6.4 6.4 6.73 6.44 6.21 5.91 6.26 6.28 5.95 6.55 6.21 6.19 6.24 6.22 6.15 6.18 7.04
GOBP_CANONICAL_WNT_SIGNALING_PATHWAY 6.78 6.68 6.87 6.7 6.87 6.96 6.97 7 6.89 6.9 6.79 6.91 6.9 6.92 6.79 6.83 6.86 6.68 6.8 6.94 6.86 6.95 6.9 7.04 6.88 6.9
GOBP_SYNAPSE_MATURATION 8.16 8.3 8.52 8.03 8.37 8.72 8.65 8.59 8.52 8.53 7.99 8.27 8.9 8.76 8.67 8.72 8.08 8.19 8.66 8.8 8.54 8.64 8.33 8.87 8.73 8.68
GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL 7.55 7.42 7.72 7.5 7.6 8.11 8.04 8.11 7.84 7.85 7.39 7.87 7.8 7.87 8.11 7.84 7.47 7.54 8.04 8.13 7.57 7.86 7.75 7.93 7.89 7.79
GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL 7.04 7.11 7.1 6.61 6.66 7.63 7.34 7.57 7.1 7.34 7.22 7.7 7.11 7.27 7.3 7.05 7.61 7.46 7.44 7.09 7.61 7.67 7.38 7.54 7.45 7.49
GOBP_MEMBRANE_HYPERPOLARIZATION 7.49 7.76 7.94 7.14 8.08 8.1 8.26 7.98 8.27 8.02 7.72 8.11 8.16 8.22 8.26 7.97 8.09 8.06 8.18 8.32 8.03 7.97 7.92 8.43 8.2 8.01
GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS_ENGULFMENT 5.71 5.64 5.79 5.82 5.57 5.57 5.26 5.31 5.71 5.4 5.46 5.2 5.67 5.62 5.61 5.65 5.47 5.49 5.35 5.58 5.72 5.64 5.53 5.47 5.58 6.06
GOBP_AUDITORY_RECEPTOR_CELL_DEVELOPMENT 6.15 6.06 6.32 5.41 5.6 6.23 6.42 5.84 6.26 5.89 6.42 6.2 6.1 6.07 6.01 5.97 5.91 6.01 5.9 5.92 5.87 6.4 6.13 5.93 6.37 5.74
GOBP_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT 6.15 6.14 5.85 5.99 5.97 6.23 6.22 6.09 6.25 5.96 6.15 6.03 6.1 6.07 6 5.94 6.5 6.12 5.93 5.92 6.1 6.12 6.06 6.15 5.96 6.34
GOBP_INNER_EAR_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION 6.04 5.91 5.63 5.92 5.89 6.13 5.92 6.09 5.99 5.98 6.16 6.01 5.95 5.81 5.88 5.59 6.2 6.02 5.92 5.89 5.98 6.09 5.68 6.03 5.96 6.21
GOBP_PREPULSE_INHIBITION 7.58 7.55 8.25 6.79 7.73 8.74 8.59 7.67 8.48 8 7.71 8.08 7.96 8.09 7.73 8.3 7.6 7.98 8.91 8.38 7.87 7.91 8.21 8.24 7.71 7.86
GOBP_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY 6.36 6.3 6.19 6.34 5.83 5.96 6.29 5.85 6.07 6.26 6.23 6.27 5.9 6.05 6.28 6.3 6.06 6.14 6.01 5.98 6.4 6.46 6.18 6.26 6.05 6.55
GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION 6.27 6.39 6.66 6.54 6.63 6.37 6.53 6.07 6.41 6.39 6.03 5.8 6.42 6.13 6.17 5.99 6.84 6.51 6.06 6.15 6.5 6.4 6.43 6.53 6.51 6.55
GOBP_POSITIVE_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING 7.33 7.32 7.52 7.23 7.97 7.87 7.82 7.49 7.62 7.43 7.56 7.44 7.8 7.89 7.38 7.79 7.48 7.55 7.89 7.9 7.93 7.92 7.62 7.72 7.67 7.62
GOBP_NEGATIVE_REGULATION_OF_POSTTRANSCRIPTIONAL_GENE_SILENCING 5.62 5.7 5.99 5.78 5.04 5.1 5.43 5.55 5.71 5.12 5.15 5.09 5.33 5.34 5.47 5.35 5.34 5.62 5.17 5.34 5.55 5.23 5.51 4.81 5.31 4.95
GOBP_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY 8.73 9.01 9.45 8.11 8.92 9.09 9.25 9.07 8.89 9.01 8.93 9.21 9.09 9.09 8.79 8.72 8.63 9.04 9.08 9.65 8.93 8.81 8.96 9.14 9.14 8.7
GOBP_LIMB_BUD_FORMATION 5.66 5.65 6.09 6.18 6.31 6.05 6.09 6.01 6.4 6.2 6.07 5.81 6 6.2 5.94 6.19 5.98 5.93 5.91 5.78 6.05 6.38 6.23 5.89 6.02 6.13
GOBP_REGULATION_OF_LIPASE_ACTIVITY 5.98 5.75 6.06 6.15 6.18 6.05 6.1 6.16 6.02 6.16 6.19 5.56 6.22 6 6.05 5.92 6.26 6.03 5.84 5.98 6.46 5.92 5.94 5.61 6.03 5.98
GOBP_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY 5.87 5.71 6.3 6.21 6 5.87 5.73 5.54 5.59 5.4 6.2 5.42 5.64 5.44 5.97 5.5 6.26 5.65 5.6 5.53 5.77 6.04 5.5 5.53 5.68 5.7
GOBP_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY 5.77 5.68 5.73 5.81 5.99 5.95 6.06 5.92 5.92 6.05 5.81 5.54 6.05 5.87 5.99 5.79 5.68 6.01 5.58 5.93 6.09 5.77 5.63 5.53 5.87 5.87
GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING 8.51 8.85 8.05 7.91 8.31 8.63 8.1 8.93 8.37 8.74 8.15 8.69 8.34 8.32 8.55 8.66 8.77 8.18 8.69 8.23 8.82 8.81 8.23 8.32 8.72 8.98
GOBP_DEFINITIVE_HEMOPOIESIS 5.6 5.73 5.55 5.62 5.73 5.69 5.89 5.7 5.86 5.56 5.66 5.61 5.87 5.82 5.66 5.58 5.8 5.67 5.77 5.7 5.97 6.02 5.61 5.74 5.87 5.63
GOBP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION 7.19 7.51 8.11 7.9 7.65 7.73 8.05 7.91 8.07 8.14 7.81 7.81 7.69 7.77 8.12 8 7.63 7.23 7.46 7.92 7.6 7.9 8.11 8.21 8.08 7.93
GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION 5.59 5.96 6.12 5.99 6.02 6.02 6.38 6.29 6.28 6.36 5.78 6.06 6.16 6.08 6.36 5.9 6.56 6.2 5.71 5.94 6.07 5.94 6.19 6.56 6.15 6.26
GOBP_RETINAL_ROD_CELL_DIFFERENTIATION 6.14 6.09 6.73 6.1 6.37 6.55 6.57 6.56 6.73 6.73 5.89 6.56 6.51 6.49 6.59 6.42 6.78 6.75 6.46 6.99 6.45 6.87 6.79 7.14 6.79 6.56
GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION 5.87 5.55 5.68 5.66 5.31 5.09 5.4 5.29 5.46 5.46 5.82 4.97 5.22 5.16 5.6 5.49 5.35 5.51 5.15 5.33 5.53 5.25 5.16 5.05 5.46 5.35
GOBP_ANATOMICAL_STRUCTURE_HOMEOSTASIS 6.34 6.25 6.59 6.7 6.42 6.55 6.52 6.44 6.48 6.44 6.53 6.42 6.48 6.43 6.41 6.37 6.39 6.28 6.33 6.36 6.47 6.51 6.47 6.54 6.53 6.6
GOBP_REGULATION_OF_GLIAL_CELL_PROLIFERATION 7.12 7.1 6.9 6.44 7.42 7.26 7.36 7.38 6.93 7.34 6.61 7.25 7.6 7.36 7.26 7.04 7.03 6.83 6.93 7.35 7.08 7.05 6.96 7.37 7.19 7.31
GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION 6.04 6.09 6.59 6.05 6.09 6.14 5.98 5.84 6.16 6.4 6.24 5.88 6.22 6.4 5.92 6.04 6.05 5.98 6.13 5.9 6.15 6.31 5.86 6.16 6.05 5.99
GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION 7.53 7.45 7.41 6.71 7.88 7.6 7.51 7.92 7.23 7.39 6.73 7.4 7.65 7.48 7.41 7.22 7.78 7.4 7.03 7.92 7.64 7.44 7.18 7.54 7.58 7.93
GOBP_REGULATION_OF_FEEDING_BEHAVIOR 5.92 6.03 5.9 6 5.51 5.36 5.8 5.93 5.87 5.89 6.07 5.56 5.65 5.81 6.02 6.22 5.81 5.93 6.05 5.72 6.09 6.08 5.79 5.39 5.73 5.9
GOBP_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER 7.78 7.86 7.77 7.88 8.03 8.07 8.2 7.9 8.13 8.34 7.53 8 8.15 8.18 7.84 7.88 7.78 7.7 8.14 8.23 7.59 7.98 8.12 8.2 7.96 7.84
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_INITIATION_FROM_RNA_POLYMERASE_II_PROMOTER 7.46 7.36 7.74 7.49 7.44 8.01 8.12 7.84 7.91 7.88 7.5 7.82 8.07 8.03 7.79 7.53 7.36 7.56 7.55 8 7.41 7.48 7.89 8.15 7.85 7.57
GOBP_REGULATION_OF_RESPIRATORY_BURST 5.61 4.96 5.68 5.58 4.84 5.14 5.49 5.59 5.08 5.36 5.54 4.69 5.71 5.81 5.81 5.56 5.59 5.38 4.79 5.12 4.97 5.39 5.05 4.98 6 5.9
GOBP_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS 4.99 4.96 5.09 5.31 4.95 4.65 5.06 4.99 4.96 4.98 4.99 4.92 4.71 4.97 5.02 5.04 4.91 4.99 4.68 4.76 5.22 5.05 4.81 4.65 5.05 4.83
GOBP_REGULATION_OF_CELL_DEVELOPMENT 6.73 6.68 6.86 6.73 7.09 7.11 7.04 7.23 7 7.07 6.84 7 7.16 7.16 7.14 7.13 6.95 6.89 6.92 7.16 6.89 7.04 7.07 7.14 6.97 7.05
GOBP_LONG_TERM_SYNAPTIC_POTENTIATION 8.83 8.53 8.48 8.15 8.8 8.94 8.87 8.91 8.83 8.81 8.29 8.64 8.84 8.96 8.76 8.87 8.3 8.57 8.89 9.03 8.54 8.49 8.63 9.05 8.86 8.57
GOBP_LONG_TERM_SYNAPTIC_DEPRESSION 8.15 8.13 7.78 7.83 8.17 8.29 8.27 8.35 8.03 8.3 7.75 8.29 8.31 8.34 8.31 8.4 7.97 8.26 8.29 8.39 8.23 8.24 8.12 8.23 8.42 8.35
GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION 7.36 7.28 7.31 7.03 7.4 7.42 7.6 7.41 7.69 7.7 8.17 8.04 7.45 7.72 7.65 7.71 7.94 7.68 7.95 7.71 7.63 7.69 8.16 8.04 7.83 7.31
GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION 6.57 6.44 6.76 6.84 6.3 6.55 6.93 6.9 6.75 7.09 7.14 6.78 6.51 6.74 7.37 7.28 6.79 6.95 6.89 6.81 6.64 6.7 6.63 6.86 6.93 6.51
GOBP_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY 7.07 7.33 7.82 7.5 7.44 7.46 7.65 7.66 7.33 7.33 7.14 7.67 7.5 7.57 7.51 7.64 7.57 7.33 7.48 7.16 7.42 7.72 8.09 7.89 7.63 7.35
GOBP_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY 7.59 7.78 8.36 7.81 8.37 8.38 7.44 7.93 7.5 7.93 7.95 7.8 7.68 7.68 7.7 8.19 7.97 7.51 7.87 7.46 7.77 7.8 8.46 8.03 8.17 8.28
GOBP_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION 6.53 6.72 6.49 6.41 6.7 6.7 6.61 6.69 6.72 6.63 6.52 6.35 6.95 6.96 6.38 6.74 6.83 6.8 6.55 6.76 6.65 6.85 6.78 6.89 6.93 6.87
GOBP_HEAD_DEVELOPMENT 6.84 6.95 7.07 7.03 7.16 7.18 7.22 7.26 7.19 7.28 6.97 7.25 7.21 7.26 7.29 7.18 7.08 7.01 7.03 7.25 7 7.21 7.2 7.28 7.16 7.19
GOBP_HEAD_MORPHOGENESIS 6.15 6.55 6.71 6.41 6.95 6.38 6.81 6.68 7.08 7.06 6.86 7.18 6.93 6.8 6.55 6.6 7.05 6.88 6.08 6.63 6.85 6.91 6.44 6.85 6.88 7.24
GOBP_FACE_DEVELOPMENT 6.15 6.55 6.71 6.5 6.95 6.38 6.42 6.68 7.08 7.06 6.86 7.18 6.69 6.8 6.55 6.6 6.47 6.88 6.08 6.63 6.84 6.82 6.44 6.85 6.88 6.9
GOBP_CELL_CHEMOTAXIS 5.92 5.7 5.77 5.81 5.68 5.56 5.65 5.61 5.72 5.46 5.72 5.56 5.65 5.58 5.64 5.66 5.83 5.72 5.45 5.44 5.97 5.86 5.59 5.41 5.85 5.78
GOBP_REGULATION_OF_RESPONSE_TO_INTERFERON_GAMMA 6.1 6.11 6 6.22 5.66 5.28 5.73 5.75 5.45 5.51 6.6 6.06 5.29 5.14 5.55 5.86 6.16 6.26 5.59 5.4 5.93 5.63 5.52 5.44 5.72 6.1
GOBP_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY 5.73 5.78 5.68 5.89 5.89 5.65 5.73 5.74 5.88 5.51 5.92 5.53 5.68 5.54 5.54 5.49 5.88 5.73 5.47 5.7 5.8 5.63 5.47 5.37 5.75 6.13
GOBP_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY 6.48 6.9 7.15 6.86 7.3 7.23 6.78 6.97 6.86 7.14 7.18 7.04 6.89 6.78 6.93 6.75 7.14 7.21 6.96 7.24 6.87 7.35 6.89 7.26 7.44 7.12
GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY 6.5 6.46 7.55 7.23 6.92 7.1 7.04 7.18 7.25 7.36 7.01 7.3 7.05 7.1 7.2 7.06 7.12 7.49 6.56 7.11 7.06 7.42 7.44 7.65 7.52 7.62
GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY 5.88 5.99 6.34 6.46 6.25 6.12 6.24 6.26 6.38 5.99 6.36 6.3 6.22 6.16 6.28 6.06 5.86 5.51 5.8 5.89 6.08 6.09 6.18 6.06 6.22 6.28
GOBP_REGULATION_OF_CELLULAR_LOCALIZATION 7.19 7.29 7.59 7.33 7.49 7.52 7.4 7.5 7.49 7.49 7.42 7.58 7.59 7.61 7.48 7.56 7.34 7.3 7.39 7.48 7.38 7.56 7.57 7.63 7.58 7.47
GOBP_TRABECULA_FORMATION 6.1 6.31 6.39 6.1 6.24 6.48 6.62 6.49 6.39 6.18 6.19 6.66 6.36 6.17 6.2 6.22 6.28 6.09 5.93 6.08 6.83 6.83 6.57 6.31 6.62 6.7
GOBP_HEART_TRABECULA_FORMATION 6.42 6.64 6.56 6.18 6.17 6.34 6.55 6.39 6.63 6.02 6.4 6.52 6.73 6.48 6.15 6.43 6.3 6.45 6.54 6.58 7.07 6.87 6.73 6.36 6.96 6.96
GOBP_BONE_DEVELOPMENT 6.02 6.13 6.02 6.19 5.92 6 6.16 6.23 6.1 6.07 6.17 6.05 6.2 6.24 6.33 6.06 6.07 6.04 6.07 6.13 6.34 6.33 6.11 6.02 6.32 6.25
GOBP_BONE_MORPHOGENESIS 5.76 5.57 5.84 6.07 5.59 5.6 5.82 5.76 5.8 5.73 6 5.64 5.6 5.63 5.82 5.83 5.85 5.85 5.77 5.78 6.06 6.06 5.62 5.68 5.75 5.84
GOBP_ENDOCHONDRAL_BONE_MORPHOGENESIS 5.75 5.67 5.84 5.87 5.63 5.63 5.93 5.99 5.85 5.73 5.96 5.74 5.81 5.76 5.82 5.88 5.86 5.85 5.93 5.88 6.06 6.26 5.85 5.8 5.86 6.02
GOBP_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS 5.51 5.29 5.31 5.48 5.1 5.27 5.39 5.36 5.12 5.16 5.16 5.49 5.15 5.21 5.51 5.23 5.35 5.51 5.16 5.13 5.31 5.3 5.15 4.93 5.34 5.29
GOBP_CELL_ADHESION_MOLECULE_PRODUCTION 6.51 6.28 6.32 6.49 6.35 6.37 6.25 6.49 6.16 6.18 6.57 6.43 6.46 6.58 6.16 6.41 6.23 6.46 6.76 6.44 6.26 6.49 6.52 6.55 6.27 6.42
GOBP_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY 7.98 7.84 7.88 7.04 8.56 8.61 8.57 8.58 8.33 8.45 7.87 8.44 8.55 8.41 8.26 8.47 8.08 8.25 8.38 8.48 8.44 8.49 8.76 8.88 8.44 8.26
GOBP_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION 6.34 6.29 6.2 6.14 6.98 6.68 6.7 7.1 6.66 6.92 6.35 6.87 7.11 6.86 6.76 6.92 6.02 6.09 6.67 6.81 7.11 7 6.81 6.82 6.87 7.16
GOBP_INNERVATION 6.29 6.23 6.56 5.98 6.07 6.23 6.23 6.97 6.96 6.57 6.32 6.18 6.62 6.66 6.88 6.51 6.26 6.1 5.81 5.75 6.4 6.77 6.63 6.46 6.31 6.4
GOBP_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION 5.95 5.87 6.01 6.06 5.72 5.69 5.72 5.84 5.93 5.78 5.94 5.48 5.97 5.84 5.79 6 5.61 5.65 5.86 5.84 5.87 6.03 5.9 5.85 5.71 5.56
GOBP_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION 6.38 6.52 6.69 6.57 6.63 6.52 6.18 6.53 6.23 6.61 6.34 6.52 6.55 6.14 6.38 6.57 6.64 6.57 6.22 6.54 6.64 6.83 6.61 6.7 6.79 6.93
GOBP_POSITIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION 6.59 6.81 6.99 7.23 6.85 6.77 6.36 6.89 6.64 6.7 6.76 6.78 6.89 6.61 6.77 6.73 6.99 6.88 6.8 6.85 6.86 6.9 7.04 7.15 7.11 7.04
GOBP_NEGATIVE_REGULATION_OF_PATHWAY_RESTRICTED_SMAD_PROTEIN_PHOSPHORYLATION 6.17 5.75 5.65 5.26 5.75 5.6 5.83 5.81 5.93 5.66 5.49 5.83 6.36 6.02 6.11 5.92 5.51 5.25 5.78 5.77 5.77 5.88 5.79 6.17 5.86 5.72
GOBP_SMAD_PROTEIN_SIGNAL_TRANSDUCTION 6.01 6.11 6.23 5.99 5.73 5.57 5.92 6.07 6.12 5.92 6 5.68 5.97 5.89 5.79 6.02 5.94 5.86 5.86 5.94 6.17 6.12 5.96 5.86 6.03 5.89
GOBP_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT 5.92 5.8 6.52 6.07 5.27 6.13 5.53 5.21 5.3 5.44 5.61 5.17 5.62 6.43 5.21 5.76 5.54 5.36 5.92 5.35 5.74 5.37 5.33 5.53 5.73 5.58
GOBP_CYTOSOLIC_CALCIUM_ION_TRANSPORT 6.52 6.45 6.57 6.64 6.57 6.34 6.52 6.6 6.48 6.51 6.56 6.54 6.44 6.42 6.54 6.41 6.54 6.45 6.41 6.55 6.61 6.55 6.48 6.65 6.51 6.56
GOBP_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL 6.36 6.34 6.36 6.44 6.29 6.19 6.38 6.33 6.29 6.39 6.39 6.2 6.31 6.27 6.4 6.27 6.46 6.37 6.09 6.27 6.51 6.37 6.45 6.29 6.38 6.34
GOBP_CARDIAC_SEPTUM_MORPHOGENESIS 6.39 6.47 6.44 6.24 6.76 6.52 6.43 6.44 6.63 6.62 6.4 6.33 6.64 6.73 6.25 6.57 6.69 6.41 6.39 6.38 6.42 6.48 6.53 6.49 6.33 6.56
GOBP_VENTRICULAR_SEPTUM_MORPHOGENESIS 6.89 7.03 6.79 6.56 7.11 6.97 6.96 6.69 6.87 6.79 6.63 6.71 7.38 7.34 6.52 6.92 6.98 6.86 7.02 6.92 6.83 6.85 7.03 6.92 6.89 7.02
GOBP_ATRIAL_SEPTUM_MORPHOGENESIS 5.93 5.64 6.34 6.41 5.6 5.75 5.91 5.91 6.1 6.11 6.07 5.81 6 6.2 5.85 6.55 6.17 6.06 5.96 6.03 5.97 6.34 6.08 5.74 5.87 6.16
GOBP_RESPONSE_TO_GROWTH_HORMONE 5.88 5.91 6.1 6.07 5.57 5.8 5.68 5.68 5.67 5.74 5.66 5.23 5.62 5.72 5.66 5.76 6.05 5.76 5.31 5.35 6 5.84 5.42 5.53 5.73 5.58
GOBP_HEART_GROWTH 6.88 6.98 6.82 7 7.29 7.26 7.14 7.1 7.16 7.03 6.61 7.15 7.23 7.12 6.95 6.91 6.9 6.86 7 7.16 6.99 6.98 7.27 7.29 7.31 7.41
GOBP_REGULATION_OF_HEART_GROWTH 6.88 7.01 6.84 7.01 7.18 7.25 7.16 7.11 7.1 7.08 6.61 7.21 7.27 7.05 6.91 6.88 6.92 6.86 7.06 7.2 7.02 6.91 7.11 7.23 7.22 7.33
GOBP_POSITIVE_REGULATION_OF_HEART_GROWTH 7.15 7.06 6.79 6.79 7.31 7.25 7.44 7.11 7.43 7.33 6.57 7.37 7.34 6.97 7.36 7.15 7.13 6.95 7.06 7.32 7.17 6.99 7.37 7.58 7.55 7.33
GOBP_LUNG_MORPHOGENESIS 5.97 6.09 6.17 6.01 6.21 6.15 6.29 6.14 6.34 6.3 6.15 5.94 6.36 6.35 6.31 6.39 6.02 6.07 5.98 6.16 6.29 6.48 6.53 6.51 6.23 6.21
GOBP_LUNG_EPITHELIUM_DEVELOPMENT 6.18 6.34 6.14 6.47 6.2 6.03 6.25 6.19 6.4 6.26 6.31 6.03 6.26 6.25 6.21 6.54 6.74 6.23 5.9 6.23 6.69 6.91 5.94 6.19 6.22 6.35
GOBP_EPITHELIUM_DEVELOPMENT 5.99 5.99 5.89 5.98 5.73 5.69 5.93 5.92 5.9 5.85 5.92 5.83 5.88 5.79 5.87 5.86 5.99 5.93 5.81 5.82 6.04 5.93 5.81 5.69 5.85 5.93
GOBP_TRACHEA_DEVELOPMENT 6.78 6.63 6.48 6.41 6.92 7.22 7.17 7.47 6.89 6.94 6.91 7.18 6.93 7.23 6.48 7.17 7.51 6.77 7.02 7.57 7.91 7.79 6.44 6.85 6.88 7.24
GOBP_TRACHEA_MORPHOGENESIS 6.73 6.85 6.44 6.45 7.35 7.19 6.98 6.89 6.81 6.57 6.68 6.57 6.96 7.15 6.34 7.07 6.99 6.76 6.96 7.09 7.27 7.33 7.04 6.93 6.96 7.31
GOBP_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS 5.67 6.01 6.11 5.86 5.94 5.9 6.09 5.91 5.98 6.2 5.78 5.77 6.07 6.07 6.12 6.19 5.86 5.88 5.84 5.89 6.22 6.48 6.09 5.85 5.76 6.03
GOBP_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS 5.41 5.64 5.76 5.65 5.47 5.37 5.69 5.38 5.86 5.54 5.77 5.25 5.67 5.71 5.29 5.59 5.69 5.38 5.23 5.28 5.47 5.72 5.35 5.46 5.35 5.31
GOBP_MAMMARY_GLAND_MORPHOGENESIS 5.86 5.89 5.78 5.54 5.72 5.49 5.67 5.94 5.79 5.58 5.8 5.85 5.62 5.54 5.96 5.74 5.72 5.89 5.63 5.59 6.14 5.87 5.51 5.47 6.13 5.78
GOBP_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS 5.64 5.4 5.77 5.81 5.53 5.4 5.57 5.49 5.65 5.58 5.7 5.47 5.51 5.54 5.79 5.44 5.7 5.66 5.29 5.36 5.79 5.72 5.25 5.14 5.63 5.53
GOBP_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS 6.07 5.95 5.97 5.99 6.75 5.9 6.3 6.34 6.27 6.2 6.27 5.94 6.28 6.31 6.04 6.19 6.44 6.31 6.1 6.25 6.39 6.39 6.59 5.85 6.14 6.16
GOBP_REGULATION_OF_GASTRIC_ACID_SECRETION 5.78 5.57 5.5 5.62 4.98 5.26 5.72 5.55 5.41 5.02 5.26 5.31 5.3 5.18 5.33 5.12 5.32 5.5 5.12 5.35 5.64 5.24 5.47 4.94 5.32 5.14
GOBP_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS 6.23 5.79 6.17 6.66 5.62 5.72 6.03 5.82 5.99 5.87 5.91 5.84 5.82 5.65 5.71 5.67 6.19 6.52 6.05 5.56 6.41 5.5 5.79 5.43 5.66 5.85
GOBP_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS 5.35 5.38 5.38 5.38 4.72 4.72 5.3 4.8 5.01 4.94 5 4.86 5.15 5.11 4.99 4.89 5.06 5.31 5.1 5.08 5.15 5.25 5.36 5.03 5.09 4.82
GOBP_LUNG_CELL_DIFFERENTIATION 6.46 6.62 7.17 6.61 6.45 6.16 6.7 6.49 6.89 6.31 6.91 6.29 6.71 6.2 6.45 7.1 6.9 6.53 5.88 6.58 7.16 7.44 6.77 6.48 6.67 6.67
GOBP_MESENCHYME_DEVELOPMENT 6.08 6.14 6.2 6.15 6.19 6.06 6.18 6.23 6.17 6.2 6.32 6.17 6.18 6.18 6.18 6.2 6.24 6.31 6.02 6.13 6.32 6.37 6.25 6.13 6.16 6.28
GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY 7.08 7.16 7.4 7.19 7.54 7.66 7.53 7.34 7.58 7.59 7.51 7.68 7.64 7.53 7.51 7.56 7.27 7.11 7.39 7.66 7.25 7.48 7.77 7.76 7.35 7.4
GOBP_PROSTATE_GLAND_MORPHOGENESIS 5.16 5.24 5.38 5.31 5 5.03 5.46 5.27 5.16 4.95 5.06 5.04 5.05 5.11 5.26 5.69 5.21 5.29 5 4.96 5.5 5.64 5.66 5.07 5.01 5.05
GOBP_PROSTATIC_BUD_FORMATION 5.04 4.94 5.05 5.2 4.84 4.89 5.21 5.18 5.04 4.92 4.94 4.99 4.75 4.85 5.13 5.15 4.96 5.09 5.01 4.77 4.99 4.89 4.9 4.59 4.74 4.65
GOBP_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT 5.75 6.1 6.13 6.25 5.83 5.78 6.38 6.18 6.09 6.18 6.14 6.37 6.13 5.8 6.11 5.95 6.03 5.66 5.18 5.23 6.08 6.26 6.15 6.1 5.79 5.87
GOBP_CARTILAGE_MORPHOGENESIS 4.93 4.7 4.84 4.98 4.42 4.36 4.73 4.75 4.89 4.51 4.94 4.45 4.58 4.59 4.85 4.85 4.86 4.46 4.41 4.5 4.73 4.77 4.45 4.89 4.65 4.32
GOBP_MUSCLE_TISSUE_DEVELOPMENT 6.21 6.31 6.41 6.28 6.41 6.28 6.31 6.32 6.41 6.4 6.44 6.37 6.44 6.43 6.32 6.42 6.53 6.35 6.24 6.34 6.44 6.43 6.48 6.46 6.39 6.53
GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT 6.17 6.15 6.24 6.26 6.16 6.16 6.22 6.3 6.27 6.34 6.42 6.27 6.27 6.4 6.28 6.3 6.41 6.19 6.1 6.3 6.29 6.37 6.32 6.27 6.27 6.27
GOBP_RESPIRATORY_SYSTEM_DEVELOPMENT 6.13 6.17 6.11 6.34 6.16 6.06 6.24 6.15 6.14 6.28 6.19 6.02 6.25 6.2 6.26 6.29 6.25 6.31 6.01 6.22 6.23 6.44 6.31 6.28 6.14 6.13
GOBP_NEGATIVE_REGULATION_OF_NECROTIC_CELL_DEATH 7.25 6.83 7.36 7.15 7.21 7.49 7.56 7.21 7.32 7.76 7.39 8.11 7.32 7.27 6.77 6.76 7.85 7.09 7.65 7.93 7.45 7.17 7.69 7.74 7.58 7.33
GOBP_NEGATIVE_REGULATION_OF_CELL_DEATH 6.49 6.52 6.79 6.65 6.68 6.66 6.69 6.73 6.68 6.7 6.66 6.62 6.73 6.76 6.67 6.65 6.62 6.54 6.59 6.7 6.79 6.82 6.81 6.84 6.79 6.81
GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS 7.33 7.42 7.28 7 7.71 7.81 7.73 7.75 7.54 7.7 7.26 7.72 7.91 7.81 7.61 7.67 7.45 7.48 7.57 7.87 7.48 7.76 7.72 7.9 7.69 7.61
GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS 6 6.28 6 6.13 5.92 5.88 6.08 6.08 6 5.76 6.13 6.07 6.2 5.96 6.11 6.01 6.25 5.91 5.77 6 6.3 6.25 5.81 5.68 6.12 6.38
GOBP_EPITHELIAL_TUBE_MORPHOGENESIS 5.99 5.99 5.95 5.93 6.05 5.95 6.02 6.08 6.02 6.14 5.98 6 6.03 6.04 6.08 5.99 6.02 5.97 5.93 5.91 6.19 6.13 6.02 6 6.02 6.16
GOBP_NEUROEPITHELIAL_CELL_DIFFERENTIATION 5.65 5.49 5.78 6.15 5.54 5.35 5.42 5.36 5.51 5.57 5.91 5.02 5.42 5.34 5.83 5.27 5.67 5.53 5.22 5.47 5.65 5.9 5.65 5.27 5.42 5.55
GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD 5.05 5.24 5.11 5.45 4.97 4.96 5.39 5.48 5.16 4.95 5.16 5.14 5.01 4.87 5.26 5.45 5.03 5.32 5.02 4.96 5.38 5.35 5.06 4.77 5.14 5.01
GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD 5.05 5 5.11 5.42 4.97 4.96 5.46 5.48 5.04 4.95 5.03 5.14 4.85 4.87 5.26 5.42 5.03 5.29 5.02 4.96 5.17 5.1 4.92 4.76 5.01 4.68
GOBP_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION 6.37 6.21 6.01 6.34 5.85 5.78 6.09 6.02 6.2 5.85 5.83 5.8 5.95 6.09 5.9 5.71 6 6.05 5.68 5.85 6.36 6 5.89 5.73 6.41 6.22
GOBP_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT 6.69 6.53 6.55 6.45 6.9 6.58 6.69 6.52 6.56 6.38 5.89 6.41 6.62 6.43 6.28 6.29 5.98 6.04 6.33 6.51 7.01 6.52 6.72 6.63 6.82 6.96
GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION 5.64 5.32 5.77 5.49 5.3 5.19 5.55 5.16 5.66 5.07 5.63 5.37 5.37 5.62 5.54 5.39 5.5 5.42 5.1 5.33 5.54 5.51 5.55 5.16 5.55 5.47
GOBP_LATERAL_SPROUTING_FROM_AN_EPITHELIUM 5.16 4.97 5.12 5.21 4.84 4.89 5.27 5.18 5.04 4.92 4.94 4.99 4.8 4.85 5.13 5.22 4.96 5.13 5.01 4.77 5.21 4.93 4.9 4.59 4.95 4.65
GOBP_BRANCH_ELONGATION_OF_AN_EPITHELIUM 6.37 6.43 6.47 6.1 5.95 6.15 6.42 6.44 6.8 6.28 6.51 5.89 6.67 6.31 6.61 6.45 6.06 6.54 6.34 6.34 6.42 6.65 6.87 6.31 6.75 6.71
GOBP_MAMMARY_GLAND_DUCT_MORPHOGENESIS 5.74 5.7 5.77 5.54 5.54 5.37 5.6 5.82 5.79 5.58 5.8 5.53 5.48 5.53 5.83 5.47 5.68 5.68 5.47 5.59 6.14 5.6 5.26 5.16 5.73 5.66
GOBP_ADIPOSE_TISSUE_DEVELOPMENT 6.71 6.74 6.63 6.27 7.08 6.96 6.95 6.76 7.07 6.97 6.43 7.1 7.24 7.1 6.92 6.84 6.8 6.75 6.62 7.03 6.81 7.01 7.06 7.42 7.16 7
GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT 7.3 7.31 7.62 7.35 7.6 7.71 7.59 7.57 7.57 7.66 7.49 7.68 7.65 7.73 7.68 7.66 7.45 7.46 7.52 7.64 7.53 7.6 7.67 7.84 7.61 7.53
GOBP_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT 8.05 7.73 8.89 8.65 8.3 8.15 8.31 8.25 8.17 8.45 8.52 7.91 8.26 8.06 8.47 8.32 7.83 7.54 7.77 8.05 8.04 8.02 8.45 8.56 8.13 7.94
GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT 5.68 5.66 5.95 5.65 5.15 5.17 5.66 5.48 5.5 5.75 5.46 5.48 5.41 5.42 5.6 5.91 5.67 5.74 5.33 5.32 5.51 5.47 5.51 5.29 5.36 5.35
GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION 7.25 6.99 7.53 7.48 6.9 6.67 7.45 7.45 7.07 6.8 7.75 7.32 6.99 6.82 7.6 7.38 7.63 7.57 6.73 7.12 7.78 7.8 7.33 7.4 7.67 7.63
GOBP_EMBRYONIC_PLACENTA_MORPHOGENESIS 5.78 6.15 5.76 5.81 5.66 5.25 5.64 5.42 5.83 5.38 5.57 5.34 5.54 5.92 5.63 5.63 6.19 5.86 5.52 5.19 5.7 5.55 5.46 5.66 5.83 5.94
GOBP_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS 5.05 5.18 5.16 5.66 4.97 4.77 5.35 5.13 5.4 4.68 5.27 5 4.96 4.96 5.13 4.84 5.11 5.29 4.91 4.88 5.37 5.27 4.9 4.51 5.53 5.13
GOBP_PLACENTA_BLOOD_VESSEL_DEVELOPMENT 7.06 7.38 7 6.74 7.28 7.07 7.27 7.41 7.2 7.04 6.93 7.43 7.38 7.15 7.26 7.49 7.46 7.16 7.04 7.32 7.41 7.26 7.36 7.21 7.13 7.19
GOBP_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE 5.8 5.61 5.94 5.73 5.4 5.35 5.86 6.01 5.41 5.62 5.77 5.45 5.45 5.38 5.86 6.08 5.52 5.66 5.53 5.43 5.88 5.68 5.72 5.49 5.63 5.69
GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT 5.19 5.03 4.96 5.37 4.84 4.66 5.23 4.86 5.21 4.63 5.23 4.72 5 4.86 4.95 4.87 4.92 4.98 4.7 4.58 5.18 4.91 4.84 4.48 5.16 4.58
GOBP_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION 5.22 4.89 4.86 5.04 4.71 4.48 4.88 4.72 5.11 4.57 4.94 4.61 4.8 4.63 4.82 4.63 4.69 4.72 4.41 4.58 4.81 4.8 4.69 4.43 4.75 4.45
GOBP_LABYRINTHINE_LAYER_DEVELOPMENT 6.09 6.32 6.48 6.18 6.11 6.58 6.71 6.59 6.51 6.61 6.44 6.44 6.93 7.02 6.48 6.86 6.68 6.5 6.61 6.73 6.99 7.05 6.27 6.28 6.46 6.44
GOBP_LABYRINTHINE_LAYER_MORPHOGENESIS 5.15 5.26 5.25 5.81 5.09 4.86 5.46 5.37 5.45 4.73 5.31 5.05 5.29 5.14 5.15 4.88 5.3 5.48 5.15 4.98 5.4 5.31 4.94 4.54 5.73 5.24
GOBP_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT 7.12 7.42 7.42 7.01 7.28 7.17 7.48 8.07 7.31 7.1 7.33 7.44 7.59 7.51 7.53 7.55 7.57 7.22 7.04 7.74 8.22 8.5 7.49 7.53 7.57 7.81
GOBP_PARENTAL_BEHAVIOR 5.56 5.43 5.67 5.26 4.93 5.17 5.49 5.1 5.34 5.13 5.66 5.19 5.27 5.22 5.31 5.28 5.41 5.31 5.02 5.39 5.64 5.64 5.6 4.98 5.35 4.85
GOBP_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT 5.23 5.34 5.81 5.72 4.8 5.12 5.59 5.56 5.47 5.56 5.5 5.21 5.49 5.23 5.89 5.54 5.46 5.43 5.48 5.35 5.51 6.13 5.31 5.41 5.57 5.66
GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS 6.28 6.32 6.38 6.43 6.44 6.25 6.18 6.41 6.52 6.27 6.55 6.33 6.32 6.24 6.26 6.3 6.4 6.35 6.18 6.38 6.39 6.49 6.23 6.1 6.36 6.51
GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS 6.12 6.38 6.26 6.3 6.54 6.25 6.06 6.19 6.28 6.21 6.43 6.33 6.29 6.12 6.04 6.36 6.26 6.21 6.31 6.18 6.29 6.43 6.25 5.98 6.02 6.43
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS 6.14 6.08 6.26 6.38 6 5.93 6.09 6.3 6.28 6.07 6.19 6.19 6.16 5.95 5.96 6.11 6.16 6.05 6 6.13 6.36 6.4 5.97 5.98 5.99 6.15
GOBP_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY 7.14 6.94 6.82 6.99 7.27 7.47 7.32 7.37 7.28 7.49 6.8 7.26 7.21 7.26 7.68 7.48 7.54 7.23 7.23 7.41 7.14 7.32 7.31 7.4 7.19 7.2
GOBP_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY 6.83 6.6 6.44 6.85 7.22 7.27 6.95 7.05 7.11 7.14 6.65 6.97 6.99 7.09 6.64 7.22 7.52 6.8 7.2 6.85 6.91 6.84 7.02 7.11 6.78 7.12
GOBP_ECTODERMAL_PLACODE_FORMATION 6.15 5.94 5.37 5.69 5.79 6.02 6.18 6.22 5.87 5.89 5.75 6.45 6.04 5.59 5.86 5.7 6.17 5.61 5.85 5.82 5.59 5.52 6.1 5.82 6.25 6.42
GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER 5.55 5.62 5.49 5.81 4.95 4.96 5.49 5.04 5.53 5.13 5.45 5.34 5.18 5.32 5.41 5.52 5.65 5.46 5.08 4.99 5.69 5.37 5.65 4.97 5.08 5.37
GOBP_ARTERY_DEVELOPMENT 6.12 6.22 6.16 6.14 6.21 6.07 6.23 6.26 6.3 6.17 6.07 6.19 6.47 6.41 6.06 6.24 6.27 6.27 6.01 6.14 6.43 6.41 6.25 6.37 6.16 6.33
GOBP_VENOUS_BLOOD_VESSEL_DEVELOPMENT 6.6 6.48 6.39 6.05 7.42 6.94 6.9 6.75 7.09 7.22 6.29 7.15 7.61 6.96 6.12 6 6.72 6.77 6.06 6.63 6.62 7.22 6.95 7.04 6.36 6.71
GOBP_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION 5.46 5.35 4.98 5.75 5.16 4.78 5.17 4.89 5.16 5.04 5.42 4.91 5.02 4.96 5.14 5.1 5.14 5.36 4.99 5.08 5.06 5.04 4.98 4.63 4.97 5.04
GOBP_CARDIAC_CELL_FATE_COMMITMENT 4.83 4.99 5.26 5.21 4.83 4.74 4.85 4.92 4.92 4.92 5.13 4.89 4.96 4.88 4.92 4.94 4.92 4.77 5.01 4.73 5.05 5.04 4.83 4.82 4.91 5.18
GOBP_HEART_FORMATION 5.55 5.35 5.52 5.39 4.9 4.9 5.31 5.36 5.22 5.01 5.7 5.15 5.06 5.05 5.12 5.42 5.41 5.45 5.3 4.93 5.4 5.32 5.16 5.19 5.25 5.4
GOBP_REGULATION_OF_GENE_SILENCING_BY_RNA 7.33 7.41 7.62 7.69 7.68 7.65 7.58 7.55 7.59 7.66 7.49 7.59 7.68 7.72 7.56 7.75 7.4 7.33 7.52 7.77 7.55 7.84 7.62 7.9 7.64 7.63
GOBP_REGULATION_OF_GENE_SILENCING 7.27 7.16 7.54 7.42 7.64 7.54 7.43 7.35 7.5 7.46 7.45 7.44 7.4 7.5 7.46 7.47 7.3 7.19 7.28 7.62 7.33 7.67 7.49 7.66 7.59 7.43
GOBP_NEGATIVE_REGULATION_OF_GENE_SILENCING 5.54 5.7 6.22 5.89 5.08 5.23 5.44 5.73 5.71 5.37 5.64 5.17 5.35 5.47 5.47 5.46 5.47 5.73 5.68 5.43 5.61 5.28 5.52 5.03 5.71 5.43
GOBP_LEFT_RIGHT_PATTERN_FORMATION 6.07 6.29 6.51 6.53 6.49 6.56 6.17 6.31 6.13 6.82 6.48 6.73 6.55 6.6 6.59 7.57 6.24 6.06 6.49 6.2 6.28 6.34 6.29 6.38 5.97 6.6
GOBP_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT 5.63 5.7 5.86 6.05 6.12 6.06 6.1 6.3 6.17 6.19 6.07 6.23 5.89 5.87 6.15 5.88 5.74 5.8 5.71 5.82 5.88 6.13 5.97 5.95 5.69 6.05
GOBP_CORONARY_VASCULATURE_DEVELOPMENT 6.63 6.65 6.42 6.18 6.85 6.78 6.57 6.53 6.61 6.69 6.34 6.57 6.62 6.61 6.38 6.51 6.45 6.53 6.17 6.3 6.52 6.7 6.57 6.55 6.56 6.6
GOBP_CORONARY_VASCULATURE_MORPHOGENESIS 7.23 6.68 6.81 6.41 7.49 7.56 7.36 7.28 6.93 7.3 6.61 7.42 7.62 7.46 7.01 6.96 7.22 6.83 7.13 7.47 7.56 7.32 7.27 7.58 7.31 7.22
GOBP_ENDOCRINE_HORMONE_SECRETION 5.58 5.67 5.72 5.72 5.51 5.41 5.62 5.88 5.87 5.48 5.73 5.29 5.69 5.55 5.78 5.53 5.65 5.6 5.42 5.53 5.68 5.65 5.69 5.49 5.54 5.39
GOBP_KIDNEY_MORPHOGENESIS 5.94 5.83 5.94 5.87 5.79 5.68 6.02 6.08 6.1 6.01 5.93 5.95 5.96 5.99 6 6.2 5.93 5.97 5.85 5.9 6.09 6.05 6.04 5.91 6.02 6.08
GOBP_DENDRITIC_SPINE_DEVELOPMENT 8.06 8.37 8.32 8.12 8.5 8.66 8.64 8.5 8.54 8.61 8.19 8.47 8.58 8.57 8.69 8.69 8.11 8.27 8.73 8.54 8.15 8.45 8.5 8.81 8.74 8.45
GOBP_DENDRITIC_SPINE_MORPHOGENESIS 7.83 8.1 8.15 7.74 8.28 8.5 8.38 8.25 8.21 8.42 8.08 8.24 8.37 8.51 8.61 8.55 7.95 8.16 8.68 8.44 7.86 8.19 8.18 8.67 8.34 8.26
GOBP_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT 8.14 8.41 8.35 8.15 8.5 8.7 8.72 8.56 8.74 8.65 8.29 8.67 8.69 8.67 8.79 8.85 8.12 8.35 8.76 8.66 8.35 8.55 8.82 8.88 8.81 8.6
GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT 8.14 8.41 8.23 8 8.46 8.54 8.58 8.5 8.52 8.56 8.08 8.44 8.54 8.55 8.69 8.88 8.01 8.22 8.68 8.48 8.09 8.3 8.35 8.69 8.78 8.6
GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT 8.67 9.01 9.07 8.21 9.33 9.43 9.32 9.16 9.3 9.21 8.81 9.27 9.38 9.44 8.86 8.87 8.64 8.58 9.34 9.14 8.65 8.74 9.42 9.44 8.96 8.7
GOBP_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS 8.03 8.39 8.3 7.95 8.51 8.66 8.57 8.43 8.48 8.61 8.28 8.71 8.6 8.75 8.75 8.69 8.22 8.36 8.74 8.51 8.12 8.42 8.57 8.87 8.71 8.37
GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS 7.99 8.1 8.04 7.79 8.3 8.52 8.39 8.43 8.23 8.53 8.05 8.33 8.23 8.55 8.55 8.69 7.79 7.99 8.63 8.46 7.82 8.13 8.25 8.62 8.41 8.37
GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT 6.14 6.11 6.26 6.16 6.08 6.07 6.09 6.18 6.31 6.2 6.23 6.09 6.24 6.06 6.34 6.29 6.24 6.07 5.97 6.06 6.44 6.37 6.22 6.14 6.2 6.37
GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT 6.45 6.22 6.49 6.31 6.49 6.45 6.32 6.63 6.45 6.35 6.28 6.3 6.31 6.39 6.35 6.34 6.62 6.31 6.07 6.61 6.28 6.37 6.36 6.47 6.55 6.51
GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS 7.73 7.95 8.17 8.04 8.13 8.25 8.25 8.18 8.26 8.35 8.09 8.24 8.29 8.22 8.31 8.3 7.96 7.8 7.92 8.23 7.86 8.18 8.38 8.46 8.4 8.2
GOBP_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS 7.68 7.9 8.04 7.8 8.13 8.24 8.06 8.14 8.18 8.31 8 8.24 8.35 8.2 8.31 8.29 7.92 7.65 7.98 8.02 8.07 8.38 8.13 8.33 8.42 8.35
GOBP_MEMBRANE_ORGANIZATION 7.32 7.36 7.79 7.56 7.77 7.84 7.72 7.68 7.73 7.77 7.51 7.74 7.83 7.78 7.66 7.74 7.52 7.47 7.57 7.81 7.47 7.67 7.85 8.02 7.74 7.71
GOBP_MEMBRANE_FUSION 7.29 7.34 7.72 7.48 7.74 7.87 7.61 7.47 7.59 7.84 7.37 7.71 7.67 7.72 7.49 7.51 7.54 7.35 7.39 7.64 7.41 7.57 7.76 7.96 7.57 7.58
GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER 6.74 6.65 7.02 6.8 6.85 7.12 6.97 6.71 7.08 6.69 6.95 6.74 7.2 7 6.57 6.86 7.31 6.85 6.9 6.77 6.97 7.06 7.28 7.05 7.19 7.15
GOBP_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE 6.24 6.41 6.28 6.27 6 6.06 6.14 6.01 6.4 5.92 6 5.37 6.26 6.54 5.79 6.56 5.27 5.46 6.57 5.78 6.1 6.03 6.34 6.34 5.39 5.29
GOBP_REGULATION_OF_CARTILAGE_DEVELOPMENT 5.98 5.69 5.93 6.06 5.99 5.69 5.88 6.08 5.93 5.81 6.1 6.06 5.84 5.8 5.94 6 5.84 5.77 5.71 5.88 5.9 5.94 5.85 5.85 6.02 6.06
GOBP_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT 5.96 5.81 5.86 6 5.81 5.7 5.96 6.18 5.85 5.69 6.06 5.89 5.65 5.67 5.89 5.93 6.02 5.73 5.78 5.89 6.33 6.3 5.75 5.83 6.04 6.13
GOBP_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT 5.4 5.14 5.44 5.7 5.44 5.24 5.49 5.19 5.44 5.44 5.61 5.25 5.47 5.59 5.45 5.78 5.12 5.35 5.24 5.44 5.26 5.1 5.5 5.47 5.35 5.6
GOBP_REGULATION_OF_WOUND_HEALING 5.78 5.61 5.67 5.74 5.42 5.34 5.6 5.63 5.57 5.49 5.61 5.39 5.61 5.61 5.73 5.63 5.8 5.59 5.42 5.41 5.78 5.73 5.67 5.48 5.48 5.49
GOBP_VASCULAR_WOUND_HEALING 6.07 6.06 6.76 5.95 6.07 6.11 6.13 6.69 6.13 6.1 6.04 6.01 6.42 6.29 6.47 6.6 6.25 6.01 6.17 6.22 6.43 6.57 6.34 6 6.07 6.12
GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING 5.52 5.47 5.43 5.54 5.15 5.06 5.3 5.18 5.25 5.23 5.22 5.32 5.32 5.13 5.32 5.17 5.55 5.48 5.31 5.16 5.63 5.42 5.41 5.26 5.39 5.43
GOBP_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT 7.8 7.51 7.97 7.47 7.65 7.97 8.45 7.6 8.46 7.91 7.02 7.41 7.34 7.37 7.92 7.39 7.06 7.34 7.81 8.33 7.42 7.51 7.91 7.9 8.6 8.87
GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT 7.81 8.2 8.42 8.16 8.17 8.37 8.55 8.19 8.3 8.39 7.64 8.01 8.07 8.08 8.49 7.99 7.74 8.1 8.01 8.52 8.11 8.2 8.51 8.45 8.47 8.2
GOBP_SOMITE_DEVELOPMENT 5.83 5.77 5.92 5.95 5.82 5.77 6.02 5.92 5.92 6.03 5.86 5.99 5.89 5.9 5.91 5.93 5.84 5.63 5.79 5.82 5.91 6.02 5.9 5.8 5.76 6.04
GOBP_MUSCLE_STRUCTURE_DEVELOPMENT 6.31 6.41 6.51 6.42 6.5 6.57 6.51 6.45 6.51 6.53 6.45 6.58 6.6 6.52 6.46 6.49 6.61 6.44 6.41 6.45 6.6 6.61 6.59 6.53 6.53 6.62
GOBP_CHAPERONE_MEDIATED_PROTEIN_FOLDING 7.3 7.55 8.04 7.93 8 7.99 7.9 8 7.95 8 7.9 7.79 8.08 7.86 8.13 8.24 7.93 7.7 7.82 8.2 7.97 8.15 8.08 8 8.1 8.2
GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE 6.25 6.35 6.82 6.28 6.41 6.2 6.6 7.08 6.67 6.24 6.37 6.41 7 6.9 6.81 6.75 6.32 6.04 6.28 6.35 6.39 6.47 6.74 7 6.63 6.82
GOBP_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION 6.19 6.35 6.82 6.38 6.95 6.38 6.72 7.08 6.88 6.88 6.37 6.92 7 6.9 6.93 6.75 6.47 6.25 6.28 6.63 6.78 6.7 7.14 7.15 7.11 6.82
GOBP_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY 6.59 6.58 6.92 6.56 6.89 6.77 6.68 6.7 6.77 6.82 6.7 6.75 6.89 6.82 6.65 6.66 6.66 6.44 6.83 6.76 6.81 6.79 6.88 6.82 6.8 6.77
GOBP_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY 6.13 6.51 6.42 6.24 6.22 6.34 6.48 6.51 6.43 6.4 6.26 6.46 6.26 6.44 6.48 6.39 6.5 6.19 6.28 6.47 6.61 6.64 6.26 6.55 6.42 6.58
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY 7.02 6.68 7.28 6.98 7.12 7.08 6.91 6.85 7.14 7.05 7.03 7.28 6.97 7.12 6.77 6.83 6.87 6.72 7.12 7.08 7 7.05 7.16 7.26 7.09 7.08
GOBP_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS 7.59 7.71 8.2 7.97 8.06 8.09 8.16 8.04 8.07 8.15 7.87 8.16 8.11 8.08 7.95 7.98 7.93 7.85 7.87 8.19 7.78 7.97 8.22 8.34 8.14 8.04
GOBP_3_UTR_MEDIATED_MRNA_DESTABILIZATION 7.06 7.44 7.84 7.32 7.23 7.82 7.75 7.5 7.87 7.87 7.3 7.84 7.56 7.66 7.85 7.66 7.45 7.35 7.72 7.86 7.44 7.88 7.9 7.69 7.84 7.36
GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT 5.86 5.77 6.19 6.14 5.66 5.48 5.88 5.95 5.75 6 5.82 5.73 5.82 5.82 6.11 6 5.96 5.98 5.72 5.62 6.17 6.08 5.49 5.53 5.79 6.06
GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY 7.04 7.1 7.59 7.06 7.76 7.82 7.56 7.38 7.27 7.63 7.35 7.26 7.51 7.26 7.77 7.57 6.97 6.99 7.59 7.25 7.3 7.54 7.94 8.01 7.47 7.69
GOBP_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE 5.97 5.93 6.07 5.86 6.19 5.95 6.23 6.55 6.08 5.97 5.98 5.99 6.42 6.37 6.01 6.05 6.22 6.12 5.75 5.95 6.33 6.33 6.35 6.32 6.21 6.21
GOBP_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE 5.82 5.9 5.39 5.4 5.92 5.65 6.19 5.82 6.08 5.97 5.56 5.47 6.22 6.35 5.51 5.47 6.14 5.77 5.72 5.75 6.23 5.98 6.26 5.98 5.85 5.69
GOBP_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE 6.04 6.01 5.94 5.9 6.13 5.64 6.14 5.6 5.99 5.87 5.83 5.95 5.88 5.79 5.85 5.97 5.6 5.97 5.56 5.46 6.1 6.32 5.94 5.31 5.94 5.63
GOBP_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT 5.5 5.56 5.7 5.99 6.11 6.16 6.3 6.08 6.33 6.61 6.07 5.85 5.74 5.71 5.27 5.48 5.42 5.38 5.09 5.58 5.64 5.5 6.27 5.8 5.1 5.26
GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT 5.24 5.23 5.84 6.04 5.32 5.32 5.7 5.7 5.47 5.29 5.39 5.33 5.89 5.76 5.49 5.83 5.46 5.55 5.45 5.64 5.59 5.57 5.75 5.36 5.84 5.85
GOBP_NOTCH_SIGNALING_INVOLVED_IN_HEART_DEVELOPMENT 6.72 6.75 6.51 6.68 7.42 7.26 7.36 8.01 6.93 7.43 6.65 7.42 7.62 7.46 7.26 7.58 7.69 7.58 7.13 7.47 8.19 7.83 8.08 7.7 7.61 7.81
GOBP_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS 5.99 6.18 5.72 6.1 6.02 5.97 5.73 5.57 5.54 6.21 6.07 5.26 6.05 6.48 5.49 6.03 6.49 5.7 5.9 5.72 5.89 6.04 6.27 5.39 6.06 6.48
GOBP_RENAL_TUBULE_DEVELOPMENT 6.07 5.95 5.97 5.87 5.76 5.64 5.96 6.08 6.18 6.15 5.81 6.03 6.24 6.04 6.04 5.86 5.95 5.94 5.91 5.91 6.18 5.8 6.02 5.92 6.02 6.14
GOBP_CARDIAC_CONDUCTION 7.15 7.05 7.24 6.82 7.52 7.35 7.45 7.24 7.54 7.41 6.93 7.29 7.43 7.47 7.36 6.91 7.35 7.22 7.48 7.64 7.08 7.16 7.76 7.63 7.64 7.23
GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY 7.98 8.15 8.26 7.54 7.84 7.85 8.13 7.54 7.71 7.82 8 7.85 8.12 8.08 8.09 7.94 7.99 7.95 7.88 7.98 7.3 8.2 8.06 8.06 8.13 8.1
GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION 6.64 6.77 6.72 6.71 6.96 6.99 7.05 7.02 6.93 7.01 6.9 6.91 6.99 7.01 6.93 6.92 6.93 6.86 6.74 6.9 6.96 7 6.9 7.01 6.88 7.09
GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY 5.29 5.31 5.62 5.53 4.89 4.67 5.23 4.98 5.38 5.14 5.3 5.39 5.04 5.06 4.82 5.04 5.14 5.44 5.06 5.09 5.33 5.6 5.28 5.11 5.21 5.16
GOBP_TRABECULA_MORPHOGENESIS 6.59 6.68 6.79 6.26 6.83 6.99 6.81 6.91 6.64 7.14 6.53 6.97 7.1 7.07 6.8 6.89 6.78 6.83 6.6 7.08 7.22 7.05 7.02 6.87 7.14 6.93
GOBP_HEART_TRABECULA_MORPHOGENESIS 6.68 6.83 6.8 6.46 7.19 7.32 7.21 7.28 6.92 7.2 6.57 7.45 7.62 7.42 6.93 6.94 7.12 6.93 6.89 7.32 7.43 7.33 7.34 7.03 7.46 7.45
GOBP_REGULATION_OF_EXTENT_OF_CELL_GROWTH 7.34 7.52 7.57 7.25 7.79 8.01 7.94 7.92 7.69 7.91 7.44 7.83 7.95 7.91 7.96 7.89 7.49 7.67 7.74 7.95 7.69 7.78 7.77 7.95 7.79 7.81
GOBP_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA 7.61 7.79 8.54 8.56 8.06 8.29 8.22 8.17 8.42 8.4 8.33 8.26 8.38 8.48 8.47 8.42 8.16 7.98 7.85 8.35 8.07 8.2 8.61 8.62 8.37 8.13
GOBP_BONE_TRABECULA_MORPHOGENESIS 5.96 6.29 6.38 5.64 6.39 6.64 6.68 6.7 6.08 6.37 6.22 6.83 6.39 6.29 6.64 6.34 6.19 6.18 5.87 6.18 6.4 6.88 6.6 6.5 6.27 6.7
GOBP_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT 6.07 6.32 6.51 5.99 6.1 6.07 6.08 6.08 6.02 6.03 6.07 6.11 6.36 5.99 6.5 6.01 5.93 6.08 6 6.08 6.32 6.35 6.27 6.28 6.19 6.38
GOBP_CONNECTIVE_TISSUE_DEVELOPMENT 6.01 5.93 5.88 6.05 5.95 5.69 5.98 6.12 5.99 5.93 6.09 6.06 5.88 5.99 6.02 6.01 5.94 6.08 5.89 5.95 6.18 6.26 5.95 5.85 6.02 6.13
GOBP_TROPHOBLAST_CELL_MIGRATION 8.02 7.82 8.76 8.06 8.47 8.43 7.93 7.97 8.03 7.26 7.41 7.8 8.19 8.02 7.63 8 9.52 9.01 7.31 8.21 8.35 8.24 7.61 7.81 8.81 8.56
GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT 6.04 6.06 6.18 6.19 5.95 5.89 6.09 6.11 6.07 6.09 6.19 6.07 6.14 5.96 6.13 6.06 6.14 6.02 6.05 5.95 6.2 6.31 6.03 5.98 6.05 6.26
GOBP_PROTEIN_LOCALIZATION_TO_LYSOSOME 8.63 8.7 9.06 8.6 8.96 8.8 9.16 8.77 9.13 9.01 8.97 9.01 9.14 9.02 8.99 8.89 8.55 8.72 8.88 8.78 8.44 8.83 8.99 9.18 8.88 8.7
GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_PROLIFERATION 7.57 7.48 7.92 7.46 7.11 7.36 7.37 7.76 7.32 7.85 7 7.28 7.81 7.72 7.68 7.34 7.63 7.27 7.55 7.37 7.57 7.69 7.18 7.73 7.64 7.52
GOBP_HEMATOPOIETIC_STEM_CELL_HOMEOSTASIS 6.71 6.68 6.66 6.91 6.36 6.05 6.52 6.23 6.42 6.6 7.26 6.07 6.22 6.2 6.36 6.47 6.25 7.44 6.5 6.49 6.74 6.56 6.23 5.97 6.33 6.79
GOBP_PROTEIN_LOCALIZATION_TO_CILIUM 6.4 6.43 6.88 6.78 6.69 6.86 6.61 6.62 6.38 6.88 6.76 6.88 6.7 6.85 6.64 6.77 6.67 6.75 6.56 6.41 6.72 6.82 6.65 6.8 6.68 6.7
GOBP_MYELOID_CELL_DEVELOPMENT 6.59 6.4 6.66 6.66 6.6 6.68 6.56 6.52 6.6 6.53 6.26 6.54 6.65 6.56 6.48 6.37 6.27 6.53 6.39 6.58 6.63 6.43 6.57 6.73 6.79 6.67
GOBP_MACROPHAGE_PROLIFERATION 8.91 8.64 9.27 8.09 9.18 9.06 9.57 9.32 8.84 8.75 8.34 8.61 8.97 8.9 8.98 9.2 8.38 8.83 8.99 9.71 8.78 9.25 8.4 8.93 9.04 9.18
GOBP_GANGLION_DEVELOPMENT 5.86 5.93 6.54 6.24 6.26 6.15 6.29 6.82 6.42 5.99 6.19 5.65 6.62 6.19 6.61 6.29 6.59 6.07 5.81 5.75 6.36 6.73 6.4 6.31 6.31 6.4
GOBP_AXON_DEVELOPMENT 7.25 7.28 7.38 7.02 7.47 7.66 7.72 7.7 7.47 7.65 7.32 7.68 7.67 7.73 7.74 7.68 7.36 7.34 7.45 7.76 7.4 7.63 7.69 7.83 7.67 7.53
GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION 6.87 6.92 7.11 7.13 7.37 7.19 7.2 7.35 7.27 7.28 7.38 7.34 7.25 7.31 7.34 7.25 7.37 7.18 7.19 7.39 7.18 7.34 7.41 7.48 7.34 7.38
GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL 7.86 8.23 8.14 7.47 8.49 8.72 8.75 8.42 8.79 8.92 8.33 8.5 8.7 8.98 8.23 8.28 8.23 7.69 8.66 8.29 7.72 8 8.73 8.64 8.5 8.37
GOBP_PRI_MIRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II 6.31 6 6.44 6.26 6.12 6.15 6.17 6.34 6.41 6.54 6.06 5.94 6.44 6.62 6.44 6.7 6.18 6.13 6.43 6 6.54 6.89 6.49 6.41 6.28 6.78
GOBP_GLYCOLYTIC_PROCESS_THROUGH_FRUCTOSE_6_PHOSPHATE 6.51 6.53 7.1 7.56 5.85 6.35 6.59 6.52 6.5 6.29 6.57 6.49 6.39 6.18 6.41 6.26 6.36 6.61 6.39 6 6.6 6.76 6.31 6.05 6.45 6.2
GOBP_CYTOSKELETON_DEPENDENT_CYTOKINESIS 6.71 6.69 7.38 7.07 7.02 6.87 7 6.8 6.93 7 6.91 6.97 7.06 7.04 7.18 7.21 6.7 6.75 6.72 6.96 6.7 6.95 7.02 7.33 7.16 7.02
GOBP_HISTONE_H3_K9_MODIFICATION 6.06 6.2 6.28 6.46 6.02 6.18 6.19 6.12 6.33 6.33 6.15 6.26 6.25 6.5 6.21 6.2 6.13 5.99 6.29 6.15 6.23 6.28 6.48 6.53 6.33 6.34
GOBP_CHAPERONE_MEDIATED_AUTOPHAGY 8.72 9.14 9.78 9.42 9.32 9.46 9.78 10.22 9.7 9.65 9.53 9.89 9.86 9.74 10.16 9.65 9.81 9.68 9.6 9.99 9.95 10.05 9.54 9.71 9.77 9.85
GOBP_DETOXIFICATION_OF_INORGANIC_COMPOUND 6.83 6.87 6.92 7.13 5.83 6.08 6.58 6.43 6.72 6.43 7.15 6.41 5.92 6.12 6.31 6.52 6.5 6.64 5.77 6.11 7.04 7.02 6.31 5.81 6.48 6.77
GOBP_MOTOR_BEHAVIOR 6.8 6.98 7.01 7.12 7.09 7.01 7.82 7.49 7.57 7.34 7.06 7.02 7.25 7.6 7.13 7.24 6.7 6.87 7.22 7.84 7.25 7.4 7.4 7.54 7.15 7.57
GOBP_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL 6.01 5.88 5.89 6.09 5.98 6.12 6.16 6.19 6.31 5.88 5.91 5.71 6 5.79 5.93 6.02 5.88 5.96 5.78 6.05 6.17 6.25 5.91 5.95 6.26 6.42
GOBP_MICROTUBULE_ORGANIZING_CENTER_LOCALIZATION 6.17 6.4 6.54 6.18 6.44 6.64 6.67 6.47 6.41 6.71 6.83 6.6 6.61 6.25 6.83 6.83 6.28 7.01 6.43 6.59 7 6.73 6.61 6.69 6.56 6.79
GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE 4.78 4.7 4.66 4.67 4.14 3.99 4.31 4.34 4.49 4.15 4.51 4.25 4.15 4.14 4.28 4.24 4.57 4.72 4.26 4.21 4.66 4.36 4.21 3.96 4.24 4.3
GOBP_SELECTIVE_AUTOPHAGY 7.97 8.09 8.25 8.01 8.18 8.19 8.05 7.94 8.23 8.35 8.18 8.12 8.13 8.13 8.13 8.14 7.94 7.93 8.26 8.06 7.91 8.06 8.4 8.54 8.19 7.94
GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM 7.41 7.54 7.95 7.68 7.89 7.85 7.92 7.82 7.77 7.84 7.63 7.8 7.85 7.87 7.87 7.83 7.63 7.49 7.64 7.87 7.64 7.84 7.92 8.07 7.94 7.79
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE 7.64 7.73 8.19 7.92 8.24 8.24 7.96 8.13 7.83 7.97 7.92 7.89 7.97 8.1 8 8.09 7.83 7.7 8.13 8.1 8.01 7.85 8.04 8.2 7.84 7.87
GOBP_MIDBODY_ABSCISSION 6.51 6.46 7.97 7.25 6.78 6.82 7.06 6.95 6.81 6.84 7.19 6.97 7.04 7.04 7.2 7.21 6.48 6.45 6.54 6.82 6.68 6.93 7.49 7.45 7.03 6.85
GOBP_MEIOSIS_I_CELL_CYCLE_PROCESS 5.02 5.1 4.8 5.06 4.79 4.52 4.73 4.87 4.72 4.61 4.91 4.83 4.56 4.53 4.7 4.75 4.98 5.12 4.95 4.74 5.09 4.68 4.68 4.56 4.67 4.78
GOBP_SECONDARY_PALATE_DEVELOPMENT 6.11 6.31 6.33 5.94 6.26 6.4 6.65 6.21 6.61 6.43 6.58 6.24 6.42 6.53 6.32 6.58 6.66 6.67 6.44 6.43 6.5 6.65 6.39 6.6 6.57 6.68
GOBP_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS 6.82 6.85 7.24 7.04 6.93 6.97 7.05 7.01 7.13 7.12 6.92 7.03 7.11 7.14 7.02 6.93 7.03 6.91 6.87 6.99 6.84 6.89 7.21 7.23 7.12 6.99
GOBP_POSITIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS 6.04 6.04 6.27 6.15 6 6.21 6.07 6.21 6.2 6.26 6.01 6.21 6.43 6.13 6.07 6.09 6.18 6.13 5.96 6.03 6.3 6.13 6.21 6.05 6.02 6.16
GOBP_NEGATIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS 5.96 5.87 5.96 6.15 6.27 6.22 6.04 6.22 6.28 6.11 6.12 6.27 6.34 6.27 6.01 6.26 6.46 5.91 6.1 6.03 6.41 6.6 6.22 6.02 6.3 6.44
GOBP_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH 7.34 6.92 7.59 7.24 7.21 7.58 7.56 7.33 7.22 7.74 7.65 7.95 7.51 7.3 6.83 7.09 7.83 7.4 7.65 7.93 7.45 7.21 7.27 7.66 7.57 7.33
GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH 7.42 7.08 7.55 7.18 7.3 7.55 7.56 7.55 7.67 7.84 7.77 8.13 7.76 7.3 7.02 6.99 7.99 7.4 7.68 7.99 7.71 7.27 8.14 7.74 7.78 7.39
GOBP_REGULATION_OF_MITOCHONDRIAL_GENE_EXPRESSION 6.71 6.81 7.68 7.65 6.98 7.37 7.04 7.05 6.97 7.13 6.74 7.14 7.2 7.31 6.67 6.69 6.53 6.67 6.82 7.42 6.64 6.72 6.98 7.24 6.97 6.59
GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN 6.83 6.81 6.68 6.47 7.33 7.82 7.54 7.61 7.17 7.57 6.86 7.39 7.19 7.32 7.45 7.43 6.89 6.71 6.84 7.44 7.37 7.59 7.09 7.03 7.22 7.13
GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS 6.73 6.81 7.25 7.03 7.04 7.03 6.92 7.01 7.08 7.07 7.02 6.99 7.11 7.08 7.09 7.14 7.02 6.96 6.8 7.06 7.06 7.18 7.12 7.27 7.14 7.05
GOBP_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY 6.11 6.08 6.01 6.4 6.07 6.02 5.99 6.01 5.94 5.86 6.1 6.19 5.89 5.9 5.86 5.9 6.06 5.85 5.86 5.59 6.11 6.03 5.75 5.65 6.08 6.03
GOBP_POSITIVE_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY 6.19 6.35 5.92 6.28 6.38 5.87 5.89 5.7 5.83 5.93 6.32 6.26 5.89 5.92 5.53 5.76 6.16 5.87 5.61 5.68 6.17 5.93 5.47 5.43 5.83 5.78
GOBP_PROTEIN_LOCALIZATION_TO_POSTSYNAPSE 7.64 7.92 8.4 8.09 8.38 8.14 8.38 8.27 8.41 8.12 8.27 8.04 8.21 8.57 8.48 8.28 8.33 8.34 8.35 8.23 8.17 8.34 8.27 8.51 8.28 7.99
GOBP_PROTEIN_LIPID_COMPLEX_ASSEMBLY 6.21 6.28 6.08 6.35 6.32 6.28 6.34 6.57 5.84 5.98 6.43 6.04 6.23 5.97 6.17 6.05 6.25 6.15 6 6.3 6.22 6.42 5.59 5.73 6.5 6.83
GOBP_NEURON_CELLULAR_HOMEOSTASIS 8.73 8.37 8.38 8 8.77 8.81 8.95 8.8 8.68 8.82 8.39 8.53 8.72 8.79 8.48 8.47 8.08 8.24 8.69 8.74 8.3 8.39 8.55 8.84 8.33 8.27
GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 6.34 6.5 6.6 6.84 6.64 6.67 6.48 6.74 7 6.77 6.8 6.79 6.67 6.77 6.91 6.78 6.54 6.72 6.68 6.79 6.77 6.66 6.88 6.96 7.09 6.73
GOBP_GLYCOSYLATION 6.8 6.74 6.94 6.89 7.01 7.02 7.12 6.86 7.05 6.86 6.79 6.89 7.1 6.86 6.87 6.88 6.86 6.7 6.83 6.94 6.67 6.86 6.95 6.91 6.92 6.97
GOBP_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY 7.93 7.76 8.08 7.74 7.85 7.88 8.04 7.31 7.76 7.92 7.56 7.77 7.91 7.96 7.7 7.81 7.07 7.39 7.87 7.86 7.47 7.65 7.89 7.81 7.61 7.4
GOBP_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY 6.78 6.98 7.16 7 7.01 7.16 6.97 7.04 7.43 7.37 7.2 7.57 7.37 7.23 7.4 7.54 7.2 6.94 6.98 7.14 7.06 7.3 7.81 7.61 7.35 7.46
GOBP_INTERLEUKIN_27_MEDIATED_SIGNALING_PATHWAY 7.49 7.85 8.32 8.14 7.62 8.24 8.09 7.52 7.86 8.27 8.25 8.29 8.2 8.26 8.3 8.3 7.93 7.89 7.79 8.07 8.19 8.5 8.2 7.89 8.32 7.97
GOBP_MITOCHONDRIAL_TRANSLATIONAL_TERMINATION 6.7 6.97 8.24 7.89 7.12 7.18 7.28 7.42 7.59 7.33 7.7 7.38 7.26 7.53 7.64 7.86 6.98 6.98 6.97 7.36 7.09 7.67 7.37 7.58 7.24 7.3
GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION 6.57 6.81 7.33 7.14 6.31 6.85 6.85 7.19 6.89 7.13 6.82 7.27 7.2 7.22 6.48 6.53 6.23 6.6 6.33 7.23 6.22 6.46 6.9 6.93 6.99 7.03
GOBP_RESPONSE_TO_UV_A 5.51 5.77 6.78 6.15 5.15 5.83 5.22 6.26 7.31 5.28 6.34 5.36 6.29 7 6.87 6.97 6.96 6.97 6.68 7.01 6.31 5.51 6.59 5.62 6.19 6.43
GOBP_SYNAPTIC_VESICLE_BUDDING 7.28 7.59 8.63 8.22 8.91 8.67 8.27 7.48 8.57 8.92 8.18 8.48 8.67 8.18 8.73 8.37 7.96 7.68 7.68 7.89 7.56 8.13 8.57 8.43 8.34 8.22
GOBP_ENAMEL_MINERALIZATION 5.33 4.99 4.65 4.99 4.95 4.03 4.6 4.45 4.67 4.55 5.15 4.77 4.75 4.1 4.61 4.37 4.57 5.07 4.7 4.38 4.87 4.63 4.45 4.25 4.78 4.98
GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE 4.99 5.09 5.25 5.38 5.11 4.88 4.59 5.01 4.85 4.63 5.21 5.15 4.82 4.6 4.71 4.9 4.83 5.14 5.13 4.83 5.08 4.75 4.71 4.58 4.68 4.9
GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION 5.34 5.25 4.75 5.12 5.17 4.96 4.75 4.91 4.89 4.46 4.99 5.05 4.84 4.71 5.14 4.87 4.96 5.15 5.24 5.14 5.1 5 4.7 4.52 4.52 4.91
GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION 7.27 7.33 7.83 7.92 7.65 7.66 7.49 7.39 7.65 7.94 7.78 7.42 7.51 7.38 7.84 7.59 7.42 7.1 7.73 7.38 7.38 7.5 7.96 7.85 8 7.83
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME 7.08 6.81 7.38 7.41 7.34 7.33 7.31 7.23 7.45 7.6 7.7 7.26 7.06 7.3 7.47 7.26 7.18 6.99 7.35 7.3 7 7.4 7.45 7.74 7.22 7.73
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE 7.09 7.15 7.82 7.36 7.4 7.33 7.39 7.23 7.45 7.85 7.78 7.26 7.29 7.3 7.77 7.57 7.18 6.99 7.72 7.3 6.74 7.4 7.45 7.74 7.43 7.76
GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME 7.65 7.97 9.31 8.67 7.79 8.07 8.71 8.63 8.46 8.45 8.59 8.33 8.37 8.07 8.42 9.11 7.96 7.79 8.01 8.06 8.26 8.48 8.59 8.68 8.53 8.05
GOBP_PROTEIN_TRIMERIZATION 6.38 6.31 6.49 6.92 6.46 6.4 6.04 6 6.4 5.75 5.76 5.78 6.33 6.28 5.74 5.51 6.16 6.53 5.49 6.22 5.75 5.73 6.18 5.98 5.99 5.24
GOBP_PROTEIN_AUTO_ADP_RIBOSYLATION 7.5 7.38 7.85 6.83 7.55 7.38 7.37 7.73 7.42 7.03 7.7 7.76 7.26 7.57 7.28 7.73 7.5 7.19 6.94 7.67 7.41 7.8 7.22 7.42 8.07 7.85
GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS 5.5 5.43 5.42 5.66 5.22 5.12 5.5 5.38 5.42 5.18 5.28 5.02 5.48 5.38 5.49 5.31 5.5 5.13 5.13 5.3 5.44 5.72 5.42 5.29 5.61 5.5
GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS 5.25 5.23 5.1 5.31 4.91 4.91 5.21 5 5.26 4.93 5.19 4.94 5.21 5.09 5.18 5.2 5.07 5.08 4.86 5.12 5.2 5.11 5.13 5.06 5.11 5.13
GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS 5.38 5.28 5.42 5.62 5.31 5.17 5.75 5.72 5.59 5.56 5.26 5.43 5.51 5.36 5.64 5.31 5.29 5.13 5.21 5.33 5.37 5.72 5.74 5.77 5.78 5.66
GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS 4.55 4.51 4.51 4.96 4.16 4.12 4.28 4.33 4.41 4.3 4.62 4.18 4.57 4.49 4.64 4.17 4.59 4.82 4.54 4.35 4.78 4.67 4.43 4.29 4.47 4.62
GOBP_T_CELL_APOPTOTIC_PROCESS 5.26 5.29 5.24 5.31 5.11 5.09 5.5 5.38 5.33 5.18 5.24 5.02 5.34 5.2 5.43 5.3 5.29 5.05 5.04 5.24 5.32 5.72 5.23 5.24 5.49 5.46
GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS 5.01 5.23 5.1 5.31 4.85 4.99 5.46 5.11 5.25 4.98 5.13 4.89 5.21 5.07 5.28 5.28 4.97 5.01 4.91 5.19 5.2 4.99 4.99 5.06 5.14 5.17
GOBP_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS 5.24 5.28 5.59 5.62 5.31 5.17 5.75 5.72 5.59 5.56 5.26 5.28 5.51 5.3 5.64 5.31 5.29 5.09 5.21 5.33 5.37 5.4 5.83 5.77 5.78 5.66
GOBP_THYMOCYTE_APOPTOTIC_PROCESS 5.88 6 5.81 6.19 5.82 5.46 5.88 5.66 5.58 5.47 5.81 6.06 5.6 5.51 5.86 6.13 6.12 5.64 5.29 5.91 6.02 5.83 5.58 5.58 5.89 5.84
GOBP_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS 5.32 5.48 5.68 6.05 4.98 5.1 5.61 5.55 5.55 5.14 5.63 5.09 5.29 5.1 5.42 5.3 5.81 5.29 5 5.69 5.94 5.67 5.28 5.18 5.48 5.53
GOBP_ACTIN_MEDIATED_CELL_CONTRACTION 6.31 6.16 6.41 6.25 5.8 5.8 6.21 6.23 6.16 6.27 6.42 6.33 6 5.97 6.48 6.43 6.46 6.44 6.3 6.24 6.44 6.35 6.39 5.95 6.12 6.39
GOBP_PEPTIDYL_SERINE_DEPHOSPHORYLATION 8.54 8.25 9.67 8.94 8.04 8.25 8.82 8.91 8.73 8.62 8.67 8.47 8.29 8.65 8.94 9.31 8.42 8.53 8.26 8.59 8.87 8.89 8.91 9.08 8.87 8.67
GOBP_NECROTIC_CELL_DEATH 6.33 6.32 7.51 7.09 6.41 6.42 6.75 6.93 6.38 6.24 6.27 6.42 6.25 6.31 6.43 6.55 6.5 6.25 6.26 6.8 6.86 7.1 6.7 6.78 7.08 7.22
GOBP_NECROPTOTIC_PROCESS 6.49 6.39 7.45 7.15 6.46 6.65 6.34 6.53 6.62 6.22 6.27 6.53 6.54 6.64 6.23 6.55 6.6 6.55 6.54 6.68 6.75 7.1 6.32 6.78 7.39 7.22
GOBP_CORNIFICATION 4.86 4.68 4.49 4.91 4.37 4.19 4.7 4.46 4.57 4.25 4.66 4.39 4.39 4.23 4.45 4.33 4.61 4.67 4.34 4.3 4.76 4.51 4.33 4.27 4.39 4.37
GOBP_PYROPTOSIS 4.61 4.89 4.14 4.41 4.02 3.97 4.11 4.3 4.13 3.92 4.36 4.24 3.98 3.97 4.3 4.28 4.41 4.67 4.56 4.39 4.62 4.22 3.96 4.03 4.17 4.31
GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY 5.28 5.1 5.07 4.77 4.67 4.99 5.05 4.74 4.71 4.96 5.02 4.9 5.05 5 5.06 5.36 5.04 5.24 4.87 4.81 5.25 4.99 4.61 4.81 4.92 4.92
GOBP_RENAL_ABSORPTION 5.98 6.12 7.24 6.59 5.66 5.78 6.15 6.48 6.25 5.69 6.66 6.5 6.35 5.9 6.14 6.67 6.51 5.84 5.85 6.17 7.21 7.39 6.19 6.29 6.07 6.83
GOBP_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT 7.17 7.09 8.19 7.88 7.62 7.36 7.53 7.94 7.68 7.84 7.28 7.14 7.72 7.81 7.78 7.57 7.34 7.32 7.57 7.86 7.62 7.58 8.12 7.7 7.76 7.73
GOBP_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE 6.53 6.5 6.65 6.61 6.82 6.58 6.95 7.02 6.8 6.87 6.83 6.72 6.87 6.88 7.06 7 6.93 6.74 6.66 6.95 7.02 7.54 6.75 6.96 7.13 6.94
GOBP_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE 6.47 6.44 6.62 6.57 6.56 6.59 6.59 6.49 6.64 6.53 6.68 6.78 6.55 6.6 6.61 6.61 6.52 6.48 6.46 6.48 6.59 6.74 6.89 6.74 6.76 6.68
GOBP_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE 6.48 6.81 7.29 6.94 7.01 6.96 6.99 6.86 7.29 7.14 6.83 7.03 7.02 7.58 7.11 7.58 6.69 6.94 7.04 7.11 6.91 6.83 7.25 7.43 7.05 7
GOBP_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE 6.08 6.06 6.05 6.18 6.21 6.13 5.95 6.16 5.93 6.2 6.23 6.09 6.16 6.31 6.11 6.26 6.01 6.17 6.13 6.12 6.34 6.31 5.98 5.89 6.1 6.12
GOBP_LENS_FIBER_CELL_DIFFERENTIATION 7.05 7.18 7.23 6.91 7.36 7.3 7.29 7.03 7.43 7.18 7.1 7.2 7.48 7.44 7.23 7.2 7.14 7.29 7.16 7.24 6.98 6.96 7.39 7.36 7.11 7.23
GOBP_LENS_FIBER_CELL_DEVELOPMENT 6.15 5.98 5.39 5.9 6.21 6.42 6.83 6.63 6.93 6.53 5.98 6.06 6.14 6.53 6.01 6 6.53 5.68 6.03 6.22 5.44 5.37 6.79 6.65 5.71 5.84
GOBP_THYROID_HORMONE_TRANSPORT 8 8.05 7.55 7.41 7.25 7.91 8.26 7.82 8.25 7.32 7.09 7.3 8.55 8.47 8.13 7.98 7.92 8.17 7.85 8.28 8.15 8.26 7.84 8.35 8.06 7.51
GOBP_HEPATOCYTE_DIFFERENTIATION 5.52 5.41 5.28 5.53 4.88 4.7 5 4.78 5.58 4.56 5.26 4.72 4.77 4.94 5.09 5.03 5.23 5.1 4.78 4.79 5.11 5.15 4.81 4.73 4.98 5.08
GOBP_ERK1_AND_ERK2_CASCADE 6.17 6.03 6.12 6.15 5.97 6.06 6.18 6.07 6.16 5.89 6.03 5.9 6.14 6.05 6.14 5.96 6.08 5.97 5.93 6.11 6.35 6.07 6.02 6.01 5.97 6.07
GOBP_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE 7.11 7.32 7.43 7.2 7.57 7.46 7.37 7.78 7.76 7.53 7.25 7.45 7.54 7.9 7.84 7.77 7.44 7.43 7.52 7.68 7.77 7.73 8.1 8.09 7.57 7.42
GOBP_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE 5.77 5.7 5.71 5.83 5.45 5.37 5.54 5.64 5.68 5.39 5.64 5.33 5.68 5.48 5.62 5.71 5.51 5.75 5.55 5.55 5.84 5.81 5.68 5.47 5.57 5.6
GOBP_DNA_CYTOSINE_DEAMINATION 4.66 5.03 5.04 4.28 4.3 4.21 4.52 4.8 4.33 4.23 4.61 4.59 4.18 4.34 4.56 4.5 4.91 5.02 4.59 4.68 5.15 4.55 4.11 4.36 4.93 4.95
GOBP_RESPONSE_TO_LIPOTEICHOIC_ACID 6.18 6.38 6.85 7.2 6.66 6.29 5.13 5.58 5.7 5.22 5.53 4.67 5.7 5.63 5.4 6.08 4.88 5.21 5.34 5.43 6.01 6.26 5.79 6.12 5.84 6.59
GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_SIGNALING_PATHWAY 7.28 6.8 7.91 7.69 7.62 7.83 7.44 7.51 7.75 7.04 7.67 7.62 7.88 7.84 7.83 7.83 7.48 7.28 7.59 7.51 7.88 8.01 8.22 8.26 7.63 7.59
GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY 7.08 6.45 7.36 7.6 7.34 7.24 7.34 7.47 7.26 7.03 6.81 7.17 7.75 7.61 7.76 7.53 7.04 7.19 7.22 7.73 8.04 8.04 7.21 7.59 7.42 7.42
GOBP_RESPONSE_TO_OXYGEN_LEVELS 6.75 6.74 7.21 7.11 7.17 7.11 7.04 7.09 7.07 7.17 7.13 7.01 7.1 7.21 6.93 7.01 7.2 6.96 6.82 7.19 7 7.1 7.11 7.17 7.3 7.12
GOBP_LEUKOCYTE_AGGREGATION 5.46 5.54 5.88 5.99 5.53 5.28 5.54 5.37 6.12 5.36 5.33 5.34 5.48 5.48 6.02 5.91 5.63 5.92 5.48 5.5 6.32 6.23 5.31 5.06 6.01 5.9
GOBP_THROMBIN_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY 5.48 5.32 4.62 4.76 4.72 4.67 4.7 4.8 5 4.83 5.07 5.02 4.7 4.85 4.71 4.8 4.91 5.24 4.79 4.8 5.2 4.93 4.77 4.4 4.66 4.9
GOBP_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY 7.38 7.58 7.95 7.9 7.84 7.81 8 7.8 8.14 7.99 7.78 7.31 7.86 7.86 7.76 7.62 7.67 7.18 7.46 7.73 7.29 7.49 8.05 8.07 7.78 7.7
GOBP_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION 7.51 7.53 7.75 7.53 7.89 8.11 7.78 7.7 7.67 7.91 7.68 7.91 7.87 7.92 8.05 7.92 7.49 7.51 7.66 7.77 7.57 7.92 8.13 7.92 7.76 7.75
GOBP_CALCIUM_ION_IMPORT 5.83 5.76 5.92 6.11 5.72 5.57 5.82 5.9 5.66 5.66 5.88 5.57 5.98 5.82 6.28 5.88 5.95 5.88 5.65 5.62 6.1 6.07 5.86 5.64 5.99 5.97
GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS 6.09 6.25 6.63 6.35 5.85 6.04 5.86 5.66 6.21 5.77 6 5.72 5.79 5.86 5.98 6.21 5.81 5.9 5.95 5.83 5.74 5.94 5.95 6.13 5.82 6.23
GOBP_PLATELET_AGGREGATION 6.51 6.16 6.43 6.54 6.36 6.42 6.16 6.29 6.31 6.11 6.26 6.2 6.08 6.43 6.2 6.28 6.29 6.27 6.42 6.4 6.48 6.43 6.48 6.15 6.44 6.43
GOBP_PROTEIN_KINASE_C_SIGNALING 5.66 5.82 5.45 5.83 5.63 5.6 5.72 5.86 5.79 5.76 5.56 5.7 5.78 5.57 5.66 5.88 5.75 5.96 5.88 5.43 6 5.86 5.4 5.56 5.71 5.99
GOBP_PROTEIN_K63_LINKED_UBIQUITINATION 6.74 6.82 7.23 7.2 6.98 7.34 7.18 7.75 6.95 7.07 7.05 6.93 7.18 7.26 7.53 7.08 6.95 7.08 7.1 7.06 7.25 7.07 7.22 7.16 7.44 7.33
GOBP_PROTEIN_K63_LINKED_DEUBIQUITINATION 7.43 7.33 7.23 7.49 7.49 7.62 7.74 7.33 7.5 7.68 7.53 7.69 7.76 7.72 7.77 7.48 7.09 7.5 7.39 8.07 7.2 7.6 8.06 8.24 7.74 7.28
GOBP_RESPONSE_TO_FATTY_ACID 6.13 6.05 6.76 6.23 6.33 6.06 6.29 6.4 6.35 6.16 6.24 6.06 6.18 6.18 6.48 6.56 6.42 6.2 6.01 6.1 6.22 6.55 6.11 6.12 6.25 6.31
GOBP_RESPONSE_TO_INTERLEUKIN_1 6.66 6.53 6.88 6.74 6.64 6.67 6.74 6.71 6.85 6.8 6.84 6.79 6.76 6.77 6.58 6.69 6.73 6.5 6.5 6.65 6.59 6.72 6.94 6.87 6.88 6.68
GOBP_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY 6.18 6.15 5.66 6.67 6.03 6.15 6 6.03 6.12 6.2 5.96 6.31 5.97 6.11 5.58 5.91 6.53 5.88 5.88 6.05 6.34 6.17 6.42 5.95 6.9 6.64
GOBP_REGULATION_OF_NEURON_PROJECTION_REGENERATION 7.83 8.17 8.11 7.69 8.1 7.95 8.35 8.72 7.96 8.24 8.05 8.29 8.34 8.25 8.42 8.4 8.58 8.55 7.91 8.58 8.83 8.76 8.68 8.36 8.55 8.3
GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION 7.83 8.17 8.27 7.79 8.03 7.95 8.41 9.01 7.93 8.01 7.7 8.12 8.34 8.25 8.42 8.4 8.63 8.52 7.71 8.59 8.49 8.9 8.8 8.51 8.44 8.5
GOBP_MITOCHONDRION_MORPHOGENESIS 7.28 7.51 8.24 7.63 7.74 7.56 7.61 8.46 8.23 8.02 7.52 8.07 7.76 7.69 7.47 8.03 7.69 7.46 7.59 7.79 7.78 8.15 7.7 7.9 8.27 8.03
GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION 7.3 7.44 8.23 8.03 7.68 7.85 8 8 7.95 8.05 7.91 7.89 8.02 7.89 7.97 7.98 7.58 7.8 7.61 8.06 7.58 7.82 8.05 8.08 7.99 7.73
GOBP_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION 6.16 5.73 6.3 6.51 6.3 6.01 6.88 6.3 6.84 5.87 6.77 5.52 6.26 5.75 6.28 7.03 6.33 6.39 5.7 5.94 6.93 6.94 5.92 5.93 6.67 6.34
GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT 6.51 6.44 6.52 6.69 6.52 6.4 6.58 6.72 6.59 6.65 6.56 6.55 6.35 6.43 6.73 6.44 6.53 6.39 6.48 6.58 6.58 6.66 6.48 6.76 6.64 6.56
GOBP_DENDRITE_SELF_AVOIDANCE 6.08 5.83 5.95 5.95 6.26 6.26 6.09 6.18 6.26 6.08 5.97 6.14 6.44 6.29 6.28 6.28 5.92 6.09 6.12 6.18 6.02 6.3 6.97 6.26 6.12 5.84
GOBP_TRANSEPITHELIAL_TRANSPORT 7.26 7.11 6.91 7.56 7.04 6.62 6.68 6.22 6.61 6.5 7.33 6.55 6.5 6.84 6.48 6.54 6.77 6.48 7.1 6.45 6.59 6.36 6.31 6.23 6.71 6.57
GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL 7.26 7.36 7.82 7.72 7.63 7.77 7.58 7.48 7.83 7.74 7.52 7.73 7.81 7.77 7.59 7.51 7.39 7.51 7.6 7.67 7.29 7.59 7.9 8.11 7.78 7.61
GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL 7.03 7.16 7.45 7.37 7.37 7.41 7.31 7.36 7.36 7.39 7.29 7.31 7.4 7.46 7.34 7.37 7.1 7.16 7.26 7.38 7.13 7.34 7.45 7.6 7.41 7.28
GOBP_LEUKOCYTE_PROLIFERATION 5.59 5.49 5.46 5.6 5.25 5.09 5.31 5.32 5.52 5.26 5.41 5.19 5.3 5.23 5.43 5.28 5.43 5.4 5.16 5.27 5.51 5.5 5.25 5.14 5.37 5.53
GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION 5.63 5.54 5.48 5.62 5.23 5.07 5.37 5.32 5.63 5.24 5.42 5.19 5.34 5.31 5.45 5.32 5.51 5.52 5.17 5.29 5.57 5.54 5.31 5.2 5.43 5.57
GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION 5.5 5.54 5.42 5.67 5.28 4.96 5.17 5.32 5.71 5.18 5.48 5.19 5.13 5.16 5.44 5.32 5.42 5.45 5.03 5.29 5.59 5.41 5.26 5.22 5.43 5.53
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION 5.65 5.49 5.47 5.53 5.28 5.06 5.2 5.28 5.53 5.23 5.38 5.1 5.37 5.31 5.42 5.26 5.43 5.39 5.22 5.2 5.49 5.5 5.27 5.11 5.41 5.53
GOBP_RESPONSE_TO_INTERLEUKIN_2 5.57 5.85 5.22 5.69 4.9 5.12 5.4 5.48 5.04 5.27 5.29 4.9 5.2 4.91 5.21 5.26 5.16 5.3 5.35 5.37 5.84 5.25 4.91 5.14 5.36 5.55
GOBP_RESPONSE_TO_INTERLEUKIN_4 6.07 6.11 5.77 6.24 6.41 5.91 6.14 6.05 6.32 5.81 6.04 6.06 5.74 5.65 5.92 6.02 5.99 5.94 5.81 5.84 6.09 6.35 6.11 5.64 6.43 6.23
GOBP_RESPONSE_TO_INTERLEUKIN_12 6.59 6.6 7.47 7.47 6.86 6.98 6.99 6.98 7.28 7.23 7.15 7.26 6.97 6.97 7.11 7.41 6.87 6.78 6.88 6.85 6.98 7.09 7.6 7.43 7.17 7.52
GOBP_RESPONSE_TO_INTERLEUKIN_15 6.75 6.71 6.79 6.75 6.55 6.36 6.55 6.16 6.36 6.61 6.6 6.31 6.51 6.79 6.47 6.53 6.72 6.47 6.08 6.67 7.03 6.63 6.4 6.4 6.64 6.7
GOBP_CELLULAR_MACROMOLECULE_LOCALIZATION 7.26 7.35 7.7 7.53 7.59 7.66 7.56 7.59 7.57 7.65 7.5 7.62 7.61 7.62 7.63 7.62 7.36 7.35 7.51 7.62 7.41 7.61 7.65 7.83 7.64 7.54
GOBP_HISTONE_H3_K27_METHYLATION 6.89 6.81 6.8 7.21 7.08 7.08 6.81 6.78 6.76 7.13 7.05 7.17 7.1 7.23 7.31 7.13 7.01 7.01 7.55 6.93 7.05 7.14 7.03 7.15 6.85 7.22
GOBP_RESPONSE_TO_INTERLEUKIN_6 6.57 6.66 6.75 6.49 6.88 6.57 6.57 6.73 6.67 6.76 6.26 6.35 6.87 6.92 6.85 6.97 6.36 6.61 6.47 6.86 6.78 7.04 6.93 6.64 6.68 6.68
GOBP_INTERLEUKIN_35_MEDIATED_SIGNALING_PATHWAY 6.62 6.81 7.99 7.92 6.86 7.35 7.04 6.89 7.09 7.23 7.74 7.66 7.16 7.13 7.34 7.18 7.11 7.01 6.96 6.85 6.86 7.09 7.98 7.49 8.07 7.52
GOBP_L_ASPARTATE_TRANSMEMBRANE_TRANSPORT 8.17 8.51 9.35 8.88 8.23 8.49 8.88 8.8 8.7 8.7 8.92 8.51 8.54 8.6 8.68 8.95 8.12 8.14 8.14 8.52 8.22 8.49 9.04 9.05 9.22 8.53
GOBP_PHOSPHORYLATION_OF_RNA_POLYMERASE_II_C_TERMINAL_DOMAIN 7.74 8.01 8.24 8.33 8.33 8.66 8.15 8.25 8.17 8.34 8.23 8.07 8.53 8.59 8.38 8.67 7.69 8.32 8.52 8.4 7.77 8.31 8.25 8.33 8.36 8.42
GOBP_HETEROCHROMATIN_ORGANIZATION 6.27 6.43 6.55 6.7 6.67 6.67 6.81 6.85 6.75 6.94 6.45 6.71 6.79 6.77 6.62 6.72 6.51 6.47 6.42 6.65 6.62 6.73 6.76 7.03 6.71 6.7
GOBP_BASEMENT_MEMBRANE_ASSEMBLY 6.44 6.73 6.75 6.22 6.58 6.03 6.28 6.65 5.81 6.5 7 6.88 6.32 6.73 6.74 6.71 6.58 6.59 6.7 6.69 6.73 6.87 6.51 6.75 6.81 6.92
GOBP_METAL_ION_EXPORT 6.57 6.53 7.13 6.27 6.31 6.19 6.66 6.46 6.65 6.63 6.79 6.45 6.59 6.48 6.49 6.8 6.62 7.03 6.73 6.93 6.68 6.81 6.65 7.08 6.88 6.53
GOBP_INCLUSION_BODY_ASSEMBLY 7.44 7.64 8.19 7.93 8.12 8.08 7.91 8.17 8.16 8.57 7.65 8.49 8.28 8.41 9.03 8.99 8.33 8.14 8.09 8.54 8.58 8.91 8.8 8.72 8.55 8.5
GOBP_RESPONSE_TO_GROWTH_FACTOR 6.56 6.55 6.73 6.59 6.67 6.68 6.76 6.74 6.7 6.72 6.56 6.65 6.89 6.84 6.77 6.82 6.71 6.61 6.58 6.73 6.88 6.9 6.91 6.8 6.85 6.86
GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR 7.68 7.35 7.45 7.32 7.91 7.85 7.43 7.75 7.66 7.81 7.48 7.91 7.66 7.91 7.79 7.57 7.79 7.49 7.77 7.44 7.78 7.91 7.76 7.9 7.69 7.74
GOBP_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM 8.41 8.43 8.55 8.51 8.74 9.02 8.56 8.39 8.92 8.9 8.52 8.59 8.78 8.75 8.67 8.74 8.12 8.41 8.7 8.52 8.08 8.37 8.89 9.09 8.83 8.5
GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM 8.99 9.12 9.32 9.46 9.73 9.78 9.7 9.62 10.08 9.67 9.14 9.54 9.92 9.78 9.46 9.24 9.48 9.32 9.24 9.65 9.39 9.34 9.85 10 9.22 9.29
GOBP_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS 6.57 6.75 6.86 7.1 6.75 6.97 7.06 7.22 6.98 7.08 6.7 6.85 7.24 6.95 7.19 7.14 6.84 6.96 6.8 7.04 6.8 6.86 7.2 6.97 6.87 6.86
GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS 6.35 6.59 6.24 6.36 6.75 7.08 7.03 7.22 6.93 6.91 6.27 6.71 6.74 6.68 7.01 7.15 6.78 6.54 6.47 6.97 6.6 6.46 7.21 7.08 6.8 6.59
GOBP_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY 6.57 6.77 7.15 7.21 7.11 6.93 7.18 7.28 6.96 7.41 7.25 7.04 6.95 7.1 7.55 7.53 6.88 7.14 7.06 7.18 6.83 7.34 7.26 7.67 7.53 7.52
GOBP_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR 7.6 7.78 8.34 8.02 8.18 8.27 7.81 7.9 7.84 7.99 7.79 8.06 8.08 7.85 8.03 7.93 7.58 7.46 8.09 8.04 7.57 7.85 8.24 8.3 8.17 7.99
GOBP_UV_DAMAGE_EXCISION_REPAIR 6.78 6.75 6.82 7.41 6.77 6.66 6.95 6.76 7.16 6.97 6.26 6.81 6.74 7.09 7.66 7.44 6.47 6.47 6.64 6.71 6.91 6.7 6.54 7.34 7.02 6.77
GOBP_PRODUCTION_OF_SMALL_RNA_INVOLVED_IN_GENE_SILENCING_BY_RNA 6.74 6.71 7.28 7.24 7.37 7.33 7.15 7.15 7.58 7.03 7.23 6.81 7.2 7.35 7.22 7.34 7.07 7.05 7.29 7.06 7.39 7.42 7.47 7.33 7.52 7.57
GOBP_REGULATION_OF_PRODUCTION_OF_SMALL_RNA_INVOLVED_IN_GENE_SILENCING_BY_RNA 5.76 5.7 6.06 5.89 5.33 5.28 5.44 5.75 5.78 5.38 5.95 5.64 5.38 5.47 5.54 5.63 5.43 5.65 5.01 5.46 5.72 5.59 5.66 4.96 5.71 5.77
GOBP_ORGANELLE_ASSEMBLY 6.84 6.85 7.09 6.99 7.07 7.09 6.95 6.96 6.86 7.01 6.89 7 7.03 7.01 6.94 7.06 6.81 6.87 6.95 6.99 6.89 7.01 6.96 7.11 7.01 6.95
GOBP_HISTONE_H3_DEACETYLATION 6.76 6.71 7.5 7.68 7.44 7.67 7.44 7.17 7.35 7.58 7.07 7.46 7.53 7.66 7.36 7.33 7.41 6.81 7.12 7.58 6.94 7.13 7.62 7.64 6.99 7.22
GOBP_HISTONE_H4_DEACETYLATION 6.9 7.11 7.5 7.41 7.7 7.91 7.6 7.06 7.54 7.74 7.13 7.46 7.54 7.64 6.91 7.25 7.41 6.81 7.12 7.38 6.85 6.97 7.66 7.75 6.79 7.23
GOBP_3_UTR_MEDIATED_MRNA_STABILIZATION 7.06 7.07 6.86 6.8 6.84 7.41 7.07 7.23 7.22 7.28 7.14 7.2 7.2 7 6.54 7.45 6.82 7.14 6.94 7.06 7.41 7.16 7.23 7.13 7.19 7.11
GOBP_PROTEIN_K48_LINKED_UBIQUITINATION 7.87 8.11 8.14 8 8.36 8.41 8.02 8.03 8.03 8.21 8.22 8.18 8.14 8.14 8 8.01 7.97 7.84 8.34 8.25 7.71 8.06 8.16 8.38 7.99 7.99
GOBP_NEUTROPHIL_MEDIATED_CYTOTOXICITY 5.24 4.98 4.84 4.86 4.73 4.25 4.56 4.66 4.87 4.32 5.28 4.49 4.45 4.58 4.69 4.98 4.78 5.38 4.66 4.45 5.28 4.5 4.54 4.18 4.7 4.51
GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM 7.64 7.81 8.33 8.15 7.64 7.5 7.66 7.71 7.74 7.73 8.03 7.45 7.71 7.83 8.09 7.86 7.66 7.75 7.74 7.67 7.76 7.85 7.98 8.23 7.84 7.59
GOBP_BONE_MATURATION 6.85 6.63 6.42 5.69 7.06 7.02 6.72 6.76 7.25 6.98 6.19 6.52 6.92 6.71 6.91 6.71 5.99 6.28 6.76 6.47 6.52 6.31 7.06 7 6.35 6.59
GOBP_PROTEIN_K11_LINKED_UBIQUITINATION 7.36 7.18 7.86 7.61 7.67 8.14 7.63 7.61 7.99 7.99 7.54 7.72 7.86 8.07 7.67 7.51 7.44 7.3 7.7 7.67 7.28 7.1 7.31 8 7.75 7.21
GOBP_LEFT_RIGHT_AXIS_SPECIFICATION 6.35 6.26 6.43 6.45 6.77 6.99 6.04 6.3 5.93 6.83 6.41 6.79 6.57 6.69 6.52 7.08 6.38 6.4 6.56 6.44 6.2 6.28 6.18 6.31 5.88 6.49
GOBP_ERROR_FREE_TRANSLESION_SYNTHESIS 6.73 6.53 7.63 7.64 6.97 7.13 7.17 7.02 6.57 6.99 7.43 7.07 7.19 7.14 6.71 7.07 6.82 6.89 7.21 6.82 6.75 7.13 7.03 7.05 6.87 6.82
GOBP_DEMETHYLATION 6.04 6.06 6.04 6.24 5.98 6.33 6.13 6.31 6.22 6.09 6.01 6.09 6.32 6.13 6.14 5.94 6.12 6.1 6.33 6 6 6.07 6.11 6.22 6.19 6.25
GOBP_OXIDATIVE_DEMETHYLATION 5.55 5.57 5.43 5.57 5.35 5.76 5.5 5.4 5.71 5.54 5.48 5.27 5.66 5.69 5.57 5.31 5.43 5.38 5.62 5.6 5.43 5.2 5.51 5.46 5.4 5.43
GOBP_NEURON_DEATH 7.19 7.19 7.7 7.48 7.43 7.52 7.55 7.6 7.47 7.56 7.45 7.46 7.59 7.45 7.77 7.47 7.27 7.22 7.22 7.59 7.5 7.65 7.61 7.71 7.69 7.62
GOBP_RNA_SURVEILLANCE 7.98 7.51 7.87 7.98 7.33 7.6 7.7 7.23 7.66 7.27 7.4 7.79 7.51 7.36 7.86 7.44 6.83 6.77 7.38 7.57 6.73 7.51 7.73 7.47 7.62 7.2
GOBP_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS 6.82 6.53 7.13 6.97 7.31 7.47 6.99 6.92 7.19 7.61 7.28 6.75 7.39 7.37 7.59 7.44 7.15 6.89 7.5 7.19 6.46 6.45 7.23 7.4 7.35 7.39
GOBP_DNA_CONFORMATION_CHANGE 6.17 6.21 6.33 6.46 6.35 6.53 6.3 6.44 6.27 6.55 6.34 6.37 6.37 6.41 6.39 6.41 6.26 6.22 6.35 6.37 6.36 6.42 6.35 6.56 6.44 6.5
GOBP_RESPONSE_TO_PARATHYROID_HORMONE 6.19 6.17 5.91 5.8 6.09 5.94 6.16 6.22 6.15 6.21 6.04 5.94 5.58 5.76 6.07 6.21 6.35 6.01 5.86 6.07 5.81 5.67 5.98 5.93 6.02 6.14
GOBP_PROTEIN_K48_LINKED_DEUBIQUITINATION 7.3 7.33 7.22 7.53 7.7 7.87 7.8 7.38 7.99 7.94 7.37 7.72 7.77 7.99 8.02 7.78 7.37 7.42 7.41 7.42 7.41 7.93 8.21 8.31 8 7.6
GOBP_REGULATION_OF_CELL_CYCLE_ARREST 6.56 6.54 6.57 6.6 6.52 6.46 6.56 6.8 6.46 6.43 6.54 6.54 6.56 6.46 6.5 6.68 6.6 6.49 6.57 6.64 6.7 6.72 6.17 6.7 6.64 6.96
GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_ARREST 7.21 6.87 6.84 7.04 6.91 7.34 7.14 6.93 6.91 6.5 6.53 6.84 6.75 6.55 6.58 6.3 7.04 6.89 6.87 6.86 6.67 6.65 6.51 6.94 6.69 7.1
GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_ARREST 6.49 6.46 6.43 6.45 6.36 6.32 6.45 6.49 6.3 6.2 6.54 6.45 6.53 6.38 6.41 6.61 6.53 6.45 6.39 6.52 6.69 6.6 6.17 6.42 6.61 6.9
GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN 7.13 7.09 7.07 7.15 7.46 7.43 7.3 7.15 7.44 7.68 7.22 7.69 7.15 7.38 7.31 7.16 7.4 6.88 7.21 7.21 7.08 7.22 7.26 7.75 6.79 7.02
GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS 6.41 6.29 6.52 6.6 6.3 6.32 6.28 6.34 6.39 6.46 6.27 6.35 6.5 6.44 6.3 6.35 6.45 6.29 6.33 6.29 6.34 6.39 6.57 6.49 6.36 6.47
GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS 6.01 5.96 5.99 6.13 5.84 5.8 5.65 5.84 5.84 5.46 5.85 5.62 5.8 5.72 5.75 5.76 5.99 5.77 5.56 5.65 6.12 6.1 5.59 5.54 5.94 6.14
GOBP_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN 5.99 5.94 5.87 6.04 5.78 5.65 5.54 5.76 5.63 5.37 5.78 5.47 5.74 5.61 5.65 5.67 5.89 5.64 5.45 5.55 6.09 6.02 5.5 5.53 5.8 6
GOBP_CELLULAR_RESPONSE_TO_ACID_CHEMICAL 6.71 6.78 7.25 7.13 6.98 7.09 6.9 6.92 7.12 7.26 7.25 7.15 6.92 6.87 7.12 7.27 7.28 6.89 6.71 6.88 7.02 7.14 7.04 7.4 7.19 7.04
GOBP_CELLULAR_RESPONSE_TO_ANTIBIOTIC 5.31 5.07 5.54 4.96 4.98 5.1 5.43 5.27 5.71 5.24 4.98 5.09 5.43 4.41 4.97 4.77 5.18 5.35 4.92 5.17 5.23 5.08 5.83 5.4 4.9 4.95
GOBP_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE 6.93 7.1 7.11 7.07 6.92 6.94 6.88 7.04 6.96 6.98 6.89 7.03 7.12 7.02 7.27 7.02 7.02 6.91 6.79 7.14 6.9 7.13 6.91 7.08 6.98 7.01
GOBP_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE 6.7 6.67 7.79 7.45 6.63 6.83 7 6.85 6.84 6.67 7.18 6.62 6.65 6.72 7.14 6.97 7.33 6.9 6.56 7.02 6.91 6.91 7.47 7.53 7.02 6.81
GOBP_CELLULAR_RESPONSE_TO_MECHANICAL_STIMULUS 6.39 6.28 6.44 6.11 6.27 6.03 5.92 6.37 6.4 6.12 6.26 6.24 6.32 6.44 6.31 6.36 6.53 6.16 6.26 6.14 6.35 6.53 6.11 6.25 6.68 6.49
GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION 6.91 6.83 7.22 7.41 6.16 6.68 6.81 6.91 6.9 6.84 7.21 6.81 6.96 6.79 7.02 7.01 6.99 6.67 6.47 6.98 7.37 7.47 6.87 6.65 6.98 6.94
GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION 7.45 7.54 7.75 7.48 7.65 7.6 7.35 7.77 7.31 7.58 7.21 7.51 7.53 7.46 7.61 7.6 7.38 7.37 7.36 7.75 7.52 7.71 7.55 7.52 7.54 7.45
GOBP_CELLULAR_RESPONSE_TO_COPPER_ION 6.86 6.86 6.95 7.51 5.91 6.47 6.91 7.31 6.92 6.82 7.62 7.2 6.87 6.79 7.47 6.98 7.22 6.96 6.39 7.14 7.5 7.44 6.54 6.62 7.43 7.56
GOBP_CELLULAR_RESPONSE_TO_LITHIUM_ION 5.47 5.73 5.51 5.52 5.41 5.18 5.57 5.89 5.88 5.44 5.21 5.45 5.68 5.23 5.65 5.36 5.32 5.67 5.52 5.81 5.36 5.47 5.76 5.5 5.06 5.33
GOBP_CELLULAR_RESPONSE_TO_ZINC_ION 6.26 6.12 6.73 7.04 5.71 5.92 6.31 6.05 6.28 6.18 6.26 6 5.79 5.88 6.1 5.9 6.36 6.27 5.77 6.15 6.39 6.28 6.28 5.73 6.14 6.41
GOBP_CELLULAR_RESPONSE_TO_VITAMIN 5.57 5.56 5.54 5.57 5.39 5.61 5.54 5.2 5.53 5.33 5.01 5.01 5.39 5.22 5.39 5.62 5.51 5.48 5.1 5.26 5.71 5.39 5.6 5.1 5.51 5.28
GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID 5.5 5.33 5.45 5.48 5.02 4.96 5.18 5.19 5.35 5.04 5.35 5.02 5.18 5.32 5.37 5.47 5.38 5.41 5.08 5.16 5.43 5.37 5.3 4.91 5.18 5.06
GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D 5.78 6.06 5.59 6.03 6.01 6.01 5.99 5.78 6.12 6.2 5.49 5.76 5.84 5.64 5.47 5.91 6.22 5.67 5.63 5.76 5.93 6.17 6.42 5.63 5.98 6.07
GOBP_CELLULAR_RESPONSE_TO_ALKALOID 5.7 5.73 5.45 5.89 5.5 5.45 5.51 5.44 5.56 5.73 5.86 5.78 5.77 5.69 5.86 5.9 5.72 5.85 5.81 5.71 5.73 5.85 5.66 5.52 5.54 5.87
GOBP_CELLULAR_RESPONSE_TO_CAFFEINE 8.03 8.45 8.99 8.51 8.5 8.39 8.42 8.65 8.65 8.38 8.47 8.42 9.05 9.31 8.65 8.86 8.3 8.48 8.71 8.77 8.55 8.62 8.72 8.92 8.73 8.6
GOBP_CELLULAR_RESPONSE_TO_ATP 5.62 5.93 5.65 6.31 5.81 5.87 5.77 6.25 5.66 5.72 5.77 6.09 5.66 5.7 5.74 5.65 6.1 5.7 5.76 5.85 5.93 5.8 5.88 5.84 5.81 6.35
GOBP_CELLULAR_RESPONSE_TO_CAMP 6.48 6.29 6.48 6 6.84 6.9 6.66 6.68 6.54 6.89 6.29 6.89 6.18 6.1 6.58 6.52 6.85 6.71 6.06 6.4 6.67 6.5 6.72 6.57 6.47 6.57
GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS 6.64 6.67 7.11 6.89 6.81 6.88 6.89 7 6.89 6.97 6.9 6.82 6.84 6.8 7.06 7.03 6.82 7.05 6.78 6.97 6.93 7.06 6.88 6.68 6.9 6.92
GOBP_CELLULAR_RESPONSE_TO_DSRNA 6.64 6.59 6.99 6.71 7.04 6.93 6.88 6.92 6.77 6.84 6.75 7.04 6.85 6.67 6.79 6.66 6.54 6.57 6.8 7.19 7.02 7.09 6.76 7.07 6.74 6.62
GOBP_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA 6.71 6.58 7.15 6.68 6.97 6.87 7.23 6.97 6.82 6.88 6.9 7.14 6.81 6.43 6.91 6.57 6.5 6.78 6.8 7.24 7.26 7.12 6.74 7.26 6.77 6.6
GOBP_CELLULAR_RESPONSE_TO_ETHANOL 6.55 6.23 6.19 6 7.85 7.1 6.88 7.05 7.1 7.41 6.31 6.74 6.92 7.39 6.94 7.11 7.36 6.67 6.78 6.96 7.02 7.1 7.04 7.34 7.09 6.99
GOBP_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS 5.8 5.59 5.43 5.62 5.41 4.99 5.44 5.18 5.18 5.18 5.72 5.34 5.11 4.94 5.3 5.28 5.34 5.64 5.39 5.06 5.32 5.23 5.13 4.94 5.17 5.12
GOBP_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS 6.73 6.71 7.37 7.1 7.17 7.15 7.05 6.96 7.12 7.19 7.06 6.95 7.1 7.19 7.16 7.1 7.03 6.9 6.83 7.19 7.04 7.11 7.32 7.34 7.26 7.17
GOBP_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS 6.03 5.87 5.58 6 6.04 6.02 6.41 5.94 5.83 5.79 5.87 5.67 5.79 5.65 5.95 5.81 6.05 5.79 5.78 5.8 6.22 5.95 5.68 5.69 5.96 5.93
GOBP_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS 5.8 6.01 5.97 6.07 5.22 5.42 5.58 5.54 5.42 5.34 5.45 5.17 5.41 5.53 5.62 5.68 5.57 5.72 5.25 5.35 5.87 5.84 5.29 5.52 5.65 5.62
GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS 5.86 6.01 6.4 6.5 6.09 6.15 6.44 6.39 6.15 6.56 6.16 6.58 6.14 5.99 6.17 6.33 6.46 5.67 5.35 5.85 6.67 6.94 6.55 5.91 6.07 6.49
GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS 7.25 7.16 6.69 6.92 7.14 7.18 7.04 7.05 6.97 7.14 6.92 7.07 6.99 6.61 7.37 7.34 7.32 7.55 7.22 7.44 7.07 7.16 7.02 7.04 7.59 7.43
GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS 6.85 6.8 7.13 7.03 7.11 7.19 6.98 7.07 7.09 7.14 6.97 7.18 7.16 7.16 7.09 7.26 7.23 7.01 7 7.12 7.05 7.2 7.12 7.36 7.21 7.07
GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS 6.2 6.03 6.72 6.23 5.8 5.89 5.85 6.02 6.23 5.97 6.25 5.92 6.23 6.22 6.36 6.39 6.48 6.17 5.91 6.06 6.66 6.75 6.1 6.19 6.62 6.63
GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS 6.99 6.4 6.33 6.46 7.21 6.9 6.81 7.05 6.39 7.14 6.27 6.97 6.99 6.4 6.47 6.24 7.46 6.41 6.11 6.63 6.11 6.56 7.02 7 6.96 7.05
GOBP_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS 6.75 6.57 6.2 6.37 6.58 6.65 6.82 6.58 6.97 6.77 6.39 6.81 6.96 6.48 6.75 6.46 6.79 6.62 6.19 6.76 5.91 6.32 6.83 6.76 6.82 6.48
GOBP_CELLULAR_RESPONSE_TO_LIPID 6.33 6.25 6.59 6.46 6.33 6.34 6.4 6.47 6.45 6.35 6.35 6.3 6.49 6.41 6.48 6.51 6.59 6.46 6.27 6.38 6.46 6.54 6.44 6.41 6.61 6.59
GOBP_CELLULAR_RESPONSE_TO_CHOLESTEROL 7.35 7.07 6.85 7.08 6.95 6.81 7.11 6.98 6.69 6.78 6.95 6.82 6.76 7.18 6.81 6.65 6.97 7.26 7.51 7.04 6.99 6.97 6.95 6.66 6.78 7.05
GOBP_CELLULAR_RESPONSE_TO_FATTY_ACID 5.98 6.12 6.85 5.92 6.21 6.06 5.93 6.38 6.24 5.77 5.91 6.24 6.28 6.14 6.45 6.76 6.73 6.12 6.11 6.1 6.41 6.55 6.12 6.03 6.25 6.24
GOBP_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS 7.3 7.4 7.56 7 7.36 7.57 7.07 7.21 7.34 7.04 7.06 7.17 7.71 7.25 7.23 7.46 7.04 7.14 7.53 7.4 7.59 7.28 7.34 7.37 7.55 7.34
GOBP_CELLULAR_RESPONSE_TO_LOW_DENSITY_LIPOPROTEIN_PARTICLE_STIMULUS 6.82 6.43 7.33 6.95 7.25 7.57 7.31 6.79 7.68 7.13 6.58 6.87 7.82 7.67 7.36 7.11 6.77 6.47 7.36 7.19 6.85 7.13 7.2 7.32 6.72 7.24
GOBP_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND 6.72 6.67 6.98 6.76 6.9 6.98 6.9 6.89 6.94 6.95 6.83 6.93 6.98 7.01 6.9 6.9 6.96 6.79 6.8 6.9 6.85 7.05 6.98 7 6.95 6.94
GOBP_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND 6.84 7.15 7.29 7.05 7.05 7.13 7.48 7.72 8.05 7.67 7.77 7.36 7.33 7.36 7.29 7.1 7.26 7.36 7.34 7.66 7.66 7.93 8.36 7.51 7.54 7.58
GOBP_HEMATOPOIETIC_STEM_CELL_PROLIFERATION 6.12 6.27 6.56 5.97 6.24 6.59 6.6 6.76 6.27 6.47 6.42 6.47 6.35 6.61 6.61 6.66 6.51 6.62 6.15 6.42 6.65 6.85 6.75 6.78 6.86 6.76
GOBP_RRNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX_EXPORT_FROM_NUCLEUS 7.18 7.56 7.55 7.52 7.35 7.43 7.45 6.92 7.55 7.44 7.57 7.56 7.51 7.22 7.02 7.27 7.11 7.01 7.03 7.13 6.52 7 7.68 7.84 7.89 6.86
GOBP_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL 5.77 5.93 5.84 5.99 5.77 5.8 5.67 5.73 5.73 5.75 6.07 5.69 5.92 5.83 6.21 5.9 6.34 5.85 5.75 6.72 6.14 5.74 6.28 6.11 6.61 6.34
GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS 7.12 7.33 7.79 7.65 7.73 7.66 7.59 7.53 7.75 7.66 7.77 7.74 7.7 7.69 7.6 7.65 7.61 7.35 7.45 7.71 7.5 7.61 7.92 7.84 7.75 7.58
GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION 5.79 5.38 6.13 6.39 5.55 5.58 5.79 5.85 5.57 5.62 5.73 5.98 5.69 5.36 5.88 5.69 5.8 5.72 5.61 5.6 5.94 5.86 5.7 5.87 5.48 5.66
GOBP_CELLULAR_RESPONSE_TO_PH 5.48 5.34 5.41 5.49 5.06 4.8 5.2 5.34 5.2 5.07 5.39 5.03 5.05 5.14 4.95 5.24 5.54 5.09 5.3 5.41 5.62 5.49 5.07 5.03 5.1 5.14
GOBP_CELLULAR_RESPONSE_TO_ACIDIC_PH 5.01 5.16 5.68 4.81 5.08 4.75 4.49 4.42 4.58 4.2 4.96 4.17 4.24 4.56 4.57 4.32 5.75 4.85 4.18 4.59 6.37 5.57 4.26 4.19 4.29 4.44
GOBP_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS 7.36 7.09 7.13 6.91 7.44 7.07 6.98 6.96 7.07 7.07 6.95 7.11 6.96 7.05 7.13 7.31 7.45 7.06 7.14 7 7.14 7.02 7.04 7.26 7.02 7.04
GOBP_CELLULAR_RESPONSE_TO_SALT_STRESS 8.09 8.48 8.77 7.81 8.16 8.39 8.01 8.29 8.14 8.41 7.7 8.27 8.4 8.21 8.83 8.8 8.42 8.25 8.33 8.39 8.83 9.12 8.7 8.62 9.23 9.07
GOBP_CELLULAR_HYPEROSMOTIC_RESPONSE 7.93 7.59 7.77 7.67 7.88 7.8 7.65 8.1 8.08 8.06 7.48 7.85 8.12 7.93 8.03 8.37 7.85 7.92 7.96 7.97 7.71 8.01 8.32 8.35 8.01 8.11
GOBP_CELLULAR_RESPONSE_TO_RADIATION 6.47 6.37 6.61 6.72 6.27 6.5 6.39 6.44 6.43 6.66 6.27 6.44 6.55 6.48 6.4 6.34 6.39 6.3 6.45 6.6 6.31 6.44 6.61 6.54 6.5 6.57
GOBP_CELLULAR_RESPONSE_TO_IONIZING_RADIATION 6.81 6.72 6.76 6.92 7.04 6.86 6.89 6.86 6.65 6.9 6.96 6.94 7.04 6.99 7.18 7.08 6.5 6.55 6.68 6.85 6.67 7.12 7.25 7.31 6.74 6.9
GOBP_CELLULAR_RESPONSE_TO_GAMMA_RADIATION 7.47 7.63 7.33 7.82 7.54 7.75 7.76 7.61 7.45 7.73 7.82 7.84 7.72 7.45 7.92 7.62 7.67 7.39 7.56 8.03 7.56 7.98 7.95 7.74 8.08 7.76
GOBP_CELLULAR_RESPONSE_TO_X_RAY 7.23 7.44 7.03 7.08 7.56 7.32 6.96 7.14 7.03 7.63 6.89 7.44 7.35 6.93 7.12 7.06 7.29 7.15 7.17 7.23 6.99 7.32 7.39 7.37 7.17 7.75
GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS 6.23 6.22 6.48 6.64 6.02 6.16 6.1 6.26 6.09 6.13 6.15 6.08 6.31 6.18 6 6.23 6.2 6.19 6.07 6.15 6.23 6.12 6.44 6.3 6.22 6.42
GOBP_CELLULAR_RESPONSE_TO_UV_A 5.08 4.99 4.82 4.46 4.66 4.5 4.84 4.6 4.8 4.48 4.66 4.27 4.8 4.84 4.7 4.46 4.54 4.73 4.37 4.6 5.05 4.94 5.56 4.49 4.69 4.54
GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS 6.56 6.62 6.76 6.72 6.69 6.69 6.68 6.84 6.67 6.66 6.54 6.75 6.83 6.69 6.76 6.74 6.68 6.47 6.59 6.67 6.82 6.95 6.86 6.88 6.94 6.86
GOBP_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS 7.6 7.58 7.82 7.97 8.05 8.4 7.87 6.99 7.78 7.51 7.64 7.57 7.71 8.08 7.23 7.49 7.71 7.29 7.86 7.78 7.58 8.12 7.76 8.19 7.32 7.47
GOBP_CELLULAR_RESPONSE_TO_STEROL_DEPLETION 7.52 7.43 7.59 7.45 7.9 7.98 7.89 7.88 7.87 8.05 7.03 7.33 8.1 7.82 7.95 7.72 7.32 7.3 7.54 8.08 7.98 7.65 7.54 7.98 7.94 8.14
GOBP_GENETIC_IMPRINTING 6.79 6.62 6.75 6.58 7.26 7.42 7.08 6.96 7.07 7.57 6.59 7.23 7.34 7.29 7.26 7.33 7.09 6.82 7.13 7.37 6.91 6.92 7.4 7.34 7.14 7.19
GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY 6.65 6.74 6.63 6.32 6.94 6.79 6.85 6.97 6.53 6.95 6.82 6.97 6.73 6.9 6.91 6.62 6.57 6.62 6.74 6.89 6.77 6.69 6.66 6.88 6.66 6.73
GOBP_DOPAMINERGIC_NEURON_DIFFERENTIATION 5.64 5.21 5.6 6.09 5.13 5.17 5.46 5.47 5.46 5.41 5.34 5.31 5.44 5.28 5.6 5.77 5.38 5.23 5.19 5.07 5.5 5.49 5.66 5.05 5.07 5.28
GOBP_INOSITOL_PHOSPHATE_CATABOLIC_PROCESS 7.1 7.21 7.46 7.3 7.34 7.23 7.5 7.64 7.58 7.48 7.4 7.29 7.38 7.25 7.46 7.21 7.21 7.12 7.19 7.3 6.75 7.09 7.6 7.47 7.41 7.52
GOBP_RESPONSE_TO_DEXAMETHASONE 6.15 6.02 6.64 6.07 5.98 6.14 5.77 5.58 6.12 5.71 6.17 5.74 6.17 6.11 6.29 6.03 6.49 6.2 5.61 6.09 6.37 6.43 5.8 6.18 6.65 6.54
GOBP_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS 6.2 6.03 6.89 6.23 5.8 6.37 6.55 6.55 6.32 6.03 6.25 5.89 6.23 6.23 6.54 6.39 6.48 6.24 6.1 6.36 6.66 6.75 6.1 6.68 6.72 6.7
GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA 6.59 6.68 6.64 6.6 6.79 6.7 6.81 6.74 6.7 6.63 6.61 6.65 6.92 6.83 6.79 6.91 6.89 6.72 6.58 6.65 6.91 6.91 7.02 6.8 6.97 6.99
GOBP_OTIC_VESICLE_DEVELOPMENT 5.36 5.44 4.94 5.34 4.62 5.06 5.33 4.7 5 4.92 5.05 4.83 4.68 4.84 5.27 4.69 5.11 5.51 4.7 4.71 4.98 4.97 4.81 4.84 4.8 5.01
GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION 6.68 6.36 6.71 6.39 6.73 6.63 7.09 6.81 6.8 6.65 6.72 6.39 6.76 6.54 6.58 6.56 7.11 6.7 6.5 6.7 7.08 6.99 7.24 6.51 6.86 7.04
GOBP_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION 5.03 4.79 4.88 5.06 4.82 4.71 4.67 4.71 4.92 4.55 4.65 4.65 4.79 4.72 5.14 4.89 4.68 4.67 4.9 4.7 4.71 4.77 4.55 4.49 4.92 4.97
GOBP_GRANULOCYTE_CHEMOTAXIS 5.71 5.48 5.57 5.44 4.95 4.94 5.24 5.18 5.15 5.03 5.35 4.86 5.09 5.06 5.28 5.25 5.52 5.51 5.04 5.14 5.69 5.51 5.05 4.89 5.62 5.6
GOBP_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS 5.92 5.86 5.94 5.62 5.1 5.56 5.49 5.58 5.76 5.38 5.59 5.39 5.64 5.58 5.55 5.66 5.81 5.56 5.22 5.47 5.83 5.75 5.56 5.63 5.75 5.9
GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS 5.81 5.68 5.61 5.43 4.97 5.55 5.49 5.4 5.44 5.37 5.47 4.79 5.61 5.57 5.47 5.36 5.57 5.43 5.12 5.28 5.58 5.55 5.2 5.55 5.68 5.83
GOBP_VOCALIZATION_BEHAVIOR 7.16 7.27 7.28 7.02 7.49 7.36 7.4 7.89 7.06 7.51 7.11 7.05 7.77 7.78 8.17 7.8 7.75 7.93 7.55 7.93 7.45 7.62 7.52 8.01 7.21 7.52
GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION 6.23 5.8 6.1 6.21 5.62 6.56 5.92 6.3 6.01 5.55 5.95 5.55 5.73 5.91 6.46 5.76 5.73 5.93 6.31 5.86 6.72 6.5 5.75 6.15 6.6 6.9
GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION 6.11 6.24 5.6 6.21 5.71 5.94 6 5.86 5.87 6.51 6.16 6.07 6.2 6.38 5.76 6.23 6.26 5.94 6.11 6.42 5.95 6.2 6.13 6.03 6.11 5.77
GOBP_MONONUCLEAR_CELL_MIGRATION 5.59 5.5 5.47 5.74 5.21 5.12 5.42 5.17 5.47 5.14 5.54 5.06 5.4 5.28 5.35 5.3 5.6 5.46 5.14 5.19 5.74 5.46 5.29 5.09 5.48 5.37
GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION 5.98 5.76 5.95 6.36 5.5 5.52 5.62 5.24 5.81 5.29 5.85 5.38 5.62 5.58 5.48 5.44 5.89 5.5 5.27 5.31 5.92 5.7 5.65 5.26 5.74 5.6
GOBP_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION 8.26 7.97 8.28 7.65 8.17 8.02 7.43 7.18 8.6 8.49 7.54 7.41 8.57 8.85 8.46 8.96 6.63 6.61 8.49 8.41 8.07 8.74 8.9 8.56 7.54 7.61
GOBP_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION 5.32 5.28 4.97 5.48 4.83 4.88 5.16 4.98 5.19 5.14 5.07 4.88 5.2 4.94 5.22 5 5.36 5.16 4.96 4.92 5.44 5.08 4.99 4.85 5.05 5.05
GOBP_COMMISSURAL_NEURON_AXON_GUIDANCE 8.02 7.46 7.62 7.24 7.99 8.19 7.75 7.62 8.07 7.26 7.41 7.8 8.26 8.59 7.96 8.1 8.4 8.59 7.89 8.08 7.83 8.24 7.19 7.63 7.19 7.15
GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE 6.77 6.79 7.82 7.33 7.08 6.76 6.99 7.01 7.15 6.96 7.33 7.03 7.14 7.05 7.48 7.31 7 7 6.97 7.37 6.94 7.68 7.17 7.44 7.17 6.87
GOBP_ANATOMICAL_STRUCTURE_MATURATION 5.95 6.08 6.04 6.11 5.77 5.85 5.98 6.08 5.86 6.01 5.92 6.07 6.06 6.05 5.88 5.85 5.99 5.99 5.88 5.91 6.13 6.2 5.86 5.98 6.07 6.19
GOBP_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION 5.67 5.56 5.57 5.76 5.35 5.11 5.32 5.32 5.55 5.15 5.56 5.28 5.39 5.34 5.44 5.35 5.4 5.47 5.14 5.35 5.63 5.57 5.28 5.18 5.48 5.59
GOBP_BASEMENT_MEMBRANE_ORGANIZATION 5.83 5.72 5.9 6.09 6.2 5.98 6.18 6.3 5.79 6.03 6.4 6.33 6.06 6.02 5.87 6.02 6.05 6.05 6.08 6.36 6.14 6.49 6.34 6.04 6.51 6.52
GOBP_ICOSANOID_TRANSPORT 5.19 5.06 5 5.11 4.72 4.53 4.84 4.95 4.83 4.56 4.85 4.55 4.61 4.73 4.81 4.85 5 4.92 4.73 4.67 5.01 4.75 4.72 4.33 4.8 4.94
GOBP_RESPONSE_TO_NITRIC_OXIDE 6.93 7.29 7.44 7.47 7.71 7.54 6.88 7.25 7.06 7.81 7.27 6.77 7.26 7.3 7.64 7.31 7.39 6.92 7.55 7 6.95 7.14 6.62 6.81 7.31 7.48
GOBP_NUCLEAR_MEMBRANE_ORGANIZATION 8.18 8.1 8.42 8.54 8.21 8.55 8.31 8.14 7.85 8.12 8.43 8.34 8.1 8.12 8.18 7.9 7.99 7.9 8.11 8.17 7.8 7.89 8.03 8.27 8.42 8.23
GOBP_RESPONSE_TO_BMP 6.14 6.32 6.04 6.18 6.21 6.2 6.25 6.21 6.17 6.34 6.05 6.21 6.37 6.12 6.3 6.16 6.16 6.14 6.12 6.11 6.18 6.22 6.39 6.4 6.18 6.29
GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR 6.43 6.5 6.85 6.59 6.55 6.68 6.39 6.66 6.67 6.72 6.45 6.6 6.94 6.78 6.73 6.78 6.3 6.54 6.55 6.57 6.9 6.89 6.91 6.83 6.66 6.8
GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION 8.79 8.93 9.83 9.49 9.48 9.71 9.57 9.36 9.77 9.79 9.66 9.38 9.6 9.49 9.57 9.53 8.84 8.77 9.09 9.42 9.29 9.21 10.25 9.77 9.37 9.19
GOBP_PODOSOME_ASSEMBLY 6.41 6.25 6.21 6.6 6.65 6.67 6.49 6.67 6.65 6.21 5.5 6.53 6.49 6.77 6.33 5.99 6.04 5.97 6.36 6.23 6.45 6.11 6.62 6.61 6.48 6.54
GOBP_REGULATION_OF_PODOSOME_ASSEMBLY 6.41 6.17 6.21 6.99 6.07 6.04 6.04 5.91 6.66 6.11 5.46 6.03 6.05 6 5.93 5.96 5.84 5.97 5.82 5.89 6.55 5.96 6.27 6.13 6.48 6.36
GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT 6.91 6.92 7.57 7.43 7.42 7.48 7.46 7.61 7.24 7.39 7.62 7.36 7.41 7.57 7.48 7.51 7.2 6.99 7.48 7.49 7.2 7.45 7.5 7.73 7.4 7.21
GOBP_PROTEIN_DNA_COMPLEX_SUBUNIT_ORGANIZATION 6.48 6.53 6.85 6.94 6.75 6.84 6.75 6.89 6.69 6.88 6.8 6.81 6.79 6.81 6.89 6.94 6.64 6.73 6.64 6.85 6.67 6.96 6.84 6.98 6.83 7.07
GOBP_PROTEIN_LIPID_COMPLEX_SUBUNIT_ORGANIZATION 6.14 6.06 5.73 6.21 6.01 5.73 5.88 5.92 5.66 5.66 6.13 5.62 6.14 5.85 5.85 5.78 6.18 5.94 5.81 5.88 5.92 6.35 5.54 5.53 5.68 5.98
GOBP_RIBONUCLEOPROTEIN_COMPLEX_SUBUNIT_ORGANIZATION 7.31 7.62 7.92 7.83 7.46 7.54 7.59 7.63 7.69 7.49 7.72 7.67 7.51 7.59 7.7 7.78 7.65 7.48 7.52 7.6 7.47 7.71 7.78 7.87 7.74 7.69
GOBP_MITOTIC_CELL_CYCLE_ARREST 5.93 6.03 6.47 6.37 5.88 5.69 5.74 6.12 6.17 6.04 6.35 5.81 5.95 5.96 5.78 6.64 5.99 5.75 5.87 5.85 6.43 6.42 6.02 6.07 6.33 6.16
GOBP_RESPONSE_TO_CATECHOLAMINE 7.22 7.21 7.43 6.81 7.73 7.7 7.78 7.63 7.72 7.96 7.4 7.51 7.97 8.02 7.9 7.82 7.37 7.63 7.89 8.09 7.32 7.82 7.75 7.96 7.86 7.74
GOBP_RESPONSE_TO_EPINEPHRINE 7.32 7.1 8 7.21 8.21 8.17 8.09 7.77 8.35 8.27 8.23 7.88 8.54 8.45 8 8.04 7.69 7.29 7.66 8.26 7.55 8.08 8.12 8.28 8.14 7.87
GOBP_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS 7.14 7.09 8.09 7.55 7.98 7.81 7.86 8.13 8.31 8.49 7.85 7.81 8.25 8.26 8.26 8.01 7.53 7.29 7.62 8.27 7.79 8.33 8.11 8.13 8.08 7.98
GOBP_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY 7.17 7.32 7.69 6.72 6.54 8.28 7.76 7.31 7.61 7.48 7.41 7 7.67 8.01 7.69 7.52 6.54 7.36 7.98 7.75 7.06 7.15 8.38 7.95 7.53 7.05
GOBP_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY 7.01 7.1 6.9 6.5 6.39 7.22 7.04 7.25 7.22 7.03 6.77 6.49 7.31 7.34 7.27 7.16 6.41 7.13 7.23 6.71 6.75 6.7 7.54 7.43 7.17 6.91
GOBP_LEUKOCYTE_APOPTOTIC_PROCESS 5.77 5.74 5.89 6.16 5.68 5.59 5.75 5.72 5.67 5.65 5.8 5.63 5.68 5.52 5.85 5.73 5.72 5.36 5.26 5.47 6.02 5.88 5.67 5.61 5.75 5.84
GOBP_DNA_BIOSYNTHETIC_PROCESS 6.53 6.55 6.91 6.95 6.75 6.91 6.69 6.75 6.57 6.89 6.69 6.75 6.85 6.76 6.63 6.88 6.48 6.41 6.68 6.9 6.57 6.83 6.87 6.96 6.82 6.72
GOBP_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY 6.48 6.44 6.58 6.46 6.56 6.53 6.64 6.72 6.63 6.62 6.54 6.57 6.7 6.64 6.64 6.68 6.52 6.56 6.43 6.59 6.75 6.65 6.83 6.71 6.69 6.7
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY 6.69 6.83 6.83 6.94 6.95 6.84 6.95 6.95 7.02 7.05 6.9 7.09 7.13 7.27 7.03 7.1 6.8 6.9 6.8 6.96 6.96 7.16 7.27 7.29 6.92 6.97
GOBP_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY 6.41 6.34 6.34 6.33 6.4 6.39 6.49 6.57 6.56 6.51 6.43 6.43 6.5 6.57 6.54 6.56 6.5 6.45 6.33 6.42 6.6 6.58 6.61 6.62 6.61 6.67
GOBP_MULTIVESICULAR_BODY_SORTING_PATHWAY 7.46 7.74 8.54 8.63 7.85 7.96 7.75 7.86 7.65 7.91 7.99 7.73 7.6 7.65 8.04 7.83 7.26 7.45 7.7 7.67 7.4 7.63 8 8.08 7.6 7.35
GOBP_NEPHRON_DEVELOPMENT 6.07 6.02 5.98 6.01 5.86 5.82 6.09 6.14 6.14 6.15 5.96 6.18 6.25 6.04 6.17 6.2 6.06 6 6 6.08 6.27 6.14 6.15 6.21 6.15 6.26
GOBP_NEPHRON_EPITHELIUM_DEVELOPMENT 6.08 6.02 6.04 6.05 5.86 5.82 6.1 6.16 6.27 6.19 6.04 6.18 6.28 6.04 6.18 6.21 6.07 6 6 6.15 6.28 6.21 6.11 6.23 6.15 6.26
GOBP_GLOMERULAR_EPITHELIUM_DEVELOPMENT 6.11 6.27 6.36 6.15 6.35 6.43 6.44 6.35 6.37 6.47 6.29 6.68 6.48 6.06 6.36 6.35 6.58 6.15 6.05 6.28 6.4 6.5 6.93 6.73 6.32 6.48
GOBP_DISTAL_TUBULE_DEVELOPMENT 6.53 6.6 5.97 6.26 6.56 6.62 6.44 6.89 6.55 6.95 6.35 7.04 6.48 6.62 6.48 6.31 6.85 6.6 6.51 6.45 6.86 6.89 6.51 6.73 6.7 6.75
GOBP_NEPHRON_MORPHOGENESIS 5.86 5.79 5.86 5.86 5.57 5.41 5.92 6.06 5.87 5.95 5.85 5.75 5.93 5.88 5.92 5.83 5.87 5.94 5.52 5.78 6.05 5.65 5.83 5.72 5.79 5.95
GOBP_COLLECTING_DUCT_DEVELOPMENT 5.66 5.57 5.35 5.79 5.55 5.06 5.33 5.42 5.4 5.13 5.77 5.18 5.18 5 5.39 5.26 5.4 5.59 5.32 5.06 5.54 5.21 5.14 5.08 5.3 5.24
GOBP_LOOP_OF_HENLE_DEVELOPMENT 5.9 5.98 5.72 5.96 6.03 5.98 5.59 5.54 5.87 6.1 5.69 5.83 5.76 6.01 5.53 5.74 5.79 5.61 5.78 5.97 6.03 5.84 5.61 5.78 5.66 5.83
GOBP_KIDNEY_EPITHELIUM_DEVELOPMENT 6.14 6.14 6.18 6.13 6.13 6.23 6.38 6.31 6.39 6.31 6.29 6.41 6.46 6.31 6.33 6.33 6.31 6.37 6.1 6.24 6.46 6.41 6.4 6.48 6.29 6.35
GOBP_KIDNEY_MESENCHYME_DEVELOPMENT 5.73 5.66 5.98 6.07 5.7 5.12 5.75 5.63 5.95 5.86 6.26 5.51 5.51 5.51 5.81 5.98 6.01 5.78 5.29 5.53 6.29 5.72 5.52 5.23 5.53 5.86
GOBP_METANEPHRIC_MESENCHYME_DEVELOPMENT 5.79 5.77 6.17 6.15 5.86 5.9 6.09 5.89 6.27 6.2 6.29 5.77 6.28 6.19 5.83 6.19 6.07 5.93 5.91 6.25 6.39 6.39 5.76 5.85 5.76 6.13
GOBP_NEPHRON_TUBULE_FORMATION 5.61 5.51 5.51 5.6 5.29 5.09 5.44 5.27 5.33 5.36 5.5 5.13 5.21 5.02 5.42 5.36 5.05 5.43 5.33 5.23 5.62 5.43 5.05 4.83 5.33 5.31
GOBP_RENAL_VESICLE_DEVELOPMENT 5.87 5.61 5.7 5.86 5.43 5.09 5.38 5.71 5.49 5.47 5.78 5.16 5.18 5.16 5.59 5.36 5.54 5.56 5.25 5.16 5.75 5.25 5.16 4.86 5.33 5.54
GOBP_STEM_CELL_PROLIFERATION 6.05 6.2 6.26 5.88 6.12 5.99 6.11 6.16 6.27 6.15 6.34 6.11 6.12 6.25 6.17 6.41 6.17 5.95 6.04 6.04 6.34 6.3 6.2 6.18 6.38 6.33
GOBP_REGULATION_OF_STEM_CELL_PROLIFERATION 5.93 6.15 6.26 5.99 5.99 5.99 6.02 6.1 6.2 6.13 6.34 6.03 6.16 6.49 6.03 6.29 6 5.93 6.09 5.89 5.98 6.32 6.14 6.14 6.28 6.27
GOBP_GLOMERULAR_MESANGIUM_DEVELOPMENT 6 6.32 6.51 5.99 5.87 6.07 6.08 6.21 6.02 6.03 6.04 6.11 6.2 5.99 6.5 6.01 5.91 6.08 6 5.82 6.32 6.35 6.17 6.06 6.19 6.26
GOBP_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION 5.44 5.09 5.66 5.46 5.7 5.05 5.42 5.64 5.51 5.23 5.36 5.1 5.69 5.49 5.83 5.56 5.65 5.45 5.3 5.27 5.66 5.84 5.25 5.37 5.6 5.87
GOBP_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT 5.36 5.37 5.55 5.36 5.01 4.87 5.42 5.37 5.46 4.97 5.09 4.95 5.16 4.9 5.16 5.24 5.38 5.37 5.23 5.22 5.53 5.32 5.13 4.92 5.29 5.78
GOBP_MESENCHYME_MORPHOGENESIS 6 6.07 6.18 6 5.88 5.97 6.14 6.19 6 5.89 6.05 6.23 6.04 6.05 6.01 6.08 6.19 6.16 5.73 5.85 6.42 6.18 6.11 6.04 6.39 6.25
GOBP_EPITHELIAL_CELL_FATE_COMMITMENT 6.51 6.15 6.04 6.05 6.44 6.58 6.23 6.63 6.58 6.33 5.65 6.27 6.62 6.6 6.2 6.09 6.63 5.71 6.12 6.63 6.35 6.51 6.31 6.42 6.31 6.4
GOBP_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION 5.94 5.8 5.35 5.65 5.76 5.55 5.6 5.37 5.42 5.17 5.63 4.99 5.18 5.51 5.33 5.59 5.61 5.71 5.54 5.72 5.38 5.24 5.34 5.13 5.3 5.03
GOBP_METANEPHRIC_TUBULE_DEVELOPMENT 6.51 6.32 5.98 6.13 6.43 6.51 6.44 6.35 6.43 6.5 6.28 6.26 6.49 6.58 6.56 6.37 6.91 6.77 6.3 6.45 6.57 6.89 6.37 6.39 6.3 6.66
GOBP_MESONEPHRIC_TUBULE_MORPHOGENESIS 5.79 5.7 5.8 5.85 5.55 5.4 5.91 6.05 5.84 5.93 5.8 5.72 5.84 5.85 5.85 5.81 5.84 5.93 5.51 5.57 6.02 5.64 5.76 5.7 5.76 5.87
GOBP_EPITHELIAL_TUBE_FORMATION 6.02 6.16 6.15 6.05 6.13 6.22 6.25 6.15 6.28 6.3 6.26 6.45 6.26 6.2 6.09 6.17 6.17 6.19 6.14 6.03 6.14 6.34 6.08 6.18 6.15 6.38
GOBP_NEPHRIC_DUCT_DEVELOPMENT 5.7 5.34 5.31 5.65 4.88 4.89 5.3 4.83 5.35 4.61 5.28 4.72 4.89 4.81 5.16 4.93 4.99 5.37 4.98 4.99 5.46 4.97 4.99 4.65 4.92 4.95
GOBP_NEPHRIC_DUCT_MORPHOGENESIS 5.6 5.3 5.28 5.49 4.78 4.83 5.19 4.81 5.33 4.61 5.09 4.72 4.8 4.76 5.08 4.91 4.98 5.33 4.92 4.89 5.42 4.93 4.9 4.59 4.86 4.87
GOBP_URETER_DEVELOPMENT 5.5 5.44 5.35 5.71 4.95 5.02 5.6 4.89 5.42 4.88 5.44 4.83 5.18 4.86 5.27 5.34 5.11 5.41 5.11 5.22 5.56 5.17 5 4.77 5.02 5.37
GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT 6.09 5.64 5.78 5.67 5.55 5.21 5.91 6.12 5.72 5.8 6.04 5.61 5.67 5.52 5.99 5.88 5.68 5.71 5.51 5.57 5.94 5.62 5.36 5.54 5.54 5.69
GOBP_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT 5.58 5.67 5.38 5.72 5.68 5.48 5.65 5.63 5.64 5.66 5.78 5.47 5.63 5.54 5.43 5.44 5.58 5.65 5.56 5.56 5.55 5.23 5.45 5.47 5.53 5.52
GOBP_METANEPHRIC_EPITHELIUM_DEVELOPMENT 6.23 6.12 5.66 6.08 6.2 6.35 6.17 6.11 6.31 6.27 6.02 5.88 6.35 6.5 6.19 5.9 6.29 6.23 5.8 6.01 6 6.11 6.19 6.24 5.8 6.07
GOBP_METANEPHRIC_NEPHRON_DEVELOPMENT 5.79 5.64 5.7 6.05 5.53 5.12 5.45 5.79 5.56 5.48 5.8 5.25 5.28 5.39 5.83 5.63 5.4 5.71 5.32 5.4 5.79 5.62 5.17 5.18 5.48 5.69
GOBP_METANEPHRIC_GLOMERULUS_DEVELOPMENT 5.5 5.01 5.35 5.65 5.01 4.87 5.3 5.05 5.42 4.98 5.28 4.95 5.18 4.9 5.27 5.15 5.27 5.41 5.11 4.99 5.56 5.17 5 4.92 5.02 5.3
GOBP_METANEPHRIC_NEPHRON_MORPHOGENESIS 6.09 5.86 6.18 6.15 5.6 5.4 6.08 6.12 6.28 6.15 6.19 6.03 5.84 5.91 6.17 6.33 5.93 6 5.53 5.95 6.08 5.8 6.08 5.54 5.82 5.8
GOBP_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS 6.01 5.61 5.49 5.66 5.2 5.09 5.38 5.71 5.45 5.25 5.67 5.16 5.18 5.16 5.31 5.36 5.29 5.56 5.25 5.11 5.75 5.25 5.07 4.86 5.33 5.39
GOBP_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT 6.13 6.65 6.44 6.17 6.56 6.7 6.72 6.86 6.82 6.9 6.36 6.99 6.73 6.66 6.37 6.69 6.79 6.41 6.48 6.85 6.79 7.12 7.26 6.78 6.92 6.66
GOBP_GLOMERULAR_EPITHELIAL_CELL_DIFFERENTIATION 6.09 6.11 6.29 6.13 6.2 6.24 6.34 6.21 6.21 6.41 6.04 6.64 6.47 5.99 6.34 6.31 6.46 5.89 6 6.15 6.32 6.49 6.92 6.72 6.21 6.3
GOBP_CHAPERONE_MEDIATED_PROTEIN_TRANSPORT 6.69 6.84 8.28 8.03 6.97 7.36 7.43 7.62 7.47 7.12 7.72 7.28 7.27 7.2 7.41 7.64 7.78 7.13 7 7.59 7.04 8.05 7.35 7.51 7.4 7.62
GOBP_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS 6.27 6.35 6.77 6.78 6.37 6.55 6.55 6.55 6.49 6.56 6.52 6.53 6.55 6.51 6.48 6.63 6.41 6.43 6.46 6.63 6.62 6.57 6.62 6.53 6.51 6.63
GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS 6.18 6.16 6.37 6.41 6.03 6.01 6.25 6.2 6.16 6.14 6.29 6.09 6.29 5.96 6.01 6 6.25 6.03 6.05 6.02 6.17 6.41 5.86 5.98 6.31 6.34
GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 6.54 6.56 6.84 6.89 6.82 6.81 6.67 6.86 6.73 6.78 6.92 6.91 6.68 6.81 6.83 6.98 6.68 6.47 6.68 6.75 6.69 6.86 6.83 7.05 6.78 6.96
GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR 6.34 6.63 6.71 6.68 6.53 6.68 6.91 7.27 6.85 6.72 6.55 6.92 6.88 6.88 7.02 6.97 6.8 6.49 6.54 7.06 6.81 6.9 7.14 7.17 6.88 7.08
GOBP_MODIFIED_AMINO_ACID_TRANSPORT 6.28 6.21 6.39 6.7 6.23 6.37 6.19 6.24 6.11 6.22 6.41 6.32 6.27 6.08 5.83 5.66 6.22 6.17 6.17 6.16 6.31 6.55 6.35 6.36 6.25 6.18
GOBP_SULFUR_COMPOUND_TRANSPORT 6.39 6.11 5.96 6.15 6.02 6.47 6.53 6.43 5.99 6.1 6.05 6.06 5.95 6.13 6.13 5.9 6.04 5.95 6.54 6.54 6.08 6.19 6.14 6.22 6.24 6.24
GOBP_TRICARBOXYLIC_ACID_METABOLIC_PROCESS 9.17 9.24 9.08 8.54 9.37 9.39 9.62 9.87 9.5 9.32 8.9 9.08 9.45 9.59 9.47 9.44 9.45 9.71 9.56 9.37 9.44 9.29 9.45 9.64 9.83 9.5
GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT 6.14 6.17 6.24 6.22 6.2 6.2 6.23 6.23 6.25 6.2 6.18 6.18 6.28 6.28 6.21 6.21 6.31 6.17 6.07 6.17 6.36 6.4 6.34 6.21 6.26 6.4
GOBP_PROTEIN_ACTIVATION_CASCADE 5.5 5.32 5.09 5.21 5.03 4.96 4.89 4.94 5.13 5.03 5.18 4.64 4.86 4.98 4.71 4.76 5.05 5.11 5.19 4.78 5.32 5.04 4.92 4.68 5.06 5.03
GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE 8.45 8.84 9 8.68 8.91 9 9.19 8.94 8.93 9.19 8.64 8.81 8.94 8.99 9.01 9 8.58 8.48 8.77 8.93 8.46 8.59 9.19 9.22 9.09 8.64
GOBP_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER 6.85 6.8 7.28 6.9 7.32 7.45 6.94 7.23 7.16 7.31 7.17 7.3 7.47 7.24 7.55 7.84 7.35 7.27 7.33 7.44 7.3 7.49 7.32 7.36 7.5 7.46
GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_CELL_CYCLE_CHECKPOINT 6.41 6.43 6.37 6.51 6.34 6.2 6.19 6.44 6.28 6.25 6.5 6.15 6.33 6.28 6.13 6.54 6.25 6.34 6.39 6.31 6.56 6.43 5.98 6.16 6.54 6.57
GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_G2_DNA_DAMAGE_CHECKPOINT 5.84 5.93 5.6 6.1 5.84 5.7 5.5 5.45 5.43 5.53 5.81 5.96 5.28 5.64 5.77 5.73 5.48 5.27 5.56 5.52 5.39 5.42 5.75 5.54 5.57 5.86
GOBP_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT 5.22 5.21 5.33 5.41 5.34 4.85 5.24 5.21 5.16 4.98 5.35 5.1 5.04 5.15 5.26 5.39 5.21 5.06 4.96 4.98 5.37 5.05 5.13 4.73 5.18 5.13
GOBP_TRIVALENT_INORGANIC_ANION_HOMEOSTASIS 5.35 4.96 4.67 5.4 4.58 4.5 4.77 4.64 4.89 4.85 5.09 4.7 4.56 4.53 4.69 4.75 4.86 4.88 4.71 4.57 4.86 4.63 4.79 4.11 4.44 4.5
GOBP_DIVALENT_INORGANIC_CATION_HOMEOSTASIS 6.07 5.94 6.02 6.11 5.68 5.75 6.03 5.95 5.99 5.93 6.06 5.76 5.86 5.95 6.13 5.84 6.02 6.06 5.78 5.84 6.13 6.09 5.86 5.83 6.02 6.14
GOBP_SEMINIFEROUS_TUBULE_DEVELOPMENT 5.88 6.04 5.76 5.82 5.95 6.37 6.2 6.24 6.03 6.38 5.91 5.94 6.19 6.15 6.29 6.61 6 6.05 5.85 6.43 6.16 6.36 6.91 6.64 6.05 6.3
GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.67 6.76 7.2 7.05 6.95 7.05 7.05 6.98 6.97 7.13 6.88 7.04 7.02 7.05 6.87 7.01 6.91 6.92 6.89 6.97 6.81 6.95 6.94 7.08 7.07 6.99
GOBP_PURINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS 6.81 6.93 7.48 7.07 7.09 7.24 7.11 7.15 7.1 7.25 7.11 7.19 7.14 7.21 6.96 7.2 7.05 7.04 7.06 7.34 6.96 7.02 7.07 7.35 7.19 7.25
GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS 6.17 6.59 7.05 6.86 6.58 6.83 6.96 7.1 6.88 7.06 6.7 6.8 7.09 6.93 6.83 6.78 6.58 6.58 6.6 6.95 6.7 6.87 6.97 7.04 6.97 6.88
GOBP_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.09 5.94 5.87 5.94 5.53 5.48 5.75 5.66 5.65 5.72 6.03 5.47 5.85 5.88 5.77 5.79 5.99 5.95 5.82 6.02 5.79 5.54 5.61 5.69 5.86 5.88
GOBP_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS 6.09 5.92 5.87 5.95 5.51 5.47 5.72 5.75 5.64 5.72 5.95 5.56 5.75 5.83 5.84 5.83 6.01 5.95 5.81 5.84 5.79 5.73 5.56 5.65 5.81 5.84
GOBP_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS 5.83 5.91 6.09 5.88 5.99 6.17 5.71 5.72 5.91 5.79 5.8 5.67 5.91 5.95 5.72 5.84 5.77 5.68 5.9 5.71 5.63 5.77 5.83 5.97 5.72 5.89
GOBP_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS 6.34 6.42 6.87 6.74 6.77 6.73 6.32 6.69 6.41 6.38 6.62 6.49 6.62 6.74 6.57 6.6 6.32 6.66 6.58 6.51 6.42 6.5 6.21 6.61 6.56 6.75
GOBP_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS 5.43 5.41 5.4 5.44 5.1 5.14 5.38 5.21 5.38 5.14 5.25 5.32 5.31 5.03 5.44 5.41 5.3 5.43 5.26 5.06 5.34 5.27 5.36 5.24 5.22 5.19
GOBP_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT 6.12 6.27 5.86 6.15 5.78 6.08 6.09 6.14 6.15 6.07 6.24 5.52 5.48 5.31 6 5.88 6.03 6 5.88 5.79 6.22 5.9 5.53 5.15 5.84 5.82
GOBP_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT 5.36 5.24 5.27 5.37 5.03 4.97 4.84 4.96 4.92 4.69 5.05 4.72 4.95 4.84 4.68 4.8 5.09 5.05 5.2 4.83 4.85 4.98 4.78 4.56 5.03 4.92
GOBP_T_HELPER_17_TYPE_IMMUNE_RESPONSE 5.53 5.15 5.05 5.4 4.91 4.93 5.06 5.07 5 4.98 5.15 4.84 5.06 5.13 5.17 4.9 5 5.09 5.1 4.85 5 5.06 4.97 4.94 4.98 5.06
GOBP_T_HELPER_17_CELL_LINEAGE_COMMITMENT 5.36 5.04 5.02 5.18 4.66 4.59 4.73 4.91 4.97 4.55 4.87 4.64 4.67 4.71 4.74 4.61 4.86 5.08 4.67 4.76 4.97 4.72 4.55 4.42 4.56 4.66
GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION 7.64 7.78 7.76 7.72 7.01 7.75 7.39 7.26 7.29 6.65 7.82 7.03 7.21 7.09 6.86 7.38 7.08 7.21 7.3 7.26 7.56 7.28 7.06 7.15 7.43 7.21
GOBP_LIVER_MORPHOGENESIS 6.66 6.74 6.76 6.89 6.95 6.56 6.86 6.82 7.07 6.9 6.55 6.79 6.67 6.71 6.18 6.4 6.82 6.44 6.23 6.82 6.83 6.72 6.67 6.66 6.7 6.99
GOBP_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS 5.63 5.4 5.39 5.55 5.33 5.12 5.59 5.29 5.46 5.07 5.44 5.18 5.54 5.58 5.36 5.35 5.53 5.47 4.93 5.22 5.8 5.81 5.26 4.89 5.87 5.75
GOBP_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING 8.66 9.2 8.58 8.88 8.9 9.35 9.32 8.99 9.34 9.05 8.81 9.3 9.38 9.48 8.92 8.87 8.64 8.78 9.77 9.14 8.34 8.55 8.87 9.38 8.92 8.35
GOBP_CLATHRIN_DEPENDENT_ENDOCYTOSIS 8.24 8.43 8.63 8.45 8.84 8.78 8.85 8.81 8.95 8.9 8.53 8.67 8.67 8.74 8.92 8.56 8.56 8.32 8.67 8.63 8.3 8.42 8.82 8.9 8.84 8.57
GOBP_CAVEOLIN_MEDIATED_ENDOCYTOSIS 7.08 6.9 8.22 8.27 7.92 7.42 8.43 7.2 7.89 7.68 8.88 8.1 6.9 7.23 7.27 6.68 8.1 6.82 7.97 7.87 7.74 7.28 8.81 8.29 7.83 7.28
GOBP_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS 6.12 6.16 6.79 6.41 6.25 6.19 6.14 6.32 6.26 6.21 6.34 6.18 6.28 6.19 6.42 6.28 6.3 6.2 6.21 6.28 6.59 6.52 6.34 6.41 6.51 6.38
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE 7.23 7.37 7.91 7.82 7.55 7.59 7.57 7.53 7.58 7.55 7.63 7.58 7.67 7.7 7.62 7.62 7.38 7.4 7.54 7.63 7.44 7.58 7.64 7.91 7.7 7.55
GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE 7.79 8.12 8.11 8.05 8.16 8.66 8.51 8.37 8.25 8.59 8.14 8.4 8.49 8.61 8.41 8.27 8.1 8.05 8.39 8.24 7.96 8.19 8.37 8.69 8.54 8.21
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM 7.22 7.41 7.89 7.91 7.22 7.15 7.09 7.35 7.13 7.41 7.51 7.09 7.26 7.52 7.57 7.49 7.27 7.46 7.19 7.08 7.34 7.29 7.56 7.44 7.31 7.46
GOBP_PROTEIN_LOCALIZATION_TO_MEMBRANE 7.35 7.46 7.91 7.69 7.73 7.79 7.72 7.79 7.71 7.75 7.75 7.77 7.79 7.84 7.83 7.8 7.46 7.52 7.72 7.8 7.58 7.71 7.78 8.01 7.73 7.59
GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE 7.51 7.6 7.82 7.65 7.96 8.04 7.8 7.92 7.71 7.77 7.75 7.88 7.81 7.91 7.9 7.81 7.68 7.62 7.77 7.89 7.63 7.82 7.82 8.05 7.73 7.58
GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE 7.8 8 8.09 7.97 8.15 8.11 8.12 8.03 8.28 7.9 7.9 8.14 8.32 8.21 8.03 8 7.75 7.71 7.99 8.24 7.89 7.84 8.17 8.32 8.23 7.95
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE 7.85 8.11 8.15 8.07 8.26 8.15 8.19 8.07 8.34 8.22 8.06 8.21 8.33 8.39 8.05 8.02 7.92 7.72 8.01 8.41 7.9 8.09 8.2 8.43 8.34 8.02
GOBP_NEUTROPHIL_EXTRAVASATION 5.71 5.75 5.68 6.05 5.1 5.07 5.54 5.38 5.48 5.29 5.63 5.57 5.54 5.24 5.86 5.3 5.83 5.35 5.32 5.42 5.97 5.71 5.28 5.13 5.59 5.89
GOBP_LAMELLIPODIUM_MORPHOGENESIS 7 7.01 7.72 7.67 6.99 7.03 7.76 7.14 7.49 7.03 6.7 7.07 7.25 7.49 7.29 7.75 7.26 7.2 7.5 7.66 7.25 7.31 6.95 7.1 7.39 7.13
GOBP_LYMPHOCYTE_MIGRATION 5.44 5.31 5.24 5.57 4.99 5.04 5.14 5.07 5.29 5.09 5.11 4.86 5.2 5.09 5.25 5.05 5.37 5.32 5.02 5.08 5.42 5.22 5.04 4.86 5.18 5.18
GOBP_EOSINOPHIL_MIGRATION 5.14 4.96 4.72 4.99 4.19 4.24 4.65 4.48 4.81 4.49 4.71 4.48 4.27 4.45 4.58 4.29 4.6 4.69 4.79 4.24 5.08 4.66 4.6 4.19 4.63 4.48
GOBP_T_CELL_MIGRATION 5.56 5.48 5.44 5.65 5.15 5.09 5.46 5.3 5.5 5.14 5.63 4.97 5.35 5.22 5.44 5.3 5.81 5.44 5.11 5.14 5.6 5.66 5.16 5.07 5.48 5.37
GOBP_T_CELL_EXTRAVASATION 5.49 5.31 5.66 6.03 5.21 5.35 5.55 5.55 5.41 5.21 5.87 5.15 5.68 5.57 5.57 5.67 5.72 5.13 5.24 5.28 6.09 5.89 5.27 5 5.92 6.35
GOBP_MRNA_METHYLATION 7.44 7.47 7.68 8.03 7.55 7.84 7.49 7.63 7.36 8.1 7.56 8.03 7.69 7.64 7.55 7.64 7.06 7.16 7.62 7.8 7.35 7.74 7.83 8.05 7.9 7.97
GOBP_DNA_DEMETHYLATION 5.48 5.65 5.68 5.55 5.4 5.71 5.49 5.49 5.43 5.44 5.29 5.16 5.45 5.43 5.56 5.35 5.31 5.37 5.79 5.56 5.41 5.27 5.48 5.15 5.18 5.53
GOBP_REGULATION_OF_RESPONSE_TO_STRESS 6.41 6.38 6.61 6.62 6.49 6.48 6.51 6.51 6.5 6.48 6.52 6.44 6.52 6.49 6.48 6.52 6.5 6.38 6.37 6.43 6.51 6.56 6.59 6.58 6.61 6.57
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS 6.9 6.85 7.32 7.22 7.22 7.23 7.14 7.17 7.31 7.25 7.16 7.18 7.23 7.28 7.19 7.2 7.02 7 7.08 7.22 7.04 7.19 7.35 7.36 7.24 7.15
GOBP_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS 6.25 6.19 6.96 6.66 6.27 6.19 6.35 6.49 6.63 6.24 6.53 6.1 6.7 6.24 6.59 6.64 6.51 6.28 6.36 6.51 6.82 6.75 6.77 6.45 6.82 6.61
GOBP_LYTIC_VACUOLE_ORGANIZATION 7.62 7.5 7.83 7.87 7.61 8.01 7.61 7.55 7.57 7.8 7.58 7.44 7.89 7.86 7.46 7.56 7.19 7.47 7.64 7.66 7.37 7.59 7.84 7.83 7.62 7.62
GOBP_HISTONE_H3_K4_TRIMETHYLATION 6.43 6.72 6.67 6.6 7.11 6.96 6.56 6.95 6.53 6.69 6.51 6.47 6.64 6.58 6.56 6.53 6.59 6.6 6.85 6.53 6.5 6.74 6.86 7.08 6.96 6.71
GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY 6.44 6.56 6.58 6.1 6.43 6.15 6.52 6.64 6.09 6.4 6.47 6.73 6.35 6.52 6.56 6.68 6.43 6.37 6.6 6.69 6.73 6.91 6.47 6.66 6.65 6.92
GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL 7.36 7.53 7.67 7.12 7.77 7.82 7.6 7.54 7.77 7.84 7.67 8.04 7.65 7.74 7.66 7.84 7.68 7.49 7.95 7.8 7.31 7.68 7.96 7.98 7.76 7.53
GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION 6.91 6.88 6.84 6.79 7.21 7.38 7.21 7.04 7.56 7.68 6.91 7.32 7.4 7.23 7.14 6.75 7.17 7.06 7.44 7.6 6.84 7.28 7.3 7.7 7.43 7.31
GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION 7.14 7.09 7.16 6.8 7.4 7.38 7.21 7.29 7.65 7.65 7.42 7.67 7.45 7.49 7.55 7.27 7.17 7.07 7.49 7.6 7.21 7.28 7.51 7.78 7.44 7.31
GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL 6.17 6.04 6.41 6.16 5.7 5.72 6.32 6.4 5.99 6.48 6.21 5.89 5.66 5.76 6.73 6.53 6.15 6.08 6.27 5.96 5.99 5.71 6.13 5.95 6.2 5.72
GOBP_MEMBRANE_REPOLARIZATION 7.41 7.53 7.83 7.3 7.73 7.61 7.71 7.48 7.84 7.93 8.13 8.13 7.87 7.89 7.76 7.8 7.98 7.73 7.97 7.8 7.68 7.81 8.21 8.09 7.88 7.45
GOBP_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL 7.74 7.85 7.41 6.99 8.04 7.88 7.66 7.99 7.64 7.84 7.67 7.83 7.77 7.81 7.93 7.88 7.68 7.9 8.01 7.95 7.84 7.81 7.67 7.92 7.76 7.59
GOBP_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL 6.31 6.16 6.49 6.67 5.72 5.72 6.32 6.58 5.99 6.48 6.6 5.89 6.22 5.97 7.09 6.53 6.15 6.78 6.34 6.18 6.11 6.68 6.39 6.7 6.2 6.44
GOBP_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL 8.62 8.51 8.4 7.87 9.08 8.61 8.35 9.1 8.98 8.47 8.55 8.54 8.8 8.61 8.72 8.31 8.49 8.22 8.2 8.77 8.59 9.32 8.82 9.04 8.3 8.57
GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION 6.05 6.16 6.31 6.67 5.41 6.08 6.45 6.58 6.02 6.32 6.1 6.52 6.22 5.97 6.82 6.53 6.33 6.88 6.27 6.4 6.52 6.48 6.39 6.7 6.48 6.55
GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_SIGNALING 6.05 6.16 6.31 6.38 5.41 5.8 6.02 6.58 6.02 6.27 5.88 6.25 6.22 5.97 7.63 6.37 6.02 6.88 6.05 6.18 6.52 6.68 6.39 6.7 6.48 6.55
GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION 7.68 7.92 8.19 8.02 8.68 8.96 8.43 8.7 7.89 8.35 8.65 8.12 8.11 8.22 8.65 8.9 8.34 7.64 8.52 8.07 8.02 8.58 8.81 8.36 8.49 8.52
GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION 7.02 6.91 7.07 6.89 7.17 7.3 7.02 6.96 7.31 7.3 6.93 7 7.18 7.22 6.93 6.8 7.12 6.99 7.17 7.36 6.85 6.87 7.49 7.1 7.42 7.29
GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION 6.05 6.12 5.47 6.38 5.41 5.8 5.77 6.25 6.02 5.72 5.87 6.25 5.87 5.39 6.3 5.78 5.76 6.08 6.05 5.71 6.52 6.48 6.04 5.78 6.48 6.55
GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION 5.67 5.89 5.89 5.73 5.21 5.41 5.58 5.39 5.22 5.49 5.88 5.64 5.42 5.33 5.43 5.52 5.89 5.86 5.71 5.42 5.77 5.51 5.43 5.19 5.68 5.76
GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION 6.01 6.14 5.72 6.48 5.34 5.66 5.72 6.04 5.87 5.96 5.87 5.95 6.1 5.68 6.39 5.84 5.76 6.48 6.04 5.95 6.27 6.58 6.18 6.24 6.3 6.49
GOBP_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION 6.91 6.58 6.41 6.79 7.06 7.1 6.82 6.85 6.73 7.25 6.51 7.07 6.89 7.19 6.82 6.62 6.98 6.78 6.59 7.12 6.67 6.68 6.75 7.02 7.06 7.18
GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS 7.08 6.58 6.61 6.8 7.12 7.26 6.72 6.88 7.05 6.92 6.95 6.69 6.89 7.23 6.8 6.66 6.54 6.78 7.39 6.77 6.82 6.55 8.81 7.05 6.97 6.79
GOBP_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS 5.81 5.75 5.84 5.53 5.35 5.6 5.55 5.58 5.68 5.42 5.57 5.22 5.64 5.62 5.74 5.54 5.71 5.62 5.33 5.49 5.72 5.71 5.28 5.64 5.85 5.92
GOBP_REGULATION_OF_MONOCYTE_CHEMOTAXIS 6.07 5.76 5.76 5.99 5.78 5.49 5.08 5.06 5.52 5.03 5.6 4.92 5.49 5.48 5.17 5.22 5.56 5.44 5.03 4.96 5.57 5.38 5.28 5.19 5.42 5.32
GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS 5.7 5.49 4.76 4.82 4.83 4.72 4.35 4.52 4.86 4.58 5.07 4.75 4.58 4.4 4.33 4.27 5.53 5.53 4.92 4.51 4.97 4.81 4.42 4.54 4.78 4.57
GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS 5.83 5.62 5.58 5.81 6.03 5.81 5.76 5.81 5.69 5.94 6.12 5.8 5.63 5.51 5.72 5.86 5.71 5.79 5.66 5.62 5.87 5.77 5.54 5.33 5.61 5.87
GOBP_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING 6.72 6.7 6.94 7.09 6.39 6.17 6.66 6.74 6.67 6.91 6.64 6.66 6.37 6.81 7.1 7.18 6.76 7.06 6.97 6.58 6.69 6.46 6.51 7.3 7.01 6.81
GOBP_TUBULIN_DEACETYLATION 8.58 8.69 8.61 8.38 8.88 8.69 8.54 8.47 8.98 8.63 8.31 8.42 8.54 8.78 8.57 8.32 8.74 8.62 8.86 9.01 8.32 8.53 8.84 8.66 8.66 8.54
GOBP_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS 6.48 6.45 6.64 6.12 6.73 6.7 6.36 6.49 6.34 6.26 6.1 6.21 6.38 6.31 6.44 6.25 6.52 6.26 6.41 6.44 6.59 6.4 6.69 6.46 6.42 6.48
GOBP_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS 6.42 6.43 6.65 6.35 6.65 6.61 6.29 6.41 6.21 6.2 6.07 6.16 6.36 6.15 6.29 6.07 6.49 6.08 6.37 6.29 6.45 6.3 6.24 6.26 6.34 6.4
GOBP_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS 5.97 6.32 5.7 5.9 6.7 6.13 6.36 5.78 6.01 6.21 5.9 6.09 6.58 6.31 6.52 6.4 5.88 6.11 6.38 6 6.01 6.4 6.78 5.98 6.24 6.35
GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE 6.56 6.68 6.88 6.69 6.88 6.93 6.84 6.97 6.89 7.01 6.7 6.83 6.88 6.97 6.99 6.8 6.86 6.8 6.81 7.02 6.94 7 6.95 7.04 6.97 7.01
GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS 6.19 6.22 6.4 6.33 6.36 6.34 6.41 6.39 6.23 6.54 6.39 6.42 6.4 6.35 6.36 6.51 6.47 6.41 6.19 6.4 6.45 6.52 6.44 6.58 6.45 6.47
GOBP_RELAXATION_OF_MUSCLE 8.76 8.57 8.46 8.49 9.06 9.03 8.64 8.82 9.08 9.01 8.62 8.52 8.66 8.75 8.78 8.69 8.45 7.86 8.64 8.87 8.3 8.47 9 8.7 8.34 8.45
GOBP_FOAM_CELL_DIFFERENTIATION 5.78 5.69 6.02 6.05 5.52 5.03 5.53 5.92 5.38 5.36 5.77 5.73 5.35 5.29 5.76 5.61 5.97 5.98 5.61 5.45 6.4 5.98 5.64 5.33 5.71 5.85
GOBP_REGULATION_OF_INCLUSION_BODY_ASSEMBLY 7.34 7.48 8.19 7.75 8.12 8.08 7.91 8.1 8.16 8.57 7.65 8.49 8.38 8.41 9.03 9.04 8.47 7.99 8.09 8.54 8.49 8.91 8.8 8.72 8.49 8.5
GOBP_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY 7.54 7.96 8.76 7.82 8.86 8.91 8.99 9.04 9.27 9.01 7.82 8.66 8.91 9.08 9.23 9.11 8.77 8.31 8.88 8.89 9.06 9.59 9.29 9.68 9.26 8.7
GOBP_REGULATION_OF_PROTEIN_DEUBIQUITINATION 7.21 7.51 7.16 7.21 7.65 8.04 7.4 7.26 7.56 7.35 7.15 7.46 7.9 8.11 7.51 7.67 6.73 7.44 8.06 7.53 6.86 7.39 8.03 8.15 7.5 7.32
GOBP_REGULATION_OF_PEPTIDE_TRANSPORT 6.86 6.92 7.29 7.1 7.08 7.14 7.16 7.22 7.14 7.17 7.11 7.18 7.24 7.19 7.14 7.16 7.11 7.08 6.96 7.23 7.08 7.28 7.16 7.37 7.23 7.3
GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY 6.83 6.72 7.29 6.85 6.96 7.11 7.08 7.05 6.93 7.14 7.03 6.96 6.89 7.1 6.85 6.82 6.89 6.8 7.03 7.17 6.97 7.05 7.02 7.23 7.16 7.05
GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY 6.19 6.3 6.31 6.35 6.22 6.36 6.35 6.4 6.33 6.31 6.29 6.35 6.48 6.38 6.27 6.46 6.36 6.14 6.17 6.26 6.56 6.58 6.61 6.36 6.32 6.49
GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY 6.18 6.32 6.35 6.27 6.21 6.16 6.33 6.4 6.29 6.33 6.31 6.27 6.42 6.37 6.29 6.55 6.45 6.14 6.16 6.35 6.54 6.65 6.52 6.33 6.29 6.38
GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY 6.48 6.53 6.51 6.56 6.81 6.7 6.64 6.53 6.64 6.62 6.52 6.66 6.98 6.9 6.39 6.59 6.66 6.57 6.33 6.62 6.71 6.83 7.02 6.73 6.63 6.77
GOBP_COCHLEA_DEVELOPMENT 5.85 5.73 5.59 5.77 5.67 5.61 6.01 5.77 5.63 5.56 5.8 5.7 5.63 5.71 5.95 5.78 5.8 6.12 5.76 5.82 5.8 5.81 5.54 5.86 5.68 5.71
GOBP_COCHLEA_MORPHOGENESIS 5.37 5.12 5.14 5.33 4.89 4.79 5.01 4.92 5.07 4.87 5.26 4.8 5.19 5.07 4.99 4.89 5.15 5.29 4.96 4.98 5.12 5.03 4.95 4.74 4.74 4.74
GOBP_COPII_COATED_VESICLE_CARGO_LOADING 8.24 8.13 8.99 9.01 8.25 8.22 8.38 8.42 8.28 8.54 8.59 8.37 8.58 8.76 8.57 8.59 8.62 8.07 8.19 8.45 8.33 8.55 8.38 8.45 8.48 8.72
GOBP_COPII_COATED_VESICLE_BUDDING 8.05 8.18 8.69 8.59 8.24 8.29 8.46 8.16 8.49 8.56 8.43 8.3 8.37 8.41 8.47 8.25 7.97 7.92 8.37 8.35 8.08 8.43 8.62 8.85 8.43 8.21
GOBP_REGULATION_OF_SYNAPSE_MATURATION 6.69 6.57 6.49 7.65 6.75 6.38 6.53 6.99 6.8 6.59 6.38 6.92 6.74 6.86 7.22 6.54 6.65 6.74 6.68 6.7 6.46 6.95 6.43 6.58 6.5 6.55
GOBP_TISSUE_MIGRATION 6.47 6.5 6.69 6.45 6.73 6.64 6.71 6.74 6.64 6.64 6.49 6.69 6.8 6.67 6.76 6.59 6.65 6.39 6.44 6.58 6.79 6.77 6.8 6.71 6.83 6.86
GOBP_EPITHELIAL_CELL_CELL_ADHESION 6.65 6.42 6.87 6.23 7.06 6.87 6.82 6.87 6.62 6.86 6.51 7.07 7.18 7.19 6.73 6.62 6.81 6.11 6.59 7.1 6.56 6.57 6.75 7.15 6.84 7.01
GOBP_REGULATION_OF_MITOCHONDRIAL_FISSION 7.39 7.83 7.42 7.7 8.41 8.17 8.31 8.2 8.35 8.5 8.11 8.62 8.19 8.13 8.25 8.29 8.43 7.75 8.1 8.15 7.82 8.75 8.48 8.57 8.31 8.09
GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION 8.22 8.48 9.42 9.05 8.59 8.56 9.02 9.33 8.76 9.27 9.7 9.1 9.08 9.07 9.41 9.53 9.44 8.16 8.62 8.86 9.04 9.38 9.47 9.32 9.05 9.33
GOBP_MEMBRANE_FISSION 7.93 8.08 9.04 8.91 8.73 8.92 9.08 8.89 8.92 8.94 8.65 8.9 8.81 8.45 9.13 8.98 8.5 8.3 8.39 8.76 8.28 8.7 9.01 8.93 8.91 8.95
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE 7.33 7.4 7.94 7.85 7.67 7.75 7.67 7.73 7.62 7.69 7.76 7.71 7.74 7.8 7.81 7.76 7.47 7.52 7.67 7.67 7.54 7.62 7.7 8 7.67 7.6
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE 7.13 7.27 8.28 8.24 7.44 7.74 7.99 7.79 7.8 8.26 7.9 7.97 8.11 7.73 8.25 7.99 7.48 7.83 7.85 7.93 7.45 7.71 8.1 8.2 8.17 7.73
GOBP_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS 6.77 7.21 7.38 6.84 7.24 7.34 7.07 7.42 7.5 6.9 7.04 7.07 6.84 7.25 7.32 7.46 6.88 6.61 6.73 7.61 7.03 7.23 7.38 7.23 7.5 7.82
GOBP_GOLGI_RIBBON_FORMATION 7.5 7.52 7.42 7.17 8.2 8.02 8.12 8.13 7.7 8.11 7.7 8.11 8.23 8.12 8.01 7.82 7.83 7.44 7.7 7.87 7.61 7.96 8.24 8.25 7.71 7.94
GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY 7.17 7.33 7.3 6.99 7.5 7.64 7.79 7.45 7.34 7.33 7.38 7.34 7.67 7.51 7.51 7.32 7.45 7.59 7.35 7.67 7.07 7.55 7.54 7.76 7.57 7.31
GOBP_REGULATION_OF_SPINDLE_ASSEMBLY 7.19 7.12 8.34 7.72 8.33 8.13 7.91 7.47 7.56 8.06 7.71 7.91 7.75 7.77 7.61 8.08 7.22 6.96 7.5 7.7 7.33 7.73 8.43 8.69 7.49 7.75
GOBP_ORGANELLE_MEMBRANE_FUSION 7.53 7.44 7.81 7.61 7.97 8.11 7.85 7.7 7.79 7.95 7.53 7.9 7.98 8.05 7.7 7.71 7.71 7.49 7.75 7.86 7.51 7.73 7.92 8.15 7.78 7.7
GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE 5.82 6.02 6.03 5.82 5.92 6.03 6.2 5.82 5.78 5.84 6.07 5.95 5.8 5.87 5.8 5.83 6.46 5.93 5.74 5.85 6.04 6.04 5.61 5.96 5.68 6.04
GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE 5.82 6.02 6.03 5.82 5.92 6.03 6.2 5.82 5.78 5.84 6.07 5.95 5.8 5.87 5.8 5.83 6.46 5.93 5.74 5.85 6.04 6.04 5.61 5.96 5.68 6.04
GOBP_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS 7.45 7.52 7.42 7.21 7.65 7.72 7.78 7.49 7.73 7.77 7.15 7.59 7.86 7.81 7.52 7.53 7.41 7.33 7.44 7.62 7.35 7.48 7.64 8.2 7.86 7.58
GOBP_REGULATION_OF_KIDNEY_DEVELOPMENT 5.62 5.51 5.74 5.75 5.31 4.97 5.42 5.37 5.41 5.25 5.62 5.06 5.17 5.01 5.31 5.36 5.35 5.51 5.23 5.23 5.66 5.43 5.16 4.83 5.3 5.54
GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS 6.01 5.64 6.12 5.96 5.57 5.46 6 6.2 5.57 5.83 5.78 5.84 5.93 6.05 6.08 6.31 5.5 5.85 5.43 5.73 6.05 5.72 5.99 5.62 5.78 5.78
GOBP_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA 6.69 6.8 7.05 7.24 6.2 6.18 6.75 6.84 6.5 6.4 6.28 6.27 6.31 6.42 6.35 6.59 6.57 6.63 6.63 6.66 6.48 6.6 5.97 6.24 6.26 6.59
GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA 6.41 6.45 6.57 6.91 6.02 5.77 6.14 6.6 6.21 5.71 5.86 6.12 5.94 6.09 5.97 6.33 6.53 5.99 6.51 6.26 6.3 6.62 5.81 5.83 6.14 6.5
GOBP_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA 8.21 8.05 7.91 7.9 8.02 8.25 8.14 8.72 8.46 8.4 7.34 8.05 8.47 7.76 8.51 8.28 8.25 8.28 7.85 8.6 8.61 8.18 8.23 8.4 8.64 8.83
GOBP_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS 6.27 6.57 6.31 6.78 6.58 6.37 6.4 6.4 6.17 6.22 6.53 6.37 6.63 6.5 6.44 6.56 6.51 6.32 6.19 6.49 6.65 6.59 6.44 6.58 6.53 6.64
GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS 6.27 6.53 6.37 6.78 6.63 6.57 6.55 6.77 6.15 6.22 6.66 6.37 6.52 6.83 6.16 6.56 6.43 6.01 6.19 6.47 6.46 6.42 6.44 6.45 6.53 6.61
GOBP_POSITIVE_REGULATION_OF_LIPID_KINASE_ACTIVITY 6.32 6.03 6.52 6.67 6.46 6.06 6.65 6.52 6.18 6.46 6.53 6.47 6.36 6.5 6.82 6.61 6.25 6.43 6.16 6.17 6.76 6.72 6.18 6.56 6.78 6.86
GOBP_REGULATION_OF_SPINDLE_ORGANIZATION 7.21 7.02 7.62 7.3 7.42 7.36 7.41 7.39 7.21 7.21 7.57 7.65 7.22 7.41 7.31 7.53 7.14 7.06 7.41 7.35 7.28 7.61 7.65 7.45 7.45 7.35
GOBP_REGULATION_OF_SPINDLE_CHECKPOINT 5.93 6.24 6.05 5.91 6.4 6.29 5.74 5.84 5.73 6.05 5.8 5.91 5.89 5.87 5.7 5.65 6.16 5.88 5.87 5.75 5.98 6.06 5.85 6.03 5.72 5.93
GOBP_REGULATION_OF_HISTONE_H4_ACETYLATION 7.16 6.78 7.33 7.7 7.48 7.22 6.95 7.33 7.41 7.17 7.68 6.93 7.24 7.22 7.49 7.97 7.35 6.96 7.16 7.25 6.91 7.26 7.64 7.72 7.16 7.03
GOBP_REGULATION_OF_MUSCLE_SYSTEM_PROCESS 6.46 6.36 6.5 6.46 6.34 6.46 6.5 6.39 6.51 6.55 6.44 6.44 6.37 6.18 6.63 6.52 6.62 6.42 6.37 6.28 6.52 6.51 6.76 6.51 6.52 6.62
GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY 7.1 6.99 7.54 7.2 7.31 7.42 7.31 7.49 7.58 7.59 7.29 7.42 7.56 7.48 7.47 7.38 7.27 7.14 7.21 7.32 7.28 7.31 7.91 7.72 7.63 7.32
GOBP_REGULATION_OF_PEPTIDE_HORMONE_SECRETION 6.25 6.11 6.42 6.33 6.21 6.18 6.66 6.69 6.4 6.45 6.35 6.35 6.27 6.29 6.6 6.48 6.32 6.53 6.27 6.37 6.4 6.58 6.25 6.44 6.32 6.44
GOBP_POSITIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION 6.15 5.9 6.05 6.15 5.56 5.78 6.11 6.21 6.12 6.14 5.97 5.96 6.04 6.01 6.23 6.28 6.12 6.35 6.09 5.96 6.03 5.99 5.93 5.91 5.93 6.25
GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_HORMONE_SECRETION 6.03 5.76 6.15 6.26 5.52 5.53 5.93 6.4 6.16 6.01 6.24 5.87 6.18 6.12 6.33 6.29 6.17 6 5.85 5.79 5.96 6.18 5.96 5.93 6.14 6.34
GOBP_REGULATION_OF_CALCIUM_ION_IMPORT 5.63 5.45 5.23 5.98 5.14 4.88 5.5 5.43 5.15 5.27 5.45 5.3 5.32 5.06 5.56 5.31 5.67 5.68 5.2 5.26 5.78 5.62 5.16 5.13 5.48 5.64
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT 5.18 5.19 5.15 5.18 4.66 4.8 5.1 5.13 5.02 4.95 5.08 5.05 4.86 4.88 5.2 5.01 5.31 5.09 4.83 4.76 5.28 5.08 4.92 4.82 5.02 5.19
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS 6.41 6.44 6.39 6.45 6.43 6.5 6.49 6.58 6.55 6.52 6.36 6.48 6.72 6.66 6.54 6.57 6.51 6.42 6.31 6.37 6.68 6.7 6.78 6.59 6.5 6.59
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS 6.24 6.12 6.13 6.35 6.17 6.25 6.1 6.38 6.39 6.54 6.14 6.34 6.4 6.26 6.36 6.16 5.98 6 6.14 6.11 6.08 6.19 6.63 6.48 6.09 6.39
GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING 5.69 5.51 5.33 5.5 5.17 5.04 5.47 5.35 5.41 5.24 5.43 5.13 5.54 5.45 5.6 5.4 5.64 5.58 5.27 5.47 5.65 5.56 5.43 5.25 5.43 5.45
GOBP_NUCLEIC_ACID_PHOSPHODIESTER_BOND_HYDROLYSIS 6.35 6.38 6.66 6.75 6.43 6.6 6.54 6.55 6.41 6.57 6.66 6.55 6.52 6.44 6.5 6.56 6.34 6.39 6.52 6.53 6.34 6.54 6.51 6.65 6.62 6.63
GOBP_MITOTIC_SPINDLE_ASSEMBLY 7.07 6.92 7.2 6.77 7.42 7.57 7.19 7.2 7.27 7.33 7.39 7.42 7.26 7.26 7.37 7.31 7.09 6.86 7.07 7.22 7.19 7.23 7.5 7.46 7.36 7.24
GOBP_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_ASSEMBLY 6 6.18 6.19 6.6 6.45 6.7 6.63 6.88 6.65 6.72 6.3 6.5 6.89 6.83 6.61 6.56 6.08 6.2 6.42 6.57 6.21 6.64 6.79 7.25 6.67 6.55
GOBP_REGULATION_OF_PROTEIN_DEACETYLATION 7.56 7.37 7.49 7.45 8.19 8.09 7.71 7.7 7.92 7.95 7.41 7.8 7.98 7.86 7.92 7.73 7.53 7.32 7.83 7.79 7.31 7.69 8.07 7.98 7.37 7.43
GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION 7.25 7.2 7.38 6.92 7.79 7.91 7.24 6.89 7.08 7.26 6.92 7.32 7.75 7.73 7.2 7.56 7.3 7.27 7.42 7.36 7 7.16 7.44 7.63 7.11 7.18
GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE 7.62 8.11 9.2 8.31 8.32 8.49 8.88 8.89 8.76 8.81 8.76 8.76 8.56 8.63 9.38 9.13 8.36 8.59 8.14 8.52 8.66 9.08 8.93 9.23 9.05 8.85
GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE 7.62 8.11 9.2 8.5 8.58 8.52 8.9 9.06 8.76 9.17 8.76 8.77 8.8 9.03 9.4 9.16 8.48 8.84 8.17 8.64 8.79 9.1 8.93 9.31 9.05 8.92
GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT 7.53 7.63 8.07 7.96 7.75 7.88 7.99 7.99 7.86 7.99 7.88 7.97 7.97 8.08 8.09 7.98 7.75 7.83 7.65 8.08 7.77 8.09 8 8.04 8.04 7.88
GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT 6.78 7.1 7.56 7.62 7.26 7.36 7.36 7.79 7.58 7.32 7.5 7.26 7.38 7.59 7.38 7.26 7.35 6.97 7.17 7.41 7.23 7.9 7.45 7.34 7.6 7.69
GOBP_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS 6.06 5.81 6.41 6.07 5.74 5.82 5.76 5.6 6.23 5.72 5.66 5.56 5.84 5.7 6.29 6.19 5.72 5.98 5.59 5.86 6.47 6.79 6.02 5.92 6.7 6.21
GOBP_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION 5.78 5.95 6.31 6.48 5.72 6.16 5.96 6.08 5.81 5.83 6.08 5.84 5.83 5.6 5.98 6.11 5.83 5.65 5.84 5.87 5.77 5.93 5.84 5.94 6.04 6.29
GOBP_REGULATION_OF_PLATELET_AGGREGATION 5.82 5.81 6.16 6 5.9 5.86 5.75 5.93 5.79 5.63 5.35 5.41 5.83 6.08 6.03 5.78 5.61 5.65 5.37 5.55 5.66 5.46 5.79 5.73 5.6 5.73
GOBP_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION 6 5.95 6.4 6.8 5.74 5.67 5.82 6.04 6.02 5.94 5.71 5.83 5.83 6.08 6.3 5.91 5.92 5.93 5.45 5.89 6.24 5.97 6.22 6.09 5.94 5.74
GOBP_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION 6.29 6.32 6.63 7.02 7.08 6.66 6.88 6.76 7.05 6.97 6.26 6.75 7.16 7.09 6.75 6.97 6.56 6.56 6.33 6.71 6.81 6.22 6.9 6.87 6.87 7.05
GOBP_POSITIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION 6.07 6.18 6.32 6.01 6.71 6.19 6.03 6.09 6.04 6.21 6.2 5.78 6.05 6.48 5.92 6.16 6.56 6.56 5.93 6.2 6.41 6.13 6.41 5.57 6.61 6.38
GOBP_REGULATION_OF_CELL_AGING 6.51 6.6 6.81 7.05 7.15 7.05 6.98 6.9 7.11 7.08 6.77 6.98 7.3 7.11 7.18 7.08 6.92 6.96 6.8 6.97 6.97 6.95 7.47 7.26 6.95 6.91
GOBP_POSITIVE_REGULATION_OF_CELL_AGING 6.09 6.38 6.81 7.14 6.72 6.52 6.49 6.38 6.61 6.71 6.38 6.68 6.45 6.29 6.18 6.69 6.4 6.63 6.33 6.56 6.09 6.68 6.88 6.97 6.69 6.49
GOBP_NEGATIVE_REGULATION_OF_CELL_AGING 6.48 6.47 5.91 6.12 7.06 6.7 6.95 6.49 6.37 6.9 6.26 6.92 7.2 7.08 7.02 6.25 6.87 6.47 6.69 6.59 6.59 6.34 6.75 6.96 6.8 6.77
GOBP_PHAGOSOME_MATURATION 7.53 7.51 7.82 7.61 7.92 8.03 7.71 7.62 7.58 7.88 7.45 7.84 7.84 8.05 7.48 7.68 7.63 7.47 7.67 7.65 7.55 7.78 7.75 7.93 7.54 7.57
GOBP_PHAGOSOME_ACIDIFICATION 7.93 8.34 9.24 8.47 8.26 8.66 8.94 8.87 8.76 8.54 9.02 8.41 8.87 8.97 9.16 8.9 7.99 8.18 8.57 8.7 7.69 8.16 8.93 8.98 8.85 8.42
GOBP_CELLULAR_SENESCENCE 6.59 6.63 6.81 7.33 7.38 7.34 6.96 6.8 7.06 7.07 6.88 7.05 7.3 7.11 7.27 7.22 6.84 6.96 6.95 6.97 6.96 6.89 7.44 7.34 6.89 6.94
GOBP_REPLICATIVE_SENESCENCE 5.91 5.6 5.55 6.17 5.35 5.3 5.36 5.17 5.75 4.97 5.9 5.1 5.59 5.6 5.21 5.16 5.5 5.46 5.32 5.08 5.63 5.34 5.24 4.98 5.21 5.25
GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS 6.82 6.91 7.24 7.08 7.03 7.23 7.11 7.05 7.13 7.13 7 7.11 7.15 7.17 7.03 6.93 7.04 6.9 6.96 7.23 6.92 7.01 7.08 7.24 7.17 7.14
GOBP_CATECHOLAMINE_UPTAKE 6.32 5.86 5.63 6.05 5.62 5.25 5.78 6.12 5.73 6.36 6.01 5.83 5.54 5.75 6.07 5.73 5.77 6.36 6.19 5.9 6.06 5.62 5.61 5.51 5.95 5.87
GOBP_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS 6.57 6.6 7.18 6.97 6.71 6.91 6.96 6.98 6.76 6.95 6.89 6.78 6.87 6.94 6.81 6.84 6.66 6.63 6.76 6.9 6.57 6.75 6.94 7.01 6.96 6.87
GOBP_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_ENDONUCLEOLYTIC 6 5.98 6.23 6.24 5.94 6.08 6.28 6.07 6.16 6.27 6.33 6.31 6.22 6.24 6.11 6.24 5.97 6.11 5.96 6.13 6.05 6.13 6.31 6.45 6.05 5.98
GOBP_RNA_PHOSPHODIESTER_BOND_HYDROLYSIS_EXONUCLEOLYTIC 7.41 7.42 7.56 7.49 7.69 7.77 7.45 7.35 7.58 7.64 7.42 7.58 7.51 7.63 7.1 7.44 7.28 7.18 7.38 7.63 6.82 7.32 7.61 7.47 7.22 7.26
GOBP_EPIBOLY 6.51 6.6 6.79 6.57 6.85 6.89 6.59 6.75 6.84 6.66 6.51 6.47 6.89 6.76 6.66 6.74 6.69 6.53 6.78 6.81 6.52 6.7 6.82 6.69 6.45 6.38
GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY 6.07 5.82 6.37 6.01 6.01 5.8 6.34 7 5.74 6.18 6.17 5.79 6.22 6.5 6.51 6.17 6.04 6.12 6.35 6.31 5.98 6.08 6.17 5.9 6.39 6.04
GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER 7.53 7.14 7.42 7.08 6.37 7.41 7.07 7.54 7.34 7.28 6.9 7.2 7.2 7 6.91 7.29 7.87 6.96 7.16 7.4 7.59 7.06 7.34 7.13 7.39 7.2
GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY 6.98 7 7.42 7.46 7.1 7.3 7.17 7.27 7.46 7.36 7.1 7.12 7.65 7.43 7.08 7.04 7.2 7.04 7.06 7.52 7.45 7.21 7.06 7.48 7.35 7.31
GOBP_INFLAMMATORY_RESPONSE_TO_WOUNDING 5.69 5.79 6.03 6.16 5.09 5.44 5.82 6.06 5.7 5.32 5.53 5.37 5.46 5.46 5.61 5.83 5.65 5.6 5.16 5.77 6.22 6.26 5.67 5.23 6.1 6.06
GOBP_SENSORY_ORGAN_MORPHOGENESIS 5.95 5.91 5.89 5.86 5.73 5.66 5.78 5.66 5.79 5.82 5.92 5.79 5.84 5.82 5.8 5.86 5.91 5.94 5.78 5.8 6.01 5.77 5.73 5.68 5.86 5.87
GOBP_ACTIVATION_OF_GTPASE_ACTIVITY 6.56 6.71 6.79 6.74 6.94 7.07 6.84 6.87 6.74 6.87 6.52 6.8 6.79 6.86 6.71 6.67 6.97 6.75 6.8 6.71 6.66 6.74 6.85 7.04 6.93 6.88
GOBP_WALKING_BEHAVIOR 7.53 7.96 8.25 8.18 8.25 8.1 7.83 7.71 7.93 8 7.55 7.8 7.96 7.8 8.27 7.97 7.57 7.44 8.25 8.37 7.41 7.78 7.79 8.08 7.65 7.37
GOBP_TELOMERASE_RNA_LOCALIZATION 7.31 7.33 8.42 8.16 7.61 7.74 8.07 8.09 7.98 7.97 8.08 7.44 8.14 7.93 8.06 8.6 7.52 7.5 7.68 7.9 7.99 8.11 8.16 8.09 8.3 7.89
GOBP_IMMUNOLOGICAL_MEMORY_PROCESS 5.44 5.2 5.68 5.62 4.94 4.98 5.6 5.76 6.03 5.02 5.27 4.67 5.34 5.07 5.08 5.32 5.75 5.39 5.08 5.21 6.06 5.57 5.31 4.56 5.27 5.46
GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS 5.44 5.2 5.68 5.62 4.94 4.98 5.6 5.76 6.03 5.02 5.27 4.67 5.34 5.07 5.08 5.32 5.75 5.39 5.08 5.21 6.06 5.57 5.31 4.56 5.27 5.46
GOBP_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS 6.3 6.41 6.31 6.37 6.63 6.22 6.58 6.47 6.34 6.24 6.2 6.37 6.46 6.17 6.19 6.3 6.36 6.32 6.15 6.43 6.65 6.35 5.75 6.04 6.21 6.42
GOBP_ENERGY_HOMEOSTASIS 6.94 7.19 7.12 7.05 7.41 7.44 7.27 7.05 7.7 7.65 7.4 7.65 7.25 7.88 7.58 7.27 7.14 7.07 7.69 7.55 7.13 7.23 7.62 7.62 7.37 7.44
GOBP_DENDRITIC_CELL_DIFFERENTIATION 5.48 5.52 5.67 5.92 5.24 5.38 5.52 5.65 5.51 5.3 5.28 5.19 5.44 5.26 5.39 5.59 5.47 5.3 5.28 5.39 5.64 5.69 5.5 5.31 5.51 5.97
GOBP_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION 6.5 6.54 6.37 6.41 7.05 6.78 6.48 6.46 6.61 6.59 6.5 6.66 6.84 6.92 6.15 6.31 6.37 6.45 6.45 6.36 6.48 6.47 6.39 6.34 6.84 6.68
GOBP_DENDRITIC_CELL_APOPTOTIC_PROCESS 5.56 5.33 5.65 5.84 5.47 5.35 4.83 5 5.31 4.84 5.06 4.84 5.1 5.39 4.89 5.23 5.25 5.21 4.86 5.17 5.49 5.01 4.96 5.21 5.18 5.27
GOBP_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS 7.28 7.19 7.62 7.37 6.6 7.02 7.44 7.88 7 7.09 7.18 7.16 7.61 7.36 7.13 7.36 7.49 7.7 7.02 7.64 7.67 8.14 7.12 6.74 8.12 8
GOBP_DENDRITIC_SPINE_MAINTENANCE 8.19 8.39 7.57 7.1 8.48 8.75 9 8.31 8.61 8.52 7.63 8.58 8.53 8.49 8.22 8.09 8.01 8.17 8.28 8.48 7.97 8.08 8.21 8.5 8.73 8.56
GOBP_NCRNA_EXPORT_FROM_NUCLEUS 7.51 7.53 7.83 7.74 7.65 7.68 7.37 7.36 7.5 7.46 7.55 7.73 7.4 7.73 7.54 7.6 7.36 7.28 7.5 7.28 7.05 7.6 7.46 7.63 7.63 7.37
GOBP_RESPONSE_TO_THYROID_HORMONE 6.33 6.33 6.91 6.92 6.47 6.41 6.66 6.47 6.49 6.49 6.53 6.59 6.4 6.4 6.61 6.68 6.82 6.76 6.18 6.74 6.93 6.87 6.26 6.54 6.8 6.89
GOBP_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS 6.79 6.77 7.12 7.23 6.51 6.7 6.91 6.75 6.67 7.01 6.86 6.8 6.81 6.76 6.99 6.99 7.28 7.09 6.6 7.1 6.99 7.05 6.78 6.64 6.92 7.1
GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEVELOPMENT 7.29 7.33 6.96 6.56 7.41 7.61 7.65 7.99 7.46 7.24 6.81 7.57 7.67 7.81 7.18 7.23 7.95 7.52 7.33 7.77 8.19 8.04 7.24 7.41 7.4 7.48
GOBP_PRESYNAPTIC_MEMBRANE_ORGANIZATION 9.32 9.54 8.42 8.16 9.44 9.55 9.45 9.38 9.56 9.46 8.53 9.36 9.5 9.47 9.13 9.07 9.05 8.92 9.55 9.64 8.38 8.61 9.66 9.7 9.24 8.57
GOBP_SYNAPTIC_VESICLE_CLUSTERING 9.25 9.42 8.61 8.34 8.98 9.52 9.45 9.2 9.17 9.3 8.48 9.12 9.37 9.42 9.14 9.01 8.96 9.01 9.49 9.32 9.15 9.02 9.35 9.5 9.12 8.93
GOBP_CRANIOFACIAL_SUTURE_MORPHOGENESIS 6.02 5.78 6.12 6.41 5.57 6 5.94 6.19 5.93 5.8 6.13 5.8 5.6 5.58 6.34 5.83 6.06 5.89 5.76 6.07 6.41 6.61 5.66 5.95 6.49 6.26
GOBP_POSTSYNAPTIC_MEMBRANE_ASSEMBLY 8.82 9.25 8.25 8.16 8.87 9.31 9.18 8.74 9.2 9.04 8.19 8.51 9.3 9.38 8.87 8.94 8.72 8.45 9.11 9.24 7.95 8.01 9.07 9.38 8.87 8.13
GOBP_RECEPTOR_LOCALIZATION_TO_SYNAPSE 8.74 8.96 9.15 8.23 9.18 9.19 9.35 9.16 9.13 9.45 8.92 9.14 9.43 9.58 9.01 9.19 8.72 8.71 9.26 9.26 8.77 8.85 9.3 9.65 9.03 8.74
GOBP_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE 6.79 6.51 6.51 6.44 6.97 6.87 6.86 6.77 6.82 7.32 6.53 7.01 7.26 6.96 6.37 6.7 7.03 6.83 6.63 6.86 6.99 7.05 6.96 7.04 6.87 6.71
GOBP_MESENCHYMAL_CELL_APOPTOTIC_PROCESS 5.94 5.77 6.04 5.63 5.95 5.9 6.09 5.89 6.02 6.2 5.81 5.77 6.28 6.31 5.79 6.19 5.95 5.93 5.91 6.25 6.28 6.39 5.76 5.85 5.76 6.03
GOBP_GABAERGIC_NEURON_DIFFERENTIATION 5.6 5.7 6.06 5.8 5.55 5.34 5.84 5.86 5.67 5.58 5.73 5.58 5.96 5.79 5.74 5.96 6.14 5.82 5.66 5.89 5.86 5.96 5.58 5.85 5.71 5.9
GOBP_AMMONIUM_ION_METABOLIC_PROCESS 5.51 5.5 5.61 5.55 5.56 5.18 5.46 5.73 5.73 5.75 5.51 5.32 5.66 5.75 5.48 5.48 5.38 5.47 5.64 5.04 5.57 5.12 5.41 5.22 5.3 5.88
GOBP_RUFFLE_ASSEMBLY 6.88 6.99 7.37 7.18 7.48 7.42 7.5 7.5 7.35 7.63 7.41 7.38 7.65 7.8 7.36 7.46 7.34 7.11 7.3 7.62 7.32 7.56 7.48 7.64 7.62 7.29
GOBP_AMELOGENESIS 5.51 5.41 5.5 5.5 5.29 4.94 5.24 5.11 5.06 4.93 5.12 5.26 5.28 4.93 5.29 4.79 5.14 5.39 5.02 4.86 5.34 5.3 4.7 4.87 5.12 5.58
GOBP_APOPTOTIC_SIGNALING_PATHWAY 6.49 6.66 6.91 6.91 6.76 6.74 6.78 6.91 6.85 6.86 6.78 6.8 6.9 6.89 6.88 6.86 6.82 6.78 6.72 6.93 6.85 6.97 7.01 6.98 7.01 6.96
GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 6.41 6.52 6.81 6.87 6.36 6.54 6.71 6.74 6.77 6.77 6.7 6.68 6.79 6.67 6.44 6.64 6.57 6.63 6.49 6.62 6.65 6.8 6.99 6.88 6.73 6.78
GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 6.68 6.7 6.97 6.91 6.92 6.95 6.88 6.94 6.94 6.94 6.83 6.98 6.89 6.91 6.99 7.03 6.84 6.8 6.87 7.17 6.91 7 7.01 7.2 7.07 7.12
GOBP_EXECUTION_PHASE_OF_APOPTOSIS 5.9 5.95 6.39 6.3 5.76 5.88 6 6.06 5.87 5.84 6.35 6.08 5.74 5.76 5.93 6.19 6.2 5.91 5.98 6.1 6.04 6.13 5.84 5.77 5.91 5.84
GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_STRESS 7.21 7.49 7.84 8.25 7.63 7.43 7.78 7.55 8.07 8.17 7.82 7.96 7.98 7.98 8.13 7.98 7.8 7.52 7.2 7.93 7.78 7.94 8.03 8.15 8.37 8.02
GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY 6.59 6.39 6.83 6.91 6.38 6.19 6.82 6.82 6.76 6.86 6.68 6.49 6.65 6.55 6.54 6.61 6.53 6.39 6.92 7.01 6.47 6.62 6.23 6.72 6.14 6.5
GOBP_RENAL_FILTRATION 6.14 6.49 7.15 6.5 6.51 7.2 6.8 6.96 7.06 6.97 6.19 6.99 6.49 6.05 6.86 6.7 6.46 6.29 6.85 6.43 6.82 7.07 7.26 6.74 6.82 7.12
GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE 5.91 5.82 6.41 6.26 5.67 5.62 6.04 6.08 6.09 5.91 6.07 5.98 6.04 6.01 6.18 6.08 6.01 5.77 5.88 5.92 6.11 6.12 6.24 6.13 6.18 6.21
GOBP_AMYLOID_BETA_CLEARANCE 6.83 6.65 7.38 7.16 7.83 7.56 7.19 6.85 7.34 7.4 6.95 7.47 7.78 7.25 7.3 7.45 7.45 6.83 7.03 6.94 7.04 7.28 7.43 7.34 7.04 7.37
GOBP_HEPATOCYTE_APOPTOTIC_PROCESS 7.59 7.35 8.03 7.6 7.89 7.87 7.08 7.34 7.54 7.83 7.89 7.49 7.47 7.35 7.2 7.36 7.88 7.39 7.83 7.4 7.39 7.35 7.61 7.31 7.58 7.38
GOBP_PROGRAMMED_NECROTIC_CELL_DEATH 6.18 6.32 7.45 7.09 6.39 6.21 6.34 6.92 6.38 6.22 6.27 6.38 6.22 6.24 6.23 6.55 6.37 6.25 6.26 6.68 6.67 7.1 6.32 6.78 7.08 7.22
GOBP_RESPONSE_TO_ALCOHOL 6.41 6.32 6.68 6.57 6.34 6.48 6.79 6.56 6.61 6.53 6.34 6.36 6.54 6.43 6.59 6.6 6.42 6.43 6.38 6.45 6.64 6.83 6.61 6.52 6.66 6.72
GOBP_CELLULAR_RESPONSE_TO_ALCOHOL 6.55 6.62 6.69 6.62 6.51 6.51 6.81 6.75 6.92 6.83 6.84 6.78 6.71 6.94 6.65 6.69 6.82 6.67 6.6 6.61 6.98 7.03 6.87 6.96 6.77 6.73
GOBP_PLASMA_MEMBRANE_TUBULATION 7.14 6.91 7.51 7.49 6.98 6.85 6.87 7.16 7.08 7 7.03 7.35 7.05 7.18 7.11 6.92 7.38 7.13 7.02 6.97 7.06 7.3 7.44 7.27 7.4 7.28
GOBP_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION 6.95 6.87 7.59 7.5 6.88 7.09 7.11 7.16 7.05 7.16 7.07 7.01 6.96 7.1 7.01 6.84 7.19 7.01 6.88 7.37 7 6.96 7.05 6.94 7.02 7.15
GOBP_AUTOPHAGOSOME_MATURATION 7.41 7.44 7.98 7.68 7.92 7.63 7.21 7.25 7.67 7.44 7.37 7.42 7.53 7.42 7.27 7.37 7.08 7.28 7.22 7.53 7.13 7.72 7.64 7.49 7.51 7.58
GOBP_PRENYLATION 6.84 6.73 7.02 6.47 6.79 7.11 7.17 6.6 6.74 7.19 6.64 7.11 6.83 7.18 6.69 6.73 6.6 6.4 7.28 7.28 6.64 6.65 7.35 7.42 6.7 6.77
GOBP_RESPONSE_TO_INTERLEUKIN_17 6.45 5.93 6.09 6.59 5.91 5.45 5.62 5.71 5.65 5.46 6.42 5.88 5.61 5.4 5.75 5.8 5.98 6.31 5.84 5.71 5.95 5.87 5.73 5.37 5.92 6.02
GOBP_LIVER_REGENERATION 6.12 5.91 6.02 5.67 6.08 6.34 6.48 6.52 6.53 6.28 5.91 5.94 6.58 6.28 6.36 6.5 6.81 6.3 6.03 6.64 6.28 6.44 6.71 6.64 6.82 6.54
GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION 6.68 6.63 6.94 6.68 6.87 6.88 6.9 7 6.88 6.98 6.74 6.96 6.93 6.84 6.89 6.96 6.81 6.84 6.8 6.82 6.91 6.91 7 7.01 7.01 7.01
GOBP_PROGRAMMED_CELL_DEATH_IN_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES 6.25 6.4 6.95 6.19 6.91 6.53 6.45 6.29 6.34 6.91 6.53 6.37 6.76 6.52 6.51 6.69 6.29 6.36 6.53 6.27 6.63 6.71 7.01 6.67 6.69 6.53
GOBP_SYNAPTIC_VESICLE_LOCALIZATION 8.52 8.78 8.67 8.28 8.84 8.97 8.9 8.98 8.8 9.18 8.29 8.81 8.94 9.05 9.08 8.87 8.48 8.58 9 8.98 8.53 8.6 8.85 9.25 8.71 8.62
GOBP_DENDRITE_EXTENSION 7.64 7.57 7.66 7.44 8.2 8.11 8 8.17 8 7.84 7.83 8.03 8.06 8.21 8.18 8.29 7.68 7.73 8.05 8.1 7.55 7.67 7.81 8 7.77 7.59
GOBP_NEURON_PROJECTION_GUIDANCE 6.71 6.84 7.01 6.67 7.11 7.23 7.15 7.34 7.09 7.23 6.92 7.24 7.35 7.38 7.36 7.23 7.12 6.96 6.96 7.38 7.1 7.51 7.27 7.17 7.19 7.13
GOBP_REGULATION_OF_VESICLE_SIZE 7.33 7.86 7.74 7.92 8.03 8.11 8.28 8.26 8.54 8.64 8.12 8.33 7.97 8.42 8.32 8.18 8.07 8.05 7.94 8.09 8.42 8.04 8.57 8.72 8.34 7.79
GOBP_STRESS_RESPONSE_TO_METAL_ION 7.03 7.04 7.01 7.16 5.94 6.58 6.79 6.76 7.15 6.9 7.39 7.16 6.92 6.71 7.15 6.8 6.84 6.94 6.5 6.61 7.29 7.36 6.73 6.37 7.05 7.11
GOBP_MANNOSYLATION 7.33 7.53 7.19 7.11 7.82 7.75 7.96 7.32 7.45 7.4 6.93 7.41 7.4 7.49 7.29 7.1 7.2 7.27 7.51 7.57 7.28 7.29 7.22 7.45 7.4 7.49
GOBP_SIALYLATION 6.85 6.79 7.36 7.61 6.83 6.98 7.14 6.76 7.1 7.31 6.85 6.66 6.99 6.98 7.14 7.21 6.84 6.77 6.76 7.04 6.97 7.11 7.18 7.11 6.89 7.03
GOBP_MYELOID_LEUKOCYTE_MIGRATION 5.73 5.54 5.7 5.69 5.16 5.13 5.37 5.32 5.33 5.14 5.5 5.28 5.38 5.29 5.34 5.31 5.62 5.54 5.18 5.23 5.8 5.59 5.24 5.16 5.63 5.73
GOBP_GRANULOCYTE_MIGRATION 5.61 5.48 5.55 5.57 5.01 4.94 5.24 5.14 5.18 5.02 5.34 4.91 5.15 5.07 5.29 5.2 5.52 5.49 5.06 5.14 5.65 5.48 5.1 4.96 5.52 5.55
GOBP_MAST_CELL_MIGRATION 5.76 5.56 5.76 5.49 5.17 5.21 5.71 5.82 5.66 5.49 5.66 5.74 5.74 5.85 6.18 5.84 5.86 5.76 5.33 5.78 5.74 5.87 5.31 5.7 6.01 5.9
GOBP_LAMELLIPODIUM_ORGANIZATION 7.09 7.17 7.51 7.35 7.64 7.65 7.48 7.41 7.56 7.53 7.37 7.47 7.45 7.47 7.54 7.52 7.28 7.25 7.36 7.5 7.25 7.56 7.74 7.72 7.38 7.29
GOBP_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE 5.93 5.8 5.75 5.65 4.92 5.12 5.67 5.53 5.45 5.55 5.79 5.07 5.16 5.22 5.59 5.51 5.47 5.69 5.28 5.03 5.47 5.14 5.35 4.85 5.35 5.42
GOBP_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT 5.71 5.78 5.67 5.83 5.66 5.51 5.73 5.68 5.51 5.38 5.62 5.59 5.62 5.58 5.55 5.4 5.64 5.71 5.52 5.36 5.84 5.62 5.4 5.4 5.73 5.8
GOBP_CONNECTIVE_TISSUE_REPLACEMENT 6.01 6.11 5.99 5.78 5.75 5.47 6.03 6.02 6.2 5.78 6.09 6.28 6.19 6.24 6.04 6.12 6.42 6.44 5.66 6.12 6.3 6.83 5.74 5.61 6.86 6.82
GOBP_CILIARY_BASAL_BODY_PLASMA_MEMBRANE_DOCKING 6.99 7.03 7.39 7.39 7.35 7.44 7.39 7.18 7.01 7.37 7.34 7.35 7.16 7.11 7.26 7.44 6.91 7.04 7.19 7.21 7.17 7.11 7.35 7.43 7.32 7.28
GOBP_CALCINEURIN_MEDIATED_SIGNALING 6.55 6.49 6.87 6.72 6.67 6.65 6.91 7.25 6.83 6.8 6.57 6.8 6.58 6.73 6.87 7.03 6.55 6.64 6.66 6.76 6.84 6.83 7.16 7.01 6.75 6.79
GOBP_SPERM_MOTILITY 5.51 5.37 5.45 5.5 5.13 5.15 5.28 5.32 5.26 5.31 5.42 5.29 5.31 5.25 5.23 5.4 5.41 5.62 5.46 5.22 5.45 5.31 5.11 4.9 5.07 5.31
GOBP_CENTRIOLE_ASSEMBLY 6.54 6.19 6.12 5.73 6.82 6.84 6.06 6 5.95 6.24 6.18 6.36 6.2 5.8 6.06 5.87 6.17 6 6.1 6.21 5.99 6.39 6.19 6.37 5.94 6.02
GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM 5.73 5.66 5.67 5.73 5.43 5.37 5.46 5.48 5.52 5.34 5.63 5.4 5.43 5.43 5.4 5.41 5.66 5.62 5.36 5.4 5.7 5.62 5.33 5.29 5.58 5.63
GOBP_DETECTION_OF_OTHER_ORGANISM 4.92 4.85 4.6 4.5 4.46 4.45 4.42 4.46 4.55 4.27 4.56 4.4 4.2 4.42 4.25 4.44 4.41 4.71 4.73 4.49 4.75 4.39 4.23 4.15 4.32 4.31
GOBP_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS 5.07 4.97 4.77 4.6 4.54 4.68 4.67 4.56 4.91 4.45 4.64 4.5 4.65 4.45 4.27 4.59 4.65 4.81 5.04 4.53 4.93 4.45 4.29 4.49 4.79 4.51
GOBP_CELLULAR_RESPONSE_TO_VIRUS 6.33 6.45 6.57 6.54 6.6 6.26 6.5 6.41 6.48 6.25 6.55 6.38 6.19 6.24 6.47 6.19 6.27 6.17 6.25 6.26 6.1 6.33 6.77 6.73 6.6 6.57
GOBP_CELL_CELL_ADHESION 6.08 6.05 6.08 6.1 6 6 6.07 6.08 6.07 6.02 6.03 5.95 6.07 6.11 6.1 6.15 6.02 6.07 5.96 6.01 6.2 6.2 6.12 6 6.16 6.18
GOBP_CATION_TRANSMEMBRANE_TRANSPORT 6.49 6.5 6.61 6.65 6.54 6.54 6.64 6.77 6.62 6.61 6.57 6.54 6.62 6.57 6.58 6.53 6.56 6.54 6.49 6.68 6.61 6.71 6.62 6.74 6.63 6.65
GOBP_ANION_TRANSMEMBRANE_TRANSPORT 6.49 6.53 6.68 6.71 6.58 6.59 6.54 6.67 6.63 6.61 6.55 6.65 6.55 6.56 6.55 6.64 6.65 6.54 6.6 6.7 6.53 6.58 6.48 6.73 6.61 6.68
GOBP_IMPORT_INTO_CELL 6.51 6.54 6.5 6.65 6.58 6.57 6.73 6.76 6.7 6.67 6.34 6.55 6.66 6.79 6.48 6.53 6.65 6.72 6.55 6.74 6.53 6.56 6.58 6.73 6.78 6.62
GOBP_INORGANIC_ION_TRANSMEMBRANE_TRANSPORT 6.38 6.38 6.5 6.59 6.33 6.39 6.55 6.6 6.45 6.52 6.43 6.36 6.35 6.43 6.51 6.43 6.44 6.39 6.43 6.57 6.48 6.54 6.47 6.62 6.53 6.48
GOBP_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT 6.13 6.05 6.08 6.02 5.84 6.08 6.34 6.22 6.07 6.24 6.08 6.08 5.91 5.99 5.97 6.17 6.15 6.09 6.25 6.34 6.19 5.97 6.21 5.93 6.44 6.27
GOBP_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY 8.66 8.81 8.42 8.61 8.58 9.03 8.95 8.44 8.74 9.1 8.3 8.79 9.3 9.45 8.62 8.82 8.37 8.46 9.29 8.76 8.32 8.38 8.46 8.88 8.6 8.14
GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE 10.03 10.2 9.76 9.45 10.05 10.15 9.94 9.29 10.71 10.16 10.02 9.81 10.95 10.72 9.16 9.9 9.93 9.01 10.12 9.79 9.43 9.93 10.45 10.32 10.25 10.13
GOBP_SODIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE 7.05 6.97 6.76 6.54 6.87 7.04 7.02 6.84 6.83 6.88 6.75 7.16 6.98 6.96 6.7 7.02 6.8 7.08 7.08 7.27 7.01 7.31 6.76 6.99 7.18 6.97
GOBP_MAINTENANCE_OF_CELL_NUMBER 6.83 6.88 6.9 6.78 7.3 7.26 7.2 7.1 7.32 7.35 6.9 7.38 7.37 7.31 7.29 7.27 7.22 7.03 7.04 7.25 7.16 7.17 7.39 7.42 7.14 7.3
GOBP_MACROMOLECULE_DEACYLATION 7.08 7.13 7.46 7.22 7.59 7.6 7.52 7.27 7.41 7.46 7.07 7.56 7.66 7.69 7.49 7.45 7.32 7.12 7.45 7.58 7.13 7.31 7.52 7.66 7.19 7.28
GOBP_IMPORT_ACROSS_PLASMA_MEMBRANE 6.18 6.36 6.06 6.52 6.29 6.39 6.41 6.47 6.43 6.42 6.2 6.37 6.56 6.56 6.2 6.26 6.54 6.39 6.33 6.36 6.51 6.54 6.44 6.53 6.53 6.56
GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES 6.23 6.16 6.11 6.06 6.22 6.19 6.28 6.22 6.32 6.13 6.09 6.05 6.21 6.14 6.23 6.27 6 6.13 6.2 6.11 6.02 6.07 6.21 6.06 6.24 6.06
GOBP_CELL_AGGREGATION 6 5.63 5.64 6 5.85 5.39 5.86 5.63 5.71 5.64 6.11 5.84 5.66 5.63 5.72 5.92 5.78 6.04 5.94 5.55 6.06 6.37 5.57 5.08 5.26 5.85
GOBP_BONE_CELL_DEVELOPMENT 6.69 6.39 6.45 6.45 6.67 6.63 6.46 6.76 6.52 6.51 6.21 6.47 6.37 6.5 6.44 6.04 6.13 6.35 6.48 6.33 6.82 6.38 6.31 6.39 6.64 6.82
GOBP_DETOXIFICATION 5.99 6.12 6.38 6.55 5.76 5.71 6.07 6.12 6.21 6.03 6.4 6.06 6.02 6.04 6.14 6.13 6.17 5.98 5.84 5.92 6.24 6.23 6.31 6.04 6.43 6.31
GOBP_RESPONSE_TO_INTERLEUKIN_7 6.41 6.85 6.34 6.5 6.29 6.83 7.07 7.29 7.14 7.3 6.92 7.41 7.35 7.19 7.36 7.29 6.94 7.14 6.34 7.01 7.93 7.82 7.15 7.58 7.56 7.67
GOBP_SKIN_EPIDERMIS_DEVELOPMENT 5.78 5.73 5.6 5.83 5.53 5.55 5.82 5.76 5.73 5.9 5.78 5.62 5.69 5.69 5.73 5.76 5.9 5.68 5.62 5.58 5.95 5.95 5.83 5.67 5.65 5.9
GOBP_RESPONSE_TO_MITOCHONDRIAL_DEPOLARISATION 7.89 8.04 8.43 7.78 8.1 8.1 7.94 8.03 8.26 8.03 7.86 8 8.26 7.8 8.22 8.11 7.83 7.34 8.29 8.1 8.14 8.07 8.05 8.31 7.91 7.94
GOBP_NCRNA_TRANSCRIPTION 6.93 7.14 7.46 7.45 7.33 7.42 7.15 7.21 7.31 7.41 7.36 7.18 7.25 7.4 7.32 7.46 7.33 7.12 7.13 7.2 7.2 7.51 7.34 7.49 7.3 7.37
GOBP_MRNA_CLEAVAGE_INVOLVED_IN_MRNA_PROCESSING 7.32 7.3 7.85 7.15 7.54 7.54 7.52 7.67 7.82 7.95 7.3 7.81 7.66 7.83 8.03 7.79 7.57 7.72 7.42 7.61 7.6 8.06 7.94 7.92 7.82 7.74
GOBP_XENOPHAGY 7.17 7.29 7.53 7.23 7.58 7.33 7.37 7.75 7.59 7.54 7.46 7.75 7.65 7.33 7.39 7.57 7.42 7.47 7.19 7.6 7.5 7.84 7.55 7.52 7.66 7.61
GOBP_REGULATION_OF_RENAL_SYSTEM_PROCESS 6.06 6.19 5.64 5.85 6.2 5.67 5.77 5.79 5.6 5.48 6.19 5.87 5.67 5.76 6.42 5.88 6.14 5.94 6.41 6.09 6.19 6.43 5.64 5.68 5.89 6.33
GOBP_NEUROTRANSMITTER_REUPTAKE 6.34 6.07 5.71 6.2 6.21 6.09 6.43 6.64 6.09 6.64 6.18 5.99 6.02 6.23 6.44 6.25 6.03 6.42 6.14 6.29 6.16 6.1 5.82 6.24 5.97 6.13
GOBP_NUCLEAR_CHROMOSOME_SEGREGATION 6.02 6 6.2 6.23 5.93 5.98 6.07 6.07 5.94 6.2 6.12 6.15 6.07 6.09 6.07 6.08 6.03 5.85 5.95 6.05 5.96 6.02 6.2 6.28 6.13 6.11
GOBP_SPONTANEOUS_SYNAPTIC_TRANSMISSION 8.93 8.92 8.86 8.96 8.86 9.43 9.62 9.37 8.96 9.46 8.98 9.29 9.64 9.55 9.3 9.4 9.12 8.7 9.42 9.33 8.99 9.15 9.42 9.65 9.18 9.04
GOBP_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL 8.13 8.24 8.26 8.03 8.19 8.64 8.55 8.31 8.34 8.52 7.96 8.44 8.43 8.45 8.55 8.45 7.83 8.24 8.29 8.51 8.07 8.13 8.21 8.62 8.76 8.35
GOBP_PROTEIN_TRANSPORT_ALONG_MICROTUBULE 7.06 7.2 7.64 7.25 7.21 7.4 7.54 7.54 7.18 7.4 7.44 7.24 7.41 7.24 7.52 7.52 6.97 7.14 7.4 7.51 7.15 7.44 7.36 7.38 7.35 7.26
GOBP_INTESTINAL_LIPID_ABSORPTION 5.19 4.74 4.69 4.91 4.59 4.37 4.5 4.42 4.52 4.56 4.93 4.46 4.6 4.31 4.46 4.47 4.73 4.85 4.59 4.49 4.79 4.66 4.32 4.24 4.3 4.54
GOBP_BONE_GROWTH 6.18 5.95 5.8 6.15 6.08 6.29 5.98 6.12 6.11 6.04 6 6.1 6.05 6.02 5.86 5.97 6.04 6.07 6.18 5.88 6.22 6.5 6.13 6.34 6.2 6.62
GOBP_CELLULAR_OXIDANT_DETOXIFICATION 5.76 5.75 6.07 6.16 5.63 5.59 5.89 6 5.83 5.72 6 5.78 5.84 5.9 5.82 5.97 5.77 5.7 5.73 5.7 5.94 5.91 5.9 5.86 5.86 6.08
GOBP_VESICLE_MEDIATED_TRANSPORT_TO_THE_PLASMA_MEMBRANE 7.6 7.83 8.21 7.94 8.19 8.35 8.03 8.11 8.23 8.31 8.16 8.09 8.02 8.11 8.17 8.14 7.83 7.73 8.03 8.08 8.01 7.98 8.26 8.6 8.12 7.8
GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_TO_PLASMA_MEMBRANE 8.99 8.99 9.34 8.61 8.92 9.19 9.38 9.98 8.98 9.5 8.92 9.14 9.75 9.83 9.5 9.45 9.1 9.3 9.06 9.82 9.38 9.73 9.27 9.6 9.61 9.59
GOBP_SYNAPSE_PRUNING 8.78 8.65 8.41 8.18 8.77 8.31 6.27 6.91 7.75 6.49 6.78 5.83 8.01 7.85 6.88 7.41 7.57 7.08 7.23 7.19 8.17 8.35 7.22 7.39 8.86 8.72
GOBP_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION 7.87 8.15 8.39 7.61 8.81 8.58 8.51 8.11 8.35 7.94 8 8.38 8.65 8.38 8.22 8.37 8.53 8.32 8.06 8.63 8.65 8.2 8.67 8.67 8.54 8.1
GOBP_REGULATION_OF_ACTION_POTENTIAL 7.23 7.1 7.42 6.74 7.84 7.6 7.55 7.51 7.75 7.76 7.47 8.07 7.62 7.52 7.82 7.64 7.39 7.07 7.74 7.76 7.34 7.56 7.77 7.95 7.79 7.51
GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL 7.08 6.95 7.41 6.99 7.62 7.42 7.37 7.41 7.65 7.68 7.42 8.04 7.4 7.2 7.14 6.96 7.34 7 6.96 7.62 7.31 7.55 7.67 7.92 7.73 7.34
GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL 7 6.73 6.9 6.27 7.34 7.26 7.29 6.96 7.6 7.52 6.64 7.58 7.15 7.2 6.89 6.58 7.25 6.45 6.77 7.61 7.16 6.84 7.25 7.43 7.68 7.31
GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL 5.43 5.2 5.35 5.86 5 4.98 5.39 5.26 5.3 5.02 5.41 5.07 5.08 4.98 5.23 5.11 5.32 5.22 5.03 4.94 5.39 4.98 5.5 4.85 5.04 5.37
GOBP_POSTSYNAPTIC_SIGNAL_TRANSDUCTION 6.77 6.93 7.86 7.51 7.5 7.55 8.06 8.02 7.68 7.87 7.66 7.83 7.95 8.04 8.19 8.06 7.91 7.94 7.93 8.18 7.91 7.9 7.71 7.71 8.05 8.14
GOBP_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS 7.77 7.6 7.95 7.52 7.97 8 8.05 7.92 8.1 7.84 7.72 7.96 7.97 7.95 7.87 7.79 7.72 7.82 7.65 7.89 7.67 7.81 8.12 8.06 7.79 7.69
GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY 7.24 7.28 7.64 7.31 7.23 7.51 7.82 7.85 7.52 8.12 7.28 7.7 8.09 8.19 8.37 7.84 7.34 7.52 8.19 7.95 7.39 7.71 7.74 7.99 7.76 7.8
GOBP_VESICLE_MEDIATED_TRANSPORT_IN_SYNAPSE 7.79 7.95 7.99 7.85 8.27 8.36 8.25 8.29 8.09 8.26 8.02 8.36 8.23 8.29 8.54 8.34 7.91 8.11 8.13 8.16 7.85 8.24 8.14 8.36 8.25 8.06
GOBP_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE 8.61 8.93 8.38 9.83 9.04 9.08 8.94 9.27 9.11 9.27 8.79 9.15 9.44 9.18 9.52 9.09 8.52 8.69 9 8.98 8.86 9.28 9.26 9.38 9.25 9.16
GOBP_POSTSYNAPSE_ASSEMBLY 8.25 8.29 7.92 7.95 8.58 8.8 8.21 8.31 8.17 8.64 7.87 8.21 8.69 8.83 8.54 8.36 8.18 8.29 8.84 8.23 7.79 7.79 8.23 8.37 8.05 8.06
GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_NEUROTRANSMITTER_RECEPTOR_LEVELS 8.4 8.58 8.56 8.11 8.81 8.6 8.85 8.77 8.57 8.45 8.28 8.69 8.65 8.67 8.73 8.37 8.57 8.39 8.48 8.78 8.65 8.66 8.67 8.73 8.54 8.74
GOBP_POSTSYNAPTIC_SPECIALIZATION_ORGANIZATION 8.18 8.24 8.53 8.4 8.24 8.61 8.41 8.29 8.57 8.67 8.13 8.35 8.48 8.61 8.29 8.12 8.32 8.02 8.2 8.43 7.88 8.08 8.46 8.44 8.58 8.09
GOBP_MICROTUBULE_BASED_TRANSPORT 7.58 7.68 8.11 7.88 7.97 8.05 8.23 8.07 7.85 8.29 8.03 8.03 8.11 7.91 8.03 8.2 7.65 7.85 7.78 8.04 7.9 7.99 8.1 8.06 7.98 7.91
GOBP_TRNA_5_END_PROCESSING 6.13 5.92 7.26 6.76 6.03 6.56 6.86 6.61 6.51 6.29 6.52 6.38 6.14 6.24 6.73 6.75 6.16 5.93 6.09 6.56 6.29 6.58 6.65 6.82 6.66 6.52
GOBP_POSTSYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION 7.94 7.2 8.58 8.03 8.19 8.59 8.28 8.14 8.79 8.48 8.02 8.39 8.53 8.72 8.12 8.3 8.27 7.78 7.76 8.49 8.07 8.07 8.47 8.84 8.4 8.16
GOBP_PRESYNAPSE_ORGANIZATION 7.28 7.47 7.17 7.13 7.66 7.86 7.68 7.46 7.12 7.46 7.34 7.48 7.75 7.76 7.74 7.43 7.45 7.68 7.45 7.56 7.19 7.54 7.48 7.74 7.43 7.29
GOBP_POSTSYNAPSE_ORGANIZATION 7.93 8.15 8.16 7.7 8.3 8.48 8.37 8.24 8.19 8.4 8.05 8.17 8.39 8.49 8.29 8.35 8.01 8.1 8.39 8.24 7.91 8.08 8.23 8.46 8.34 8.18
GOBP_REGULATION_OF_PRESYNAPSE_ORGANIZATION 6.81 7.3 6.88 6.78 7.09 7.58 7.5 7.43 7.12 7.33 7.05 7.15 7.23 7.13 7.66 7.28 7.33 7.13 7.03 7.14 6.83 7.29 7.35 7.22 7.43 7
GOBP_REGULATION_OF_POSTSYNAPSE_ORGANIZATION 8.06 8.37 8.36 8 8.47 8.7 8.58 8.38 8.5 8.61 8.35 8.39 8.58 8.67 8.64 8.73 8.16 8.23 8.73 8.48 8.01 8.38 8.55 8.75 8.69 8.37
GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING 7.72 7.89 8.01 7.7 7.95 8.16 8.24 8.22 8.02 8.23 7.91 8.19 8.23 8.29 8.29 8.18 7.88 7.99 8.17 8.18 8 8.18 8.07 8.32 8.21 8.1
GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION 8.3 8.39 8.3 7.53 8.45 8.47 8.37 8.75 8.16 8.21 8.06 8.35 8.4 8.08 8.07 8.69 8.4 8.44 8.26 8.79 8.48 8.48 8.15 8.81 9.39 9.47
GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE 7.4 7.43 7.73 7.49 7.71 7.85 7.37 7.7 7.9 7.46 7.36 7.69 7.79 7.74 7.79 7.37 7.43 7.03 7.33 7.84 7.47 7.55 7.77 7.99 7.76 7.43
GOBP_REGULATION_OF_PRESYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION 8.95 8.4 8.33 8.02 8.68 8.95 9.23 9.13 8.63 8.73 8.38 8.66 9.22 9.36 8.9 8.82 8.28 8.55 8.87 9.46 8.43 8.51 8.43 9.02 8.56 8.34
GOBP_SYNAPTIC_VESICLE_CYTOSKELETAL_TRANSPORT 7.85 7.98 8.97 8.35 8.59 8.53 8.27 8.31 8.28 8.68 8.15 8.03 8.63 8.46 7.9 7.49 7.96 7.75 7.81 8.14 8.1 7.97 8.57 8.43 8.34 7.95
GOBP_ACTIN_FILAMENT_BASED_TRANSPORT 5.74 5.76 5.36 5.48 5.93 5.75 5.86 5.83 6.02 6.18 5.78 5.94 5.89 5.6 5.94 5.72 5.97 5.43 5.55 5.72 5.9 5.84 6.03 5.72 6.08 6.2
GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING 8 8 8.51 7.85 8.71 8.6 8.47 8.39 8.38 8.79 8.18 8.52 8.6 8.55 8.24 8.29 8.25 8.43 8.17 8.28 8.12 8.34 8.61 8.75 8.31 8.09
GOBP_SYNAPTIC_SIGNALING 7.43 7.52 7.73 7.43 7.72 7.87 7.99 7.97 7.72 7.88 7.51 7.82 7.93 7.95 8.03 7.86 7.51 7.69 7.85 8.02 7.62 7.83 7.84 8.02 7.75 7.69
GOBP_MAINTENANCE_OF_SYNAPSE_STRUCTURE 7.76 7.62 7.81 7.84 7.81 8.01 8.24 7.54 8.08 8.22 8.05 7.85 8.39 8.55 8.09 7.89 7.75 7.95 7.9 8.15 8.07 8.2 8.49 8.34 8.28 7.29
GOBP_SYNAPTIC_MEMBRANE_ADHESION 7.15 7.23 7.33 6.85 7.55 7.96 7.91 7.67 7.33 7.86 7.07 7.58 7.45 7.67 7.89 7.41 7.23 7.8 7.52 7.51 7.37 7.44 7.58 7.66 7.66 7.5
GOBP_MODIFICATION_OF_SYNAPTIC_STRUCTURE 8.59 8.73 8.36 8.22 9.02 9.04 8.85 9.1 9.04 9.08 8.63 8.96 9.15 9.05 9.33 9.08 8.5 8.67 9 8.95 8.37 9.02 8.89 9.12 9.21 8.87
GOBP_CHEMICAL_SYNAPTIC_TRANSMISSION_POSTSYNAPTIC 6.92 7.04 7.19 7.09 7.23 7.22 7.58 7.62 7.15 7.42 7.08 7.37 7.2 7.21 7.55 7.11 6.99 7.15 7.4 7.14 7.23 7.14 7.26 7.48 7.11 7.22
GOBP_REGULATION_OF_POSTSYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION 9.53 9.61 8.82 8.39 9.52 9.97 9.96 9.37 9.7 9.57 9.5 9.69 9.79 10.05 9.72 9.92 8.91 9.35 10.06 9.71 9.21 9.12 9.66 10.03 9.47 9.41
GOBP_INORGANIC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE 5.95 5.82 5.65 5.92 5.53 5.54 5.96 5.9 6.03 5.69 5.82 5.67 5.9 5.97 5.96 5.91 5.86 5.72 5.9 5.62 6.12 5.8 6 5.82 5.99 5.68
GOBP_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION 7.92 8.36 8.48 8.09 8.87 8.59 9.04 8.51 8.75 8.46 8.05 8.57 8.66 8.59 8.48 8.37 8.55 8.35 8.35 8.7 8.75 8.43 8.78 8.79 8.68 8.42
GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY 7.92 7.89 7.96 7.53 8.17 8.24 8.36 8.19 8.39 8.36 7.89 8.21 8.26 8.52 8.36 8.2 7.68 7.94 8.29 8.31 7.71 7.94 8.17 8.39 8.2 8.01
GOBP_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION 7.04 7.06 6.83 6.91 7.05 7.36 7.11 7.07 6.84 7.47 7.23 7.5 7.2 7.49 7.6 7.13 7.21 7.58 7.6 7.39 6.64 7.28 6.84 7.4 7.36 7.24
GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION 6.57 6.5 6.28 6.64 6.3 6.53 6.5 6.62 6.08 6.87 6.75 6.61 6.59 6.61 6.96 6.77 6.57 7.2 6.89 6.65 6.27 6.98 6.36 6.86 6.63 6.87
GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION 6.24 5.95 6.35 6.84 5.71 5.46 6.17 6.49 5.91 6.31 6.41 5.8 5.6 5.75 7.32 6.53 6.12 6.24 6.08 5.52 5.9 5.63 6.04 5.69 5.86 5.62
GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT 8.49 8.79 8.88 8.13 9 8.96 9.29 9.16 8.95 9.18 8.84 8.79 9.11 8.96 9.11 9.2 8.71 8.84 8.85 8.95 9 8.97 9.16 9.3 9.39 8.99
GOBP_AXO_DENDRITIC_PROTEIN_TRANSPORT 10.63 10.74 10.39 9.77 10.86 11.04 10.97 10.72 10.9 10.71 10.51 10.69 11.11 11.09 10.87 10.86 10.65 10.71 10.48 10.65 10.58 10.46 11.08 11.24 10.62 10.66
GOBP_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE 8.04 8.09 8.87 8.09 8.53 8.37 8.85 8.68 8.71 8.2 8.41 8.33 8.41 8.71 8.62 8.49 8.6 8.46 8.39 8.27 8.38 8.61 8.48 8.51 8.37 8.36
GOBP_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION 6.31 6.49 6.84 6.54 6.56 6.53 6.22 6.4 6.62 6.62 6.37 6.67 6.65 6.57 5.97 6.35 6.66 6.57 6.25 6.39 6.91 6.8 6.78 6.72 6.58 7.01
GOBP_NEURON_PROJECTION_ORGANIZATION 8.01 8.28 8.27 7.85 8.46 8.61 8.56 8.31 8.48 8.56 8.09 8.34 8.54 8.56 8.61 8.55 8.07 8.2 8.68 8.48 7.94 8.19 8.23 8.75 8.69 8.37
GOBP_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING 6.44 6.48 6.88 6.74 6.67 6.44 6.93 7.43 6.84 6.82 6.53 6.78 6.66 6.51 7.11 7.03 6.49 6.42 6.48 6.58 6.74 6.76 7.28 7.18 6.67 6.61
GOBP_NEGATIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING 6.22 6.31 6.39 6.51 6.48 6.33 6.88 6.47 6.83 6.77 6.45 6.57 6.43 6.46 6.63 7.03 6.21 6.42 6.32 6.2 6.74 6.94 6.89 6.48 6.67 6.55
GOBP_POSITIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING 7.09 7.07 7.04 6.92 7.39 7.42 7.74 7.68 7.71 7.55 6.57 7.24 7.46 7.27 7.85 7.4 6.99 6.63 7.62 7.99 6.88 6.64 7.32 7.64 7.28 7.26
GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY 8.72 8.57 9.12 8.59 8.48 8.84 9.32 8.92 9.04 9.4 8.71 8.61 8.92 9.1 8.83 9.18 8.86 8.32 8.95 9.12 8.76 8.64 8.89 9.07 9.17 8.98
GOBP_REGULATION_OF_ACTOMYOSIN_STRUCTURE_ORGANIZATION 6.49 6.43 6.65 6.6 6.85 6.88 6.81 7.05 6.78 7.14 6.77 7.15 6.79 6.86 6.78 6.66 7 6.88 6.34 6.63 6.69 6.82 7.07 7.04 7.14 7.2
GOBP_REGULATION_OF_ACTIN_FILAMENT_ORGANIZATION 6.88 6.9 7.11 6.91 7.29 7.19 7.2 7.28 7.21 7.28 6.93 7.23 7.25 7.2 7.31 7.17 7.2 7.07 6.93 7.35 7.15 7.22 7.29 7.42 7.3 7.28
GOBP_CELLULAR_RESPONSE_TO_ALDEHYDE 5.62 6.3 8.25 8.31 6.9 6.79 7.17 7.24 7.14 7.39 7.56 6.23 7.11 6.93 6.83 7.06 7.05 7.21 6.02 7.23 5.85 6.36 7.11 6.98 6.66 6.54
GOBP_POSITIVE_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS 5.47 5.44 5.49 5.48 5.08 5.12 5.6 5.27 5.4 5.37 5.56 5.04 5.05 5.12 5.35 5.36 5.6 5.46 5.51 5.22 5.38 5.17 5.07 5.07 5.34 5.39
GOBP_BIOMINERALIZATION 5.89 5.65 5.88 5.87 5.6 5.51 5.79 5.84 5.77 5.77 6.08 5.74 5.61 5.7 5.85 5.75 5.84 5.87 5.54 5.75 5.94 5.77 5.71 5.56 5.79 6.04
GOBP_REGULATION_OF_BIOMINERALIZATION 6.04 5.93 6.1 6.06 5.54 5.52 5.87 5.86 6 5.84 6.18 5.69 5.61 5.79 5.85 5.9 5.79 5.65 5.75 5.72 6.2 6.19 5.77 5.92 5.81 5.81
GOBP_NEGATIVE_REGULATION_OF_BIOMINERALIZATION 6.05 6.21 6.13 5.94 5.78 5.53 5.94 5.83 6.21 5.97 6.08 6.12 5.76 5.85 6.08 6.26 5.91 5.68 5.81 5.75 6.24 6.51 6.69 5.9 6.25 6.08
GOBP_POSITIVE_REGULATION_OF_BIOMINERALIZATION 5.9 5.41 6.04 6.09 5.58 5.58 5.68 5.94 5.72 5.99 6.18 5.49 5.4 5.55 6.04 5.69 5.54 5.6 5.49 5.6 5.7 5.68 5.69 5.84 5.75 5.69
GOBP_RNA_DECAPPING 6.88 6.76 7.06 6.96 7.39 7.49 7.53 6.84 7.28 7.31 7 6.9 7.21 7.06 6.76 6.86 6.72 6.47 6.58 7.06 7.22 6.99 7.36 7.41 6.99 6.7
GOBP_INTERMEMBRANE_LIPID_TRANSFER 6.87 6.59 7 6.57 6.45 6.95 7.35 7.36 6.45 7.04 6.55 7.03 6.81 7.06 7.1 6.73 6.54 7.17 6.95 6.96 7.34 7.52 6.76 7 7.01 7.18
GOBP_NEGATIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY 6.87 7.04 7.38 6.9 7.49 7.25 7.61 7.29 7.38 7.45 7.33 7.67 7.38 7.15 7.4 7.4 7.09 7 6.96 7.29 7.19 7.58 7.28 7.69 7.21 7.35
GOBP_POSITIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY 7.09 7.3 7.51 7.32 7.92 7.83 7.8 7.85 7.64 7.84 7.44 7.82 7.99 7.9 8 7.69 7.57 7.21 7.52 7.94 7.44 7.59 8.02 8.32 7.51 7.73
GOBP_POSITIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS 6.28 6 6.2 6.36 6.21 6.43 6.46 6.5 6.46 6.35 6.33 6.2 6.42 6.57 6.3 6.51 6.36 6.41 6.39 6.64 6.5 6.71 6.67 6.48 6.46 6.48
GOBP_NEGATIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS 6.45 6.54 6.97 6.6 6.7 6.95 6.85 7.06 6.92 6.73 6.68 6.94 7.03 7.2 6.91 6.81 6.9 6.99 6.7 7.05 7.17 7.35 6.85 7.12 7.22 6.99
GOBP_STEROID_HORMONE_BIOSYNTHETIC_PROCESS 5.84 5.78 5.79 5.9 5.96 5.36 5.79 5.62 5.81 5.57 5.91 5.49 5.66 5.66 5.7 5.63 5.76 5.78 5.42 5.46 5.8 6 5.51 5.57 5.84 5.68
GOBP_OLEFINIC_COMPOUND_METABOLIC_PROCESS 5.87 5.64 5.69 5.68 5.31 5.29 5.52 5.5 5.51 5.35 5.49 5.47 5.47 5.26 5.58 5.33 5.56 5.79 5.42 5.26 5.67 5.46 5.39 5.27 5.55 5.56
GOBP_OLEFINIC_COMPOUND_BIOSYNTHETIC_PROCESS 5.53 5.3 5.47 5.35 5.11 4.91 5.52 5.42 5.51 5.24 5.49 4.96 4.77 5.12 5.35 4.91 5.64 5.35 5.15 5.19 5.12 5.35 5.17 4.93 5.34 5.25
GOBP_MITOTIC_NUCLEAR_DIVISION 6.24 6.33 6.54 6.39 6.51 6.5 6.68 6.53 6.49 6.65 6.44 6.57 6.43 6.31 6.56 6.49 6.46 6.29 6.34 6.52 6.34 6.5 6.66 6.75 6.61 6.46
GOBP_EXOCYTIC_PROCESS 7.4 7.33 7.77 7.45 7.86 7.87 7.67 7.66 7.69 7.54 7.43 7.69 7.78 7.72 7.53 7.43 7.35 7.39 7.5 7.78 7.38 7.53 7.39 7.87 7.49 7.52
GOBP_LIPID_DROPLET_FORMATION 6.86 6.88 7.35 7.23 7.25 7.57 7.49 7.07 7.12 8.18 7.07 6.77 7.76 7.85 7.52 7.69 6.65 7.08 7.22 7.17 7.23 6.99 7.5 7.64 7.47 7.56
GOBP_MITOCHONDRIAL_GENE_EXPRESSION 6.66 6.81 7.72 7.64 6.97 7.1 7.05 7.25 7.1 7.2 7.29 7.04 7.11 7.24 7.17 7.32 6.88 6.81 6.95 7.19 6.98 7.13 7.06 7.32 7 6.96
GOBP_NEURON_PROJECTION_ARBORIZATION 6.72 6.66 7.21 6.51 7.87 7.36 7.39 7.29 7.03 7.39 7.09 7.52 7.35 7.55 7.28 7.11 6.98 6.95 6.96 7.3 6.92 7.32 7 7.27 7.16 7.3
GOBP_EXTRACELLULAR_VESICLE_BIOGENESIS 7.34 7.38 8.34 7.4 7.53 7.5 8.01 7.84 7.73 7.61 7.87 7.96 7.46 7.95 7.61 7.44 7.82 7.56 7.48 7.87 8.09 7.84 7.77 7.98 7.79 7.83
GOBP_EXPORT_ACROSS_PLASMA_MEMBRANE 6.35 6.41 6.61 6.41 6.46 6.57 6.55 6.38 6.29 6.33 6.41 6.24 6.47 6.46 6.48 6.53 6.63 6.58 6.45 6.9 6.45 6.68 6.46 6.7 6.92 6.48
GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS 5.6 5.44 5.32 5.76 5.1 5.1 5.44 5.37 5.66 5.43 5.55 5.36 5.64 5.49 5.34 5.35 5.76 5.81 5.45 5.5 5.97 5.46 5.29 5.65 5.42 5.04
GOBP_PRESYNAPTIC_ENDOCYTOSIS 7.98 8.01 8.26 8.17 8.18 8.65 8.24 8.43 8.17 8.37 8.12 8.27 8.25 8.34 8.73 8.51 8.26 8.06 8.13 8.22 7.82 8.28 8.58 8.48 8.54 8.18
GOBP_PROTEIN_MONO_ADP_RIBOSYLATION 6.29 6.2 5.87 5.98 6.26 6.18 5.86 6.02 5.95 6.21 6.58 6.27 6.02 5.98 5.91 6.23 6.91 6.4 6.04 5.93 6.07 6.33 6.05 5.81 6.1 6.26
GOBP_LIPID_EXPORT_FROM_CELL 6.24 6.27 6.7 6.25 6.03 6.03 6.36 6.57 6.09 6.18 6.46 6.2 6.09 6.31 6.71 6.53 6.25 6.11 6.41 6.24 6.19 6.33 6.36 6.36 6.09 6.28
GOBP_LIPID_IMPORT_INTO_CELL 7.62 7.88 8.2 7.79 8.36 8.47 8.07 8.36 8.57 8.41 7.82 8.39 8.44 8.28 8.17 8.02 8.03 7.93 8.16 8.49 7.94 8.05 8.62 8.6 8.27 8.34
GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE 6.08 5.91 5.64 6.18 5.83 5.64 5.35 5.72 5.68 5.83 6.5 6.29 5.96 5.69 6.21 6.35 5.87 5.65 5.86 5.92 6.04 6.02 5.7 6.01 5.46 5.62
GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING 5.64 5.63 5.79 5.35 5.49 5.36 5.62 5.69 5.41 5.36 5.32 5.51 5.69 5.46 5.49 5.5 5.8 5.62 5.51 5.47 5.6 5.35 6 5.52 5.65 5.39
GOBP_INTEGRATED_STRESS_RESPONSE_SIGNALING 7.72 7.71 7.65 7.48 7.7 7.51 7.42 7.44 7.67 7.72 7.74 7.37 7.47 7.57 7.35 7.22 7.42 7.37 7.48 7.5 7.52 7.63 7.69 7.97 7.66 7.6
GOBP_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION 6.42 6.41 6.37 6.78 6.63 6.57 7.27 6.86 6.73 6.26 6.84 6.51 6.84 7.36 6.69 6.58 6.93 6.65 6.36 6.66 6.76 6.8 5.79 6.25 6.81 7.28
GOBP_REGULATION_OF_DEACETYLASE_ACTIVITY 7.57 7.34 7.61 7.51 8.09 8.08 7.72 7.85 8 7.68 7.45 7.89 8.01 7.83 7.73 7.86 7.31 7.31 7.9 7.77 7.41 7.79 8.24 7.91 7.2 7.2
GOBP_NEUROINFLAMMATORY_RESPONSE 5.5 5.62 5.98 6 5.3 5.15 5.53 5.6 5.55 5.39 5.41 5.06 5.66 5.54 5.57 5.38 5.39 5.45 5.31 5.45 5.95 5.95 5.54 5.21 5.47 6.03
GOBP_NEGATIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE 7.17 6.55 6.64 7.07 7.11 7.43 7.53 7.18 7.13 7.44 6.46 6.62 7.62 7.11 7.06 6.69 7.1 6.44 6.79 7.05 6.49 6.47 6.91 7.12 6.53 6.71
GOBP_PROTEIN_LOCALIZATION_TO_CELL_CELL_JUNCTION 6.74 6.65 6.46 6.64 6.51 6.59 7.02 7.06 6.67 6.53 6.37 6.88 6.88 6.76 6.66 6.4 6.71 6.41 6.56 6.6 6.96 7.27 7.37 7.12 7.15 7.41
GOBP_CELL_SUBSTRATE_JUNCTION_ORGANIZATION 7.5 7.62 7.61 7.35 7.99 8.23 7.98 7.93 7.92 7.89 7.63 7.88 8.06 8.21 7.88 7.79 7.82 7.49 7.66 8.03 7.83 8.16 8 8.11 8.21 8.09
GOBP_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION 7.8 7.84 8.09 7.66 8.5 8.57 8.36 8.58 8.54 8.3 8.06 8.33 8.74 8.55 8.41 8.49 8.17 7.88 8.13 8.42 8.18 8.44 8.64 8.5 8.39 8.39
GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION 7.5 7.62 7.69 7.52 7.99 8.23 7.93 7.91 8.07 7.9 7.8 7.94 8.24 8.22 7.88 7.81 7.94 7.7 7.82 8.03 7.83 8.24 8.33 8.13 8.16 8.07
GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION 7.61 8 7.61 7.11 9.14 8.97 8.87 8.89 8.97 8.34 8.66 8.99 9.16 8.81 8.85 8.82 8.17 8.43 8.82 8.42 8.09 8.67 9.14 9.21 8.61 8.35
GOBP_CELL_JUNCTION_DISASSEMBLY 8.64 8.75 8.57 8.22 8.69 8.68 8.49 8.35 8.9 8.6 7.96 8.08 8.56 8.56 8.5 8.27 8.28 7.91 8.07 8.77 8.2 8.49 8.84 9.03 8.89 8.7
GOBP_CELL_CELL_SIGNALING_BY_WNT 6.83 6.79 6.97 6.76 6.96 7.09 7.04 7.08 7.08 7.04 6.87 7.02 7.07 7.09 6.99 7 7.02 6.84 6.96 7.12 6.97 7 6.96 7.16 7.03 7.04
GOBP_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT 7.31 7.12 7.37 7.51 7.86 7.9 7.5 7.74 7.66 7.63 7.12 7.62 8.03 7.91 7.86 7.67 7.79 7.47 7.49 7.62 7.78 7.61 7.4 8 7.43 7.58
GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE 5.51 5.42 5.25 5.4 5.53 5.18 5.45 5.18 5.92 5.48 5.18 5.06 5.34 5.23 5.58 5.31 5.22 5.43 4.99 5.3 5.38 5.28 5.06 5.24 5.18 5.12
GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE 5.32 4.98 5.01 5.23 5.1 4.86 4.67 4.61 5.15 4.73 5.08 4.64 5.08 4.75 5.3 4.97 5.01 4.82 5.19 4.88 4.85 4.64 5.2 4.6 4.79 4.42
GOBP_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING 6.93 6.75 6.87 6.66 7.28 7.12 7.07 7.42 7.16 6.96 7.03 6.91 7.45 7.36 7.32 7.22 7.13 6.75 7.38 7.18 7 7.3 7.15 7.21 6.93 7.08
GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING 6.97 6.87 6.98 6.66 7.4 7.12 7.15 7.5 7.19 6.96 7.07 7.13 7.55 7.66 7.32 7.22 7.45 7.05 7.5 7.26 7 7.31 7.15 7.21 7.06 7.24
GOBP_REGULATION_OF_RUFFLE_ASSEMBLY 7.19 7 7.47 7.15 7.62 7.72 7.95 7.88 7.52 7.68 7.5 7.68 7.69 7.91 7.5 7.68 7.56 7.15 7.31 8 7.59 7.61 7.68 8.14 7.79 7.68
GOBP_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY 6.97 7.38 8.37 7.58 7.84 7.83 8.14 8.18 7.99 8.2 7.64 7.93 8.29 8.09 8.1 7.87 7.56 7.49 7.3 8.31 7.71 7.69 8.22 8.55 8 7.88
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT 7.52 7.65 8.13 8.08 8.08 8.14 7.96 7.69 7.72 7.88 7.72 7.87 7.83 7.89 7.89 7.8 7.73 7.39 7.8 7.9 7.53 8.1 8.05 7.97 7.89 7.81
GOBP_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION 7.79 7.6 7.44 7.2 7.69 8.18 7.56 7.83 8.06 7.84 7.72 8.13 8.01 8.12 8 7.97 7.61 7.32 7.8 7.95 7.71 8.07 8.16 8.38 8.37 7.99
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS 6.82 7.02 7.39 7.42 7.47 7.7 7.57 7.39 7.51 7.25 7.2 7.26 7.4 7.34 7.55 7.41 7.09 7.06 7.46 7.42 7.27 7.28 7.51 7.66 7.49 7.42
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS 6.82 7.02 7.42 7.25 7.47 7.7 7.57 7.39 7.62 7.25 7.2 7.4 7.58 7.5 7.51 7.33 7.16 7.15 7.46 7.42 7.27 7.28 7.48 7.72 7.66 7.46
GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS 6.44 6.53 6.63 7.17 7.08 6.66 6.95 6.76 6.91 6.97 6.31 6.92 6.65 6.57 7.59 7.38 6.74 6.56 6.49 6.71 7.15 7.2 7.52 6.83 6.91 7
GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE 6.55 6.81 7.19 6.97 7.16 7.15 7.19 7.03 7.2 7.06 7.15 7.16 7.2 7.27 6.96 7.13 7.03 7.14 6.87 7.26 7.3 7.38 6.95 7.08 7.27 7.3
GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE 6.71 6.87 7.65 7.48 7.31 7.39 7.33 7.4 7.65 7.35 7.2 7.29 7.52 7.37 7.46 7.27 7.14 7.2 7.15 7.47 7.52 7.4 7.35 7.74 7.48 7.47
GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE 7.17 6.91 7.93 7.97 7.91 7.55 7.9 7.44 7.67 7.38 7.42 7.37 7.71 7.55 7.5 7.55 7.16 7.21 7.48 7.56 7.56 7.46 7.47 7.87 7.58 7.49
GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE 6.71 6.91 6.82 6.91 7 7.39 6.95 7.27 7.37 7.18 7.18 7.33 7.47 7.37 7.35 7.22 7.14 7.21 6.92 7.44 6.87 7.4 7.3 7.74 7.43 7.47
GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION 6.54 6.25 5.85 5.38 6.77 6.55 6.02 6.05 6.08 6.29 5.85 6.38 6.03 5.98 6.12 6.33 5.77 5.64 6.38 6.17 6.11 6.08 6.51 5.98 6.31 6.44
GOBP_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS 7.48 7.99 7.54 6.73 8.43 8.33 8.23 7.89 8.36 8.02 7.79 7.95 8.18 8.19 7.69 7.34 8.15 7.44 7.98 8.39 7.21 7.47 8.09 8.22 8.02 8.05
GOBP_REGULATION_OF_RECEPTOR_BINDING 5.43 5.52 5.89 5.47 5.21 5.49 6.04 5.73 5.45 5.5 5.87 5.16 5.72 5.73 6.25 5.61 5.59 5.46 5.34 5.75 5.63 5.64 5.82 5.19 6.02 5.87
GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING 5.8 5.52 6.05 6.5 5.55 5.51 6.35 6.16 6.12 5.77 5.9 5.42 6.93 6.8 6.48 6.6 5.78 5.53 5.43 6 6.08 6.09 5.9 6.48 6.02 5.98
GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY 8.51 8.87 8.4 7.92 9.05 8.63 9.07 8.97 8.97 9.02 8.61 9.16 9.33 9.14 9.01 8.87 9.19 8.24 8.98 8.82 8.82 9.09 8.66 9.19 9.36 9.02
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS 6.7 6.79 7.05 6.81 6.9 6.91 6.94 6.94 6.87 6.99 6.97 7.01 7.05 7.03 6.88 7.02 6.94 6.64 6.62 6.85 6.83 7.03 6.93 7.16 7.11 7.09
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS 6.6 6.64 6.85 6.48 6.74 6.89 6.79 6.67 6.85 6.81 6.55 6.82 7.03 6.93 6.49 6.66 6.9 6.23 6.48 6.76 6.67 6.69 6.87 6.91 6.73 6.66
GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS 6.78 7.04 7.19 7.07 6.93 6.94 7.17 7.01 6.96 7.14 7.21 7.18 7.18 7.08 6.93 7.14 7.14 7.03 6.83 7.02 6.99 7.21 6.99 7.37 7.47 7.35
GOBP_REGULATION_OF_AMYLOID_BETA_CLEARANCE 6.82 6.6 8.04 7.72 7.22 7.27 7.19 6.85 7.34 7.38 6.95 7.47 7.15 7.14 7.3 7.45 7 6.83 7.03 6.75 6.86 6.98 7.43 7.26 7.04 7.37
GOBP_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS 7.45 7.88 8.04 8.35 7.97 7.9 8.02 8.35 8.03 8.06 7.99 8.05 7.86 8.03 8.78 8.48 8.05 8.02 8.17 7.96 7.67 8.04 8.32 8.23 8.37 7.9
GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION 9 8.75 8.86 8.51 9.22 9.31 9.12 9.06 9.24 8.93 8.9 8.84 9.36 9.35 8.98 9.34 8.52 8.69 9.14 9.23 8.59 8.63 8.87 9.18 9.03 8.78
GOBP_NEGATIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION 9.18 9.53 9.42 8.54 9.12 9.35 8.79 9.21 9.34 8.7 8.57 8.83 9.61 9.74 9.18 9.6 8.64 8.81 9.47 9.3 9.17 9.49 9.11 9.25 9.17 9.21
GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION 8.9 8.63 8.82 8.4 9.22 9.27 9.15 9.08 9.3 9.1 9.09 8.97 9.2 9.35 8.96 9.34 8.37 8.78 9.14 9.23 8.56 8.59 9.02 9.27 8.98 8.63
GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY 5.41 5.5 5.34 5.44 5.41 5.75 5.7 5.54 5.41 5.81 5.25 5.33 5.45 5.5 5.44 5.35 5.48 5.81 5.39 5.66 5.94 5.56 5.48 5.37 5.34 5.71
GOBP_REGULATION_OF_MRNA_POLYADENYLATION 7.55 8.06 7.76 7.82 8.19 8.39 8.32 8.39 7.92 7.87 7.82 8.03 8.04 8.02 8.03 7.77 8.33 7.73 7.89 8.39 7.97 8.46 8.07 8.26 8.08 8.04
GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM 5.93 5.52 5.3 5.61 4.92 4.94 5.3 5.41 5.32 5.32 5.61 4.8 5.3 5.5 5.62 5.71 5.44 5.59 5.33 5.47 5.63 5.83 4.99 4.87 5.5 5.02
GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION 7.37 7.43 7.49 7.3 8.07 8.16 8.15 8.17 7.99 8.11 7.12 7.87 7.95 7.89 8.03 8.09 6.88 6.87 7.84 7.98 7.81 7.71 7.97 8.1 7.88 7.75
GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE 5.75 6.02 5.95 6.15 6.28 6 6.04 6.49 6.1 6.33 6.34 6.15 6.21 6.23 5.99 6.27 6.38 6.23 6 6.18 6.55 6.33 5.99 6.52 6.41 6.61
GOBP_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.36 7.29 7.41 7.05 7.46 7.36 7.67 7.28 7.52 7.67 7.37 7.77 7.1 7.26 7.66 6.97 7.28 7.27 7.5 7.52 7.27 7.31 7.64 7.71 7.78 7.5
GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.37 7.53 7.44 7.07 7.7 7.37 7.77 7.41 7.43 7.9 7.62 7.7 7.24 7.59 7.92 7.92 6.87 7.51 7.29 7.65 7.28 7.34 7.33 7.73 7.74 7.64
GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.99 7.09 7.54 7.28 7.13 7.31 7.09 7.13 7.18 7.16 7.2 7.11 7.41 7.47 7.25 7.51 7.04 7.13 7.35 7.09 7.13 7.47 7.54 7.5 7.24 7.1
GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.86 6.44 7.47 7.41 6.54 7.02 6.58 6.92 6.74 6.82 7.03 6.26 7.24 7.15 6.59 7.39 6.21 6.33 7.05 6.88 6.42 6.9 7.58 7.32 6.68 6.39
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.59 7.78 7.93 7.64 8.25 8.11 7.78 7.94 7.78 7.95 7.65 7.89 8.04 8.15 8.09 7.88 7.79 7.69 7.73 8.14 7.71 8.04 7.83 8.03 8.14 7.76
GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY 6.98 6.96 7.85 7.67 7.02 6.87 7.1 7.25 7.05 7.13 7.49 7.02 7.01 7.04 7.08 7.04 7.31 7.13 6.92 7.35 7.45 6.97 7.06 6.88 7.05 7.22
GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY 7.12 6.96 7.85 7.67 7.02 6.87 7.1 7.27 7.05 7.36 7.49 7.02 7.01 7.04 7.08 7.07 7.31 7.25 6.92 7.35 7.45 6.97 7.06 6.88 7.05 7.31
GOBP_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES 6.3 6.4 6.72 6.24 7.49 7.15 6.71 6.81 6.75 7.09 6.4 7.07 7.27 7.14 6.78 6.81 6.88 6.82 6.66 6.85 7.07 7.13 7.63 7.01 6.75 6.53
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES 8.91 8.82 9.42 8.68 9.48 9.12 9.32 9.27 9.18 8.72 8.85 8.96 9.11 8.85 8.78 8.7 8.85 8.48 8.73 9.09 8.93 9.02 9.04 9.33 9.11 9.04
GOBP_GUANOSINE_CONTAINING_COMPOUND_METABOLIC_PROCESS 7.09 7.22 7.76 7.68 7.56 7.51 7.35 7.22 7.05 7.34 7.81 7.49 7.26 7.44 7.03 7.42 7.59 7.22 7.55 7.45 7.46 7.11 7.44 7.36 7.65 7.51
GOBP_GUANOSINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS 7.22 7.59 8.49 8.18 7.78 7.68 8.1 7.73 6.78 7.96 8.12 8.42 7.59 7.72 7.71 8.34 7.84 7.93 7.63 8.04 7.89 7.99 7.59 7.39 8.22 8.16
GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS 6.02 6.04 6.42 6.31 6.38 6.31 6.22 6.04 6.65 6.5 6.34 6.27 6.5 6.39 6.02 6.15 6.18 6.13 6.18 6.97 6.11 6.07 6.86 6.35 6.46 6.23
GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND 5.95 5.8 5.69 6.26 5.76 5.44 5.64 5.99 5.98 5.77 5.93 5.73 5.75 5.72 6.05 5.82 6.21 6.06 5.7 5.59 6.29 5.81 5.79 5.88 6.02 5.92
GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS 6.59 6.58 6.86 6.79 6.8 6.81 6.8 6.74 6.77 6.78 6.67 6.76 6.79 6.74 6.7 6.7 6.71 6.63 6.72 6.76 6.54 6.69 6.8 6.87 6.8 6.79
GOBP_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS 6.12 6.03 6.13 6.3 6.12 6.19 5.99 6.02 5.99 6.01 5.99 5.98 6.03 6.08 5.89 5.99 6 6.02 6.08 6.08 6.11 6.1 6.08 6.28 6 6.2
GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS 6.75 6.81 6.99 6.92 6.96 7.06 7.06 6.93 6.98 6.96 6.79 6.94 7.03 7.01 6.91 6.82 6.87 6.74 6.85 7.04 6.72 6.84 7.01 7.07 6.97 6.97
GOBP_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS 6.06 6.34 6.62 6.33 6.61 6.29 6.54 6.26 6.69 6.58 6.5 6.36 6.35 6.34 6.48 6.27 6.03 6.01 6.69 6.26 6.43 6.05 6.82 6.96 6.02 6.22
GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY 6.97 6.84 6.78 6.61 7.03 7.15 6.89 6.85 7.09 7.04 6.76 7.01 7.03 7.11 6.89 6.88 6.73 6.75 7.03 6.99 6.76 6.91 7.12 7.13 7.01 7.04
GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY 7.21 7.23 7.44 7.31 7.77 7.39 7.37 7.22 7.58 7.07 7.12 7.34 7.52 7.64 7.27 7.43 7.21 7.47 7.49 7.44 7.3 7.6 7.41 7.59 7.53 7.4
GOBP_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY 5.95 5.82 6.15 6.03 6.03 5.94 5.81 6.05 6.04 6.13 5.9 5.91 5.91 5.85 5.88 5.95 6.03 5.86 6.03 5.89 5.87 5.98 5.91 6.06 5.98 6.22
GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY 7.31 7.07 7.76 6.29 7.96 7.72 7.86 7.81 7.71 7.69 7.19 7.7 7.94 8.04 7.76 7.84 8.11 8.19 7.71 7.95 8.29 8.1 7.86 8.05 8.03 7.97
GOBP_NEGATIVE_REGULATION_OF_NEURON_DEATH 7.09 7.1 7.69 7.54 7.38 7.48 7.56 7.6 7.41 7.46 7.44 7.44 7.48 7.37 7.77 7.4 7.28 6.99 7.22 7.56 7.31 7.71 7.62 7.71 7.7 7.6
GOBP_POSITIVE_REGULATION_OF_NEURON_DEATH 7.39 7.61 7.88 7.63 7.78 7.66 7.5 7.85 7.63 7.78 7.61 7.46 7.68 7.71 7.84 7.72 7.22 7.41 7.65 7.54 7.46 7.77 7.65 7.74 7.65 7.71
GOBP_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING 6.42 6.37 6.62 6.33 6.39 6.07 6.13 6.12 6.24 6.07 6.35 6.26 5.99 6.1 6.01 6.09 6.42 6.17 6.07 6.09 6.46 6.51 6.22 5.99 6.49 6.33
GOBP_NEGATIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING 6.56 6.38 6.91 6.87 6.61 6.44 6.56 6.25 6.6 6.38 6.51 6.56 6.4 6.53 6.48 6.62 6.85 6.5 6.28 6.37 7.24 6.94 6.88 6.62 6.55 6.59
GOBP_POSITIVE_REGULATION_OF_NIK_NF_KAPPAB_SIGNALING 6.2 6.35 6.5 6.2 6.25 5.92 5.88 5.8 5.93 5.56 6.29 6.14 5.84 5.84 5.75 5.82 5.87 5.64 5.68 5.99 6.19 6.15 5.83 5.8 6.11 6.04
GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT 6.27 6.17 6.37 6.42 6.31 6.22 6.25 6.51 6.18 6.33 6.3 5.99 6.35 6.37 6.28 6.33 6.18 6.38 6.35 6.38 6.22 6.36 6 6.5 6.37 6.34
GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS 6.08 5.98 6.27 6.55 5.98 6.32 6.31 6.22 6.13 6.13 6.27 6.29 6.42 6.24 6.32 6.23 6.07 6.2 6.24 6.33 6.23 6.34 6.31 6.5 6.17 6.41
GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS 6.65 6.69 6.93 6.85 6.89 6.89 6.89 6.78 6.74 7 6.76 7.03 6.82 6.82 6.75 6.74 6.82 6.72 6.76 6.87 6.64 6.77 6.75 6.98 6.82 6.88
GOBP_REGULATION_OF_FLAGELLATED_SPERM_MOTILITY 4.8 4.3 4.51 5.08 3.98 3.96 4.26 4.39 4.45 4.01 4.64 4.59 4.06 4.24 4.24 4.22 4.23 4.45 4.39 4.13 4.39 4.22 3.91 3.98 4.17 4.12
GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT 6.07 6.01 6.15 6.01 6.05 5.98 6.05 6.07 5.93 5.88 6.04 5.86 6.03 5.92 6.08 5.93 6.25 5.99 5.77 5.92 6.3 6.19 6.17 6.06 6.19 6.28
GOBP_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT 5.91 5.83 5.79 5.83 5.79 5.69 5.74 5.91 5.82 5.69 6.03 5.81 5.91 5.77 6 5.73 6.19 6.08 5.64 5.68 6.14 6.04 6.15 5.7 6.14 6.23
GOBP_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS 6.83 6.9 7.3 7.21 7.04 7.08 7.05 7.13 7.01 7.11 7.25 7.04 7.2 7.19 7.01 7.09 6.89 6.87 7.04 7.1 6.95 7.11 7.14 7.18 7.19 7.08
GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT 7.29 6.3 7.04 6.8 7.08 7.1 7.07 6.54 7.03 7.17 7.29 7 6.8 7.15 6.02 6.75 7.63 6.66 7 7.23 7.03 6.65 8.05 7.39 6.93 6.62
GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT 6.44 6.57 7.2 6.64 6.81 6.81 6.99 7.17 6.79 7.48 6.54 6.97 6.93 6.97 7.65 6.94 6.51 6.89 6.69 6.65 6.9 6.93 6.78 7.21 6.85 6.83
GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY 6.75 6.81 7.9 7.72 6.7 7.7 7.57 7.51 7.32 7.28 7.26 7.21 7.51 7.61 7.69 7.69 6.89 7.33 7.43 7.76 7.55 7.89 7.46 7.81 7.45 7.13
GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY 6.1 6.06 7.83 7.23 6.54 7.02 6.58 7.03 6.74 6.82 6.58 6.11 7.36 7.22 7.18 7.52 6.21 6.33 7.05 7.08 6.21 7.15 7.31 7.68 6.64 6.39
GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY 8.15 7.99 8.13 8.68 8.6 8.67 8.56 8.07 9.01 9.1 7.84 8.3 8.3 8.83 8.23 7.98 8.07 7.74 7.79 8.33 7.87 8.01 9.05 9.05 8.27 7.42
GOBP_ETHER_BIOSYNTHETIC_PROCESS 7.14 7.04 7.21 7.3 7.58 7.67 7.16 7.05 7.73 8.15 6.69 7.29 7.54 7.42 7.03 6.92 6.84 6.61 7.07 7.37 6.8 6.93 7.63 7.55 6.97 7.5
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_INVOLVED_IN_CELLULAR_RESPONSE_TO_CHEMICAL_STIMULUS 7.8 7.67 7.63 7.6 7.96 7.78 7.93 8.01 8.2 7.58 7.41 7.8 8 8.19 8.13 7.98 7.86 8.02 7.89 7.87 8.13 8.02 7.87 8.09 8.1 8
GOBP_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION 7.5 7.71 8.36 8.2 8.04 8.19 8.2 8.04 8.19 8.31 8.01 8.16 8.24 8.16 8.21 8.21 7.8 7.68 7.91 8.12 7.77 7.98 8.37 8.34 8.24 8.14
GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION 8.36 7.78 8.58 8.4 8.16 8.62 8.37 8.35 8.64 8.45 8.48 8.5 8.64 8.63 8.38 8.63 8.48 8.71 8.21 8.67 8.33 8.45 8.65 8.52 8.31 8.68
GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT 6.58 6.35 6.42 6.45 6.1 6.46 6.48 6.46 6.41 6.17 6.28 6.12 6.28 6.42 6.22 6.13 6.58 6.4 6.44 6.25 6.78 6.61 6.25 5.94 7.02 6.96
GOBP_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS 6.96 6.99 7.41 7.29 7.27 7.23 7.18 7.23 7.18 7.25 7.15 7.19 7.32 7.33 7.22 7.23 7.1 7.07 7.15 7.24 7.08 7.32 7.32 7.42 7.3 7.23
GOBP_ORGANONITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS 6.87 6.95 7.35 7.23 7.11 7.15 7.16 7.12 7.12 7.17 7.12 7.07 7.16 7.16 7.2 7.11 7.03 6.92 7.08 7.19 6.99 7.11 7.13 7.27 7.17 7.16
GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS 6.73 6.77 7.18 6.88 6.67 6.88 6.98 6.75 6.81 7.03 6.81 7.14 7.04 7.02 6.85 6.9 6.92 6.99 6.8 7.31 7.01 7.13 6.97 6.91 6.89 7.01
GOBP_FATTY_ACID_DERIVATIVE_CATABOLIC_PROCESS 5.96 6.35 6.68 5.92 5.31 5.44 5.49 5.84 6.13 5.49 5.72 5.54 5.47 5.93 6.13 6.12 5.69 5.65 5.29 5.84 6.17 6.71 5.56 6.22 5.77 6.72
GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS 6.84 6.9 7.18 6.98 6.94 7.04 7.06 6.94 7.1 7.18 6.87 7.16 7.07 7.16 6.96 7.05 7.11 7.02 7.23 7.54 7.04 7.37 7.19 7.34 7.19 7.05
GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS 6.28 6.28 6.83 6.67 6.32 6.38 6.35 6.5 6.34 6.41 6.51 6.45 6.36 6.39 6.31 6.47 6.43 6.42 6.43 6.59 6.66 6.56 6.3 6.37 6.45 6.41
GOBP_ALPHA_AMINO_ACID_CATABOLIC_PROCESS 6.07 6.29 6.88 6.61 6.44 6.33 6.37 6.47 6.28 6.45 6.53 6.37 6.46 6.37 6.22 6.56 6.48 6.45 6.46 6.65 6.93 6.81 6.27 6.41 6.54 6.42
GOBP_ALPHA_AMINO_ACID_BIOSYNTHETIC_PROCESS 6.67 6.71 7.23 7.13 6.56 6.97 6.62 6.75 6.62 6.41 7.03 6.84 6.75 6.54 6.75 6.56 6.76 6.78 6.81 6.89 6.8 6.82 6.89 6.95 6.68 6.46
GOBP_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS 6.19 6.18 6.24 6.33 6.14 6.22 6.19 6.22 6.17 6.26 6.23 6.22 6.23 6.1 6.18 6.14 6.17 6.1 6.04 6.16 6.21 6.28 6.29 6.25 6.24 6.3
GOBP_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS 5.93 6.26 6.29 6.23 5.91 5.9 5.98 6.11 6.06 6.02 6.11 6.11 6.22 6 5.98 6.1 6.17 6.05 5.85 6.06 6.3 6.29 6.26 6.09 6.28 6.37
GOBP_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS 6.29 6.22 6.25 6.34 6.17 6.36 6.35 6.35 6.37 6.25 6.28 6.33 6.22 6.16 6.27 6.16 6.31 6.17 6.18 6.3 6.2 6.43 6.22 6.32 6.43 6.32
GOBP_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS 5.51 5.42 5.32 5.76 6.08 5.62 5.25 4.93 4.94 4.82 5.06 4.79 5.19 5.5 5.15 5.07 6.38 5.99 4.76 4.89 5.97 5.46 5.06 4.72 5.34 5.04
GOBP_RESPONSE_TO_PEPTIDE 6.48 6.53 6.96 6.71 6.86 6.86 6.77 6.77 6.87 6.85 6.63 6.75 6.82 6.83 6.83 6.83 6.74 6.66 6.57 6.86 6.77 6.79 6.92 6.91 6.81 6.72
GOBP_CELLULAR_RESPONSE_TO_PEPTIDE 6.71 6.65 7.35 6.97 7.08 7.06 6.95 6.92 7.09 7.09 6.93 6.93 6.97 7.07 7.13 7.08 6.93 6.86 6.81 7.01 6.91 7.04 7.21 7.21 7.12 7.01
GOBP_RESPONSE_TO_KETONE 6.38 6.28 6.68 6.59 6.42 6.43 6.63 6.45 6.49 6.29 6.32 6.28 6.49 6.29 6.48 6.52 6.55 6.45 6.26 6.49 6.75 6.85 6.66 6.49 6.66 6.66
GOBP_CELLULAR_RESPONSE_TO_KETONE 6.6 6.56 6.9 6.66 6.94 6.66 6.81 6.8 6.92 6.83 6.91 6.77 6.99 6.61 6.65 6.76 6.82 6.66 6.6 6.71 6.91 6.99 6.87 6.8 6.77 6.77
GOBP_GLYCOSYL_COMPOUND_METABOLIC_PROCESS 6.09 6.17 6.39 6.65 6.32 6.29 6.01 6.15 6.24 6.2 6.26 6.34 6.37 6.19 6.24 6.31 6.18 6.3 6.15 6.26 5.99 6.29 6.18 6.51 6.46 6.5
GOBP_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS 5.46 5.5 5.71 5.78 5.28 5.19 5.36 5.35 5.39 5.48 5.54 5.15 5.27 5.15 5.51 5.51 5.38 5.4 5.29 5.31 5.48 5.39 5.43 5.11 5.54 5.64
GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS 6.12 6.42 6.87 6.76 6.7 6.83 6.59 6.75 6.41 6.64 6.62 6.49 6.75 6.74 6.75 6.88 6.44 6.67 6.9 6.73 6.47 6.74 6.71 6.61 6.56 6.79
GOBP_QUINONE_METABOLIC_PROCESS 5.83 6.15 6.45 6.31 5.87 6.07 6.08 5.91 5.99 5.7 5.86 6.04 6.41 6.16 6.12 6.03 5.78 5.82 5.97 6.06 5.81 5.9 6.2 6.1 6.22 6.33
GOBP_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY 7.19 7.12 8.74 7.72 8.33 8.13 7.91 7.47 7.56 8.06 7.71 7.91 7.75 7.77 7.61 8.08 7.22 6.96 7.5 7.7 7.33 7.73 8.43 8.69 7.49 7.75
GOBP_IRON_COORDINATION_ENTITY_TRANSPORT 6 6.22 6.52 6.53 5.99 6.05 6.53 6.35 6.03 6.25 6.54 6.32 6.47 6.47 6.3 6.5 6.17 6.49 6.12 6.13 6.41 6.66 6.26 6.41 6.47 6.47
GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT 6.5 6.95 7.18 7.39 6.66 7.12 6.62 6.88 6.81 7.09 7.09 6.85 6.82 6.94 6.64 7.07 6.6 6.56 6.82 6.86 6.53 6.88 6.91 7.13 6.54 6.44
GOBP_GLUTATHIONE_DERIVATIVE_METABOLIC_PROCESS 7.7 8.02 8.78 8.63 6.94 7.72 7.68 7.82 7.16 7.72 8.14 7.98 7.43 7.23 7.77 7.77 7.06 7.42 7.62 8.29 8.24 7.97 7.93 7.72 8.62 8.53
GOBP_RESPONSE_TO_NITROGEN_COMPOUND 6.66 6.67 7.12 6.86 6.9 6.98 6.9 6.96 6.91 7.02 6.79 6.93 6.97 7.01 6.98 6.94 6.75 6.79 6.78 6.94 6.85 6.99 6.99 7.05 6.94 6.89
GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND 6.69 6.63 7.19 6.85 6.98 7.05 6.95 6.97 7.02 7.1 6.91 6.94 6.99 7.07 7.12 7.05 6.88 6.85 6.8 6.99 6.91 7.03 7.08 7.21 7.09 6.99
GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND 6.32 6.26 6.5 6.46 6.32 6.35 6.44 6.45 6.44 6.41 6.34 6.35 6.44 6.36 6.47 6.51 6.42 6.38 6.28 6.39 6.46 6.53 6.48 6.5 6.52 6.54
GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND 6.45 6.42 6.71 6.6 6.51 6.54 6.68 6.74 6.66 6.71 6.57 6.61 6.68 6.6 6.75 6.66 6.67 6.57 6.44 6.61 6.69 6.81 6.72 6.67 6.76 6.71
GOBP_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT 5.36 5.37 5.55 5.36 5.01 4.87 5.42 5.37 5.46 4.97 5.09 4.95 5.16 4.9 5.16 5.24 5.38 5.37 5.23 5.22 5.53 5.32 5.13 4.92 5.29 5.78
GOBP_REGULATION_OF_MYOBLAST_FUSION 5.78 6.31 6.17 6.2 5.71 5.73 5.99 5.56 5.86 5.69 5.91 5.19 5.85 5.78 5.68 5.61 6.63 6.33 5.57 5.84 6.34 6.28 6.09 5.94 6.45 6.53
GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION 5.84 6.42 6.38 6.23 6.36 6.22 6.37 5.71 6.34 6.25 5.92 5.22 6.46 6.17 5.91 5.81 6.48 6.33 5.92 6.41 6.38 6.31 6.68 6.63 6.72 6.65
GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 6.53 6.49 6.84 6.88 6.96 6.81 6.59 6.85 6.66 6.97 6.93 6.87 6.73 6.83 6.83 6.98 6.53 6.45 6.68 6.75 6.67 6.83 6.79 7.05 6.78 6.73
GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 6.67 6.63 6.55 7.02 7.33 6.73 6.73 6.62 6.95 7.11 6.45 6.83 7.12 7.11 7.18 7.11 6.67 6.71 6.96 6.82 6.82 6.69 7.41 7.37 7.05 6.9
GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR 6.11 6.39 6.65 7.04 6.86 6.98 6.08 6.13 6.09 6.73 6.92 6.53 6.5 6.34 6.45 6.51 6.25 6.45 6.57 6.22 6.01 6.63 6.36 6.23 6.07 6.57
GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS 8.18 8.29 8.58 8.14 8.3 8.39 8.48 8.55 8.44 8.47 8.4 8.66 8.33 8.5 8.31 8.52 8.61 8.39 8.38 8.6 8.49 8.57 8.62 8.64 8.77 8.69
GOBP_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY 8.72 8.57 9.12 8.66 9.18 9.63 9.32 9.22 9.01 9.1 8.71 8.7 9.12 9.12 8.83 9.18 8.93 8.32 9.26 9.33 8.76 9.09 8.89 9.07 9.23 9.2
GOBP_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT 5.73 6.14 5.8 5.8 5.95 5.9 5.79 5.9 6.27 6.35 6.29 6.18 6.6 6.57 5.97 5.86 6.02 6.13 6.08 6.2 6.39 6.21 6.29 6.23 6.27 6.22
GOBP_REGULATION_OF_PROTEIN_DEPOLYMERIZATION 7.44 7.43 7.55 7.6 7.88 7.66 7.78 7.92 7.82 7.9 7.55 7.83 7.87 7.93 8.1 7.72 7.4 7.56 7.58 7.78 7.58 8.03 7.95 8.03 7.76 7.78
GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION 7.54 7.48 7.97 7.49 7.88 7.86 7.89 7.75 7.82 7.9 7.28 7.76 7.87 8.04 7.97 7.72 7.37 7.7 7.85 7.93 7.24 7.65 7.95 8.2 7.89 7.95
GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY 7.03 7.1 7.18 6.94 7.5 7.4 7.45 7.48 7.36 7.47 7.2 7.39 7.4 7.51 7.64 7.43 7.34 7.16 7.22 7.47 7.36 7.51 7.54 7.72 7.59 7.48
GOBP_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY 6.99 6.77 7.17 7.02 7.37 7.4 6.8 7.12 6.88 7.3 7.21 7.3 7.38 7.14 7.19 7.35 7.3 6.9 7.1 7.41 7.13 7.49 7.34 7.34 7.26 7.43
GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY 6.73 6.71 6.86 6.6 7.09 7.25 7.36 7.24 7.07 7.26 7.05 6.97 7.01 7.23 7.27 7.13 6.87 6.85 6.92 7.14 6.8 7.06 7.27 7.3 7.17 7.28
GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT 6.02 6.07 5.97 6.05 6.19 6.05 5.8 6.22 6.01 6.06 5.81 5.91 6.05 5.92 6.08 5.98 5.63 5.68 5.79 5.99 5.74 5.77 6.25 6.37 6.25 6.32
GOBP_REGULATION_OF_PROTEIN_ACETYLATION 7.18 7.01 7.61 7.4 7.68 7.53 7.65 7.71 7.59 7.64 7.52 7.81 7.64 7.59 7.78 7.86 7.52 7.18 7.23 7.63 7.3 7.62 7.9 7.84 7.9 7.57
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION 6.41 6.55 7.45 7.22 6.58 6.66 6.95 6.85 7.19 6.81 6.98 6.9 6.65 6.87 7.42 7.33 6.47 6.68 6.28 6.79 6.91 6.7 7.52 7.67 7 6.78
GOBP_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION 7.18 7.17 8.01 7.4 7.74 7.6 8.14 7.76 7.81 8 7.69 7.86 7.87 8.17 7.88 8.05 7.65 7.08 7.2 7.64 7.3 7.82 8.11 8.01 8.16 7.82
GOBP_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION 6.73 6.81 6.94 7.01 6.87 6.99 6.89 6.92 6.84 6.96 6.87 6.97 6.89 7.03 6.93 7.03 6.79 6.85 6.78 6.99 6.87 7.03 6.95 7.12 6.99 7.03
GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION 6.61 6.73 6.83 6.74 6.75 6.95 6.81 6.88 6.73 6.9 6.75 6.81 6.78 7.01 6.87 6.92 6.68 6.43 6.66 6.68 6.73 6.97 6.95 7.04 6.88 6.98
GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION 6.55 6.62 7.1 7 6.91 6.94 6.91 6.96 6.86 6.9 6.88 6.86 6.9 6.99 6.92 7.15 6.78 6.88 6.8 7 6.94 7.04 6.94 6.97 6.86 7.03
GOBP_TOXIN_TRANSPORT 6.8 6.81 6.8 6.77 7.29 7.24 7.37 7.55 7.05 7.4 6.71 7.25 7.39 7.26 7.05 7.09 7.29 6.92 7.13 7.66 7.02 7.35 7.16 7.58 7.54 7.6
GOBP_FATTY_ACID_TRANSMEMBRANE_TRANSPORT 7.27 7.19 7.43 7.51 7.3 7.45 7.53 7.51 7.54 7.4 7.28 7.61 7.76 7.8 7.9 7.34 7.21 7.28 7.16 7.39 7.21 7.5 7.66 8.12 7.56 7.27
GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_FORMATION 7.57 8.05 8.48 7.92 8.71 8.73 8.83 8.91 8.51 8.35 8.6 7.88 8.94 8.56 8.2 8.12 8.41 8.37 7.68 8.54 8.23 9.02 8.87 8.61 9.13 8.5
GOBP_REGULATION_OF_CILIUM_ASSEMBLY 6.7 6.74 7.19 6.82 6.9 7 7.01 6.91 6.7 7.01 6.97 6.86 6.63 6.67 6.99 7.21 7.03 6.76 6.8 6.86 6.81 7.11 6.95 7.12 6.86 6.97
GOBP_NEGATIVE_REGULATION_OF_CILIUM_ASSEMBLY 6.61 6.68 7.33 7.12 7.18 7.17 7.37 7.26 7.15 7.45 7.08 7.11 7.08 6.8 7.29 7.19 7.13 6.86 6.86 7.15 6.83 7.17 7.16 7.3 7.02 7.11
GOBP_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY 5.15 4.95 5.07 5.19 4.58 4.47 4.89 4.56 4.81 4.4 4.94 4.79 4.48 4.43 4.8 4.74 4.58 4.7 4.56 4.51 4.63 4.82 4.45 4.32 4.63 4.8
GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION 7.52 7.72 8.37 8.31 8.06 8.2 8.27 8.1 8.31 8.3 8.12 8.14 8.25 8.19 8.28 8.23 7.75 7.74 7.9 8.14 7.81 7.97 8.48 8.35 8.25 8.22
GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS 5.76 5.69 5.94 6.16 5.54 5.56 5.64 5.74 5.58 5.7 6.07 5.79 5.89 5.83 5.54 5.87 6.01 5.68 5.58 5.48 6.04 5.97 5.65 5.29 5.89 6.29
GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS 5.51 5.38 5.58 5.52 5.27 5.22 5.48 5.27 5.35 5.43 5.91 5.56 5.44 5.72 5.41 5.32 5.53 5.37 5.33 5.17 5.57 5.85 5.3 5.07 5.55 5.8
GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS 7.18 7.28 8.06 7.13 7.26 7.38 7.33 7.05 7.76 7.45 7.65 7.31 7.63 7.68 7.32 7.85 7.46 7.31 7.14 7.58 7.3 7.64 8.2 7.92 7.77 7.47
GOBP_RESPONSE_TO_SALT 6.18 6.08 6.07 5.85 5.58 5.56 5.7 5.79 5.67 5.53 6.37 5.65 5.54 5.76 5.66 6.08 6.26 6.34 6.08 6.03 6.19 6 5.67 5.68 5.93 6
GOBP_NEGATIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE 5.83 5.93 5.8 5.76 5.71 5.77 5.64 5.81 5.51 5.48 5.65 5.79 5.59 5.56 5.6 5.7 5.63 5.52 5.76 5.49 5.44 5.69 5.5 5.7 5.72 5.93
GOBP_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE 7.18 6.81 7.7 7.78 7.08 7.28 7.36 7.37 7.01 7.03 6.94 6.67 6.97 7.15 7.17 7.44 6.65 6.95 7.25 7.21 7.24 7.07 7.34 7.49 7.21 7.01
GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION 5.69 5.64 5.72 5.84 5.49 5.3 5.6 5.62 5.74 5.43 5.6 5.35 5.54 5.51 5.67 5.63 5.72 5.52 5.41 5.47 5.81 5.68 5.56 5.35 5.69 5.91
GOBP_REGULATION_OF_ORGANELLE_ASSEMBLY 7.38 7.5 7.74 7.71 7.56 7.72 7.49 7.39 7.53 7.59 7.52 7.59 7.67 7.61 7.59 7.58 7.47 7.25 7.57 7.7 7.57 7.69 7.77 7.9 7.49 7.48
GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY 7.2 7.37 7.63 7.55 7.15 7.42 7.4 7.31 7.39 7.44 7.33 7.29 7.41 7.29 7.48 7.27 7.28 7.23 7.39 7.4 7.47 7.6 7.41 7.67 7.33 7.44
GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY 7.38 7.42 7.56 7.58 7.74 7.72 7.4 7.31 7.65 7.62 7.64 7.51 7.46 7.49 7.77 7.48 7.56 7.24 7.53 7.5 7.64 7.63 7.78 7.98 7.56 7.54
GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR 7.16 6.7 6.63 7.7 7.08 6.79 6.95 6.76 7.41 7.24 6.49 6.92 7.24 7.13 7.66 7.44 6.88 6.96 6.91 6.93 6.91 6.7 7.44 7.45 7.16 7.03
GOBP_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES 7.15 7.47 7.54 7.53 7.9 8 7.66 7.72 7.84 8.03 7.9 8.02 8.1 7.97 8.02 7.88 7.68 7.23 7.82 7.92 7.24 7.65 8.09 8.24 7.78 7.9
GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 8.08 7.81 8.51 7.94 8.4 8.17 8.14 8.19 8.51 8.35 8.33 8.3 8.53 8.6 8.37 8.6 8.53 7.93 8.39 8.31 8.13 8.53 8.57 8.75 8.62 8.69
GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 7.89 7.59 8.42 7.91 8.26 8.1 7.95 7.9 8.09 8.17 8.19 8 8.15 7.8 8.15 8.37 7.75 7.15 8.29 8.24 7.89 8.07 7.95 8.08 8.22 8.16
GOBP_NEGATIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL 6.62 6.59 6.74 6.68 6.65 6.46 6.34 6.39 6.97 6.63 6.12 6.56 6.2 6.42 6.54 6.62 6.01 6.74 6.76 6.67 6.29 6.12 7.08 7.34 6.95 6.89
GOBP_POSITIVE_REGULATION_OF_VIRAL_RELEASE_FROM_HOST_CELL 7.36 7.36 8.65 8.72 7.45 7.51 7.91 7.87 7.84 7.9 7.87 8.14 8.05 8.05 7.78 7.79 7.45 6.84 7.76 8.2 7.48 7.84 8.14 8.31 8.24 7.96
GOBP_KETONE_BODY_METABOLIC_PROCESS 6.12 5.88 6.68 6.63 5.95 6.33 6.36 6.29 6.43 6.27 6.29 6.06 6.17 6.27 6.51 6.34 5.82 6.55 5.85 6.04 5.99 5.94 6.19 6.27 6.61 5.96
GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE 6.88 6.67 6.78 6.84 6.91 6.85 6.99 6.92 7.15 6.96 6.71 6.81 7.15 7.11 7.07 7.16 6.49 6.45 6.87 7.08 6.9 6.95 7.16 7.06 6.99 6.9
GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE 6.59 6.62 6.72 6.99 6.67 6.64 6.73 6.68 6.69 6.58 6.59 6.49 6.87 7.06 6.97 7.09 6.42 6.43 6.65 6.82 6.86 6.88 6.98 6.8 6.99 6.88
GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 7.3 7.53 8.12 8.35 7.67 8.06 8.03 7.73 8.29 8.13 8.07 7.9 8.01 8.09 8.08 7.92 7.91 8.05 7.85 8.14 7.61 7.8 8.31 8.6 8.09 7.97
GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 9.26 9.53 9.59 9.09 9.14 9.47 9.29 9.09 9.49 9.2 9.18 8.88 9.55 9.48 8.98 8.66 9.13 8.92 8.9 9.45 9.15 8.75 9.21 9.36 9.51 9.26
GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 5.97 6.32 7.06 7.59 6.82 6.81 6.42 5.81 7.51 7.09 6.83 6.95 6.62 7.03 6.53 6.72 6.57 6.78 6.71 6.79 6.75 6.55 6.61 6.82 7.09 6.58
GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR 7.16 6.7 6.63 7.7 7.57 6.79 6.95 6.76 7.41 7.24 6.49 6.92 7.24 7.13 7.66 7.44 6.88 6.96 7.01 6.93 6.91 6.7 7.44 7.45 7.16 7.03
GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR 6.67 6.63 6.55 6.86 7.33 6.73 6.73 6.62 6.95 7.11 6.45 6.83 7.12 7.11 7.18 7.23 6.67 6.71 6.96 6.82 6.82 6.69 7.41 7.37 7.05 6.9
GOBP_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY 5.35 5.14 5.5 5.7 4.56 4.82 5.26 5.18 5.31 5.1 5.18 4.81 5.08 4.98 5.17 5.04 5.25 4.95 4.72 4.87 4.8 4.97 4.95 4.41 4.78 4.77
GOBP_REGULATION_OF_CHROMATIN_ORGANIZATION 6.88 6.87 6.9 6.86 7.33 7.26 7.12 7.27 7.2 7.28 6.94 7.33 7.2 7.23 7.32 7.35 7.21 6.91 7.13 7.32 6.97 7.22 7.41 7.45 7.14 7.26
GOBP_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE 6.8 6.84 6.88 6.51 7.28 7.39 7.09 7.66 7.09 7.26 6.84 7.28 7.4 7.55 7.16 7.05 7.15 6.94 7.12 7.21 6.9 6.77 7.19 7.09 7.2 6.98
GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE 6.74 6.89 6.36 6.13 6.87 6.83 6.92 7.26 6.75 6.93 6.73 7.02 6.92 6.98 7.21 6.83 7.1 6.95 6.95 7.05 7 7.07 6.69 6.84 6.83 6.72
GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY_INVOLVED_IN_AXON_GUIDANCE 6.9 6.93 6.36 6.21 6.97 7.14 7.07 7.38 7.01 7.08 6.86 7.2 7.26 7.1 7.3 7.3 7.2 7.1 7.23 7.4 7.14 7.29 6.89 6.95 7.15 6.95
GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT 7.85 8.15 8.84 8.08 8.45 8.63 8.62 8.86 8.57 8.32 8.51 8.51 8.74 8.72 8.76 8.63 8.41 8.25 8.74 8.82 8.55 8.68 8.5 8.76 8.52 8.54
GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT 7.64 7.91 8.71 8.75 8.6 8.68 8.36 8.39 8.41 8.39 8.24 7.93 8.16 8.59 8.51 8.55 7.89 7.75 8.68 8.03 7.86 8.16 8.35 8.34 8.08 8.23
GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT 7.85 8.18 8.4 8.15 8.39 8.74 8.54 8.84 8.46 8.16 8.22 8.81 8.74 8.73 8.61 8.38 8.57 8.25 8.76 8.96 8.51 8.68 8.4 8.74 8.75 8.81
GOBP_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS 7.13 7.38 7.52 7.18 7.39 7.54 7.32 7.25 7.37 7.67 7.41 7.47 7.57 7.46 7.34 7.63 7.15 7.22 7.58 7.42 7.41 7.52 7.53 7.56 7.53 7.32
GOBP_NEGATIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS 6.94 7.11 7.01 6.76 7.16 7.46 7.19 7.24 7.32 7.41 7.01 7.37 7.29 7.2 7 7.28 6.93 7.11 7.24 7.37 7.34 7.17 7.42 7.4 7.3 7.21
GOBP_MITOTIC_CYTOKINETIC_PROCESS 6.28 6.35 7.43 6.99 6.35 6.53 6.94 6.57 6.6 6.68 6.73 6.86 6.73 6.82 7.11 6.9 6.27 6 6.14 6.54 6.48 6.83 7.25 7.33 6.91 6.7
GOBP_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION 7.79 8.17 8.25 7.94 8.29 8.39 8.37 8.28 8.32 8.22 8.05 8.24 8.17 8.51 8.41 8.28 8.13 8.07 8.2 8.23 8.08 8.34 8.46 8.4 8.51 8.24
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE 8.15 8.39 8.54 8.15 8.4 8.41 8.37 8.3 8.68 8.45 8.26 8.56 8.26 8.63 8.68 8.73 8.4 8.38 8.29 8.24 8.45 8.41 8.59 8.73 8.45 8.19
GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE 7.33 8.39 8.26 7.76 8.26 8.41 7.76 8.15 8.68 8.09 8.05 8.35 7.94 7.94 7.95 8.69 7.9 7.99 8.05 8.19 7.87 8.11 7.82 8.26 8.21 8.07
GOBP_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT 7.27 7.31 7.43 7.52 7.3 7.45 7.53 7.52 7.31 7.37 6.94 7.2 7.52 7.65 7.58 7.24 6.95 7.01 7.33 7.58 7.43 7.38 7.14 7.51 7.37 7.1
GOBP_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION 6.48 6.45 6.68 6.63 6.61 6.66 6.64 6.67 6.62 6.68 6.59 6.61 6.63 6.63 6.7 6.62 6.56 6.55 6.55 6.6 6.63 6.72 6.77 6.73 6.74 6.72
GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION 6.74 6.74 7.04 6.94 7.06 6.96 6.99 7.12 7.02 6.99 6.78 6.97 7.08 7.17 7.08 7.16 6.89 6.91 6.91 7.05 6.93 7.05 7.17 7.25 7.05 6.98
GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION 6.28 6.25 6.42 6.37 6.22 6.16 6.28 6.34 6.28 6.33 6.31 6.26 6.22 6.3 6.4 6.3 6.29 6.31 6.19 6.23 6.43 6.42 6.29 6.32 6.32 6.45
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS 6.55 6.43 6.48 5.98 6.8 6.84 6.34 6.87 6.39 6.63 6.31 6.39 6.89 7.1 6.62 7.01 6.4 6.24 7.15 6.63 6.72 6.79 6.9 6.89 6.68 6.6
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS 7.59 7.88 7.6 7.8 8.17 7.98 7.86 8.1 8.13 7.95 7.85 8.36 7.9 8.02 8.06 7.82 8.32 7.77 7.98 8.15 8.13 8.33 8.33 8.22 8.11 7.94
GOBP_REGULATION_OF_NEUTROPHIL_ACTIVATION 5.26 5.06 5.22 5.41 5.17 4.9 5 5.22 5.05 4.97 4.92 4.66 5.17 4.95 5.22 5.16 4.79 4.9 4.73 4.98 5.15 5.2 4.8 5.06 5.17 5.3
GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOLUS 6.48 6.41 6.52 6.39 6.51 6.32 6.01 6.17 6.56 6.57 6.65 6.74 6.22 6.31 6.21 6.4 6.38 6.23 6.15 6.24 5.99 6.62 6.4 6.67 6.56 6.5
GOBP_MULTI_ORGANISM_LOCALIZATION 7.32 7.19 7.87 7.8 7.65 7.59 7.5 7.3 7.53 7.55 7.58 7.74 7.35 7.62 7.41 7.59 7.4 7.2 7.26 7.37 7.08 7.58 7.52 7.76 7.61 7.5
GOBP_PROTON_TRANSMEMBRANE_TRANSPORT 6.56 6.62 7.11 6.91 6.62 7 6.73 7.04 6.85 6.71 6.73 6.69 6.84 6.86 6.86 6.65 6.64 6.78 6.67 7 6.73 7.11 6.82 7.07 7.06 7.12
GOBP_REGULATION_OF_NEUTROPHIL_MIGRATION 5.71 5.75 5.73 5.85 5.1 5.54 5.54 5.58 5.6 5.38 5.59 5.57 5.64 5.58 5.74 5.41 5.81 5.56 5.34 5.47 5.83 5.71 5.28 5.47 5.75 5.9
GOBP_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION 5.71 5.75 5.94 5.85 5.1 5.56 5.6 5.59 5.76 5.38 5.63 5.57 5.64 5.58 5.86 5.66 5.81 5.67 5.34 5.5 5.93 5.78 5.28 5.63 5.86 5.94
GOBP_TERTIARY_ALCOHOL_METABOLIC_PROCESS 5.53 5.46 5.47 5.62 5.54 5.1 5.59 5.81 5.65 5.57 5.49 5.75 5.59 5.12 5.47 5.56 5.64 5.21 5 5.08 5.12 5.51 5.51 5.27 5.6 5.75
GOBP_CALCIUM_ION_IMPORT_INTO_CYTOSOL 5.7 5.31 5.19 5.14 5.33 5.54 5.7 5.29 5.36 5.58 5.16 5.39 5.68 5.64 5.93 5.17 5.36 5.08 5.41 5.6 5.36 5.66 5.56 5.35 5.36 5.29
GOBP_REGULATION_OF_AXON_GUIDANCE 7.37 7.35 7.7 6.54 7.25 7.99 7.69 7.63 7.65 7.4 7.26 7.54 7.83 8.05 8.43 7.83 6.99 7.18 7.6 7.58 7.31 7.92 7.27 7.75 7.21 7.14
GOBP_REGULATION_OF_RECEPTOR_LOCALIZATION_TO_SYNAPSE 7.47 8.08 8.54 8.15 8.26 8.19 8.29 8.3 8.49 8.29 8.06 8.35 8.05 8.32 8.25 8.69 8.26 8.36 8.2 8.22 8.45 8.41 8.36 8.63 8.29 8.19
GOBP_REGULATION_OF_NEUROBLAST_PROLIFERATION 7.93 7.77 7.62 7.52 7.99 7.95 7.93 8.01 8.07 7.43 7.41 7.42 8.24 8.33 8.09 8.49 8.08 7.86 7.89 8.3 8.18 7.97 7.39 7.63 7.61 8.09
GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT 6.23 6.37 6.49 6.23 6.06 6.13 6.18 6.31 6.13 6.03 6.36 6.2 6.32 6.27 6.27 6.14 6.54 6.13 6.11 6.01 6.36 6.62 6.18 5.97 6.39 6.76
GOBP_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION 7.19 7.12 7.33 6.97 7.55 7.66 7.2 7.14 7.6 7.52 6.93 7.38 7.61 7.38 7.13 7.27 7.15 7.02 6.99 7.55 7.14 7.01 7.68 7.73 7.31 7.08
GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION 7.37 7.88 7.97 7.67 8.45 8.02 8.1 8.02 8.16 8.21 7.86 7.87 8.03 8.08 8.04 8.35 7.84 7.92 7.76 8.15 7.71 7.59 8.15 8.36 8.54 8.07
GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION 6.86 6.91 7.07 7.1 7.08 7.14 7.03 7.02 7.16 7.3 7.04 7.03 7.16 7.26 7.07 7.15 6.86 6.95 7.06 7.22 7.03 7.13 7.31 7.29 7.31 7.18
GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION 7.11 7.11 7.45 7.28 7.29 7.36 7.18 7.22 7.41 7.58 7.15 7.22 7.54 7.47 7.25 7.27 7.12 7.02 7.29 7.3 7 7.21 7.57 7.73 7.4 7.33
GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION 6.5 6.7 6.9 6.41 6.83 6.93 6.91 7.27 7.01 7.3 6.54 7.01 6.93 7.17 6.92 6.97 6.88 7.3 6.63 7.03 6.83 6.93 7.35 7.43 7.35 7.21
GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION 6.58 6.71 6.8 6.72 6.66 6.83 6.72 6.82 6.64 6.76 6.7 6.88 6.76 6.75 6.86 6.9 6.84 6.63 6.68 6.63 6.84 6.98 6.9 6.96 6.76 7.03
GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION 6.39 6.47 6.61 6.46 6.36 6.53 6.43 6.78 6.48 6.35 6.61 6.37 6.56 6.64 6.5 6.63 6.56 6.41 6.43 6.43 6.72 6.92 6.82 6.72 6.64 6.87
GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION 6.65 6.67 7.03 6.98 7.08 7.13 7.17 6.89 6.92 6.97 6.87 7.01 7.18 7.13 6.94 7.14 6.92 7.01 6.83 7.13 7.26 7.32 6.93 7.03 7.06 7.2
GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS 7.05 6.95 7.17 6.69 7.16 7.16 6.98 7.03 6.91 7.08 7.15 7.33 7.14 7.07 7.18 7.17 6.84 6.96 7.05 6.99 7.11 7.14 6.96 7.3 7.26 6.96
GOBP_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS 6.7 7.02 7.8 7.6 7.86 7.38 7.73 7.73 7.41 7.92 7.55 7.74 7.62 7.57 7.96 7.7 7.05 7.03 7.62 7.41 7.48 7.65 7.86 7.96 7.37 7.42
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS 8.73 8.82 8.42 8.68 9.4 9.12 8.76 9.06 9.18 8.72 8.85 8.96 9.09 8.85 8.99 8.7 8.77 8.48 8.73 9.09 8.3 8.9 9.04 9.33 8.97 8.96
GOBP_NEGATIVE_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II 6.87 6.47 6.83 6.07 6.82 6.91 6.96 6.83 6.77 6.8 6.72 7.07 7 6.98 6.86 7.07 7.16 7.28 7 6.93 6.72 7.06 6.8 7.05 7.19 7.21
GOBP_POSITIVE_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II 5.83 5.92 6.37 6.41 5.66 5.67 6.09 6.09 6.04 6.06 5.82 5.64 6.19 5.98 6.28 5.75 6.04 5.98 5.66 5.83 6.43 6.75 6.17 5.78 6.04 6.58
GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY 7.52 7.5 8.31 7.96 7.15 7.52 7.69 7.58 7.59 7.51 7.52 7.16 7.93 7.52 7.8 7.49 7.52 7.33 7.58 7.8 7.57 7.74 7.85 7.75 8.22 7.67
GOBP_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION 7.08 7.12 7.41 7.24 7.36 7.47 7.42 7.52 7.4 7.52 7.48 7.42 7.61 7.57 7.69 7.48 7.36 7.29 7.17 7.46 7.34 7.48 7.52 7.72 7.55 7.38
GOBP_NEGATIVE_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION 6.92 6.95 7.52 7.42 7.23 7.19 7.47 7.61 7.39 7.47 7.47 7.3 7.48 7.32 7.65 7.43 7.15 7.12 6.89 7.36 7.29 7.45 7.52 7.66 7.35 7.38
GOBP_REGULATION_OF_PROTEIN_POLYUBIQUITINATION 6.82 6.97 7.33 7.11 6.89 7.08 6.76 6.86 7.41 7.04 6.91 7.17 7.2 7 7.26 7 6.75 6.96 7.08 6.82 6.99 7.01 7.29 7.45 7.14 7.01
GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION 6.26 6.43 6.95 6.6 6.39 6.45 6.33 6.4 6.82 6.36 6.18 6.41 6.34 6.65 6.33 6.48 5.92 6.08 6.47 6.33 6.32 6.16 6.58 6.57 6.39 6.34
GOBP_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS 6.82 6.72 6.95 6.77 6.96 6.69 6.9 6.85 7.08 7.19 6.76 7.18 7.07 7.01 6.76 6.73 7.08 6.82 6.8 6.82 6.83 6.8 7.19 7.26 7.14 6.79
GOBP_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS 5.63 5.61 5.69 5.62 6.53 6.1 6.08 5.81 6.26 5.77 5.79 5.65 5.91 5.77 5.56 6.01 5.85 5.74 6.2 5.63 6.19 6.18 5.51 5.83 6.11 6.37
GOBP_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS 5.53 5.52 5.78 6.13 5.54 5.33 5.15 5.29 5.51 5.57 6.23 4.96 5.6 5.95 5.75 5.29 5.68 5.72 5.07 5.83 5 5.18 5.41 5.37 5.25 5.57
GOBP_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME 8.11 7.98 8 7.39 8.43 8.35 8.45 8.26 8.33 8.7 7.91 8.57 8.71 8.65 8.39 8.59 8.24 8.07 8.15 8.23 8.15 8.74 8.53 8.47 8.43 8.36
GOBP_REGULATION_OF_TAU_PROTEIN_KINASE_ACTIVITY 8.37 8.37 8.83 8.1 8.69 8.99 9.04 8.37 9.44 8.98 8.22 8.2 9.45 8.93 8.65 7.73 8.55 8.04 8.55 8.84 8.65 8.38 8.96 9.09 8.86 8.38
GOBP_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE 8.68 9.12 8.69 8.52 9.38 9.39 9.49 8.94 9.4 9.12 9.04 9.09 9.83 9.77 9.44 9.52 8.88 9.33 9.8 9.26 8.64 9.32 9.25 9.49 9.52 9.02
GOBP_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS 8.48 8.61 8.56 8.02 9.22 9.03 8.89 9.16 9.31 9.25 8.75 9.25 9.33 9.53 9.2 8.98 8.57 8.6 8.39 8.83 8.44 8.92 9.14 9.25 9.23 8.76
GOBP_MITOTIC_DNA_REPLICATION 5.55 5.5 5.42 5.98 5.02 4.83 5.26 5.63 5.37 5.15 5.54 5.33 5.11 5.11 5.3 5.42 5.23 5.43 5.29 5.37 5.5 5.38 5.22 5.21 5.44 5.74
GOBP_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS 8.23 8.53 8.81 8.17 8.98 9.03 8.99 9.25 9.25 8.78 8.7 8.71 8.95 9.12 9.04 8.81 8.56 8.52 8.62 8.81 8.6 9.04 9.14 9.25 9.23 8.76
GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS 8.71 9.16 9.06 8.51 9.1 9.35 9.42 9.52 9.52 9.64 8.88 9.49 9.33 9.48 9.46 9.5 9.25 8.94 9.21 9.66 9.52 9.59 9.4 9.66 9.41 9.25
GOBP_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS 7.73 8.06 8.53 7.9 8.54 8.72 8.72 8.64 8.44 8.32 8.18 7.87 8.81 8.41 8.14 8.13 8.25 8.15 7.79 8.47 7.94 8.83 8.41 8.41 8.63 8.42
GOBP_ORGANELLE_DISASSEMBLY 7.55 7.59 8.25 7.97 7.94 7.96 7.97 7.99 8.08 8.04 7.99 8.01 7.93 7.98 8.13 8.12 7.79 7.87 7.81 7.97 7.9 8.06 8.06 8.26 7.99 7.94
GOBP_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS 6.93 7.38 7.22 6.93 7.24 7.27 7.43 7.47 7.42 7.22 6.8 7.14 7.33 7.37 7.56 7.42 7.16 7.12 7.38 7.5 7.17 7.2 7.67 7.52 7.54 7.36
GOBP_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS 6.2 6.5 6.23 6.18 6.22 6.52 6.35 6.55 6.31 6.16 5.98 6.62 6.47 6.52 6.47 6.2 6.32 5.9 6.41 6.42 6.11 6.31 6.59 6.12 6.78 6.67
GOBP_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS 7.21 7.29 7.22 7.06 7.26 7.29 7.46 7.61 7.64 7.65 7.25 7.36 7.42 7.49 7.75 7.57 7.28 7.36 7.38 7.71 7.57 7.44 7.7 7.68 7.88 7.51
GOBP_REGULATION_OF_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING 6.19 6.65 6.88 6.68 6.44 6.82 6.46 6.49 7.21 7.14 6.73 7.07 6.76 7.17 6.45 6.59 6.76 6.97 7.07 6.78 6.61 6.98 6.59 7.47 6.83 6.54
GOBP_REGULATION_OF_RESPONSE_TO_WOUNDING 6.03 5.79 5.97 6.13 5.73 5.73 6.04 6 6 5.81 5.91 5.87 5.99 5.91 6.06 6.01 6.24 5.86 5.87 5.82 6.14 5.89 5.93 5.7 5.96 5.95
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING 5.84 5.65 5.97 6.12 5.33 5.46 5.77 5.79 5.72 5.66 5.91 5.69 5.64 5.76 5.92 5.88 5.89 5.57 5.52 5.51 5.98 5.79 5.71 5.6 5.74 5.95
GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING 5.81 5.65 5.6 5.69 5.55 5.62 5.74 5.56 5.68 5.71 5.7 5.39 5.82 5.61 5.75 5.66 5.88 5.62 5.65 5.76 5.82 5.82 5.72 5.62 5.78 5.61
GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION 5.5 5.57 5.28 5.57 5.12 5 5.26 5.34 5.33 5.22 5.47 5.21 5.22 5.21 5.24 5.32 5.41 5.3 5.08 5.26 5.57 5.39 5.09 5.16 5.34 5.51
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION 5.52 5.49 5.48 5.56 5.32 5.2 5.48 5.35 5.42 5.29 5.37 5.21 5.4 5.35 5.45 5.41 5.54 5.37 5.22 5.35 5.56 5.54 5.33 5.14 5.49 5.57
GOBP_MEIOTIC_CELL_CYCLE_PROCESS 5.21 5.13 5.09 5.4 5.11 4.81 4.87 5.03 5 4.76 5.21 4.96 4.71 4.82 4.88 4.9 5.09 5.16 5.11 4.91 5.15 4.98 4.92 4.86 4.91 5.04
GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS 8 8.09 8.42 8.08 8.14 8.26 8.32 8.37 8.29 8.38 8.16 8.25 8.15 8.21 8.14 8.1 8.47 8.27 8.04 8.42 8.19 8.27 8.32 8.38 8.31 8.15
GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_CELLULAR_PROTEIN_CATABOLIC_PROCESS 7.3 7.3 7.78 7.48 7.73 7.75 7.73 7.67 7.78 7.82 7.53 7.79 7.77 7.75 7.77 7.78 7.6 7.3 7.49 7.75 7.58 7.68 7.88 8.02 7.57 7.47
GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION 6.59 6.45 6.37 6.08 6.37 6.55 6.41 6.77 6.7 6.52 6.46 6.4 6.65 6.59 6.25 6.67 6.93 6.66 6.53 6.89 6.98 6.98 6.54 6.44 7.18 7.02
GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION 6.78 6.83 7.51 6.54 6.92 7.22 6.82 7.25 6.89 6.98 6.91 6.77 7.26 7.23 6.79 7.17 7.93 7.52 7.07 7.21 7.14 7.14 7 6.8 7.4 7.5
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE 6.99 7.05 7.52 7.31 7.45 7.29 7.18 7.27 7.2 7.29 7.4 7.42 7.12 7.23 7.36 7.4 7 7.04 7.37 7.29 7.1 7.38 7.34 7.48 7.22 7.29
GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT 6.91 6.78 6.84 6.54 6.66 6.87 6.82 6.88 7.05 6.92 6.77 6.71 6.89 7.18 6.8 6.63 6.84 6.48 6.59 6.83 6.7 6.55 7.46 7.05 6.97 7.01
GOBP_MONONUCLEAR_CELL_DIFFERENTIATION 5.71 5.66 5.68 5.84 5.42 5.4 5.59 5.57 5.69 5.37 5.61 5.38 5.59 5.5 5.58 5.51 5.66 5.5 5.41 5.42 5.71 5.6 5.48 5.35 5.62 5.59
GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION 8.2 8.31 8.36 8.03 8.36 8.53 8.27 8.91 8.21 8.49 8.32 8.35 8.44 8.55 8.47 8.43 8.21 8.17 8.37 8.32 8.06 8.61 8.54 8.76 8.41 8.49
GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT 6.86 6.95 6.84 7.04 6.73 7.02 6.94 7 7.03 6.97 7.03 6.93 7.18 7.12 7.04 7.1 6.79 6.81 7.06 6.88 6.8 6.98 7.32 7.2 7 7.02
GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT 7.01 7.1 7.47 7.48 6.54 7.02 6.58 6.98 7.31 6.82 7.14 6.81 7.24 7.15 6.75 7.39 6.67 6.79 7.21 7.05 6.64 6.9 7.58 7.32 6.9 6.94
GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH 7.23 7.38 8.06 7.6 8.01 7.78 7.83 7.9 7.91 8.03 8.01 7.9 8.1 7.78 7.99 8.1 7.05 7.15 7.91 7.47 7.7 7.99 7.89 8.08 7.7 7.74
GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH 7.25 7.07 8.21 7.8 7.99 7.44 7.89 7.77 7.69 8.1 8.02 7.97 7.7 7.67 7.93 8.17 7.71 7.09 8.09 7.55 7.8 8.01 7.84 7.78 7.96 8.02
GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH 7.81 8.33 8.6 7.97 8.59 8.57 8.39 8.33 8.51 8.46 8.25 8.26 8.93 8.57 8.72 8.73 8.4 8.18 8.34 8.52 8.63 8.86 8.52 8.58 8.72 8.88
GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_DEATH 8.61 8.45 8.61 9.05 8.59 8.69 8.63 8.93 8.12 8.98 8.25 8.63 8.8 8.53 8.72 8.74 8.66 8.45 8.76 8.88 8.63 8.86 8.51 8.58 8.72 9.13
GOBP_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_CELL_DEATH 6.29 6.23 6.36 6.27 6.83 6.57 6.4 6.31 6.49 6.53 6.26 6.48 6.76 6.5 6.27 6.37 6.45 6.31 6.44 6.27 6.63 6.63 7.04 6.67 6.69 6.53
GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION 7.68 7.65 8.28 8.02 8.19 8.1 8.09 8.19 7.95 8.04 7.88 7.89 8.11 8.04 7.94 7.97 7.7 7.82 7.61 8.33 7.69 8.12 7.85 8.04 7.96 7.85
GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING 5.28 5.33 4.94 4.99 5.29 4.88 4.92 5.07 5.02 5.04 5.16 4.72 5.07 5.14 5.29 4.81 4.65 5.04 4.7 4.75 5.41 5.18 5.19 4.89 5.25 5.31
GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY 7.46 6.99 7.77 8.11 8 8.3 7.34 7.51 7.82 7.44 6.78 7.26 7.76 7.81 7.65 7.6 6.81 7.13 7.53 8.02 7.11 7.6 7.99 8.54 7.46 7.52
GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY 6.75 7.06 7.2 6.81 7.13 7.13 7.32 7.22 7.24 7.24 7.05 7.22 7.45 7.49 7.51 7.49 7.13 7.08 7.31 7.29 7.21 7.29 7.13 7.43 7.31 7.34
GOBP_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY 6.49 6.09 6.16 5.71 5.72 5.59 5.93 5.81 5.98 6.01 5.57 6.09 5.66 6.27 5.76 5.62 6.07 6.63 6.19 5.78 6.24 5.69 5.99 5.76 6.11 6.13
GOBP_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY 6.63 6.43 6.88 6.76 6.92 6.94 6.75 7.01 7.18 7.23 6.74 7.02 6.98 6.76 7.21 7.3 7.23 6.98 6.46 6.73 7 7.26 6.91 7.06 7.34 7.45
GOBP_REGULATION_OF_MRNA_METABOLIC_PROCESS 7.76 7.95 8.18 8.02 8.19 8.26 8.25 8.24 8.22 8.29 8.03 8.14 8.3 8.21 8.3 8.33 8.03 7.86 8.02 8.25 7.91 8.24 8.39 8.46 8.38 8.22
GOBP_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS 7.33 7.61 7.7 7.58 7.87 8.15 7.91 7.81 7.89 8.06 7.59 7.94 7.84 8.09 7.97 8.17 7.7 7.4 7.86 7.91 7.82 7.88 8.02 8.29 8.08 7.82
GOBP_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS 7.74 8.09 8.04 7.83 8.14 8.29 8.26 8.29 8.2 8.36 8.11 8.25 8.37 8.28 8.33 8.33 7.92 7.82 8.06 8.25 8 8.45 8.22 8.36 8.44 8.45
GOBP_REGULATION_OF_PROTEIN_MATURATION 5.87 5.64 5.97 6.05 5.75 5.71 5.75 5.91 6.02 5.81 5.91 5.77 6.08 6.01 5.83 5.57 6.17 5.92 5.67 5.74 6.11 5.99 5.94 5.63 5.64 5.77
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION 5.66 5.47 5.69 5.99 5.15 5.24 5.52 5.33 5.84 5.37 5.38 5.34 5.85 5.66 5.38 5 5.46 5.5 5.39 5.41 5.73 5.41 5.64 5.51 5.45 5.26
GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION 5.51 5.48 5.53 6.02 5.59 5.51 5.58 5.57 5.6 5.38 5.64 5.42 5.37 5.62 5.64 5.41 5.81 5.41 5.63 5.35 5.94 5.76 5.46 5.28 5.47 5.38
GOBP_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL 7.15 7.34 7.74 7.51 7.65 7.72 7.55 7.55 7.77 7.68 7.37 7.49 7.77 7.69 7.61 7.74 7.37 7.3 7.54 7.77 7.41 7.65 7.77 7.76 7.61 7.6
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL 7.15 7.44 7.58 7.39 7.67 7.81 7.6 7.28 7.76 7.82 7.34 7.73 7.76 7.7 7.53 7.46 7.44 7.33 7.55 7.8 7.33 7.39 7.88 7.99 7.48 7.3
GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION_OR_REMOVAL 7.17 7.32 7.66 7.49 7.5 7.52 7.54 7.55 7.77 7.58 7.36 7.41 7.66 7.64 7.31 7.54 7.2 7.15 7.45 7.71 7.47 7.43 7.69 7.74 7.65 7.62
GOBP_REGULATION_OF_PROTEIN_FOLDING 7.11 7.42 7.84 7.43 7.78 7.68 7.35 7.8 7.34 7.96 7.75 7.79 7.62 7.39 8.08 7.94 7.56 7.34 7.26 7.53 7.43 7.95 7.6 7.52 8.04 8.04
GOBP_RESPONSE_TO_DOPAMINE 7.18 7.3 7.35 6.68 7.12 7.55 7.58 7.33 7.65 7.55 7.26 7.25 7.92 7.83 7.7 7.7 7.21 7.74 7.89 7.95 7.07 7.66 7.6 7.74 7.34 7.58
GOBP_REGULATION_OF_GOLGI_ORGANIZATION 7.37 7.53 8.25 8.47 8.55 8.46 7.77 7.62 7.92 8.41 8.09 8.22 8.26 8.18 7.92 8.04 7.72 7.61 7.79 7.65 7.79 7.93 8.17 8.53 7.93 7.41
GOBP_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS 7.51 7.53 7.93 7.75 7.84 7.91 7.92 7.91 7.82 7.87 7.65 7.94 7.95 7.93 7.81 7.81 7.7 7.57 7.6 7.99 7.62 7.82 7.91 8.06 7.93 7.77
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS 7.86 7.81 8.21 7.92 7.96 7.88 7.96 8.02 8.02 8.04 7.78 8.17 8.01 7.99 7.98 7.84 7.92 7.95 7.82 8.17 7.87 8 8.12 8.22 8.21 8.04
GOBP_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_CATABOLIC_PROCESS 7.41 7.44 7.81 7.73 7.86 7.96 7.91 7.82 7.86 7.87 7.58 7.94 7.93 7.93 7.82 7.81 7.66 7.38 7.6 7.85 7.6 7.79 7.96 8.1 7.83 7.72
GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_BODY 6.99 7.33 8.77 7.86 7.68 7.72 8.42 8.59 8.35 8.24 8.38 7.79 8.22 7.93 8.39 9.02 7.56 7.39 7.73 7.94 7.78 8.04 8.45 8.39 8.36 7.97
GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS 6.17 6.18 6.82 6.61 6.27 6.35 6.35 6.4 6.44 6.31 6.47 6.29 6.45 6.39 6.53 6.53 6.5 6.28 6.34 6.35 6.72 6.75 6.57 6.48 6.72 6.46
GOBP_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING 7.59 7.99 8.17 8.61 8.13 7.99 8.06 8.43 8.09 8.35 8.03 8.07 8.03 8.22 8.86 8.51 8.42 8.22 8.25 8.04 7.71 8.05 8.57 8.54 8.76 8.07
GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS 6.22 6.19 6.84 6.61 6.33 6.36 6.43 6.46 6.46 6.38 6.5 6.35 6.5 6.37 6.55 6.58 6.54 6.34 6.38 6.42 6.82 6.77 6.6 6.5 6.73 6.56
GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS 6.69 6.25 6.79 6.96 6.57 6.75 6.7 6.61 6.43 6.57 6.59 6.59 6.83 6.8 6.51 6.58 6.86 6.55 6.67 6.68 6.78 6.63 6.75 6.78 6.86 6.51
GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS 6.17 6.19 6.36 6.49 6.27 6.16 6.14 6.3 6.63 6.24 6.52 6.09 6.16 5.89 6.45 6.22 6.5 6.28 6.34 6.29 6.82 6.43 6.39 6.41 6.65 6.61
GOBP_REGULATION_OF_CELL_MATURATION 5.58 5.7 5.21 5.69 5.07 5.21 5.51 5.73 5.41 5.69 5.34 5.82 5.76 5.36 5.91 5.41 5.53 5.74 5.35 5.34 6.09 5.62 5.2 5.34 5.78 5.76
GOBP_REGULATION_OF_TORC1_SIGNALING 6.94 7.09 7.53 7.67 6.89 7.1 7.02 7.09 7.23 7.52 7.09 7.05 6.98 7.09 7.23 7.25 6.68 6.85 7.1 6.94 6.93 7.06 7 7.35 7.27 7.2
GOBP_LIPOSACCHARIDE_METABOLIC_PROCESS 7.17 7.15 7.39 7.19 7.34 7.53 7.54 7.35 7.31 7.32 6.99 7.13 7.33 7.26 7.18 7.17 7.09 6.93 7.28 7.56 6.98 7.17 7.14 7.27 7.43 7.33
GOBP_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS 6.55 6.32 6.44 6.57 6.74 6.72 6.5 6.47 6.45 6.5 6.44 6.66 6.63 6.46 6.5 6.62 6.49 6.23 6.41 6.52 6.38 6.66 6.7 6.71 6.72 6.91
GOBP_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT 8.39 8.85 8.75 8.59 8.72 8.99 8.84 8.7 8.97 8.85 8.44 8.88 8.91 8.89 8.8 8.75 8.55 8.26 8.69 8.95 8.48 8.66 8.79 9.05 9.03 9.02
GOBP_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_ENDOPLASMIC_RETICULUM 7.17 7.09 8.19 7.88 7.62 7.36 7.53 7.99 7.68 7.84 7.28 7.14 7.72 7.81 7.78 7.57 7.34 7.32 7.57 7.86 7.62 7.58 8.12 7.7 7.76 7.73
GOBP_REGULATION_OF_BLOOD_CIRCULATION 6.35 6.22 6.23 6.24 6.18 6.12 6.45 6.3 6.16 6.27 6.27 6.32 6.22 6.12 6.73 6.39 6.46 6.35 6.34 6.26 6.36 6.43 6.39 6.49 6.43 6.42
GOBP_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION 6.59 6.81 6.39 6.78 6.78 6.66 6.35 6.16 6.33 6.52 6.49 6.55 6.15 6.09 6.17 6.1 5.99 6.35 6.83 6.14 6.53 6.06 7.51 6.69 6.43 6.58
GOBP_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION 5.84 5.93 5.8 5.85 5.43 5.67 6.02 6.21 5.66 5.85 5.97 5.77 5.77 5.91 6.26 5.66 5.83 5.86 5.71 5.98 5.94 6.4 5.81 5.68 5.76 5.77
GOBP_REGULATION_OF_PROTEIN_TARGETING 7.63 7.85 8.36 8.08 8.22 8.26 8.24 8.39 8.05 8.25 7.94 8.16 8.3 8.36 8.18 8.21 7.97 7.93 7.65 8.35 7.97 8.22 8.11 8.19 8.24 8.16
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_POSTSYNAPTIC_MEMBRANE 8.17 8.49 8.41 8.27 8.37 8.64 8.77 9.23 8.36 8.9 8.51 8.63 8.9 8.97 9.09 8.81 8.68 8.85 8.74 9.03 8.79 9.24 8.65 9.17 8.94 8.89
GOBP_REGULATION_OF_EXOSOMAL_SECRETION 7.58 8.14 8.44 8.55 7.96 8.11 8.23 8.15 8.29 8.24 7.9 8.14 8.19 8.05 8.03 8 7.97 7.61 8.21 8.41 8.17 7.98 8.18 8.34 7.79 8
GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION 5.59 5.51 5.52 5.68 5.25 5.06 5.11 5.26 5.54 5.33 5.35 5.19 5.4 5.33 5.36 5.23 5.32 5.28 5.13 5.19 5.61 5.36 5.01 5.03 5.28 5.22
GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION 5.54 5.49 5.46 5.7 5.35 5 5.26 5.3 5.33 5.08 5.63 5.25 5.29 5.3 5.39 5.32 5.32 5.47 5.1 5.18 5.54 5.55 5.24 5.15 5.48 5.53
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 7.8 7.93 8.29 8.45 8.04 8.06 8.1 7.83 8.14 8.12 7.81 7.96 8.03 7.97 8.15 7.97 8 7.93 7.81 8.3 7.83 7.9 8.09 8.35 8.4 8.05
GOBP_REGULATION_OF_ATP_METABOLIC_PROCESS 7.31 7.29 7.42 7.48 7.39 7.45 7.37 7.45 7.39 7.38 7.34 7.45 7.24 7.51 7.35 7.55 7.28 7.19 7.33 7.32 7.13 7.54 7.34 7.55 7.39 7.33
GOBP_NEGATIVE_REGULATION_OF_ATP_METABOLIC_PROCESS 6.57 6.41 7.19 7.02 6.49 6.57 6.58 6.68 6.56 6.71 6.33 6.61 6.65 6.97 6.8 6.93 7.27 7.05 6.66 6.59 7.12 7.38 6.85 6.7 6.74 7.02
GOBP_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS 6.89 6.85 7.11 6.98 6.98 7.23 7.23 7.18 7.15 7.36 6.4 6.84 7.03 7.09 7.47 7.14 6.75 6.89 7.01 7.42 6.87 6.76 7.25 7.53 6.67 6.63
GOBP_REGULATION_OF_DNA_CATABOLIC_PROCESS 5.22 5.94 6.44 6.61 5.64 5.63 6.08 6.39 5.42 5.58 5.42 6.07 5.77 5.71 6.06 6.22 6.3 5.84 5.62 6.04 6.2 5.94 5.52 5.54 6.2 6.08
GOBP_REGULATION_OF_CYTOPLASMIC_TRANSPORT 8.71 8.71 9.06 8.29 8.78 8.83 8.97 8.75 9.24 8.97 8.65 8.91 9.52 9.22 9 8.92 8.88 8.23 8.88 8.75 8.41 8.57 9.31 9.04 9.09 8.71
GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSPORT 8.79 8.94 9.07 8.59 8.82 9.26 9.26 9.1 9.41 9.34 8.76 9 9.53 9.23 9.42 9.37 9.34 8.56 8.88 9.22 8.63 9.08 9.96 9.8 9.21 8.72
GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS 6.65 6.62 7.62 6.93 7.04 6.87 6.7 6.49 7.16 6.63 7.23 6.68 6.71 6.6 6.63 6.76 6.7 7.2 6.17 6.61 7.83 7.42 7.09 6.58 6.72 7.15
GOBP_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS 6.65 6.62 7.56 7.33 6.45 6.16 6.7 6.49 7.25 6.31 7.25 6.68 6.71 6.2 6.63 6.76 8.07 7.2 5.88 6.61 8.01 7.93 7.09 6.48 6.72 7.33
GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS 6.24 6.06 6.94 6.49 6.28 6.51 6.04 6.03 6.37 6.26 5.97 6.02 6.5 6.26 6.04 6.28 6.27 6.37 6.15 6.02 6.92 6.47 6.46 6.41 6.26 6.36
GOBP_REGULATION_OF_HEMOPOIESIS 5.93 5.97 6.04 6.1 5.82 5.76 5.82 5.92 6 5.88 5.92 5.66 5.97 5.85 5.92 5.86 5.98 5.84 5.86 5.84 6.1 6.05 5.83 5.77 6.02 6.21
GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS 5.61 5.55 5.48 5.67 5.36 5.24 5.49 5.51 5.68 5.37 5.53 5.28 5.51 5.34 5.59 5.71 5.56 5.47 5.4 5.44 5.62 5.57 5.45 5.34 5.54 5.64
GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS 5.69 5.66 5.72 5.85 5.53 5.37 5.64 5.84 5.76 5.45 5.67 5.51 5.61 5.53 5.67 5.61 5.79 5.66 5.48 5.49 5.85 5.83 5.63 5.35 5.71 6.02
GOBP_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS 7.29 7.48 7.4 7.26 7.59 7.69 7.35 7.71 7.64 7.61 7.28 7.06 7.92 7.58 7.78 7.81 7.4 7.72 7.77 7.4 7.46 8.12 7.58 7.69 7.74 7.71
GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS 6.84 6.96 6.89 6.66 6.73 7.06 7.31 7.5 7.15 6.52 6.74 6.68 7.26 7.22 7.94 7.03 6.21 6.94 6.73 7.06 7.16 7.01 6.93 7.13 6.88 6.61
GOBP_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION 7.56 7.64 8.02 7.82 8.31 8.38 8.58 8.5 8.31 8.36 8.04 8.4 8.16 8.19 8.52 8.32 7.79 7.89 7.99 8.39 8.25 8.37 8.62 8.5 8.56 8.34
GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION 7.56 7.63 8.17 8.01 7.92 8.04 8.09 8.11 7.98 8.05 7.86 7.97 8.1 7.91 7.95 7.96 7.58 7.82 7.57 8.26 7.64 8.05 7.92 8.06 7.98 7.71
GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION 7.28 7.37 7.98 7.96 7.62 7.9 7.86 7.95 7.96 8.01 7.8 7.98 8.02 7.76 7.93 7.92 7.39 7.67 7.55 8 7.59 7.84 7.85 8.01 7.7 7.6
GOBP_REGULATION_OF_CARDIAC_CONDUCTION 6.78 6.84 7.19 6.91 7.67 7.28 6.95 6.84 7.2 7.34 6.76 7.07 7.58 7.7 7.41 6.87 7.68 7.22 7.19 7.02 7.17 7.16 8.02 7.7 7.28 6.92
GOBP_NEGATIVE_REGULATION_OF_ANION_TRANSPORT 6.64 6.61 7.21 6.78 7.01 7 7.19 7.18 7.12 7.13 6.9 7.01 7.17 7.2 7.11 7.07 6.85 6.84 6.81 7.05 6.91 6.98 7.11 7.09 7.11 7.01
GOBP_POSITIVE_REGULATION_OF_ANION_TRANSPORT 6.68 6.78 7.14 6.88 6.86 6.92 6.91 6.98 6.89 6.86 6.92 6.93 7 6.98 6.96 7.03 6.95 6.88 6.84 7.01 6.91 7.06 6.91 7.13 7.11 7.18
GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MIRNAS_INVOLVED_IN_GENE_SILENCING_BY_MIRNA 5.54 5.28 5.64 5.51 5.04 5.1 5.43 5.55 5.71 4.98 5.03 5.09 5.33 5.34 5.28 5.33 5.18 5.62 4.96 5.34 5.54 5.05 5.22 4.8 5.31 4.95
GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MIRNAS_INVOLVED_IN_GENE_SILENCING_BY_MIRNA 5.49 5.62 6.03 5.97 5.63 5.58 5.46 5.7 5.78 5.59 5.66 5.73 5.48 5.76 5.41 5.95 5.72 5.69 4.87 5.69 6.38 6.44 5.97 5.19 5.96 6.08
GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY 5.33 5.06 5.37 5.32 4.58 4.23 4.66 4.74 4.72 4.53 5.08 4.44 4.34 4.32 4.35 4.5 4.93 4.86 4.48 4.52 4.77 4.69 4.38 4.22 4.61 4.89
GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY 6.08 6.04 7.25 6.61 5.7 5.72 5.58 6.4 6.28 6.48 5.93 5.89 5.58 5.69 7.09 5.83 5.96 5.35 5.98 5.96 5.8 5.71 5.96 5.95 5.52 5.72
GOBP_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT 6.73 6.61 6.73 6.72 6.84 6.89 6.75 7.01 6.8 6.67 6.54 6.72 6.72 6.81 6.77 6.61 6.72 6.58 6.68 6.88 6.86 6.7 6.65 6.84 6.99 6.76
GOBP_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION 7.27 7.37 7.73 7.54 7.61 7.72 7.55 7.65 7.58 7.67 7.51 7.72 7.72 7.73 7.67 7.68 7.42 7.43 7.54 7.61 7.44 7.68 7.7 7.83 7.69 7.56
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION 7.28 7.28 7.56 7.62 7.57 7.63 7.57 7.68 7.62 7.7 7.59 7.62 7.58 7.77 7.56 7.52 7.45 7.29 7.55 7.56 7.23 7.56 7.68 7.62 7.6 7.55
GOBP_POSITIVE_REGULATION_OF_CELLULAR_PROTEIN_LOCALIZATION 7.22 7.37 7.79 7.56 7.58 7.75 7.53 7.62 7.58 7.66 7.52 7.74 7.77 7.73 7.77 7.73 7.3 7.49 7.53 7.6 7.55 7.63 7.76 7.83 7.71 7.56
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS 6.59 6.74 6.64 6.61 6.85 6.79 6.82 6.86 6.88 6.7 6.61 6.77 6.96 6.99 6.82 6.92 6.95 6.72 6.73 6.93 6.91 6.93 7.24 6.76 6.97 6.93
GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS 7.02 6.91 6.93 6.68 6.93 7.26 7.1 7.15 7.09 7.15 6.59 6.95 7.04 7.02 7.13 7.04 7.1 6.58 6.98 7.42 6.97 6.97 7.26 6.77 7.14 7.2
GOBP_REGULATION_OF_DENDRITE_EXTENSION 7.71 7.6 7.71 7.58 8.3 8.15 8.08 8.31 8.02 7.91 7.87 8.08 8.08 8.22 8.39 8.42 7.75 7.75 8.05 8.17 7.58 7.68 7.77 8.07 7.79 7.51
GOBP_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE 6.61 6.74 7.37 7.27 7.31 7.39 7.31 7.27 7.47 7.35 7.18 7.29 7.47 7.37 7.46 7.27 7.14 7.2 7.13 7.44 7.05 7.24 7.35 7.74 7.43 7.15
GOBP_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE 6.48 6.91 7.48 7.48 7.36 7.53 6.95 7.23 7.67 7.22 7.41 7.37 7.47 7.37 7.35 7.22 7.14 7.09 7.23 7.47 7.52 7.46 7.47 7.74 7.48 7.49
GOBP_REGULATION_OF_VIRAL_LIFE_CYCLE 6.15 5.98 6.02 6.04 6.28 6.17 6.14 6.34 6.19 6.27 6.24 6.23 6.2 6.27 6.07 6.02 6.2 6.23 6.07 6.39 6.12 6.17 6.15 6.18 6.36 6.47
GOBP_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE 5.82 5.65 5.36 5.65 5.44 5.32 5.85 5.49 5.62 5.78 5.38 5.4 5.46 5.39 5.73 5.63 5.75 5.8 5.15 5.62 5.74 6.11 5.35 4.93 5.95 5.57
GOBP_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE 7.01 6.46 7.44 7.15 6.68 6.88 7.09 6.92 7.01 7.04 7.21 6.65 6.69 7.09 7.27 6.88 6.87 6.8 7.13 7.03 6.82 7.04 7.43 7.43 7.09 7.21
GOBP_REGULATION_OF_RECEPTOR_CLUSTERING 8.08 8.54 8.2 8.47 8.41 8.54 8.69 8.52 8.18 8.45 8.15 8.38 8.51 8.62 8.63 8.53 8.41 8.07 8.27 8.42 8.3 8.72 8.4 8.82 8.62 8.44
GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION 7.79 7.63 8.36 8.01 7.92 8.1 7.89 8.11 8.01 8.03 7.9 8 8.13 8.16 7.93 7.99 7.41 7.82 7.64 8.34 7.67 8 7.92 8.02 7.71 7.68
GOBP_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT 6.79 7.04 7.52 7.24 7.3 7.17 7.56 7.29 7.31 7.3 7.39 7.29 7.34 7.27 7.51 7.29 6.99 6.91 7.12 7.38 7.22 7.24 7.33 7.63 7.48 7.17
GOBP_NEGATIVE_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT 7.7 7.83 7.8 8.18 8.44 8.47 7.91 8.14 7.84 8.25 7.75 8.17 8.18 8.11 8.03 7.87 7.98 7.72 8.15 8.32 7.91 8.05 7.79 8.13 8.15 7.95
GOBP_POSITIVE_REGULATION_OF_ANION_TRANSMEMBRANE_TRANSPORT 6.62 6.89 7.13 6.88 7.22 7.1 7.32 7.33 7.2 7.2 6.88 7.04 7 6.99 7.47 7.34 6.96 6.81 6.79 7.13 6.93 6.67 7.21 7.46 7.19 6.88
GOBP_REGULATION_OF_GLIAL_CELL_MIGRATION 7.72 7.83 8.31 8.1 8.32 8.26 8.47 8.45 8.73 8.22 7.94 7.5 8.37 8.46 8.62 8.71 7.96 7.82 7.66 8.29 7.98 8.73 8.57 8.78 7.98 8.19
GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_MIGRATION 7.72 7.83 8.31 8.1 8.32 8.26 8.47 8.45 8.73 8.22 7.94 7.5 8.37 8.46 8.62 8.71 7.96 7.82 7.66 8.29 7.98 8.73 8.57 8.78 7.98 8.19
GOBP_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION 6.24 6.17 6.83 7.1 6.42 6.37 5.99 5.95 6.22 5.94 5.59 5.66 6.09 5.98 5.69 5.79 5.62 5.71 5.49 5.73 6.11 6.59 6.18 5.88 5.98 6.48
GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT 6 5.93 6.06 5.8 5.93 5.95 6.03 5.92 5.9 5.71 5.94 5.71 6.04 5.92 5.78 5.85 6.09 5.86 5.87 5.89 6.14 6.06 6.04 6.04 6.17 6.16
GOBP_EPITHELIAL_CELL_APOPTOTIC_PROCESS 6.33 6.08 6.65 6.46 6.3 6.32 6.35 6.51 6.5 6.21 6.34 6.42 6.36 6.35 6.28 6.42 6.38 6.13 5.91 6.24 6.82 6.79 6.16 6.2 6.55 6.84
GOBP_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY 6.5 6.42 6.69 6.44 6.54 6.6 6.71 6.89 6.6 6.62 6.61 7.06 6.69 6.64 6.72 6.92 6.52 6.53 6.46 6.61 6.87 6.95 6.79 6.71 6.66 6.86
GOBP_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY 6.18 6.28 6.6 6.45 5.8 5.99 6.43 6.86 6.29 5.93 6.34 6.08 6.05 6.28 6.29 6.37 6.26 6.09 6.1 6.21 6.82 6.52 6.54 6.23 6.47 6.54
GOBP_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY 6.98 7.16 7.59 7.36 7.91 7.35 7.31 7.34 7.58 7.51 7.29 7.57 7.65 7.69 6.96 7.49 7.51 7.49 6.87 7.41 7.77 7.75 7.47 7.59 7.64 7.4
GOBP_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS 5.9 5.73 6.1 6.11 5.93 5.69 5.86 6.23 5.83 5.53 5.92 5.57 5.86 5.79 5.66 5.76 6.14 5.82 5.51 5.94 6.47 6.51 5.92 5.74 6.14 6.5
GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS 5.86 5.7 5.95 5.89 5.73 5.65 6 5.84 5.81 5.53 5.92 5.52 5.75 5.7 5.66 5.46 5.96 5.82 5.51 5.94 6.14 6.04 5.68 5.65 6.18 6.34
GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS 6.24 5.74 6.55 6.66 6.44 5.98 5.76 6.23 5.87 5.81 6.03 6.41 6.07 6.22 6.04 6.33 6.37 5.7 5.86 5.97 6.43 6.88 6.26 6.09 5.99 6.46
GOBP_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT 7.19 7.21 7.6 7.16 7.41 7.43 7.57 7.69 7.61 7.54 7.36 7.65 7.44 7.66 7.74 7.61 7.31 7.44 7.53 7.61 7.39 7.41 7.58 7.75 7.54 7.47
GOBP_NEGATIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT 7.25 7.1 7.5 7.41 7.02 7.06 6.93 6.98 7.31 7.2 7.15 6.92 7.01 7.15 6.75 7.12 7.11 7.03 7.21 7.08 6.99 7.06 7.31 7.32 7.11 7.11
GOBP_POSITIVE_REGULATION_OF_CATION_TRANSMEMBRANE_TRANSPORT 6.64 6.58 7.16 6.76 6.85 6.96 6.96 6.98 6.81 7.17 7.02 6.81 7.01 6.86 7.08 6.68 6.79 6.79 6.92 6.66 6.61 6.72 6.84 7.11 6.82 7.04
GOBP_REGULATION_OF_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL 6.88 6.93 8.28 8.37 7.32 7.29 7.28 8.23 7.94 7.79 7.92 7.71 7.4 7.73 8.23 8.05 7.43 7.29 7.29 7.44 7.38 8.15 8.13 7.93 8.08 7.92
GOBP_POSITIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION 5.95 6.18 8.22 6.68 6.01 5.89 6.28 5.96 6.18 6.5 6.22 5.6 6.01 6.14 6.89 6.31 6.36 5.91 6.14 6.13 6.15 6.28 6.34 6.19 6.18 6.27
GOBP_REGULATION_OF_BILE_ACID_METABOLIC_PROCESS 5.71 5.48 5.37 5.68 5.64 5.56 5.53 5.55 6.01 5.99 5.73 6 5.6 5.5 5.42 5.38 5.73 5.34 5.48 5.75 4.87 5.22 5.81 6.04 5.63 5.64
GOBP_NEGATIVE_REGULATION_OF_TORC1_SIGNALING 6.77 6.8 6.53 7.08 6.59 6.65 6.79 6.85 6.45 6.52 6.52 6.49 6.52 6.52 6.76 6.47 6.49 6.43 6.39 6.55 6.68 6.76 6.67 6.62 6.72 6.77
GOBP_POSITIVE_REGULATION_OF_TORC1_SIGNALING 7.63 7.81 8.24 7.87 7.82 7.73 8.05 8.06 7.85 7.68 7.44 7.77 7.69 7.85 8.26 8.04 7.73 7.52 7.84 7.7 7.69 8 8 7.99 7.93 7.84
GOBP_REGULATION_OF_ERAD_PATHWAY 7.77 8.04 8.06 7.74 8.27 8.06 8.43 8.14 7.97 8.39 8.53 8.21 8.11 7.88 8.15 8.06 8.52 8.14 7.97 8.74 8.29 8.56 8.81 8.66 8.51 8.6
GOBP_POSITIVE_REGULATION_OF_ERAD_PATHWAY 7.77 8.04 8.06 7.74 8.27 8.06 8.43 8.14 7.97 8.39 8.53 8.21 8.11 7.88 8.15 8.06 8.52 8.14 7.97 8.74 8.29 8.56 8.81 8.66 8.51 8.6
GOBP_RESPONSE_TO_FORSKOLIN 7.81 7.54 8 7.38 8.79 8.19 8.77 8.2 8.93 8.53 8.55 8.42 8.95 8.89 8.54 8.3 7.67 7.27 8.41 8.47 7.44 7.65 8.76 8.87 8.5 8.17
GOBP_REGULATION_OF_DOPAMINERGIC_NEURON_DIFFERENTIATION 6.05 6.22 6.16 6.55 6.37 6.34 6.45 6.57 6.33 6.67 6.28 6.44 6.64 6.35 6.39 6.2 6.13 5.94 5.96 6.07 6.18 6.61 6.43 6.55 5.82 6.26
GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE 8.57 8.26 8.61 8.18 8.4 8.49 8.54 8.54 8.05 8.35 8.07 8.31 8.31 8.37 8.46 8.47 7.88 8 8.56 8.52 8.23 8.33 7.94 8.38 8.69 8.55
GOBP_REGULATION_OF_TELOMERE_CAPPING 7.59 7.78 8 7.9 8.08 8.17 7.18 7.61 7.7 7.98 7.29 7.9 7.99 7.85 7.92 7.65 7.65 7.5 7.77 7.62 7.62 8.11 8.02 7.82 7.66 7.79
GOBP_POSITIVE_REGULATION_OF_TELOMERE_CAPPING 6.77 7.08 7.58 7.13 7.03 7.27 7.09 6.96 6.88 7.39 6.94 7.29 6.78 6.84 7.1 6.98 6.78 6.86 6.95 7.1 6.87 6.63 7.32 7.35 6.9 7.12
GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING 7.43 7.52 7.68 7.29 7.6 7.67 7.44 7.49 7.45 7.74 7.52 7.49 7.42 7.3 7.4 7.35 7.34 7.22 7.58 7.4 7.22 7.38 7.58 7.74 7.82 7.76
GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING 7.01 6.89 6.92 7.33 7.37 7.31 7.07 6.84 7.05 7.19 7.25 6.78 6.91 7 6.73 6.85 6.8 6.52 7.01 7.13 7 7.1 7.15 7.28 7.29 7.16
GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING 7.45 7.58 7.95 7.62 7.72 8.12 8.05 7.74 7.98 8.07 7.97 7.64 8.04 7.93 7.98 7.91 7.63 7.41 7.73 7.9 7.48 7.84 8.32 8.09 8.21 7.89
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY 7.28 7.22 7.78 7.54 7.61 7.75 7.37 7.62 7.43 7.63 7.53 7.65 7.66 7.8 7.5 7.63 7.07 7.26 7.56 7.51 7.37 7.56 7.71 7.8 7.5 7.39
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY 7.32 7.22 7.78 7.51 8.39 8.24 7.59 7.35 7.57 7.94 7.75 7.89 7.74 8.11 7.89 8.09 7.27 7.27 7.68 7.63 7.06 7.24 7.71 7.8 7.5 7.38
GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY 7.18 7.13 7.58 7.54 7.72 7.8 7.39 7.72 7.49 7.58 7.47 7.54 7.73 7.72 7.57 7.66 7.08 7.28 7.74 7.55 7.44 7.58 7.61 7.82 7.56 7.34
GOBP_ENDOPLASMIC_RETICULUM_MANNOSE_TRIMMING 7.32 7.18 7.64 7.76 7.51 7.47 7.28 7.8 7.56 7.46 7.55 7.7 7.63 7.68 7.72 7.91 7.48 7.04 7.32 7.13 7.43 7.68 7.93 7.7 7.88 7.81
GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS 6.83 6.5 7.4 7.01 6.6 6.81 7.22 7.04 6.88 6.47 6.79 6.97 6.83 6.64 6.39 6.67 7.16 6.37 6.74 7.37 6.83 7.07 7.23 7.03 7.32 6.64
GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS 6.12 6.17 6.28 6.55 6.26 6.11 5.98 6.26 6.36 6.18 6.44 6.02 6.08 5.83 6.51 6.21 6.32 6.25 6.31 6.32 6.52 6.32 6.19 6.3 6.53 6.56
GOBP_REGULATION_OF_GTP_BINDING 7.51 6.98 7.97 7.69 7.74 7.85 7.29 7.27 7.42 7.35 7.62 7.23 7.72 7.68 6.77 6.95 7.44 6.88 7.36 7.67 6.97 7.29 7.77 7.83 7.69 7.56
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT 6.77 6.54 6.92 6.89 7.08 7.07 6.93 6.97 6.58 6.76 7.07 6.67 6.99 6.64 6.67 6.75 6.79 6.72 6.85 6.73 6.71 6.85 6.74 7.16 6.97 7.1
GOBP_REGULATION_OF_INTESTINAL_ABSORPTION 5.42 4.97 5 5.7 4.98 4.61 4.99 4.73 5.44 5.05 5.02 4.71 4.93 5 4.91 4.69 5.06 5.5 5.14 4.9 4.84 4.73 5.21 4.65 4.78 4.63
GOBP_REGULATION_OF_MICROTUBULE_BINDING 8.15 8.37 8.62 8.31 8.92 8.99 8.24 8.67 9.02 8.5 8.13 8.84 8.65 8.69 8.89 8.62 8.63 8.66 8.51 8.62 8.52 8.56 9.02 9.06 8.7 8.85
GOBP_REGULATION_OF_PROTEIN_IMPORT 6.99 7.06 7.35 7.2 7.03 7.18 7.27 7.04 7.03 7.14 7.47 7.18 7.29 7.17 6.93 7.19 7.14 7.09 6.94 7.23 7.3 7.56 7.08 7.38 7.56 7.47
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT 6.47 6.31 6.42 6.19 6.1 6.64 6.73 6.48 6.33 6.69 6.39 6.57 7.03 6.79 6.39 6.76 6.45 6.06 6.44 6.73 6.66 6.51 6.42 6.54 6.56 6.6
GOBP_POSITIVE_REGULATION_OF_PROTEIN_IMPORT 7.34 7.35 7.72 7.24 7.55 7.57 7.37 7.49 7.5 7.21 7.62 7.66 7.66 7.23 7.31 7.32 7.69 7.73 7.28 7.6 7.66 8.05 7.35 7.57 7.9 7.6
GOBP_RESPONSE_TO_AMYLOID_BETA 6.05 6.39 6.92 6.42 6.35 6.36 6.29 6.15 6.21 6.1 5.9 5.81 5.95 5.83 6.3 6.08 6.16 6.38 6.17 6.5 6.12 5.82 5.99 5.95 6.45 6.41
GOBP_CELLULAR_RESPONSE_TO_AMYLOID_BETA 7.81 7.7 8.36 7.71 8.65 8.57 8.76 8.01 8.61 8.61 8 8.51 8.93 8.57 8.22 8.41 8.01 7.41 7.91 8.59 7.9 8.36 8.79 8.85 8.73 8.01
GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY 5.73 5.93 5.97 5.76 5.54 5.67 5.57 5.63 5.28 5.52 5.81 6.12 5.3 5.51 6.07 5.9 5.5 5.39 5.7 5.49 5.51 5.69 6.01 5.75 5.72 6.08
GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY 6.05 6.31 6.76 6.32 6.67 6.79 7.1 6.92 6.82 7.03 6.61 6.85 7.34 6.94 7.14 7.05 6.89 6.59 6.53 6.8 6.61 6.9 6.74 6.84 7.09 6.89
GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION 6.28 6.36 6.83 6.63 6.86 6.59 6.15 6.4 6.88 7.06 6.48 6.84 6.92 6.85 6.77 6.65 6.75 6.53 6.5 6.26 6.85 6.74 7.34 7.15 6.56 6.52
GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION 5.89 6.23 6.99 6.57 5.85 6.35 6.01 6.21 5.83 5.91 5.89 5.41 6.27 5.91 5.92 5.55 5.98 6.25 5.51 5.54 7.01 6.52 7.52 5.7 6.51 6.96
GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION 6.69 6.81 6.78 6.65 6.86 7.09 6.35 6.85 6.89 7.14 6.48 6.84 7.03 6.9 6.81 6.67 6.75 6.53 6.83 6.82 6.82 6.74 6.97 7.26 6.56 6.51
GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION 5.86 6.24 5.88 5.89 5.85 6.35 5.78 6.04 6.64 5.89 6 5.85 6.5 6.9 6.81 6.65 6.28 6.25 6.25 5.94 6.85 6.74 6.9 7 6.62 6.51
GOBP_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT 6.04 6.3 6.54 6.03 6.06 5.93 6.13 6.31 6.1 5.87 6.25 6.08 6.11 5.91 6.1 6.02 6.25 5.85 5.87 6.01 6.34 6.22 6.08 5.82 6.39 6.6
GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION 6.65 6.71 6.79 6.36 6.74 6.92 6.69 6.62 7 6.62 6.8 6.69 7.3 7.54 7.11 7.36 7 6.81 7.03 6.67 7.3 7.37 7.42 7.31 7.16 6.86
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION 7.46 7.52 8.24 7.84 7.57 7.64 8.12 8.55 8.24 8.03 8.17 7.58 8.08 7.8 8.36 8.92 7.94 7.22 7.74 7.82 7.21 7.61 8.31 8.1 8.19 7.96
GOBP_BETA_CATENIN_TCF_COMPLEX_ASSEMBLY 6.83 7.08 6.67 6.6 7.07 7.2 7.31 7.51 7.2 7.13 6.93 7.2 7.21 7.21 7.26 7.28 7.39 7.05 7.07 7.44 7.48 7.52 7.02 7.28 7.41 7.41
GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE 7.64 7.86 9.49 9.27 8.07 8.22 8.77 8.76 8.53 8.52 8.72 8.34 8.54 8.47 8.54 9.12 8.28 8.15 8.07 8.39 8.28 8.48 8.75 8.79 8.61 8.1
GOBP_EXCITATORY_SYNAPSE_ASSEMBLY 7.66 7.56 7.78 8.15 8.05 8.18 8.43 8.25 7.87 8.4 7.61 8.14 8.37 8.66 8.54 8.14 8.06 8.35 8.15 8.14 7.74 7.87 8.21 8.24 7.75 8.06
GOBP_INHIBITORY_SYNAPSE_ASSEMBLY 8.13 8.29 8.11 7.79 8.68 8.59 8.44 9.01 8.25 8.64 7.83 8.42 8.57 8.56 8.5 8.51 8.44 8.62 8.25 8.69 8.36 8.35 8.49 8.55 8.41 8.57
GOBP_POSITIVE_REGULATION_OF_TELOMERASE_RNA_LOCALIZATION_TO_CAJAL_BODY 7.31 7.33 8.42 8.16 7.61 7.74 8.07 8.09 7.98 7.97 8.08 7.44 8.14 7.93 8.06 8.63 7.52 7.5 7.68 7.9 7.99 8.11 8.16 8.09 8.3 7.89
GOBP_BETA_CATENIN_DESTRUCTION_COMPLEX_DISASSEMBLY 5.98 6.26 6.13 6.21 5.98 6.51 6.29 6.19 6.11 6.11 6.24 6.29 6.39 6.06 6.13 6.06 6.77 6.45 6.38 6.28 6.41 6.38 6.12 6.21 6.15 6.35
GOBP_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT 6.05 6.17 6.36 6.43 6.04 6.03 6.08 6.2 6.21 6.24 6.3 6.01 6.32 6.06 6.28 6.2 6.2 6.25 6 6.03 6.36 6.48 6.51 6.19 6.35 6.26
GOBP_REGULATION_OF_EXCITATORY_SYNAPSE_ASSEMBLY 7.96 7.95 7.93 8.41 7.92 8.46 8.51 8.22 7.96 8.06 7.79 8 8.77 9.04 8.02 8.16 8.01 8.39 8.53 8.26 8.27 8.38 7.74 8.01 7.97 8.07
GOBP_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT 5.56 5.82 5.39 5.68 5.28 5.2 5.5 5.48 5.45 5.38 5.37 5.49 5.2 5.34 5.25 5.3 5.5 5.59 5.43 5.34 5.54 5.49 5.22 5.31 5.53 5.65
GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT 6.7 6.74 6.9 7.09 7.18 7.24 7.48 7.22 7.28 7.34 6.92 7.37 7.09 7.23 7.41 7.43 7.54 7.01 7.17 7.45 7.16 7.64 7.33 7.31 7.64 7.28
GOBP_POSITIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT 5.43 5.53 5.35 5.5 5.05 5.03 5.5 5.25 5.24 5.18 5.28 5.04 5.16 5.35 5.19 5.24 5.33 5.57 5.36 5.25 5.52 5.17 5.19 5.07 5.4 5.19
GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION 8.19 8.07 8.43 7.71 8.18 8.35 7.97 8.08 8.18 8.31 7.99 8.21 8.32 8.12 8.27 8.13 8 7.63 8.34 8.23 8.21 8.26 7.97 8.49 7.97 7.94
GOBP_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION 5.72 5.46 5.96 6.09 5.17 5.61 5.61 5.89 5.69 5.83 5.52 5.59 6.22 5.86 6.38 6.08 5.65 5.25 5.55 5.37 5.5 5.94 6.2 5.55 5.23 5.83
GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION 6.66 6.5 7.05 6.77 6.97 6.95 7.18 7.14 7.14 7.11 7 6.97 7.15 7.1 7.04 7.07 6.93 6.79 6.82 6.95 6.91 7.12 7.08 7.04 7.12 6.79
GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION 7.09 7.12 7.47 7.24 7.33 7.25 7.36 7.37 7.36 7.23 7.31 7.29 7.4 7.28 7.28 7.4 7.2 7.23 7.45 7.48 7.37 7.5 7.36 7.49 7.6 7.43
GOBP_WNT_SIGNALING_PATHWAY_INVOLVED_IN_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION 5.72 5.46 5.96 6.09 5.49 5.7 5.82 5.89 5.76 5.97 5.68 5.79 6.22 5.67 6.39 6.08 5.35 5.4 6.08 5.78 5.79 5.94 6.21 6.17 5.82 6.21
GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL 5.61 5.78 5.63 5.93 5.36 5.47 5.71 5.43 5.63 5.35 5.88 5.46 5.56 5.64 5.64 5.41 5.52 5.27 5.29 5.62 5.79 5.86 5.48 5.28 5.87 5.98
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL 5.74 5.82 5.78 5.99 5.44 5.56 5.99 5.84 5.89 5.55 5.91 5.64 5.63 5.69 5.76 5.58 5.74 5.35 5.44 5.88 6.05 6.04 5.6 5.45 6.24 6.24
GOBP_AUTOPHAGOSOME_ORGANIZATION 7.69 7.8 8.32 8.13 8.03 8.06 8 8.05 7.87 8.08 7.83 7.88 8.06 8.02 8.03 8.09 7.77 7.75 7.84 8.04 7.98 8.02 8.07 8.12 8.02 7.95
GOBP_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY 8.71 9.16 9.04 8.66 9.15 8.99 9.49 9.24 9.46 9.37 8.58 9.34 9.3 9.48 8.87 9.2 9.7 9.33 8.88 9.34 9.25 9.29 9.39 9.4 9.64 9.46
GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION 6.58 6.71 6.83 6.62 7.2 6.92 7.5 7.38 7.49 7.29 6.9 7.39 7.19 7.52 7.1 7.26 7.41 6.73 7.09 7.09 7.1 7.18 7.62 7.49 7.57 7.6
GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_CELL_CELL_SIGNALING 6.82 6.78 6.88 6.77 6.93 7.04 7.06 7.05 6.93 7.01 6.83 7 7.02 7.02 7 6.94 6.92 6.83 6.92 7.08 6.97 6.99 6.94 7.14 6.96 6.99
GOBP_RESPONSE_TO_ACETYLCHOLINE 6.91 7.06 7.92 7.46 7.8 7.63 8.1 8.41 7.71 7.97 8.05 8.17 8.03 8.14 8.35 8.27 8.02 8.09 8.02 8.26 8.29 8.64 7.8 7.83 8.32 8.53
GOBP_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS 8.55 8.11 8.08 8.81 8.47 8.27 8.45 7.96 8.43 8.14 8.29 8.35 7.93 8.07 8.26 7.92 7.97 7.8 8.51 7.79 7.82 8.54 8.01 8.34 8.14 8.01
GOBP_REGULATION_OF_MEMBRANE_INVAGINATION 5.47 5.78 5.85 5.62 5.57 5.42 5.44 5.35 5.66 5.38 5.49 4.96 5.65 5.56 5.55 5.59 5.5 5.49 5.31 5.47 5.79 5.49 5.54 5.47 5.62 6.14
GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION 5.99 6.23 6.94 7.01 6.6 6.46 6.49 6.5 7.12 6.99 6.93 6.93 6.84 6.48 6.46 6.35 6.36 6.46 6.53 6.49 6.22 6.4 7.35 7.11 6.68 6.31
GOBP_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION 6.22 6.35 6.01 6.32 6.68 6.55 6.08 6.37 6.49 6.64 6.27 6.51 6.78 6.81 6.19 6.29 5.96 5.72 6.4 6.41 6.56 6.83 6.72 6.5 6.39 6.64
GOBP_NEGATIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION 6.56 6.86 6.87 6.47 7.04 6.87 6.31 6.81 7.4 6.77 6.6 6.6 6.97 7.01 6.82 6.72 7.03 7.49 6.82 6.62 6.85 6.84 7.15 6.77 7.1 6.99
GOBP_POSITIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION 5.89 5.62 5.84 6.28 5.4 5.23 5.86 5.84 5.87 5.26 5.95 5.34 5.49 5.34 5.51 5.63 5.34 5.65 5.56 5.46 6.2 6.83 6.04 4.97 5.71 5.77
GOBP_REGULATION_OF_RNA_BINDING 8.09 8.32 8.79 8.22 8.53 8.6 8.71 8.57 8.65 8.53 8.42 8.58 8.78 8.75 8.92 8.95 8.26 8.12 8.19 8.61 8.64 8.81 9.1 9.16 8.92 8.82
GOBP_REGULATION_OF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY 8.41 8.38 8.56 8.01 8.74 8.68 8.89 9.16 9.18 8.73 8.39 8.98 9.18 9.21 8.8 8.77 8.53 8.46 7.97 8.83 8.44 8.92 8.56 8.85 9.23 8.76
GOBP_NEGATIVE_REGULATION_OF_CHROMATIN_ORGANIZATION 6.68 6.53 6.27 6.5 6.81 6.86 6.7 6.85 6.96 6.87 6.48 6.87 6.92 6.85 6.82 6.73 6.42 6.47 6.64 6.71 6.59 6.7 7.06 7.16 6.85 6.77
GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ORGANIZATION 6.93 7.06 7.06 7 7.39 7.3 7.27 7.3 7.33 7.38 6.94 7.34 7.31 7.45 7.42 7.45 7.3 7.04 7.18 7.33 7.06 7.3 7.53 7.54 7.18 7.35
GOBP_SEMI_LUNAR_VALVE_DEVELOPMENT 6.13 6.01 5.91 6.08 5.98 5.71 6.01 5.85 6.02 5.74 6.03 5.99 5.93 6.11 5.54 5.94 6.08 5.91 5.75 5.97 6.28 6.11 5.7 5.82 6.31 6.1
GOBP_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM 5.56 5.44 5.5 5.55 5.1 5.1 5.54 5.37 5.31 5.48 5.56 5.23 5.18 4.99 5.35 5.39 5.44 5.48 5.34 5.17 5.5 5.56 5.18 5.07 5.3 5.42
GOBP_POSITIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM 5.56 5.45 5.78 5.8 5.36 5.12 5.61 5.38 5.42 5.48 5.63 5.24 5.18 5.18 5.38 5.46 5.4 5.41 5.34 5.24 5.5 5.56 5.32 5.11 5.36 5.44
GOBP_PROTEIN_LOCALIZATION_TO_PRESYNAPSE 10.63 10.74 10.39 9.77 10.86 11.04 10.97 10.72 10.9 10.71 10.51 10.69 11.11 11.09 11.13 10.98 10.65 10.71 10.48 10.65 10.58 10.46 11.08 11.24 10.62 10.66
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE 7.35 7.35 7.97 7.69 7.78 7.8 7.77 7.91 7.69 7.82 7.75 7.86 7.84 8.07 8.03 7.91 7.42 7.63 7.68 7.83 7.61 7.73 7.91 8.09 7.72 7.55
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE 7.22 7.19 7.66 7.56 8.01 7.89 7.5 7.56 7.61 7.8 7.75 7.77 7.64 7.96 7.7 7.79 7.32 7.27 7.6 7.51 7.25 7.46 7.71 7.71 7.59 7.42
GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE 7.33 7.44 7.97 7.74 7.79 7.8 7.93 7.98 7.82 7.82 7.75 7.87 8.09 8.11 8.08 7.91 7.42 7.78 7.74 7.99 7.79 7.78 7.94 8.2 7.84 7.56
GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE_ORGANIZING_CENTER 7.34 7.04 7.42 7.55 7.52 7.46 6.81 7 7.15 7.34 7.21 7.5 7.48 7.39 7.41 7.45 7.12 7.25 7.59 7.22 6.94 7.27 7.41 7.38 7.19 6.97
GOBP_NON_MOTILE_CILIUM_ASSEMBLY 6.61 6.7 7.26 6.97 6.97 7.01 6.64 6.78 6.7 7.02 6.93 7 6.64 6.78 7.06 7.23 6.63 6.75 6.8 7 6.77 6.85 7.06 7.12 6.98 6.97
GOBP_MACROPHAGE_MIGRATION 6.08 6.04 6.26 6.54 5.68 5.73 5.72 5.56 5.77 5.27 5.49 5.55 5.69 5.58 5.58 5.56 5.85 5.56 5.31 5.26 5.93 5.87 5.71 5.36 5.75 6.14
GOBP_REGULATION_OF_MACROPHAGE_MIGRATION 6.25 6.49 6.84 6.8 6.82 6.66 5.84 6.3 6.28 5.66 6 5.79 6 5.7 5.93 6.69 6.1 5.62 5.89 6.16 6.7 6.51 6.2 6.09 6.52 6.56
GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_MIGRATION 6.25 6.49 6.84 6.8 6.82 6.66 5.84 6.3 6.28 5.66 6 5.57 6 5.7 5.93 6.69 6.1 5.56 5.89 6.16 6.7 6.51 6.2 6.09 6.52 6.56
GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION 6.36 6.51 6.64 6.53 6.78 6.85 6.6 6.75 6.66 6.66 6.46 6.69 6.72 6.55 6.4 6.48 6.74 6.58 6.37 6.42 6.87 6.73 7.04 6.77 6.75 6.94
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_ENDOSOME 8.7 8.58 8.53 8.02 8.8 8.96 8.81 8.55 8.86 9.05 8.44 8.87 9.16 8.78 8.57 8.61 8.48 8.42 8.87 8.81 8.32 8.88 8.98 8.89 9.02 8.71
GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PERMEABILITY 7.12 7.09 7.85 7.67 7.29 7.45 7.18 7.27 7.49 7.52 7.34 7.33 7.75 7.73 7.31 7.07 7.31 7.25 7.22 7.75 7.51 7.59 7.25 7.69 7.49 7.56
GOBP_REGULATION_OF_CHROMOSOME_SEPARATION 6.07 5.93 6.1 6.05 5.71 5.81 5.67 5.91 5.8 6 5.81 5.79 5.72 5.7 5.93 6.13 6.04 6.04 5.94 5.6 6.06 6.09 5.9 6.04 6.12 6.19
GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEPARATION 7.18 6.81 7.7 7.78 7.08 7.28 7.36 7.37 7.01 7.03 7.28 6.68 6.97 7.27 7.17 7.44 6.81 6.95 7.25 7.21 7.24 7.07 7.34 7.49 7.33 7.17
GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ORGANIZATION 8.61 8.68 8.87 8.61 8.97 9.25 8.79 8.54 9.08 8.83 8.45 8.5 9.38 9.37 8.47 8.86 8.72 8.13 8.89 9.07 8.59 8.8 8.87 8.59 8.99 8.44
GOBP_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 7.08 7.26 7.85 7.91 7.51 7.55 7.71 7.73 7.67 7.58 7.44 7.45 7.71 7.82 7.75 7.55 7.57 7.3 7.43 7.64 7.56 7.63 7.7 8.13 7.66 7.58
GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 6.98 7.06 7.37 7.48 7.31 7.35 6.95 7.09 7.6 7.3 7.29 7.33 7.24 7.37 7.35 6.81 7.09 7.09 7.09 7.26 7.2 7.44 7.47 8 7.43 7.42
GOBP_REGULATION_OF_AMYLOID_FIBRIL_FORMATION 7.39 6.97 9.43 8.96 7.61 7.48 8.29 8.43 7.87 8.25 8.78 7.72 8.2 7.94 8.35 8.77 7.7 7.64 7.52 8.23 8.31 8.42 8.22 8.29 7.98 8.17
GOBP_NEGATIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION 7.31 6.52 9.38 8.89 7.34 7.22 8.21 8.16 7.8 8.02 8.43 7.66 8.18 7.72 8.18 8.72 7.58 7.5 7.03 7.66 7.76 7.57 8.15 8.24 7.8 7.92
GOBP_REGULATION_OF_GONAD_DEVELOPMENT 5.76 5.94 5.78 6.1 5.54 5.41 5.76 5.77 5.85 5.57 6.16 5.48 5.64 5.53 6.08 5.96 5.98 5.92 5.76 5.7 6.05 6.02 6.01 5.32 5.78 5.66
GOBP_POSITIVE_REGULATION_OF_GONAD_DEVELOPMENT 6.15 6.23 5.7 5.88 5.56 5.56 5.91 5.89 5.92 5.73 6.05 5.82 5.89 5.73 6.12 6.01 6.12 5.94 5.97 5.86 6.08 6.1 6.03 5.65 5.96 5.81
GOBP_REGULATION_OF_LIPID_LOCALIZATION 6.01 6.12 6.17 6.21 5.96 6 5.98 6.1 6.08 6.12 6.16 6 6.04 6.1 6.08 6.15 6.13 5.95 5.92 5.95 6.15 6.24 6.08 6.09 5.97 6.31
GOBP_NEGATIVE_REGULATION_OF_LIPID_LOCALIZATION 5.92 6.59 6.1 6.59 6.08 6.27 5.98 6.28 6.37 6.33 6.24 6.24 6.41 6.43 6.31 6.31 6.25 6.13 5.91 6.14 6.16 6.36 6.48 6.41 6.14 6.45
GOBP_POSITIVE_REGULATION_OF_LIPID_LOCALIZATION 6.06 6.12 6.1 6.11 5.8 5.81 5.88 5.95 5.89 5.94 6.15 5.97 5.73 5.87 6.02 6.01 5.87 5.95 5.76 5.82 6.09 6.22 5.85 5.9 5.84 6.27
GOBP_AMYLOID_FIBRIL_FORMATION 7.48 7.41 8.74 8.52 7.89 7.74 8.37 8.16 7.95 8.48 8.68 7.78 8.21 8.17 8.33 8.72 7.82 7.78 8.01 8.54 8.16 8.1 8.3 8.33 8.16 8.21
GOBP_RESPONSE_TO_NERVE_GROWTH_FACTOR 8.26 8.55 8.66 8.5 8.95 8.95 8.73 8.67 9.02 8.84 8.5 8.74 8.83 8.72 8.82 8.68 8.64 8.33 8.74 8.88 8.43 8.55 8.97 8.98 8.68 8.37
GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_PLASMA_MEMBRANE 7.56 7.76 8.25 8 7.85 7.96 7.78 7.8 7.78 7.98 8.27 8.02 7.98 8.23 8.38 8.2 7.88 7.76 8.07 7.73 8.05 7.97 8.1 8.47 8.01 7.88
GOBP_NEURON_PROJECTION_EXTENSION 7.49 7.6 7.6 7.32 8 8.03 8.02 7.97 7.89 8 7.62 8.03 8.03 8.1 8.03 7.94 7.68 7.73 7.81 8.03 7.69 7.85 7.87 8.15 7.85 7.84
GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOPLASM 7.46 7.52 8.87 8.67 7.79 8.07 8.71 8.63 8.46 8.45 8.59 8.33 8.37 8.07 8.42 9.11 7.94 7.79 7.74 8.06 8.26 8.48 8.59 8.68 8.53 8.05
GOBP_NEUTROPHIL_MIGRATION 5.6 5.47 5.55 5.66 5.01 4.94 5.18 5.15 5.14 5.09 5.34 4.96 5.19 5.07 5.3 5.2 5.52 5.52 5.08 5.14 5.58 5.5 5.05 5.02 5.52 5.51
GOBP_EMBRYONIC_BRAIN_DEVELOPMENT 6.21 5.74 5.78 6.62 5.92 6.01 6.09 6.14 5.67 6.13 6.21 6.17 6.07 5.99 6.36 6.36 6.16 6.13 6.16 5.89 6.09 6.35 5.98 6.28 5.99 6.24
GOBP_CELLULAR_RESPONSE_TO_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_STIMULUS 8.94 9.27 9.55 9.44 9.17 9.49 9.58 9.31 9.51 9.56 9.53 9.59 9.32 9.34 9.6 9.4 9.15 9.19 9.43 9.41 9.44 9.34 9.72 9.67 9.64 9.2
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS 6.67 7.08 7.67 7.83 6.73 6.82 6.96 6.74 7.34 7.26 7.27 7.22 6.66 7.06 6.91 7.01 6.87 7.15 6.76 7.16 7.03 7.69 6.81 7.77 7.58 7.31
GOBP_NEURON_PROJECTION_MAINTENANCE 8.47 8.42 8.5 8.82 8.59 8.62 8.62 8.81 9.41 8.71 8.92 8.85 9 9.21 8.58 8.75 8.58 8.27 8.56 8.66 8.56 8.26 8.89 9.15 8.76 8.29
GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT 6.82 7 7.48 7.45 7.26 7.19 7.1 7.29 7.13 7.13 7.24 7.2 7.19 7.49 7.22 7.36 7.14 6.97 7.24 7.06 7.09 7.27 7.16 7.37 7.26 7.17
GOBP_POTASSIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE 5.89 5.77 5.71 5.84 5.85 5.66 6.22 5.8 6.09 6.12 5.88 5.85 6.08 6.05 5.97 6.24 5.96 6.01 6.01 5.76 6.12 5.73 5.98 5.82 5.96 5.6
GOBP_RESPONSE_TO_ANGIOTENSIN 7.08 6.68 7.72 7.6 8.13 7.7 7.76 6.89 7.89 7.41 7.58 7.88 7.2 7.63 7.15 7.45 7.67 6.94 7.22 7.87 7.74 7.34 7.91 7.71 7.74 7.38
GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY 7.48 7.59 7.82 7.68 7.97 8.05 7.88 7.91 7.72 7.77 7.75 7.88 7.83 8.03 7.9 7.82 7.65 7.61 7.77 7.89 7.62 7.74 7.82 8.07 7.77 7.58
GOBP_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORT 5.97 6.27 5.81 6.59 5.45 5.91 6.12 5.87 5.83 5.94 5.8 5.78 5.96 6.16 5.66 5.85 6.07 6.4 6.35 6.12 5.91 5.57 5.95 5.7 6.65 6.47
GOBP_RESPONSE_TO_LEUKEMIA_INHIBITORY_FACTOR 6.36 6.34 6.93 7.04 6.57 6.47 6.7 6.81 6.75 6.73 6.63 6.43 6.6 6.58 6.75 6.59 6.41 6.48 6.31 6.75 6.83 6.68 6.53 6.5 6.75 6.71
GOBP_ADAPTIVE_THERMOGENESIS 6.33 6.24 6.54 6.48 6.5 6.72 6.68 6.64 6.65 6.54 6.42 6.56 6.85 6.62 6.68 6.76 6.61 6.69 6.58 6.66 6.69 6.94 6.69 6.75 6.65 6.66
GOBP_RESPONSE_TO_CHEMOKINE 5.49 5.17 5.2 5.18 4.91 4.72 5.06 4.91 4.81 4.74 4.8 4.74 4.71 4.76 4.73 4.73 5.18 5.34 4.87 4.88 5.34 5.01 4.73 4.61 4.82 4.75
GOBP_RESPONSE_TO_AMINO_ACID_STARVATION 7.2 7.25 7.59 7.33 7.37 7.51 7.37 7.79 7.31 7.47 7.42 7.47 7.57 7.59 7.9 7.58 7.36 7.18 7.43 7.61 7.49 7.88 7.74 7.62 7.69 7.62
GOBP_REGULATION_OF_DNA_DAMAGE_CHECKPOINT 6 5.97 5.8 6.05 6.11 6.02 5.97 6.26 6.1 5.96 5.87 5.84 6.03 5.88 6.11 6.03 5.61 5.54 5.69 5.93 5.85 5.84 6.25 6.36 6.28 6.16
GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE 7.28 7.59 7.67 7.65 7.96 7.82 7.46 7.72 8.01 7.88 7.53 7.73 7.74 7.79 7.84 8.09 7.25 7.69 7.52 7.53 7.48 7.5 7.71 7.96 7.5 7.64
GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE 7.45 7.6 8.86 7.8 8.43 8.44 8.6 8.32 9.06 8.86 8.4 8.58 8.64 8.67 8.27 8.64 8.13 8.05 7.9 8.61 7.68 8.22 8.92 8.86 8.5 7.81
GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE 6.91 7.23 7.07 7.21 7.24 7.17 6.53 7.12 6.91 7.29 7.05 6.97 7.06 6.99 7.04 7.38 7.12 7.07 6.62 6.97 7.26 7.34 7.12 6.95 6.99 7.4
GOBP_REGULATION_OF_MALE_GONAD_DEVELOPMENT 5.65 5.64 5.82 6.1 5.57 5.32 5.8 5.53 5.68 5.75 6.09 5.56 5.65 5.53 5.99 5.48 5.83 5.74 5.38 5.6 5.65 5.72 5.59 5.45 5.66 5.68
GOBP_REGULATION_OF_MULTICELLULAR_ORGANISMAL_DEVELOPMENT 6.3 6.23 6.38 6.32 6.27 6.34 6.32 6.4 6.4 6.3 6.27 6.28 6.35 6.32 6.35 6.42 6.37 6.27 6.18 6.24 6.45 6.43 6.41 6.37 6.45 6.48
GOBP_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS 6.15 6.32 6.57 6.47 6.26 6.44 6.47 6.61 6.32 6.44 6.51 6.42 6.45 6.53 6.55 6.47 6.59 6.41 6.38 6.52 6.4 6.46 6.49 6.65 6.48 6.52
GOBP_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE 6.07 6.32 6.25 5.99 6.53 6.6 6.24 6.7 6.52 6.91 6.54 6.42 6.6 6.55 6.55 6.67 6.21 6.21 6.65 6.76 6.21 6.34 7.01 6.84 6.38 6.6
GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN 5.85 6.07 6.11 6.06 5.71 5.98 5.99 6.17 6 5.8 6.1 5.89 5.86 6.01 6.05 5.83 5.81 6.07 5.92 5.9 6.29 5.89 6.02 5.54 6.07 6.24
GOBP_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY 5.99 6.16 5.86 6.36 5.99 6.15 6.01 6.15 5.82 6.22 6.04 6.11 5.76 5.84 6.03 6.18 6.15 6.13 5.96 5.83 6.07 6.03 6.09 6.03 5.79 6.31
GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY 5.83 5.77 5.67 5.9 5.75 5.82 5.95 5.47 5.66 6.19 5.83 5.69 5.58 5.72 6.09 5.85 5.8 5.63 5.54 5.79 5.46 5.6 5.55 5.44 5.66 6.12
GOBP_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS 7.58 7.6 7.89 7.95 8.11 8.06 8 7.95 7.91 7.97 7.77 8.08 8.08 8.01 7.87 7.87 7.82 7.7 7.86 8.05 7.62 7.85 8 8.21 7.92 7.95
GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS 7.95 7.9 8.24 8.07 8.18 8.06 8 8.15 8.07 8.15 7.79 8.19 8.11 8.01 8.05 7.88 8 8.14 7.99 8.3 7.97 7.97 8.17 8.23 8.23 7.97
GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS 7.51 7.38 7.8 7.74 7.86 8.03 7.93 7.9 7.91 7.95 7.59 7.96 7.94 7.95 7.87 7.84 7.72 7.56 7.66 7.87 7.6 7.87 8 8.27 7.83 7.74
GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY 5.83 6.02 5.86 6.36 5.62 5.72 5.93 5.95 5.78 6.07 5.86 5.89 5.59 5.73 5.93 6 5.9 6.01 5.71 5.77 5.75 5.74 5.87 5.68 5.68 5.91
GOBP_NEGATIVE_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION 5.48 5.82 5.95 5.87 5.4 5.42 5.28 5.73 5.42 5.48 6 5.7 5.3 5.3 5.59 6.05 5.54 5.29 5.76 5.23 5.68 5.85 5.15 5.7 5.94 6.58
GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS 5.57 5.52 5.63 5.99 5.31 5.09 5.62 5.61 5.52 5.25 5.39 5.17 5.52 5.35 5.61 5.34 5.43 5.3 5.14 5.3 5.56 5.5 5.42 5.29 5.61 5.56
GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS 5.52 5.42 5.75 6.02 5.43 5.17 5.77 5.77 5.67 5.72 5.54 5.63 5.55 5.36 5.75 5.51 5.43 5.23 5.21 5.32 5.76 5.58 5.6 5.57 5.75 5.74
GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS 5.44 5.32 5.57 5.91 5.17 5.08 5.2 5.25 5.41 5.09 5.35 4.98 5.39 5.29 5.22 5.28 5.42 5.32 5.13 5.35 5.33 5.34 5.22 5.13 5.32 5.4
GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY 6.04 6.1 6.52 6.38 6.01 6.02 6.25 6.26 6.17 6.21 6.15 6.17 6.28 6.1 6.24 6.24 6.16 5.99 6.12 6.14 6.32 6.27 6.08 6.07 6.25 6.4
GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY 6.25 6.49 6.68 6.57 6.2 6.06 6.59 6.6 6.35 6.47 6.34 6.41 6.39 6.43 6.32 6.24 6.42 6.24 6.29 6.39 6.73 6.36 6.32 6.15 6.36 6.45
GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION 7.65 7.78 7.75 7.5 8.01 8.02 8.16 7.87 7.96 8.1 7.52 7.94 8.1 8.1 7.79 7.74 7.57 7.66 7.93 8.06 7.53 7.84 8.06 8.1 7.88 7.77
GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION 7.25 7.3 7.43 7.45 7.44 7.87 8.09 7.8 7.8 7.72 7.4 7.81 8.06 7.94 7.79 7.52 7.34 7.53 7.53 7.96 7.37 7.53 7.65 7.99 7.76 7.54
GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION 6.6 6.54 6.52 6.52 6.61 6.64 6.87 6.79 6.77 6.45 6.48 6.55 6.78 6.88 6.47 6.57 6.65 6.72 6.14 6.58 6.7 6.84 6.64 6.59 6.57 6.84
GOBP_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION 7.28 7.13 7.81 6.84 7.33 6.94 7.45 7.75 7.36 7.6 7.52 7.13 7.38 7.65 7.86 7.87 7.54 7.09 6.94 7.45 7.73 7.77 6.96 7.72 7.72 7.59
GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION 6.4 6.32 6.05 6.43 6.38 6.24 6.17 6.36 6.24 6.1 6.17 6.16 6.26 6.42 6 6.34 6.39 6.07 6.02 6.22 6.39 6.36 6.2 5.99 6.31 6.59
GOBP_REGULATION_OF_FATTY_ACID_TRANSPORT 5.96 5.87 5.84 5.88 5.69 5.67 5.77 6.13 5.94 5.98 5.97 5.9 5.66 6.08 5.97 5.91 6.03 6.11 5.91 5.84 5.84 6.13 5.88 5.8 5.96 6.33
GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT 6.95 7.18 7.58 7.57 7.25 7.58 7.48 7.44 7.37 7.57 7.34 7.41 7.71 7.66 7.6 7.54 6.89 7.39 7.66 7.46 7.46 7.28 7.54 7.68 7.38 7.66
GOBP_REGULATION_OF_ANOIKIS 6.63 6.58 6.55 6.46 6.34 6.59 6.69 6.69 6.85 6.77 6.53 6.59 7.01 7.04 6.55 6.61 6.88 6.78 6.43 6.8 7.17 6.95 7.06 7.34 7.19 6.85
GOBP_REGULATION_OF_RRNA_PROCESSING 6.46 6.7 6.69 6.72 6.89 6.91 6.92 7 7.11 7.14 7.02 6.98 7.18 7.3 6.62 6.77 6.58 6.67 6.93 6.58 6.92 6.65 7.03 6.9 7.12 7.2
GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS 5.5 5.37 5.81 5.67 5.1 5.12 5.3 5.32 5.45 5.05 5.51 5.23 5.16 5.22 5.53 5.29 5.27 5.45 5.2 5.18 5.41 5.27 5.47 5.11 5.25 5.39
GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS 5.26 5.15 5.45 5.8 5.01 4.84 5.19 5.25 5.21 4.98 5.41 5.15 4.92 4.9 5.53 5.03 5.17 5.27 4.95 4.97 5.24 5.04 4.97 4.92 5.16 5.3
GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS 5.53 5.34 5.78 5.51 5.22 5.19 5.46 5.32 5.53 5.07 5.64 5.23 5.31 5.53 5.37 5.42 5.24 5.46 5.2 5.44 5.41 5.24 5.47 5.18 5.25 5.25
GOBP_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION 6.38 6.5 6.74 6.59 6.63 6.5 6.74 6.98 6.56 6.54 6.38 6.78 6.64 6.51 6.76 6.66 6.46 6.33 6.43 6.93 6.81 6.91 6.45 6.62 7.02 7.09
GOBP_POSITIVE_REGULATION_OF_ACTIN_CYTOSKELETON_REORGANIZATION 5.5 5.73 6.16 5.88 6.26 5.8 6.05 5.94 6.25 5.97 5.87 5.45 6.36 6.05 6.73 6.51 5.75 5.82 5.81 5.93 6.19 6.77 6.44 6.05 6.11 6.21
GOBP_NEGATIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY 5.63 5.61 5.96 6.07 5.67 5.58 5.8 5.57 5.69 5.45 5.87 5.37 5.68 5.41 5.63 5.55 5.62 5.73 5.53 5.49 5.7 5.72 5.51 5.46 5.68 5.66
GOBP_POSITIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY 6.53 6.58 6.3 6.46 7 7.06 6.54 6.81 6.83 6.94 6.33 6.81 7.01 6.97 6.64 6.51 6.66 6.48 6.83 6.66 6.39 6.6 6.78 6.72 6.58 6.74
GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS 6.85 6.85 7.12 7.04 7.07 7.22 7.05 7.14 6.68 7.26 7.06 7.1 6.96 7.14 6.98 7.08 6.8 6.62 7.04 7.13 7.01 7.11 7.2 7.29 7.16 7.04
GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS 6.65 6.66 6.61 6.96 6.62 6.87 6.44 6.46 6.46 6.61 6.46 6.46 6.62 6.59 6.33 6.46 6.45 6.39 6.78 6.67 6.7 6.59 6.59 6.9 6.68 6.71
GOBP_REGULATION_OF_MYOBLAST_PROLIFERATION 6.74 6.83 6.75 6.45 6.83 6.75 6.7 6.57 6.61 6.72 6.81 6.74 7.09 6.88 6.85 6.66 6.75 7.41 7.15 7.07 6.25 6.92 6.73 7.06 6.89 6.89
GOBP_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS 8.01 8.07 8.26 8.02 8.54 8.87 8.84 8.77 8.45 8.58 8.39 8.59 8.8 8.76 8.95 8.85 8 8.26 8.68 8.59 8.14 8.61 8.52 8.98 8.82 8.44
GOBP_REGULATION_OF_NMDA_RECEPTOR_ACTIVITY 8.45 8.4 8.55 7.78 8.82 8.89 9.13 8.48 8.86 8.77 8.35 8.92 8.83 9.23 8.86 8.88 8.38 8.34 8.76 9.06 8.13 8.32 8.84 9.07 8.79 8.7
GOBP_REGULATION_OF_AMPA_RECEPTOR_ACTIVITY 8.04 8.01 7.93 7.73 8.23 8.36 8.78 8.08 8.39 8.15 7.59 8 8.48 8.63 8.27 8.31 7.59 8.18 8.23 8.37 7.5 7.57 8.1 8.47 8.02 7.8
GOBP_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE 5.53 5.16 5.06 5.43 4.89 4.93 5.11 5.1 5.08 5.01 5.27 4.75 5.02 5.18 5.18 4.91 5 5.2 5.07 4.85 5.03 5.07 4.98 4.93 5.02 5.07
GOBP_NEGATIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE 5.43 5.05 4.99 5.42 4.89 4.81 5.11 5.05 5.16 4.98 4.75 4.75 5.02 5.18 5.19 4.91 5 4.86 5.07 4.91 4.97 5.04 4.98 4.93 4.81 5.07
GOBP_REGULATION_OF_HEPATOCYTE_PROLIFERATION 6.71 6.99 6.84 6.78 7 6.45 6.82 7.01 7.06 6.99 7.13 6.77 6.73 6.87 6.35 6.78 6.93 7.21 6.78 7 6.95 7.02 6.62 6.52 6.84 7.01
GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS 5.64 5.47 5.44 5.56 5.55 5.39 5.6 5.36 5.64 5.23 5.79 5.22 5.57 5.44 5.41 5.37 5.64 5.57 5.26 5.43 5.91 5.83 5.24 5.09 5.87 5.83
GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS 5.28 5.34 5.16 4.79 4.77 4.74 5.35 4.89 5 4.8 5.14 4.88 4.94 5.28 4.77 4.69 5.32 5.18 4.69 4.88 5.6 5.2 5.06 4.59 5.26 5.54
GOBP_REGULATION_OF_CLATHRIN_DEPENDENT_ENDOCYTOSIS 8.17 8.03 8.63 8.47 8.69 8.78 8.56 7.87 8.59 8.9 8.32 8.34 8.2 8.44 8.73 8.37 8.41 8.27 8.29 8.44 7.96 8.18 8.82 8.62 8.23 8.09
GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS 6.23 6.31 6.82 6.41 6.42 6.4 6.36 6.46 6.46 6.46 6.48 6.54 6.61 6.44 6.51 6.64 6.55 6.43 6.38 6.32 6.78 6.76 6.66 6.65 6.65 6.51
GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS 6.61 6.4 6.84 6.64 6.69 6.66 6.62 6.85 6.48 6.58 6.59 6.71 6.76 6.73 6.56 6.58 6.88 6.64 6.44 6.7 6.84 6.66 6.75 6.83 6.7 6.64
GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS 6.08 6.09 6.42 6.31 6.2 6.18 5.94 6.21 6.15 6.22 6.25 6.08 6.2 5.97 6.34 6.24 6.32 6.2 6.25 6.22 6.57 6.63 6.46 6.18 6.46 6.51
GOBP_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS 6.6 6.38 6.48 6.47 6.34 6.23 6.71 6.59 6.62 6.26 6.16 6.48 6.32 6.43 6.31 6.45 6.85 6.37 6.39 6.81 6.74 6.76 6.54 6.47 6.41 6.3
GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION 5.87 5.53 5.77 6.24 5.75 5.52 5.68 5.37 5.77 5.67 5.73 5.48 5.66 5.53 5.48 5.44 6.06 5.76 5.37 5.39 5.87 5.73 5.6 5.21 5.74 5.5
GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION 7.85 7.43 7.95 7.65 8.1 8.05 7.83 7.6 7.63 7.26 7.39 7.49 7.71 8.36 7.55 7.63 7.75 7.51 7.48 7.41 8.02 8.35 7.55 7.49 7.83 8.56
GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION 5.46 5.48 5.68 6.05 5.33 5.47 5.61 5.16 5.55 5.71 5.63 5.58 5.29 5.35 5.44 5.46 5.81 5.29 5.26 5.42 5.57 5.8 5.38 5.23 5.48 5.38
GOBP_REGULATION_OF_T_CELL_MIGRATION 5.48 5.48 5.46 6.05 5.27 5.13 5.61 5.18 5.55 5.28 5.63 5.17 5.42 5.12 5.44 5.35 5.81 5.44 5.26 5.27 5.6 5.43 5.28 5.16 5.5 5.37
GOBP_POSITIVE_REGULATION_OF_T_CELL_MIGRATION 5.32 5.28 5.68 6.05 5.27 5.2 5.61 5.01 5.55 5.71 5.63 4.95 5.29 5.1 5.44 5.31 5.81 5.29 5.14 5.35 5.57 5.8 5.28 5.18 5.48 5.38
GOBP_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL 8.46 8.93 8.56 8.61 8.73 9.2 8.69 8.31 8.97 9.3 8.26 9.14 8.97 9.07 8.69 8.89 8.03 8.71 9.11 9.14 8.23 8.49 8.68 9.18 8.86 8.55
GOBP_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY 6.74 7.19 7.69 7.33 7.36 6.91 7.32 6.98 7.41 7.74 7.86 7.54 7.27 7.19 7.66 7.44 7.33 6.89 7.14 7.49 7.04 7.56 7.52 7.45 7.46 7.2
GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION 5.53 5.4 5.28 5.44 5.31 5.21 5.49 5.44 5.26 5.2 5.36 5.21 5.37 5.24 5.27 5.26 5.22 5.38 5.27 5.26 5.55 5.3 5.15 4.97 5.27 5.51
GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION 5.73 5.67 5.48 5.61 5.49 5.36 5.6 5.44 5.7 5.51 5.75 5.32 5.5 5.37 5.38 5.45 5.97 5.88 5.38 5.48 5.82 5.76 5.52 5.32 5.73 5.65
GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION 5.58 5.45 5.34 5.59 5.31 5.21 5.52 5.48 5.26 5.3 5.36 5.21 5.37 5.27 5.34 5.34 5.28 5.38 5.34 5.26 5.64 5.44 5.18 4.99 5.32 5.54
GOBP_REGULATION_OF_T_HELPER_2_CELL_CYTOKINE_PRODUCTION 5.36 5.19 5.03 5.39 4.72 4.81 4.92 4.71 5.21 4.61 4.88 4.83 4.69 4.86 5.04 4.67 5 5.37 4.7 4.85 5.13 4.88 4.81 4.54 4.8 5.03
GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS 6.62 6.75 7.18 7.16 6.86 7.17 7 7 6.67 7.16 7.07 7.07 6.85 6.95 6.83 6.99 6.6 6.37 7.02 6.98 6.62 6.84 7.24 7.15 6.9 6.78
GOBP_REGULATION_OF_HISTONE_H3_K9_ACETYLATION 5.59 5.81 5.64 5.88 5.18 5.32 6.11 5.92 5.6 5.7 5.31 5.51 5.55 5.51 5.74 5.53 5.7 5.61 5.26 5.75 5.75 5.63 5.58 5.98 5.56 5.59
GOBP_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT 8.89 8.57 9.07 8.35 8.8 8.88 9.01 8.84 9.32 8.74 8.69 8.92 9.52 9.23 9.14 9.14 8.92 8.2 8.95 8.91 8.44 8.64 9.6 9.27 9.04 8.85
GOBP_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS 7.03 6.91 6.82 6.37 7.51 7.53 7.06 7.4 7.37 7.18 7.13 7.33 7.47 7.37 7.31 7.49 6.96 7.21 7.13 7.47 7.25 7.4 7.63 7.74 7.66 7.65
GOBP_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION 6.09 6.37 6.34 6.32 6.26 6.06 6.51 6.14 6.4 6.22 7.24 6.16 6.34 6.54 6.59 6.81 5.98 5.97 6.2 5.95 6.1 6.38 6.34 6.62 6.29 6.31
GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.81 7.92 8.39 7.99 8.42 8.52 8.52 8.82 8.39 8.15 8.46 8.41 8.52 8.38 8.73 8.37 8.03 8.22 8.26 8.62 8.28 8.42 8.45 8.57 8.33 8.36
GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.32 7.09 7.42 7.27 7.71 7.19 7.57 7.77 7.89 7.55 7.46 7.74 7.97 8.08 7.93 7.79 7.49 7.39 7.66 8.26 7.56 8.08 7.32 7.48 8.02 8.09
GOBP_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING 6.03 6.17 6.51 6.61 6.44 6.55 6.33 6.49 6.76 6.73 6.43 6.75 6.67 6.58 6.45 6.6 6.64 6.76 6.82 6.49 6.52 6.65 6.32 6.86 6.36 6.49
GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING 6.27 6.29 6.88 6.5 6.44 6.55 6.46 6.49 7.07 6.97 6.47 6.82 6.76 6.94 6.45 6.6 6.69 6.71 7.01 6.78 6.56 6.75 6.39 7.31 6.54 6.52
GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING 5.54 5.73 5.99 7.24 5.35 5.62 5.62 6.16 5.79 5.74 6.22 6.31 6.02 5.62 5.91 5.93 6.06 5.65 5.64 5.73 5.85 6.19 5.99 5.68 5.85 6.23
GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT 5.87 5.51 5.35 5.33 5.01 5.09 5.38 5.17 5.38 5.15 5.56 4.97 5.17 5.02 5.3 5.46 5.5 5.59 5.39 5.23 5.38 5.21 4.99 4.83 5.16 5.02
GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION 6.22 6.35 6.01 6.41 6.68 6.55 6.02 6.37 6.49 6.64 6.18 6.51 6.78 6.81 6.19 6.29 5.79 5.56 6.4 6.41 6.56 6.83 6.72 6.5 6.39 6.64
GOBP_REGULATION_OF_STEM_CELL_DIFFERENTIATION 7.38 7.51 7.77 7.36 7.53 7.73 7.79 7.61 7.83 8 7.54 7.74 7.69 7.69 7.88 7.86 7.63 7.47 7.46 7.75 7.6 7.88 8.05 8.09 7.9 7.87
GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION 8.26 7.69 7.29 7.15 7.55 8.17 7.79 8.14 7.81 8.25 7.4 7.96 8.12 8.32 8.15 8.45 7.87 8.24 8.2 8.25 8.29 8.05 8.13 8.21 8.24 8.16
GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION 5.98 5.89 6.46 6.15 6.33 6.33 6.27 6.42 6.38 6.05 6.46 6.38 6.52 6.86 6.5 6.59 6.6 6.65 6.59 6.59 6.5 6.53 6.63 6.73 6.49 6.21
GOBP_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION 7.04 6.96 7.4 7.26 7.48 7.26 7.4 7.47 7.53 7.59 7.45 7.71 7.24 7.42 7.58 7.75 7.42 7.09 7.16 7.52 7.21 7.52 7.71 7.75 7.66 7.34
GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION 6.19 6.32 6.63 6.75 5.67 6.41 6.68 6.76 6.96 6.5 6.4 6.64 6.64 5.9 7.15 7 6.26 6.47 6.1 6.71 6.52 6.5 6.85 7.45 6.64 6.77
GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION 7.16 6.95 7.33 7.3 7.36 7.3 8.02 7.7 7.6 7.96 7.68 7.82 7.66 7.44 7.83 7.92 7.7 6.96 7.05 7.63 7.27 7.51 7.98 7.89 8.16 7.43
GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION 7.45 7.88 8.19 8.04 8.15 8.32 8.25 8.26 8.37 8.28 8.08 8.12 8.51 8.16 8.38 8.27 8.01 7.82 7.95 8.36 8.03 8.13 8.07 8.73 8.41 8.39
GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION 7.88 8.13 8.36 8.2 8.28 8.4 8.26 8.08 8.46 8.45 8.35 8.22 8.39 8.13 8.43 8.36 7.98 7.95 8.5 8.41 7.9 8.04 8.24 8.8 8.41 8.42
GOBP_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE 6.33 6.42 5.83 6.01 6.93 6.68 6.65 6.39 6.35 6.58 6.13 6.56 6.79 6.58 6.67 6.18 6.67 6.37 6.51 6.54 6.53 6.33 6.59 6.82 6.71 6.65
GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR 6.08 6.12 6.7 6.42 6.2 6.35 6.49 6.55 6.54 6.36 6.59 6.47 6.59 6.34 6.35 6.49 6.25 6.3 5.96 6.34 6.34 6.34 6.58 6.68 6.65 6.66
GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR 6.22 6.61 6.53 6.56 6.56 6.61 6.63 6.51 6.71 6.88 6.61 6.76 6.65 6.4 6.4 6.52 6.48 6.56 6.19 6.44 6.41 6.34 7.08 6.81 6.66 6.73
GOBP_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY 7.72 7.85 8.4 8.25 8.06 8.09 8.13 8.05 7.74 8.15 7.77 7.75 8.11 8.02 8.05 8.03 7.76 7.54 8.14 8.18 7.72 8.1 8.19 8.3 8.14 7.93
GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY 6.15 6.2 5.97 5.98 5.85 5.83 6.15 6.07 6.2 6.19 6.28 6.11 6.19 6.24 5.84 6.12 6.42 6.35 6.03 5.98 6.12 6.23 5.77 5.7 6.33 6.12
GOBP_NEGATIVE_REGULATION_OF_ANOIKIS 6.69 6.58 7.14 7.12 7.42 7.26 7.2 6.88 7.3 7.43 7.32 7.42 7.27 7.23 7.18 7.08 7.03 6.83 7.13 7.47 7.21 6.98 7.39 7.7 7.37 7.13
GOBP_REGULATION_OF_HEART_MORPHOGENESIS 4.68 4.72 5.09 5.27 4.36 4.5 4.8 4.59 4.79 4.59 5.07 4.47 4.75 4.67 4.82 4.7 4.32 4.66 4.78 4.51 4.71 4.92 4.61 4.44 4.76 4.74
GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION 7.01 6.63 7.23 7.17 7.28 7.08 7.14 7.12 7.09 6.61 7.05 7.15 7.61 7.61 7.23 7.51 6.74 7.02 6.7 7.26 7.15 7.42 7.2 7.36 7.18 6.89
GOBP_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS 6.53 6.58 6.88 7.04 6.65 6.79 6.65 6.74 6.64 6.73 6.81 6.71 6.84 6.73 6.62 6.84 6.5 6.51 6.61 6.81 6.72 6.79 6.91 6.88 6.81 6.73
GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS 6.79 6.69 6.97 7.23 7.08 6.79 6.79 6.81 7.11 6.96 6.75 6.92 7.08 7.04 6.86 7.05 6.5 6.47 6.75 6.93 6.84 7.01 7.07 7.01 7.05 6.98
GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_DNA_DAMAGE_STIMULUS 6.34 6.6 6.83 6.99 6.66 6.95 6.79 6.73 6.59 6.88 7 6.79 6.67 6.7 6.54 6.75 6.51 6.59 6.74 6.79 6.58 6.69 7.03 7.07 6.79 6.75
GOBP_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS 6.24 6.01 6.31 6.14 6.37 6.17 6.2 6.6 6.04 5.89 6.14 6.08 6.28 6.17 6.49 6.52 6.26 6 6.11 6.09 6.46 6.48 6.8 6.38 5.93 6.29
GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS 6.43 6.33 6.76 6.27 6.54 6.58 6.6 7 6.39 6.37 6.49 6.41 6.93 6.94 6.92 6.97 6.56 6.51 6.79 6.71 6.82 6.73 6.85 6.86 6.51 6.61
GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING 6.09 6.25 6.77 6.42 6.56 6.61 6.49 6.55 6.54 6.36 6.59 6.47 6.63 6.39 6.53 6.42 6.38 6.3 6.32 6.37 6.4 6.39 6.58 6.9 6.72 6.69
GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING 6.34 6.94 6.04 6.47 6.65 7.23 6.35 6.18 6.49 6.35 6.51 6.47 6.57 6.4 6.44 6.09 6.45 6.23 6.43 6.12 6.3 6.33 6.33 6.77 6.44 6.79
GOBP_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY 7.46 7.2 7.16 6.67 7.97 7.78 7.24 7.54 7.15 6.99 7.44 7.75 7.75 7.55 7.2 7.61 7.78 7.31 7.28 7.36 7.5 7.62 7.87 7.82 7.22 8.09
GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY 5.94 6.05 6.34 6.35 5.77 5.88 6.04 6.11 6.11 6.02 6.11 6.09 6.16 6.06 6.23 6.22 6.1 5.92 6.01 6 6.3 6.25 6.01 5.93 6.17 6.35
GOBP_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS 6.25 6.19 6.96 6.66 6.45 6.19 6.19 6.4 6.28 6.24 6.47 6.1 6.24 6.24 6.57 6.64 6.5 6.22 6.34 6.35 6.36 6.75 6.7 6.45 6.73 6.46
GOBP_REGULATION_OF_ENDOCYTIC_RECYCLING 8.61 8.07 8.08 7.3 9.72 9.9 9.6 7.67 9.66 9.29 7.86 9.52 9.55 9.65 7.65 8.33 7.92 8.49 8.74 9.27 7.74 7.64 9.46 9.68 8.14 7.65
GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSPORT 7.14 7.35 7.4 7.54 7.61 6.74 7.07 7.26 7.59 6.91 7.03 6.73 7.48 7.46 7.76 7.22 6.93 7.49 7.46 6.72 6.5 7.56 7.32 6.91 7.27 7.81
GOBP_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS 6.81 7.29 7.24 7.05 6.85 6.87 6.87 6.77 6.98 7.26 7.4 7.66 6.83 7.45 7.14 7.78 7.51 7.41 7.95 6.86 7.41 6.77 7.08 6.75 7.07 7.02
GOBP_POSITIVE_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS 6.84 7.12 7.8 7.39 7.76 7.42 7.43 7.17 7.42 7.38 7.22 7.16 7.78 8.13 7.57 7.6 7.23 7.37 7.33 7.29 7.06 7.36 7.64 7.47 7.34 7.21
GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION 5.31 5.48 5.42 5.79 5.66 5.47 5.07 5.21 5.95 5.38 5.12 4.69 5.65 5.56 5.55 5.25 5.83 5.11 5.22 5.47 5.61 5.78 5.24 5.37 5.62 5.77
GOBP_REGULATION_OF_OSTEOCLAST_DEVELOPMENT 5.78 6.24 4.97 5.6 5.71 5.73 5.71 5.62 5.48 6.07 5.51 6.05 5.91 5.83 5.76 5.68 5.84 5.64 6.32 6.07 5.63 5.73 6.11 5.38 6.22 5.72
GOBP_REGULATION_OF_VASCULOGENESIS 6.3 7.11 7.04 6.39 7.24 7.32 6.9 7.47 7.03 6.85 6.88 7.3 7.21 7.24 6.64 6.76 7.31 7.18 7 7.35 7.25 7.31 7.1 7.14 7.2 7.36
GOBP_POSITIVE_REGULATION_OF_VASCULOGENESIS 5.77 6.31 6.36 6.02 6.14 6.33 6.03 6.76 6.27 6.24 5.99 6.26 6.22 6.45 6.13 5.92 6.4 6.51 6.38 6.55 6.19 6.6 6.11 6.37 6.43 6.74
GOBP_REGULATION_OF_NEURON_MIGRATION 7.08 7.52 7.23 6.54 7.29 7.34 7.31 7.37 7.56 7.44 7.15 7.68 7.62 7.66 7.63 7.57 7.22 7.32 7.54 7.32 7.27 7.37 7.53 7.87 7.43 7.42
GOBP_POSITIVE_REGULATION_OF_NEURON_MIGRATION 7.15 7.6 7.38 7.21 7.97 7.78 7.6 7.66 7.86 8.14 7.73 8 7.97 8.04 7.86 7.73 7.53 7.46 7.83 7.89 7.45 8.02 7.94 8.04 7.78 7.63
GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY 6.54 6.66 6.82 6.87 6.84 6.73 6.82 6.89 6.84 6.93 6.73 6.79 6.99 6.92 6.8 6.95 6.79 6.78 6.83 6.91 6.88 6.97 6.99 6.92 7.06 6.96
GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY 6.58 6.7 6.85 6.87 6.98 6.76 6.9 6.89 6.86 6.85 6.75 6.79 7.02 7 6.8 7.02 6.86 6.77 6.87 6.92 6.87 7.02 6.99 7.01 7.09 6.96
GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY 6.44 6.55 6.63 6.94 6.63 6.62 6.76 6.76 6.8 6.96 6.36 6.78 6.82 6.76 6.58 6.8 6.47 6.74 6.59 6.88 6.8 6.83 7.02 6.85 7.05 6.93
GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 6.34 6.42 6.47 6.71 6.23 6.28 6.59 6.53 6.65 6.47 6.4 6.38 6.54 6.56 6.3 6.41 6.37 6.38 6.25 6.3 6.54 6.52 6.74 6.65 6.62 6.52
GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 6.13 6.13 6.2 6.39 5.95 6 6.05 6.31 6.26 6.19 6.2 6.23 6.15 6.02 6.21 6.1 6.3 6.19 6.12 6.05 6.47 6.23 5.99 6.07 6.58 6.37
GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 7.06 6.71 6.9 7.15 6.96 6.83 7.06 6.97 6.95 7.14 7.03 7.02 7.05 7.01 6.81 6.95 6.69 6.84 6.81 6.95 7.19 6.86 7.24 7.1 7.18 6.97
GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND 6.22 6.45 6.11 6.67 6 6.06 6.65 6.12 6.74 6.24 6.25 6.18 6.79 6.52 6.21 6.47 6.33 6.36 6.25 5.98 6.44 6.41 6.78 6.36 6.67 6.27
GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 6.91 6.99 7.45 7.36 7.32 7.27 7.32 7.31 7.63 7.43 7.24 7.32 7.43 7.59 7.62 7.55 7.19 7.15 7.23 7.51 7.4 7.45 7.46 7.69 7.59 7.61
GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 7.04 7.24 7.57 7.63 7.77 7.57 7.79 7.69 8.04 7.77 7.51 7.72 7.89 7.79 8.05 7.6 7.59 7.15 7.74 7.51 7.63 7.59 7.87 7.94 7.73 7.59
GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY 6.65 6.57 7.07 6.82 6.85 6.94 6.83 6.91 7.17 6.99 6.66 6.91 6.82 7 7.07 6.91 6.71 7.06 6.84 7.11 7 6.93 7 6.9 7.06 7.28
GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION 6.41 6.4 6.11 6.36 6.31 6.64 6.16 6.23 6.12 6.26 6.06 6.38 6.2 6.17 6.07 6.17 6.25 6.24 6.43 6.14 6.39 6.37 6.38 6.74 6.32 6.26
GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION 7.08 7.15 7.36 7.22 7.45 7.43 7.31 7.36 7.42 7.54 7.05 7.36 7.4 7.54 7.52 7.57 7.3 7.08 7.33 7.39 7.12 7.44 7.54 7.8 7.32 7.45
GOBP_REGULATION_OF_CATION_CHANNEL_ACTIVITY 7.26 7.25 7.83 7.26 7.54 7.62 7.96 7.88 7.67 7.67 7.38 7.77 7.55 7.67 8.09 7.89 7.48 7.5 7.58 7.86 7.49 7.72 7.68 8.05 7.86 7.6
GOBP_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY 6.1 6 6.48 6.74 5.72 5.69 6.32 6.88 6.08 6.63 6.58 6.11 6.34 6.15 5.96 6.64 6.09 6.08 5.98 5.73 5.99 6.06 6.93 6.9 6.45 6.33
GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY 6.64 6.67 7.27 7.33 7.38 7.26 6.96 6.98 7.03 7.23 7.03 6.81 7.15 6.97 7.09 7.41 6.68 6.79 7.06 6.88 6.8 6.98 6.93 7.2 7.11 7.04
GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY 6.59 6.45 6.9 6.49 6.02 6.14 6.35 7 6.42 5.93 6.34 6.04 5.94 5.83 6.29 6.19 6.26 6.2 5.61 6.43 6.66 6.28 6.07 6.04 6.68 7.52
GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY 7.13 7.23 7.57 7.41 7.4 7.47 7.29 7.65 7.54 7.52 7.57 7.66 7.5 7.23 7.4 7.34 7.43 6.9 7.13 7.4 6.81 7.3 7.82 7.6 7.48 7.62
GOBP_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS 5.31 5.04 5.06 5.22 5.31 4.6 5.57 5.16 5.2 5.14 5.25 4.83 5.33 5.48 5.62 5.01 5.55 5.32 5.27 5.04 5.47 5.8 5.64 5 5.12 5.57
GOCC_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX 7.13 7.07 6.94 7.11 7.35 7.6 6.97 7.21 7.31 7.24 6.65 7.37 7.53 7.15 7.45 7.05 7.18 6.9 7.38 7.38 6.98 7.36 7.12 7.42 7.62 7.53
GOCC_HISTONE_DEACETYLASE_COMPLEX 7.2 7.28 7.42 7.22 7.66 7.6 7.83 7.71 7.6 7.78 7.31 7.77 7.83 7.93 7.82 7.61 7.73 7.65 7.54 7.89 7.54 7.65 7.68 8.05 7.94 7.71
GOCC_GOLGI_CIS_CISTERNA 7.69 7.74 7.51 7.38 8.17 8.17 7.81 7.64 7.49 8.14 7.49 7.81 7.47 7.93 7.86 7.52 8.09 7.76 8.12 7.68 7.92 8.04 7.69 8.11 7.99 8.01
GOCC_GOLGI_TRANS_CISTERNA 6.14 6.33 7.5 7.43 6.58 6.5 6.59 6.53 6.64 6.37 6.28 6.2 6.11 6 6.33 6.39 6.43 6.28 6.4 6.88 6.32 6.35 6.46 6.51 6.53 6.45
GOCC_EXOCYST 7.11 7.15 7.68 7.39 7.76 7.79 7.52 7.43 7.71 7.9 7.61 7.65 7.88 7.62 7.42 7.84 7.71 7.48 7.53 7.73 7.06 7.71 7.96 8.04 7.52 7.67
GOCC_UBIQUITIN_LIGASE_COMPLEX 7.32 7.35 7.78 7.7 7.6 7.62 7.58 7.56 7.68 7.76 7.65 7.65 7.69 7.71 7.56 7.65 7.45 7.44 7.61 7.54 7.44 7.53 7.74 7.9 7.72 7.63
GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX 6.97 7.18 7.26 7.33 7.2 7.04 7.21 7.24 7.06 7.07 7.08 7.23 7.08 7.21 7.19 7.32 7.05 6.95 7.3 7.27 7.19 7.1 7.23 7.12 7.24 7.3
GOCC_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX 8.55 8.85 9.02 8.91 8.8 9.03 9.2 9.03 9.27 9.03 9.06 8.91 9.01 9.14 8.97 8.79 8.62 8.33 9.03 9.23 8.77 8.82 9.45 9.42 9.12 9.09
GOCC_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX 8.27 8.24 8.89 8.88 8.26 8.56 8.57 9.06 8.36 8.43 8.42 8.37 8.72 8.58 8.7 8.83 8.16 8.91 8.43 8.38 8.67 8.89 8.57 8.65 9.09 8.3
GOCC_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX 6.73 7 7.48 8.12 7.36 7.32 7.37 7.69 7.67 7.75 7.71 7.37 7.66 7.55 7.73 8.02 6.81 7.44 7.48 7.26 7.93 7.82 7.69 7.97 7.47 7.49
GOCC_NUCLEAR_EXOSOME_RNASE_COMPLEX 6.95 7.32 7.86 7.86 7.2 7.44 7.63 7.04 7.32 7.05 7.38 7.43 7.28 7.32 7.03 7.23 6.67 6.7 7.21 7.5 6.53 7.01 7.07 7.31 7.37 7.22
GOCC_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX 7.26 7.37 7.86 7.7 7.58 7.76 7.63 7.39 7.39 7.67 7.43 7.59 7.63 7.49 7.05 7.47 6.83 6.93 7.23 7.5 6.74 7.26 7.58 7.4 7.21 7.21
GOCC_NUCLEAR_CHROMOSOME 5.98 6.12 6.4 6.47 6.13 6.22 6.32 6.33 6.15 6.35 6.26 6.23 6.24 6.26 6.34 6.34 6.15 6.08 6.02 6.31 6.23 6.25 6.33 6.5 6.2 6.37
GOCC_PERICENTRIOLAR_MATERIAL 7.52 7.55 8.01 7.83 7.64 8.17 7.37 7.48 8.04 7.61 7.73 7.86 8 8.04 7.38 7.5 7.21 7.47 7.73 7.83 7.21 7.27 8.31 7.92 7.33 6.97
GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX 6.71 6.81 7.29 6.88 7.37 7.15 7.31 7.16 7.64 7.35 7.15 7.64 7.15 7.27 7.21 7.38 7.3 6.97 6.73 7 7.26 7.38 7.35 7.27 6.99 7.54
GOCC_ORGANELLAR_RIBOSOME 6.82 7.14 8.24 7.95 7.19 7.2 7.37 7.56 7.72 7.47 7.7 7.42 7.26 7.59 7.74 7.86 7.07 6.98 6.97 7.53 7.17 7.7 7.84 7.7 7.35 7.41
GOCC_PHAGOPHORE_ASSEMBLY_SITE 7.43 7.52 8.27 7.99 7.87 7.88 7.72 7.72 7.77 7.69 8.01 7.95 7.65 7.74 7.8 8.04 7.72 7.94 7.77 7.87 8.11 7.99 7.95 7.82 7.84 7.65
GOCC_AUTOPHAGOSOME_MEMBRANE 7.42 7.51 7.71 7.85 8 7.92 8.04 7.92 8.07 7.56 7.78 7.74 7.81 7.88 7.81 7.8 7.95 7.47 7.69 7.91 7.83 8.13 8.01 8.08 7.85 7.96
GOCC_CHROMOSOME_CENTROMERIC_REGION 6.23 6.41 6.39 6.74 6.34 6.54 6.46 6.58 6.48 6.7 6.62 6.46 6.47 6.24 6.52 6.42 6.47 6.29 6.38 6.53 6.44 6.67 6.68 6.76 6.4 6.36
GOCC_KINETOCHORE 6.32 6.4 6.84 6.95 6.66 6.7 6.54 6.66 6.48 6.88 6.74 6.53 6.44 6.2 6.52 6.42 6.53 6.29 6.43 6.69 6.51 6.87 6.68 6.79 6.4 6.36
GOCC_CONDENSED_NUCLEAR_CHROMOSOME_KINETOCHORE 5.62 5.54 4.53 5.03 4.97 5.14 5.16 5.55 4.78 5.15 5.19 5.38 4.86 5.39 5.21 5.71 5.23 5.33 5.35 5.09 5.24 5.46 4.94 4.96 5.19 5.72
GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION 5.97 6.1 6.05 6.36 6.05 6.22 6.13 6.15 5.97 6.48 5.94 6.38 6.05 5.94 6.13 6.2 6.3 5.9 5.94 6.11 6.18 6.23 6.33 6.21 6.12 6.17
GOCC_CHROMOSOME_TELOMERIC_REGION 6.68 6.69 6.72 7.23 7.07 7.12 6.85 6.99 6.9 7.06 6.92 6.98 6.86 7.09 7.04 7.04 6.72 6.77 6.74 7.09 6.87 6.85 7.2 7.27 6.93 7.02
GOCC_CHROMATIN 6.04 6.06 6.13 6.23 5.99 5.93 6.09 6.15 6.08 6.07 6.11 6.03 6.11 6.03 6.11 6.09 6.09 6.1 5.96 6.02 6.16 6.2 6.04 6.03 6.05 6.2
GOCC_EUCHROMATIN 6.44 6.55 6.95 7.7 6.86 6.66 6.87 6.89 7.09 7.07 7.26 6.92 7.06 6.87 7.08 7 6.56 6.58 6.62 6.78 6.83 7.09 7.26 7.34 7.09 6.77
GOCC_HETEROCHROMATIN 6.3 6.41 6.63 6.55 6.59 6.66 6.88 6.85 6.77 6.97 6.58 6.92 6.75 6.72 6.9 6.91 6.47 6.45 6.44 6.71 6.62 6.73 6.78 6.85 6.87 6.73
GOCC_CONDENSED_CHROMOSOME 5.94 5.93 6.05 6.24 5.98 5.98 6.05 6.14 5.87 6.16 5.94 6.12 6.01 5.9 5.99 6.03 6.01 5.83 5.93 6.08 5.91 6.13 6.1 6.12 6.14 6.12
GOCC_CONDENSED_NUCLEAR_CHROMOSOME 5.58 5.44 5.6 5.77 5.41 5.11 5.3 5.5 5.15 5.13 5.43 5.42 5.09 5.34 5.57 5.57 5.36 5.39 5.49 5.37 5.24 5.47 4.96 5.17 5.37 5.7
GOCC_LATERAL_ELEMENT 4.9 4.85 4.61 5.16 4.47 4.21 4.29 4.64 4.28 4.39 4.64 4.76 4.39 4.38 4.39 4.22 4.8 5.11 4.86 4.74 5.06 4.69 4.5 4.48 4.4 4.59
GOCC_SEX_CHROMOSOME 7.2 7.08 7.41 7.35 7.63 7.76 7.13 7.51 7.17 7.63 7.32 7.55 7.43 7.47 7.32 7.44 7.28 7.24 7.57 7.49 7.1 7.32 7.43 7.41 7.57 7.79
GOCC_SWR1_COMPLEX 7.05 6.96 6.96 7.25 7.44 7.3 7.85 7.24 7.5 7.63 7.2 7.42 7.24 7.45 7.58 7.53 7.22 7 7.14 7.61 7.27 7.43 7.58 7.99 7.8 7.31
GOCC_SPINDLE_POLE 6.53 6.63 6.5 6.67 6.61 6.67 6.49 6.48 6.48 6.67 6.42 6.61 6.53 6.49 6.69 6.64 6.53 6.43 6.52 6.55 6.51 6.73 6.64 6.67 6.61 6.56
GOCC_GAMMA_TUBULIN_COMPLEX 6.62 6.78 7.43 7.29 7.11 7.23 7.34 7.05 7.49 7.67 6.83 7.01 7.1 7.46 7.06 6.88 6.79 6.52 6.9 7.52 6.86 7.16 7.23 7.69 7.49 7.72
GOCC_P_BODY 7.41 7.48 7.84 7.87 8 7.82 8.01 7.55 7.93 7.91 7.91 7.78 7.76 7.81 7.71 7.66 7.56 7.59 7.64 7.82 7.38 7.88 7.95 7.99 8.02 7.76
GOCC_CONDENSED_CHROMOSOME_OUTER_KINETOCHORE 4.98 5.38 4.53 4.83 4.23 4.12 4.9 5.43 4.64 4.37 4.38 4.62 4.34 4.3 4.89 4.52 4.71 5.01 4.84 4.33 5.05 4.46 4.55 4.71 4.76 4.82
GOCC_PRP19_COMPLEX 7.08 7.6 7.98 7.43 7.84 8.06 7.93 7.53 7.82 7.67 7.25 7.9 8.07 7.67 7.71 7.69 7.59 7.29 7.5 8.07 7.5 7.51 8.25 8.27 8.31 7.32
GOCC_SAM_COMPLEX 7.88 7.88 8.73 8.49 7.83 8.12 8.71 8.24 8.53 8.67 8.36 8.36 8.5 8.6 8.55 8.36 7.59 7.9 8.12 8.04 7.91 8.29 8.48 8.29 8.34 8.21
GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX 7.36 7.56 6.56 6.25 8.04 7.67 7.62 7.47 7.59 7.7 7.54 7.68 7.77 7.72 7.93 7.88 7.16 7.9 7.96 7.87 7.23 7.68 7.67 7.92 7.71 7.53
GOCC_MICROFIBRIL 5.55 5.51 5.22 4.75 5.41 5.43 5.64 5.4 5.62 5.58 5.31 5.38 5.18 5.21 5.62 5.51 5.68 5.7 5.24 5.4 5.63 5.45 5.83 5.35 5.66 5.45
GOCC_CORNIFIED_ENVELOPE 4.89 4.53 4.41 4.69 4.34 4.19 4.7 4.41 4.56 4.22 4.71 4.4 4.3 4.17 4.26 4.41 4.53 4.69 4.42 4.27 4.79 4.29 4.27 4.08 4.31 4.34
GOCC_FIBRILLAR_CENTER 6.7 6.72 6.92 7.04 7.02 6.99 6.95 7.02 7.21 7.08 6.94 7.13 7.1 7.09 6.99 7.14 7 6.78 6.93 7 6.91 6.94 7.01 7.29 7.19 7.15
GOCC_ACROSOMAL_VESICLE 5.43 5.26 5.08 5.32 4.98 4.62 5.14 4.93 5.11 5.07 5.23 4.92 4.94 4.95 5.05 5.01 5.26 5.4 4.94 4.93 5.18 5.23 4.97 4.8 5.03 4.93
GOCC_MALE_GERM_CELL_NUCLEUS 6.09 6.15 6.74 6.3 6.71 6.45 6.05 6.29 6.53 7.09 6.48 6.76 6.31 6.12 5.88 7.06 6.14 5.99 5.93 6.38 6.11 6.13 6.55 6.29 6.29 6.15
GOCC_RUFFLE 7.2 7.32 7.48 7.24 7.54 7.66 7.56 7.57 7.6 7.61 7.41 7.62 7.75 7.81 7.61 7.68 7.39 7.38 7.44 7.49 7.41 7.66 7.68 7.79 7.55 7.41
GOCC_PHOTORECEPTOR_OUTER_SEGMENT 5.22 5.15 5.15 5.26 4.86 4.71 5.16 5.04 5.07 4.98 5.11 4.88 4.97 5 5.17 5.13 4.96 5.28 4.92 4.82 5.27 4.88 4.87 4.84 4.98 4.91
GOCC_IMMUNOLOGICAL_SYNAPSE 5.74 5.84 5.73 6.18 6.31 6.14 5.91 6.08 6.47 5.45 5.8 5.55 5.98 5.5 5.91 5.74 5.63 5.98 5.66 6.33 6.13 5.85 5.96 5.82 6.24 6.17
GOCC_PHAGOCYTIC_CUP 7.08 7.49 8.12 7.73 7.58 8.03 7.91 7.85 7.9 7.83 7.45 7.84 8.22 8.18 7.99 7.7 7.27 7.36 7.57 8.17 8.12 7.92 7.9 8.05 7.85 7.76
GOCC_PHOTORECEPTOR_INNER_SEGMENT 5.33 5.19 5.64 5.37 5.02 4.84 5.35 5.34 5.34 5.16 5.32 5.03 5.04 5.15 5.38 5.29 4.98 5.4 4.98 5.17 5.31 5.11 5.25 5.1 5.22 5
GOCC_ACROSOMAL_MEMBRANE 5.05 5.04 4.97 5.27 4.64 4.42 5.03 4.89 4.84 4.6 4.96 4.74 4.69 4.83 4.74 4.56 5.07 5.13 4.67 4.63 4.79 5.08 4.54 4.3 4.87 4.79
GOCC_PODOSOME 6.69 6.75 6.23 6.51 6.71 6.95 6.49 6.69 6.98 6.58 6.09 6.62 6.98 6.8 6.33 6.36 6.55 6.68 6.47 6.38 6.64 6.25 7.4 7.07 6.95 7.16
GOCC_SEMAPHORIN_RECEPTOR_COMPLEX 6.74 6.89 6.36 6.13 6.87 6.83 6.92 7.26 6.75 6.93 6.73 7.02 6.92 6.98 7.21 6.83 7.2 6.95 6.95 7.05 7 7.07 6.69 6.84 6.83 6.72
GOCC_COLLAGEN_TRIMER 5.35 5.13 5.06 5.3 5.04 4.78 4.95 4.91 4.94 4.9 5.19 4.86 4.69 4.81 4.94 4.91 5.1 5.19 5.07 4.88 5.18 4.99 4.94 4.6 4.85 4.77
GOCC_FIBRILLAR_COLLAGEN_TRIMER 5.66 5.38 4.99 5.13 5.15 4.92 4.98 5.07 4.91 4.91 5.21 5.01 4.89 4.87 5.15 4.98 5.16 5.39 5.1 4.91 5.23 5.01 5.05 4.68 5.04 4.97
GOCC_BASEMENT_MEMBRANE 5.85 5.67 5.29 5.62 5.63 5.6 5.63 5.62 5.52 5.47 5.55 5.62 5.58 5.41 5.5 5.56 5.67 5.64 5.45 5.38 5.87 5.62 5.64 5.17 5.55 5.43
GOCC_NUCLEAR_ENVELOPE 6.99 7.06 7.33 7.32 7.23 7.23 7.15 7.18 7.21 7.26 7.13 7.16 7.24 7.25 7.23 7.31 7.23 7.03 7.13 7.23 7.15 7.4 7.26 7.39 7.41 7.31
GOCC_NUCLEAR_INNER_MEMBRANE 6.99 6.98 7.29 7.36 7.24 7.15 7.23 7.27 7.21 7.13 7.2 7.17 7.11 7.06 7.2 7.25 7.37 7.08 7.13 7 7.01 7.38 7.17 7.32 7.21 7.3
GOCC_NUCLEAR_OUTER_MEMBRANE 7.1 7.43 7.29 6.59 7.66 7.98 7.54 7.63 7.15 7.46 6.75 7.25 7.74 7.53 7.67 7.45 7.5 7.37 7.51 7.17 7.12 7.53 7.51 7.46 7.68 7.95
GOCC_NUCLEAR_PORE 7.12 7.08 7.54 7.76 7.12 7.18 7.15 7.17 7.21 7.14 7.06 7.16 7.11 7.19 7.29 7.24 7.07 7.11 7.07 7.09 7.03 7.29 7.15 7.35 7.22 7.24
GOCC_NUCLEAR_LAMINA 7.08 7.31 7.57 7.81 7.46 7.44 7.58 7.56 7.39 7.36 7.37 7.73 7.25 7.44 7.56 7.65 7.14 7.62 7.61 7.64 7.22 7.61 7.23 7.55 7.34 7.62
GOCC_REPLICATION_FORK 6.15 6.08 6.53 6.87 6.07 6.28 6.06 6.18 6.01 6.23 6.19 6.03 5.96 6.02 6.19 6.19 6.05 5.87 6 6.24 6.05 5.97 6.12 6.31 6.11 6.4
GOCC_DNA_REPLICATION_FACTOR_A_COMPLEX 6.74 6.77 6.61 6.05 7.32 7.19 6.78 6.79 6.29 6.9 6.26 6.99 7.11 6.79 7 6.92 7 6.34 7.24 7.14 6.46 7.13 6.81 7.02 7.59 7.02
GOCC_RNA_POLYMERASE_II_CORE_COMPLEX 8.53 8.54 8.92 9.04 8.86 8.62 9.25 9.06 9.03 8.91 8.48 8.95 8.93 9.07 8.91 9.04 8.44 8.48 8.88 9.15 8.64 8.83 9 9.16 8.91 9.17
GOCC_RNA_POLYMERASE_III_COMPLEX 6.98 6.76 7.2 7.56 6.7 7.05 7.08 6.99 7.27 7.14 6.9 7.32 7.21 7.25 7.29 7.12 6.9 7.08 7.09 7.37 6.96 7.16 7.35 7.74 7.17 7.01
GOCC_TRANSCRIPTION_REGULATOR_COMPLEX 6.49 6.57 6.8 6.78 6.74 6.79 6.74 6.82 6.75 6.82 6.75 6.79 6.81 6.87 6.82 6.95 6.67 6.67 6.72 6.86 6.69 6.91 6.83 7.02 6.81 6.96
GOCC_TRANSCRIPTION_FACTOR_TFIID_COMPLEX 6.64 6.9 7.56 7.33 7.09 7.08 7.11 7.21 7 7.17 7.32 6.98 6.95 7.02 7.15 7.33 6.83 7.02 6.87 7.26 6.78 7.04 7.01 7.49 7.43 7.3
GOCC_ADA2_GCN5_ADA3_TRANSCRIPTION_ACTIVATOR_COMPLEX 8.46 8.52 9.18 8.93 8.95 8.94 8.63 8.75 8.88 8.93 8.74 8.65 8.8 8.89 8.83 8.91 8.92 9.05 8.81 8.97 8.63 8.74 8.81 8.76 8.68 8.75
GOCC_TRANSCRIPTION_FACTOR_TFIIH_HOLO_COMPLEX 7.61 7.64 8.06 8.11 8.17 8.4 7.78 7.97 8.05 8.13 7.85 8.06 8.12 8.14 8.09 8.31 7.52 7.66 8.15 8.21 7.54 8.15 8.19 8.27 8.24 8.1
GOCC_ANAPHASE_PROMOTING_COMPLEX 6.73 6.62 7.04 7.48 7.04 6.94 7.18 7.13 6.79 6.68 6.85 6.7 6.9 6.71 6.89 7.15 6.3 6.86 6.98 6.76 7.54 7.04 6.75 6.76 6.84 6.85
GOCC_SPLICEOSOMAL_COMPLEX 6.95 7.1 7.4 7.34 7.37 7.35 7.29 7.43 7.32 7.36 7.31 7.37 7.27 7.18 7.47 7.46 7.1 7.04 7.3 7.5 7.17 7.45 7.35 7.47 7.41 7.49
GOCC_U5_SNRNP 7.02 7.27 8.06 7.99 7.27 7.32 7.62 7.69 7.73 7.44 7.29 7.37 7.29 7.3 7.67 7.67 7.29 6.81 7.29 7.65 7.45 7.7 7.69 7.97 7.89 7.65
GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX 7.07 7.13 7.46 7.56 7.56 7.37 7.34 7.62 7.34 7.36 7.32 7.37 7.27 7.23 7.55 7.49 7.08 7.2 7.38 7.55 7.42 7.62 7.28 7.7 7.44 7.53
GOCC_U1_SNRNP 7.52 7.71 7.83 8.01 7.53 7.7 7.04 7.87 6.93 7.29 7.22 7.49 7.23 7.3 7.52 7.7 7.19 7.31 7.77 7.25 7.87 7.84 7.2 7.56 7.48 7.92
GOCC_U2_SNRNP 7.74 7.93 8.23 8.39 7.73 7.53 7.91 8.56 7.63 7.5 7.85 7.62 7.51 7.72 7.82 8.04 7.75 7.85 7.58 8.26 8.03 8.44 7.55 7.83 8.46 8.54
GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX 6.41 6.47 7.44 7.56 6.85 6.72 6.68 7.09 6.67 6.89 6.85 7.23 6.83 6.88 7.34 7.28 6.77 6.62 6.7 6.71 7.14 7.68 6.97 7.18 7.26 7.38
GOCC_CHROMOSOME 6.1 6.14 6.25 6.34 6.14 6.15 6.25 6.28 6.21 6.22 6.22 6.22 6.23 6.17 6.24 6.25 6.23 6.17 6.08 6.19 6.24 6.32 6.21 6.26 6.21 6.31
GOCC_TELOMERASE_HOLOENZYME_COMPLEX 6.48 6.6 6.11 6.39 6.34 6.64 6.41 6.25 5.93 6.01 6.43 6.22 6.28 6.02 6.25 6.21 5.9 6.42 6.56 6.61 6.47 6.58 6.13 5.88 6.17 6.61
GOCC_PERICENTRIC_HETEROCHROMATIN 5.69 5.68 5.97 5.96 5.86 6.06 6.24 6.54 6.48 6.4 5.76 6.11 6.17 6.03 6.29 6.3 6.18 5.99 6.05 6.24 6.08 6.19 6.68 6.52 6.06 6.13
GOCC_NUCLEOLUS 6.71 6.78 7.05 7.02 6.86 7.01 6.99 7 6.97 7.08 6.92 7.05 7.01 6.98 6.99 7 6.8 6.78 6.89 7.02 6.81 6.98 7.05 7.18 7.09 7.05
GOCC_SNO_S_RNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX 6.38 6.4 7.25 7.05 6.37 6.27 6.58 6.72 6.49 6.65 6.78 6.83 6.69 6.77 6.86 6.93 6.55 6.49 6.58 6.67 6.68 6.97 6.53 6.77 6.49 6.73
GOCC_RNA_POLYMERASE_I_COMPLEX 8.04 8.25 9.02 8.87 8.25 8.07 8.58 8.37 8.39 8.43 8.06 8.24 8.21 8.27 8.37 8.54 8.27 8.41 8.37 8.42 8.15 8.48 8.33 8.47 8.41 8.47
GOCC_MITOCHONDRION 6.85 6.92 7.5 7.38 7.07 7.17 7.08 7.2 7.1 7.2 7.19 7.16 7.15 7.16 7.19 7.2 7.05 6.98 7.02 7.2 7.04 7.19 7.2 7.36 7.16 7.16
GOCC_MITOCHONDRIAL_ENVELOPE 6.97 7.05 7.81 7.58 7.25 7.26 7.26 7.44 7.28 7.31 7.47 7.39 7.28 7.37 7.41 7.47 7.26 7.14 7.17 7.39 7.16 7.49 7.32 7.48 7.39 7.35
GOCC_TIM23_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_TRANSLOCASE_COMPLEX 6.41 7.04 8.29 7.7 7.66 7.73 7.48 7.61 7.72 7.7 8.31 7.34 7.88 8.01 7.71 7.8 7.11 6.94 7.57 7.73 7.02 7.04 7.89 7.95 7.69 7.04
GOCC_MITOCHONDRIAL_MATRIX 6.83 6.88 7.59 7.47 7.09 7.12 7.05 7.2 7.11 7.18 7.18 7.16 7.1 7.2 7.16 7.21 6.95 6.98 7 7.17 7 7.13 7.17 7.27 7.11 7.03
GOCC_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT 7.27 7.36 8.29 7.95 7.23 7.2 7.23 7.47 7.74 7.34 7.73 7.36 7.23 7.59 7.7 7.85 6.91 6.75 6.96 7.52 7.21 7.3 7.85 7.76 7.23 7.1
GOCC_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT 6.78 7.14 8.35 8.24 7.33 7.38 8.02 7.9 7.78 7.82 7.87 7.81 7.58 7.75 7.85 8.25 7.3 7.56 7.31 7.79 7.51 7.85 8.06 7.87 7.95 7.9
GOCC_SECONDARY_LYSOSOME 7.33 6.4 7.72 7.45 7.84 7.91 7.11 8.26 7.28 8.03 8.05 7.3 7.36 7.45 8.26 7.81 7.87 7.48 6.98 8.1 7.86 8.2 7.5 7.23 6.96 7.2
GOCC_ENDOSOME 7.21 7.25 7.61 7.41 7.43 7.53 7.54 7.48 7.45 7.5 7.36 7.46 7.5 7.49 7.49 7.49 7.36 7.37 7.39 7.55 7.35 7.55 7.61 7.74 7.61 7.47
GOCC_EARLY_ENDOSOME 7.41 7.46 7.57 7.4 7.59 7.69 7.65 7.59 7.63 7.67 7.43 7.62 7.67 7.74 7.58 7.61 7.4 7.49 7.61 7.74 7.39 7.66 7.66 7.84 7.66 7.55
GOCC_LATE_ENDOSOME 7.08 7.11 7.73 7.43 7.3 7.38 7.36 7.28 7.51 7.34 7.41 7.38 7.35 7.37 7.43 7.42 7.3 7.09 7.23 7.36 7.34 7.51 7.63 7.76 7.53 7.39
GOCC_MULTIVESICULAR_BODY 6.89 6.53 7.71 7.21 6.88 7.03 7.12 7.05 7.26 6.96 7.23 7.16 7.05 7.04 7.2 7.02 6.75 6.69 6.98 7.16 6.81 7.16 7.42 7.48 7.03 6.9
GOCC_VACUOLE 7.04 7.05 7.43 7.34 7.3 7.26 7.22 7.22 7.24 7.22 7.14 7.16 7.24 7.18 7.28 7.23 7.17 7.04 7.1 7.27 7.31 7.41 7.27 7.4 7.4 7.35
GOCC_VACUOLAR_MEMBRANE 7.29 7.42 7.74 7.6 7.64 7.66 7.69 7.64 7.51 7.62 7.39 7.5 7.59 7.63 7.62 7.61 7.4 7.38 7.39 7.66 7.55 7.67 7.64 7.7 7.7 7.65
GOCC_VACUOLAR_LUMEN 7.02 6.96 7.36 7.27 7.15 7.24 7.38 7.26 7.05 7.26 7.03 7.14 7.27 7.26 7.38 7.4 7.29 7.07 7.34 7.53 7.42 7.51 7.29 7.23 7.41 7.25
GOCC_AUTOPHAGOSOME 7.4 7.42 7.7 7.66 7.64 7.75 7.48 7.84 7.55 7.59 7.59 7.62 7.65 7.62 7.74 7.79 7.55 7.32 7.49 7.85 7.67 7.85 7.77 7.65 7.71 7.74
GOCC_ENDOPLASMIC_RETICULUM 6.75 6.81 7.13 6.95 6.98 6.99 7.01 7.01 7.04 6.99 6.89 6.93 7.04 7 6.96 6.93 6.85 6.78 6.84 6.99 6.86 7 7.09 7.15 7.05 7.04
GOCC_ENDOPLASMIC_RETICULUM_LUMEN 5.83 5.64 5.68 5.85 5.79 5.61 5.72 5.63 5.74 5.71 5.76 5.57 5.66 5.62 5.63 5.79 5.74 5.59 5.61 5.64 5.79 5.71 5.79 5.57 5.62 5.72
GOCC_SMOOTH_ENDOPLASMIC_RETICULUM 7.93 8.4 7.92 8.13 8.81 8.83 8.48 8.9 8.93 8.88 8.2 8.44 8.68 8.34 8.74 8.32 8.47 7.95 7.81 8.09 8.22 8.35 8.66 8.78 8.26 8.38
GOCC_ROUGH_ENDOPLASMIC_RETICULUM 6.92 7.36 7.68 7.23 7.72 7.54 7.21 7.19 7.71 7.42 7.19 7.31 7.47 7.62 7.41 7.77 7.25 7.38 7.16 7.5 7.38 7.26 7.89 7.54 7.35 7.29
GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT 7.03 7.06 7.95 7.83 7.65 7.55 7.45 7.66 7.35 7.4 7.4 7.47 7.5 7.46 7.57 7.6 7.46 7.27 7.38 7.71 7.47 7.71 7.49 7.73 7.68 7.69
GOCC_GOLGI_APPARATUS 7.04 7.08 7.42 7.25 7.3 7.35 7.35 7.33 7.27 7.34 7.14 7.27 7.39 7.35 7.3 7.26 7.18 7.1 7.21 7.38 7.15 7.34 7.37 7.47 7.36 7.33
GOCC_GOLGI_STACK 7.06 7.11 7.55 7.35 7.41 7.65 7.53 7.4 7.32 7.48 7.29 7.36 7.47 7.59 7.5 7.38 7.42 7.23 7.29 7.5 7.21 7.51 7.65 7.83 7.55 7.4
GOCC_GOLGI_LUMEN 5.73 5.56 5.65 5.76 5.37 5.15 5.52 5.67 5.42 5.48 5.47 5.37 5.42 5.34 5.39 5.32 5.61 5.53 5.5 5.47 5.79 5.57 5.66 5.19 5.5 5.48
GOCC_GOLGI_ASSOCIATED_VESICLE 8.05 8.03 8.41 8.5 8.58 8.61 8.53 8.24 8.72 8.49 8.29 8.35 8.46 8.44 8.43 8.12 7.91 8.08 8.16 8.4 7.96 8.29 8.58 8.64 8.43 8.41
GOCC_CIS_GOLGI_NETWORK 7.61 7.66 8.14 8.28 8.22 8.42 8.05 7.9 7.75 8.26 8.35 8.09 8.12 8.26 7.98 7.97 7.73 7.58 8.05 8.11 7.64 8.05 8.17 8.12 8.14 8.15
GOCC_TRANS_GOLGI_NETWORK 7.23 7.31 7.79 7.56 7.73 7.73 7.57 7.78 7.57 7.67 7.44 7.59 7.55 7.47 7.63 7.6 7.42 7.39 7.44 7.66 7.41 7.57 7.71 7.89 7.62 7.64
GOCC_LIPID_DROPLET 7.06 6.71 7.3 7.01 6.96 7.12 7.16 7.13 7.05 7.19 7.05 7.13 7.29 7.14 7.01 7.14 7.05 6.9 6.77 7.18 7.22 7.06 7.23 7.38 7.37 7.34
GOCC_CENTROSOME 6.7 6.75 7.15 6.95 7.02 6.99 6.91 6.93 6.83 7.1 6.9 7.04 6.93 6.87 6.9 6.94 6.88 6.8 6.83 6.97 6.81 6.99 6.97 7.09 7.03 7.03
GOCC_CENTRIOLE 6.15 6.21 6.37 6.29 6.4 6.37 6.26 6.16 6.19 6.27 6.22 6.42 6.23 6.23 6.23 6.03 6.18 6.4 6.21 6.28 6.06 6.36 6.13 6.42 6.24 6.22
GOCC_MICROTUBULE_ORGANIZING_CENTER 6.69 6.7 7.02 6.9 6.83 6.97 6.87 6.85 6.72 6.99 6.88 7 6.84 6.83 6.85 6.9 6.78 6.76 6.8 6.86 6.72 6.95 6.94 7.07 6.98 6.94
GOCC_SPINDLE 6.87 6.87 7.06 7.01 7.08 7.09 7.06 7 7.07 7.13 7.01 7.09 7.07 7.13 7.18 7.14 6.81 7.02 6.98 7.02 6.97 7.14 7.04 7.19 7.29 7.04
GOCC_CHAPERONIN_CONTAINING_T_COMPLEX 7.64 7.86 9.49 9.27 8.07 8.22 8.77 8.76 8.53 8.52 8.72 8.34 8.54 8.47 8.54 9.12 8.28 8.15 8.07 8.39 8.28 8.48 8.75 8.79 8.61 8.1
GOCC_PROTEASOME_CORE_COMPLEX 7.52 8.23 9.6 9.36 8.06 8.47 8.54 8.33 8.79 8.49 8.84 8.48 8.57 8.7 8.77 8.68 8.06 7.88 7.62 8.19 7.98 8.32 8.69 8.45 8.39 7.97
GOCC_RIBOSOME 6.83 7.11 7.81 7.63 7.23 7.18 7.23 7.38 7.3 7.31 7.51 7.11 7.22 7.37 7.57 7.74 7.1 7.08 7.16 7.27 7.15 7.29 7.45 7.51 7.18 7.22
GOCC_POLYSOME 7.67 7.78 8.33 8.01 8.28 8.22 8.08 8.17 8.26 8.42 7.93 8.16 8.18 8.1 8.44 8.62 7.96 7.81 7.83 8.23 7.88 8.15 8.56 8.53 8.24 8.27
GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX 7.32 7.15 7.74 7.25 7.63 7.54 7.36 7.5 7.66 7.67 7.16 7.55 7.52 7.57 7.58 7.67 7.35 7.24 7.14 7.6 7.38 7.64 7.63 7.52 7.65 7.57
GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX 7.37 7.25 7.73 7.33 7.65 7.57 7.52 7.6 7.72 7.68 7.22 7.48 7.53 7.44 7.43 7.62 7.26 7.24 7.15 7.59 7.25 7.42 7.67 7.62 7.71 7.64
GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX 8.24 8.47 9.08 8.92 8.9 8.64 9.02 8.7 9.18 8.96 8.86 8.72 9.06 9.06 8.99 9.21 8.68 8.27 8.48 8.74 8.66 8.73 9.31 9 9.31 8.93
GOCC_AXONEMAL_DYNEIN_COMPLEX 4.99 5.13 4.76 4.66 4.63 4.93 5.09 4.52 4.7 4.63 4.84 4.99 5.02 4.98 4.78 5.49 5 5.24 4.93 4.77 5.25 5.12 4.65 4.75 4.83 4.75
GOCC_MUSCLE_MYOSIN_COMPLEX 4.9 4.57 4.26 4.6 4.07 4.11 4.66 4.29 4.64 4.21 4.62 4.22 4.14 4.44 4.61 4.2 4.31 4.56 4.37 4.37 4.64 4.57 4.17 4.01 4.27 4.37
GOCC_STRIATED_MUSCLE_THIN_FILAMENT 5.54 5.68 5.59 5.79 5.33 4.83 5.42 5.02 5.48 5.13 5.48 4.9 5.02 5 5.39 5.26 5.46 5.69 4.95 5.07 5.19 5.19 5.65 4.97 5.31 5.13
GOCC_CYTOPLASMIC_DYNEIN_COMPLEX 8.26 8.21 8.91 8.29 8.65 8.85 8.85 9.12 8.85 9.01 9.02 8.69 8.68 8.71 8.88 8.85 7.99 8.31 8.84 8.96 8 8.53 8.94 8.58 8.52 8.8
GOCC_DYNACTIN_COMPLEX 7.58 7.19 8.12 6.76 7.49 8.14 8.42 7.8 7.86 7.88 8.52 7.5 8.2 8.12 7.26 7.33 7.91 7.98 8.04 8.31 8.11 7.89 8.72 8.1 8.39 8.39
GOCC_KINESIN_COMPLEX 6.3 6.19 6.1 6.03 6.24 6.37 6.3 6.12 6.36 6.35 6.07 6.45 6.3 6.13 6.43 6.33 6.35 6.07 6.16 6.34 6.43 6.07 6.24 6.27 6.3 6.29
GOCC_MICROTUBULE 6.91 6.89 7.07 6.86 7.15 7.08 7.04 7.19 6.91 7.09 7.03 7.09 7.17 7.04 7.1 7.15 7.04 7.01 6.94 7.03 6.95 7.21 6.96 7.1 7.16 7.21
GOCC_MICROTUBULE_ASSOCIATED_COMPLEX 6.36 6.31 6.31 6.19 6.48 6.43 6.48 6.47 6.47 6.54 6.47 6.59 6.34 6.38 6.52 6.59 6.53 6.29 6.33 6.43 6.52 6.5 6.51 6.4 6.47 6.69
GOCC_SPINDLE_MICROTUBULE 6.61 6.71 7.03 6.95 6.53 6.84 6.9 7.01 6.79 6.81 6.52 6.75 6.88 6.74 6.77 6.73 6.58 6.84 6.65 6.7 6.57 7.05 6.79 6.72 6.83 6.91
GOCC_CYTOPLASMIC_MICROTUBULE 7.52 7.36 7.76 7.42 7.61 8.02 7.57 7.86 8.03 7.91 7.81 8.01 8.15 7.89 8.17 8.23 7.22 7.57 7.88 7.81 7.55 7.89 8.28 8.15 8.11 7.6
GOCC_INTERMEDIATE_FILAMENT 5.14 5.11 4.93 5.2 4.57 4.45 4.97 4.63 4.8 4.6 5.01 4.68 4.69 4.54 4.85 4.59 4.9 5.23 4.67 4.6 5.1 4.76 4.59 4.42 4.77 4.63
GOCC_ACTIN_FILAMENT 6.48 6.77 6.95 6.79 6.76 6.65 6.9 7 6.77 6.82 6.42 6.85 6.81 6.74 6.79 6.99 6.81 6.68 6.54 6.77 6.8 6.71 7.01 6.85 7.08 6.89
GOCC_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX 7.36 7.4 7.94 6.97 7.27 6.93 7.35 7.32 7.06 6.98 7.24 6.77 7.12 7.22 6.98 7.47 7.5 7.68 7.57 7.88 7.45 7.12 6.64 6.86 7.47 6.97
GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX 7.36 7.56 6.99 6.79 7.62 7.88 7.75 7.97 7.59 7.84 7.43 8.16 7.9 7.93 7.92 7.73 7.41 7.89 7.95 8.16 7.72 7.71 7.67 8.04 7.76 7.73
GOCC_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX 5.31 5.18 4.73 5.07 4.41 4.34 4.89 4.9 5.25 4.62 4.98 4.78 4.7 4.69 4.95 4.92 4.76 5.12 4.72 4.8 5.06 4.82 4.71 4.53 4.74 4.62
GOCC_CAVEOLA 6.61 6.54 6.98 6.7 6.53 6.73 6.76 6.85 6.74 6.96 6.85 6.91 6.78 6.84 6.85 6.54 6.74 6.69 6.51 6.85 6.74 6.77 7.08 6.66 6.89 6.69
GOCC_MICROVILLUS 6.03 6.06 6.02 6.07 5.76 5.79 5.84 5.84 5.9 5.94 5.95 5.76 6.08 5.97 5.78 6 5.95 5.84 5.68 5.93 6.19 5.9 6.19 5.95 5.87 5.84
GOCC_BRUSH_BORDER 5.95 5.52 5.54 5.75 5.53 5.28 5.45 5.24 5.6 5.4 5.66 5.34 5.43 5.41 5.33 5.34 5.88 5.53 5.55 5.14 5.47 5.51 5.35 5.07 5.38 5.46
GOCC_CLATHRIN_COATED_PIT 7.68 7.64 8.12 7.61 8.06 8.05 8.16 8.12 7.93 8.07 7.87 8.05 7.96 8.11 8.13 8.12 7.82 7.86 7.86 8.16 7.78 8.13 7.95 8.4 8.23 8.02
GOCC_CELL_CELL_JUNCTION 6.68 6.56 6.83 6.62 6.75 6.67 6.83 6.72 6.82 6.89 6.54 6.71 6.75 6.79 6.73 6.76 6.77 6.58 6.55 6.79 6.75 6.8 6.87 6.95 7.01 6.86
GOCC_ADHERENS_JUNCTION 6.87 6.86 7.05 6.81 7.11 7.24 7.21 7.23 7.04 7.16 6.93 7.19 7.21 7.1 7.25 7.11 7.06 7.06 7.12 7.25 7.09 7.22 7.26 7.63 7.3 7.3
GOCC_GAP_JUNCTION 5.56 5.34 5.45 5.7 5.25 4.93 5.29 5.29 5.37 4.59 5.51 5.73 5.4 5.28 5.01 4.82 5.27 4.99 4.77 4.95 5.04 5.24 5.14 4.76 5.44 5.81
GOCC_CONNEXIN_COMPLEX 5.3 4.97 4.9 5.57 4.67 4.56 4.87 4.85 5.05 4.5 4.8 4.72 4.99 4.69 4.78 4.69 4.81 4.81 4.48 4.78 4.94 4.91 5.01 4.63 4.84 4.64
GOCC_CILIUM 6.01 6.08 6.06 6.18 5.89 5.98 6.05 6.02 5.98 6.17 6.17 6.14 6.02 6.1 6.1 6.23 6.03 6.1 6.05 6.03 6.1 6.18 6.03 6.05 6.1 6.14
GOCC_CELL_CORTEX 7.34 7.49 7.69 7.38 7.8 7.98 7.85 7.8 7.6 7.77 7.7 7.9 7.91 7.84 7.71 7.79 7.71 7.48 7.67 7.89 7.63 7.78 7.77 7.99 7.91 7.8
GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX 6.85 6.39 6.64 6.21 7.16 7.1 6.78 6.58 6.72 7.01 6.65 6.78 6.92 6.89 6.83 6.61 6.56 6.62 6.69 6.99 6.76 6.66 7.11 6.87 6.78 7.07
GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX 7.89 7.94 8.27 7.81 8.4 8.3 8.43 8.31 8.23 8.31 7.88 8.05 8.44 8.47 8.03 8 8.08 7.84 8.5 8.71 7.94 8.14 8.29 8.36 8.18 8.04
GOCC_COP9_SIGNALOSOME 8.09 8.26 8.99 8.85 8.3 8.52 8.57 8.52 8.57 8.68 8.35 8.51 8.37 8.43 8.66 8.75 8.46 8.5 8.28 8.47 8.77 8.48 8.62 8.68 8.67 8.5
GOCC_OLIGOSACCHARYLTRANSFERASE_COMPLEX 8.91 9.18 9.58 9.18 9.1 9.33 9.63 9.37 9.42 9.3 8.83 9.03 9.41 9.46 9.03 8.99 9.1 8.67 9 9.52 9.24 9.24 9.62 9.63 9.49 9.21
GOCC_COHESIN_COMPLEX 6.93 6.85 6.47 6.81 6.71 6.86 7.01 7.14 7 7.36 6.8 7.23 6.67 6.67 7.06 7.14 6.85 6.6 6.68 7.18 6.95 7.06 6.83 6.96 6.64 7.02
GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX 8.74 8.65 8.36 8.44 8.69 8.98 8.69 8.93 9.05 8.63 8.76 8.75 8.94 8.86 9.08 9.02 8.34 8.46 8.99 8.76 8.44 8.7 9.16 8.95 8.82 8.61
GOCC_NUCLEOID 7.1 7.07 7.57 7.69 7.22 7.16 7.34 7.65 7.61 7.53 7.67 7.5 7.58 7.52 7.43 7.8 7.1 7.25 7.49 7.57 7.33 7.7 7.53 7.83 7.9 7.78
GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE 5.44 5.26 5.23 5.34 5.11 4.87 5.16 5.1 5.17 4.97 5.21 4.94 5.08 5.03 5.03 5.04 5.21 5.24 5 4.94 5.33 5.2 4.99 4.85 5.04 5.24
GOCC_CELL_SURFACE 5.84 5.62 5.68 5.76 5.52 5.38 5.55 5.64 5.58 5.46 5.65 5.38 5.54 5.48 5.56 5.55 5.69 5.63 5.48 5.41 5.74 5.7 5.57 5.33 5.59 5.66
GOCC_ENDOSOME_MEMBRANE 7.45 7.42 7.74 7.6 7.66 7.71 7.76 7.55 7.7 7.67 7.59 7.65 7.72 7.76 7.67 7.58 7.57 7.48 7.55 7.78 7.5 7.71 7.85 7.96 7.74 7.56
GOCC_CHROMOCENTER 6.69 6.71 6.48 6.15 6.65 6.69 6.9 7.36 7.22 6.72 6.08 6.8 6.76 6.84 6.94 6.88 6.84 6.41 6.6 7.2 6.83 7.15 6.91 6.85 7.34 7.54
GOCC_CYTOPLASMIC_STRESS_GRANULE 8.42 8.29 8.54 8.36 8.74 8.7 8.46 8.21 8.73 8.62 8.3 8.34 8.58 8.58 8.41 8.45 8.12 8.08 8.75 8.51 8.03 8.36 8.76 8.83 8.61 8.45
GOCC_VESICLE_MEMBRANE 6.98 7.09 7.35 7.17 7.31 7.26 7.16 7.21 7.16 7.19 7.15 7.1 7.22 7.27 7.17 7.24 7.18 7.08 7.21 7.26 7.1 7.21 7.17 7.31 7.28 7.28
GOCC_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE 7.94 7.86 8.36 8.33 8.31 8.23 8.3 8.16 7.93 8.27 8.21 7.76 8.19 8.46 7.95 8.21 7.97 7.81 7.54 8.32 8.15 8.27 8.55 8.53 8.23 8.21
GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE 8.26 8.24 8.7 8.8 8.81 8.73 8.91 9 9 8.76 8.36 8.67 8.77 8.98 9.05 9.08 8.36 8.6 8.91 8.88 8.58 8.69 8.77 9.07 9.01 8.95
GOCC_INTERCALATED_DISC 7.19 7.11 7.42 7.01 7.19 7.1 7.21 7.34 7.46 7.45 7.46 7.48 7.46 7.2 7.36 7.11 7.26 7.07 6.77 7.58 7.46 7.32 7.68 7.43 7.68 7.39
GOCC_CAJAL_BODY 7.3 7.24 7.38 7.28 6.87 7.4 7.1 7.15 7.21 7.04 7.41 7.12 7.11 7.01 7.22 7.37 7 7.01 7.48 7.08 6.92 7.15 7.04 7.51 7.26 7.07
GOCC_ACTIN_CYTOSKELETON 6.68 6.65 6.66 6.57 6.79 6.7 6.8 6.92 6.82 6.82 6.6 6.83 6.82 6.74 6.75 6.8 6.86 6.76 6.77 6.79 6.74 6.8 6.97 6.81 6.88 6.89
GOCC_MICROTUBULE_CYTOSKELETON 6.7 6.73 7.02 6.89 6.94 6.98 6.95 6.92 6.88 7.05 6.91 7.01 6.99 6.9 6.94 6.99 6.87 6.86 6.8 6.93 6.78 6.99 6.97 7.08 7.03 7.02
GOCC_LARGE_RIBOSOMAL_SUBUNIT 6.99 7.17 8 7.79 6.94 7 7.12 7.34 7.12 7.21 7.49 7.04 7.14 7.1 7.49 7.57 6.84 6.8 6.97 7.19 7.1 7.18 7.31 7.35 7.1 7.07
GOCC_SMALL_RIBOSOMAL_SUBUNIT 6.66 6.99 7.8 7.36 6.78 7.16 7.16 7.1 7.11 7.29 7.39 6.94 7.17 7.38 7.28 7.66 7.11 6.98 6.97 7.4 7.14 7.24 7.29 7.51 7.11 7.21
GOCC_INCLUSION_BODY 7.64 7.68 8.06 7.72 8.21 8.13 8.1 8.13 8.05 8.3 7.83 8.16 8.13 8.1 8.13 8.08 7.83 7.96 7.95 8.05 8.08 8.1 8.38 8.52 8.13 8.25
GOCC_AGGRESOME 6.53 6.45 6.34 6.26 6.97 6.93 6.54 6.81 6.57 6.84 6.48 6.65 6.74 6.93 6.5 6.49 6.83 6.62 6.74 6.54 6.69 6.6 6.43 6.79 6.49 6.67
GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX 8.78 8.86 9.43 8.75 9.38 9.11 8.76 8.14 9.44 9.43 9.05 9.43 9.29 9.18 8.87 9.02 8.27 8.64 8.75 9 8.22 8.2 9.57 9.54 8.66 8.48
GOCC_BASOLATERAL_PLASMA_MEMBRANE 6.42 6.41 6.3 6.5 6.19 6.22 6.35 6.36 6.3 6.36 6.3 6.32 6.25 6.37 6.35 6.26 6.37 6.3 6.38 6.28 6.52 6.35 6.34 6.4 6.44 6.4
GOCC_APICAL_PLASMA_MEMBRANE 5.97 5.92 5.84 5.89 5.66 5.53 5.75 5.61 5.73 5.75 5.83 5.53 5.72 5.69 5.67 5.78 5.83 5.86 5.64 5.76 5.9 5.78 5.73 5.55 5.79 5.71
GOCC_APICOLATERAL_PLASMA_MEMBRANE 6.02 5.5 5.92 6.36 5.54 5.34 6.32 6.18 6.34 5.71 6.02 5.98 5.86 5.88 6.37 6.15 5.78 5.74 5.43 5.94 5.77 6.28 5.55 5.44 6.13 6.12
GOCC_LATERAL_PLASMA_MEMBRANE 6.51 6.84 6.97 6.66 6.66 6.87 7.37 7.38 6.94 7.35 7.1 7.23 6.89 7.18 7.3 7.3 6.83 7 7.02 6.86 7.26 7.26 7.35 7.53 7.15 7.23
GOCC_CATENIN_COMPLEX 6.66 6.57 6.93 6.27 6.79 7.05 7 6.78 7.04 6.93 6.5 6.69 6.84 6.78 7.18 6.92 6.73 6.44 6.76 6.91 6.45 6.73 6.93 7.12 6.94 6.72
GOCC_MYOSIN_COMPLEX 5.28 5.43 5.05 5.16 5 4.91 5.24 5.2 5.09 4.98 5.24 5.12 4.99 5.05 5.18 4.98 5.36 5.35 5.29 5.1 5.77 5.12 4.86 4.66 5.02 5.15
GOCC_MYOSIN_II_COMPLEX 5.19 5.41 4.84 4.78 4.47 4.28 4.74 5.05 4.71 4.6 4.76 4.77 4.52 4.65 4.83 4.96 5.66 5.51 5.4 4.71 5.91 4.74 4.5 4.29 4.55 4.79
GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX 8.37 8.36 9.32 8.81 8.6 8.84 8.96 8.88 8.89 8.84 9.1 8.91 8.9 8.97 9.18 8.9 8.25 8.26 8.6 8.79 8.56 8.63 9.05 9.19 8.87 8.44
GOCC_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX 6.43 6.52 6.92 6.44 6.63 6.69 6.47 6.73 6.49 6.38 6.28 6.4 6.24 6.46 6.28 6.24 6.83 6.74 6.48 6.92 6.78 6.67 6.4 6.24 6.49 6.44
GOCC_SWI_SNF_COMPLEX 8.22 8.21 8.26 7.97 8.59 8.38 8.76 8.8 8.43 8.45 8.17 8.4 8.56 8.52 8.6 8.67 8.22 8.04 8.49 8.57 8.46 8.38 8.41 8.57 8.71 8.38
GOCC_SARCOPLASM 6.94 7.03 7.45 7.04 7.19 7.31 7.49 7.31 7.34 7.25 7.25 7.43 7.41 7.56 7.65 7.45 7.39 7.25 7.25 7.3 7.52 7.68 7.58 7.73 7.5 7.43
GOCC_SIN3_COMPLEX 7.2 7.54 7.4 6.89 7.77 7.86 8.14 7.67 7.72 7.66 7.02 7.86 7.69 7.8 7.61 7.45 7.49 7.68 7.62 8.03 7.37 7.59 7.77 7.81 7.92 7.64
GOCC_NURD_COMPLEX 7.69 7.9 7.85 7.35 8.42 8.39 8.36 8.41 8.39 8.24 7.68 8.29 8.31 8.35 8.39 8.3 8.11 8.5 8.48 8.37 8.12 8.28 8.2 8.23 8.35 8.31
GOCC_RNA_POLYMERASE_II_HOLOENZYME 7.56 7.42 8.34 8.23 7.71 8.06 7.81 8.14 8.04 8.19 7.96 8.06 8.08 8.14 8.14 8.21 7.59 7.72 7.84 7.96 7.58 8.15 8.05 8.11 8.04 8
GOCC_MEDIATOR_COMPLEX 7 7.43 7.24 7.45 7.99 7.69 8.14 7.46 7.68 7.82 7.45 7.73 7.93 7.88 7.63 7.69 7.57 7.44 7.77 7.65 7.4 7.4 7.72 7.98 7.66 7.52
GOCC_NUCLEAR_BODY 6.93 7.02 7.03 7.07 7.32 7.3 7.18 7.19 7.15 7.23 7.06 7.22 7.21 7.24 7.27 7.29 7.07 6.95 7.14 7.28 7.03 7.21 7.23 7.37 7.26 7.3
GOCC_PML_BODY 6.83 6.88 6.84 7.09 7.27 7.1 6.99 7.03 7.1 7.09 6.95 7.22 7.33 7.05 7.23 7.17 7.14 6.9 7 7.26 6.94 7.12 7.4 7.44 7.27 7.01
GOCC_NUCLEAR_SPECK 7.14 7.24 7.18 7.21 7.52 7.57 7.32 7.39 7.34 7.44 7.16 7.39 7.42 7.45 7.52 7.48 7.3 7.22 7.38 7.4 7.16 7.38 7.43 7.61 7.41 7.44
GOCC_TRANSCRIPTION_REPRESSOR_COMPLEX 7.12 7.24 7.26 6.97 7.56 7.48 7.8 7.3 7.66 7.63 7.27 7.82 7.74 7.75 7.5 7.4 7.78 7.67 7.47 7.87 7.41 7.48 7.52 7.8 7.92 7.64
GOCC_GOLGI_TRANSPORT_COMPLEX 7.01 6.87 7.9 7.67 7.3 7.5 7.4 7.28 7.44 7.24 6.93 7.36 7.31 7.08 6.99 6.94 6.77 6.5 6.97 7.26 6.8 6.59 7.71 7.47 7.19 7.08
GOCC_HOST_CELLULAR_COMPONENT 7.44 7.47 8.11 7.89 7.65 7.65 7.56 7.47 7.59 7.55 7.58 7.79 7.53 7.78 7.6 7.66 7.52 7.4 7.39 7.58 7.28 7.72 7.48 7.83 7.79 7.65
GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX 7.12 7.05 7.65 7.55 7.44 7.21 7.44 7.37 7.77 7.26 7.55 7.3 7.51 7.61 7.38 7.53 7.22 7.12 7.46 7.37 7.23 7.51 7.6 7.72 7.22 7.22
GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX 7.16 8.04 9.77 9.53 8.27 8.63 8.86 8.39 8.79 8.69 9.22 8.66 8.57 8.7 8.78 8.93 8.18 7.38 7.62 8.34 7.93 8.36 8.69 8.55 8.57 8.14
GOCC_ORGANELLE_INNER_MEMBRANE 6.88 6.96 7.79 7.63 7.13 7.2 7.24 7.42 7.15 7.28 7.4 7.2 7.21 7.31 7.33 7.44 7.08 7.08 7.17 7.31 7.08 7.41 7.2 7.39 7.29 7.27
GOCC_OUTER_MEMBRANE 7.16 7.45 7.83 7.48 7.66 7.72 7.73 7.72 7.68 7.72 7.55 7.81 7.68 7.69 7.78 7.76 7.6 7.62 7.62 7.48 7.54 7.79 7.8 7.96 7.68 7.68
GOCC_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE 6.98 6.87 7.41 7.13 7.06 7.22 7.28 7.18 7.31 7.27 7.12 7.21 7.38 7.2 7.53 7.26 7.07 7.01 7.24 7.15 7.19 7.4 7.35 7.42 7.42 7.4
GOCC_EXTRINSIC_COMPONENT_OF_MEMBRANE 6.81 6.72 7.03 6.99 6.97 7.1 6.97 7.01 7.04 7.04 6.91 6.95 7.11 6.99 7.24 7.05 6.94 6.84 7.03 7.08 6.98 7.14 7.13 7.24 7.09 7.04
GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX 8.32 8.43 8.31 8.42 8.65 8.79 8.46 8.36 8.54 8.71 8.36 8.17 8.6 8.65 8.34 8.49 8.52 8.41 8.59 8.6 8.29 8.44 8.82 8.67 8.46 8.45
GOCC_PROTEASOME_ACCESSORY_COMPLEX 7.74 8.04 8.47 8.63 8.44 8.44 8.45 8.56 8.62 8.46 8.33 8.26 8.38 8.53 8.88 8.58 7.66 8.06 8.28 8.68 8.11 8.48 8.76 8.77 8.6 8.47
GOCC_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT 6.8 6.59 7.52 7.63 6.4 6.46 6.92 7.05 6.69 6.62 7.31 6.23 6.81 6.73 6.98 6.83 6.64 6.8 6.73 6.48 7.07 7.14 6.64 6.67 6.92 7
GOCC_CYTOSOLIC_RIBOSOME 6.67 6.7 7.24 7.15 6.4 6.46 6.86 6.89 6.69 6.43 7.23 6.22 6.81 6.73 6.98 6.74 6.83 6.8 6.7 6.48 7.08 6.96 6.69 6.67 6.78 6.73
GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT 6.07 6.11 7.17 6.06 5.59 5.6 5.91 5.47 5.65 5.72 6.61 5.57 5.91 5.92 6.2 6.27 5.84 5.95 5.65 5.58 6.34 5.66 5.95 6.08 5.59 5.53
GOCC_TRAPP_COMPLEX 7.39 7.74 8.48 8.9 8.22 8.33 8.31 7.9 8.33 8.48 7.99 8.1 8.12 8.36 8.04 8.44 7.51 7.58 8.32 8.5 7.52 8 8.6 8.85 7.87 7.68
GOCC_CCR4_NOT_COMPLEX 7.9 7.9 7.8 7.9 8.07 7.82 7.99 8.01 7.8 7.75 7.51 7.73 7.89 7.99 7.69 7.69 7.76 7.81 7.8 7.99 7.7 7.9 8.01 8.04 7.78 7.67
GOCC_LAMELLIPODIUM 7.25 7.37 7.43 7.12 7.61 7.76 7.56 7.66 7.6 7.63 7.47 7.68 7.68 7.79 7.59 7.6 7.48 7.39 7.41 7.61 7.39 7.58 7.82 7.83 7.59 7.51
GOCC_CELL_SUBSTRATE_JUNCTION 7.22 7.16 7.37 7.23 7.62 7.62 7.58 7.41 7.53 7.49 7.47 7.54 7.61 7.61 7.52 7.55 7.67 7.34 7.34 7.63 7.6 7.61 7.72 7.77 7.68 7.53
GOCC_DESMOSOME 5.28 5.03 4.98 5.21 4.93 4.72 5.05 4.82 4.94 4.93 5.19 5.03 4.93 5.13 4.88 4.77 5.09 5.21 5.06 4.73 5.29 4.98 4.77 4.84 4.98 4.89
GOCC_MEMBRANE_COAT 8.1 8.14 8.74 8.53 8.73 8.63 8.54 8.35 8.8 8.48 8.35 8.4 8.61 8.64 8.4 8.48 8.07 8.13 8.23 8.47 8.25 8.47 8.57 8.73 8.55 8.54
GOCC_CLATHRIN_COAT 8.13 8.21 8.64 8.43 8.81 8.66 8.67 8.68 8.73 8.61 8.27 8.53 8.69 8.8 8.73 8.6 8.26 8.25 8.34 8.52 8.42 8.58 8.57 8.81 8.7 8.68
GOCC_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX 8.13 8.05 8.52 7.97 8.74 8.63 8.54 8.42 8.65 8.51 8.12 8.44 8.59 8.68 8.49 8.58 8.01 8.11 8.17 8.47 8.16 8.38 8.56 8.69 8.64 8.63
GOCC_VESICLE_COAT 8.31 8.38 9.02 9.03 8.84 8.72 9.1 8.64 9.11 8.7 8.62 8.64 8.86 8.88 8.78 8.96 8.42 8.53 8.88 8.92 8.59 8.57 8.77 9 8.79 8.7
GOCC_CLATHRIN_VESICLE_COAT 8.38 8.43 9 9.01 8.84 8.73 9.28 9.49 9.12 8.91 8.63 8.76 9.02 9.17 9.46 9.16 8.8 8.84 8.9 9.29 8.8 8.79 8.77 9.22 9.32 9.11
GOCC_COPI_VESICLE_COAT 7.9 8.17 8.95 8.86 8.55 8.51 8.5 8.21 8.93 8.48 8.45 8.3 8.71 8.64 8.24 8.09 8.1 7.9 8.29 8.45 7.9 8.21 8.68 8.86 8.37 7.85
GOCC_COPII_VESICLE_COAT 8.23 8.01 9.18 9.38 8.64 8.86 8.73 8.34 9.2 8.74 8.87 8.5 8.77 8.94 8.34 8.56 7.93 8.12 8.53 8.67 8.1 8.37 8.96 9.01 8.52 8.35
GOCC_CLATHRIN_COAT_OF_ENDOCYTIC_VESICLE 8.95 9.33 9.04 9.18 9.03 8.73 9.42 9.66 9.17 9.13 8.89 9.2 9.28 9.18 9.59 9.2 9.07 9.34 9.09 9.31 9.43 9.47 9.02 9.48 9.55 9.41
GOCC_CLATHRIN_ADAPTOR_COMPLEX 8.14 8.06 8.61 8.02 8.83 8.67 8.79 8.86 8.79 8.61 8.15 8.58 8.63 8.8 8.56 8.6 8.23 8.14 8.18 8.54 8.37 8.57 8.58 8.88 8.71 8.69
GOCC_CLATHRIN_COAT_OF_COATED_PIT 9.18 9.21 9.32 9.3 9.07 9.19 9.52 9.75 9.31 9.45 9.04 9.35 9.29 9.42 9.75 9.56 9.36 9.44 9.37 9.46 9.24 9.49 9.47 9.49 9.57 9.57
GOCC_TRANSPORT_VESICLE 7.57 7.62 7.98 7.89 7.86 8.04 8.03 7.97 7.8 8.09 7.76 7.91 8 8.02 8 7.87 7.77 7.72 7.75 8.1 7.76 8.01 8 8.17 7.89 7.95
GOCC_COPII_COATED_ER_TO_GOLGI_TRANSPORT_VESICLE 7.59 7.8 8.27 8.07 7.93 8 8.15 8.03 7.67 7.87 7.67 7.69 7.95 7.87 7.67 8.06 7.69 7.59 7.51 8.11 7.84 8.21 8.12 8.13 8.04 8
GOCC_COATED_VESICLE 7.43 7.46 7.98 7.75 7.83 7.95 8.01 7.87 7.55 7.86 7.54 7.67 7.81 7.81 7.8 7.78 7.67 7.48 7.57 8.05 7.6 7.82 7.75 7.99 7.94 7.74
GOCC_CLATHRIN_COATED_VESICLE 7.23 7.23 7.53 7.33 7.54 7.67 7.53 7.48 7.34 7.4 7.4 7.42 7.46 7.66 7.49 7.49 7.35 7.33 7.45 7.52 7.26 7.5 7.55 7.59 7.64 7.55
GOCC_COPI_COATED_VESICLE 8.53 8.9 8.95 8.96 8.77 9.2 9.22 8.71 9 8.81 8.68 8.85 8.88 8.96 8.98 9.07 8.83 8.76 8.89 9.38 8.54 8.55 8.87 9.01 8.92 8.98
GOCC_ENDOCYTIC_VESICLE 7.01 7 7.38 7.15 7.34 7.34 7.21 7.33 7.39 7.33 7.28 7.29 7.35 7.37 7.17 7.39 7.36 7.19 7.18 7.44 7.28 7.45 7.44 7.48 7.36 7.38
GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE 8.11 8.06 8.34 8.59 8.8 8.64 8.55 8.34 8.91 8.6 8.1 8.58 8.51 8.58 8.73 8.93 7.84 8.1 8.79 8.45 8.05 8.58 8.76 8.91 8.7 8.56
GOCC_SECRETORY_GRANULE 6.4 6.37 6.56 6.56 6.53 6.43 6.5 6.53 6.43 6.32 6.51 6.34 6.47 6.33 6.46 6.47 6.5 6.33 6.32 6.43 6.5 6.59 6.47 6.52 6.72 6.71
GOCC_FILOPODIUM 7.55 7.44 8.06 7.19 7.95 8.05 7.96 7.7 8 7.75 7.8 7.9 8.08 7.88 7.98 7.95 7.71 7.44 7.77 7.95 7.71 7.7 8.12 8.03 8.03 7.82
GOCC_INTEGRAL_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE 8.39 7.95 8.07 8.43 8.75 8.63 8.59 8.6 8.67 8.6 8.44 8.61 8.73 8.83 8.58 8.53 8.44 8.27 8.62 8.92 7.85 8.3 8.37 8.61 8.6 8.8
GOCC_DYNEIN_COMPLEX 6.33 6.27 6.09 6.02 5.96 6.31 6.29 6.42 6.03 6.39 6.26 6.28 6.28 6.34 6.32 6.6 6.5 6.27 6.43 6.54 6.27 6.54 5.87 6.33 6.21 6.33
GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE 5.6 5.43 5.38 5.56 5.17 5.08 5.43 5.34 5.36 5.18 5.47 5.24 5.25 5.25 5.39 5.32 5.42 5.47 5.21 5.2 5.61 5.34 5.41 4.99 5.37 5.37
GOCC_T_TUBULE 7.36 7.89 7.94 7.75 7.71 7.88 7.58 7.77 7.89 7.84 7.93 8.22 7.77 7.81 7.93 7.79 7.75 7.64 7.95 8.26 7.84 8.08 7.67 7.73 8.02 8.09
GOCC_AXON 7.84 8 8.05 7.68 8.36 8.42 8.38 8.28 8.29 8.38 8.04 8.4 8.4 8.42 8.36 8.26 8.01 8.07 8.16 8.29 8.04 8.27 8.43 8.52 8.34 8.13
GOCC_SITE_OF_POLARIZED_GROWTH 7.99 8.09 8.17 8.02 8.52 8.57 8.52 8.47 8.52 8.56 8.08 8.51 8.4 8.43 8.56 8.37 8.36 8.26 8.23 8.36 8.43 8.47 8.57 8.65 8.58 8.33
GOCC_MIDBODY 7.08 7.15 7.47 7.35 7.34 7.5 7.3 7.47 7.29 7.52 7.26 7.45 7.56 7.47 7.39 7.38 7.24 7.34 7.37 7.52 7.14 7.58 7.56 7.6 7.58 7.5
GOCC_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX 7.17 7.48 7.63 7.88 7.34 7.31 7.27 7.4 7.43 7.37 7.47 7.35 7.29 7.3 7.53 7.61 7.19 7.09 7.37 7.52 7.34 7.56 7.25 7.74 7.55 7.49
GOCC_TRANSPORT_VESICLE_MEMBRANE 7.9 7.85 8.14 8.06 8.3 8.26 8.32 8.25 7.99 8.3 7.92 8.02 8.24 8.29 8.22 8.1 7.83 7.84 7.98 8.3 7.85 8.16 8.28 8.37 8.15 8.14
GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE 8.07 8.01 8.54 8.64 8.5 8.52 8.49 8.08 8.8 8.47 8.11 8.34 8.46 8.34 8.31 8.08 7.87 7.81 8.13 8.34 7.91 8.21 8.61 8.73 8.28 7.94
GOCC_COATED_VESICLE_MEMBRANE 7.75 7.71 8.21 8.05 8.05 8.22 8.21 8.08 7.91 8.16 7.76 7.84 8.17 8.01 8.1 7.92 7.8 7.71 7.82 8.21 7.74 7.98 8.02 8.24 8.12 7.91
GOCC_COPI_COATED_VESICLE_MEMBRANE 8.22 8.53 8.95 8.97 8.69 8.66 8.64 8.34 8.86 8.51 8.48 8.4 8.84 8.64 8.38 8.12 8.43 8.16 8.86 8.49 7.91 8.29 8.71 8.9 8.47 7.92
GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE 7.48 7.34 7.64 7.39 7.77 7.84 7.8 7.51 7.47 7.4 7.47 7.52 7.66 7.8 7.5 7.49 7.58 7.67 7.61 7.89 7.41 7.64 7.52 7.49 7.71 7.67
GOCC_ENDOCYTIC_VESICLE_MEMBRANE 6.85 6.81 7.5 7.28 7.42 7.39 7.1 7.24 7.4 7.16 7.1 6.92 7.26 7.29 6.83 7.39 7.29 7.08 6.91 7.47 7.12 7.44 7.19 7.44 7.38 7.38
GOCC_SECRETORY_GRANULE_MEMBRANE 6.59 6.65 6.69 6.67 6.92 6.84 6.77 6.84 6.81 6.5 6.73 6.65 6.68 6.68 6.58 6.53 6.64 6.6 6.53 6.8 6.8 6.7 6.76 6.9 6.93 7.04
GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE 7.05 7.41 7.65 7.14 7.99 8.13 8.32 7.7 7.4 7.08 6.14 6.89 7.66 7.62 7.15 7.37 7.96 7.5 7.29 8.17 6.67 7.29 7.31 7.46 7.56 7.32
GOCC_PHAGOCYTIC_VESICLE_MEMBRANE 6.99 7.1 7.83 7.54 7.42 7.29 6.98 7.29 7.57 7.33 7.45 6.92 7.38 7.4 7.07 7.62 7.29 7.15 6.92 7.47 7.4 7.63 7.71 7.8 7.49 7.58
GOCC_SYNAPTIC_VESICLE_MEMBRANE 8.1 8.01 8.25 8.32 8.47 8.57 8.64 8.79 8.38 8.53 8.33 8.44 8.64 8.43 8.66 8.54 8.12 8.3 8.53 8.88 7.92 8.34 8.53 8.52 8.59 8.48
GOCC_AXOLEMMA 8.81 8.49 8.08 7.89 9.02 9.09 9.34 8.82 9.07 9.24 8.5 8.57 8.84 8.89 9.51 9.39 7.73 8.57 8.87 8.97 8.59 8.25 8.89 9.39 8.71 8.34
GOCC_RIBONUCLEASE_P_COMPLEX 6.13 5.92 7.26 6.76 6.03 6.56 6.86 6.61 6.51 6.29 6.52 6.38 6.14 6.24 6.73 6.75 6.16 5.93 6.09 6.56 6.29 6.58 6.65 6.82 6.66 6.52
GOCC_MULTIMERIC_RIBONUCLEASE_P_COMPLEX 6.12 5.82 7.02 6.68 5.93 6.6 6.82 6.52 6.49 6.13 6.11 6.16 5.96 6.01 6.13 6.33 5.91 5.87 6.04 6.49 5.82 6.25 6.58 6.38 6.43 5.98
GOCC_PRERIBOSOME 6.14 6.43 6.51 6.58 6.51 6.33 6.3 6.6 6.26 6.57 6.48 6.59 6.62 6.39 6.64 6.84 6.3 6.34 6.54 6.51 6.44 6.52 6.41 6.69 6.51 6.52
GOCC_90S_PRERIBOSOME 6.09 6.32 6.78 6.45 6.51 6.2 6.28 6.37 6.24 6.44 6.35 6.78 6.62 6.39 6.74 6.71 6.3 6.43 6.48 6.45 6.31 6.41 6.33 6.52 6.41 6.51
GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR 6.8 6.65 6.51 6.6 6.53 6.67 6.5 6.93 6.46 6.96 6.77 6.99 7.02 6.77 7.19 6.85 6.35 6.45 6.73 6.67 6.44 6.95 6.81 6.95 6.57 6.52
GOCC_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR 5.87 6.19 5.64 5.48 5.8 5.99 5.88 5.81 5.99 5.96 5.97 5.98 5.88 5.93 5.9 6.29 6.13 6.1 5.96 5.94 5.79 5.8 6.08 6.24 5.82 5.95
GOCC_CORTICAL_CYTOSKELETON 7.44 7.54 7.7 7.29 7.72 8.01 8.02 7.93 7.85 8.01 7.7 8.08 7.94 7.94 7.99 7.98 7.76 7.64 7.85 8.02 7.63 7.92 7.84 8.1 8.07 7.99
GOCC_CORTICAL_ACTIN_CYTOSKELETON 7.23 7.44 7.24 7.11 7.6 7.88 8.02 7.75 7.64 7.8 7.5 8.04 7.79 7.81 7.77 7.87 7.65 7.47 7.64 7.91 7.62 7.85 7.79 8.11 7.97 7.89
GOCC_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE 7.67 7.54 8.54 8.09 7.98 8.01 8.14 8.33 8.29 8.29 8.29 8.36 8.36 8.18 8.15 8.14 8.1 7.89 7.93 8.09 7.94 8.05 8.3 8.51 8.19 8.09
GOCC_BETA_CATENIN_DESTRUCTION_COMPLEX 7.11 6.74 7.44 7.3 7.32 7.52 6.76 7.06 6.96 7.38 7.54 7 7.32 7.15 7.39 7.11 7.29 6.78 7.26 6.92 7.02 7.27 7.36 7.57 7.06 6.85
GOCC_RNA_POLYMERASE_COMPLEX 6.91 7.26 7.48 7.81 7.17 7.26 7.32 7.6 7.59 7.56 7.35 7.54 7.37 7.46 7.67 7.68 7.23 7.28 7.16 7.53 7.32 7.63 7.56 7.82 7.48 7.52
GOCC_REPLISOME 5.95 5.96 6.47 6.41 6.04 6.26 6.15 6.18 6.09 6.3 6.06 6 5.9 6.02 6.14 6.16 5.99 5.8 5.94 6.19 6.09 6.15 6.14 6.55 6.41 6.52
GOCC_HOPS_COMPLEX 6.63 6.28 6.98 7.19 6.72 6.6 7.03 7.22 7.23 6.95 7.33 6.64 6.63 6.86 6.71 6.8 6.3 6.58 7.12 6.87 6.75 6.66 7 7.36 6.87 6.56
GOCC_RETROMER_COMPLEX 8.27 8.2 9.32 8.7 8.64 8.55 8.85 8.83 9.23 8.77 8.63 8.83 9.02 8.79 8.76 8.6 8.39 8.17 8.11 8.99 8.1 8.58 9.52 9.12 8.63 8.41
GOCC_STAGA_COMPLEX 7.96 8.08 8.51 8.43 8.39 8.61 8.11 8.31 8.16 8.5 7.89 8.27 8.44 8.33 8.21 8.39 8.05 8.29 8.58 8.37 7.95 8.5 7.98 8.18 8.16 8.22
GOCC_NADH_DEHYDROGENASE_COMPLEX 8.34 8.4 9.54 9.47 8.47 8.55 8.93 9.21 8.66 8.77 9.07 8.66 8.54 8.64 9.4 9.48 8.65 8.63 8.32 8.82 8.61 9.15 8.53 8.74 8.6 9.05
GOCC_INTRACILIARY_TRANSPORT_PARTICLE 6.32 6.42 6.87 6.58 6.32 6.4 6.33 6.46 6.21 6.57 6.85 6.73 6.35 6.41 6.45 6.77 6.28 6.54 6.8 6.35 6.36 6.7 6.49 6.48 6.59 6.69
GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B 6.21 6.37 6.99 6.57 6.29 6.4 6.34 6.46 6.41 6.57 6.63 6.73 6.29 6.38 6.59 6.84 6.2 6.34 6.77 6.25 6.36 6.58 6.38 6.71 6.59 6.46
GOCC_ISWI_TYPE_COMPLEX 6.5 6.61 7 6.94 7.14 7.01 6.86 6.71 7.15 6.63 6.92 6.75 7.11 7.34 6.39 6.68 6.58 6.36 6.72 7 6.28 6.71 6.93 7.12 6.91 6.66
GOCC_DENSE_CORE_GRANULE 8.62 8.4 7.84 8.35 8.72 8.47 8.72 8.7 8.4 8.6 8.18 8.67 8.51 8.43 8.49 8.32 8.12 7.86 8.56 8.86 7.84 8.54 8.06 8.25 8.22 8.2
GOCC_BLOC_COMPLEX 6.53 6.8 7.29 7.1 6.66 7.03 6.99 6.84 6.78 7.14 6.83 6.8 6.81 6.96 6.98 7.01 6.6 7 6.78 7.11 6.62 6.71 7.25 7.33 6.94 7.05
GOCC_BLOC_1_COMPLEX 6.61 6.84 8.19 7.51 6.81 7.49 7.54 6.91 7.13 7.22 6.98 6.92 6.87 6.97 7.07 7.04 6.7 7.01 6.8 7.48 6.67 7.27 7.31 7.55 7.05 7.13
GOCC_PLATELET_DENSE_GRANULE_LUMEN 5.95 5.87 5.52 6.02 5.1 5.09 5.53 5.6 5.89 5.34 6.01 5.07 5.55 5.26 5.46 5.55 5.91 5.24 5.27 5.21 5.56 5.41 5.28 4.78 5.55 5.3
GOCC_PLATELET_ALPHA_GRANULE 6.06 6.11 6.4 6.22 6.06 6.14 6.01 6 5.72 6.23 6.14 6.1 5.98 5.91 6.06 6.18 6.33 6.06 6.25 5.89 6.31 6.42 6.32 6.17 6.24 6.28
GOCC_PLATELET_ALPHA_GRANULE_MEMBRANE 6.17 6.36 6.85 6.53 6.99 6.94 6.84 6.8 7.08 6.63 6.8 6.6 6.92 7.09 6.59 6.36 6.64 6.24 6.76 6.64 6.94 6.89 7.13 7.09 6.69 6.7
GOCC_PLATELET_ALPHA_GRANULE_LUMEN 5.89 5.56 6.07 5.78 5.86 5.54 5.65 5.79 5.63 5.48 5.91 5.82 5.82 5.65 5.68 5.88 6.01 5.94 5.67 5.5 6.2 6.35 6.16 5.64 6.12 5.95
GOCC_PSEUDOPODIUM 8.92 8.78 8.79 8.58 8.88 8.91 9.03 8.86 9.11 8.99 8.68 8.76 9.13 9.04 8.73 8.95 8.59 8.82 8.82 9.05 8.82 8.71 9.1 9.15 8.8 8.92
GOCC_SNARE_COMPLEX 6.88 7.32 8.12 8.04 7.88 7.9 7.59 7.7 7.62 7.88 7.65 7.84 7.85 7.74 7.79 7.53 7.61 7.36 7.4 7.84 7.4 7.72 7.94 8.09 7.62 7.58
GOCC_ANCHORED_COMPONENT_OF_MEMBRANE 5.79 5.58 5.68 5.67 5.36 5.42 5.55 5.67 5.47 5.38 5.6 5.5 5.41 5.41 5.66 5.61 5.56 5.54 5.45 5.38 5.62 5.66 5.5 5.45 5.45 5.41
GOCC_INTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE 5.95 5.84 5.81 5.94 5.67 5.54 5.77 5.75 5.82 5.72 5.78 5.57 5.72 5.71 5.78 5.76 5.81 5.86 5.66 5.69 5.87 5.73 5.67 5.57 5.75 5.77
GOCC_INTRINSIC_COMPONENT_OF_ENDOPLASMIC_RETICULUM_MEMBRANE 7.59 7.92 8.1 7.87 7.94 8.06 8.07 8.06 7.94 7.79 7.59 7.68 7.98 7.9 7.95 7.73 7.66 7.62 7.81 8.17 7.55 7.75 7.96 8.18 7.94 7.79
GOCC_INTRINSIC_COMPONENT_OF_GOLGI_MEMBRANE 7.28 7.43 7.84 7.86 7.73 7.93 7.87 7.77 7.94 7.82 7.47 7.7 7.72 7.69 7.55 7.56 7.32 7.26 7.2 7.93 7.34 7.68 7.66 7.76 7.66 7.36
GOCC_INTRINSIC_COMPONENT_OF_NUCLEAR_INNER_MEMBRANE 6.7 6.66 6.57 6.8 6.94 6.98 6.65 6.61 6.77 6.53 6.47 6.76 6.59 6.79 6.66 6.37 6.51 6.82 6.68 6.67 6.71 6.59 6.42 6.57 6.53 6.55
GOCC_INTRINSIC_COMPONENT_OF_PEROXISOMAL_MEMBRANE 6.88 6.89 7.07 7.02 7.13 7.48 7.03 6.67 7 7.21 6.6 6.92 7.21 7.5 6.48 6.64 6.85 6.8 7.05 7.03 6.84 6.46 7.02 7.28 6.37 6.1
GOCC_INTRINSIC_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE 6.07 5.85 6.2 6.48 5.58 5.56 5.7 5.84 5.72 5.48 5.66 5.35 5.42 5.49 5.67 5.77 6.03 5.87 5.53 5.62 6.16 5.94 5.7 5.68 6 5.75
GOCC_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE 7.13 6.93 7.46 7.17 7.11 7.24 7.26 7.47 7.6 7.33 7.22 7.27 7.56 7.32 7.63 7.59 7.29 7.05 7.26 7.37 7.24 7.48 7.54 7.54 7.51 7.47
GOCC_PROTEIN_ACETYLTRANSFERASE_COMPLEX 7.72 7.77 8.19 8.17 8.05 8.12 8.02 7.97 7.81 8.13 7.99 7.86 8.17 8.17 8.16 8.32 7.83 7.72 8.04 7.84 7.69 8.15 8.05 8.09 8.13 8.05
GOCC_CELL_LEADING_EDGE 7.36 7.44 7.55 7.38 7.72 7.83 7.77 7.7 7.7 7.76 7.54 7.75 7.88 7.84 7.73 7.74 7.6 7.46 7.61 7.77 7.48 7.82 7.88 8.01 7.69 7.57
GOCC_CELL_PROJECTION_MEMBRANE 6.89 6.94 6.9 6.75 7.08 7.15 6.97 7.04 6.93 7.05 6.85 7.01 7.12 7.04 7.06 7.14 6.92 6.79 7.05 7.04 7.02 6.95 6.98 6.97 7.01 6.94
GOCC_CELL_TRAILING_EDGE 6.73 6.89 7.46 7.53 7.33 7.53 7.67 7.32 7.37 7.09 7.6 7.45 7.41 7.78 7.3 7.41 7.76 7.03 6.71 7.64 7.67 8.26 7.43 7.47 7.88 7.87
GOCC_LEADING_EDGE_MEMBRANE 7.36 7.54 7.46 7.27 7.6 7.75 7.8 7.78 7.62 7.76 7.28 7.62 7.7 7.66 7.55 7.64 7.43 7.42 7.61 7.68 7.39 7.62 7.7 7.95 7.51 7.45
GOCC_LAMELLIPODIUM_MEMBRANE 6.51 6.23 6.37 6.07 6.19 6.43 5.77 6.23 6.75 6.11 5.76 5.88 6.25 6.43 6.2 6.63 6.37 6.48 6.7 6.64 6.45 6.51 6.31 5.77 6.26 5.96
GOCC_DNA_REPLICATION_PREINITIATION_COMPLEX 5.65 5.5 5.45 5.98 5.34 5.08 5.47 5.65 5.4 5.4 5.64 5.35 5.34 5.2 5.45 5.55 5.28 5.46 5.32 5.41 5.59 5.23 5.34 5.72 5.63 6.03
GOCC_INTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE 7.36 7.51 7.87 7.84 7.79 7.81 7.81 7.92 7.76 7.83 7.62 7.68 7.81 7.78 7.75 7.66 7.59 7.61 7.7 7.93 7.54 7.72 7.83 7.99 7.75 7.65
GOCC_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE 7.09 7.23 7.83 7.84 7.51 7.61 7.69 7.64 7.53 7.59 7.61 7.57 7.68 7.75 7.68 7.89 7.35 7.52 7.72 7.77 7.46 7.66 7.79 7.96 7.58 7.73
GOCC_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_OUTER_MEMBRANE 7.34 7.33 7.09 7.43 7.83 7.83 7.68 7.78 7.76 7.93 7.62 8.25 7.98 7.96 7.89 7.76 7.82 7.5 7.78 7.73 8 7.81 7.96 8.05 7.82 7.6
GOCC_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE 6.46 6.66 6.59 6.5 6.61 6.66 6.65 6.95 6.64 6.6 6.69 6.81 6.77 6.63 7.01 6.7 6.57 6.68 6.5 6.65 6.64 6.78 6.54 6.72 6.82 6.81
GOCC_RNAI_EFFECTOR_COMPLEX 7.85 7.76 7.76 7.63 8.02 7.82 7.86 7.35 7.93 8.09 7.61 7.81 7.79 8.06 7.47 7.77 7.47 7.59 7.87 7.68 7.45 7.67 7.76 7.66 7.71 7.63
GOCC_ANCHORED_COMPONENT_OF_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE 6.07 5.85 6.09 7.05 5.58 5.56 5.65 5.84 5.72 5.35 5.66 5.35 5.42 5.49 5.67 5.77 6.03 5.87 5.53 5.62 6.15 5.89 5.7 5.68 6 5.69
GOCC_M_BAND 6.05 5.58 5.57 5.92 5.59 5.59 5.53 5.45 5.62 5.46 6.22 5.82 5.6 5.49 5.74 5.6 5.81 5.94 5.71 5.78 5.77 5.59 5.59 5.73 5.52 5.52
GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX 7.16 7.28 7.71 7.68 7.53 7.55 7.42 7.41 7.74 7.55 7.58 7.42 7.62 7.64 7.44 7.59 7.27 7.28 7.47 7.35 7.37 7.46 7.77 7.77 7.52 7.37
GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX 7.33 7.33 8.17 8.08 7.87 8.12 7.93 7.52 7.98 8.1 8.06 8.02 8.02 8.2 7.79 7.76 7.79 7.57 7.91 7.58 7.55 7.68 8.08 8.16 7.94 7.78
GOCC_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX 9.06 9.02 9.61 9.19 9.16 9.28 9.16 9.2 9.36 9.47 8.93 8.97 9 8.98 9.17 9.23 9.08 8.61 8.41 8.99 9.08 8.87 9.12 9.17 9.27 9.47
GOCC_MOTILE_CILIUM 5.67 5.56 5.5 5.78 5.33 5.31 5.52 5.42 5.39 5.67 5.89 5.48 5.31 5.43 5.61 5.81 5.59 5.71 5.59 5.37 5.54 5.41 5.37 5.24 5.3 5.64
GOCC_PCG_PROTEIN_COMPLEX 7.55 7.62 7.56 7.63 7.95 8.12 7.69 7.59 7.41 7.67 7.6 7.77 7.86 7.87 7.66 8.13 7.44 7.75 7.86 7.71 7.35 7.54 7.56 7.78 7.73 7.94
GOCC_BRUSH_BORDER_MEMBRANE 5.52 5.27 5.33 5.46 5.16 5.11 5.32 5.1 5.26 5.14 5.44 5.14 5.06 4.99 5.08 5.15 5.38 5.39 5.12 5.01 5.3 5.11 4.99 4.93 5.14 5.12
GOCC_FILOPODIUM_MEMBRANE 7.35 7.36 6.69 6.52 7.14 7.13 7.52 7.35 7.35 7.16 7.07 7.38 7.28 7.41 7.21 7.34 7.43 7.4 7.51 7.28 7.09 7.1 7.35 7.3 7.22 7.3
GOCC_MICROVILLUS_MEMBRANE 5.95 5.83 5.46 6.07 5.72 5.51 5.43 5.56 5.74 5.34 5.63 5.3 5.46 5.49 5.64 5.48 5.61 5.65 5.51 5.21 6 5.41 5.39 5.13 5.5 5.48
GOCC_NEUROMUSCULAR_JUNCTION 6.95 7.06 7.57 7.04 7.19 7.47 7.48 7.57 7.35 7.41 7.22 7.47 7.43 7.47 7.24 7.54 7.2 7.22 7.44 7.45 7.36 7.47 7.38 7.54 7.47 7.46
GOCC_SPINDLE_POLE_CENTROSOME 5.5 5.55 5.7 5.55 5.86 5.68 5.87 5.65 5.85 6.05 5.69 5.86 5.89 5.66 5.92 5.76 5.63 5.52 5.73 5.77 5.3 5.69 5.96 5.96 5.24 5.59
GOCC_A_BAND 6.12 5.87 5.67 6.1 5.6 5.59 5.53 5.45 5.62 5.59 6.31 5.83 5.6 5.59 5.74 5.6 6.27 6.11 5.86 5.78 5.93 5.68 5.61 5.73 5.61 5.66
GOCC_I_BAND 6.31 6.14 6.21 6.24 6.32 5.72 6.03 6.09 6.16 6.39 6.25 6.37 5.93 5.88 6.23 6.39 6.46 6.3 6.3 6 6.17 6.09 6.54 5.95 6.12 6.15
GOCC_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX 7.19 6.83 8.17 7.38 7.11 7.54 7.36 8.02 7.55 7.64 7.94 7.54 7.68 7.4 7.7 7.72 8.06 8.06 8.04 8.08 7.29 8.07 7.6 7.76 8.14 8.1
GOCC_EARLY_ENDOSOME_MEMBRANE 7.59 7.66 7.9 7.71 7.88 7.9 7.92 7.79 7.89 7.78 7.66 7.9 7.94 7.98 7.84 7.72 7.54 7.65 7.71 8 7.54 7.78 8.02 7.97 7.77 7.58
GOCC_LATE_ENDOSOME_MEMBRANE 7.3 7.36 8 7.71 7.51 7.8 7.81 7.39 7.68 7.69 7.38 7.62 7.57 7.49 7.5 7.46 7.31 7.36 7.34 7.65 7.49 7.72 7.9 7.97 7.73 7.55
GOCC_MICROBODY_MEMBRANE 7.19 7.17 7.97 7.71 7.56 7.57 7.56 7.83 7.59 7.68 7.7 7.59 7.68 7.84 7.51 7.79 7.51 7.46 7.48 7.49 7.35 7.54 7.98 8.07 7.65 7.52
GOCC_ENDOSOME_LUMEN 5.88 5.93 5.72 5.79 5.41 5.12 5.4 5.44 5.3 5.26 5.58 5.59 5.37 5.27 5.29 5.53 5.52 5.39 5.5 5.27 5.79 5.56 5.47 5.25 5.35 5.5
GOCC_MICROBODY_LUMEN 6.44 6.44 6.95 7.13 6.37 6.55 6.55 6.4 6.24 6.55 6.74 6.63 6.51 6.58 6.41 6.53 6.57 6.27 6.56 6.57 6.34 6.34 6.62 6.53 6.32 6.41
GOCC_TORC2_COMPLEX 8.07 8.43 8.19 8.35 8.34 8.06 8.41 8.36 7.98 8.32 8.36 8.38 8.2 8.23 8.43 8.55 8.55 8.53 8.25 8.82 8.2 8.75 8.37 8.47 8.54 8.41
GOCC_FILAMENTOUS_ACTIN 6.33 6.2 6.5 6.43 6.16 5.85 6.56 6.92 6.59 6.76 6.31 6.38 6.35 6.27 6.59 6.62 6.5 6.35 5.96 6.03 6.67 6.71 6.46 6.46 7.08 6.89
GOCC_NUCLEAR_MEMBRANE 6.97 7.04 7.24 7.17 7.23 7.16 7.13 7.16 7.13 7.13 7.02 7.12 7.11 7.17 7.22 7.16 7.11 7.03 7.08 7.16 7.08 7.38 7.14 7.34 7.28 7.27
GOCC_ORGANELLE_ENVELOPE_LUMEN 6.93 6.97 7.82 7.74 7.6 7.56 7.22 7.37 7.34 7.46 7.52 7.15 7.37 7.36 7.41 7.54 7.35 7.18 7.19 7.51 7.27 7.43 7.28 7.55 7.34 7.19
GOCC_ENVELOPE 6.99 7.07 7.63 7.49 7.23 7.26 7.24 7.35 7.25 7.3 7.31 7.31 7.27 7.34 7.33 7.42 7.23 7.11 7.15 7.32 7.15 7.44 7.3 7.45 7.39 7.33
GOCC_VESICLE_LUMEN 6.43 6.46 6.86 6.72 6.55 6.53 6.61 6.63 6.44 6.49 6.55 6.51 6.51 6.41 6.69 6.69 6.63 6.32 6.49 6.59 6.58 6.73 6.59 6.61 6.81 6.84
GOCC_ORGANELLE_SUBCOMPARTMENT 7.05 7.1 7.46 7.24 7.31 7.36 7.35 7.38 7.29 7.37 7.21 7.3 7.35 7.36 7.32 7.31 7.16 7.09 7.19 7.41 7.14 7.33 7.41 7.48 7.41 7.35
GOCC_GOLGI_CISTERNA 6.96 7.08 7.55 7.31 7.42 7.42 7.5 7.41 7.26 7.3 7.19 7.24 7.43 7.65 7.46 7.33 7.42 7.23 7.24 7.44 7.2 7.49 7.4 7.67 7.55 7.37
GOCC_EARLY_PHAGOSOME 8.6 8.34 8.22 7.96 8.37 8.19 8.72 8.72 8.21 8.26 8.15 8.56 8.68 8.6 8.49 8.5 8.27 8.31 8.79 8.61 8.68 8.68 8.45 8.66 8.7 8.83
GOCC_INTEGRATOR_COMPLEX 6.65 6.75 7.03 6.88 7.14 7.24 6.41 6.85 6.68 6.85 6.77 6.76 6.88 6.86 6.64 6.84 6.82 6.59 6.76 6.9 6.59 6.9 6.79 6.83 6.77 6.7
GOCC_SMALL_SUBUNIT_PROCESSOME 6.14 6.35 6.82 6.65 6.53 6.24 6.52 6.61 6.77 6.76 6.47 6.78 6.63 6.39 6.74 6.85 6.37 6.34 6.13 6.45 6.54 6.52 6.53 6.69 6.61 6.62
GOCC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX 7.49 7.61 7.52 7.71 7.81 8.01 7.91 8.03 7.81 8.2 7.39 8.05 7.86 7.89 7.9 7.41 7.82 7.55 7.57 8.23 7.32 7.74 7.68 7.89 7.6 7.82
GOCC_CELL_DIVISION_SITE 7.16 7.17 7.41 7.29 7.47 7.52 7.54 7.69 7.29 7.6 7.28 7.58 7.43 7.24 7.52 7.4 7.56 7.22 7.34 7.53 7.38 7.6 7.39 7.81 7.6 7.41
GOCC_CLEAVAGE_FURROW 7.16 7.13 7.29 7.24 7.38 7.52 7.54 7.63 7.24 7.37 7.28 7.44 7.29 7.14 7.46 7.4 7.56 7.31 7.27 7.43 7.46 7.6 7.39 7.69 7.6 7.34
GOCC_AMPA_GLUTAMATE_RECEPTOR_COMPLEX 8.64 8.9 8.89 8.09 9.13 9.19 9.46 9.11 8.99 9.11 8.47 9.19 9.07 9.07 9.22 8.69 8.61 8.8 8.94 9.31 8.36 8.73 8.98 9.32 9.13 8.91
GOCC_PHOTORECEPTOR_CONNECTING_CILIUM 5.81 5.72 5.87 5.8 5.8 5.63 5.82 5.59 5.77 6.11 6.13 6 5.82 5.87 5.89 5.83 5.68 5.77 5.79 5.94 5.91 6.09 5.85 5.82 5.77 5.74
GOCC_STEREOCILIUM_BUNDLE 5.42 5.41 5.75 5.87 5.34 5.2 5.57 5.41 5.61 5.32 5.55 5.48 5.37 5.37 5.48 5.35 5.59 5.62 5.54 5.31 5.59 5.52 5.23 5.23 5.47 5.42
GOCC_STEREOCILIUM_TIP 5.11 5.34 5.24 5.2 4.99 5.12 5.01 5.21 5.26 5.11 5.52 5.32 5.19 5.14 5.38 5.18 5.46 5.47 4.96 4.96 5.44 5.31 5.04 5.08 5.28 5.26
GOCC_ACTIN_FILAMENT_BUNDLE 6.81 6.63 6.51 6.5 6.79 6.7 6.56 6.52 6.93 6.79 6.65 6.65 6.89 6.54 6.73 6.66 6.81 6.87 6.88 6.68 6.67 6.91 6.7 6.67 7.01 7.01
GOCC_FILOPODIUM_TIP 8.32 9.19 8.59 8.65 8.52 8.6 8.75 8.43 8.93 8.49 8.41 8.58 8.9 8.71 8.8 8.87 8.33 8.15 8.79 8.96 8.1 8.12 8.8 9.21 8.92 8.36
GOCC_GOLGI_CISTERNA_MEMBRANE 6.9 6.96 7.27 7.2 7.26 7.14 7.38 7.25 7.13 7.17 7.05 7.11 7.38 7.34 7.35 7.13 7.21 7.11 7.12 7.25 7.14 7.22 7.28 7.5 7.29 7.21
GOCC_MULTIVESICULAR_BODY_MEMBRANE 7.99 8.87 9.06 8.9 7.33 8.07 8.01 8.33 8.2 8.4 8.48 8.29 8.01 8.57 8.73 8.46 7.97 8.51 7.75 8.52 7.81 8.11 8.58 9.18 8.52 8.09
GOCC_RUFFLE_MEMBRANE 7.15 7.37 7.33 6.98 7.3 7.47 7.29 7.5 7.25 7.33 7.18 7.48 7.39 7.4 7.31 7.45 7.31 7.26 7.29 7.36 7.34 7.6 7.33 7.58 7.35 7.23
GOCC_TRANS_GOLGI_NETWORK_MEMBRANE 7.08 7.34 7.93 7.58 7.92 7.76 7.59 7.69 7.58 7.69 7.35 7.61 7.46 7.37 7.71 7.54 7.39 7.38 7.2 7.68 7.45 7.72 7.73 7.94 7.58 7.61
GOCC_NEURON_PROJECTION_MEMBRANE 7.88 7.86 8.04 7.7 8.2 8.43 8.77 8.55 8.47 8.71 7.78 8.21 8.44 8.15 8.53 8.38 7.73 8.19 8.29 8.48 8.02 8.19 8.6 8.69 8.53 8.17
GOCC_DENDRITE_MEMBRANE 7.76 7.84 8.3 7.56 7.88 8.43 8.8 8.49 8.31 8.71 7.66 8.16 8.58 8.33 8.67 8.51 7.9 8.19 8.21 8.48 8.03 8.24 8.63 8.73 8.53 8.29
GOCC_DENDRITIC_SPINE_MEMBRANE 6.83 7 7.09 6.9 7.25 7.32 7.49 8 7.66 7.75 7.28 8.15 7.87 7.91 8.11 8.05 7.35 7.76 7.77 7.87 7.93 7.82 7.74 8.23 7.61 7.33
GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX 7.95 8.11 8.39 8.38 8.43 8.62 8.12 8.25 8.17 8.36 8.14 8.11 8.29 8.51 8.09 8.44 7.88 8.16 8.32 8.36 7.77 8.31 8.27 8.37 8.36 8.28
GOCC_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_CYTOPLASM 6.91 6.95 7.51 7.24 7.35 7.4 7.27 7.17 7.14 7.4 7.35 7.12 7.17 7.19 7.4 7.47 7.23 7.17 7.17 7.38 6.89 7.38 7.45 7.57 7.25 7.2
GOCC_DENDRITE_CYTOPLASM 9.36 9.46 9.86 9.29 9.82 9.78 9.82 9.57 10.09 9.84 9.59 9.57 10.06 10 10.01 9.87 9.73 9.58 9.73 9.82 9.41 9.75 9.92 9.82 10.03 9.55
GOCC_MYOSIN_FILAMENT 5.1 4.97 4.89 4.78 4.2 4.25 4.74 4.93 4.91 4.6 5.07 5.07 4.52 4.68 4.83 5.1 5.19 5.09 4.9 5.02 5.4 5 4.82 4.34 4.76 4.92
GOCC_PROTEIN_DNA_COMPLEX 6.13 6.21 6.44 6.51 6.1 6.52 6.32 6.23 6.2 6.42 6.26 6.2 6.35 6.11 6.28 6.23 6.23 6.11 6.28 6.31 6.38 6.44 6.28 6.58 6.06 6.43
GOCC_PROTEIN_LIPID_COMPLEX 5.87 5.22 5.41 5.71 5.06 4.61 5.24 5.53 5.5 5.23 5.17 5.3 4.93 5.44 5.31 5.31 5.54 5.38 5.25 4.9 5.65 5.32 5.21 4.68 5.61 5.7
GOCC_SARCOPLASMIC_RETICULUM_MEMBRANE 6.85 7.21 7.04 6.94 7.29 7.38 7.5 7.54 7.43 7.31 6.75 7.51 7.49 7.43 7.48 7.29 7.56 7.28 7.15 7.02 7.6 7.56 8 7.8 7.45 7.05
GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE 6.88 7.11 8.07 7.84 7.65 7.55 7.52 7.75 7.38 7.4 7.4 7.4 7.49 7.34 7.57 7.63 7.41 7.27 7.18 7.9 7.61 7.77 7.63 7.73 7.68 7.69
GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX 8.52 8.38 9.41 8.81 8.73 9.01 8.97 8.89 9.01 9.15 9.19 9.06 8.93 8.97 9.2 8.91 8.25 8.24 8.64 8.87 8.53 8.97 9.16 9.39 8.88 8.44
GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN 9.39 8.98 9.8 9.31 9.57 9.71 9.8 9.24 9.85 9.93 9.59 9.38 9.67 9.71 9.82 9.66 8.74 9.02 9.67 9.61 8.85 9.05 9.91 10.02 9.33 8.89
GOCC_DNA_HELICASE_COMPLEX 6.48 6.63 7.11 6.93 6.77 6.76 6.85 6.98 6.78 6.77 7.01 6.74 6.61 6.66 6.99 6.95 6.51 6.54 6.64 7.17 6.75 6.94 6.54 6.94 6.78 6.87
GOCC_NODE_OF_RANVIER 9.57 9.53 8.54 8.18 9.72 9.95 9.75 9.6 9.66 9.68 8.99 9.7 9.7 9.53 9.12 9.12 9.27 8.49 9.36 9.85 8.94 9.14 9.58 9.65 9.41 9.12
GOCC_TRANSCRIPTION_FACTOR_TFTC_COMPLEX 7.89 7.77 8.6 8.58 7.92 8.25 8.08 8.15 8.09 8.23 8.09 8.19 8.37 8.27 8.11 8.21 7.64 8.08 8.23 8.28 7.61 7.96 7.81 8.06 8.06 8.11
GOCC_EUKARYOTIC_48S_PREINITIATION_COMPLEX 8.61 8.75 9.45 9 9.17 9.11 9.27 8.81 9.64 9.17 9.14 8.94 9.16 9.32 9.02 9.21 8.87 8.5 8.75 9 8.77 8.88 9.5 9.29 9.43 8.94
GOCC_CHROMATOID_BODY 6.28 6.56 7.46 7.2 7 7.43 7.08 6.96 7.07 7.21 7.35 6.95 7.44 7.44 7.3 7.5 6.72 6.77 6.65 7.11 7.15 6.98 7.5 7.2 6.86 6.92
GOCC_PHAGOPHORE_ASSEMBLY_SITE_MEMBRANE 7.43 7.4 7.75 7.85 7.52 7.63 7.8 7.57 7.67 7.59 7.96 7.59 7.65 7.74 7.78 8.04 7.72 7.94 7.77 7.87 7.95 7.78 7.62 7.64 7.74 7.46
GOCC_LOW_DENSITY_LIPOPROTEIN_PARTICLE 5.92 5.98 6.3 5.71 6 5.99 6.1 5.92 5.59 5.49 6.1 5.48 5.92 5.75 5.88 5.5 5.46 5.5 5.53 5.72 5.77 6.17 5.5 5.53 5.61 5.98
GOCC_HIGH_DENSITY_LIPOPROTEIN_PARTICLE 5.11 4.96 4.75 5.15 4.28 4.12 4.82 4.75 4.65 4.18 5.02 4.37 4.3 4.48 4.6 4.52 4.82 5.01 4.87 4.34 4.79 4.65 4.09 4.17 4.51 4.8
GOCC_TRIGLYCERIDE_RICH_PLASMA_LIPOPROTEIN_PARTICLE 5.42 5.22 5.18 5.71 5.06 4.61 4.99 5.16 5.5 5.11 5.06 5.3 4.93 5 4.91 5.1 5.46 5.38 5.25 4.87 5.52 5.32 5.14 4.68 5 5.18
GOCC_NUCLEAR_PERIPHERY 7.19 7.08 7.56 7.48 7.52 7.54 7.44 7.44 7.55 7.57 7.48 7.73 7.49 7.46 7.58 7.53 7.38 7.27 7.34 7.46 7.41 7.49 7.6 7.86 7.59 7.44
GOCC_CENTRIOLAR_SATELLITE 6.41 6.47 6.58 6.56 6.78 6.84 6.69 6.61 6.46 6.65 6.68 6.66 6.81 6.66 6.72 6.76 6.62 6.55 6.49 6.68 6.41 6.71 6.45 6.65 6.64 6.71
GOCC_CATION_CHANNEL_COMPLEX 6.85 6.7 6.79 6.76 7.11 7.08 7.03 7.19 7.05 7.25 6.91 7 7.02 7.18 7.31 6.95 6.87 7.3 7.29 7.12 6.79 6.98 6.94 6.96 6.79 6.79
GOCC_CALCIUM_CHANNEL_COMPLEX 7.34 7.55 6.91 6.79 7.59 7.51 7.68 7.88 7.58 7.77 7.12 7.76 7.82 7.87 7.9 7.68 7.37 7.8 7.83 8.05 7.7 7.6 7.76 7.86 7.76 7.52
GOCC_POTASSIUM_CHANNEL_COMPLEX 6.7 6.63 6.71 6.67 6.63 6.91 6.99 7.11 6.67 6.8 6.9 6.64 6.99 6.91 7.12 6.95 6.59 7.06 6.91 6.96 6.72 6.83 6.82 6.77 6.61 6.7
GOCC_SODIUM_CHANNEL_COMPLEX 6.92 7.1 6.35 6.4 6.87 6.84 7.22 7.16 6.91 7.47 6.98 6.94 7.29 7.24 7.43 7.53 6.9 7.04 7.17 7.52 6.9 7.12 6.79 7.18 6.92 6.98
GOCC_CHLORIDE_CHANNEL_COMPLEX 5.95 5.58 6.07 5.96 5.51 5.31 5.92 6.18 5.69 6.08 5.54 5.65 5.31 5.44 5.84 6.08 5.88 5.58 5.89 5.69 5.53 5.79 5.93 5.58 5.96 6.12
GOCC_METHYLTRANSFERASE_COMPLEX 6.9 6.9 7.35 7.29 7.1 7.14 7.05 7.12 7.06 7.06 7.12 7.03 7 7.09 7.26 7.18 6.87 6.86 7.2 7.09 6.95 7.13 7.08 7.45 7.02 7.19
GOCC_METHYLOSOME 6.87 7.3 7.87 8.09 6.72 6.76 7.18 7.87 6.77 7.05 7.12 7.35 7.14 7.3 7.52 7.7 7.05 7.46 7.4 7.28 7.87 7.75 7.14 7.56 7.48 7.92
GOCC_SMN_SM_PROTEIN_COMPLEX 6.25 6.06 6.73 7.28 6.01 6.18 6.31 7.05 6.67 6.85 6.81 6.86 6.83 6.89 7.34 7.02 6.6 6.08 6.28 6.71 7 7.52 6.75 6.75 6.89 7.38
GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX 6.88 6.85 7.31 7.29 7.11 7.28 7.14 7.2 7.12 7.11 7.13 6.99 7 7.09 7.15 7.18 6.87 6.86 7.2 7.13 6.91 7.09 7.24 7.49 7.02 7.14
GOCC_ESC_E_Z_COMPLEX 7.33 7.36 6.8 7.67 7.59 7.69 7.14 7.33 7.12 7.29 7.06 7.45 7.24 7.62 7.37 7.44 7.16 7.54 7.57 7.24 7.21 7.14 7.52 7.45 7.12 7.44
GOCC_PRC1_COMPLEX 7.12 7.34 7.58 7.37 7.27 7.21 7.32 7.59 7.28 7.35 7.3 7.29 7.2 7.54 7.34 7.53 7.39 7.36 7.61 7.52 7.32 7.54 7.27 7.28 7.73 7.94
GOCC_EXON_EXON_JUNCTION_COMPLEX 7.47 7.65 7.71 7.57 8.53 8.3 8.19 8.08 7.88 8.14 7.68 8 8.19 8.12 8.15 8.13 7.85 7.32 8.06 8.29 7.82 7.8 7.97 8.33 8.08 8.09
GOCC_TRANSCRIPTIONALLY_ACTIVE_CHROMATIN 7.52 7.64 7.87 7.58 7.25 7.5 7.81 7.8 7.68 7.64 7.45 7.72 7.68 7.74 8.13 7.63 7.22 7.15 7.29 7.9 7.68 7.9 7.7 7.91 7.71 7.91
GOCC_MICROTUBULE_PLUS_END 8.34 8.43 8.29 7.87 9.09 9.05 8.21 8.32 8.89 8.64 8.19 8.68 8.83 8.68 8.8 8.6 8.43 8.26 8.7 8.42 8.42 8.67 8.97 9.21 8.52 8.58
GOCC_AZUROPHIL_GRANULE_MEMBRANE 7.19 7.3 8.05 7.49 7.36 7.47 7.63 7.49 7.28 7.49 7.39 7.62 7.39 7.16 7.63 7.63 7.45 7.38 7.4 7.38 7.48 7.72 7.55 7.49 7.72 7.71
GOCC_AZUROPHIL_GRANULE_LUMEN 7.26 7.06 7.43 7.31 7.08 7.03 7.39 7.25 6.95 7.31 6.77 6.99 7.06 6.82 7.52 7.18 6.93 6.84 6.94 6.86 7.33 7.49 7.26 7.19 7.46 7.54
GOCC_SPECIFIC_GRANULE_MEMBRANE 6.5 6.32 6.32 6.25 6.63 6.4 6.24 6.24 6.79 6.18 6.16 5.92 6.6 6.3 6.21 6.19 6.21 6.2 5.93 6.26 6.39 6.47 6.54 6.69 6.75 6.73
GOCC_SPECIFIC_GRANULE_LUMEN 5.59 5.62 5.69 5.86 5.31 5.24 5.48 5.63 5.32 5.52 5.82 5.53 5.27 5.32 5.71 5.51 5.62 5.58 5.49 5.52 6.1 5.93 5.43 5.49 5.67 5.75
GOCC_CD40_RECEPTOR_COMPLEX 6.74 6.91 6.77 6.52 6.79 7.04 6.83 6.92 6.86 6.75 7.05 6.88 6.82 6.95 7.27 6.56 6.63 6.52 6.9 6.9 6.85 7.04 6.89 6.96 7.5 7.4
GOCC_RIBONUCLEOPROTEIN_GRANULE 7.39 7.47 7.89 7.75 7.91 7.83 7.82 7.7 7.8 7.94 7.76 7.79 7.81 7.85 7.8 7.66 7.57 7.39 7.64 7.83 7.39 7.68 7.95 8 7.88 7.74
GOCC_SEH1_ASSOCIATED_COMPLEX 7.2 7.43 7.97 7.8 7.32 7.53 7.57 7.57 7.38 7.51 7.26 7.41 7.57 7.56 7.45 7.31 7.42 7.24 7.33 7.35 7.49 7.49 7.37 7.41 7.53 7.42
GOCC_SITE_OF_DOUBLE_STRAND_BREAK 6.53 6.38 6.61 6.9 6.67 6.71 6.46 6.59 6.44 6.65 6.85 7 6.75 6.6 6.5 6.83 6.72 6.75 6.96 6.61 6.62 6.72 6.42 6.77 6.61 6.9
GOCC_CILIARY_TRANSITION_ZONE 5.9 6.1 6.17 6.25 5.97 6.2 6.14 6.21 6.21 6.34 6.3 6.34 6.11 6.39 6.2 6.31 5.94 6.02 6.25 5.99 6.18 6.23 6.36 6.32 6.28 6.1
GOCC_ENDOLYSOSOME 7.75 7.6 8.27 7.71 8.13 8.06 8.32 8.48 8.48 8.22 7.83 7.97 8.08 8.19 8.31 8.01 7.93 7.74 7.92 8.15 7.9 8.29 7.91 8.3 8.66 8.05
GOCC_ENDOLYSOSOME_MEMBRANE 8.07 8.4 8.63 8.87 8.34 8.43 8.56 9.07 8.9 8.28 8.23 8.46 8.21 8.66 8.97 8.59 8.36 8.19 8.49 8.69 8.55 8.72 8.18 8.86 9.04 8.61
GOCC_MKS_COMPLEX 6.47 6.53 6.85 6.52 6.05 6.23 6.44 6.41 6.14 6.42 6.48 6.15 5.89 6.39 6.56 7.08 6.13 6.56 6.44 6.16 6.71 6.41 6.41 6.41 6.68 6.2
GOCC_CILIARY_BASAL_BODY 6.54 6.7 7.01 6.78 6.67 6.77 6.47 6.56 6.66 6.83 6.83 6.73 6.6 6.67 6.77 6.9 6.51 6.75 6.88 6.73 6.59 6.87 6.95 7.07 6.86 6.75
GOCC_MYOFILAMENT 5.57 5.64 5.42 5.84 5.38 5.01 5.63 5.12 5.48 5.4 5.73 5.15 5.35 5.31 5.46 5.33 5.51 5.79 5 5.33 5.37 5.47 6.06 5.01 5.48 5.21
GOCC_ESCRT_COMPLEX 7.05 7.26 8.41 8.47 7.52 7.57 7.69 7.2 7.69 7.48 7.8 7.7 7.35 7.49 7.9 7.72 7.26 7.14 7.35 7.67 7.59 7.57 7.89 8.08 7.74 7.42
GOCC_SOMATODENDRITIC_COMPARTMENT 7.61 7.79 7.96 7.56 7.94 8.13 8.15 8.08 7.95 8.1 7.8 8.04 8.15 8.16 8.17 8.11 7.74 7.84 7.96 8.16 7.81 8.03 8.05 8.24 8.13 8
GOCC_TOR_COMPLEX 7.98 8.28 8.04 8.28 8.24 7.98 8.27 8.19 7.94 8.23 8.27 8.34 8.16 8.07 8.27 8.31 8.35 8.09 8.13 8.46 7.84 8.48 8.2 8.33 8.43 8.33
GOCC_T_CELL_RECEPTOR_COMPLEX 5.02 4.81 4.74 5 4.37 4.16 4.64 4.75 4.69 4.25 4.7 4.34 4.32 4.29 4.5 4.44 4.48 4.75 4.66 4.44 4.73 4.45 4.34 4.21 4.52 4.35
GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK 7.03 7.06 7.39 7.12 7.34 7.34 7.31 7.34 7.3 7.31 7.16 7.27 7.3 7.35 7.27 7.27 7.16 7.03 7.16 7.41 7.11 7.28 7.4 7.45 7.39 7.33
GOCC_SARCOLEMMA 7.04 7.04 7.23 6.8 7.2 7.26 7.21 7.29 7.24 7.31 7.39 7.53 7.16 7.27 7.48 7.45 7.34 7.29 7.11 7.3 7.31 7.33 7.54 7.39 7.45 7.28
GOCC_NUCLEAR_INCLUSION_BODY 8.01 7.87 8.11 7.74 8.33 8.28 8.28 8.26 8.31 8.17 8.04 8.16 8.39 8.13 8.04 8.06 7.81 7.95 8.12 8.17 8.11 8.15 8.4 8.55 8.49 8.28
GOCC_DNA_POLYMERASE_COMPLEX 5.68 5.84 6.16 6.47 5.86 6.07 6.08 5.92 5.99 6.12 5.99 5.96 5.97 5.8 6 5.99 5.78 5.73 5.89 5.83 5.95 5.95 6.09 6.25 6.07 6.22
GOCC_MICROBODY 6.93 6.93 7.42 7.44 7.14 7.35 7.16 7.27 7.32 7.36 7.28 7.23 7.38 7.47 7.19 7.44 7.23 6.99 7.27 7.35 7.09 7.23 7.58 7.54 7.4 7.39
GOCC_SPECIFIC_GRANULE 6.04 6.01 6.08 6.11 5.79 5.88 5.89 5.94 5.99 6.04 5.97 5.92 5.88 5.75 5.99 5.81 5.94 5.83 5.74 5.77 6.33 6.24 5.82 6.03 6.27 6.22
GOCC_AZUROPHIL_GRANULE 7.22 7.24 7.67 7.43 7.37 7.42 7.61 7.31 7.26 7.43 7.32 7.24 7.32 7.12 7.56 7.47 7.13 7.28 7.16 7.4 7.4 7.58 7.34 7.4 7.57 7.59
GOCC_CHROMAFFIN_GRANULE 8.78 8.69 9.59 8.93 8.95 9.19 9.09 9.68 9.05 8.93 8.99 8.66 8.89 8.8 9.5 9.1 8.75 8.97 9.09 9.36 9.16 9.78 9.37 8.87 9.07 9.6
GOCC_ZYMOGEN_GRANULE 6.22 6.15 6.03 6.25 6.66 5.95 6.12 6.13 7.28 6.34 6.69 6.24 6.04 5.79 6.26 6.67 6.94 7.2 5.48 6.61 6.3 6.11 6.93 6.02 6.61 6.02
GOCC_ZYMOGEN_GRANULE_MEMBRANE 5.91 5.86 6.15 5.96 5.57 6.26 6.16 6.05 6.42 6.39 6.1 6.1 5.91 5.96 6.71 6.17 5.74 6.35 6.07 6.03 5.86 5.48 6.43 6.25 6.08 5.77
GOCC_LAMELLAR_BODY 5.32 5.38 5.22 5.31 4.6 4.48 4.95 5.29 4.92 4.76 5.05 5.1 4.67 4.89 5.35 4.85 4.89 5.22 4.97 4.69 5.14 4.61 4.76 4.7 4.94 4.97
GOCC_MHC_PROTEIN_COMPLEX 6.36 6.23 6.65 7.41 6.19 5.87 6.6 6.92 6.94 6.12 5.94 5.41 5.83 6.2 5.72 5.64 6.54 6.96 6.46 7.25 6.42 6.54 6.55 5.83 6.43 6.13
GOCC_MHC_CLASS_II_PROTEIN_COMPLEX 5.9 5.91 5.84 6.6 5.94 5.47 6.34 6.26 6.64 5.45 5.46 4.93 5.4 5.88 5.3 5.54 6.85 6.98 6.06 6.79 5.98 6.08 5.8 5.56 5.77 5.55
GOCC_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE 5.32 5.25 5.44 5.47 5.37 4.79 5.26 5.24 5.41 5.17 5.67 4.8 5.1 5.14 5.38 5.2 5.24 5.44 4.9 4.86 5.54 5.02 4.85 4.82 5.01 4.94
GOCC_CHYLOMICRON 5.42 5.22 5.18 5.71 5.06 4.61 4.99 5.16 5.5 5.11 5.06 5.3 4.93 5 4.91 5.1 5.46 5.38 5.25 4.87 5.52 5.32 5.14 4.68 5 5.18
GOCC_ACTOMYOSIN 6.84 6.84 6.85 7.1 6.89 6.86 6.82 7 6.96 6.91 6.89 6.66 7.07 6.78 6.8 6.94 7.13 7 6.96 7.07 6.7 7.02 6.88 6.77 7.24 7.08
GOCC_PRESYNAPTIC_MEMBRANE 7.56 7.6 7.76 7.7 7.85 8.12 8.07 7.84 7.84 8.07 7.73 7.88 7.87 8.05 8.23 8 7.68 7.84 7.88 7.86 7.65 7.9 7.89 8.01 7.87 7.84
GOCC_POLYSOMAL_RIBOSOME 7.69 7.78 8.33 8.01 8.26 8.23 8.31 8.39 7.95 8.23 7.83 8.04 7.88 7.84 8.23 8.71 7.75 7.82 7.73 8.35 8.11 8.31 8.42 8.55 8.25 8.21
GOCC_PLATELET_DENSE_GRANULE 6.04 6.03 5.97 6.22 5.59 5.51 5.74 5.82 6.09 6.14 6.23 5.77 5.62 5.45 5.53 6.69 6.56 5.64 5.64 5.78 5.94 6.02 5.88 5.29 5.79 5.73
GOCC_NEURON_PROJECTION 7.39 7.45 7.64 7.32 7.63 7.87 7.79 7.79 7.69 7.86 7.52 7.7 7.88 7.85 7.9 7.85 7.49 7.55 7.67 7.87 7.51 7.82 7.75 7.92 7.76 7.71
GOCC_NADPH_OXIDASE_COMPLEX 4.72 4.68 4.9 4.75 4.37 4.48 4.75 4.61 4.76 4.46 5.24 4.52 4.58 4.54 4.67 4.85 4.62 4.85 4.52 5.12 4.71 5.39 4.84 4.29 4.62 4.74
GOCC_COSTAMERE 6.75 6.45 6.45 6.63 6.73 6.76 6.9 6.63 7.21 7.2 6.47 7.12 6.74 6.69 7.15 7.06 7.13 6.64 6.49 6.42 7.43 7.02 7.69 7.09 6.93 6.52
GOCC_GERM_CELL_NUCLEUS 6.09 6.15 6.74 6.3 6.71 6.45 6.05 6.29 6.53 6.91 6.48 6.76 6.31 6.12 5.88 7.06 6.14 5.99 5.93 6.38 6.11 6.13 6.55 6.29 6.29 6.15
GOCC_SYNAPTIC_CLEFT 6.57 6.56 6.74 6.76 7.14 7.03 6.83 6.82 6.85 6.79 6.65 7.03 6.65 6.94 6.43 6.69 6.78 6.79 6.84 7.04 6.46 6.68 6.92 6.82 6.57 6.36
GOCC_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX 7.15 7.5 7.46 7.91 7.68 7.44 7.69 7.42 7.57 7.68 7.22 7.5 7.35 7.63 7.58 7.53 7.22 7 7.35 7.61 7.16 7.65 7.62 7.99 7.83 7.56
GOCC_AXON_INITIAL_SEGMENT 9.51 9.57 8.51 7.65 9.84 9.92 9.63 9.53 9.48 9.65 8.88 9.47 9.62 9.6 9.01 8.76 9.43 9.04 9.28 9.77 8.86 8.75 9.4 9.55 9.12 9
GOCC_TERMINAL_BOUTON 6.52 6.65 7.08 7.04 5.92 6.54 6.88 7.54 6.74 7.34 6.46 6.62 7 6.62 7.51 6.93 6.54 6.59 6.81 7.09 6.67 6.88 6.54 6.81 7 6.77
GOCC_DENDRITIC_SHAFT 8.28 8.56 8.47 8.06 8.45 8.65 8.7 8.49 8.69 8.57 8.12 8.54 8.78 8.64 8.54 8.84 8.48 8.25 8.36 8.74 8.31 8.47 8.64 8.68 8.72 8.34
GOCC_LYSOSOMAL_LUMEN 7.1 7.03 7.4 7.27 7.22 7.26 7.4 7.31 7.24 7.3 7.32 7.32 7.46 7.42 7.49 7.5 7.49 7.26 7.47 7.6 7.62 7.54 7.33 7.53 7.42 7.48
GOCC_PERIKARYON 7.08 7.19 7.54 7.15 7.59 7.53 7.73 7.8 7.54 7.88 7.29 7.53 7.62 7.71 7.89 7.64 7.27 7.4 7.33 7.84 7.5 7.6 7.51 7.71 7.69 7.72
GOCC_MYELIN_SHEATH 8.54 8.74 8.65 8.42 9.34 9.1 9.04 9.62 9.32 9.1 8.65 9.37 8.97 8.73 9.08 8.9 8.89 8.21 8.52 9.29 8.52 9.02 9.14 9.2 9.11 9.53
GOCC_RECEPTOR_COMPLEX 6.14 6.07 6.27 6.2 6.21 6.12 6.13 6.21 6.26 6.19 6.1 6.1 6.22 6.21 6.2 6.14 6.19 6.2 6.11 6.15 6.23 6.28 6.25 6.26 6.23 6.19
GOCC_LAMININ_COMPLEX 5.73 5.45 5.36 5.68 5.77 5.57 5.28 5.51 5.2 5.56 5.26 5.36 5.51 5.39 5.67 5.67 5.54 5.4 5.7 5.54 5.62 5.46 5.52 5.52 5.2 5.48
GOCC_CONTRACTILE_FIBER 6.15 6.09 6.21 6.12 5.97 5.86 6.03 5.97 6.17 6.27 6.23 6.36 6.07 6 6.11 6.14 6.33 6.26 6.18 6.04 6.17 6.14 6.61 6.19 6.15 6.13
GOCC_APICAL_JUNCTION_COMPLEX 6.49 6.46 6.71 6.44 6.44 6.49 6.54 6.68 6.58 6.31 6.45 6.37 6.51 6.52 6.54 6.56 6.56 6.3 6.4 6.43 6.67 6.63 6.56 6.6 6.71 6.77
GOCC_NUCLEAR_REPLICATION_FORK 5.82 5.89 6.2 6.19 5.76 5.93 5.73 6.09 5.97 5.82 5.96 5.95 5.73 5.77 5.85 6.13 5.83 5.72 5.81 5.79 5.85 5.91 6.06 6.36 6.05 6.4
GOCC_SPANNING_COMPONENT_OF_PLASMA_MEMBRANE 6.56 6.59 7.29 6.47 7.44 7.57 7.32 7.81 7.5 7.75 6.74 7.59 6.82 7.57 7.75 7.4 6.46 7.26 7.47 7.19 7.22 6.8 7.95 8.18 7.71 7.54
GOCC_JUXTAPARANODE_REGION_OF_AXON 9.54 9.53 9.27 8.85 9.98 10.08 9.94 10.01 9.83 9.83 9.33 10.04 9.63 9.52 9.55 9.63 9.43 9.43 9.79 9.97 9.07 9.46 9.75 9.93 9.62 9.45
GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE 7.48 7.76 8.07 7.93 7.85 8.13 8.23 8.15 8.15 8.26 7.82 7.79 8.24 8.01 8.11 8.06 7.63 7.77 7.69 7.87 7.75 7.78 8.29 8.42 8.04 7.65
GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE 6.98 6.94 7.61 7.27 7.21 7.22 7.02 7.3 7.41 6.91 7.24 7.04 7.46 7.33 7.46 7.6 6.7 6.76 7.15 7.22 6.89 7.34 7.46 7.6 7.2 6.98
GOCC_CELL_CELL_CONTACT_ZONE 7.42 7.21 7.51 7.44 8.06 8.04 7.73 7.81 7.89 7.89 7.59 7.77 7.68 7.77 7.94 7.79 7.85 7.68 7.49 8.04 7.63 8.03 8.01 8.1 8.02 8.09
GOCC_DENDRITE_TERMINUS 8.87 8.96 9.05 8.87 9.16 9.3 9.35 9.55 8.82 9.32 8.96 9.23 9.31 9.19 9.22 9.18 8.83 9.13 8.97 9.36 8.94 9.16 9.08 9.4 9.3 9.24
GOCC_AXONAL_GROWTH_CONE 8.13 8.37 8.37 8.31 8.75 8.94 8.84 8.92 8.5 8.95 8.51 8.75 8.78 8.72 8.91 8.4 8.57 8.62 8.44 8.6 8.57 8.55 8.97 8.94 8.79 8.29
GOCC_CELL_BODY 7.55 7.6 7.82 7.48 7.86 8.07 8.02 8 7.93 8.01 7.79 7.94 8.08 8.1 8.02 8.04 7.67 7.66 7.79 7.98 7.7 7.93 8.02 8.18 8.07 7.85
GOCC_CELL_BODY_MEMBRANE 7.08 6.93 7.32 6.86 7.78 7.38 7.59 7.75 7.45 7.71 7.37 7.22 7.53 7.75 7.76 7.55 7.12 7.43 7.4 7.89 7.33 7.62 7.32 7.71 7.32 7.19
GOCC_MAIN_AXON 8.44 8.49 8.32 7.89 8.87 9.09 8.95 9.05 9.07 9.12 8.5 8.69 8.8 8.8 8.91 8.53 8.52 8.4 8.87 9.24 8.51 8.75 8.86 9.2 8.73 8.58
GOCC_CALYX_OF_HELD 9.42 9.37 9.38 8.99 9.33 9.29 9.77 9.89 9.4 9.32 9.32 9.53 9.6 9.7 10.05 9.85 9.08 9.82 9.73 10.09 9.52 9.68 9.32 9.59 9.68 9.43
GOCC_NEURON_PROJECTION_TERMINUS 7.45 7.54 7.91 7.39 7.86 8 8.22 8.1 8.02 8.1 7.73 8.29 8.1 7.98 8.26 7.94 7.68 7.49 7.96 8.15 7.71 7.89 7.96 8.03 7.98 8.04
GOCC_NEURON_SPINE 8.32 8.4 8.38 7.94 8.48 8.76 8.61 8.63 8.57 8.63 8.09 8.51 8.67 8.68 8.68 8.47 8.32 8.32 8.68 8.65 8.37 8.55 8.57 8.85 8.73 8.48
GOCC_ENDOPLASMIC_RETICULUM_QUALITY_CONTROL_COMPARTMENT 7.82 7.82 7.73 7.91 8.46 8.59 7.79 7.89 8.33 8.02 7.93 8 8.35 8.44 8.06 8.12 7.52 7.61 8.01 7.81 7.48 7.69 8.16 8.41 7.93 7.91
GOCC_RIBOSOMAL_SUBUNIT 6.77 6.99 7.81 7.7 6.78 7 7.09 7.28 7.11 7.21 7.45 6.98 7.13 7.13 7.41 7.51 6.91 6.82 6.96 7.21 7.09 7.17 7.28 7.34 7.08 7.03
GOCC_NUCLEAR_PORE_NUCLEAR_BASKET 7.09 7.1 7.93 8 7.99 7.68 7.64 7.19 7.59 7.55 7.83 7.82 7.35 7.79 7.56 7.47 7.1 7.2 7.81 7.28 7.23 7.64 7.66 7.76 7.35 7.38
GOCC_MLL1_2_COMPLEX 6.77 6.75 7.52 7.3 6.93 7.04 6.95 7.14 7.17 7.06 7.16 6.91 6.83 6.89 7.2 7.17 6.83 6.82 7.01 7.03 6.69 6.9 7.02 7.49 6.89 7
GOCC_DNA_PACKAGING_COMPLEX 5.87 5.74 5.59 5.57 5.73 5.44 6.02 5.61 5.93 5.7 5.51 5.53 5.92 5.83 5.57 5.7 5.85 5.6 5.89 5.73 5.95 5.68 5.75 5.58 5.59 5.65
GOCC_PLASMA_MEMBRANE_RAFT 6.49 6.47 6.78 6.62 6.46 6.39 6.56 6.66 6.46 6.47 6.52 6.5 6.38 6.43 6.76 6.53 6.54 6.42 6.35 6.77 6.61 6.58 6.48 6.47 6.65 6.54
GOCC_CHITOSOME 5.34 5.28 5.27 5.26 4.72 4.99 4.74 5.19 4.81 4.63 5.04 5.04 4.81 4.75 4.82 4.97 4.88 4.93 4.95 4.89 5.08 5.14 5.24 5.24 4.87 5
GOCC_KERATIN_FILAMENT 4.9 4.9 4.71 4.91 4.38 4.22 4.72 4.46 4.67 4.35 4.67 4.47 4.45 4.34 4.57 4.4 4.65 5.01 4.42 4.39 4.92 4.58 4.34 4.3 4.55 4.42
GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON 5.43 5.37 5.21 5.52 4.88 4.82 5.2 4.99 5.13 4.88 5.31 4.98 4.92 4.77 5.08 4.88 5.22 5.43 5.09 4.86 5.33 5.09 4.91 4.66 5.09 4.99
GOCC_PRONUCLEUS 5.71 5.76 5.48 5.69 6.79 6.35 5.51 5.66 6.29 5.92 5.1 5.54 6.06 6.13 5.56 5.78 5.68 6.59 6.03 5.47 5.39 5.21 5.48 6.28 5.67 5.55
GOCC_INTERCELLULAR_BRIDGE 6.5 6.71 7.07 6.72 6.44 6.54 6.76 6.87 6.52 6.73 6.45 6.81 6.6 6.8 6.77 6.4 6.65 6.47 6.57 6.6 6.76 6.66 6.61 6.67 7.12 7.03
GOCC_APICAL_PART_OF_CELL 6.02 5.95 5.86 5.92 5.76 5.62 5.8 5.72 5.81 5.94 5.89 5.68 5.84 5.83 5.72 5.82 5.92 5.91 5.71 5.8 5.95 5.83 5.78 5.77 5.88 5.77
GOCC_BASAL_PART_OF_CELL 6.44 6.41 6.27 6.48 6.27 6.24 6.35 6.49 6.29 6.39 6.33 6.35 6.32 6.32 6.24 6.34 6.52 6.33 6.39 6.48 6.52 6.39 6.36 6.45 6.45 6.48
GOCC_SYNAPSE 7.58 7.7 7.82 7.57 7.85 8.03 8.07 8.02 7.88 8.07 7.72 7.99 8.08 8.12 8.1 7.95 7.73 7.8 7.94 8.07 7.72 7.92 8 8.2 8 7.86
GOCC_POSTSYNAPTIC_MEMBRANE 7.36 7.59 7.77 7.31 7.69 8.03 8.01 7.95 7.75 7.93 7.45 7.84 7.94 8.02 8.09 7.83 7.45 7.76 7.85 8.07 7.59 7.62 7.82 8.13 7.77 7.66
GOCC_TRICARBOXYLIC_ACID_CYCLE_ENZYME_COMPLEX 7.87 8.1 8.66 8.18 8.27 8.56 8.26 8.44 8.15 8.56 8.37 8.6 8.38 8.33 8.66 8.43 7.91 7.88 8.35 8.27 7.93 8.51 8.25 8.76 8.16 8.06
GOCC_RESPIRATORY_CHAIN_COMPLEX_IV 6.16 6.34 7.64 6.79 6.37 6.44 7.14 7.31 6.53 6.17 7.03 6.28 6.52 6.77 6.63 6.59 7.39 6.89 6.43 7.18 7.09 7.61 6.28 6.5 6.5 6.73
GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE 6.7 6.97 6.8 6.99 7.51 7.42 7.64 7.35 7.2 7.04 6.36 6.96 7.39 7.37 7.14 6.98 7.63 7.17 7.23 7.75 6.79 7.19 7.4 7.12 7.33 7.24
GOCC_PHAGOCYTIC_VESICLE 6.86 6.83 7.38 7.47 7.18 7.01 6.94 7.28 7.1 6.95 7.38 6.92 7.01 6.99 7.07 7.41 7.22 7.07 6.9 7.33 7.24 7.54 7.21 7.18 7.27 7.44
GOCC_POLE_PLASM 4.99 4.9 4.98 4.97 4.68 4.48 4.28 4.53 4.44 4.35 4.52 4.63 4.53 4.57 4.51 4.52 4.82 5.17 4.96 4.73 4.93 4.28 4.5 4.61 4.32 4.45
GOCC_ANCHORED_COMPONENT_OF_PLASMA_MEMBRANE 5.8 5.55 5.53 5.84 5.37 5.15 5.45 5.67 5.41 5.17 5.51 5.37 5.41 5.41 5.64 5.73 5.32 5.49 5.3 5.38 5.53 5.67 5.54 5.38 5.41 5.27
GOCC_PORE_COMPLEX 5.88 6.22 6 6.39 5.73 5.71 5.98 6 5.65 5.85 6.21 6.15 5.9 5.77 5.96 6.05 6.12 5.98 5.63 6.08 6.11 5.96 5.47 5.73 6.09 6.16
GOCC_PERINUCLEAR_REGION_OF_CYTOPLASM 7.07 7.12 7.43 7.31 7.37 7.47 7.49 7.49 7.51 7.48 7.28 7.43 7.5 7.56 7.41 7.41 7.29 7.17 7.3 7.55 7.29 7.44 7.51 7.6 7.51 7.41
GOCC_PIGMENT_GRANULE 7.73 7.92 8.44 8.1 8.06 8.11 8.3 8.12 8.17 8.2 8.08 8.16 8.4 8.37 8.06 8.17 8.11 7.99 7.98 8.16 7.88 8.27 8.44 8.38 8.12 8.25
GOCC_PRESYNAPTIC_ACTIVE_ZONE 7.66 7.65 7.91 7.89 8.36 8.11 8.16 8.3 8 8.26 8.05 8.14 8.05 8.19 8.55 8.24 7.81 8.24 8.21 8.17 8.07 8.27 8.02 8.1 7.97 8.05
GOCC_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE 6.75 6.75 7.1 7.02 7.02 7.09 7.35 6.96 7.29 7.21 6.94 6.88 7.28 7.55 7.22 7.33 7.18 7.05 7.04 6.89 7.05 7.05 7.08 6.95 6.77 6.81
GOCC_SPINDLE_MIDZONE 5.97 6.87 6.9 6.98 6.71 6.42 6.91 6.83 6.83 6.68 6.6 6.47 6.46 6.78 6.95 6.43 6.47 6.22 6.02 6.58 6.65 7.28 6.73 6.95 6.51 6.56
GOCC_RECYCLING_ENDOSOME 7.58 7.54 8 7.78 7.83 7.81 7.8 7.85 7.9 7.81 7.79 7.85 7.88 7.94 8 7.73 7.79 7.67 7.75 7.85 7.58 7.69 7.96 8.18 7.78 7.63
GOCC_RECYCLING_ENDOSOME_MEMBRANE 7.56 7.45 7.65 7.83 7.68 7.63 7.87 7.85 7.79 7.73 7.56 7.85 7.95 7.87 7.99 7.64 7.86 7.67 7.73 8.01 7.6 7.62 7.97 8.06 7.75 7.57
GOCC_EXCITATORY_SYNAPSE 8.13 8.24 7.99 7.96 8.3 8.57 8.59 8.51 7.89 8.58 7.79 8.6 8.75 8.52 8.54 8.26 8.26 8.32 8.73 8.5 8.07 8.05 7.89 8.36 8.27 8.19
GOCC_INHIBITORY_SYNAPSE 9.27 9.12 8.75 9.02 8.94 9.37 9.76 9.61 9.35 9.31 9.24 9.42 9.78 9.82 9.25 9.41 8.92 9.33 9.56 9.97 9.11 8.95 9.46 9.53 9.64 9.6
GOCC_CILIARY_MEMBRANE 6.55 6.72 6.83 6.52 6.39 6.66 6.51 6.68 6.36 6.83 6.8 6.74 6.72 6.65 6.74 7.08 6.53 6.58 6.76 6.25 6.73 6.69 6.83 6.88 6.7 6.8
GOCC_CLATHRIN_SCULPTED_VESICLE 9.05 8.97 9.74 9.04 9 9.68 10.24 9.65 9.49 9.86 9.36 9.37 9.97 9.97 9.96 9.92 8.78 9.35 9.28 9.67 9.53 9.83 9.73 9.84 9.9 9.74
GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS 6.84 6.91 7.3 7.32 7.13 7.17 7.22 7.16 7.26 7.3 7.27 7.24 7.28 7.29 7.31 7.26 7.08 7.03 7.07 7.27 7.05 7.19 7.41 7.66 7.38 7.37
GOCC_INFLAMMASOME_COMPLEX 4.73 4.95 4.77 4.93 4.28 4.28 4.6 4.53 4.61 4.33 4.42 4.44 4.43 4.21 4.32 4.34 4.59 4.8 4.61 4.53 4.85 4.5 4.46 4.23 4.52 4.61
GOCC_SPERM_HEAD 5.04 4.77 4.35 4.3 4.33 4.23 4.3 4.3 4.28 4.09 4.53 4.58 4.14 4.12 4.07 4.33 4.78 5.07 4.49 4.27 5.22 4.26 4.05 4.15 4.24 4.35
GOCC_COLLAGEN_CONTAINING_EXTRACELLULAR_MATRIX 5.7 5.48 5.44 5.56 5.28 5.21 5.47 5.4 5.39 5.25 5.5 5.26 5.3 5.31 5.4 5.38 5.5 5.52 5.25 5.27 5.69 5.43 5.52 5.01 5.46 5.44
GOCC_CYTOCHROME_COMPLEX 6.85 6.93 7.88 7.27 6.86 7.16 7.13 7.41 7.18 6.94 7.25 6.96 7.14 7.32 7.1 7.37 7.36 7.14 6.73 7.44 7.22 7.61 6.92 7.32 7.06 7.35
GOCC_TIGHT_JUNCTION 6.47 6.44 6.61 6.36 6.25 6.38 6.42 6.53 6.5 6.28 6.39 6.32 6.42 6.51 6.41 6.39 6.54 6.29 6.24 6.28 6.61 6.62 6.46 6.48 6.64 6.69
GOCC_ANCHORING_JUNCTION 6.93 6.84 7.04 6.83 7.06 7.1 7.15 7.06 7.08 7.09 7.01 7.07 7.11 7.08 7.04 7.05 7.05 6.97 6.93 7.09 7.05 7.09 7.28 7.27 7.19 7.2
GOCC_EXOCYTIC_VESICLE 7.82 7.85 8 7.92 7.99 8.12 8.15 8.24 7.99 8.27 7.92 8.2 8.23 8.22 8.38 8.12 7.82 7.88 8.13 8.27 7.81 8.04 8.06 8.3 8.11 8.1
GOCC_SAGA_TYPE_COMPLEX 7.9 7.77 8.59 8.43 8.15 8.45 8.11 8.16 8.16 8.28 8.12 8.27 8.44 8.27 8.21 8.32 8.05 8.22 8.41 8.37 7.64 8.15 8.1 8.18 8.18 8.22
GOCC_RESPIRASOME 8.23 8.16 9.48 9.21 8.13 8.21 8.74 9.06 8.4 8.61 9.01 8.52 8.48 8.59 9.12 9.25 8.64 8.44 8.27 8.58 8.52 9.01 8.5 8.68 8.56 8.8
GOCC_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX 7.33 7.48 7.45 7.32 7.42 7.65 7.63 7.8 7.53 7.67 7.36 7.67 7.66 7.72 7.86 7.65 7.45 7.39 7.52 7.75 7.44 7.73 7.68 8.02 7.88 7.83
GOCC_TERTIARY_GRANULE 6.15 6.11 6.52 6.25 6.53 6.42 6.11 6.24 5.99 6.16 6.1 5.99 6.27 6.1 6.24 6.13 6.3 6.19 5.83 6.3 6.27 6.33 6.13 6.3 6.71 6.53
GOCC_TERTIARY_GRANULE_MEMBRANE 6.15 6.23 6.48 6.08 6.59 6.42 6.07 6.21 6.42 6.18 6.01 5.93 6.28 5.97 6.23 6.13 6.22 6 5.71 6.3 6.11 6.3 6.41 6.49 6.67 6.6
GOCC_SIN3_TYPE_COMPLEX 7.19 7.25 7.38 6.85 7.59 7.6 7.83 7.3 7.44 7.38 6.98 7.81 7.28 7.52 7.26 7.39 7.42 7.46 7.54 7.84 7.15 7.54 7.63 7.57 7.9 7.46
GOCC_CONTRACTILE_RING 7.75 7.45 7.46 6.65 7.8 8.01 7.84 7.66 7.85 7.83 7.41 7.83 7.91 7.83 7.87 7.74 7.63 7.31 7.85 7.81 7.23 7.59 8.22 8.15 7.97 7.48
GOCC_ENDOPLASMIC_RETICULUM_EXIT_SITE 7.87 7.68 8.67 8.55 8.04 8.04 8.15 7.91 8.27 8.33 8.42 8.04 8.19 8.46 7.8 7.91 7.79 7.45 7.92 7.97 7.64 7.98 8.28 8.34 7.94 7.98
GOCC_TRANSLATION_PREINITIATION_COMPLEX 8.54 8.29 8.98 8.94 9.06 8.68 9.12 8.66 8.99 8.88 8.62 8.62 8.79 8.78 8.74 8.81 8.59 8.39 8.5 8.67 8.64 8.74 9.31 8.93 8.7 8.72
GOCC_U2_TYPE_CATALYTIC_STEP_2_SPLICEOSOME 6.93 7.25 7.78 7.52 7.21 7.32 7.46 7.65 7.39 7.35 7.12 7.41 7.19 7.21 7.6 7.7 7.19 7.33 7.34 7.58 7.42 7.69 7.31 7.71 7.52 7.56
GOCC_PRESPLICEOSOME 7.74 7.93 8.21 8.12 7.87 7.87 7.93 8.43 7.79 7.5 7.47 7.84 7.51 7.72 7.82 7.91 7.75 7.45 7.58 8.13 8.03 7.96 7.65 7.73 8.42 8.54
GOCC_PRECATALYTIC_SPLICEOSOME 7.08 7.55 7.54 7.88 7.48 7.27 7.36 7.94 7.4 7.38 7.65 7.37 7.38 7.35 7.6 7.82 7.14 7.36 7.43 7.52 7.46 7.7 7.28 7.77 7.43 7.85
GOCC_CATALYTIC_STEP_1_SPLICEOSOME 7.73 7.53 8.05 8.01 8.13 8.22 8.74 8.15 7.96 7.78 8.18 7.52 8.55 8.43 8.5 8.13 8.23 7.46 8.19 8.51 7.62 8.27 8.04 8.48 8.21 8.1
GOCC_CATALYTIC_STEP_2_SPLICEOSOME 7.15 7.53 7.66 7.46 7.66 7.54 7.5 7.64 7.51 7.51 7.47 7.51 7.46 7.31 7.69 7.61 7.33 7.27 7.5 7.66 7.42 7.63 7.58 7.77 7.49 7.6
GOCC_POST_MRNA_RELEASE_SPLICEOSOMAL_COMPLEX 6.48 6.63 7.21 6.87 6.83 6.87 6.77 6.47 6.87 6.8 6.41 6.99 6.51 6.63 6.85 6.84 6.31 6.12 6.52 6.61 6.39 6.53 7.03 7.1 6.82 6.78
GOCC_CMG_COMPLEX 5.65 5.5 5.45 5.98 5.34 5.08 5.47 5.65 5.4 5.4 5.64 5.35 5.34 5.2 5.45 5.55 5.28 5.46 5.32 5.41 5.59 5.23 5.34 5.72 5.63 6.03
GOCC_NPBAF_COMPLEX 8.12 8.32 8.36 8.03 8.56 8.32 8.66 8.83 8.41 8.58 7.95 8.58 8.37 8.53 8.59 8.77 8.26 8.21 8.29 8.49 8.36 8.38 8.32 8.51 8.79 8.39
GOCC_NBAF_COMPLEX 8.24 8.44 8.46 8.09 8.59 8.6 8.83 9.01 8.44 8.72 8.19 8.6 8.83 8.63 8.87 8.92 8.5 8.6 8.49 8.79 8.46 8.5 8.47 8.6 8.86 8.63
GOCC_ENDOCYTIC_VESICLE_LUMEN 5.69 5.49 5.63 5.63 5.27 5.36 5.54 5.49 5.18 5.38 5.86 5.14 5.59 5.39 5.63 5.1 5.12 5.27 5.26 5.48 5.54 5.87 5.12 5.01 5.33 5.63
GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK 8.37 8.52 9.19 8.75 8.63 8.78 9.01 8.73 8.72 9.02 8.79 8.87 9.03 9.11 8.91 8.8 8.51 8.43 8.75 9.05 8.77 8.8 8.92 9.23 9.26 8.68
GOCC_BLOOD_MICROPARTICLE 5.49 5.18 5.41 5.33 5 5.02 5.07 5.03 5.06 4.98 5.19 4.94 4.72 4.88 5.08 4.91 5.32 5.3 4.99 5.01 5.37 5.2 5.17 4.71 5.25 5.52
GOCC_MITOTIC_SPINDLE 6.53 6.54 6.52 6.41 6.53 6.52 6.52 6.5 6.47 6.68 6.46 6.54 6.62 6.59 6.54 6.71 6.55 6.56 6.41 6.61 6.65 6.55 6.53 6.55 6.8 6.7
GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX 7.52 7.96 8.19 8.05 8.15 7.96 8.04 8.04 8.07 8.19 8.09 8.3 8.24 8.35 8.09 8.1 8 7.67 7.91 8.24 7.82 7.68 8.36 8.41 8.11 7.9
GOCC_SPANNING_COMPONENT_OF_MEMBRANE 7.99 7.78 7.8 7.52 8.36 8.64 8.39 7.9 8.09 8.03 7.47 7.84 8.37 8.39 7.96 7.91 7.96 8.04 8.73 8.33 7.25 7.11 8.31 8.56 7.97 7.72
GOCC_FLEMMING_BODY 7.01 7 7.38 7.47 7.02 7.05 7.02 6.86 7.01 7.3 7.16 6.62 6.93 7.09 7.24 7.02 6.51 6.84 7.13 7.03 6.98 6.89 7.41 7.43 7.19 6.39
GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX 6.75 6.99 7.06 7.25 7.07 6.95 7.01 7.07 7.05 7.13 7.17 7.08 7.09 7.16 7.21 7.18 6.91 7.02 6.94 7.2 7.15 7.23 7.19 7.39 7.29 7.3
GOCC_GLYCOPROTEIN_COMPLEX 7.14 7.14 6.85 6.45 6.89 7.14 7.51 7.35 7.34 7.3 7.41 7.36 7.27 7.64 7.53 7.55 7.3 7.12 7.29 7.17 7.81 7.36 7.56 7.4 7.35 7.08
GOCC_SITE_OF_DNA_DAMAGE 6.5 6.5 6.71 6.97 6.93 6.72 6.5 6.6 6.52 6.79 6.93 7.13 6.98 6.64 6.65 6.86 6.77 6.83 7.01 6.65 6.67 6.72 6.87 7.01 6.7 6.86
GOCC_CILIARY_PLASM 5.55 5.67 5.44 5.52 5.5 5.63 5.71 5.53 5.54 6 5.82 5.82 5.62 5.56 5.76 6.18 5.69 5.84 5.7 5.67 5.91 5.76 5.85 5.66 5.58 5.77
GOCC_PERINUCLEAR_ENDOPLASMIC_RETICULUM 7.42 7.56 7.98 7.01 8.25 8.13 7.76 7.5 7.96 7.49 7.27 7.61 7.66 7.8 7.33 7.81 7.41 7.6 7.41 7.73 7.32 7.84 7.74 7.96 7.78 7.45
GOCC_SYNAPTIC_MEMBRANE 7.49 7.59 7.81 7.46 7.76 8.04 8.02 7.9 7.77 7.93 7.54 7.85 7.91 8.01 8.17 7.9 7.6 7.76 7.86 8.02 7.6 7.83 7.85 8.14 7.87 7.78
GOCC_SPERM_MIDPIECE 5.76 5.57 5.66 5.79 5.36 5.19 5.36 5.25 5.29 5.36 5.79 5.37 5.26 5.41 5.29 5.29 5.33 5.55 5.38 5.29 5.42 5.18 5.21 5.11 5.29 5.31
GOCC_SPERM_PRINCIPAL_PIECE 4.95 5.08 4.65 4.96 4.65 4.5 5.52 4.48 4.85 5.75 4.8 4.73 4.58 4.34 5.4 5.7 4.91 4.92 5.46 4.8 4.95 4.52 4.61 4.73 4.3 4.29
GOCC_INO80_TYPE_COMPLEX 6.52 6.64 7.03 7.2 7.1 7.17 7 6.98 7.25 7.31 7.13 7.03 7.05 6.98 7.35 7.21 6.87 6.78 6.71 7.23 6.9 7.35 7.48 7.66 6.88 7.06
GOCC_PHOTORECEPTOR_DISC_MEMBRANE 5.12 4.99 4.59 5.02 4.68 4.21 4.79 4.58 4.75 4.31 4.98 4.44 4.3 4.56 4.5 4.81 4.84 5.11 4.76 4.59 4.87 4.38 4.49 4.24 4.65 4.71
GOCC_GLIAL_CELL_PROJECTION 8.78 8.47 9.26 8.37 9.04 9.04 9.13 8.73 9.31 9.22 9.02 8.83 8.97 9.15 9.21 9.02 8.98 8.47 9.04 8.83 8.77 9.11 9.36 9.21 9.06 8.98
GOCC_MITOTIC_SPINDLE_POLE 6.75 6.6 6.33 6.63 6.94 6.82 6.6 6.37 6.71 6.93 6.79 6.94 6.56 6.54 6.64 6.8 6.58 6.52 6.54 6.65 6.72 6.68 6.59 6.57 6.77 6.53
GOCC_APICAL_DENDRITE 8.5 8.73 8.63 8.17 8.75 8.76 9.05 9.06 8.95 8.86 8.59 8.61 8.94 9.06 8.87 9 8.44 8.76 8.76 8.8 9.03 8.89 9.25 8.87 8.99 8.72
GOCC_DENDRITIC_TREE 7.87 8.03 8.08 7.69 8.05 8.33 8.31 8.23 8.13 8.28 7.9 8.2 8.29 8.36 8.27 8.25 7.94 8.1 8.2 8.28 8 8.24 8.21 8.35 8.28 8.17
GOCC_ASTROCYTE_PROJECTION 9.75 9.64 9.85 9.06 9.77 9.85 9.72 9.75 10.26 9.88 10.06 9.94 10.18 10.34 9.8 10.28 9.59 10 9.89 9.78 10.05 10.16 10.11 10.1 10.1 10.01
GOCC_SPERM_PLASMA_MEMBRANE 4.68 4.74 3.97 4.24 4.27 3.92 4.24 4.41 4.15 4 4.53 4.39 4.26 3.99 4.15 4.23 4.33 5.07 4.54 4.03 4.78 4.17 3.98 3.95 4.03 4.19
GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX 7.17 7.48 7.75 7.99 7.18 7.24 7.34 7.53 7.61 7.32 7.47 7.37 7.29 7.3 7.73 7.71 7.24 7.09 7.37 7.52 7.41 7.6 7.57 7.85 7.64 7.51
GOCC_CILIARY_TIP 6.65 6.59 7.04 6.9 6.67 6.76 6.68 6.54 6.49 6.69 6.95 6.84 6.6 6.67 6.65 6.94 6.56 6.66 6.93 6.82 6.52 6.9 6.73 6.82 6.71 6.8
GOCC_CILIARY_BASE 6.42 6.33 6.3 6.2 6.27 6.52 6.58 6.47 6.55 6.45 6.56 6.67 6.46 6.49 6.38 6.32 6.32 6.5 6.65 6.7 6.31 6.28 6.57 6.73 6.47 6.64
GOCC_TRANSCRIPTION_PREINITIATION_COMPLEX 6.3 6.13 6.98 7.28 6.08 6.13 6.17 6.68 6.63 6.38 6.68 6.55 6.33 6.52 6.61 6.4 6.11 6.51 6.36 6.15 6.18 6.41 6.24 6.44 6.27 6.77
GOCC_9PLUS2_MOTILE_CILIUM 5.53 5.43 5.43 5.71 5.22 5.15 5.49 5.33 5.29 5.67 5.61 5.41 5.22 5.28 5.47 5.71 5.33 5.45 5.4 5.39 5.42 5.28 5.17 5.03 5.08 5.39
GOCC_NON_MOTILE_CILIUM 5.75 5.67 5.86 5.79 5.57 5.51 5.68 5.53 5.64 5.48 5.74 5.48 5.48 5.51 5.62 5.67 5.62 5.76 5.65 5.56 5.64 5.59 5.59 5.43 5.59 5.63
GOCC_9PLUS0_NON_MOTILE_CILIUM 5.53 5.56 5.7 5.75 5.41 5.29 5.51 5.35 5.59 5.26 5.58 5.44 5.44 5.44 5.51 5.57 5.41 5.68 5.54 5.34 5.54 5.51 5.39 5.25 5.38 5.51
GOCC_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX 6.27 6.52 6.99 6.69 6.17 6.53 6.4 6.51 5.99 6.33 6.5 5.99 6.14 6.1 6.22 6.57 6.38 6.82 6.43 6.52 6.46 6.77 5.84 6.08 6.38 6.45
GOCC_SIDE_OF_MEMBRANE 6.04 5.85 5.94 5.92 5.72 5.76 5.83 5.95 5.83 5.71 5.75 5.63 5.73 5.73 5.68 5.72 5.88 5.9 5.67 5.65 5.95 5.89 5.72 5.58 5.84 5.97
GOCC_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE 8.87 8.31 8.65 8.4 8.2 8.3 8.77 8.38 8.22 7.62 7.86 7.56 8.29 8.4 8.12 8.92 8.8 8.52 7.92 8.58 9.51 9.36 8.86 8.65 8.23 8.4
GOCC_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE 7.25 7.41 7.47 7.41 7.68 7.61 7.12 7.23 7.42 7.2 7.25 7.52 7.29 7.37 7.22 7.24 7.14 7.52 7.21 7.47 7.02 7.4 7.6 7.48 7.72 7.41
GOCC_CYTOPLASMIC_SIDE_OF_MEMBRANE 7.04 6.98 7.38 7.12 7.19 7.29 7.26 7.43 7.52 7.33 7.22 7.27 7.41 7.35 7.4 7.27 7.14 7.15 7.21 7.37 7.13 7.45 7.52 7.54 7.56 7.42
GOCC_INTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE 8.35 8.02 8.53 8.53 8.48 8.66 8.6 8.69 8.69 8.6 8.54 8.48 8.75 8.67 8.73 8.55 8.45 8.54 8.56 8.97 8.37 8.46 8.58 8.74 8.76 8.83
GOCC_INTRINSIC_COMPONENT_OF_MITOCHONDRIAL_MEMBRANE 7.12 7.15 7.83 7.69 7.66 7.57 7.53 7.62 7.46 7.52 7.61 7.57 7.65 7.73 7.65 7.71 7.35 7.25 7.71 7.72 7.51 7.66 7.53 7.73 7.55 7.56
GOCC_LUMENAL_SIDE_OF_MEMBRANE 8.85 8.24 8.35 8.33 8.05 7.97 8.34 8.16 7.84 7.51 7.93 7.54 7.35 7.6 7.93 8.89 8.66 8.24 7.81 8.32 9.45 9.25 8.67 8.35 7.95 7.56
GOCC_PLASMA_MEMBRANE_REGION 6.73 6.75 6.88 6.7 6.87 6.91 6.91 6.99 6.89 6.95 6.77 6.85 6.95 6.93 6.92 6.91 6.8 6.78 6.88 6.97 6.84 6.83 6.92 6.94 6.92 6.89
GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION 5.92 5.53 5.41 5.57 5.4 5.06 5.31 5.16 5.5 5.04 5.33 5.08 5.62 5.47 5.13 5.32 5.6 5.36 5.41 5.29 5.64 5.49 5.7 5.36 5.38 5.58
GOCC_COMPLEX_OF_COLLAGEN_TRIMERS 5.57 5.36 4.93 5.07 5.09 4.76 4.89 5.01 4.85 4.86 5.02 4.95 4.75 4.79 4.93 4.84 5.04 5.24 5.03 4.8 5.19 4.98 5.05 4.53 4.91 4.75
GOCC_SCHAFFER_COLLATERAL_CA1_SYNAPSE 8.34 8.55 8.44 8.11 8.68 8.84 8.92 8.77 8.92 8.96 8.36 8.64 9 9.03 9.09 9.09 8.53 8.63 8.95 8.93 8.23 8.62 8.54 9.1 8.99 8.63
GOCC_HIPPOCAMPAL_MOSSY_FIBER_TO_CA3_SYNAPSE 7.89 8.11 8.07 7.84 8.28 8.19 8.4 8.5 8.49 8.29 8.06 8.28 8.29 8.47 8.54 8.49 8.16 8.19 8.2 8.25 7.93 8.05 8.05 8.36 8.43 8.49
GOCC_CHROMOSOMAL_REGION 6.44 6.53 6.65 6.87 6.76 6.82 6.63 6.66 6.6 6.8 6.64 6.59 6.6 6.53 6.55 6.76 6.56 6.39 6.45 6.68 6.56 6.74 6.81 6.91 6.77 6.59
GOCC_PARALLEL_FIBER_TO_PURKINJE_CELL_SYNAPSE 6.11 5.86 6.09 7.6 5.84 5.63 6.13 6.58 6.2 7.12 5.88 6.37 5.62 5.66 7.65 6.37 6.15 5.76 6.4 6.4 6.24 5.86 6.5 6.36 5.63 5.78
GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT 7.22 7.29 7.71 7.49 7.54 7.63 7.54 7.56 7.46 7.61 7.36 7.48 7.53 7.54 7.55 7.53 7.35 7.28 7.38 7.61 7.33 7.57 7.59 7.72 7.55 7.52
GOCC_PRESYNAPSE 7.5 7.64 7.84 7.71 7.85 8 8.04 7.93 7.81 8.08 7.73 8.01 8.03 8.05 8.1 7.87 7.69 7.82 7.93 8.04 7.7 7.87 7.89 8.1 7.88 7.85
GOCC_POSTSYNAPSE 7.98 8.13 8.23 7.8 8.24 8.4 8.38 8.33 8.31 8.35 8.01 8.32 8.46 8.49 8.38 8.32 8.03 8.14 8.26 8.41 8.12 8.34 8.35 8.5 8.39 8.23
GOCC_MEMBRANE_PROTEIN_COMPLEX 6.86 6.88 7.3 7.05 7.12 7.15 7.21 7.21 7.22 7.22 7.08 7.06 7.17 7.22 7.27 7.26 7.08 6.97 7.18 7.23 7.07 7.23 7.29 7.39 7.27 7.26
GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX 6.28 6.33 6.51 6.4 6.34 6.5 6.45 6.47 6.51 6.52 6.33 6.33 6.43 6.46 6.5 6.42 6.37 6.36 6.42 6.58 6.43 6.53 6.53 6.6 6.5 6.47
GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX 7.27 7.37 8.43 8.09 7.59 7.75 7.75 7.81 7.82 7.74 7.98 7.71 7.83 7.73 8 8.19 7.44 7.52 7.62 7.92 7.44 7.98 7.95 8.02 7.89 7.82
GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX 7.51 7.14 8.43 7.69 7.83 8.07 7.75 7.92 7.98 8.11 7.83 7.67 7.9 7.94 8.03 8.26 7.27 7.64 7.91 7.93 7.64 7.94 7.95 8.18 8.06 7.88
GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX 7.54 7.9 9.06 8.66 8.02 8.08 8.34 8.42 8.19 8.37 8.53 8.23 8.23 8.42 8.51 8.67 8.05 8.07 8.02 8.39 7.95 8.49 8.34 8.53 8.36 8.36
GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX 6.04 5.94 6.1 6.05 6 6.04 5.94 6.11 6 6.06 5.96 5.95 5.94 6.05 6.01 5.87 5.98 6.08 5.92 6.09 6.11 6.05 6.17 6.02 6.11 6.06
GOCC_RESPIRATORY_CHAIN_COMPLEX 8.06 8.16 9.49 9.21 8.16 8.21 8.64 8.92 8.27 8.59 8.93 8.52 8.47 8.55 9.12 9.2 8.62 8.44 8.18 8.56 8.43 8.91 8.44 8.66 8.51 8.8
GOCC_PRESYNAPTIC_ACTIVE_ZONE_CYTOPLASMIC_COMPONENT 7.8 7.64 7.81 7.44 8.36 8.15 8.19 8.31 8.02 8.22 8.4 8.49 8.21 8.46 8.91 8.42 7.76 8.28 8.21 8.17 7.96 8.61 8.11 8.45 8.21 8.05
GOCC_POSTSYNAPTIC_DENSITY_MEMBRANE 8.18 8.33 8.25 7.61 8.47 8.7 8.66 8.32 8.53 8.4 8.13 8.31 8.5 8.6 8.49 8.38 8.11 8.34 8.48 8.55 8.03 8.09 8.46 8.89 8.41 8.27
GOCC_POSTSYNAPTIC_ENDOCYTIC_ZONE 7.7 8.22 8.95 8.99 8.95 9 9.06 9.34 8.82 9.18 8.61 8.89 9.06 8.8 9.29 8.98 8.87 8.75 8.48 9 8.86 9.17 9.12 9.14 9.05 9.21
GOCC_POSTSYNAPTIC_ENDOSOME 8.26 8.36 9.14 8.51 8.46 8.95 9.06 9.11 9.06 9.33 9.08 8.94 8.95 9.06 9.4 9.24 8.51 8.74 8.54 8.97 9 8.96 9.59 9.26 9.5 8.89
GOCC_MEMBRANE_MICRODOMAIN 6.51 6.53 6.63 6.65 6.56 6.56 6.54 6.72 6.77 6.61 6.56 6.64 6.66 6.6 6.76 6.57 6.6 6.44 6.44 6.57 6.7 6.74 6.63 6.6 6.8 6.74
GOCC_ACTIN_BASED_CELL_PROJECTION 6.42 6.38 6.36 6.49 6.57 6.51 6.67 6.61 6.71 6.65 6.51 6.73 6.42 6.41 6.63 6.65 6.71 6.32 6.16 6.35 6.52 6.62 6.93 6.7 6.74 6.8
GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS 5.72 5.46 5.61 5.89 5.49 5.27 5.46 5.4 5.63 5.4 5.66 5.44 5.4 5.41 5.48 5.38 5.63 5.54 5.55 5.26 5.61 5.59 5.32 5.22 5.38 5.46
GOCC_NEUROTRANSMITTER_RECEPTOR_COMPLEX 8.31 8.34 8.08 7.87 8.12 8.42 8.47 8.25 8.47 8.32 7.83 8.27 8.26 8.51 8.44 8.46 8.1 8.22 8.35 8.4 8.01 8.16 8.21 8.37 8.34 8.22
GOCC_INTRINSIC_COMPONENT_OF_PRESYNAPTIC_MEMBRANE 7.89 7.88 7.74 7.43 7.49 7.93 7.97 7.91 7.53 8.04 7.46 7.77 7.81 7.94 8.11 8.04 7.15 8.03 7.82 7.72 7.73 7.82 7.67 8.01 7.78 7.61
GOCC_INTRINSIC_COMPONENT_OF_POSTSYNAPTIC_MEMBRANE 7.5 7.93 7.9 7.29 7.95 8.25 8.19 8.07 8.17 8.14 7.46 7.89 8.36 8.29 8.25 8.11 7.43 7.96 8.14 8.16 7.49 7.72 7.98 8.32 7.9 7.65
GOCC_INTRINSIC_COMPONENT_OF_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE 6.62 6.7 7.09 7.5 6.29 6.86 7.72 6.81 7.29 7.1 6.84 6.55 7.45 7.7 7.54 6.95 6.64 6.94 7.04 6.89 6.64 6.75 7.51 7.02 6.65 6.54
GOCC_INTRINSIC_COMPONENT_OF_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE 7.66 8.11 8.2 7.61 8.21 8.33 8.7 8.28 8.5 8.41 7.63 8.21 8.45 8.49 8.49 8.32 7.67 8.07 8.31 8.51 7.53 7.82 8.33 8.47 8.33 7.98
GOCC_GLUTAMATERGIC_SYNAPSE 8.17 8.34 8.38 8.02 8.54 8.68 8.69 8.47 8.48 8.45 8.09 8.41 8.57 8.63 8.61 8.45 8.22 8.35 8.6 8.63 8.12 8.34 8.57 8.77 8.53 8.31
GOCC_GABA_ERGIC_SYNAPSE 8.54 8.88 8.65 8.17 8.76 9.24 9.05 9.05 8.97 9.04 8.37 8.64 9.19 9.09 9.12 9.02 8.22 8.67 9.08 9.13 8.14 8.52 9.04 9.26 8.74 8.45
GOCC_NEURON_TO_NEURON_SYNAPSE 8.27 8.41 8.35 7.88 8.52 8.6 8.59 8.48 8.54 8.53 8.15 8.51 8.62 8.68 8.64 8.62 8.26 8.32 8.65 8.69 8.25 8.44 8.49 8.8 8.58 8.36
GOCC_NEURONAL_DENSE_CORE_VESICLE 9.37 9.67 9.94 9.17 9.14 9.56 9.7 9.23 9.3 9.53 9.51 9.34 8.89 9.32 9.65 9.2 8.84 9.32 9.84 9.57 9.06 9.26 9.29 9.29 9.15 9.03
GOCC_ANCHORED_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE 8.31 8.2 8.77 8.54 8.43 8.66 8.91 9.3 8.69 8.6 8.99 8.45 8.89 8.37 9.5 9.05 8.62 8.72 8.17 9.27 9.16 9.37 8.75 8.74 8.9 9.55
GOCC_VESICLE_TETHERING_COMPLEX 7.13 7.1 7.94 7.59 7.75 7.74 7.45 7.47 7.57 7.48 7.36 7.51 7.49 7.41 7.43 7.34 7.21 7.04 7.51 7.44 7.01 7.34 7.71 7.66 7.52 7.37
GOCC_INTEGRAL_COMPONENT_OF_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE 8.77 9.06 9.07 8.51 8.48 8.84 9.54 8.92 9.02 9.14 8.56 8.42 8.92 9.1 9.05 9.08 8.86 8.07 8.95 9.12 9.16 8.64 9.44 9.2 9.17 8.9
GOCC_SUPRAMOLECULAR_COMPLEX 6.38 6.35 6.47 6.3 6.39 6.43 6.45 6.38 6.44 6.5 6.37 6.47 6.43 6.41 6.49 6.49 6.49 6.43 6.34 6.43 6.47 6.55 6.54 6.49 6.44 6.44
GOCC_SUPRAMOLECULAR_POLYMER 6.21 6.19 6.13 6.08 6.03 6.06 6.22 6.09 6.1 6.27 6.17 6.23 6.11 6.04 6.13 6.25 6.2 6.21 6.09 6.17 6.26 6.17 6.23 6.17 6.2 6.13
GOCC_SYNAPTONEMAL_STRUCTURE 4.99 4.89 4.6 5.11 4.35 4.21 4.43 4.64 4.3 4.25 4.67 4.79 4.42 4.41 4.48 4.47 4.75 5.07 4.86 4.74 5.11 4.69 4.39 4.39 4.4 4.6
GOCC_POSTSYNAPTIC_SPECIALIZATION_INTRACELLULAR_COMPONENT 7.86 8.23 8.52 7.78 8.31 8.46 8.47 8.72 8.33 8.64 8.53 8.47 8.33 8.35 8.8 8.44 8.49 8.51 8.1 8.53 8.5 8.45 8.54 8.45 8.65 8.75
GOCC_POSTSYNAPTIC_DENSITY_INTRACELLULAR_COMPONENT 8.32 8.36 8.64 7.88 9.07 8.95 8.85 8.9 8.59 9.05 8.57 8.81 8.67 8.68 8.91 8.68 8.64 9.28 8.19 8.74 8.79 8.88 9.15 8.9 8.89 8.82
GOCC_INTRINSIC_COMPONENT_OF_POSTSYNAPTIC_DENSITY_MEMBRANE 7.71 8.09 8.06 7.55 8.32 8.49 8.69 8.33 8.52 8.23 7.7 8.27 8.53 8.51 8.54 8.32 7.8 8.16 8.33 8.38 7.7 8.02 8.21 8.4 8.34 8.22
GOCC_INTRINSIC_COMPONENT_OF_SYNAPTIC_MEMBRANE 7.5 7.84 7.84 7.29 7.85 8.17 8.02 8.05 7.93 8.02 7.44 7.81 8.14 8.07 8.21 8.07 7.38 7.85 8.06 8.07 7.49 7.72 7.84 8.23 7.86 7.64
GOCC_SECRETORY_VESICLE 6.58 6.58 6.85 6.73 6.73 6.72 6.77 6.85 6.77 6.67 6.72 6.68 6.68 6.66 6.87 6.76 6.71 6.67 6.62 6.76 6.74 6.83 6.77 6.89 6.91 6.98
GOCC_POLYMERIC_CYTOSKELETAL_FIBER 6.3 6.28 6.32 6.21 6.26 6.29 6.34 6.27 6.29 6.37 6.28 6.39 6.33 6.26 6.4 6.41 6.33 6.36 6.25 6.37 6.39 6.35 6.34 6.31 6.37 6.33
GOCC_REGION_OF_CYTOSOL 8.43 8.39 8.52 8.4 8.59 9.09 8.58 8.47 8.58 8.62 8.36 8.63 8.77 8.82 8.69 8.69 8.58 8.59 8.92 8.95 8.45 8.59 8.45 8.89 8.61 8.47
GOCC_POSTSYNAPTIC_CYTOSOL 8.43 8.39 8.54 8.4 8.54 9.09 9 9.08 8.71 9 8.37 8.63 8.77 9.21 8.69 8.95 8.58 8.73 8.92 8.95 8.45 8.75 8.75 8.89 8.71 8.85
GOCC_CYTOPLASMIC_REGION 7.21 7.26 7.7 7.43 7.48 7.72 7.58 7.57 7.41 7.77 7.59 7.49 7.49 7.47 7.55 7.65 7.52 7.35 7.57 7.65 7.38 7.68 7.59 7.73 7.46 7.47
GOCC_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE 7.99 8.32 8.26 7.66 8.32 8.55 8.65 8.24 8.48 8.41 7.81 8.27 8.39 8.49 8.3 8.32 8.03 8.16 8.35 8.46 7.74 7.93 8.4 8.55 8.34 8.11
GOCC_CELL_CORTEX_REGION 8.46 8.42 8.01 8.11 8.84 9.05 8.92 8.77 8.31 9.18 8.4 8.97 8.99 8.99 8.95 8.62 8.53 8.28 8.88 9.14 7.96 8.71 8.83 9.05 8.82 8.96
GOCC_FICOLIN_1_RICH_GRANULE 6.73 6.64 7.44 7.18 7.06 7.08 7.04 7.25 7 7.07 7.15 6.92 7.02 7.17 7.15 7.18 7.04 6.95 7.03 7.26 6.97 7.27 7.21 7.22 7.33 7.34
GOCC_FICOLIN_1_RICH_GRANULE_MEMBRANE 6.22 5.96 6.52 6.15 6.57 6.5 6.02 6.23 5.93 6.06 6.18 6.01 6.15 6.04 6.21 6.08 6.13 6.25 5.61 6.32 6.19 6.27 6.07 5.92 6.77 6.64
GOCC_CHAPERONE_COMPLEX 7.71 7.69 8.47 8.51 8.17 8.26 8.44 8.76 8.3 8.45 8.17 8.34 8.49 8.22 8.65 8.83 8.34 8.26 8.03 8.44 8.47 8.48 8.55 8.63 8.61 8.21
GOCC_NEURON_PROJECTION_CYTOPLASM 8.77 8.92 9.32 8.88 9.26 9.3 9.4 9.12 9.25 9.32 9.14 9.16 9.4 9.28 9.44 9.42 9.01 8.92 9.16 9.17 8.72 9.08 9.38 9.42 9.34 8.98
GOCC_SM_LIKE_PROTEIN_FAMILY_COMPLEX 6.89 7.16 7.44 7.73 7.26 7.24 7.18 7.25 7.17 7.27 7.32 7.23 7.2 7.25 7.42 7.48 6.77 6.97 7.32 7.36 7.17 7.37 7.19 7.4 7.34 7.36
GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX 6.92 7.07 7.26 7.29 7.25 7.28 7.19 7.21 7.22 7.28 7.19 7.28 7.23 7.23 7.29 7.32 7.03 7.04 7.14 7.3 7.09 7.29 7.3 7.46 7.28 7.33
GOCC_ENDOPLASMIC_RETICULUM_PROTEIN_CONTAINING_COMPLEX 7.81 8.26 8.35 8.24 8.22 8.41 8.51 8.52 8.57 8.52 8.21 8.47 8.54 8.43 8.45 8.34 8.2 7.76 8.16 8.52 7.73 8.04 8.58 8.75 8.38 8.24
GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX 7.42 7.47 7.97 7.97 7.75 7.82 7.73 7.76 7.81 7.89 7.8 7.79 7.83 7.86 7.79 7.81 7.59 7.49 7.7 7.72 7.5 7.74 7.96 8.02 7.82 7.74
GOCC_DISTAL_AXON 7.84 8 8.06 7.71 8.36 8.4 8.35 8.31 8.19 8.36 8.05 8.41 8.24 8.22 8.38 8.32 8.02 8.11 8.16 8.22 8.23 8.38 8.31 8.51 8.44 8.22
GOCC_CATALYTIC_COMPLEX 7.19 7.36 7.73 7.67 7.59 7.57 7.55 7.58 7.63 7.67 7.55 7.61 7.63 7.64 7.64 7.62 7.41 7.32 7.51 7.59 7.39 7.61 7.71 7.82 7.65 7.61
GOCC_ENDORIBONUCLEASE_COMPLEX 6.26 6.23 6.65 6.73 6.19 6.49 6.55 6.57 6.38 6.34 6.39 6.44 6.08 6.15 6.44 6.24 6.29 6.2 6.25 6.46 6.31 6.4 6.38 6.41 6.45 6.55
GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX 7.83 7.97 8.32 8.21 8.49 8.22 8.05 8.01 8.18 8.18 7.99 8.22 8.18 8.33 8.41 8.41 7.91 7.81 8.16 8.19 7.95 8.4 8.1 8.26 8.25 8.24
GOCC_GABA_RECEPTOR_COMPLEX 7.72 8.73 9.01 9.11 7.87 8.57 9.65 9.05 8.95 9.67 7.78 7.93 8.84 8.74 9.73 9.1 7.73 7.6 8.29 8.78 8.28 8.66 9.12 8.87 8.53 8.23
GOCC_PROTEIN_KINASE_COMPLEX 7.04 7.08 7.38 7.42 7.3 7.35 7.32 7.16 7.29 7.51 7.37 7.44 7.67 7.6 7.25 7.34 7.28 7.02 7.2 7.33 7.24 7.25 7.53 7.48 7.44 7.62
GOCC_PHOSPHATASE_COMPLEX 8.22 8.2 8.63 8.58 8.25 8.56 8.57 8.93 8.39 8.43 8.42 8.35 8.5 8.56 8.65 8.69 8.08 8.49 8.43 8.38 8.35 8.45 8.61 8.65 8.44 8.19
GOCC_AXON_CYTOPLASM 8.77 8.94 9.32 8.68 9.36 9.36 9.66 9.12 9.2 9.43 8.94 9.16 9.22 9.26 9.4 9.42 9.01 8.92 9.13 9.17 8.63 9.08 9.59 9.61 9.34 8.89
GOCC_TERTIARY_GRANULE_LUMEN 5.8 5.92 6.02 6.57 5.52 5.18 5.68 6.09 5.6 5.78 5.7 5.8 5.43 5.41 5.88 5.5 5.8 6.09 5.73 5.77 6.14 6.32 5.43 5.79 5.73 6.23
GOCC_FICOLIN_1_RICH_GRANULE_LUMEN 6.85 6.87 8.06 7.57 7.19 7.36 7.38 7.48 7.37 7.46 7.52 7.13 7.5 7.37 7.45 7.5 7.36 7.09 7.16 7.61 7.34 7.5 7.52 7.57 7.58 7.51
GOCC_ATPASE_COMPLEX 7.17 7.2 7.39 7.31 7.35 7.43 7.34 7.44 7.47 7.63 7.33 7.58 7.48 7.53 7.58 7.5 7.39 7.25 7.33 7.56 7.27 7.5 7.58 7.86 7.52 7.41
GOCC_EXORIBONUCLEASE_COMPLEX 7.01 7.32 7.66 7.51 7.3 7.76 7.63 7.35 7.4 7.31 7.38 7.53 7.48 7.43 7.08 7.43 6.86 6.93 7.34 7.58 6.98 7.41 7.17 7.4 7.37 7.22
GOCC_GTPASE_COMPLEX 8.07 7.55 8.38 7.76 7.62 7.98 8.53 8.48 8.82 8.69 8.4 8 7.98 8.18 8.51 8.23 8.53 8.26 8.22 8.17 7.91 8.36 8.77 8.62 8.79 8.55
GOCC_PEPTIDASE_COMPLEX 7.83 8.1 8.79 8.66 8.36 8.4 8.41 8.49 8.67 8.49 8.46 8.38 8.51 8.57 8.53 8.48 8.07 8 8.23 8.58 7.93 8.37 8.56 8.65 8.42 8.23
GOCC_ENDOPEPTIDASE_COMPLEX 7.79 8.14 9.15 8.77 8.36 8.47 8.46 8.53 8.76 8.57 8.54 8.43 8.53 8.6 8.7 8.58 8.07 8 8.23 8.61 8.06 8.4 8.69 8.76 8.43 8.19
GOCC_MITOTIC_SPINDLE_MIDZONE 7.43 6.87 6.9 6.98 7.22 7.14 6.91 7.5 7.17 7.3 7.29 7.01 7.65 7.53 7.49 7.72 7.24 7.36 7.42 7.46 7.38 7.7 7.6 7.64 7.35 7.54
GOCC_MESSENGER_RIBONUCLEOPROTEIN_COMPLEX 6.83 6.69 7.47 7.32 6.74 7.04 7 7.05 7.28 7.18 6.98 7.11 6.74 7.04 7.11 7.12 7.03 6.61 7.1 7.06 7.3 7.15 7.46 7.38 7.09 7.08
GOCC_OXIDOREDUCTASE_COMPLEX 7.41 7.9 9.03 8.52 8.07 8.05 8.22 8.25 8.03 8.2 8.46 8.14 8.13 8.31 8.54 8.51 7.99 8.01 8.04 8.25 7.91 8.53 8.3 8.45 8.16 8.22
GOCC_TRANSFERASE_COMPLEX 7.1 7.24 7.61 7.61 7.37 7.41 7.43 7.45 7.47 7.56 7.47 7.45 7.5 7.52 7.5 7.46 7.26 7.22 7.35 7.47 7.3 7.47 7.62 7.75 7.52 7.49
GOCC_TRANSPORTER_COMPLEX 6.52 6.54 6.52 6.63 6.57 6.78 6.68 6.78 6.68 6.81 6.56 6.59 6.79 6.79 6.87 6.61 6.55 6.71 6.8 6.77 6.5 6.56 6.61 6.71 6.6 6.54
GOCC_DNA_REPAIR_COMPLEX 7.43 7.49 7.58 7.52 7.62 7.89 7.47 7.26 7.45 7.71 7.38 7.76 7.64 7.45 7.5 7.48 7.37 6.95 7.51 7.3 7.16 7.19 7.48 7.82 7.42 7.39
GOCC_L_TYPE_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX 7.63 7.71 6.67 6.7 7.42 7.61 7.11 7.31 7.08 7.55 7.09 7.76 7.34 7.53 7.44 7.21 7.16 7.71 8.08 7.59 7.03 7.43 7.06 7.36 7.41 7.52
GOCC_MITOTIC_SPINDLE_MICROTUBULE 6.02 6.11 6.14 6.35 6.16 6.05 5.72 5.94 5.93 5.89 5.99 6.06 6.03 5.85 5.77 5.98 5.87 6.08 5.91 6.34 6.17 6.16 5.87 6.24 6.26 6.38
GOCC_MICROTUBULE_END 7.8 8.21 7.99 7.67 8.53 8.58 8.09 7.95 8.28 8.47 8.02 8.15 8.47 8.36 8.42 8.25 8.13 7.99 8.32 8 7.96 8.55 8.7 8.79 8.02 7.99
GOCC_RIBONUCLEOPROTEIN_COMPLEX 6.88 7 7.47 7.36 7.24 7.2 7.26 7.36 7.25 7.35 7.32 7.32 7.22 7.23 7.43 7.47 6.99 6.98 7.19 7.37 7.15 7.3 7.35 7.51 7.27 7.36
GOCC_BETA_CATENIN_TCF_COMPLEX 7.38 7.39 7.06 6.7 7.55 7.23 7.47 7.73 7.23 7.15 7.38 7.26 7.61 7.52 7.46 7.48 7.59 7.3 7.14 7.57 7.89 7.79 7.04 7.28 7.92 7.82
GOCC_WNT_SIGNALOSOME 6.12 6.49 6.4 6.37 7.01 6.93 7 6.91 6.4 6.8 6.58 7.18 6.92 7.05 7.02 7 6.98 6.67 6.95 6.46 7.05 7.17 6.84 6.89 6.89 6.86
GOMF_MANNOSYLTRANSFERASE_ACTIVITY 7.33 7.53 7.19 7.11 7.95 7.75 7.96 7.32 7.52 7.4 7.16 7.43 7.41 7.69 7.29 7.21 7.2 7.27 7.51 7.57 7.4 7.29 7.66 7.75 7.4 7.5
GOMF_TRNA_BINDING 6.27 6.25 6.72 6.8 6.72 6.56 6.4 6.4 6.44 6.67 6.43 6.37 6.41 6.2 6.59 6.71 6.47 6.43 6.7 6.43 6.33 6.68 6.18 6.44 6.51 6.69
GOMF_MICROFILAMENT_MOTOR_ACTIVITY 5.17 5.31 4.98 5.16 4.89 4.91 5.22 4.97 4.95 4.93 5.08 4.87 4.96 4.86 5.18 4.92 5.13 5.27 5.01 4.9 5.45 5.07 4.78 4.69 4.92 5.15
GOMF_SNARE_BINDING 7.27 7.29 7.73 7.49 7.71 7.92 7.58 7.7 7.58 7.46 7.53 7.69 7.71 7.71 7.58 7.66 7.43 7.42 7.45 7.76 7.47 7.9 7.77 7.91 7.75 7.68
GOMF_DNA_SECONDARY_STRUCTURE_BINDING 5.85 6.05 6.4 6.11 5.71 5.96 5.94 6.02 6.04 6.22 6.13 6.14 5.99 6.02 5.81 5.91 6.02 5.67 5.9 5.91 5.67 5.95 5.88 6.15 6.07 6.24
GOMF_MAGNESIUM_ION_BINDING 6.81 6.74 7.21 7.13 7.14 7.26 7 7.16 7.27 7.25 7.13 7.12 7.34 7.26 7.13 7.17 7.21 6.92 6.87 7.04 6.76 6.9 7.22 7.43 7.14 7.15
GOMF_RNA_CAP_BINDING 7.53 7.95 8.42 8.21 7.55 7.82 8 7.66 8.01 8.21 8.15 8.08 7.96 8.1 8.14 8.4 7.77 7.69 7.34 7.68 7.38 8.06 8.28 8.25 7.87 7.83
GOMF_FOUR_WAY_JUNCTION_DNA_BINDING 5.93 6.06 5.95 5.89 5.75 5.86 5.34 5.72 5.65 5.96 5.91 5.96 5.86 5.87 5.75 5.65 5.61 5.73 5.85 5.56 5.55 5.85 5.73 5.96 5.98 6.16
GOMF_ADENYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY 6.58 6.82 7.54 6.82 7.03 7.25 7.51 7.47 7.35 7.14 7.24 6.72 7.3 7.61 7.31 7.34 7.2 6.84 7.21 7.3 7.32 7.2 7.4 7.37 7.43 7.12
GOMF_TRANSLATION_REPRESSOR_ACTIVITY_MRNA_REGULATORY_ELEMENT_BINDING 7.75 7.99 8.35 8.19 7.43 8.23 8.04 8.05 8.11 8.34 7.52 8.19 8.29 8.46 8.45 8.1 7.8 7.82 8.13 8.35 7.84 8.09 8.27 8.67 8.28 7.97
GOMF_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING 7.22 7.2 7.65 7.66 7.16 7.35 7.74 7.55 7.36 7.8 7.48 7.46 7.2 7.35 7.71 7.75 7.51 7.34 7.31 7.37 7.62 8.05 7.43 7.54 7.83 7.51
GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING 5.88 5.85 5.8 5.87 5.69 5.69 5.75 5.83 5.8 5.74 5.84 5.76 5.87 5.78 5.84 5.75 5.79 5.8 5.71 5.78 5.85 5.85 5.77 5.71 5.79 5.8
GOMF_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING 6.87 6.79 7.35 7.2 7.11 6.86 7.32 7.48 7.09 7.49 7.07 7.27 7.03 7.22 7.57 7.32 7.26 7.08 7.16 7.12 7.42 7.53 7.23 7.45 7.57 7.5
GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_BINDING 6.24 6.03 6.11 6.34 5.89 6.01 5.99 6.21 6.21 6.2 6.1 6.1 6.11 6.38 6.22 6.05 6.12 5.99 6.18 6.12 6.5 6.25 6 6.27 6.01 6.6
GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING 7.85 7.78 8.08 8.21 8.12 8.16 7.86 7.5 7.7 8.12 8.21 7.79 8.06 8.14 7.67 7.54 7.36 7.22 7.89 7.81 7.44 7.51 7.58 7.82 7.66 7.77
GOMF_TFIID_CLASS_TRANSCRIPTION_FACTOR_COMPLEX_BINDING 7.72 7.57 8.06 7.21 7.79 8.08 7.69 7.48 7.65 7.86 7.71 7.77 8.06 7.99 7.61 7.5 7.32 7.16 7.7 7.72 7.23 7.38 7.57 7.86 7.66 7.72
GOMF_BASAL_TRANSCRIPTION_MACHINERY_BINDING 7.16 7.29 7.68 7.65 7.46 7.89 7.46 7.5 7.64 7.62 7.54 7.66 7.8 7.78 7.71 7.59 7.25 7.26 7.36 7.71 7.44 7.6 7.68 7.85 7.62 7.69
GOMF_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING 7.8 7.71 7.56 7.74 7.99 8.12 8.12 7.8 7.84 7.94 7.72 7.87 8.25 8.21 7.76 7.67 7.81 7.6 7.54 8.12 8.13 8.19 8.1 8.18 7.78 7.73
GOMF_RNA_POLYMERASE_II_REPRESSING_TRANSCRIPTION_FACTOR_BINDING 7.38 7.65 7.97 7.68 7.75 7.75 7.57 7.3 7.56 7.73 7.44 7.81 7.94 7.82 7.67 7.53 7.53 7.26 7.49 7.73 7.02 7.43 7.83 7.75 8.12 7.39
GOMF_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING 6.12 5.84 6.05 6.25 5.68 5.5 5.46 5.88 5.76 5.62 5.69 5.66 5.9 5.78 5.77 6.14 5.46 6.05 5.78 5.59 5.81 5.77 6.12 6.08 5.83 5.9
GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY 5.76 5.7 5.78 5.82 5.53 5.48 5.68 5.7 5.73 5.67 5.83 5.57 5.71 5.68 5.75 5.7 5.67 5.69 5.61 5.68 5.85 5.81 5.64 5.54 5.66 5.68
GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY 5.94 5.98 5.86 6.01 5.84 5.81 5.76 5.83 5.81 5.74 5.89 5.79 5.96 5.84 5.74 5.8 5.9 5.95 5.85 5.84 5.96 5.87 5.87 5.81 5.87 6.08
GOMF_TRANSCRIPTION_COREGULATOR_BINDING 7.02 7.32 7.38 7.17 7.54 7.63 7.58 7.55 7.66 7.57 7.49 7.79 7.78 7.7 7.66 7.7 7.49 7.38 7.59 7.85 7.28 7.44 7.53 7.64 7.87 7.5
GOMF_TRANSCRIPTION_COREPRESSOR_BINDING 7.58 7.73 7.72 7.7 8.02 7.88 7.92 7.73 7.81 7.9 7.8 8.07 8.09 8.15 7.72 8.13 7.91 8.09 7.78 7.99 8.05 8.36 7.87 8.08 8.12 7.95
GOMF_TRANSCRIPTION_COACTIVATOR_BINDING 6.83 6.66 7.27 6.77 6.58 6.92 6.83 6.88 6.92 6.91 7.3 7.31 7.28 7.15 7.1 7.14 6.79 6.97 6.66 6.9 6.7 6.99 6.79 7 7.26 7.32
GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_COREGULATOR_BINDING 7.33 7.18 6.8 7.23 7.4 7.47 7.11 6.95 7.12 7.29 7.06 7.45 7.23 7.57 7.25 7.19 7.16 7.54 7.62 7.09 7.21 7.14 7.21 7.52 6.94 7.38
GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_COREPRESSOR_BINDING 7.33 7.18 6.8 7.29 7.4 7.47 7.11 6.95 7.12 7.29 7.06 7.45 7.23 7.57 7.25 7.19 7.16 7.54 7.62 7.09 7.21 7.14 7.5 7.52 6.94 7.38
GOMF_LIPOPOLYSACCHARIDE_BINDING 6.1 5.96 6.76 6.67 6.24 5.91 4.97 5.58 5.81 5.06 5.53 4.74 5.68 5.63 5.42 6 4.88 5.21 5.32 5.5 5.96 6.51 5.64 5.56 6 6.46
GOMF_AMYLOID_BETA_BINDING 7.19 7.22 8.08 7.55 7.59 7.73 7.88 7.78 7.61 7.72 7.5 7.57 7.83 7.82 7.71 7.6 7.4 7.22 7.5 7.66 7.39 7.52 7.49 7.92 7.64 7.63
GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY 4.91 4.74 4.56 4.76 4.49 4.19 4.25 4.14 4.53 4.29 4.51 4.21 4.33 4.32 4.23 4.18 4.33 4.55 4.6 4.42 4.56 4.06 4.27 4.26 4.42 4.17
GOMF_PEPTIDE_RECEPTOR_ACTIVITY 5.34 5.19 5.2 5.26 4.79 4.78 5.04 5.06 5.14 5.03 5.38 4.89 4.89 4.9 5.07 4.91 5.1 5.27 5.02 4.92 5.21 4.91 4.93 4.73 4.89 5.06
GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING 5.98 5.93 5.83 5.98 5.68 5.68 5.89 5.81 5.71 5.74 5.99 5.84 5.78 5.78 5.81 5.8 5.98 5.92 5.72 5.63 6.05 5.84 5.67 5.51 5.75 5.79
GOMF_ATPASE_ACTIVATOR_ACTIVITY 7.53 7.6 8.36 7.89 8.03 7.86 7.42 7.38 7.97 8.16 7.9 8.02 8.08 8.21 7.95 8.08 7.76 7.73 7.95 7.61 7.62 8.06 8 7.92 7.74 7.7
GOMF_PHOSPHOTYROSINE_RESIDUE_BINDING 6.41 6.36 6.39 6.55 6.56 6.64 6.27 6.26 6.5 6.94 6.44 6.72 6.88 6.05 6.07 6.29 7.02 6.53 6.24 6.47 6.82 6.31 6.63 6.25 6.45 6.34
GOMF_PHOSPHATIDYLSERINE_BINDING 6.89 6.64 6.93 6.79 6.71 6.81 7.14 7.17 6.93 7.1 6.94 6.95 7.23 7.31 7.29 7.32 7.02 7.18 7.05 7.32 6.74 6.95 6.95 7.14 6.98 7.17
GOMF_OPSONIN_BINDING 5.48 4.98 5.35 5.78 5.2 5.01 5.02 5.03 5.15 5.19 4.98 5.23 5.15 5.02 5.33 5.05 4.88 4.99 4.86 4.8 5.46 5.38 5.16 5.02 5.65 5.82
GOMF_COMPLEMENT_BINDING 5.37 4.93 4.92 5.21 5.01 4.83 4.85 4.95 5.01 4.94 4.92 4.87 4.94 4.98 4.99 4.88 4.75 5.06 4.75 4.77 5.2 5.16 4.76 4.75 4.86 4.97
GOMF_G_PROTEIN_ALPHA_SUBUNIT_BINDING 6.94 7 6.65 6.58 6.94 7.25 6.81 7.22 6.92 7.42 6.84 7.19 7.27 7.18 7.48 7.24 7.04 6.78 7.18 7.13 7.35 7.16 6.99 7.35 7.19 7.34
GOMF_FIBRONECTIN_BINDING 5.9 5.89 5.55 5.81 5.38 5.34 5.53 5.53 5.76 5.4 5.6 5.5 5.43 5.6 5.39 5.81 6.06 6.17 5.59 5.39 5.96 5.82 5.94 5.36 5.49 5.78
GOMF_RETINOIC_ACID_BINDING 5.39 5.31 5.45 5.52 5.18 4.96 5.49 5.37 5.42 5.3 5.09 5.23 5.23 5.41 5.5 5.42 5.45 5.38 5.51 5.44 5.56 5.55 5.27 4.9 5.29 5.29
GOMF_PROTEASE_BINDING 6.19 6.31 6.16 6.37 6.25 6.31 6.16 6.24 6.25 6.23 6.11 6.41 6.37 6.36 6.33 6.12 6.29 6.17 6.23 6.23 6.17 6.25 6.37 6.38 6.53 6.22
GOMF_P53_BINDING 7.16 7.23 7.35 7.33 7.39 7.73 7.31 7.64 7.44 7.67 7.38 7.77 7.45 7.55 7.73 7.44 7.52 7.16 7.68 7.59 7.08 7.43 7.52 7.73 7.18 7.24
GOMF_DNA_HELICASE_ACTIVITY 6.22 6.21 6.33 6.51 6.19 6.29 6.1 6.34 6.04 6.42 6.35 6.2 6.27 6.34 6.21 6.46 6.25 6.16 6.34 6.25 6.22 6.12 6.27 6.25 6.2 6.53
GOMF_CHROMATIN_BINDING 6.66 6.7 6.84 6.74 6.91 6.89 7.03 7.06 6.91 6.97 6.8 6.98 7.03 6.92 6.96 7.05 6.87 6.75 6.83 6.98 6.89 6.98 6.96 7.11 6.93 7.05
GOMF_DAMAGED_DNA_BINDING 6.48 6.41 6.67 7.04 6.46 6.37 6.46 6.5 6.5 6.66 6.72 6.52 6.53 6.42 6.33 6.56 6.31 6.31 6.43 6.46 6.29 6.47 6.54 6.73 6.66 6.61
GOMF_DNA_REPLICATION_ORIGIN_BINDING 5.84 5.85 5.71 6.27 5.72 5.55 5.6 5.68 5.85 5.87 5.74 5.78 5.63 5.44 5.7 5.77 5.62 5.66 5.41 5.62 5.59 5.62 5.83 5.93 5.75 6.06
GOMF_SINGLE_STRANDED_DNA_BINDING 6.98 6.99 7.74 7.42 7.36 7.34 7.3 7.16 7.34 7.59 7.43 7.66 7.41 7.39 7.33 7.37 7.12 7.18 7.16 7.37 7.03 7.33 7.42 7.47 7.39 7.42
GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY 5.76 5.72 5.7 5.8 5.57 5.52 5.64 5.66 5.68 5.58 5.76 5.62 5.68 5.64 5.7 5.59 5.7 5.7 5.54 5.66 5.74 5.7 5.62 5.58 5.65 5.63
GOMF_STEROID_HORMONE_RECEPTOR_ACTIVITY 6.85 6.55 6.48 6.49 6.85 7.04 6.78 7.02 6.98 6.95 6.93 6.65 6.93 7 6.71 7.03 7.1 6.5 6.72 6.85 6.4 7.16 6.44 6.94 6.7 7.24
GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY 7.08 7.18 7.38 7.27 7.39 7.46 7.38 7.45 7.37 7.43 7.24 7.35 7.51 7.39 7.48 7.44 7.31 7.22 7.34 7.48 7.25 7.45 7.41 7.59 7.48 7.43
GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY 7.13 7.26 7.44 7.32 7.42 7.52 7.53 7.56 7.46 7.58 7.31 7.44 7.66 7.44 7.69 7.53 7.43 7.27 7.39 7.58 7.33 7.56 7.52 7.71 7.69 7.66
GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY 7.22 7.25 7.53 7.4 7.46 7.57 7.5 7.49 7.42 7.62 7.27 7.46 7.57 7.55 7.67 7.51 7.43 7.26 7.45 7.66 7.32 7.45 7.52 7.58 7.65 7.45
GOMF_RNA_BINDING 7.02 7.16 7.5 7.38 7.36 7.42 7.41 7.4 7.43 7.46 7.37 7.41 7.45 7.44 7.48 7.48 7.25 7.16 7.3 7.43 7.23 7.49 7.51 7.64 7.46 7.42
GOMF_RNA_HELICASE_ACTIVITY 6.61 6.59 6.9 6.86 6.78 7.09 6.77 6.83 6.69 6.88 6.57 6.88 6.72 6.71 6.79 6.78 6.73 6.65 6.94 6.79 6.58 6.78 6.99 6.9 6.8 6.86
GOMF_DOUBLE_STRANDED_RNA_BINDING 7.28 7.46 7.8 7.67 7.68 7.94 7.78 7.81 8.18 8.14 7.72 7.82 8.04 7.88 7.83 8.03 7.3 7.16 7.87 7.86 7.41 8.03 8.03 8.34 7.97 7.7
GOMF_SINGLE_STRANDED_RNA_BINDING 6.67 6.84 7.06 6.98 7.02 6.9 7.17 7.08 7.18 7.15 6.87 7.22 6.94 7.03 7.06 7.12 6.77 6.64 7.02 7.12 7.02 7.15 7.19 7.16 7.01 7.2
GOMF_MRNA_BINDING 7.58 7.71 7.84 7.77 8.01 8.14 7.98 7.91 7.95 8.11 7.75 7.94 8.17 8.13 8.14 8.09 7.82 7.67 7.88 8.04 7.73 8.06 8.16 8.34 8.15 7.99
GOMF_MRNA_3_UTR_BINDING 7.8 7.83 7.97 7.93 7.99 8.12 7.79 8.13 7.88 8.06 8.01 8 8.12 8.17 8.08 8.09 7.98 7.67 7.87 7.95 7.95 8.22 8 8.26 8.12 7.97
GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME 6.61 6.65 7.63 7.52 6.43 6.74 6.9 7.09 6.66 6.77 7.17 6.68 6.8 6.89 7.14 7.12 6.67 6.71 6.66 6.84 7.02 7.06 6.82 7.04 6.89 6.92
GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY 7.97 8.09 8.52 8.53 8.43 8.39 8.3 8.14 8.42 8.21 8.17 8.16 8.38 8.36 8.38 8.29 8.24 8.06 7.93 8.33 7.91 8.47 8.37 8.5 8.47 8.23
GOMF_TRANSLATION_ELONGATION_FACTOR_ACTIVITY 7.05 6.54 7.65 7.43 7.09 7.3 6.8 6.81 7.18 7.14 7.49 6.96 7.16 7.19 7.17 7.25 6.66 7.23 7.14 6.92 7.03 6.8 7.35 7.1 6.84 6.81
GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY 5.79 5.67 5.78 6.22 6.07 5.84 5.91 6.3 5.91 6.12 6.38 5.92 5.99 6.02 6.21 6.32 5.93 6.06 5.63 5.91 5.84 6.6 5.61 5.87 5.72 6.2
GOMF_MOTOR_ACTIVITY 5.82 5.76 5.68 5.67 5.64 5.74 5.88 5.79 5.77 5.92 5.87 5.79 5.89 5.78 5.93 6.02 6.01 5.97 5.74 5.8 6.01 5.92 5.63 5.76 6.02 6.08
GOMF_MICROTUBULE_MOTOR_ACTIVITY 5.52 5.54 5.68 5.54 5.44 5.35 5.78 5.49 5.47 5.79 5.63 5.78 5.75 5.3 5.89 5.75 5.69 5.81 5.64 5.55 5.77 5.69 5.29 5.49 5.82 5.77
GOMF_ACTIN_BINDING 6.6 6.57 6.53 6.36 6.85 6.7 6.85 6.96 6.82 6.86 6.6 6.79 6.78 6.7 6.75 6.77 6.8 6.68 6.72 6.74 6.69 6.73 6.97 6.78 6.85 6.89
GOMF_ACTIN_MONOMER_BINDING 6.7 6.5 6.2 6.57 5.9 6.45 6.41 6.52 6.43 6.55 6.38 6.66 6.84 6.85 6.48 6.66 6.77 7.04 6.88 6.81 6.61 6.4 6.32 6.43 6.72 6.89
GOMF_ANTIGEN_BINDING 5.29 5.37 5.22 5.29 4.65 4.63 5.17 5.19 5.01 4.71 5.1 4.88 4.7 4.76 5.03 4.71 5.34 5.43 5.17 5.46 5.25 5.01 4.67 4.59 4.82 4.99
GOMF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY 5.81 5.91 6.58 6.42 5.96 6.23 6.03 6.01 5.95 6.26 6.06 6.08 5.88 5.85 6 6.06 5.75 5.77 6.17 5.76 5.97 6.03 6.06 6.29 6.14 6.23
GOMF_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY 6.09 6.27 6.42 6.55 5.72 5.78 6.43 5.84 6.22 5.82 5.56 5.67 5.83 5.95 5.71 5.99 5.73 6.09 6.18 6.07 5.46 5.86 5.97 6.15 6.01 5.85
GOMF_GTPASE_ACTIVITY 7.3 7.36 7.96 7.74 7.44 7.71 7.63 7.53 7.6 7.68 7.69 7.47 7.64 7.58 7.74 7.71 7.38 7.33 7.48 7.68 7.44 7.63 7.72 7.89 7.73 7.56
GOMF_NADPLUS_ADP_RIBOSYLTRANSFERASE_ACTIVITY 6.29 5.88 6.18 5.98 5.59 5.61 5.77 5.8 5.61 5.64 6.29 5.87 5.63 5.77 5.84 5.97 6.33 6.15 5.77 5.71 5.92 6.27 5.67 5.78 5.96 5.95
GOMF_NADPLUS_KINASE_ACTIVITY 6.72 7.14 7.01 8.42 6.94 7.44 7.51 7.16 7.03 7.15 6.96 7.42 7.19 7.17 7.46 7.18 7.02 7.39 7.39 7.43 6.79 7.14 7.14 7.3 7.13 6.83
GOMF_NADPLUS_NUCLEOSIDASE_ACTIVITY 5.34 5.27 4.98 4.77 5.02 4.71 4.4 4.69 4.81 4.75 5.08 4.8 4.81 4.46 4.68 4.61 4.98 5.18 5.06 4.52 5.19 4.79 4.7 4.86 4.97 5.23
GOMF_NAD_P_H_DEHYDROGENASE_QUINONE_ACTIVITY 8.23 8.36 9.62 9.41 8.53 8.63 8.82 9.15 8.48 8.75 9.01 8.68 8.53 8.62 9.33 9.46 8.64 8.66 8.27 8.67 8.57 9.07 8.57 8.77 8.81 9.16
GOMF_ACYL_COA_DEHYDROGENASE_ACTIVITY 6.77 6.92 7.18 6.79 7.09 7.1 7.08 6.63 6.9 7.01 7 6.97 6.95 6.83 6.52 7.09 7.07 6.85 7.08 6.85 6.62 7.17 6.85 6.87 6.81 7.24
GOMF_ADENOSINE_DEAMINASE_ACTIVITY 6.11 6.24 6.34 6.39 7.1 7.25 7.09 7.15 5.99 7.33 6.26 6.72 6.63 6.53 6.76 6.57 6.74 6.34 6.48 7.21 6.13 6.17 6.93 6.89 6.44 6.91
GOMF_ADENYLATE_CYCLASE_ACTIVITY 7.07 6.86 6.62 6.62 7.2 7.26 7.53 7.75 7.26 7.49 7.11 7.68 7.43 7.62 7.69 7.47 7.5 7.05 7.21 7.4 7.51 7.33 7.35 7.4 7.69 7.64
GOMF_ALDEHYDE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY 4.93 5.11 5.59 6.21 4.87 4.87 5.95 6.22 5.65 5.52 5.66 5.23 5.36 4.95 5.32 5.14 5.63 5.84 4.85 4.99 5.43 5.36 5.43 5.32 5.36 5.44
GOMF_ALDITOL_NADPPLUS_1_OXIDOREDUCTASE_ACTIVITY 5.3 5.61 6.19 6.21 5.11 5.1 5.59 5.85 5.91 5.16 5.45 5.85 6.37 4.27 5.47 5.61 4.85 4.59 4.66 4.82 5.1 5.04 6.18 5.98 5.86 5.8
GOMF_ALDO_KETO_REDUCTASE_NADP_ACTIVITY 5.79 5.93 6.48 6.47 5.45 5.96 5.98 6.29 6.17 5.99 6.28 6.12 6.39 5.99 6.27 6.59 5.93 5.78 5.52 6.01 5.92 5.99 6.2 6.18 6.22 6.26
GOMF_ARYLSULFATASE_ACTIVITY 5.92 5.94 5.94 5.64 6.23 6.59 6.68 6.13 6.19 6.27 5.74 6.26 6.29 6.13 6.46 6.41 6.08 6.11 6.16 6.56 6.04 6.49 6.19 6.7 6.2 6.06
GOMF_CARBONATE_DEHYDRATASE_ACTIVITY 5.62 5.51 5.93 6.89 5.25 5.31 5.57 5.57 5.55 5.02 5.4 5.05 5.4 5.54 5.43 5.23 5.4 5.47 5.35 5.36 5.37 5.3 5.2 5.07 5.82 5.47
GOMF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY 6.51 6.68 6.56 6.91 7.2 7.35 6.9 6.82 7.08 7.1 6.68 6.84 7.18 7.36 6.92 6.69 6.58 6.74 7.07 6.95 6.61 6.79 7.1 6.99 6.93 6.77
GOMF_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY 7.17 7.09 6.73 7.51 7.12 7.26 7.21 7.05 7.05 6.92 6.95 6.82 7.42 7.49 6.83 6.86 6.54 7.1 7.39 7.13 7.07 7.03 7.57 7.05 6.97 6.79
GOMF_CYTIDINE_DEAMINASE_ACTIVITY 4.74 5.03 4.95 4.52 4.43 4.12 4.52 4.71 4.64 4.29 4.61 4.59 4.08 4.34 4.4 4.43 5.1 4.97 4.83 4.68 5.15 4.55 4.04 4.14 4.93 4.91
GOMF_DIACYLGLYCEROL_KINASE_ACTIVITY 7.28 7.77 7.92 8.49 7.94 7.93 8.04 7.27 7.96 8.27 7.75 7.87 7.63 7.87 7.93 7.83 7.39 8.05 7.84 7.89 7.23 7.49 8.01 8.53 7.67 7.51
GOMF_ENDOPEPTIDASE_ACTIVITY 5.63 5.58 5.55 5.72 5.27 5.17 5.43 5.37 5.37 5.25 5.57 5.39 5.28 5.25 5.48 5.45 5.5 5.56 5.33 5.33 5.6 5.47 5.27 5.28 5.38 5.49
GOMF_AMINOPEPTIDASE_ACTIVITY 6.09 6.07 6.5 6.73 6.56 6.55 6.58 6.58 6.59 6.62 6.32 6.5 6.43 6.55 6.69 6.35 6.53 6.4 6.14 6.6 6.64 6.54 6.5 6.51 6.51 6.57
GOMF_CARBOXYPEPTIDASE_ACTIVITY 5.6 5.61 5.43 5.19 5.31 5.17 5.07 5.48 5.05 5.17 5.22 4.93 5.15 5.08 4.98 5.54 5.24 5.41 5.21 5.19 5.6 5.26 5.27 4.8 5.16 5.14
GOMF_METALLOCARBOXYPEPTIDASE_ACTIVITY 5.17 4.98 4.75 4.95 4.82 4.57 4.58 4.77 4.64 4.6 4.84 4.7 4.56 4.5 4.49 5 4.92 4.92 4.7 4.65 4.86 4.8 4.66 4.51 4.41 4.75
GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY 6.48 6.56 6.6 7.04 6.98 7.05 6.72 6.73 6.54 6.88 6.6 6.73 6.85 6.82 6.6 6.66 6.6 6.48 6.65 6.88 6.53 6.82 6.88 6.92 6.87 6.86
GOMF_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY 6.35 6.13 6.19 6.17 6.15 6.31 6.29 6.2 5.92 6.21 6.12 6.52 6.17 6.05 6.37 6.23 6.4 6.35 6.13 6.05 6.23 6.4 5.93 6.11 5.92 6.45
GOMF_METALLOENDOPEPTIDASE_ACTIVITY 5.5 5.45 5.36 5.5 5.14 5.08 5.25 5.28 5.32 5.14 5.35 5.26 5.15 5.12 5.47 5.29 5.5 5.34 5.13 5.25 5.42 5.42 5.2 5.18 5.29 5.38
GOMF_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY 6.86 7.58 9.64 8.95 8.09 8.45 8.74 8.15 8.74 8.57 9 8.49 8.26 8.51 8.73 8.71 8.04 6.96 7.43 8.06 7.6 7.96 8.46 8.27 8.34 7.76
GOMF_ESTRADIOL_17_BETA_DEHYDROGENASE_ACTIVITY 6.13 5.95 7.18 6.73 5.98 5.39 5.8 6.2 5.91 5.51 5.91 5.89 6.1 5.66 5.87 6.63 6.38 5.72 5.16 5.86 5.98 6.35 5.7 5.87 6.26 6.32
GOMF_FATTY_ACID_SYNTHASE_ACTIVITY 6.89 7.24 7.37 7.79 7.45 7.23 7.5 7.69 7.67 7.82 7.36 7.84 7.78 7.79 7.58 7.79 7.31 7.48 7.66 7.66 6.89 7.1 7.83 8.1 7.5 7.6
GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY 7.22 7.4 8.68 7.92 6.25 6.58 6.75 6.98 6.95 6.63 7.03 6.87 6.65 6.56 6.75 6.68 6.49 6.99 6.12 7.48 7.19 6.97 7.39 7.11 8.47 7.9
GOMF_HELICASE_ACTIVITY 6.57 6.49 6.65 6.65 6.71 6.79 6.63 6.52 6.54 6.78 6.62 6.73 6.71 6.66 6.67 6.75 6.61 6.56 6.64 6.62 6.46 6.7 6.65 6.79 6.61 6.8
GOMF_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY 6.28 6.05 6.28 6.28 6.14 6.26 6.14 6.25 6.09 6.29 5.88 6.13 5.96 6.05 5.68 5.72 6.51 6.28 5.73 6.18 6.61 6.19 5.67 6.16 6.71 6.84
GOMF_MONOOXYGENASE_ACTIVITY 5.27 5.18 5.04 5.13 4.73 4.54 4.89 4.88 4.81 4.63 4.93 4.83 4.72 4.63 4.79 4.75 4.97 5.09 4.84 4.72 5.13 4.78 4.61 4.53 4.92 4.83
GOMF_NUCLEASE_ACTIVITY 6.32 6.24 6.51 6.37 6.28 6.42 6.32 6.37 6.29 6.27 6.41 6.41 6.42 6.2 6.19 6.28 6.15 6.27 6.37 6.41 6.17 6.25 6.33 6.56 6.49 6.47
GOMF_ENDONUCLEASE_ACTIVITY 6.02 6.01 6.3 6.17 5.84 5.92 6.24 6.03 5.93 5.89 6.14 5.99 5.82 5.78 5.72 6.1 5.88 5.94 5.96 6.11 6 5.92 5.91 6.38 6.03 6.03
GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY 6.04 6.07 6.28 6.17 5.89 5.97 5.86 6.18 5.88 5.91 6.13 6.25 5.82 5.78 5.68 6.09 5.91 5.8 5.96 6.1 5.74 5.83 5.87 6.39 5.96 5.98
GOMF_ENDORIBONUCLEASE_ACTIVITY 5.99 6 6.25 6.21 5.9 6.03 6.35 6.25 6.16 5.9 6.37 6.13 6.12 5.97 5.93 6.29 5.88 6.03 5.98 6.4 6.11 6.11 6.25 6.51 6.12 6.03
GOMF_RIBONUCLEASE_P_ACTIVITY 6.12 5.82 7.02 6.68 5.93 6.6 6.82 6.52 6.49 6.13 6.11 6.16 5.96 6.01 6.13 6.33 5.91 5.87 6.04 6.49 5.82 6.25 6.58 6.38 6.43 5.98
GOMF_EXONUCLEASE_ACTIVITY 6.72 6.83 6.6 6.74 6.97 6.94 6.66 6.88 6.74 6.87 6.96 6.87 6.79 7.08 6.63 6.71 6.61 6.63 6.84 6.9 6.57 6.75 6.8 7.04 6.86 6.69
GOMF_EXODEOXYRIBONUCLEASE_ACTIVITY 5.8 5.68 5.68 5.96 5.67 5.6 5.81 6.06 6.01 5.73 5.62 5.59 5.81 5.78 5.79 5.71 5.79 5.7 5.68 5.75 5.42 5.86 5.64 5.68 5.96 5.98
GOMF_EXORIBONUCLEASE_ACTIVITY 7.39 7.35 7.52 7.56 7.69 7.76 7.42 7.31 7.45 7.61 7.43 7.51 7.51 7.63 7.08 7.42 7.28 7.17 7.34 7.64 6.85 7.32 7.5 7.42 7.21 7.29
GOMF_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY 7.8 7.9 8.08 8.11 8.13 7.81 7.53 7.27 7.71 7.77 7.91 7.71 7.75 7.95 7.36 7.48 7.56 7.26 7.71 7.65 7 7.38 7.94 7.99 7.69 7.41
GOMF_DEOXYRIBONUCLEASE_ACTIVITY 6.04 6.07 6.28 5.97 5.84 5.92 6.06 6.07 6.01 5.85 5.98 5.98 5.99 5.78 5.79 5.93 5.91 5.8 5.96 6.1 5.74 5.89 5.91 6.32 6.01 5.98
GOMF_RIBONUCLEASE_ACTIVITY 6.58 6.6 6.85 6.82 6.64 6.79 6.92 6.94 6.64 6.99 6.89 6.67 6.82 6.87 6.73 6.72 6.46 6.62 6.76 6.76 6.43 6.69 6.85 6.99 6.87 6.78
GOMF_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY 6.38 6.03 6.79 6.76 6.03 6.77 7 6.61 6.47 6.29 6.52 6.38 6.14 6.24 6.73 6.75 6.16 5.93 6.09 6.56 6.29 6.58 6.65 6.82 6.35 6.52
GOMF_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY 6.81 7.29 7.93 7.91 6.7 7.24 7.42 7.57 6.98 7.94 7.9 7.66 7.09 7.45 7.71 8.34 7.53 7.77 7.63 7.6 7.88 7.99 7.08 6.93 7.76 8.06
GOMF_NUCLEOTIDE_DIPHOSPHATASE_ACTIVITY 6.8 7.05 7.9 7.02 6.33 6.52 7.09 7.14 6.96 7.36 7.15 7.06 7.2 7.37 6.85 7.4 6.75 6.08 6.3 6.97 6.66 6.5 7.41 7.59 6.57 6.61
GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS 6.13 6.06 6.41 6.36 6.07 6.15 6.1 6.13 6.15 6.02 5.9 6.07 5.86 6.13 5.96 6 5.99 5.92 6.13 6.25 6.03 5.94 5.96 6.2 5.99 6.24
GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY 6.11 5.86 7.24 6.83 6.18 6.17 6.21 6.32 6.28 5.94 6.39 6.05 6.01 5.96 6.15 6.15 6.21 6.22 5.96 6.33 6.08 6.13 6.05 6.15 5.93 6.15
GOMF_PHOSPHOLIPASE_ACTIVITY 6.11 6.12 6.09 6.23 6.14 6 6.09 6.14 6.14 6.12 5.88 6.06 6.08 6.33 6.02 5.85 6.15 5.97 6.15 6.34 6.27 6.01 6.01 6.13 6.15 6.11
GOMF_LYSOPHOSPHOLIPASE_ACTIVITY 6.32 6.36 7.01 6.6 6.68 6.75 6.75 6.83 6.75 6.83 6.51 6.76 6.57 6.52 6.57 6.41 6.67 6.47 6.18 6.51 6.86 6.83 6.66 6.88 6.57 6.58
GOMF_PHOSPHOLIPASE_A2_ACTIVITY 5.45 5.23 5.02 5.26 4.73 4.5 4.88 4.78 4.85 4.67 5.17 4.58 4.53 4.72 4.72 4.99 5.03 4.99 4.75 4.69 5.1 4.78 4.69 4.46 4.8 4.81
GOMF_PHOSPHOLIPASE_C_ACTIVITY 6.05 5.7 5.56 5.6 6.16 6.02 6.11 6.07 6.17 6.43 5.85 6.22 6.01 6.04 5.9 5.82 6.13 5.88 6.36 6.39 6.2 5.76 6.22 6.17 6.05 6.27
GOMF_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY 5.69 5.38 5.52 5.94 5.47 5.19 5.65 5.93 5.31 5.37 5.12 5.58 5.25 5.34 5.82 5.33 5.2 5.07 5.33 5.61 5.26 5.11 5.66 4.92 5.29 5.53
GOMF_PRENYLTRANSFERASE_ACTIVITY 7.04 7.04 8.01 8.03 7.4 7.52 7.43 6.9 7.51 7.85 7.45 7.5 7.43 7.55 7.06 7.4 6.89 7.39 7.71 7.6 7.02 7.47 7.53 7.51 7.32 7.21
GOMF_PROTEIN_KINASE_ACTIVITY 6.82 6.81 6.91 6.89 7.11 7.15 6.99 7 6.95 7.06 6.9 7.01 7.19 7.12 7.03 7.01 7.03 6.99 7.02 7.1 7.01 7.06 7.09 7.14 7.12 7.18
GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY 7.02 6.94 7.22 7.07 7.33 7.36 7.15 7.24 7.13 7.26 7.16 7.27 7.36 7.33 7.2 7.19 7.21 7.19 7.29 7.27 7.18 7.43 7.28 7.47 7.27 7.38
GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY 6.69 6.71 6.76 6.57 6.81 6.88 6.97 6.8 6.63 6.73 6.48 6.5 6.87 6.91 6.34 6.9 6.76 6.6 6.49 6.95 6.65 6.89 7.17 6.68 6.89 6.87
GOMF_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY 7.68 7.87 8.33 7.34 7.41 7.85 7.93 8.02 7.44 7.7 7.7 7.72 8.08 8 7.95 7.97 7.66 7.5 8.07 7.7 7.49 8.27 7.79 7.94 7.99 7.76
GOMF_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY 6.2 6.04 5.98 5.28 5.95 6.15 6.22 5.99 6.08 6.73 5.87 6.42 5.99 5.89 6.32 6.47 6.55 6.61 5.81 5.92 6.84 6.34 6.1 6.42 6.8 6.62
GOMF_PROTEIN_KINASE_C_ACTIVITY 7.54 7.35 7.56 7.6 8 8 7.71 8 7.71 7.63 7.77 7.78 7.8 8.19 8.24 8.08 7.25 7.74 7.92 8.04 7.82 7.9 7.94 8.01 7.73 7.9
GOMF_MAP_KINASE_ACTIVITY 7.88 8.04 8.92 8.5 8.45 8.93 8.53 8.06 9.1 8.75 8.61 8.59 8.39 8.51 8.22 8.16 8.42 8.03 8.86 8.77 7.62 8.58 9.07 9.06 8.27 7.68
GOMF_MAP_KINASE_KINASE_ACTIVITY 7.56 7.39 8.24 7.96 7.73 8.27 7.92 7.86 7.83 7.97 8.22 7.77 7.92 7.86 7.85 8 7.74 7.96 7.89 7.83 7.96 8.09 7.94 8.11 7.78 7.56
GOMF_MAP_KINASE_KINASE_KINASE_ACTIVITY 6.98 7.05 6.78 6.46 7.38 7.35 7.02 7.12 7.1 7.15 6.86 7.22 7.22 7.46 6.97 7.1 7.06 7.1 7.17 7.36 6.8 7.16 7.12 7.28 7.13 7.42
GOMF_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY 7.57 7.39 7.78 7.79 7.83 8 7.86 7.78 7.63 8.09 7.74 7.87 7.91 7.82 7.87 7.96 7.8 7.75 8.01 8.07 7.81 7.93 7.57 7.67 7.81 7.82
GOMF_PROTEIN_TYROSINE_KINASE_ACTIVITY 6.33 6.37 6.5 6.48 6.64 6.44 6.32 6.64 6.58 6.65 6.55 6.54 6.63 6.54 6.66 6.6 6.41 6.39 6.33 6.45 6.68 6.56 6.43 6.5 6.31 6.62
GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY 6.41 6.65 6.54 6.5 6.67 6.66 6.47 6.99 6.63 6.77 6.44 6.54 6.79 6.76 6.82 6.64 6.41 6.42 6.57 6.71 6.92 6.76 6.62 6.64 6.77 6.91
GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY 5.75 5.91 6.3 6.1 5.64 5.84 5.85 6.1 6.1 5.65 5.78 5.68 5.86 6.01 6.02 5.76 5.87 5.96 5.88 5.56 6.19 5.88 5.76 5.78 5.95 5.77
GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY 7.15 7.16 7.5 7.29 7.4 7.53 7.36 7.41 7.37 7.54 7.26 7.37 7.48 7.48 7.44 7.28 7.35 7.27 7.3 7.4 7.24 7.37 7.66 7.74 7.37 7.36
GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY 7.13 7.15 7.55 7.65 7.35 7.25 7.36 7.28 7.37 7.46 7.31 7.19 7.48 7.48 7.44 7.24 7.2 7.27 7.17 7.4 7.12 7.27 7.66 7.58 7.28 7.19
GOMF_MAGNESIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY 6.16 6.61 6.69 6.55 6.39 6.5 6.38 6.45 6.63 6.62 6.66 6.25 6.69 6.77 6.77 6.12 6.33 6.51 6.37 6.28 6.5 6.33 6.47 6.56 6.58 6.43
GOMF_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY 6.98 7.01 6.98 6.97 7.26 7.2 7.01 7.28 7.1 7.17 7 7.08 7.14 7.36 7.09 7.19 7.11 7.13 7.2 7.06 7.07 7.31 7.21 7.39 7.08 7.09
GOMF_RETINOL_DEHYDROGENASE_ACTIVITY 5.15 4.91 5.04 5.11 4.15 4.25 4.97 4.71 4.83 4.25 5.02 4.28 4.67 4.39 4.39 4.61 4.68 4.68 4.37 4.34 4.57 4.69 4.63 4.28 4.44 4.51
GOMF_TRIGLYCERIDE_LIPASE_ACTIVITY 5.03 4.79 4.54 5.47 4.46 4.33 4.34 4.62 4.41 4.48 4.72 4.5 4.56 4.47 4.46 4.44 4.82 4.91 4.74 4.6 5.01 4.43 4.3 4.27 4.56 4.64
GOMF_ENZYME_INHIBITOR_ACTIVITY 6.07 6 6.01 6.23 5.78 5.77 5.77 5.83 5.89 5.87 5.97 6 5.97 5.96 5.88 5.86 6.06 5.88 5.82 5.94 5.96 6.06 5.87 5.83 6.03 6.06
GOMF_PHOSPHOLIPASE_INHIBITOR_ACTIVITY 5.23 5.17 5.27 5.23 4.89 4.95 4.82 5.03 5.32 4.73 5.34 5.94 4.78 4.68 4.82 4.53 5.58 5.66 5.21 5.01 5.26 5.05 4.85 4.59 4.69 4.57
GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY 5.72 5.92 6.45 6.44 5.73 5.66 5.87 5.79 5.96 5.88 6.3 5.87 5.84 6.03 6.06 6.14 6.01 5.47 5.68 5.76 6.25 6.45 6.11 6.08 6.07 6.2
GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY 5.05 5.05 4.72 4.76 4.49 4.33 4.65 4.6 4.62 4.49 4.79 4.44 4.4 4.46 4.59 4.61 4.87 4.92 4.65 4.47 4.87 4.54 4.61 4.34 4.57 4.56
GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY 5.21 5.15 4.99 5.13 4.88 4.62 5.21 4.93 4.84 4.9 5.18 4.93 4.78 4.77 4.95 4.82 5.2 5.31 4.9 5.04 5.14 4.9 4.81 4.7 4.98 5.07
GOMF_CYTOKINE_RECEPTOR_ACTIVITY 5.38 5.17 5.13 5.31 4.83 4.87 5.11 4.95 5.07 4.97 5.06 4.91 4.98 4.89 5.08 4.91 5.17 5.27 4.91 4.91 5.17 5.04 4.99 4.8 4.97 5.12
GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY 5 4.87 4.5 4.76 4.26 4.19 4.51 4.49 4.51 4.32 4.67 4.44 4.29 4.3 4.4 4.34 4.71 4.85 4.52 4.36 4.81 4.43 4.31 4.12 4.37 4.39
GOMF_ICOSANOID_RECEPTOR_ACTIVITY 4.96 5.03 4.6 4.58 4.67 4.35 4.62 4.55 4.68 4.75 4.65 4.61 4.33 4.35 4.31 4.49 4.92 5.02 5.09 4.48 5.15 4.86 4.6 4.31 4.68 4.41
GOMF_PROSTANOID_RECEPTOR_ACTIVITY 5.19 5.17 4.89 5.01 4.72 4.34 4.74 4.65 4.84 4.79 5.31 4.68 4.39 4.53 4.33 4.52 4.99 5.03 5.13 4.71 5.23 5.09 4.85 4.32 4.7 4.64
GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY 8.05 8.23 8.07 7.37 7.8 8.22 8.16 8.26 7.96 8.11 7.71 8.21 8.24 8.19 8.4 8.29 7.76 8.05 8.08 8.22 8.01 8.27 7.84 8.17 8.22 8.27
GOMF_OLFACTORY_RECEPTOR_ACTIVITY 4.39 4.37 3.94 4.13 3.77 3.72 3.91 3.95 3.96 3.75 4.08 3.98 3.79 3.77 3.86 3.79 4.15 4.39 4 3.94 4.24 3.95 3.72 3.7 3.82 3.91
GOMF_EPHRIN_RECEPTOR_ACTIVITY 6.17 5.81 6.11 6.24 6.28 5.53 6.08 6.44 6.26 6.5 6.49 5.81 6.05 6.24 6.33 6.16 6.08 6.18 6.27 6.13 6.08 5.72 5.73 5.95 5.8 6.07
GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_ACTIVATED_RECEPTOR_ACTIVITY 7.42 7.18 6.89 6.92 6.9 7.18 7.03 6.9 6.8 6.88 6.86 6.69 7.14 7.35 6.63 6.91 7.1 6.92 7.04 7.04 7.15 7.21 7.28 6.93 7.22 7.17
GOMF_DEATH_RECEPTOR_ACTIVITY 6.23 5.94 5.37 5.99 5.38 5.33 5.66 5.8 5.52 5.76 5.39 5.25 5.31 5.38 5.52 5.58 5.63 5.68 5.6 5.49 5.96 5.56 5.43 5.25 5.49 5.46
GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY 6.71 7.03 7.02 6.44 7.61 7.48 7.02 7.39 7.61 7.1 6.74 7.24 7.69 7.24 6.71 6.84 7.56 6.94 6.77 7.29 7.07 7.38 7.13 7.59 6.74 7.15
GOMF_SCAVENGER_RECEPTOR_ACTIVITY 4.98 4.96 4.71 4.99 4.58 4.39 4.66 4.55 4.79 4.63 4.67 4.68 4.54 4.49 4.55 4.67 4.75 5.02 4.78 4.49 4.98 4.67 4.46 4.36 4.56 4.91
GOMF_SIGNAL_SEQUENCE_BINDING 8.15 8.27 8.64 8.48 8.54 8.79 8.54 8.48 8.7 8.68 8.27 8.39 8.57 8.57 8.44 8.39 8.41 8.13 8.45 8.41 8.3 8.47 8.82 8.68 8.67 8.51
GOMF_NUCLEAR_EXPORT_SIGNAL_RECEPTOR_ACTIVITY 8.32 8.42 7.96 8.41 8.56 8.64 8.36 7.89 8.39 8.24 7.89 8.41 8.38 8.51 8.13 8.11 8.42 8.19 8.54 8.4 7.93 8.1 8.25 8.52 8.09 7.93
GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY 6.04 6.11 5.96 5.91 6.03 5.97 6.05 6.1 5.81 6.16 5.87 5.57 5.99 6.14 6.45 6.01 6.25 6.55 6.06 6.4 6.07 6.04 5.83 5.86 6.21 6.14
GOMF_MAP_KINASE_SCAFFOLD_ACTIVITY 7.89 8.08 8.13 7.39 8.46 8.41 8.4 8.13 8.49 8.6 7.97 8.59 8.27 8.32 7.77 8.23 8.22 8.06 7.97 8.21 8.31 8.16 8.66 8.54 8.13 8.02
GOMF_PROTEIN_KINASE_C_BINDING 6.93 7.04 7.38 6.83 7.18 7.36 7.4 7.45 7.45 7.36 7.11 7.32 7.46 7.19 7.36 7.61 7.44 7.34 6.91 7.63 7.75 7.38 7.57 7.53 7.72 7.35
GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY 6.96 7.09 7.28 6.94 7.41 7.48 7.16 7.3 7.22 7.41 7.1 7.38 7.42 7.29 7.33 7.39 7.2 7.19 7.21 7.32 7.17 7.27 7.39 7.54 7.29 7.21
GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY 7.15 7.84 8.69 8.41 7.93 8.09 7.66 7.85 8.14 7.53 7.58 7.65 7.45 7.58 7.9 7.45 7.73 7.38 7.26 7.85 7.56 8.11 8.04 7.88 7.87 7.8
GOMF_GTPASE_INHIBITOR_ACTIVITY 8.27 7.98 7.94 7.13 8.97 8.79 8.35 8.1 8.99 8.67 8.05 8.35 8.42 8.21 8.13 8.16 8.4 7.7 8.24 8.83 7.65 7.99 8.44 8.68 8.14 8.36
GOMF_GTPASE_ACTIVATOR_ACTIVITY 6.88 7.09 7.21 7.04 7.33 7.36 7.28 7.42 7.26 7.35 7.07 7.4 7.46 7.48 7.38 7.31 7.22 7.21 7.18 7.43 7.24 7.42 7.3 7.53 7.39 7.38
GOMF_SIGNALING_RECEPTOR_BINDING 6.14 6.11 6.13 6.18 5.98 5.97 6.02 6.1 6 6.04 6.1 6.04 5.99 6.02 6.02 6.02 6.13 6.08 5.94 6.03 6.21 6.14 6.04 5.89 6.07 6.21
GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING 5.55 5.27 5.52 6.15 5.09 5.04 5.32 5.18 5.54 5.19 5.72 5.34 5.34 5.22 5.63 5.26 5.3 5.49 5.15 5 5.61 5.44 5.43 5.01 5.07 5.25
GOMF_FRIZZLED_BINDING 5.64 5.15 5.62 5.86 5.37 4.95 5.2 5.01 5.54 5.63 5.8 5.3 5.34 5.32 5.44 5.57 5.4 5.23 5.2 5.24 5.27 5.07 5.38 5.07 5.23 5.36
GOMF_NOTCH_BINDING 6.79 6.72 6.64 6.7 7 7.26 6.86 7.1 6.91 7.35 6.93 7.23 6.97 6.99 7.1 6.77 6.79 6.79 6.87 7.09 6.92 7.2 7.28 7.13 6.93 6.84
GOMF_DEATH_RECEPTOR_BINDING 5.98 6.12 6.06 6.84 5.78 5.88 5.64 6.11 6.25 6.07 6.16 6.19 6.16 6.1 6.01 6.26 6.42 6.17 6.14 5.56 6.26 6.36 6.01 6.09 6.21 6.39
GOMF_CYTOKINE_ACTIVITY 5.17 4.93 4.82 5 4.66 4.41 4.65 4.6 4.8 4.5 4.84 4.55 4.58 4.58 4.66 4.58 4.75 4.9 4.67 4.53 4.99 4.6 4.57 4.27 4.6 4.53
GOMF_CYTOKINE_RECEPTOR_BINDING 5.49 5.34 5.36 5.46 5.03 4.98 5.12 5.16 5.26 4.98 5.26 5.11 5.17 5.08 5.19 5.08 5.38 5.33 5.09 5.04 5.4 5.12 5.1 4.9 5.22 5.21
GOMF_TYPE_I_INTERFERON_RECEPTOR_BINDING 4.17 3.98 3.76 4 3.69 3.56 3.74 3.98 3.76 3.43 3.68 3.89 3.66 3.54 3.68 3.73 4.05 4.3 3.81 3.67 4.11 3.7 3.6 3.53 3.61 3.86
GOMF_INTERLEUKIN_1_RECEPTOR_BINDING 5.61 5.64 5.61 5.62 5.57 5.52 5.2 5.18 5.31 5.35 5.59 5.63 5.45 5.69 5.05 5.15 5.76 5.86 5.63 5.43 5.8 5.59 5.25 5.44 5.26 5.68
GOMF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING 6.82 6.68 6.83 6.88 7.32 7.2 6.85 6.71 6.83 7.04 7.06 6.93 7.1 7.45 6.99 6.8 6.95 6.71 6.81 6.96 6.83 6.85 7.07 7.11 7.12 7.15
GOMF_INSULIN_RECEPTOR_BINDING 7.24 6.97 7.35 7.24 8.07 7.86 7.83 7.68 8 7.83 7.54 7.7 7.71 7.7 7.7 7.39 7.39 7.29 7.35 7.91 7.47 7.82 7.81 7.77 7.61 7.59
GOMF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING 6.33 6.68 6.6 7.07 7.33 7.27 7.24 7.14 6.77 7.42 6.5 6.84 6.79 6.88 7.31 7.06 6.89 6.54 6.47 7.4 7.07 6.88 7.25 7.08 6.87 6.91
GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING 6.1 6.86 6.56 6.55 6.94 6.58 6.41 6.45 6.63 6.55 6.48 6.5 6.56 6.42 6.51 6.58 6.85 6.84 6.36 6.77 7.2 6.94 7.2 6.95 7.13 7.28
GOMF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING 5.92 5.63 5.83 5.86 5.53 5.25 5.54 5.57 5.68 5.27 5.29 5.25 5.89 5.89 5.98 5.88 5.83 5.93 5.41 5.35 5.79 6.07 6.18 5.53 5.86 6.16
GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING 5.32 5.14 5.32 5.33 4.88 4.97 5.17 5.11 5.24 4.85 5.25 5.03 5.08 4.75 5.22 5.06 5.28 5.17 5.01 4.85 5.28 5.05 5.11 4.68 5.09 5.17
GOMF_NEUROTROPHIN_RECEPTOR_BINDING 6.41 6.71 7.24 7.15 7.32 6.64 6.68 6.34 6.5 7.09 7.54 6.81 6.88 7.45 7.03 6.8 7.39 7.37 6.19 6.97 7.13 7 6.92 6.66 7.12 7.35
GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING 7.06 7.35 7.37 7.51 7.58 7.39 7.15 7 7.66 7.26 7.07 7.45 7.44 7.66 6.79 7.57 7.31 6.13 7.49 7.09 7.06 7.25 7.19 7.4 7.14 7.15
GOMF_INTEGRIN_BINDING 6.35 6.15 6.05 6.26 6.41 6.35 6.17 6.25 6.32 6.26 6.23 6.33 6.08 6.35 6.14 6.39 6.23 6.27 6.14 6.29 6.39 6.32 6.52 6.38 6.63 6.47
GOMF_HORMONE_ACTIVITY 5.2 5.26 5.08 5.18 4.66 4.66 5.12 4.83 5 4.8 5.02 4.84 4.9 4.79 4.9 4.94 5.1 5.14 4.77 4.68 5 4.88 4.73 4.55 4.86 4.82
GOMF_NEUROPEPTIDE_HORMONE_ACTIVITY 5.15 5.27 5.57 5.31 4.75 4.83 5.3 5.29 5.12 5.09 5.42 5.16 4.96 4.94 5.37 5.05 5.14 5.43 5.02 5.15 5.12 5 5.16 4.77 4.99 5.03
GOMF_STRUCTURAL_MOLECULE_ACTIVITY 5.98 5.83 5.88 6.08 5.75 5.66 5.84 5.87 5.75 5.75 6.05 5.82 5.77 5.71 5.79 5.92 5.99 6 5.79 5.78 5.99 5.87 5.9 5.56 5.79 5.9
GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON 7.1 7.22 7.07 6.96 6.92 7 7.34 7.05 7.38 7.39 7.23 7.34 7.17 7.22 7.37 7.28 7.41 7.37 7.01 6.93 7.12 7.21 7.43 7.27 7.24 7.16
GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT 5.49 5.26 5.1 5.2 5.09 4.87 5.17 5.07 5.08 4.97 5.22 5.01 4.92 4.91 4.96 4.94 5.16 5.34 5.1 5 5.31 5.01 5.17 4.72 5.04 5.02
GOMF_STRUCTURAL_CONSTITUENT_OF_EYE_LENS 5.25 5.15 5.14 5.38 4.79 4.6 4.85 4.95 4.9 4.68 5.1 4.73 4.96 4.83 4.8 4.83 5.15 5.21 5.07 5.03 5.01 4.88 4.79 4.57 4.82 4.93
GOMF_TRANSPORTER_ACTIVITY 6.19 6.16 6.25 6.32 6.05 6.1 6.26 6.27 6.2 6.22 6.19 6.13 6.2 6.13 6.19 6.1 6.25 6.23 6.16 6.19 6.3 6.22 6.12 6.23 6.28 6.31
GOMF_INTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY 5.82 5.75 5.35 5.53 5.65 5.89 5.97 6.12 5.72 6.26 5.63 5.9 5.97 5.73 6.38 6.02 5.75 5.98 5.59 5.74 6.11 6.09 5.59 5.55 6.09 6.14
GOMF_CALCIUM_ACTIVATED_CATION_CHANNEL_ACTIVITY 5.75 5.88 5.43 5.34 5.29 5.35 5.52 5.4 5.4 5.32 5.66 5.43 5.42 5.33 5.73 5.22 5.78 5.89 5.46 5.31 5.96 5.41 5.3 5.07 5.64 5.57
GOMF_INTRACELLULAR_CALCIUM_ACTIVATED_CHLORIDE_CHANNEL_ACTIVITY 6.55 6.26 6.21 5.93 6.58 6.21 5.77 6.18 5.69 6.28 6.03 6.5 6.17 5.68 6.1 6.36 6.33 6.39 5.85 6.07 6.43 6.53 5.93 5.85 6.66 6.68
GOMF_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY 5.98 5.96 5.81 6.49 5.68 5.64 6.19 5.99 6.02 5.78 5.77 5.53 5.4 5.56 6.25 5.69 6.18 6.27 6.27 6.11 5.84 5.61 5.68 5.73 5.66 5.75
GOMF_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY 5.38 5.24 5.12 5.59 5.08 4.95 5.5 5.31 5.34 4.91 5.3 4.95 4.96 5.03 5.33 5.08 4.94 5.24 5.05 4.96 5.2 5.14 4.98 4.76 4.93 4.9
GOMF_INHIBITORY_EXTRACELLULAR_LIGAND_GATED_ION_CHANNEL_ACTIVITY 8.66 9.2 9.81 9.72 8.44 9.45 9.65 9.54 9.84 9.83 9.03 8.17 9.42 9.36 9.82 9.36 8.26 8.78 9.46 9.26 8.36 8.66 9.7 9.62 8.67 8.45
GOMF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY 5.23 5.26 5.37 5.5 5.29 4.98 5.53 5.17 5.69 5.62 5.06 5.44 5.62 5.69 5.96 5.4 5.42 5.42 5.17 5.03 5.28 5.14 5.77 5.54 5.4 5.37
GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY 5.3 4.97 4.9 5.57 4.67 4.56 4.87 4.85 5.05 4.5 4.8 4.72 4.99 4.69 4.78 4.69 4.81 4.81 4.48 4.78 4.94 4.91 5.01 4.63 4.84 4.64
GOMF_VOLTAGE_GATED_ION_CHANNEL_ACTIVITY 6.27 6.31 6.25 6.04 6.12 6.03 6.47 6.58 6.26 6.28 6.21 6.23 6.23 6.14 6.51 6.26 6.28 6.35 6.46 6.48 6.18 6.38 6.21 6.29 6.19 6.14
GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY 7.65 7.58 7.07 6.79 7.87 7.96 7.95 8.02 7.62 7.86 7.45 8.18 7.93 7.99 7.92 7.75 7.46 7.9 8.08 8.19 7.78 7.76 7.76 8.03 7.82 7.65
GOMF_CALCIUM_CHANNEL_REGULATOR_ACTIVITY 7.04 7.18 7.76 7.91 7.38 7.45 6.96 6.98 7.15 7.17 7.39 6.92 7.38 7.59 7.15 7.41 6.68 6.8 7.52 7.1 7.29 7.38 7.33 7.2 7.45 7.18
GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY 6.42 5.8 5.36 6.04 5.61 5.48 5.32 5.71 5.47 5.64 6 5.74 5.25 5.64 5.32 5.44 6.05 5.88 5.96 5.5 5.73 5.41 5.18 5.03 5.3 5.68
GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY 7.36 7.56 6.79 6.95 8.04 7.67 7.62 7.47 7.34 7.55 7.43 7.59 7.64 7.59 7.66 7.73 7.41 7.54 7.38 7.87 7.23 7.57 7.6 7.72 7.38 7.39
GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY 6.07 5.99 6.06 5.98 5.84 5.55 6.32 5.99 6.03 6.27 6.07 5.94 6.18 6.01 6.48 5.99 5.96 6.09 6.04 6.1 5.91 5.8 6.16 6.19 5.98 5.76
GOMF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY 6.15 6.1 5.99 5.95 5.83 5.53 6.26 5.99 5.98 6.27 5.88 5.84 5.95 5.97 6.48 5.93 5.96 6.17 6.04 6.16 5.91 5.73 6.21 6.19 5.98 5.76
GOMF_ANION_CHANNEL_ACTIVITY 6.27 6.26 6.08 6.4 5.78 6.03 6.26 6.29 5.88 6.28 6.66 6.08 5.62 5.62 5.94 6.1 6.33 6.35 6.05 6.11 6.38 5.79 6.05 5.85 5.96 6.48
GOMF_CATION_CHANNEL_ACTIVITY 6 5.94 5.7 5.95 5.68 5.53 6.08 5.84 5.88 5.93 5.81 5.68 5.8 5.72 6.12 5.85 5.88 6.08 5.82 5.75 5.85 5.76 5.81 5.72 5.79 5.65
GOMF_POTASSIUM_CHANNEL_ACTIVITY 6.11 6.02 6.14 6.04 5.84 5.55 6.27 6.1 6.15 6.26 6.07 5.89 6.09 5.97 6.51 5.99 6 6.17 6.04 6.1 5.92 5.88 6.13 6.07 5.82 5.76
GOMF_SODIUM_CHANNEL_ACTIVITY 6.98 6.97 6.5 6.59 7.09 7.13 7.15 7.43 7.03 7.19 6.88 7.25 7.28 7.24 7.3 7.41 7.05 7.08 7.26 7.52 7.06 6.92 6.71 7.32 7.1 7.12
GOMF_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY 7.77 7.81 8.32 8.08 8.16 8.21 8.29 8.29 8.33 8.32 7.44 8.51 8.54 8.52 8.23 7.98 8.12 7.85 7.7 8.41 7.81 8.01 8.01 8.32 7.81 7.92
GOMF_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.12 6.04 5.84 5.97 5.63 5.68 5.85 6.11 5.82 5.64 5.97 5.92 5.88 6.06 5.73 5.89 5.88 5.64 5.76 6.11 6 5.74 5.57 5.77 6.12 6.22
GOMF_LIPID_TRANSPORTER_ACTIVITY 6.34 6.12 6.29 6.23 6.29 6.41 6.38 6.29 6.12 6.2 6.31 6.15 6.34 6.43 6.16 6.09 6.28 6.29 6.23 6.15 6.41 6.32 6.1 6.24 6.51 6.51
GOMF_LONG_CHAIN_FATTY_ACID_TRANSPORTER_ACTIVITY 6.16 5.77 5.7 6.17 5.73 5.78 5.9 6 5.63 6.12 5.69 5.69 5.49 5.41 5.68 5.85 5.78 5.98 5.68 5.61 6.01 5.83 5.32 5.38 5.58 5.87
GOMF_NEUROTRANSMITTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.28 5.04 4.94 5.31 4.71 4.68 5.27 5.31 5.16 5.02 5.02 4.87 4.77 4.91 5.54 5.08 5.28 5.38 5.46 4.88 5.2 4.81 4.97 4.61 4.88 4.86
GOMF_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.59 7.56 7.73 7.32 8.06 7.92 7.3 7.92 7.67 8.09 7.62 7.52 7.39 7.07 7.7 7.54 7.48 6.77 7.2 7.68 6.99 7.63 7.49 7.25 7.23 7.59
GOMF_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.05 5.96 5.99 6.11 5.74 5.71 6.07 6.07 5.88 5.73 5.92 5.69 5.84 5.97 5.74 5.68 5.96 5.78 5.9 5.81 6.02 5.79 5.75 5.95 6.17 5.96
GOMF_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY 7.03 6.81 6.87 6.88 6.38 6.79 7.29 7.21 7.13 7.06 6.39 6.39 7.2 7.14 6.66 6.48 6.55 6.55 6.68 7.02 7.14 6.68 6.82 6.36 6.8 6.61
GOMF_OXYGEN_CARRIER_ACTIVITY 5.66 5.83 5.85 6.21 5.63 5.44 5.68 5.52 5.92 5.58 5.79 5.37 5.56 5.55 6.33 5.76 5.62 5.47 5.54 5.15 5.64 5.46 5.67 5.27 5.56 5.71
GOMF_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.23 6.36 6.42 6.54 6.45 6.34 6.45 6.64 6.76 6.71 6.34 6.99 6.75 6.56 6.61 6.74 6.25 6.46 6.51 6.7 6.37 6.62 6.88 7.06 6.54 6.3
GOMF_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.55 5.49 5.23 5.89 4.76 4.87 5.12 5.14 5.25 5.12 5.19 5.04 4.99 4.99 5.19 4.85 5.09 5.37 4.94 4.98 5.12 4.93 4.95 4.8 4.94 5.02
GOMF_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.21 7.65 7.84 7.67 7.84 8.03 7.88 7.42 7.91 8.09 7.47 7.74 7.6 7.71 7.71 7.3 7.52 7.17 7.67 7.78 7.08 7.53 7.77 8.06 7.7 7.87
GOMF_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.63 6.45 6.55 6.44 7.04 6.82 6.66 6.53 6.85 6.73 6.45 6.93 7.06 7.07 6.37 6.36 6.67 6.78 6.69 6.78 6.74 6.82 6.94 7.02 6.71 7.03
GOMF_CARBOHYDRATE_CATION_SYMPORTER_ACTIVITY 5.62 5.47 5.47 5.59 5.27 5.12 5.33 5.37 5.42 5.11 5.74 5.31 5.62 5.62 5.28 5.41 5.81 5.37 5.48 5.41 5.58 5.53 5.32 5.1 5.3 5.55
GOMF_AMINO_ACID_CATION_SYMPORTER_ACTIVITY 7.77 7.81 7.84 8.08 8.16 8.21 8.07 8.23 8.33 8.32 7.44 7.82 8.23 8.44 8.07 7.92 8.12 7.85 7.7 7.77 7.66 7.98 7.81 8.15 7.81 7.89
GOMF_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY 5.36 4.96 4.83 5.34 4.51 4.26 4.71 4.78 5.02 4.99 5.21 4.86 4.6 4.63 4.64 4.74 5.43 5.21 5 4.73 4.88 5.03 4.77 4.34 4.85 4.7
GOMF_INORGANIC_ANION_EXCHANGER_ACTIVITY 6.02 5.98 5.91 5.86 5.75 5.39 6.05 5.74 6.12 5.63 5.53 5.4 5.68 5.85 6.35 5.97 5.72 5.88 5.64 6.58 6.59 5.99 6.25 5.86 6 6.08
GOMF_SNAP_RECEPTOR_ACTIVITY 6.87 7.24 7.42 7.49 7.67 7.67 7.34 7.43 7.36 7.35 7.34 7.68 7.53 7.1 7.34 7.37 7.43 7.03 7.33 7.74 7.34 7.55 7.43 7.87 7.47 7.39
GOMF_STEROID_BINDING 6.11 6.07 6.29 6.38 6.03 6.2 6.06 6.19 6.2 6.07 6.16 5.87 5.99 5.97 5.97 6 6.03 6.17 6.25 5.95 6.11 6.02 5.93 6.18 6.18 6.26
GOMF_FATTY_ACID_BINDING 6.01 5.93 6.46 6.32 5.35 5.63 5.9 5.61 6.17 5.43 5.87 5.71 5.94 5.97 6.14 6.52 6.2 6.6 5.64 6.3 6.43 7.02 6 5.78 7.17 7.08
GOMF_IRON_ION_BINDING 5.68 5.68 5.5 5.59 5.3 5.5 5.56 5.6 5.5 5.39 5.52 5.47 5.44 5.56 5.58 5.6 5.72 5.73 5.44 5.56 5.68 5.43 5.46 5.47 5.42 5.52
GOMF_COPPER_ION_BINDING 5.6 5.49 5.64 5.66 5.68 5.55 5.5 5.55 5.61 5.37 5.49 5.54 5.82 5.47 5.39 5.44 5.69 5.85 5.38 5.5 6.02 5.8 5.77 5.46 5.72 6.28
GOMF_CALCIUM_ION_BINDING 6.25 6.15 6.19 6.13 6.2 6.09 6.16 6.05 6.17 6.2 6.1 6.15 6.14 6.14 6.08 6.19 6.08 6.09 6.12 6.14 6.21 6.19 6.22 6.17 6.09 6.23
GOMF_CALMODULIN_BINDING 7.07 6.99 6.99 6.54 7.13 7.37 7.19 7.16 7.17 7.34 7.22 7.31 7.39 7.34 7.21 7.16 7.34 7.06 7.27 7.16 7.22 7.38 7.37 7.31 7.25 7.31
GOMF_COLLAGEN_BINDING 5.96 5.81 5.62 5.64 5.66 5.69 5.83 5.97 5.81 5.75 5.7 5.56 5.72 5.91 5.82 5.91 6.06 5.91 5.84 5.93 6.11 6.14 6.46 5.83 5.74 5.89
GOMF_INSULIN_LIKE_GROWTH_FACTOR_BINDING 6.73 6.65 6.5 6.49 6.7 6.56 6.79 6.59 6.86 7.02 6.43 6.93 6.48 6.33 6.71 6.47 6.74 6.33 6.12 6.83 7.36 6.96 6.83 6.52 6.78 6.65
GOMF_LAMIN_BINDING 8.53 8.58 8.33 7.81 8.77 9.12 8.51 8.26 7.94 8.76 8.5 8.93 8.57 8.85 8.29 8.27 8.45 8.05 8.46 8.24 8.62 8.59 8.38 8.63 8.46 8.48
GOMF_TROPOMYOSIN_BINDING 6.43 5.75 5.31 5.78 5.26 5.28 5.55 5.07 5.5 5.3 5.91 5.23 5.33 5.22 5.75 5.6 5.91 5.87 5.79 5.52 5.35 5.31 5.9 5.14 5.46 5.89
GOMF_MACROLIDE_BINDING 6.14 6.13 6.31 6 6.09 6.13 6.08 6.45 6.57 6.15 6.83 6.23 6.51 6.03 6.12 5.98 6.27 6.07 6.12 6.56 6.78 7.11 5.73 6.64 6.53 6.59
GOMF_GLUCOSE_BINDING 6.2 6.58 6.35 6.5 6.09 6.01 6.26 6.22 6.21 6.12 6.14 6.61 6.36 6.32 6.49 6.32 6.42 6.45 6.11 6.13 6.43 6.55 6.14 6.49 6.89 7.08
GOMF_MANNOSE_BINDING 5.37 4.99 5.11 5.78 4.58 4.54 5.15 5.01 4.87 4.74 5.14 5.16 5.18 4.88 4.58 4.52 5.26 5.04 4.9 4.54 5.38 4.83 4.56 4.37 4.94 4.79
GOMF_GLYCOSAMINOGLYCAN_BINDING 5.54 5.45 5.38 5.55 5.28 5.06 5.44 5.31 5.21 5.13 5.48 5.18 5.25 5.22 5.29 5.38 5.41 5.52 5.22 5.18 5.61 5.33 5.19 4.94 5.42 5.41
GOMF_HYALURONIC_ACID_BINDING 5.54 5.69 5.97 5.99 5.93 5.2 5.54 5.27 5.57 5.39 5.5 5.49 5.37 5.53 5.24 5.64 5.75 5.49 5.51 5.56 5.5 5.69 5.56 5.16 5.51 5.33
GOMF_PHOSPHOLIPID_BINDING 6.89 6.85 7.1 6.83 7.06 7.09 7.05 7.11 7.05 7.14 6.96 7.12 7.19 7.17 7.18 7.06 7.04 7.08 7.07 7.09 7.03 7.08 7.18 7.23 7.12 7.18
GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING 6.57 6.54 6.78 6.79 6.94 6.76 6.82 7.13 7.09 6.99 6.91 7.07 7.1 6.99 7.27 6.79 7.17 7.22 6.61 7.16 6.74 6.87 6.89 6.91 7.4 7.15
GOMF_1_PHOSPHATIDYLINOSITOL_BINDING 7.6 7.54 7.96 8.07 8.27 8.33 8 7.84 7.93 7.85 7.93 8.03 8.09 8.29 7.99 8.12 7.86 7.67 7.91 8.11 7.48 7.96 8.12 8.2 8 7.97
GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING 6.22 6.13 6.39 6.27 6.4 6.64 6.3 6.29 6.34 6.74 6.21 6.8 6.43 6.38 6.25 6.34 6.37 6.39 6.24 6.31 6.41 6.44 6.36 6.49 6.38 6.79
GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING 7.13 7 6.94 6.48 7.02 6.91 6.97 7.01 6.89 7.17 7.16 7.26 7.29 7 7.46 7.22 6.97 7.09 7.21 7.09 7.06 7.26 7.41 7.47 7.01 7.32
GOMF_PHOSPHOLIPID_TRANSPORTER_ACTIVITY 6.5 6.54 6.67 6.48 6.58 6.72 6.85 6.86 6.64 6.74 6.59 6.7 6.84 7.05 6.76 6.56 6.54 6.85 6.45 6.37 6.76 6.72 6.75 6.93 7.07 7.21
GOMF_ODORANT_BINDING 4.34 4.24 3.96 4.08 3.75 3.66 3.88 3.96 3.96 3.74 4.04 3.98 3.73 3.72 3.8 3.76 4.18 4.42 3.98 3.9 4.27 3.85 3.71 3.63 3.79 3.86
GOMF_CHEMOKINE_ACTIVITY 5 4.92 4.72 4.92 4.19 4.06 4.61 4.48 4.6 4.27 4.66 4.48 4.35 4.32 4.58 4.29 4.86 5.08 4.46 4.2 4.85 4.4 4.27 4.04 4.37 4.42
GOMF_BETA_CATENIN_BINDING 7.13 7.2 7.22 6.51 7.47 7.42 7.41 7.45 7.27 7.37 7.11 7.39 7.48 7.63 7.4 7.27 7.59 7.11 7.28 7.47 7.34 7.47 7.42 7.46 7.23 7.37
GOMF_MICROTUBULE_BINDING 7.05 7.14 7.22 7.08 7.32 7.28 7.3 7.39 7.29 7.47 7.27 7.42 7.55 7.45 7.38 7.47 7.16 7.14 7.24 7.51 7.18 7.44 7.22 7.53 7.49 7.45
GOMF_PROTEIN_C_TERMINUS_BINDING 7.12 7.15 7.25 7.22 7.38 7.49 7.31 7.35 7.38 7.52 7.31 7.58 7.36 7.37 7.54 7.58 7.35 7.21 7.52 7.32 7.23 7.32 7.47 7.73 7.6 7.53
GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.92 5.62 5.85 5.89 5.55 5.47 5.83 5.82 5.86 5.61 5.8 5.57 5.69 5.86 5.76 5.69 6.04 5.65 5.84 5.61 5.88 5.76 5.55 5.71 5.82 5.61
GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING 6.22 6.18 6.58 6.7 6.42 6.32 6.09 5.73 6.18 5.65 6.48 5.79 6.08 5.72 5.96 5.76 6.17 5.52 5.78 5.78 6.07 6.43 5.67 5.5 5.65 6.17
GOMF_ENZYME_ACTIVATOR_ACTIVITY 6.84 6.94 7.27 7.08 7.21 7.26 7.16 7.27 7.14 7.22 7.07 7.2 7.26 7.3 7.26 7.24 7.09 6.97 7.09 7.2 7.2 7.32 7.22 7.36 7.29 7.21
GOMF_GLUTAMATE_RECEPTOR_ACTIVITY 7.35 7.51 7.39 7.37 7.45 7.83 7.78 7.91 7.72 7.66 7.57 7.73 8.05 7.78 7.72 7.58 7.33 7.73 7.81 7.8 7.37 7.77 7.49 7.91 7.45 7.84
GOMF_N_ACETYLTRANSFERASE_ACTIVITY 7.23 7.5 7.48 7.4 7.54 7.4 7.6 7.48 7.44 7.68 7.32 7.39 7.45 7.43 7.4 7.37 7.37 7.03 7.24 7.49 7.24 7.55 7.57 7.75 7.63 7.56
GOMF_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY 6.51 6.42 6.34 6.48 6.5 6.55 6.54 6.39 6.46 6.71 6.36 6.69 6.46 6.42 6.25 6.45 6.45 6.37 6.42 6.39 6.35 6.27 6.46 6.38 6.36 6.42
GOMF_GROWTH_FACTOR_ACTIVITY 5.51 5.26 5.3 5.48 5.03 4.86 5.15 5.22 5.3 4.91 5.29 5.17 5.03 4.92 5.23 5.14 5.36 5.38 5.18 5.01 5.46 5.33 4.96 4.89 5.11 5.04
GOMF_CYTOSKELETAL_PROTEIN_BINDING 6.93 7 7.07 6.87 7.19 7.23 7.23 7.22 7.2 7.3 7.08 7.25 7.3 7.19 7.27 7.27 7.14 6.99 7.11 7.23 7.09 7.2 7.29 7.42 7.24 7.27
GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY 6.91 6.88 7.61 7.44 7.32 7.1 7.37 7.45 7.56 7.35 7.67 7.07 7.4 7.19 7.14 6.99 7.17 7.2 7.48 7.6 7.03 7.25 6.93 7.15 7.6 7.17
GOMF_DNA_DEPENDENT_ATPASE_ACTIVITY 6.18 6.11 6.34 6.49 6.15 6.2 6 5.97 6.17 6.24 6.17 6.27 6.21 6.15 6.15 6.21 6.2 6.08 6.25 6.22 5.89 6.08 6.24 6.39 6.06 6.22
GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY 5.65 5.93 6.32 6.31 5.44 5.61 5.9 6.04 5.99 5.57 6.04 5.94 6.39 5.41 5.88 6.19 5.69 5.66 5.27 5.55 5.74 5.51 6.08 6.12 6.02 6.01
GOMF_TRANSCRIPTION_FACTOR_BINDING 6.85 7.05 7.18 7.12 7.22 7.22 7.18 7.25 7.22 7.25 7.13 7.27 7.33 7.3 7.27 7.34 7.16 7.01 7.08 7.29 7.06 7.25 7.25 7.42 7.33 7.32
GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING 7.55 7.78 8.14 7.76 7.77 7.97 7.99 7.85 7.94 8.02 7.84 7.96 8.09 8.07 8.1 8.13 7.82 7.71 7.69 7.86 7.45 8.12 8 8.16 8.27 7.92
GOMF_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY 6.48 6.74 6.54 6.99 6.92 6.9 6.63 6.39 6.9 6.71 6.82 6.47 7.08 7.1 6.86 6.81 6.24 6.91 6.81 6.83 6.75 6.7 7.01 7.07 6.8 6.96
GOMF_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING 8.26 8.32 8.64 8.59 8.62 8.87 8.8 8.48 8.96 8.71 7.97 8.29 8.73 8.88 8.47 8.39 8.38 8.29 8.33 8.47 8.3 8.59 8.75 8.84 8.76 8.51
GOMF_POLY_A_BINDING 7.3 7.38 7.74 7.41 7.38 7.97 7.74 7.94 7.64 7.79 7.44 7.57 7.98 7.89 7.81 7.65 7.16 7.05 7.66 7.74 7.61 7.41 7.94 8.11 7.89 7.8
GOMF_DRUG_BINDING 6.66 6.33 7.04 6.58 6.78 6.56 6.62 6.45 6.8 6.64 6.89 6.73 6.98 6.78 6.79 7.31 6.82 6.87 6.7 6.71 6.79 7.1 6.7 7.24 6.83 7.13
GOMF_SULFOTRANSFERASE_ACTIVITY 6.15 6.14 6.48 6.64 6.48 6.8 6.9 6.44 6.65 6.84 6.57 6.57 7.04 6.36 6.5 6.35 6.32 6.29 6.09 6.55 6.29 6.48 6.82 6.92 6.46 6.52
GOMF_PROTEIN_PHOSPHATASE_1_BINDING 7.09 7.14 7.79 7.94 8.02 7.98 7.37 7.62 7.66 7.75 7.79 8.15 7.66 7.55 7.93 8.05 7.29 7.44 7.52 7.36 7.42 7.75 7.74 8.23 7.31 7.02
GOMF_N_METHYLTRANSFERASE_ACTIVITY 6.43 6.44 6.72 6.86 6.71 6.71 6.54 6.73 6.6 6.73 6.73 6.85 6.74 6.68 6.85 6.85 6.73 6.5 6.6 6.6 6.69 6.89 6.58 6.87 6.71 6.84
GOMF_O_METHYLTRANSFERASE_ACTIVITY 6.43 6.1 7.53 7.09 6.48 6.84 7.26 6.86 6.64 6.9 6.86 6.59 7.12 7.02 6.98 6.98 6.5 6.67 6.85 7.06 7.03 7.11 6.72 6.84 7.14 6.88
GOMF_RNA_METHYLTRANSFERASE_ACTIVITY 6.46 6.56 6.91 7.13 6.82 6.73 6.41 6.65 6.55 6.53 6.6 6.67 6.69 6.45 6.44 6.48 6.41 6.37 6.67 6.69 6.59 6.47 6.65 6.71 6.65 6.6
GOMF_TRNA_METHYLTRANSFERASE_ACTIVITY 6.32 6.25 6.8 6.84 6.25 6.42 6.17 6.27 6.34 6.36 6.31 6.32 6.32 6.18 6.26 6.35 6.2 6.23 6.55 6.14 6.44 6.31 6.5 6.51 6.47 6.41
GOMF_ADENYLATE_CYCLASE_BINDING 8.87 9.09 9.29 8.48 9.01 9.32 9.47 9.72 9.28 9.52 9.22 9.24 9.41 9.45 10.04 9.79 9.29 9.22 9.13 9.17 9.61 9.31 9.52 9.69 9.96 9.79
GOMF_POLY_PYRIMIDINE_TRACT_BINDING 7.22 7.22 7.61 7.55 7.78 8.11 7.57 7.55 7.41 7.64 7.33 7.58 7.93 7.65 7.24 7.61 7.52 7.35 7.56 7.79 7.27 7.42 7.83 7.93 7.28 7.58
GOMF_NEUROPEPTIDE_RECEPTOR_ACTIVITY 5.42 5.43 5.36 5.46 4.68 4.71 5.19 5.31 5.19 5.22 5.49 5.02 5.14 4.94 5.26 5.14 5.18 5.39 5.17 5.08 5.2 5.09 4.89 4.76 4.98 5.21
GOMF_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY 5.79 6.47 5.91 6.09 5.6 5.47 5.41 5.47 5.61 5.96 5.84 5.71 5.69 5.69 5.57 5.8 6.48 6.59 5.87 5.78 5.73 5.77 5.78 5.76 6.52 6.41
GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY 6.02 5.95 5.99 6.08 6.25 6.16 6.06 6.16 6.18 6.23 6.04 6.08 6.28 6.27 6.16 6.18 6.08 5.99 6.12 6.06 5.96 6.23 6.23 6.26 6.23 6.13
GOMF_FERROUS_IRON_BINDING 6.14 6.29 6.66 6.53 6.32 6.37 6.45 6.68 6.31 6.44 6.28 6.31 6.32 6.32 6.65 6.5 6.48 6.43 6.65 6.36 6.56 6.69 6.54 6.33 6.69 6.55
GOMF_HEPARIN_BINDING 5.49 5.35 5.29 5.53 5.11 4.97 5.24 5.13 5.17 5.05 5.37 5.07 5.02 5.14 5.16 5.2 5.38 5.47 5.1 5.05 5.49 5.22 5.15 4.93 5.23 5.31
GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY 5.26 5.29 5.06 5.19 4.88 4.73 5.08 4.95 4.97 5.23 4.98 5.05 5.06 5.1 5.15 4.92 5.17 5.15 5.13 5.27 5.62 5.25 4.96 4.71 4.81 5.09
GOMF_PEPTIDASE_ACTIVITY 5.83 5.77 5.91 6.02 5.78 5.72 5.68 5.82 5.67 5.67 5.84 5.77 5.71 5.62 5.81 5.76 5.81 5.84 5.73 5.67 5.84 5.8 5.6 5.59 5.68 5.89
GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY 6.83 7.03 7.22 7.27 7.32 7.3 7.11 7.05 7.36 7.35 7.11 7.24 7.3 7.31 7.03 7 7.1 7 6.99 7.02 6.95 7.11 7.35 7.42 7.22 7.13
GOMF_METALLOEXOPEPTIDASE_ACTIVITY 5.58 5.62 5.78 5.51 5.56 5.26 5.45 5.64 5.45 5.48 5.83 5.42 5.46 5.35 5.53 5.54 5.76 5.5 5.5 5.45 5.76 5.54 5.39 5.32 5.44 5.34
GOMF_METALLOPEPTIDASE_ACTIVITY 5.55 5.56 5.54 5.59 5.33 5.2 5.37 5.55 5.37 5.26 5.57 5.36 5.35 5.34 5.55 5.51 5.63 5.47 5.33 5.42 5.62 5.5 5.32 5.29 5.35 5.43
GOMF_EXOPEPTIDASE_ACTIVITY 5.76 5.65 6.29 6.05 5.83 5.81 5.83 5.96 5.76 5.77 5.85 5.84 5.71 5.84 5.78 5.98 5.8 5.68 5.87 5.87 6.07 5.9 5.75 5.83 5.68 6.22
GOMF_DIPEPTIDYL_PEPTIDASE_ACTIVITY 6.17 6.3 6.31 6.42 6.54 6.58 6.46 6.34 6.74 6.54 6.24 6.35 6.34 6.38 6.19 6.12 6.18 5.89 6.18 6.37 6.31 6.55 6.62 6.39 6.51 6.43
GOMF_OMEGA_PEPTIDASE_ACTIVITY 7.16 7.33 7.45 7.64 7.82 7.67 7.56 7.47 7.68 7.77 7.44 7.69 7.84 7.77 7.73 7.65 7.39 7.5 7.45 7.39 7.37 7.56 7.93 7.98 7.76 7.44
GOMF_NUCLEOTIDASE_ACTIVITY 5.9 5.97 6.38 6.08 6.58 6.26 6.11 6.08 6.55 6.28 6.41 6.2 6.74 6.67 6.32 6.5 6.34 6.37 6.68 6.31 6.15 6.47 6.68 6.4 6.61 6.24
GOMF_ZINC_ION_BINDING 6.3 6.3 6.42 6.48 6.41 6.46 6.38 6.37 6.4 6.41 6.36 6.43 6.46 6.5 6.45 6.41 6.38 6.25 6.36 6.36 6.36 6.43 6.51 6.49 6.47 6.44
GOMF_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.55 5.29 4.59 5.23 4.83 4.59 4.52 4.83 5.03 4.69 4.92 4.91 4.78 4.67 4.8 4.66 5.04 4.81 4.69 4.85 5.2 4.8 4.43 4.41 4.76 4.74
GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY 6.68 6.9 6.91 7.17 6.96 7.21 6.98 7.02 7.03 7.22 6.91 7.08 6.88 6.91 7.21 7.24 6.87 6.86 7.41 6.87 6.85 7.16 7.02 7.31 6.92 7.22
GOMF_LIPID_BINDING 6.5 6.5 6.78 6.54 6.62 6.71 6.64 6.71 6.76 6.83 6.55 6.73 6.73 6.74 6.71 6.7 6.66 6.57 6.54 6.7 6.64 6.78 6.72 6.77 6.7 6.84
GOMF_DNA_BINDING_BENDING 5.78 5.35 5.76 5.29 5.32 4.95 5.54 6.18 5.26 5.7 6.22 5.79 5.35 5.62 5.58 5.27 5.6 5.37 5.41 5.19 5.75 6.19 5.59 5.21 5.85 6.12
GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE 5.76 5.7 5.7 5.68 5.62 5.37 5.72 5.65 5.42 5.53 5.77 5.7 5.5 5.58 5.75 5.54 6.32 6.03 5.64 5.6 5.91 5.74 5.9 5.47 5.68 5.62
GOMF_VOLTAGE_GATED_ANION_CHANNEL_ACTIVITY 6.42 6.05 5.8 6.38 5.76 5.44 5.81 6.07 5.69 5.96 6.13 5.97 5.7 5.49 5.73 5.94 6.05 5.88 6.38 6.07 5.82 5.9 5.4 5.33 5.66 5.82
GOMF_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.15 7.4 8.33 7.43 7.42 7.92 7.7 8.1 8.1 7.47 7.82 7.46 8.28 8.33 7.83 7.99 7.58 7.17 7.85 7.61 7.64 7.94 8.18 8.18 8.07 7.95
GOMF_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.22 6.31 6.21 6.28 6.09 6.1 6.38 6.39 6.27 6.27 6.18 6.13 6.23 6.18 6.29 6.06 6.32 6.32 6.19 6.21 6.24 6.31 6.21 6.29 6.35 6.27
GOMF_METHYL_CPG_BINDING 6.37 6.4 6.87 6.55 6.59 6.68 6.71 6.85 6.53 6.89 6.41 6.94 6.69 6.66 6.41 6.85 6.66 6.1 6.68 6.82 6.86 6.73 6.52 6.56 6.48 6.6
GOMF_PROTEIN_TYROSINE_THREONINE_PHOSPHATASE_ACTIVITY 6.11 6.07 6.12 7.12 6.48 6.23 5.95 6.26 6.99 6.27 6.33 6.09 7.01 6.84 6.05 6.19 5.96 5.84 6.35 6.27 5.97 6.15 6.52 6.83 6.32 6.42
GOMF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY 8.38 8.38 7.54 7.74 8.4 8.74 8.56 8.78 8.19 8.5 8.02 8.8 8.43 8.61 8.68 8.38 8.35 8.71 8.83 8.84 8.46 8.58 8.32 8.57 8.68 8.68
GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_KINASE_ACTIVITY 7.99 8.15 8.9 8.39 8.35 8.42 8.51 8.46 8.43 8.39 8.42 8.21 8.44 8.4 8.53 8.66 8.23 8.42 8.19 8.46 8.24 8.48 8.74 8.67 8.49 8.37
GOMF_SIALYLTRANSFERASE_ACTIVITY 6.85 6.62 7.16 7.59 6.81 6.8 6.87 6.75 7.07 7.26 6.81 6.61 6.94 6.92 6.94 7.08 6.68 6.68 6.75 6.9 6.64 6.79 7.14 7.07 6.88 6.97
GOMF_O_ACYLTRANSFERASE_ACTIVITY 6.31 6.69 6.82 6.95 6.99 6.88 6.75 6.85 6.84 6.99 6.69 6.71 7.04 7.2 6.62 6.66 6.7 6.61 6.7 6.89 6.65 6.83 6.95 7.01 6.5 7.07
GOMF_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY 6.37 6.21 6.39 6.53 6.56 6.51 6.33 6.51 6.49 6.34 6.27 6.43 6.54 6.42 6.32 6.53 6.53 6.55 6.55 6.3 6.17 6.58 6.48 6.62 6.53 6.48
GOMF_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY 5.86 5.87 5.78 6.01 5.85 6.01 5.98 5.94 5.98 6.13 6.04 6.02 6.16 6.18 5.99 6.05 5.88 6.04 6.11 5.84 5.9 5.66 6.05 6.05 6.08 5.95
GOMF_GALACTOSYLTRANSFERASE_ACTIVITY 6.61 6.62 6.97 6.64 7.12 7.37 6.9 6.54 7.17 7.02 6.93 6.83 7.35 7.36 6.84 6.74 7.07 6.83 6.81 7.09 6.72 6.64 6.64 7.36 6.64 6.91
GOMF_MECHANOSENSITIVE_ION_CHANNEL_ACTIVITY 5.66 5.47 5.1 5.31 5 5.11 5.57 5.33 5.42 5.07 5.12 5.09 4.96 4.73 5.24 5.11 4.89 5.41 4.96 5.14 5.18 5.02 5.04 5.02 5.2 4.92
GOMF_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY 5.53 5.31 5.04 4.87 4.18 4.14 4.56 4.88 4.57 4.2 4.87 4.71 4.35 4.4 4.69 4.66 4.75 5.27 4.8 4.71 5.49 4.65 4.23 4.3 4.58 4.58
GOMF_ARACHIDONIC_ACID_EPOXYGENASE_ACTIVITY 5.53 5.37 5.04 4.87 4.24 4.46 5.09 4.95 4.57 4.3 5.08 4.86 4.68 4.4 4.79 4.66 4.97 5.65 4.92 4.75 5.5 4.65 4.23 4.47 4.77 4.72
GOMF_STEROID_HYDROXYLASE_ACTIVITY 5.13 5.08 4.92 4.93 4.4 4.38 4.77 4.7 4.57 4.43 4.81 4.52 4.65 4.42 4.65 4.66 4.86 5.12 4.7 4.67 5.21 4.63 4.31 4.35 4.68 4.68
GOMF_RETINOIC_ACID_4_HYDROXYLASE_ACTIVITY 5.1 5.03 4.45 4.69 4.18 4.21 4.39 4.68 4.4 4.15 4.54 4.63 4.4 4.26 4.54 4.53 4.66 4.92 4.45 4.42 4.76 4.34 4.02 4.18 4.57 4.63
GOMF_3_5_EXONUCLEASE_ACTIVITY 7.01 7.2 7.4 7.32 7.42 7.39 7.19 7.1 7.15 7.29 7.36 7.29 7.3 7.35 7.02 7.25 7.03 6.93 7.16 7.34 6.82 7.22 7.17 7.31 7.05 7.21
GOMF_5_3_EXONUCLEASE_ACTIVITY 6.04 6.07 6.34 6.17 6.26 6.51 6.16 6.07 6.31 5.85 5.84 6.04 6.26 5.91 5.87 5.91 6.05 6.16 6.37 6.03 5.8 6.13 6.31 6.39 5.95 5.98
GOMF_FUCOSYLTRANSFERASE_ACTIVITY 5.37 5.65 5.3 5.45 5.08 4.95 5.27 5.14 5.22 5.05 5.13 5.02 5.11 5.07 5.64 5.01 5.19 5.06 5.05 4.98 5.34 5.43 5.14 5.14 5.32 5.35
GOMF_PHOSPHATIDYLETHANOLAMINE_BINDING 7.94 8.02 9.04 8.75 7.88 8.29 8.89 8.78 8.32 8.13 7.96 8.07 8.7 8.72 8.6 8.44 8.28 8.2 7.91 8.8 8.34 8.69 8.15 8.34 8.29 8.15
GOMF_SULFURIC_ESTER_HYDROLASE_ACTIVITY 6.21 6.16 6.2 6.3 6.33 6.6 6.8 6.49 6.3 6.36 5.97 6.47 6.33 6.27 6.5 6.51 6.16 6.2 6.49 6.56 6.31 6.54 6.41 6.75 6.58 6.46
GOMF_BENZODIAZEPINE_RECEPTOR_ACTIVITY 8.72 9.27 9.81 9.72 8.44 9.88 10.06 9.54 9.95 10.03 9.03 8.17 9.42 9.36 9.82 9.36 8.26 8.88 9.46 9.83 8.36 8.66 9.7 9.7 8.67 8.45
GOMF_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.1 6.03 6.13 6.25 5.88 6 6.11 6.16 6.05 6.1 6.08 6.01 5.96 6.04 5.94 5.97 6.08 6.05 6.05 6.11 6.13 5.99 6 6.01 6.15 6.21
GOMF_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.16 6.16 6.16 6.23 5.96 6.1 6.14 6.21 6.03 5.98 6.17 5.9 5.98 6.07 6.09 5.95 6.06 6.05 6.09 6.19 6.22 6.09 6 6.25 6.25 6.21
GOMF_PHOSPHATIDYLCHOLINE_TRANSPORTER_ACTIVITY 6.87 6.59 6.99 6.48 7.37 7.03 7.01 7.05 6.92 7.17 6.66 7.24 6.85 7.05 6.89 6.73 7.18 7.16 6.95 7.07 7.1 7.07 6.75 7.45 7.09 7.27
GOMF_TASTE_RECEPTOR_ACTIVITY 5.33 5.21 4.25 4.54 4.51 4.38 4.28 4.21 4.21 4.06 4.79 4.67 4.44 4.4 4.27 4.16 4.56 4.7 4.98 4.37 4.81 4.52 4.27 4.15 4.3 4.62
GOMF_N_ACETYLLACTOSAMINIDE_BETA_1_3_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY 5.38 5.13 5.87 5.34 4.89 5.07 5.55 5.49 5.4 5.23 5.73 4.89 5.48 5.53 5.54 4.89 5.08 5.1 5.05 5.32 5.8 5.36 5.38 5.22 5.34 5.36
GOMF_PROTON_EXPORTING_ATPASE_ACTIVITY_PHOSPHORYLATIVE_MECHANISM 5.05 5.06 4.89 5.22 4.58 4.67 5.01 4.9 5.02 4.77 4.72 4.98 4.96 4.97 5.17 4.91 4.95 4.9 4.69 4.73 5.27 4.92 4.8 4.78 4.78 4.64
GOMF_ABC_TYPE_XENOBIOTIC_TRANSPORTER_ACTIVITY 6.01 5.94 5.56 5.83 5.84 6.01 5.98 5.67 5.69 5.97 5.88 5.99 5.66 5.93 5.69 5.56 5.7 5.78 5.88 6.1 5.98 5.78 5.51 5.3 5.68 5.67
GOMF_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY_MINUS_END_DIRECTED 4.99 5.13 5.03 4.68 4.81 4.86 5.01 4.71 4.64 5.05 4.84 5.07 4.77 4.98 4.78 5.49 5 5.19 5.27 4.73 5.36 4.98 4.72 4.66 4.73 4.84
GOMF_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY_PLUS_END_DIRECTED 6.37 6.7 6.81 5.91 7.05 7.05 6.81 7.1 6.93 7.27 6.87 7.36 7.08 6.84 7.01 7.08 7.22 7.09 6.55 6.87 7.34 7.34 7.03 7.2 7.26 7.34
GOMF_UBIQUITIN_LIKE_MODIFIER_ACTIVATING_ENZYME_ACTIVITY 7.67 7.62 8.4 8.58 8.51 8.46 8.35 7.7 8.51 8.38 7.97 8.25 8.22 8.45 7.96 8.18 7.66 7.46 8.07 8.04 7.57 7.8 8.54 8.7 7.94 7.45
GOMF_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY 6.54 6.61 6.88 7.05 6.82 6.94 6.63 6.83 6.76 6.73 6.78 6.85 6.86 6.85 6.65 6.81 6.59 6.53 6.75 6.78 6.69 6.88 6.65 6.98 6.77 6.87
GOMF_ELECTRON_TRANSFER_ACTIVITY 7.34 7.66 8.77 8.39 7.75 7.69 7.99 8.05 7.99 7.92 8.23 7.78 7.94 7.77 8.1 8.22 7.79 7.83 7.68 8.14 7.73 8.44 8.26 8.18 8.09 8.07
GOMF_PHOTORECEPTOR_ACTIVITY 5.32 5.71 5.7 5.99 5.63 5.99 5.45 5.77 6.01 5.66 5.89 5.44 5.91 5.84 5.38 5.2 5.22 5.71 5.37 5.88 5.73 5.51 5.95 5 5.48 5.52
GOMF_CYCLASE_ACTIVITY 5.97 5.62 5.38 5.91 5.5 5.48 6.01 6.03 5.8 5.82 5.89 5.07 5.79 5.6 5.96 5.83 6.08 5.72 5.63 5.76 6.07 6.03 5.73 5.82 6.14 6.26
GOMF_PSEUDOURIDINE_SYNTHASE_ACTIVITY 5.74 5.58 6.15 6.07 5.59 5.31 5.97 6 6 5.93 5.72 5.76 5.62 5.76 5.98 6.04 5.9 5.57 5.73 5.8 5.85 6.22 6.13 5.82 5.66 5.92
GOMF_FMN_BINDING 5.13 5.17 5.02 5.06 4.46 4.7 4.82 5.07 5.12 4.74 5.26 5.16 5.38 4.81 4.94 5.46 5.21 4.57 5.2 4.84 5.19 4.99 4.84 4.66 4.81 5.25
GOMF_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING 5.97 5.96 5.83 5.76 6.48 6.1 5.97 6.33 6 6.14 5.87 6.48 6.23 6.33 6.03 5.99 6.26 6.17 6.41 6.07 5.7 6.15 6.06 6.29 6.07 6.37
GOMF_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY 7.65 7.63 7.64 7.61 8.04 8.09 7.97 8.06 7.92 7.73 7.82 7.86 7.94 8.28 8.25 8.17 7.33 7.79 8.17 8.1 7.84 8.04 8.1 8.17 7.74 7.98
GOMF_HEME_COPPER_TERMINAL_OXIDASE_ACTIVITY 6.32 6.77 7.88 7 6.84 7.04 6.98 7.31 7.18 6.85 7.1 6.67 7.08 7.03 6.97 6.45 7 6.89 6.69 7.2 7.16 7.57 6.92 7.32 7.01 7.3
GOMF_GLUCURONOSYLTRANSFERASE_ACTIVITY 5.71 5.48 5.79 4.92 5.27 5.76 5.66 5.33 5.8 5.79 5.83 5.38 6.12 6.12 6.13 6.03 5.23 5.91 5.94 5.52 5.81 5.48 6 6.18 5.51 5.52
GOMF_CORECEPTOR_ACTIVITY 5.59 5.55 5.65 5.64 5.47 5.38 5.63 5.75 5.62 5.39 5.61 5.27 5.6 5.48 5.5 5.46 5.61 5.57 5.56 5.43 5.53 5.66 5.71 5.3 5.34 5.42
GOMF_PROTEIN_DISULFIDE_OXIDOREDUCTASE_ACTIVITY 6.18 5.92 6.04 6.31 6.21 6.09 6.36 6.15 6.26 6.5 6.09 6.29 6.26 6.19 6.39 6.35 5.87 5.94 6.04 6 6.07 6.22 6.74 6.89 6.49 6.18
GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY 5.94 5.76 6.12 6.86 6.04 6.22 6.64 6.38 6.31 6.56 6.38 6.28 6.29 6.15 6.39 6.68 5.93 5.82 5.95 6.01 6.2 6.45 6.74 7.01 6.48 6.23
GOMF_PEPTIDE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY 5.05 5.3 5.71 7.31 5.65 5.73 5.42 5.81 5.96 6.34 5.88 5.88 5.41 5.69 5.82 6.05 5.7 5.57 5.37 5.73 5.45 5.9 5.68 5.83 5.42 6.22
GOMF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.15 6.18 6.18 6.26 5.99 6.06 6.26 6.25 6.18 6.21 6.13 6.1 6.15 6.1 6.18 6.06 6.23 6.2 6.16 6.18 6.19 6.18 6.09 6.19 6.24 6.23
GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.56 6.61 6.99 6.9 6.69 6.95 6.94 6.99 6.89 6.68 6.84 6.77 6.92 6.86 6.71 6.55 6.8 6.78 6.73 7.04 7 6.87 6.8 7.1 6.88 7.16
GOMF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.13 6.23 6.22 6.04 6.01 5.79 6.36 6.31 6.19 6.28 6.12 5.97 6.18 6.05 6.34 6.18 6.16 6.35 6.27 6.17 6 6.02 6.18 6.13 6.15 5.79
GOMF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.23 6.08 6.26 6.24 6.07 5.85 6.43 6.48 6.17 6.04 6.09 5.85 5.98 5.88 6.19 5.99 6.24 6.16 6.03 6.32 6.08 5.94 6.16 6.03 6.22 5.75
GOMF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.47 6.36 6.13 6.11 6.25 6.31 6.49 6.66 6.25 6.26 6.02 6.32 6.26 6.42 6.48 6.09 6.4 6.42 6.44 6.58 6.28 6.44 6.18 6.49 6.51 6.4
GOMF_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.79 7.81 8.29 7.92 8.05 8.08 8.19 8.2 8.11 8.21 7.97 8.32 8.2 8.22 8.19 7.99 7.86 7.84 8.08 7.89 8.05 8.22 8.51 8.32 8.16 8.37
GOMF_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.55 5.57 5.56 5.53 5.61 5.18 5.47 5.48 5.55 5.46 5.52 5.36 5.55 5.7 5.53 5.45 5.52 5.38 5.7 5.38 5.31 5.38 5.43 5.27 5.48 5.34
GOMF_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.06 5.98 5.88 5.96 5.6 5.54 5.81 5.96 5.66 5.95 5.91 5.6 5.57 5.66 5.75 5.82 5.75 5.61 5.85 5.63 5.83 5.58 5.71 5.57 5.82 5.97
GOMF_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.95 5.76 5.16 5.77 5.56 5.2 5.04 5.07 5.2 5.4 5.45 5.05 5.13 5.24 5.03 5.05 5.53 5.38 5.43 5.1 5.45 5.02 5.18 4.72 5.3 5.58
GOMF_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.01 5.76 5.74 5.91 5.53 5.35 5.65 5.77 5.43 5.77 5.83 5.47 5.48 5.54 5.49 5.53 5.63 5.56 5.79 5.35 5.51 5.28 5.31 5.28 5.63 5.8
GOMF_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.56 5.32 5.22 5.37 4.91 4.87 5.04 5.12 5.13 5.32 5.05 5 4.96 4.89 4.98 5.12 4.95 5.12 4.79 4.94 5.39 4.95 4.67 4.45 4.96 5.16
GOMF_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 4.94 4.69 4.5 4.87 4.16 4.18 4.61 4.51 4.65 4.21 4.66 4.41 4.31 4.15 4.56 4.41 4.58 5.01 4.47 4.1 5.04 4.39 4.21 3.96 4.35 4.42
GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.71 5.48 5.67 5.71 5.36 5.21 5.48 5.49 5.47 5.38 5.59 5.47 5.67 5.46 5.39 5.56 5.71 5.65 5.43 5.42 5.55 5.7 5.19 5.21 5.64 5.66
GOMF_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.54 5.47 5.67 5.51 5.36 5.03 5.16 5.22 5.47 5.14 5.35 5.47 5.46 5.26 5.27 5.26 5.68 5.65 5.35 5.08 5.42 5.45 4.99 5.21 5.62 5.54
GOMF_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.29 5.99 6.02 6.31 5.27 5.4 6.17 5.64 6.29 5.82 5.69 5.65 5.75 5.53 5.99 5.84 5.78 5.95 6.13 5.61 5.55 5.72 5.91 5.24 5.71 6.06
GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.01 7.05 6.93 6.73 6.91 6.97 7.18 7.22 7.08 7.08 6.84 6.73 6.9 7.08 7.26 6.96 6.67 6.71 7.11 7.2 7.09 6.75 7.07 7.17 7.12 7.03
GOMF_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.77 7.34 7.98 8.48 7.7 7.77 7.75 8.16 7.39 8.01 7.36 7.52 7.64 7.73 8.46 7.61 6.9 7.67 7.37 7.38 7.46 7.48 7.37 7.9 7.53 7.14
GOMF_AROMATIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.27 7.52 7.47 7.61 7.44 7.58 7.93 7.78 8.15 7.41 6.91 7.2 8.3 8.22 7.58 7.65 7.89 7.1 7.22 7.94 7.79 7.71 7.49 8.14 8.15 7.59
GOMF_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.88 6 5.98 6.58 5.63 6.1 6.19 6.17 5.84 5.68 5.97 5.92 6.13 6.17 5.82 5.92 6.08 6.4 6.22 6.24 6.22 6.2 5.89 5.85 6.46 6.51
GOMF_NEUTRAL_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.27 7.43 7.36 7.67 7.2 7.55 7.53 7.66 7.98 7.73 7.09 7.49 7.91 7.87 7.65 7.44 7.3 7.6 7.63 7.93 7.54 7.45 7.53 7.52 7.91 7.64
GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.01 7.05 6.97 6.9 7.11 7.14 7.01 7.36 7.03 6.75 6.58 6.68 7.2 7.45 7.28 6.81 6.76 6.8 7.13 7.25 6.79 6.56 7.07 7.33 7.11 7.04
GOMF_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.12 6.45 6.44 6.71 6.6 6.59 6.21 6.61 6.76 6.7 6.43 6.77 6.81 6.88 6.53 6.84 6.03 6.2 6.53 6.7 6.22 6.87 6.87 7.07 6.37 6.27
GOMF_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.12 6.27 6.4 6.15 6.31 6.08 6.09 6.61 6.76 6.33 6.25 6.92 6.7 6.24 6.48 6.64 6.03 6.2 6.48 6.57 6.22 6.36 6.87 6.94 6.37 5.94
GOMF_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.27 6.41 6.37 6.78 6.58 6.57 6.55 6.86 6.07 6.08 6.06 5.92 6.36 6.31 6.19 6.17 6.3 5.91 6.35 6.64 6.45 6.38 6.2 6.53 6.23 6.69
GOMF_STEROL_TRANSPORTER_ACTIVITY 7.17 7.12 7 6.49 7 7.12 7.42 7.21 7.38 7.3 6.95 7.18 7.33 7.35 7.19 7.28 7.22 7.26 7.29 7.16 7.32 7.62 7.37 7.56 7.04 7.4
GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY 5.76 5.84 5.63 5.4 5.18 5.4 5.8 5.46 5.35 5.33 5.62 5.39 5.58 5.46 5.78 5.26 5.79 6.04 5.47 5.32 5.99 5.18 5.28 5 5.48 5.5
GOMF_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY 6.39 6.31 6.84 5.96 5.83 7 6.26 5.99 6.19 6.7 6.4 6.64 6.74 6.56 6.59 6.84 6.02 6.79 6.85 6.48 6.52 6.68 6.61 6.7 6.45 6.44
GOMF_LIGAND_GATED_ION_CHANNEL_ACTIVITY 5.66 5.75 5.53 5.79 5.52 5.34 5.72 5.75 5.68 5.64 5.5 5.5 5.45 5.53 5.74 5.54 5.63 5.58 5.59 5.37 5.66 5.57 5.47 5.46 5.59 5.46
GOMF_CALCIUM_RELEASE_CHANNEL_ACTIVITY 6.48 6.59 5.81 5.94 7.06 7.02 6.64 6.91 6.48 7.04 6.11 7.01 6.89 6.8 6.65 6.5 6.86 6.63 6.91 6.77 6.8 6.68 6.52 7.03 6.85 7.01
GOMF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY 5.47 5.36 5.91 6.03 5.48 5.37 5.83 5.67 5.71 5.3 6.03 5.39 5.41 5.45 5.37 5.24 5.93 5.94 5.33 5.5 5.51 5.7 4.92 5.54 5.75 5.26
GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.02 5.98 6 6.04 5.65 5.51 6.05 6 5.88 5.96 5.9 5.72 5.81 5.92 5.73 5.85 5.99 5.86 5.85 5.75 5.89 5.78 5.82 5.86 6.07 6.08
GOMF_SYMPORTER_ACTIVITY 5.98 5.76 5.77 5.89 5.54 5.38 5.82 5.53 5.6 5.63 5.83 5.6 5.47 5.75 5.54 5.55 5.93 5.69 5.64 5.53 5.68 5.7 5.53 5.28 5.73 5.58
GOMF_SOLUTE_CATION_SYMPORTER_ACTIVITY 6.09 6.01 6.09 5.98 5.97 5.7 6.25 6.21 5.9 6.02 6.06 5.9 5.98 5.97 5.68 5.73 6.22 5.86 5.91 5.62 5.71 5.84 5.82 5.59 5.9 5.7
GOMF_SOLUTE_PROTON_SYMPORTER_ACTIVITY 6.57 7.21 7.09 7.61 7.64 7.12 7.23 7.13 7.66 7.1 7.61 7.16 7.45 7.6 7.11 6.92 7.29 6.75 7.38 7.1 6.68 6.54 7.52 7.52 7.22 7.29
GOMF_ANION_CATION_SYMPORTER_ACTIVITY 5.89 5.74 5.31 5.56 5.38 5.2 5.55 5.3 5.31 5.59 5.46 5.44 5.05 5.43 5.26 5.36 5.51 5.46 5.67 5.19 5.35 5.27 5.11 4.9 5.1 5.06
GOMF_ANTIPORTER_ACTIVITY 6.25 6.29 6.41 6.52 5.94 6.17 6.43 6.51 6.3 6.55 6.19 6.31 5.97 6.39 6.54 6.59 6.1 6.5 6.51 6.65 6.35 6.17 6.35 6.51 6.71 6.44
GOMF_SOLUTE_CATION_ANTIPORTER_ACTIVITY 7.06 6.93 6.89 6.64 6.83 7.1 7.19 6.99 7.01 6.97 6.88 7 7.06 6.99 7.03 7.08 7 7.04 7.07 7.36 7.01 6.93 6.99 7.29 7.36 7.28
GOMF_SOLUTE_PROTON_ANTIPORTER_ACTIVITY 7.08 6.93 6.89 6.64 6.83 7.1 7.19 6.99 7.01 6.97 6.93 7 7.06 6.99 7.03 7.08 7 7.04 7.07 7.36 7.01 7.21 6.99 7.29 7.36 7.28
GOMF_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.25 5.32 5.28 5.71 5.19 4.89 5.1 5.14 5.19 5.31 5.41 4.98 5.21 5 5.06 5.15 5.42 5.19 4.97 5.1 5.44 5.04 5.35 4.9 5.23 5.3
GOMF_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.32 7.18 7.64 7.04 6.83 6.86 7.74 7.72 7.67 7.62 7.15 7.13 7.47 7.77 7.29 7.28 6.67 7.56 7.26 7.38 7.43 7.28 7.45 7.19 7.25 6.94
GOMF_SOLUTE_SODIUM_SYMPORTER_ACTIVITY 5.8 5.7 5.45 5.77 5.49 5.21 5.67 5.36 5.46 5.57 5.43 5.3 5.13 5.54 5.45 5.26 5.77 5.38 5.53 5.21 5.55 5.24 5.39 5.03 5.23 5.25
GOMF_ANION_SODIUM_SYMPORTER_ACTIVITY 5.28 5.09 4.82 5.06 4.71 4.48 4.71 4.68 4.82 4.45 4.98 4.61 4.65 4.54 4.66 4.77 4.88 5.09 4.79 4.46 5.11 4.61 4.6 4.34 4.51 4.68
GOMF_CATION_CHLORIDE_SYMPORTER_ACTIVITY 5.99 5.7 5.35 5.63 5.53 5.25 5.41 5.36 5.34 5.51 5.76 5.65 5.13 5.75 5.45 5.36 5.49 5.54 5.85 5.25 5.2 5.31 5.12 4.99 5.07 4.88
GOMF_SODIUM_CHLORIDE_SYMPORTER_ACTIVITY 5.27 4.76 4.7 4.77 4.6 4.37 4.57 4.68 4.59 4.42 5.02 4.5 4.52 4.34 4.6 4.55 4.76 5.18 4.85 4.24 5.02 4.41 4.54 4.32 4.47 4.7
GOMF_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6 5.98 5.89 6.26 6.06 6.04 6.09 5.87 5.8 5.93 6.02 6.18 5.87 5.88 5.91 6.06 5.92 6.14 6.29 6.13 6.16 6.06 5.67 5.89 6.19 5.92
GOMF_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY 7.27 7.29 6.81 6.7 7.75 7.4 7.59 7.48 7.34 7.52 7.38 7.66 7.24 7.38 7.12 7.09 7.5 7.37 7.37 7.41 7.32 7.2 7.71 7.65 7.71 7.46
GOMF_ACETYLCHOLINE_RECEPTOR_ACTIVITY 5.24 5.37 4.83 5.34 4.57 4.55 5.12 5.02 5.32 5.17 5.09 5.08 4.83 4.88 5.21 4.92 4.99 5.12 5.13 4.84 5.17 5.3 4.82 4.7 4.94 4.73
GOMF_CHOLESTEROL_BINDING 6.89 6.77 6.91 6.49 6.77 6.74 7.2 7.02 7.06 7.05 6.66 6.79 6.72 6.89 6.69 6.67 7.02 6.9 7.19 6.99 6.73 6.75 6.82 6.95 7 7.23
GOMF_CATION_CATION_ANTIPORTER_ACTIVITY 7.06 6.93 6.89 6.54 6.83 7.1 7.19 6.99 7.01 6.97 6.88 6.96 6.82 6.81 6.89 7.08 6.87 7.04 7.07 7.36 7.01 6.93 6.86 7.1 7.36 7.21
GOMF_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.27 7.31 6.93 7.38 7.3 7.45 7.29 7.51 7.13 7.4 7.01 7.44 7.51 7.65 7.21 7.22 6.85 6.89 7.15 7.37 7.18 6.7 7.07 7.37 7.29 7.07
GOMF_EFFLUX_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.17 5.96 5.9 6.04 5.94 6.26 6.28 6.11 5.9 6.19 5.74 6.18 6.09 6.12 5.89 5.79 6 5.97 6.03 6.13 6.42 6.33 6.07 6.23 6.17 6.12
GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.95 6.22 6.24 6.14 6.07 6.06 6.15 6.47 6.54 6.15 6.25 6.1 6.52 6.43 6.33 6.45 6 5.96 6.28 6.47 6.21 6.45 5.84 6.38 6.18 6.09
GOMF_TUBULIN_BINDING 7.21 7.16 7.43 7.18 7.38 7.43 7.44 7.5 7.43 7.67 7.47 7.61 7.66 7.53 7.57 7.59 7.26 7.18 7.33 7.46 7.23 7.55 7.4 7.67 7.51 7.54
GOMF_FATTY_ACID_LIGASE_ACTIVITY 5.57 5.55 5.91 5.9 5.14 5.15 5.06 5.52 5.34 5.49 5.63 5.81 5.19 5.11 5.26 5.13 5.51 5.66 4.9 5.07 5.84 5.62 5.15 5.27 5.19 5.9
GOMF_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.28 5.45 5.09 5.35 5.04 4.69 5.04 4.79 5.17 4.73 5.22 5 4.8 4.88 4.87 5.02 5.13 5.35 5.09 4.94 5.13 4.63 5.07 4.58 4.73 4.89
GOMF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY_PHOSPHORYLATIVE_MECHANISM 5.4 5.34 5.81 6.11 4.97 5.15 5.81 5.52 5.74 5.61 5.61 5.27 5.51 5.38 5.79 5.49 5.58 5.35 5.18 5.45 5.85 5.74 5.74 5.19 5.89 5.8
GOMF_MANNOSIDASE_ACTIVITY 6.92 6.71 7.2 7.74 7.47 7.55 7.26 7.25 6.89 7.59 7.57 7 7.17 7.04 7.17 7.24 6.78 6.88 7.11 7.71 6.65 6.88 6.81 7.03 6.97 7.25
GOMF_GLUCOSIDASE_ACTIVITY 6.38 6.07 6.56 6.55 6.12 6.49 6.72 6.17 6.5 6.29 5.97 6.58 6.13 6.24 6.45 6.22 5.98 5.89 6.22 6.57 5.84 5.89 6.33 6.39 6.42 6.24
GOMF_HEXOSAMINIDASE_ACTIVITY 6.16 6.37 6.73 6.72 5.93 5.8 6.03 6.45 6.12 5.67 5.91 5.87 5.83 5.74 5.8 5.8 5.93 6.16 6.45 5.65 6.05 5.89 5.85 6.39 5.99 6.01
GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.32 6.44 6.44 6.69 6.31 6.22 6.14 6.43 6.34 6.36 6.34 6.48 6.22 6.37 6.48 6.64 6.03 6.38 6.48 6.57 6.41 6.36 6.02 6.52 6.17 6.27
GOMF_CYCLOSPORIN_A_BINDING 7.28 7.26 7.45 7.91 7.54 7.58 7.25 6.72 7.04 7.42 7.49 7.5 7.81 7.37 7.76 7.9 6.94 7.42 7.53 7.23 7.34 7.66 7.33 7.37 6.97 7.64
GOMF_SUPEROXIDE_GENERATING_NAD_P_H_OXIDASE_ACTIVITY 4.85 4.77 4.81 4.68 4.34 4.33 4.57 4.64 4.55 4.42 4.73 4.51 4.51 4.47 4.58 4.74 4.78 4.86 4.51 4.76 4.73 4.74 4.45 4.23 4.6 4.71
GOMF_AMP_BINDING 7.68 7.83 8.18 7.75 7.75 7.81 7.82 8.29 8.05 8 8.21 8.4 8.07 7.98 8.03 8.09 8.14 8.07 7.78 7.8 8.14 8.31 8.24 8.31 8.14 8.11
GOMF_ANTIOXIDANT_ACTIVITY 5.62 5.64 6.06 6.16 5.61 5.5 5.87 5.98 5.81 5.56 5.76 5.74 5.77 5.45 5.81 5.87 5.71 5.67 5.67 5.63 5.75 5.85 5.73 5.71 5.78 5.92
GOMF_STEROID_DEHYDROGENASE_ACTIVITY 5.55 5.3 5.34 5.68 5.11 4.91 5.29 5.07 5.23 5.01 5.21 4.79 5.15 4.93 5.19 4.8 4.86 5.29 4.71 4.82 5.11 5.02 5.02 4.71 5.45 5.23
GOMF_CHANNEL_REGULATOR_ACTIVITY 6.98 7.11 7.41 7.06 7.08 7.21 7.16 7.36 7.27 7.24 7.41 7.35 7.19 7.28 7.19 7.16 7.18 7.16 7.34 7.13 7.1 7.15 7.33 7.42 7.45 7.26
GOMF_CHANNEL_INHIBITOR_ACTIVITY 6.53 6.58 7.24 7.12 6.42 6.38 6.67 6.87 6.86 6.44 6.94 6.74 6.63 6.63 6.72 6.92 6.49 6.78 6.61 6.62 7.03 6.98 6.85 6.94 6.89 6.78
GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY 6.64 6.9 7.56 7.32 6.96 7.06 6.91 7.21 6.96 7.02 7.26 6.98 6.95 6.87 7.15 7.21 6.78 7.02 6.87 7.2 6.78 7.04 7.01 7.08 7.26 7.2
GOMF_LYSINE_N_METHYLTRANSFERASE_ACTIVITY 6.26 6.32 6.56 6.85 6.67 6.69 6.3 6.6 6.34 6.53 6.51 6.72 6.63 6.61 6.83 6.82 6.71 6.47 6.6 6.45 6.68 6.88 6.35 6.77 6.59 7
GOMF_COA_HYDROLASE_ACTIVITY 6.27 6.31 6.33 6.26 6.35 6.28 6.02 6.41 5.98 6.28 6.4 6.4 6.7 6.57 6.31 6.35 6.32 6.14 6.32 5.98 6.05 6.59 6.5 6.46 5.72 6.09
GOMF_PALMITOYL_COA_HYDROLASE_ACTIVITY 6.45 6.54 6.67 6.77 6.66 6.65 6.62 6.67 6.42 6.68 6.54 6.88 6.86 6.65 6.5 6.51 6.72 6.36 6.84 6.92 6.25 6.69 6.62 6.56 6.25 6.65
GOMF_LIPASE_ACTIVITY 6.06 6.06 6.09 6.26 6.14 6 6.09 6.14 6.02 6.12 5.96 6.06 6.08 6.23 6.02 5.85 6.23 5.97 6.16 6.34 6.24 6.02 5.9 6.1 6.14 6.21
GOMF_KINASE_ACTIVITY 6.76 6.81 6.95 6.98 7 7.16 7 6.99 6.97 7.06 6.9 7.03 7.14 7.1 7.03 7 7.03 6.92 7 7.08 6.94 7.03 7.09 7.18 7.09 7.11
GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY 7.63 7.52 7.3 8.64 8.36 8.05 7.24 7.27 7.93 7.88 7.5 7.83 7.76 7.9 7.75 7.57 7.67 7.17 7.81 7.43 7.18 7.27 7.98 7.85 7.59 8.08
GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_KINASE_ACTIVITY 7.2 7.45 6.85 7.53 7.88 7.87 7.44 7.24 7.66 7.77 7.44 7.73 7.74 7.96 7.53 7.47 7.32 7.08 7.67 7.55 6.91 7.14 7.82 8.03 7.49 7.35
GOMF_ACETYLTRANSFERASE_ACTIVITY 7.17 7.36 7.56 7.53 7.63 7.56 7.66 7.46 7.46 7.68 7.35 7.39 7.47 7.51 7.4 7.37 7.26 7.03 7.38 7.53 7.24 7.65 7.6 7.79 7.77 7.67
GOMF_C_ACYLTRANSFERASE_ACTIVITY 6.16 5.99 6.94 6.72 6.4 6.19 6.15 6.38 6.17 6.94 6.98 6.6 5.54 6.02 7.02 6.77 6.16 5.83 5.88 6.33 7.16 6.6 6.29 6.79 6.82 7.22
GOMF_PALMITOYLTRANSFERASE_ACTIVITY 7.56 7.32 7.51 7 7.68 7.81 7.37 7.72 7.38 7.36 7.35 7.72 7.67 7.7 7.52 7.61 7.25 7.17 7.79 7.51 7.47 7.35 7.41 7.46 7.54 7.42
GOMF_N_ACYLTRANSFERASE_ACTIVITY 6.92 7.03 7.22 7.24 7.12 7.19 7.4 7.17 7.36 7.47 7.22 7.34 7.26 7.36 7.36 7.25 7.16 6.84 7.09 7.4 7.13 7.32 7.54 7.7 7.35 7.14
GOMF_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY 7.28 7.36 7.62 7.13 7.31 7.47 7.47 7.32 7.59 7.53 7.17 7.1 7.39 7.48 7.18 7.66 6.8 7.27 7.23 7.23 7.07 7.98 7.54 8.09 7.25 7.36
GOMF_S_ACYLTRANSFERASE_ACTIVITY 7.65 7.87 7.72 7.54 7.85 7.88 7.75 7.94 7.8 7.66 7.62 7.79 7.95 8.08 7.8 8.03 7.69 7.97 7.98 7.65 7.81 7.62 7.6 7.92 7.76 7.72
GOMF_OXIDOREDUCTASE_ACTIVITY 6.26 6.31 6.66 6.59 6.31 6.35 6.4 6.39 6.34 6.32 6.41 6.4 6.39 6.31 6.43 6.37 6.34 6.3 6.33 6.36 6.37 6.46 6.36 6.45 6.46 6.44
GOMF_PROTEIN_HORMONE_RECEPTOR_ACTIVITY 5.51 5.44 5.31 5.52 5 5.09 5.28 5.31 5.19 5.16 5.49 5.16 5.13 5.03 5.18 5.27 5.32 5.41 5.23 5.11 5.25 5.25 5.2 4.93 5.1 5.11
GOMF_NUCLEOTIDE_RECEPTOR_ACTIVITY 5.54 5.5 5.41 5.68 5.66 5.47 5.62 5.38 5.62 5.31 5.59 5.35 5.41 5.43 5.72 5.25 5.27 5.2 5.28 5.33 5.44 5.43 5.5 5.31 5.24 5.51
GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY 6.32 6.16 7.16 7.02 6.36 6.44 6.55 6.56 6.56 6.61 6.03 6.15 6.38 6.21 6.24 6.46 6.55 6.33 6.35 6.7 6.65 6.75 6.37 6.35 6.25 6.73
GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS 5.39 5.57 5.74 6.07 5.77 5.54 5.98 5.73 5.64 5.77 5.62 5.29 5.72 5.73 6.12 5.61 5.74 5.71 5.74 5.64 5.68 6.09 5.82 5.63 6.02 5.98
GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY 6.57 6.44 7.31 6.85 6.99 7 7.21 7.12 6.67 7.06 6.88 7.21 6.9 6.74 6.91 7.14 7.2 6.94 6.72 6.98 7.01 7.16 7.13 6.83 6.75 7.19
GOMF_GLYCINE_BINDING 5.4 5.76 6.63 6.63 5.26 6.71 7.94 5.99 7.1 6.81 5.51 6.08 6.09 5.62 6.61 6.03 5.4 6.51 6.31 6.32 5.17 5.48 6.34 7.25 6.77 6.43
GOMF_AMINO_ACID_BINDING 5.9 5.92 6.18 6.15 5.89 6.06 6.29 5.91 6.12 6.02 6.1 5.87 5.87 5.84 5.84 6.05 6.15 5.81 5.88 6.11 5.75 5.79 5.82 5.79 6.43 6.31
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS 6.28 6.3 6.85 6.66 6.33 6.31 6.48 6.23 6.55 6.26 6.53 6.49 6.44 6.6 6.59 6.63 6.51 6.2 6.3 6.23 6.23 6.36 6.29 6.26 6.39 6.44
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR 6.2 6.3 6.89 6.8 6.49 6.37 6.59 6.64 6.51 6.38 7.12 6.66 6.5 6.45 6.28 6.74 7.15 6.63 6.25 6.36 7.16 6.79 6.44 6.64 6.46 6.61
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS 6.54 6.6 7.23 6.91 6.76 6.75 6.58 6.63 6.76 6.72 6.82 6.81 6.64 6.64 6.48 6.78 6.87 6.58 6.55 6.74 6.68 6.7 6.79 6.71 6.87 6.83
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR 6.55 6.21 7.33 7.21 6.5 6.23 6.74 6.84 6.88 6.62 6.93 6.94 6.61 6.56 7.21 6.79 6.97 6.59 6.26 6.41 6.85 6.55 6.93 6.51 7.15 6.83
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR 6.28 6.38 5.84 5.9 6.13 5.96 6.24 6.23 6.11 6.63 6.15 6.38 5.83 5.97 6.35 6.58 6.11 6.14 6.11 6.28 6.21 6.32 6.35 6.16 6.15 6.14
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS 5.47 5.12 5.26 5.74 4.96 5.16 5.14 4.98 5.38 5.26 5.52 5.26 5.66 5.38 5.1 5.38 5.46 5.31 5.44 5.35 5.29 5.2 5.54 5.2 5.38 5.34
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR 5.43 5.12 5.26 5.74 4.96 5 5.09 4.98 5.08 5.26 5.46 5.26 5.23 5.03 5.01 5.13 5.38 5.14 5.25 5.17 5.29 5.2 5.38 4.82 5.03 5.34
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS 6.29 6.25 6.42 6.44 6.08 6.06 6.37 6.16 6.11 6.38 6.36 6.5 6.16 6.32 6.15 6.24 6.46 6.49 6.5 6.36 6.33 6.42 6.22 6.07 6.17 6.46
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR 6.67 6.55 7.49 7.34 6.52 6.37 6.82 7.06 6.61 6.62 7.59 7.49 6.9 7.15 7 7.58 6.97 7.06 6.75 7.03 6.99 7.58 7.2 7.05 7.42 7.8
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H 7 6.96 8.03 7.39 7.24 7.19 7.06 7.51 7.5 7.5 7.18 7.1 6.94 7.17 7.1 7.46 7.07 6.87 6.99 7.3 7.11 7.38 7.43 7.34 7.51 7.48
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR 7.95 8.05 9.41 9.05 8.12 8.07 8.23 8.45 8.11 8.29 8.71 8.43 8.25 8.37 8.45 8.62 8.23 8.16 7.99 8.28 8.31 8.71 8.34 8.57 8.47 8.73
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS 6.44 6.52 6.85 6.9 6.36 6.49 6.71 6.67 6.72 6.62 6.62 6.34 6.39 6.29 6.75 6.71 6.45 6.5 6.22 6.4 6.86 6.71 6.89 7.05 6.77 6.67
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR 5.86 6.11 7.16 6.69 5.82 5.92 7.02 6.7 6.94 6.43 6.6 6.61 6.49 6.57 6.64 6.65 6.29 6.24 6.11 6.21 6.71 6.3 7.16 7.18 6.43 6.21
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR 5.78 5.64 6.08 6.23 5.59 5.19 5.63 5.89 5.77 5.48 5.76 5.68 5.49 5.39 5.81 5.73 5.71 5.57 5.67 5.54 5.63 5.79 5.57 5.51 5.74 5.65
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN 5.33 5.35 5.43 5.4 5 5.14 5.25 5.02 5.21 5.18 5.18 4.91 4.95 4.75 5 5.01 4.85 5.55 4.92 4.96 5.08 4.88 4.84 4.7 5.06 5.07
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN 5.69 5.75 5.68 5.74 5.44 5.57 5.55 5.63 5.51 5.46 5.53 5.47 5.42 5.52 5.6 5.49 5.56 5.63 5.5 5.53 5.63 5.4 5.45 5.39 5.48 5.56
GOMF_2_OXOGLUTARATE_DEPENDENT_DIOXYGENASE_ACTIVITY 6.37 6.56 6.6 6.71 6.77 6.77 6.41 6.49 6.63 6.55 6.54 6.73 6.61 6.71 6.61 6.25 6.74 6.4 6.66 6.37 6.74 6.66 6.87 6.96 6.67 6.65
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN 5.63 5.35 5.38 5.29 5.1 4.86 4.91 5.08 5.22 4.89 5.09 5.31 5.09 4.95 5.19 5.15 5.09 5.21 5.01 4.95 5.46 4.85 4.87 4.69 5.14 5
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN 5.4 5.21 4.99 4.93 4.26 4.36 4.9 4.74 4.58 4.32 4.98 4.71 4.38 4.46 4.74 4.66 4.96 5.22 4.86 4.69 5.37 4.66 4.3 4.29 4.53 4.58
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS 5.71 5.8 5.96 5.93 5.5 5.5 5.91 5.67 5.37 5.59 5.71 5.45 5.71 5.56 5.53 5.64 6.17 5.88 5.25 5.63 5.72 6.06 5.72 5.58 5.81 5.64
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS 6.38 6.35 6.78 6.84 6.63 6.6 6.41 6.59 6.47 6.52 6.52 6.59 6.62 6.46 6.5 6.48 6.41 6.43 6.54 6.48 6.59 6.52 6.47 6.61 6.59 6.57
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS 6.85 6.96 7.28 7.16 7.07 7.13 7.19 7.1 7.1 7.16 7.02 7.1 7.19 7.19 7.21 7 6.92 6.82 7.11 7.2 7.04 7.1 7.3 7.42 7.19 7.15
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_AMINO_ACYL_GROUPS 5.87 5.79 5.39 5.63 5.13 4.93 5.12 5.05 5.15 5.18 5.29 4.88 4.64 4.62 5.3 5.14 5.19 5.25 5.23 4.73 5.36 5.26 5.29 5.15 5.15 5.36
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS 6.34 6.25 6.42 6.42 6.52 6.48 6.33 6.48 6.36 6.38 6.36 6.42 6.59 6.39 6.33 6.44 6.45 6.32 6.37 6.3 6.15 6.37 6.39 6.56 6.41 6.48
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_HEXOSYL_GROUPS 6.34 6.25 6.42 6.34 6.53 6.4 6.34 6.51 6.37 6.38 6.3 6.42 6.6 6.45 6.33 6.42 6.46 6.32 6.51 6.29 6.15 6.38 6.5 6.59 6.47 6.48
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PENTOSYL_GROUPS 6.09 5.91 6.17 6 5.84 5.76 5.78 5.77 5.9 6 5.99 5.84 5.92 5.89 5.81 5.99 6.01 6.07 5.85 5.87 5.92 6.08 6 5.91 5.96 5.95
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS 6.83 7.04 7.77 7.59 6.94 7.25 7.24 6.97 7.16 7.07 7.22 7.01 6.97 7.1 6.95 7.13 6.86 6.99 6.96 7.2 7.02 7.13 7.19 7.22 7.32 7.22
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS 6.87 6.73 7.09 6.44 7.16 7.05 7.11 7.07 6.6 7.07 6.82 7.01 7.14 7.17 6.91 7.04 7.11 7.24 7.2 6.83 7.02 6.89 6.68 6.97 6.73 7.22
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS 6.73 6.75 7.02 6.98 6.95 7.1 6.98 6.92 6.94 7.03 6.9 7 7.12 7.06 6.97 6.93 6.94 6.87 6.95 7.07 6.86 7 7 7.11 7.03 7.03
GOMF_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR 7.23 7.15 7 7.28 6.83 7.41 7.13 6.79 7.31 7.52 7.2 7.6 7.11 7.44 7.08 7.21 7.46 7.15 7.32 7.12 7.27 7.41 7.16 7.26 7.4 7.22
GOMF_NUCLEOTIDYLTRANSFERASE_ACTIVITY 6.48 6.45 7 6.89 6.65 6.6 6.6 6.64 6.56 6.62 6.86 6.62 6.67 6.74 6.59 6.79 6.46 6.53 6.68 6.77 6.31 6.59 6.68 6.61 6.68 6.68
GOMF_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS 7.38 7.73 8.63 8.29 7.88 8.19 7.81 8.13 7.93 7.84 7.86 8.06 8.24 8.12 7.89 8.3 7.53 7.54 8.01 8.19 7.32 7.73 8.37 8.08 8.06 8
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_SULFUR_CONTAINING_GROUPS 6.21 6.25 6.59 6.56 6.5 6.52 6.86 6.45 6.55 6.8 6.59 6.49 6.41 6.36 6.48 6.49 6.23 6.21 6.27 6.61 6.29 6.47 6.69 6.48 6.4 6.54
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS 6.54 6.6 6.73 6.75 6.65 6.82 6.68 6.71 6.68 6.73 6.74 6.77 6.81 6.79 6.65 6.63 6.63 6.58 6.7 6.72 6.55 6.7 6.69 6.8 6.76 6.7
GOMF_THIOLESTER_HYDROLASE_ACTIVITY 6.83 6.91 7.5 7.11 7.05 7.26 7.08 6.84 6.93 7.01 6.95 7.12 7.26 7.25 7.05 6.69 7.03 7.01 7.16 7.62 6.57 7.09 6.98 7.15 7.08 7.25
GOMF_PHOSPHATASE_ACTIVITY 6.99 7.05 7.28 7.17 7.25 7.24 7.21 7.28 7.31 7.32 7.21 7.17 7.35 7.35 7.28 7.19 7.18 7.04 7.15 7.26 7.03 7.27 7.36 7.47 7.25 7.17
GOMF_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS 6.93 7.11 7.18 7.2 7.2 7.28 7.13 7.05 6.98 7.24 7.27 7.15 7.04 7.19 7.01 6.86 6.78 6.77 7.13 7.24 6.69 7.19 7.05 7.2 7 7.17
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS 6.06 5.92 6.1 5.95 5.7 5.67 5.86 5.81 5.8 5.67 5.84 5.76 5.69 5.73 5.73 5.81 5.79 5.84 5.9 5.63 5.93 5.85 5.8 5.74 5.79 5.97
GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS 5.68 5.65 5.49 5.38 5.27 5.4 5.4 5.28 5.38 5.23 5.47 5.3 5.58 5.3 5.67 5.65 5.55 5.62 5.67 5.22 5.56 5.59 5.44 5.25 5.54 5.66
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS 5.5 5.96 6.2 6.08 5.26 5.37 5.53 5.61 5.48 5.34 5.84 5.79 5.74 5.66 5.8 5.54 5.69 6.42 5.57 5.41 6.12 5.81 5.5 5.51 5.71 5.49
GOMF_DIPEPTIDASE_ACTIVITY 6.01 6.15 5.78 5.66 6.56 6.08 5.64 5.57 5.87 5.49 6.03 5.99 5.65 5.74 5.62 5.53 5.91 5.77 6.21 6 5.99 5.76 5.39 5.83 5.64 5.34
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS 6.07 6.06 6.02 6.08 5.97 6.18 5.87 6 5.89 6.02 5.91 5.95 6.1 6.07 5.81 5.97 5.9 5.8 6.04 6.12 6.08 5.84 5.94 5.95 5.81 6
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES 6.65 6.48 6.86 6.82 6.98 6.78 6.66 6.58 6.56 6.67 6.52 6.65 6.5 6.68 6.59 6.49 6.61 6.51 6.52 6.61 6.67 6.6 6.69 6.68 6.49 6.73
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES 5.22 4.97 4.95 5.17 4.85 4.33 4.72 4.63 4.96 4.9 5.22 4.56 4.59 4.57 4.64 4.75 4.79 4.79 4.95 4.52 4.9 4.37 4.58 4.25 4.6 4.56
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES 5.77 5.49 5.64 5.42 5.15 5.14 5.05 5.29 5.36 5.07 5.58 5.16 5.3 5.14 5.42 5.35 5.38 5.58 5.49 5.33 5.35 5.29 5.27 5.35 5.38 5.53
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES 6.64 6.57 6.89 6.8 6.83 6.9 6.77 6.85 6.84 7.03 6.84 6.93 6.93 6.87 6.88 6.92 6.75 6.66 6.69 6.78 6.69 6.83 6.93 7.01 6.87 6.91
GOMF_LYASE_ACTIVITY 6.23 6.19 6.44 6.76 6.29 6.21 6.21 6.34 6.02 6.25 6.26 6.22 6.24 6.26 6.13 6.11 6.08 6.09 6.06 6.35 6.25 6.12 6.14 6.28 6.32 6.28
GOMF_CARBON_CARBON_LYASE_ACTIVITY 6.37 6.38 6.78 7.15 6.48 6.89 6.5 6.53 6.33 6.42 6.45 6.57 6.45 6.62 6.39 6.3 6.34 6.53 6.57 6.46 6.39 6.34 6.21 6.34 6.44 6.47
GOMF_CARBOXY_LYASE_ACTIVITY 6.88 6.94 8.02 7.65 6.55 7.21 7.37 7.12 6.79 7.28 7.3 7.05 7.06 7.24 7.14 7.21 6.68 6.87 6.82 7.17 7.09 7.05 6.99 7.61 6.91 7.44
GOMF_CARBON_OXYGEN_LYASE_ACTIVITY 6.4 6.21 6.12 6.69 6.11 6.14 6.19 6.37 5.93 6.29 6 6.04 6.3 6.26 5.71 6.02 6.02 6.11 6.25 6.37 6.18 5.88 6.17 6.3 6.33 6.34
GOMF_HYDRO_LYASE_ACTIVITY 6.59 6.42 6.36 6.91 6.56 6.43 6.28 6.59 6.52 6.45 6.42 6.3 6.81 6.54 6.43 6.26 6.41 6.25 6.61 6.77 6.44 6.5 6.62 6.63 6.47 6.75
GOMF_CARBON_NITROGEN_LYASE_ACTIVITY 5.7 5.69 6.7 6.54 5.65 5.49 5.8 5.89 5.76 5.84 6.06 5.85 5.72 5.6 6 6.11 5.83 5.76 5.83 5.61 5.75 6.25 5.46 5.38 5.57 6.03
GOMF_CARBON_SULFUR_LYASE_ACTIVITY 6.65 6.42 7.94 7.94 6.97 7.15 6.65 6.41 7.47 6.84 6.67 6.38 6.66 6.63 6.33 6.54 6.33 6.13 6.15 7 6.55 6.42 6.7 6.8 6.27 6.23
GOMF_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY 6.46 5.99 5.55 5.91 5.58 5.5 6.01 6.03 5.88 5.82 6.04 6.56 5.9 6.2 5.96 5.83 6.08 5.93 6.01 6.07 6.25 6.1 5.82 5.83 6.14 6.26
GOMF_ISOMERASE_ACTIVITY 6.48 6.34 6.77 6.7 6.26 6.25 6.08 6.41 6.27 6.48 6.68 6.36 6.52 6.38 6.4 6.51 6.31 6.39 6.43 6.45 6.36 6.58 6.4 6.47 6.48 6.53
GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY 6.63 6.55 6.47 6.69 6.14 6.48 6.94 6.02 6.11 5.92 6.51 6.2 6.21 6.27 6.41 6.11 6.12 6.09 6.75 6.88 6.21 6.17 6.97 6.39 6.5 6.24
GOMF_CIS_TRANS_ISOMERASE_ACTIVITY 6.9 6.86 7.2 7.29 6.81 6.51 7.21 6.98 7.01 6.91 7.34 7.04 7.09 6.8 7.51 7.48 6.92 7.05 7.25 7.01 7.29 7.43 7.23 7.34 7.11 7.52
GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY 6.5 6.34 6.57 6.3 6.07 5.99 6.02 6.4 5.93 6.2 6.47 6.11 6.12 6.16 6.21 6.32 5.99 6.09 6.11 6.17 6.29 6.64 6.01 5.97 5.99 6.2
GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS 6.44 6.38 6.78 6.62 5.39 5.6 5.85 6.3 6.02 6.34 6.61 5.73 5.9 6.03 6.45 6.1 6.36 6.25 5.89 6.21 6.35 6.63 6.07 6.12 6.4 6.41
GOMF_INTRAMOLECULAR_TRANSFERASE_ACTIVITY 6.01 5.99 6.59 6.71 5.97 5.87 5.98 6.03 6.16 6.05 6.32 6.15 6.08 5.93 6.09 6.23 5.91 5.78 5.94 6.06 5.9 6.35 6.17 5.99 5.94 6.44
GOMF_LIGASE_ACTIVITY 6.93 6.9 7.18 6.92 7.17 7.24 7.05 7.09 6.93 7.19 7.05 7.11 7.06 7.15 7.12 7.19 7.01 6.93 7.14 7.18 6.95 6.93 6.96 7.15 7.16 7.24
GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS 6.4 6.45 6.62 6.85 6.6 6.47 6.53 6.38 6.66 6.61 6.55 6.37 6.81 6.78 6.34 6.5 6.42 6.71 6.62 6.64 6.4 6.43 6.25 6.5 6.55 6.6
GOMF_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS 6.91 6.75 6.99 6.71 7.06 7.15 6.65 7.01 6.82 7.18 6.79 7.02 6.96 6.82 6.79 6.78 7.06 6.54 6.81 6.84 6.81 6.82 6.96 7.08 6.97 6.93
GOMF_ACID_THIOL_LIGASE_ACTIVITY 6.6 6.32 6.55 6.34 6.16 6.36 6.45 6.43 6.3 6.31 6.06 6.23 6.35 6.29 6.3 6.25 6.47 6.32 6.2 6.14 6.31 6.44 6.2 6.41 6.62 6.7
GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS 6.95 7.19 7.41 7.2 7.26 7.31 7.16 7.06 6.92 7.34 7.25 7.49 7.17 7.26 7.24 7.44 7.03 6.91 7.56 7.3 6.97 7.32 6.94 7.25 7.17 7.4
GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY 7.62 7.6 7.85 7.28 8.03 8.34 7.34 7.64 7.09 7.72 7.3 7.96 7.81 7.7 7.26 7.53 7.65 7.54 7.91 7.94 7.38 7.8 7.07 7.72 7.45 8.16
GOMF_ATPASE_ACTIVITY 6.34 6.34 6.39 6.38 6.54 6.56 6.43 6.47 6.44 6.57 6.41 6.56 6.5 6.56 6.34 6.55 6.43 6.37 6.45 6.51 6.44 6.47 6.47 6.62 6.57 6.61
GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS 5.94 5.97 5.29 6.06 5.74 5.71 5.59 6.02 5.47 5.66 5.48 5.36 5.47 5.49 5.51 5.61 5.56 5.78 5.79 5.56 5.5 5.57 5.33 5.86 5.61 5.85
GOMF_ENDORIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS 6.29 5.92 6.79 6.59 5.94 6.42 6.96 6.44 6.51 6.29 6.52 6.38 6.3 6.24 6.36 6.69 5.97 6.11 6 6.41 6.17 6.32 6.65 6.68 6.66 6.4
GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS 6.12 5.97 6.47 6.31 5.89 5.92 6.33 6.29 5.9 6.04 6.07 5.99 5.82 5.78 5.89 6.29 5.95 5.98 5.96 6.12 6.04 6.01 6.11 6.36 6 5.97
GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS 5.89 5.99 5.72 6.12 5.8 5.84 5.91 5.88 5.89 5.8 5.68 5.57 5.82 5.77 5.79 5.61 5.87 5.9 5.79 5.76 5.59 5.75 5.8 5.86 5.7 5.76
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS 6.36 6.43 7.11 6.91 6.5 6.4 6.62 6.73 6.56 6.4 7.01 6.91 6.7 6.7 6.56 6.68 7.21 6.69 6.38 6.44 7.16 6.98 7.03 6.93 6.53 6.79
GOMF_GABA_RECEPTOR_ACTIVITY 7.72 8.73 9.01 9.11 7.87 8.57 9.65 9.05 8.95 9.67 7.78 7.93 8.84 8.74 9.73 9.1 7.73 7.6 8.29 8.78 8.28 8.66 9.12 8.87 8.53 8.23
GOMF_RETINAL_BINDING 5.32 5.31 5.45 5.09 5 4.51 5.01 5.16 5.28 4.62 5.09 4.52 4.68 4.74 4.61 5.04 5.25 5.3 4.8 4.86 5.39 4.78 4.68 4.32 4.7 4.94
GOMF_NUCLEAR_RECEPTOR_BINDING 7.31 7.52 7.45 7.3 7.84 7.69 7.48 7.59 7.56 7.56 7.25 7.65 7.61 7.55 7.7 7.53 7.51 7.31 7.51 7.57 7.5 7.58 7.57 7.62 7.7 7.64
GOMF_MYOSIN_BINDING 6.69 6.48 7.02 6.66 6.75 6.67 7.12 7.2 7.05 7.06 6.94 6.8 6.64 6.48 7.17 6.95 6.56 6.89 6.41 6.78 6.54 6.92 7.43 7.18 6.76 6.44
GOMF_TBP_CLASS_PROTEIN_BINDING 6.52 6.71 7.59 7.18 7.09 7.12 6.99 7.24 7.51 7.44 7.42 7.51 7 7.25 7.51 7.5 6.74 6.69 6.96 7.02 6.82 7.06 7.5 7.64 7.47 7.34
GOMF_PEPTIDE_HORMONE_BINDING 5.92 5.6 6 5.87 5.48 5.47 5.68 5.68 5.58 5.72 5.87 5.55 5.52 5.49 5.3 5.56 5.55 5.67 5.55 5.71 5.57 5.51 5.37 5.18 5.39 5.41
GOMF_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE 7.27 7.12 7.54 7.87 7.69 8.02 7.43 7.18 7.55 7.46 7.62 7.73 7.58 7.81 7.54 7.59 6.93 7.16 7.5 7.33 7.03 7.68 7.42 7.63 7.49 7.33
GOMF_SNRNA_BINDING 6.97 6.92 6.97 7.21 6.81 6.87 7.14 6.95 6.68 7.03 6.91 6.87 7.04 6.92 7.07 7.11 6.57 6.95 7.11 6.99 6.92 7.01 6.95 6.96 7 7.02
GOMF_U6_SNRNA_BINDING 6.61 6.28 6.75 6.83 6.7 6.56 6.61 6.52 6.68 6.93 6.61 6.89 7.07 6.8 6.84 7.07 6.29 6.4 6.51 6.72 6.67 6.72 6.85 6.67 6.85 6.86
GOMF_SYNTAXIN_1_BINDING 9.03 9.15 8.87 9.05 9.22 9.13 9.35 9.56 9.26 9.1 8.97 9.33 9.14 9.24 9.1 9.47 9.1 9.48 9.33 9.59 9.1 8.9 8.92 9.33 9.42 9.49
GOMF_SODIUM_CHANNEL_REGULATOR_ACTIVITY 7.3 7.41 8.16 7.6 7.88 8.02 7.56 7.84 7.7 7.77 7.97 7.88 7.63 7.85 7.88 8.1 7.52 7.38 7.73 7.63 7.34 7.67 7.76 8.12 7.58 7.49
GOMF_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY 6.04 6.16 7.24 7.19 6.42 6.28 6.53 6.98 6.73 6.44 6.48 6.31 6.61 6.48 7.15 6.95 6.34 6.71 6.47 6.46 7.03 6.98 6.71 6.94 6.84 6.44
GOMF_NUCLEOSIDE_DIPHOSPHATASE_ACTIVITY 6.21 6.37 6.38 6.64 6.26 6.46 6.64 6.72 6.49 6.7 6.33 6.22 6.72 6.61 6.43 6.65 6.25 6.3 6.17 6.59 6.93 6.31 6.7 6.49 6.95 6.57
GOMF_SINGLE_STRANDED_DNA_HELICASE_ACTIVITY 5.83 5.83 5.63 6.25 5.5 5.59 5.82 5.73 5.77 5.75 5.77 5.64 5.71 5.52 5.83 5.68 5.59 5.63 5.62 5.54 5.59 5.48 5.65 5.85 5.99 5.98
GOMF_SH3_DOMAIN_BINDING 7.31 7.35 7.37 7.12 7.6 7.49 7.57 7.72 7.5 7.59 7.33 7.47 7.53 7.67 7.71 7.66 7.66 7.51 7.53 7.67 7.2 7.5 7.3 7.67 7.51 7.65
GOMF_FIBROBLAST_GROWTH_FACTOR_BINDING 6.6 6.72 6.83 6.7 6.4 6.38 6.72 6.74 6.57 6.61 6.85 6.66 6.55 6.32 6.84 6.91 6.08 6.66 6.43 6.79 6.99 6.9 6.63 6.55 7.02 6.84
GOMF_WNT_PROTEIN_BINDING 6 6.03 5.87 6.19 5.81 5.88 5.97 5.91 6.08 5.82 6 6.02 6.14 6.06 6.03 5.99 6.22 5.91 6.11 5.85 6.11 5.92 6.25 6 5.87 5.96
GOMF_SEMAPHORIN_RECEPTOR_ACTIVITY 6.65 6.85 6.34 6.07 6.79 6.79 6.85 7.21 6.62 6.85 6.63 6.97 6.68 6.93 7.14 6.71 7.18 6.94 6.8 6.71 6.9 6.91 6.66 6.8 6.66 6.62
GOMF_VINCULIN_BINDING 7.5 7.41 7.03 6.62 8.21 7.98 7.83 7.45 7.81 7.8 7.37 7.98 7.86 8.03 7.56 7.62 7.83 7.56 7.63 7.64 7.81 7.81 8.26 8.19 7.99 7.7
GOMF_SERINE_HYDROLASE_ACTIVITY 5.34 5.34 5.24 5.32 4.94 4.83 5.14 4.99 5.09 4.82 5.21 4.94 4.87 4.92 5.08 4.88 5.04 5.18 5 4.78 5.3 5.11 4.94 4.69 4.97 4.9
GOMF_HISTONE_LYSINE_N_METHYLTRANSFERASE_ACTIVITY 6.45 6.44 6.62 6.87 6.76 6.73 6.52 6.86 6.45 6.73 6.73 6.81 6.69 6.72 6.88 6.87 6.75 6.52 6.65 6.63 6.69 6.9 6.46 6.97 6.64 7.02
GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY 4.7 4.69 4.16 4.48 4.01 3.98 3.99 4.25 3.93 4.02 4.98 4.32 4.34 4.05 4.01 4.08 4.49 4.53 4.18 4.19 4.42 4.21 3.93 3.91 3.99 4.53
GOMF_GUANYL_NUCLEOTIDE_BINDING 7.05 7.08 7.51 7.43 7.06 7.23 7.24 7.2 7.3 7.34 7.36 7.24 7.22 7.32 7.39 7.38 7.11 7.04 7.06 7.23 6.99 7.19 7.32 7.43 7.26 7.12
GOMF_GDP_BINDING 7.56 7.77 8.29 7.93 7.9 7.96 8.35 7.84 8.34 8.25 8.18 8.24 8.08 8.36 8.17 8.08 7.94 7.73 7.68 8 7.61 7.99 8.57 8.3 8.28 7.9
GOMF_DNA_N_GLYCOSYLASE_ACTIVITY 5.82 5.73 6.42 6.55 5.56 5.83 5.84 5.84 5.91 5.79 5.99 5.83 5.83 5.95 5.74 5.94 5.85 6.09 5.91 5.83 5.8 5.79 5.97 6.12 5.57 5.85
GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY 7.25 7.52 7.41 6.76 7.88 8.06 7.77 7.9 7.86 7.85 7.19 7.66 7.94 7.7 7.78 7.92 7.39 7.33 7.52 7.57 7.49 7.57 7.92 8.15 7.83 7.64
GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY 6.5 6.65 6.65 6.54 6.7 6.78 6.62 6.96 6.63 6.77 6.44 6.54 6.79 6.8 6.75 6.71 6.42 6.42 6.54 6.91 6.83 6.77 6.93 6.64 6.77 6.91
GOMF_CARBOHYDRATE_KINASE_ACTIVITY 6.37 6.45 7.28 7.05 5.84 5.88 6.77 6.39 6.73 6.7 6.71 6.49 6.4 6.64 6.44 6.48 6.13 6.41 6.37 6.35 6.27 6.21 6.56 6.41 6.36 6.31
GOMF_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY 7.22 7.35 7.93 7.77 7.12 7.56 7.42 7.26 7.41 7.57 7.9 7.67 7.18 7.45 7.26 7.78 7.51 6.96 7.63 7.63 7.24 7 7.37 7.51 7.39 7.41
GOMF_KINASE_REGULATOR_ACTIVITY 6.64 6.72 7.15 6.88 7.03 6.89 7.04 6.99 6.97 7.04 6.98 7.13 7.07 7.08 6.99 7.09 6.81 6.87 6.81 6.94 7 7.13 7.21 7.01 6.97 7.17
GOMF_PHOSPHATASE_REGULATOR_ACTIVITY 7.94 8.04 8.14 8.02 8.11 8.34 8.33 8.3 8.31 8.25 8.18 8.19 8.3 8.25 8.35 8.31 8.05 8.05 8.2 8.3 8.14 8.33 8.36 8.6 8.26 8.15
GOMF_KINASE_ACTIVATOR_ACTIVITY 6.41 6.57 7.13 6.71 6.79 6.77 6.77 6.72 6.91 6.87 6.81 6.87 6.95 6.72 6.96 7.07 6.52 6.43 6.65 6.57 6.91 7.04 7.12 6.84 6.95 7.08
GOMF_KINASE_INHIBITOR_ACTIVITY 6.7 6.86 7.38 6.91 7.11 6.87 7.19 7.03 7.11 6.96 7.08 7.07 7.19 7.17 7.17 7.08 7.13 6.97 7.11 7.1 7 7.16 7.31 7.23 6.98 7.13
GOMF_PHOSPHATASE_ACTIVATOR_ACTIVITY 8.2 8.14 8.65 8.45 8.25 8.49 8.51 8.84 8.32 8.39 8.39 8.16 8.43 8.39 8.8 8.76 8.29 8.37 8.34 8.32 8.57 8.77 8.43 8.62 9.06 8.85
GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY 7.75 7.48 7.84 8.02 7.99 8.26 8.1 7.84 8.18 8.07 7.83 8.17 8.14 8.17 7.87 8.1 7.92 7.49 7.92 8.23 7.51 7.72 8.3 8.33 7.3 7.39
GOMF_DEACETYLASE_ACTIVITY 6.83 6.58 6.9 6.84 7.12 7.1 6.85 6.79 7 7.16 6.76 7.02 6.95 7.11 6.75 7.02 6.77 6.71 6.7 6.73 6.85 6.81 7.1 7.09 6.75 6.94
GOMF_INTERMEDIATE_FILAMENT_BINDING 6.19 6.27 6.41 5.99 5.45 6.61 6.95 6.1 6.73 6.92 6.26 6.71 6.86 6.61 7.04 6.53 6.33 6.47 6.27 6.37 6.7 5.74 6.84 7.01 7.16 6.5
GOMF_DEAMINASE_ACTIVITY 5.9 5.49 5.71 5.55 5.29 5.14 5.34 5.3 5.43 5.32 5.58 5.2 5.45 5.14 5.53 5.42 5.71 5.58 5.49 5.33 5.41 5.32 5.25 5.46 5.38 5.53
GOMF_OXALATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.25 5.03 4.48 5.16 4.67 4.48 4.51 4.74 4.84 4.6 4.79 4.77 4.78 4.63 4.66 4.54 4.87 4.79 4.68 4.73 4.9 4.58 4.39 4.42 4.61 4.69
GOMF_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_PROTEASE_ACTIVITY 7.12 7.31 8.31 8.09 7.68 8 7.8 7.65 7.83 7.83 7.69 7.8 7.95 7.98 7.87 7.85 7.37 7.41 7.98 8.04 7.12 7.92 8.3 8.2 7.74 7.5
GOMF_UBIQUITIN_LIKE_PROTEIN_TRANSFERASE_ACTIVITY 6.91 6.95 7.21 7.21 7.11 7.21 7.18 7.24 7.15 7.25 7.12 7.13 7.19 7.26 7.2 7.23 6.98 6.95 7.09 7.3 6.98 7.19 7.22 7.34 7.22 7.14
GOMF_SUMO_TRANSFERASE_ACTIVITY 6.68 7.19 7.52 7.4 7.15 7.17 7.2 7.27 7.47 7.18 6.97 7.1 7.35 7.46 7.21 7.16 7.05 6.74 7.11 7.74 6.89 7.09 7.14 7.32 7.69 7.27
GOMF_OXYGEN_BINDING 5.23 5.1 5.04 5.02 4.27 4.1 4.88 4.71 4.76 4.46 5.11 4.83 4.65 4.59 4.81 4.78 4.95 5.11 4.92 4.71 5.13 4.73 4.57 4.53 4.62 4.72
GOMF_GROWTH_FACTOR_BINDING 5.95 5.96 6.08 6.07 5.93 5.83 6.05 5.96 6.01 6.05 6.16 6.22 6.02 6 6.07 5.82 6.18 6.09 5.77 5.89 6.38 6.24 6.16 6.15 6.14 6.29
GOMF_ISOPRENOID_BINDING 5.4 5.35 5.45 5.37 5.02 4.83 5.2 5.24 5.36 4.87 5.09 5.06 5.04 5.23 5.27 5.22 5.38 5.38 5.1 5.2 5.48 5.15 4.94 4.8 5.1 5.05
GOMF_RETINOL_BINDING 5.45 5.31 5.3 5.08 4.94 4.69 4.99 5.08 5.31 4.63 5.07 4.68 4.82 4.78 4.77 4.88 5.3 5.34 5.04 4.95 5.36 4.77 4.66 4.47 4.84 4.92
GOMF_VITAMIN_BINDING 6.17 6.19 6.58 6.34 5.94 5.9 6.31 6.36 6.14 6.33 6.51 6.29 6.29 6.26 6.3 6.19 6.19 6.02 5.97 6.35 6.53 6.36 6.01 6.12 6.49 6.43
GOMF_RRNA_BINDING 6.41 6.38 7.04 7.33 6.78 6.64 6.56 7 6.54 6.72 7.09 6.61 6.95 6.87 6.83 6.8 6.49 6.53 6.76 6.66 6.48 6.74 6.94 7.33 6.66 6.63
GOMF_IMMUNOGLOBULIN_BINDING 5.12 5.04 5.32 5.25 4.69 4.65 5.07 5.14 4.94 4.81 4.9 4.6 4.79 4.74 5.2 5.08 4.94 5.15 4.68 4.71 5.06 5.25 4.79 4.53 4.97 5.63
GOMF_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY 5.92 5.86 6.82 6.54 6.34 6.25 6.48 6.92 6.51 6.41 6.47 6.25 6.57 6.42 6.93 6.85 6.32 6.43 6.42 6.41 6.88 6.75 6.65 6.93 6.55 6.41
GOMF_KINESIN_BINDING 7.57 7.56 7.72 7.91 8.03 8.19 8.13 7.99 8.07 8.09 7.84 8.3 8.28 8.16 8.2 8 8.09 7.7 7.85 8 7.68 8.08 8.13 8.38 7.91 7.96
GOMF_ENZYME_BINDING 7 7.04 7.25 7.11 7.28 7.32 7.23 7.27 7.24 7.34 7.17 7.31 7.39 7.37 7.26 7.24 7.24 7.11 7.19 7.34 7.15 7.32 7.34 7.45 7.36 7.31
GOMF_KINASE_BINDING 7.05 7 7.19 7.03 7.26 7.27 7.22 7.25 7.23 7.2 7.15 7.29 7.32 7.27 7.22 7.17 7.3 7.05 7.16 7.34 7.16 7.32 7.34 7.42 7.32 7.28
GOMF_PHOSPHATASE_BINDING 7.28 7.29 7.41 7.21 7.71 7.69 7.37 7.5 7.66 7.54 7.29 7.52 7.62 7.9 7.5 7.57 7.37 7.37 7.52 7.6 7.58 7.6 7.51 7.73 7.64 7.53
GOMF_PROTEIN_PHOSPHATASE_BINDING 7.23 7.22 7.41 7.22 7.71 7.69 7.29 7.48 7.59 7.53 7.27 7.53 7.6 7.53 7.44 7.57 7.37 7.33 7.49 7.6 7.58 7.6 7.47 7.73 7.63 7.49
GOMF_PROTEIN_DOMAIN_SPECIFIC_BINDING 7.05 7.14 7.4 7.15 7.42 7.39 7.35 7.42 7.5 7.47 7.26 7.35 7.46 7.51 7.37 7.39 7.36 7.21 7.26 7.45 7.18 7.37 7.41 7.59 7.43 7.47
GOMF_SYNTAXIN_BINDING 7.5 7.48 7.84 7.58 8.14 8.06 7.85 7.86 7.9 8.05 7.64 7.78 7.91 8.11 7.66 7.8 7.42 7.46 7.71 7.89 7.64 7.93 8.02 8.05 7.79 7.72
GOMF_CYTOKINE_BINDING 5.5 5.41 5.4 5.48 5.15 5.05 5.44 5.33 5.39 5.16 5.32 5.05 5.48 5.33 5.36 5.25 5.53 5.5 5.14 5.2 5.5 5.33 5.25 4.97 5.43 5.36
GOMF_CHEMOKINE_BINDING 4.93 4.75 4.57 4.96 4.83 4.72 4.26 4.19 4.86 4.51 4.76 4.41 4.58 4.4 4.33 4.23 5.1 4.79 4.69 4.57 4.81 4.11 4.78 4.38 4.78 4.77
GOMF_C_C_CHEMOKINE_BINDING 4.8 4.6 4.17 4.66 4.16 3.81 4.09 4 4.01 3.94 4.37 3.96 3.97 4.01 4.07 3.92 4.23 4.3 4.27 3.99 4.22 4 4.1 3.78 4.04 4
GOMF_DIACYLGLYCEROL_BINDING 7.59 7.49 7.19 7.07 7.57 7.63 7.66 7.77 7.33 7.92 7.22 7.7 7.23 7.32 7.41 7.47 7.61 7.46 7.54 7.75 7.66 7.91 7.67 8.17 7.13 7.6
GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.93 5.86 5.7 5.96 5.62 5.51 5.91 5.83 5.75 5.85 5.76 5.66 5.64 5.65 5.92 5.82 5.79 5.95 5.74 5.68 5.79 5.64 5.72 5.58 5.72 5.72
GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.02 5.97 5.91 6.05 5.78 5.73 6.05 5.94 5.84 5.95 5.92 5.85 5.81 5.93 5.73 5.85 5.95 5.9 5.94 5.95 5.99 5.85 5.74 5.87 6.09 6.01
GOMF_POTASSIUM_ION_ANTIPORTER_ACTIVITY 7.11 6.96 6.96 6.54 6.63 7.11 7.32 6.81 6.85 6.65 6.66 6.73 6.49 6.56 6.57 6.66 7.14 6.86 6.9 7.54 7 6.92 6.64 6.75 7.28 7.15
GOMF_WIDE_PORE_CHANNEL_ACTIVITY 5.51 5.44 5.54 5.86 5.13 4.91 5.48 5.38 5.39 5.08 5.52 5.64 5.39 5.1 5.36 4.88 5.21 5.12 4.8 5.23 5.26 5.33 5.18 5.07 5.41 5.72
GOMF_TRANSMITTER_GATED_CHANNEL_ACTIVITY 6.16 6.33 6.21 6.65 6.36 6.61 6.42 6.34 6.64 6.43 6 6.11 6.09 5.91 6.62 5.99 6.45 6.43 6.43 6.46 5.87 5.84 6.26 6.38 6.25 6.1
GOMF_GATED_CHANNEL_ACTIVITY 6.1 5.99 5.84 5.99 5.76 5.74 6.12 5.99 5.92 6.13 5.87 5.86 5.91 5.73 6.16 5.95 6.02 6.09 5.98 5.98 5.91 5.8 5.89 5.83 5.96 5.77
GOMF_ION_GATED_CHANNEL_ACTIVITY 6.12 5.95 5.76 5.67 5.55 5.45 5.7 5.79 5.47 5.55 5.97 5.63 5.54 5.48 5.78 5.52 5.79 6.01 5.6 5.46 5.96 5.47 5.36 5.55 5.71 5.65
GOMF_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY 5.8 5.55 5.36 5.73 5.19 5.39 5.81 5.39 5.48 5.25 5.37 5.21 5.22 5.29 5.37 5.24 5.24 5.47 5.3 5.19 5.6 5.59 5.49 5.37 5.34 5.15
GOMF_NARROW_PORE_CHANNEL_ACTIVITY 5.8 5.58 5.36 5.78 5.28 5.48 5.86 5.4 5.61 5.25 5.48 5.33 5.29 5.3 5.42 5.4 5.26 5.47 5.3 5.28 5.61 5.63 5.69 5.46 5.37 5.26
GOMF_VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY 6.46 6.43 6.45 6.12 6.36 6.32 6.64 6.75 6.47 6.52 6.25 6.49 6.57 6.41 6.66 6.42 6.4 6.5 6.55 6.65 6.23 6.52 6.42 6.7 6.48 6.3
GOMF_ACETYLCHOLINE_GATED_CATION_SELECTIVE_CHANNEL_ACTIVITY 5.27 5.06 4.78 5.15 4.41 4.5 4.78 4.9 4.9 4.54 4.9 4.72 4.56 4.57 4.77 4.77 4.71 5.07 4.69 4.7 4.82 4.77 4.71 4.36 4.59 4.64
GOMF_GABA_GATED_CHLORIDE_ION_CHANNEL_ACTIVITY 9.01 9.59 9.95 9.72 9.57 9.94 10.33 9.59 10.39 10.25 9.81 9.67 10.09 10.51 10.14 9.92 9.33 9.63 9.49 9.87 9.45 9.88 10.38 10.22 10.05 9.34
GOMF_ACTIVE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6 5.85 5.86 5.9 5.61 5.47 5.81 5.77 5.7 5.78 5.85 5.57 5.74 5.84 5.66 5.6 5.9 5.79 5.71 5.67 5.7 5.7 5.71 5.55 5.86 5.85
GOMF_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.79 7.57 7.37 7.73 7.64 7.9 7.57 7.44 8.19 7.8 7.16 7.63 7.57 7.99 7.58 7.65 7.63 7.72 7.52 7.53 7.41 6.81 7.46 7.51 8.01 7.57
GOMF_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.15 7.4 8.27 7.43 7.42 7.92 7.7 8.1 8.1 7.47 7.82 7.46 8.28 8.33 7.83 7.99 7.58 7.17 7.85 7.61 7.64 7.94 8.18 8.18 8.07 7.94
GOMF_MHC_PROTEIN_COMPLEX_BINDING 6.69 6.68 6.65 7.41 6.19 5.87 6.6 6.11 6.34 6.12 5.98 5.39 6.07 6.48 5.89 6.16 6.99 6.79 5.67 6.32 6.42 6.61 6.55 5.83 6.26 6.39
GOMF_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING 8.81 8.45 9.49 8.63 8.16 8.61 8.54 8.42 8.54 7.8 7.31 6.59 7.65 7.76 8.01 8.79 8.92 8.84 7.94 8.63 9.27 9.52 8.53 8.51 8.66 8.8
GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH 5.25 5.13 4.86 5.08 5.01 4.66 4.8 4.71 4.81 4.73 5.08 4.79 4.59 4.74 4.9 4.79 4.94 5.11 5.04 4.75 4.97 4.66 4.88 4.47 4.66 4.61
GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE 5.26 5.03 4.83 5.15 4.95 4.55 4.86 4.8 5.06 4.92 5.32 5.03 4.86 4.69 4.65 4.93 4.77 5.34 5.21 4.76 5.06 5.06 4.81 4.53 4.58 4.63
GOMF_MANGANESE_ION_BINDING 6.46 6.39 7.04 6.94 7.04 6.9 7 6.85 7 6.91 6.95 6.83 7.23 7.21 6.92 6.83 6.96 6.87 6.8 6.99 6.95 6.74 7.19 7.41 7.04 7.06
GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY 6.81 6.75 7.11 7.13 6.74 6.64 6.68 6.85 6.71 7.09 6.44 6.81 6.82 6.8 6.98 6.8 6.9 6.92 6.81 6.92 7.01 6.72 6.86 6.66 7.02 6.87
GOMF_PDZ_DOMAIN_BINDING 7.41 7.55 7.84 7.39 7.56 7.76 7.78 7.71 7.78 7.84 7.78 8.02 8.1 8.1 7.93 7.79 7.82 7.63 7.85 7.86 7.58 8.03 7.83 7.97 8.02 7.88
GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING 5.8 5.39 5.34 5.64 4.84 5.08 5.41 5.22 5.55 5.22 5.33 5.39 5.17 5.56 5.26 5.56 5.41 5.47 5.21 5.36 5.8 5.62 5.53 4.9 5.35 5.73
GOMF_SEMAPHORIN_RECEPTOR_BINDING 6.71 6.84 7.04 6.51 7.11 7.23 7.09 7.66 7.14 7.41 6.87 7.38 7.39 7.55 7.16 7.05 7.03 6.59 7.27 7.59 6.78 6.69 7.26 7.09 7.22 7.11
GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY 6.71 7.03 7.02 6.44 7.61 7.48 7.02 7.39 7.61 7.1 6.74 7.24 7.69 7.24 6.71 6.84 7.56 6.94 6.77 7.29 7.07 7.38 7.13 7.59 6.74 7.15
GOMF_ENZYME_REGULATOR_ACTIVITY 6.69 6.71 7.08 6.85 7.02 7.01 6.91 6.99 6.89 6.98 6.84 6.92 6.98 7.01 6.97 6.97 6.88 6.84 6.82 6.99 6.93 7.06 7.03 7.06 7.04 7.04
GOMF_CARBOHYDRATE_BINDING 5.4 5.35 5.37 5.48 4.9 5 5.22 5.27 5.23 5.04 5.23 5.12 5.05 4.99 5.11 5.08 5.32 5.25 5.12 5.05 5.39 5.08 4.96 4.74 5.12 5.28
GOMF_POLYSACCHARIDE_BINDING 5.07 4.94 4.51 5.17 4.51 4.51 5.02 4.75 4.73 4.52 4.97 4.55 4.63 4.51 4.55 4.53 5.46 5.05 5 4.81 5.06 4.77 4.56 4.25 4.37 4.76
GOMF_LRR_DOMAIN_BINDING 6.34 7.3 7.41 7.48 6.78 7.19 6.9 7.23 7.29 7.4 6.82 7.1 7.34 7.45 7.23 7.38 6.62 7.1 7.08 7.32 6.75 7.25 7.65 7.71 7.41 6.95
GOMF_CLATHRIN_BINDING 8.11 8.06 8.1 7.95 8.31 8.43 8.45 8.36 8.23 8.32 8.02 8.38 8.33 8.48 8.52 8.56 7.93 7.97 8.1 8.45 8.05 8.44 8.13 8.44 8.69 8.61
GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS 4.75 4.46 4.6 4.83 4.24 4.03 4.44 4.41 4.46 4.09 4.62 4.34 4.12 4.04 4.21 4.33 4.63 4.77 4.35 4.3 4.86 4.6 4.37 4.15 4.24 4.41
GOMF_TESTOSTERONE_DEHYDROGENASE_NAD_P_ACTIVITY 5.55 5.46 6.27 6.05 5.05 5 5.52 5.55 5.65 4.9 5.33 5.41 5.39 4.57 5.61 5.78 4.85 4.97 4.54 4.85 5.1 5.37 5.35 5.29 5.64 5.63
GOMF_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY 6.7 6.98 7.59 7.15 7.05 6.87 7.3 7.22 7.12 7.38 7.01 7.19 7.24 6.99 7.42 7.1 7.13 6.79 6.81 7.41 7.02 7.36 7.27 7.11 7.12 7.12
GOMF_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY 6.19 6.6 6.49 6.3 6.56 6.6 6.65 6.62 6.75 6.63 6.4 6.87 6.67 6.34 6.54 6.7 6.21 6.24 6.85 6.47 6.71 6.69 6.61 6.74 6.57 6.74
GOMF_ESTROGEN_RECEPTOR_BINDING 7.46 7.58 7.5 7.62 8.04 8.08 7.39 7.45 7.88 7.56 7.41 7.67 8 7.93 7.7 7.53 7.53 7.27 7.7 7.57 7.41 7.62 7.57 7.52 7.52 7.5
GOMF_CYCLIN_BINDING 6.74 6.72 6.78 6.46 6.95 7.12 6.63 6.43 6.92 7.11 7.07 7.13 7.35 7.45 6.63 6.69 6.87 6.74 6.92 6.59 6.84 6.79 7.03 7.22 6.56 7.25
GOMF_TRANSLATION_REPRESSOR_ACTIVITY 7.52 7.97 8.01 7.77 7.67 8.09 8.35 8.01 8.24 8.34 7.74 8.11 8.39 8.3 8.41 8.2 7.79 7.35 7.87 7.94 7.97 8.2 8.56 8.86 8.66 8.1
GOMF_NUCLEAR_RECEPTOR_COACTIVATOR_ACTIVITY 7.68 7.87 7.66 7.62 8.02 8.15 8.22 8.08 8.27 8.11 7.54 8.07 8.31 8.25 7.94 8.07 7.85 7.74 8.31 8.18 7.78 7.86 8.02 8.29 8.3 8.16
GOMF_ANKYRIN_BINDING 6.42 6.06 5.81 5.75 6.58 6.35 6.33 6.51 6.12 6.69 6.35 6.3 6.45 6.47 6.05 6.31 6.27 6.4 6.26 6.23 6.16 6.1 6.27 6.41 6.1 6.43
GOMF_SPECTRIN_BINDING 7.87 7.98 7.12 7.79 8.62 8.45 7.89 8.34 7.6 7.54 8.14 8.27 8.03 8.45 7.98 8.39 8.02 7.65 8.88 8.38 7.85 8.77 7.46 7.81 8.29 8.06
GOMF_SNORNA_BINDING 6.04 6.22 6.56 6.41 6.37 6.21 6.34 6.66 6.37 6.3 6.28 6.44 6.46 6.39 6.42 6.65 6.19 6.45 6.14 6.17 6.32 6.44 6.44 6.63 6.41 6.67
GOMF_HSP70_PROTEIN_BINDING 6.82 6.99 7.77 7.52 6.85 7.21 7.36 7.17 7.15 7.1 7.07 7.26 7.69 7.31 7.24 7.82 6.93 6.85 7.32 7.14 7.07 7.19 7.3 7.28 7.15 7.32
GOMF_RECEPTOR_REGULATOR_ACTIVITY 5.35 5.21 5.18 5.29 4.84 4.73 5.08 4.97 5.08 4.88 5.16 4.9 4.87 4.81 5.01 4.98 5.14 5.23 4.9 4.83 5.21 4.92 4.84 4.65 4.93 4.91
GOMF_RECEPTOR_INHIBITOR_ACTIVITY 5.21 5.13 5.05 5.02 4.63 4.79 4.99 4.85 4.8 4.69 4.98 4.73 4.63 4.6 4.6 4.98 4.86 5.1 4.84 4.93 5.07 5.04 5.17 4.66 4.71 4.74
GOMF_CYCLIC_NUCLEOTIDE_BINDING 6.51 6.71 6.46 6.54 6.53 6.45 6.89 6.71 6.52 6.7 6.57 6.72 6.62 6.36 6.67 6.69 6.55 6.86 6.34 6.65 6.57 6.43 6.36 6.47 6.5 6.44
GOMF_CAMP_BINDING 7.59 7.64 7.9 7.24 7.67 7.85 7.47 7.99 8.12 8.2 7.84 8 7.88 7.59 7.65 7.94 7.5 7.32 7.49 7.91 7.19 6.91 7.47 7.25 7.28 7.52
GOMF_CGMP_BINDING 5.04 4.8 4.6 4.84 4.25 4.34 4.83 4.54 4.71 4.49 4.55 4.59 4.38 4.35 4.32 4.49 4.81 4.94 4.35 4.32 5.13 4.45 4.29 4.26 4.56 4.35
GOMF_ADENYL_NUCLEOTIDE_BINDING 6.65 6.65 6.82 6.76 6.82 6.93 6.78 6.8 6.73 6.92 6.77 6.87 6.86 6.84 6.79 6.76 6.76 6.72 6.76 6.79 6.71 6.79 6.87 6.9 6.86 6.87
GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY 6.01 6 5.93 6.33 5.8 6.15 6.14 6.14 6.12 6.09 5.82 5.61 5.82 5.63 6.18 5.82 5.87 6.23 6.29 6.11 5.97 5.78 5.95 6.07 6.04 5.97
GOMF_PROTEIN_MACROMOLECULE_ADAPTOR_ACTIVITY 6.87 6.91 7.25 7.12 7.27 7.27 7.27 7.38 7.21 7.32 7.2 7.21 7.09 7.18 7.14 7.19 7.05 7.04 7.07 7.31 7.16 7.25 7.21 7.35 7.31 7.24
GOMF_GTP_DEPENDENT_PROTEIN_BINDING 7.16 7.21 7.9 7.85 7.03 7.4 7.35 7.35 7.56 7.65 7.05 7.8 7.37 7.48 7.5 7.76 7.59 7.35 7.32 7.38 7.21 7.61 7.65 7.8 7.58 7.61
GOMF_ACTIN_DEPENDENT_ATPASE_ACTIVITY 5.39 5.51 5.19 5.28 5.7 5.65 5.25 5.49 5.39 5.92 5.66 5.18 5.44 5.25 5.66 5.3 5.49 5.35 5.29 5.46 5.83 5.82 4.97 4.93 6.01 6.09
GOMF_POTASSIUM_ION_BINDING 8.03 8.3 8.64 7.64 7.55 8.06 8.74 8.74 8.88 8.55 8.6 8.45 8.73 8.46 8.88 8.57 8.36 8.32 8.43 8.55 8.72 8.58 8.94 9.04 9.25 8.58
GOMF_TAT_PROTEIN_BINDING 7 7.48 6.89 7.13 7.41 7.96 7.65 7.9 7.69 7.36 7.08 7.52 7.55 7.78 7.98 7.55 6.9 7.01 7.76 7.57 7.31 7.51 7.57 8.01 7.72 7.42
GOMF_RECEPTOR_TYROSINE_KINASE_BINDING 6.7 6.49 6.99 6.77 6.63 6.64 6.67 6.69 6.59 6.66 6.66 6.78 6.6 6.97 6.6 6.8 6.88 6.86 6.68 6.88 6.84 6.94 6.75 6.66 7.02 7.05
GOMF_MISMATCHED_DNA_BINDING 6.29 6.39 6.8 6.72 6.2 6.25 6.49 6.29 6.62 6.44 6.27 6.06 6.42 6.09 6.1 6.48 6.1 6.42 6 6.18 6.17 6.04 6.59 6.32 6.38 6.35
GOMF_HEAT_SHOCK_PROTEIN_BINDING 7 6.99 7.69 7.33 7.21 7.36 7.41 7.3 7.47 7.46 7.39 7.52 7.69 7.73 7.63 7.59 7.16 6.95 7.25 7.33 7.32 7.6 7.57 7.6 7.37 7.38
GOMF_HISTONE_DEACETYLASE_ACTIVITY_H3_K14_SPECIFIC 6.76 6.71 7.5 7.26 7.44 7.67 7.51 7.09 7.17 7.58 7.07 7.52 7.32 7.6 6.9 7.09 7.68 6.81 7.42 7.34 7.13 6.97 7.22 7.47 6.75 7.22
GOMF_TRANSLATION_INITIATION_FACTOR_BINDING 7.2 7.15 7.48 7.48 7.43 7.6 7.6 7.63 7.77 7.85 7.41 7.48 7.57 8.01 7.38 7.57 7.22 7.08 7.58 7.55 7.19 7.57 7.64 7.78 7.72 7.83
GOMF_PROTEIN_TAG 6.8 6.14 7.77 6.75 6.18 6.34 6.27 7.22 6.52 6.74 6.51 6.95 6.62 6.78 6.49 6.63 6.65 6.42 6.5 6.98 6.23 6.66 6.42 6.87 6.3 6.25
GOMF_CARBOXYLIC_ACID_BINDING 5.96 5.93 6 6.15 5.63 5.7 5.86 6.07 6 5.73 6.02 5.95 5.77 5.67 5.96 6 5.99 5.91 5.76 5.8 6.14 5.91 5.71 5.72 6.27 6.28
GOMF_L_ASCORBIC_ACID_BINDING 6.47 6.6 7.32 7.04 7.42 7.12 6.72 7 7.5 6.98 7.12 7.24 7.56 7.25 6.78 7.03 7.33 7.04 6.66 6.87 7.03 6.81 7.47 7.54 6.92 7.07
GOMF_ALKALI_METAL_ION_BINDING 7.15 7.28 6.49 6.03 6.71 6.89 6.52 6.44 6.64 6.62 6.52 6.65 6.34 6.72 6.55 6.47 6.84 6.61 6.64 6.28 6.55 6.49 6.54 6.68 6.73 7.06
GOMF_TITIN_BINDING 6.24 5.95 5.42 5.84 6.35 6.21 5.76 6.07 5.64 6.13 6.06 6.54 6.15 5.78 5.64 6.05 6.32 6.29 6.43 6 6.37 6.21 5.72 5.88 5.68 6.31
GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING 7.65 7.35 7.37 7.35 7.86 7.52 7.43 7.85 7.66 7.68 7.7 8.16 8.38 7.95 7.86 8.07 7.79 8.01 7.78 7.74 7.99 8.32 7.7 8 7.86 8.09
GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING 7.19 7.35 7.45 7.32 8.05 7.96 7.36 7.63 7.48 7.51 7.17 7.51 7.62 7.95 7.48 7.46 7.91 7.28 7.75 7.45 7.22 7.24 7.44 7.81 7.73 7.68
GOMF_MYOSIN_V_BINDING 7.8 8.01 8.23 7.66 7.36 8.06 8.16 8 8.47 8.49 7.96 8.08 7.73 7.84 8.81 8 7.74 8.37 7.8 7.79 7.96 7.58 8.59 8.31 7.47 7.58
GOMF_CHROMATIN_DNA_BINDING 6.92 6.82 7.03 6.85 7.29 7.27 7.4 7.31 6.95 7.32 7.09 7.32 7.21 7.19 7.08 7.07 7.43 7.02 7.17 7.32 7.31 7.19 7.21 7.59 7.3 7.25
GOMF_NUCLEOSOME_BINDING 7.1 7.12 7.38 7.31 7.48 7.73 7.57 7.43 7.38 7.64 7.38 7.43 7.51 7.46 7.36 7.53 7.66 7.14 7.39 7.49 7.41 7.56 7.83 8 7.54 7.55
GOMF_NUCLEOSOMAL_DNA_BINDING 7.31 7.25 7.35 7.26 7.39 7.73 7.5 7.43 7.3 7.38 7.19 7.41 7.45 7.19 7.13 7.65 7.68 7.12 7.36 7.34 7.4 7.82 7.15 7.72 7.71 7.92
GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING 7.01 6.87 6.68 7.08 7.06 7.23 6.81 6.79 6.87 7.1 6.89 7.07 7.14 7.16 6.78 6.76 6.88 6.86 7.11 6.99 6.77 6.91 7.15 7.03 6.87 7.03
GOMF_UBIQUITIN_CONJUGATING_ENZYME_BINDING 7.32 7.45 7.53 7.64 7.52 7.83 7.95 7.66 7.94 8.12 7.05 7.37 7.77 7.7 7.71 7.75 7.58 7.49 7.62 7.54 7.22 7.11 7.77 7.77 7.6 7.63
GOMF_G_PROTEIN_BETA_SUBUNIT_BINDING 6.52 6.22 7.74 7.38 7.07 7.16 7.1 7.16 7.27 7.2 7.28 7.13 7.4 7.03 7.41 7.22 7.82 7.54 7.23 7.56 7.1 7.71 7.27 7.27 7.65 7.92
GOMF_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING 9.04 8.76 8.46 8.45 9.1 9.04 8.96 9 8.99 9.07 8.41 9.25 9.08 9.31 9 8.95 9.06 8.75 8.9 9.12 8.84 8.46 9.23 9.43 8.84 8.84
GOMF_ADRENERGIC_RECEPTOR_BINDING 8.52 8.74 8.79 8.59 8.53 9.03 9.05 9.02 9.07 9.08 8.8 8.68 9.21 9.27 9.08 8.8 8.79 8.61 8.92 8.88 8.89 8.7 8.97 9.06 9.19 8.92
GOMF_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING 6.83 6.65 7.22 6.67 6.71 6.79 6.82 6.68 6.87 7.05 6.51 7.01 6.55 6.57 6.75 6.71 6.74 6.45 6.17 6.94 7.64 7.32 7.04 6.57 6.83 6.76
GOMF_THIOESTERASE_BINDING 6.08 5.7 5.92 5.64 5.98 6.01 5.92 6.16 5.69 5.86 6.23 5.86 6.21 6.54 6.11 6.23 5.98 6.17 5.47 5.55 5.8 6.17 5.55 5.74 6.29 5.94
GOMF_MYOSIN_HEAVY_CHAIN_BINDING 5.62 5.84 5.59 6.21 5.54 4.97 5.38 5.41 5.57 5.33 6.23 5.2 5.25 5.31 5.47 5.03 6.34 6.04 5.49 5.13 6.12 5.6 5.46 4.66 5.51 5.79
GOMF_BILE_ACID_BINDING 5.07 4.56 4.22 4.46 4.22 4.2 4.41 4.45 4.5 4.4 4.32 4.93 4.37 3.95 4.71 4.38 4.09 4.27 4.13 4.42 4.94 4.46 4.19 4.24 4.49 4.63
GOMF_UBIQUITIN_LIKE_PROTEIN_BINDING 7.4 7.47 8.08 7.93 7.67 7.86 7.81 7.74 7.87 7.78 7.54 7.84 7.8 7.7 7.92 7.81 7.66 7.4 7.68 7.84 7.5 7.75 7.89 8.06 7.78 7.7
GOMF_SUMO_BINDING 7.2 7.49 7.69 7.8 7.85 7.81 8.03 7.67 7.96 8.16 7.63 7.98 8.04 7.94 8.09 7.79 7.79 7 7.78 7.86 7.45 7.75 8.22 8.36 7.96 7.72
GOMF_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING 6.23 6.52 6.73 6.53 6.83 6.85 6.62 6.81 6.75 6.52 6.65 6.77 6.98 6.68 6.68 6.48 6.51 6.49 6.42 6.56 6.82 6.72 6.61 6.87 7.04 6.71
GOMF_OXIDIZED_DNA_BINDING 6.67 6.48 6.82 7.13 7.16 7.01 6.27 6.44 6.62 6.81 6.89 6.36 6.69 6.6 5.87 6.36 6.19 6.33 6.89 6.35 6.29 6.48 6.46 6.71 6.63 6.71
GOMF_MISMATCH_REPAIR_COMPLEX_BINDING 6.22 6.3 6.59 6.81 6.52 6.31 6.02 6.07 6.27 6.66 6.56 6.17 6.55 6.27 5.97 6.43 6.05 6.3 5.98 6.22 6.03 6.03 6.4 6.37 6.18 6.36
GOMF_DEMETHYLASE_ACTIVITY 6.68 6.55 6.41 6.74 7.09 6.97 6.67 6.87 6.81 6.69 6.54 6.74 7.07 6.94 6.9 6.8 6.83 6.53 6.77 6.85 6.66 6.81 6.76 7.12 6.81 6.93
GOMF_HISTONE_DEMETHYLASE_ACTIVITY_H3_K9_SPECIFIC 6.78 6.76 6.64 6.86 7.4 7.06 6.84 7.06 7.12 7.14 6.77 7.11 7.22 7.22 7.35 6.94 6.9 6.68 7.15 6.89 7 6.97 7.09 7.27 6.76 7.38
GOMF_RIBONUCLEOTIDE_BINDING 6.7 6.68 6.9 6.88 6.86 6.97 6.85 6.89 6.81 6.97 6.85 6.92 6.94 6.91 6.88 6.88 6.81 6.76 6.84 6.87 6.74 6.85 6.92 6.99 6.93 6.91
GOMF_GTPASE_ACTIVATING_PROTEIN_BINDING 8.29 8.26 7.69 7.52 8.59 8.68 8.28 8.46 8.12 8.46 8.02 8.63 8.49 8.46 8 8.47 8.53 7.91 8.36 8.55 7.91 8.22 8.51 8.54 8.42 8.68
GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING 5.5 5.56 5.59 5.82 5.29 5.48 5.41 5.37 5.52 5.43 5.74 5.75 5.6 5.61 5.51 5.49 5.5 5.5 5.41 5.42 5.58 5.8 5.36 5.4 5.4 5.68
GOMF_STEROL_BINDING 6.95 6.6 7 6.57 6.97 7.02 7.35 7.05 7.45 7.27 6.77 6.8 6.89 7.14 6.76 6.73 7.05 6.95 7.12 7.02 6.91 6.98 7.37 7.35 7.08 7.28
GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY 5.34 5.71 4.17 4.54 4.79 4.76 4.14 4.26 4.21 4.25 4.79 4.67 4.56 4.51 4.23 4.16 4.73 4.78 5.29 4.41 4.99 4.4 4.27 4.3 4.3 4.62
GOMF_ACETYLCHOLINE_RECEPTOR_BINDING 6.95 7.1 7.95 8.39 7.18 7.35 7.28 7 6.75 7.4 7.39 7.17 7.17 7.21 7.43 6.95 7.2 7.06 7.09 7.12 7.44 7.22 7.29 7.33 7.61 7.33
GOMF_RIBONUCLEASE_P_RNA_BINDING 6.12 5.82 7.02 6.68 5.93 6.6 6.82 6.52 6.49 6.13 6.11 6.16 5.96 6.01 6.13 6.33 5.91 5.87 6.04 6.49 5.82 6.25 6.58 6.38 6.43 5.98
GOMF_AMIDE_BINDING 6.59 6.56 7.08 6.93 6.74 6.74 6.8 6.84 6.89 6.74 6.83 6.73 6.82 6.76 6.76 6.81 6.76 6.72 6.68 6.8 6.78 6.75 6.86 6.79 6.74 6.87
GOMF_MONOCARBOXYLIC_ACID_BINDING 5.96 5.61 6.16 6.28 5.33 5.24 5.69 5.84 5.91 5.49 5.72 5.82 5.75 5.55 5.87 6.06 5.74 6.09 5.61 5.65 6.32 6.21 5.52 5.34 6.26 6.45
GOMF_MAP_KINASE_PHOSPHATASE_ACTIVITY 6.11 6.07 6.12 7.09 6.18 6.23 5.95 6.26 6.91 6.23 6.33 6.09 6.97 6.84 6.05 6.19 5.77 5.84 6.35 6.27 5.97 6.15 6.52 6.83 6.32 6.23
GOMF_PROTEIN_DEACETYLASE_ACTIVITY 6.83 6.6 7.35 7.66 7.22 7.31 6.95 6.81 7.12 7.38 7.07 7.22 7.24 7.14 6.85 7.22 6.84 6.81 6.99 6.97 6.98 6.86 7.51 7.4 6.78 7.08
GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING 5.15 5.28 5.94 5.83 5.27 5.22 5.62 5.41 5.37 5.14 5.82 5.16 5.33 5.22 5.45 5.08 5.41 5.46 5.13 5.06 5.79 5.94 5.41 5.58 5.39 5.49
GOMF_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING 6.8 6.68 7.29 7.13 6.96 6.87 7.04 6.93 7.1 7.11 6.79 6.86 7.38 7.22 7.15 7.22 6.96 6.91 6.96 7.04 7.15 7.39 7.01 7.05 6.82 7.42
GOMF_SIALIC_ACID_BINDING 5 4.98 5.1 4.89 4.38 4.23 4.89 4.72 4.73 4.25 4.61 4.53 4.57 4.36 4.91 4.64 4.71 4.98 4.58 4.57 4.85 4.75 4.55 4.34 4.99 4.89
GOMF_DNA_POLYMERASE_ACTIVITY 5.85 5.88 6.16 6.37 5.86 6.07 5.98 6.11 5.99 6.22 6 6.05 5.97 5.8 6 6.12 5.78 5.8 5.92 5.75 5.95 6.19 6.09 6.37 6.07 6.24
GOMF_APOLIPOPROTEIN_BINDING 6.67 6.7 6.98 6.75 7.26 7.2 6.95 7.34 6.97 7.06 7.03 7.24 7.09 7.01 6.76 6.84 6.69 6.94 6.93 7.07 6.95 7.22 6.86 7.24 6.42 6.73
GOMF_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY 7.5 7.66 7.76 7.86 7.81 7.73 7.69 7.86 7.64 7.88 7.55 7.63 7.68 7.8 7.76 7.86 7.94 7.51 7.41 7.71 7.48 8.01 7.98 7.84 8.02 7.85
GOMF_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING 8.98 9.09 9.1 8.96 9.36 9.54 9.33 8.93 9.4 9.4 9.21 9.27 9.61 9.58 9.47 9.44 8.79 9.01 9.29 9.19 8.77 9.1 9.52 9.47 9.2 8.83
GOMF_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING 8.21 8.3 8.1 7.77 8.45 8.47 8.33 8.5 8.55 8.45 8.35 8.32 8.52 8.39 8.6 8.35 8.3 8.23 8.41 8.41 8.02 8.17 8.61 8.81 8.72 8.52
GOMF_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY 8.46 8.53 8.7 8.67 8.61 9.05 8.81 8.91 9.03 8.92 8.51 8.83 8.91 8.98 8.89 8.94 8.63 8.75 8.75 8.94 8.38 9 8.93 9.05 8.73 8.79
GOMF_DYNACTIN_BINDING 7.35 6.95 7.85 7.5 7.53 7.48 7.45 7.34 7.28 7.74 7.57 7.56 7.55 7.51 7.66 7.94 7.46 7.65 7.1 7.61 7.3 7.66 7.43 7.8 7.51 7.69
GOMF_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY 6.87 7.5 6.75 6.82 7.09 7.5 7.39 7.63 7.27 7.41 6.97 7.09 7.31 7.33 7.57 6.9 6.81 7.3 7.37 7.01 6.72 7.32 7.04 7.36 7.21 6.52
GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY 7.35 7.58 7.52 7.62 7.59 8.06 7.74 7.64 7.76 7.97 7.48 7.72 8.04 7.81 7.51 7.64 7.59 7.49 7.75 7.61 7.44 7.81 8.08 8.16 7.94 7.74
GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY 6.94 7.13 6.83 7.56 7.34 7.35 7.57 7.61 7.6 7.74 7.4 7.43 7.62 7.51 7.48 7.36 7.44 7.12 7.28 7.49 7.25 7.55 7.75 7.98 7.53 7.65
GOMF_NAD_DEPENDENT_PROTEIN_DEACETYLASE_ACTIVITY 6.83 6.6 7.47 7.7 7.22 7.57 7.19 7.11 7.24 7.46 7.07 7.33 7.29 7.14 7.21 7.44 7.73 6.81 6.99 7.25 7.28 6.96 7.52 7.45 6.78 7.13
GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY 7.59 7.42 7.46 8.57 8.06 7.66 7.28 7.31 7.96 8.12 7.52 7.9 7.8 7.91 7.77 7.62 7.85 7.26 7.85 7.55 7.21 7.41 8.15 7.9 7.82 7.81
GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY 6.02 6.2 6.1 5.96 5.89 6.2 6.01 6.1 6.08 5.64 6.09 6.02 5.77 6.24 6.15 5.69 5.39 6.14 6.45 6.33 5.62 5.87 6.36 6.34 6.11 6.1
GOMF_HISTONE_ACETYLTRANSFERASE_BINDING 7.36 7.92 8.25 8.01 8.43 8.38 7.96 7.75 8.45 8.33 8.14 8.16 8.48 8.35 8.08 8.16 8.08 7.46 7.28 8.05 7.9 8.39 8.48 8.45 8.36 8.27
GOMF_METHYLATED_HISTONE_BINDING 6.43 6.46 6.62 6.87 6.57 6.79 6.58 6.55 6.55 6.84 6.64 6.86 6.71 6.74 6.77 6.54 6.46 6.43 6.73 6.82 6.63 6.78 6.87 6.89 6.64 6.67
GOMF_PHOSPHATIDYLINOSITOL_BINDING 7.01 6.93 7.13 7.03 7.31 7.23 7.17 7.2 7.13 7.2 6.99 7.23 7.29 7.34 7.34 7.18 7.09 7 7.2 7.12 7.05 7.17 7.41 7.47 7.23 7.2
GOMF_HISTONE_KINASE_ACTIVITY 6.73 6.77 7.35 7.61 6.97 7.2 6.92 7.07 7.25 7.41 7.37 7.68 7.19 7.11 7.35 7.16 7.18 6.92 6.84 7.07 7 7.36 7.75 7.69 7.64 7.3
GOMF_MIRNA_BINDING 6.82 6.97 6.92 7.42 7.18 7.51 7.13 7.55 7.14 7.46 7.14 7.52 7.38 7.23 7.43 7.45 7.45 7.01 7.16 7.11 7.29 7.31 7.23 7.33 7.17 7.11
GOMF_UDP_GALACTOSYLTRANSFERASE_ACTIVITY 6.73 6.84 7.07 6.81 7.4 7.5 7.04 6.97 7.24 7.17 7 7.03 7.51 7.41 6.87 6.86 7.07 6.86 7.22 7.21 6.85 6.64 6.97 7.45 6.71 7.02
GOMF_GLUTAMATE_RECEPTOR_BINDING 8.42 8.58 8.88 8.22 8.95 9.23 9.12 8.9 9.09 9.18 8.87 8.96 8.94 9.16 9 8.95 8.43 8.67 8.99 9.16 8.52 8.65 8.86 9.18 8.91 8.58
GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING 8.46 8.74 9.04 8.16 9.29 9.62 9.24 8.91 9.27 9.32 9.2 8.92 8.92 9.07 8.92 8.64 8.53 9 9.11 9.27 8.52 8.55 8.87 9.18 8.92 8.55
GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING 8.02 8.44 8.73 8.55 8.95 9.23 9.13 8.95 8.59 9.18 8.87 9.05 9.48 9.58 9.37 9.04 8.45 8.54 9.09 9.26 8.66 9.09 9 9.31 8.97 8.73
GOMF_NUCLEAR_HORMONE_RECEPTOR_BINDING 7.13 7.19 7.15 7.27 7.38 7.24 7.39 7.45 7.37 7.35 7.2 7.32 7.4 7.37 7.53 7.48 7.27 7.25 7.3 7.47 7.4 7.55 7.38 7.52 7.52 7.57
GOMF_STEROID_HORMONE_RECEPTOR_BINDING 7.31 7.52 7.46 7.31 7.61 7.57 7.45 7.45 7.47 7.56 7.2 7.37 7.45 7.55 7.68 7.53 7.47 7.27 7.51 7.57 7.5 7.65 7.5 7.52 7.52 7.63
GOMF_GLUCOCORTICOID_RECEPTOR_BINDING 7.57 7.76 8.03 7.48 7.96 7.57 8.11 7.84 7.95 8 7.75 7.77 7.82 7.81 8.25 7.93 7.83 7.82 7.66 8.09 8.01 8.26 7.97 7.9 8.13 8
GOMF_TOLL_LIKE_RECEPTOR_BINDING 5.38 5.2 5.13 5.43 4.92 4.93 4.5 4.96 5.36 4.98 5.11 4.73 4.92 4.7 5.59 5.73 5.08 5.42 5.35 4.77 6.13 5.94 4.79 5.02 6.03 6.07
GOMF_CAMP_RESPONSE_ELEMENT_BINDING 7.54 7.45 7.05 7.39 8.22 8.15 7.76 8.28 7.76 7.7 6.94 7.71 7.91 7.4 7.27 7.51 7.42 6.68 7.2 8.08 7.52 7.58 7.43 7.7 7.92 8.14
GOMF_SIGNALING_ADAPTOR_ACTIVITY 6.94 6.89 7.29 6.85 6.91 6.88 6.97 7.38 6.96 7.14 7.16 6.89 6.95 7.04 7.02 7.14 6.96 7.18 7.02 6.92 7.15 7.04 7.04 6.99 7.07 7.1
GOMF_RNA_STEM_LOOP_BINDING 7.79 7.88 8.17 7.56 8.49 8.45 8.59 8.48 8.77 8.67 8.08 8.41 8.43 8.45 8.41 8.8 7.96 7.35 8.13 8.64 8.34 8.21 8.55 8.78 8.88 8.83
GOMF_MRNA_3_UTR_AU_RICH_REGION_BINDING 7.59 7.69 7.86 7.73 7.47 7.82 7.73 7.84 7.73 7.83 7.36 7.82 7.54 7.67 7.89 7.65 7.72 7.55 7.8 7.85 7.6 8.17 7.4 7.64 7.78 7.8
GOMF_PRE_MRNA_BINDING 7.89 7.91 8.26 7.92 7.99 8.64 8.33 8.52 8.17 8.35 7.74 8.56 8.4 8.14 8.51 8.38 8.14 8.23 8.26 8.31 8.02 8.54 8.48 8.7 8.62 8.59
GOMF_LONG_CHAIN_FATTY_ACID_BINDING 5.84 4.79 5.27 6.28 4.51 4.29 4.24 5.12 4.98 4.71 5.13 4.41 4.52 4.83 5.22 5.55 5.52 5.81 5.17 5.03 6.01 5.74 4.74 4.16 5.22 5.4
GOMF_BMP_BINDING 4.87 4.61 4.71 5.44 4.43 4.51 4.63 5.53 4.86 4.85 5.05 4.75 4.72 4.75 5.76 4.68 4.73 4.65 4.65 4.82 4.88 4.79 4.8 4.49 4.53 4.58
GOMF_CARGO_RECEPTOR_ACTIVITY 5.65 5.3 5.31 5.49 5.15 5.03 5.18 5.1 5.21 4.98 5.17 5.01 5.12 5.07 5.1 5.3 5.19 5.28 5.1 4.93 5.33 5.19 5.02 4.82 5.15 5.21
GOMF_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY 4.98 5 4.79 5.03 4.54 4.71 4.67 4.88 4.67 4.55 4.86 4.61 4.76 4.72 4.72 4.89 4.83 5.08 4.9 4.83 5.08 4.71 4.37 4.53 5.25 5.15
GOMF_CO_RECEPTOR_BINDING 4.96 4.72 4.75 4.86 4.41 4.24 4.61 4.68 4.72 4.07 4.72 4.45 4.25 4.26 4.46 4.26 4.36 4.64 4.55 4.55 4.54 4.41 4.4 4.12 4.36 4.34
GOMF_NEUREXIN_FAMILY_PROTEIN_BINDING 8.25 8.59 8.05 7.01 8.76 9.08 8.59 7.87 8.3 8.06 8.15 7.99 8.66 8.83 8.23 8.31 8.45 8.45 8.84 8.61 6.92 7 8.39 8.87 8.19 7.5
GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY 6.6 6.68 6.65 6.87 6.9 7.13 6.69 6.9 6.76 6.82 6.74 6.97 6.85 6.85 7.14 7.13 6.86 6.62 7.04 6.78 6.69 7.05 6.99 7.05 6.85 7.06
GOMF_CHEMOATTRACTANT_ACTIVITY 5.77 5.51 5.23 5.43 4.9 4.73 5.54 5.79 5.16 5.27 5.48 5.25 5.1 5.15 5.56 5.41 5.44 5.68 5.17 5.17 5.74 5.65 5.03 5.04 5.45 5.61
GOMF_TELOMERIC_DNA_BINDING 7.5 7.71 7.73 7.46 7.75 7.81 7.76 7.58 7.82 7.9 7.54 7.88 7.79 7.69 7.79 7.59 7.6 7.32 7.7 7.86 7.77 7.6 7.88 8.22 7.98 7.86
GOMF_NEUROTRANSMITTER_BINDING 5.93 6.05 6.05 6.61 6.03 6.68 6.09 5.8 6.02 5.64 5.75 5.61 5.91 5.39 5.85 5.69 6.37 6.7 5.85 6.36 6.2 5.85 5.53 5.73 6.27 5.63
GOMF_ACETYLCHOLINE_BINDING 5.64 5.6 5.01 6.29 5.27 5.3 5.76 5.5 5.69 5.17 5.22 5.4 5.34 5.19 5.54 5.15 5.49 5.81 5.44 4.96 5.78 5.61 4.95 5.24 5.06 4.86
GOMF_SH2_DOMAIN_BINDING 6.54 6.55 6.3 6.25 6.86 6.65 6.35 6.73 6.68 6.54 6.07 6.62 6.6 6.73 6.6 6.38 6.44 6.69 6.54 6.6 6.24 6.56 6.65 6.61 6.53 6.39
GOMF_LYSOPHOSPHATIDIC_ACID_ACYLTRANSFERASE_ACTIVITY 7.28 7.36 8.05 7.76 7.73 7.66 7.61 7.32 7.96 7.61 7.56 7.28 7.61 7.48 7.69 7.68 7.22 7.37 7.34 7.52 7.39 8.02 7.82 8.09 7.85 7.71
GOMF_PEPTIDE_BINDING 6.57 6.56 6.99 6.88 6.71 6.66 6.8 6.63 6.89 6.72 6.77 6.68 6.72 6.66 6.69 6.76 6.64 6.59 6.63 6.78 6.53 6.66 6.87 6.77 6.65 6.75
GOMF_MHC_PROTEIN_BINDING 6.06 5.97 6.11 5.76 5.81 5.97 5.53 5.48 5.82 5.85 5.98 5.42 5.84 6.2 5.59 6.12 5.75 5.7 5.56 5.55 5.93 6.32 5.7 5.42 5.89 6.21
GOMF_MHC_CLASS_I_PROTEIN_BINDING 6.54 6.65 6.43 6.92 6.6 6.43 6.51 6.34 6.07 6.46 7.3 6.51 6.4 6.53 5.99 6.88 7.01 6.65 6.43 6.46 6.49 6.9 6.38 6.19 6.66 6.85
GOMF_PHOSPHATE_ION_BINDING 5.82 5.54 6.06 6.09 5.35 5.66 5.86 4.94 5.51 5.18 6.38 5.01 5.67 5.74 5.07 5.31 5.37 6.23 5.64 5.69 5.33 4.8 5.96 6.47 6.9 6.75
GOMF_CHEMOKINE_RECEPTOR_BINDING 5.07 4.94 4.73 4.92 4.22 4.09 4.56 4.5 4.61 4.29 4.69 4.57 4.41 4.34 4.5 4.29 4.86 5.07 4.47 4.21 4.83 4.56 4.28 4.15 4.45 4.44
GOMF_HISTONE_BINDING 6.67 6.78 6.79 6.87 6.93 7.04 6.96 6.94 7.07 7.05 6.89 7.12 7.07 6.96 7.12 7.09 6.9 6.81 6.93 6.93 6.95 7.18 7.13 7.24 6.99 7.09
GOMF_HORMONE_BINDING 5.98 5.96 6.27 6.07 5.51 5.59 6 5.86 5.7 5.92 5.87 5.64 5.75 5.69 5.86 5.59 5.83 5.71 5.92 5.9 5.87 5.61 5.64 5.48 5.6 5.84
GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY 6.84 6.91 7.05 6.99 7.12 7.07 7.01 7.08 7.08 7.02 7.01 7.06 7.17 7.18 6.99 7.07 7.1 6.9 6.97 7.03 6.91 6.99 7.09 7.21 7.03 7.03
GOMF_PEPTIDE_ANTIGEN_BINDING 7.27 7.75 7.36 7.29 7.38 6.82 8.23 7.58 7.34 6.72 6.95 6.69 7.21 6.83 6.67 7.08 7.98 7.88 6.94 8.06 7.49 6.95 7.03 6.96 6.69 7.38
GOMF_T_CELL_RECEPTOR_BINDING 5.03 4.79 4.64 4.88 4.76 4.78 5.15 5.21 4.86 4.79 5.03 4.55 4.86 4.69 4.76 4.83 5.27 5.49 5.2 5.06 4.94 5.09 4.72 4.42 4.66 4.94
GOMF_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.65 7.84 7.85 7.62 7.62 7.97 7.91 7.84 7.88 7.81 7.38 7.89 7.72 7.9 7.89 7.66 7.79 7.71 7.72 8.16 7.62 7.73 8.26 8.16 7.69 7.58
GOMF_IDENTICAL_PROTEIN_BINDING 6.49 6.5 6.76 6.7 6.59 6.65 6.71 6.73 6.69 6.68 6.64 6.65 6.7 6.67 6.65 6.67 6.64 6.57 6.57 6.71 6.66 6.74 6.83 6.78 6.76 6.76
GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY 6.68 6.58 6.88 6.84 6.77 6.91 6.93 6.87 6.96 7.01 6.83 6.95 6.98 7.03 6.83 6.82 6.8 6.66 6.83 7 6.78 6.89 7.08 7.09 7.04 6.94
GOMF_ACTININ_BINDING 5.79 5.54 5.87 5.98 5.69 5.51 5.68 5.88 5.54 5.72 5.88 5.53 5.61 5.5 5.79 5.83 5.9 5.95 5.9 5.63 5.85 6 5.85 5.28 5.7 5.93
GOMF_VITAMIN_D_RECEPTOR_BINDING 6.96 7.08 7.35 7.34 7.44 7.33 7.84 7.81 7.36 7.35 7.32 7.81 7.66 7.4 7.79 7.51 7.46 7.44 7.43 8 7.56 7.48 7.56 7.67 7.85 7.74
GOMF_WNT_ACTIVATED_RECEPTOR_ACTIVITY 5.97 5.93 5.54 6.14 5.8 5.65 5.71 5.8 6.08 5.67 5.94 5.96 6.06 5.99 5.72 5.88 6.14 5.77 6 5.9 6.12 5.86 6.1 5.78 5.79 5.94
GOMF_HISTONE_DEACETYLASE_BINDING 6.9 7.09 7.02 6.85 7.27 7.29 7.26 7.3 7.11 7.11 7.11 7.16 7.15 7.14 6.95 7.32 7.31 7.01 7.02 7.32 7.07 7.16 7.23 7.38 7.16 7.35
GOMF_PEPTIDOGLYCAN_BINDING 4.76 4.67 4.61 4.3 4.3 4.21 4.46 4.54 4.52 4.17 4.54 4.33 4.12 4.28 4.2 4.23 4.53 4.59 4.28 4.35 4.53 4.39 4.23 4.12 4.24 4.28
GOMF_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.46 6.75 6.99 6.98 6.66 6.73 6.73 7.01 6.87 6.62 7.11 6.77 6.49 6.5 6.83 7.07 7.05 6.58 6.58 6.64 6.73 6.77 6.54 6.84 6.7 6.9
GOMF_XENOBIOTIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.09 6.04 5.72 5.88 5.73 5.63 6.02 5.98 5.89 6.1 5.64 5.57 5.88 6.01 5.71 5.84 5.84 5.94 5.76 6.11 6.21 6.14 5.83 5.53 5.87 5.77
GOMF_NEUROPEPTIDE_BINDING 5.51 5.38 5.27 5.39 4.72 4.92 5.07 5.06 5.23 5.18 5.63 5.12 5.05 4.97 5.15 5.18 5.1 5.29 4.89 5.18 5.29 5 5.22 5.12 5.08 5.38
GOMF_RETINOIC_ACID_RECEPTOR_BINDING 6.48 6.71 6.96 7 7.01 7.07 6.81 6.94 6.75 7.04 6.66 7.18 6.97 6.96 7.28 6.81 6.91 6.49 6.61 6.85 6.69 7.05 7.05 6.91 6.97 7.01
GOMF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING 6.13 6.65 6.88 6.62 7.01 6.7 6.72 6.85 6.62 6.9 6.64 6.79 6.78 6.64 7.09 6.73 6.91 6.67 6.61 6.58 6.68 7.05 6.95 6.91 6.86 6.87
GOMF_ALPHA_TUBULIN_BINDING 7.22 7.01 8.01 7.94 7.32 7.33 7.51 7.26 7.24 7.7 7.95 7.8 7.91 7.8 7.45 7.79 7.2 6.91 7.84 7.45 7.32 7.63 7.76 7.83 7.58 7.79
GOMF_GAMMA_TUBULIN_BINDING 6.91 6.93 7.14 7.03 7.09 7.12 7.2 6.83 7.01 6.99 6.73 6.97 6.95 7 6.92 6.84 6.69 6.66 6.78 6.87 6.79 6.95 7.05 7.22 6.95 6.8
GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING 7.45 7.55 8.05 7.85 7.75 7.61 7.86 7.91 7.87 7.87 7.75 7.68 7.83 7.84 7.89 8.05 7.47 7.29 7.64 7.69 7.45 7.75 8.04 8 8.16 7.82
GOMF_RIBOSOME_BINDING 7.65 7.83 8.29 8.21 8.35 8.3 8.48 8.12 8.45 8.4 8.15 8.23 8.53 8.47 8.49 8.43 8.17 7.85 7.88 8.28 7.82 8.26 8.4 8.43 8.41 8.2
GOMF_RIBOSOMAL_LARGE_SUBUNIT_BINDING 7.34 7.69 7.08 7.74 7.82 7.82 7.82 8.05 7.92 7.93 7.51 7.57 7.6 7.43 7.92 7.85 7.2 7 7.66 7.62 7.6 7.83 8.17 7.95 7.99 7.7
GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING 7.67 7.24 8.17 7.65 8.28 7.45 7.84 7.82 7.79 8.02 8.02 7.85 8.32 8.15 8.38 8.16 7.58 7.48 7.68 7.86 7.45 8.28 7.86 8.14 8.43 8
GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS 6.25 6.12 6.33 6.46 5.17 5.86 6.26 6.19 6.25 6.07 5.72 6.19 6.14 6.01 5.74 5.57 6 5.63 5.67 6.28 6.11 6.05 5.94 5.59 5.89 6.15
GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS 5.49 5.58 5.72 6.02 5.19 5.36 5.49 5.34 5.62 5.32 5.5 5.32 5.57 5.56 5.59 5.18 5.78 5.52 5.43 5.56 5.71 5.78 5.56 5.26 5.31 5.17
GOMF_UBIQUITIN_BINDING 7.42 7.48 8.09 7.96 7.69 7.93 7.82 7.9 7.91 7.71 7.59 8.01 7.83 7.72 7.99 7.82 7.66 7.51 7.69 7.95 7.66 7.76 7.89 8.07 7.82 7.74
GOMF_3_5_DNA_HELICASE_ACTIVITY 6.18 6.19 6.04 6.46 6.11 5.96 6.08 6.06 5.95 6.27 6.04 6.09 6.13 5.96 5.97 6.06 6.06 5.92 6.14 5.97 6.12 6.02 6.28 6.25 5.96 6.32
GOMF_RNA_POLYMERASE_CORE_ENZYME_BINDING 6.77 7.07 7.55 7.61 7.32 7.61 7.25 7.45 7.45 7.31 6.95 7.49 7.48 7.51 7.56 7.31 7.1 7.15 7.13 7.54 7.33 7.59 7.66 7.84 7.54 7.62
GOMF_AMINE_BINDING 5.85 5.91 5.86 5.43 5.2 6.02 6.07 6.08 5.83 5.94 5.54 5.47 5.99 5.85 6.37 5.61 5.59 6.17 5.67 5.84 6.26 5.72 5.65 5.93 5.8 5.33
GOMF_ORGANIC_ACID_BINDING 6.16 6.16 6.4 6.37 5.99 5.92 6.26 6.13 6.25 6.21 6.19 6.18 6.2 6.04 6.42 6.19 6.22 6.1 5.89 6.11 6.4 6.39 6.21 5.94 6.62 6.47
GOMF_ALCOHOL_BINDING 6.6 6.12 6.37 6.35 6.49 6.38 6.34 6.51 6.4 6.41 6.48 6.11 6.39 6.33 6.18 6.2 6.39 6.52 6.48 6.19 6.43 6.5 6.21 6.41 6.51 6.58
GOMF_GLYCOSPHINGOLIPID_BINDING 6.39 6.34 6.3 7.19 6.48 6.29 6.38 6.73 6.51 5.96 5.56 6.07 6.07 6.23 6.57 6.22 6.95 6.3 6.2 6.25 6.37 6.07 5.91 6.08 6.33 6.18
GOMF_LAMININ_BINDING 6.42 6.24 6.28 6.33 6.06 5.96 6.55 6.42 6.33 6.2 6.29 6.28 6.37 6.31 6.3 6.39 6.14 6.4 6.03 6.25 6.42 6.39 6.67 6.38 6.62 6.47
GOMF_PHOSPHOLIPASE_BINDING 6.32 6.57 5.72 7.17 5.97 5.65 6.03 5.85 5.82 6.16 6.09 5.75 5.66 5.66 5.8 5.76 6.21 6.13 5.91 5.54 5.88 6.09 5.51 5.55 6.1 5.75
GOMF_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING 6.23 5.98 6.15 5.94 6.62 6.46 6.11 6.25 6.38 6.32 6 6.6 6.43 6.43 5.9 6.3 6.37 6.22 6.36 6.23 6.6 6.53 6.13 6.43 6.03 6.37
GOMF_PROTEOGLYCAN_BINDING 6.35 6.06 5.56 5.72 5.94 6.2 5.7 5.78 5.75 6.03 5.56 5.39 5.52 5.58 5.4 5.78 5.79 5.64 5.49 5.65 6.02 6.11 6.24 5.42 5.71 5.84
GOMF_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING 6.37 6.28 5.63 5.81 6.82 6.33 5.77 5.98 5.91 6.1 6.13 6 5.7 5.81 5.69 5.96 6.21 5.8 6 6.04 5.73 6.01 6.03 5.92 5.77 5.91
GOMF_PROTEIN_KINASE_B_BINDING 7.31 7.35 7.82 8.5 8.24 8.43 8.4 7.8 7.93 8.12 7.05 7.31 7.99 7.9 8.22 7.36 8.03 7.08 8.07 7.64 7.5 7.04 8.23 8.4 7.79 7.6
GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING 6.38 6.39 6.63 6.51 6.92 6.66 6.95 6.88 6.89 6.97 6.64 6.92 6.8 7.05 6.83 6.61 6.59 6.41 6.62 6.71 6.69 6.8 7.22 7.27 7.16 6.77
GOMF_PROTEIN_MEMBRANE_ADAPTOR_ACTIVITY 6.82 6.86 6.99 6.8 7.05 7.01 7.07 7.43 7.03 6.44 6.51 7.06 7 6.89 6.75 6.62 7.17 6.11 6.21 7.13 7.68 7.55 6.75 6.96 7.53 7.45
GOMF_LEUCINE_ZIPPER_DOMAIN_BINDING 6.34 7.3 7.98 7.82 6.78 7.19 6.8 7.52 7.27 7.31 6.7 7.1 7.03 7.25 6.71 7.01 6.62 6.93 7.08 7.38 7.22 7.48 7.62 7.92 7.41 6.78
GOMF_ADP_BINDING 7.04 7.16 7.29 7 7.46 7.42 7.56 7.63 7.57 7.69 7.62 7.58 7.47 7.4 7.77 7.47 7.4 7.22 7.47 7.56 7.51 7.51 7.82 8.11 7.65 7.5
GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY 7.18 7.48 8.08 7.53 8.14 8.07 7.99 8.19 7.68 8.32 8.05 8.04 8.11 7.91 7.96 8.16 7.82 7.61 7.8 7.83 8.2 8.21 8.17 8.4 8.15 7.98
GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING 7.09 7.35 7.41 7.51 7.49 7.5 7.81 7.66 7.66 7.3 7.44 7.89 7.62 7.75 7.77 7.37 7.68 7.46 7.49 7.63 7.93 7.92 7.67 7.79 7.92 7.64
GOMF_INSULIN_RECEPTOR_SUBSTRATE_BINDING 7.77 7.84 7.85 7.99 8.15 8.25 8.46 8.08 8.37 8.21 8.04 8.21 8.41 8.33 8.26 8.34 7.57 7.71 8.2 8.35 7.92 8.19 8.44 8.61 8.36 8.03
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING 5.95 5.92 5.9 6 5.77 5.81 5.8 5.9 5.9 5.85 5.93 5.84 5.96 5.88 5.92 5.85 5.9 5.92 5.82 5.83 5.91 5.91 5.85 5.87 5.86 5.92
GOMF_PROTEIN_SELF_ASSOCIATION 6.42 6.09 6.87 6.76 6.07 6.35 6.24 6.52 5.99 6.3 6.39 6.54 6.2 6.14 6.27 6.21 6.24 6.48 6.18 6.37 6.32 6.59 6.23 6.24 6.42 6.65
GOMF_CYCLIC_NUCLEOTIDE_GATED_ION_CHANNEL_ACTIVITY 5.09 4.87 4.91 5.16 4.58 4.43 4.89 4.67 4.83 4.75 4.73 4.67 4.65 4.48 4.68 4.49 4.84 5.04 4.59 4.67 4.99 4.74 4.47 4.31 4.7 4.5
GOMF_PROTEIN_FOLDING_CHAPERONE 8.1 8.2 9.52 9.15 8.7 8.5 8.91 8.95 8.92 8.9 8.59 8.46 8.75 9.04 8.95 9.45 8.66 8.4 8.69 8.89 8.68 8.89 9.15 9.15 8.77 8.29
GOMF_ION_CHANNEL_BINDING 7.46 7.58 7.78 7.44 8.05 7.99 7.99 7.92 7.86 7.96 7.95 8.07 7.94 8.04 8.03 8.12 7.76 7.81 7.96 7.86 7.74 7.82 8.08 8.26 7.93 7.64
GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING 7.28 7.35 8.01 7.68 7.71 7.77 7.65 7.73 7.7 7.79 7.6 7.67 7.9 7.95 7.81 7.65 7.47 7.42 7.61 7.82 7.42 7.72 7.87 7.99 7.77 7.74
GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING 7.32 7.45 7.53 7.64 7.67 8.09 7.95 7.66 7.94 8.12 7.7 7.51 7.94 7.75 7.71 7.75 7.58 7.32 7.67 7.54 7.22 7.48 7.77 7.77 7.79 7.64
GOMF_S100_PROTEIN_BINDING 6.87 6.42 7.16 7.12 6.91 7.18 6.62 7.03 7.03 7.57 7.55 7.15 7.43 7.06 7.55 7.19 6.78 6.69 7.37 7.2 8.32 7.91 7.35 7.72 6.8 6.82
GOMF_ATPASE_ACTIVITY_COUPLED_TO_TRANSMEMBRANE_MOVEMENT_OF_IONS_ROTATIONAL_MECHANISM 8.6 8.58 9.43 8.81 9.06 9.06 9.38 8.94 9.11 9.2 9.36 9.11 9.27 9.23 9.31 9.16 8.39 8.39 9.03 9.23 8.56 9.04 9.27 9.42 8.96 8.44
GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING 6.65 6.64 6.88 6.84 6.92 6.9 6.94 6.93 6.93 6.98 6.76 6.89 6.95 6.93 6.91 6.98 6.8 6.76 6.73 6.94 6.92 6.96 7 7.02 7 7.03
GOMF_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY 5.14 5.08 4.66 5.02 5.81 5.82 4.9 5.16 4.98 5.04 5.17 4.79 5.43 5.3 5.29 5.29 5.18 5.04 5.07 5.59 5.23 5.18 5.54 5.37 5.23 5.46
GOMF_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY 5.46 5.48 5.71 5.72 5.44 5.65 5.74 5.98 5.49 5.82 5.56 5.45 5.93 5.82 6.2 5.9 5.72 5.77 5.48 5.5 5.89 5.72 5.58 5.2 5.69 5.84
GOMF_MYOSIN_II_BINDING 7.07 6.96 7.58 7.01 7.74 7.42 7.21 7.42 7.05 7.16 7.2 7.1 6.97 6.97 7 6.8 6.9 7.01 6.65 7.2 7 7.17 7.18 7.12 6.97 7.14
GOMF_TRANSLATION_REGULATOR_ACTIVITY 7.32 7.29 7.95 7.56 7.58 7.82 7.8 7.82 7.87 7.91 7.74 7.69 8 7.95 8.02 7.95 7.68 7.48 7.61 7.72 7.44 7.84 7.88 7.88 8.1 7.83
GOMF_CXCR_CHEMOKINE_RECEPTOR_BINDING 5.71 5.52 5.52 5.5 4.92 4.62 4.76 4.74 4.65 4.41 5.38 5.05 4.75 4.85 4.52 4.63 6.09 5.82 4.74 4.61 5.75 5.44 4.52 4.02 4.55 4.73
GOMF_GAMMA_CATENIN_BINDING 7.42 7.8 6.93 6.51 7.94 8.15 7.57 7.93 7.58 7.48 7.31 7.39 7.88 7.68 7.45 7.42 7.66 7.5 7.33 7.58 7.66 7.85 7.55 7.55 7.52 7.64
GOMF_CADHERIN_BINDING 7.46 7.51 7.78 7.52 7.86 7.9 7.91 7.87 7.85 7.86 7.71 8.01 7.94 7.99 7.86 7.86 7.74 7.59 7.72 7.96 7.7 7.91 7.86 8 7.98 7.91
GOMF_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING 6.9 7.2 7.12 7.08 7.24 7.21 7.28 7.31 6.93 7.14 7.19 7.24 7.46 7.44 7.03 6.8 7.07 7.26 7.11 7.08 6.96 7.04 6.92 7.01 7.12 7.35
GOMF_CHEMOREPELLENT_ACTIVITY 6.51 6.43 6.94 6.49 7.08 7.18 6.99 7.1 7.11 7.24 6.84 7.05 6.88 6.9 7.04 6.62 6.8 6.48 6.52 7.29 6.72 6.51 7.23 7.06 6.89 6.84
GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING 5.41 5.63 5.19 5.36 5.64 5.61 5.49 5.42 5.16 5.96 5.48 5.73 5.6 5.28 5.61 6.04 5.8 6.03 5.52 5.53 5.76 5.54 4.96 5.16 5.38 5.66
GOMF_SMAD_BINDING 7.53 7.52 7.58 7.4 7.67 7.6 7.48 7.58 7.77 7.51 7.47 7.44 7.85 8.02 7.63 7.93 7.45 7.57 7.73 7.8 7.46 7.63 8.08 8.05 8.02 7.92
GOMF_GLUCOSYLTRANSFERASE_ACTIVITY 6.43 6.62 7.16 6.88 7.11 7.03 6.82 6.84 6.85 6.65 7.07 7.16 6.98 6.91 6.84 6.63 6.69 6.4 6.81 7.16 6.72 6.64 6.99 7.09 6.71 6.73
GOMF_SPHINGOLIPID_TRANSPORTER_ACTIVITY 6.59 6.54 6.4 6.41 7.14 6.98 6.48 6.18 6.61 6.63 6.55 6.14 6.47 6.92 6.02 6.31 6.37 6.58 6.45 6.29 6.52 6.29 6.57 6.75 6.74 6.67
GOMF_SPHINGOLIPID_BINDING 6.17 5.86 6.07 7.05 6.15 5.86 5.94 6.14 6.16 5.94 5.76 5.96 6.07 6.08 6.08 6.21 6.25 6.08 5.95 5.62 6.13 5.93 5.91 6.08 6.06 5.94
GOMF_VIRION_BINDING 4.6 4.55 4.51 4.86 4.24 4.17 4.62 3.86 4.21 4.12 4.78 4.74 4.21 3.88 4.36 4.28 4.66 4.84 4.33 4.4 4.4 4.14 4.13 3.96 4 4.44
GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.28 6.33 6.25 6.17 6.2 6.3 6.42 6.5 6.28 6.28 6.17 6.13 6.27 6.3 6.33 6.11 6.36 6.32 6.39 6.42 6.19 6.31 6.31 6.36 6.41 6.34
GOMF_EPHRIN_RECEPTOR_BINDING 7.44 7.74 7.48 7.47 7.36 7.95 7.69 7.72 7.37 7.94 7.6 7.86 7.95 7.98 7.99 7.55 7.35 7.44 7.77 8.04 7.13 7.54 7.47 7.83 7.69 7.83
GOMF_TETRAPYRROLE_BINDING 5.7 5.66 5.43 5.58 5.15 5.23 5.44 5.28 5.38 5.26 5.48 5.33 5.38 5.4 5.42 5.26 5.46 5.61 5.45 5.21 5.56 5.45 5.29 5.11 5.42 5.5
GOMF_TRANSITION_METAL_ION_BINDING 6.14 6.14 6.36 6.38 6.23 6.26 6.25 6.29 6.27 6.25 6.26 6.26 6.27 6.3 6.26 6.26 6.28 6.15 6.24 6.28 6.27 6.34 6.33 6.3 6.38 6.39
GOMF_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.84 7.03 7.2 7.25 7.2 7.43 6.95 7 7.33 7 7.02 6.99 7.2 7.35 6.74 6.81 7.26 6.85 7.23 7.14 6.97 7.04 7.19 7.45 7.11 7.05
GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY 6.02 6.2 6.1 5.96 5.89 6.2 6.01 6.1 6.08 5.64 6.09 6.02 5.77 6.24 6.15 5.69 5.3 6.14 6.45 6.33 5.56 5.84 6.42 6.34 6.11 6.1
GOMF_RETINOID_X_RECEPTOR_BINDING 6.47 6.71 6.96 7.03 7.23 6.55 6.7 6.88 6.62 6.61 6.66 6.79 7.34 7.29 6.82 6.73 6.39 6.49 6.37 6.69 6.65 6.37 6.78 6.32 6.46 6.82
GOMF_THYROID_HORMONE_RECEPTOR_BINDING 6.92 7.07 6.95 7.26 7.09 7.18 7.2 7.27 7.36 7.31 7.18 7.32 7.1 7.19 7.37 7.33 7.27 7.2 7.36 7.19 7.03 7.25 7.3 7.46 7.41 7.4
GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY_H3_K9_SPECIFIC 6.11 6.13 6.15 6.8 6.19 6.26 5.98 6.31 6.33 6.24 6.34 6.36 6.51 6.44 6.29 6.39 6.39 6.23 6.34 6.23 6.42 6.46 6.25 6.25 6.42 6.5
GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY 6.93 7.01 7.34 7.32 7.16 7.26 7.1 7.05 7.11 7.32 7.33 7.16 7.11 7.28 7.19 7.21 7.1 6.93 7.05 7.21 7.16 7.15 7.39 7.58 7.45 7.33
GOMF_PROTEIN_DIMERIZATION_ACTIVITY 6.54 6.54 6.84 6.83 6.62 6.76 6.78 6.85 6.84 6.78 6.71 6.78 6.87 6.87 6.76 6.74 6.73 6.6 6.67 6.88 6.71 6.86 6.96 6.99 6.94 6.84
GOMF_ACYLGLYCEROL_LIPASE_ACTIVITY 6.51 6.55 7.51 6.85 6.97 6.81 7.3 7.57 7.11 7.19 6.98 7.39 6.85 6.98 6.75 6.44 6.98 6.49 6.43 7.1 6.52 6.44 6.77 7.4 7.19 7.48
GOMF_PROTEIN_N_TERMINUS_BINDING 7.4 7.37 7.56 7.69 7.91 8 7.65 7.81 7.56 7.79 7.47 7.78 7.76 7.76 7.93 7.73 7.72 7.44 7.74 7.84 7.6 7.85 7.69 7.94 7.79 7.75
GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY 5.19 4.77 4.81 5 4.64 4.28 4.8 4.57 4.74 4.51 4.83 4.43 4.36 4.44 4.6 4.69 4.84 4.74 4.63 4.63 4.9 4.65 4.49 4.22 4.66 4.62
GOMF_3_5_CYCLIC_GMP_PHOSPHODIESTERASE_ACTIVITY 6.39 6.23 5.99 6.61 7.88 7.79 6.47 6.79 7.13 7.51 6.26 7 7.09 6.72 7.06 6.2 6.88 6.43 6.67 6.69 6.18 6.3 6.63 7.09 6.23 6.84
GOMF_ARACHIDONATE_COA_LIGASE_ACTIVITY 6.44 6.53 6.65 6.45 6.58 6.57 6.55 6.92 6.1 6.35 5.97 6.37 6.36 6.31 6.09 6.17 6.59 6.39 6.19 6.64 6.78 6.42 6.2 6.53 7.19 6.98
GOMF_RECEPTOR_ANTAGONIST_ACTIVITY 4.95 4.52 4.52 4.96 4.45 4.1 4.43 4.58 4.65 4.09 4.59 4.41 4.15 4.34 4.37 4.31 4.35 4.58 4.27 4.55 4.51 4.25 4.36 4.15 4.22 4.48
GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING 4.61 4.66 4.39 4.92 4.05 3.89 4.4 4.39 4.23 4.19 4.38 4.42 4.19 4.16 4.4 4.13 4.42 4.38 4.22 4.05 4.46 4.23 4.17 4.02 4.32 4.14
GOMF_MRNA_5_UTR_BINDING 7.52 7.34 8.04 7.54 7.56 7.63 7.54 7.59 7.73 7.67 7.9 7.51 7.57 7.59 8.09 8.18 7.36 7.13 7.78 7.83 7.21 7.7 7.81 7.87 8.19 7.82
GOMF_MONOSACCHARIDE_BINDING 6.19 6.28 6.46 6.7 5.9 5.88 6.28 6.35 6.37 6.38 6.56 6.49 6.2 6.36 6.49 6.38 6.21 6.13 6.33 6.28 6.34 6.29 6.26 6.17 6.48 6.61
GOMF_QUINONE_BINDING 7.04 7.03 7.18 7.35 7.25 7.2 6.62 6.2 6.68 7.59 6.99 7.17 6.77 7.07 6.59 7.15 6.71 6.61 7.54 6.93 6.73 6.51 6.9 7.02 6.64 6.93
GOMF_TAU_PROTEIN_BINDING 8.98 9.24 9.29 8.95 9.63 9.67 9.54 9.35 9.52 9.64 9.36 9.34 9.62 9.66 9.59 9.35 9.3 9.11 9.53 9.67 9.15 9.3 9.61 9.76 9.41 9.28
GOMF_ACTIVIN_BINDING 6.15 6.18 6.74 6.54 6.21 6.78 6.24 6.74 6.61 6.35 6.29 6.34 6.55 6.61 6.29 6.57 6.37 6.42 6.16 6.22 6.64 6.7 6.57 6.55 6.5 6.81
GOMF_CALCIUM_DEPENDENT_PROTEIN_BINDING 6.63 6.3 6.65 6.54 6.32 5.96 6.35 6.87 6.47 6.54 6.89 6.67 6.38 6.48 6.65 6.88 6.45 6.43 6.36 6.35 6.65 6.57 6.52 6.16 6.93 6.92
GOMF_PLATELET_DERIVED_GROWTH_FACTOR_BINDING 5.68 5.49 5.35 5.17 5.57 5.13 5.72 5.5 5.54 5.38 5.5 5.44 5.51 5.36 5.5 5.69 5.26 5.36 5.17 5.35 5.74 5.63 5.76 5.13 5.44 5.34
GOMF_BETA_TUBULIN_BINDING 8.08 8.13 8.83 8.74 8.4 8.45 8.45 8.52 8.6 8.45 8.51 8.46 8.67 8.55 8.72 8.8 8.05 8.41 8.32 8.48 8.26 8.48 8.71 8.88 8.33 8.38
GOMF_NUCLEOSIDE_MONOPHOSPHATE_KINASE_ACTIVITY 7.56 7.14 7.11 7.45 8.08 8.12 7.42 7.57 7.43 7.71 6.84 7.67 8.04 7.45 7.31 7.78 7.53 7.7 7.16 7.71 7.85 7.34 7.08 7.67 7.39 7.41
GOMF_TAU_PROTEIN_KINASE_ACTIVITY 8.52 8.55 8.32 8.17 8.74 8.67 8.84 8.85 8.54 8.76 8.3 8.74 8.82 8.75 9.07 8.75 8.63 8.9 8.93 8.94 8.58 8.62 8.66 8.73 8.67 8.67
GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING 6.01 6.18 6.64 6.44 6.79 6.42 6.18 6.53 6.44 6.18 6.34 6.28 6.55 6.08 6.2 6.57 6.6 6.42 6.16 6.27 6.67 6.7 7.09 6.5 6.6 6.81
GOMF_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING 6.21 6.19 6.65 6.41 6.31 6.47 6.36 6.38 6.21 6.3 6.26 6.4 6.51 6.39 6.17 6.53 6.44 6.27 6.48 6.15 6.32 6.45 6.2 6.37 6.38 6.42
GOMF_NADP_BINDING 6.82 6.79 7.4 7.18 7.13 7.11 6.95 7.04 7.09 7.25 7.02 7.09 7.07 7.01 7.19 6.87 7 6.87 7.28 6.99 6.85 6.8 7.24 7.34 6.97 6.97
GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR 5.03 4.89 5.02 4.76 4.48 4.61 4.72 4.79 4.73 4.49 4.87 4.75 4.68 4.72 4.63 4.74 5.05 4.96 4.58 4.91 5.07 4.84 4.55 4.51 4.61 4.79
GOMF_ANDROGEN_RECEPTOR_BINDING 7.09 7.19 7.13 6.93 7.39 7.41 7.38 7.31 7.3 7.56 7.1 7.37 7.22 7.24 7.47 7.53 7.27 7.14 7.25 7.48 7.11 7.3 7.31 7.5 7.41 7.53
GOMF_WW_DOMAIN_BINDING 6.37 6.28 7.11 6.79 6.3 6.01 6.48 7.23 6.57 6.61 6.79 6.72 6.53 6.11 7.13 6.92 6.72 6.65 6.1 6.43 6.87 7.18 6.85 6.74 6.79 7.05
GOMF_CARD_DOMAIN_BINDING 4.76 5.18 4.97 5.17 4.92 4.74 5.02 4.98 5.32 4.68 5.01 4.9 5.12 5.26 5.14 4.89 4.92 4.94 4.9 4.8 5.11 5.11 5.16 4.86 4.98 4.8
GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING 7.99 8.23 8.79 8.7 8.53 8.33 8.55 8.62 8.77 8.37 8.31 8.67 8.49 8.43 8.98 8.61 8.23 8.44 8.45 8.46 8.35 8.48 8.6 8.57 8.36 8.38
GOMF_DOPAMINE_RECEPTOR_BINDING 8.45 8.32 8.46 8.06 9.03 8.95 8.63 8.83 8.77 8.97 8.32 8.93 9.06 9.3 8.84 8.61 9.02 8.51 8.53 8.81 8.79 8.96 8.84 9.23 8.72 8.79
GOMF_GABA_RECEPTOR_BINDING 8.83 9.41 9.76 8.44 8.62 9.4 9.76 9.54 9.53 10.15 9.29 9.38 9.78 9.82 9.9 9.92 8.58 9.2 9.46 9.83 9.36 8.92 9.94 9.98 9.73 9.25
GOMF_CELL_ADHESION_MOLECULE_BINDING 7.01 7.06 7.23 6.99 7.36 7.41 7.45 7.34 7.34 7.33 7.23 7.34 7.42 7.37 7.39 7.31 7.25 7.14 7.27 7.37 7.31 7.47 7.41 7.49 7.41 7.42
GOMF_EXTRACELLULAR_MATRIX_BINDING 6.24 6.06 6.23 6.29 6.18 5.93 6.3 6.36 6.14 6.08 6.06 6.17 6.13 6.18 6.23 6.37 6.13 6.25 6.04 6.22 6.4 6.31 6.52 5.89 6.11 6.13
GOMF_QUATERNARY_AMMONIUM_GROUP_BINDING 7.15 7.29 7.04 6.48 6.54 6.95 7.01 7.34 6.92 7.04 7.14 7.46 6.85 7.05 7.13 7.43 7.18 7.38 7.29 7.37 7.45 7.08 6.75 6.93 7.28 7.37
GOMF_NITRIC_OXIDE_SYNTHASE_BINDING 6.95 6.71 7.91 7.44 7.54 7.4 7.76 7.39 7.69 7.82 8.14 7.86 7.5 7.64 7.5 7.24 8.05 7.33 7.71 7.8 8.12 7.83 8.22 8.27 8 7.3
GOMF_MICROTUBULE_PLUS_END_BINDING 8.87 9.04 9.05 8.67 9.21 9.26 9.32 8.92 9.66 9.4 8.83 9.23 9.52 9.38 9.1 9.43 9.11 9.25 8.89 9.28 8.9 8.96 9.39 9.57 9.15 8.91
GOMF_MICROTUBULE_MINUS_END_BINDING 7 7.26 7.43 7.36 7.56 7.23 7.34 7.7 7.77 7.61 6.89 7.9 7.66 7.46 7.57 7.24 6.94 7.07 7.31 7.56 7.69 7.76 7.23 7.74 7.49 7.72
GOMF_ACTIN_FILAMENT_BINDING 6.43 6.42 6.47 6.24 6.71 6.57 6.65 6.78 6.84 6.77 6.57 6.72 6.57 6.6 6.74 6.64 6.76 6.54 6.39 6.66 6.74 6.64 6.79 6.66 6.74 6.94
GOMF_PROTEIN_KINASE_A_BINDING 7.76 7.52 7.87 7.6 7.8 8.04 7.95 7.91 7.92 7.95 7.86 8.05 8.19 8.12 7.89 8.18 7.61 7.64 8.09 7.91 7.78 7.92 8.15 8.24 7.92 7.77
GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING 6.61 6.37 6.54 6.8 7.09 6.74 6.81 6.79 7.19 6.86 6.78 6.58 7.2 7.22 6.68 6.96 6.67 6.97 6.47 6.63 6.89 6.82 7.1 7.29 6.96 7.05
GOMF_GTPASE_BINDING 7.31 7.4 7.48 7.46 7.55 7.61 7.5 7.57 7.7 7.65 7.43 7.62 7.71 7.75 7.68 7.6 7.48 7.36 7.52 7.64 7.43 7.54 7.69 7.84 7.69 7.6
GOMF_NF_KAPPAB_BINDING 7.67 7.54 7.47 7.3 7.74 7.62 7.45 7.5 7.31 7.47 7.37 7.75 7.92 7.61 7.57 7.56 7.65 7.75 7.67 7.84 7.47 7.64 7.14 7.5 7.78 7.78
GOMF_UNFOLDED_PROTEIN_BINDING 7.11 7.03 7.9 7.52 7.32 7.26 7.42 7.52 7.36 7.67 7.7 7.45 7.33 7.46 7.82 7.77 7.35 7.19 7.24 7.25 7.43 7.53 7.79 7.83 7.48 7.45
GOMF_CHAPERONE_BINDING 6.94 6.78 7.56 7.43 7.01 6.95 7.12 7.3 7.02 7.17 7.17 7.27 7.24 7.31 7.3 7.31 7.05 6.92 6.91 7.13 7.1 7.23 7.21 7.37 7.18 7.07
GOMF_ATPASE_BINDING 7.19 6.93 7.45 7.35 7.67 7.56 7.52 7.34 7.58 7.57 7.51 7.7 7.81 7.71 7.49 7.47 7.51 7.44 7.43 7.61 7.57 7.75 7.83 7.92 7.65 7.4
GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.71 5.54 5.68 5.69 5.51 5.3 5.32 5.4 5.5 5.47 5.62 5.58 5.73 5.62 5.28 5.45 5.82 5.75 5.52 5.5 5.49 5.65 5.42 5.25 5.72 5.68
GOMF_METAL_ION_PROTON_ANTIPORTER_ACTIVITY 7.08 6.93 6.89 6.54 6.83 7.1 7.19 6.99 7.01 6.97 6.93 6.96 6.82 6.81 6.89 7.08 6.87 7.04 7.07 7.36 7.01 7.21 6.86 7.1 7.36 7.21
GOMF_DIOXYGENASE_ACTIVITY 6.39 6.56 6.4 6.57 6.62 6.57 6.39 6.43 6.4 6.47 6.24 6.58 6.46 6.5 6.54 6.29 6.51 6.33 6.62 6.36 6.67 6.61 6.5 6.46 6.62 6.58
GOMF_PHOSPHOPROTEIN_BINDING 6.9 7 7.12 7.14 7.2 7.21 6.9 7.22 7.31 7.16 7.2 7.24 7.24 7.44 6.88 7.09 7.07 6.79 7.1 7.08 7.02 7.16 7.23 7.28 7.31 7.24
GOMF_NAD_BINDING 7.25 7.42 8.42 7.86 7.93 7.81 7.51 7.67 7.94 7.78 7.72 7.67 7.77 7.82 7.86 7.91 7.73 7.39 7.69 7.87 7.54 7.53 8 8.13 7.67 7.8
GOMF_MUSCLE_ALPHA_ACTININ_BINDING 5.54 5.34 5.51 5.75 5.48 4.94 5.53 5.43 5.46 5.43 5.74 5.22 5.41 5.16 5.16 5.15 5.4 5.55 5.64 5.41 5.63 5.73 5.57 4.76 4.98 5.33
GOMF_ALPHA_ACTININ_BINDING 5.76 5.51 5.85 6.12 5.61 5.47 5.69 5.83 5.52 5.47 5.87 5.39 5.59 5.5 5.78 5.76 5.84 5.95 5.84 5.65 5.82 6.08 6.13 5.12 5.87 5.94
GOMF_HORMONE_RECEPTOR_BINDING 6.82 6.84 6.97 7.07 7.05 7.04 7.05 7.14 7.05 7.11 6.98 7.13 7.13 7.13 7.3 7.15 6.98 6.76 6.84 7.01 7.04 7.22 7.18 7.37 7.19 7.16
GOMF_PEPTIDE_HORMONE_RECEPTOR_BINDING 5.39 5.61 5.8 5.75 5.23 4.93 5.31 5.39 5.16 5.05 5.95 5.48 5.52 5.13 5.76 5.05 5.53 5.57 5.54 5.15 5.36 5.29 5.03 5.21 5.47 5
GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING 5.72 5.82 6.64 6.86 6.21 6.17 6.34 6.68 6.35 6.3 6.54 6.31 6.15 6.31 6.71 6.5 6.37 6.28 6.18 6.17 6.29 6.43 6.78 6.56 6.27 6.65
GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING 6.22 6.07 6.56 6.72 6.35 6.11 6.34 6.23 6.3 6.22 6.29 6.42 6.2 6.25 6.29 6.19 6.25 6.25 6.35 6.18 6.25 6.1 6.07 6.56 6.25 6.31
GOMF_METAL_CLUSTER_BINDING 6.14 6.03 6.56 6.72 6.3 6.11 6.34 6.47 6.16 6.29 6.29 6.39 6.17 6.25 6.38 6.21 6.28 6.25 6.34 6.18 6.29 6.26 6.16 6.43 6.21 6.31
GOMF_PROTEIN_PHOSPHATASE_2A_BINDING 7.46 7.35 7.35 7.26 7.78 7.72 7.31 7.58 7.66 7.66 7.26 7.68 7.62 7.91 7.51 7.58 7.55 7.42 7.49 7.47 7.67 7.4 7.65 7.78 7.5 7.47
GOMF_MISFOLDED_PROTEIN_BINDING 7.08 6.74 8.13 8.14 8.11 7.55 7.49 7.47 7.94 7.79 7.89 7.7 7.75 7.73 8.34 8.22 7.43 6.85 7.66 7.52 7.38 7.75 7.9 8.16 7.49 7.97
GOMF_GLYCOLIPID_BINDING 6.84 6.51 7.7 7.67 7.08 6.99 7.35 7.07 7.45 7.72 6.96 6.87 6.36 6.56 7.69 6.81 7.53 6.93 7.07 7.3 7.05 7.04 7.33 6.7 6.54 7.16
GOMF_HSP90_PROTEIN_BINDING 6.85 6.86 7.67 7.67 7.17 7.21 7.56 7.36 7.1 7.27 7.19 7.32 7.82 7.87 7.76 7.51 6.89 6.92 7.37 7.32 7.2 7.52 7.85 7.46 7.27 6.95
GOMF_DYNEIN_LIGHT_INTERMEDIATE_CHAIN_BINDING 5.49 5.68 5.58 5.7 5.64 5.72 5.64 5.74 5.5 6.14 5.75 5.83 5.75 5.49 6.03 6.35 5.8 6.23 5.81 5.72 5.91 5.92 5.5 5.7 5.62 5.75
GOMF_NADP_RETINOL_DEHYDROGENASE_ACTIVITY 5.9 6.3 6.45 6.41 6.33 6.16 6.64 6.23 6.07 6.26 6.33 6.23 6.41 6.19 5.87 6.55 6.1 5.67 6.01 6.11 6.17 6.28 6.18 6.26 6.17 6.22
GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY 6.2 6.17 6.38 6.51 6.13 6.31 6.23 6.33 6.21 6.2 6.38 6.39 6.3 6.37 6.3 6.34 6.31 6.23 6.06 6.36 6.19 6.28 6.2 6.44 6.35 6.26
GOMF_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY 7.68 7.63 7.46 8.57 8.18 8.44 7.67 7.31 7.96 8.12 7.49 7.9 8.03 8.02 7.73 7.67 7.5 7.39 7.92 7.55 7.15 7.41 8.15 8.17 7.54 7.76
GOMF_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY 8.25 7.83 8.35 7.93 8.37 8.42 8.34 8.16 8.67 8.24 8.11 8.02 8.44 8.39 8.27 8.37 7.95 7.97 8.42 8.18 7.95 8.27 8.54 8.84 8.2 8.11
GOMF_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY 6.69 6.74 6.76 6.89 7.12 6.89 6.96 7.42 7.24 7.05 6.96 7.14 7.34 7.2 7.34 7.08 7.17 6.69 6.89 7.03 7.04 7.2 7.49 7.2 6.74 7.06
GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY 7.32 7.53 7.41 7.61 7.56 7.86 7.7 7.63 7.7 7.92 7.44 7.67 7.9 7.7 7.5 7.59 7.56 7.48 7.67 7.57 7.43 7.72 8.01 8.14 7.81 7.73
GOMF_LIPASE_INHIBITOR_ACTIVITY 5.49 5.48 5.22 5.47 4.97 5.12 4.95 5.3 5.41 4.98 5.77 5.39 5.21 5.06 4.88 4.82 5.52 5.44 5.4 4.94 5.39 5.19 5 4.63 5.15 5.44
GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY 6.57 6.84 7.04 6.68 7.21 6.93 6.56 6.89 6.61 6.75 6.85 6.47 6.81 7.08 7.19 7.15 6.93 6.84 7.13 6.81 6.84 6.51 6.36 6.62 7.03 6.47
GOMF_MOLECULAR_TRANSDUCER_ACTIVITY 5.32 5.2 5 5.19 4.76 4.68 4.91 4.93 4.96 4.82 5.04 4.84 4.78 4.78 4.86 4.84 5.08 5.18 4.94 4.82 5.17 4.9 4.79 4.56 4.85 4.91
GOMF_MOLECULAR_ADAPTOR_ACTIVITY 6.94 7.04 7.3 7.1 7.32 7.35 7.35 7.42 7.29 7.36 7.27 7.27 7.26 7.33 7.29 7.27 7.14 7.16 7.21 7.44 7.22 7.33 7.28 7.38 7.47 7.37
GOMF_LIPASE_ACTIVATOR_ACTIVITY 6.86 6.78 6.72 6.84 7.18 6.92 6.53 6.66 6.66 7.22 6.7 6.94 7.02 6.89 6.95 6.79 6.98 7.03 6.48 6.59 7.29 7.26 6.96 6.87 6.87 7.19
GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY 6.96 7.15 7.38 7.04 7.39 7.48 7.33 7.4 7.33 7.43 7.25 7.43 7.47 7.53 7.41 7.42 7.27 7.28 7.25 7.44 7.27 7.52 7.39 7.59 7.42 7.36
GOMF_ATPASE_REGULATOR_ACTIVITY 7.26 7.33 7.79 7.52 7.47 7.52 7.5 7.6 7.78 7.6 7.77 7.65 7.86 7.87 7.6 7.75 7.42 7.3 7.29 7.61 7.54 7.91 7.95 7.83 7.74 7.64
GOMF_PEPTIDASE_REGULATOR_ACTIVITY 5.38 5.44 5.19 5.31 4.98 4.9 5.16 5.1 5.09 5.02 5.29 4.97 5.06 4.95 5.14 5.04 5.24 5.33 5.08 5.02 5.34 5.14 4.97 4.84 5.07 5.12
GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY 5.29 5.22 5.13 5.09 4.78 4.72 5.08 4.99 4.93 4.88 5.26 4.88 4.74 4.79 5.07 5.02 5.17 5.3 4.92 4.91 5.32 5.07 4.91 4.7 5.06 5.05
GOMF_NUCLEAR_IMPORT_SIGNAL_RECEPTOR_ACTIVITY 8.41 8.54 8.82 8.54 8.89 8.93 8.9 8.65 9.11 8.99 8.64 8.57 8.87 9.06 8.71 8.48 8.42 8.45 8.79 8.69 8.33 8.42 9.09 8.99 8.78 8.46
GOMF_RNA_POLYMERASE_II_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING 7.13 7.24 7.41 7.39 7.41 7.44 7.39 7.43 7.36 7.37 7.26 7.45 7.5 7.42 7.51 7.53 7.31 7.21 7.36 7.56 7.24 7.52 7.47 7.6 7.64 7.52
GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY 7.38 7.47 8.36 8.32 7.93 8.26 8.02 8.23 8 8.15 8.27 7.99 8.26 8.14 8.11 7.93 7.97 7.72 7.81 8.26 7.28 8.06 8.13 8.16 8.08 7.92
GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY 6.85 6.94 7.13 7.07 6.87 7 7.15 7.08 7.11 7.1 7 6.96 7.04 7.02 7.12 7.14 6.84 6.82 7.01 7.1 6.95 7.15 7.13 7.24 7.11 7.01
GOMF_PEPTIDE_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY 7.6 7.67 7.8 8.05 8.28 8.36 8.15 7.97 8.02 8.18 7.72 8.21 8.03 8.33 8.16 8.27 8.03 7.76 8.4 8.06 7.91 8.2 8 8.09 8.16 7.86
GOMF_PEPTIDOGLYCAN_MURALYTIC_ACTIVITY 4.63 4.42 4.34 4.24 4.24 3.98 4.06 4.19 4.22 4.08 4.29 4.1 4.05 4.28 4.12 3.99 4.36 4.47 4.14 4.02 4.26 4.27 4.15 3.81 4.14 4.25
GOMF_REGULATORY_RNA_BINDING 6.88 6.84 6.89 7.42 7.02 7.44 6.96 7.37 6.9 7.18 7.12 7.33 7.19 7.09 7.24 7.24 7.14 6.98 7.05 7.1 7.28 7.16 7.19 7.22 7.09 7.11
GOMF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY 6.17 6.14 6.41 6.8 6.15 6.32 5.93 6.38 5.99 6.26 6.32 6.2 6.06 6.46 6.21 6.57 5.99 6.22 6.29 6.02 5.88 6.18 6.5 6.35 6.21 6.06
GOMF_THREONINE_TYPE_PEPTIDASE_ACTIVITY 6.7 7.12 7.53 7.22 7.04 7.22 7.37 7.18 6.97 7.41 7.45 7.46 6.73 7.21 7.25 7.02 7.92 6.99 7.38 7.25 7.52 7.48 7.07 7.18 7.57 7.36
GOMF_METALLOAMINOPEPTIDASE_ACTIVITY 6.09 6.06 6.45 6.35 6.44 6.46 6.39 6.2 6.27 6.57 6.23 6.37 6.28 6.36 6.49 6.2 6.44 6.28 6.11 6.22 6.23 6.52 6.27 6.33 6.15 6.41
GOMF_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY 6.64 7.26 7 7.88 7.06 7.46 6.57 6.67 6.86 7.17 6.39 6.86 6.56 6.54 7.12 6.89 6.23 6.19 6.81 6.93 6.71 6.87 6.86 7.41 7.1 7.18
GOMF_TELOMERASE_RNA_BINDING 6.67 7.57 6.73 7.2 7.01 7.16 7.27 7.63 6.67 7.27 7.26 7.32 7.24 7.13 7.4 7.35 6.8 7.42 7.19 7.13 7.41 7.73 7.1 7.23 7.24 7.54
GOMF_RNA_POLYMERASE_BINDING 7.11 7.29 7.52 7.65 7.46 7.81 7.31 7.58 7.45 7.6 7.31 7.55 7.58 7.67 7.68 7.5 7.54 7.41 7.31 7.63 7.53 7.74 7.62 7.65 7.56 7.84
GOMF_PROLINE_RICH_REGION_BINDING 7.15 7.29 6.98 6.62 7.51 7.52 7.88 7.64 7.91 7.54 7.38 7.84 7.7 7.57 7.8 7.79 7.46 7.57 7.48 7.72 7.85 7.68 7.99 7.91 7.84 7.36
GOMF_ISOPEPTIDASE_ACTIVITY 7.67 7.69 8.5 8.5 7.94 8.34 7.58 7.7 7.6 7.94 7.73 8.06 7.82 8.03 7.66 7.77 7.58 7.4 8.11 8 7.42 7.8 8.04 8.26 7.93 7.72
GOMF_DNA_POLYMERASE_BINDING 6.13 6.22 6.2 6.39 5.91 6.43 6.69 6.98 6.5 6.6 6.48 6.08 6.5 6.11 6.5 6.71 6.48 6.42 6.01 6.68 6.47 6.58 6.87 6.72 6.66 6.43
GOMF_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING 6.36 6.41 7.6 6.92 6.6 6.7 6.61 6.62 6.74 6.62 6.71 6.84 6.96 6.95 6.98 6.92 6.38 6.9 6.8 6.34 6.62 7.05 6.88 6.64 6.75 7.02
GOMF_VITAMIN_B6_BINDING 6.05 6.18 6.75 6.29 6.27 6.13 6.36 6.27 6.03 6.37 6.53 6.3 6.55 6.22 6.2 6.05 6.27 6.05 6.21 6.71 6.65 6.63 5.8 6.07 6.44 6.44
GOMF_PHOSPHATIDIC_ACID_BINDING 7.86 8.04 7.77 7.47 8.57 8.58 8.52 8.32 8.53 8.25 7.94 8.46 8.51 8.64 8.3 8.33 8.11 8.05 8.49 8.52 8.21 8.05 8.3 8.8 8.4 8.3
GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING 7.43 7.96 8.64 8.62 8.3 8.24 8.38 8.1 8.52 8.23 8.12 8.16 8.45 8.33 8.34 8.52 7.77 8.37 8.41 8.37 7.1 8 8.19 8.55 8.1 7.93
GOMF_AROMATASE_ACTIVITY 5.23 5.07 4.47 4.8 4.18 4.03 4.46 4.65 4.44 4.13 4.57 4.52 4.35 4.14 4.57 4.46 4.77 5.01 4.73 4.4 5.13 4.6 4.15 4.19 4.35 4.51
GOMF_NADPH_BINDING 8.17 7.58 8.17 7.76 8.17 8.13 7.67 7.83 8.18 8.21 8 8.01 8.08 8.48 7.9 8.22 7.59 7.19 7.97 8.15 7.61 7.91 8 8.1 7.75 7.74
GOMF_NADPLUS_BINDING 6.67 6.55 7.47 7.7 6.55 6.78 6.94 7.07 6.88 7.3 7.54 7.33 7.24 7.13 7.14 7.41 6.47 6.7 6.33 7.17 6.91 6.7 7.33 7.27 6.91 6.96
GOMF_CO_SMAD_BINDING 6.09 7.24 6.23 6.16 7.37 7.46 6.51 6.05 6.51 5.8 6.22 5.31 7.14 7.27 7 6.74 6.7 7.55 7.29 6.82 6.38 6.12 7.42 7.3 6.29 5.8
GOMF_I_SMAD_BINDING 6.34 6.97 6.65 6.32 7.11 7.12 6.84 6.53 6.9 6.83 6.79 6.69 6.84 6.94 6.83 6.82 6.7 7.11 6.93 6.55 6.79 6.69 7.35 7.16 7.36 7.45
GOMF_R_SMAD_BINDING 7.6 7.56 7.62 7.26 8.15 7.81 7.89 7.82 8.12 7.88 7.55 7.89 7.99 8.23 8 8.2 7.84 7.65 8.15 7.97 7.77 7.98 8.09 8.22 7.99 7.98
GOMF_REPRESSING_TRANSCRIPTION_FACTOR_BINDING 6.92 6.99 7.55 7.28 7.44 7.52 7.15 7.18 7.22 7.45 7.26 7.39 7.37 7.48 7.3 7.4 7.11 7 7.2 7.52 7.07 7.08 7.29 7.42 7.26 7.35
GOMF_OLIGOSACCHARIDE_BINDING 4.61 4.51 4.32 4.53 3.99 3.92 4.08 4.25 4.1 4.01 4.37 4.17 4.18 3.79 4.08 4 4.44 4.64 4.32 3.98 4.29 3.87 3.99 3.94 4.32 4.22
GOMF_K63_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING 6 5.86 6.03 6.33 6.26 5.87 6.24 5.93 6.08 6.61 6.44 6.05 5.83 5.79 6.06 6.02 6.31 5.84 5.74 5.94 5.79 5.85 6.15 6.01 5.86 6.37
GOMF_ADENYLYLTRANSFERASE_ACTIVITY 6.2 6.18 6.34 6.18 6.26 6.17 6.35 6.33 6.19 6.33 6.37 6.46 6.09 6.03 6.54 6.31 6 5.89 5.9 6.45 6.15 6.09 6.27 6.24 6.33 6.36
GOMF_LYSINE_ACETYLATED_HISTONE_BINDING 7.31 7.85 7.24 7.21 7.91 8.18 7.93 7.89 7.73 7.96 7.25 7.85 8.25 8.19 8.09 7.65 7.86 7.76 7.82 7.99 7.56 7.8 7.85 8.16 8.03 8.25
GOMF_PROTEASOME_BINDING 7.8 7.76 8.32 8.33 8.34 8.14 8.34 8.09 8.16 7.91 8.12 8.13 7.99 7.93 8.2 8.01 7.91 7.95 8.36 8.55 7.94 8.21 8.18 8.15 8.09 8.08
GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING 7.08 6.58 6.19 6.1 7.67 7.66 7.04 7.05 7.51 7.38 6.89 7.37 7.92 7.97 7.41 7.11 7.21 7.16 7.13 6.96 7.11 7.15 7.96 7.82 7.35 6.99
GOMF_BMP_RECEPTOR_BINDING 5.32 5.18 5.57 5.91 5.2 4.91 5.24 5.06 5.35 4.88 5.76 4.97 5.07 4.98 5.23 5.04 5.27 5.76 4.99 4.95 5.26 5.25 4.95 5.18 5.11 5.31
GOMF_POLY_PURINE_TRACT_BINDING 7.18 7.19 7.74 7.6 7.53 8.11 7.74 7.94 7.64 7.71 7.44 7.57 7.98 7.89 7.64 7.65 7.54 7.01 7.66 7.74 7.5 7.43 7.94 8 7.77 7.8
GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING 7.17 7.5 6.32 6.83 7.73 7.31 7.2 7 7.23 7.11 7.3 7.18 7.15 7.52 6.77 6.76 6.95 6.77 7.22 7.4 6.69 7.05 7.05 7.05 6.88 6.89
GOMF_DYNEIN_COMPLEX_BINDING 7.32 7.43 7.97 7.49 8.33 8.13 7.91 8.31 7.82 7.91 7.8 7.91 8.27 8.13 8.1 8.05 7.38 7.16 7.5 7.78 8.34 8.52 8.3 7.9 8.26 8.14
GOMF_GROWTH_FACTOR_RECEPTOR_BINDING 5.93 5.68 5.77 6.04 5.64 5.48 5.72 5.58 5.73 5.41 5.75 5.38 5.69 5.54 5.82 5.53 5.79 5.82 5.44 5.62 5.81 5.74 5.46 5.47 5.69 5.78
GOMF_E_BOX_BINDING 5.62 5.51 5.74 6.32 5.63 5.68 5.44 5.74 5.93 5.67 5.65 5.43 5.76 5.47 5.92 5.78 6.04 5.52 5.4 5.69 5.99 5.83 5.82 5.88 5.68 5.97
GOMF_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY 7.3 7.37 8.15 8.01 7.97 8.15 7.65 7.62 8.06 7.73 7.67 7.32 7.9 7.7 7.73 7.79 7.4 7.45 7.47 7.75 7.46 8.02 7.89 8.09 8.03 7.97
GOMF_LIPOPEPTIDE_BINDING 5.4 4.97 4.77 4.68 4.66 4.24 4.24 4.53 4.72 4.43 4.52 4.31 4.46 4.41 4.45 4.61 4.3 4.71 4.89 4.52 4.54 4.28 4.23 4.34 4.83 4.92
GOMF_PROTEIN_LIPID_COMPLEX_BINDING 6.31 5.87 5.95 6.1 6.03 5.81 6.09 5.85 6.04 5.65 6.09 5.53 5.96 5.72 5.87 5.75 6.06 5.67 5.67 5.73 5.91 5.94 5.78 5.38 5.71 6.11
GOMF_HMG_BOX_DOMAIN_BINDING 5.89 5.98 6.03 5.74 5.8 5.97 6.41 6.08 6.19 6.21 5.83 5.62 6.74 6.67 6.05 6.61 6.25 6.15 6.08 6.43 6.09 6.48 6.69 5.69 6.02 6.15
GOMF_NEUROPEPTIDE_RECEPTOR_BINDING 5.54 5.59 5.68 5.79 5.02 4.84 5.28 5.29 5.24 5.13 5.66 5.48 4.96 5.19 5.32 5.09 5.18 5.57 4.92 5.17 5.5 5.29 5.19 4.79 4.98 5
GOMF_14_3_3_PROTEIN_BINDING 7.06 7.01 7.39 7.45 7.07 7.26 7.44 7.33 7.4 7.44 7.02 7.62 7.56 7.45 7.44 7.36 7.51 7.2 7.11 7.48 7.57 7.61 7.33 7.79 7.42 7.46
GOMF_ARP2_3_COMPLEX_BINDING 8.05 7.84 7.72 7.67 8.45 8.47 8.1 7.8 8.07 8.01 7.7 8.1 7.91 8.08 7.77 7.78 7.91 7.39 8.15 8.17 7.48 7.48 8.15 8.23 8.05 7.87
GOMF_FAD_BINDING 6.53 6.3 6.94 6.59 6.58 6.76 6.57 6.66 6.38 6.49 6.3 6.66 6.67 6.43 6.17 6.53 6.65 6.39 6.51 6.63 6.36 6.45 6.29 6.53 6.49 6.45
GOMF_MODIFIED_AMINO_ACID_BINDING 6.45 6.49 6.93 6.83 6.58 6.71 6.82 6.73 6.77 6.75 6.63 6.82 6.73 6.72 6.8 6.7 6.7 6.53 6.47 6.77 6.74 6.7 6.76 6.77 6.82 6.9
GOMF_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.42 6.55 6.39 6.71 6.23 6.43 6.73 6.49 6.3 6.33 6.41 6.24 6.56 6.47 6.2 6.22 6.22 6.53 6.66 6.6 6.53 6.7 6.35 6.45 6.56 6.38
GOMF_PROTEIN_PHOSPHATASE_ACTIVATOR_ACTIVITY 8.18 8.05 8.78 8.55 8.26 8.56 8.47 8.89 8.32 8.35 8.45 8.14 8.5 8.22 8.7 8.69 8.16 8.51 8.36 8.27 8.52 8.65 8.3 8.6 9.09 8.74
GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING 7.47 7.27 7.23 7.3 7.46 7.63 7.8 7.39 7.63 7.59 7.49 7.59 7.62 7.45 7.58 7.33 7.65 7.38 7.77 7.85 7.29 7.24 7.48 7.52 7.62 7.47
GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION 5.9 5.75 5.99 5.83 5.13 5.05 5.77 5.73 5.69 5.62 5.67 5.12 5.31 5.65 5.88 5.91 5.42 5.49 5.26 5.03 5.5 4.98 5.82 5.21 5.4 5.47
GOMF_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION 6.91 6.88 6.97 6.76 7.06 7.1 7.37 7.49 7.56 7.35 6.51 7.07 7.4 7.19 7.14 6.62 7.17 6.2 6.59 7.6 6.7 7.55 6.84 7.15 7.73 7.45
GOMF_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING 7.45 7.71 8.11 7.73 7.57 7.82 7.84 7.84 7.91 7.99 7.75 7.86 8 7.99 8.06 8.03 7.82 7.59 7.61 7.75 7.44 7.91 7.92 7.94 8.13 7.83
GOMF_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.18 6.38 6.09 6.65 5.96 6 6.19 6.21 6.03 5.97 5.89 6.24 5.85 6.07 6.09 6.17 6.22 5.9 5.88 6.1 6.05 5.78 6.08 6.11 6.23 6.17
GOMF_CERAMIDE_BINDING 6.35 6.3 6.82 7.34 6.21 5.96 6.47 6.93 6.45 6.33 6.55 6.25 6.36 6.4 6.78 6.51 6.4 6.65 6.1 6.03 6.97 6.71 6.42 6.7 6.42 6.39
GOMF_SCAFFOLD_PROTEIN_BINDING 7.41 7.55 7.84 7.64 7.92 8.01 7.67 7.74 8.04 7.8 7.7 7.91 7.96 8.16 8.08 7.91 7.82 7.99 8.03 8.11 7.6 7.62 8.13 8.31 7.87 7.91
GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS 4.73 5.03 4.93 4.81 4.38 4.33 4.25 4.39 4.47 4.33 4.93 4.48 4.15 4.15 4.52 4.4 4.92 4.92 4.7 4.61 5.07 4.59 4.36 4.29 4.58 4.67
GOMF_PRE_MRNA_INTRONIC_BINDING 8.18 8.22 7.92 7.45 8.71 8.99 7.94 7.83 7.61 8.31 7.82 8.1 8.55 8.24 8.05 8.14 8.16 8.22 8.5 7.93 8.2 8.25 8.06 8.23 8.48 8.15
GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY 4.75 5.16 4.78 4.83 4.52 4.33 4.21 4.46 4.43 4.23 4.81 4.81 4.29 4.14 4.42 4.57 5.04 4.95 4.79 4.6 5.09 4.54 4.4 4.32 4.51 4.77
GOMF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY 7.84 8.13 8.07 7.96 8 8.07 8.01 7.73 8.11 8.29 8.32 7.96 8.14 8.16 8.25 8.45 7.89 7.92 7.99 8.19 7.86 8.34 8.07 8.43 8.1 8.11
GOMF_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY 6.12 5.98 5.65 5.95 6.3 6.11 5.87 5.72 5.72 6.31 5.61 6.3 5.91 5.83 6 6.07 6 5.64 6.12 6.07 5.9 5.74 6.12 5.49 6.08 5.98
GOMF_CULLIN_FAMILY_PROTEIN_BINDING 7.48 6.96 7.77 7.83 7.29 7.83 7.5 7.52 7.37 7.57 7.78 7.37 7.7 7.44 7.65 7.32 6.8 7.26 7.48 7.37 7.51 7.24 7.77 7.74 7.54 7.31
GOMF_ANNEALING_ACTIVITY 6.04 5.98 5.75 5.68 6.45 6.57 6.03 6.34 5.75 5.78 5.94 5.99 5.87 6.07 5.73 6.23 6.03 5.24 5.9 6.47 6.11 6.29 6.12 6.41 5.84 6.99
GOMF_DISORDERED_DOMAIN_SPECIFIC_BINDING 8.38 8.41 8.78 8.32 8.91 9.01 8.79 8.61 9.14 8.96 8.63 8.85 9 8.85 8.89 8.76 8.82 8.48 8.67 8.8 8.72 8.76 9.16 9.1 8.88 9.11
GOMF_RNA_POLYMERASE_ACTIVITY 6.84 6.91 7.27 7.78 6.82 7.02 7.06 7.24 7.16 7.22 6.99 7.28 7.21 7.25 7.37 7.12 7.09 7.15 7.03 7.49 6.88 7.16 7.37 7.74 7.33 7.22
GOMF_LIGAND_ACTIVATED_TRANSCRIPTION_FACTOR_ACTIVITY 6.31 6.38 6.29 6.48 6.09 6.26 6.01 6.36 6.45 6.25 6.13 6.02 6.72 6.73 6.76 6.44 6.22 6.06 6.25 6.54 6.4 6.5 6.4 6.39 5.87 6.25
GOMF_CELL_ADHESION_MEDIATOR_ACTIVITY 6.37 6.27 6.27 6.36 6.43 6.45 6.72 6.61 6.57 6.2 6.5 6.46 6.44 6.38 6.27 6.41 6.54 6.21 6.35 6.45 6.63 6.47 6.79 6.54 6.64 6.66
GOMF_CELL_CELL_ADHESION_MEDIATOR_ACTIVITY 6.8 6.67 6.6 6.52 6.75 6.61 7.17 7.18 6.73 6.92 6.51 6.71 6.86 6.63 7.04 6.62 6.66 6.41 6.91 6.91 6.7 6.77 7.02 7.01 7.25 7.17
GOMF_CADHERIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION 6.95 6.74 6.64 6.49 7.15 6.84 7.16 7.15 6.82 6.76 6.97 7.06 7.06 6.76 7.02 6.98 6.88 7.13 6.96 7.12 6.82 6.97 6.93 7.26 7.27 7.12
GOMF_SEQUENCE_SPECIFIC_SINGLE_STRANDED_DNA_BINDING 7.65 8 8.29 7.9 8.01 8.16 8.45 8.22 8.14 7.85 8.08 7.93 7.99 7.91 7.88 7.78 7.96 7.61 8.01 8.31 8.1 8.26 8.1 8.62 8.37 8.42
GOMF_STRUCTURAL_CONSTITUENT_OF_SYNAPSE 8.83 8.86 8.17 7.74 9 9.4 9.07 8.93 8.39 9.29 8.42 9.01 9.09 9.01 9.21 8.81 8.37 9.05 9.24 9.07 8.69 9.16 8.9 9.14 9 8.7
GOMF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY 6.53 6.8 6.57 6.74 6.39 6.7 7.02 7.01 6.86 7.03 6.27 6.32 6.79 6.74 7.32 6.26 6.48 6.64 6.77 6.63 6.55 6.5 6.44 6.67 6.62 6.61
GOMF_LIGAND_GATED_CATION_CHANNEL_ACTIVITY 5.47 5.51 5.38 5.59 5.35 5.22 5.63 5.38 5.63 5.51 5.49 5.39 5.32 5.39 5.65 5.22 5.58 5.41 5.16 5.32 5.45 5.42 5.37 5.23 5.41 5.31
GOMF_LIGAND_GATED_ANION_CHANNEL_ACTIVITY 8.69 9.23 9.83 9.51 8.74 9.58 9.81 9.54 9.88 9.92 9.41 8.73 9.32 9.48 9.86 9.53 8.33 8.83 9.46 9.33 8.43 8.89 9.74 9.66 9.01 8.65
GOMF_ION_CHANNEL_REGULATOR_ACTIVITY 7.03 7.11 7.26 7.06 7.27 7.21 7.08 7.03 7.09 7.24 7.34 7.24 7.19 7.28 7.13 7.12 7.21 6.98 7.34 7.1 7.1 7.15 7.29 7.28 7.46 7.23
GOMF_G_PROTEIN_COUPLED_NEUROTRANSMITTER_RECEPTOR_ACTIVITY 6.55 7.08 7.07 7.15 6.57 7.28 7.46 8.07 7.18 7.36 6.83 7.24 7.53 7.56 8.08 7.73 7.04 7.58 7.45 7.45 7.96 8.4 7.27 7.74 7.46 7.88
GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY_INVOLVED_IN_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL 6.52 6.65 6.51 6.76 6.38 6.71 7.2 6.98 7.1 7.11 6.21 6.3 6.79 6.89 7.33 6.11 6.64 6.67 6.57 6.64 6.72 6.67 6.4 6.7 6.47 6.73
GOMF_SEROTONIN_RECEPTOR_ACTIVITY 5.25 5.39 5.12 5.06 4.69 4.8 5.2 5.56 5.05 5.43 4.98 5.14 5.08 5.1 5.41 5 5.22 5.14 5.28 5.35 5.62 5.41 5.29 5.29 5.35 5.5
GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY 6.38 6.42 7.6 6.98 6.46 6.29 6.5 6.69 6.27 6.77 7.12 6.78 6 6.49 6.92 6.98 6.89 6.39 6.44 6.43 6.55 6.91 6.44 6.38 7.04 6.9
GOMF_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY 6.12 6.02 5.62 6 6.35 6.34 6.38 6.59 6.2 6.27 5.87 6.51 6.27 6.37 6.39 6.12 6.42 6.39 6.48 6.61 6.58 6.38 6.18 6.24 6.51 6.74
GOMF_PHOSPHOLIPASE_A2_ACTIVITY_CONSUMING_1_2_DIPALMITOYLPHOSPHATIDYLCHOLINE 5.31 5.08 5.02 5.2 4.73 4.43 4.85 4.67 4.83 4.65 5.09 4.52 4.49 4.6 4.7 4.89 4.87 4.9 4.74 4.66 5.08 4.75 4.65 4.3 4.8 4.79
GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY 6.74 7.13 6.6 7.57 7.32 6.98 7.41 7.6 7.64 7.29 7.4 7.25 7.34 7.32 7.48 7.16 7.22 6.91 6.96 7.33 7.05 7.13 7.49 7.63 7.52 7.72
GOMF_PROTEIN_SERINE_PHOSPHATASE_ACTIVITY 7.08 7.15 7.55 7.53 7.28 7.23 7.31 7.37 7.27 7.3 7.24 7.08 7.4 7.48 7.36 7.23 7.21 7.18 7.15 7.41 7.36 7.31 7.32 7.44 7.19 7.14
GOMF_PROTEIN_SERINE_KINASE_ACTIVITY 6.89 6.86 7.14 7.02 7.31 7.29 7.07 7.23 7.02 7.24 7.12 7.21 7.3 7.2 7.18 7.19 7.26 7.18 7.06 7.2 7.09 7.24 7.35 7.43 7.23 7.28
GOMF_LIPID_TRANSFER_ACTIVITY 6.87 6.59 7 6.57 6.45 6.95 7.35 7.36 6.45 7.04 6.55 7.03 6.81 7.06 7.1 6.73 6.54 7.17 6.95 6.96 7.34 7.52 6.76 7 7.01 7.18
GOMF_PHOSPHOLIPID_TRANSFER_ACTIVITY 7.07 6.94 7.39 7.22 6.91 7.3 7.57 7.76 6.82 7.71 6.92 7.72 7.46 7.64 7.81 7.65 6.74 7.62 7.13 7.45 7.83 7.87 7.23 7.94 7.57 7.65
GOMF_STEROL_TRANSFER_ACTIVITY 6.74 6.76 6.65 6.4 6.63 6.81 6.73 6.61 6.3 6.42 6.51 6.32 6.6 6.78 6.45 6.27 6.77 7.06 7.06 6.47 6.82 6.71 6.13 6.52 6.78 6.91
GOMF_ACYL_COA_BINDING 6.58 6.82 7.52 7.44 6.95 6.76 6.89 6.99 6.79 7.25 7.03 6.8 6.9 7.23 6.63 6.93 7.1 6.76 7.09 6.72 6.5 6.91 7.02 6.87 6.98 7.3
GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING 6.68 6.74 6.64 6.89 6.85 6.95 6.66 6.83 6.83 6.99 6.76 6.96 6.83 6.81 6.84 6.82 6.83 6.72 6.93 6.9 6.77 6.94 7.01 7.08 6.8 6.89
GOMF_UBIQUITINATION_LIKE_MODIFICATION_DEPENDENT_PROTEIN_BINDING 6.98 7.29 7.27 6.83 7.14 7.4 6.79 7.14 6.56 7.36 6.6 7.07 6.87 6.67 6.98 7 6.79 6.94 7.08 7.02 7.16 7.04 7.13 7.18 7.08 7.47
GOMF_UBIQUITIN_DEPENDENT_PROTEIN_BINDING 7.37 7.59 7.35 7.17 7.54 7.65 7.05 7.45 7.11 7.84 7.1 7.56 7.23 7.2 7.44 7.75 7.26 7.07 7.23 7.52 7.56 7.47 7.3 7.45 7.57 7.79
GOMF_CATALYTIC_ACTIVITY_ACTING_ON_DNA 6.05 6.06 6.28 6.32 5.96 6.2 6.03 6.09 6.04 6.14 6.12 6.02 6.04 5.99 6.1 6.1 6.02 6.04 6.03 6.09 6.01 6.06 6.06 6.24 6.14 6.22
GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA 6.58 6.59 6.98 6.97 6.7 6.76 6.65 6.78 6.66 6.81 6.78 6.67 6.79 6.81 6.64 6.74 6.55 6.59 6.74 6.75 6.53 6.62 6.81 6.82 6.7 6.81
GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA 6.32 6.14 6.79 6.81 6.39 6.45 6.41 6.38 6.43 6.39 6.43 6.35 6.55 6.45 6.38 6.43 6.21 6.25 6.52 6.42 6.33 6.4 6.49 6.49 6.42 6.44
GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_RRNA 6.5 6.83 7.25 7.35 7.15 7.25 6.67 6.75 7.05 6.79 7.15 6.83 7 7.04 6.35 6.51 6.67 6.73 6.99 6.82 6.54 6.63 6.8 7.04 6.75 6.78
GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_GLYCOPROTEIN 6.25 6.21 6.42 6.64 6.61 6.4 6.33 6.52 6.38 6.58 6.51 6.55 6.77 6.57 6.58 6.72 6.55 6.35 6.56 6.31 6.44 6.58 6.53 6.73 6.46 6.77
GOMF_MOLECULAR_CARRIER_ACTIVITY 7.85 7.74 8.3 8.39 7.73 7.85 8.26 7.87 8.42 8.41 8.05 7.88 8.1 8.08 8.2 8.37 7.69 7.71 8.06 8.04 7.48 7.73 8.25 8.39 7.82 7.91
GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY 6.02 6.08 6.05 6.18 5.99 6.02 6.02 6.08 6.06 6.02 6.08 6.04 6.08 6.01 6.05 6.01 6.1 6.03 5.99 6.02 6.08 6.15 6.07 6.02 6.02 6.13
GOMF_NUCLEOCYTOPLASMIC_CARRIER_ACTIVITY 8.41 8.48 8.77 8.54 8.89 8.93 8.82 8.42 9.11 8.96 8.58 8.57 8.87 9.06 8.71 8.45 8.42 8.45 8.79 8.69 8.33 8.42 8.82 8.99 8.55 8.27
GOMF_MONOCARBOXYLATE_SODIUM_SYMPORTER_ACTIVITY 6.73 6.6 7.13 6.45 6.37 6.54 7.43 7.21 6.8 7.06 6.48 6.33 6.79 7.07 6.38 6.53 6.55 6.64 6.53 6.98 7.16 6.96 6.72 6.32 6.8 6.61
GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY 6.57 6.77 7.49 7.26 6.96 6.89 6.91 7.21 6.95 6.92 6.94 6.93 6.85 6.86 7.14 7.15 6.88 7.02 6.87 7.18 6.78 7.19 7.01 7.08 7.26 7.23
GOMF_EXOGENOUS_PROTEIN_BINDING 6.17 5.82 5.84 5.82 6.1 5.86 5.91 6.29 6.15 6.12 5.92 5.52 6.22 6.29 6 6.1 6.14 5.98 5.81 5.96 6.13 6.07 6.28 5.92 5.92 6.25
GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING 6.64 6.9 7.97 7.33 7.39 7.58 7.32 7.28 7.56 7.6 7.7 7.76 8.02 7.85 7.55 7.54 6.88 6.78 7.35 7.62 6.98 7.25 7.56 7.75 7.53 7.52
GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING 6.86 7.02 7.18 7.16 7.16 7.18 7.17 7.16 7.21 7.17 7.11 7.18 7.31 7.21 7.27 7.33 7.12 6.98 7.06 7.27 7.12 7.25 7.25 7.4 7.33 7.35
GOMF_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY 6.59 6.6 6.4 6.41 7.14 6.98 6.58 6.47 6.64 6.62 6.56 6.66 6.84 6.94 6.15 6.55 6.54 6.58 6.45 6.41 6.52 6.61 6.47 6.34 6.98 7.15
GOMF_CARGO_ADAPTOR_ACTIVITY 8.39 8.33 7.94 7.62 8.43 8.52 8.51 8.48 8.54 8.34 7.8 8.62 8.59 8.62 8.17 7.9 8.01 7.97 8.29 8.56 8.42 8.45 7.95 8.49 9.2 8.74
GOMF_PROTEIN_TRANSPORTER_ACTIVITY 6.69 6.84 8.05 7.3 7.42 7.74 7.43 7.63 7.47 7.39 7.62 7.35 7.27 7.2 7.49 7.82 7.27 6.97 7 7.51 7.04 7.91 7.6 7.78 7.4 7.62
GOMF_SOLUTE_ANION_ANTIPORTER_ACTIVITY 5.95 5.76 5.41 5.86 5.49 5.3 5.21 5.31 5.35 5.42 5.48 5.05 5.21 5.31 5.21 5.31 5.66 5.37 5.23 5.14 5.49 5.13 5.34 4.92 5.36 5.58
GOMF_ATPASE_COUPLED_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY 6.63 6.67 6.46 6.45 7.27 7.13 6.77 6.94 6.91 6.85 6.57 6.91 6.9 7.04 6.39 6.63 6.79 6.75 6.58 6.54 6.64 6.71 6.88 6.8 7.02 7.22
GOMF_FLIPPASE_ACTIVITY 6.54 6.54 6.39 6.4 7.37 7.01 6.53 6.52 6.82 6.63 6.57 6.52 6.65 7.1 6.11 6.43 6.45 6.4 6.58 6.36 6.52 6.45 6.52 6.54 6.96 6.95
GOMF_GLYCEROPHOSPHOLIPID_FLIPPASE_ACTIVITY 6.42 6.54 6.39 6.4 7.37 7.01 6.53 6.52 6.82 6.38 6.57 6.51 6.65 6.99 6.11 6.32 6.45 6.06 6.4 6.3 6.52 6.45 6.28 6.54 6.96 6.95
GOMF_ABC_TYPE_TRANSPORTER_ACTIVITY 6.12 6.16 6.03 6.26 6.39 6.23 6.27 6.01 5.9 6.06 6.28 6.18 6.13 6.25 5.99 6.11 6.05 6.03 6.36 6.21 6.16 6.3 6.07 6.01 6.41 6.15
GOMF_IMMUNE_RECEPTOR_ACTIVITY 5.24 5.05 4.92 5.15 4.7 4.65 4.98 4.89 4.9 4.84 4.97 4.74 4.72 4.65 4.85 4.82 5.09 5.1 4.76 4.76 5.08 4.93 4.82 4.53 4.82 4.96
GOMF_TRANSCRIPTION_REGULATOR_INHIBITOR_ACTIVITY 5.72 5.66 5.22 5.39 5.59 5.61 5.61 5.44 5.9 5.46 5.63 5.51 5.53 5.66 5.59 5.92 5.83 5.84 5.84 5.64 5.95 6.03 5.64 5.41 5.87 5.93
GOMF_PROTEIN_DEMETHYLASE_ACTIVITY 6.79 6.85 6.41 6.67 7.41 7.22 6.97 7.09 6.98 7 6.6 7.08 7.24 7.23 6.97 6.88 6.88 6.66 7.2 6.99 6.82 6.99 7.09 7.25 6.9 7.21
GOMF_OLIGOPEPTIDE_BINDING 6.89 7.2 8.77 8.44 7.11 7.72 7.68 7.3 7.29 7.72 7.22 7.56 7.55 7.59 7.26 7.33 6.78 6.89 6.76 7.94 7.43 7.63 7.56 7.49 8.47 8.53
GOMF_CATECHOLAMINE_BINDING 5.99 5.99 6.39 6.33 5.73 5.93 6.5 5.8 6.23 6.11 6.14 5.9 5.85 5.79 5.76 6.08 5.77 5.88 5.51 6.14 5.79 5.96 5.9 5.72 6.39 5.87
GOMF_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.71 5.64 5.81 5.87 5.63 6 5.45 5.53 5.65 5.54 5.64 5.51 5.85 5.74 5.63 5.43 5.54 5.3 5.64 5.59 5.56 5.56 5.5 5.97 5.81 6.17
GOMF_CARBOHYDRATE_DERIVATIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.73 5.97 5.86 6.02 5.71 5.77 5.88 6.08 5.9 6.07 5.7 5.57 5.72 5.84 5.99 5.69 5.84 5.87 5.79 6.01 6.07 6.03 5.61 5.71 6.01 5.85
GOMF_FATTY_ACID_DERIVATIVE_BINDING 6.4 6.55 7.35 7.21 6.73 6.75 6.62 6.78 6.72 6.99 6.86 6.76 6.9 7 6.57 6.85 6.99 6.51 6.93 6.69 6.45 6.85 6.81 6.79 6.89 7.16
GOMF_PHOSPHATIDYLGLYCEROL_BINDING 7.22 7.7 8.68 7.16 6.65 7.56 8.1 8.5 7.8 7.96 7.87 8.58 8.03 7.72 8.4 8.34 8.19 8.33 7.63 8.04 7.64 8.64 7.59 6.93 8.57 8.57
GOMF_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.27 5.16 4.86 5.43 4.6 4.41 4.86 4.69 4.81 4.48 5.02 4.81 4.77 4.77 4.72 4.87 4.84 5.26 4.8 4.78 5.07 4.58 4.77 4.51 4.67 4.73
GOMF_SULFUR_COMPOUND_BINDING 6.07 6.04 6.12 6.08 6.13 5.99 5.81 6.01 5.98 5.96 6.04 5.91 5.84 5.87 6 6.02 6 5.96 5.87 5.77 5.99 6.15 6.12 5.9 5.91 5.98
GOMF_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.95 5.92 5.61 5.87 5.64 6.01 5.58 5.67 5.65 5.67 5.61 5.65 5.66 5.93 5.63 5.52 5.7 5.64 5.76 5.59 5.82 5.56 5.51 5.72 5.76 6.04
GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING 6.63 6.64 7.08 6.83 7.06 7.05 6.97 6.97 7.02 7.13 6.89 7.07 7.11 7.1 7.07 7.03 6.99 6.75 7.02 7.04 6.97 6.94 7.18 7.38 7.07 7.07
GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION 5.35 5.1 5.04 5.41 5 4.98 5.17 5.16 5.23 4.89 5.11 5.07 5.02 4.89 5.02 5.11 5.29 5.19 4.94 4.93 5.1 4.87 5.47 4.85 5.04 5.37
GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING 6.42 6.64 6.78 6.67 7.02 6.91 6.79 6.96 6.89 7.08 6.82 7.1 7.03 6.68 6.94 6.74 7.07 6.58 6.71 6.86 6.82 6.82 6.97 7.18 7.07 7.06
GOMF_S_ADENOSYL_L_METHIONINE_BINDING 6.21 6.56 6.65 7.38 6.82 7.21 7.45 7.2 7.11 7.05 6.42 7.16 7.48 7.44 7.38 6.65 6.99 6.97 6.65 6.77 7.04 7.33 6.88 7 6.81 7.08
GOMF_PEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.92 7.31 7.8 7.26 7.37 7.8 7.23 7.76 7.36 7.43 7.54 7.41 7.69 7.46 7.48 7.8 7.43 6.94 7.28 7.46 7.3 7.75 7.52 7.78 7.69 7.7
GOMF_UBIQUITIN_SPECIFIC_PROTEASE_BINDING 8.21 8.64 8.65 8.67 8.74 8.52 9.17 9.31 8.91 8.81 8.29 8.9 8.81 8.87 8.92 8.67 8.62 8.34 8.43 9.14 8.59 8.33 8.86 8.8 9.01 8.75
GOMF_PROTEIN_ADP_RIBOSYLASE_ACTIVITY 7 6.99 7.37 6.55 7.32 7.08 7.22 6.96 7.18 6.97 6.86 7.01 7.2 7.23 6.85 6.9 7.39 7.06 6.86 7.22 6.97 7.03 7.18 7.12 7.45 7.03
GOMF_TRANSFERRIN_RECEPTOR_BINDING 7.3 7.55 8.28 7.51 7.85 7.67 8.05 7.53 7.84 8.02 7.7 7.99 8.24 8.06 7.74 7.74 8.24 7.33 7.41 7.74 7.12 7.51 8.38 7.8 7.93 7.86
GOMF_UBIQUITIN_LIGASE_SUBSTRATE_ADAPTOR_ACTIVITY 6.88 6.81 6.8 7.03 7.1 7 7.05 6.83 6.73 7.38 7.17 6.96 7.39 7.28 7.01 6.74 6.79 6.98 7.05 7.36 6.85 7.3 6.83 6.96 6.88 7.17
GOMF_PROTEIN_TYROSINE_KINASE_BINDING 6.83 6.71 7.07 7.05 7.15 6.96 6.78 6.79 6.7 7.04 6.95 6.89 6.85 7.07 6.77 6.91 7.01 6.96 6.9 6.92 6.85 6.99 6.95 6.82 7.02 7.06
GOMF_SEQUENCE_SPECIFIC_MRNA_BINDING 7.44 7.61 7.63 7.48 8.45 8.12 8.02 8.04 8.52 8.54 7.98 8.47 8.1 8.1 8.18 8.51 7.98 7.45 7.87 8.03 7.75 7.91 8.58 8.63 8.13 8.15
GOMF_PROMOTER_SPECIFIC_CHROMATIN_BINDING 6.83 6.61 7.13 7.33 7.08 6.79 7.15 7.24 7.11 7.07 6.95 7.08 7.1 7.09 7.26 7.22 7.25 6.89 6.93 6.95 6.91 6.98 6.97 7.26 7.11 7.37
GOMF_ATP_DEPENDENT_MICROTUBULE_MOTOR_ACTIVITY 5.52 5.38 5.1 5.52 5.44 5.09 5.45 5.42 5.25 5.79 5.33 5.78 5.04 5.21 5.52 5.73 5.69 5.81 5.39 5.52 5.83 5.39 4.91 5.33 5.42 5.77
